<SEC-DOCUMENT>0001140361-24-013254.txt : 20240314
<SEC-HEADER>0001140361-24-013254.hdr.sgml : 20240314
<ACCEPTANCE-DATETIME>20240314163643
ACCESSION NUMBER:		0001140361-24-013254
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		113
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240314
DATE AS OF CHANGE:		20240314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eterna Therapeutics Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		24750797

	BUSINESS ADDRESS:	
		STREET 1:		1035 CAMBRIDGE STREET
		STREET 2:		SUITE 18A
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		10531 4S COMMONS DRIVE
		STREET 2:		SUITE 166-550
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Brooklyn ImmunoTherapeutics, Inc.
		DATE OF NAME CHANGE:	20210325

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ef20015352_10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:erna="http://eternatx.com/20231231" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="background-color: #ffffff; color: #000000;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_629cc0c7d07b4e578787a6de4aa918a0" contextRef="c20230101to20231231" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_99e4d27530914e4bbc045d6727e85b94" contextRef="c20230101to20231231" format="ixt:date-month-day">12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="Fact_60d02b68a361407c944f1e068a03541a" contextRef="c20230101to20231231">2023</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="Fact_0c3de09103e447dfb2642e4d0c1cbf35" contextRef="c20230101to20231231">FY</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_960200065d13403f95244e3870700475" contextRef="c20230101to20231231">0000748592</ix:nonNumeric><ix:nonNumeric name="erna:NumberOfConsecutiveTradingDays" id="Fact_35ada709acde4da985c53db06fba5394" contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">P10D</ix:nonNumeric><ix:nonNumeric name="erna:NumberOfConsecutiveTradingDays" id="Fact_fe2e977747fa41309cc95a33766e6e30" contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">P10D</ix:nonNumeric><ix:nonFraction name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" id="Fact_1686a4286739492e851a84f95f37d027" contextRef="c20230101to20231231" unitRef="U001" decimals="-5">500000</ix:nonFraction><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_5269f7037c524c0e8f946b93d07e4c92" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">P5Y6M</ix:nonNumeric><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_e3ad1a6b59fa4c388062e2bab91b442b" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember">P5Y6M</ix:nonNumeric><ix:nonNumeric name="us-gaap:OpenTaxYear" id="Fact_27587e86962c450fb8de5335527ed5c8" contextRef="c20230101to20231231">2020 2021 2022 2023</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_a18828d7e3b54c4d80f7f0a71c4d08d7" contextRef="c20230101to20231231">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:AuditorFirmId" id="Fact_bb4f95767a444ec094e91a06596f509d" contextRef="c20230101to20231231">248</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="erna-20231231.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20230101to20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20240312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231001to20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230430_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_LegalEntityAxis_LincolnParkCapitalFundLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240101to20240131_ShortTermDebtTypeAxis_ConvertibleDebtMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230701to20231231_ShortTermDebtTypeAxis_ConvertibleDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">erna:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationThreeMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230401to20230430_RangeAxis_MaximumMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230426_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230426_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230426_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230426_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230426_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230221to20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-21</xbrli:startDate><xbrli:endDate>2023-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_TimingOfTransferOfGoodOrServiceAxis_TransferredOverTimeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_DebtInstrumentAxis_December2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20240131_DebtInstrumentAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_ClassOfWarrantOrRightAxis_December2023WarrantsMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:December2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_DebtInstrumentAxis_December2022ConvertibleNotesMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2022ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_ClassOfWarrantOrRightAxis_July2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714to20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-14</xbrli:startDate><xbrli:endDate>2023-07-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231214to20231214_LongtermDebtTypeAxis_ConvertibleDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-14</xbrli:startDate><xbrli:endDate>2023-12-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_DebtInstrumentAxis_July2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_DebtInstrumentAxis_December2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodOneMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodTwoMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodTwoMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodThreeMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodOneMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_DebtInstrumentAxis_December2022ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2022ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_DebtInstrumentAxis_December2022ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2022ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:December2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714to20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-14</xbrli:startDate><xbrli:endDate>2023-07-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230714to20230714_LongtermDebtTypeAxis_July2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-14</xbrli:startDate><xbrli:endDate>2023-07-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231215to20231215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-15</xbrli:startDate><xbrli:endDate>2023-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230714to20230714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-14</xbrli:startDate><xbrli:endDate>2023-07-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-15</xbrli:startDate><xbrli:endDate>2023-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-15</xbrli:startDate><xbrli:endDate>2023-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExercisePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExercisePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_SanDiegoLeaseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:SanDiegoLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190418to20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-18</xbrli:startDate><xbrli:endDate>2019-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:MarketCapContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:MarketCapContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20230630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementBasisAxis_EstimateOfFairValueFairValueDisclosureMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementBasisAxis_CarryingReportedAmountFairValueDisclosureMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230219to20230220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-19</xbrli:startDate><xbrli:endDate>2023-02-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230501to20230531_TitleOfIndividualAxis_DirectorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220909_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_TitleOfIndividualAxis_DirectorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221130_OwnershipAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">erna:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230219to20230220_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-19</xbrli:startDate><xbrli:endDate>2023-02-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221001to20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123to20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-23</xbrli:startDate><xbrli:endDate>2022-11-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">erna:RetirementPlan401KMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_RangeAxis_MaximumMember_RetirementPlanNameAxis_RetirementPlan401KMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">erna:RetirementPlan401KMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleCommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_PlanNameAxis_InducementPlan2021Member_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20230101_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240101to20240101_PlanNameAxis_EquityIncentivePlan2020Member_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AwardTypeAxis_NonQualifiedStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AwardTypeAxis_IncentiveStockOptionsMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:IncentiveStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_PlanNameAxis_InducementPlan2021Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_PlanNameAxis_InducementPlan2021Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_PlanNameAxis_EquityIncentivePlan2020Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_TimeBasedStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:TimeBasedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_PerformanceBasedStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:PerformanceBasedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221123to20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-23</xbrli:startDate><xbrli:endDate>2022-11-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-12</xbrli:startDate><xbrli:endDate>2022-07-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221202to20221202_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-02</xbrli:startDate><xbrli:endDate>2022-12-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220712to20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-12</xbrli:startDate><xbrli:endDate>2022-07-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220306to20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-06</xbrli:startDate><xbrli:endDate>2022-03-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220601to20220630_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023AndDecember2023ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023AndDecember2023ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ClassOfWarrantOrRightAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_December2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:December2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_July2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:July2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:December2023WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20230405to20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-05</xbrli:startDate><xbrli:endDate>2023-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20231231_IncomeTaxAuthorityAxis_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_IncomeTaxAuthorityAxis_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20231231_IncomeTaxAuthorityAxis_DomesticCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">erna:PresidentChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">erna:PresidentChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">erna:PresidentChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240111to20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-11</xbrli:startDate><xbrli:endDate>2024-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20240111_ClassOfWarrantOrRightAxis_WarrantMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>erna:Patents</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>erna:Contract</xbrli:measure></xbrli:unit><xbrli:unit id="U007"><xbrli:measure>erna:Segments</xbrli:measure></xbrli:unit><xbrli:unit id="U008"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U009"><xbrli:measure>erna:Installment</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold; font-family: 'Times New Roman';">UNITED STATES<br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold; font-family: 'Times New Roman';">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold; font-family: 'Times New Roman';">Washington, D.C. 20549</div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;"/></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold; font-family: 'Times New Roman';">Form <ix:nonNumeric name="dei:DocumentType" id="Fact_91dc94c9bc684a98920a361540c10b9d" contextRef="c20230101to20231231">10-K</ix:nonNumeric> <br/>
      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;"/></div>

        <div><span style="font-weight: bold;"> </span></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">(Mark One)</span><br/>
        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: normal;"><ix:nonNumeric name="dei:DocumentAnnualReport" id="Fact_659bf4f5b1234f9494cd180c2d9a096b" contextRef="c20230101to20231231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></div>
              </td>

    <td style="vertical-align: top; width: auto;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
<div>For the Fiscal Year Ended <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_af37064148ca47d58e2043bc9b95c482" contextRef="c20230101to20231231" format="ixt:date-monthname-day-year-en">December 31, 2023</ix:nonNumeric></div>

        <div><br/>
        </div>

        <div>OR<br/>
        </div>

        <div> <br/>
        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-weight: normal;"><ix:nonNumeric name="dei:DocumentTransitionReport" id="Fact_0cc9e6b9aab946d29364196f80684622" contextRef="c20230101to20231231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></div>
              </td>

    <td style="vertical-align: top; width: auto;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
        </div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the transition period from ________ to ________</div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
        </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Commission File Number <ix:nonNumeric name="dei:EntityFileNumber" id="Fact_9ab982465a034a1ea804a026c5023738" contextRef="c20230101to20231231">1-11460</ix:nonNumeric></div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><img src="image00007.jpg" alt="graphic"/> </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;"/></div>

        <div style="text-align: center; margin-right: 216pt; margin-left: 216pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_073cca32bf90494b86a206a43bcea367" contextRef="c20230101to20231231">Eterna Therapeutics Inc.</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;"/></div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_da7a04f44135437295da943eb4212429" contextRef="c20230101to20231231" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_5cedbaa61dd24d959516ad4079c9fcdc" contextRef="c20230101to20231231">31-1103425</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(State or Other Jurisdiction of </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Incorporation or Organization)</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(I.R.S. Employer </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_b6c8d27c669a48a1ab15d08e5346f780" contextRef="c20230101to20231231">1035 Cambridge Street, Suite 18A,</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_33ad2fa07c384e12bcf49e2b7138ec96" contextRef="c20230101to20231231">Cambridge</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_dca17a9e23d1419f8ba4e0c6f3e25dc0" contextRef="c20230101to20231231">MA</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_2dea8d0e321240219bdbc047196c8b66" contextRef="c20230101to20231231">02141</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_34977c76abbf47f2829712552a60ae3d" contextRef="c20230101to20231231">212</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_bf7eccb8472a47a28e2a0939ab6b4dea" contextRef="c20230101to20231231">582-1199</ix:nonNumeric></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(Registrant&#8217;s telephone number, including Area Code)</div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

        <div>
          <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 15%; color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto;"/></div>

        <div style="text-align: center; margin-right: 216pt; margin-left: 216pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title of Each Class</div>
              </div>
            </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Trading Symbol(s)</div>
              </div>
            </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name of Each Exchange on Which Registered</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_bad5b8f702004fa58571d6a704444939" contextRef="c20230101to20231231">Common Stock, $0.005 par value</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_7e416b1f7db4474d9a660057de321cb1" contextRef="c20230101to20231231">ERNA</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: normal;"><span style="-sec-ix-hidden:Fact_a18828d7e3b54c4d80f7f0a71c4d08d7">Nasdaq Capital Market</span></span><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes&#160; &#9744; <ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" id="Fact_2cf6c0d4894b4223b1c85fcfd23ae3d0" contextRef="c20230101to20231231">No</ix:nonNumeric>&#160; &#9746;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.&#160; Yes&#160; &#9744;&#160; <ix:nonNumeric name="dei:EntityVoluntaryFilers" id="Fact_ab24b0c62ddc472b89f614df2ebeacea" contextRef="c20230101to20231231">No</ix:nonNumeric>&#160; &#9746;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act
        of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.&#160; &#160; <ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="Fact_8422077ac14d4d3880fe721d23300d6c" contextRef="c20230101to20231231">Yes</ix:nonNumeric>&#160; &#9746;&#160; &#160; No&#160; &#9744;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
        405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160; &#160; <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="Fact_eaed3623a1c94a79898929981e7298b1" contextRef="c20230101to20231231">Yes</ix:nonNumeric>&#160; &#9746;&#160; &#160; No&#160; &#9744;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
        company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

      <div style="margin-left: 27pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">


  <tr>

    <td style="width: 50%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Large accelerated filer&#160; &#9744;</div>
              </td>

    <td style="width: 50%; vertical-align: bottom;">
                <div style="text-align: center; color: rgb(0, 0, 0);">Accelerated filer&#160; &#9744;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:EntityFilerCategory" id="Fact_a3b6a223b415410b83a4997416156479" contextRef="c20230101to20231231" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric>&#160; &#9746;</div>
              </td>

    <td style="width: 50%; vertical-align: bottom;">
                <div style="text-align: center; color: rgb(0, 0, 0);">Smaller reporting company&#160; <ix:nonNumeric name="dei:EntitySmallBusiness" id="Fact_a22d019a8c43455388e2349bfa0c64e5" contextRef="c20230101to20231231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>

    <td style="width: 50%; vertical-align: bottom; text-align: center;" rowspan="1">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_99693850800b48179ffd8e3bfd6882bc" contextRef="c20230101to20231231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
        any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
<div>Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its
        internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <ix:nonNumeric name="dei:IcfrAuditorAttestationFlag" id="Fact_d971d201374f4d9998a35b221fe82f83" contextRef="c20230101to20231231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

        <div><br/>
        </div>

        <div>If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric name="dei:DocumentFinStmtErrorCorrectionFlag" id="Fact_fdd8c221fc814a188093d10fe246869f" contextRef="c20230101to20231231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

        <div><br/>
        </div>

        <div>Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period
          pursuant to &#167;240.10D- 1(b). &#9744;</div>

        <div><br/>
        </div>

      </div>

      <div style="margin-left: 27pt;">Indicate by check mark whether the registrant is a shell compan<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">y (as defined in Rule 12b-2 of the Act).&#160; </span>&#160; Yes&#160; <ix:nonNumeric name="dei:EntityShellCompany" id="Fact_6b4aa3d47ae942d08a734b41ddc2b640" contextRef="c20230101to20231231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric>&#160; &#160; No&#160; &#9746; </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The aggregate market value of the common stock held by non-affiliates of the registrant as of the last business day of the registrant&#8217;s most
        recently completed second fiscal quarter (June 30, 2023), computed by reference to the closing sale price of the common stock on the Nasdaq Capital Market on such date, was approximately $<ix:nonFraction name="dei:EntityPublicFloat" id="Fact_58d033db59ea44bcb29736da431f9868" contextRef="c20230630" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">9.7</ix:nonFraction> million. <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">For purposes of this determination shares beneficially owned by executive officers, directors and ten percent stockholders have been excluded, which does not represent an admission by the registrant as
          to the affiliate status of such person</span>.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-indent: 24.5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of March <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 32.6667px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">12,</span> 2024, the registrant had <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" id="Fact_c60f6e92ea4140a286f2d94a8f836ce9" contextRef="c20240312" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">5,410,331</ix:nonFraction>
        shares of common stock outstanding.</div>

      <div>
<div>&#160; <br/></div>

        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/> </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"/></div>

      </div>

      <!--PROfilePageNumberReset%LCR%1%%%--> </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div> <a id="TABLEOFCONTENTS"><!--Anchor--></a>
      <div style="text-align: center; font-weight: bold;">TABLE OF CONTENTS</div>

      <div><br/>
      </div>

      <div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="font-weight: bold;">Item</div>
                </td>

    <td style="width: 89%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td style="width: 5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; font-weight: bold;">Page</div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 89%; vertical-align: bottom;">
                  <div style="text-align: center; font-weight: bold;">Part I</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle;">&#160;</td>

    <td style="width: 89%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>1.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM1.">Business</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">1<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>1A.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM1A.">Risk Factors</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">14<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>1B.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM1B.">Unresolved Staff Comments</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">36<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>1C.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM1C.">Cybersecurity</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">36<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>2.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM2.">Properties</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">37<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>3.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM3.">Legal Proceedings</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">37<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>4.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM4.">Mine Safety Disclosures<br/>
                    </a> </div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">37<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle;">&#160;</td>

    <td style="width: 89%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-weight: bold;">Part II</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle;">&#160;</td>

    <td style="width: 89%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>5.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM5.">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">38</div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>6.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM6.">[Reserved]</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">38<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>7.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM7.">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">38<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>7A.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM7A.">Quantitative and Qualitative Disclosures About Market Risk</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">47<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>8.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM8.">Financial Statements and Supplementary Data</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">47<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>9.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM9.">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">47<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>9A.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM9A.">Controls and Procedures</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">47<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>9B.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM9B.">Other Information</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">48<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>9C.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM9C.">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">48<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle;">&#160;</td>

    <td style="width: 89%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-weight: bold;">Part III</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle;">&#160;</td>

    <td style="width: 89%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>10.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM10.">Directors, Executive Officers and Corporate Governance</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">49<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>11.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM11.">Executive Compensation</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">51<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>12.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: 0.3pt;"><a href="#ITEM12.">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">59<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>13.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM13.">Certain Relationships and Related Transactions, and Director Independence</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">63<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>14.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM14.">Principal Accountant Fees and Services</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">63<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle;">&#160;</td>

    <td style="width: 89%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 89%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-weight: bold;">Part IV</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle;">&#160;</td>

    <td style="width: 89%; vertical-align: middle;">&#160;</td>

    <td style="width: 5%; vertical-align: middle; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>15.</div>
                </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM15.">Exhibits and Financial Statement Schedules</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">65<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                  <div>16.</div>
                </td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#ITEM16.">Form 10-K Summary<br/>
                    </a> </div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">67<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#SIGNATURES">Signatures</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: right;">68<br/>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 89%; vertical-align: top;">
                  <div style="text-indent: -12pt; margin-left: 12pt;"><a href="#INDEX">Index to Financial Statements and Schedule</a></div>
                </td>

    <td style="width: 5%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: right;">F-1</div>
                </td>

  </tr>


</table>
          <div> <br/>
          </div>

        </div>

      </div>

    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">i</span></div>

      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

      <div style="width: 100%;" class="BRPFPageHeader">
        <div>
          <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
            </a></div>

        </div>

      </div>

    </div>

    <div>
      <div style="text-align: center;"><span style="font-weight: bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; as that term is defined under the Private Securities Litigation Reform Act of 1995 (&#8220;PSLRA&#8221;), Section 27A of the Securities Act
        of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements include statements related to future events, results, performance, prospects and
        opportunities, including statements related to our strategic plans, capital needs, and our financial position. Forward-looking statements are based on information currently available to us, on our current expectations, estimates, forecasts, and
        projections about the industries in which we operate and on the beliefs and assumptions of management. Forward looking statements often contain words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;targets,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221;
        &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar expressions. In addition, any statements that refer to projections of our future financial performance, our anticipated growth and trends in our business, and other characterizations of
        future events or circumstances, are forward-looking statements. Forward-looking statements by their nature address matters that are, to different degrees, subject to risks and uncertainties that could cause actual results to differ materially and
        adversely from those expressed in any forward-looking statements. For us, particular factors that might cause or contribute to such differences include those identified in the &#8220;Summary of Principal Risk Factors&#8221; below and the other risks and
        uncertainties described in Part I, Item 1A &#8220;Risk Factors&#8221; of this Annual Report on Form 10-K and described in other documents we file from time to time with the Securities and Exchange Commission (the &#8220;SEC&#8221;), including our Quarterly Reports on Form
        10-Q.</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Readers are urged not to place undue reliance on the forward-looking statements in this Annual Report on Form 10-K, which speak only as of the date of this Annual Report on Form 10-K. We are
        including this cautionary note to make applicable, and take advantage of, the safe harbor provisions of the PSLRA. Except as required by law, we do not undertake, and expressly disclaim any obligation, to disseminate, after the date hereof, any
        updates or revisions to any such forward-looking statements to reflect any change in expectations or events, conditions or circumstances on which any such statements are based.</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">We believe that the expectations reflected in forward-looking statements in this Annual Report on Form 10-K are based upon reasonable assumptions at the time made. However, given the risks and
        uncertainties, you should not rely on any forward-looking statements as a prediction of actual results, developments or other outcomes. You should read these forward-looking statements with the understanding that we may be unable to achieve
        projected results, developments or other outcomes and that actual results, developments or other outcomes may be materially different from what we expect.</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Unless stated otherwise or the context otherwise requires, all references in this Annual Report on Form 10-K to &#8220;Eterna&#8221; refer to Eterna Therapeutics Inc., references to &#8220;Eterna LLC&#8221; refer to
        Eterna Therapeutics LLC, and references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Eterna and its consolidated subsidiaries, including Eterna LLC, Novellus, Inc. and Novellus Therapeutics Limited.</div>

      <div>&#160;</div>

      <div style="text-align: center; margin-left: 0.05pt; font-weight: bold;">SUMMARY OF PRINCIPAL RISK FACTORS</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Below is a summary of the principal factors that make an investment in our securities speculative or risky. This summary does not address all of the risks that we face. We urge investors to
        carefully review and consider the additional discussion of the risks summarized in this risk factor summary, and other risks that we face, which can be found below under the heading &#8220;Risk Factors&#8221; in Item 1A of this Annual Report on Form 10-K,
        together with other information in this report, before making investment decisions regarding our securities.</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to our Business and Industry</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We will require substantial additional capital to fund our operations, and if we fail to obtain the necessary financing, we may not be able to continue as a going concern.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We have a limited operating history, have incurred significant losses since our inception and expect to continue to incur losses for the foreseeable future, which, together with our limited financial resources and substantial capital
                requirements, make it difficult to assess our prospects.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We depend substantially, and expect in the future to continue to depend, on in-licensed intellectual property, and in particular on intellectual property we in-license from Factor Limited.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Our intellectual property rights may not adequately protect our business.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We or our licensors may be subject to claims challenging the inventorship or ownership of the patents and other intellectual property that we own or license now or in the future.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">ii</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We have identified a material weakness in our internal control over financial reporting, which may adversely affect investor confidence in us, result in litigation and materially and adversely affect our business and operating results.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Our business and operations would suffer in the event of system failures, cyber-attacks or a deficiency in our cyber-security.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to New, Cutting Edge Technologies</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Because gene-editing and cell therapy product candidates that may be developed using our mRNA technology platform are based on novel technologies, we cannot assure that such products will be successful.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We face intense competition and rapid technological change and the possibility that our competitors may develop therapies that are more advanced, safer or more effective than any therapy we may develop in the future, which may adversely
                affect our financial condition and our ability to successfully develop and commercialize our products.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Negative public opinion and increased regulatory scrutiny of gene therapy and genetic research may damage public perception of product candidates that may be developed using our mRNA technology platform or adversely affect our ability to
                conduct our business.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to Ownership of our Common Stock</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A substantial number of shares may be issued upon the exercise and/or conversion of outstanding securities, which would result in substantial dilution to the interests of our existing stockholders.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The terms of our outstanding convertible notes could limit our growth and our ability to finance our operations, fund our capital needs, respond to changing conditions and engage in other business activities that may be in our best
                interests.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The requirement that we redeem our outstanding convertible notes in cash could adversely affect our business plan, liquidity, financial condition, and results of operations.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our common stock.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Anti-takeover provisions of Delaware law and provisions in our charter and bylaws could make a third-party acquisition of us difficult.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to Regulatory Requirements and Our Intellectual Property</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time-consuming and inherently unpredictable. If potential strategic partners are ultimately unable to obtain regulatory approval for
                their product candidates, our business will be substantially harmed.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Healthcare legislative reform measures may have a material and adverse effect on our business, financial condition, results of operations, and prospects.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If we are unable to obtain and maintain patent and other intellectual property protection, or if the scope of the patent and other intellectual property protection obtained is not sufficiently broad, our business, financial condition,
                results of operations, and/or prospects may be materially and adversely effected.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We cannot ensure that patent rights relating to inventions described and claimed in our pending patent applications will issue, or that our issued patents or patents that issue in the future will not be challenged and rendered invalid
                and/or unenforceable.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Issued patents covering future products and product candidates that our strategic partners or collaborators may develop could be found invalid or unenforceable if challenged in court or in administrative proceedings.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or
                eliminated for non-compliance with these requirements.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If we do not obtain patent term extension for future products that our strategic partners or collaborators may successfully develop, our business may be materially harmed.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Changes in patent law in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect future products and product candidates that we or our strategic partners or
                collaborators may develop.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We may not be able to protect our intellectual property rights throughout the world.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">iii</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent, and our business, financial condition, results of operations, and/or prospects may be materially
                and adversely effected.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We may be subject to claims by third parties asserting that our employees or we have misappropriated their intellectual property or claiming ownership of what we regard as our own intellectual property.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>We may become involved in lawsuits to protect or enforce our patents and other intellectual property rights, which could be expensive, time-consuming and unsuccessful.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">iv</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%1%%%-->
      <div style="text-align: center; font-weight: bold;">PART I</div>

      <div>&#160;</div>

      <a id="ITEM1."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; font-weight: bold;">ITEM 1.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Business</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="text-align: justify; font-weight: bold;"><span style="text-decoration: underline;">Overview</span></div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">We are a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines.&#160; We have in-licensed a portfolio of over 100
        patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> and UltraSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> gene-editing proteins, and the ToRNAdo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> mRNA delivery system, which we collectively
        refer to as our &#8220;mRNA technology platform.&#8221; We refer to aspects of our mRNA technology platform as &#8220;mRNA delivery,&#8221; &#8220;mRNA gene editing&#8221; and &#8220;mRNA cell reprogramming.&#8221; We license our mRNA technology platform from Factor Bioscience Limited (&#8220;Factor
        Limited&#8221;) under an exclusive license agreement.</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;"><span style="text-decoration: underline;">Objectives and Business Strategy</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-indent: 40.8pt;">We believe that our proprietary technology platform can be used to develop novel pharmaceutical products to treat a broad range of diseases and address unmet medical needs.</div>

        <div>&#160;</div>

        <div style="text-indent: 40.8pt;">In the short term, we are planning to derive revenue by leveraging our core intellectual property (&#8220;IP&#8221;) portfolio by licensing to our IP third parties in out-licensing or co-development arrangements. In addition,
          we are also planning to enhance our developmental activities through preclinical studies in selected indications.</div>

        <div>&#160;</div>

        <div style="text-indent: 40.8pt;">In the mid-term, we are planning to transform our preclinical stage company into a clinical-stage company through IND-enabling studies, IND approval, and initiation of our first-in-human study. After achieving the
          initial milestones, we&#8217;ll seek to diversify our pipeline of product candidates and strengthen the mRNA technology platform with the goal of generating IND applications each year.</div>

        <div>&#160;</div>

        <div style="text-indent: 40.8pt;">In the long term, we aspire to become a therapeutics company with multiple approved gene and cellular therapy products across multiple indications in oncology, autoimmune diseases, and rare diseases.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; text-indent: 36pt;">As discussed in more detail below, following receipt in June 2022 of the results from the INSPIRE phase 2 trial of IRX-2, our only former product candidate, we determined to cease the development
        of IRX-2. We do not currently plan to develop any product candidates. In the future we may develop and advance product candidates, either internally and/or through strategic partnerships.</div>

      <div>&#160;</div>

      <div style="text-align: justify;"><span style="text-decoration: underline;">mRNA Delivery, Gene-Editing, and Cellular Medicines</span></div>

      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic;">mRNA Delivery</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Nucleic acids, such as mRNA, can be used to induce cells to express desired proteins, including proteins that are capable of re-writing genetic and epigenetic cellular programs. However, the plasma
        membrane surrounding cells normally protects cells from exogenous nucleic acids, preventing efficient uptake and protein translation. Delivery systems can be used to enhance the uptake of nucleic acids by cells.&#160; Conventional delivery systems, such
        as lipid nanoparticle (&#8220;LNP&#8221;)-based delivery, often suffer from endosomal entrapment and toxicity, which can limit their therapeutic use.&#160; Our mRNA delivery technology is designed to use a novel chemical substance that is designed to deliver
        nucleic acids, including mRNA, to cells both <span style="font-style: italic;">ex vivo</span> and <span style="font-style: italic;">in vivo</span>. Our nucleic-acid delivery technology is also designed for <span style="font-style: italic;">ex
          vivo</span> delivery of mRNA encoding gene-editing proteins and reprogramming factors, including to primary cells, insertion of exogenous sequences into genomic safe-harbor loci, and <span style="font-style: italic;">in vivo</span> delivery of
        mRNA to the brain, eye, skin, and lung, which may be useful for the development of mRNA-based therapeutic.</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic;">mRNA Gene Editing</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Our mRNA gene-editing technology is designed to delete, insert, and repair DNA sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to
        infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.</div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt;">Conventional gene-editing technologies typically employ plasmids or viruses to express gene-editing proteins, which can result in low-efficiency editing and unwanted mutagenesis when an exogenous
        nucleic acid fragment is inserted at random locations in the genome. Our mRNA gene-editing technology instead is designed to employ mRNA to express gene-editing proteins, which can potentially enable gene editing without unwanted insertional
        mutagenesis, because, unlike conventional gene-editing technologies that employ viruses or DNA-based vectors, mRNA does not typically cause unwanted insertional mutagenesis. We believe the efficiency of our mRNA gene-editing technology has the
        potential to support development of product candidates that could create new therapeutic approaches. For example, we anticipate that our mRNA gene-editing technology can be used to generate allogeneic chimeric antigen receptor T-cell (&#8220;CAR-T&#8221;)
        therapies for the treatment of cancer. In such allogeneic CAR-T therapies, mRNA encoding gene-editing proteins would be used to inactivate the endogenous T-cell receptor to prevent therapeutic T-cells from causing graft-versus-host disease
        (&#8220;GvHD&#8221;). GvHD occurs when transplanted cells view the patient&#8217;s (i.e. the host&#8217;s) cells as a threat and attack the host&#8217;s cells. We expect that this same mechanism of action can generate allogeneic stem cell-derived therapies in which mRNA
        encoding gene-editing proteins could be used to inactivate one or more components of the human leukocyte antigen (&#8220;HLA&#8221;) complex to render the cells immuno-nonreactive or &#8220;stealth,&#8221; which may be useful for the development of allogeneic cell-based
        therapies.</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic;">mRNA Cell Reprogramming</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Our mRNA cell-reprogramming technology is capable of generating clonal lines of pluripotent stem cells that can be expanded and differentiated into many desired cell types that may be useful for
        the development of regenerative cell therapies.</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Conventional cell-reprogramming technologies (e.g., using Sendai virus or episomal vectors) can result in low efficiency reprogramming, can select for cells with abnormal growth characteristics,
        and can leave traces of the vector in reprogrammed cells.<span style="font-weight: bold;">&#160;</span>Our mRNA cell-reprogramming technology instead is designed to employ mRNA to express reprogramming factors, which can enable cell reprogramming
        without leaving traces of the vector in reprogrammed cells, because, unlike conventional cell-reprogramming technologies that employ viruses or DNA-based vectors, mRNA does not typically leave traces of the vector in reprogrammed cells.</div>

      <div>&#160;</div>

      <div style="text-align: justify;"><span style="text-decoration: underline;">Former Product Candidate -- IRX-2</span></div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">We currently do not have plans to further develop IRX-2, our former clinical product candidate. Results of the 150-patient Phase 2b INSPIRE trial, released in June 2022, showed outcomes favored
        IRX-2 in certain predefined subgroups but did not meet its primary endpoint of event-free survival at two years of follow up. There were no new safety signals observed with IRX-2. The INSPIRE trial was our only sponsored study of IRX-2.&#160; IRX-2 has
        been studied externally in other clinical settings outside of head and neck cancer in the form of investigator sponsored trials, all of which have either ended or are not currently active. We previously provided IRX-2 as a study drug and financial
        support to conduct those investigator sponsored trials, but are no longer providing either.</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;"><span style="text-decoration: underline;">License Agreement</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 24.5pt;">On November 14, 2023, we entered into an amended and restated exclusive license agreement (the &#8220;A&amp;R Factor License Agreement&#8221;) with Factor Limited to replace in its entirety the exclusive
          license agreement we entered into with Factor dated February 20, 2023, as amended on July 12, 2023.&#160; Under the terms of the A&amp;R Factor License Agreement, Factor Limited granted to us an exclusive, sublicensable license under certain patents
          owned by Factor Limited (the &#8220;Factor Patents&#8221;).&#160; The A&amp;R Factor License Agreement also provides for, among other things, the expansion of our license rights to include (i) the field of use of the Factor Patents to include veterinary uses,
          (ii) know-how that is necessary or reasonably useful to practice to the licensed patents, (iii) the ability to sublicense through multiple tiers (as opposed to only permitting a direct sublicense), and (iv) the transfer of technology to us,
          subject to the use restrictions in the Amended and Restated License Agreement.&#160; The term of the A&amp;R Factor License Agreement expires on November 22, 2027, but will be automatically extended for an additional five years if we pay at least $6.0
          million to Factor Limited from fees from sublicenses to the Factor Patents (&#8220;Sublicense Fees&#8221;), other cash on hand or a combination of both sources of funds.&#160; We will pay to Factor Limited 20% of any Sublicense Fee received by us during the term
          of the A&amp;R Factor License Agreement.&#160; In September 2023, we will also begin paying Factor Limited a monthly maintenance fee of approximately $0.4 million.&#160; We may terminate the A&amp;R Factor License Agreement upon 120 days&#8217; written notice to
          Factor Limited, and both parties have additional customary termination rights.&#160; Under the A&amp;R Factor License Agreement, we are obligated to pay the expenses incurred by Factor Limited in preparing, filing, prosecuting and maintaining the
          Factor Patents and we agreed to bear all costs and expenses associated with enforcing and defending the Factor Patents in any action or proceeding arising from pursuit of sublicensing opportunities under the license granted under the A&amp;R
          Factor License Agreement.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="font-weight: bold;"><span style="text-decoration: underline;">Patent Portfolio</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our strategy is to develop and advance a pipeline of therapeutic products both internally and through strategic partnerships, leveraging our in-licensed mRNA technology platform, with the
          near-term focus on deploying our mRNA technology platform through strategic partnerships. As of February 06, 2024, we had in-licensed 16 patent families filed in the United States and other major markets worldwide, including 138 granted patents,
          5 allowed patent applications, 11 nationalized PCT applications, 100 pending non-provisional patent applications or provisional patent applications, and 1 pre-nationalization PCT application. Patent protection for the mRNA technology platform
          includes:</div>

        <div>&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45%; vertical-align: middle;">
              <div style="text-align: center;"><span style="text-decoration: underline;">Family Number and Title</span></div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: bottom;">
              <div style="text-align: center;"><span style="text-decoration: underline;">United States or Foreign </span></div>
              <div style="text-align: center;"><span style="text-decoration: underline;">Jurisdiction</span></div>
            </td>

    <td style="width: 22%; vertical-align: bottom;">
              <div style="text-align: center;"><span style="text-decoration: underline;">Earliest Effective Date </span></div>
              <div style="text-align: center;"><span style="text-decoration: underline;">of Patent Application</span></div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: middle;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: bottom;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-001: &#8220;Methods and Products for Transfecting Cells&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 9,422,577, 9,605,277, 9,605,278, 10,472,611, 10,662,410, 10,829,738, 10,982,229, ,11,466,293, 11,692,203 and 11,708,586), EP (CH, DE, FR, GB, IE), EP (BE,
                CH, DE, DK, FR, GB, IE, NL), AU (6X), CA, CN (4X), HK (5X), JP (2X), KR (2X), MX(2X), RU</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Nationalized PCT</span>: (1X)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US (4X), AU, BR (4X), CA, CN, EP, HK (2X), KR, MX (3X), RU</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">12/05/2011</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-003: &#8220;Methods and Products for Transfection&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 8,497,124, 9,127,248, 9,399,761, 9,562,218, 9,695,401, 9,879,228, 9,969,983, 10,131,882, 10,301,599, 10,443,045, 11,492,600)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">5/07/2012</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-005: &#8220;Methods and Products for Expressing Proteins in Cells&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 9,447,395, 9,376,669, 9,464,285, 9,487,768, 9,657,282, 9,758,797, 10,415,060, 10,590,437, 11,339,409, 10,752,917, 11,339,410 ,10,724,053, 11,332,758,
                10,767,195, 11,332,759, 10,752,918 and 10,752,919</div>
              <div>), EP (CH, DE, FR, GB, IE), AU (2X), BR (3X), CA, HK, JP (3X), KR (3X), MX, RU</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Nationalized PCT</span>: (1X)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Allowed:</span> BR, JP, MX and US</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: AU, CA, CN, EU, HK, KR and US</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">11/01/2012</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-008: &#8220;Methods and Products for Nucleic Acid Production and Delivery&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 9,770,489 and 10,124,042), EP (DE, FR, GB, CH, ES, IE), EP (BE; DK; FI; FR; DE; IE; NL; NO; ES; SE; CH; GB), AU, HK, JP, KR, MX, RU</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Nationalized PCT</span>: (1X)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: AU, BR, CA, CN, EP, JP, KR, MX and US (2X)</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">08/18/2014</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-009: &#8220;Nucleic Acid Products and Methods of Administration Thereof&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (No. 11,241,505), AU, JP</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Nationalized PCT</span>: (1X)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: AU, CA, CN, EP, HK (2X), JP, NZ and US</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">02/16/2016</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-010: &#8220;Nucleic Acid Products and Methods of Administration Thereof&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 10,576,167, 10,137,206, 10,350,304, 10,363,321, 10,369,233, 10,888,627, and 10,894,092), AU, CN</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Nationalized PCT</span>: (1X)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Issue Fees Paid:</span> US</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US (3X), AU, CN, EP, HK, IL (2X), JP (2X), NZ (2X)</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">08/17/2017</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-011: &#8220;Nucleic Acid-Based Therapeutics&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="font-weight: bold;">Nationalized PCT: (1X)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending:</span> US, AU, CA, EP and HK</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">03/27/2019</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-012: &#8220;Cationic Lipids and Transfection Methods&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Granted</span>: US (Nos. 10,501,404, 10,556,855, 10,611,722, 10,752,576, 11,242,311 and 11,814,333)</div>
              <div>&#160;</div>
              <div style="font-weight: bold;">Nationalized PCT: (1X)</div>
              <div>&#160;</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US (2X), AU, CA, CN, EP, HK, JP, KR, MX, NZ</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">US: 07/30/2019</div>
              <div>&#160;</div>
              <div style="text-align: center;">Foreign: 07/03/2019</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-013: &#8220;Engineered Gene-Editing Proteins&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US, EP</div>
              <div style="font-weight: bold;">Nationalized PCT: (1X)</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">05/12/2021</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-016: &#8220;Mesenchymal Stem Cell Therapies&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="font-weight: bold;">Nationalized PCT: (1X)</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending</span>: US, AU, CN, EP, HK and JP</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">04/28/2021</div>
              <div>&#160;</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-017: &#8220;Engineered Immune Cell Therapies&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="font-weight: bold;">Nationalized PCT: (1X)</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending:</span> US, AU, CA, CN, EP and JP</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">03/04/2022</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-018: &#8220;Circular RNA&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="font-weight: bold;">Nationalized PCT: (1X)</div>
              <div style="color: #000000;"><span style="font-weight: bold;">Pending:</span> US, AU, CA, CN, EP and JP</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">04/27/2022</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>FAB-019: &#8220;Methods for reprogramming and gene editing cells&#8221;</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">
              <div style="font-weight: bold;">Pre-nationalization PCT: (1X)</div>
            </td>

    <td style="width: 22%; vertical-align: top;">
              <div style="text-align: center;">01/05/2022</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 45%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td rowspan="1" style="width: 22%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 45%; vertical-align: top;">
              <div>US &#8211; United States of America</div>
              <div>EP &#8211; European Patent Convention</div>
              <div>PCT &#8211; Patent Cooperation Treaty</div>
              <div>AU &#8211; Australia</div>
              <div>BE &#8211; Belgium</div>
              <div>BR &#8211; Brazil</div>
              <div>CA &#8211; Canada</div>
              <div>CH &#8211; Switzerland</div>
              <div>CN &#8211; Peoples&#8217; Republic of China</div>
              <div>DE &#8211; Germany</div>
              <div>DK &#8211; Denmark</div>
              <div>ES &#8211; Spain</div>
              <div>FI &#8211; Finland</div>
              <div>FR &#8211; France</div>
              <div>GB &#8211; Great Britain</div>
              <div>HK &#8211; Hong Kong</div>
              <div>IE &#8211; Ireland</div>
              <div>IL &#8211; Israel</div>
              <div>IN &#8211; India</div>
              <div>JP &#8211; Japan</div>
              <div>KR &#8211; Republic of Korea (South Korea)</div>
              <div>MX &#8211; Mexico</div>
              <div>NL &#8211; Netherlands</div>
              <div>NO &#8211; Norway</div>
              <div>NZ &#8211; New Zealand</div>
              <div>RU &#8211; Russian Federation</div>
              <div>SE &#8211; Sweden</div>
            </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

    <td style="width: 27.83%; vertical-align: top;">&#160;</td>

    <td style="width: 22%; vertical-align: middle;">&#160;</td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic;">Patent Families</div>

      <div>&#160;</div>

      <div style="text-align: justify;">Descriptions of our patent families are as follows:</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-001: &#8220;Methods and Products for Transfecting Cells&#8221; - The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits,
                and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for
                inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using
                these methods are also disclosed.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-003: &#8220;Methods and Products for Transfection&#8221; - The present invention relates in part to methods for producing tissue-specific cells from patient samples, and to tissue-specific cells produced using these methods. Methods for
                reprogramming cells using RNA are disclosed. Therapeutics comprising cells produced using these methods are also disclosed.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-005: &#8220;Methods and Products for Expressing Proteins in Cells&#8221; - The present invention relates in part to nucleic acids encoding proteins, therapeutics comprising nucleic acids encoding proteins, methods for inducing cells to express
                proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods and products for altering the
                DNA sequence of a cell are described, as are methods and products for inducing cells to express proteins using synthetic RNA molecules. Therapeutics comprising nucleic acids encoding gene-editing proteins are also described.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-008: &#8220;Methods and Products for Nucleic Acid Production and Delivery&#8221; - The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods
                for delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells,
                organisms, therapeutics, and cosmetics produced using these methods, kits, and devices. Methods and products for altering the DNA sequence of a cell are described, as are methods and products for inducing cells to express proteins using
                synthetic RNA molecules, including cells present in vivo. Therapeutics comprising nucleic acids encoding gene-editing proteins are also described.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-009: &#8220;Nucleic Acid Products and Methods of Administration Thereof&#8221; - The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods for
                delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms,
                therapeutics, and cosmetics produced using these methods, kits, and devices.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-010: &#8220;Nucleic Acid Products and Methods of Administration Thereof&#8221; - The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods for
                delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms,
                therapeutics, and cosmetics produced using these methods, kits, and devices.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-011: &#8220;Nucleic Acid-Based Therapeutics&#8221; - The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods for delivering nucleic acids to
                cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, therapeutics, and cosmetics
                produced using these methods, kits, and devices.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-012: &#8220;Cationic Lipids and Transfection Methods&#8221; - The present invention relates in part to novel cationic lipids and their use, e.g., in delivering nucleic acids to cells.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-013: &#8220;Engineered Gene-Editing Proteins&#8221; - The present invention relates in part to nucleic acids encoding gene editing proteins, including novel engineered variants.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-016: &#8220;Mesenchymal Stem Cell Therapies&#8221; - Cell-based therapies based on mesenchymal stem cells (MSCs) are described.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-017: &#8220;Engineered Immune Cell Therapies&#8221; - The present disclosure relates in part to engineered immune cells that are, inter alia, silenced from a host immune response.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-018: &#8220;Circular RNA&#8221; - Nucleic acid structures that promote formation of circular RNAs (circRNAs), which may comprise hybridization of substantially complimentary regions within the nucleic acid and contact with an RNA ligase. The
                nucleic acid structures may be used in gene editing and/or therapeutic applications. In some embodiments, the nucleic acid comprises the structure: 5'-X-Y-A-IRES-B-CDS-C-Y'-Z-3', wherein X, Y, Y' and Z each independently comprise one or
                more nucleotides; Y and Y' are substantially complementary; X and Z are not substantially complementary; IRES comprises an internal ribosome entry site; CDS comprises a coding sequence; and A, B, and C are each independently a spacer
                comprising one or more nucleotides or null.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>FAB-019: &#8220;Methods for reprogramming and gene editing cells&#8221; The present disclosure provides improved methods for reprogramming and gene editing cells, including manufacturing a population of cells comprising cells of the lymphoid lineage
                and/or cells of the myeloid lineage.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;"><span style="text-decoration: underline;">Patent Term and Term Extensions</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Individual patents have terms for varying periods depending on the date of filing of the patent application or the date of patent issuance and the legal term of patents in the countries in which
          they are obtained. Generally, utility patents issued for applications filed in the United States and the European Union are granted a term of 20 years from the earliest effective filing date of a non-provisional patent application. In addition,
          in certain instances, a patent term can be extended to recapture a portion of the U.S. Patent and Trademark Office, or the USPTO, delay in issuing the patent as well as a portion of the term effectively lost as a result of the United States Food
          and Drug Administration (&#8220;FDA&#8221;) regulatory review period. However, as to the FDA component, the restoration period cannot be longer than five years and the restoration period cannot extend the patent term beyond 14 years from FDA approval. The
          duration of foreign patents varies in accordance with provisions of applicable local law, but typically are also 20 years from the earliest effective filing date. All taxes or annuities for a patent, as required by the USPTO and various foreign
          jurisdictions, must be timely paid in order for the patent to remain in force during this period of time.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The actual protection afforded by a patent may vary on a product-by-product basis, from country to country, and can depend upon many factors, including the type of patent, the scope of its
          coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Our patents and patent applications may be subject to procedural or legal challenges by others. We may be unable to obtain, maintain and protect the intellectual property rights necessary to
          conduct our business, and we may be subject to claims that we infringe or otherwise violate the intellectual property rights of others, which could materially harm our business. For more information, see Item 1A &#8220;Risk Factors-Risks Related to Our
          Intellectual Property&#8221; contained in this Annual Report on Form 10-K.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;"><span style="text-decoration: underline;">Supply and Manufacturing</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We currently do not have any agreements for the supply or manufacturing of cell lines. However, together with our licensor, Factor Limited, we believe that we have considerable experience in
          developing engineered cell lines. Pursuant to a Master Services Agreement, dated as of September 9, 2022 (the &#8220;MSA&#8221;), by and between us and Factor Bioscience Inc. (&#8220;Factor Bioscience&#8221;), the parent company of Factor Limited, Factor Bioscience has
          agreed to provide us with certain mRNA cell engineering research support services, including (i) access to Factor Bioscience&#8217;s research laboratory facilities located in Cambridge, Massachusetts, (ii) access to Factor Bioscience&#8217;s scientific
          equipment, (iii) training of our research staff in certain mRNA, iPSC, and gene editing technologies, (iv) copies of protocols, formulations, and sequences that may be useful for the development of mRNA cell engineering products and (v) in vitro
          transcription templates, mRNA constructs, and iPS cells that may be useful for the development of mRNA cell engineering products. To the extent that we need to obtain a supply of cell lines or manufacture them, we expect to contract with a
          contract manufacturing organization or to enter into a new work order under the MSA.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="color: rgb(0, 0, 0);"> <span style="font-weight: bold;"><span style="text-decoration: underline;">Regulatory Matters</span></span></div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">As discussed above, our near-term focus is on entering into strategic partnerships to deploy our mRNA technology platform, and we expect that potential strategic partners will use our mRNA
          technology platform for preclinical and eventual clinical development of product candidates for a variety of clinical indications. To the extent we enter into agreements with strategic partners, the fees, payments or other compensation we may be
          eligible to receive may be based on or related to the clinical, regulatory or commercial development of their product candidates, which development we expect will be largely out of our control.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In addition, as discussed in this section, government authorities in the United States, at the federal, state and local level, and in other countries extensively regulate, among other things, the
          research, development, testing, manufacture, labeling, record-keeping, promotion, storage, advertising, distribution, marketing and export and import of product candidates and products that potential strategic partners may seek to develop.
          Accordingly, although we do not currently plan to directly develop any product candidates, the regulatory framework related to products and the development of product candidates may continue to impact our operations and financial condition.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Government regulation and product approval</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Drugs and biologics must be approved by the FDA through the New Drug Application (&#8220;NDA&#8221;) process or the Biologic License Application (&#8220;BLA&#8221;) process before they may be legally marketed in the
          United States. We use the terms &#8220;marketing application&#8221; or &#8220;MA&#8221; to apply to both.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">There are two centers within the FDA that are responsible for the review and approval of drug and biologic marketing applications and general regulatory oversight: the Center for Drug Evaluation
          and Research (&#8220;CDER&#8221;) and the Center for Biologics Evaluation and Research (&#8220;CBER&#8221;). While all conventional drug products are regulated by CDER, biologic products can be regulated by either CDER or CBER, depending on the product&#8217;s classification.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The majority of BLA submissions are assigned to CBER; however, BLAs for certain biologic product categories are reviewed by CDER. These product categories include monoclonal antibodies for in
          vivo use, most proteins for therapeutic use, and categories such as cytokines, enzymes, and other novel proteins. Regardless of the category, NDAs for all drug products fall under the jurisdiction of CDER.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In the United States, drugs are subject to rigorous regulation by the FDA under the federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and implementing regulations, and biologics under the FDCA, the
          Public Health Services Act (&#8220;PHSA&#8221;), and their implementing regulations. Additionally, drugs and biologics are subject to other federal and state statutes. The process of obtaining regulatory approvals and the subsequent compliance with
          appropriate federal, state, local, and foreign statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with the applicable United States requirements at any time during the product
          development process, approval process, or after approval, may subject an applicant to administrative or judicial sanctions. These sanctions could include the FDA&#8217;s refusal to approve pending applications, license suspension or revocation,
          withdrawal of an approval, a clinical hold, warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties or criminal prosecution. Any agency or judicial
          enforcement action could have a material adverse effect on us. The process required by the FDA before a drug or biologic may be marketed in the United States generally involves the following:</div>

        <div>&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>completion of preclinical laboratory tests, animal studies and formulation studies according to the FDA&#8217;s good laboratory practice, or GLP, regulations;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>submission of an investigational new drug application (&#8220;IND&#8221;), which must become effective before human clinical trials may begin and which must include approval by an institutional review board (&#8220;IRB&#8221;) at each clinical site before the
                trials are initiated;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the proposed drug for its intended use conducted in compliance with federal regulations and good clinical practice (&#8220;GCP&#8221;), an
                international standard meant to protect the rights and health of human clinical trial subjects and to define the roles of clinical trial sponsors, administrators, and monitors;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>submission to, and acceptance by, the FDA of a MA;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>satisfactory completion of an FDA inspection of our manufacturing facility or other facilities at which the drug or biologic is produced to assess compliance with current good manufacturing practice (&#8220;cGMP&#8221;), regulations to assure that
                the facilities, methods and controls are adequate to preserve the drug&#8217;s identity, strength, quality and purity;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>potential FDA audit of the non-clinical and clinical trial sites that generated the data in support of the MA: and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>FDA review and approval of the MA.</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The testing and approval process require substantial time, effort and financial resources, and the receipt and timing of any approval is uncertain.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">United States drug development process</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Once a pharmaceutical candidate is identified for development it enters the preclinical testing stage. Preclinical tests include laboratory evaluations of product chemistry, toxicity and
          formulation, as well as animal studies. Prior to beginning human clinical trials, a sponsor must submit an IND to the FDA, which includes the results of the preclinical tests, together with manufacturing information and analytical data. Some
          preclinical or non-clinical testing may continue even after the IND is submitted. In addition to including the results of the preclinical studies, the IND will also include a protocol detailing, among other things, the objectives of the clinical
          trial, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated, if the trial lends itself to an efficacy evaluation. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA,
          within the 30-day time period, raises concerns or questions about the conduct of the trial. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. The FDA may, at any time, impose a
          clinical hold on ongoing clinical trials. If the FDA imposes a clinical hold, clinical trials cannot commence or recommence without FDA authorization and then only under terms authorized by the FDA.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Clinical trials involve the administration of the investigational new drug to healthy volunteers or patients under the supervision of one or more qualified investigators in accordance with
          federal regulations and GCP.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Clinical trials must be conducted under protocols detailing the objectives of the trial and the safety and effectiveness criteria to be evaluated. Each protocol must be submitted to the FDA as
          part of the IND. Further, an IRB affiliated with each institution participating in the clinical trial must review and approve each protocol before any clinical trial commences at that institution. All research subjects must provide informed
          consent, and informed consent information must be submitted to the IRB for approval prior to initiation of the trial and prior to providing it to potential subjects. Progress reports detailing the results of the clinical trials must be submitted
          at least annually to the FDA and more frequently if adverse events or other certain types of other changes occur.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Human clinical trials are typically conducted in three phases. A fourth, or post-approval, phase may include additional clinical studies. These phases generally include the following, and may be
          sequential, or may overlap or be combined:</div>

        <div>&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>Phase 1 clinical trials involve the initial introduction of the drug or biologic into human subjects. These studies are designed to determine the safety of usually single doses of the compound and determine any dose limiting intolerance,
                as well as evidence of the metabolism and pharmacokinetics of the drug in humans. For some products for severe or life-threatening diseases, especially if the product may be too toxic to administer to healthy humans, the initial clinical
                trials may be conducted in individuals having a specific disease for which use the tested product is indicated.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>Phase 2 clinical trials usually involve studies in a limited patient population to evaluate the safety and efficacy of the drug or biologic for specific, targeted indications, to determine dosage tolerance and optimal dosage, and to
                identify possible adverse effects and safety risks.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>In Phase 3, if a compound is found to be potentially effective and to have an acceptable safety profile in Phase 2 (or occasionally Phase 1) studies, the Phase 3 studies will be conducted to further confirm clinical efficacy, optimal
                dosage and safety within an expanded population which may involve geographically diverse clinical trial sites. Generally, but not always, two adequate and well-controlled Phase 3 clinical trials are required by the FDA for approval of a
                marketing application.</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>Phase 4 clinical trials are studies required of or agreed to by a sponsor that are conducted after the FDA has approved a product for marketing. These studies are used to gain additional experience from the treatment of patients in the
                intended therapeutic indication and to document a clinical benefit in the case of drugs approved under accelerated approval regulations. If the FDA approves a product while a company has ongoing clinical trials that were not necessary for
                approval, a company may be able to use the data from these clinical trials to meet all or part of any Phase 4 clinical trial requirement. Failure to promptly conduct Phase 4 clinical trials where necessary could result in withdrawal of
                approval for products approved under accelerated approval regulations.</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">While Phase 1, Phase 2, and Phase 3 studies are generally required for approval of a marketing application, certain drugs and biologics may not require one or more steps in the process depending
          on other testing and the situation involved. Additionally, the FDA, an IRB, or the sponsor may stop testing at any time if results show patients being exposed to unnecessary health risks or overly dangerous side effects.&#160; Prior to the initiation
          of a clinical trial or at any time during the conduct of studies with human subjects, the FDA may place a study on clinical hold where patients may not be enrolled and ongoing trial activities are suspended until questions around potential safety
          issues with investigational products are addressed.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In addition, the manufacturer of an investigational drug in a Phase 2 or Phase 3 clinical trial for a serious or life-threatening disease is required to make available, such as by posting on its
          website, its policy on evaluating and responding to requests for expanded access to such investigational drug.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Concurrent with clinical trials, companies usually complete additional animal studies and must also develop additional information about the mechanism of action and physical characteristics of
          the drug and finalize a process for manufacturing the product in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product and, among other requirements, the manufacturer
          must develop methods for testing the identity, strength, quality, potency, and purity of the final product. Additionally, appropriate packaging must be selected and validated, and stability studies must be conducted to demonstrate that the
          product does not undergo unacceptable deterioration over its shelf life.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Additional Regulation for Gene Therapy Clinical Trials</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In addition to the regulations discussed elsewhere in this section, there are a number of additional standards that apply to clinical trials involving the use of gene therapy. The FDA has issued
          various guidance documents regarding gene therapies, which outline additional factors the FDA will consider at each of the above stages of development and relate to, among other things: the proper preclinical assessment of gene therapies; the CMC
          information that should be included in an IND application; the proper design of tests to measure product potency in support of an IND or BLA application; and measures to observe delayed adverse effects in subjects who have been exposed to
          investigational gene therapies when the risk of such effects is high. Further, the FDA usually recommends that sponsors observe subjects for potential gene therapy-related delayed adverse events for a 15-year period, including a minimum of five
          years of annual examinations followed by 10 years of annual queries, either in person or by questionnaire. The NIH and the FDA have a publicly accessible database, the Genetic Modification Clinical Research Information System, which includes
          information on gene therapy trials and serves as an electronic tool to facilitate the reporting and analysis of adverse events on these trials.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">United States drug review and approval process</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Following completion of clinical studies, the results are evaluated and, depending on the outcome, submitted to the FDA in the form of an NDA or BLA in order to obtain FDA approval of the product
          and authorization to commence commercial marketing. In responding to an NDA or BLA, the FDA may require additional testing or information, may require that the product labeling be modified, may impose a post-approval study and other commitments
          or reporting requirements or other restrictions on product distribution, or may deny the application.&#160; The timing of final FDA review and action varies greatly but can take years in some cases and may involve the input of an FDA advisory
          committee of outside experts. Product sales in the United States may commence only upon FDA approval of an NDA or BLA.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">FDA approval of a marketing application is required before marketing of the product may begin in the United States. The MA must include the results of product development, preclinical studies and
          clinical studies, together with other detailed information, including information on the chemistry, manufacture and controls utilized in manufacture of the product. In addition, an MA must also demonstrate purity, specifically in terms of showing
          that the final product does not contain extraneous material. The FDA has 60 days from its receipt of the MA to review the application to ensure that it is sufficiently complete for substantive review before accepting it for filing. The FDA may
          request additional information rather than accept an MA for filing. In this event, the MA must be resubmitted with the additional information. The resubmitted application also is subject to review before the FDA accepts it for filing. Once the
          submission is accepted for filing, the FDA begins an in-depth substantive review. The submission of an MA is also subject to the payment of a substantial application fee (although a waiver of such fee may be obtained under certain limited
          circumstances, including when the drug that is subject of the application has received Orphan Drug Designation for the indication sought). Further, the sponsor of an approved MA is subject to an annual program fee. User fees typically increase
          annually. The approval process is lengthy and complex, and the FDA may refuse to approve an MA if the applicable regulatory criteria are not satisfied or may require additional clinical or other data and information. Even if such data and
          information is submitted, the FDA may ultimately decide that the NDA or BLA does not satisfy the criteria for approval. The FDA may also refer applications for novel drug products or drug products which present difficult questions of safety or
          efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved. The FDA is not bound by the recommendation of an
          advisory committee. The FDA reviews an application to determine, among other things, whether a product is safe and effective for its intended use. Before approving an MA, the FDA will inspect the facility or facilities where the product is
          manufactured to determine whether its manufacturing is cGMP&#8211;compliant to assure and preserve the product&#8217;s identity, potency, quality, purity and stability.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">If the FDA&#8217;s evaluation of the marketing submission or manufacturing facilities is not favorable, the FDA will issue a complete response letter. The complete response letter outlines the
          deficiencies in the submission and often requires additional testing or information in order for the FDA to reconsider the application. Even after submitting this additional information, the FDA ultimately may decide that the application does not
          satisfy the regulatory criteria for approval. With limited exceptions, the FDA may withhold approval of an MA regardless of prior advice it may have provided or commitments it may have made to the sponsor.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Once an MA is approved, changes to the conditions of approval, including additional indications, are made by the submission of a supplement to the MA The supplemental NDA (&#8220;sNDA&#8221;) or the
          supplemental BLA (&#8220;sBLA&#8221;) must contain all of the information necessary to support the change. In the case of a new indication, that information usually consists of at least one clinical trial, and often more. Like an MA, FDA determines whether
          the supplemental application is sufficiently complete to permit review before it is filed. FDA then reviews the supplemental application. The FDA can either approve or issue a complete response letter outlining the deficiencies.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Manufacturing readiness</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">As part of the approval process, the FDA must inspect and approve each manufacturing facility. Among the conditions of approval is the requirement that a manufacturer&#8217;s quality control and
          manufacturing procedures conform to cGMP. Manufacturers must expend significant time, money and effort to ensure continued compliance, and the FDA conducts periodic inspections to verify compliance.&#160; If a manufacturer fails to comply or cannot
          remedy regulator identified deficiencies, then the FDA may prohibit the product from being marketed.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">If the FDA grants approval, the approval will be limited to those conditions and patient populations for which the product is safe and effective, as demonstrated through clinical studies.
          Further, a product may be marketed only in those dosage forms and for those indications approved in the MA. Certain changes to an approved MA, including, with certain exceptions, any significant changes to labeling, require approval of a
          supplemental application before the drug may be marketed as changed. Any products manufactured or distributed pursuant to FDA approvals are subject to continuing monitoring and regulation by the FDA, including compliance with cGMP and the
          reporting of adverse experiences with the drugs. The nature of marketing claims that the FDA permits in the labeling and advertising of products will generally be limited to those specified in FDA approved labeling, and the advertising of
          products will be subject to comprehensive monitoring and regulation by the FDA. Products whose review was accelerated may carry additional restrictions on marketing activities, including the requirement that all promotional materials are
          pre-submitted to the FDA. Claims exceeding those contained in approved labeling will constitute a violation of the FDCA. Violations of the FDCA or regulatory requirements at any time during the product development process, approval process, or
          marketing and sale following approval may result in agency enforcement actions, including corrective advertising, cessation of violative promotion, withdrawal of approval, recall, seizure of products, warning letters, injunctions, fines and/or
          civil or criminal penalties.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In addition, federal, state and foreign laws and regulations regarding the manufacture and sale of new drugs are subject to future changes.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Post-approval requirements and consideration</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Once an MA is approved, a product will be subject to certain post-approval requirements. For instance, the FDA and Federal Trade Commission closely regulate the post-approval marketing and
          promotion of drugs and biologics, including standards and regulations for direct-to-consumer advertising, off-label promotion, industry-sponsored scientific and educational activities and promotional activities involving the internet. As a
          condition of MA approval, the FDA may also require a risk evaluation and mitigation strategy (&#8220;REMS&#8221;) to help ensure that the benefits of the drug or biologic outweigh the potential risks. REMS can include medication guides, communication plans
          for the healthcare professionals, and other Elements to Assure Safe Use (&#8220;ETASU&#8221;). ETASU can include, but are not limited to, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special
          monitoring, and the use of patient registries. The requirement for a REMS can materially affect the potential market and profitability of the drug or biologic.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Drugs and biologics may be marketed only for the approved indications and in accordance with the provisions of the approved labeling. Changes to some of the conditions established in an approved
          application, including changes in indications, labeling, or manufacturing processes or facilities, require submission and FDA approval of a new MA supplement before the change can be implemented. An MA supplement for a new indication typically
          requires clinical data similar to that in the original application, and the FDA uses the same procedures and actions in reviewing MA supplements as it does in reviewing MAs.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Adverse event reporting and submission of periodic reports are required following FDA approval of an MA. The FDA also may require post-marketing testing, known as Phase 4 testing, and
          surveillance to monitor the effects of an approved product or place conditions on an approval that could restrict the distribution or use of the product. In addition, quality control as well as drug manufacture, packaging, and labeling procedures
          must continue to conform to cGMPs after approval. Drug and biologic manufacturers and certain of their subcontractors are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced
          inspections by the FDA during which the agency inspects manufacturing facilities to assess compliance with cGMPs. Accordingly, manufacturers must continue to expend time, money and effort in the areas of production and quality control to maintain
          compliance with cGMPs. Regulatory authorities may withdraw product approvals or request product recalls if a company fails to comply with regulatory standards, if it encounters problems following initial marketing, or if previously unrecognized
          problems are subsequently discovered.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Foreign regulatory requirements</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In addition to regulation by the FDA and certain state regulatory agencies, there are a variety of foreign regulations governing clinical trials and the marketing of products. Outside of the
          United States, the ability of a company to market a product depends upon receiving a marketing authorization from the appropriate regulatory agencies. The requirements governing the conduct of clinical trials, marketing authorization, pricing and
          reimbursement vary widely from country to country. In any country, however, a company will only be permitted to commercialize its products if the appropriate regulatory agency is satisfied that the company presented adequate evidence of safety,
          quality and efficacy. Whether or not FDA approval has been obtained, approval of a product by the comparable regulatory authorities of foreign countries must be obtained prior to the commencement of marketing of the product in those countries.
          The regulatory approval and oversight process in other countries includes all of the risks associated with regulation by the FDA and certain state regulatory agencies as described above.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Under the European Union regulatory system, applications for drug approval may be submitted either in a centralized or decentralized manner. Under the centralized procedure, a single application
          to the European Medicines Agency (&#8220;EMA&#8221;) may lead to an approval granted by the European Commission which permits marketing of the product throughout the European Union. The decentralized procedure provides for mutual recognition of nationally
          approved decisions and is used for products that do not comply with requirements for the centralized procedure. Under the decentralized procedure, the holders of national marketing authorization in one of the countries within the European Union
          may submit further applications to other countries within the European Union, who will be requested to recognize the original authorization based on an assessment report provided by the country in which marketing authorization is held.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Pharmaceutical pricing and reimbursement</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In both United States and foreign markets, the ability of a company to commercialize its products successfully, and to attract commercialization partners for its products, depends in significant
          part on the availability of adequate financial coverage and reimbursement from third-party payors, including, in the United States, governmental payors such as Medicare and Medicaid, managed care organizations, private commercial health insurers
          and pharmacy benefit managers (&#8220;PBMs&#8221;). Third party payors are increasingly challenging the prices charged for medicines and examining their cost effectiveness, in addition to their safety and efficacy. Companies may need to conduct expensive
          pharmacoeconomic or other studies to further demonstrate the value of its products. Even with the availability of such studies, products may be considered less safe, less effective or less cost-effective than alternative products, and third-party
          payors may not provide coverage and reimbursement for any product, in whole or in part.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Political, economic and regulatory influences are subjecting the health care industry in the United States to fundamental changes. There have been, and we expect there will continue to be,
          legislative and regulatory proposals to change the healthcare system in ways that could significantly affect the development and commercialization of products, including the Patient Protection and Affordable Care Act of 2010 (the &#8220;Affordable Care
          Act&#8221;).</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In the United States, Congress, state legislatures, and private sector entities are expected to continue to consider and may adopt healthcare policies intended to curb rising healthcare costs.
          These cost containment measures could include:</div>

        <div>&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>controls on government-funded reimbursement for drugs;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>mandatory rebates or additional charges to manufacturers for their products to be covered on Medicare Part D formularies;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>controls on healthcare providers;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>controls on pricing of pharmaceutical products, including the possible reference of the pricing of United States drugs to non-United States drug pricing for the same product;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>challenges to the pricing of drugs or limits or prohibitions on reimbursement for specific products through other means;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>reform of drug importation laws;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>entering into contractual agreements with payors; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#160;&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>expansion of use of managed-care systems in which healthcare providers contract to provide comprehensive healthcare for a fixed cost per person</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) contained several provisions designed to curb the prices of drugs and biologics to Medicare beneficiaries. For instance, the IRA will require the
          federal government to directly negotiate the prices of certain drugs and biologics beginning in 2026.&#160; Additionally, beginning in 2023, the IRA requires manufacturers of drugs and biologics to offer rebates if the price of the drug or biologic
          raises faster than inflation.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We are unable to predict what additional legislation, regulations or policies, if any, relating to the healthcare industry or third-party coverage and reimbursement may be enacted in the future
          or what effect such legislation, regulations or policies would have on our business.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Competition</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In the United States and internationally, major multinational pharmaceutical companies, established biotechnology companies, specialty pharmaceutical companies, universities and other research
          institutions have intellectual property and other technology that is competitive with our mRNA technology platform and the aspects thereof. The gene therapy market is characterized by rapidly advancing technologies, intense competition and a
          strong emphasis on proprietary products. Many of our competitors have significantly greater financial, marketing, technical and human resources than we do, and may also have strategic partnerships and collaborative arrangements with leading
          companies and research institutions. Established pharmaceutical companies may also invest heavily to accelerate discovery and development of technology that could make our mRNA technology platform or obsolete. Mergers and acquisitions in the
          pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. As a result of all of these factors, our competitors may succeed in obtaining patent protection and/or
          discovering, developing and commercializing technology that is competitive with or superior to our mRNA technology platform.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Human Capital Resources</div>

      <div>&#160;</div>

      <div style="font-style: italic;">Employees</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We operate in a highly competitive industry and recognize that our success relies upon our ability to attract, develop and retain a diverse team of talented individuals. We place high value on
          the satisfaction and well-being of our employees and operate with fair labor standards and industry-competitive compensation and benefits. As of March 12, 2024, we had eight full-time employees, which includes four research and development
          positions and four administrative positions. None of our employees are covered by collective bargaining agreements.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Compensation, Benefits and Development</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our approach to employee compensation and benefits is designed to deliver cash, equity and benefit programs that are competitive with those offered by leading companies in the biotechnology and
          pharmaceutical industries to attract, motivate and retain talent with a focus on encouraging performance, promoting accountability and adherence to our values and alignment with the interests of our stockholders.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our base pay program aims to compensate our employees relative to the value of the contributions of their role, which takes into account the skills, knowledge and abilities required to perform
          each position, as well as the experience brought to the job. We may also provide our employees with opportunities to earn performance-based cash and equity compensation to reward the achievement of company-wide goals established annually and
          designed to drive aspects of our strategic priorities that support and advance our strategy across our company. Our employees are also eligible to receive equity awards under our long-term incentive program that are designed to align their
          interests with the interests of our stockholders.&#160; All employees also participate in a regular performance measurement process through which staff receive performance and development feedback, which is taken into account in determining annual
          compensation.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Our benefit programs are generally broad-based, promote health and overall well-being and emphasize saving for retirement. All employees are eligible to participate in the same health and
          retirement savings plans.</div>

        <div>&#160;</div>

      </div>

      <div style="font-style: italic;">Code of Business Conduct and Ethics</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We are committed to conducting business in accordance with the highest ethical standards. Our Code of Conduct and Ethics, which applies to all our employees, emphasizes the importance of
          integrity, honesty, forthrightness, respect and fairness.</div>

        <div>&#160;</div>

      </div>

      <div style="font-style: italic;">Health, Safety and Well-Being</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We actively promote the safety, health and well-being of our employees. For example, we focused on employee safety throughout the COVID-19 pandemic by implementing extensive safety measures,
          which included on-site COVID-19 testing protocols and flexible remote working options for most of our employees.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Corporate Information</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our principal executive offices are located at 1035 Cambridge Street, Suite 18A, Cambridge, Massachusetts 02141, and our phone number is (212) 582-1199. We maintain a website at www.eternatx.com.
          Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended, are available free of charge on
          our website at www.eternatx.com, as soon as reasonably practicable after such reports are available on the Securities and Exchange Commission (SEC) website at www.sec.gov. Additionally, copies of our Annual Report will be made available, free of
          charge, upon written request. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference into this Annual Report on Form 10-K.</div>

        <div>&#160;</div>

      </div>

      <div> <a id="ITEM1A."><!--Anchor--></a>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top;"><span style="font-weight: bold;">ITEM 1A</span><span style="font-weight: bold; font-style: italic;">.</span></td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Risk Factors</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our business, financial condition and operating results can be affected by many factors, whether currently known or unknown, many of which are not exclusively within our control, including but
          not limited to those described below, any one or more of which could, directly or indirectly, cause our financial condition and operating results to differ materially from historical or anticipated future financial condition and operating
          results. Any of these factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price. We urge investors to carefully consider the risk factors described below in evaluating
          our stock and the information in this Annual Report on Form 10-K, including the consolidated financial statements and the notes thereto and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</div>

        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to our Business and Industry</div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We will require substantial additional capital to fund our operations and execute our business strategy, and we may not be able to raise adequate capital on a timely basis, on
        favorable terms, or at all.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Based on our current financial condition and forecasts of available cash, we will not have sufficient capital to fund our operations for the 12 months following the issuance date of the
          accompanying consolidated financial statements. We can provide no assurance that we will be able to obtain additional capital when needed, on favorable terms, or at all. If we cannot raise capital when needed, on favorable terms or at all, we
          will need to reevaluate our planned operations and may need to reduce expenses, file for bankruptcy, reorganize, merge with another entity, or cease operations. If we become unable to continue as a going concern, we may have to liquidate our
          assets, and might realize significantly less than the values at which they are carried on our financial statements, and stockholders may lose all or part of their investment in our common stock.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our future funding requirements, both near- and long-term, will depend on many factors, including, but not limited to:</div>

        <div>&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>our ability to enter into strategic partnerships to deploy our mRNA technology platform, and the terms of such strategic partnerships, including the economic terms and the proceeds we receive, if any, thereunder;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>the pace and success of our potential strategic partners in developing and commercializing their product candidates and/or products that deploy our mRNA technology platform and the proceeds to us, if any, as a result;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>the cost of filing, prosecuting, defending and enforcing our patent claims and other intellectual property rights;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>the cost of defending potential intellectual property disputes, including patent infringement actions brought by third parties against us or any of our potential strategic partners or collaborators; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 36pt; vertical-align: top;">&#9679;</td>

    <td style="width: auto; vertical-align: top;">
              <div>the effect of competing market developments.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We may seek to raise additional capital through a variety of means, including through equity, equity-linked or debt securities offerings, collaborations, strategic alliances or marketing,
          distribution or licensing arrangements with third parties. Our past success in raising capital through equity and convertible note offerings should not be viewed as an indication we will be successful in raising capital through those or any other
          means in the future. We expect that our ability to raise additional capital and the amount of capital available to us will depend not only on progress we make toward entering into strategic partnerships to deploy our mRNA technology platform and
          the terms thereof, but also on factors outside of our control, such as the pace and success of our potential strategic partners in developing and commercializing their product candidates and/or products that deploy our mRNA technology platform
          and the proceeds to us, if any, as a result, macroeconomic and financial market conditions.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">To the extent that we raise additional capital by issuing equity or equity-linked securities, existing stockholder ownership may experience substantial dilution, and the securities may include
          preferred shares with liquidation or other preferences that could harm the rights of a common stockholder. Servicing the interest and principal repayment obligations under our outstanding convertible notes and under any other debt we incur will
          divert funds that might otherwise be available to support our operations. In addition, debt financing involves covenants that restrict our ability to operate our business. To the extent we raise additional capital through arrangements with third
          parties, such arrangements would likely require us to relinquish valuable rights to our technologies or grant licenses on terms that may not be favorable to us.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Unstable and unfavorable market and economic conditions may harm our ability to raise additional capital. An economic downturn, recession or recessionary concerns, increased inflation, rising
          interest rates, adverse developments affecting financial institutions or the financial services industry, or the occurrence or continued occurrence of events similar to those in recent years, such as the COVID-19 pandemic or other public health
          emergencies, geopolitical conflict, natural/environmental disasters, terrorist attacks, strained relations between the U.S. and a number of other countries, social and political discord and unrest in the U.S. and other countries, and government
          shutdowns, among others, increase market volatility and have long-term adverse effects on the U.S. and global economies and financial markets. Volatility and deterioration in the financial markets and liquidity constraints or other adverse
          developments affecting financial institutions may make equity or debt financings more difficult, more costly or more dilutive and may increase competition for, or limit the availability of, funding from other third-party sources, such as from
          strategic collaborations.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We cannot be certain that additional capital will be available on acceptable terms, or at all. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we
          may have to significantly delay, scale back or discontinue our business activities, or potentially discontinue operations altogether. In addition, attempting to secure additional capital may divert the time and attention of our management from
          day-to-day activities and harm its ability to execute on our business strategy.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We have a limited operating history, have incurred significant losses since our inception and expect to continue to incur losses for the foreseeable future, which, together with
        our limited financial resources and substantial capital requirements, make it difficult to assess our prospects.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We have a limited operating history upon which to evaluate our business and prospects. We were formed in September 2018, for the purpose of consummating a business combination with IRX
          Therapeutics, Inc., which business combination was consummated in November 2018. Since inception, we have incurred significant net losses. As of December 31, 2023, we had an accumulated deficit of approximately $187.0 million. Since inception, we
          have primarily financed our operations by raising capital through the sale of shares of our common stock, warrants to purchase shares of our common stock and convertible notes.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We have not been profitable since we commenced operations and may never achieve profitability. We devoted significant resources to the development of our former product candidate, IRX-2, and in
          2022 we determined to cease the development of IRX-2. Our near-term focus is now on entering into strategic partnerships to deploy our mRNA technology platform. As discussed above, we must raise additional capital to finance our operations and
          remain a going concern and adequate additional capital may not be available to us on a timely basis, or at all.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We depend substantially, and expect in the future to continue to depend, on in-licensed intellectual property. Such licenses impose obligations on our business, and if we fail
        to comply with those obligations, we could lose license rights, which would substantially harm our business.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We rely on patents, know-how and proprietary technology licensed from Factor Limited under the A&amp;R Factor License Agreement. We may in the future become party to additional license agreements
          pursuant to which we in-license key intellectual property. The A&amp;R Factor License Agreement imposes various sublicense fees and other obligations on us. For example, we are obligated to pay the expenses incurred by Factor Limited in
          preparing, filing, prosecuting and maintaining the Factor Patents and have agreed to bear all costs and expenses associated with enforcing and defending the Factor Patents in any action or proceeding arising from pursuit of sublicensing
          opportunities under the license granted under the A&amp;R Factor License Agreement. Factor Limited has customary termination rights under the A&amp;R Factor License Agreement, including in connection with certain uncured material breaches of the
          A&amp;R Factor License Agreement and specified bankruptcy events. Any termination of our existing or future licenses could result in the loss of significant rights and would harm our business significantly.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Disputes may also arise between us and our licensors regarding intellectual property subject to a license agreement, including:</div>

        <div>&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the scope of rights granted under the license agreement and other interpretation-related issues;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>whether and the extent to which our technology and processes infringe intellectual property of the licensor that is not subject to the licensing agreement;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>our right to sublicense patents and other intellectual property to third parties under the license agreement;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>our diligence obligations under the agreement and what activities satisfy those diligence obligations;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the priority of invention of patented technology; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the ownership of inventions and know-how resulting from any joint creation or use of intellectual property by our licensors and us or our partners.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">If disputes over intellectual property that we have licensed, or license in the future, prevent or impair our ability to maintain our current licensing arrangements on acceptable
          terms, we may be unable to successfully enter into strategic partnerships. In addition, the resolution of any such disputes could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or
          increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Additionally, we may have limited control over the maintenance, prosecution or enforcement of rights we in-license, and we may also have limited control over activities previously or separately
          conducted by our licensors. For example, we cannot be certain that activities conducted by Factor Limited or any other present or future licensors have been or will be conducted in compliance with applicable laws and regulations or will result in
          valid and enforceable patents and other intellectual property rights. We may also have limited control over other intellectual property that is not licensed to us but that may be related to our in-licensed intellectual property. We may have
          limited control over the manner in which our licensors initiate an infringement proceeding against a third-party infringer or the intellectual property or defend certain of the intellectual property that is licensed to us. It is possible that the
          licensors&#8217; infringement proceedings or defense activities may be less vigorous than had we conducted them ourselves.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may have to abandon
          development of the relevant program or drug candidate and our business, financial condition, results of operations and prospects could suffer.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We are generally also subject to all of the same risks with respect to protection of intellectual property that we own, as we are for intellectual property that we license. If we or our licensors
          fail to adequately protect the intellectual property underlying our mRNA technology platform and any other in-licensed intellectual property, our ability to enter into strategic partnerships could materially suffer.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Our intellectual property rights may not adequately protect our business.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business. For
          example:</div>

        <div>&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>we, or our license partners or current or future collaborators, might not have been the first to make the inventions covered by the issued patent or pending patent application that we license or may own in the future;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>we, or our license partners or current or future collaborators, might not have been the first to file patent applications covering certain of our or their inventions;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating or otherwise violating any of our owned or licensed intellectual property rights;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>it is possible that our pending licensed patent applications or those that we may own in the future will not lead to issued patents;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors or other third parties;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>our competitors or other third parties might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>we may not develop additional proprietary technologies that are patentable;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the patents of others may harm our business;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>we may choose not to file a patent in order to maintain certain trade secrets or proprietary know- how, and a third party may subsequently file a patent covering such intellectual property; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>our trade secrets or proprietary know-how may be unlawfully disclosed, thereby losing their trade secret or proprietary status.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations and prospects.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We are substantially dependent on intellectual property we have in-licensed from Factor Limited, and if we lose the license to such intellectual property or the A&amp;R Factor
        License Agreement is terminated for any reason, our ability to enter into strategic partnerships would be harmed, and our business, financial condition and results of operations would be materially and adversely affected.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our business is substantially dependent upon the mRNA technology platform licensed from Factor Limited. Pursuant to the A&amp;R Factor License Agreement, Factor Limited has customary termination
          rights, including in connection with certain uncured material breaches of the A&amp;R Factor License Agreement, failure to make payments and specified bankruptcy events. Our ability to enter into strategic partnerships or develop therapeutics
          products using the Factor Patents depends entirely on the effectiveness and continuation of the A&amp;R Factor License Agreement. If we lose the right to license any of the mRNA technology platform, our ability to enter into strategic would be
          harmed.&#160; Further, if the A&amp;R Factor License Agreement is terminated, there is no guarantee that we will be able to enter into a new license agreement that aligns with our business strategy on the same or similar terms, if at all, and our
          competitors could in-license the technology, which would result in a significant market disadvantage to us.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We or our licensors may be subject to claims challenging the inventorship or ownership of the patents and other intellectual property that we own or license now or in the
        future.</div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an ownership interest in the patents and intellectual property that we in-license or
          that we may own or in-license in the future. While it is our policy to require our employees or contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may
          be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own or such assignment may not be self-executing, for example, as part of employment or consulting agreements, or may
          be breached. Our licensors may face similar obstacles. Litigation may be necessary to defend against any claims challenging inventorship or ownership, including in derivation proceedings in the USPTO. If we or our licensors fail in defending any
          such claims, we may have to pay monetary damages and may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property, which could adversely impact our business, results of operations and
          financial condition.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We have identified a material weakness in our internal control over financial reporting. If we are unable to develop and maintain an effective system of internal control over
        financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us, and materially and adversely affect our business and operating results.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our
          annual or interim financial statements will not be prevented or detected and corrected on a timely basis. Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In prior periods, we identified a material weakness as discussed below. We were unable to timely file our Quarterly Report on Form 10-Q for the three months ended March 31, 2022 with the SEC due
          to identifying errors in our financial statements reported in the Annual Report on Form 10-K for the years ended December 31, 2021 and 2020 during our preparation of the financial statements for the quarter ended March 31, 2022. On June 30, 2022,
          we filed an amendment to our Annual Report on Form 10-K for the years ended December 31, 2021 and 2020 to correct the errors in our financial statements for the years ended December 31, 2021 and 2020 and for the quarters ended June 30, 2020,
          September 30, 2020, March 31, 2021, June 30, 2021 and September 30, 2021. Management concluded that the errors were the result of accounting personnel&#8217;s lack of technical proficiency in the accounting for complex matters. This material weakness
          remained unremediated as of December 31, 2023.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">As disclosed in Part II, Item 9A to this Annual Report on Form 10-K, our Chief Executive Officer and Senior Vice President of Finance concluded that, as of December 31, 2023, our disclosure
          controls and procedures were not effective and did not provide reasonable assurance of achieving the desired control objectives. For a discussion of management&#8217;s consideration of its material weaknesses and plans for remediation, see Part II,
          Item 9A: Controls and Procedures included in this Annual Report on Form 10-K.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Management has implemented measures designed to ensure that the deficiencies contributing to the ineffectiveness of our internal control over financial reporting are remediated, such that the
          internal controls are designed, implemented and operating effectively. The remediation actions implemented to date include: enhancing the business process controls related to reviews over technical, complex, and non-recurring transactions;
          providing additional training to accounting personnel and using an external accounting advisor to review management&#8217;s conclusions on certain technical, complex and non-recurring matters. We will continue to season and further enhance the controls
          to ensure that they will continue to operate effectively for a sufficient period of time before management can make conclusions on the operating effectiveness. These remediation measures may be costly and there is no assurance that these
          initiatives will ultimately have the intended effects.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">If we identify any additional material weaknesses in the future, any such newly identified material weakness could limit our ability to prevent or detect a misstatement of our accounts or
          disclosures and could result in a material misstatement of our annual or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports, investors
          may lose confidence in our financial reporting and our stock price may decline as a result. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to avoid potential future
          material weaknesses.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We may face litigation and other risks as a result of the material weaknesses in our internal control over financial reporting.</div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We identified a material weakness in our internal controls over financial reporting. As a result of the material weakness, restating our previously issued financial statements, and other matters
          that may in the future be raised by the SEC, we may face the potential for litigation or other disputes which may include, among others, claims invoking the federal and state securities laws, contractual claims or other claims arising from the
          material weakness in our internal control over financial reporting and the preparation of our financial statements. As of the date of this Annual Report on Form 10-K, we have no knowledge of any such litigation or dispute. However, we can provide
          no assurance that such litigation or dispute will not arise in the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition or our
          ability to complete a business combination.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Our business and operations would suffer in the event of system failures, cyber-attacks or a deficiency in our cyber-security.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our computer systems, as well as those of various third parties on which we rely, may sustain damage from computer viruses, unauthorized access, data breaches, phishing attacks, cybercriminals,
          natural disasters (including hurricanes and earthquakes), terrorism, war and telecommunication and electrical failures. We rely on our third-party providers to implement effective security measures and identify and correct for any such failures,
          deficiencies or breaches. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusion, including by computer hackers, foreign governments and cyber terrorists, has generally increased as the number,
          intensity and sophistication of attempted attacks and intrusions from around the world have increased. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our drug development and
          other programs. To the extent that any disruption or security breach were to result in a loss of or damage to our data, or inappropriate disclosure of personal, confidential or proprietary information, we could incur liability and it could have a
          material adverse effect on our business, results of operations and financial condition. See Part I, Item 1C. Cybersecurity for more information on information regarding our cybersecurity risk management, strategy, and governance.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">If we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our ability to compete in the highly competitive life science industry depends in large part upon the ability to attract highly qualified personnel. In order to induce valuable employees to
          remain with us, we intend to provide employees with stock options and/or restricted stock units that vest over time. The value to employees of stock options that vest over time will be significantly affected by movements in the price of the
          common stock that it will not be able to control and may at any time be insufficient to counteract more lucrative offers from other companies.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Competition for skilled personnel in our industry is intense and competition for experienced scientists may limit our ability to hire and retain highly qualified personnel on acceptable terms.
          Despite our efforts to retain valuable employees, our employees may terminate their employment with us on short notice.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Other companies with which we compete for qualified personnel have greater financial and other resources, different risk profiles, and a longer history in the industry than we do, and such
          companies also may provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates than what we have to offer. If we are unable to continue to attract
          and retain high-quality personnel, our business, results of operations and financial condition may be materially adversely affected.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to New, Cutting Edge Technologies</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Because gene-editing and cell therapy product candidates that may be developed using our mRNA technology platform are based on novel technologies, we cannot assure that such
        products will be successful.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Cellular immunotherapies, stem cell therapies, gene-edited, and iPSC-derived product candidates represent relatively new therapeutic areas, and the FDA has cautioned consumers about potential
          safety risks associated with them. To date, there are relatively few approved cell therapies. As a result, the regulatory approval process for a gene-editing or cellular therapy product candidates is uncertain and may be more expensive and take
          longer than the approval process for product candidates based on other, better known or more extensively studied technologies and therapeutic approaches.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">19</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Cell reprogramming technology and related cell therapy products using iPSC lines represent novel therapeutic approaches, and to our knowledge no iPSC-derived cell products are currently approved
          for commercial sale anywhere in the world. As such, it is difficult to accurately predict the type and scope of challenges that potential strategic partners may confront in developing and advancing a pipeline of iPSC-derived therapeutic products.
          We and our strategic partners thus face uncertainties associated with the preclinical and clinical development, manufacture, and regulatory compliance for the initiation and conduct of clinical trials, regulatory approval, and reimbursement
          required for successful commercialization of future product candidates. Further, the processes and requirements imposed by the FDA or other applicable regulatory authorities may cause delays and additional costs in obtaining approvals for
          marketing authorization for any future product candidates. Because our platform is novel, and cell- and gene-based therapies are relatively new, regulatory agencies may lack experience in evaluating product candidates using our mRNA technology
          platform. This novelty may lengthen the regulatory review process, including the time it takes for the FDA to review IND applications if and when such applications are submitted, increase development costs, and delay or prevent commercialization
          of future products, if such products are approved for marketing.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Due to the rapid advancements in cellular and genetic technologies, regulatory processes and requirements in the United States and in other jurisdictions governing cellular and gene therapy
          products are evolving and the FDA or other regulatory bodies may change the requirements, or identify different regulatory pathways, for the clinical testing and approval of these product candidates. For example, in recent years the FDA has
          issued several new guidance documents related to developing and manufacturing cellular and gene therapy products. In addition, adverse developments in clinical trials of cellular gene therapy products conducted by others, or in treated patients
          after such products are commercialized, may cause the FDA or other oversight bodies to change the requirements for approval of any of our strategic partners&#8217; product candidates. For example, in November 2023, the FDA announced that it was
          investigating reports of T-cell malignancy in patients following their treatment with BCMA-directed or CD19-directed autologous chimeric antigen receptor (CAR) T-cell immunotherapies, although more recent public statements by agency leadership
          indicate that the benefits of such treatments are expected to still outweigh those risks. Future adverse events or safety issues could lead to more significant regulatory action applicable to either a specific product or a broader product class,
          based on case-by-case science-based benefit-risk assessments. Similarly, the EMA oversees the development of cellular and gene therapies in the EU and may issue new guidelines concerning the development and marketing authorization for cellular or
          gene therapy products and require that we comply with these new guidelines. These regulatory agencies and committees and any new regulations, requirements or guidelines they promulgate may lengthen the regulatory review process, which may reduce
          the anticipated benefits of our strategic partnerships or adversely affect the commercialization of any future therapeutic products they may develop.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Accordingly, our strategic partners may be required to change regulatory strategies or to modify applications for clinical investigations or regulatory approval, which could delay and impair
          their ability to complete the preclinical and clinical development and manufacture of, and obtain regulatory approval for, their product candidates. Changes in regulatory authorities and advisory groups, or any new regulations, requirements or
          guidelines they promulgate, may lengthen the regulatory review process, require additional studies, increase development and manufacturing costs, lead to changes in regulatory pathways, positions and interpretations, delay or prevent approval and
          commercialization of product candidates developed through our strategic partners or lead to significant post-approval limitations or restrictions that may reduce the anticipated benefits of our strategic partnerships.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Likewise, gene editing technology is relatively new, with the first cell-based gene therapy product incorporating such technology having been approved by the FDA in December 2023. In addition,
          only a limited number of clinical trials of product candidates based on gene-editing technologies have been commenced. It is therefore difficult to accurately predict the developmental challenges we may incur pursuing our business strategy. There
          may be long-term effects from treatment with any product candidates that our strategic partners may develop that we cannot predict at this time. Any such product candidates may interact with genetic material (RNA/DNA) and because animal genetic
          materials differ from human genetic material, past testing of any such product candidates in animal models may not be predictive of results in human clinical trials designed to demonstrate safety or efficacy. As a result of these factors, it is
          more difficult to predict the time and cost of such product candidate development, and we cannot predict whether the application of gene editing technology, or other similar or competitive gene editing technologies, will result in the
          identification, development or regulatory approval of any products.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The clinical trial requirements of the FDA, the EMA and other regulatory authorities and the criteria these regulators use to determine the safety and efficacy of a product candidate vary
          substantially according to the type, complexity, novelty and intended use and market of the product candidate. Due to the novelty and complexity of gene-edited cellular products, the regulatory approval process for such product candidates is
          uncertain and may be more expensive and take longer than the approval process for product candidates based on other, better known or more extensively studied technologies. It is difficult to determine how long it will take or how much it will
          cost to obtain regulatory approvals for product candidates using this technology in either the United States or the E.U. or how long it will take to commercialize any product candidates. Delay or failure to obtain, or unexpected costs in
          obtaining, the regulatory approval necessary to bring a potential product candidate to market could decrease our ability to generate sufficient product revenue, and our business, financial condition, results of operations and prospects may be
          harmed.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">20</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; font-style: italic; font-weight: bold;">We face intense competition and rapid technological change and the possibility that our competitors may develop therapies that are more advanced, safer, or more effective than
          any therapy we develop in the future, which may adversely affect our financial condition.</div>

        <div>&#160;</div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We are engaged in the development of gene therapies, which is a competitive and rapidly changing field. We have competitors both in the United States and internationally, including major
          multinational pharmaceutical companies, biotechnology companies, universities, and other research institutions. Many of our competitors have substantially greater financial, technical, research and human resources than we do, and may also have
          strategic partnerships and collaborative arrangements with leading companies and research institutions. Our competitors may succeed in developing, acquiring, or licensing on an exclusive basis, products that are more effective, safer, or less
          costly than any products that we may develop in the future, or achieve patent protection, marketing approval, product commercialization, and market penetration earlier than us. Additionally, technologies developed by our competitors may render
          any product candidates we are seeking to develop uneconomical or obsolete. For additional information regarding our competition, see &#8220;Part I, Item 1. Business&#8212;Competition&#8221;.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Negative public opinion and increased regulatory scrutiny of gene therapy and genetic research may damage public perception of our future product candidates or adversely affect
        our ability to conduct our business or obtain and maintain marketing approvals for our future product candidates.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Public perception may be influenced by claims that gene therapy, including gene editing technologies, is unsafe or unethical, and research activities and adverse events in the field, even if not
          ultimately attributable to us or our future product candidates, could result in increased governmental regulation, unfavorable public perception, challenges in recruiting patients to participate in future clinical studies involving product
          candidates using our mRNA technology platform, potential regulatory delays in the testing or approval of product candidates using our mRNA technology platform, labeling restrictions for any future approved products, and a decrease in demand for
          any such product. More restrictive government regulations or negative public opinion would have a negative effect on our business or financial condition and may delay or impair the development and commercialization of future product candidates
          using our mRNA technology platform or demand for any approved products.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">The manufacture of biotechnology products is complex, and manufacturers often encounter difficulties in production.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The manufacture of biotechnology products, including cellular and gene therapy products, is generally complex and requires significant expertise and capital investment. Manufacturers for any
          product candidates developed using our mRNA technology platform will be required to comply with cGMP regulations and guidelines for clinical trial product manufacture and subsequently for commercial product manufacture. Manufacturers of
          biotechnology products often encounter difficulties in production, particularly in scaling up, addressing product quality, product comparability, validating production processes and mitigating potential sources of contamination. These problems
          include difficulties with raw material procurement, production costs and yields, quality control, product quality, including stability of the product, quality assurance testing, operator error, shortages of qualified personnel, as well as
          compliance with strictly enforced federal, state and foreign regulations. Any delay or interruption in the supply of preclinical study supplies (or clinical trial supplies in the future) could delay the completion of such studies, increase the
          costs associated with the affected development programs and, depending upon the period of delay, require new studies to be commenced at additional expense or terminated completely.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to Ownership of our Common Stock</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Six stockholders collectively own a significant percentage of our outstanding common stock, and as a result of such ownership, such stockholders may influence the election of
        directors and other matters submitted to stockholders.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">According to their most recent Schedule 13G filings and/or our corporate records, six stockholders&#8212;Charles Cherington, Nicholas Singer, John D. Halpern, George P. Denny III, Freebird Partners LP
          and IAF, LLC&#8212;collectively own approximately 43% of our outstanding shares of common stock. Although, to our knowledge, such stockholders are not a &#8220;group&#8221; or &#8220;acting in concert,&#8221; they have and are expected to continue to have, individually and/or
          collectively, the ability to influence the election of our board of directors and the outcome of other matters submitted to our stockholders. In addition, each of those stockholders own note warrants and convertible notes, which if exercised
          and/or converted would increase their ownership percentage of our outstanding common stock. Pursuant to the terms of the note warrants and convertible notes, the number of shares of common stock that may be acquired by a particular holder upon
          exercise of the note warrants and/or conversion of the convertible notes is limited, to the extent necessary, to ensure that following such exercise and/or conversion, the number of shares of common stock then beneficially owned by the holder and
          any other persons or entities whose beneficial ownership of common stock would be attributed to the holder for purposes of Section 13(d) of the Exchange Act does not exceed 9.99% (for Messrs. Singer and Halpern and IAF, LLC) or 19.99% (for
          Messrs. Cherington and Denny and Freebird Partners LLP) of the total number of shares of our common stock then outstanding. The interests of these stockholders may not always coincide with our interests or the interests of other stockholders, and
          such stockholders, individually or collectively, may act in a manner that advances their best interests and not necessarily those of other stockholders. One consequence to this substantial influence is that it may be difficult for investors to
          remove our management and it could also deter unsolicited takeovers, including transactions in which stockholders might otherwise receive a premium for their shares over then current market prices.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">21</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; color: #000000;"><span style="font-weight: bold; font-style: italic;">The sale of our common stock to</span>&#160;<span style="font-weight: bold; font-style: italic;">Lincoln Park Capital Fund LLC (&#8220;Lincoln Park&#8221;) may
          cause dilution to our other stockholders and the subsequent sale of the shares of common stock acquired by Lincoln Park, or the perception that such sales may occur, could cause the price of our common stock to fall.</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Lincoln Park committed to purchase up to $10.0 million of our common stock under a standby equity purchase agreement (&#8220;SEPA&#8221;). Through December 31, 2023, we have issued and sold approximately
          214,000 shares of our common stock to Lincoln Park for approximately $0.3 million in gross proceeds under the SEPA, leaving an approximately $9.7 million balance of the $10.0 million total commitment. The purchase price for the shares that we may
          sell to Lincoln Park under the SEPA is subject to a pricing formula in the SEPA and will vary based on the price of our common stock at the time we initiate the sale. Depending on market liquidity at the time, sales of such shares may cause the
          trading price of our common stock to fall.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We generally have the right to control the timing and amount of any future sales of our shares to Lincoln Park under the SEPA. Sales of shares of our common stock to Lincoln Park under the SEPA,
          if any, will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Lincoln Park all, some or none of the shares of our common stock that may be available for us to sell pursuant to the SEPA.
          If and when we do sell shares to Lincoln Park, after Lincoln Park has acquired the shares, Lincoln Park may resell all, some or none of those shares at any time or from time to time in its discretion. Therefore, sales to Lincoln Park by us could
          result in substantial dilution to the interests of other holders of our common stock. Additionally, the sale of a substantial number of shares of our common stock to Lincoln Park, or the anticipation of such sales, could make it more difficult
          for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">There may be future sales or other dilution of our equity, which may adversely affect the market price of our common stock.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We are generally not restricted from issuing additional common stock, including any securities that are convertible into or exchangeable for, or that represent the right to receive, common stock.
          To raise additional capital, we may in the future sell additional shares of our common stock or other securities convertible into or exchangeable for our common stock at prices that are lower than the prices paid by existing stockholders, and
          investors purchasing shares or other securities in the future could have rights superior to existing stockholders, which could result in substantial dilution to the interests of existing stockholders. The market price of our common stock could
          decline as a result of sales of common stock or securities that are convertible into or exchangeable for, or that represent the right to receive, common stock or the perception that such sales could occur.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In addition, under the terms of the asset purchase agreement pursuant to which we acquired assets from Exacis Biotherapeutics Inc. (&#8220;Exacis&#8221;), we agreed to issue to Exacis shares of our common
          stock as contingent consideration. If our market capitalization equals or exceeds $100.0 million during the three-year period commencing on April 26, 2023 and ending on the three-year anniversary thereof, the number of shares of common stock we
          would issue is determined by a formula specified in the asset purchase agreement. In addition, if our market capitalization equals or exceeds $200.0 million during the same three-year period, we agreed to issue to Exacis additional shares of our
          common stock determined by a formula specified in the asset purchase agreement. See Note 4 to the accompanying consolidated financial statements for additional information.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">In addition to the shares that may be sold to Lincoln Park under the SEPA, a large number of shares may be issued and subsequently sold upon the exercise of outstanding options
        and warrants and upon the conversion of our outstanding convertible notes.</div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">22</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">As of March 12, 2024, there were approximately 5.4 million shares of our common stock outstanding. In addition, there were approximately 2.2 million shares of common stock issuable under
          outstanding options with a weighted average exercise price of $9.29 per share, 20.4 million shares of common stock issuable upon exercise of outstanding warrants with a weighted average exercise price of $2.05 per share, 3.1 million shares of
          common stock issuable upon conversion of our outstanding July 2023 convertible notes (assuming all principal and accrued interest is converted at a conversion rate of $2.86 per share) and 4.8 million shares of common stock issuable upon
          conversion of our outstanding December 2023 convertible notes (assuming all principal and accrued interest is converted at a conversion rate of $1.9194 per share). To the extent that holders of such securities sell the shares of common stock
          issued upon the exercise or conversion of such securities, the market price of our common stock may decrease due to the additional selling pressure in the market. In addition to the risk of dilution from the sale of shares of our common stock to
          Lincoln Park described above, the risk of dilution from issuances of shares of common stock underlying outstanding securities and/or to Exacis described above may cause stockholders to sell their common stock, which could further decline in the
          market price.</div>

        <div>&#160;</div>

        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">The terms of our convertible notes could limit our growth and our ability to finance our operations, fund our capital needs, respond to changing conditions and engage in other
        business activities that may be in our best interests.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our convertible notes contain a number of restrictive covenants that, among other things, generally limit our ability to create liens, pay dividends, acquire shares of capital stock and make
          payments on subordinated debt, incur indebtedness, or enter into transactions with affiliates. Our ability to comply with these covenants may be adversely affected by events beyond our control, and we cannot assure you that we can comply with
          these covenants. The financial covenants could limit our ability to make needed expenditures or otherwise conduct necessary or desirable business activities.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">The requirement that we redeem our convertible notes in cash could adversely affect our business plan, liquidity, financial condition, and results of operations.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">If not converted, we are required to redeem some or all of the principal of our convertible notes for cash under certain circumstances. These obligations could have important consequences on our
          business. In particular, they could:</div>

        <div>&#160;</div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>limit our flexibility in planning for, or reacting to, changes in our businesses and the industries in which we operate;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>increase our vulnerability to general adverse economic and industry conditions; and</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>place us at a competitive disadvantage compared to our competitors.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div><br/>
        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">No assurances can be given that we will be successful in making the required payments to the holders of our convertible notes or that we will be able to comply with the financial or other
          covenants in our convertible notes. If we are unable to make the required cash payments or otherwise comply with the covenants in our convertible notes:</div>

        <div>&#160;</div>

        <div><br/>
        </div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the holders of our convertible notes may require us to repurchase some or all of their convertible notes at a price equal to 100% of the principal amount being repurchased, plus accrued and unpaid interest;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the holders of our convertible notes could foreclose against our assets; and/or</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>we could be forced into bankruptcy or liquidation.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our common stock.</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our common stock is listed on The Nasdaq Capital Market. The Nasdaq Capital Market requires that listed companies satisfy continued listing requirements, one of which that listed companies have:
          (x) stockholders' equity of at least $2.5 million; (y) a market value of listed securities of at least $35 million; or (z) net income from continuing operations of $500,000 in the company&#8217;s most recently completed fiscal year or in two of the
          three most recently completed fiscal years. Our stockholders&#8217; equity at December 31, 2023 was approximately $2.2 million and we do not currently meet either of the two alternative compliance standards described in clause (y) and (z). Accordingly,
          we expect to receive a notice from Nasdaq informing us that we do not meet the foregoing continued listing requirements. If we receive such a notice, we expect to be afforded 45 days to submit a plan to regain compliance with the stockholders&#8217;
          equity requirement for Nasdaq&#8217;s consideration, and if the plan is accepted, to be granted an extension period of up to 180 calendar days from the date of the deficiency notice to regain compliance. If the plan is not accepted or if we are unable
          to regain compliance within any extension period granted by Nasdaq, Nasdaq would be required to issue a delisting determination, which we expect we would be entitled to request a hearing before a Nasdaq Hearings Panel to present a plan to regain
          compliance and to request a further extension period to regain compliance.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">23</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">If we fail to satisfy any of the Nasdaq continued listing requirements, Nasdaq may take steps to delist our common stock. In the event of a delisting, we can provide no assurance that any action
          taken by us to restore compliance with Nasdaq continued listing requirements would be successful.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">If our common stock is ultimately delisted by Nasdaq, and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an
          over-the-counter market. If this were to occur, then we could face significant material adverse consequences, including: a material reduction in the liquidity of our common stock and a corresponding material reduction in the trading price of our
          common stock; a more limited market quotations for our securities; a determination that our common stock is a &#8220;penny stock&#8221; that requires brokers to adhere to more stringent rules and possibly resulting in a reduced level of trading activity in
          the secondary trading market for our securities; more limited research coverage by stock analysts; loss of reputation; more difficult and more expensive equity financings in the future; the potential loss of confidence by investors; and fewer
          business development opportunities.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as
          &#8220;covered securities.&#8221; If our common stock remains listed on Nasdaq, our common stock will be covered securities. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to
          investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. If our securities were no longer listed on Nasdaq
          and therefore not &#8220;covered securities,&#8221; we would be subject to regulation in each state in which we offer our securities.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Anti-takeover provisions of Delaware law and provisions in our charter and bylaws could make a third-party acquisition of us difficult.</div>

      <div>
        <div><br/>
        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Because we are a Delaware corporation, the anti-takeover provisions of Delaware law could make it more difficult for a third party to acquire control of us, even if the change in control would be
          beneficial to stockholders. We are subject to the provisions of Section 203 of the General Corporation Law of Delaware, which prohibits us from engaging in certain business combinations, unless the business combination is approved in a prescribed
          manner. In addition, our restated certificate of incorporation and restated bylaws also contain certain provisions that may make a third-party acquisition of us difficult, including the ability of our board of directors to issue preferred stock
          and the inability of our stockholders to call a special meeting or act by written consent.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to our Financial Position and Capital Requirements</div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We may acquire businesses, assets or products, or form strategic alliances, in the future, and we may not realize the benefits of such acquisitions.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We may acquire additional businesses, assets or products, form strategic alliances or create joint ventures with third parties that we believe will complement or augment our existing business. If
          we acquire businesses with promising intellectual property, markets or technologies, we may not be able to realize the benefit of acquiring such businesses if we are unable to successfully integrate them with our existing operations and company
          culture. We may encounter numerous difficulties in developing, manufacturing and marketing any new acquisition. Difficulties may prevent us from realizing its expected benefits or enhancing our business. We cannot assure you that, following any
          such acquisition, we will achieve the expected synergies to justify the transaction.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Our ability to utilize our net operating loss carryforwards and tax credit carryforwards may be subject to limitations.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our ability to use our federal and state net operating losses (&#8220;NOLs&#8221;) to offset potential future taxable income and related income taxes that would otherwise be due is dependent upon our
          generation of future taxable income, and we cannot predict with certainty when, or whether, we will generate sufficient taxable income to use all of our NOLs.</div>

        <div><br/>
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">24</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Under Section 382 and Section 383 of the Code and corresponding provisions of state law, if a corporation undergoes an &#8220;ownership change,&#8221; its ability to use its pre-change NOL carryforwards and
          other pre-change tax attributes (such as research tax credits) to offset its post-change income may be limited. A Section 382 &#8220;ownership change&#8221; is generally defined as a greater than 50 percentage point change (by value) in its equity ownership
          by certain stockholders over a three-year period. Even if we achieve profitability, we may not be able to utilize a material portion of our NOL carryforwards and other tax attributes, which could have a material adverse effect on cash flow and
          results of operations. Similar provisions of state tax law may also apply to limit our use of accumulated state tax attributes. There is also a risk that due to regulatory changes, such as suspensions on the use of NOLs, or other unforeseen
          reasons, our existing NOLs could expire or otherwise be unavailable to offset future income tax liabilities.</div>

        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Risks Related to Regulatory Requirements</div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We are subject to extensive and costly government regulation.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Product candidates employing medical technology are subject to extensive and rigorous domestic government regulation including regulation by the FDA, other divisions of the United States
          Department of Health and Human Services, the United States Department of Justice, state and local governments, and their respective foreign equivalents. If products employing our technologies are marketed abroad, they will also be subject to
          extensive regulation by foreign governments, whether or not they have obtained FDA approval for one or more uses. Such foreign regulation may be equally or more demanding than corresponding United States regulation.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Government regulation substantially increases the cost and risk of researching, developing, manufacturing, and selling medical products. Even if we or our strategic partners are able to obtain
          regulatory approval for a particular product candidate, the approval may limit the indicated medical uses for the product, may otherwise limit the ability to promote, sell, and distribute the product, may require costly post-marketing
          surveillance, and/or may require ongoing post-marketing studies. Material changes to an approved product, such as, for example, manufacturing changes or revised labeling, may require further regulatory review and approval. Once obtained, any
          approvals may be withdrawn, including, for example, if there is a later discovery of previously unknown problems with the product, such as a previously unknown safety issue.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In addition, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of a product candidate. For example, regulatory agencies
          may approve a product candidate for fewer or more limited indications than requested or may grant approval subject to the performance of post-marketing studies. Regulators may approve a product candidate for a smaller patient population, a
          different drug formulation or a different manufacturing process, than we or our strategic partners are seeking.</div>

        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">The regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time-consuming and inherently unpredictable. If our potential strategic
        partners are ultimately unable to obtain regulatory approval for their product candidates, we may be unable to product revenue and our business will be substantially harmed.</div>

      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We cannot commercialize a product until the appropriate regulatory authorities have reviewed and approved the product candidate. The time required to obtain approval by the FDA and comparable
        foreign regulatory authorities is unpredictable, typically takes many years following the commencement of clinical studies and depends upon numerous factors, including the type, complexity, and novelty of the product candidates involved. Regulatory
        authorities have substantial discretion in the approval process and may refuse to accept an application for review, or may decide that our data are insufficient for approval and require additional non-clinical, clinical or other studies.</div>

      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We may never be able to obtain regulatory approval for any product candidates that we develop in the future. If our future product candidates are ultimately not approved for any reason, our
        business, prospects, results of operations and financial condition would be adversely affected.</div>

      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;">In addition, even once clinical development of a future product candidate is initiated, such clinical studies may not start or be completed on schedule, if at all. The completion or commencement of
        clinical studies can be delayed or prevented for a number of reasons, including, among others:</div>

      <div><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the FDA or comparable foreign regulatory authorities may not authorize us or our future clinical investigators to commence planned clinical studies, or require that we suspend ongoing clinical studies through imposition of clinical
                holds;</div>
            </td>

  </tr>


</table>
      <div> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">25</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>negative results from our ongoing studies or other industry studies involving engineered or gene-edited cell therapy product candidates;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>delays in reaching or failing to reach agreement on acceptable terms with prospective clinical research organizations (&#8220;CROs&#8221;) and clinical study sites, the terms of which can be subject to considerable negotiation and may vary
                significantly among different CROs and study sites;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>inadequate quantity or quality of a product candidate or other materials necessary to conduct clinical studies, for example delays in the manufacturing of sufficient supply of finished drug product;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>difficulties obtaining ethics committee or IRB, approval to conduct a clinical study at a prospective site or sites;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>challenges in recruiting and enrolling subjects to participate in clinical studies, the proximity of subjects to study sites, eligibility criteria for the clinical study, the nature of the clinical study protocol, the availability of
                approved effective treatments for the relevant disease and competition from other clinical study programs for similar indications;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>severe or unexpected drug-related side effects experienced by subjects in a clinical study, such as severe neurotoxicity and cytokine release syndrome;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the FDA or comparable foreign regulatory authorities may disagree with a proposed clinical study design, implementation of clinical trials or our interpretation of data from clinical studies, or may change the requirements for approval
                even after it has reviewed and commented on the design for our clinical studies;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>reports from non-clinical or clinical testing of other competing candidates that raise safety or efficacy concerns; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>difficulties retaining subjects who have enrolled in a clinical study but may be prone to withdraw due to rigors of the clinical studies, lack of efficacy, side effects, personal issues, or loss of interest.</div>
            </td>

  </tr>


</table>
      <div>
        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Changes in regulatory requirements, agency guidance or unanticipated events during our non-clinical studies and future clinical studies of our future product candidates may
        occur, which may result in changes to non-clinical or clinical study protocols or additional non-clinical or clinical study requirements, which could result in increased costs to us and could delay our projected development timeline.</div>

      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Changes in regulatory requirements or FDA or EMA guidance, or unanticipated events during our non-clinical studies and future clinical studies, may force us to amend non-clinical studies and future
        clinical study protocols. The FDA, EMA or comparable foreign regulatory authorities may also impose additional non-clinical studies and clinical study requirements. Amendments to protocols for or other aspects of our non-clinical studies may
        increase the cost or delay the timing or successful completion of those studies. If we experience delays completing, or if we terminate, any of our non-clinical or future clinical studies, or if we are required to conduct additional non-clinical or
        clinical studies, the commercial prospects for our future product candidates may be harmed and our ability to recognize product revenue will be delayed.</div>

      <div>
        <div><br/>
        </div>

        <div style="text-align: justify; font-style: italic; font-weight: bold;">The results of non-clinical studies and early-stage clinical trials of our future therapeutic candidates may not be predictive of the results of later stage clinical trials.</div>

      </div>

      <div>
        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Success in non-clinical studies and early clinical trials does not ensure that later and pivotal clinical trials will generate the same results, or otherwise provide adequate data to demonstrate
          the safety and efficacy of a therapeutic candidate. Frequently, therapeutic candidates that have shown promising results in non-clinical studies or early clinical trials have subsequently suffered significant setbacks in later clinical trials.
          There can be no assurance that any of our non-clinical and preclinical programs will ultimately be successful or support initiating clinical development of any of our future therapeutic candidates. A number of companies in the pharmaceutical and
          biotechnology industries have suffered significant setbacks in clinical development even after achieving promising results in earlier non-clinical studies or clinical trials, and any such setbacks in our development pipeline could have a material
          adverse effect on our business and operating results.</div>

        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Disruptions at the FDA and other government agencies caused by funding shortages or other events or conditions outside of their control could negatively impact our business.</div>

      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">26</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt;">The ability of the FDA to review and approve INDs, proposed clinical trial protocols, or new product candidates can be affected by a variety of factors, including, but not limited to, government
        budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, statutory, regulatory, and policy changes, and other events that may otherwise affect the FDA&#8217;s ability to perform routine functions. Average
        review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is
        subject to the political process, which is inherently fluid and unpredictable.</div>

      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Disruptions at the FDA and other regulatory agencies may also slow the time necessary for new product candidates to be reviewed or approved by necessary government agencies, which would adversely
        affect our business. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical employees and stop critical activities. In
        addition, during the COVID-19 pandemic, the FDA&#8217;s inspectional activities were interrupted and restarted on a risk-based basis, which had the effect of delaying review and potential approval of product candidate marketing applications.</div>

      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;">If a prolonged government shutdown occurs, or if global health concerns prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory
        activities, it could significantly impact the ability of the FDA to timely review and process our future regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our
        ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</div>

      <div><br/>
      </div>

      <div style="font-style: italic; font-weight: bold;">If we do not comply with laws regulating the protection of the environment and health and human safety, our business could be adversely affected.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We maintain quantities of various flammable and toxic chemicals in our facilities in Massachusetts that are used for our research and development activities. We are subject to federal, state and
          local laws and regulations governing the use, manufacture, storage, handling and disposal of these hazardous materials. We believe our procedures for storing, handling and disposing these hazardous materials in our laboratory facilities comply
          with the relevant guidelines of the relevant local, state, and the Occupational Safety and Health Administration of the U.S. Department of Labor. Although we believe that our safety procedures for handling and disposing of these materials comply
          with the standards mandated by applicable regulations, the risk of accidental contamination or injury from these materials cannot be eliminated. If an accident occurs, we could be held liable for resulting damages, which could be substantial. We
          are also subject to numerous environmental, health and workplace safety laws and regulations, including those governing laboratory procedures, exposure to blood-borne pathogens and the handling of animals and biohazardous materials. Any insurance
          coverage we have may not be sufficient to cover these liabilities. Additional federal, state and local laws and regulations affecting our operations may be adopted in the future. We may incur substantial costs to comply with, and substantial
          fines or penalties if we violate, any of these laws or regulations which would adversely affect our business.</div>

      </div>

      <div><br/>
      </div>

      <div style="font-style: italic; font-weight: bold;">Healthcare legislative reform measures may have a material and adverse effect on our business, financial condition, results of operations, and prospects.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Third-party payors, whether domestic or foreign, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In both the United States and
          certain foreign jurisdictions, there have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal, and state levels directed at containing or lowering the cost of healthcare. We cannot predict the
          initiatives that may be adopted in the future. The continuing efforts of the government, insurance companies, managed care organizations, and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price
          controls may adversely affect:</div>

      </div>

      <div><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>the demand for our therapeutic candidates, if we obtain marketing approval;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>our ability to receive or set a price that we believe is fair for our future products;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>our ability to generate revenue and achieve or maintain profitability;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>the level of taxes that we are required to pay; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>the availability of capital.</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">27</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The Affordable Care Act of 2010 (&#8220;ACA&#8221;) includes measures that have significantly changed the way healthcare is financed by both governmental and private insurers in the United States. It also
          included the provisions that created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed reference biological product. The ACA continues to significantly impact the United
          States&#8217;s pharmaceutical industry.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Moreover, there has been heightened governmental scrutiny over the manner in which prescription drug and biological product manufacturers set prices for their marketed products, which has
          resulted in several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient
          programs, and reform government program reimbursement methodologies for drug products. In August 2022, President Biden signed into the law the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;), which includes (among other things) multiple provisions that
          may impact the prices of drug products that are both sold into the Medicare program and throughout the United States. A manufacturer of drug products covered by Medicare Parts B or D must pay a rebate to the federal government if their drug
          product&#8217;s price increases faster than the rate of inflation. The IRA is in the process of being implemented by CMS and its impact on the pharmaceutical industry in the United States remains uncertain at this time, in part because multiple large
          pharmaceutical companies and other stakeholders (e.g., the U.S. Chamber of Commerce) have initiated federal lawsuits against CMS arguing a separate price negotiation program is unconstitutional for a variety of reasons, among other complaints.
          Those lawsuits are currently ongoing.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient
          reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. For example, in
          recent years, several states have formed prescription drug affordability boards (&#8220;PDABs&#8221;). These PDABs have attempted to implement upper payment limits on drugs sold in their respective states in both public and commercial health plans. For
          example, in August 2023, Colorado&#8217;s PDAB announced a list of five prescription drugs that would undergo an affordability review. The effects of these efforts similarly remain uncertain pending the outcomes of several federal lawsuits challenging
          state authority to regulate prescription drug payment limits.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We expect that the ACA, the IRA, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare funding, more
          rigorous coverage criteria, lower reimbursement, and new payment methodologies. This could lower the price that we receive for any future approved therapeutic product. Any denial in coverage or reduction in reimbursement from Medicare or other
          government-funded programs may result in a similar denial or reduction in payments from private payors, which may prevent us from being able to generate sufficient revenue, attain profitability, or commercialize our future therapeutic candidates,
          if approved.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">In the European Union, similar political, economic and regulatory developments may affect our ability to profitably commercialize our current or any future products. In addition to continuing
          pressure on prices and cost containment measures, legislative developments at the European Union or member state level may result in significant additional requirements or obstacles that may increase our operating costs. In international markets,
          reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific products and therapies. Our future products, if any, might not be considered medically reasonable and
          necessary for a specific indication or cost-effective by third-party payors, an adequate level of reimbursement might not be available for such products and third-party payors&#8217; reimbursement policies might adversely affect our ability to sell any
          future products profitably.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Legislative and regulatory proposals have also been made to expand post-approval requirements and restrict sales and promotional activities for biologic therapeutics, and FDA&#8217;s statutory
          authorities are periodically amended by Congress. For example, as part of the Consolidated Appropriations Act for 2023, Congress provided FDA additional authorities related to the accelerated approval pathway for human drugs and biologics. Under
          these recent amendments to the FDCA, the agency may require a sponsor of a product granted accelerated approval to have a confirmatory trial underway prior to approval. The amendments also give FDA the option of using expedited procedures to
          withdraw product approval if the sponsor&#8217;s confirmatory trial fails to verify the claimed clinical benefits of the product. We cannot be sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or
          interpretations will be changed, or what the impact of such changes on the marketing approvals of our therapeutic candidates, if any, may be. Increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent
          marketing approval, as well as subject us to more stringent product labeling and post-approval testing and other requirements.</div>

        <div><br/>
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">28</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In addition, in April 2023 the European Commission issued a proposal that will revise and replace the existing general pharmaceutical legislation governing drug and biological products intended
          for the EU market. If adopted and implemented as currently proposed, these revisions will significantly change several aspects of drug development and approval in the EU.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow
          or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, our therapeutic candidates may lose any marketing approval that may have been
          obtained and we may not achieve or sustain profitability, which would adversely affect our business.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-weight: bold;">Risks Relating to Eterna&#8217;s Intellectual Property</div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">If we are unable to obtain and maintain patent and other intellectual property protection, or if the scope of the patent and other intellectual property protection obtained is
        not sufficiently broad, our competitors could develop and commercialize products similar or identical to those derived from our intellectual property, and our ability to achieve profitability may be adversely affected.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our ability to compete effectively will depend, in part, on our ability to maintain the proprietary nature of our technology and manufacturing processes. We rely on research, manufacturing and
          other know-how, patents, trade secrets, license agreements and contractual provisions to establish our intellectual property rights. These legal means, however, afford only limited protection and may not adequately protect our rights.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In certain situations, and as considered appropriate, we have sought, and we intend to continue to seek to protect our proprietary position by filing patent applications in the United States and,
          in at least some cases, one or more countries outside the United States relating to future products and product candidates that we or our strategic partners or collaborators may develop that are important to our business. However, we cannot
          predict whether the patent applications currently being pursued will issue as patents, or whether the claims of any resulting patents will provide us with a competitive advantage or whether we will be able to successfully pursue patent
          applications in the future relating to such products and product candidates. Moreover, the patent application and approval processes are expensive and time-consuming. We may not be able to file and prosecute all necessary or desirable patent
          applications at a reasonable cost or in a timely manner. Furthermore, we, or any future partners, collaborators, or licensees, may fail to identify patentable aspects of inventions made in the course of development and commercialization
          activities before it is too late to obtain patent protection on them. Therefore, we may miss potential opportunities to seek additional patent protection. It is possible that defects of form in the preparation or filing of patent applications may
          exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we fail to establish, maintain or protect such patents and other intellectual property
          rights, such rights may be reduced or eliminated. If there are material defects in the form, preparation, prosecution or enforcement of our patents or patent applications, such patents may be invalid and/or unenforceable, and such applications
          may never result in valid, enforceable patents.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Even if they are unchallenged, our patents and patent applications, if issued, may not provide us with any meaningful protection or prevent competitors from designing around our patent claims by
          developing similar or alternative technologies or therapeutics in a non-infringing manner. For example, a third party may develop a competitive therapy that provides benefits similar to one or more of the future products and product candidates
          that we or our strategic partners or collaborators may develop but that falls outside the scope of our patent protection. If the patent protection provided by the patents and patent applications we hold or pursue with respect to such product
          candidates is not sufficiently broad to impede such competition, the successful commercialization of such product candidates could be negatively affected.</div>

      </div>

      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">29</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Other parties, many of whom have substantially greater resources and have made significant investments in competing technologies, have developed or may develop technologies that may be related or
          competitive with our approach, and may have filed or may file patent applications and may have been issued or may be issued patents with claims that overlap or conflict with our patent applications, either by claiming the same compositions,
          formulations or methods or by claiming subject matter that could dominate our patent position. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. As a result, any patents we
          may obtain in the future may not provide us with adequate and continuing patent protection sufficient to exclude others from commercializing products similar to future products and product candidates that we or our strategic partners or
          collaborators may develop.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain. No consistent policy regarding the breadth of claims allowed in biotechnology and pharmaceutical
          patents has emerged to date in the United States or in many foreign jurisdictions. The standards applied by the USPTO and foreign patent offices in granting patents are not always applied uniformly or predictably. In addition, the determination
          of patent rights with respect to pharmaceutical compounds commonly involves complex legal and factual questions, which has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and
          commercial value of our patent rights are highly uncertain. Our competitors may also seek approval to market their own products similar to or otherwise competitive with our products. Alternatively, our competitors may seek to market generic
          versions of any approved products by submitting ANDAs or ABLAs to the FDA in which they claim that our patents are invalid, unenforceable or not infringed. In these circumstances, we may need to defend or assert our patents, or both, including by
          filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or other agency with jurisdiction may find our patents invalid or unenforceable, or that our competitors are competing in a non-infringing manner. Thus,
          we cannot offer any assurances about which, if any, patents will issue, the breadth of any such patents, whether any issued patents will be found invalid and unenforceable or will be threatened by third parties or whether any issued patents will
          effectively prevent others from commercializing competing technologies and drug candidates.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In addition to patent protection, we expect to rely heavily on trade secrets, know-how and other unpatented technology, which are difficult to protect. Although we seek such protection in part by
          entering into confidentiality agreements with our vendors, employees, consultants and others who may have access to proprietary information, we cannot be certain that these agreements will not be breached, adequate remedies for any breach would
          be available, or our trade secrets, know-how and other unpatented proprietary technology will not otherwise become known to or be independently developed by our competitors. If we are unsuccessful in protecting our intellectual property rights,
          sales of our products may suffer and our ability to generate revenue could be severely impacted.</div>

        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We cannot ensure that patent rights relating to inventions described and claimed in our pending patent applications will issue, or that our issued patents or patents that issue
        in the future will not be challenged and rendered invalid and/or unenforceable.</div>

      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;">The patent application process is subject to numerous risks and uncertainties, and there can be no assurance that we or any of our potential future collaborators will be successful in protecting
        our drug candidates by obtaining and defending patents. We have pending and issued U.S. and foreign patents and patent applications in our portfolio; however, we cannot predict:</div>

      <div><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>if and when patents may issue based on our patent applications;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>the scope of protection of any patent issuing based on our patent applications;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>whether the claims of any issued patent will provide protection against competitors;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>whether or not third parties will find ways to invalidate or circumvent our patent rights;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>whether or not others will obtain patents claiming aspects similar to those covered by our patents and patent applications;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>whether we will need to initiate litigation or administrative proceedings to enforce and/or defend our patent rights which will be costly whether we win or lose; and/or</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
              <div>whether the patent applications will result in issued patents with claims that cover each of our drug candidates or uses thereof in the United States or in other foreign countries.</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">30</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt;">We may be subject to a third-party pre-issuance submission of prior art to the USPTO or become involved in post-grant review procedures, oppositions, derivations, revocation, reexaminations, inter
        partes review or interference proceedings, in the United States or elsewhere, challenging our patent rights or the patent rights of others. An adverse determination in any such challenge may result in loss of exclusivity or in our patent claims
        being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technology and products or limit the duration of the patent protection of our
        technology and products. Such challenges also may result in substantial cost and require significant time from our scientists and management, even if the eventual outcome is favorable to us. Any of the foregoing could have a material adverse effect
        on our business, financial condition, results of operations, and prospects. Furthermore, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies
        from collaborating with us to license, develop or commercialize current or future drug candidates.</div>

      <div>
        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We may rely on more than one patent to provide multiple layers of patent protection for our drug candidates. If the latest-expiring patent is invalidated or held unenforceable, in whole or in
          part, the overall protection for the drug candidate may be adversely affected. For example, if the latest-expiring patent is invalidated, the overall patent term for our drug candidate could be adversely affected.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; color: #000000;"><span style="font-weight: bold; font-style: italic;">Issued patents covering future products and product candidates that we or our strategic partners or collaborators may develop</span>&#160;<span style="font-weight: bold; font-style: italic;">could be found invalid or unenforceable if challenged in court or in administrative proceedings. We may not be able to protect our trade secrets in court.</span></div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">If we initiate legal proceedings against a third-party to enforce a patent covering future products and product candidates that we or our strategic partners or collaborators may develop, the
          defendant could counterclaim that the patent covering such products or product candidates is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace.
          Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, written description or non-enablement. Grounds for an unenforceability assertion could be an
          allegation that someone connected with prosecution of the patent withheld information material to patentability from the USPTO, or made a misleading statement, during prosecution. Third parties also may raise similar claims before administrative
          bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re- examination, post grant review, <span style="font-style: italic;">inter partes</span> review and equivalent proceedings in foreign
          jurisdictions. An adverse determination in any of the foregoing proceedings could result in the revocation or cancellation of, or amendment to, our patents in such a way that they no longer cover future products and product candidates that we or
          our strategic partners or collaborators may develop. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no
          invalidating prior art, of which the patent examiner and we were unaware during prosecution. If a defendant or third party were to prevail on a legal assertion of invalidity or unenforceability, we could lose at least part, and perhaps all, of
          the patent protection on one or more of the future products and product candidates that we or our strategic partners or collaborators may develop. Such a loss of patent protection could have a material adverse impact on our business.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In addition, our trade secrets may otherwise become known or be independently discovered by competitors. Competitors and other third parties could purchase future products and product candidates
          that we or our strategic partners or collaborators may develop and attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe, misappropriate or otherwise violate our intellectual
          property rights, design around our protected technology or develop their own competitive technologies that fall outside of our intellectual property rights. If any of our trade secrets were to be lawfully obtained or independently developed by a
          competitor or other third party, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If our trade secrets are not adequately protected or sufficient to
          provide an advantage over our competitors, our competitive position could be adversely affected, as could our business. Additionally, if the steps taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse
          against third parties for misappropriating our trade secrets.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent
        agencies, and our patent protection could be reduced or eliminated for non- compliance with these requirements.</div>

      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">31</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and applications are required to be paid to the USPTO and various governmental patent agencies
          outside of the United States in several stages over the lifetime of the patents and applications. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedurals, documentary, fee payment and other
          similar provisions during the patent application process and after a patent has issued. There are situations in which non- compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of
          patent rights in the relevant jurisdiction. The terms of one or more licenses that we enter into the future may not provide us with the ability to maintain or prosecute patents in the portfolio and must therefore rely on third parties to do so.
          If we fail to obtain and maintain the patents and patent applications covering our products or procedures, we may not be able to stop a competitor from marketing products that are the same as our product candidates, which could have a material
          adverse effect on our business.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">If we do not obtain patent term extension for future products that we or our strategic partners or collaborators may successfully develop, our business may be materially harmed.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional
          filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering future products and product candidates that we or our strategic partners or collaborators may develop
          are obtained, once the patent life has expired for a particular product, we or our strategic partners or collaborators may be open to competition from competitive products. Given the amount of time required for the development, testing and
          regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are approved and commercialized. As a result, our patent portfolio may not provide us with sufficient rights to
          exclude others from commercializing products similar or identical to ours.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In the future, if we obtain an issued patent covering one of the product candidates that we or our strategic partners or collaborators may develop, depending upon the timing, duration and
          specifics of any FDA marketing approval of such product candidates, such patent may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, or Hatch-Waxman Amendments. The
          Hatch-Waxman Amendments permit a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process for drugs and biologics. A patent term extension cannot extend the remaining term of a patent
          beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. A patent may only be extended
          once and only based on a single approved product. However, we may not be granted an extension because of, for example, failure to obtain a granted patent before approval of a product candidate, failure to exercise due diligence during the testing
          phase or regulatory review process, failure to apply within applicable deadlines, failure to apply prior to expiration of relevant patents or otherwise our failure to satisfy applicable requirements. A patent licensed to us by a third party may
          not be available for patent term extension. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or the term of any such extension is less
          than we request, our competitors may obtain approval of competing products following our patent expiration, and our revenue could be reduced, possibly materially.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">Changes in patent law in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect future products and
        product candidates that we or our strategic partners or collaborators may develop.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Changes in either the patent laws or the interpretation of the patent laws in the United States or other jurisdictions could increase the uncertainties and costs surrounding the prosecution of
          patent applications and the enforcement or defense of issued patents. On September 16, 2011, the Leahy-Smith America Invents Act, or the Leahy-Smith Act, was signed into law. When implemented, the Leahy-Smith Act included several significant
          changes to U.S. patent law that impacted how patent rights could be prosecuted, enforced and defended. In particular, the Leahy-Smith Act also included provisions that switched the United States from a &#8220;first-to-invent&#8221; system to a
          &#8220;first-to-file&#8221; system, allowed third- party submission of prior art to the USPTO during patent prosecution and set forth additional procedures to attack the validity of a patent by the USPTO administered post grant proceedings. Under a
          first-to-file system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to the patent on an invention regardless of whether another inventor had made the
          invention earlier. The USPTO developed new regulations and procedures governing the administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, and in particular, the first to file
          provisions, only became effective on March 16, 2013. Some of the Company&#8217;s patents and patent applications have effective dates later than March 16, 2013 and thus will be subject to the provisions of the Leahy-Smith Act.</div>

      </div>

      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">32</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent rulings from the U.S. Court of Appeals
          for the Federal Circuit and the U.S. Supreme Court have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events has created uncertainty
          with respect to the validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that
          could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We may not be able to protect our intellectual property rights throughout the world.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Filing, prosecuting, maintaining, defending and enforcing patents on products and product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual
          property rights in some countries outside the United States could be less extensive than those in the United States. The requirements for patentability may differ in certain countries, particularly in developing countries; thus, even in countries
          where we do pursue patent protection, there can be no assurance that any patents will issue with claims that cover our products. There can be no assurance that we will obtain or maintain patent rights in or outside the United States under any
          future license agreements. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties
          from utilizing our inventions in all countries outside the United States, even in jurisdictions where we pursue patent protection, or from selling or importing products made using our inventions in and into the United States or other
          jurisdictions. Competitors may use our technologies in jurisdictions where we have not pursued and obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent
          protection, but enforcement is not as strong as that in the United States. These products may compete with future products and product candidates that we or our strategic partners or collaborators may develop and our patents or other intellectual
          property rights may not be effective or sufficient to prevent them from competing with us.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Moreover, our ability to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in foreign intellectual property laws. Additionally, laws of some
          countries outside of the United States and Europe do not afford intellectual property protection to the same extent as the laws of the United States and Europe. Many companies have encountered significant problems in protecting and defending
          intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries including India and China, do not favor the enforcement of patents, trade secrets and other intellectual
          property protection, particularly those relating to biotechnology and pharmaceutical products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights
          generally. For example, many foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. Consequently, we may not be able to prevent third parties from practicing our inventions in certain
          countries outside the United States and Europe. In addition, many countries limit the enforceability of patents against government authorities or government contractors. In these countries, the patent owner may have limited remedies, which could
          materially diminish the value of such patent. If we are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of
          operations, and prospects may be adversely affected.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Proceedings to enforce our patent rights, even if obtained, in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business,
          could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the
          damages or other remedies awarded, if any, may not be commercially meaningful. While we intend to protect our intellectual property rights in major markets for our products, we cannot ensure that we will be able to initiate or maintain similar
          efforts in all jurisdictions in which we may wish to market our products. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual
          property that we develop.</div>

        <div><br/>
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">33</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent, which might adversely affect our
        ability to develop and market our products.</div>

      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We cannot guarantee that any of our patent searches or analyses, including the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or
        thorough, nor can we be certain that we have identified each and every third-party patent and pending application in the United States and abroad that is relevant to or necessary for the commercialization of our drug candidates in any jurisdiction.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#8217;s prosecution history. Our interpretation of the relevance or the
          scope of a patent or a pending application may be incorrect. For example, we may incorrectly determine that our products are not covered by a third-party patent or may incorrectly predict whether a third-party&#8217;s pending application will issue
          with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect. Our failure to identify and correctly interpret relevant patents may negatively
          impact our ability to develop and market our products.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We may be subject to claims by third parties asserting that our employees or we have misappropriated their intellectual property or claiming ownership of what we regard as our
        own intellectual property.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Many of our current and former employees, including our senior management, were previously employed at universities or at other biotechnology or pharmaceutical companies, including some which may
          be competitors or potential competitors. Some of these employees may be subject to proprietary rights, non-disclosure and non- competition agreements, or similar agreements, in connection with such previous employment. Although we try to ensure
          that our employees do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees have used or disclosed intellectual property, including trade secrets or other
          proprietary information, of any such third party. Litigation may be necessary to defend against such claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or
          personnel or sustain damages. Such intellectual property rights could be awarded to a third party, and we could be required to obtain a license from such third party to commercialize our technology or products. Such a license may not be available
          on commercially reasonable terms or at all. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In addition, while we typically require our employees, consultants and contractors who may be involved in the development of intellectual property to execute agreements assigning such
          intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own, which may result in claims by or against us related to the ownership of such
          intellectual property. If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. Even if we are successful in prosecuting or defending against such claims,
          litigation could result in substantial costs and be a distraction to our senior management and scientific personnel.</div>

        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our patents, trade secrets, or other intellectual property as an
          inventor or co- inventor. For example, we or our collaborators may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our drug candidates. Litigation may be necessary
          to defend against these and other claims challenging inventorship or ownership of our patents, trade secrets or other intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may
          lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our drug candidates. Even if we are successful in defending against such claims, litigation could result in
          substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</div>

      </div>

      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">34</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">We may become involved in lawsuits to protect or enforce our patents and other intellectual property rights, which could be expensive, time-consuming and unsuccessful.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Competitors may infringe our patents, trademarks, copyrights or other intellectual property. To counter infringement or unauthorized use, we may be required to file infringement claims, which can
          be expensive and time consuming and divert the time and attention of our management and scientific personnel. In addition, our patents may become, involved in inventorship, priority, or validity disputes. To counter or defend against such claims
          can be expensive and time-consuming, and our adversaries may have the ability to dedicate substantially greater resources to prosecuting these legal actions than we can. Any claims we assert against perceived infringers could provoke these
          parties to assert counterclaims against us alleging that we infringe their patents, in addition to counterclaims asserting that our patents are invalid or unenforceable, or both.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In an infringement proceeding, a court may decide that a patent is invalid or unenforceable or may refuse to stop the other party from using the technology at issue on the grounds that our
          patents do not cover the technology in question. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing upon or misappropriating intellectual property rights we own or control. An adverse result in any
          litigation proceeding could put one or more of our owned or in-licensed patents at risk of being invalidated or interpreted narrowly. Further, because of the substantial amount of discovery required in connection with intellectual property
          litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Even if resolved in our favor, the court may decide not to grant an injunction against further infringing activity and instead award only monetary damages, which may or may not be an adequate
          remedy. Litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. Alternatively, we may be required to obtain a
          license from such third party in order to use the infringing technology and continue developing, manufacturing or marketing the infringing drug candidate. However, we may not be able to obtain any required license on commercially reasonable terms
          or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, we could be found liable for monetary damages, including treble damages
          and attorneys&#8217; fees if we are found to have willfully infringed a patent. Furthermore, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors
          perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for
          development activities or any future sales, marketing, or distribution activities.</div>

      </div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or
          proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other
          proceedings could have a material adverse effect on our ability to compete in the marketplace.</div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic; font-weight: bold;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our marks of interest and our business may be adversely
        affected.</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our current or future trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We rely on both registration and
          common law protection for our trademarks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our
          markets of interest. During trademark registration proceedings, we may receive rejections. Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, with the USPTO and
          with comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our
          trademarks, and our trademarks may not survive such proceedings. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected. We may
          license our trademarks and trade names to third parties, such as distributors. Although these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks
          and tradenames by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names.</div>

        <div><br/>
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">35</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Moreover, any proprietary name we have proposed to use with our drug candidates in the United States must be approved by the FDA, regardless of whether we have registered it, or applied to
          register it, as a trademark. Similar requirements exist in Europe. The FDA typically conducts a review of proposed proprietary product names, including an evaluation of potential for confusion with other product names. If the FDA (or an
          equivalent administrative body in a foreign jurisdiction) objects to any of our proposed proprietary product names, we may be required to expend significant additional resources in an effort to identify a suitable substitute name that would
          qualify under applicable trademark laws, not infringe the existing rights of third parties, and be acceptable to the FDA. Furthermore, in many countries, owning and maintaining a trademark registration may not provide an adequate defense against
          a subsequent infringement claim asserted by the owner of a senior trademark. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly
          leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks
          or trade names. If we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or unenforceable, or that the party against whom we have asserted trademark infringement has superior rights to the
          marks in question. In this case, we could ultimately be forced to cease use of such trademarks.</div>

        <div><br/>
        </div>

      </div>

      <a id="ITEM1B."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 1B.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-style: italic; font-weight: bold;">Unresolved Staff Comments</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-indent: 36pt;">We do not have any unresolved comments issued by the SEC Staff.</div>

      <div><br/>
      </div>

      <a id="ITEM1C."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 1C.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-style: italic; font-weight: bold;">Cybersecurity</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic;">Risk Management and Strategy</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have integrated these processes into our overall risk management
          systems and processes. We monitor cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that we use through third party providers that may result in adverse effects on the
          confidentiality, integrity, or availability of our information systems or any information residing therein.</div>

        <div style="text-indent: 36pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We engage consultants in connection with our risk assessment processes. These service providers assist us in designing and implementing our cybersecurity policies and procedures, as well as
          monitoring and testing our safeguards. We require each third-party service provider to certify that it has the ability to implement and maintain appropriate security measures, consistent with all applicable laws, to implement and maintain
          reasonable security measures in connection with their work with us, and to promptly report any suspected breach of its security measures that may affect our company.</div>

        <div style="text-indent: 36pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">As of December 31, 2023 and through the date of the filing of this report, we are not aware&#160; of any cybersecurity incidents that have materially affected or are reasonably likely to materially
          affect us, including our business strategy, results of operations or financial condition. For additional information regarding risks from cybersecurity threats, please refer to Item 1A, &#8220;Risk Factors,&#8221; in this report.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Governance</div>

      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for
          monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our board of directors administers its cybersecurity risk oversight function through its
          audit committee, which provides oversight of our cybersecurity program as part of its periodic review of enterprise risk management.</div>

        <div style="text-indent: 36pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Our Chief Executive Officer and Senior Vice President of Finance are primarily responsible for assessing and managing our material risks from cybersecurity threats. In this regard, our Chief
          Executive Officer and Senior Vice President of Finance have assistance from consultants.</div>

        <div style="text-indent: 36pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Our Chief Executive Officer and Senior Vice President of Finance oversee our cybersecurity policies and processes, including those described in &#8220;Risk Management and Strategy&#8221; above. Under such
          policies and processes, our Chief Executive Officer and Senior Vice President are responsible for reporting to our audit committee regarding any cybersecurity incidents.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">36</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The audit committee, in turn, provides periodic reports to our board of directors regarding our cybersecurity processes, including the results of cybersecurity risk assessments.</div>

        <div>&#160;</div>

      </div>

      <a id="ITEM2."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 2.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Properties</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We currently lease approximately 49,000 square feet of office and laboratory space in the aggregate in New York and Massachusetts, of which, approximately 45,000 square feet is new office and
          laboratory space in Somerville, Massachusetts that we subleased in October 2022. The terms of our leases expire from December 2026 through approximately November 2033. We believe that our leased properties are generally well maintained, in good
          operating condition and meet our current business needs.</div>

        <div>&#160;</div>

      </div>

      <a id="ITEM3."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 3.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Legal Proceedings</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">For a description of our legal proceedings, refer to Note 13 to the consolidated financial statements, which is incorporated herein by reference.</div>

        <div>&#160;</div>

      </div>

      <a id="ITEM4."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 4.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Mine Safety Disclosures</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-indent: 36pt;">Not Applicable.</div>

      <div style="color: rgb(0, 0, 0);"> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">37</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: center; font-weight: bold;">PART II</div>

      <div style="text-align: center; color: #000000; font-weight: bold;"> <br/>
      </div>

      <a id="ITEM5."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 5.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;">Market Information</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our common stock is listed on The Nasdaq Capital Market under the symbol &#8220;ERNA.&#8221;</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Holders of Common Stock</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">As of March 12, 2024, there were approximately 155 stockholders of record. The number of stockholders of record is based upon the actual number of holders registered on our books at such date. A
          substantially greater number of holders of our common stock are &#8220;street name&#8221; or beneficial holders, whose shares are held by banks, brokers and other financial institutions.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Preferred Stock</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We have 156,112 shares of Series A Preferred Stock issued and outstanding. The Series A Preferred Stock provides for a cumulative annual dividend of 10 cents per share, payable in semi-annual
          installments in June and December. Dividends may be paid in cash or in shares of our common stock. In 2023, we paid approximately $16,000 in cash dividends to the holders of our Series A Preferred Stock. We expect to pay the dividends on our
          Series A Preferred Stock in accordance with its terms.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Dividend Policy</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We have not declared or paid any cash dividends on our common stock. We currently do not anticipate paying any cash dividends in the foreseeable future. Any future determination to declare cash
          dividends will be made at the discretion of our board of directors, subject to applicable laws and contractual limitations, and will depend on our financial condition, results of operations, capital requirements, general business conditions and
          other factors that our board of directors may deem relevant.</div>

        <div><br/>
        </div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Securities Authorized for Issuance under Equity Compensation Plans</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Information about our equity compensation plans is incorporated herein by reference to Item 12 of Part III of this report.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Recent Sales of Unregistered Securities</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We did not sell any unregistered securities during the period covered by this report that were not previously reported in a Quarterly Report on Form 10-Q or Current Report on Form 8-K.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Issuer Purchases of Equity Securities</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">None.</div>

        <div>&#160;</div>

      </div>

      <a id="ITEM6."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 6.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">[Reserved]</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <a id="ITEM7."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 7.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000;">The following discussion should be read in conjunction with our consolidated financial statements and the notes thereto included in Part II, Item 8 of this report. The following
          discussion contains forward-looking statements. See &#8220;CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS&#8221; in Part I of this report. Forward-looking statements are not guarantees of future activities or results. Many factors could cause our
          actual activities or results to differ materially from those anticipated in forward-looking statements, including those discussed in &#8220;Item 1A. Risk Factors&#8221; of Part I of this report.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Overview</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">We are a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines.&#160; We have in-licensed a portfolio of over 100
        patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> and UltraSlice<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> gene-editing proteins, and the ToRNAdo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> mRNA delivery system, which we collectively
        refer to as our &#8220;mRNA technology platform.&#8221; We refer to aspects of our mRNA technology platform as &#8220;mRNA delivery,&#8221; &#8220;mRNA gene editing&#8221; and &#8220;mRNA cell reprogramming.&#8221; We license our mRNA technology platform from Factor Bioscience Limited (&#8220;Factor
        Limited&#8221;) under an exclusive license agreement.</div>

      <div>&#160;</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">38</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Our near-term focus is on entering into strategic partnerships to deploy our mRNA technology platform. We expect that potential strategic partners will use our mRNA technology
        platform for preclinical and eventual clinical development of product candidates for a variety of clinical indications.</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Following receipt of the results from the INSPIRE phase 2 trial of IRX-2, our only product candidate, in June 2022, we determined to cease the development of IRX-2. We do not currently plan to
        develop any product candidates. In the future we may develop and advance product candidates, either internally and/or through strategic partnerships.</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-weight: bold;">Recent Financings</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In July 2023, we received $8.7 million from a private placement in which we issued $8.7 million in aggregate principal amount of convertible notes (the &#8220;July 2023 convertible notes&#8221;) and warrants
          to purchase an aggregate of approximately 6.1 million shares of our common stock (the &#8220;July 2023 warrants&#8221;).</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">On December 8, 2023, we received $1.5 million in exchange for a 6% promissory note with an aggregate principal amount of $1.5 million we issued to Charles Cherington. The promissory note was to
          mature on January 8, 2024, and interest accrued at a rate of 6.0% per annum, payable at maturity.&#160; On December 14, 2023, we repaid the $1.5 million of principal and $1,500 of accrued interest due under the promissory note.&#160; There are no further
          obligations under the promissory note.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">On December 14, 2023, we entered into a purchase agreement with certain purchasers for the private placement of $9.2 million of convertible notes (the &#8220;December 2023 convertible notes&#8221; and
          together with the July 2023 convertible notes, the &#8220;convertible notes&#8221;) and warrants to purchase an aggregate of approximately 9.6 million shares of our common stock (the &#8220;December 2023 warrants&#8221; and together with the July 2023 warrants, the
          &#8220;note warrants&#8221;).&#160; There were two closings under this purchase agreement: on December 15, 2023, we received $7.8 million and issued $7.8 million in December 2023 convertible notes and December 2023 warrants to purchase approximately 8.1 million
          shares of our common stock, and on January 11, 2024, we received the remaining $1.4 million and issued an aggregate of $1.4 million in December 2023 convertible notes and December 2023 warrants to purchase approximately 1.5 million shares of our
          common stock.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The July 2023 convertible notes bear interest at 6% per annum, and the December 2023 convertible notes bear interest at 12% per annum, both of which are payable quarterly in arrears.&#160; At our
          election, we may pay interest either in cash or in-kind by increasing the outstanding principal amount of the applicable notes.&#160; The July 2023 convertible notes mature on July 14, 2028, and the December 2023 convertible notes mature on December
          15, 2028 and January 11, 2029, depending on the issuance date of such notes, unless earlier converted or repurchased.&#160; We may not redeem any of the convertible notes prior to maturity.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">At the option of the holder, the July 2023 convertible notes and the December 2023 convertible notes may be converted from time-to-time in whole or in part into shares of our common stock at a
          conversion rate of $2.86 per share and $1.9194 per share, respectively, subject to customary adjustments for stock splits, stock dividends, recapitalization and the like.&#160; The convertible notes contain conversion limitations such that no
          conversion may be made if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99%, 9.99% or 19.99% immediately after conversion thereof, subject to certain increases not in excess of either 9.99%
          or 19.99% at the option of the holder.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The convertible notes provide for customary events of default (subject in certain cases to customary grace and cure periods), which include, among others: nonpayment of principal or interest;
          breach of covenants or other agreements in the convertible notes; the occurrence of a material adverse effect event and certain events of bankruptcy. Generally, if an event of default occurs and is continuing under the convertible notes, the
          holder thereof may require us to repurchase some or all of their convertible notes at a repurchase price equal to 100% of the principal amount of the convertible notes being repurchased, plus accrued and unpaid interest thereon.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In connection with the issuance of the December 2023 convertible notes, we agreed to reduce the exercise price of the warrants we issued in a private placement in December 2022 to purchase an
          aggregate of approximately 4.4 million shares of our common stock from $3.28 to $1.43 per share and of the July 2023 warrants from $2.61 to $1.43 per share.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">39</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Basis of Presentation</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic;">Revenue</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our near-term focus is on deploying our mRNA technology platform through strategic partnerships. We are not currently developing any product candidates. Our future revenue, if any, is primarily
          expected to come from out-licensing our mRNA technology platform and/or aspects thereof.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In February 2023, we entered into an exclusive option and license agreement with a third party, under which we granted such third party an option to obtain an exclusive sublicense to certain of
          our technology for preclinical, clinical and commercial purposes in exchange for a non-refundable up-front payment to us of $0.3 million. In August 2023, that third party requested that we begin developing certain induced pluripotent stem cell
          lines in exchange for a cell line customization fee. The third party paid us $0.4 million towards the customization fee, which we are recognizing ratably over the customization period, which is expected to be approximately 20 to 25 months.&#160; We
          will only earn the remaining amount of the customization fee if we make certain progress towards delivery of the customized cell line. We estimate the amount of consideration we expect to recognize as revenue that is not probable of having a
          significant reversal of such recognized revenue, and we place a constraint on the remaining contractual consideration. As it becomes evident that the constrained amounts are no longer at risk of a significant reversal of revenue, we will remove
          the constraint from the related revenue and recognize a cumulative catch-up adjustment to revenue in the period in which the constraint was removed. For additional information, see Note 5 to the consolidated financial statements included in Part
          II, Item 8 of this report.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">License Costs</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We recognize certain license costs payable to Factor Limited under the exclusive license agreement we entered into with Factor Limited.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Research and Development Expenses</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We expense our research and development costs as incurred. Our research and development expenses consist of costs incurred for company-sponsored research and development activities, as well as
          support for selected investigator-sponsored research. Upfront payments and milestone payments we make for the in-licensing of technology are expensed as research and development in the period in which they are incurred if the technology is not
          expected to have any alternative future uses other than the specific research and development project for which it was intended.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The major components of research and development costs include salaries and employee benefits, stock-based compensation expense, supplies and materials, preclinical study costs, expensed licensed
          technology, consulting, scientific advisors and other third-party costs, and allocations of various overhead costs related to our product development efforts. Research and development costs for the year ended December 31, 2022 also included
          expenses related to our former IRX-2 clinical trials as well as insurance coverage for the clinical trials.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We have contracted with third parties to perform various studies.&#160; The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. We accrue for
          third party expenses based on estimates of the services received and efforts expended during the reporting period.&#160; If the actual timing of the performance of the services or the level of effort varies from the estimate, the accrual is adjusted
          accordingly.&#160; The expenses for some third-party services may be recognized on a straight-line basis if the expected costs are expected to be incurred ratably during the period. Payments under the contracts depend on factors such as the
          achievement of certain events or milestones, the successful enrollment of patients, the allocation of responsibilities among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">General and Administrative Expenses</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our general and administrative expenses consist primarily of salaries, benefits and other costs, including equity-based compensation, for our executive and administrative personnel, legal and
          other professional fees, travel, insurance, and other corporate costs.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">40</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Comparison of the Years Ended December 31, 2023 and 2022</div>

      <div><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2023</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Revenue</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>68</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>68</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Cost of revenues</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>236</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>236</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Gross loss</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(168</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(168</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Operating expenses:</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Research and development</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>5,920</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>10,392</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(4,472</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">General and administrative</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>14,587</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>16,835</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(2,248</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Acquisition of Exacis IPR&amp;D</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>460</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>460</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Impairment of IRX-2 IPR&amp;D</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>5,990</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(5,990</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total operating expenses</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>20,967</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>33,217</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(12,250</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss from operations</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(21,135</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(33,217</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>12,082</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other expense, net:</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Change in fair value of warrant liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>215</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>10,795</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(10,580</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Change in fair value of contingent consideration</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>118</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>118</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss on non-controlling investment</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(59</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(941</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>882</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt; text-indent: -9pt;">Interest income<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1">138</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1">-</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1">138</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="margin-left: 9pt; text-indent: -9pt;">Interest expense<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">(614</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">)<br/>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">(30</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">)<br/>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">(584</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">)<br/>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other expense, net</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">(334</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(1,141</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">807</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total other (expense) income, net</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(536</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>8,683</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(9,219</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss before income taxes</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(21,671</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(24,534</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>2,863</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Benefit (provision) for income taxes</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>3</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(45</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>48</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Net loss</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(21,668</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(24,579</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>2,911</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="text-align: justify; font-style: italic;">Revenue</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">During the year ended December 31, 2023, we recognized revenue related to the cell line customization activities we performed for a third party.&#160; We did not perform any such activities, or
          otherwise recognize any revenue, during the year ended December 31, 2022.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Cost of Revenue</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">During the year ended December 31, 2023, our cost of revenues includes direct labor and materials to perform the customization cell line activities for a third party, as well as royalty expense
        owed to Factor Limited in accordance with our exclusive license agreement with Factor Limited.&#160; There were no comparable expenses for the year ended December 31, 2022.</div>

      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic;">Research and Development Expenses</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;"> 2023</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">License and MSA expense</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>3,250</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>4,761</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(1,511</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Payroll-related</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>701</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>2,426</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(1,725</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Stock-based compensation</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>234</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>1,249</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(1,015</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Clinical</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>74</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>1,047</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(973</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Professional fees</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>810</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>312</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>498</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other expenses, net</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>851</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>597</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>254</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total research and development expenses</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>5,920</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>10,392</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(4,472</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Total research and development expenses decreased by approximately $4.5 million for the year ended December 31, 2023 compared to the year ended December 31, 2022 primarily due to (a) decreased
          expenses under our master services agreement (&#8220;MSA&#8221;) with Factor Bioscience during 2023 and (b) decreased payroll expense and stock-based compensation expense due to employee terminations and a reduction in clinical trial expense as a result of
          our clinical trial ending in 2022, partially offset by (i) a full year of fees paid to Factor Bioscience under the MSA during 2023 and (ii) an increase in professional fees in 2023 related to consulting activities.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">41</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic;">General and Administrative Expenses</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;"> 2023</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Professional fees</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>6,464</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>8,499</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(2,035</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Payroll-related</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>2,045</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>2,942</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(897</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Insurance</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>1,140</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>1,951</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(811</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Stock-based compensation</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>1,008</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>1,686</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(678</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss on disposal or sale of fixed assets</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>1</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>280</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(279</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Occupany expense</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>3,306</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>640</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>2,666</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other expenses, net</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>623</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>837</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(214</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total general and administrative expenses</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>14,587</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>16,835</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(2,248</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our general and administrative expenses decreased by approximately $2.2&#160; million for the year ended December 31, 2023 compared to the year ended December 31, 2022 primarily due to (a) decreases
          in professional fees resulting from less legal and consulting fees, (b) decreases in payroll expense and stock-based compensation expense resulting from lower headcount, (c) a reduction in insurance premiums and (d) a reduction in the loss on
          disposal of fixed assets.&#160; These decreases were offset by increased occupancy expenses as a result of the June 2023 rent commencement date for our Somerville lease and the recognition of the related rent expense.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We expect our occupancy expenses to increase substantially in 2024 compared to 2023 due to our payment obligations under our sublease for office and laboratory space in Somerville,
          Massachusetts.&#160; The term of the sublease is approximately 10 years, and our base rent obligations over the term is estimated to be approximately $63.0 million, plus our share of the sublessor&#8217;s parking spaces and operating expenses.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Acquisition of Exacis In-Process Research and Development</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We acquired from Exacis Biotherapeutics Inc. (&#8220;Exacis&#8221;) substantially all of its intellectual property assets, including all of its right, title and interest in and to an exclusive license
          agreement by and between Exacis and Factor Limited (the &#8220;Purchased License&#8221;).&#160; The Purchased License was determined to be an IPR&amp;D asset that has no alternative future use and no separate economic value from its original intended purpose,
          which is expensed in the period the cost is incurred.&#160; As a result, we expensed the fair value of the Purchased License of approximately $0.5 million during the year ended December 31, 2023. For additional information, see Note 4 to the
          accompanying consolidated financial statements included in this report.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Impairment of In-Process Research and Development</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">During the year ended December 31, 2022, we received the results from the INSPIRE phase 2 trial of IRX-2. Despite outcomes that favored IRX-2 in certain predefined subgroups, the trial did not
          meet its primary endpoint of event-free survival at two years of follow up.&#160; Based on the totality of available information, following receipt of the results described above we determined we would not further develop IRX-2 and that the carrying
          value of the IPR&amp;D asset was impaired.&#160; Accordingly, we recognized a non-cash impairment charge of approximately $6.0 million during the year ended December 31, 2022, which reduced the value of this asset to zero.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Change in Fair Value of Warrant Liabilities</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">For the year ended December 31, 2023 and 2022, we recognized credits to expense related to the change in the fair value of warrant liabilities due to a decrease in the market price of our common
          stock.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Change in Fair Value of Contingent Consideration</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">On the closing date of our acquisition of the intellectual property assets of Exacis, we recognized a contingent consideration liability of $0.2 million for future payments that may be payable to
          Exacis, which was included as part of the $0.5 million fair value of the Purchased License and expensed as IPR&amp;D for the year ended December 31, 2023.&#160; We remeasured the fair value of the contingent consideration liability at the end of each
          quarterly period enduring the year, and for the year ended December 31, 2023, the change in fair value was approximately $0.1 million, which is recognized in the consolidated statement of operations.&#160; There were no contingent consideration
          liabilities during the same period in 2022.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">42</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic;">Loss on Non-Controlling Investment</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We account for our 25% non-controlling investment in NoveCite, Inc. (&#8220;NoveCite&#8221;) under the equity method.&#160; We have not guaranteed any obligations of NoveCite, nor are we otherwise committed to
          providing further financial support for NoveCite.&#160; Therefore, we only record 25% of NoveCite&#8217;s losses up to our investment carrying amount of $1.0 million.&#160; For the years ended December 31, 2023 and 2022, we recognized losses of approximately
          $0.1 million and $0.9 million, and as of December 31, 2023, the carrying value of our initial investment is zero.</div>

        <div>
<div>&#160;
          </div>
<div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Interest Income</div>

          <div>&#160;</div>

          <div>
            <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We recognized interest income for the year ended December 31, 2023 due to depositing our cash into interest bearing accounts
              compared to the same period in 2022.</div>

            <div>&#160;</div>

            <div><br/>
            </div>

          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Interest Expense</div>

          <div>&#160;</div>

          <div>
            <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We recognized an increase in interest expense for the year ended December 31, 2023 primarily due to interest related to the
              convertible notes of approximately $0.3 million as well as the amortization of the debt discount and debt issuance costs associated with the convertible note financings.&#160; There were no convertible notes for the same period in 2022.</div>

            <div>&#160;</div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic;">Other (Expense) Income, Net</div>

      <div>&#160;</div>

      <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;"> 2023</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">SEPA fees</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(280</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(280</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Q1-22 PIPE transaction fees</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(1,007</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>1,007</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Liquidated damages</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>-</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(240</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>240</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other (expense) income, net</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(54</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>106</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(160</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total other expense, net</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(334</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(1,141</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">807</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
      <div><br/>
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">For the year ended December 31, 2023, we recognized (a) commitment fees and other fees related to the SEPA we entered into with Lincoln Park in April 2023 and (b) other miscellaneous expense.
          During the year ended December 31, 2022, we expensed fees associated with a private placement we completed in the first quarter of 2022, as all of the fees incurred were allocated to the warrants issued in connection with such transaction, and we
          incurred a loss for liquidated damages under a registration rights agreement we entered into with investors in the private placement resulting from not timely filing our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Provision for Income Taxes</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">During 2023, we expect to incur state income tax liabilities related to our operations. We have established a full valuation allowance for all deferred tax assets, including our net operating
          loss carryforwards, since we could not conclude that we were more likely than not able to generate future taxable income to realize these assets. The effective tax rate differs from the statutory tax rate due primarily to our full valuation
          allowance.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Liquidity and Capital Resources</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">At December 31, 2023, we had cash and cash equivalents of approximately $11.7 million, of which approximately $4.1 million was restricted cash (see &#8212;Material Cash Requirements&#8212;Somerville
          Sublease, below) and an accumulated deficit of approximately $187.0 million. We have to date incurred operating losses, and we expect these losses to continue in the future. For the year ended December 31, 2023, we incurred a net loss of $21.7
          million, and we used $20.4 million in operating activities.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Currently, our sole source of liquidity is through sales of our common stock under the standby equity purchase agreement (the &#8220;SEPA&#8221;) we entered into with Lincoln Park Capital Fund, LLC (&#8220;Lincoln
          Park&#8221;) in April 2023, pursuant to which Lincoln Park committed to purchase up to $10.0 million of our common stock. Such sales of common stock by us, if any, are subject to certain conditions and limitations set forth in the SEPA, including a
          condition that we may not direct Lincoln Park to purchase any shares of common stock under the SEPA if such purchase would result in Lincoln Park beneficially owning more than 4.99% of our issued and outstanding shares of common stock. Sales
          under the SEPA may occur from time to time, at our sole discretion, through April 2025.&#160; To date, we have issued and sold approximately 214,000 shares of our common stock to Lincoln Park, including the 74,000 commitment shares, and have received
          approximately $0.3 million in gross proceeds from such sales.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">43</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Based on our current financial condition and forecasts of available cash, we will not have sufficient capital to fund our operations for the 12 months following the issuance date of the
          accompanying consolidated financial statements. We can provide no assurance that we will be able to obtain additional capital when needed, on favorable terms, or at all. If we cannot raise capital when needed, on favorable terms or at all, we
          will need to reevaluate our planned operations and may need to reduce expenses, file for bankruptcy, reorganize, merge with another entity, or cease operations. If we become unable to continue as a going concern, we may have to liquidate our
          assets, and might realize significantly less than the values at which they are carried on our financial statements, and stockholders may lose all or part of their investment in our common stock. See the risk factor in Item 1A of Part II of this
          report titled, &#8220;We will require substantial additional capital to fund our operations, and if we fail to obtain the necessary financing, we may not be able to pursue our business strategy.&#8221;</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Historically, the cash used to fund our operations has come from a variety of sources and predominantly from sales of shares of our common stock and of convertible notes. We will continue to
          evaluate and plan to raise additional funds to support our working capital needs through public or private equity offerings, debt financings, strategic partnerships, out-licensing our intellectual property or other means. There can be no
          assurance that capital will be available when needed or that, if available, it will be obtained on terms favorable to us and our stockholders. Our ability to raise capital through sales of our common stock will depend on a variety of factors
          including, among others, market conditions, the trading price and volume of our common stock, and investor sentiment. In addition, macroeconomic factors and volatility in the financial market, which may be exacerbated in the short term by
          concerns over inflation, interest rates, impacts of the wars in Ukraine and the Middle East, strained relations between the U.S. and several other countries, and social and political discord and unrest in the U.S., among other things, may make
          equity or debt financings more difficult, more costly or more dilutive to our stockholders.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In addition, equity or debt financings may have a dilutive effect on the holdings of our existing stockholders, and debt financings may subject us to restrictive covenants, operational
          restrictions and security interests in our assets. If we raise capital through collaborative arrangements, we may be required to relinquish some rights to our technologies or grant sublicenses on terms that are not favorable to us.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We prepared the accompanying consolidated financial statements on a going concern basis, which assumes that we will realize our assets and satisfy our liabilities in the normal course of
          business. As discussed above, there is substantial doubt about our ability to continue as a going concern because we do not have sufficient cash to satisfy our working capital needs and other liquidity requirements over at least the next 12
          months from the date of issuance of the accompanying consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and
          reclassification of assets or the amounts and classifications of liabilities that may result from the outcome of the uncertainty of our ability to remain a going concern.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In addition, while we are not presently pursuing product development, we may do so in the future.&#160; Developing product candidates, conducting clinical trials and commercializing products requires
          substantial capital, and we would need to raise substantial additional funds if we were to pursue the development of one or more product candidates.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Cash Flows</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Cash flows from operating, investing and financing activities, as reflected in the accompanying consolidated statements of cash flows, are summarized as follows:</div>

        <div>&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">For the years ended<br/>
                December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2023</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Cash (used in) provided by:</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Operating activities</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(20,408</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>(20,976</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>568</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Investing activities</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(19</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(47</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>28</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Financing activities</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>16,556</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>19,579</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(3,023</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Net decrease in cash and cash equivalents</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div>(3,871</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div>(1,444</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div>(2,427</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>


</table>
      <div><br/>
      </div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Net Cash Used in Operating Activities</span></div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">There was an increase of approximately $0.6 million in cash used in operating activities for the year ended December, 2023, as compared to year ended December 31, 2022.&#160; This change was due to an
        increase in cash used in operating assets and liabilities of $5.5 million, primarily related to MSA fees, insurance premiums and accrued severance payments, offset by a $6.1 million decrease in net loss, after giving effect to adjustments made for
        non-cash transactions, for the year ended December 31, 2023 when compared to the year ended December 31, 2022.</div>

      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">44</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Net Cash Used in Investing Activities</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Total cash used in investing activities remained relatively flat for the year ended December 31, 2023 compared to 2022.&#160; Purchases of property and equipment decreased by $0.3 million for the year
          ended December 31, 2023 compared to 2022, which was offset by a decrease in proceeds received from the sale of fixed assets of $0.3 million for the year ended December 31, 2022 compared to 2022.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Net Cash Provided by Financing Activities</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Net cash provided by financing activities for the year ended December 31, 2023 includes approximately $16.3 million in net proceeds received from convertible note financings and approximately
          $0.3 million in net proceeds received under the SEPA. Net cash provided by financing activities for the year ended December 31, 2022 includes approximately $19.6 million in net proceeds received from capital raising transactions.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Material Cash Requirements</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Somerville Sublease</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In October 2022, we entered into a sublease for approximately 45,500 square feet of office and laboratory space in Somerville, Massachusetts.&#160; The term of the sublease is approximately 10 years,
          and our base rent obligations over the term is estimated to be approximately $63.0 million, plus our share of the sublessor&#8217;s parking spaces and operating expenses. Our base rent obligations under the sublease during 2024 are expected to be $0.5
          million per month. As part of the sublease, we delivered a security deposit in the form of a letter of credit in the amount of $4.1 million, which will be reduced on an incremental basis throughout the term of the sublease.&#160; The letter of credit
          was issued by our commercial bank, which required that we cash collateralize the letter of credit with $4.1 million of cash deposited in a restricted account maintained by such bank.&#160; The amount of required restricted cash collateral will decline
          in parallel with the reduction in the amount of the letter of credit over the term of the sublease.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Convertible Notes</span></div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">As of the date of this report, the aggregate amount outstanding under our convertible notes, including accrued interest, is $18.2 million, of which $9.0 million and $9.2 million relates to the
          July 2023 convertible notes and the December 2023 convertible notes, respectively. The July 2023 convertible notes mature on July 14, 2028, and the December 2023 convertible notes mature on December 15, 2028 and January 11, 2029, depending on the
          issuance date of such notes, unless earlier converted or repurchased.&#160; We may not redeem any of the convertible notes prior to maturity.</div>

        <div>&#160;</div>

      </div>

      <div style="font-weight: bold;">Off-Balance Sheet Arrangements</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined under applicable SEC rules.</div>

        <div>&#160;</div>

      </div>

      <div style="font-weight: bold;">Critical Accounting Estimates</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The
          preparation of these consolidated financial statements requires us to make judgments, estimates, and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the
          consolidated financial statements, as well as the reported expenses during the reporting periods. We continually evaluate our judgments, estimates and assumptions. We base our estimates on the terms of underlying agreements, our expected course
          of development, historical experience and other factors we believe are reasonable based on the circumstances, the results of which form our management&#8217;s basis for making judgments about the carrying value of assets and liabilities that are not
          readily apparent from other sources. Actual results may differ from these estimates. We believe the following critical accounting estimates affect our more significant judgments and estimates used in the preparation of our consolidated financial
          statements.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">45</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div style="text-align: justify; font-style: italic;">Goodwill Impairment</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition of IRX Therapeutics, Inc. in November 2018, which was accounted for
          as a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events occur or circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying
          value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and other
          relevant events.&#160; Management evaluates our company as a single reporting unit, therefore, our goodwill is tested for impairment at the entity level. Goodwill is tested for impairment as of December 31<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> of each year, or more frequently as warranted by events or changes in circumstances mentioned above.&#160; Accounting guidance also permits an optional qualitative assessment for goodwill to determine
          whether it is more likely than not that the carrying value of a reporting unit exceeds its fair value. If, after this qualitative assessment, we determine that it is not more likely than not that the fair value of a reporting unit is less than
          its carrying amount, then no further quantitative testing would be necessary. A quantitative assessment is performed if the qualitative assessment results in a more likely than not determination or if a qualitative assessment is not performed.
          The quantitative assessment considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#8217;s carrying value exceeds its fair value.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Contingent Consideration</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Contingent consideration from an asset acquisition that is indexed to or settled in shares of our common stock and that is classified as a liability is initially measured at fair value, with
          subsequent changes in fair value recognized in earnings.&#160; Measuring the fair value requires various inputs, and a significant change in one or more of these inputs used in the calculation of the fair value may cause a significant change to the
          fair value of the contingent consideration liability, which could also result in material non-cash gains or losses being reported in the Company&#8217;s consolidated statement of operations.</div>

        <div>&#160;</div>

      </div>

      <div style="font-weight: bold;">Recent Accounting Pronouncements</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In June 2022, the Financial Accounting Standard Board (the &#8220;FASB&#8221;)&#160;issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2022-03, <span style="font-style: italic;">Fair Value Measurement (Topic 820):
            Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </span>(&#8220;ASU 2022-03&#8221;). The FASB issued ASU 2022-03 to (1) clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an
          equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for equity related securities subject to contractual
          sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and,
          therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years with early adoption permitted. We do not expect a material impact on
          our consolidated financial statements as a result of adopting this ASU.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In October 2023, the FASB issued ASU No. 2023-06, <span style="font-style: italic;">Disclosure Improvements &#8211; Codification Amendment in Response to the SEC&#8217;s Disclosure Update and Simplification
            Initiative. </span> This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC&#8217;s regulations.&#160; The amendments to the various topics should be applied prospectively, and the
          effective date will be determined for each individual disclosure based on the effective date of the SEC&#8217;s removal of the related disclosure.&#160; If the SEC has not removed the applicable requirements from Regulation S-X or Regulation S-K by June 30,
          2027, then this ASU will not become effective.&#160; Early adoption is prohibited.&#160; We do not expect the amendments in this ASU to have a material impact on our consolidated financial statements.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In November 2023, the FASB issued ASU No. 2023-07, <span style="font-style: italic;">Segment Reporting &#8211; Improvements to Reportable Segment Disclosures</span>, which provides updates to
          qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. ASU No. 2023-07 is effective for fiscal years
          beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. We do not expect the amendments in this ASU to have a
          material impact on our consolidated financial statements.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">46</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">In December 2023, the FASB issued ASU No. 2023-09, <span style="font-style: italic;">Improvements to Income Tax Disclosures</span>, which requires disclosure of disaggregated income taxes paid,
          prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption
          on a prospective basis, with a retrospective option. Early adoption is permitted. We do not expect the amendments in this ASU to have a material impact on our consolidated financial statements.</div>

        <div>&#160;</div>

      </div>

      <a id="ITEM7A."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 7A.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Quantitative and Qualitative Disclosures about Market Risk</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Under SEC rules and regulations, as a smaller reporting company we are not required to provide the information otherwise required by this item.</div>

        <div>
<div>&#160; </div>
<a id="ITEM8."><!--Anchor--></a>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ITEM 8.</td>

    <td style="width: auto; vertical-align: top; text-align: left;">
                  <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Financial Statements and Supplementary Data</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <div>
            <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">See &#8220;Index to Consolidated Financial Statements&#8221; on page F-1 for the consolidated financial statements filed with this report.</div>

            <div>&#160;</div>

          </div>

        </div>

      </div>

      <a id="ITEM9."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 9.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">None.</div>

      <div>&#160;</div>

      <a id="ITEM9A."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 9A.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-style: italic; font-weight: bold;">Controls and Procedures</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-align: justify; font-style: italic;">Disclosure Controls and Procedures</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">We maintain &#8220;disclosure controls and procedures,&#8221; as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act, designed to ensure that information required to be disclosed in
          our reports filed pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including
          our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In designing and evaluating the disclosure controls and procedures, we recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance
          of achieving the desired control objectives, and we were required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures. We have carried out an evaluation as of the end of the period covered by this
          Annual Report on Form 10-K under the supervision, and with the participation, of our management, including our President and Chief Executive Officer (who serves as our principal executive officer) and our Senior Vice President of Finance (who
          serves as our principal financial officer) of the effectiveness of the design and operation of our disclosure controls and procedures.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Based on that evaluation, our Chief Executive Officer and Senior Vice President of Finance concluded that our disclosure controls and procedures were not effective as of the end of the period
          covered by this Annual Report on Form 10-K in providing reasonable assurance of achieving the desired control objectives due primarily to the material weakness discussed below.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Management&#8217;s Plan for Remediation of Material Weakness in Internal Control over Financial Reporting</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is a process designed to provide
          reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We were unable to timely file our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022 with the SEC due to identifying errors in our financial statements reported in our
          Annual Report on Form 10-K for the years ended December 31, 2021 and 2020 during our preparation of the financial statements for the quarter ended March 31, 2022. Management concluded that the errors were the result of accounting personnel&#8217;s lack
          of technical proficiency in complex matters. On June 30, 2022, we filed an amendment to our Annual Report on Form 10-K for the years ended December 31, 2021 and 2020 to correct the errors in our financial statements for the years ended December
          31, 2021 and 2020 and for the quarters ended June 30, 2020, September 30, 2020, March 31, 2021, June 30, 2021 and September 30, 2021.</div>

        <div>&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">47</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Management has implemented measures designed to ensure that the deficiencies contributing to the ineffectiveness of our internal control over financial reporting are remediated, such that the
          internal controls are designed, implemented and operating effectively. The remediation actions to date include:</div>

        <div>&#160;</div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>enhancing the business process controls related to reviews over technical, complex, and non-recurring transactions;</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>providing additional training to accounting personnel; and</div>
              </td>

  </tr>


</table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>using an external accounting advisor to review management&#8217;s conclusions on technical, complex and non-recurring matters.</div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <div><br/>
        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The material weakness cannot be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these
          controls are operating effectively.&#160; As of December 31, 2023, we continue to season and enhance such controls to ensure that they will continue to operate effectively for a sufficient period of time before management can make conclusions on the
          operating effectiveness.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We are committed to developing a strong internal control environment, and we believe the remediation efforts that we have implemented and will implement will result in significant improvements in
          our control environment. Our management will continue to monitor and evaluate the relevance of our risk-based approach and the effectiveness of our internal controls and procedures over financial reporting on an ongoing basis and is committed to
          taking further action and implementing additional enhancements or improvements, as necessary.</div>

        <div>&#160;</div>

      </div>

      <div style="text-align: justify; font-style: italic;">Changes in Internal Control over Financial Reporting</div>

      <div>&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Except for the actions intended to remediate the material weakness as described above, there was no change in our internal control over financial reporting during the most recent fiscal quarter
          that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</div>

        <div>&#160;</div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
    <div> <a id="ITEM9B."><!--Anchor--></a>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; width: 1841px; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">ITEM 9B.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Other Information</div>
            </td>

  </tr>


</table>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">During the period from October 1, 2023, to December 31, 2023, none of our executive officers or directors <ix:nonNumeric name="ecd:Rule10b51ArrAdoptedFlag" id="Fact_9c0b66bdc7934a46812cb864f7b44f7e" contextRef="c20231001to20231231" format="ixt:fixed-false"><ix:nonNumeric name="ecd:NonRule10b51ArrAdoptedFlag" id="Fact_3040567776b9490284ef343a16fc2f5c" contextRef="c20231001to20231231" format="ixt:fixed-false">adopted </ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric name="ecd:Rule10b51ArrTrmntdFlag" id="Fact_a0c0f2d4513e42e7aca101d0819f83da" contextRef="c20231001to20231231" format="ixt:fixed-false"><ix:nonNumeric name="ecd:NonRule10b51ArrTrmntdFlag" id="Fact_9c8f65c57b004657aa064db7efcb08d4" contextRef="c20231001to20231231" format="ixt:fixed-false">terminated</ix:nonNumeric></ix:nonNumeric> contracts, instructions or
          written plans for the purchase or sale of our securities.</div>

        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);"> <br/>
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div> <a id="ITEM9C."><!--Anchor--></a>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 63pt;">
                  <div style="text-indent: -55.45pt; margin-left: 55.45pt; font-weight: bold; text-align: left;">ITEM 9C.</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-indent: -55.45pt; margin-left: 55.45pt; font-weight: bold;"><span style="font-style: italic;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div>
                </td>

  </tr>


</table>
        </div>

        <div>&#160;</div>

        <div>
          <div style="text-align: justify; text-indent: 36pt;">Not Applicable.</div>

          <div>&#160;</div>

        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">48</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: center; font-weight: bold;">PART III</div>

        <div><br/>
        </div>

        <a id="ITEM10."><!--Anchor--></a>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 10.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Directors, Executive Officers and Corporate Governance</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div style="text-align: center; font-weight: bold;">DIRECTORS &amp; EXECUTIVE OFFICERS</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The names of our directors and executive officers and their respective ages, positions, biographies and, in the case of directors, their qualifications to serve as directors, are set forth below
          as of March 12, 2024.</div>

        <div><br/>
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Name</div>
              </td>

    <td style="width: 2%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Age</div>
              </td>

    <td style="width: 2%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 55%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Position<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

  </tr>

  <tr>

    <td style="width: 35.54%; vertical-align: bottom;">
                <div>Sanjeev Luther</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom; white-space: nowrap;">
                <div>62</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 55%; vertical-align: bottom;">
                <div>President and Chief Executive Officer and Director</div>
              </td>

  </tr>

  <tr>

    <td style="width: 35.54%; vertical-align: bottom;">
                <div>Dorothy Clarke</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom; white-space: nowrap;">
                <div>59</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 55%; vertical-align: bottom;">
                <div>General Counsel and Director</div>
              </td>

  </tr>

  <tr>

    <td style="width: 35.54%; vertical-align: bottom;">
                <div>Sandra Gurrola</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom; white-space: nowrap;">
                <div>56</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 55%; vertical-align: bottom;">
                <div>Senior Vice President, Finance</div>
              </td>

  </tr>

  <tr>

    <td style="width: 35.54%; vertical-align: bottom;">
                <div>James Bristol</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom; white-space: nowrap;">
                <div>77</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 55%; vertical-align: bottom;">
                <div>Chairman of the Board</div>
              </td>

  </tr>

  <tr>

    <td style="width: 35.54%; vertical-align: bottom;">
                <div>Peter Cicala</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom; white-space: nowrap;">
                <div>62</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 55%; vertical-align: bottom;">
                <div>Director</div>
              </td>

  </tr>

  <tr>

    <td style="width: 35.54%; vertical-align: bottom;">
                <div>William Wexler</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom; white-space: nowrap;">
                <div>64</div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 55%; vertical-align: bottom;">
                <div>Director</div>
              </td>

  </tr>


</table>
        <div style="text-align: justify; text-indent: 36pt;"><span style="font-weight: bold; font-style: italic;"> <br/>
          </span></div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Sanjeev Luther</span> has served as President, Chief Executive Officer and as a member of our Board of Directors since January
          1, 2024. Prior to that, Mr. Luther served as President, Chief Executive Officer and a board member of Cornerstone Pharmaceuticals from November 2017 to December 2023 and as its Chief Operations Officer and Chief Business Officer from December
          2014 to November 2017. Prior to that, Mr. Luther served in various leadership roles at Bristol-Myers Squibb, Novartis, Bausch and Lomb and GE Healthcare.&#160; Mr. Luther holds an MBA in Marketing and a B.S. in Marketing and Business Administration
          from the State University of New York at Buffalo.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Mr. Luther&#8217;s qualifications to serve on our Board include his expertise in the healthcare industry, his business training and education, and his extensive experience managing life science
          companies.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;"><span style="font-weight: bold; font-style: italic;">Dorothy Clarke</span> has served as our General Counsel since January 1, 2024 and as a member of our Board of Directors since August 28, 2023.
          From April 2002 until November 2022, Ms. Clarke worked at Johnson &amp; Johnson (&#8220;J&amp;J&#8221;), serving in various roles, including in the law department as a regulatory attorney for pharmaceutical, medical device and consumer businesses, a vice
          president of law and vice president of regulatory affairs in the medical devices sector, the chief privacy officer of J&amp;J, and a vice president of health care compliance for medical devices and for research and development functions. Since
          November 2023, Ms. Clarke also serves as a board member of Comera Life Sciences.&#160; Ms. Clarke received a B.A. in history from Wesleyan University and a J.D. from the New York University School of Law.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Ms. Clarke&#8217;s qualifications to serve on our Board include her expertise in the healthcare industry, risk management, regulatory affairs and compliance.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Sandra Gurrola</span> has served as our Senior Vice President of Finance since May 2023 and as our Vice President of Finance
          from June 2021 until May 2023. Prior to that, she served as the Senior Vice President of eGames.com Holdings, LLC from March 2021 to June 2021 and as a consultant to us. Ms. Gurrola served as Senior Vice President of Finance to NTN Buzztime, Inc.
          from September 2019 to March 2021 and its Vice President of Finance from 2014 until 2019. From 2009 to 2014, Ms. Gurrola served NTN Buzztime, Inc. in various leadership accounting roles, including Controller, Director of Accounting, and Director
          of Financial Reporting and Compliance. Previously, she was a senior manager of financial reporting for Metabasis Therapeutics, Inc., a biotechnology company. Ms. Gurrola received a B.A. in English from San Diego State University.</div>

        <div><br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">49</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">James Bristol </span>has served as a member of our Board of Directors since October 2023. Dr. Bristol worked for 32 years in
          drug discovery, research and preclinical development at Schering<span style="font-weight: bold;">-</span>Plough Corporation, Parke<span style="font-weight: bold;">-</span>Davis, and Pfizer Inc. (&#8220;Pfizer&#8221;), serving in various senior research and
          development roles. From 2003 until his retirement in 2007, Dr. Bristol served as Senior Vice President of Worldwide Drug Discovery Research at Pfizer Global Research &amp; Development, where he oversaw 3,000 scientists at seven Pfizer sites as
          they produced an industry leading number of drug development candidates in 11 therapeutic areas. In 2009, Dr. Bristol joined Frazier Healthcare Partners as a Senior Advisor. Since August 2007, Dr. Bristol has served as a member of the board of
          directors of Deciphera Pharmaceuticals, and since 2018 he has served as a member of the board of directors of Erasca, Inc., both of which are publicly traded life science companies. Dr. Bristol also served on the board of directors of Ignyta from
          2014 until its acquisition by Roche in 2018, and served on the board of directors of SUDO Biosciences, Inc. from June 2021 until December 2023, and of Cadent Therapeutics, Inc. from 2011 until 2020. Dr. Bristol is the author of over 100
          publications, abstracts and patents, and he conducted postdoctoral research at the University of Michigan (NIH Postdoctoral Fellow) and at The Squibb Institute for Medical Research. Dr. Bristol holds a Ph.D. in organic chemistry from the
          University of New Hampshire and a B.S. in Chemistry from Bates College.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Dr. Bristol&#8217;s qualifications to serve on our Board include his vast experience in the biopharmaceutical industry, including in management and as a director, as well as his expertise in drug
          discovery and development.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;"><span style="font-weight: bold; font-style: italic;">Peter Cicala</span> has served as a member of our Board of Directors since February 2024.&#160; Mr. Cicala currently serves as General Counsel for
          a private biotechnology company, where he has been since March of 2021.&#160; In November of 2019, he co-founded Pretzel Therapeutics, Inc., a biotechnology company, and still serves as an executive advisor.&#160; From March 2020 until March 2021, Mr.
          Cicala served as Chief Intellectual Property Counsel for Intercept Pharmaceuticals, Inc. and from March 2014 until November 2019, he served as Chief Patent Counsel for Celgene Corporation, both publicly traded biopharmaceutical companies.&#160; Mr.
          Cicala has practiced law for over 25 years, and also has over 10 years of experience as a medicinal chemist.&#160; He received his B.S. in chemistry from Fairleigh Dickinson University and a J.D. from Seton Hall University School of Law.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Mr. Cicala&#8217;s qualifications to serve on our Board include his expertise in pharmaceutical and biotechnology intellectual property law and in strategic management of proprietary technology and
          products.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">William Wexler</span> has served as a member of our Board of Directors since June 2022. Prior to joining our Board of
          Directors, Mr. Wexler worked on over 150 individual projects, serving in various capacities including as Chairman, Chief Executive Officer, Chief Restructuring Officer and other designated roles of senior responsibility. Mr. Wexler has served as
          the Managing Member of WEXLER Consulting LLC, a management consulting firm, since 2012. From 2012 to 2019, he served in various roles, including as Chairman of the Board, interim Chief Executive Officer, Chief Executive Officer and sole director
          and stockholder representative of Upstate New York Power Products, Inc., a holding company that owned and operated power plants throughout upstate New York. From 2012 to 2013, Mr. Wexler served as Chief Restructuring Officer of VMR Electronics,
          LLC, a manufacturer of cable assembly products for the electronics interconnect industry. Prior to that, he served as a Managing Director and national finance practice lead at BBK, Ltd., a turn-around advisory firm, from 2006 to 2011. Mr. Wexler
          served as group Managing Director of corporate restructuring at Huron Consulting Group, LLC from 2002 to 2005. Previously, he was a Managing Director at Berenson Minella &amp; Co., a boutique investment-banking firm, from 2000 to 2002. Between
          1986 and 2000 he served as a Senior Director at BNP Paribas, where he established and led Paribas Properties, Inc., a real estate investment arm of the bank, and also where he was a lead officer of the then newly created U.S. asset workout group.
          Mr. Wexler started his professional career in 1981 in commercial lease brokerage, asset management and investment sales at Jones Lang Wootton (now Jones Lang LaSalle) where he worked until 1986. He earned a B.A. in Political Science from Johns
          Hopkins University.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Mr. Wexler&#8217;s qualifications to serve on our Board include his experience in investment and senior management roles, as well as his business training and education.</div>

        <div><br/>
        </div>

        <div style="font-weight: bold;">Family Relationships</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">There are no family relationships between any of our officers or directors.</div>

        <div><br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">50</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="font-weight: bold;">Involvement in Certain Legal Proceedings</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">None of our directors or executive officers is involved in any legal proceeding that requires disclosure under Item 401(f) of Regulation S-K.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Code of Ethics.</span> Our Board has adopted a Code of Conduct and Ethics that applies to all of our employees, officers and
          directors, including our Chief Executive Officer, Chief Financial Officer and other executive and senior financial officers. The full text of our Code of Conduct and Ethics is available on our website at www.eternatx.com under Investor
          Relations&#8212;Governance and is available in print to any stockholder who requests a copy from our Secretary. We intend to disclose future amendments to certain provisions of our Code of Business Conduct and Ethics, or waivers of certain provisions
          as they relate to our directors and executive officers, at the same location on our website or in our public filings. The information on our website is not intended to form a part of or be incorporated by reference into this Annual Report on Form
          10-K.</div>

        <div><br/>
        </div>

        <div style="font-weight: bold;">Audit Committee</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We have a standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act. Our Audit Committee consists of William Wexler (Chair), James Bristol and Peter Cicala,
          all of whom meet the requirements for independence of Audit Committee members under applicable Nasdaq and SEC rules, including Rule 10A-3 promulgated under the Exchange Act. All of the members of our Audit Committee meet the requirements for
          financial literacy under the applicable rules and regulations of the SEC and Nasdaq. In addition, Mr. Wexler qualifies as our &#8220;Audit Committee financial expert,&#8221; as such term is defined in Item 407 of Regulation S-K.</div>

        <div>&#160;</div>

        <div style="font-weight: bold;">Section 16(a) Beneficial Ownership Reporting Compliance</div>

        <div>&#160;</div>

        <div style="text-indent: 36pt;">Section 16(a) of the Exchange Act requires our directors, executive officers and persons who beneficially own more than 10% of a registered class of our equity securities to file with the SEC reports of ownership of,
          and transactions in, our equity securities. To our knowledge, based solely on a review of copies of such reports that we received, our records and written representations received from our directors, executive officers and certain of those
          persons who own greater than 10% of any class of our equity securities, for the year ended December 31, 2023, all applicable Section 16(a) filing requirements were complied with on a timely basis, with the exception of Dr. Bristol&#8217;s inadvertent
          late filing of his Form 3 filed on November 13, 2023, and which was due on November 9, 2023.</div>

        <div>&#160;</div>

        <div style="font-weight: bold;">Changes in Stockholder Nomination Procedures</div>

        <div>&#160;</div>

        <div style="text-indent: 36pt;">There have been no material changes to the procedures by which stockholders may recommend nominees to our Board of Directors since such procedures were last described in our proxy statement filed with the SEC on May
          5, 2023.</div>

        <div>&#160;</div>

        <a id="ITEM11."><!--Anchor--></a>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; font-weight: bold;">ITEM 11.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Executive Compensation</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="font-weight: bold;">Introduction</div>

        <div>&#160;</div>

        <div style="font-style: italic; font-weight: bold;">Overview</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">When determining executive officer compensation, and the various components that comprise it, our Compensation Committee evaluates and considers publicly available executive officer compensation
          survey data to present a competitive compensation package to attract and retain top talent, including an appropriate level of salary, performance-based bonus and equity incentives. Typically, the Compensation Committee evaluates competitive
          market benchmark data for a given executive role. Additionally, the Compensation Committee is authorized to engage outside advisors and experts to assist and advise the Compensation Committee on matters relating to executive compensation. In
          2023, the Compensation Committee retained the services of Pearl Meyer, an independent compensation consultant, to review the cash and equity compensation package to be offered to Mr. Luther prior to his appointment as our Chief Executive Officer.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Our Chief Executive Officer presents compensation recommendations to the Compensation Committee with respect to the executive officers other than himself. The Compensation Committee considers
          such recommendations, in conjunction with possible input from the Compensation Committee&#8217;s independent compensation consultant, in making compensation decisions or recommendations to the full Board. The full Board participates in evaluating the
          performance of our executive officers, except that our Chief Executive Officer does not participate when the Board evaluates his or her performance and is not present during voting or deliberations regarding his or her performance or compensation
          matters.</div>

        <div>&#160;</div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">51</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="font-style: italic; font-weight: bold;">Compensation-Related Risk Assessment</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Our Compensation Committee assesses and monitors whether any of our compensation policies and programs are reasonably likely to have a material adverse effect on our Company. The Compensation
          Committee and management do not believe that the Company presently maintains compensation policies or practices that are reasonably likely to have a material adverse effect on the Company&#8217;s risk management or create incentives that could lead to
          excessive or inappropriate risk taking by employees. In reaching this conclusion, the Compensation Committee considered all components of our compensation program and assessed any associated risks. The Compensation Committee also considered the
          various strategies and measures employed by the company that mitigate such risk, including: (i) the overall balance achieved through our use of a mix of cash and equity, annual and long-term incentives and time-and performance-based compensation;
          (ii) our use of multi-year vesting periods for equity grants; and (ii) the oversight exercised by the Compensation Committee over performance metrics, if any, established for performance-based bonuses and its administration of our equity
          incentive plans.</div>

        <div>&#160;</div>

        <div style="font-style: italic; font-weight: bold;">Compensation Recoupment (Clawback) Policy</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In 2023, we adopted a clawback policy providing for the recovery of erroneously-awarded incentive-based compensation related to the three fiscal years preceding the date on which the company is
          required to prepare an accounting restatement. The clawback policy complies with the requirements of Nasdaq&#8217;s listing rules.</div>

        <div>&#160;</div>

        <div style="font-weight: bold;">Named Executive Officers</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Under applicable SEC rules and regulations, our &#8220;named executive officers&#8221; are all individuals who served as our principal executive officer during 2023, our two most highly compensated executive
          officers (other than our principal executive officer) who were serving as executive officers at December 31, 2023, and up to two additional individuals who would have been one of our top two most highly compensated executive officer had they been
          serving as an executive officer at the end of 2023. Our 2023 named executive officers are identified in the table below:</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.66%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Name</div>
              </td>

    <td style="width: 2%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 64%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Title</div>
              </td>

  </tr>

  <tr>

    <td style="width: 33.66%; vertical-align: top;">
                <div>Matthew Angel<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 64%; vertical-align: bottom;">
                <div>Former Chief Executive Officer</div>
              </td>

  </tr>

  <tr>

    <td style="width: 33.66%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Sandra Gurrola</div>
              </td>

    <td style="width: 2%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 64%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
                <div>Senior Vice President of Finance</div>
              </td>

  </tr>

  <tr>

    <td style="width: 33.66%; vertical-align: top;">
                <div>Andrew Jackson <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td style="width: 2%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 64%; vertical-align: bottom;">
                <div>Former Chief Financial Officer</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top;">(1)</td>

    <td style="width: auto; vertical-align: top;">
                <div>Dr. Angel and Mr. Jackson resigned as our Chief Executive Officer and Chief Financial Officer, respectively, effective December 31, 2023 and May 4, 2023, respectively.</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div style="font-weight: bold;">Summary Compensation Table</div>

        <div>&#160;</div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">52</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">The following table sets out the compensation for our Named Executive Officers for the years ended December 31, 2023 and December 31, 2022:</div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br/>
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="19">
                <div style="text-align: center; font-weight: bold;">2023 Summary Compensation Table</div>
              </td>

  </tr>

  <tr>

    <td style="width: 17%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="font-weight: bold;">Name and</div>
                <div style="font-weight: bold;">Principal Position</div>
              </td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 3.96%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Fiscal</div>
                <div style="text-align: center; font-weight: bold;">Year</div>
              </td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.66%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Salary</div>
                <div style="text-align: center; font-weight: bold;">(US$)</div>
              </td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; font-weight: bold;">Bonus (US$)</div>
              </td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Stock-</div>
                <div style="text-align: center; font-weight: bold;">Based</div>
                <div style="text-align: center; font-weight: bold;">Awards</div>
                <div style="text-align: center; font-weight: bold;">(US$)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Option-</div>
                <div style="text-align: center; font-weight: bold;">Based</div>
                <div style="text-align: center; font-weight: bold;">Awards</div>
                <div style="text-align: center; font-weight: bold;">(US$)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Non-Equity</div>
                <div style="text-align: center; font-weight: bold;">Incentive Plan</div>
                <div style="text-align: center; font-weight: bold;">Compensation</div>
                <div style="text-align: center; font-weight: bold;">(US$)</div>
              </td>

    <td style="width: 0.25%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.41%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Nonqualified</div>
                <div style="text-align: center; font-weight: bold;">deferred</div>
                <div style="text-align: center; font-weight: bold;">compensation</div>
                <div style="text-align: center; font-weight: bold;">earnings</div>
                <div style="text-align: center; font-weight: bold;">(US$)</div>
              </td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">All Other</div>
                <div style="text-align: center; font-weight: bold;">Compensation</div>
                <div style="text-align: center; font-weight: bold;">(US$)</div>
              </td>

    <td style="width: 0.25%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Total</div>
                <div style="text-align: center; font-weight: bold;">Compensation</div>
                <div style="text-align: center; font-weight: bold;">(US$)</div>
              </td>

  </tr>

  <tr>

    <td style="width: 17%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="2">
                <div>Matthew Angel, Former Chief Executive Officer and President<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 3.96%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>2023</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.66%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$350,000</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.54%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.29%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.28%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$461,680</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$13,000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
              </td>

    <td style="width: 0.25%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.41%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">)</sup></div>
              </td>

    <td style="width: 0.25%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$824,680</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 3.96%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>2022</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.66%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.54%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$210,959<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.29%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.28%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$910,453</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 0.25%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.41%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$29,842<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div>
              </td>

    <td style="width: 0.25%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$1,151,254</div>
              </td>

  </tr>

  <tr>

    <td style="width: 17%; vertical-align: bottom;">
                <div>Sandra Gurrola, Sr. Vice President of Finance<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 3.96%; vertical-align: top; white-space: nowrap;">
                <div>2023</div>
              </td>

    <td style="width: 1%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.66%; vertical-align: top; white-space: nowrap;">
                <div>$255,833</div>
              </td>

    <td style="width: 1%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.54%; vertical-align: top; white-space: nowrap;">
                <div>$50,050<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.29%; vertical-align: top; white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.28%; vertical-align: top; white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 10%; vertical-align: top; white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 0.25%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.41%; vertical-align: top; white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 0.25%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; white-space: nowrap;">
                <div>$305,883</div>
              </td>

  </tr>

  <tr>

    <td style="width: 17%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="2">
                <div>Andrew Jackson, Former Chief Financial Officer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 3.96%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>2023</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.66%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$144,621</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.54%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.29%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.28%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 0.25%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.41%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$217,487<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup></div>
              </td>

    <td style="width: 0.25%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$362,108</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 3.96%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>2022</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.66%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$243,679</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.54%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.29%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.28%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$305,466</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 0.25%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.41%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$&#8212;</div>
              </td>

    <td style="width: 0.25%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$549,145</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 20pt;">
                  <div style="text-align: justify; text-indent: -13.7pt; margin-left: 13.7pt;">1.</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify;">The amounts reported in this column represent the aggregate grant date fair value of stock options granted during the applicable year. These amounts were calculated in accordance with FASB ASC Topic 718,
                    Compensation &#8211; Stock Compensation, except that any estimate of forfeitures was disregarded. For a description of the assumptions used in computing the dollar amount recognized for financial statement reporting purposes, see Note 15,
                    Stock-Based Compensation, in the Notes to the Consolidated Financial Statements</div>
                </td>

  </tr>


</table>
        </div>

        <div>&#160;</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 20pt;">
                    <div style="text-align: justify; text-indent: -13.7pt; margin-left: 13.7pt;">2.</div>
                  </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="text-align: justify;">Dr. Angel was appointed our Interim Chief Executive Officer and President on May 26, 2022 and to our Board effective June 6, 2022.&#160; Dr. Angel was appointed our Chief Executive Officer and President on
                      January 1, 2023. Dr. Angel resigned as our Chief Executive Officer and President and from our Board effective August 4, 2023 and was reappointed as our Chief Executive Officer and President on August 9, 2023.&#160; Dr. Angel subsequently
                      resigned as our Chief Executive Officer and President effective December 31, 2023.</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div> <br/>
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt; vertical-align: top;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Represents amounts earned pursuant to Dr. Angel&#8217;s employment offer letter equal to two percent of the gross proceeds that we received from an exclusive option and license agreement entered into with a third party.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt; vertical-align: top;">4.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>A cash signing bonus, which represents the salary Dr. Angel would have earned for the period during which he served as interim Chief Executive Officer and President, had Dr. Angel&#8217;s appointment as Chief Executive Officer and President
                  been in effect beginning May 26, 2022.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt; vertical-align: top;">5.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Represents a reimbursement of legal fees Dr. Angel incurred in connection with entering into his employment offer letter.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt; vertical-align: top;">6.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Ms. Gurrola has served as our Senior Vice President of Finance since May 2023 and was not a named executive officer for the year ended December 31, 2022.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt; vertical-align: top;">7.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Represents a discretionary spot bonus paid to Ms. Gurrola and approved by our Board.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt; vertical-align: top;">8.</td>

    <td style="width: auto; vertical-align: top;">
                <div>Mr. Jackson was appointed Chief Financial Officer effective May 31, 2022 and resigned as our Chief Financial Officer effective May 4, 2023.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt; vertical-align: top;">9.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Includes $207,500 of severance payments, $9,787 in reimbursement payments for COBRA and $200 for cell phone reimbursement.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="font-weight: bold;">Narrative to Summary Compensation Table</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The following is a discussion of each component of our executive compensation program for 2023.</div>

        <div>&#160;</div>

        <div style="font-style: italic; font-weight: bold;">Base Salary</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Each of our named executive officers receives a base salary. The base salary is the fixed cash compensation component of our executive compensation program and it recognizes individual
          performance, time in role, scope of responsibility, leadership skills and experience. The base salary compensates an executive for performing his or her job responsibilities on a day-to-day basis. Generally, base salaries are reviewed annually
          company-wide and adjusted (upward or downward) when appropriate based upon individual performance, expanded duties, changes in the competitive marketplace and, with respect to upward adjustments, if we are, financially and otherwise, able to pay
          it. We try to offer competitive base salaries to help attract and retain executive talent.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In December 2023, upon the recommendation of the Compensation Committee, the Board approved an increase to Ms. Gurrola&#8217;s annual base salary from $220,000 to $275,000.&#160; In addition, the Board
          approved a lump sum payment of $33,542 to Ms. Gurrola, representing the additional amount of salary Ms. Gurrola would have received had the increase to her annual base salary taken effect as of May 5, 2023.</div>

        <div>&#160;</div>

        <div style="font-style: italic; font-weight: bold;">Bonus and Incentive Compensation</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In addition to base salaries, our Compensation Committee has the authority to award discretionary annual bonuses to our named executive officers based on corporate and individual performance.
          Each year, the Compensation Committee or the Board may establish performance goals, which may be based on measures such as revenue, achievement of certain research and development milestones, completion of a strategic transaction, and other
          metrics the directors and management believe to provide proper incentives for achieving long-term shareholder value. The Board retains full discretion over performance evaluation and the amount of any bonuses to be paid to a named executive
          officer. Annual bonuses, if any, are intended to reward the individual performance of each named executive officer. In addition to an assessment of corporate and individual performance, the determination of the amount of a named executive
          officer&#8217;s bonus may vary from year to year depending on our financial condition and conditions in the industry in which we operate.&#160; The amount of such bonuses increase with executive rank so that, as rank increases, a greater portion of total
          annual cash compensation is based on annual corporate and individual performance.</div>

        <div>&#160;</div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">53</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">For the year ended December 31, 2023, no performance goals were established for any named executive officer, however, the Compensation Committee approved a discretionary spot bonus to be paid to
          Ms. Gurrola in the amount of $50,050 to reward her individual performance during the year.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Under the terms of his offer, Dr. Angel was eligible to receive a performance bonus equal to two percent of the gross proceeds that we actually received under licensing, option, collaboration,
          partnership, joint venture, settlement, and similar agreements that we enter into, or other actions, judgments, or orders, that generate cash proceeds to us, that are originated, negotiated and/or entered into by us during Dr. Angel&#8217;s employment,
          subject to certain conditions.&#160; During 2023, Dr. Angel received $13,000 in performance bonus payments as a result of an exclusive option and license agreement we entered into with a third party.</div>

        <div>&#160;</div>

        <div style="font-style: italic; font-weight: bold;">Equity-Based Compensation Programs</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Historically we have issued stock options to our employees, including our named executive officers, to provide a means whereby our employees may develop a sense of proprietorship and personal
          involvement in our development and financial success, and to encourage them to devote their best efforts to us, thereby advancing our interests and the interests of stockholders. The Board believes that the granting of equity awards promotes
          continuity of management and increases incentive and personal interest in our welfare by those who are primarily responsible for shaping and carrying out our long-range plans and pursuing our growth and financial success.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In 2023, we granted to Dr. Angel a time-based incentive stock option covering 132,003 shares of common stock, of which 110,043 shares vested immediately on the grant date and the remaining 21,960
          shares vest in 35 substantially equal monthly installments on the first day of each month thereafter, subject to his continuous service. In connection with Dr. Angel&#8217;s resignation effective December 31, 2023, all unvested options were immediately
          cancelled, and he has 90 days from the date of termination of his employment to exercise any vested options, at which time any unexercised vested options will be cancelled.</div>

        <div>&#160;</div>

        <div style="font-style: italic; font-weight: bold;">Benefits and Perquisites</div>

        <div>&#160;</div>

        <div><span style="text-decoration: underline;">Employee Benefit Plans</span></div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Named executive officers are eligible to participate in our employee benefit plans, including our medical, disability and life insurance plans, in each case, on the same basis as all of our other
          employees. Our employee benefit plans are designed to assist in attracting and retaining skilled employees. We also maintain a 401(k) plan for the benefit of our eligible employees, including the named executive officers, as discussed below.</div>

        <div>&#160;</div>

        <div><span style="text-decoration: underline;">401(k) Plan</span></div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We maintain a retirement savings plan, or 401(k) plan, that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Under the 401(k) Plan, eligible
          employees may defer up to 90% of their compensation subject to applicable annual contribution limits imposed by the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and limits imposed by non-discrimination testing. Our employees&#8217; pre-tax
          contributions are allocated to each participant&#8217;s individual account and participants are immediately and fully vested in their contributions. The 401(k) plan is intended to be qualified under Section 401(a) of the Code with the 401(k) plan&#8217;s
          related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k)
          plan. Beginning on January 1, 2023, we began matching employees&#8217; contributions at a rate of 100% of the first 3% of the employee&#8217;s contribution and 50% of the next 2% of the employee&#8217;s contribution, for a maximum match of 4%.</div>

        <div>&#160;</div>

        <div><span style="text-decoration: underline;">Pension Benefits</span></div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We do not maintain any pension benefit or retirement plans other than the 401(k) Plan.</div>

        <div>&#160;</div>

        <div><span style="text-decoration: underline;">Nonqualified Deferred Compensation</span></div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We do not maintain any nonqualified deferred compensation plans.</div>

        <div>&#160;</div>

        <div style="font-style: italic; font-weight: bold;">Named Executive Officer Employment Agreements and Change in Control Arrangements</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The following descriptions summarize the principal terms of our employment agreements with our named executive officers.</div>

        <div>&#160;</div>

        <div style="text-align: justify;"><span style="text-decoration: underline;">Matthew Angel</span></div>

        <div>&#160;</div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">54</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">On December 30, 2022, we entered into an offer letter with Dr. Angel effective on January 1, 2023 with respect to terms of his employment as our Chief Executive Officer and President.&#160; The
          compensatory terms of the offer letter, including equity awards, were approved by the Compensation Committee. Dr. Angel&#8217;s hiring, and his offer letter, were approved by the Board.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">From May 24, 2022 until he was appointed as Chief Executive Officer and President, Dr. Angel served as our interim Chief Executive Officer and President.&#160; Dr. Angel did not receive any salary or
          other cash compensation during his tenure as interim Chief Executive Officer and President.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Under the terms of his offer letter, we paid Dr. Angel an annual base salary of $350,000. We also paid Dr. Angel a cash signing bonus of $210,959, which represented the salary Dr. Angel would
          have earned for the period during which he served as interim Chief Executive Officer and President.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Dr. Angel was eligible to receive a performance bonus equal to two percent of the gross proceeds that we actually received pursuant to all licensing, option, collaboration, partnership, joint
          venture, settlement, other similar agreements that we entered into, or other actions, judgments, or orders that generate cash proceeds to us, that are originated, negotiated and/or entered into by us during Dr. Angel&#8217;s employment (commencing on
          May 26, 2022), subject to certain conditions.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In accordance with the terms of his offer letter, in January 2023, we granted to Dr. Angel a time-based incentive stock option covering 132,003 shares of common stock, of which 110,043 shares
          vested immediately on the grant date and the remaining 21,960 shares vest in 35 substantially equal monthly installments on the first day of each month thereafter, subject to his continuous service.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;">Dr. Angel resigned as our Chief Executive Officer and President effective December 31, 2023. Upon termination of Dr. Angel&#8217;s employment, all unvested options were immediately
          cancelled, and Dr. Angel has 90 days from the date of termination of his employment to exercise any vested options, at which time any unexercised vested options will be cancelled.</div>

        <div>&#160;</div>

        <div>
          <div style="text-align: justify; text-indent: 36pt;">For information on related party transactions with Dr. Angel, see Item 13, <span style="font-style: italic;">Certain Relationships and Related Transactions, and Director Independence.</span></div>

          <div>&#160;</div>

        </div>

        <div><span style="text-decoration: underline;">Sandra Gurrola</span></div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We entered into an employment agreement, dated as of June 16, 2021, with Sandra Gurrola, which provides for our at-will employment of Ms. Gurrola commencing on June 21, 2021 and continuing until
          terminated by us or Ms. Gurrola.&#160; Ms. Gurrola&#8217;s employment agreement provides for an annual base salary of $220,000, which amount is subject to periodic review by the Board or the Compensation Committee. Ms. Gurrola is also eligible to receive an
          annual cash bonus award in an amount up to 35% of her base salary upon achievement of agreed upon performance targets. The bonus will be determined by the Board or the Compensation Committee and paid annually by March 15 in the year following the
          performance year on which such bonus is based.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In accordance with the terms of her employment agreement, in June 2021, Ms. Gurrola was granted 1,750 restricted stock units, 25% of which vests on each anniversary of the grant date over four
          years.&#160; Vesting generally requires Ms. Gurrola&#8217;s continued employment through the relevant vesting date.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">If Ms. Gurrola&#8217;s employment is terminated by us without Cause (as defined in the employment agreement) or by Ms. Gurrola for Good Reason (as defined in the employment agreement), we will pay Ms.
          Gurrola all amounts accrued but unpaid as of the effective date of such termination, as well as continuation of her salary and benefits for the following six-month period. Notwithstanding the foregoing, if a termination of employment without
          Cause or for Good Reason occurs within 90 days before or 12 months after a Change in Control (as defined in the employment agreement), Ms. Gurrola will receive the benefits described in the preceding sentence, but the continuation of her salary
          and benefits will be for 12-month period, and, in addition, Ms. Gurrola will receive a lump-sum payment of her target bonus and the restricted stock units granted to her in June 2021 will fully vest. Any such severance benefits under the
          employment agreement are contingent on Ms. Gurrola entering into and not revoking a general release of claims in favor of our company.</div>

        <div>&#160;</div>

        <div><span style="text-decoration: underline;">Andrew Jackson</span></div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We entered into an amended and restated employment agreement, dated as of May 10, 2022, which provided for our at-will employment of Mr. Jackson commencing on May 31, 2022 and continuing until
          terminated by us or Mr. Jackson.&#160; Mr. Jackson resigned as our Chief Financial Officer on May 4, 2023.</div>

        <div>&#160;</div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">55</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">Under the terms of his employment agreement, we paid Mr. Jackson an annual base salary of $415,000. Mr. Jackson was also eligible to receive an annual cash bonus award in an amount up to 40% of
          his base salary upon achievement of agreed upon performance targets. The bonus would be determined by the Board or the Compensation Committee and paid annually by March 15 in the year following the performance year on which such bonus was based.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In accordance with the terms of his employment agreement, Mr. Jackson received a time-based nonqualified stock option covering 33,239 shares of common stock, 25% of which would vest on the first
          anniversary of the employment agreement&#8217;s effective date, and the remainder would vest ratably on a monthly basis over the three-year period thereafter. Vesting generally required Mr. Jackson&#8217;s continued employment through the relevant vesting
          date.&#160; Due to Mr. Jackson&#8217;s termination prior to the first anniversary of the employment agreement&#8217;s effective date, none of the shares subject to such option vested and all 33,239 shares were immediately cancelled upon his termination.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We entered into a separation agreement and general release with Mr. Jackson on May 2, 2023, pursuant to which, we paid Mr. Jackson a continuation of his salary for the following six-month period
          as well as reimbursement of up to six months of his COBRA premiums in exchange for Mr. Jackson entering into and not revoking a general release of claims in favor or our company.</div>

        <div>&#160;</div>

        <div style="font-weight: bold;">Outstanding Equity Awards at 2023 Fiscal Year-End</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The following table summarizes the number of shares of our common stock underlying outstanding equity incentive plan awards for each named executive officer as of December 31, 2023.</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 19%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="12">
                <div style="text-align: center; font-weight: bold;">Option Awards</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="7">
                <div style="text-align: center; font-weight: bold;">Stock Awards</div>
              </td>

  </tr>

  <tr>

    <td style="width: 19%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Name</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Grant Date</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Number of</div>
                <div style="text-align: center; font-weight: bold;">securities</div>
                <div style="text-align: center; font-weight: bold;">underlying</div>
                <div style="text-align: center; font-weight: bold;">unexercised</div>
                <div style="text-align: center; font-weight: bold;">options (#)</div>
                <div style="text-align: center; font-weight: bold;">exercisable</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Number of</div>
                <div style="text-align: center; font-weight: bold;">securities</div>
                <div style="text-align: center; font-weight: bold;">underlying</div>
                <div style="text-align: center; font-weight: bold;">unexercised</div>
                <div style="text-align: center; font-weight: bold;">options (#)</div>
                <div style="text-align: center; font-weight: bold;">unexercisable</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Equity</div>
                <div style="text-align: center; font-weight: bold;">incentive</div>
                <div style="text-align: center; font-weight: bold;">plan</div>
                <div style="text-align: center; font-weight: bold;">awards:</div>
                <div style="text-align: center; font-weight: bold;">Number of</div>
                <div style="text-align: center; font-weight: bold;">securities</div>
                <div style="text-align: center; font-weight: bold;">underlying</div>
                <div style="text-align: center; font-weight: bold;">unexercised</div>
                <div style="text-align: center; font-weight: bold;">unearned</div>
                <div style="text-align: center; font-weight: bold;">options (#)</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Option</div>
                <div style="text-align: center; font-weight: bold;">exercise</div>
                <div style="text-align: center; font-weight: bold;">price</div>
                <div style="text-align: center; font-weight: bold;">($)</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Option</div>
                <div style="text-align: center; font-weight: bold;">expiration</div>
                <div style="text-align: center; font-weight: bold;">date</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Number of</div>
                <div style="text-align: center; font-weight: bold;">shares or</div>
                <div style="text-align: center; font-weight: bold;">units of</div>
                <div style="text-align: center; font-weight: bold;">stock that</div>
                <div style="text-align: center; font-weight: bold;">have not</div>
                <div style="text-align: center; font-weight: bold;">vested (#)</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Market</div>
                <div style="text-align: center; font-weight: bold;">value of</div>
                <div style="text-align: center; font-weight: bold;">shares of</div>
                <div style="text-align: center; font-weight: bold;">units of</div>
                <div style="text-align: center; font-weight: bold;">stock that</div>
                <div style="text-align: center; font-weight: bold;">have not</div>
                <div style="text-align: center; font-weight: bold;">vested ($)</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Equity</div>
                <div style="text-align: center; font-weight: bold;">incentive</div>
                <div style="text-align: center; font-weight: bold;">plan</div>
                <div style="text-align: center; font-weight: bold;">awards:</div>
                <div style="text-align: center; font-weight: bold;">Number</div>
                <div style="text-align: center; font-weight: bold;">of</div>
                <div style="text-align: center; font-weight: bold;">unearned</div>
                <div style="text-align: center; font-weight: bold;">shares,</div>
                <div style="text-align: center; font-weight: bold;">units or</div>
                <div style="text-align: center; font-weight: bold;">other</div>
                <div style="text-align: center; font-weight: bold;">rights</div>
                <div style="text-align: center; font-weight: bold;">that have</div>
                <div style="text-align: center; font-weight: bold;">not</div>
                <div style="text-align: center; font-weight: bold;">vested</div>
                <div style="text-align: center; font-weight: bold;">(#)</div>
              </td>

    <td style="width: 1%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 6.68%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Equity</div>
                <div style="text-align: center; font-weight: bold;">incentive</div>
                <div style="text-align: center; font-weight: bold;">plan</div>
                <div style="text-align: center; font-weight: bold;">awards:</div>
                <div style="text-align: center; font-weight: bold;">Market or</div>
                <div style="text-align: center; font-weight: bold;">payout</div>
                <div style="text-align: center; font-weight: bold;">value of</div>
                <div style="text-align: center; font-weight: bold;">unearned</div>
                <div style="text-align: center; font-weight: bold;">shares,</div>
                <div style="text-align: center; font-weight: bold;">units or</div>
                <div style="text-align: center; font-weight: bold;">other</div>
                <div style="text-align: center; font-weight: bold;">rights that</div>
                <div style="text-align: center; font-weight: bold;">have not</div>
                <div style="text-align: center; font-weight: bold;">vested</div>
                <div style="text-align: center; font-weight: bold;">shares ($)</div>
              </td>

  </tr>

  <tr>

    <td style="width: 19%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Matthew Angel,</div>
                <div>Former Chief <br/>
                </div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>8/1/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>46,629</div>
              </td>

    <td style="width: 0.74%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>9.80</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>3/30/2024</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 6.68%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 19%; vertical-align: top; background-color: rgb(204, 238, 255);">Executive Officer and President</td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>1/12/2023<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>116,753</div>
              </td>

    <td style="width: 0.74%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>4.84</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>3/30/2024</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 6.68%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 19%; vertical-align: top;" rowspan="2">
                <div>Sandra Gurrola,</div>
                <div>Sr. Vice President of Finance<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>6/21/2021<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.74%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>874</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>1,573</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 6.68%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>3/11/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>3,339</div>
              </td>

    <td style="width: 0.74%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>2,386</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>38.60</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>3/11/2032</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top;">
                <div>&#8203;</div>
              </td>

    <td style="width: 6.68%; vertical-align: top; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 19%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Andrew Jackson,</div>
                <div>Former Chief Financial Officer</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.74%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 6.68%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top;">1.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Dr. Angel resigned effective December 31, 2023.&#160; Unvested options were immediately cancelled and vested options will expire 90 days from the date of termination.</div>
              </td>

  </tr>


</table>
        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top;">2.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>The restricted stock units vest at a rate of 25% of the shares subject to the award in four substantially equal annual installments on the anniversary date of the grant date.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top;">3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div>The option vests in 36 substantially equal monthly installments.</div>
                </td>

  </tr>


</table>
          <div>&#160;</div>

        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">56</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="font-weight: bold;">Employment Agreement with Current Chief Executive Officer</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Sanjeev Luther was appointed as our President and Chief Executive Officer effective January 1, 2024. Mr. Luther did not serve as one of our executive officers during 2023, and is therefore not
          one of our 2023 named executive officers.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We entered into an employment agreement, dated as of December 19, 2023, with Mr. Luther, which provides for at-will employment until terminated by us or Mr. Luther. Mr. Luther&#8217;s employment
          agreement provides for an annual base salary of $550,000, which amount is subject to periodic review by the Board or the Compensation Committee.&#160; Mr. Luther also received a one-time signing bonus of $75,000.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Mr. Luther is eligible to receive an annual cash bonus award in an amount up to 50% of his base salary upon achievement of agreed upon performance targets. The bonus will be determined by the
          Board or the Compensation Committee and paid annually by March 15 in the year following the performance year on which such bonus is based.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">In accordance with the terms of his employment agreement, Mr. Luther was granted an equity award on January 1, 2024, consisting of 1,685,218 non-qualified stock options, which will vest over a
          four-year period, with 25% of the options vesting on the first anniversary of the grant date, and the remaining options vesting monthly over the remaining three years.&#160; Vesting generally requires Mr. Luther&#8217;s continued employment through the
          relevant vesting date.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">If Mr. Luther&#8217;s employment is terminated by us without Cause (as defined in his employment agreement) or by Mr. Luther for Good Reason (as defined in his employment agreement), we will pay Mr.
          Luther all amounts accrued but unpaid as of the effective date of such termination, as well as a lump sum payment equal to nine months of his salary, as well as up to nine months of continued benefits. Mr. Luther will also be paid a pro-rata
          performance bonus equal to (x) the performance bonus Mr. Luther would have received based on actual performance for such fiscal year if Mr. Luther had remained employed for the entire fiscal year multiplied by (y) a fraction, the numerator of
          which is the number of days Mr. Luther was employed during such fiscal year.&#160; Notwithstanding the foregoing, if a termination without Cause or for Good Reason occurs beginning upon the occurrence of a Change in Control (as defined in the
          employment agreement) and ending on the first anniversary of the occurrence of the Change in Control (&#8220;Change in Control Protection Period&#8221;), Mr. Luther will receive the benefits described in the preceding sentence, but the lump sum severance
          payment and the payment of benefits will be for a 12-month period and he will receive 100% of his target bonus. In addition, all outstanding and unvested equity awards granted to Mr. Luther during his employment will become immediately vested and
          exercisable upon such date of termination during the Change in Control Protection Period and will be exercisable for a period of 12 months following the date of termination during the Change in Control Protection Period.&#160; Any such severance
          benefits under the employment agreement are contingent on Mr. Luther entering into and not revoking a general release of claims in favor of our company.</div>

        <div>&#160;</div>

        <div style="font-weight: bold;">Director Compensation</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">We have a non-employee director compensation program to compensate our non-employee directors for their service in such capacity with annual retainers and equity compensation as described below.
          However, since August 2022, we have not compensated our non-employee directors in accordance with our non-employee director compensation program. Our Compensation Committee and Board are assessing our non-employee director compensation program,
          and if and when we restart compensating our non-employee directors for their service in such capacity, the elements of our non-employee director compensation program may be different from what is described below.</div>

        <div style="text-align: justify; color: rgb(0, 0, 0);"> <br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">57</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 46%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Compensation Element</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="3">
                <div style="text-align: center; font-weight: bold;">Amount</div>
              </td>

  </tr>

  <tr>

    <td style="width: 46%; vertical-align: top;" rowspan="3">
                <div>Annual Board Member Compensation</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="vertical-align: bottom;" colspan="3">
                <div>Paid in cash or stock options, at the Board&#8217;s discretion. Cash paid in quarterly installments or upon the effective date of an earlier resignation of the non-employee director.&#160; Stock Options to vest quarterly over one year from grant
                  date:</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom;">
                <div style="text-align: right;">a.</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: bottom;">
                <div>Board Member: $40,000</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom;">
                <div style="text-align: right;">b.</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: bottom;">
                <div>Board Chair: $70,000</div>
              </td>

  </tr>

  <tr>

    <td style="width: 46%; vertical-align: top;">&#160;</td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46%; vertical-align: top;" rowspan="4">
                <div>Committee Member Retainers</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="vertical-align: bottom;" colspan="3">
                <div>Paid in cash or stock options, at the Board&#8217;s discretion. Cash paid in quarterly installments or upon the effective date of an earlier resignation of the non-employee director.&#160; Stock Options to vest quarterly over one year from grant
                  date:</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom;">
                <div style="text-align: right;">c.</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: bottom;">
                <div>Audit Committee: $7,500</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom;">
                <div style="text-align: right;">d.</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: bottom;">
                <div>Compensation Committee: $5,000</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom;">
                <div style="text-align: right;">e.</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: bottom;">
                <div>Nominating/Governance Committee: $4,000</div>
              </td>

  </tr>

  <tr>

    <td style="width: 46%; vertical-align: top;">&#160;</td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46%; vertical-align: top;" rowspan="4">
                <div>Leadership Supplemental Retainer</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="vertical-align: bottom;" colspan="3">
                <div>Paid in cash or stock options, at the Board&#8217;s discretion. Cash paid in quarterly installments or upon the effective date of an earlier resignation of the non-employee director.&#160; Stock Options to vest quarterly over one year from grant
                  date:</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: top; text-align: right;">
                <div>f.</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: top; text-align: left;">
                <div>Audit Committee Chair: $15,000</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: top; text-align: right;">
                <div>g.</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: top; text-align: left;">
                <div>Compensation Committee Chair: $10,000</div>
              </td>

  </tr>

  <tr>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: top; text-align: right;">
                <div>h.</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: top; text-align: left;">
                <div>Nominating/Governance Committee Chair: $8,000</div>
              </td>

  </tr>

  <tr>

    <td style="width: 46%; vertical-align: top;">&#160;</td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 5%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="width: 47.4%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46%; vertical-align: top;">
                <div>New Director Equity Award (outside directors)</div>
              </td>

    <td style="width: 1.24%; vertical-align: middle;">
                <div style="font-size: 2pt;">&#8203;</div>
              </td>

    <td style="vertical-align: bottom;" colspan="3">
                <div>Option for 8,290 shares of Common Stock, which option shall have an exercise price equal to the fair market value per share of common stock, as determined under the 2020 Plan, and, subject to continued service on the Board, vest in an
                  initial installment of 1/3 of the shares on the first anniversary of the grant date, with the remaining shares to vest in 24 substantially equal installments thereafter.</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The Board and the Compensation Committee designed our non-employee director compensation program to reward directors for their contributions to our success, align the director compensation
          program with stockholder interests, and provide competitive compensation necessary to attract and retain high quality non-employee directors. We do not pay fees to any of our directors for meeting attendance.</div>

        <div>&#160;</div>

        <div style="font-style: italic; font-weight: bold;">2023 Director Compensation</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">During 2023, we did not compensate any of our directors, in either cash or equity, for their service in such capacity.&#160; On January 1, 2024, we granted to Dorothy Clarke a stock option to purchase
          84,261 shares of our common stock as compensation for her services as a member of our Board from August 28, 2023 until December 31, 2023, for which she had previously not been compensated.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">As of December 31, 2023, none of our directors held any outstanding equity awards other than William Wexler, who held a stock option to purchase 15,895 shares of our common stock. As of December
          31, 2023, Gregory Fiore, a former director who resigned from our Board effective October 4, 2023, held stock options to purchase 10,742 shares of our common stock, which expired unexercised 90 days following the date of his resignation.</div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">58</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <a id="ITEM12."><!--Anchor--></a>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; font-weight: bold;">ITEM 12.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The following table sets forth information known to us regarding beneficial ownership of common stock as of March 12, 2024 (the &#8220;Measurement Date&#8221;) by:</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt;"><br/>
              </td>

    <td style="width: 34pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div>each person known by us to be the beneficial owner of more than 5% of outstanding common stock;</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt;"><br/>
              </td>

    <td style="width: 34pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div>each of our named executive officers and directors; and</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 20pt;"><br/>
              </td>

    <td style="width: 34pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top;">
                <div>all of our executive officers and directors as a group.</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting
          or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days after the Measurement Date. In computing the number of shares beneficially owned by a person or entity and the
          percentage ownership of that person or entity in the table below, all shares subject to options, warrants and restricted stock units held by such person or entity were deemed outstanding if such securities are currently exercisable, or
          exercisable or would vest based on service-based vesting conditions within 60 days of the Measurement Date, assuming that the liquidity event vesting conditions had been satisfied as of such date. These shares were not deemed outstanding,
          however, for the purpose of computing the percentage ownership of any other person or entity.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The beneficial ownership of our common stock is based on 5,410,331 shares of our common stock outstanding as of the Measurement Date.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Unless otherwise indicated, we believe that each person named in the table below has sole voting and investment power with respect to all shares of common stock beneficially owned by him.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Unless otherwise noted, the business address of each of these stockholders is c/o Eterna Therapeutics, Inc., 1035 Cambridge Street, Suite 18A, Cambridge, MA 02141.</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="3">
                <div style="font-weight: bold;">Name and Address of Beneficial Owner</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Common</div>
                <div style="text-align: center; font-weight: bold;">Shares</div>
                <div style="text-align: center; font-weight: bold;">Beneficially</div>
                <div style="text-align: center; font-weight: bold;">Owned</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Percentage</div>
                <div style="text-align: center; font-weight: bold;">of Common</div>
                <div style="text-align: center; font-weight: bold;">Shares</div>
                <div style="text-align: center; font-weight: bold;">Beneficially</div>
                <div style="text-align: center; font-weight: bold;">Owned</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Series A</div>
                <div style="text-align: center; font-weight: bold;">Convertible</div>
                <div style="text-align: center; font-weight: bold;">Preferred</div>
                <div style="text-align: center; font-weight: bold;">Stock</div>
                <div style="text-align: center; font-weight: bold;">Beneficially</div>
                <div style="text-align: center; font-weight: bold;">Owned</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Percentage</div>
                <div style="text-align: center; font-weight: bold;">of Series A</div>
                <div style="text-align: center; font-weight: bold;">Convertible</div>
                <div style="text-align: center; font-weight: bold;">Preferred</div>
                <div style="text-align: center; font-weight: bold;">Stock</div>
                <div style="text-align: center; font-weight: bold;">Beneficially</div>
                <div style="text-align: center; font-weight: bold;">Owned</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; font-weight: bold;">Percentage</div>
                <div style="text-align: center; font-weight: bold;">of Total</div>
                <div style="text-align: center; font-weight: bold;">Voting</div>
                <div style="text-align: center; font-weight: bold;">Power</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" colspan="3">
                <div style="color: #000000;"><span style="font-weight: bold; font-style: italic;">Greater than 5% Stockholders</span>:</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
                <div>Charles Cherington<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>1,212,707</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>19.99%</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>71,306</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>45.7%</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="2">
                <div>19.99%</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" colspan="3">
                <div>George Denny<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; white-space: nowrap;">
                <div>1,237,448</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; white-space: nowrap;">
                <div>19.99%</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>71,306</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>45.7%</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                <div>19.99%</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
                <div>Freebird Partners LP<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>1,283,634</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>19.99%</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="2">
                <div>19.99%</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" colspan="3">
                <div>Nicholas J. Singer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; white-space: nowrap;">
                <div>600,480</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; white-space: nowrap;">
                <div>9.99%</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                <div>9.99%</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
                <div>IAF, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>576,899</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>9.99%</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="2">
                <div>9.99%</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" colspan="3">
                <div>John Halpern<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; white-space: nowrap;">
                <div>550,282</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; white-space: nowrap;">
                <div>9.99%</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                <div>9.99%</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
                <div style="color: #000000;"><span style="font-weight: bold; font-style: italic;">Named Executive Officers and Directors</span>:</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="2">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" colspan="3">
                <div>Matthew Angel<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; white-space: nowrap;">
                <div>337,864</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; white-space: nowrap;">
                <div>6.06%</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                <div>6.06%</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
                <div>Sandra Gurrola<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>4,903</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>*</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="2">
                <div>*</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" colspan="3">
                <div>Andrew Jackson</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                <div>&#8212;</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
                <div>James Bristol</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="2">
                <div>&#8212;</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" colspan="3">
                <div>Dorothy Clarke</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                <div>&#8212;</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
                <div>Sanjeev Luther</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="2">
                <div>&#8212;</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom;" colspan="3">
                <div>William Wexler<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; white-space: nowrap;">
                <div>15,204</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; white-space: nowrap;">
                <div>*</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle;">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                <div>*</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="3">
                <div style="font-weight: bold;">All current directors and executive officers as a group (5 persons)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup></div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>20,107</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 8.91%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>6.43%</div>
              </td>

    <td style="width: 0.74%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="width: 9.03%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>&#8212;</div>
              </td>

    <td style="width: 0.87%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                <div>&#8203;</div>
              </td>

    <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="2">
                <div>6.43%</div>
              </td>

  </tr>


</table>
        <div> <br/>
        </div>

        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="text-align: left;">*</div>
                  </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                    <div>Less than 1%</div>
                  </td>

  </tr>


</table>
          </div>

        </div>

        <div><br/>
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">59</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(1)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>The number of common shares beneficially owned consists of (i) 556,465 shares of common stock, (ii) 8,460 shares of common stock issuable upon the conversion of shares of Series A convertible preferred stock (assuming a conversion
                    rate of 8.4282 per share) and (iii) 656,242 shares of common stock issuable upon exercise of note warrants and/or the conversion of convertible notes (assuming a conversion price of $1.9194 per share). As further described below, such
                    warrants and convertible notes are subject to a 19.99% blocker. The number of common shares beneficially owned, the percentage of common shares beneficially owned and the percentage of total voting power shown in the table gives effect
                    to such blocker. Pursuant to the terms of the note warrants and convertible notes, the number of shares of common stock that may be acquired by the holder thereof upon exercise of the note warrants and/or conversion of the convertible
                    notes is limited, to the extent necessary, to ensure that following such exercise and/or conversion, the number of shares of common stock then beneficially owned by the holder and any other persons or entities whose beneficial ownership
                    of common stock would be attributed to the holder for purposes of Section 13(d) of the Exchange Act does not exceed 19.99% of the total number of shares of our common stock then outstanding. Upon delivery of a written notice to us, the
                    holder may from time to time increase (with such increase not effective until the 61st day after delivery of such notice) or decrease the blocker to any other percentage not in excess of 9.99%.&#160;&#160; Mr. Cherington&#8217;s address is c/o Ara
                    Partners, LLC, 200 Berkeley Street, 26<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, Boston, MA, 02116.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(2)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>Denny Family Partners II, LLC owns 50,453 shares of common stock and the George Denny III Trust dated 6/11/1981 owns 406,785 shares of common stock. Mr. Denny disclaims beneficial ownership of the shares held by Denny Family Partners
                    II, LLC except to the extent of his pecuniary interest therein.&#160; Mr. Denny has sole voting and dispositive power over 204 shares of common stock and has shared voting and dispositive power over 460,209 shares of common stock. Mr.
                    Denny&#8217;s address is PO Box 423, Poland, ME 04274. The foregoing information has been included solely in reliance upon, and without independent investigation of, the disclosures contained in the Schedule 13G/A filed by Mr. Denny with the
                    SEC on March 6, 2023. </div>
                  <div> <br/>
                  </div>
                  <div>The number of common shares beneficially owned consists of (i) 457,442 shares of common stock, (ii) 8,460 shares of common stock issuable upon the conversion of shares of Series A convertible preferred stock (assuming a conversion
                    rate of 8.4282 per share) and (iii) 780,006 shares of common stock issuable upon exercise of note warrants and/or the conversion of convertible notes (assuming a conversion price of $1.9194 per share). As further described below, such
                    warrants and convertible notes are subject to a 19.99% blocker. The number of common shares beneficially owned, the percentage of common shares beneficially owned and the percentage of total voting power shown in the table gives effect
                    to such blocker. Pursuant to the terms of the note warrants and convertible notes, the number of shares of common stock that may be acquired by the holder thereof upon exercise of the note warrants and/or conversion of the convertible
                    notes is limited, to the extent necessary, to ensure that following such exercise and/or conversion, the number of shares of common stock then beneficially owned by the holder and any other persons or entities whose beneficial ownership
                    of common stock would be attributed to the holder for purposes of Section 13(d) of the Exchange Act does not exceed 19.99% of the total number of shares of our common stock then outstanding. Upon delivery of a written notice to us, the
                    holder may from time to time increase (with such increase not effective until the 61st day after delivery of such notice) or decrease the blocker to any other percentage not in excess of 9.99%.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(3)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>The number of common shares beneficially owned consists of (i) 272,583 shares of common stock and (ii) 1,011,055 shares of common stock issuable upon exercise of note warrants and/or the conversion of convertible notes (assuming a
                    conversion price of $1.9194 per share). As further described below, such warrants and convertible notes are subject to a 19.99% blocker. The number of common shares beneficially owned, the percentage of common shares beneficially owned
                    and the percentage of total voting power shown in the table gives effect to such blocker. Pursuant to the terms of the note warrants and convertible notes, the number of shares of common stock that may be acquired by the holder thereof
                    upon exercise of the note warrants and/or conversion of the convertible notes is limited, to the extent necessary, to ensure that following such exercise and/or conversion, the number of shares of common stock then beneficially owned by
                    the holder and any other persons or entities whose beneficial ownership of common stock would be attributed to the holder for purposes of Section 13(d) of the Exchange Act does not exceed 19.99% of the total number of shares of our
                    common stock then outstanding. Upon delivery of a written notice to us, the holder may from time to time increase (with such increase not effective until the 61st day after delivery of such notice) or decrease the blocker to any other
                    percentage not in excess of 9.99%.&#160; Curtis Huff is the sole member of Freebird Partners, LP.&#160; Freebird Partners, LP&#8217;s address is 2800 Post Oak Blvd, Suite 2000, Houston, TX 77056.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(4)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>The number of common shares beneficially owned consists of shares of common stock issuable upon exercise of note warrants and/or the conversion of convertible notes held by Purchase Capital LLC, of which Mr. Singer is the controlling
                    person, or by Pacific Premier Trust as custodian for the benefit of Mr. Singer .&#160; The foregoing information has been included in reliance upon, and without independent investigation of, the disclosures contained in the Schedule 13G/A
                    filed by Mr. Singer with the SEC on January 19, 2024.&#160; As further described below, such warrants and convertible notes are subject to a 9.99% blocker. The number of common shares beneficially owned, the percentage of common shares
                    beneficially owned and the percentage of total voting power shown in the table gives effect to such blocker. Pursuant to the terms of the note warrants and convertible notes, the number of shares of common stock that may be acquired by
                    the holder thereof upon exercise of the note warrants and/or conversion of the convertible notes is limited, to the extent necessary, to ensure that following such exercise and/or conversion, the number of shares of common stock then
                    beneficially owned by the holder and any other persons or entities whose beneficial ownership of common stock would be attributed to the holder for purposes of Section 13(d) of the Exchange Act does not exceed 9.99% of the total number
                    of shares of our common stock then outstanding. Upon delivery of a written notice to us, the holder may from time to time increase (with such increase not effective until the 61st day after delivery of such notice) or decrease the
                    blocker to any other percentage not in excess of 9.99%.&#160; Mr. Singer&#8217;s address is 1395 Brickell Avenue, Suite 800, Miami, FL 33131.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">60</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(5)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>The number of common shares beneficially owned consists of (i) 212,464 shares of common stock and (ii) 364,435 shares of common stock issuable upon exercise of note warrants and/or the conversion of convertible notes (assuming a
                    conversion price of $1.9194 per share).&#160; As further described below, such warrants and convertible notes are subject to a 9.99% blocker. The number of common shares beneficially owned, the percentage of common shares beneficially owned
                    and the percentage of total voting power shown in the table gives effect to such blocker. Pursuant to the terms of the note warrants and convertible notes, the number of shares of common stock that may be acquired by the holder thereof
                    upon exercise of the note warrants and/or conversion of the convertible notes is limited, to the extent necessary, to ensure that following such exercise and/or conversion, the number of shares of common stock then beneficially owned by
                    the holder and any other persons or entities whose beneficial ownership of common stock would be attributed to the holder for purposes of Section 13(d) of the Exchange Act does not exceed 9.99% of the total number of shares of our
                    common stock then outstanding. Upon delivery of a written notice to us, the holder may from time to time increase (with such increase not effective until the 61st day after delivery of such notice) or decrease the blocker to any other
                    percentage not in excess of 9.99%. IAF, LLC has sole voting and dispositive powers.&#160; IAF LLC&#8217;s address is 115 Church Street, Charleston, SC 29401.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(6)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>The number of common shares beneficially owned consists of (i) 452,284 shares of common stock held by the John D. Halpern Revocable Trust, of which, Mr. Halpern and Katherine H. Halpern are trustees and (ii) 97,998 shares of common
                    stock issuable upon exercise of note warrants and/or the conversion of convertible notes (assuming a conversion price of $1.9194 per share).&#160; As further described below, such warrants and convertible notes are subject to a 9.99%
                    blocker. The number of common shares beneficially owned, the percentage of common shares beneficially owned and the percentage of total voting power shown in the table gives effect to such blocker. Pursuant to the terms of the note
                    warrants and convertible notes, the number of shares of common stock that may be acquired by the holder thereof upon exercise of the note warrants and/or conversion of the convertible notes is limited, to the extent necessary, to ensure
                    that following such exercise and/or conversion, the number of shares of common stock then beneficially owned by the holder and any other persons or entities whose beneficial ownership of common stock would be attributed to the holder
                    for purposes of Section 13(d) of the Exchange Act does not exceed 9.99% of the total number of shares of our common stock then outstanding. Upon delivery of a written notice to us, the holder may from time to time increase (with such
                    increase not effective until the 61st day after delivery of such notice) or decrease the blocker to any other percentage not in excess of 9.99%. Mr. Halpern and Ms. Halpern share voting and dispositive powers.&#160; Mr. Halpern&#8217;s address is
                    PO Box 540 Portsmouth, New Hampshire 03802.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(7)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>Includes 163,382 shares of common stock issuable upon exercise of options.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(8)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>Includes 3,975 shares of common stock issuable upon exercise of options.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(9)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>Represents shares of common stock issuable upon exercise of options.</div>
                </td>

  </tr>


</table>
        </div>

        <div> <br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(10)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>Includes 19,179 shares of common stock issuable upon exercise of options.</div>
                </td>

  </tr>


</table>
        </div>

        <div><br/>
        </div>

        <div style="text-align: center; font-weight: bold;">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The following table contains information as of December 31, 2023 with respect to compensation plans under which our equity securities are authorized for issuance.</div>

        <div><br/>
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">
                <div>&#8203;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="10">
                <div style="text-align: center; font-weight: bold;">Equity Compensation Plan Information</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Plan Category</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Number of</div>
                <div style="text-align: center; font-weight: bold;">securities to be</div>
                <div style="text-align: center; font-weight: bold;">issued upon</div>
                <div style="text-align: center; font-weight: bold;">exercise of</div>
                <div style="text-align: center; font-weight: bold;">outstanding</div>
                <div style="text-align: center; font-weight: bold;">options,</div>
                <div style="text-align: center; font-weight: bold;">warrants and</div>
                <div style="text-align: center; font-weight: bold;">rights</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Weighted-</div>
                <div style="text-align: center; font-weight: bold;">average</div>
                <div style="text-align: center; font-weight: bold;">exercise price of</div>
                <div style="text-align: center; font-weight: bold;">outstanding</div>
                <div style="text-align: center; font-weight: bold;">options,</div>
                <div style="text-align: center; font-weight: bold;">warrants and</div>
                <div style="text-align: center; font-weight: bold;">rights</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Number of</div>
                <div style="text-align: center; font-weight: bold;">securities</div>
                <div style="text-align: center; font-weight: bold;">remaining</div>
                <div style="text-align: center; font-weight: bold;">available for future</div>
                <div style="text-align: center; font-weight: bold;">issuance under</div>
                <div style="text-align: center; font-weight: bold;">equity</div>
                <div style="text-align: center; font-weight: bold;">compensation</div>
                <div style="text-align: center; font-weight: bold;">plans (excluding</div>
                <div style="text-align: center; font-weight: bold;">securities reflected</div>
                <div style="text-align: center; font-weight: bold;">in column (a))</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-left: 24%;">
                <div>&#8203;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">
                <div style="text-align: center; font-weight: bold;">(a)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">
                <div style="text-align: center; font-weight: bold;">(b)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="2">
                <div style="text-align: center; font-weight: bold;">(c)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 32%; background-color: rgb(204, 238, 255);">
                <div>Equity compensation plans approved by securityholders<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>296,116</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>9.79</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>684,023</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 2px;">
                <div>Equity compensation plans not approved by securityholders<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>93,545</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>158.80</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>67,863</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 32%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div>Total</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>389,661</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>45.00</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>751,886</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        <div>&#160;</div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">61</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18.05pt; vertical-align: top;">(1)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>At our 2021 annual meeting of stockholders, our stockholders approved a restatement of the Eterna Therapeutics Inc. Restated 2020 Stock Incentive Plan (the &#8220;Restated 2020 Plan&#8221;). The Restated 2020 Plan is a broad-based incentive plan,
                  which allows for the grant of stock options, restricted stock, restricted stock units, performance awards, unrestricted stock awards and similar kinds of equity-based compensation to employees, directors, consultants and prospective
                  employees.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18.05pt; vertical-align: top;">(2)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>In May 2021, our Board adopted our 2021 Inducement Stock Incentive Plan (the &#8220;2021 Inducement Plan&#8221;). The 2021 Inducement Plan was adopted without stockholder approval pursuant to Section 711 of the Company Guide of the NYSE American
                  LLC, the stock exchange on which our common stock was listed at the time the 2021 Inducement Plan was adopted by our Board. The 2021 Inducement Plan provides for the grant of equity-based awards, including non-qualified stock options,
                  performance shares, performance units, restricted stock, restricted stock units, and stock appreciation rights. The awards available for grant under the 2021 Inducement Plan are available only to new employees and incentive stock options
                  may not be issued under the 2021 Inducement Plan.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">62</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <a id="ITEM13."><!--Anchor--></a>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; font-weight: bold;">ITEM 13.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Certain Relationships and Related Transactions, and Director Independence</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Except as described in Note 11 (Related Party Transactions) to the consolidated financial statements included in Part II, Item 8 of this report, which is incorporated by reference into this Item
          13, since January 1, 2022, there has not been nor are there currently proposed any transactions or series of similar transactions to which we were or are to be a party in which the amount involved exceeds the lesser of $120,000 or one percent
          (1%) of the average of our total assets at year-end for the last two completed fiscal years and in which any director, executive officer, holder of more than 5% of the common stock or any member of the immediate family of any of the foregoing
          persons had or will have a direct or indirect material interest.</div>

        <div>&#160;</div>

        <div style="font-weight: bold;">Related Party Transaction Policy</div>

        <div>&#160;</div>

        <div>
          <div style="text-align: justify; text-indent: 36pt;">Our Audit Committee is responsible for the review, approval, or ratification of any potential conflict of interest transaction involving any of our directors or executive officers, director
            nominees, any person known by us to be the beneficial owner of more than 5% of our outstanding capital stock, or any family member of or related party to such persons, including any transaction required to be reported under Item 404(a) of
            Regulation S-K promulgated by the SEC.</div>

          <div>&#160;</div>

          <div style="text-align: justify; text-indent: 36pt;">In reviewing any such proposed transaction, our Audit Committee is tasked with considering all relevant facts and circumstances, including the commercial reasonableness of the terms, the
            benefit or perceived benefit, or lack thereof, to us, opportunity costs of alternate transactions, the materiality and character of the related person&#8217;s direct or indirect interest and the actual or apparent conflict of interest of the related
            person.</div>

          <div>&#160;</div>

          <div style="text-align: justify; text-indent: 36pt;">Under our policy, employees are required to report any material transaction or relationship that could result in a conflict of interest to our compliance officer.</div>

          <div>&#160;</div>

        </div>

        <div style="font-weight: bold;">Director Independence</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Our Board undertook a review of the independence of each individual serving on our Board. Based on information provided by each such individual concerning his or her background, employment, and
          affiliations, our Board determined that the Board meets the independence requirements under Nasdaq&#8217;s listing rules and the SEC&#8217;s applicable rules and regulations. Our Board affirmatively determined that each of our non-employee directors&#8212;James
          Bristol, Peter Cicala and William Wexler&#8212;are &#8220;independent&#8221; as defined in Nasdaq&#8217;s listing rules. In making these determinations, our Board considered the current and prior relationships that each individual director has with us and other facts
          and circumstances our Board deemed relevant in assessing their independence. Under Nasdaq&#8217;s listing rules, a director who is, or at any time during the past three years was, employed by us cannot be considered &#8220;independent.&#8221; Accordingly, our
          Board determined that neither of the other two members of our Board (Sanjeev Luther, our President and Chief Executive Officer, and Dorothy Clarke, our General Counsel) are &#8220;independent&#8221; as defined in Nasdaq&#8217;s listing rules.</div>

        <div>&#160;</div>

        <a id="ITEM14."><!--Anchor--></a>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54.05pt; vertical-align: top; font-weight: bold;">ITEM 14.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Principal Accounting Fees and Services</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="font-weight: bold;">Fees and Services of Independent Registered Public Accounting Firm</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">The table below summarizes the fees and expenses billed to us by Grant Thornton for the years ended December 31, 2023 and 2022.</div>

        <div><br/>
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Year</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; font-weight: bold;">Audit Fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; font-weight: bold;">Audit-Related Fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; font-weight: bold;">Tax Fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; font-weight: bold;">All Other Fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; font-weight: bold;">Total</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: rgb(204, 238, 255);">
                <div style="text-align: center;">2023</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>516,224</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>516,224</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 10%;">
                <div style="text-align: center;">2022</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>435,750</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>&#8212;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>435,750</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Audit Fees.</span> Audit fees consist of services rendered by an independent registered public accounting firm for the audit
          of our consolidated financial statements (including tax services performed to fulfill the auditor&#8217;s responsibility under generally accepted auditing standards) and our internal control over financial reporting, reviews of the interim financial
          statements included in Forms 10-Q and includes services that generally only an external auditor can reasonably provide, such as comfort letters, statutory audits, attest services, consents and assistance with and review of documents filed with
          the SEC.</div>

        <div><br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">63</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Audit-Related Fees.</span> Audit-related fees consist of assurance and related services (e.g., due diligence) by an external
          auditor that are reasonably related to the audit or review of financial statements, including employee benefit plan audits, due diligence related to mergers and acquisitions, accounting consultations and audits in connection with proposed or
          consummated acquisitions, internal control reviews, attest services related to financial reporting that are not required by statute or regulation, and consultation concerning financial accounting and reporting standards.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">Tax Fees.</span> Tax fees consist of services rendered by an external auditor for tax compliance, tax consulting and tax
          planning.</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="font-weight: bold; font-style: italic;">All Other Fees.</span> All other fees are for any other permissible work that is not an Audit, Audit-Related or Tax Fee.</div>

        <div><br/>
        </div>

        <div style="font-weight: bold;">Policy for Approval of Audit and Permitted Non-Audit Services</div>

        <div><br/>
        </div>

        <div style="text-align: justify; text-indent: 36pt;">All audit and permissible non-audit services provided by the independent auditors are pre-approved by the Audit Committee (or the Chair of the Audit Committee, pursuant to a delegation of
          authority). These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of
          services and is generally subject to a specific budget. The independent auditors and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent auditors in accordance with
          this pre-approval, and the fees for the services performed to date. The Audit Committee may also pre-approve particular services on a case-by-case basis.</div>

        <div><br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">64</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: center; font-weight: bold;">PART IV</div>

        <div><br/>
        </div>

        <a id="ITEM15."><!--Anchor--></a>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; font-weight: bold;">ITEM 15.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Exhibits, Financial Statement Schedules</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div>&#160;</div>

        <div style="text-indent: 27pt;">(a) The following documents are filed as a part of this Annual Report on Form 10-K:</div>

        <div>&#160;</div>

        <div style="text-indent: 27pt;"><span style="font-style: italic;">(1)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic;">Consolidated Financial Statements.</span> The consolidated financial statements of the Company and its consolidated subsidiaries
          are set forth in the &#8220;Index to Consolidated Financial Statements&#8221; on page F-1.</div>

        <div>&#160;</div>

        <div style="text-indent: 27pt;"><span style="font-style: italic;">(2)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic;">Financial Statement Schedules. </span>None</div>

        <div>&#160;</div>

        <div style="text-indent: 27pt;"><span style="font-style: italic;">(3)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-style: italic;">Exhibits. </span>The following exhibits are submitted with this Annual Report on Form 10-K or, where indicated, incorporated by
          reference to other filings.</div>

        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
                <div style="font-weight: bold;">Exhibit</div>
              </td>

    <td style="width: 1%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
                <div style="font-weight: bold;">Description</div>
              </td>

    <td style="width: 1%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Incorporated By Reference</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top;" colspan="3">
                <div style="font-style: italic; font-weight: bold;">Plans of Acquisition</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123022489/brhc20052311_ex10-1.htm">2.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Asset Purchase Agreement, dated April 26, 2023, by and among Eterna Therapeutics Inc., Exacis Biotherapeutics Inc., the stockholders party thereto and, with respect to certain provisions, Factor Bioscience Limited.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.1 to Form 8-K filed on May 2, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top;" colspan="3">
                <div style="font-style: italic; font-weight: bold;">Articles of Incorporation and Bylaws</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="ef20015352_ex3-1.htm">3.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Composite Restated Certificate of Incorporation of the Company</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122036744/brhc10042808_ex3-2.htm">3.2</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Second Amended and Restated Bylaws of the Company</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 3.2 to Form 8-K filed on October 11, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121030987/brhc10028852_ex3-1.htm">3.3</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Certificate of Validation of Eterna Therapeutics Inc., as filed with the Secretary of State of the State of Delaware on September 3, 2021</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 3.1 to Form 8-K filed on September 13, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top;" colspan="3">
                <div style="font-style: italic; font-weight: bold;">Instruments Defining Rights of Security Holders</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122014764/brhc10036185_ex4-1.htm">4.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Description of Registrant&#8217;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 4.1 to Form 10-K filed on April 15, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top;" colspan="3">
                <div style="font-style: italic; font-weight: bold;">Material Contracts</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122008622/brhc10034972_ex10-1.htm">10.1(a)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Securities Purchase Agreement, dated as of March 6, 2022, between Eterna Therapeutics Inc. and the purchaser party thereto</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.1 to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122008622/brhc10034972_ex10-4.htm">10.1(b)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Registration Rights Agreement, dated as of March 6, 2022, between Eterna Therapeutics Inc. and the purchaser party thereto</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.4 to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122008622/brhc10034972_ex10-2.htm">10.1(c)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Form of Pre-Funded Warrant (March 2022)</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.2 to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122008622/brhc10034972_ex10-3.htm">10.1(d)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Form of Common Stock Warrant (March 2022)</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.3 to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122043061/brhc10044682_ex10-1.htm">10.2(a)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Securities Purchase Agreement, dated as of November 23, 2022, by and among Eterna Therapeutics Inc. and the purchasers party thereto</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.1 to Form 8-K filed on November 25, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122044329/brhc10045002_ex10-1.htm">10.2(b)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Form of Warrant (November 2022)</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.1 to Form 8-K filed on December 5, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122044329/brhc10045002_ex10-2.htm">10.2(c)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Registration Rights Agreement, dated as of December 2, 2022, by and among Eterna Therapeutics Inc. and the purchasers party thereto</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.2 to Form 8-K filed on December 5, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123017671/brhc10050812_ex10-2.htm">10.3(a)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Registration Rights Agreement, dated as of April 5, 2023, by and between Eterna Therapeutics Inc. and Lincoln Park Capital Fund, LLC</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.2 to Form 8-K filed on April 11, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123017671/brhc10050812_ex10-1.htm">10.3(b)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Purchase Agreement, dated as of April 5, 2023, by and between Eterna Therapeutics Inc. and Lincoln Park Capital Fund, LLC</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.1 to Form 8-K filed on April 11, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123034885/brhc20055909_ex10-1.htm">10.4(a)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Securities Purchase Agreement, dated as of July 13, 2023, by and among Eterna Therapeutics Inc. and the purchasers party thereto.</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.1 to Form 8-K filed on July 18, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123034885/brhc20055909_ex10-4.htm">10.4(b)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Registration Rights Agreement, dated as of July 13, 2023, by and among Eterna Therapeutics Inc. and the purchasers party thereto.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.4 to Form 8-K filed on July 18, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123034885/brhc20055909_ex10-2.htm">10.4(c)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Form of 6% Senior Convertible Note (July 2023)</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.2 to Form 8-K filed on July 18, 2023</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">65</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123034885/brhc20055909_ex10-3.htm">10.4(d)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Form of Common Stock Purchase Warrant (July 2023)</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.3 to Form 8-K filed on July 18, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123058648/ef20016457_ex10-1.htm">10.5(a)#</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Securities Purchase Agreement, dated as of December 14, 2023, by and among Eterna Therapeutics Inc. and the purchasers party thereto.</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.1 to Form 8-K filed on December 20, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123058648/ef20016457_ex10-2.htm">10.5(b)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Registration Rights Agreement, dated as of December 14, 2023, by and among Eterna Therapeutics Inc. and the parties thereto.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.2 to Form 8-K filed on December 20, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123058648/ef20016457_ex4-1.htm">10.5(c)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div>Form of 12.0% Senior Convertible Note (December 2023 and January 2024)</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 4.1 to Form 8-K filed on December 20, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123058648/ef20016457_ex4-2.htm">10.5(d)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Form of Warrant (December 2023 and January 2024)</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 4.2 to Form 8-K filed on December 20, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123053659/ef20014811_ex10-1.htm">10.6**&#x5E;</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Amended and Restated Exclusive License Agreement, dated November 14, 2023, by and between Factor Bioscience Limited and Eterna Therapeutics Inc.</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.1 to Form 8-K filed on November 16, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122033478/brhc10041894_ex10-1.htm">10.7</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt; color: rgb(0, 0, 0);">Master Services Agreement, dated September 9, 2022, by and between Factor Bioscience Inc. and Eterna Therapeutics Inc.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.1 to Form 8-K filed on September 15, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123000340/brhc10046238_ex10-1.htm">10.8*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Offer Letter, dated December 30, 2022, by and among Eterna Therapeutics Inc. and Dr. Matthew Angel</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.1 to Form 8-K filed on January 4, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122024669/brhc10039260_ex10-5.htm">10.9(a)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Agreement to Assign Space Lease dated March 5, 2022 between Eterna Therapeutics LLC and Regen Lab USA LLC.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.5 to Form 10-Q filed on July 1, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122024669/brhc10039260_ex10-6.htm">10.9(b)</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Assignment and Assumption of Lease dated March 25, 2022 between Eterna Therapeutics LLC and Regen Lab USA LLC</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.6 to Form 10-Q filed on July 1, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123012418/brhc10049677_ex10-16.htm">10.10</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Sublease Agreement, dated October 18, 2022, by and between E.R. Squibb &amp; Sons, LLC and Eterna Therapeutics Inc.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.16 to Form 10-K filed on March 20, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036122021148/brhc10038309_ex10-1.htm">10.11(a)*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Amended and Restated Executive Employment Agreement, dated as of May 10, 2022, by and between Eterna Therapeutics Inc. and Andrew Jackson</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.1 to Form 8-K filed on May 31, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123023068/brhc20052521_ex10-1.htm">10.11(b)*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Separation Agreement and General Release, dated May 2, 2023, by and between Eterna Therapeutics Inc. and Andrew Jackson.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.1 to Form 8-K filed on May 5, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036123058648/ef20016457_ex10-3.htm">10.12*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Employment Agreement, dated as of December 19, 2023, by and among Eterna Therapeutics Inc. and Sanjeev Luther.</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.3 to Form 8-K filed on December 20, 2023</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121018871/brhc10025183_ex10-3.htm">10.13(a)*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Eterna Therapeutics Inc. 2021 Inducement Stock Incentive Plan (the &#8220;2021 Inducement Plan&#8221;)</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.3 to Form 8-K filed on May 26, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="ef20015352_ex10-13b.htm">10.13(b)*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Form of Stock Option Inducement Award for issuances under the 2021 Inducement Plan</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="ef20015352_ex10-13c.htm">10.13(c)*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Form of Restricted Stock Unit Inducement Award for issuances under the 2021 Inducement Plan</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121030987/brhc10028852_ex99-1.htm">10.14(a)*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Eterna Therapeutics Inc. Restated 2020 Stock Incentive Plan (the &#8220;Restated 2020 Plan&#8221;)</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 99.1 to Form 8-K filed on September 13, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="ef20015352_ex10-14b.htm">10.14(b)*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Form of Stock Option Inducement Award for issuances under the Restated 2020 Plan</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="ef20015352_ex10-14c.htm">10.14(c)*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Form of Restricted Stock Unit Inducement Award for issuances under the Restated 2020 Plan</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036124002340/ny20018157x2_ex99-1.htm">10.15*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Inducement Stock Option Award Agreement entered into with Sanjeev Luther</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 99.1 to Form S-8 filed on January 16, 2024</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="ef20015352_ex10-16.htm">10.16*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Employment Agreement, effective January 1, 2023, by and among Eterna Therapeutics Inc. and Dorothy Clarke.</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121021741/brhc10026052_ex10-1.htm">10.17*</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Employment Agreement, dated June 16, 2021, by and among Eterna Therapeutics Inc. and Sandra Gurrola.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Exhibit 10.1 to Form 8-K filed on June 21, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121013151/brhc10023212_ex10-1.htm">10.18</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Form of indemnification agreement for directors and officers</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Exhibit 10.1 to Form 8-K filed on April 16, 2021</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="ef20015352_ex21-1.htm">21.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Subsidiaries of the Company</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="ef20015352_ex23-1.htm">23.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Consent of the Independent Registered Accounting Firm, Grant Thornton LLP</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="ef20015352_ex31-1.htm">31.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">66</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="ef20015352_ex31-2.htm">31.2</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="ef20015352_ex32-1.htm">32.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Furnished herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="ef20015352_ex32-2.htm">32.2</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Furnished herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div><a href="ef20015352_ex97.htm">97</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Eterna Therapeutics Inc. Clawback Policy</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>101.INS</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div>101.SCH</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Inline XBRL Taxonomy Extension Schema Document</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>101.CAL</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div>101.DEF</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Inline XBRL Taxonomy Extension Definition Linkbase Document</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>101.LAB</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="margin-left: 0.5pt;">Inline XBRL Taxonomy Extension Label Linkbase Document</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top;">
                <div>101.PRE</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top;">
                <div style="margin-left: 0.5pt;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</div>
              </td>

    <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 11.63%; vertical-align: top; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div>104</div>
              </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 61%; vertical-align: top; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div>Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</div>
              </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td style="width: 25.37%; vertical-align: top; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

  </tr>


</table>
        <div><br/>
        </div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27.35pt; vertical-align: top;">*</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Indicates management contract or compensatory plan.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27.35pt; vertical-align: top;">**</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Pursuant to Item 601(a)(5) of Regulation S-K, schedules and similar attachments to this exhibit have been omitted because they do not contain information material to an investment or voting decision and such information is not
                  otherwise disclosed in such exhibit. The Company will supplementally provide a copy of any omitted schedule or similar attachment to the U.S. Securities and Exchange Commission or its staff upon request.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27.35pt; vertical-align: top;">#</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Pursuant to Regulation S-K Item 601(b)(2), certain exhibits and schedules to this exhibit have been omitted. The Company agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its request.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27.35pt; vertical-align: top;">&#x5E;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit were omitted by means of marking such portions with an asterisk because such information is both not material and is the type that the Company
                  treats as private or confidential.</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <a id="ITEM16."><!--Anchor--></a>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; font-weight: bold;">ITEM 16.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Form 10-K Summary</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="text-indent: 27pt;">None.<br/>
          <br/>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">67</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <a id="SIGNATURES"><!--Anchor--></a>
        <div style="text-align: center; font-weight: bold;">SIGNATURES</div>

        <div>&#160;</div>

        <div style="text-indent: 24.5pt;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
          authorized<span style="font-weight: bold;">.</span></div>

        <div><br/>
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="vertical-align: bottom;" colspan="2">
                <div>ETERNA THERAPEUTICS INC.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle;">&#160;</td>

    <td style="width: 3%; vertical-align: bottom;">&#160;</td>

    <td style="width: 47%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">
                <div>Date: March 14, 2024</div>
              </td>

    <td style="width: 3%; vertical-align: top;">
                <div>By:</div>
              </td>

    <td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-variant: small-caps;">/s/ Sandra Gurrola</span><br/>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">&#160;</td>

    <td style="width: 3%; vertical-align: middle;">&#160;</td>

    <td style="width: 47%; vertical-align: bottom;">
                <div style="text-align: center; font-weight: bold;">Sandra Gurrola</div>
              </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">&#160;</td>

    <td style="width: 3%; vertical-align: bottom;">&#160;</td>

    <td style="width: 47%; vertical-align: bottom;">
                <div style="text-align: center; font-weight: bold;">Senior Vice President of Finance</div>
                <div style="text-align: center; font-weight: bold;">(Principal Financial Officer and</div>
                <div style="text-align: center; font-weight: bold;">Principal Accounting Officer)</div>
              </td>

  </tr>


</table>
        <div>&#160;</div>

        <div style="text-indent: 24.5pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</div>

        <div><br/>
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.05%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Name</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Title</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: center; font-weight: bold;">Date</div>
              </td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-variant: small-caps;">/s/ Sanjeev Luther</span><br/>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">
                <div>President, Chief Executive Officer, and Director (Principal Executive Officer)</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">
                <div>&#160;March 14, 2024</div>
              </td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">
                <div style="text-align: center; font-weight: bold;">Sanjeev Luther</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-variant: small-caps;">/s/ Sandra Gurrola</span><br/>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">
                <div>Senior Vice President of Finance (Principal Financial Officer and Principal Accounting Officer)</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">
                <div>&#160;March 14, 2024</div>
              </td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">
                <div style="text-align: center; font-weight: bold;">Sandra Gurrola</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-variant: small-caps;">/s/ James Bristol</span><br/>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">
                <div>&#160;Chairman of the Board</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">
                <div>&#160;March 14, 2024</div>
              </td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">
                <div style="text-align: center; font-weight: bold;">James Bristol</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-variant: small-caps;">/s/ Peter Cicala</span><br/>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">
                <div>&#160;Director</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">
                <div>&#160;March 14, 2024</div>
              </td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">
                <div style="text-align: center; font-weight: bold;">Peter Cicala</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-variant: small-caps;">/s/ Dorothy Clarke</span><br/>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">
                <div>&#160;Director</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">
                <div>&#160;March 14, 2024</div>
              </td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">
                <div style="text-align: center; font-weight: bold;">Dorothy Clarke</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;"><span style="font-variant: small-caps;">/s/ William Wexler</span><br/>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">
                <div>&#160;Director</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">
                <div>&#160;March 14, 2024</div>
              </td>

  </tr>

  <tr>

    <td style="width: 32.05%; vertical-align: bottom;">
                <div style="text-align: center; font-weight: bold;">William Wexler</div>
              </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 45.06%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 20.88%; vertical-align: bottom;">&#160;</td>

  </tr>


</table>
        <div>&#160;</div>

      </div>

    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>

      <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">68</span></div>

      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

      <div class="BRPFPageHeader" style="width: 100%;">
        <div>
          <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
            </a></div>

        </div>

      </div>

    </div>

    <!--PROfilePageNumberReset%Num%1%F-%%--> </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC. AND SUBSIDIARIES</div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><!--Anchor--><!--Anchor--><a id="INDEX"><!--Anchor--></a>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 92%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td style="width: 8%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Page</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);"><a href="#REPORTOFINDEPENDENTREGIST">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID: <span style="-sec-ix-hidden:Fact_bb4f95767a444ec094e91a06596f509d">248</span>) </td>

    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right; white-space: nowrap;">&#160;F-2</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">&#160;</td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Consolidated Financial Statements:</div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">
              <div style="margin-left: 18pt;">&#160;</div>
            </td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;"><a href="#BALANCESHEETS">Consolidated Balance Sheets as of December 31, 2023 and 2022</a></div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-3</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">
              <div style="margin-left: 18pt;">&#160;</div>
            </td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;"><a href="#STATEMENTSOFOPERATIONS">Consolidated Statements of Operations for the years ended December 31, 2023 and 2022</a></div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-4</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">
              <div style="margin-left: 18pt;">&#160;</div>
            </td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;"><a href="#STOCKHOLDERSEQUITY">Consolidated Statements of Stockholders&#8217; Equity for the years ended December 31, 2023 and 2022</a></div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-5</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">&#160;</td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); margin-left: 18pt;"><a href="#CASHFLOWS">Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022</a></div>
            </td>

    <td style="width: 8%; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-6</div>
            </td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: middle;">&#160;</td>

    <td style="width: 8%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><a href="#NOTESTO">Notes to the Consolidated Financial Statements</a></div>
            </td>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: right; color: rgb(0, 0, 0);">F-7</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-1</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%3%F-%%--> </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <a id="REPORTOFINDEPENDENTREGIST"><!--Anchor--></a>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

        <div>
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
          </div>

          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Board of Directors and Stockholders</div>

          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics Inc.</div>

          <div style="font-family: 'Times New Roman';"><br/>
          </div>

          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Opinion on the financial statements</div>

          <div style="text-align: justify; margin-bottom: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">We have audited the accompanying consolidated balance sheets of Eterna Therapeutics Inc. (a Delaware corporation) and subsidiaries (the
            &#8220;Company&#8221;) as of December 31, 2023 and 2022, the related consolidated statements of operations, stockholders&#8217; equity, and cash flows for each of the two years in the period ended December 31, 2023, and the related notes<span style="font-size: 10pt; color: rgb(0, 0, 255);">&#160;</span>(collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company<span style="font-size: 10pt; color: rgb(0, 0, 255);">&#160;</span>as of December 31, 2023 and 2022, and the results of its<span style="font-size: 10pt; color: rgb(0, 0, 255);">&#160;</span>operations and its<span style="font-size: 10pt; color: rgb(0, 0, 255);">&#160;</span>cash
            flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</div>

          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Going concern</div>

          <div style="text-align: justify; margin-bottom: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to
            the financial statements, the Company incurred a net loss of $21,668,000 during the year ended December 31, 2023, and had an accumulated deficit of approximately $187,000,000 as of December 31, 2023. These conditions, along with other matters
            as set forth in Note 2, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that
            might result from the outcome of this uncertainty.</div>

          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Basis for opinion</div>

          <div style="text-align: justify; margin-bottom: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
            financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with
            the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>

          <div style="text-align: justify; margin-bottom: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
            reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
            reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial
            reporting. Accordingly, we express no such opinion.</div>

          <div style="text-align: justify; margin-bottom: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
            fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting
            principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</div>

          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Critical audit matters</div>

          <div style="text-align: justify; margin-bottom: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be
            communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no
            critical audit matters.</div>

          <div style="font-family: 'Times New Roman';"><br/>
          </div>

          <div style="text-align: justify; margin-bottom: 14.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">/s/ <ix:nonNumeric name="dei:AuditorName" id="Fact_369a0c9c16e34d95a6bfafd8cadddb42" contextRef="c20230101to20231231">GRANT THORNTON LLP</ix:nonNumeric></div>

          <div style="text-align: justify; margin-bottom: 14.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We have served as the Company&#8217;s auditor since 2022.</div>

          <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:AuditorLocation" id="Fact_9b7d245530af4b0f8cac403f52f0186c" contextRef="c20230101to20231231">New York, New York</ix:nonNumeric><br/>
          </div>

          <div><span style="font-family: 'Times New Roman';"> </span></div>

          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">March 14, 2024</div>

            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>

          </div>

        </div>

        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="width: 100%;" class="BRPFPageFooter"></div>

            <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-2</span></div>

            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

            <div style="width: 100%;" class="BRPFPageHeader">
              <div>
                <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                  </a></div>

              </div>

            </div>

          </div>

          <div><br/></div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">ETERNA THERAPEUTICS INC.<br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">CONSOLIDATED
        <!--Anchor-->BALANCE SHEETS<a id="BALANCESHEETS"><!--Anchor--></a></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(In thousands, except par value amounts)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">December 31,</div>
              <div style="text-align: center; font-weight: bold;">2023<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">December 31,</div>
              <div style="text-align: center; font-weight: bold;">2022<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="font-weight: bold;">ASSETS</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;"><br/>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;"><br/>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="margin-left: 9pt;">Current assets:</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Cash</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Cash" id="Fact_4d6c08d38c45460aab422d206980b6c5" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,575</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Cash" id="Fact_fa4216fe2b2545c18eefd83f63559cdf" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,446</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Other receivables</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" id="Fact_a25c429eac74421cb7f11979dda690ff" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">425</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" id="Fact_d129541be24b45569d87311250fca146" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">951</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Prepaid expenses and other current assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_096caa837e3e47b9a586941facf1705a" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,599</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_e0518ad7e2d54eeb985bb5394968b0c7" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,284</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total current assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_2a4e0cdd20ae47febb93a9d36cd2dddb" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,599</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_0199ec07a3364086886bbbb1afe041ff" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,681</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Restricted cash<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:RestrictedCashNoncurrent" id="Fact_dca6b6e7e7064a239705de6adcf6a8dd" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,095</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:RestrictedCashNoncurrent" id="Fact_bddc55d04fc442c1a5f7b4ea0399372b" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,095</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Property and equipment, net</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_559b8bffd03f4eb1a2b2b85006f96050" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">493</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_3441247eb41549809a8dc9e1c5376d7c" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">236</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Right-of-use assets - operating leases</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_4780d8a0e2ec4d32965bddd68e4e64ae" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">32,781</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_c92593d9d4fd45fcac546968ae47d2fc" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,030</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Goodwill</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Goodwill" id="Fact_8c6a8be77f4a43ab95cc31b6b00b6f04" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,044</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Goodwill" id="Fact_e12ac8776c5f44f38d3565680fd35230" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,044</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Investment in non-controlling interest</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_b4df2b38209c469b8048584daf03b517" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_4b806e181fe34a728a1fa10e374ff550" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">59</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Other assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_56ea93ebfa0f404bbfdda81aab753ac8" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">120</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_5deba22fb82547adbecd9cd94a3e9769" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,134</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Assets" id="Fact_d55ddb17f75940899552f5dbcbe5ca6f" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">49,132</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Assets" id="Fact_cc07c99f4d094a4e99e49cc445468ac2" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,279</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="font-weight: bold;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Current liabilities:</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Accounts payable</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_6a87d02e2e2d404aa79d6d048e45787d" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,067</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_9428a2a24e3b446fad63385cb95718f4" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,620</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Accrued expenses</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_72c80b0d4bb941f0b4836b6667b5ee24" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,893</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_e40d068275154c51a5e9d01fe8faa47e" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,626</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Income taxes payable <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" id="Fact_87187394fae3414587c9c95fc1ec03a2" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" id="Fact_a02a482625314393900860c7601335e6" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Operating lease liabilities, current <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_e10e8616a5ed4ae5b87d8b7699d72721" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,216</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_590c6510b9434bdfb4a886e9bce523cf" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">295</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">
                <div style="margin-left: 9pt;">Due to related party, current <br/>
                </div>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_333b50c41dfc49faa328d65d9bbd0ccf" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,205</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_59bca42bfb394f129d7d5879c6fd6fa0" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,750</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Deferred revenue, current</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" id="Fact_e3a7479c0e0944aa80c490955a4213a4" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">190</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" id="Fact_8672c9422bc54bee8626d50e2eff6d5d" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Other current liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_c56446bf1ace474295302e5f8a648d60" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_d3968758f9ba457da226f88119bcb149" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">363</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total current liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_d0db517431d2467cb7580a76e24a20c3" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,573</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_8d75bf20760843a187d08b822efe95e0" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,654</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 18pt;">Convertible notes, net </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" id="Fact_9832126f6970407495942c4b276f545a" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,773</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" id="Fact_bd03911c773c4a0f87e5e02d93f3ad19" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 18pt;">Warrant liabilities<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" id="Fact_f15c1d79cdb642f5bc96ea7740575be2" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">116</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" id="Fact_74f42e7b69664793ba9d6ff733e7d8c6" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Operating lease liabilities, non-current</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_be38b114bd654c7ea4f5d4039d3e6c66" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">32,854</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_d97446b97d524f5b9261d9c5c1a178d4" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">887</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Due to related party, non-current <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_1610bb952e1141f79622ac5d79796654" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_caa93de4a46b4eed9c16d777cba3a9d5" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,206</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Deferred revenue, non-current <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" id="Fact_baf621403ef347febd9a503e24078626" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">392</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" id="Fact_68fcfb1a3de04524910a125118630a66" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Contingent consideration liability <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" id="Fact_2854743a8e654962878e2fee5daf853a" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">107</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" id="Fact_073a5957ecf445eba84b9bb96c08b7de" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Other liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_337cf3c0c30d4e8b913900f2cb147051" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">84</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_ab4d1647afa147459fae6e9c70bac40e" contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">94</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="margin-left: 18pt;">Total liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Liabilities" id="Fact_ef521011624d46799d0cf8b010d7197c" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">46,899</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:Liabilities" id="Fact_8d467db2bc084f999dc7508255130ebd" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,172</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Stockholder&#8217;s equity:</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Preferred stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_6017e08797084dbfb77816978f71608b" contextRef="c20231231" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_01b245be86134eddb7d3627cdf857083" contextRef="c20221231" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal">0.005</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_b13bb3bbe0074a339df9a7874070a235" contextRef="c20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_26ac4c14d9ee40a4baafd8848ce3d3af" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></ix:nonFraction></span> shares authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_9f8016c60a574428b4a2d6230f579b82" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_0a12f4ff50a547f98b1bf23e79ee5680" contextRef="c20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_1aef977bd5eb4c0cbea66703048adbf2" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_95ae1f1607154928ba9eea571e7003c3" contextRef="c20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span> designated and
                outstanding of Series A convertible preferred stock at <span style="text-indent: 0pt;">December 31, 2023</span> and <span style="text-indent: 0pt;">2022</span>, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" id="Fact_3358e6fbe7f34ff093a12aa3764fa44b" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" id="Fact_2a2feaef5eb24c0caa2217eca6afb3d8" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></ix:nonFraction></span> liquidation preference <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_f176c9300f714c2f943a1bb6848ef5b8" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_dffbc502186f44c9b9deb741760727e7" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_b7792e63291c4405998a0ea8bfc06a71" contextRef="c20231231" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_1c2ec87765df47cfa1d8ce04b5530d75" contextRef="c20221231" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal">0.005</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_547e1fc06cd24abbb539c716a0b0fc06" contextRef="c20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_3478ab00207149648f759d42c5b616e5" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">100,000</ix:nonFraction></ix:nonFraction></span> shares authorized at <span style="text-indent: 0pt;">December 31, 2023</span> and
                <span style="text-indent: 0pt;">2022</span>; <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_4fba1a51450b4c8183fe0e0196c35f84" contextRef="c20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_0e42136741c54654b4eecfd28f57782b" contextRef="c20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,410</ix:nonFraction></ix:nonFraction></span>
                and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_7ed27b6fb585414a9210c78b3ef181e5" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_196458a81c2b4582914a2cff08cac4bc" contextRef="c20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,127</ix:nonFraction></ix:nonFraction></span> issued and outstanding at <span style="text-indent: 0pt;">December 31, 2023</span> and <span style="text-indent: 0pt;">2022</span>, respectively</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_c58b9481d58b468881661ee656eefb3f" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">27</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_c332b82d7dae4a078de9fd062293dbe1" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">26</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="margin-left: 9pt;">Additional paid-in capital</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_5090af07b5034b148d8ffa132e2a9ecc" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">189,186</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_95681a219a9a47979c03c08b575d789c" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">177,377</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Accumulated deficit</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_c28db29db75b40a880d6198d633d7fd0" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">186,981</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_52e29e084d914b47b6303c262fae77ae" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">165,297</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="margin-left: 18pt;">Total stockholders&#8217; equity<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_c285b2393179401f96e4ce6c810451a2" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,233</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_1a665a92419c435797a1de8c6d1b94df" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,107</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="margin-left: 18pt;">Total liabilities and stockholders&#8217; equity<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_9df133542e254975a181acb894863bfe" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">49,132</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_bc8d9fd8f24249baac8b53a73f617996" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,279</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying notes are an integral part of these consolidated financial statements.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-3</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">CONSOLIDATED STATEMENTS OF
        <!--Anchor-->OPERATIONS<a id="STATEMENTSOFOPERATIONS"><!--Anchor--></a></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(In thousands, except per share amounts)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2023<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2022<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt; text-indent: -9pt;">Revenue <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_9c57d2961c5243c7804758446362d266" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">68</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_f386c10dcce744e39578dc2f4265ff80" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt; text-indent: -9pt;">Cost of revenues <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><ix:nonFraction name="us-gaap:CostOfRevenue" id="Fact_dff85eb0c53845f0b56614c88e7aa3f8" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">236</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><ix:nonFraction name="us-gaap:CostOfRevenue" id="Fact_151245f3eeac4fb0bf9c7e9ca07860ef" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 18pt; text-indent: -9pt;">Gross loss <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:GrossProfit" id="Fact_ca23458ba2ce4654beb67954643a9aa8" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">168</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_2454edeef3664b6281bd71abcb4d23a6" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Operating expenses:</div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div>Research and development</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" id="Fact_e08c059fff1b43a49e57b359cc17b951" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,920</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" id="Fact_aab2b0e229d743aba3cdcc2faf44c529" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,392</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div>General and administrative</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_2a45a6a9d773439e87e292dee93cbefd" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">14,587</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_78610be6d0674883880ee22dff2bff21" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,835</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt; text-indent: -9pt;">Acquisition of Exacis in-process research and development<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="erna:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_5e3387f7b736452285b7da2a371f6d4c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">460</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div><ix:nonFraction name="erna:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_0815c84b2d75471bbc463e53dce935a6" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt; text-indent: -9pt;">Impairment of in-process research and development <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_7c7aa666ea354e329f9c35236e03b195" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_b6f1995c60cb49eebeb16ef074a42ca2" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,990</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Total operating expenses</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_4cda2738666e4360959c8b057cff78e6" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">20,967</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_c15733253f69402ca202fe690eeee00d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">33,217</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Loss from operations</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_48275537a4a34b6db026e3e25b12b70b" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,135</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_b38d7d3e579d48169c4183f281689e51" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">33,217</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Other expense, net:</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Change in fair value of warrant liabilities <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="erna:WarrantLiabilitiesExpense" id="Fact_fc6da15ada4348e8a309b3ad6a9c7275" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">215</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="erna:WarrantLiabilitiesExpense" id="Fact_06229dfc8e8d486bb2137bd5f13e3727" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,795</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Change in fair value of contingent consideration</div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="erna:ChangeInFairValueOfContingentConsideration" id="Fact_acacfc0fc3d9400cbf287cea4a5a4072" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">118</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="erna:ChangeInFairValueOfContingentConsideration" id="Fact_b1e8f0144f114a5e9c775fc61d109ad9" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: -9pt; margin-left: 9pt; width: 76%; white-space: nowrap;">
              <div style="margin-left: 9pt;">Loss on non-controlling investment <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="erna:LossOnNonControllingInvestment" id="Fact_97e7c5792e974d9c9225dbff32550d1e" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">59</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="erna:LossOnNonControllingInvestment" id="Fact_dc4b07ac9918405ca4f440a30cb96348" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">941</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">Interest income <br/>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" id="Fact_f450109cd64045b380466c5debe2a3a3" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">138</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" id="Fact_f579855643a84be2ba58e8410c557f89" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">Interest expense <br/>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:InterestExpense" id="Fact_9bcefda45dbc4f6980d30f9a6d3bebf5" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">614</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:InterestExpense" id="Fact_8c493381b0f4410f991beaef18bfed4e" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">30</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Other expense, net</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_8c0ce0f37a73416cb33c96937b38d7de" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">334</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_29162345e1cd4b6a93506063bc7a1bd0" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,141</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Total other (expense) income , net</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_bf2a073d681a42abbb145f8abede3091" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">536</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_073cba25519842ebb94d23d4746ba362" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,683</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div>Loss before income taxes <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_3aff42effc934babab2dbbc0f79e5c12" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,671</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_fd97bac0eeb645569a5a5cdfa2afcd65" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,534</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Benefit (provision) for income taxes</div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_576b5a3f691e45ed8072acdb21caff56" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_90ac2edb68364de58268c75cd6d613ad" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">45</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; width: 76%; white-space: nowrap;">
              <div>Net loss</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_30f4f222aef1474ba5f920642b307c8b" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,668</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a947ba21d25742d696a8801454066227" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,579</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt; text-indent: -9pt;">Series A convertible preferred stock dividend</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:PreferredStockDividendsAndOtherAdjustments" id="Fact_e8a3181d92e542c1a94e2e32ab82284b" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:PreferredStockDividendsAndOtherAdjustments" id="Fact_de336daaa0cf428b830dd8464c2fb306" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div>Net loss attributable to common stockholders</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_9c8af24a963c43e38d9b1e1c77db81c2" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,684</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_bc8a68ba0f68485badd4349e983cddbd" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,595</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div>Net loss per common share - basic and diluted</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_d0cb27a84d6849a38ec7b70a107483dc" contextRef="c20230101to20231231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_cb074f5d46c240a6ae4f00ddbdfd2ffd" contextRef="c20230101to20231231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal">4.08</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
              <div>)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div>(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_4b52e655a03b4ddbbdb856ea1053491d" contextRef="c20220101to20221231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_cf4e3640668d451f94234ac5951e5d1d" contextRef="c20220101to20221231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal">8.06</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div>Weighted average shares outstanding - basic and diluted</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_c24a68b1ab2c4f4ea6c344f353e0ae8a" contextRef="c20230101to20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_aa3530300c8046619c4360e8eb819a8d" contextRef="c20230101to20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,314</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_662dd55fb5df4136a1dbd807f4a5f671" contextRef="c20220101to20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_37a45672ef3f4b438e836d7a976bd2ec" contextRef="c20220101to20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,051</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying notes are an integral part of these consolidated financial statements.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-4</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217;
        <!--Anchor-->EQUITY<a id="STOCKHOLDERSEQUITY"><!--Anchor--></a> </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">For the years December 31, 2023
        and 2022</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(In thousands)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" rowspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="6">
                <div>Series A Convertible</div>
                <div>Preferred Stock</div>
              </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="6">Common Stock</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; text-align: center; white-space: nowrap;" rowspan="1" colspan="2">
                <div><span style="font-weight: bold;">Additional</span> Paid-</div>
                <div>in</div>
              </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; text-align: center; white-space: nowrap;" rowspan="1" colspan="2">Accumulated</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; font-weight: bold;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Shares</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Amount</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Shares</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Amount</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Capital</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Deficit</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Total</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Balances at January 1, <span style="text-indent: 0pt;">2022</span></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_8348917587ba4810878a412b4a887a4a" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_ba76188cc9b14422b0d55838dae3af0a" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_c85635a315844727adb1ff9e0b928787" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,601</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_018ead85e3804b93b702b72592a77c41" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">13</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_b592fb5b8ad3436ca48151c64ba07dd5" contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">166,191</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_9164b3e768214b4f8f8a88cae91855a2" contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">140,702</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_933106efa6d14ab59fcd764e5a3656a2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">25,503</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock in connection with private offering</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesPrivateOffering" id="Fact_33e586a587664fa1a4a76bcf0a0168e6" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_e49f948bf476465aa8fa1b9e66df184b" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesPrivateOffering" id="Fact_1dd35f5c7e534623bfd3be526b97569a" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">275</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_9dd5c8a05fd64732942a16c8ce6ea3e3" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="erna:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_40a54a2a866c473bbd8c79088fed3678" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_96006f93258c46a8a2350f45958a06b8" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_f25d88b881ae4ff88629fb3fc981e57c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255);">
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock from vested restricted stock units</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_29056b643ad74d2a84f291f637178618" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_e94b9352eb6a4274935555dffab53b8d" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_edc1578484d44993b5b4c7b5bb3ace9b" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_95c8201d26b34effb4a6f04e189a89a9" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_01e2ce28ebd943d0840b2e19b80ad2ed" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_bba16ca166c24e1892efed2b646e0937" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_7d8edbe8ea90477aabf6fdf0ccdb021e" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock and warrants in connection with November 2022 private offering, net.</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_cde2d1689e364178a315ec0a93b94f28" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_6e6992bf082f4b899120820b0e35791d" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_992901fe2c294012b9d0a66bdea035bd" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,185</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_ca67442d7e69427b96f4a8729eb52209" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_c516ddb4c2d243f4b326870dc4e495f1" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,383</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_b988ace2492f4f219dcae27eb48ce162" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="Fact_81514d2ee9284b6b81fc3fc681134d9f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,395</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Forfeiture of unvested restricted stock</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_2ce5ee502b004ed7a6c74ba3eabc83e4" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_2e5e00c8ac0445c0b86d61b9a2a84075" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_b6a8cb9d97d2498d930893f7fa26b7c9" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_2a5c3c890a90471bbb1b9458137f37a4" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_65927fb628f5401db91cad319353eb91" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_5d770ef83d5447e5a2e8b62827fd0380" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_b2a887a5c6994e5484cf5bf77f77c03d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Cash dividends to Series A convertible preferred stockholders</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_d9c5baee224d4043906367e4cc071dd0" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_71a706d8ff99483b971b0e8ab9c5018b" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_9c77b7e90f9c4648a4c6c4c770fac6d1" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_39ac8950d1d846268c752b0be5eec51d" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_7600bbae067d485191a3f4b1228d5c00" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_8026db955fab43358c6aea3f4cca97d8" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_84d1b46e1ce44ee2b1b4f1023b0d703f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Stock-based compensation</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_ff670234c13042c8a8b76b37a046925c" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_3343af0d698a4c84b68a32d84a409b8d" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_c7f5cea361794230b8678e83e42d9816" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_4d53fc49b23c41019dba8aabfaf36d73" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_2bc27d9af0b04541a9a2932c953dcd42" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Net loss</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_2cd1f0cee67947418e25b3d7e824d6e9" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a62b9a9b36c947b28789ad36373cc931" contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_c472217ccc3b402e9b533a6f88b0dbc3" contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_641b5b235b6742b18c716bef53a5ece8" contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,579</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_15ecd4241e52472795b405bf576b7a6d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,579</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">&#160;</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; white-space: nowrap;">
                <div style="font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Balances at January 1, <span style="text-indent: 0pt;">2023</span></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_22e5cb46b0354cb4992a423417b80874" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_49f696e51be3482586c64284630e5bc4" contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_c633c166644f4ec18bab07f070a4041f" contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,127</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_560027aefa094d37ab03b8fbba00f3fc" contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">26</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_3d63221e8c0548f1b4d435a8fd93ec89" contextRef="c20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">177,377</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_442615502b6643c68aa5640665b55d8c" contextRef="c20221231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">165,297</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_edce8ae476f14097b3fcb9528126e4e6" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,107</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255);">
                <div>
                  <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock in connection with Exacis asset acquisition</div>
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesAcquisitions2" id="Fact_d3a08f033dc8403da02a790114bb847f" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_33b476afbd2c4d85b523ad02a0e3d098" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesAcquisitions2" id="Fact_e22f2f7e607d4565971bdd9e68bebaf2" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">69</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_e82b42b71cb04134a668049f78d9c3c1" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_9fcea42ca4344e2b81bba89832af6725" contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">208</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_eb6d9f7c2a5f40ce81445a4c6329ee3d" contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueAcquisitions2" id="Fact_8c520435a4a345a2bf113208ee951652" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">208</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%;">
                <div>
                  <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</div>
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="Fact_98d746f5509d4327831c48f943d2981f" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_d45ab070eb1a4ae49a814ff1699375a4" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="Fact_aca1ebaa845c4e56804dc7403db3278a" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">214</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_efdd30749a2141779161db39b28c55ae" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_9c8ae0030f0245eeb7bee3788ad55b39" contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">579</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_d40e5974e18f44e59c13ac33e3f2ba84" contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="erna:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_6608d341fe754c69bb40832d34e4818e" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">580</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Issuance of note warrants</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" id="Fact_dc13c4ccc8c84395a3e874eebdca6931" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" id="Fact_ea54172070af499f8e7df63f40b98a9e" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" id="Fact_4f295e2413e247e292629736c7157a3d" contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,014</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" id="Fact_4cbff6bb2fbc411ead439529d1673b3e" contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" id="Fact_c4b71a18a2d343c8b9449b27ca453292" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,014</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Repricing of warrants in connection with December 2023 financing</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" id="Fact_79b1c93997f949c78e7ae017d4f27a89" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" id="Fact_4d0d7b5219994eaf9bc51c8e6eecfa27" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" id="Fact_8e5c8e7a6c794d2eb366c2ff58a96598" contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">766</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" id="Fact_1d9dd94f0cb54024bba065c6f004069a" contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" id="Fact_da258e7ed0604091a7081d2efc9006fc" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">766</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="background-color: #CCEEFF; vertical-align: bottom; width: 16%;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Cash dividends to Series A convertible preferred stockholders</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_2e9dedaaa3fe420ab25ad2cd69e4d5db" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_0e3b916ae6314eeabe8ead0c5cd1343d" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_38e62dab9f2b4a3b95fc9e6164b68cd4" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_59d4d3ebf85544da83a84dbeaedc7fb4" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_f396b9f0a0db449297aa682819526263" contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_85e53a1fe16e47cab54f8b91efd35f62" contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_3f22bb0b93ca414eae31a4670e1c3938" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; white-space: nowrap;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Stock-based compensation</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_40056182a31541258deabac920659082" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_4f82f6f3e7ed43ddbcc2f9fb7cb55342" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_157729159f4546a189daee09b479e6df" contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,242</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_da6939322d834dd3b1e027c16486805f" contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_ef68120875804bcd9a3748e633623060" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,242</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -9pt; margin-left: 9pt;">Net loss</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_5e94de285e064f50be9c10e61dd7da25" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_7abbb59cda7c46d9aa99a43b9fb0e030" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_fbce8fb74045404bbfbbc65e22f97fb5" contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_858dba46c6614942b001493f1c1253a3" contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,668</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_64753e1bff954cb2a5a50061e64d886d" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,668</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 16%; padding-bottom: 4px; white-space: nowrap;">
                <div style="font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Balances at December 31, <span style="text-indent: 0pt;">2023</span></div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_eb18778a4ae047a0baba0751762bb02c" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">156</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_f0773f4aa1c74a28982353be9e8e9e59" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_ef5fe7f3c8374d70ab9a3385c4c45940" contextRef="c20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,410</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_2cb7328ae4c54103a38674559f332b1d" contextRef="c20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">27</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_4cd6e60cad4d4d2c93a0be60106046d0" contextRef="c20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">189,186</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_0c36973b2ef94a0588b4e7933368cff7" contextRef="c20231231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">186,981</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_394836c6103a46fcb32c7fbb3519808b" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,233</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying notes are an integral part of these consolidated financial statements.</div>

      <div><br/></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-5</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">ETERNA THERAPEUTICS INC.</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">CONSOLIDATED STATEMENTS OF
        <!--Anchor-->CASH FLOWS<a id="CASHFLOWS"><!--Anchor--></a></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(In thousands)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; font-weight: bold;" rowspan="1" colspan="6"> For years ended</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
              <div style="text-align: center; font-weight: bold;">December 31,</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2023<br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2022<br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div>Cash flows from operating activities:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 18pt;">Net loss</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_97ae97b0f746486ab74dd483d3309d3f" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,668</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_521cc7943d01464ca6e251e21eff2472" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,579</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 18pt;">Adjustments to reconcile net loss to net cash used in operating activities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Depreciation and amortization</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_995212e6d7184a7cbbae0e9179dd308c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">84</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_2c406f47175c4a5484cc73223f49329b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">161</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Stock-based compensation</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_8f2be070befa432c884fbc3e24a49e0a" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,242</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_6b2077a4216a428e82fd850c11a0e4a5" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 27pt;">Commitment shares issued to Lincoln Park Capital, LLC <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:CommitmentSharesIssueExpense" id="Fact_cf85527266df43538e27a032b5d8835c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">249</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:CommitmentSharesIssueExpense" id="Fact_f9ac5d02e120443f8efdc9a95ac9ac12" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 27pt;">Loss on shares sold to Lincoln Park Capital, LLC <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_4a2c27993dec4a55a7635e92989aab68" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">11</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_dc2c03e02af449db8a3c08b3337e4669" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Amortization of right-of-use asset</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_229dec39c4e4464fad5ca19ecd0e4621" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,039</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_d4da1ffadf11438db601c99e73c91571" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">336</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Impairment of right-of-use asset</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_7f6bdbe4830f42d69639e2febca59529" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_6b180a0afa2e433a8674f35779cea118" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">772</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 27pt;">Non-cash component of acquisition of Exacis in-process research and development <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:NonCashResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_5e3389237711425b92d385cb4d62ec9f" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">433</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:NonCashResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_ee4ae2603a4f49e9a02dc80a56d8085f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div>
                <div>
                  <div style="text-indent: -9pt; margin-left: 27pt;">Gain on remeasurement of operating lease liability and right-of-use-asset<br/>
                  </div>
                </div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" id="Fact_2fe99dcba24c4aa5ab24f7ae577af80f" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" id="Fact_f3f2e3219e8649bd9f2860f26f21cf41" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">642</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div>
                <div>
                  <div style="text-indent: -9pt; margin-left: 27pt;">Impairment of in-process research and development</div>
                </div>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_d993c1127ba14c158d937fc6f1a48e3d" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_5f3bc78ff44d45fc9fb3dcf7afe18214" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,990</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Loss on disposal of fixed assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:GainLossOnDisposalOfFixedAssets" id="Fact_b0854ac69a594f3e86a8baf811ae16aa" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:GainLossOnDisposalOfFixedAssets" id="Fact_8caa3400228d4360962cd19c51b3a98f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">280</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Gain on lease termination</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:GainOnTerminationOfLease" id="Fact_322e5d7f53e34b69b33f8d566347b33e" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:GainOnTerminationOfLease" id="Fact_8c1b1221683f42d6a528b240ca8970f0" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">85</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; text-indent: 18pt; white-space: nowrap;" rowspan="1"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued interest expense</span><br/>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:InterestExpenseDebt" id="Fact_d222a91c9d57454b8959bfab7a7970aa" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">176</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:InterestExpenseDebt" id="Fact_50d65e4dbe11445b8c7896f49b3581ba" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: 18pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div>Paid-in-kind interest expense</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PaidInKindInterest" id="Fact_b9da2ae50407461b9d1703cfb25600fb" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">113</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PaidInKindInterest" id="Fact_567113df8c08417b9d259975b62a58c8" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 27pt;">Amortization of debt discount and debt issuance costs <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" id="Fact_d1e7e5c582e84181951243cf7268842c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">303</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" id="Fact_5f6f45a572754b31bae77f3ea32a7abf" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 27pt;">Change in fair value of warrant liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" id="Fact_5f906708b2954ed2aafcd7f1dbffbbd7" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">215</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" id="Fact_d900b71a9de74a88a48cbf187fa216e6" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,795</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 27pt;">Change in fair value of contingent consideration liability <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:GainLossOnChangeInFairValueOfContingentConsideration" id="Fact_b8ccee90e6ab499fac4e959644ca9201" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">118</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:GainLossOnChangeInFairValueOfContingentConsideration" id="Fact_0a8b61e6ef6d42b6bdbf54c2b1d61e4e" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Loss on non-controlling investment</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:LossOnNonControllingInvestment" id="Fact_91b436d942aa41f39f7bc2971c76346d" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">59</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:LossOnNonControllingInvestment" id="Fact_593d0fba8f1649159ddae3202cfd14cb" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">941</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Changes in operating assets and liabilities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 36pt;">Other receivables</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" id="Fact_76a60c2b18354f0cb755833b2c05e689" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">527</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" id="Fact_9cc65d45214d45218d8cdf13cdabaea9" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">262</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 36pt;">Prepaid expenses and other current assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_a04557f2838f4eb7a8bfc2f2a0d84f04" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">556</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_6a2c7e939cba4cb281f91a8ff6e524b8" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">187</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 36pt;">Other non-current assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" id="Fact_dcbcd166c4494d61b3e6a9e0b857c3f6" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,014</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" id="Fact_a1001d16b9194180b215a3d4496f0f5e" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">646</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 36pt;">Accounts payable and accrued expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_4926bf6ac3ce4d5fb8df01210c228472" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,898</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_64b9a54055c149ed8bde7b198f49c0d7" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,034</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 36pt;">Operating lease liability</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="erna:IncreaseDecreaseInOperatingLeaseLiabilities" id="Fact_6bb2bd76db7245288e1f4d882e122027" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,338</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="erna:IncreaseDecreaseInOperatingLeaseLiabilities" id="Fact_c076d51c96214f50a9ca001259b8f5a5" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">340</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 36pt;">Due to related party <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" id="Fact_943554a8fe4940fc90383cff1cbcb60d" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,750</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" id="Fact_d9e14488e5f34146bdb7a9be2479b537" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,956</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 36pt;">Deferred revenue <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" id="Fact_d2df18fde0b94446977e1e42c6c24403" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">582</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" id="Fact_2292c750ef3b4ff98cf33bba34810c06" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 36pt;">Other liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" id="Fact_a0e003339978464d98080c31e4ebd301" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">374</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" id="Fact_7580c48d09f5451bac3101db0d8e187d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">155</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 36pt;">Net cash used in operating activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_9438c6d8a00446beb4803abe7545c1a0" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">20,408</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_c218a9208bd54844b95c96b7b03c7b6c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">20,976</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Cash flows from investing activities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 18pt;">Purchase of property and equipment</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_90c2b0f080d442ddaa45704c187d7964" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">19</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_9967ecc016e945adb3b34ec01ac26e53" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">297</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Proceeds from the sale of fixed assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" id="Fact_4ef1ec54c5004d99ae288f0465d1be67" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" id="Fact_1fdf53e94a394869bd943ac9046e6256" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">250</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Net cash used in investing activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_91a9d98a2e8a4770a5e4b6bfc676b5eb" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">19</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_2518c08135a642b3864b8d85c80c0620" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">47</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Cash flows from financing activities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 18pt;">Proceeds received from the convertible notes financings <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_180ed5d0467d4662addc634b110fe91d" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,503</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_c76c1c6a48af434796b3d79f161ac7f6" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 18pt;">Fees paid related to the Convertible Notes Financings<br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" id="Fact_3a336cffc7714ab7bd39a34f13ccf6e6" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">251</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" id="Fact_ceb4dcd105f24c02ad824c11b4dab357" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: 9pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div>Proceeds received under promissory note </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" id="Fact_93a8c06761f641459cc9fe2b459a0bfe" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" id="Fact_b933481b31284c839ba51dd0d700442f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; text-indent: 9pt; width: 76%; white-space: nowrap;" rowspan="1">
              <div>Principal payment made on promissory note </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_f8476d8d26cc48a38fb0831e7dcbf90d" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_9b7a65f3ae0f4612888ec6d442e6553f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 18pt;">Proceeds from sale of common stock pursuant to stock purchase agreement with Lincoln Park Capital Fund, LLC <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" id="Fact_c84e6240a8634cbdbea425c584d0cbf0" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">320</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" id="Fact_55d291f0a1b2409592402b809f2aadec" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Proceeds from issuance of common stock and warrants in connection with private offering</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_8a33d494f58d43208c34c609ac7be65c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_0f6c1d2e96094d949ec039dd1d4b0d63" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,706</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Fees paid in connection with private offering<br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ExpensesPaidInConnectionWithPrivateOffering" id="Fact_68c2ff06f92e4ca7a0ca676d92ce0f7f" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:ExpensesPaidInConnectionWithPrivateOffering" id="Fact_fd8289819c8c4464947d59b8bb2fe795" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">110</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 18pt;">Issuance of common stock from exercise of pre-funded warrants <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" id="Fact_2acea41995d247f384e727bea044204c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" id="Fact_eedd1a24d03d46e1a9cdc589b7de8408" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 18pt;">Payroll tax remitted on net share settlement of equity awards <br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_19dd11c31af54ac780a62a9e50798fe0" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_7bbeefe3a4b541db9419da5adb62c51f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -9pt; margin-left: 18pt;">Dividends paid to Series A convertible preferred stockholders</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" id="Fact_2cd5d320c4b3447bbdf10524202f3909" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" id="Fact_3a8f9dd656d34990a21318d03cae1789" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Cash paid for fractional shares in connection with reverse stock split</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit" id="Fact_d80f39083e844ef88135cba101b4e409" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit" id="Fact_5286e282163b489ea6b1eebec9060420" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 18pt;">Principal payments on finance leases</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:FinanceLeasePrincipalPayments" id="Fact_46256f2dbc4643e59164b07c033e807c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:FinanceLeasePrincipalPayments" id="Fact_4523452ea396420fb4aa5df88ffc392d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Net cash provided by financing activities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_7e0935250a9d425586ca9850bc3d79fe" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,556</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_ebb648f21fe448009b43ff11e100ee12" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">19,579</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Net decrease in cash and cash equivalents</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="Fact_a392c83c1f964fe4a1ebef3bf636d557" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3,871</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="Fact_e6da942c86bc4f1fa36e6c1e89b89acb" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,444</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Cash, cash equivalents and restricted cash at beginning of period</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_cd16d33f438845489c4a507bbec427d4" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,541</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_a3a7542fb7124aba941849042f4847da" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,985</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Cash, cash equivalents and restrictd cash at end of period</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_0e1a65aa80df482d84072238ea16f061" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,670</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_55d5dbdf0bda431cb015e1b474c98ff6" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,541</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="margin-left: 9pt; text-indent: -9pt;">&#160;</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 18pt;">Supplemental disclosures of cash flow information:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 18pt;">Cash paid during the period for:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Interest</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_16158331690542da9563876126fe224c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">20</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_6036a4ad6cb147e1bf0cb91113e13497" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">30</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 27pt;">Income taxes</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_ce5e6271ff3b45c5956e0cd02e8fc7d1" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_107a4b9de5944a26a6c1dd7619ff65b2" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">15</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -9pt; margin-left: 9pt;">Supplemental disclosure of non-cash investing and financing activities:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Contingent consideration for Exacis asset acquisition</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ContingentConsiderationForAssetAcquisition" id="Fact_92bbd2ca144c494c8d25d2cd02955e36" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">225</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ContingentConsiderationForAssetAcquisition" id="Fact_01563fd66f7949f09c3d5b147526e11f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Issuance of common stock for Exacis asset acquisition</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:IssuanceOfCommonStockForAssetAcquisition" id="Fact_a919ef802c904454bc7af39116fbeee6" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">208</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:IssuanceOfCommonStockForAssetAcquisition" id="Fact_92d9f75828124e74850e4d4fca63d94d" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Note warrants issued</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:WarrantsIssued" id="Fact_b7636f6653d24ab78c57e9c6cb490fbb" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,219</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:WarrantsIssued" id="Fact_f96804be5a2d4443852d39402727d754" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Repricing of warrants in connection with December 2023 financing</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:RepricingOfWarrantsInConnectionWithFinancing" id="Fact_e05578449fae4de5afd6d4f920c37039" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">766</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:RepricingOfWarrantsInConnectionWithFinancing" id="Fact_c19c0618a479479caf7806b01356b3a1" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Unpaid fees incurred in connection with the December 2023 financing</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" id="Fact_ad5c1fe86bfa41ef8da28276b803f2d8" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">116</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" id="Fact_c6d4cca5fa894fdcb1b5af9f7303b715" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Paid-in-kind interest added to convertible notes principal</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:PaidInKindInterestAddedToConvertibleNotesPrincipal" id="Fact_bd80fcb5ce8240a69cdb3c07e59e3045" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">113</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:PaidInKindInterestAddedToConvertibleNotesPrincipal" id="Fact_f7edb9a35e1447fe9e8b17356d658671" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Initial measurement of ROU assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfRightOfUseAssets" id="Fact_72e7b001b34e4717bcead6feabcc07ea" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">34,410</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfRightOfUseAssets" id="Fact_a2f9bd4a71cf4364a030520464ec3566" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,706</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Initial measurement of lease liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfLeaseLiabilities" id="Fact_d0ec4b4ccfd04365a8f92e298c745d25" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">34,170</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfLeaseLiabilities" id="Fact_1423b267e1324488a937e514d701d40b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,706</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Adjustment to lease liability and ROU asset due to remeasurement</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" id="Fact_fe63a90b179641e59806015b22e33dfd" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,620</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" id="Fact_caba6a75b70f4bb29f16d52d75d6c811" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Accrual for purchases of property and equipment</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:AccrualForPurchasesOfPropertyAndEquipment" id="Fact_a9f620f60e86444dbcbad91cf36e9f5b" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">323</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:AccrualForPurchasesOfPropertyAndEquipment" id="Fact_75f584f2e2dc415696dc52f988fe947a" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Conversion of warrant liability to equity</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ConversionOfWarrantLiabilityToEquity" id="Fact_b0bf096838bb41609bc0a3d383dff436" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:ConversionOfWarrantLiabilityToEquity" id="Fact_acd0f5189fb84a598451bf3cd6a05572" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">867</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-indent: -18pt; margin-left: 36pt;">Unpaid fees incurred in connction with November 2022 private offering<br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:UnpaidFeesIncurredInConnectionWithPrivateOffering" id="Fact_b1be55513a314f7c8ed96e2dd373ad75" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:UnpaidFeesIncurredInConnectionWithPrivateOffering" id="Fact_7162d1ed923a4894a103eed6053c9584" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">208</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -18pt; margin-left: 36pt;">Initial measurement of finance lease liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfFinanceLeaseLiabilities" id="Fact_7a310ed939304861aa170fcd5f120549" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="erna:InitialMeasurementOfFinanceLeaseLiabilities" id="Fact_e924fbeaf7e047b1bbbb85471febc32b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="margin-left: 9pt;"><br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Reconciliation of cash, cash equivalents and restricted cash at end of period:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Cash and cash equivalents</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_432e2e37f14842ea8e2140377e01f649" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,575</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_a43f6f5bbd084f9886b9485ec94b06a7" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,446</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Restricted cash</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" id="Fact_616e4d25d2cd41eda1b0215c19a53d2b" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,095</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" id="Fact_78d4ee5de04b465d9fb6b4a4c4ee93e0" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,095</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Total cash, cash equivalents and restriced cash at end of period</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_cc2d14d3c67f4c95907aee6c0af64665" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,670</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_fbbcf0ee649d46dfaa8409b08cf1c01d" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">15,541</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The accompanying notes are an integral part of these consolidated financial statements.</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-6</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%7%F-%%--> </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ETERNA THERAPEUTICS INC. AND SUBSIDIARIES</div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><!--Anchor--><a id="NOTESTO"><!--Anchor--></a>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">For the Years Ended December 31, 2023 and 2022</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>


      <ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Text_e8e4b46423fc459bb75555fc7279ec7b" contextRef="c20230101to20231231" escape="true" continuedAt="Text_1c41db2ebc894ef89e91e588b3a7d6081">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">1)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Organization and Description of Business Operations</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_1c41db2ebc894ef89e91e588b3a7d6081" continuedAt="Text_1c41db2ebc894ef89e91e588b3a7d6082">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);"> </span><br/>
        </div>
</ix:continuation>
      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_1c41db2ebc894ef89e91e588b3a7d6082">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics Inc. is a life science company committed to realizing the potential of mRNA cell engineering to provide
            patients with transformational new medicines.&#160; Eterna has in-licensed a portfolio of over <ix:nonFraction name="erna:NumberOfInLicensedPortfolioPatents" id="Fact_6599a8b890094b36aa94e1b3b27b8efd" contextRef="c20230101to20231231" unitRef="U004" decimals="0" scale="0" format="ixt:num-dot-decimal">100</ix:nonFraction> patents covering key mRNA cell
            engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSliceTM and UltraSliceTM gene-editing proteins, and the ToRNAdoTM mRNA delivery system, which Eterna collectively refers to as our &#8220;mRNA
            technology platform.&#8221; Eterna refers to aspects of its mRNA technology platform as &#8220;mRNA delivery,&#8221; &#8220;mRNA gene editing&#8221; and &#8220;mRNA cell reprogramming.&#8221; Eterna licenses its mRNA technology platform from Factor Bioscience Limited (&#8220;Factor Limited&#8221;)
            under an exclusive license agreement. As used herein, the &#8220;Company&#8221; or &#8220;Eterna&#8221; refers collectively to Eterna and its consolidated subsidiaries (Eterna LLC, Novellus, Inc. and Novellus Therapeutics Limited) unless otherwise stated or the
            context otherwise requires.</div>
</ix:continuation>
        </div>


      </div>

      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="erna:LiquidityAndCapitalResourcesTextBlock" id="Text_fc15066e43c442738a9103a62a510e6f" contextRef="c20230101to20231231" escape="true" continuedAt="Text_e2e067d7326d41e6beac34690d324c591">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">2)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Liquidity and Capital Resources</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c591" continuedAt="Text_e2e067d7326d41e6beac34690d324c592">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c592" continuedAt="Text_e2e067d7326d41e6beac34690d324c593">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has incurred significant operating losses and has an accumulated deficit as a result of its efforts to develop
        product candidates, including conducting clinical trials and providing general and administrative support for operations. As of December 31, 2023, the Company had an unrestricted cash balance of approximately $<ix:nonFraction name="us-gaap:Cash" id="Fact_1be9de5a8249481fab31ad1c0dd9cc17" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.6</ix:nonFraction> million and an accumulated deficit of approximately $<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_4a36e72ca6b84fb3893193b0c03de336" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">187.0</ix:nonFraction>
        million. For the year ended December 31, 2023, the Company incurred a net loss of $<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_8d01e63cf4e849d8a2c1b3907d5fda31" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">21.7</ix:nonFraction> million, and the Company used cash of $<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_dbb602b7dfbc46b4a7eb2fb2d191acd5" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">20.4</ix:nonFraction> million in operating activities.</div>
</ix:continuation>
      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c593" continuedAt="Text_e2e067d7326d41e6beac34690d324c594">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c594" continuedAt="Text_e2e067d7326d41e6beac34690d324c595">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;In October 2022, the Company entered into a sublease for approximately <ix:nonFraction name="us-gaap:AreaOfRealEstateProperty" id="Fact_f7798d76446a45ffa2d9daffa472e868" contextRef="c20221031" unitRef="U005" decimals="0" scale="0" format="ixt:num-dot-decimal">45,500</ix:nonFraction> square feet of office and laboratory space in Somerville, Massachusetts.&#160; Pursuant to the sublease, the Company delivered to the sublessor a security deposit in the form of a letter
          of credit in the amount of $<ix:nonFraction name="us-gaap:LineOfCredit" id="Fact_9f2de0426f684de499f06b79b185bd0a" contextRef="c20221031" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.1</ix:nonFraction> million, which will be reduced on an incremental basis throughout the term of the sublease.&#160; The letter
          of credit was issued by the Company&#8217;s commercial bank, which required that the Company cash collateralize the letter of credit by depositing $<ix:nonFraction name="us-gaap:RestrictedCash" id="Fact_fe8e39df2eb949b499cfac5c21b5629f" contextRef="c20221031" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.1</ix:nonFraction>
          million in a restricted cash account with such bank.&#160; The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the sublease.</span></div>
</ix:continuation>
      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c595" continuedAt="Text_e2e067d7326d41e6beac34690d324c596">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c596" continuedAt="Text_e2e067d7326d41e6beac34690d324c597">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In April 2023, the Company entered into a standby equity purchase agreement (the &#8220;SEPA&#8221;) and a registration rights agreement with Lincoln Park Capital Fund, LLC (&#8220;Lincoln Park&#8221;), pursuant to which
            Lincoln Park committed to purchase up to $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_3642793f8cc2410099a58e09e1079d89" contextRef="c20230430_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction> million of the Company&#8217;s common stock in an &#8220;equity line&#8221; financing arrangement.
            During the year ended December 31, 2023, the Company issued and sold approximately <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" id="Fact_9f32889c32724c3587652375980b06a1" contextRef="c20230101to20231231_LegalEntityAxis_LincolnParkCapitalFundLLCMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">214,000</ix:nonFraction> shares of common stock under the SEPA for
            gross proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" id="Fact_97dc4fdc29b941a38cfd5d3e0886ee6c" contextRef="c20230101to20231231_LegalEntityAxis_LincolnParkCapitalFundLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">.</span></span></span></div>
</ix:continuation>
      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c597" continuedAt="Text_e2e067d7326d41e6beac34690d324c598">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </span></span></span></div>
</ix:continuation>
      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c598" continuedAt="Text_e2e067d7326d41e6beac34690d324c599">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In July and December 2023, the Company received $<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_94751a1cd78940448727e67e44a9296c" contextRef="c20230701to20231231_ShortTermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">16.5</ix:nonFraction> million in gross proceeds from the
            issuance of convertible notes and in January 2024 received an additional $<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_efff07005c12434aa651ba5eb9d063b2" contextRef="c20240101to20240131_ShortTermDebtTypeAxis_ConvertibleDebtMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction> million in gross proceeds from the issuance of
            additional convertible notes. See Notes 6 and 18 for additional information regarding these financings.</span></span></div>
</ix:continuation>
      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c599" continuedAt="Text_e2e067d7326d41e6beac34690d324c5910">
<div><br/></div>
</ix:continuation>
      <div><ix:continuation id="Text_e2e067d7326d41e6beac34690d324c5910" continuedAt="Text_e2e067d7326d41e6beac34690d324c5911">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:continuation id="Text_e2e067d7326d41e6beac34690d324c5911" continuedAt="Text_e2e067d7326d41e6beac34690d324c5912">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c5912" continuedAt="Text_e2e067d7326d41e6beac34690d324c5913">
<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">In










            connection with preparing the accompanying consolidated financial statements as of and for the year ended December 31, 2023, the Company&#8217;s management concluded that there is substantial doubt regarding the Company&#8217;s ability to continue as a
            going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these consolidated financial statements. The Company will need to
            raise additional capital, which could be through the sales of shares of its common stock under the SEPA, public or private equity offerings, debt financings, out-licensing the Company&#8217;s intellectual property, strategic partnerships or other
            means. Other than the SEPA, the Company currently has no arrangements for capital, and no assurances can be given that it will be able to raise capital when needed, on acceptable terms, or at all.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c5913" continuedAt="Text_e2e067d7326d41e6beac34690d324c5914">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_e2e067d7326d41e6beac34690d324c5914">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The
        accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying consolidated financial
        statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company&#8217;s ability
        to continue as a going concern.</div>
</ix:continuation>
       </div>

    <div> <br/>
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="Text_58dd98addd9c452ab1c0163aa9b955ed" contextRef="c20230101to20231231" escape="true" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138221">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">3)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Basis of Accounting Presentation and Summary of Significant Accounting Policies</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138221" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138222">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138222" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138223"><ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Text_fb9977bbb433498b8cfb2852a951b3a8" contextRef="c20230101to20231231" escape="true" continuedAt="Text_c0f59e2c2ef840d58709d5cf48ad10271">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Basis of Accounting Presentation</div>
</ix:nonNumeric></ix:continuation>
      <div>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138223" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138224"><ix:continuation id="Text_c0f59e2c2ef840d58709d5cf48ad10271" continuedAt="Text_c0f59e2c2ef840d58709d5cf48ad10272">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138224" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138225"><ix:continuation id="Text_c0f59e2c2ef840d58709d5cf48ad10272">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). All
        significant intercompany balances and transactions have been eliminated in consolidation.</div>
</ix:continuation></ix:continuation>
      </div>

    <div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138225" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138226">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-style: italic;"> <br/>
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-7</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138226" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138227">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-style: italic;">Summary of Significant Accounting Policies</div>
</ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138227" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138228">
<div><br class="Apple-interchange-newline"/></div>
</ix:continuation>
      </div>


      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138228" continuedAt="Text_9e40ef861d61450dbc33ddcdb82138229"><ix:nonNumeric name="us-gaap:UseOfEstimates" id="Text_6b97bb1fe89949e1ac78336d4cd3f300" contextRef="c20230101to20231231" escape="true" continuedAt="Text_0a7124b9ad54436fab62aa2f172434ec1">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Use of Estimates</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb82138229" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382210"><ix:continuation id="Text_0a7124b9ad54436fab62aa2f172434ec1" continuedAt="Text_0a7124b9ad54436fab62aa2f172434ec2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382210" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382211"><ix:continuation id="Text_0a7124b9ad54436fab62aa2f172434ec2">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; contingent consideration and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of
        historical experience and various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382211" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382212">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382212" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382213"><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="Text_48422aca8e0b4de1b6a610801a9b8cb8" contextRef="c20230101to20231231" escape="true" continuedAt="Text_ec275cc6828a424d815f9526aad7afc91">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Cash, Cash Equivalents and Restricted Cash</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382213" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382214"><ix:continuation id="Text_ec275cc6828a424d815f9526aad7afc91" continuedAt="Text_ec275cc6828a424d815f9526aad7afc92">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382214" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382215"><ix:continuation id="Text_ec275cc6828a424d815f9526aad7afc92" continuedAt="Text_ec275cc6828a424d815f9526aad7afc93">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had <ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" id="Fact_e4948a2535344e88a145a0d18fd09f3f" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" id="Fact_6e9be2dd6e6a4bc1b8824c1391f3ed7a" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> cash equivalents as of December 31, 2023 or 2022.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382215" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382216"><ix:continuation id="Text_ec275cc6828a424d815f9526aad7afc93" continuedAt="Text_ec275cc6828a424d815f9526aad7afc94">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382216" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382217"><ix:continuation id="Text_ec275cc6828a424d815f9526aad7afc94">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Restricted cash consists of a cash collateralization of $<ix:nonFraction name="us-gaap:RestrictedCash" id="Fact_1917172e89074e839112de32ef2f8c3e" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.1</ix:nonFraction> million for a security deposit in the form of a letter of credit issued by the Company&#8217;s commercial bank and delivered to the sublessor of office and laboratory space the Company
        subleases in Somerville, Massachusetts. The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the sublease.<br/>
      </div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382217" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382218">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382218" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382219"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="Text_2da43536e14c489382ce5eef9701b4b4" contextRef="c20230101to20231231" escape="true" continuedAt="Text_a275ba7bfca24ffc8fb2ae2c5bb19d9b1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Property and Equipment</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382219" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382220"><ix:continuation id="Text_a275ba7bfca24ffc8fb2ae2c5bb19d9b1" continuedAt="Text_a275ba7bfca24ffc8fb2ae2c5bb19d9b2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382220" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382221"><ix:continuation id="Text_a275ba7bfca24ffc8fb2ae2c5bb19d9b2">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_a45db9a78f024ac8a715d7bbf21da8d0" contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember" format="ixt-sec:durwordsen">seven years</ix:nonNumeric>. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Furniture and fixtures are depreciated over an estimated useful life of <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_a6ea70cbb87448c39686dc9f469bb4aa" contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.&#160; Computer equipment are depreciated over an estimated useful life of <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_8acc4891053a481784f35d7da7055a3d" contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>. Upon retirement or other
        disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of operations. Expenditures for maintenance and repairs are
        charged to operations. Renewals and betterments are capitalized.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382221" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382222">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382222" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382223"><ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="Text_c6a6f33ca0aa4d9d911c3133c23c4c45" contextRef="c20230101to20231231" escape="true" continuedAt="Text_62fd45fffdc14492889f2ff7042fdc761">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Goodwill</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382223" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382224"><ix:continuation id="Text_62fd45fffdc14492889f2ff7042fdc761" continuedAt="Text_62fd45fffdc14492889f2ff7042fdc762">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382224" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382225"><ix:continuation id="Text_62fd45fffdc14492889f2ff7042fdc762">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#8220;IRX&#8221;) in November 2018, which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events occur or circumstances indicate it is more likely
        than not that the fair value of a reporting unit is less than&#160; its carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, macroeconomic conditions, industry and market
        considerations, cost factors, overall financial performance and other relevant events.&#160; Management evaluates the Company as a single reporting unit, therefore, goodwill is tested for impairment at the entity level. Goodwill is tested for impairment
        as of December 31st of each year, or more frequently as warranted by events or changes in circumstances mentioned above.&#160; Accounting guidance also permits an optional qualitative assessment for goodwill to determine whether it is more likely than
        not that the carrying value of a reporting unit exceeds its fair value. If, after this qualitative assessment, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then
        no further quantitative testing would be necessary. A quantitative assessment is performed if the qualitative assessment results in a more likely than not determination or if a qualitative assessment is not performed. The quantitative assessment
        considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#8217;s carrying value exceeds its fair value.<br/>
      </div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382225" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382226">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-8</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>


      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382226" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382227"><ix:nonNumeric name="us-gaap:InProcessResearchAndDevelopmentPolicy" id="Text_c2367262f15e42dd88fba84a270f0b9e" contextRef="c20230101to20231231" escape="true" continuedAt="Text_c0970ac74560424a9dd3158c6cba880c1">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">In-Process Research &amp; Development</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382227" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382228"><ix:continuation id="Text_c0970ac74560424a9dd3158c6cba880c1" continuedAt="Text_c0970ac74560424a9dd3158c6cba880c2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382228" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382229"><ix:continuation id="Text_c0970ac74560424a9dd3158c6cba880c2">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In-process research and development (&#8220;IPR&amp;D&#8221;) assets represent the fair value assigned to technologies that were acquired
        in connection with the acquisition of IRX in November 2018, which have not reached technological feasibility and have no alternative future use. IPR&amp;D assets are considered to be indefinite lived until the completion or abandonment of the
        associated research and development projects. During the period that the IPR&amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or
        changes in circumstances that indicate that the fair value of the IPR&amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize
        products associated with the IPR&amp;D assets, these assets are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a
        full or partial impairment charge related to the IPR&amp;D assets, calculated as the excess of carrying value of the IPR&amp;D assets over fair value.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382229" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382230">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382230" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382231"><ix:nonNumeric name="us-gaap:RevenueRecognitionPolicyTextBlock" id="Text_05beddd75c8246a682bc9683a3d459a6" contextRef="c20230101to20231231" escape="true" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a1">
<div style="text-align: left;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Revenue
              Recognition</span></span><br/>
        </div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382231" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382232"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a1" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a2">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382232" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382233"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a2" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a3">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company recognizes the related revenue under ASC 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). Under ASC 606, the Company recognizes revenue when a customer obtains
            control of promised services or goods in an amount that reflects the consideration to which the Company expects to receive in exchange for those goods or services. </span></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382233" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382234"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a3" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a4">
<div>
        &#160; <br/></div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382234" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382235"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a4" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a5">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In general, the Company applies the following steps when recognizing revenue from contracts with customers: (i) identify the contract, (ii) identify the performance obligations,
          (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations and (v) recognize revenue when a performance obligation is satisfied. Recognition of revenue is driven by satisfaction of the performance
          obligations using one of two methods: revenue is either recognized over time or at a point in time. Contracts containing multiple performance obligations classify those performance obligations into separate units of account either as standalone
          or combined units of account. Allocation of revenue to individual elements that qualify for separate accounting is based on the separate selling prices determined for each component, and total contract consideration is then allocated across the
          components of the arrangement. If separate selling prices are not available, the Company will use its best estimate of such selling prices, consistent with the overall pricing strategy and after consideration of relevant market factors.</span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382235" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382236"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a5" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a6">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382236" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382237"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a6" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a7">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company estimates the amount of consideration it expects to recognize as revenue that is not probable of having a significant reversal of such recognized revenue, and it places
          a constraint on the remaining contractual consideration. As it becomes evident that the constrained amounts are no longer at risk of a significant reversal of revenue, the Company will remove the constraint from the related revenue and recognize
          a cumulative catch-up adjustment to revenue in the period in which the constraint was removed.</span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382237" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382238"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a7" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a8">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382238" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382239"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a8" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a9">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has <ix:nonFraction name="erna:NumberOfRevenueGeneratingContracts" id="Fact_1010609b576e4bf7b61d377923a6d42e" contextRef="c20230101to20231231" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> revenue generating contract. Such contract
          relates to an option and license agreement as well as certain development activities.&#160; See Note 5.</span><br/>
        <br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382239" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382240"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a9" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a10">
<div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt; text-align: justify;"> Contract Assets:<br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382240" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382241"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a10" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a11">
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382241" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382242"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a11" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a12">
<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> A contract asset is an entity&#8217;s right to payment for goods and services already transferred to a customer if that right to payment is conditional on something other than the passage of time.
          Generally, an entity will recognize a contract asset when it has fulfilled a contract obligation but must perform other obligations before being entitled to payment. Contract assets consist primarily of the cost of project contract work performed
          by third parties whereby the Company expects to recognize any related revenue at a later date, upon satisfaction of the contract obligations. The Company had <ix:nonFraction name="us-gaap:ContractWithCustomerAssetNet" id="Fact_94e336b326ef466ab44215ea1c6e920b" contextRef="c20221231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:ContractWithCustomerAssetNet" id="Fact_05d55bba4cd14be0bc9c59f1ebd5ef1f" contextRef="c20231231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> contract assets as of December 31, 2023 or 2022.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382242" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382243"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a12" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a13">
<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382243" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382244"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a13" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a14">
<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contract Liabilities:</span></div>
</ix:continuation></ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382244" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382245"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a14" continuedAt="Text_a8d9d8962c444e7eb04bb7d71affec6a15">
<div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382245" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382246"><ix:continuation id="Text_a8d9d8962c444e7eb04bb7d71affec6a15">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contract liabilities consist primarily of consideration received, usually in the form of payment, on project work to be performed whereby the Company expects to recognize any related revenue at a later date, upon
            satisfaction of the contract obligations. As of December 31, 2023, contract liabilities were $<ix:nonFraction name="us-gaap:DeferredRevenue" id="Fact_812895507fad47329ba8c33871c3644c" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million and are recognized as
            deferred revenue in the accompanying consolidated balance sheet. The Company recognized $<ix:nonFraction name="us-gaap:ContractWithCustomerLiability" id="Fact_41bf0a5629a4416ba26ee8ac3c758073" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million of revenue during the year ended
            December 31, 2023 from contract liabilities that arose in 2023. There were <ix:nonFraction name="us-gaap:ContractWithCustomerLiability" id="Fact_0c6a1d6972e1420f8742f5b377a43a84" contextRef="c20221231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction> contract liabilities as of December 31, 2022.</span><br/>
        </div>
</ix:continuation></ix:continuation>
      </div>


      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382246" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382247">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382247" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382248"><ix:nonNumeric name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="Text_3a7f085e167c4fe3adab4b68b5c77eb4" contextRef="c20230101to20231231" escape="true" continuedAt="Text_d0a32769c1304016816da778ced7ccc91">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Research and Development</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382248" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382249"><ix:continuation id="Text_d0a32769c1304016816da778ced7ccc91" continuedAt="Text_d0a32769c1304016816da778ced7ccc92">
<div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382249" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382250"><ix:continuation id="Text_d0a32769c1304016816da778ced7ccc92" continuedAt="Text_d0a32769c1304016816da778ced7ccc93">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382250" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382251"><ix:continuation id="Text_d0a32769c1304016816da778ced7ccc93" continuedAt="Text_d0a32769c1304016816da778ced7ccc94">
<div><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382251" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382252"><ix:continuation id="Text_d0a32769c1304016816da778ced7ccc94" continuedAt="Text_d0a32769c1304016816da778ced7ccc95">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The major components of research and development costs include salaries and employee benefits, stock-based compensation expense, supplies and
        materials, preclinical study costs, expensed licensed technology, consulting, scientific advisors and other third-party costs, and allocations of various overhead costs related to our product development efforts. </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382252" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382253"><ix:continuation id="Text_d0a32769c1304016816da778ced7ccc95" continuedAt="Text_d0a32769c1304016816da778ced7ccc96">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-9</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382253" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382254"><ix:continuation id="Text_d0a32769c1304016816da778ced7ccc96">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has contracted with third parties to perform various studies. The financial terms of these agreements vary from
        contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts expended during the reporting period. If the actual timing of the performance of the
        services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a straight-line basis if the expected costs are expected to be incurred ratably during
        the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the allocation of responsibilities among the parties to the agreement, and the completion of
        portions of the clinical study or trial or similar conditions.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382254" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382255">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382255" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382256"><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" id="Text_498e5018dea24bdf8cc2b8a498488b16" contextRef="c20230101to20231231" escape="true" continuedAt="Text_47c17a77c15347c3977fbd318cfc0c8a1">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Income Taxes</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382256" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382257"><ix:continuation id="Text_47c17a77c15347c3977fbd318cfc0c8a1" continuedAt="Text_47c17a77c15347c3977fbd318cfc0c8a2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382257" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382258"><ix:continuation id="Text_47c17a77c15347c3977fbd318cfc0c8a2" continuedAt="Text_47c17a77c15347c3977fbd318cfc0c8a3">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382258" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382259"><ix:continuation id="Text_47c17a77c15347c3977fbd318cfc0c8a3" continuedAt="Text_47c17a77c15347c3977fbd318cfc0c8a4">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382259" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382260"><ix:continuation id="Text_47c17a77c15347c3977fbd318cfc0c8a4">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382260" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382261">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382261" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382262"><ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" id="Text_7951f8cc83434eda9aa97204d7a1dd30" contextRef="c20230101to20231231" escape="true" continuedAt="Text_3bb620a537e54c078be02296b82bd1531">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Loss Per Share</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382262" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382263"><ix:continuation id="Text_3bb620a537e54c078be02296b82bd1531" continuedAt="Text_3bb620a537e54c078be02296b82bd1532">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382263" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382264"><ix:continuation id="Text_3bb620a537e54c078be02296b82bd1532" continuedAt="Text_3bb620a537e54c078be02296b82bd1533">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the
        two-class method required for participating securities.&#160; The Company&#8217;s convertible notes contractually entitle the holders of such notes to participate in dividends but does not contractually require the holders to participate in the Company&#8217;s
        losses.&#160; As such, the two-class method is not applicable during periods with a net loss.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382264" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382265"><ix:continuation id="Text_3bb620a537e54c078be02296b82bd1533" continuedAt="Text_3bb620a537e54c078be02296b82bd1534">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation></ix:continuation>
    </div>

    <div>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382265" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382266"><ix:continuation id="Text_3bb620a537e54c078be02296b82bd1534">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number
        of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of
        shares of common stock outstanding plus dilutive securities.&#160; Shares of common stock issuable upon exercise, conversion or vesting of stock options, restricted stock units, warrants and the outstanding Series A convertible preferred stock are
        considered potential shares of common stock and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. The Company&#8217;s convertible notes are also considered potential shares of common
        stock and are included in the calculation of diluted net loss per share using the &#8220;if-converted&#8221; method, and the more dilutive of either the two-class method or the if-converted method is reported.&#160; Diluted net loss per share is the same as basic
        net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382266" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382267">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382267" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382268"><ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="Text_eed8acfbc096446e81415cdb77dd5376" contextRef="c20230101to20231231" escape="true" continuedAt="Text_594ee864b89d4cd6b93beac06ef76fe01">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Segment Reporting</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382268" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382269"><ix:continuation id="Text_594ee864b89d4cd6b93beac06ef76fe01" continuedAt="Text_594ee864b89d4cd6b93beac06ef76fe02">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382269" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382270"><ix:continuation id="Text_594ee864b89d4cd6b93beac06ef76fe02">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, <span style="font-style: italic;">Segment Reporting,</span> the Company has determined that it operates as <ix:nonFraction name="us-gaap:NumberOfOperatingSegments" id="Fact_7d462c41db9b4c5fba461db583183138" contextRef="c20230101to20231231" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> operating segment.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382270" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382271">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382271" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382272"><ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" id="Text_8b2098fc4dcc48598043cbdf4eb2f4e7" contextRef="c20230101to20231231" escape="true" continuedAt="Text_7fdbd2f7b3f44df8ad5475658708d7b61">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Concentration of Credit Risk</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382272" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382273"><ix:continuation id="Text_7fdbd2f7b3f44df8ad5475658708d7b61" continuedAt="Text_7fdbd2f7b3f44df8ad5475658708d7b62">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382273" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382274"><ix:continuation id="Text_7fdbd2f7b3f44df8ad5475658708d7b62" continuedAt="Text_7fdbd2f7b3f44df8ad5475658708d7b63">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000. The Company&#8217;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382274" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382275"><ix:continuation id="Text_7fdbd2f7b3f44df8ad5475658708d7b63" continuedAt="Text_7fdbd2f7b3f44df8ad5475658708d7b64">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382275" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382276"><ix:continuation id="Text_7fdbd2f7b3f44df8ad5475658708d7b64">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In the Company&#8217;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#8217;s supply chain, which
        could ultimately impact the Company&#8217;s ability to continue its research and development activities. For the years ended December 31, 2023 and 2022, there was no vendor concentration related to the Company&#8217;s research and development activities.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382276" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382277">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382277" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382278"><ix:nonNumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Text_2791aa3d01e245a0bf8c2ac430d9635d" contextRef="c20230101to20231231" escape="true" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c1">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Fair Value of Financial Instruments</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382278" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382279"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c1" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382279" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382280"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c2" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c3">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382280" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382281"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c3" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c4">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-10</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382281" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382282"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c4" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c5">
<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 1 Inputs &#8211; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382282" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382283"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c5" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c6">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382283" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382284"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c6" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c7">
<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 2 Inputs &#8211; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382284" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382285"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c7" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c8">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382285" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382286"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c8" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c9">
<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 3 Inputs &#8211; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.</span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382286" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382287"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c9" continuedAt="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c10">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382287" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382288"><ix:continuation id="Text_c5e0fecb61394d24b29c1ea9e2fbdf8c10">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The carrying amounts reported on the balance sheet for cash and cash equivalents, other receivables, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value due to their short maturities.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382288" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382289">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/></div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382289" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382290"><ix:nonNumeric name="us-gaap:LesseeLeasesPolicyTextBlock" id="Text_50f18a33557b4d308295462934021741" contextRef="c20230101to20231231" escape="true" continuedAt="Text_3547a3ae17024dcf91547adc011766e41">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Leases</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382290" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382291"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e41" continuedAt="Text_3547a3ae17024dcf91547adc011766e42">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382291" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382292"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e42" continuedAt="Text_3547a3ae17024dcf91547adc011766e43">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company accounts for its leases under
        ASC Topic 842, <span style="font-style: italic;">Leases.</span> Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382292" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382293"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e43" continuedAt="Text_3547a3ae17024dcf91547adc011766e44">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382293" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382294"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e44" continuedAt="Text_3547a3ae17024dcf91547adc011766e45">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382294" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382295"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e45" continuedAt="Text_3547a3ae17024dcf91547adc011766e46">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382295" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382296"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e46" continuedAt="Text_3547a3ae17024dcf91547adc011766e47">
<div style="display:none;"><br/></div>
<div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.</div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382296" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382297"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e47" continuedAt="Text_3547a3ae17024dcf91547adc011766e48">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>
</ix:continuation></ix:continuation>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382297" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382298"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e48" continuedAt="Text_3547a3ae17024dcf91547adc011766e49">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less. </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382298" continuedAt="Text_9e40ef861d61450dbc33ddcdb821382299"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e49" continuedAt="Text_3547a3ae17024dcf91547adc011766e410">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb821382299" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822100"><ix:continuation id="Text_3547a3ae17024dcf91547adc011766e410">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for lease modifications as a separate contract when the modification (i) grants the lessee an additional
          right of use not included in the original lease contract, and (ii) increases the lease payments commensurate with the stand-alone price for the additional right of use.&#160; In this case, the Company would be treated as a new lease and measured in
          accordance with ASC 842 at the commencement date of the new lease without any impact on the existing lease.&#160; Otherwise, the Company accounts for lease modifications as a continuance of the existing lease, in which case, the Company reassesses the
          lease classification, remeasures the lease liability using an updated discount rate, and unless there is a full or partial termination of the lease, adjusts the ROU asset by the amount of change to the lease liability.&#160; For a full or partial
          lease termination, the lessee reduces the carrying amount of the ROU asset on a basis proportionate to the full or partial termination of the lease, and any difference between the adjustment to the ROU asset and the lease liability is recognized
          as a gain or loss in the current period.</div>
</ix:continuation></ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822100" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822101">
<div><br/>
        </div>
</ix:continuation>
      </div>


      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822101" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822102"><ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="Text_4f18285a39af4e629713ec9c7a2a2f1d" contextRef="c20230101to20231231" escape="true" continuedAt="Text_2b54ef1c97894ff0a6533315b80301101">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Commitment and Contingencies</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822102" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822103"><ix:continuation id="Text_2b54ef1c97894ff0a6533315b80301101" continuedAt="Text_2b54ef1c97894ff0a6533315b80301102">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822103" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822104"><ix:continuation id="Text_2b54ef1c97894ff0a6533315b80301102">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company follows ASC No.450-20, <span style="font-style: italic;">Loss Contingencies,</span> to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822104" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822105">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822105" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822106"><ix:nonNumeric name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="Text_326ab3d8fd264d64a32f3ad506798d11" contextRef="c20230101to20231231" escape="true" continuedAt="Text_ae5cd92004f64d298aff27c42c2a76a61">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock-Based Compensation</span></div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822106" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822107"><ix:continuation id="Text_ae5cd92004f64d298aff27c42c2a76a61" continuedAt="Text_ae5cd92004f64d298aff27c42c2a76a62">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822107" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822108"><ix:continuation id="Text_ae5cd92004f64d298aff27c42c2a76a62">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-line basis.</div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822108" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822109">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-11</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>


      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822109" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822110"><ix:nonNumeric name="us-gaap:DerivativesMethodsOfAccountingNonhedgingDerivatives" id="Text_80aad676cc3543da99880f689a019949" contextRef="c20230101to20231231" escape="true" continuedAt="Text_7573b608a3214952979291c962a6671d1">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Warrants</span><br/>
      </div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822110" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822111"><ix:continuation id="Text_7573b608a3214952979291c962a6671d1" continuedAt="Text_7573b608a3214952979291c962a6671d2">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br/>
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822111" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822112"><ix:continuation id="Text_7573b608a3214952979291c962a6671d2">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, <span style="font-style: italic;">Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.</span> The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#8217;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.<span style="text-decoration: underline;"><br/>
        </span></div>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822112" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822113">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <div><ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822113" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822114"><ix:nonNumeric name="us-gaap:DebtPolicyTextBlock" id="Text_d3e14252f96b4f4b808b88f1facdd12d" contextRef="c20230101to20231231" escape="true" continuedAt="Text_4150ce05e68f432b87cf03dbb9ad048f1">
<div><span style="text-decoration: underline;">Convertible Notes</span></div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822114" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822115"><ix:continuation id="Text_4150ce05e68f432b87cf03dbb9ad048f1" continuedAt="Text_4150ce05e68f432b87cf03dbb9ad048f2">
<div><br/>
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822115" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822116"><ix:continuation id="Text_4150ce05e68f432b87cf03dbb9ad048f2" continuedAt="Text_4150ce05e68f432b87cf03dbb9ad048f3">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The Company accounts for its convertible
          notes as a long-term liability equal to the proceeds received from issuance, including the embedded conversion feature, plus any interest paid-in-kind, net of the unamortized debt issuance costs and debt discount on the consolidated balance
          sheets. The Company evaluates all embedded features contained in the convertible notes, such as the conversion feature, the paid-in-kind feature and the redemption feature in the event of a default, to determine if such features require
          bifurcation as a derivative. The conversion feature included in the convertible notes is not required to be accounted for separately as an embedded derivative because the conversion feature is considered both indexed to the Company&#8217;s own stock
          and qualifies to be classified in stockholders&#8217; equity. The paid-in-kind feature is considered to be a commitment to originate a loan, and the terms of the additional loans have the same terms as the original debt instrument. Therefore, the
          paid-in-kind feature qualifies for the scope exception under the applicable accounting guidance and is not required to be bifurcated as a derivative. The redemption feature in the event of a default was determined to be clearly and closely
          related to the convertible notes and not required to be bifurcated as a derivative.</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822116" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822117"><ix:continuation id="Text_4150ce05e68f432b87cf03dbb9ad048f3" continuedAt="Text_4150ce05e68f432b87cf03dbb9ad048f4">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822117" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822118"><ix:continuation id="Text_4150ce05e68f432b87cf03dbb9ad048f4" continuedAt="Text_4150ce05e68f432b87cf03dbb9ad048f5">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822118" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822119"><ix:continuation id="Text_4150ce05e68f432b87cf03dbb9ad048f5" continuedAt="Text_4150ce05e68f432b87cf03dbb9ad048f6">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822119" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822120"><ix:continuation id="Text_4150ce05e68f432b87cf03dbb9ad048f6">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Proceeds from the sale of convertible
          notes with stock purchase warrants are allocated to the two elements based on their relative fair values. The portion of the proceeds allocated to warrants are recorded as a debt discount to the convertible note proceeds and presented on a net
          basis in the consolidated balance sheet. Debt issuance costs directly attributable to the transaction are capitalized and allocated to the convertible notes and warrants in the same manner as the proceeds. The amount of debt issuance costs
          allocated to the convertible notes represent a reduction of the face value of the convertible note proceeds. The Company amortizes debt issuance costs and debt discounts over the contractual term of the convertible notes, using the effective
          interest method, as interest expense on the consolidated statements of operations.</div>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822120" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822121">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation>

        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822121" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822122"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Text_ebab9e05a0a34b64914cfb784e536bc2" contextRef="c20230101to20231231" escape="true" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d1">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Recent Accounting Standards</span></div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822122" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822123"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d1" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d2">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br/>
          </span></div>
</ix:continuation></ix:continuation>
      </div>

      <div><ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822123" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822124"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d2" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d3">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>  <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822124" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822125"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d3" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d4">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> In June 2022, the Financial Accounting
          Standard Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#8220;ASU 2022-03&#8221;). The FASB issued ASU
          2022-03 to (1) clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative
          example, and (3) to introduce new disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on
          the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and
          interim periods within those fiscal years with early adoption permitted. The Company does not expect a material impact to its consolidated financial statements as a result of adopting this ASU.</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822125" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822126"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d4" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d5">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822126" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822127"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d5" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d6">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822127" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822128"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d6" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d7">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822128" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822129"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d7" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d8">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In October 2023, the FASB issued ASU No.
          2023-06, Disclosure Improvements &#8211; Codification Amendment in Response to the SEC&#8217;s Disclosure Update and Simplification Initiative. This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning
          them with the SEC&#8217;s regulations.&#160; The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC&#8217;s removal of the related
          disclosure.&#160; If the SEC has not removed the applicable requirements from Regulation S-X or Regulation S-K by June 30, 2027, then this ASU will not become effective.&#160; Early adoption is prohibited.&#160; The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822129" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822130"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d8" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d9">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822130" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822131"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d9" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d10">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822131" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822132"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d10" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d11">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822132" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822133"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d11" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d12">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In November 2023, the FASB issued ASU
          No. 2023-07, Segment Reporting &#8211; Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses
          and increased interim disclosure requirements, among others. ASU No. 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. Early adoption is permitted, and
          the amendments should be applied retrospectively. The Company does not expect the amendments in this ASU to have a material impact on its consolidated financial statements.</div>
</ix:continuation></ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822133" continuedAt="Text_9e40ef861d61450dbc33ddcdb8213822134"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d12" continuedAt="Text_22a4bb2b8dc34b67af2aec34a6ab847d13">
<div><br/>
        </div>
</ix:continuation></ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-12</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <ix:continuation id="Text_9e40ef861d61450dbc33ddcdb8213822134"><ix:continuation id="Text_22a4bb2b8dc34b67af2aec34a6ab847d13">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In December 2023, the FASB issued ASU
          No. 2023-09, Improvements to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related
          disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.</div>
</ix:continuation></ix:continuation>
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
         <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>

        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <ix:nonNumeric name="us-gaap:AssetAcquisitionTextBlock" id="Text_14b266b3119b4a67a97ab669e2d1ce15" contextRef="c20230101to20231231" escape="true" continuedAt="Text_297d5006b6514364afda401e3d06f54e1">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 36pt; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.4pt; margin-left: 0.4pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">4)</span></div>
            </td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.4pt; margin-left: 0.4pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Asset Acquisition</span></div>
            </td>

  </tr>


</table>
    </div>
</ix:nonNumeric>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e1" continuedAt="Text_297d5006b6514364afda401e3d06f54e2">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e2" continuedAt="Text_297d5006b6514364afda401e3d06f54e3">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">In April 2023, the Company entered into an
      asset purchase agreement (the &#8220;Exacis Purchase Agreement&#8221;), with Exacis Biotherapeutics Inc. (&#8220;Exacis&#8221;), the stockholders party thereto and, with respect to specified provisions therein, Factor Limited (the &#8220;Exacis Acquisition&#8221;). Pursuant to the
      Exacis Purchase Agreement, the Company acquired from Exacis substantially all of Exacis&#8217; intellectual property assets (the &#8220;Exacis Assets&#8221;), including all of Exacis&#8217; right, title and interest in and to an exclusive license agreement by and between
      Exacis and Factor Limited (the &#8220;Purchased License&#8221;).&#160; The Company assumed none of Exacis&#8217; liabilities, other than liabilities under the Purchased License that accrue subsequent to the closing date.</div>
</ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e3" continuedAt="Text_297d5006b6514364afda401e3d06f54e4">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e4" continuedAt="Text_297d5006b6514364afda401e3d06f54e5">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">In consideration for the Exacis Assets, on
      the closing date of the transaction, the Company issued to Exacis an aggregate of approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_6958ac1cb915430d9ace9f6241bc6d54" contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">69,000</ix:nonFraction> shares of the Company&#8217;s common
      stock, which shares are subject to a <ix:nonNumeric name="erna:LockUpPeriodForCommonStock" id="Fact_01772be8413e4042af59901ae0337a51" contextRef="c20230101to20231231_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" format="ixt-sec:durwordsen">12-month</ix:nonNumeric> lockup, pursuant to which Exacis may not sell or otherwise transfer such shares.&#160; The shares
      were issued to Exacis at a price based on the Company having an assumed equity valuation of $<ix:nonFraction name="erna:EstimatedEquityValueOfStockIssuedInAssetAcquisition" id="Fact_97507d7b957548d4a512dbf2344ba462" contextRef="c20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">75.0</ix:nonFraction> million, divided by the number of issued
      and outstanding shares of common stock as of the close of business two trading days prior to the closing date.&#160; For accounting purposes, the shares issued were valued at $<ix:nonFraction name="erna:AssetAcquisitionSharePrice" id="Fact_6c3c0b56f77843bd9983cc2e1a36835b" contextRef="c20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.00</ix:nonFraction> per share, which was the closing price of the Company&#8217;s common stock on the date of issuance.&#160; The Company additionally agreed to make the following contingent payments:</div>
</ix:continuation>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">
      <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e5" continuedAt="Text_297d5006b6514364afda401e3d06f54e6">
<div style="font-size: 10pt;">&#160;</div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e6" continuedAt="Text_297d5006b6514364afda401e3d06f54e7">
<div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt; text-align: left;">(i)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;">if, at any time during the <ix:nonNumeric name="erna:CommencementPeriodOfCommonStockInPurchaseAgreement" id="Fact_3428d3791c2649469e0ef5e7c312ea2b" contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric>
                    period commencing on the closing date and ending on the <ix:nonNumeric name="erna:CommencementPeriodOfCommonStockInPurchaseAgreement" id="Fact_6f37ce9820cb4875aa11fefdfa5fa7d3" contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric> anniversary of the closing date, the Company&#8217;s market
                    capitalization equals or exceeds $<ix:nonFraction name="erna:MinimumCapitalizationRequirementAmount" id="Fact_897f4c89b1514843b6b6510da1d26e04" contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">100.0</ix:nonFraction> million for at least <span style="-sec-ix-hidden:Fact_35ada709acde4da985c53db06fba5394">ten</span> consecutive trading days, then the Company will issue to Exacis a number of shares of common stock equal to (x) $<ix:nonFraction name="erna:NumeratorValueForStockIssuance" id="Fact_ad8b85c579c345138c480a7373a05f79" contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction> million divided by (y) the quotient of $<ix:nonFraction name="erna:MinimumCapitalizationRequirementAmount" id="Fact_e2689f070e8643f9806500c2406d4a2f" contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-4" scale="6" format="ixt:num-dot-decimal">100.00</ix:nonFraction>
                    million divided by the number of the Company&#8217;s then issued and outstanding shares of common stock;</div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e7" continuedAt="Text_297d5006b6514364afda401e3d06f54e8">
<div style="font-size: 10pt;">&#160;</div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e8" continuedAt="Text_297d5006b6514364afda401e3d06f54e9">
<div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt; text-align: left;">(ii)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;">if, at any time during the <ix:nonNumeric name="erna:CommencementPeriodOfCommonStockInPurchaseAgreement" id="Fact_602db52d29b4454c8a19480c1d5e35a4" contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric>
                    period commencing on the closing date and ending on the three-year anniversary of the closing date, the Company&#8217;s market capitalization equals or exceeds $<ix:nonFraction name="erna:MinimumCapitalizationRequirementAmount" id="Fact_5ea6ea6d9e6d4f67b019b88a22795ff1" contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">200.0</ix:nonFraction> million for at least <span style="-sec-ix-hidden:Fact_fe2e977747fa41309cc95a33766e6e30">ten</span> consecutive trading days, then the Company will issue to
                    Exacis a number of additional shares of common stock equal to (x) $<ix:nonFraction name="erna:NumeratorValueForStockIssuance" id="Fact_a6bef33e356e4d64afc92249832737c6" contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction> million divided by (y) the quotient of $<ix:nonFraction name="erna:MinimumCapitalizationRequirementAmount" id="Fact_2b964015050748e3864402d02c46b612" contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-4" scale="6" format="ixt:num-dot-decimal">200.00</ix:nonFraction> million divided by the number of the Company&#8217;s then issued and outstanding shares of common stock (collectively with (i) above, the
                    &#8220;Market Cap Contingent Consideration&#8221;); and</div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e9" continuedAt="Text_297d5006b6514364afda401e3d06f54e10">
<div style="font-size: 10pt;">&#160;</div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e10" continuedAt="Text_297d5006b6514364afda401e3d06f54e11">
<div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: left;">(iii)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto; font-family: 'Times New Roman';">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;">during the five-year period commencing on the closing date and ending on the <ix:nonNumeric name="erna:CommencementPeriodOfCommonStockInPurchaseAgreement" id="Fact_37709f9334ee41518846c12e81dff968" contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationThreeMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" format="ixt-sec:durwordsen">five-year</ix:nonNumeric> anniversary of the closing date, the Company will pay or deliver to Exacis <ix:nonFraction name="erna:PercentageOfCashConsideration" id="Fact_136c81d2e71843848209398739330c3a" contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% of all cash or other consideration (collectively, &#8220;License Contingent Consideration&#8221;) actually received by the Company during such five-year period from (i) third-party licensees or sublicensees of
                    the intellectual property rights acquired by the Company from Exacis pursuant to the Exacis Purchase Agreement, or (ii) subject to certain exceptions, the sale of such intellectual property rights; provided, that the License Contingent
                    Consideration shall not in any event exceed $<ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" id="Fact_8913641705c3434aa6d8d0f5fdb14668" contextRef="c20230401to20230430_RangeAxis_MaximumMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">45.0</ix:nonFraction> million.</div>
                </td>

  </tr>


</table>
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e11" continuedAt="Text_297d5006b6514364afda401e3d06f54e12">
<div style="font-size: 10pt;">&#160;</div>
</ix:continuation>
    </div>

    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e12" continuedAt="Text_297d5006b6514364afda401e3d06f54e13">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">The Company accounted for the Exacis
      Acquisition as an asset acquisition because it determined that substantially all of the fair value of the assets acquired was concentrated in the Purchased License.&#160; Assets acquired in an asset acquisition are recognized based on their cost to the
      acquirer and generally allocated to the assets on a relative fair value basis.&#160; The Company&#8217;s cost for acquiring the Exacis Assets includes the issuance of the shares of the Company&#8217;s common stock, direct acquisition-related costs and contingent
      consideration.</div>
</ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e13" continuedAt="Text_297d5006b6514364afda401e3d06f54e14">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;"></div>

      <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-13</span></div>

      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

      <div class="BRPFPageHeader" style="width: 100%;">
        <div>
          <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
            </a></div>

        </div>

      </div>

    </div>

    <!--PROfilePageNumberReset%Num%14%F-%%-->
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e14" continuedAt="Text_297d5006b6514364afda401e3d06f54e15">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">The Market Cap Contingent Consideration is
      indexed to or settled in the Company&#8217;s own shares.&#160; As a result, the Company classified the Market Cap Contingent Consideration as a liability measured at fair value because the financial instrument embodies a conditional obligation (the Company
      would only issue the shares on the condition that the market capitalization thresholds are met), and at inception, the monetary value of the obligation is based solely on a fixed monetary amount ($<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" id="Fact_5b205a1e6e364641b5b149f90c00dbc9" contextRef="c20230426_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction> million of shares for each target), which will be settleable with a variable number of the Company&#8217;s shares.&#160; <ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="Text_d61bc62ca1b844638e60aeab93dc6570" contextRef="c20230101to20231231" escape="true" continuedAt="Text_08af6cf942694506b13e93c3ac1fd0241"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;">The Company used a Monte Carlo simulation model to estimate the fair value of the Market
      Cap Contingent Consideration as of the acquisition date using the following assumptions:</span></ix:nonNumeric></div>
</ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e15" continuedAt="Text_297d5006b6514364afda401e3d06f54e16"><ix:continuation id="Text_08af6cf942694506b13e93c3ac1fd0241" continuedAt="Text_08af6cf942694506b13e93c3ac1fd0242">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e16" continuedAt="Text_297d5006b6514364afda401e3d06f54e17"><ix:continuation id="Text_08af6cf942694506b13e93c3ac1fd0242">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">
      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Stock price</div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_621e6a1c267b4ab4aba1ded78fee713b" contextRef="c20230426_MeasurementInputTypeAxis_MeasurementInputSharePriceMember" unitRef="U001" decimals="2" scale="0" format="ixt:num-dot-decimal">3.00</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; font-size: 10pt; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Risk-free rate</div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_5fc65abc127449c6b741bf1b7396e8e9" contextRef="c20230426_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember" unitRef="U001" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.58</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Volatility</div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_2afde1d140dc4f1bac0dec6614805f9e" contextRef="c20230426_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U001" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; font-size: 10pt; width: 88%;">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_aaf8ab313e274b25b9943e665f04c189" contextRef="c20230426_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember" unitRef="U001" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;">
              <div style="text-align: right; color: rgb(0, 0, 0);"><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_313f64db450d47b09bf763181b5eb87e" contextRef="c20231231_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember" format="ixt-sec:duryear">3.0</ix:nonNumeric> years</div>
            </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
      </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e17" continuedAt="Text_297d5006b6514364afda401e3d06f54e18">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;"><br/>
    </div>
</ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e18" continuedAt="Text_297d5006b6514364afda401e3d06f54e19">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">The License Contingent Consideration is to be
      settled in cash and is generally recognized when the liability is probable and estimable.&#160; As of the acquisition date and as of December 31, 2023, the Company concluded that paying the License Contingent Consideration was not probable or estimable.&#160;
      Therefore, there was no applicable contingent consideration liability recognized.</div>
</ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e19" continuedAt="Text_297d5006b6514364afda401e3d06f54e20">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
      <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e20" continuedAt="Text_297d5006b6514364afda401e3d06f54e21"><ix:nonNumeric name="us-gaap:AssetAcquisitionTableTextBlock" id="Text_ace078aa41c1453dba3f627ab72bb372" contextRef="c20230101to20231231" escape="true" continuedAt="Text_d90630a2e7f94022a7ed8347c1f96f911">
<div style="text-align: justify;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The table below shows the total fair value of
          the consideration paid for the Exacis Assets (in thousands).</span><br/>
      </div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e21" continuedAt="Text_297d5006b6514364afda401e3d06f54e22"><ix:continuation id="Text_d90630a2e7f94022a7ed8347c1f96f911" continuedAt="Text_d90630a2e7f94022a7ed8347c1f96f912">
<div><br/>
      </div>
</ix:continuation></ix:continuation>
    </div>

    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e22" continuedAt="Text_297d5006b6514364afda401e3d06f54e23"><ix:continuation id="Text_d90630a2e7f94022a7ed8347c1f96f912">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value of<br/>
              Consideration</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Shares issued</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" id="Fact_29d26d432f6c4c43b9d4d025e005b924" contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">208</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 88%; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Contingent consideration</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AssetAcquisitionFairValueOfConsiderationPaid" id="Fact_233d51666abc45e5bd5f9734b874ad6b" contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">225</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Direct costs</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost" id="Fact_998c438b5a2f4bd9ba1176173914c72b" contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">27</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 4px; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Total fair value</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_36e819e267de438788a595ba5fce6d8a" contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">460</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e23" continuedAt="Text_297d5006b6514364afda401e3d06f54e24">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>
</ix:continuation>
    <ix:continuation id="Text_297d5006b6514364afda401e3d06f54e24">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.4pt;">The Company allocated <ix:nonFraction name="erna:AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" id="Fact_60bdfb58752142ebb4bae4eb65d3c495" contextRef="c20230430" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the fair value of the consideration to the Purchased License, which the Company determined is an IPR&amp;D asset.&#160; IPR&amp;D assets acquired
      through an asset purchase that have no alternative future uses and no separate economic values from their original intended purpose are expensed in the period the cost is incurred.&#160; As a result, the Company expensed the fair value of the Purchased
      License during the year ended December 31, 2023.</div>
</ix:continuation>

    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.4pt;"> <br/>
    </div>

  </div>


  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="Text_478532efb41e493da3d48b4476b5c000" contextRef="c20230101to20231231" escape="true" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">5)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Contract with Customer</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf1" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf2">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf2" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf3">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt; margin-left: 0.5pt;">On February 21, 2023, the Company and
        Lineage Cell Therapeutics, Inc. (&#8220;Lineage&#8221;) entered into an exclusive option and license agreement (the &#8220;Lineage Agreement&#8221;), which provided Lineage with the option (the &#8220;Option Right&#8221;) to obtain an exclusive sublicense of intellectual property
        from the Company and to request the Company to develop a customized cell line.&#160; The Lineage Agreement was amended in August 2023 to provide for changes specifically related to the cell line customization activities such as (i) payment terms, (ii)
        certain definitions, (iii) certain courses of action if the customized cell line selected by Lineage is not successful and (iv) documentation requirements.&#160; Lineage paid the Company a $<ix:nonFraction name="erna:ProceedsFromOptionAndLicenseAgreement" id="Fact_8873aaddeeaf4e5ca0631363dd4879b5" contextRef="c20230221to20230221" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million non-refundable up-front payment (the &#8220;Option Fee&#8221;) for the Option Right and paid an initial payment of $<ix:nonFraction name="erna:ProceedsFromCellLineCustomizationActivities" id="Fact_0f884bac6f394c39b5133105fc8222b5" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million to commence the cell line customization activities, per the amended payment terms. If Lineage obtains the sublicense, the Company would be entitled to receive
        additional license fees, including milestone payments and royalties.</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf3" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf4">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf4" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf5">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">Pursuant to ASC 606, the Company determined
        that the Option Right was an unexercised right held by Lineage under the Lineage Agreement at contract inception, as the cell line customization activities and the sublicense were optional purchases at contract inception. These optional purchases
        of goods and services would be treated as separate contracts if and when Lineage determines that it will make such purchases. Therefore, <ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligationPercentage" id="Fact_f91e6c3d5bcb4d72ab727ca3246f0578" contextRef="c20230221" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>%
        of the Option Fee was allocated to the Option Right.&#160; The Option Fee will remain in deferred revenue until such time that Lineage enters into the sublicense or when the Option Right expires.</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf5" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf6">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf6" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf7">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">The Option Right and the cell line
        customization activities are accounted for as separate contracts, and the Company has determined that the amended terms discussed above represent a modification to the cell line customization contract.&#160; Because there were no goods or services
        transferred to Lineage before entering into the amendment, and therefore, <ix:nonFraction name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" id="Fact_e1b25f3251bf47ef8d8e201bb68915f2" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction> previously recognized revenue, there was <ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" id="Fact_d8cf53002e004d42932237f587ce0fd1" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction> catch-up adjustment to revenue required at the time of the amendment.</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf7" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf8">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf8" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf9">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">Lineage will make payments to the Company
        for the cell line customization activities over the development period.&#160; The Company will only earn the remaining full amount of the cell line customization fee if it makes certain progress towards delivery of the customized cell line.&#160; The Company
        has determined that $<ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" id="Fact_3918f519c0c740cda6ff85da6736062f" contextRef="c20230101to20231231_TimingOfTransferOfGoodOrServiceAxis_TransferredOverTimeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million of consideration received could be recognized without the probability of being reversed, and it has
        placed a constraint on the remaining contractual customization fee.&#160; The $<ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" id="Fact_b373da1eab3d4d8797d0cef22912fddf" contextRef="c20230101to20231231_TimingOfTransferOfGoodOrServiceAxis_TransferredOverTimeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million is being recognized equally over the development
        period, which is expected to be approximately 20 to 25 months, as the level of effort to perform the services is happening at the same rate over time.&#160; If the development period is expected to be longer or shorter than originally planned, the
        Company will recognize a cumulative catch-up adjustment in the period that such determination is made. For the year ended December 31, 2023, the Company recognized approximately $<ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" id="Fact_dbebf9849df646439dbf712ae111cedf" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million of revenue for the customization activities.</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf9" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf10">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-14</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf10" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf11">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">The granting of the license that the
        Company may provide to Lineage if Lineage exercises the Option Right is not considered a performance obligation at this time, as it is an optional request that the customer may make in the future and will be accounted for as a separate contract
        when the customer exercises the Option Right.</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf11" continuedAt="Text_97d902f5117f4796ab3b535304d6a0bf12">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_97d902f5117f4796ab3b535304d6a0bf12">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">The Company recognizes direct labor and
        supplies used in the customization activities as incurred and are recorded as a cost of revenue.&#160; As provided for in the A&amp;R Factor License Agreement discussed in Note 11, the Company is obligated to pay Factor Limited <ix:nonFraction name="erna:OptionFeeObligationPaymentPercentage" id="Fact_06f8fa53621e439c9f4eb4670b07ada5" contextRef="c20230101to20231231" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% of any amounts the Company receives from a customer that is related to the licensed technology under the A&amp;R Factor License Agreement, which is
        also recorded as a cost of revenue.</div>
</ix:continuation>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" id="Text_c2985972558d465daa662c05c9d35410" contextRef="c20230101to20231231" escape="true" continuedAt="Text_a86a1e243cb847bd8bd369ca822776341">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">6)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Promissory Note and Convertible Note Financings</span></div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776341" continuedAt="Text_a86a1e243cb847bd8bd369ca822776342">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">&#160;</span><br/>
        </div>
</ix:continuation>
      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776342" continuedAt="Text_a86a1e243cb847bd8bd369ca822776343">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On



            <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">July 14, 2023, the Company received $<ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" id="Fact_590478fe817f4319b97c8c830ed68daa" contextRef="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.7</ix:nonFraction> million from a private placement in which the Company issued $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_79446ec0355249af8eb9b3ab3f530398" contextRef="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.7</ix:nonFraction>
              million in aggregate principal amount of convertible notes (the &#8220;July 2023 convertible notes&#8221;) and warrants to purchase an aggregate of approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_969d3ba577604d738ba3d9f3cb079bf5" contextRef="c20230714_ClassOfWarrantOrRightAxis_July2023WarrantsMember" unitRef="U002" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.1</ix:nonFraction> million shares of its common stock (the &#8220;July 2023 warrants&#8221;). The Company recognized approximately $<ix:nonFraction name="erna:TransactionFeesRelatedToDebtIssuanceAndWarrants" id="Fact_ac39a840d1a04beaa8879d2ebe4237e8" contextRef="c20230714to20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million in fees associated with the transaction</span>.</div>
</ix:continuation>
          <ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776343" continuedAt="Text_a86a1e243cb847bd8bd369ca822776344">
<div><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776344" continuedAt="Text_a86a1e243cb847bd8bd369ca822776345">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On



            <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">December 8, 2023, the Company received $<ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" id="Fact_89c988ac62234037a28720aa6babd16e" contextRef="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction> million in exchange for the issuance of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_da8cc93be7bc40788f1cbdb82dac82d5" contextRef="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% promissory note with an
              aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_2ea51b0270b0409a99e51fe22f6c4379" contextRef="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction> million to Charles Cherington. The promissory note was to mature on <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_c6f7f437e19a474a8ff4ebea1ff1ca5c" contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" format="ixt:date-monthname-day-year-en">January 8, 2024</ix:nonNumeric>, and interest accrued at a rate of <ix:nonFraction name="erna:DebtInstrumentAccruedInterestRate" id="Fact_2549167fd61040f7a634b88327a6b44f" contextRef="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U008" decimals="3" scale="-2" format="ixt:num-dot-decimal">6.0</ix:nonFraction>%
              per annum, payable at maturity. On December 14, 2023, the Company repaid the $<ix:nonFraction name="us-gaap:DebtInstrumentRepaidPrincipal" id="Fact_26ea066a814048e89794ea2570e2e94d" contextRef="c20231214to20231214_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction> million of principal and $<ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" id="Fact_b58e68a582c44b2c8bf2ca2853cf46ab" contextRef="c20231214to20231214_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">1,500</ix:nonFraction> of accrued interest due under the promissory note. There are no further obligations under the promissory note</span>.</div>
</ix:continuation>
          <ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776345" continuedAt="Text_a86a1e243cb847bd8bd369ca822776346">
<div><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776346" continuedAt="Text_a86a1e243cb847bd8bd369ca822776347">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On



            <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">December 14, 2023, the Company entered into a purchase agreement with certain purchasers for the private placement
              of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_5fc9069293344e49a1b22cde558d3091" contextRef="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">9.2</ix:nonFraction> million of convertible notes (the &#8220;December 2023 convertible notes&#8221; and together with the July 2023 convertible notes, the
              &#8220;convertible notes&#8221;) and warrants to purchase an aggregate of approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_f9d2d9c258a5426288261af053a820dd" contextRef="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember" unitRef="U002" decimals="-5" scale="6" format="ixt:num-dot-decimal">9.6</ix:nonFraction> million shares of the Company&#8217;s common stock (the
              &#8220;December 2023 warrants&#8221; and together with the July 2023 warrants, the &#8220;note warrants&#8221;). There were two closings under this purchase agreement. The first closing occurred on December 15, 2023, and the Company received $<ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" id="Fact_8476d0b5eb194048913aad6271745c85" contextRef="c20231215_DebtInstrumentAxis_December2023ConvertibleNotesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.8</ix:nonFraction> million and issued $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_cb20ed0ddf5243ccad5d06454dd32235" contextRef="c20231215_DebtInstrumentAxis_December2023ConvertibleNotesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.8</ix:nonFraction> million
              of December 2023 convertible notes and December 2023 warrants to purchase approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_50476fc10f5e40feae5da468f9e0eb55" contextRef="c20231215_ClassOfWarrantOrRightAxis_December2023WarrantsMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.1</ix:nonFraction> million shares of our common stock.
              The second closing, in which the Company received the reaming $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_057904c6f0cb429f81571a89ac5d657f" contextRef="c20240131_DebtInstrumentAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction> million under the purchase agreement, occurred in January 2024.
              See Note 18 for additional information regarding the second closing</span>.</div>
</ix:continuation>
          <ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776347" continuedAt="Text_a86a1e243cb847bd8bd369ca822776348">
<div><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776348" continuedAt="Text_a86a1e243cb847bd8bd369ca822776349">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #FFFFFF; display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;">See Note 16 for more information on the note
              warrants</span><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">.</span></div>
</ix:continuation>
          <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:continuation id="Text_a86a1e243cb847bd8bd369ca822776349" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763410">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/></div>
</ix:continuation>
            <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763410" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763411">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">July 2023 convertible notes bear interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_4ebfdb36cf1b4ddfb8d12293c3ca51ca" contextRef="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% per annum, and the December 2023 convertible notes bear interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_c4653d71306c42118d04213697e1ae09" contextRef="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">12</ix:nonFraction>%
                per annum, both of which are payable quarterly in arrears. At the Company&#8217;s election, it may pay interest either in cash or in-kind by increasing the outstanding principal amount of the convertible notes. The July 2023 convertible notes
                mature on <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_8a6038197b884e068354633dc032515e" contextRef="c20230101to20231231_DebtInstrumentAxis_July2023ConvertibleNotesMember" format="ixt:date-monthname-day-year-en">July 14, 2028</ix:nonNumeric>, and the December 2023 convertible notes issued on December 15, 2023 mature on <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_a0ba53eb51b748e6a26556a13a783752" contextRef="c20230101to20231231_DebtInstrumentAxis_December2023ConvertibleNotesMember" format="ixt:date-monthname-day-year-en">December 15, 2028</ix:nonNumeric>, unless earlier converted or repurchased.&#160; The Company does not have the option to redeem any of the convertible notes prior
                to maturity</span>.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763411" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763412">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </span></div>
</ix:continuation>
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
            <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763412" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763413">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">At <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">the option of the holders, the convertible notes may be converted from time-to-time in whole or in
                part into shares of the Company&#8217;s common stock at an initial conversion rate of, with respect to the July 2023 convertible notes, $<ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" id="Fact_e152273f0f934cdb9e4ed8f5f8a63331" contextRef="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">2.86</ix:nonFraction>
                per share and, with respect to the December 2023 convertible notes, $<ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" id="Fact_c45b58e7181f4ac2ac6005e86a09143a" contextRef="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember" unitRef="U003" decimals="4" scale="0" format="ixt:num-dot-decimal">1.9194</ix:nonFraction> per share, subject to customary adjustments for stock
                splits, stock dividends, recapitalization and the like.&#160; As of December 31, 2023, <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" id="Fact_9c5c0365a8b04126ac9a278534f8a19d" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">none</ix:nonFraction> of the convertible notes were converted
                into shares of common stock</span>.</div>
</ix:continuation>
            <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763413" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763414">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>
</ix:continuation>
            <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">
              <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763414" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763415">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">convertible notes do not contain any ratchet or other financial antidilution provisions.&#160; The
                  convertible notes contain conversion limitations such that no conversion may be made if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed <ix:nonFraction name="erna:ConvertibleNotesBeneficialConversionFeaturePercentage" id="Fact_67fc96e82526436bbaeff93badd0a7ae" contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodOneMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.99</ix:nonFraction>%, <ix:nonFraction name="erna:ConvertibleNotesBeneficialConversionFeaturePercentage" id="Fact_08779acf25d0487e9d979cfd5e6eb38f" contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodTwoMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">9.99</ix:nonFraction>% or <ix:nonFraction name="erna:ConvertibleNotesBeneficialConversionFeaturePercentage" id="Fact_c809c1bb6ccc4910b4a73d265fae0703" contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodThreeMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">19.99</ix:nonFraction>% immediately after conversion thereof, subject to certain increases not in excess of either <ix:nonFraction name="erna:ConvertibleNotesBeneficialConversionFeaturePercentage" id="Fact_6db4f49e6c0840aeace563ac988af677" contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodOneMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MaximumMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">9.99</ix:nonFraction>% or <ix:nonFraction name="erna:ConvertibleNotesBeneficialConversionFeaturePercentage" id="Fact_b655bc9f68784aa2a9204e6c25751d67" contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodTwoMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MaximumMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">19.99</ix:nonFraction>% at the option of such holder</span>.</div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763415" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763416">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>
</ix:continuation>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">
              <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763416" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763417">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">convertible notes provide for customary events of default which include (subject in certain cases to customary grace and cure periods), among others: nonpayment of principal or interest, breach
                  of covenants or other agreements in the convertible notes; the occurrence of a material adverse effect event (as defined in the related securities purchase agreement) and certain events of bankruptcy. Generally, if an event of default
                  occurs and is continuing under the convertible notes, the holder thereof may require the Company to repurchase some or all of their convertible notes at a repurchase price equal to <ix:nonFraction name="erna:RepurchasePricePercentageToPrincipalAmount" id="Fact_8c9dd648b5e64c3091156e56faa57c9f" contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the principal amount of the convertible notes being repurchased, plus accrued and unpaid interest thereon</span>.</div>
</ix:continuation>
              <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763417" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763418">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
              </div>
</ix:continuation>
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">
                <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763418" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763419">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">In <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">connection with the issuance of the December 2023 convertible notes, the Company agreed to reduce the exercise price of the warrants the Company issued in a private placement in December 2022
                    (see Note 16) to purchase an aggregate of approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_be518a5c215545d993322ee329d41cdb" contextRef="c20221231_DebtInstrumentAxis_December2022ConvertibleNotesMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.4</ix:nonFraction> million shares of the Company&#8217;s common stock from $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_80ec1372eeda42639f50fdfc2dac4195" contextRef="c20221231_DebtInstrumentAxis_December2022ConvertibleNotesMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.28</ix:nonFraction> to $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_40645a86dfd04a4fbd1d8e362025336a" contextRef="c20231231_DebtInstrumentAxis_December2022ConvertibleNotesMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.43</ix:nonFraction> per share and
                    of the July 2023 warrants from $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_594ae224a53344d5a38aee51c7cace1d" contextRef="c20230714_ClassOfWarrantOrRightAxis_July2023WarrantsMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">2.61</ix:nonFraction> to $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_26b9e2985dfb4272877bfdb68cf2581d" contextRef="c20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.43</ix:nonFraction> per share. The effect of the reduction of the exercise price of these warrants was approximately $<ix:nonFraction name="erna:EffectOfReductionOfExercisePriceOfWarrants" id="Fact_01269721381a4aabbf49f7616343f3dd" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.6</ix:nonFraction> million and measured as the excess of the fair value of the modified instruments over the fair value of the instruments immediately before they were modified. The change in
                    the fair value of the repriced warrants is considered an issuance cost to the December 2023 convertible notes and December 2023 warrants. As such, the $<ix:nonFraction name="erna:EffectOfReductionOfExercisePriceOfWarrants" id="Fact_e5222758b0604374abaa9ca6c8da98c2" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.6</ix:nonFraction> million was allocated to each of those respective instruments based on their relative fair values, or approximately $<ix:nonFraction name="erna:EffectOfReductionOfExercisePriceOfWarrants" id="Fact_a6171d3fd2a44f70bdd3d87fbf45ea30" contextRef="c20231231_DebtInstrumentAxis_December2022ConvertibleNotesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal"><ix:nonFraction name="erna:EffectOfReductionOfExercisePriceOfWarrants" id="Fact_21751628af5346d1a92f5fb1aea6f4cd" contextRef="c20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction></ix:nonFraction> million to each of the December 2023 convertible notes and December 2023 warrants</span>.</div>
</ix:continuation>
                <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763419" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763420">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
                </div>
</ix:continuation>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div class="BRPFPageFooter" style="width: 100%;"></div>

                  <div class="BRPFPageNumberArea" style="text-align: center; text-indent: -9pt; margin-left: 9pt;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-15</span></div>

                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

                  <div class="BRPFPageHeader" style="width: 100%;">
                    <div>
                      <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt; text-indent: -9pt; margin-left: 9pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                        </a></div>

                    </div>

                  </div>

                </div>

                <!--PROfilePageNumberReset%Num%16%F-%%--></div>

              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763420" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763421"><ix:nonNumeric name="us-gaap:ScheduleOfDebtTableTextBlock" id="Text_b0cc436d0f19469591241bb890fb0420" contextRef="c20230101to20231231" escape="true" continuedAt="Text_4e22da9ca290420d92b033129fa92d341">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The Company determined that there were no embedded derivatives within the convertible
                      notes that required bifurcation from the host agreement.&#160; The Company allocated the gross proceeds received, the fees incurred, and as applicable, the impact of repricing the warrants discussed above, over the July 2023 convertible
                      notes and July 2023 warrants and over the December 2023 convertible notes and December 2023 warrants, as applicable, based on their relative fair values as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763421" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763422"><ix:continuation id="Text_4e22da9ca290420d92b033129fa92d341" continuedAt="Text_4e22da9ca290420d92b033129fa92d342">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763422" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763423"><ix:continuation id="Text_4e22da9ca290420d92b033129fa92d342" continuedAt="Text_4e22da9ca290420d92b033129fa92d343">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="6">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of Proceeds and Costs:</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Relative<br/>
                              Fair Value</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation<br/>
                              Percentage</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Costs</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds,<br/>
                              Net</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">July 2023 convertible notes</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" id="Fact_406b96c9e5e9411493423f69c118993a" contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,715</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AllocationPercentageOfFairValue" id="Fact_f4fb500f3392464c964df6dfd536c58b" contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">39.94</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_5bc474e474404a6c8203946e1b97ec1d" contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,481</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" id="Fact_aaed2a19718647ccb7a46082e094e587" contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">80</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ProceedsFromConvertibleDebtNet" id="Fact_f5290a88a99c42e29f9dc9616013199a" contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,401</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">July 2023 warrants</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" id="Fact_bcda54632d4346af8c630b673259cc50" contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,103</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AllocationPercentageOfFairValue" id="Fact_ce0f8971228f49b7aedc452715d7929f" contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">60.06</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_c096ca2501034ce9bab2c0eff8febcc6" contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,234</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" id="Fact_840bf69f14e54f219a1b843fa3b9c1fa" contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">121</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ProceedsFromConvertibleDebtNet" id="Fact_9553c5d39a7a493ba46cc3547e054bff" contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,113</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" id="Fact_45ae452e62514a41b4bf062e375ba4a1" contextRef="c20230714" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">21,818</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AllocationPercentageOfFairValue" id="Fact_1d2acca8161b467d9bc39bd4d2359107" contextRef="c20230714" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">100.00</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_f734b17ced6a4eebaf1a235672dc57f4" contextRef="c20230714to20230714" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,715</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" id="Fact_4f5f75513a3946459eefd1a856126839" contextRef="c20230714to20230714" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">201</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ProceedsFromConvertibleDebtNet" id="Fact_8b08aaa380064f78aff42e9933c31002" contextRef="c20230714to20230714" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,514</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
                      <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763423" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763424"><ix:continuation id="Text_4e22da9ca290420d92b033129fa92d343" continuedAt="Text_4e22da9ca290420d92b033129fa92d344">
<div><br/>
                      </div>
</ix:continuation></ix:continuation>
                    </div>

                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763424" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763425"><ix:continuation id="Text_4e22da9ca290420d92b033129fa92d344">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of Proceeds and Costs:</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Relative<br/>
                              Fair Value</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation<br/>
                              Percentage</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Costs</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrant<br/>
                              Repricing</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds,<br/>
                              Net</div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">December 2023 convertible notes</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" id="Fact_63f9658a6d29465ba7b141734d70959e" contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,059</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AllocationPercentageOfFairValue" id="Fact_41edf28c959a4526a449a5eba9e17e23" contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">48.83</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_edcf027ee3e149cab2a2fc352b766e9f" contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,803</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" id="Fact_7090f9ed1df3447ca3d524b92888025a" contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">81</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:WarrantRepricing" id="Fact_a79674c75a6a4853b88f6e3e9ced0178" contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">766</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ProceedsFromConvertibleDebtNet" id="Fact_ff550e1be5f649579a349f1b9351d530" contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,956</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">December 2023 warrants</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" id="Fact_13f2c4545b8343ab96e0469b352ce4e3" contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,495</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AllocationPercentageOfFairValue" id="Fact_d9beeb69fc3945f09786bdd44f128bf7" contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">51.17</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_e7302c9be32d40e3b2e5c447a737f278" contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,985</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" id="Fact_110d118421744396919421f096de40e0" contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">85</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:WarrantRepricing" id="Fact_764375aa72314f79904631ee51ec0f0e" contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">802</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ProceedsFromConvertibleDebtNet" id="Fact_9f9bb06df04e4e57b05d67948e44abe9" contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,098</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" id="Fact_b5b7688413f047c3b1a171a9b59bfcb9" contextRef="c20231215" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,554</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AllocationPercentageOfFairValue" id="Fact_f1400c2afa0e4fafaeadb9e0ae746d75" contextRef="c20231215" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">100.00</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_5c8b9a4c9ea6432882526b81a88d64cb" contextRef="c20231215to20231215" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,788</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" id="Fact_f6c4ac296c02470bac3c9dc5849aea62" contextRef="c20231215to20231215" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">166</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:WarrantRepricing" id="Fact_06d3b2a32ec84f9185c6860c4b6736d1" contextRef="c20231215to20231215" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,568</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ProceedsFromConvertibleDebtNet" id="Fact_cfabf07c7952478e8c3ff1989997446a" contextRef="c20231215to20231215" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,054</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
                      <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763425" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763426">
<div><br/>
                      </div>
</ix:continuation>
                    </div>


                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763426" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763427"><ix:nonNumeric name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" id="Text_525ea38c1d20421fb3ee03262dcd3722" contextRef="c20230101to20231231" escape="true" continuedAt="Text_e404526660984380ad2c8ff4f649752f1">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Company estimated the fair values of the convertible notes as of July 14, 2023 and December 15, 2023 based off a valuation
                      performed by a third-party specialist using a binomial tree model and the following assumptions:</div>
</ix:nonNumeric></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763427" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763428"><ix:continuation id="Text_e404526660984380ad2c8ff4f649752f1" continuedAt="Text_e404526660984380ad2c8ff4f649752f2">
<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
                    </div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763428" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763429"><ix:continuation id="Text_e404526660984380ad2c8ff4f649752f2" continuedAt="Text_e404526660984380ad2c8ff4f649752f3">
<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">
                      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;">
                              <div>&#160;</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" colspan="2">
                              <div style="text-align: center;">Stock<br/>
                                Price</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" colspan="2">
                              <div style="text-align: center;">Credit<br/>
                                Spread</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                              <div style="text-align: center;">Volatility</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" colspan="2">
                              <div style="text-align: center;">Risk-Free<br/>
                                Rate</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; background-color: #CCEEFF; white-space: nowrap;">
                              <div>July 2023 convertible notes</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div>$</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:LongTermDebtMeasurementInput" id="Fact_4da0bccfa2614636934c0b9b2d1f9abc" contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">2.81</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:LongTermDebtMeasurementInput" id="Fact_d2f7fc73eabf465b8b625fff7065a81b" contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,500</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:LongTermDebtMeasurementInput" id="Fact_3fd29de5fd6948999fab8d4fcc3ae94e" contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">108</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:LongTermDebtMeasurementInput" id="Fact_d0e90f949c834faeae0143b73214a96e" contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.60</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; white-space: nowrap;">
                              <div>December 2023 convertible notes</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                              <div>$</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:LongTermDebtMeasurementInput" id="Fact_bc50df46eaa24d29b221ba19ce65d58c" contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.51</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:LongTermDebtMeasurementInput" id="Fact_67e6fbc6fbb643be88cd8b593fff9343" contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,000</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:LongTermDebtMeasurementInput" id="Fact_cb1d6c5c6c96461caec80c88c9e6c67a" contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">109</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:LongTermDebtMeasurementInput" id="Fact_406327759b1344d980d75350449b497c" contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.90</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

  </tr>


</table>
                    </div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763429" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763430"><ix:continuation id="Text_e404526660984380ad2c8ff4f649752f3" continuedAt="Text_e404526660984380ad2c8ff4f649752f4">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763430" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763431"><ix:continuation id="Text_e404526660984380ad2c8ff4f649752f4" continuedAt="Text_e404526660984380ad2c8ff4f649752f5">
<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763431" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763432"><ix:continuation id="Text_e404526660984380ad2c8ff4f649752f5" continuedAt="Text_e404526660984380ad2c8ff4f649752f6">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763432" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763433"><ix:continuation id="Text_e404526660984380ad2c8ff4f649752f6" continuedAt="Text_e404526660984380ad2c8ff4f649752f7">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The fair value of the note warrants, all of which qualified for equity classification, was determined using the Black-Scholes pricing model as of each
                      of July 14, 2023 and December 15, 2023 using the following assumptions:</div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763433" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763434"><ix:continuation id="Text_e404526660984380ad2c8ff4f649752f7" continuedAt="Text_e404526660984380ad2c8ff4f649752f8">
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
                    </div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763434" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763435"><ix:continuation id="Text_e404526660984380ad2c8ff4f649752f8">
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">
                      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;">
                              <div>&#160;</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" colspan="2">
                              <div style="text-align: center;">Stock<br/>
                                Price</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" colspan="2">
                              <div style="text-align: center;">Exercise<br/>
                                Price</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">
                              <div style="text-align: center;">Expected<br/>
                                Life</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                              <div style="text-align: center;">Volatility</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                              <div style="text-align: center;">Dividend</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" colspan="2">
                              <div style="text-align: center;">Risk-Free<br/>
                                Rate</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;">
                              <div>July 2023 warrants</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div>$</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_7700063312824a32a33f5814b484edbb" contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">2.81</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div>$</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_8e09d5f07ba4421d9c384faa1a937389" contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExercisePriceMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">2.61</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;">
                              <div style="text-align: center;"><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_875668411b8e413f86874adc05ef9c00" contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember" format="ixt-sec:duryear">5</ix:nonNumeric> years</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_3e384afd27ec46958f74e0ade1c2fd8c" contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">98</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_d6f0f480e4b74ba7ba9c5fd06bc8fb07" contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_d1a6fc144f824a8d8cd9793fb8dd3bb2" contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.04</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;">
                              <div>December 2023 warrants</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                              <div>$</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_6bb8aca3acb74bcf9a6662bbd89e384a" contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.51</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                              <div>$</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_b4b96989e22f458b8697bbe65a7ce27f" contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExercisePriceMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.43</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;">
                              <div style="text-align: center;"><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_45c0e87748c84f8c8334f09613057cb2" contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember" format="ixt-sec:duryear">5</ix:nonNumeric> years</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_adbbe9bf43e44b3fa55850240d73e095" contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">101</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_9d18e56c58934190bc7ba0f86b7d5f9d" contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.00</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                              <div><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_a7051ccecf204a81a12607509089ffc3" contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.91</ix:nonFraction></div>
                            </td>

    <td valign="bottom" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                              <div>%</div>
                            </td>

  </tr>


</table>
                    </div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763435" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763436">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span>
                    </div>
</ix:continuation>
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763436" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763437">
<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
                    <div style="text-indent: 36pt;">
                      <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763437" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763438">
<div><span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The amount of proceeds
                          allocated to the note warrants resulted in a corresponding reduction in the carrying value of the respective convertible notes as a debt discount, which is amortized with the debt issuance costs as a component of interest expense
                          based on the effective interest rate method over the contractual terms of the convertible notes.</span><br/>
                      </div>
</ix:continuation>
                      <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763438" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763439">
<div><br/>
                      </div>
</ix:continuation>
                    </div>

                    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div class="BRPFPageFooter" style="width: 100%;"></div>

                      <div class="BRPFPageNumberArea" style="text-align: center; text-indent: -9pt; margin-left: 9pt;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-16</span></div>

                      <div class="BRPFPageBreak" style="page-break-after: always;">
                        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

                      <div class="BRPFPageHeader" style="width: 100%;">
                        <div>
                          <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt; text-indent: -9pt; margin-left: 9pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                            </a></div>

                        </div>

                      </div>

                    </div>

                  </div>

                  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">
                    <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763439" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763440">
<div>&#160;<ix:nonNumeric name="us-gaap:ConvertibleDebtTableTextBlock" id="Text_70c164c86b74494bb6a9f20fe87e869d" contextRef="c20230101to20231231" escape="true" continuedAt="Text_8862915857214fea8f7fe8b50053ea0e1"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;">
                    </span></ix:nonNumeric></div>
</ix:continuation>
                    <ix:continuation id="Text_8862915857214fea8f7fe8b50053ea0e1" continuedAt="Text_8862915857214fea8f7fe8b50053ea0e2"><ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763440" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763441">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The following table shows the activity that occurred during the year ended December 31,
                      2023 for the convertible notes on the accompanying consolidated balance sheet:</div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_8862915857214fea8f7fe8b50053ea0e2" continuedAt="Text_8862915857214fea8f7fe8b50053ea0e3"><ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763441" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763442">
<div> <br/>
                    </div>
</ix:continuation></ix:continuation>
                    <ix:continuation id="Text_8862915857214fea8f7fe8b50053ea0e3"><ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763442" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763443">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">Gross convertible notes at issuance</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_63c4827cb3254fdf9de6b60fb39afaa7" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,503</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">Debt discount and debt issuance costs</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" id="Fact_73ebc809f52d4313a49b05fff39a6b44" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,146</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">
                              <div style="color: rgb(0, 0, 0);">Amortization of debt discount and debt issuance costs</div>
                            </div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" id="Fact_cea4552c04f54924ad0354eb2e9b1b68" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">303</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">Paid-in-kind interest added to principal</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:PaidInKindInterestAddedToConvertibleNotesPrincipal" id="Fact_4c17560ffe204ed598bc533a23cceda3" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">113</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                            <div style="color: rgb(0, 0, 0);">Convertible notes, net, at December 31, 2023</div>
                          </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" id="Fact_904b164462304a3f95d1a3732c68fabb" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,773</ix:nonFraction></div>
                          </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
                      <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763443" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763444">
<div><br/>
                      </div>
</ix:continuation>
                    </div>

                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">
                      <div>
                        <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763444" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763445"><ix:nonNumeric name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="Text_1d727813baf8425889e1a435e38ac7fb" contextRef="c20230101to20231231" escape="true" continuedAt="Text_4a183804dd6243c5a962ba1a17ad576f1">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The future minimum principal payments under the convertible notes as of December 31, 2023
                          are as follows:</div>
</ix:nonNumeric></ix:continuation>
                        <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763445" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763446"><ix:continuation id="Text_4a183804dd6243c5a962ba1a17ad576f1" continuedAt="Text_4a183804dd6243c5a962ba1a17ad576f2">
<div>&#160;</div>
</ix:continuation></ix:continuation>
                      </div>

                      <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763446" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763447"><ix:continuation id="Text_4a183804dd6243c5a962ba1a17ad576f2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ending December 31,</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Principal</div>
                              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Payments</div>
                            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" id="Fact_2d5e6b724b794cfc8979c1e4830dddf0" contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" id="Fact_8e1a1e7729034488a09613723162b93e" contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: #CCEEFF;">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" id="Fact_216a505f422e4dd1b5b04025f812f4a4" contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%;">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2027</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" id="Fact_eefa87e3ba8e44c88d8dafc6ebbd6603" contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2028</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" id="Fact_50e0c430948b4389b97ac865f4bf7689" contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,616</ix:nonFraction></div>
                            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 88%; padding-bottom: 4px;">
                              <div style="text-align: left; color: rgb(33, 37, 41); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_0f622ce394cd4519ab2d78633cbd382c" contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,616</ix:nonFraction></div>
                            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
                      <div>
                        <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763447" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763448">
<div><br/>
                        </div>
</ix:continuation>
                        <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763448" continuedAt="Text_a86a1e243cb847bd8bd369ca8227763449">
<div>&#160;</div>
</ix:continuation>
                      </div>

                      <ix:continuation id="Text_a86a1e243cb847bd8bd369ca8227763449">
<div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has recognized approximately $<ix:nonFraction name="us-gaap:InterestExpenseDebt" id="Fact_66a6969eca024808bdebca30bbb664aa" contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million in interest expense for the year ended December 31, 2023
                          for the convertible notes, which includes $<ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" id="Fact_728407b46c6e44c9a0293353d55e21b2" contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million for the amortization of the debt discount and debt issuance
                          costs.&#160; Of the remaining $<ix:nonFraction name="us-gaap:PaidInKindInterest" id="Fact_436c136cdffd4ff795f5cb0dbf95b438" contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million in interest expense, $<ix:nonFraction name="erna:InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" id="Fact_543fc3632359450c8a52c9fff3026276" contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million was paid in-kind and added to the principal of the respective notes and $<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_894430f69dda4b10b3480c5abd6fc1e8" contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million of interest is in accrued expenses in the accompanying consolidated balance sheet.</span></div>
</ix:continuation>
                    </div>

                  </div>


                  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
                  </div>

                </div>

              </div>

            </div>

            <div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="Text_04f70f6d71f24cdaa97b8877306a3d65" contextRef="c20230101to20231231" escape="true" continuedAt="Text_612bfe15b74d4c45b13d3443484060f11">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">7)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Property and Equipment</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_612bfe15b74d4c45b13d3443484060f11" continuedAt="Text_612bfe15b74d4c45b13d3443484060f12">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation>
      </div>


      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_612bfe15b74d4c45b13d3443484060f12" continuedAt="Text_612bfe15b74d4c45b13d3443484060f13"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="Text_d6baae7027f6405f93a110b8d03de481" contextRef="c20230101to20231231" escape="true" continuedAt="Text_0e95b68a90d54dd899ffaff29e20ee431">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment consist of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      </div>

      <ix:continuation id="Text_612bfe15b74d4c45b13d3443484060f13" continuedAt="Text_612bfe15b74d4c45b13d3443484060f14"><ix:continuation id="Text_0e95b68a90d54dd899ffaff29e20ee431" continuedAt="Text_0e95b68a90d54dd899ffaff29e20ee432">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_612bfe15b74d4c45b13d3443484060f14" continuedAt="Text_612bfe15b74d4c45b13d3443484060f15"><ix:continuation id="Text_0e95b68a90d54dd899ffaff29e20ee432">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Laboratory and manufacturing equipment</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_9e2f1602d04e4242b6ede5af9e4ea321" contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">40</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_830215d7815d46618919493e4713a942" contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">28</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%;">Furniture and fixtures<br/>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_a2601bd7d7e8429398852b55d2f6a7c3" contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">19</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_e4b41c4aded044ab9d608a5ba4f4f63b" contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Leasehold improvements<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_8569afc13287401f86633e2f8642cdd4" contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">274</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_18c4c83c4aac45c1b511acead67303ca" contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">Computer equipment and programs</div>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_2de7963b98b54e158316722fd4901cfb" contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">274</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_64514dc007904ebcac5a07f90f0009d3" contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">240</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_3924a78dadc74a938b7d301effc64a02" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">607</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_38c008fd1d7e4a1cac1979622e88d608" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">268</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">Less accumulated depreciation and amortization</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_d295ff3f811947b8a58078d587521b54" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">114</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_13bf528f25d14211a831c3a17ea2a5c4" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">32</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_4f6a503ec46a429dbc6e78f790970715" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">493</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_ec6ec274c1574efb8494f00dd8007f04" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">236</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_612bfe15b74d4c45b13d3443484060f15" continuedAt="Text_612bfe15b74d4c45b13d3443484060f16">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_612bfe15b74d4c45b13d3443484060f16" continuedAt="Text_612bfe15b74d4c45b13d3443484060f17">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December 31, 2023, the Company recognized a <span style="font-style: italic;">de minimis</span> loss on
        disposal of fixed assets. During the year ended December 31, 2022, the Company consolidated its research and development activities in Cambridge, Massachusetts and entered into lease termination agreements for its Brooklyn, New York and San Diego,
        California facilities. As a result, the Company disposed of certain assets it would no longer use and recognized a loss on disposal of fixed assets of approximately $<ix:nonFraction name="erna:GainLossOnDisposalOfFixedAssets" id="Fact_048a85a1d0ce4a248fa5ec996d9a7df0" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million, which was composed of $<ix:nonFraction name="erna:RemainingNetBookValueOfFixedAssets" id="Fact_88c181d27d814ad3b15d3390a39b0b3b" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million in remaining net book value of
        such assets, offset by proceeds received from selling certain fixed assets for approximately $<ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" id="Fact_38de3bebfa1c4f5f94be48d6a10fcf4b" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million. </div>
</ix:continuation>
      <ix:continuation id="Text_612bfe15b74d4c45b13d3443484060f17" continuedAt="Text_612bfe15b74d4c45b13d3443484060f18">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_612bfe15b74d4c45b13d3443484060f18">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation expense totaled $<ix:nonFraction name="us-gaap:Depreciation" id="Fact_b1e739c247f74d87b78738da281742ed" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction>
        million and $<ix:nonFraction name="us-gaap:Depreciation" id="Fact_35e579f71c76407aa1256ba48bc0876a" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million for the years ended December 31, 2023 and 2022, respectively. No depreciation expense is recorded on fixed
        assets in process until such time as the assets are completed and are placed into service.</div>
</ix:continuation>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_78e995807758407d9d97f05dc600df1c" contextRef="c20230101to20231231" escape="true" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42521">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">8)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Leases</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42521" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42522">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42522" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42523">
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Operating Leases</div>
</ix:continuation>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42523" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42524">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42524" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42525">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he </span>Company currently has operating leases for office
        and laboratory space in (a) the borough of Manhattan in New York, New York, (b) Cambridge, Massachusetts, and (c) Somerville, Massachusetts, which expire in 2026, 2028, and 2033, respectively<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42525" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42526">
<div><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42526" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42527">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Until March 2022, the Company also leased a facility in Brooklyn, New York. In March 2022, the Company entered into an
        agreement to assign that lease to an unaffiliated third party, who also agreed to purchase certain equipment from the Company for $<ix:nonFraction name="erna:LesseeCommitmentToPurchaseProperty" id="Fact_5327989e232b4eb4a231f51ee9dbece0" contextRef="c20220331" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">50,000</ix:nonFraction>,
        which partially reimbursed the Company for certain existing unamortized leasehold improvements, and to reimburse the Company for the approximately $<ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" id="Fact_d7df29d81dfb4af68b52a8a0d9a4b950" contextRef="c20220331" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">63,000</ix:nonFraction>
        security deposit under the lease. Under the assignment agreement, the unaffiliated third party assumed all of the obligations, liabilities, covenants and conditions of the Company as tenant under the lease.&#160; As a result of the lease assignment, the
        Company wrote off the remaining ROU asset balance of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_761af41158db47b285666df4c2ee54b0" contextRef="c20220331" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction> million and the corresponding lease liability of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_dc3213f819524457af480534c7e1916b" contextRef="c20220331" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction> million.</div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42527" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42528">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42528" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e42529">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company had also leased a facility in San Diego, California. During the second quarter of 2022, the Company determined to consolidate its research and
          development efforts in Cambridge, Massachusetts and sublease its San Diego lab and office space.&#160; As a result, the Company recognized an impairment charge of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_05c4747e7e7b4459bf46c409884b95c5" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.8</ix:nonFraction> million on the San Diego lease ROU asset during the year ended December 31, 2022.&#160; In November 2022, the Company entered into a lease termination agreement, effective January 31, 2023;
          and as of December 31, 2023, there was <ix:nonFraction name="erna:InitialMeasurementOfOperatingLeaseLiabilities" id="Fact_cfc19765c7284e5d8708d5ef870a6fcc" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_SanDiegoLeaseMember" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="erna:InitialMeasurementOfOperatingLeaseROUAssets" id="Fact_5ea804bc06ae45fe85674f0301bd18bb" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_SanDiegoLeaseMember" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> lease liability or ROU asset balances remaining for the San Diego lease.</span><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e42529" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425210">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-17</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425210" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425211">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In October 2022, the Company entered into a sublease with a subsidiary of Bristol-Myers Squibb Company, as sublessor (&#8220;Sublessor&#8221;), for office, laboratory and
          research and development space of approximately <ix:nonFraction name="us-gaap:AreaOfRealEstateProperty" id="Fact_50509eadbd8e4bb6abc69ffa5a5adcfe" contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U005" decimals="0" scale="0" format="ixt:num-dot-decimal">45,500</ix:nonFraction> square feet in Somerville, Massachusetts.&#160; The lease expires in November 2033
          and is subject to a <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="Fact_3ec84b04e55048eeb904df119a1801e3" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" format="ixt-sec:durwordsen">five-year</ix:nonNumeric> extension. Rent payments under the sublease began on November 29, 2023. The Company pays base rent of
          approximately $<ix:nonFraction name="erna:OperatingLeasesMonthlyBaseRent" id="Fact_4241b94a08ee4f57a5b52cfc113f02ab" contextRef="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million per month during the first year of the term, which will increase <ix:nonFraction name="erna:OperatingLeasesIncreaseInBaseRentPercentage" id="Fact_0c80cdd23fe44d8ea05adbee9094aee6" contextRef="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">3</ix:nonFraction>% per year thereafter.&#160; The Company also makes monthly payments for parking, which are based on market rates that can change from time to time, and pay its share of
          traditional lease expenses, including certain taxes, operating expenses and utilities.</span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425211" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425212">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425212" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425213">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company paid the Sublessor a security deposit in the form of a letter of credit in the amount of approximately $<ix:nonFraction name="us-gaap:LineOfCredit" id="Fact_4b9051c968fb4274be1e4afd451481a3" contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.1</ix:nonFraction> million. Provided there are no events of default by the Company under the sublease, the letter of credit will be reduced on an incremental basis throughout the term.</span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425213" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425214">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425214" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425215">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Sublessor agreed to provide the Company with a tenant improvement allowance (&#8220;TIA&#8221;) of $<ix:nonFraction name="erna:TenantImprovementAllowancePerRentableSquareFoot" id="Fact_34057784d2964a108489817234296190" contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">190</ix:nonFraction> per rentable square foot, or $<ix:nonFraction name="erna:TenantImprovementAllowance" id="Fact_b506c2164a1b4034b747af829cbcc0c8" contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.6</ix:nonFraction> million.&#160; Tenant improvements in excess
          of this amount will be at the Company&#8217;s own cost.&#160; Construction was substantially complete in January 2024 and the total out-of-pocket costs for the improvements is estimated to be approximately $<ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" id="Fact_a4ee19d7920c4db68d6b9ca6343d5942" contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.1</ix:nonFraction> million.&#160; As of December 31, 2023, the Company received the entire $<ix:nonFraction name="erna:ReceivedAmountOfTenantImprovementAllowance" id="Fact_9d06910a3c264d38b961b660088d5ec6" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.6</ix:nonFraction>
          million TIA.</span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425215" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425216">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425216" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425217">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company obtained access and control of the premises on June 21, 2023, and as such, the Company determined that the commencement date for accounting purposes was
          June 21, 2023.&#160; The Company also performed an analysis on the accounting ownership of the tenant improvement assets and determined that such assets were sublessor/lessor owned.&#160; As a result, TIA payments made by the Sublessor to the Company for
          the tenant improvement assets are considered a reimbursement rather than a lease incentive and not included as part of the consideration of the contract.&#160; Amounts paid by the Company for sublessor/lessor owned assets in excess of the TIA are
          considered non-cash lease payments and are added to the consideration in the contract.</span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425217" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425218">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425218" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425219">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company measured the lease liability and corresponding ROU asset for the sublease as of June 21, 2023, which includes lease payments the Company must make over
          the ten-year lease term.&#160; The Company did not include the option to extend the lease for an additional five years in the initial measurement because the Company was not reasonably certain as of June 21, 2023 that it would exercise its right to
          extend the lease term. As a result, the Company recorded a lease liability of $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_a2ce54f790914a969e033da1140e0e0f" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">34.4</ix:nonFraction> million, which included $<ix:nonFraction name="erna:LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" id="Fact_e3bf44242983492891371295cec29ed3" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million for the incremental amount above the TIA that the Company expected to pay for sublessor/lessor owned assets as of the initial measurement
          date, and a corresponding ROU asset of $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_6a833bf6a3b0419ca03b7091158f5406" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">34.7</ix:nonFraction> million as of June 30, 2023.</span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425219" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425220">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425220" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425221">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In December 2023, the Company incurred additional out-of-pocket expenses of approximately $<ix:nonFraction name="erna:OutOfPocketExpenses" id="Fact_66b9dc0388154035a8ba183b3c0f3f1c" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million for sublessor/lessor owned assets as a result of out-of-scope changes.&#160; These cost changes were accounted for as a lease modification of the existing lease.&#160; The Company
          determined that the lease continued to be classified as an operating lease after modification and remeasured the liability for the remaining unpaid lease payments, including the aggregate $<ix:nonFraction name="erna:UnpaidOutOfPocketCostsTenantImprovementAllowance" id="Fact_743c663f961d4331a7a404b1b8f8c29c" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction> million of unpaid out-of-pocket costs above the TIA that the Company will pay for sublessor/lessor owned assets, as well as remeasuring any variable lease payment that is based on an
          index or rate.&#160; The Company also requested a third-party specialist to reassess the incremental borrowing rate, which is the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal
          to the lease payments in a similar economic environment.&#160; This reassessment resulted in an increased incremental borrowing rate from <ix:nonFraction name="erna:OperatingLeaseIncrementalBorrowingRate" id="Fact_f062b1ea9eab491fa5a89a255415a6f0" contextRef="c20230101to20231231_RangeAxis_MinimumMember" unitRef="U008" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.7</ix:nonFraction>%
          as of the initial measurement date to <ix:nonFraction name="erna:OperatingLeaseIncrementalBorrowingRate" id="Fact_5403c9a4274146d8bae4845ac63c9c06" contextRef="c20230101to20231231_RangeAxis_MaximumMember" unitRef="U008" decimals="3" scale="-2" format="ixt:num-dot-decimal">14.4</ix:nonFraction>% as of the modification date.&#160; The remeasurement resulted in a decrease to the lease
          liability of approximately $<ix:nonFraction name="erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" id="Fact_81360ae177fb4badb74a4baa50bdebca" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" sign="-" format="ixt:num-dot-decimal">1.6</ix:nonFraction> million with a corresponding adjustment to the ROU asset.<br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425221" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425222">
<div> <br/>
      </div>
</ix:continuation>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <div>
            <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425222" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425223"><ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" id="Text_48e17f2ddd0d43088c17bf4695ba7c4a" contextRef="c20230101to20231231" escape="true" continuedAt="Text_ba4377f78f574776b223fe93fdaa125a1">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2023 and 2022, the net operating lease expenses were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425223" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425224"><ix:continuation id="Text_ba4377f78f574776b223fe93fdaa125a1" continuedAt="Text_ba4377f78f574776b223fe93fdaa125a2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425224" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425225"><ix:continuation id="Text_ba4377f78f574776b223fe93fdaa125a2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2023</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_2ea39fb9e2b840bc85fa4fe3c75e4cef" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,399</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_90565d57598f4142ad763587557526e0" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">595</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_4b20b18f8618431eabd825d76d97c6b9" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">84</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_097931b87e0f452986f25843edac987b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">84</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_42b0a21634324410bf2faa56316c7578" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">136</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_53287d19dfc6406596a25ae2c736c4cd" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">150</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total lease expense</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_69e49c0f7f094201b70e705c740d800a" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,451</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_9fa2016d796e4bbebbbc7c68bea0c8f9" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">661</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <div>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425225" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425226">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-18</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

      </div>


      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425226" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425227"><ix:nonNumeric name="erna:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" id="Text_a21c6faafd8b41f3b40b59e2c3ab2115" contextRef="c20230101to20231231" escape="true" continuedAt="Text_bf6a9e5fec9b4adfb4c1416f36da7dd91">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2023 and
            the ending balances as of December 31 2023, including the changes during the period (in thousands).</div>
</ix:nonNumeric></ix:continuation>
        </div>

        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425227" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425228"><ix:continuation id="Text_bf6a9e5fec9b4adfb4c1416f36da7dd91" continuedAt="Text_bf6a9e5fec9b4adfb4c1416f36da7dd92">
<div><br/>
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425228" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425229"><ix:continuation id="Text_bf6a9e5fec9b4adfb4c1416f36da7dd92" continuedAt="Text_bf6a9e5fec9b4adfb4c1416f36da7dd93">
<table cellspacing="0" cellpadding="0" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating Lease</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ROU Assets</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at January 1, 2023</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_3afc325497894aed8bc8afe3d4931dbb" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,030</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Recognition of ROU asset for Somerville Sublease</div>
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:InitialMeasurementOfOperatingLeaseROUAssets" id="Fact_cd128aded0684b1f8839a85bed73201c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">34,410</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Adjustment to ROU asset for remeasurement of Somvervile Sublease liability</div>
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:AdjustmentToRemeasurementOfOperatingLeaseROUAssets" id="Fact_28ab608491df4c09b78ef0758635647a" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,620</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Amortization of operating lease ROU assets</div>
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_c033f8c345d845c99cb28e3c0667fac6" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,039</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at December 31, 2023</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_a4ba3cc2dcde4eb9bd1ffd91a3d7d772" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">32,781</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425229" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425230"><ix:continuation id="Text_bf6a9e5fec9b4adfb4c1416f36da7dd93" continuedAt="Text_bf6a9e5fec9b4adfb4c1416f36da7dd94">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425230" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425231"><ix:continuation id="Text_bf6a9e5fec9b4adfb4c1416f36da7dd94">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating Lease</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Liabilities</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at January 1, 2023</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_5519358a61f84c94be2b1100b93320a6" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,182</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Recognition of lease liability for Somerville Sublease</div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:InitialMeasurementOfOperatingLeaseLiabilities" id="Fact_19b7698b26734649902ec06adbfbb6dd" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">34,169</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accretion of interest for Somerville Sublease</div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccretionOfInterestSublease" id="Fact_7dfde89cef0c4a24b9f69faa463fa5e1" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,858</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Adjustment to lease liablity due to remeasurement of Somerville Sublease</div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" id="Fact_a4c29748dab148929138f6097b1a3dd1" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,620</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Principal payments on operating lease liabilities</div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="erna:PrincipalPaymentsOnOperatingLeaseLiabilities" id="Fact_e1d304fabfc74d1b8f3002841f88e99b" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">519</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at December 31, 2023</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_4305bd8f898f421a9694473b2bb10088" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">35,070</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Less non-current portion</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_f01ba5c6ded748b5ac6ab8fe0605d139" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">32,854</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Current portion at December 31, 2023</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_30a6a9b690fe4439967d3243ab4cfd7d" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,216</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        </div>
</ix:continuation></ix:continuation>
      </div>


      <div>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425231" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425232">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425232" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425233">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2023, the Company&#8217;s operating leases had a weighted-average remaining life of <ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_c9fbc42a254c48faad3696acd1d7d4d7" contextRef="c20231231" format="ixt-sec:duryear">9.8</ix:nonNumeric> years with a weighted-average discount rate of <ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_410ab4a4d70b42a998f0a7d903f237c2" contextRef="c20231231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">14.24</ix:nonFraction>%.
          <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_e03d0948964e4f94bf38b0d419663594" contextRef="c20230101to20231231" escape="true" continuedAt="Text_70257ec90f914b2bbe7f0b3694f82f4a1"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of the
          operating lease liabilities are as follows (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
      </div>

      <div>
        <ix:continuation id="Text_70257ec90f914b2bbe7f0b3694f82f4a1" continuedAt="Text_70257ec90f914b2bbe7f0b3694f82f4a2"><ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425233" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425234">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_70257ec90f914b2bbe7f0b3694f82f4a2"><ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425234" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425235">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2024</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_091a3ac38dbd49ecb7ebd0c7e9ccbfc3" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,972</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2025</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_94d3c32f02f4474cb10c0e0d03b41062" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,075</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2026</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_c041c45a880f4cf1b9545566956f0ca9" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,238</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2027</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" id="Fact_ce30809a7a6c496c9d7ef205f3baede7" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,308</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">2028</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" id="Fact_1e351fc6781a4fb2a59a64f2db0651c4" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,406</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" id="Fact_abcf3dc3658a4006b07c0dc895afee47" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">33,879</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Total payments</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_8fc4052fe95943beb3da85605fb3beb9" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">65,878</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Less imputed interest</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_67d2cbae486d4c0fadbdc560a12d290c" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,808</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Total operating lease liabilities</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_c8295a862628492689f7e71196d6bcee" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">35,070</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425235" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425236">
<div><br/>
          </div>
</ix:continuation><ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425236" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425237">
<div><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Manhattan Sublease</span>
          <br/></div>
</ix:continuation>
          <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
            <div>
              <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425237" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425238">
<div> <br/>
              </div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425238" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425239">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">In April 2019, the Company entered into a sublease with an unaffiliated third party (the
              &#8220;Subtenant&#8221;), whereby the Subtenant agreed to sublease approximately <ix:nonFraction name="erna:AreaOfSubleaseSpaceCurrentlyRented" id="Fact_b2859915796a4e2daa80d4ddb30c3671" contextRef="c20190418" unitRef="U005" decimals="0" scale="0" format="ixt:num-dot-decimal">999</ix:nonFraction> square feet of space rented by the Company in the borough
              of Manhattan in New York, New York commencing on May 15, 2019. The term of this sublease expires on October 31, 2026 with no option to extend. Rent payments by the Subtenant under the sublease began on September 1, 2019. The sublease
              stipulates an annual rent increase of <ix:nonFraction name="erna:PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" id="Fact_c2d09b3923ac4287a02506ef0f367d17" contextRef="c20190418to20190418" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">2.25</ix:nonFraction>%. The Subtenant is also responsible for paying to the Company all tenant energy costs,
              annual operating costs, and annual tax costs attributable to the subleased space during the term of the sublease.</div>
</ix:continuation>
            <div>
              <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425239" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425240">
<div><br/>
              </div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425240" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425241">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company received sublease payments of approximately $<ix:nonFraction name="us-gaap:ProceedsFromLeasePayments" id="Fact_96cb6dfe73ac40ee9f3a100b6d15f672" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ProceedsFromLeasePayments" id="Fact_17c8ea9959a2494aa63a80be2fe0ee58" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction></ix:nonFraction> million for each of the years ended December 31, 2023 and 2022, respectively. In accordance with ASC Topic 842, the Company treats the sublease as a separate
              lease, as the Company was not relieved of the primary obligation under the related lease. The Company continues to account for the related lease as a lessee and in the same manner as prior to the commencement date of the sublease. The Company
              accounts for the sublease as a lessor of the lease. The sublease is classified as an operating lease, as it does not meet the criteria of a sale-type or direct financing lease.</div>
</ix:continuation>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter" style="width: 100%;"></div>

              <div class="BRPFPageNumberArea" style="text-align: center; text-indent: -9pt; margin-left: 9pt;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-19</span></div>

              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"/></div>

              <div class="BRPFPageHeader" style="width: 100%;">
                <div>
                  <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt; text-indent: -9pt; margin-left: 9pt;"> <a href="#TABLEOFCONTENTS">Table








                      of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                    </a></div>

                </div>

              </div>

            </div>


            <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425241" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425242"><ix:nonNumeric name="erna:FutureLeasePaymentsSubleaseAgreementTableTextBlock" id="Text_f0a9922499d64eb99d8824582071229d" contextRef="c20230101to20231231" escape="true" continuedAt="Text_aee2de29bf5a4ddd952839ab9de031471">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The following tables shows the future payments the Company expects to receive from the Subtenant over
              the remaining term of the sublease (in thousands):</div>
</ix:nonNumeric></ix:continuation>
            <div>
              <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425242" continuedAt="Text_e68ee4a276744dae9cd4eef13b1e425243"><ix:continuation id="Text_aee2de29bf5a4ddd952839ab9de031471" continuedAt="Text_aee2de29bf5a4ddd952839ab9de031472">
<div><br/>
              </div>
</ix:continuation></ix:continuation>
            </div>

            <ix:continuation id="Text_e68ee4a276744dae9cd4eef13b1e425243"><ix:continuation id="Text_aee2de29bf5a4ddd952839ab9de031472">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2023</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" id="Fact_7076697e90f44117b5453b6d44bfb52d" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">86</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" id="Fact_4332e02d17b44cf9b1201aa122fffd9d" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">88</ix:nonFraction><br/>
                    </div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" id="Fact_ce1e3a837a204622af5386a606fc5ac6" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">75</ix:nonFraction><br/>
                    </div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; padding-bottom: 4px; white-space: nowrap;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total payments <br/>
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentals" id="Fact_3ce3a30fa6004bac9ff68ae4aa5ab5a9" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">249</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
              </div>

          <div><br/></div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" id="Text_37da32b66e184899b6d646f65abc294e" contextRef="c20230101to20231231" escape="true" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e01">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">9)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Fair Value of Financial Instruments</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e01" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e02">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e02" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e03"><ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="Text_d9601f8f73d845b7aec21c6a48296618" contextRef="c20230101to20231231" escape="true" continuedAt="Text_64674a31028c4e5c8a4fe21a9c02bd311">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The following tables summarize the liabilities that are measured at fair value as of December 31, 2023 and, 2022 (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e03" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e04"><ix:continuation id="Text_64674a31028c4e5c8a4fe21a9c02bd311" continuedAt="Text_64674a31028c4e5c8a4fe21a9c02bd312">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_64674a31028c4e5c8a4fe21a9c02bd312"><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e04" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e05">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="6">
                <div style="text-align: center; color: #000000; font-weight: bold;">As of December 31,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-weight: bold;">Description</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: #000000; font-weight: bold;">Level</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: #000000; font-weight: bold;">2023<br/>
                </div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: #000000; font-weight: bold;">2022<br/>
                </div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-style: italic;">Liabilities:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Warrant liabilities - Common Warrants</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">3</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_340d3df0ceb348f78ad33003eebc0910" contextRef="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">116</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: #000000;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_db2753c07889447b9ee13ed5c9ee5139" contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Market Cap Contingent Consideration</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">3</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_9881695433654ff689ad6cb92ad31a52" contextRef="c20231231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">107</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_d6c5dfa6571d44a3b83ef93ea086fcfc" contextRef="c20221231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
         </div>
</ix:continuation></ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e05" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e06">
<div><br/>
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e06" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e07">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company uses a Black-Scholes option pricing model to estimate the fair value of its warrant liabilities and a Monte Carlo simulation model to
        estimate the fair value of the Market Cap Contingent Consideration, both of which are considered a Level 3 fair value measurement. The Company remeasures the fair value of the warrant liabilities and the Market Cap Contingent Consideration at each
        reporting period and changes in the fair values are recognized in the statement of operations.<br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e07" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e08">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e08" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e09">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">Certain inputs used in Black-Scholes and Monte Carlo models may fluctuate in future periods based upon factors that are outside of the Company&#8217;s
        control.&#160; A significant change in one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the Company&#8217;s warrant liabilities or contingent consideration liabilities, which could also
        result in material non-cash gains or losses being reported in the Company&#8217;s consolidated statement of operations<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">.</span> </div>
</ix:continuation>
      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e09" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e010">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e010" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e011">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span></span></div>
</ix:continuation>
      <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e011" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e012">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal;"> </span> </span></div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e012" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e013">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div style="text-align: justify;">
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e013" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e014"><ix:nonNumeric name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="Text_e5ea32809c4e478c8d0836bfcf6cad75" contextRef="c20230101to20231231" escape="true" continuedAt="Text_1ad75a8116f942f6a6b025755fdbbf6f1">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following table presents the changes in the liabilities
                measured at fair value from January 1, 2023, or from the initial measurement date if later than January 1, 2023, through December 31, 2023 (in thousands): </span></span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e014" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e015"><ix:continuation id="Text_1ad75a8116f942f6a6b025755fdbbf6f1" continuedAt="Text_1ad75a8116f942f6a6b025755fdbbf6f2">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e015" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e016"><ix:continuation id="Text_1ad75a8116f942f6a6b025755fdbbf6f2" continuedAt="Text_1ad75a8116f942f6a6b025755fdbbf6f3">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e016" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e017"><ix:continuation id="Text_1ad75a8116f942f6a6b025755fdbbf6f3">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Warrant<br/>
                    Liabilities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contingent<br/>
                    Consideration</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>
                </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Fair value at January 1, <span style="text-indent: 0pt;">2023</span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_567ed5610f1f44879c2a6348d465f07e" contextRef="c20221231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_265adc9f39ad44549276a2ba8ea937ac" contextRef="c20221231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Initial measurement</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_d50c3782f51d458fb443ed7e309de9e9" contextRef="c20230101to20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_16c1fdc484ba47c2b43e9faf5567cb7b" contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">225</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Change in fair value</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_0de70c075ca3422d88794fa1a55e81a8" contextRef="c20230101to20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">215</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_ba6ba6fce89540bb9445b9e07285f965" contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">118</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Fair value at December 31, <span style="text-indent: 0pt;">2023</span></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_2f5c966553fe41599687539d5164fd35" contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">116</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_f02814ca6e414d24b56e024e1d0491e1" contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">107</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e017" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e018">
<div>
           <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <div><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e018" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e019">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"> </span></div>
</ix:continuation>
            <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e019" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e020">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
              </span> </div>
</ix:continuation>
            <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e020" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e021">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></div>

          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e021" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e022">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e022" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e023">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; margin-left: 0.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Black-Scholes valuation assumptions used at December 31, 2023 for the warrant liabilities were <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_42346b6bb46e4ab091ed09381bb42866" contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember" format="ixt-sec:duryear">3.69</ix:nonNumeric> years expected term,
            <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_d36726eadc6442268975df12f0539951" contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.93</ix:nonFraction>% risk-free rate, <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_9b3026904add4974a868a96728b5a66d" contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">103</ix:nonFraction>%
            volatility and <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_81f340f26ef841fd81c3c706086a0c2e" contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>% dividend yield.</div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e023" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e024">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e024" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e025">
<div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e025" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e026">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e026" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e027">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">With the assistance of a third-party specialist, the Company assesses the fair value of the Market Cap Contingent Consideration at each quarterly reporting period using the Monte Carlo model, and as of June 30, 2023, determined that the
            fair value of the contingent consideration had been reduced by approximately $<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" id="Fact_c46300d9582b4e49b7501a9d1f17fc1d" contextRef="c20230101to20230630" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million from the initial measurement.&#160; The Company
            assessed the fair value of the Market Cap Contingent Consideration as of September 30, 2023 and as of December 31, 2023, and determined that there was no material change to the Market Cap Contingent Consideration for either period, and
            therefore, did <ix:nonFraction name="erna:ChangeInFairValueOfContingentConsideration" id="Fact_933ff0754f354281825c26e94f233b2e" contextRef="c20230101to20230630" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction>t recognize a change in the fair value of the Market Cap Contingent Consideration since the June 30, 2023
            remeasurement. The Company assessed the fair value as of December 31, 2023, and the inputs used for that assessment was risk-free rate of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_7318a33a34f9479f98016e4bf3555b11" contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.07</ix:nonFraction>%,
            expected term of <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_3e9d603c137740f9b10902ee219de4a8" contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember" format="ixt-sec:duryear">2.3</ix:nonNumeric> years, stock price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_1a81c1a5e202492db021540519ac99cd" contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.80</ix:nonFraction>, volatility of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_85ab7857a2154b028345ec4154768f5b" contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">108</ix:nonFraction>% and dividend yield of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" id="Fact_2fd028a789264e39bc92d2db9b4ff3ff" contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%.</div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e027" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e028">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: -9pt; margin-left: 9pt;"> <br/>
          </div>
</ix:continuation>
        </div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-20</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt; text-indent: -9pt; margin-left: 9pt;"> <a href="#TABLEOFCONTENTS">Table



                  of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="text-align: justify;"><ix:nonNumeric name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="Text_7e8859617ff84f3a9f4b9215f2765a12" contextRef="c20230101to20231231" escape="true" continuedAt="Text_84df947e7ac44bb09e23d08784c5d3561"><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e028" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e029">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:nonNumeric>
          <ix:continuation id="Text_84df947e7ac44bb09e23d08784c5d3561" continuedAt="Text_84df947e7ac44bb09e23d08784c5d3562"><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e029" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e030">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The table below is provided for comparative purposes only and presents information about the fair value of the convertible notes relative to the carrying values recognized in the consolidated balance sheet as of December 31, 2023 (in
            thousands).&#160; The Company did not have any of the convertible notes or similar instruments outstanding as of December 31, 2022.</div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_84df947e7ac44bb09e23d08784c5d3562" continuedAt="Text_84df947e7ac44bb09e23d08784c5d3563"><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e030" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e031">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_84df947e7ac44bb09e23d08784c5d3563" continuedAt="Text_84df947e7ac44bb09e23d08784c5d3564"><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e031" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e032">
<div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_84df947e7ac44bb09e23d08784c5d3564" continuedAt="Text_84df947e7ac44bb09e23d08784c5d3565"><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e032" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e033">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_84df947e7ac44bb09e23d08784c5d3565"><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e033" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e034">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">December 31,<br/>
                    </span> <span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2023</span></div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Carrying<br/>
                    Value</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Fair<br/>
                    Value</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Convertible Notes</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" id="Fact_b625c3b26ce14b949259c31f0722495f" contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementBasisAxis_CarryingReportedAmountFairValueDisclosureMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,616</ix:nonFraction><br/>
                    </span> </div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" id="Fact_2513025cedff4068b1bbb100c767083c" contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementBasisAxis_EstimateOfFairValueFairValueDisclosureMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">17,594</ix:nonFraction><br/>
                    </span> </div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e034" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e035">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
          <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e035" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e036">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e036" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e037">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e037" continuedAt="Text_90daaabf049146eeb636ab8ac56e54e038">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The carrying value in the table above is shown before the allocation of the proceeds to the note warrants. The Company assesses the fair value of the convertible notes using the binomial model, which is considered a Level 3 measurement.&#160;
            The weighted average inputs used in the binomial model as of December 31, 2023 was stock price of $<ix:nonFraction name="erna:ConvertibleDebtMeasurementInput" id="Fact_fb5beb0670ed495cb87f701b13034b69" contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputSharePriceMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.80</ix:nonFraction>, credit spread of <ix:nonFraction name="erna:ConvertibleDebtMeasurementInput" id="Fact_b5a006cd45754ff8bf4565a080c8c302" contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,891</ix:nonFraction>, volatility of <ix:nonFraction name="erna:ConvertibleDebtMeasurementInput" id="Fact_b495c71fe3f34b988e88bdba12509dd0" contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">109</ix:nonFraction>% and
            risk-free rate of <ix:nonFraction name="erna:ConvertibleDebtMeasurementInput" id="Fact_99ced119dea24769a455bbfea640f367" contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.87</ix:nonFraction>%.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_90daaabf049146eeb636ab8ac56e54e038">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>
</ix:continuation></div>

      <div>
        <div> </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);"> <div><span style="font-family: 'Times New Roman';"> </span></div>

    <div>
      <div style="font-family: 'Times New Roman';">
        <ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="Text_c714f7bc59f8401fb9f2dd1beb6e3514" contextRef="c20230101to20231231" escape="true" continuedAt="Text_406663d8a65d4047a7eac048e3e560891">
<div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">10)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">Goodwill and In-Process Research &amp; Development</div>
                </td>

  </tr>


</table>
        </div>
</ix:nonNumeric>
      </div>

      <div style="font-family: 'Times New Roman';">
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560891" continuedAt="Text_406663d8a65d4047a7eac048e3e560892">
<div><br/>
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560892" continuedAt="Text_406663d8a65d4047a7eac048e3e560893">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Goodwill</div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman';">
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560893" continuedAt="Text_406663d8a65d4047a7eac048e3e560894">
<div><br/>
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560894" continuedAt="Text_406663d8a65d4047a7eac048e3e560895">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          November 2018, the Company acquired IRX, which was accounted for as a business combination.&#160; The Company recorded goodwill in the amount of $<ix:nonFraction name="us-gaap:Goodwill" id="Fact_9906e5d705774bd99357f81e7cdc495e" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_02aa9688bbf944cd810475c6d583fc97" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction></ix:nonFraction>
          million related to the acquisition. The Company performed its annual qualitative assessment as of December 31, 2023 and 2022, and based on the assessments, the Company determined that it was more likely than not that the fair value of the entity
          exceeded its carrying value for such years and that the performance of the quantitative impairment test was not required.&#160; Therefore, <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_e8c3f112af344732a14fda9d03c5d211" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_0bfeb5d4b3ab4642b8bf0beaf152a4aa" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>
          impairment was required for any of the periods presented.</div>
</ix:continuation>
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560895" continuedAt="Text_406663d8a65d4047a7eac048e3e560896">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560896" continuedAt="Text_406663d8a65d4047a7eac048e3e560897">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> In-Process Research &amp; Development</span><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560897" continuedAt="Text_406663d8a65d4047a7eac048e3e560898">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560898" continuedAt="Text_406663d8a65d4047a7eac048e3e560899">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          In 2018, Company recorded IPR&amp;D in the amount of $<ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_3ef2e8d362c349829ef982517cc1754e" contextRef="c20181231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.0</ix:nonFraction> million, which represented the fair value assigned to technologies that were
          acquired in connection with the acquisition of IRX in November 2018 and which had not reached technological feasibility and had no alternative future use.</div>
</ix:continuation>
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e560899" continuedAt="Text_406663d8a65d4047a7eac048e3e5608910">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
        <ix:continuation id="Text_406663d8a65d4047a7eac048e3e5608910">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral cavity. The IRX-2 multi-cytokine
          biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE trial did not meet its primary
          endpoint of event-free survival. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate the treatment effect of IRX-2 in patient subgroups and in
          combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial was the only Company-sponsored study of IRX-2.&#160; Based on the totality of available information, the Company decided not to further develop IRX-2. As such, the Company determined
          that the carrying value of the IPR&amp;D asset was impaired and recognized a non-cash impairment charge of approximately $<ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_2ecfcfe426d34ba6ae5f98692d7592e0" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.0</ix:nonFraction> million
          on the consolidated statement of operations during 2022, which reduced the value of the asset to <ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_2187cdbd4b6b4bb5a98d8192392427d8" contextRef="c20221231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">zero</ix:nonFraction>.</div>
</ix:continuation>

      </div>
<div>
      &#160; </div>
</div>

    <div><span style="font-family: 'Times New Roman';"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div>
      <ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="Text_bc2710f125df424085bda4a398060ae7" contextRef="c20230101to20231231" escape="true" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce71">
<div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: -36pt; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11)</span></div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Related Party Transactions</span></span></div>
              </td>

  </tr>


</table>
      </div>
</ix:nonNumeric>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce71" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce72">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"><br/>
        </span> </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce72" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce73">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce73" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce74">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce74" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce75">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Agreements with
          Factor Bioscience Inc. and Affiliates</div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce75" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce76">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>
</ix:continuation>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce76" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce77">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As
          of December 31, 2023, the Company had the agreements described below with Factor Bioscience Inc. and/or Dr. Matthew Angel. These agreements have been deemed related party transactions because the Company&#8217;s former chief executive officer, Dr.
          Angel, is the chairman and chief executive officer of Factor Bioscience Inc. and a director of its subsidiary, Factor Bioscience Limited (&#8220;Factor Limited&#8221; and together with Factor Bioscience Inc. and its other affiliates, &#8220;Factor Bioscience&#8221;).
          Dr. Angel resigned as the Company&#8217;s chief executive officer effective December 31, 2023.</div>
</ix:continuation>
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce77" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce78">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce78" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce79">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          September 2022, the Company entered into a Master Services Agreement (the &#8220;MSA&#8221;) with Factor Bioscience, pursuant to which Factor Bioscience agreed to provide services to the Company as agreed between the Company and Factor Bioscience and as set
          forth in one or more work orders under the MSA, including the first work order included in the MSA (&#8220;WO1&#8221;). The MSA contains customary confidentiality provisions and representations and warranties of the parties, and the MSA may be terminated by
          either party upon <ix:nonNumeric name="erna:NoticePeriodForSupersedingTerminationProvisions" id="Fact_302ca321de1344fdacca8ce8dd8969e0" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" format="ixt-sec:durwordsen">30 days</ix:nonNumeric>&#8217; prior notice, subject to any superseding termination provisions contained in a particular work order. </div>
</ix:continuation>
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce79" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce710">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="width: 100%;" class="BRPFPageFooter"></div>

          <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-21</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div style="width: 100%;" class="BRPFPageHeader">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce710" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce711">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Under
























          WO1, Factor Bioscience agreed to provide the Company with mRNA cell engineering research support services, including access to certain facilities, equipment, materials and training, and the Company agreed to pay Factor Bioscience an initial fee
          of $<ix:nonFraction name="erna:MasterServiceAgreementInitialFeesPayable" id="Fact_4a0ca25d42f44a5291a474d9ba87b204" contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction> million, payable in <ix:nonFraction name="erna:NumberOfMonthlyInstallmentsForFeesPayable" id="Fact_0143ccae4b7e4997b6b3ee521ae405b8" contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U009" decimals="0" scale="0" format="ixt:num-dot-decimal">12</ix:nonFraction>
          equal monthly installments of approximately $<ix:nonFraction name="erna:RelatedPartyTransactionPeriodicFeesPaymentAmount" id="Fact_375bfb649d2644c28669ad3da8603e20" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million. Of the $<ix:nonFraction name="erna:MonthlyMasterServicesAgreementFeesPayable" id="Fact_7e71cfa286314f49bdff993d26e1e705" contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction> million, the Company allocated $<ix:nonFraction name="erna:InitialLicenseFeeObligation" id="Fact_c72d5883ff724da4b3b34c25eb3a6f11" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million to the License Fee Obligation
          (as defined below). Following the initial 12-month period, the Company agreed to continue paying Factor Bioscience the monthly fee of $<ix:nonFraction name="erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" id="Fact_2229d196d83443d5a66c1b4627c5c587" contextRef="c20220909_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction>
          million until such time as WO1 is terminated. Upon entering into the MSA, the Company paid a deposit of $<ix:nonFraction name="erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" id="Fact_8c2daab075a64f0a9658b341b35f5777" contextRef="c20220909_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million, which will be
          applied to the last month of WO1. The Company may terminate WO1 on or after the second anniversary of the date of the MSA, subject to providing Factor Bioscience with <ix:nonNumeric name="erna:NoticePeriodForFirstTerminationOfContract" id="Fact_b07a0d59aeeb47a881f6df14da9777c9" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" format="ixt-sec:durwordsen">120 days</ix:nonNumeric>&#8217; prior notice.&#160; Factor Bioscience may terminate WO1 only on and after the fourth anniversary of the date of the MSA, subject to providing the Company with <ix:nonNumeric name="erna:NoticePeriodForFirstTerminationOfContract" id="Fact_6597705e6d2947ee968b6f79b56f70e0" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" format="ixt-sec:durwordsen">120 days</ix:nonNumeric>&#8217; prior notice.</div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce711" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce712">
<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"><br/>
        </div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce712" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce713">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In connection with entering into the MSA, Factor Limited entered into a waiver agreement with Eterna LLC, pursuant to which
          Factor Limited agreed to waive payment of $<ix:nonFraction name="erna:AgreedWaivePayment" id="Fact_9456628f320e4468ba4ecc0eab25969e" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million otherwise payable to it (the &#8220;License Fee Obligation&#8221;) in October 2022 by Eterna
          LLC under the exclusive license agreement entered into in April 2021 by and among Eterna LLC, Novellus Limited and Factor Limited (the &#8220;Original Factor License Agreement&#8221;).&#160; Under the terms of the waiver agreement, the License Fee Obligation is
          waived conditionally on the Company paying Factor Bioscience a minimum of $<ix:nonFraction name="erna:AgreedWaivePayment" id="Fact_876bb15aceb3404d97348a00e47fe7a0" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million due under the MSA.</div>
</ix:continuation>
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce713" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce714">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce714" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce715">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Because the License Fee Obligation was conditionally waived until the Company paid Factor Bioscience a minimum of $<ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" id="Fact_e2fc3a8164254d9ea5f139fb7d29ba2a" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million under the MSA, the Company recorded a liability of $<ix:nonFraction name="erna:AgreedWaivePayment" id="Fact_da9d53f77e9145debde26fbefe8bd707" contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million.&#160; As of December 31, 2023, there was approximately $<ix:nonFraction name="erna:RemainingUnamortizedLicenseFeeObligation" id="Fact_fdbba5e015e741049d733cb567d12198" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction> million
          of the unamortized License Fee Obligation remaining, which is recorded on the accompanying consolidated balance sheet in the &#8220;due to related party, current&#8221; line item.</div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce715" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce716">
<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"><br/>
        </div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce716" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce717">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In September 2022, Novellus Inc. (&#8220;Novellus&#8221;) and the Company entered into a Second
        Amendment to the Limited Waiver and Assignment Agreement (the &#8220;Waiver and Assignment Agreement&#8221;) with Drs. Matthew Angel and Christopher Rohde (the &#8220;Founders&#8221;) whereby the Company agreed to be responsible for all future, reasonable and
        substantiated legal fees, costs, settlements and judgments incurred by the Founders, the Company or Novellus. for certain claims and actions and any pending or future litigation brought against the Founders, Novellus and/or the Company by or on
        behalf of the Westman and Sowyrda legal matters described in Note 13 (the &#8220;Covered Claims&#8221;).&#160; The Founders will continue to be solely responsible for any payments made to satisfy a judgement or settlement of any pending or future wage act claims.&#160;
        Under the Waiver and Assignment Agreement, the Founders agreed that they are not entitled to, and waived any right to, indemnification or advancement of past, present or future legal fees, costs, judgments, settlement or other liabilities they may
        have been entitled to receive from the Company or Novellus in respect of the Covered Claims. The Company and the Founders will share in any recoveries up to the point at which the parties have been fully compensated for legal fees, costs and
        expenses incurred, with the Company retaining any excess recoveries. The Company has the sole authority to direct and control the prosecution, defense and settlement of the Covered Claims.</div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce717" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce718">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce718" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce719">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> In November 2022, following the expiration of one of the milestone deadlines for
        certain regulatory filings required under the Third Amended and Restated Exclusive License Agreement between Novellus Limited and Factor Limited entered into in November 2020 (the &#8220;Novellus-Factor License Agreement&#8221;), which permitted Factor Limited
        to terminate the license granted to Novellus Limited thereunder, the Company entered into the first amendment to the Original Factor License Agreement (as amended, the &#8220;2021 Factor License Agreement&#8221;), pursuant to which, among other things, Factor
        Limited granted to Eterna LLC an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#8220;Factor Patents&#8221;) for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the
        Factor Patents. The Original Factor License Agreement also (i) terminated the Novellus-Factor License Agreement, (ii) confirmed Factor Limited&#8217;s grant to Eterna LLC of the rights and licenses Novellus Limited previously granted to Eterna LLC under
        the Novellus-Factor License Agreement on the same terms and conditions as granted by Novellus Limited to Eterna LLC under such agreement, (iii) confirmed that the sublicense granted by Novellus Limited in accordance with the Novellus-Factor License
        Agreement to NoveCite, Inc., a company which the Company has a <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" id="Fact_c2ab9e783824441985ab51365b1e784a" contextRef="c20221130_OwnershipAxis_NoveCiteINCMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">25</ix:nonFraction>% non-controlling interest (&#8220;NoveCite&#8221;), survived termination of the
        Novellus-Factor License Agreement; and (iv) removed Novellus Limited from the Original Factor License Agreement and the license agreement entered into on October 6, 2020 between Novellus Limited and NoveCite, Inc, as amended, and replaced Novellus
        Limited with Factor Limited as the direct licensor to Eterna LLC and NoveCite under such agreements, respectively.<br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce719" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce720">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce720" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce721">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> On February 20, 2023, the Company, entered into an exclusive license agreement (the
        &#8220;Feb 2023 Factor Exclusive License Agreement&#8221;) with Factor Limited, pursuant to which Factor Limited granted to the Company an exclusive, sublicensable, worldwide license under certain patents owned by Factor Limited for the purpose of, among other
        things, identifying and pursuing certain opportunities to develop products in respect of such patents and to otherwise grant to third parties sublicenses to such patents. The Feb 2023 Factor Exclusive License Agreement, which terminated and
        superseded the Amended Factor License Agreement, was subsequently terminated and superseded by the A&amp;R Factor License Agreement (as defined below).</div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce721" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce722">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-22</span></div>

        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce722" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce723">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On November 14, 2023, the Company entered into an amended and restated exclusive
        license agreement (the &#8220;A&amp;R Factor License Agreement&#8221;) with Factor Limited to replace in its entirety the exclusive license agreement between the parties dated February 20, 2023 and the amendment thereto.&#160; Under the terms of the A&amp;R Factor
        License Agreement, Factor Limited granted to the Company an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#8220;Factor Patents&#8221;).&#160; The A&amp;R Factor License Agreement also provides for, among other things, the
        expansion of the Company&#8217;s license rights to include (i) the field of use of the Factor Patents to include veterinary uses (ii) know-how that is necessary or reasonably useful to practice to the licensed patents, (iii) the ability to sublicense
        through multiple tiers (as opposed to only permitting a direct sublicense) and (iv) the transfer of technology to the Company, subject to the use restrictions in the A&amp;R Factor License Agreement.&#160; The term of the A&amp;R Factor License
        Agreement expires on November 22, 2027, but will be automatically extended for an additional <ix:nonNumeric name="erna:LicenseAgreementAutomaticRenewalTerm" id="Fact_6afacd717e5c4482830a4a634a07f468" contextRef="c20230101to20231231" format="ixt-sec:durwordsen">five years</ix:nonNumeric> (such period, the &#8220;Renewal
        Term&#8221;) if the Company pays at least $<ix:nonFraction name="erna:SublicenseFees" id="Fact_fb083f3e9ac2437f8b81a76f03f1d715" contextRef="c20230219to20230220_RangeAxis_MinimumMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.0</ix:nonFraction> million to Factor Limited from fees from sublicenses to the Factor Patents (&#8220;Sublicense Fees&#8221;),
        other cash on hand or a combination of both sources of funds.&#160; The Company will pay to Factor Limited <ix:nonFraction name="erna:PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" id="Fact_b9d4afa546934883a05b8e19a397c39f" contextRef="c20230220" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% of any Sublicense Fee received
        by the Company during the term of the A&amp;R Factor License Agreement.&#160; Beginning in September 2024, the Company will also begin paying Factor Limited a monthly maintenance fee of approximately $<ix:nonFraction name="erna:RelatedPartyTransactionPeriodicFeesPaymentAmount" id="Fact_5d7c565c379c44e0b2914469f295dd1f" contextRef="c20230219to20230220" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million until the expiration of the A&amp;R Factor License Agreement, including any Renewal Term. The Company may terminate the A&amp;R Factor License Agreement upon <ix:nonNumeric name="erna:NoticePeriodForFirstTerminationOfContract" id="Fact_65c5158fc7574942bc5f6b32bae5d23a" contextRef="c20230101to20231231" format="ixt-sec:durday">120</ix:nonNumeric> days&#8217; written notice to Factor Limited, and both parties have additional customary termination rights.&#160; Under the A&amp;R Factor License Agreement,
        the Company is obligated to pay the expenses incurred by Factor Limited in preparing, filing, prosecuting and maintaining the Factor Patents and the Company agreed to bear all costs and expenses associated with enforcing and defending the Factor
        Patents in any action or proceeding arising from pursuit of sublicensing opportunities under the license granted under the A&amp;R Factor License Agreement.</div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce723" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce724">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce724" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce725">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Exacis Asset Acquisition</span></div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce725" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce726">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce726" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce727">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On April 26, 2023, the Company entered into the Exacis Purchase Agreement to acquire
        the Exacis Assets, including all of Exacis&#8217; right, title and interest in the Purchased License. The Company assumed none of Exacis&#8217; liabilities, other than liabilities under the Purchased License that accrue subsequent to the closing date. See Note
        4.</div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce727" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce728">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce728" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce729">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Exacis Acquisition was deemed a related party transaction because Dr. Gregory
        Fiore, who was the chief executive officer of Exacis at the time of the Exacis Acquisition, was also a member of the Company&#8217;s board of directors at the time of the Exacis Acquisition.&#160; Additionally, Dr. Angel, who was the Company&#8217;s chief executive
        officer at the time of the Exacis Acquisition, was chairman of Exacis&#8217; scientific advisory board, and an affiliate of Factor Bioscience was the majority stockholder of Exacis at the time of the Exacis Acquisition.</div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce729" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce730">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce730" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce731">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> In October 2022, the Company entered into an Option Agreement on October 8, 2022 with
        Exacis (the &#8220;Exacis Option Agreement&#8221;), pursuant to which Exacis granted the Company the option to negotiate and enter into an exclusive worldwide license to certain of the technology licensed by Exacis for the treatment of cancer in humans. The
        Exacis Option Agreement provided for the Company paying Exacis a fee of $<ix:nonFraction name="erna:PaymentOfOptionFee" id="Fact_34efe6958ee44727b7225623dc1fe6c1" contextRef="c20221001to20221031" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction> for the option, which would be creditable against the
        fees or purchase price payable under any such license if entered into by the Company in accordance with Exacis Option Agreement. The Company did not exercise the option, and the Exacis Option Agreement terminated on December 31, 2022. </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce731" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce732">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce732" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce733">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Consulting Agreement with Former Director</span></div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce733" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce734">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce734" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce735">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In May 2023, the Company entered into a consulting agreement with Dr. Fiore, whereby
        Dr. Fiore agreed to provide business development consulting services to the Company for a monthly retainer of $<ix:nonFraction name="erna:RelatedPartyTransactionPeriodicFeesPaymentAmount" id="Fact_e85a07e64fcf4bdcacc66c6a24b9553a" contextRef="c20230501to20230531_TitleOfIndividualAxis_DirectorMember" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">20,000</ix:nonFraction>.&#160; The consulting
        agreement was terminable for any reason by either party upon <ix:nonNumeric name="erna:NoticePeriodForFirstTerminationOfContract" id="Fact_58a9083286524832b1cbadd05329bed9" contextRef="c20230101to20231231_TitleOfIndividualAxis_DirectorMember" format="ixt-sec:durday">15</ix:nonNumeric> days&#8217; written notice. The Company terminated the consulting agreement,
        effective July 31, 2023. Dr. Fiore served on the Company&#8217;s board of directors from June 2022 to October 4, 2023.</div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce735" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce736">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce736" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce737">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">July 2023 and December 2023 Financings</span></div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce737" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce738">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce738" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce739">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Investors in the July 2023 convertible note financing included Brant Binder, Richard
        Wagner, Charles Cherington and Nicholas Singer, and investors in the December 2023 convertible note financing included Messrs. Cherington and Singer. Each of them participated in the applicable financing under the same terms and subject to the same
        conditions as all the other investors. See Note 6 for additional information regarding the financings. Mr. Binder served on the Company&#8217;s board of directors from July 6, 2023 to August 8, 2023, Mr. Wagner served on the Company&#8217;s board of directors
        from July 6, 2023 to August 8, 2023, Mr. Cherington served on the Company&#8217;s board of directors from March 2021 to July 6, 2023, and Mr. Singer served on the Company&#8217;s board of directors from June 2022 to July 6, 2023.</div>
</ix:continuation>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce739" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce740">
<div><br/></div>
</ix:continuation>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce740" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce741">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Q4-22 PIPE </div>
</ix:continuation>
            <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce741" continuedAt="Text_eaf3dfffa25f4a5994e365c4fba89ce742">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"> <br/>
            </div>
</ix:continuation>
          </div>

          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_eaf3dfffa25f4a5994e365c4fba89ce742">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In November 2022, the Company entered into a securities purchase agreement with certain investors providing for the
              issuance of approximately of <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_bc107ae8adba4570bfad2dfece0a48fc" contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">2,185,000</ix:nonFraction> units, each unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_9c73259e3f17435aad9ac4ff84dc2c49" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of the Company&#8217;s common stock and (ii) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_2eeceb43158a49ee87669fa5c04bd2ee" contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> warrants to
              purchase shares of the Company&#8217;s common stock, at a purchase price of $<ix:nonFraction name="erna:UnitPriceOfWarrants" id="Fact_e567edc67eb04c0fb03cc5e7bb939cbe" contextRef="c20221123to20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.53</ix:nonFraction> per unit. The financing closed in December 2022.
              Messrs. Cherington and Singer invested in the financing on the same terms and subject to the same conditions as all other investors in the financing. Mr. Cherington served on the Company&#8217;s board of directors from March 2021 to July 6, 2023,
              and Mr. Singer served on the Company&#8217;s board of directors from June 2022 to July 6, 2023.</div>
</ix:continuation>

            <div><br/>
            </div>

            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="width: 100%;" class="BRPFPageFooter"></div>

              <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-23</span></div>

              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

              <div style="width: 100%;" class="BRPFPageHeader">
                <div>
                  <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                    </a></div>

                </div>

              </div>

            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_09ff2d1d1d51425899784ee7a9d40e93" contextRef="c20230101to20231231" escape="true" continuedAt="Text_d88b46578ec8418b9ffdf1c3da7bd69f1">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">12)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Accrued Expenses</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_d88b46578ec8418b9ffdf1c3da7bd69f1" continuedAt="Text_d88b46578ec8418b9ffdf1c3da7bd69f2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_d88b46578ec8418b9ffdf1c3da7bd69f2" continuedAt="Text_d88b46578ec8418b9ffdf1c3da7bd69f3"><ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_7d93a6d21dd346b99df188153b132581" contextRef="c20230101to20231231" escape="true" continuedAt="Text_a79ee7e5409f4f49bec1c48b88b8c8df1">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;">Accrued expenses consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_d88b46578ec8418b9ffdf1c3da7bd69f3" continuedAt="Text_d88b46578ec8418b9ffdf1c3da7bd69f4"><ix:continuation id="Text_a79ee7e5409f4f49bec1c48b88b8c8df1" continuedAt="Text_a79ee7e5409f4f49bec1c48b88b8c8df2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_d88b46578ec8418b9ffdf1c3da7bd69f4"><ix:continuation id="Text_a79ee7e5409f4f49bec1c48b88b8c8df2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Legal fees and related</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccruedLegalFeesAndRelatedCurrent" id="Fact_edeee9c515964324b4d26b6a649f1a81" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">643</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccruedLegalFeesAndRelatedCurrent" id="Fact_d5aee57682e14bedbd135d744dfb19fc" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,139</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Professional fees</span></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" id="Fact_e0e71466743a4f308a7988e180216bca" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">239</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" id="Fact_f82894ff5e9c4bdbb8d8cb67b178eed1" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">124</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" rowspan="1">Somerville facility <br/>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="erna:AccruedSomervilleFacilityCurrent" id="Fact_915d3a1eaf5942ae988182349b02ae5d" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">218</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="erna:AccruedSomervilleFacilityCurrent" id="Fact_7531c63a0ac34aecb9c780844b1a4c59" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">138</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">Convertible Notes interest <br/>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:InterestPayableCurrent" id="Fact_94017557e9bc45edae44c0d64b1d4414" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">176</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:InterestPayableCurrent" id="Fact_a570c8ad2deb413d8889bafdfcc28c56" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Accrued compensation</span></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_7c43cfe91990434480f609db45101412" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">109</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_c9d0334ce54244ebbd574c56f0b025a1" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,065</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Clinical</span></td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccruedClinicalCurrent" id="Fact_315e20ffbbf14a748061b95b9ad9d697" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">18</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:AccruedClinicalCurrent" id="Fact_629416be2e9b46fb931367cd766c49e1" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">570</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1">Other<br/>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_cadb8b788ad44a15b718453064e258c2" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">490</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_805c5adaaf0a49debbce19e701227f6b" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">590</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total accrued expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_e5181e18f7154869ae8d5a0d35281929" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,893</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_c58a114de53349c09a52d30c4aac76ff" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,626</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        </div>

    <div><br/>
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Text_2fde8b23a8364cbd9fe75501088788fb" contextRef="c20230101to20231231" escape="true" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">13)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Commitments and Contingencies</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb1" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb2" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb3">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The










          Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a
          liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the amount can be reasonably estimated.</div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb3" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb4">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb4" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb5">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Novellus, Inc. v.
            Sowyrda et al., C.A. No. 2184CV02436-BLS2</span><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb5" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb6">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;"> <br/>
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb6" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb7">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On October 25, 2021 Novellus, Inc. filed a
            complaint in the Superior Court of Massachusetts, Suffolk County, against former Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#8217;s former parent company prior to the
            Company&#8217;s acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract and civil conspiracy. The Company acquired Novellus, Inc. on July 16, 2021.&#160; On May 27, 2022, Novellus, Inc. amended the complaint to withdraw all
            claims against all defendants except Messrs. Sowyrda and Westman.&#160; On July 1, 2022, Mr. Westman filed a motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain litigation in the Court of
            Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr. Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned Zelickson et al., v. Angel et al., C.A. 2021-1014-JRS and by Mr. Westman
            against Novellus LLC captioned Westman v. Novellus LLC, C.A. No. 2021-0882-NAC (together, the &#8220;Delaware Actions&#8221;).&#160; On July 1, 2022, Mr. Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants
            Dr. Angel and Dr. Rohde alleging violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit.&#160; Mr. Sowyrda also joined in Mr. Westman&#8217;s
            motion to stay the case pending the Delaware Actions.&#160; Novellus, Inc.&#8217;s claims and Mr. Sowyrda&#8217;s counterclaims relate to alleged conduct that took place before the Company acquired Novellus, Inc.</span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb7" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb8">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"><br/>
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb8" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb9">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On November 15, 2022, prior to a decision
            on Messrs. Westman&#8217;s and Sowyrda&#8217;s motion to compel or stay, the parties agreed to voluntarily dismiss and consolidate the Delaware Actions with this action.&#160; On December 15, 2022, Mr. Sowyrda filed an Amended Answer to the Amended Complaint,
            asserted affirmative defenses and filed Amended Counterclaims against Dr. Angel, Dr. Rohde, Novellus LLC, Novellus Inc., Factor Bioscience Inc., and the Company (collectively, the &#8220;Counterclaim Defendants&#8221;) alleging against various Counterclaim
            Defendants breach of contract, breaches of the implied duty of good faith and fair dealing, breaches of fiduciary duty, breaches of the operating agreement, aiding and abetting breaches of fiduciary duty, tortious interference with contract,
            equitable accounting, violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, unjust enrichment, and quantum meruit.&#160; Also on December 15, 2022, Mr. Westman filed an answer to the Amended
            Complaint and asserted similar counterclaims against the same Counterclaim Defendants.&#160; Messrs. Westman and Sowyrda each asserted claims for indemnification and/or advancement against Novellus, Inc.&#160; On January 11, 2023, Messrs. Westman and
            Sowyrda served a joint motion to enforce their advancement and/or indemnification rights against Novellus Inc.&#160; Novellus Inc. vigorously opposes this motion and served its opposition on January 27, 2023.&#160; On February 8, 2023, Messrs. Westman
            and Sowyrda served a reply in support of their motion to enforce indemnification/advancement rights, and submitted the motion to the Court.&#160; Novellus Inc. answered Messrs. Westman and Sowyrda&#8217;s counterclaims on January 27, 2023, denying
            liability.&#160; The remaining Counterclaim Defendants served a motion to dismiss most of the remaining counterclaims on January 27, 2023.&#160; The Court entered an order granting the Counterclaim Defendants&#8217; motion to dismiss and denying Messrs.&#160;
            Sowyrda and Westman&#8217;s motion to enforce on June 15, 2023.&#160; The Court&#8217;s order dismissed all of Mr. Westman&#8217;s claims against Counterclaim Defendants except his claim for indemnification, and all of Mr. Sowyrda&#8217;s claims except his claim for
            indemnification and his employment-related claims, which Counterclaim Defendants did not move to dismiss.&#160; On July 6, 2023, Messrs. Westman and Sowyrda filed a petition for interlocutory review with a single justice of the Massachusetts Appeals
            Court, seeking to overturn the judge&#8217;s decision granting the Counterclaim Defendants&#8217; motion to dismiss most of the remaining counterclaims, but not the decision denying Messrs. Westman and Sowyrda&#8217;s motion to enforce advancement rights.&#160; On
            July 25, 2023, the parties to the appeal filed a joint motion to the single justice in the appellate court to stay the appeal to allow for amended counterclaims to be filed by Counterclaim Plaintiffs and a motion to dismiss to be filed by
            Counterclaim Defendants.&#160; Counterclaim Plaintiffs filed an initial set of amended counterclaims on August 15, 2023.&#160; Counterclaim Plaintiffs amended and refiled their amended counterclaims on September 29, 2023.&#160; Counterclaim Defendants served
            their motion to dismiss all of the amended counterclaims, except for Mr. Sowyrda&#8217;s employment-related claims, on October 13, 2023.</span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb9" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb10">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"><br/>
          </span></div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-24</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb10" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb11">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Under applicable Delaware law and Novellus
            Inc.&#8217;s organizational documents, the Company may be required to advance or reimburse certain legal expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing matters. However, a future advance or
            reimbursement is not currently probable nor can it be reasonably estimated.</span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb11" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb12">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"><br/>
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb12" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb13">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">eTheRNA
            Immunotherapies NV and eTheRNA Inc. v. Eterna Therapeutics Inc. C.A. No. 123CV11732</span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb13" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb14">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;"> <br/>
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb14" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb15">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On July 31, 2023, eTheRNA Immunotherapies
            NV and eTheRNA Inc. filed a complaint in court against the Company alleging: (1) federal trademark infringement; (2) federal unfair competition; (3) Massachusetts state common law trademark infringement; (4) Massachusetts state unfair
            competition.&#160; Service of process for the complaint was completed on August 1, 2023. The Company&#8217;s answer was filed on October 10, 2023. At this stage in the litigation, the Company is not able to predict the probability of a favorable or
            unfavorable outcome.</span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb15" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb16">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"><br/>
          </span></div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb16" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb17">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Dhesh Govender v. Eterna Therapeutics LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb17" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb18">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb18" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb19">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On










            or about February 5, 2021, Dhesh Govender, a former short-term consultant of Eterna LLC, filed a complaint against Eterna LLC and certain individuals that plaintiff alleged were directors of Eterna LLC. Plaintiff alleged that Eterna LLC and
            certain of its officers and directors engaged in unlawful and discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserted various breach of contract, fraud and quantum meruit claims based on an
            alleged oral agreement pursuant to which he alleged Eterna LLC agreed to hire him as an executive once the merger involving the Company and NTN Buzztime, Inc. was completed. On December 15, 2022, the parties executed a Confidential Settlement
            Agreement and Release of All Claims. On January 11, 2023, the parties filed a Stipulation to Discontinue in the Court action. Also on January 11, 2023, plaintiff voluntarily dismissed the arbitration.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb19" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb20">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb20" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb21">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">John Westman v.
              Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949 (Middlesex County (Massachusetts) Superior Court)</span></div>
</ix:continuation>
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb21" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb22">
<div><br/>
          </div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb22" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb23">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On or about September 7, 2021, John Westman, a former employee of Novellus, Inc.
          filed a complaint in Middlesex County (Massachusetts) Superior Court against Novellus, Inc. and Novellus, Inc.&#8217;s founders and former executives, Dr. Rohde and Dr. Angel.&#160; The case includes allegations that Novellus, Inc. violated the
          Massachusetts Wage Act.&#160; The Company acquired Novellus, Inc. on July 16, 2021.&#160; Mr. Westman&#8217;s claims relate to alleged conduct that took place before the Company acquired Novellus, Inc.&#160;&#160; Mr. Westman agreed to dismiss the lawsuit and proceed with
          his claims in arbitration.&#160; Following mediation, the parties settled this dispute in December 2022.</div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb23" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb24">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb24" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb25">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The aggregate settlement amount payable by the Company for the Westman and Govender
          matters discussed above was approximately $<ix:nonFraction name="erna:LitigationSettlementAmountPayable" id="Fact_5a87d79d90644440b3aa3a76d1911965" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million, both of which were recognized as expense in the consolidated statement of
          operations for the year ended December 31, 2022 and were fully <span style="-sec-ix-hidden:Fact_1686a4286739492e851a84f95f37d027">paid</span> during the year ended December 31, 2023.<br/>
          <br/>
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb25" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb26">
<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"> <span style="text-decoration: underline;">Emerald Private Equity Fund, LLC Matter</span></div>
</ix:continuation>
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb26" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb27">
<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"><span style="text-decoration: underline;"> <br/>
            </span></div>
</ix:continuation>
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb27" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb28">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#8220;Emerald&#8221;), a stockholder of the Company, made a demand
            pursuant to 8 Del. C. 220 to inspect certain books and records of the Company. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the merger involving the Company and NTN
            Buzztime, Inc. and the issuance of paper stock certificates, including investigating whether: (i) the Company&#8217;s stock certificates were issued in accordance with the merger agreement; (ii) certain restrictions on the sale of the Company&#8217;s
            common stock following the merger were proper and applied without favor; (iii) anyone received priority in post-merger issuances of the Company&#8217;s stock certificates that allowed them to benefit from an increase in the trading price of the
            Company&#8217;s common stock; and (iv) it should pursue remedial measures and/or report alleged misconduct to the SEC. The Company responded to the demand letter and produced certain information to Emerald in connection with the demand, which is
            subject to the terms of a confidentiality agreement entered into among the parties, including certain additional stockholders who subsequently joined as parties to such agreement.&#160; Following discussions, with no admission of wrongdoing, the
            Company and Emerald entered into a confidential settlement agreement, pursuant to which the Company paid $<ix:nonFraction name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" id="Fact_34b74c1d96664995ac3fde9a9aacc8a3" contextRef="c20220101to20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction> million in 2022 in full
            settlement of all of the Emerald&#8217;s purported claims, including a release by the Emerald in favor of the Company in respect of any and all such claims.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb28" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb29">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-25</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb29" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb30">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Licensing
            Agreements</div>
</ix:continuation>
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb30" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb31">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb31" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb32">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Factor Limited</span></div>
</ix:continuation>
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb32" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb33">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb33" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb34">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On










            November 14, 2023, the Company and Factor Limited entered into the A&amp;R Factor License Agreement, which terminated and superseded the exclusive license agreement between the parties dated February 20, 2023 and the amendment thereto.&#160; See
            Note 11 for additional information regarding the A&amp;R Factor License Agreement.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb34" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb35">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb35" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb36">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has other license, collaboration and royalty agreements with third parties related to IRX-2, including
            an agreement entered into with University of South Florida Research Association, Inc. (&#8220;USFRF&#8221;) in February 2024 to revoke certain license agreements with USFRF related to IRX-2.&#160; The Company does not intend to further develop IRX-2 and has
            provided USFRF with notice that the Company intends to abandon the IRX-2 patents. USFRF has <ix:nonNumeric name="erna:NoticePeriodToAssumeControlPatents" id="Fact_31ef9ab1451d44129f8f8070dc4a4f53" contextRef="c20230101to20231231" format="ixt-sec:durday">30</ix:nonNumeric> days to provide the Company with its
            notice to assume control of such patents.&#160; As a result of abandoning the IRX-2 patents, the Company will no longer have any obligations under the existing related agreements. existing related agreements.</span><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb36" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb37">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb37" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb38">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;">Retirement Savings
            Plan</div>
</ix:continuation>
          <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb38" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb39">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></div>

      </div>

      <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb39" continuedAt="Text_4b4d6df497dd4f0dbb6b6c723be86cdb40">
<div><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_4b4d6df497dd4f0dbb6b6c723be86cdb40">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company established a defined contribution plan, organized under Section 401(k) of the Internal Revenue Code, which allows
        employees to defer up to <ix:nonFraction name="erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" id="Fact_a47f18c4c61d46439822761f6e1798d3" contextRef="c20220101to20221231_RangeAxis_MaximumMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">90</ix:nonFraction>% of their pay on a pre-tax basis. Beginning on January 1, 2023, the Company began matching employees&#8217;
        contributions at a rate of <ix:nonFraction name="erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" id="Fact_3f88a5c5b24f4996a81e1c1fc73f83e2" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the first <ix:nonFraction name="erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" id="Fact_7d973127094f49999febe2cec2e3a98a" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">3</ix:nonFraction>% of the employee&#8217;s contribution and <ix:nonFraction name="erna:DefinedContributionPlanEmployeeContributionAtThresholdOne" id="Fact_02e84fb9e33f4350a9b05b8885557130" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">50</ix:nonFraction>% of the next <ix:nonFraction name="erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" id="Fact_c69074a311ae4bd39be0068cbc6e89f5" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">2</ix:nonFraction>% of the employee&#8217;s contribution, for a maximum Company match of <ix:nonFraction name="erna:DefinedContributionPlanEmployeeContributionAtThresholdTwo" id="Fact_a50c542a52494c1781d6f37b46f3e53c" contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">4</ix:nonFraction>%.
        <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">For the year ended December 31, 2023, the
          Company matched less than $<ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" id="Fact_8461d676db074e039f16c105ae78166e" contextRef="c20230101to20231231_RangeAxis_MaximumMember_RetirementPlanNameAxis_RetirementPlan401KMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million towards employees&#8217; 401k contributions.</span><br/>
      </div>
</ix:continuation>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_73a0f143ec0e4578abb3a368832ca6c7" contextRef="c20230101to20231231" escape="true" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6651">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">14)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">
                <div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">B</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">asic and Diluted Net Loss per
                    Common Share</span></div>
              </div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6651" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6652">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <div>
        <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6652" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6653"><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="Text_c19e7119e4a548ffb060bab5e55e09b5" contextRef="c20230101to20231231" escape="true" continuedAt="Text_c9f7a0e5ff274066bfa65c17dad287e71">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;">The following table sets forth the computation of the net loss per share attributable to common stockholders, basic and diluted (in thousands, except per share data):</div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6653" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6654"><ix:continuation id="Text_c9f7a0e5ff274066bfa65c17dad287e71" continuedAt="Text_c9f7a0e5ff274066bfa65c17dad287e72">
<div>&#160;</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6654" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6655"><ix:continuation id="Text_c9f7a0e5ff274066bfa65c17dad287e72">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="6">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years Ended December 31,</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2023</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Numerator:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net loss attributable to common stockholders</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_dfc14212ce504f3da121750cc5ed24d5" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,684</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_2f12390b1f35435995e0f33b2e35d17f" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,595</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Denominator</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted average shares outstanding - basic and diluted</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_c194e11a8169419b8b8226cba0ad9c02" contextRef="c20230101to20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_731642c4ef2b43f0a53fac237d1f489b" contextRef="c20230101to20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,314</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_254d945cece442aaaf2198024500cd51" contextRef="c20220101to20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_0ae16c1267874824b1ff99a86842bc21" contextRef="c20220101to20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,051</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net loss per common share - basic and diluted</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_a5fab069f225441782c9568fb7ca56e1" contextRef="c20230101to20231231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_2e95d737dc4c4b44a65e95e752b3f259" contextRef="c20230101to20231231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal">4.08</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_206ecc49cbb44bcf9c2314ef1b293b3d" contextRef="c20220101to20221231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_352ba7a4502946aa9f862347bd988267" contextRef="c20220101to20221231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:num-dot-decimal">8.06</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6655" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6656">
<div>&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6656" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6657">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Since the Company was in a net loss position for all periods presented, the net loss per share
          attributable to common stockholders was the same on a basic and diluted basis, as the inclusion of all potential common equivalent shares outstanding would have been anti-dilutive.</div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6657" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6658">
<div><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6658" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f6659"><ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="Text_30ee998ff1ad439abc28ac8cc254cf80" contextRef="c20230101to20231231" escape="true" continuedAt="Text_9869c06a7ccc4a3cb17e991171d2e6041">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="font-size: 10pt;">The <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 48px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">following table presents the amount of warrants, stock options, convertible preferred stock, convertible notes and restricted stock units (&#8220;RSUs&#8221;) that were excluded
            from the computation of diluted net loss per share of common stock for the years ended December 31, 2023 and 2022, as their effect was anti-dilutive (in thousands):</span></span> </div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f6659" continuedAt="Text_69826bbb4f6b4a5c92a502cbebe9f66510"><ix:continuation id="Text_9869c06a7ccc4a3cb17e991171d2e6041" continuedAt="Text_9869c06a7ccc4a3cb17e991171d2e6042">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_9869c06a7ccc4a3cb17e991171d2e6042"><ix:continuation id="Text_69826bbb4f6b4a5c92a502cbebe9f66510">
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" rowspan="1" colspan="6">
                <div style="text-align: center; font-size: 10pt;"><span style="font-weight: bold;">Years ended December 31,<br/>
                  </span></div>
              </td>

    <td valign="bottom" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;"><br/>
              </td>

    <td valign="bottom" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">2023</div>
              </td>

    <td valign="bottom" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-size: 10pt;"><span style="font-weight: bold;">2022</span></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">
                <div style="margin-left: 9pt; font-size: 10pt;">Warrants</div>
              </td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_a842c271d384479b90fce3abbb00960e" contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,922</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_dd6d67332dc440238eaf2d83249ad2cd" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,713</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; font-size: 10pt; white-space: nowrap;" rowspan="1">C<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: -9.6px; text-transform: none; word-spacing: 0px; white-space: nowrap; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">onvertible Notes converted into common stock</span></td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_dbbe05106ac54783a91b49515937185b" contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleCommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,877</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_8fb1eaf23b1845ee9e80f38142945d86" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleCommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Stock options</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_a2b2c79ff0d2492da4630d665ae086bb" contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">389</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_2e4aa8673b514f1980fce043dd24f72f" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">359</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock converted into common stock</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_5a92d9b048a84b67954e31194c8bc4d6" contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">18</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_24930f81cc6e428787029e1ce7a7b29b" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" rowspan="1">RSUs</td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_f36bfd7c62c84fa98d5d0f8d9c56db86" contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_4a01019597704f619e8947e5d815176e" contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total potential common shares excluded from computation</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_04068f2447dc49808ccc26dddcdfadde" contextRef="c20230101to20231231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">27,207</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_b6f4b333be2e4cf4afd2e78161e70f15" contextRef="c20220101to20221231" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,083</ix:nonFraction></td>

    <td valign="bottom" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>

      </div>
</ix:continuation></ix:continuation>

      <div><br/>
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Text_cbefb7b6443c4b948ef2e409c69e0a9e" contextRef="c20230101to20231231" escape="true" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b421">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">15)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Stock-Based Compensation</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b421" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b422">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b422" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b423">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Incentive Plans</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b423" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b424">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b424" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b425">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s stock-based compensation plans consist of the Restated 2020 Equity Incentive Plan (the &#8220;Restated 2020 Plan&#8221;) and
        the 2021 Inducement Equity Incentive Plan (the &#8220;2021 Inducement Plan&#8221;). The Company&#8217;s board of directors has designated its compensation committee as the administrator of the foregoing plans (the &#8220;Plan Administrator&#8221;). Among other things, the Plan
        Administrator selects persons to receive awards under the foregoing plans and determines the number of shares subject to each award and the terms, conditions, performance measures, if any, and other provisions of the award.</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b425" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b426">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b426" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b427">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The
        Restated 2020 Plan provides for (a) approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_7d83f35da7ee445c90df8bb18bb0cf15" contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">724,000</ix:nonFraction> shares of common stock that can be issued under the Restated 2020 Plan, which
        includes an increase to the Restated 2020 Plan of <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" id="Fact_cc8c4dac08864bc3953f429beaf590f4" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">300,000</ix:nonFraction> that was approved by the Company&#8217;s stockholders at the 2023 annual meeting of
        stockholders on June 16, 2023, and (b) an annual increase in the number of shares reserved for issuance on January 1 of each year from 2022 through 2031 equal to the lesser of (i) <ix:nonFraction name="erna:PercentageOfSharesOfCommonStockOutstanding" id="Fact_9ae364e380a04b90b08f3d6cb14c0885" contextRef="c20231231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the number of shares of common stock outstanding on the immediately preceding December 31 and (ii) such smaller number of shares of common stock as may be determine by
        the board of directors (the provision providing for the increase described in clause (b) is referred to as the &#8220;evergreen provision&#8221;). As of January 1, 2023, pursuant to the evergreen provision, the number of shares issuable under the Restated 2020
        Plan was increased by approximately <ix:nonFraction name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" id="Fact_945c03e77ec44847b0e1e2c8a6ed1a30" contextRef="c20230101to20230101_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">256,000</ix:nonFraction>. Based on the number of shares of common stock outstanding on December 31, 2023, as of
        January 1, 2024, pursuant to the evergreen provision, the number of shares issuable under the Restated 2020 Plan was increased by approximately <ix:nonFraction name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" id="Fact_8d7c418ff02647dc943f6be86b4217dc" contextRef="c20240101to20240101_PlanNameAxis_EquityIncentivePlan2020Member_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">271,000</ix:nonFraction>.<br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b427" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b428">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b428" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b429">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-26</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b429" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4210">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Awards under the Restated 2020 Plan may be granted to officers, directors, employees and consultants of the Company.&#160; Stock
        options granted under the Restated 2020 Plan may either be incentive stock options or nonqualified stock options, may have a term of up to <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_df18ca3ab4cb495fa9d112ff18401180" contextRef="c20230101to20231231_AwardTypeAxis_IncentiveStockOptionsMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember" format="ixt-sec:durwordsen"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_8def3c3186b1473ca92bdfcb2dd5840e" contextRef="c20230101to20231231_AwardTypeAxis_NonQualifiedStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">ten years</ix:nonNumeric></ix:nonNumeric>,
        and are exercisable at a price per share not less than the fair market value, as defined in the Restated 2020 Plan, on the date of grant. </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4210" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4211">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4211" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4212">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As of December 31, 2023, there was approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_8c843d53cade4ac5bc1c991cb04e9c0d" contextRef="c20231231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">684,000</ix:nonFraction> shares of common stock remaining to be issued under the Restated 2020 Plan. As of December 31, 2023, there were approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_2ba894d5656e43a1a12ba74f6a62303d" contextRef="c20231231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">296,000</ix:nonFraction> stock options outstanding under the Restated 2020 Plan and <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_7631f10fc3334f458cd89aae8ed0e5b6" contextRef="c20230101to20231231_PlanNameAxis_EquityIncentivePlan2020Member" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>
        RSUs granted under the Restated 2020 Plan were outstanding.</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4212" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4213">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4213" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4214">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The 2021 Inducement Plan provides for the grant of up to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_0c62928975d54481b81c702168d229fc" contextRef="c20231231_PlanNameAxis_InducementPlan2021Member_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">75,000</ix:nonFraction> share-based awards as material inducement awards to new employees in accordance with the employment inducement grant rules set forth in Section 711(a) of the NYSE
        American LLC Company Guide (the Company&#8217;s common stock was listed on the NYSE American at the time the 2021 Inducement Plan was adopted). The 2021 Inducement Plan expires in May 2031. As of December 31, 2023, there was approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_455b91be74d744509d41ea6c2186048f" contextRef="c20231231_PlanNameAxis_InducementPlan2021Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">68,000</ix:nonFraction> shares of common stock remaining to be issued under the 2021 Inducement Plan. As of December 31, 2022, there were approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_1efef25d9d434f228d5cc0a363d31760" contextRef="c20221231_PlanNameAxis_InducementPlan2021Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,000</ix:nonFraction> stock options outstanding and approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_1ef8cbe238c449b8bbbdb546c88781fe" contextRef="c20221231_PlanNameAxis_InducementPlan2021Member" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000</ix:nonFraction>
        RSUs outstanding that were granted under the 2021 Inducement Plan.</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4214" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4215">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4215" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4216">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Awards</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4216" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4217">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4217" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4218">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock Options</span></div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4218" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4219">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4219" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4220">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records stock-based compensation in accordance with ASC Topic 718, Compensation &#8211; Stock Compensation.&#160; The Company
        estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4220" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4221">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4221" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4222">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The risk-free rate is based on the observed interest rates appropriate for the expected life. The expected life (estimated
        period of time outstanding) of the stock options granted is estimated using the &#8220;<span style="font-style: normal;">simplified</span>&#8221; method as permitted by the SEC&#8217;s Staff Accounting Bulletin No. 110, <span style="font-style: italic;">Share-Based
          Payment</span>. Expected volatility is based on the volatility of the Company&#8217;s peer group over the expected life of the stock option granted, and the Company assumes no dividends. Forfeitures are recognized as incurred.</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4222" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4223">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>
</ix:continuation><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Text_31c66c958f1e437391ba9045c9da98d1" contextRef="c20230101to20231231" escape="true" continuedAt="Text_75ff5bc0a06e4e14873231f0566b0f6d1"><ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4223" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4224">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
      </div>
</ix:continuation></ix:nonNumeric>
      <ix:continuation id="Text_75ff5bc0a06e4e14873231f0566b0f6d1" continuedAt="Text_75ff5bc0a06e4e14873231f0566b0f6d2"><ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4224" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4225">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The
        following weighted-average assumptions were used for stock options granted during the years ended December 31, 2023 and 2022: </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_75ff5bc0a06e4e14873231f0566b0f6d2" continuedAt="Text_75ff5bc0a06e4e14873231f0566b0f6d3"><ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4225" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4226">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_75ff5bc0a06e4e14873231f0566b0f6d3"><ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4226" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4227">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;"><span style="font-weight: bold;">Year ended</span> <span style="font-weight: bold;">December 31,</span></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;">2022</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Weighted average risk-free rate</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_ce9ddbe8e3c248c397f94c11efbc0463" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.82</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_b2fb6325d44445108cda34126174dc31" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">2.52</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Weighted average volatility</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_2bdcd19f8bf24fba811876963d5275a3" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">95.15</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_be9e0981ea71474491db22d51ad2a0f9" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">90.49</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_3204cb1195ab40139baa10a49a4d6e42" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_a7b455bad8184a1882a1c5bd88c12b99" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_24d44e01804d421a9f67cb88fae82dce" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">5.44</ix:nonNumeric> years </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_fc3b56c46b394e8283a301284fdac33a" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">5.79</ix:nonNumeric> years <br/>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4227" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4228">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-27</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>


      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4228" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4229"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="Text_e14ca8bd850640aaa46f800cb8a5947e" contextRef="c20230101to20231231" escape="true" continuedAt="Text_c5b3cc96424641c7a0276806c038b3e21">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes stock option activity for the years ended December 31, 2023 and 2022 (in thousands except for
        per-share and remaining contractual life data):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4229" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4230"><ix:continuation id="Text_c5b3cc96424641c7a0276806c038b3e21" continuedAt="Text_c5b3cc96424641c7a0276806c038b3e22">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4230" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4231"><ix:continuation id="Text_c5b3cc96424641c7a0276806c038b3e22">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold;">Outstanding</span></div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">
                <div>Weighted </div>
                <div>Average </div>
                <div>Exercise</div>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Price per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Remaining </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Contractual </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Life (in</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">years)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Aggregate</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Intrinsic</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding January 1, 2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_3cbc12106cb94e28bc2ba2a793281114" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">199</ix:nonFraction><br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_962df8613a8a4224a64cf732eef07a93" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">168</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_828838980f994d7e8f4589c8a790d1ff" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">9.38</ix:nonNumeric></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_90960bdd20024e859d6222188ffefa24" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_fefb53629e744f40ae19e0c3afd43f96" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">287</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" id="Fact_b448de3af2b640639fe86b9f550b2088" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">17</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" id="Fact_b88954f186434ac684111eaf50b43b65" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">127</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="Fact_6b40bd19963544cf86ce34f216a36b72" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">141</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding December 31, 2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_40ebdaf762214f4ca989f54a2aa38325" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">359</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_5eb52d1fa659456ca8cb9b98b6ed9bea" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">57</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_90a4441a7bcc433083da2998d6c3fb0c" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">7.57</ix:nonNumeric></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_56cba969722a4d648e60b13cc746a625" contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_34767dfd8e8645f1aaf9bcb8234a7c73" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">237</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" id="Fact_56246699ac154659a9c4ea217cef8b56" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">4</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" id="Fact_3f1cdcfd975441c4bc149ded5e28c6d0" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">207</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="Fact_aa9839c697c74e9fbffec78e5943d342" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">19</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">Outstanding December 31, 2023</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_f040de0e51124cd290ad1c6ede1aa9fe" contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">389</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_acb6b56f2d02407cbc62072dc106db10" contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">45</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_8868ed0c351444d5b030e838a20704ef" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">7.04</ix:nonNumeric></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_03c01dfc39f241d587ca2414b94fcae5" contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">Options vested and exercisable at December 31, 2023</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" id="Fact_328f9b7fd4cc4cb5ac44b764f028b8ed" contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">331</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" id="Fact_6e52760ae0784e909bd4a426354aa19c" contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">50</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="Fact_3bf1c12a12bc4e03887772134fb89737" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">6.69</ix:nonNumeric><br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" id="Fact_e23b4512f61a44f49214b641529ae483" contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4231" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4232">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4232" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4233">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;">The per-share weighted average grant-date fair value of stock options granted during the year ended December 31, 2022 and 2021
        was $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_3b837d5064564d21925f9c444c60e256" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">2.99</ix:nonFraction> and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_ede81eef33184fab94976f9821ff2ac3" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">12.91</ix:nonFraction>,
        respectively.</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4233" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4234">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4234" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4235">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As of December 31, 2023, the unamortized stock-based compensation expense related to outstanding unvested options was approximately $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" id="Fact_3e284a97f99d4124aa520e17e24e123f" contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="1" scale="0" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million with a weighted average remaining requisite service period of <ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_f2f83f6720ec44159836cb24c9b53916" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">1.91</ix:nonNumeric> years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.</span><br/>
      </div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4235" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4236">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4236" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4237">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Vesting of all stock options is subject to continuous service with the Company through their applicable vesting dates.<br/>
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4237" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4238">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4238" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4239">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">During
























          the year ended December 31, 2022, the Company accelerated the vesting of approximately <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" id="Fact_57316ac01ade4891971ab9c1a506bd27" contextRef="c20220101to20221231_AwardTypeAxis_TimeBasedStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">40,000</ix:nonFraction> stock options under certain time-based
          vesting stock option grants previously awarded to Dr. Howard Federoff, the Company&#8217;s former chief executive officer, pursuant to a separation agreement entered into with Dr. Federoff. The Company also waived a performance condition under a
          performance-based stock option grant and accelerated the vesting of approximately <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" id="Fact_1a41c1f5ab154c9e832d4026cb454e6f" contextRef="c20220101to20221231_AwardTypeAxis_PerformanceBasedStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">21,000</ix:nonFraction> stock options under such grant.&#160; Lastly, the
          Company extended the post-termination exercise period from <ix:nonNumeric name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="Fact_108c2bb68fdd4382aa91b017c771d4f2" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember" format="ixt-sec:durwordsen">90 days</ix:nonNumeric> to <ix:nonNumeric name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="Fact_e5cf5142c64b419a8b453d19c0c39b62" contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">36 months</ix:nonNumeric> immediately following his separation date for any options that were vested, including the options that accelerating in vesting, as described above.</div>
</ix:continuation>
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4239" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4240">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4240" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4241">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The above modifications to Dr. Federoff&#8217;s stock options grants resulted in modification accounting under ASC 718, <span style="font-style: italic;">Compensation









              &#8211; Stock Compensation</span>. As a result, the Company immediately recognized approximately $<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" id="Fact_7c3d475c64fc45f2942c2abf4d1aa4f5" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million during 2022 for the
            incremental fair value of stock options that were vested prior to the modification by calculating the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For
            stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and
            immediately recognized approximately $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_746c62d8948d4706af56753b2bbfe864" contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction> million during 2022 of stock compensation expense in full since there was no future service
            period required to be provided.</span></div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4241" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4242">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>
</ix:continuation>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageFooter" style="width: 100%;"></div>

        <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-28</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4242" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4243">
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Restricted Stock Units</span></span></div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4243" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4244">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>
</ix:continuation>
      <ix:nonNumeric name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="Text_9cd4792e81544e4da3dcf0dcca53502c" contextRef="c20230101to20231231" escape="true" continuedAt="Text_e971b52abbbc425e918ecc04485d263f1"><ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4244" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4245">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes RSU activity for the years ended December 31, 2023 and 2022 (in thousands except for per-share data):</div>
</ix:continuation></ix:nonNumeric>
      <ix:continuation id="Text_e971b52abbbc425e918ecc04485d263f1" continuedAt="Text_e971b52abbbc425e918ecc04485d263f2"><ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4245" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4246">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_e971b52abbbc425e918ecc04485d263f2"><ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4246" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4247">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Outstanding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Restricted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock Units</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">January 1, 2022</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_98e5775dea1c4a7bb8c3b7d27443412c" contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">12</ix:nonFraction><br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="Fact_6f011afd38d04dad89f3ec575c2227a0" contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">276</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_81b7c169f7064831a56290f983cfd497" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">55</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_7011278047e0404589891d0c3dfd9cb9" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">39</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" rowspan="1">
              <div style="margin-left: 9pt;">Released<br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_eb0686ff8da7422f8fd8308cedf533b7" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" id="Fact_354a8a7d151d410facfee63016638e80" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">271</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;" rowspan="1">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_444d603369294d02b3757d37a184e499" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">60</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_16fb500c981545d48a79bffe7fbbbe7e" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">61</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">December 31, 2022</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_09e188944dc546b586bbbe68f5e804b3" contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="Fact_865f430005a64f4c9628e8d0c85476ca" contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">236</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" rowspan="1">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_88ec631ac5f14594971cabf9b7011fed" contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_ef633bda0a9e475584ccebacc28eca49" contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">199</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1">December 31, 2023</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_0199d779336741d1a620a7fdaa833556" contextRef="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="Fact_be78a5210c5d44b2aff7f2cd8a3036af" contextRef="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">322</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; width: 76%;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">Balance expected to vest at December 31, 2023</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" id="Fact_614ce50a90a8471d84ee654a75930f52" contextRef="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$<br/>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" id="Fact_7784cbdb235948e994f0047ec97cdec3" contextRef="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="0" scale="0" format="ixt:num-dot-decimal">322</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4247" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4248">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;">
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4248" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4249">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The










          Company recognizes the fair value of RSUs granted as expense on a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal
          is determined to be probable.</div>
</ix:continuation>
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4249" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4250">
<div><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4250" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4251">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Outstanding




















































          RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the
          respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date,
          which is the grant date.</div>
</ix:continuation>
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4251" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4252">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>
</ix:continuation>
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4252" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4253">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4253" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4254">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In lieu of paying cash to satisfy withholding taxes due upon the settlement of vested RSUs, at the Company&#8217;s discretion, an employee may elect to have shares of
            common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable. During the year ended December 31, 2023, less than <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_5e6423109bc4410285fa527df1c9db2e" contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000</ix:nonFraction> RSUs vested. During the year ended December 31, 2022, approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_97f3ac93487c4f6392ce5e3e9c8ef249" contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">3,000</ix:nonFraction>
            RSUs vested. The Company withheld approximately <ix:nonFraction name="erna:RestrictedStockUnitesWithheldToCoverTaxes" id="Fact_f7ea08c117844979ab8d092a8328efc1" contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000</ix:nonFraction> RSUs to cover withholding taxes, and the net <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_447d3deb0c164d188a05542ed71fd373" contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">2,000</ix:nonFraction> shares were issued upon settlement.</span></div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4254" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4255">
<div><br/></div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4255" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4256">
<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Stock-Based Compensation Expense</div>
</ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4256" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4257">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4257" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4258"><ix:nonNumeric name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="Text_ba87933c6b6740c9be4aa9fc77f92191" contextRef="c20230101to20231231" escape="true" continuedAt="Text_7c2d5b138f474950a4cd154eadda96df1">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For the years ended December 31, 2023 and 2022, the Company recognized stock-based compensation expense as follows (in
        thousands): <br/>
      </div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4258" continuedAt="Text_c3a65f7b433e4f3c8fb5b866c90f5b4259"><ix:continuation id="Text_7c2d5b138f474950a4cd154eadda96df1" continuedAt="Text_7c2d5b138f474950a4cd154eadda96df2">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"> <br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_c3a65f7b433e4f3c8fb5b866c90f5b4259"><ix:continuation id="Text_7c2d5b138f474950a4cd154eadda96df2">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: top; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="2" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2023
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="2" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2022
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">$<br/>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_1936e5f74679499086b3481385df7f9f" contextRef="c20230101to20231231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">234</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">$<br/>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_6a242c7555fe4f26b87217d9947ca04c" contextRef="c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,249</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">General and administrative</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_e16285bb2793473f9007eb89ca0304da" contextRef="c20230101to20231231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,008</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_f9bdcf3147404e7ba06d80e8a0e1758b" contextRef="c20220101to20221231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,686</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">$<br/>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_661918ef489e43d28f272e0518fe64dd" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,242</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">$<br/>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_ffd1f6fb06ab4f84ba201cdbd1366677" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>


</table>
         </div>
</ix:continuation></ix:continuation>
      <div><br/>
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_521b4bd2711b4967be514bf5dae19c4c" contextRef="c20230101to20231231" escape="true" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">16)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Equity and Warrants</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <div>
        <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc1" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>
</ix:continuation>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc2" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc3">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-style: italic;">Private Placements<br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc3" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc4">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc4" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc5">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Q4-22 PIPE Transaction<br/>
            </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc5" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc6">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc6" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc7">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On November 23, 2022, the Company entered into a purchase agreement with certain
            investors pursuant to which the Company issued an aggregate of approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_fa66095ecb5a400ca29c2c26e4fdae96" contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U002" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.2</ix:nonFraction> million units, with each unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_126c347542e94e898c0fc42ef886698f" contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock and (ii) <ix:nonFraction name="erna:NumberOfWarrantsInEachUnit" id="Fact_14f6241e078d4298a8de9c28eef33e89" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction>
            warrants, each exercisable to purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_9d92686591fa41ec81da3f5522494a35" contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_bf98abc8301b4051a94efea57416e54b" contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.28</ix:nonFraction> per, at a purchase price of $<ix:nonFraction name="erna:UnitPriceOfWarrants" id="Fact_ff2492c65e8e4153adb26a331e961c46" contextRef="c20221123to20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.53</ix:nonFraction> per unit (inclusive of
            $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_5381a8d0e8b14d179861e9fff14779b4" contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U003" decimals="3" scale="0" format="ixt:num-dot-decimal">0.125</ix:nonFraction> per warrant). The transaction closed on December 2, 2022. The Company received aggregate gross proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" id="Fact_66966494c8874625807d493a3e6ddabd" contextRef="c20221202to20221202_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.7</ix:nonFraction> million. The Company incurred fees of approximately $<ix:nonFraction name="erna:TransactionFeesPayable" id="Fact_905b60f805694655ad786a00c87f1cfe" contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million through December 31, 2022 related to the transaction.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc7" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc8">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc8" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc9">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each warrant had an exercise price
              of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_0448dbf7d12547fbbdae342b9030b5ce" contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.28</ix:nonFraction> per share (subject to customary adjustments), became exercisable <ix:nonNumeric name="erna:ClassOfWarrantOrRightsExercisableTerm" id="Fact_b2590009db384b78b3fb52bfd31fb7ed" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" format="ixt-sec:durwordsen">six months</ix:nonNumeric> from the date of issuance, and expires <span style="-sec-ix-hidden:Fact_e3ad1a6b59fa4c388062e2bab91b442b">five-and-one-half</span>
              years from the date of issuance. The warrants meet the criteria for equity classification.</div>
</ix:continuation>
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc9" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc10">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc10" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc11">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc11" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc12">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc12" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc13">
<div style="display:none;"><br/></div>
<div style="text-indent: 27pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">As discussed in Note 6, in connection with the December 2023
              convertible note financing, the exercise price of the warrants was reduced from $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_8435e3dd01c64b4c88359f2768d372d2" contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">3.28</ix:nonFraction> per share to $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_18c4c21ce4bd4c1397eb57e795baffdf" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.43</ix:nonFraction> per share.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc13" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc14">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>
</ix:continuation>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageFooter" style="width: 100%;"></div>

            <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-29</span></div>

            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

            <div class="BRPFPageHeader" style="width: 100%;">
              <div>
                <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                  </a></div>

              </div>

            </div>

          </div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc14" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc15">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Q1-22 Private Placement</span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc15" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc16">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc16" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc17">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On March 6, 2022, the Company entered into a purchase agreement with an investor
            pursuant to which the Company issued approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_3b65f6f302ba40799409b02b49c1629f" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">343,000</ix:nonFraction> units, each unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_82727e5d05104ca9b5c7b9d880841d97" contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of the Company&#8217;s common stock (or, in lieu thereof, one pre-funded warrant to purchase one share of common stock) and (ii) one warrant to
            purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_5787be7e89f54a9f9e6c4fd91f296750" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock, for an aggregate gross purchase price of approximately $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_0ca2e1b94a894de1b94dab018243e7e3" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.0</ix:nonFraction> million. The transaction closed on March 9, 2022. The Company issued <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_8d0193b5439846ff81499eb26fbcb7f9" contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">275,000</ix:nonFraction>
            shares of common stock, approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_f61ef0a85d3042c8ab6e915a62267308" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">68,000</ix:nonFraction> pre-funded warrants and warrants to purchase approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_417ea3e3b2e14beeb43aa14f1b6a0732" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">343,000</ix:nonFraction> shares of common stock. The Company incurred fees of approximately $<ix:nonFraction name="erna:TransactionFeesPayable" id="Fact_41c6c2161bc74fbeb03bdeae3556947c" contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction> million through December 31, 2022 related to this transaction, which were allocated to the fair value of the pre-funded warrants and warrants and Each pre-funded
            warrant had an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_a2784f4355844d679f45127efb34ecad" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">0.10</ix:nonFraction> per share (subject to customary adjustments), was immediately exercisable, could be exercised
            at any time, and had no expiration date.<span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc17" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc18">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
              </span> </div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc18" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc19">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc19" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc20">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each warrant has an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_ac723e8d8cff4bf88ae7e656454f3e09" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">38.20</ix:nonFraction> per share (subject to customary adjustments), became exercisable <ix:nonNumeric name="erna:ClassOfWarrantOrRightsExercisableTerm" id="Fact_f69702c355424efebac6a24d21a62899" contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" format="ixt-sec:durwordsen">six months</ix:nonNumeric> following the date of issuance, and expires <span style="-sec-ix-hidden:Fact_5269f7037c524c0e8f946b93d07e4c92">five-and-one-half</span>
              years from the date of issuance.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc20" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc21">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc21" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc22">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc22" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc23">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc23" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc24">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The pre-funded warrants and warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet
            the requirements of the indexation guidance under ASC 815-40. These warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations. (See Note 9 for
            more information related to changes in fair value.) Upon exercise, the fair value of the pre-funded warrants and/or warrants on the exercise date is reclassified from warrant liabilities to equity.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc24" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc25">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc25" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc26">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc26" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc27">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The fair values of the pre-funded warrants and warrants
              at the issuance date totaled $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_8c22e9cabe204f1c8abc38c4c450ee41" contextRef="c20220306to20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.6</ix:nonFraction> million in the aggregate, or $<ix:nonFraction name="erna:OverSubscriptionAmountReceived" id="Fact_010e54a034c1485680425c99cd8300d6" contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million more than the aggregate gross purchase price of the units sold in the offering. The $<ix:nonFraction name="erna:OverSubscriptionAmountReceived" id="Fact_2daa1f5cecdc423290b5ac855a40c32a" contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction> million represents an inducement to the investor to enter into the purchase agreement and was recorded in warrant liabilities expense in the accompanying consolidated statement of
              operations.<br/>
            </div>
</ix:continuation>
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc27" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc28">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc28" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc29">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On July 12, 2022, all the pre-funded warrants were exercised. The Company issued approximately <ix:nonFraction name="erna:ClassOfWarrantOrRightExercised" id="Fact_2ab34474db78444b980cf145cc313d53" contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U002" decimals="INF" scale="0" format="ixt:num-dot-decimal">68,000</ix:nonFraction> shares of common stock upon exercise and received approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" id="Fact_30d903d2d31e4421adb9bc6ddaa5be0b" contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:num-dot-decimal">7,000</ix:nonFraction>
            of proceeds. The fair value of the pre-funded warrants as of the exercise date (approximately $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_ca89bd31578c4ca1a2079656ce57673e" contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction> million) was reclassified from
            warrant liabilities to equity.<br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc29" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc30">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc30" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc31">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In connection with the transaction, the Company and the investor also entered into a registration rights agreement pursuant to which the Company agreed to prepare and file a registration statement
              with the SEC to register the resale of the shares of common stock issued in the offering and issuable upon exercise of the pre-funded warrants and warrants. The resale registration statement became effective on May 11, 2022.</span><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc31" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc32">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc32" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc33">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc33" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc34">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc34" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc35">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0);">Pursuant to the registration rights agreement, the Company is obligated to pay the investor
            liquidated damages equal to <ix:nonFraction name="erna:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" id="Fact_6f4b2b2f358542a3a881536bb1f30ab8" contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">2</ix:nonFraction>% of the purchase price for the units per month, with a maximum aggregate payment of <ix:nonFraction name="erna:ObligationToPayLiquidatedDamagesPercentage" id="Fact_abfb7fe60665465fbc1e5b0cd1258947" contextRef="c20231231_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">12</ix:nonFraction> of the purchase price for the units, in the event the investor is not permitted to use the registration statement to resell the securities
            registered for resale thereunder for more than a specified period of time.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc35" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc36">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc36" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc37">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc37" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc38">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc38" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc39">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On May 24, 2022, the Company notified the investor that the investor was not able to use the registration agreement because the Company had not timely
            filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 with the SEC, and that the investor could not use the registration statement until the Company filed that quarterly report, which was filed on June 30, 2022. The
            Company accrued $<ix:nonFraction name="us-gaap:LossContingencyEstimateOfPossibleLoss" id="Fact_2b77d1232ee8480ab2c7da397e45b89b" contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million during 2022 for the contingent loss the Company incurred as liquidated damages as a result of the late
            filing, which is recorded in other expense, net for the year ended December 31, 2022 in the accompanying consolidated statements of operations. The Company paid the $<ix:nonFraction name="us-gaap:LossContingencyDamagesPaidValue" id="Fact_6e1277af9e82444f92e681f41e5af475" contextRef="c20220601to20220630_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million liquidated damages to the investor in June 2022.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc39" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc40">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"> <br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc40" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc41">
<div><span style="text-decoration: underline;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Note&#160;Warrants</span></span></div>
</ix:continuation></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc41" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc42">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration: underline;"></span></div>
</ix:continuation>
          <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc42" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc43">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>
</ix:continuation>
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc43" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc44">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">As discussed in Note 6, in connection with the July
              2023 and December 2023 convertible note financings, the Company issued note warrants to purchase an aggregate of approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_6f4e3715a23249e5a23ef1cba7b8f0e9" contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-5" scale="6" format="ixt:num-dot-decimal">14.2</ix:nonFraction>
              million shares of common stock.&#160; The exercise price of all such warrants is currently $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_c6ff0c7790b44c229a50580ffc605d0a" contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.43</ix:nonFraction> per share (subject to customary
              adjustments), are expire <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_fe25762c4dd446a68c9f5d5e7c1f3d96" contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> following the date of issuance. All such warrants qualified for equity classification.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc44" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc45">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc45" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc46">
<div><br/>
            </div>
</ix:continuation>
          </div>


          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc46" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc47"><ix:nonNumeric name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="Text_be9dff19f7964586a75f66027ef892fa" contextRef="c20230101to20231231" escape="true" continuedAt="Text_43681ac225684619995163649342447e1">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following table shows the Company&#8217;s warrant activity for the year ended
            December 31, 2023 (in thousands except for per-share data):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc47" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc48"><ix:continuation id="Text_43681ac225684619995163649342447e1" continuedAt="Text_43681ac225684619995163649342447e2">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc48" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc49"><ix:continuation id="Text_43681ac225684619995163649342447e2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Q1-22 Common<br/>
                  </div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Q4-22</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; font-weight: bold;">July 2023 <br/>
                  </div>
                  <div style="text-align: center;"><span style="font-weight: bold;">Warrants</span><br/>
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 2023</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Balance as of January 1, 2023</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_609b338425c8436f8be82beb87a63efc" contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">343</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_1d65751859ab4cb2a5a9b00a563f2bf6" contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,370</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_cc5f29f84ab240c8ab0db56e42338f56" contextRef="c20221231_ClassOfWarrantOrRightAxis_July2023WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_f8e02b68907b41c49a34316e213bc2e2" contextRef="c20221231_ClassOfWarrantOrRightAxis_December2023WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_f765b50d872a41329c40686d0e221772" contextRef="c20221231" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,713</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Granted</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_bd6433b138dc4396999f2294cdda5aa9" contextRef="c20230101to20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_ad37bf8b801b4304b1792c4b8029573e" contextRef="c20230101to20231231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember" unitRef="U002" decimals="0" scale="0" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_efb57c3b326141dcbe7edbc87e5ddc13" contextRef="c20230101to20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">6,094</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_7a7d626fe7c74e4c800a43441d84976a" contextRef="c20230101to20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">8,115</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:ClassOfWarrantOrRightGrantsInPeriod" id="Fact_da3eff9b3a7d42e1b01a74ace2589c25" contextRef="c20230101to20231231" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">14,209</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Balance as of December 31, 2023</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_72b198bd70c6476ab45f102066d8f964" contextRef="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">343</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_dc3249231c6a454b836c1da05b57680e" contextRef="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">4,370</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_c40e70b3bc3d492a9d8b190e8392382e" contextRef="c20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">6,094</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_46fd82393b124ef08f5776a77c0a5aba" contextRef="c20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">8,115</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_e218a4cd74a14d5880c38784e35b7382" contextRef="c20231231" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">18,922</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <div>
              <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc49" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc50">
<div><br/>
              </div>
</ix:continuation>
            </div>

            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageFooter" style="width: 100%;"></div>

              <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-30</span></div>

              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

              <div class="BRPFPageHeader" style="width: 100%;">
                <div>
                  <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                    </a></div>

                </div>

              </div>

            </div>

          </div>

          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc50" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc51">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As of December 31, 2023, the weighted average remaining
              contractual life of the warrants outstanding was <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_1542104966174bb0890ed4a0dce3e515" contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember" format="ixt-sec:duryear">4.68</ix:nonNumeric> years and the weighted average exercise price was $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_3aedf5dd7cf34cb1ab376ea63c28674a" contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">2.10</ix:nonFraction> per share.</div>
</ix:continuation>
          </div>

          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc51" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc52">
<div><br/>
            </div>
</ix:continuation>
          </div>

        </div>

        <div>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc52" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc53">
<div style="margin: 0px 0.3pt 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; font-weight: normal; text-align: left; text-transform: none;">SEPA</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc53" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc54">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc54" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc55">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">On April 5, 2023, the
            Company entered into the SEPA with Lincoln Park, pursuant to which Lincoln Park committed to purchase up to $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_8f47478ff34a4f15bcc4abf817687e8e" contextRef="c20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction> million of the
            Company&#8217;s common stock. Such sales of common stock by the Company, if any, are subject to certain conditions and limitations set forth in the SEPA, including a condition that the Company may not direct Lincoln Park to purchase any shares of
            common stock under the SEPA if such purchase would result in Lincoln Park beneficially owning more than <ix:nonFraction name="erna:BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" id="Fact_463bc1d97d9a4589bf0c4af0ce827892" contextRef="c20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.99</ix:nonFraction>% of the Company&#8217;s
            issued and outstanding shares of common stock. Sales under the SEPA may occur from time to time, at the Company&#8217;s sole discretion, through April 2025.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc55" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc56">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc56" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc57">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">In consideration of
            Lincoln Park&#8217;s entry into the SEPA, the Company issued to Lincoln Park approximately <ix:nonFraction name="erna:EquityLineOfCreditConsiderationSharesOfCommonStock" id="Fact_07d8a77426384021bb406be6efc7168e" contextRef="c20230405to20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">74,000</ix:nonFraction> shares of common stock (the &#8220;Commitment
            Shares&#8221;).&#160; The value of the Commitment Shares was recorded as a period expense and included in other expense, net, in the accompanying consolidated statements of operations for year ended December 31, 2023.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc57" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc58">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc58" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc59">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The Company evaluated the contract that includes the right to require Lincoln Park to purchase shares of common stock in the future (&#8220;put right&#8221;) considering the
              guidance in ASC 815-40, Derivatives and Hedging &#8212; Contracts on an Entity&#8217;s Own Equity and concluded that it is an equity-linked contract that does not qualify for equity classification, and therefore requires fair value accounting. The
              Company analyzed the terms of the freestanding put right and concluded that it has an immaterial value as of December 31, 2023.</span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc59" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc60">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc60" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc61">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">During the year ended
            December 31, 2023, the Company issued and sold approximately <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" id="Fact_69a6589b62a2459db92356a05605c562" contextRef="c20230101to20231231_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">214,000</ix:nonFraction> shares of common stock under the SEPA, including the <ix:nonFraction name="erna:EquityLineOfCreditConsiderationSharesOfCommonStock" id="Fact_f9010a50fb4942c9bd8bc37e3707fbae" contextRef="c20230405to20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">74,000</ix:nonFraction> Commitment Shares, for gross proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" id="Fact_663845121096440cb2c04f0c730ddf0f" contextRef="c20230101to20231231_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction> million.&#160; As of December 31, 2023, there were approximately <ix:nonFraction name="erna:SaleOfStockNumberOfSharesToIssuedInTransaction" id="Fact_d4471dfc65184b2cb430fa29b5ca0d5e" contextRef="c20230101to20231231_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">2,860,000</ix:nonFraction> shares remaining to be
            sold under the SEPA.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc61" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc62">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc62" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc63">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">In connection with entry
            into the SEPA, the Company terminated its prior purchase agreements with Lincoln Park entered into during 2021.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc63" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc64">
<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc64" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc65">
<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Cumulative Convertible Preferred Stock </span></div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc65" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc66">
<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc66" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc67">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has authorized <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_ee8447cf0b154f5489310744b40a4d2c" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_7daad3fed53f4f69b9d6dcdfe4ee4428" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_65f32448c779417da1d836668e8521ce" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">156,000</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares of preferred stock, all of which is designated as Series A Cumulative Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;), and all of which were issued and
            outstanding as of December 31, 2023.</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc67" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc68">
<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc68" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc69">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Series A Preferred Stock provides for a cumulative annual dividend of $<ix:nonFraction name="us-gaap:DividendsPayableAmountPerShare" id="Fact_b09ef00a078d45f9ac53b3c7671ad5e7" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">0.10</ix:nonFraction> per share, payable in semi-annual installments in June and December. Dividends may be paid in cash or with shares of common stock.<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company paid approximately $<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_ab3efc8efc49478e9ac0be6f1f93d5a3" contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_9fdf266425634ec6964bdd07b4a3c07b" contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16</ix:nonFraction></ix:nonFraction>,000 in cash for payment of dividends during the years ended December 31, 2023 and 2022</span>.</span><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc69" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc70">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
            </span></div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc70" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc71">
<div style="display:none;"><br/></div>
<div style="background-color: #FFFFFF; margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">The Series A Preferred Stock has no voting rights and has a $<ix:nonFraction name="us-gaap:PreferredStockLiquidationPreference" id="Fact_0dc09987d6da44fab7e97686c47aef46" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.00</ix:nonFraction> per share liquidation preference over the Company&#8217;s common
              stock. The holder of shares of Series A Preferred Stock has the right at any time to convert such shares into that number of shares of common stock that equals the number of shares of Series A Preferred Stock that are surrendered for
              conversion divided by the conversion rate.&#160; At December 31, 2023, the conversion rate was <ix:nonFraction name="us-gaap:PreferredStockConvertibleConversionRatio" id="Fact_d7d01e9a6315408285f0c58e473c961e" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U008" decimals="4" scale="0" format="ixt:num-dot-decimal">8.8016</ix:nonFraction> and, based on that conversion
              rate, one share of Series A Preferred Stock would have converted into approximately <ix:nonFraction name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" id="Fact_6f29d2c3b3b341309dceda5d20d03ce7" contextRef="c20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="2" scale="0" format="ixt:num-dot-decimal">0.11</ix:nonFraction> shares of common stock, and all the
              outstanding shares of the Series A Preferred Stock would have converted into approximately <ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" id="Fact_b50b89457cd6415e92f9209ef4b433d8" contextRef="c20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">18,000</ix:nonFraction> shares of common stock in the
              aggregate. There were <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" id="Fact_d59c84d4f1614edf81e3fbedc2ac21a0" contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" id="Fact_af48cf12d1c44390b2b9641e2fdad6b4" contextRef="c20220101to20221231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> conversions during the years ended December 31, 2023 and 2022. There is no mandatory conversion term,
              date or any redemption features associated with the Series A Preferred Stock. The conversion rate will adjust under the following circumstances:</div>
</ix:continuation>
            <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc71" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc72">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>
</ix:continuation></div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc72" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc73">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc73" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc74">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">1.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0);">If the Company (a) pays a dividend or makes a distribution in shares of its common stock, (b) subdivides its outstanding shares of common stock into a greater number of shares, (c) combines its
                    outstanding shares of common stock into a smaller number of shares, or (d) issues by reclassification of its shares of common stock any shares of its common stock (other than a change in par value, or from par value to no par value, or
                    from no par value to par value), then the conversion rate in effect immediately prior to the applicable event will be adjusted so that the holders of the Series A Preferred Stock will be entitled to receive the number of shares of
                    common stock which they would have owned or have been entitled to receive immediately following the happening of the event, had the Series A Preferred Stock been converted immediately prior to the record or effective date of the
                    applicable event.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc74" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc75">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>
</ix:continuation>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageFooter" style="width: 100%;"></div>

            <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-31</span></div>

            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

            <div class="BRPFPageHeader" style="width: 100%;">
              <div>
                <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                  </a></div>

              </div>

            </div>

          </div>

          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc75" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc76">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">2.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0);">If the outstanding shares of the Company&#8217;s common stock are reclassified (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a
                    subdivision, combination or stock dividend), or if the Company consolidates with or merge into another corporation and the Company is not the surviving entity, or if the Company sells all or substantially all of its property, assets,
                    business and goodwill, then the holders of the Series A Preferred Stock will thereafter be entitled upon conversion to the kind and amount of shares of stock or other equity securities, or other property or assets which would have been
                    receivable by such holders upon such reclassification, consolidation, merger or sale, if the Series A Preferred Stock had been converted immediately prior thereto.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc76" continuedAt="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc77">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>
</ix:continuation>
          <ix:continuation id="Text_fa2e74eb8fa8494eb15fe1cc2661f3cc77">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0);">If the Company issues common stock without consideration or for a consideration per share less than the then applicable Equivalent Preference Amount (as defined below), then the Equivalent Preference
                    Amount will immediately be reduced to the amount determined by dividing (A) an amount equal to the sum of (1) the number of shares of common stock outstanding immediately prior to such issuance multiplied by the Equivalent Preference
                    Amount in effect immediately prior to such issuance and (2) the consideration, if any, received by the Company upon such issuance, by (B) the total number of shares of common stock outstanding immediately after such issuance. The
                    &#8220;Equivalent Preference Amount&#8221; is the value that results when the liquidation preference of one share of Series A Preferred Stock (which is $<ix:nonFraction name="us-gaap:PreferredStockLiquidationPreference" id="Fact_38cc6990ce9947d89efb791a637259a8" contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.00</ix:nonFraction>)
                    is multiplied by the conversion rate in effect at that time; thus the conversion rate applicable after the adjustment in the Equivalent Preference Amount as described herein will be the figure that results when the adjusted Equivalent
                    Preference Amount is divided by the liquidation preference of one share of Series A Preferred Stock.</div>
                </td>

  </tr>


</table>
</ix:continuation>

          <div>
            <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="Text_5e8fbae6b1184b969719cbe3a9c28eb5" contextRef="c20230101to20231231" escape="true" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56061">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">17)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Income Taxes</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56061" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56062">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56062" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56063"><ix:nonNumeric name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="Text_a3f4ee5e0f204eb396b5a3cc7b336925" contextRef="c20230101to20231231" escape="true" continuedAt="Text_1082f8406c8d41a4852e06b5e2ea7c421">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Loss before income taxes consist of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56063" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56064"><ix:continuation id="Text_1082f8406c8d41a4852e06b5e2ea7c421" continuedAt="Text_1082f8406c8d41a4852e06b5e2ea7c422">
<div><br/>
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56064" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56065"><ix:continuation id="Text_1082f8406c8d41a4852e06b5e2ea7c422">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="6">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1"><span style="font-weight: bold;">&#160;<span style="font-style: italic;">(in thousands)</span></span><br/>
              </td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2"><br/>
              </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" rowspan="1" colspan="2"><br/>
              </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Domestic</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" id="Fact_53e8570e004442f48fccf62adcc8537a" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,654</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" id="Fact_f002bcfcce3a4d9ca59b3c9ac9616e20" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,513</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" id="Fact_fa4a3c646ea44b93901dcf6348c85396" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">17</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" id="Fact_4ab33e32816543449c58ffd81a37f87b" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total loss before income taxes</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_4c5445cfc7d740beb0076926e5debc44" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">21,671</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_6f439a6b502649b790f816ad04813f2c" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24,534</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        </div>

      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56065" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56066">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>
</ix:continuation>

      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56066" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56067"><ix:nonNumeric name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Text_d7cc4244179e400cafb6c5f814b5ad21" contextRef="c20230101to20231231" escape="true" continuedAt="Text_f219274043a54863a1ca5d01766128181">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For each of the years ended December 31, 2023 and 2022, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56067" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56068"><ix:continuation id="Text_f219274043a54863a1ca5d01766128181" continuedAt="Text_f219274043a54863a1ca5d01766128182">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56068" continuedAt="Text_4c89f3c0e5f44727b35c554c45df56069"><ix:continuation id="Text_f219274043a54863a1ca5d01766128182">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Current Tax Provision</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_70d2a2da040d495ea5d87d7dcaf75fa6" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_99d588a3ac9e4192a58bbb1fd35d91de" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_b6f39c6ffc6442d68a42bedabe46755c" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_e2f4cdd1889b4b8e9fc7e5628342a050" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" id="Fact_088cd547e63743f88cfec3165211d3bc" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" id="Fact_4ba1aa3ea4094cbdb26a78acf044e430" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_733b0859eb7749ccbd18d33c2d48efd1" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_36300791f16047fd9dcbd3db15a47afe" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">4</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Deferred Tax Provision<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_9cb8e8faec3747fab4599926b7350477" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,155</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_bd733ae8decc4215a037eac8c5bc7410" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">6,851</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_701a5f0dd44e4129af5dfed079450aec" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_8d154d7ed66141a8bc39b69d74114a28" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,602</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" id="Fact_84d2cd7b7642419096cad5cb2f8ad31b" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" id="Fact_05854b2c08f648b19caa0f3967b01b01" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">187</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_e1c52032fe2049a993807dd85ac6ae6a" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,149</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_fe90d234ba4e473fa875132ff9c29eb3" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">8,640</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="color: rgb(0, 0, 0);">Change in valuation allowance</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" id="Fact_24c52b99e3204a61935c142c375c2f3a" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,145</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" id="Fact_6add53ef7eca4eb095217b8cf84f87f0" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,681</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">Total tax<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: -9.6px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: nowrap; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> (benefit) </span>provision for income taxes</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_c6731f716646404bbe16cc6d7d4aba02" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_a2e909324a3f4175b44a9061048b6dde" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">45</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df56069" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560610">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter"></div>

        <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-32</span></div>

        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

        <div style="width: 100%;" class="BRPFPageHeader">
          <div>
            <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
              </a></div>

          </div>

        </div>

      </div>


      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560610" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560611"><ix:nonNumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="Text_ef8831b411254551aae495607bc6a985" contextRef="c20230101to20231231" escape="true" continuedAt="Text_2eaf9a6b63134172a82e43184af014a31">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560611" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560612"><ix:continuation id="Text_2eaf9a6b63134172a82e43184af014a31" continuedAt="Text_2eaf9a6b63134172a82e43184af014a32">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_2eaf9a6b63134172a82e43184af014a32"><ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560612" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560613">
<div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023<br/>
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022<br/>
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Assets:</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Net operating losses</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" id="Fact_fbcae8302d39444a9f1df1e6fbfd6326" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,740</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" id="Fact_af2fca773048408aa331c9a67fd2e123" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,382</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign net operating losses<br/>
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" id="Fact_5c920b295c0f4bd9afbf145307630c44" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">784</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" id="Fact_5734d52ca19b4d77be8b97fd0b1e98f8" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">782</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;&#160;&#160; Stock compensation</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" id="Fact_0cc4157665044a3b94b82a5e5b28ae46" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,141</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" id="Fact_1622c186ddcb4a57890fae86376de3cf" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,173</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">&#160; &#160; In-process research and development</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" id="Fact_094b0431b0c84f5295533c40579dd103" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,009</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" id="Fact_15cfece8f1dc4892b7ec8aeec6608956" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,233</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;&#160;&#160; Capitalized rearch and development expenses</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" id="Fact_ad04a66c37604ec0bf9554cf9d19619c" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,105</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" id="Fact_01e5b2b0ad234c6b8feff94f9c3cde32" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,502</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">R&amp;D credit carryforwards</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" id="Fact_b7edab38f0dc45cf9cec94dec6968608" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">437</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" id="Fact_42f8b9e4a7f94907b0da38528f6d660f" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">517</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Compensation accrual</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" id="Fact_4e93e505f0f04d3ea7e00468691da907" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" id="Fact_2d0852e8ccaa4469950616359521a80d" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">81</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;">ROU Liabilities<br/>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="erna:DeferredTaxAssetsRightOfUseLiabilities" id="Fact_b2842311b2704cfe8f64ae89eb5cd3b4" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,932</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="erna:DeferredTaxAssetsRightOfUseLiabilities" id="Fact_dc2838b4826b4c75833c86a9bdf8e248" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">334</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;&#160;&#160; Other<br/>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" id="Fact_e28129e25cb4453cbe6324f86831ae00" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">132</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" id="Fact_bb7e286556eb4a82a8831fab082361c3" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">549</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total gross deferred tax assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_a525d9bddd774d3e9a9ce73fac74661e" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">29,283</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_42b2a6d38446474eac2b0c5a665b2ba4" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,553</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" id="Fact_66c39894ad95420e9e5a6c71971a445a" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,302</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" id="Fact_cab17b49bc904a3caa002cad40db56e9" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,157</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" id="Fact_26a5bb274fe24cf7a5606b93cf47bb8b" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,981</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" id="Fact_c5165ecef17f4a3c82b4624a3fa97e68" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">396</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Liabilities:</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Fixed assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" id="Fact_c276f1a16e4f4a1c85c103499ab90e2d" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">6</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" id="Fact_89fe0b6f35e44e69b299d276c5a1c5c6" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="margin-left: 9pt;">ROU Assets<br/>
                </div>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="erna:DeferredTaxAssetsRightOfUseAssets" id="Fact_dd030c9fbe0649918d8344c5db31aaff" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,349</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="erna:DeferredTaxAssetsRightOfUseAssets" id="Fact_07e7bc44d6af4bc7b985344772e3ca3c" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">291</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="margin-left: 9pt;">Convertible debt<br/>
                </div>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="erna:DeferredTaxLiabilitiesConvertibleDebt" id="Fact_7b569752e1394fe8bb89734ff41412dc" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,507</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="erna:DeferredTaxLiabilitiesConvertibleDebt" id="Fact_36254028792c4fd6afcd2d2eb27c3ead" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Intangibles - goodwill</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" id="Fact_a6c69466751e4ea4b8841b3f29eb8241" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">179</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" id="Fact_9d386fea452f4c0494fb0b52940bd460" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">160</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_fcab8052a7394801a9dba056fc16dfb1" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,041</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_8a9e838a302f4c84b20958eaaae3d469" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">461</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred taxes</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" id="Fact_fe64122a961a4f8e9decb92c197072b2" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">60</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" id="Fact_b78854d5bd7a4f1e92f703bfa946d4df" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">65</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
         </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560613" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560614">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560614" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560615"><ix:nonNumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Text_b153d71df5ac49be98073b30e08b0673" contextRef="c20230101to20231231" escape="true" continuedAt="Text_99ec845d80fd42aeb8d0653fb70b68fe1">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">The reconciliation of computed expected
          income taxes to effective income taxes by applying the federal statutory rate of <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_cc4f0aaf9a64487ba33b93135ec4437b" contextRef="c20220101to20221231" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_9e366c8b7f064d6f9930129f8619cb6a" contextRef="c20230101to20231231" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">21</ix:nonFraction></ix:nonFraction>% is as follows:</div>
</ix:nonNumeric></ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560615" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560616"><ix:continuation id="Text_99ec845d80fd42aeb8d0653fb70b68fe1" continuedAt="Text_99ec845d80fd42aeb8d0653fb70b68fe2">
<div style="display:none;"><br/></div>
<div style="text-indent: 27pt;">&#160;<br/>
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_99ec845d80fd42aeb8d0653fb70b68fe2"><ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560616" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560617">
<div>
          <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;">2023</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;">2022</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax at federal income tax rate</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_d031fc75908544e6920f9e16590c5f23" contextRef="c20230101to20231231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">21.00</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_bcda68a636c0440e92d65620971dff88" contextRef="c20220101to20221231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">21.00</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income tax, net of federal tax</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_62bf5bf3c4534bfdbf7d334b7cb50da5" contextRef="c20230101to20231231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.92</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_5ff7a8f33ba94d69a58c8ac0a8944d5d" contextRef="c20220101to20221231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">6.52</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">Foreign tax differential</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" id="Fact_c5f46f2aec52408f805fd66ee5c22df5" contextRef="c20230101to20231231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" id="Fact_1c669490b0eb49d8816556bd6b7e30cf" contextRef="c20220101to20221231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses/excludable items</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_748d9bf9f9d4473c8a29890077e27b92" contextRef="c20230101to20231231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.74</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_16289f9d5fe849e68d5ace321d033f34" contextRef="c20220101to20221231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">6.09</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in valuation allowance</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="Fact_12d534bf65104c599bee15c408865a9b" contextRef="c20230101to20231231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">9.90</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="Fact_cdf2e58e411c46e69db149f2b3653d3a" contextRef="c20220101to20221231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">35.38</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; white-space: nowrap;">
                  <div style="text-align: left; font-size: 10pt;">Convertible debt</div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" id="Fact_1d1dce816bfc499cba563731c2c7afad" contextRef="c20230101to20231231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">11.92</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" id="Fact_7482e752a58e45d7b89a95c2587cfd54" contextRef="c20220101to20221231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>.00</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%<br/>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credits</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" id="Fact_8d2d6e690b534e04aa513d70ff6c2370" contextRef="c20230101to20231231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>.00</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%<br/>
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" id="Fact_9af8fe879f2a40208531b0a95feac95d" contextRef="c20220101to20221231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.98</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">Uncertain tax positions<br/>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" id="Fact_24ade2eb582f44e7b884088f36d63b32" contextRef="c20230101to20231231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>.00</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" id="Fact_0d678c8921084dc090544be8897901c0" contextRef="c20220101to20221231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.49</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">%)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" id="Fact_433bce862e054350b09482b9fb34d5b0" contextRef="c20230101to20231231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">3.34</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" id="Fact_b0ea1633840c437cb0dfaa9da3eef24b" contextRef="c20220101to20221231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">1.11</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">%</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Benefit (provision) for income taxes</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_d2346fe2d6b743d38a106434fe2d894f" contextRef="c20230101to20231231" unitRef="U008" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_33863b6376cc410ca3002cbdcc3ffb05" contextRef="c20220101to20221231" unitRef="U008" decimals="4" sign="-" scale="-2" format="ixt:num-dot-decimal">0.18</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">%)</td>

  </tr>


</table>
          </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560617" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560618">
<div style="display:none;"><br/></div>
<div style="text-indent: 18pt;">&#160; <br/>
        </div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560618" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560619">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The net increase in the total valuation allowance for the year ended December 31, 2023 was an increase of approximately $<ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" id="Fact_91f7f47bfdd54b7ba867f0d9ce75900f" contextRef="c20230101to20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.1</ix:nonFraction>
              million. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets
              is dependent upon the generation of future taxable income during periods in which those temporary difference become deductible. Management considered the scheduled reversal of deferred tax liabilities, projected future taxable income and
              planning strategies in making this assessment.&#160; Based on the level of historical operating results and projections for the taxable income for the future, management has determined that it is more likely than not that the deferred taxes assets
              will not be utilized. Accordingly, the Company has recorded a full valuation allowance. The net deferred tax liability represents an indefinite life intangible liability related to tax deductible goodwill, partially offset by an indefinite
              life deferred tax asset.</span> </div>
</ix:continuation>
          <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560619" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560620">
<div><br/>
          </div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560620" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560621">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">At December 31, 2023 and 2022, the Company has available net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_7d9fcadabadb4f7a912e97e50432d539" contextRef="c20231231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">48.4</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_694a5cfd1b8b4e149cff27a295d4ab1d" contextRef="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">35.6</ix:nonFraction> million for
          federal income tax purposes, respectively, of which approximately $<ix:nonFraction name="erna:TaxCutsAndJobsActOperatingLossCarryforwards" id="Fact_64758985433d48c1b11b416657503a83" contextRef="c20231231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">48.4</ix:nonFraction> million can be carried forward indefinitely. The Company has
          available $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_f52a78802c24402db3d95878bf2be637" contextRef="c20231231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">39.6</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_72d306fc9fdf48cdbc682e92c5af5228" contextRef="c20221231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">28.8</ix:nonFraction>
          million state NOLs for the years ended December 31, 2023 and 2022, respectively. The Company also has foreign NOL carryforwards of approximately $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_485e87102945479c99368baad0e2f104" contextRef="c20231231_IncomeTaxAuthorityAxis_ForeignCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_3b09c0398b6f431d89555d6509c34a82" contextRef="c20221231_IncomeTaxAuthorityAxis_ForeignCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.3</ix:nonFraction></ix:nonFraction>
          million for each of the years ended December 31, 2023 and 2022, which carry forward indefinitely. Section 382 of the Internal Revenue Code (&#8220;IRC&#8221;) imposes limits on the ability to use NOL carryforwards that existed prior to a change in control to
          offset future taxable income. Such limitations would reduce, potentially significantly, the gross deferred tax assets disclosed in the table above related to the NOL carryforwards.&#160; The Company continues to disclose the NOL carryforwards at their
          original amount in the table above as no potential limitation has been quantified. The Company has also established a full valuation allowance for all deferred tax assets, including the NOL carryforwards, since the Company could not conclude that
          it was more likely than not able to generate future taxable income to realize these assets.&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560621" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560622">
<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>
</ix:continuation>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="width: 100%;" class="BRPFPageFooter"></div>

          <div style="text-align: center;" class="BRPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-33</span></div>

          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div style="width: 100%;" class="BRPFPageHeader">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <!--PROfilePageNumberReset%Num%34%F-%%-->
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560622" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560623">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">At December 31, 2023 and 2022 the Company has federal and state income tax credit carryforwards of approximately $<ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" id="Fact_22b5dcf9110f4a6b80aed42b8002f694" contextRef="c20231231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.4</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" id="Fact_1ca5275642f2404589762c19cb21b5ae" contextRef="c20221231" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction> million,
          respectively. The credits begin to expire in <ix:nonNumeric name="erna:TaxCreditCarryforwardExpirationYear" id="Fact_b115f536acc648369d24724295acbf67" contextRef="c20230101to20231231">2041</ix:nonNumeric>.</div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560623" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560624">
<div><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560624" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560625">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">In accordance with authoritative guidance, the impact of an uncertain income tax position on the income tax return must be
          recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. <ix:nonNumeric name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="Text_415d751357954ea8bbe74b54f23b1d54" contextRef="c20230101to20231231" escape="true" continuedAt="Text_c927a604e17749b384284a87c31125d11"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2023 and 2022 (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
        <ix:continuation id="Text_c927a604e17749b384284a87c31125d11" continuedAt="Text_c927a604e17749b384284a87c31125d12"><ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560625" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560626">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br/>
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_c927a604e17749b384284a87c31125d12"><ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560626" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560627">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
          <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: center; font-weight: bold;"> 2023<br/>
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: center; font-weight: bold;">2022<br/>
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Beginning balance of uncertain tax positions</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" id="Fact_51ad6c90bf8842928b2d5d064a1413c1" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">121</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" id="Fact_45baee6807154964ab9f26b384f217f2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Additions based on current year&#8217;s tax positions</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" id="Fact_cd6b3263f97f45d79187030fac79c46d" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:fixed-zero">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" id="Fact_757c23886ecd42c5af2590ecaacb2487" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">45</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Net changes based on prior year&#8217;s tax positions</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" id="Fact_c24bcf9531db4279a3327e7d129dc75f" contextRef="c20230101to20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">272</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" id="Fact_f99e0d4475de4f0abe20d7eca0fcf3de" contextRef="c20220101to20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">76</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">Ending balance of uncertain tax positions</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" id="Fact_3b4037b3f1cf4e84bfc8f07e119c1082" contextRef="c20231231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">393</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" id="Fact_63ce6acce11642acb339d33ca7e6e9cd" contextRef="c20221231" unitRef="U001" decimals="-3" scale="3" format="ixt:num-dot-decimal">121</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
           </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560627" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560628">
<div><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560628" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560629">
<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">It
          is reasonably possible that unrecognized tax benefits may increase or decrease within the next twelve months due to tax examination changes, expiration of statute of limitations, or changes in tax law.&#160; The Company does not anticipate any
          significant changes to unrecognized tax benefits over the next 12 months. </div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560629" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560630">
<div> <br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560630" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560631">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company recognizes interest and penalties related to unrecognized tax positions within the income tax expense line in the
          accompanying consolidated statements of operations. There were <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_c2b1d15039d8444c88355b499ed8d11e" contextRef="c20231231" unitRef="U001" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_27ebddd7407944e68de4ba4d387c0a83" contextRef="c20221231" unitRef="U001" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> accrued interest and penalties associated with uncertain tax
          positions as of December 31, 2023 or December 31, 2022.</div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560631" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560632">
<div><br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560632" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560633">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company is subject to U.S. federal, state, and foreign income tax. The Company&#8217;s income tax returns are subject to
          examination by the relevant taxing authorities. As of December 31, 2023, the <span style="-sec-ix-hidden:Fact_27587e86962c450fb8de5335527ed5c8">2020 &#8211; 2023</span> tax years remain subject to examination in
          the U.S. federal tax, various state, and foreign tax jurisdictions. The Company is not currently under examination by federal state, or foreign jurisdictions.</div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560633" continuedAt="Text_4c89f3c0e5f44727b35c554c45df560634">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
        </div>
</ix:continuation>
        <ix:continuation id="Text_4c89f3c0e5f44727b35c554c45df560634">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) was enacted into law. Among other changes to the tax code, the IRA imposes a 1% excise tax on
            certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022.&#160; A number of exceptions to
            the stock buyback tax are available including exceptions to certain reorganizations. However, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more
            guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.<br/>
          </span></div>
</ix:continuation>
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
        <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/>
        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" id="Text_70b25e83691d4a44b87beca2cb618a2c" contextRef="c20230101to20231231" escape="true" continuedAt="Text_b65e423567bd420c87de3738ba69996e1">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">18)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Subsequent Event</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e1" continuedAt="Text_b65e423567bd420c87de3738ba69996e2">
<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>
</ix:continuation>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e2" continuedAt="Text_b65e423567bd420c87de3738ba69996e3">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.2pt; margin-left: 0.2pt; font-style: italic;">CEO Inducement Grant</div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e3" continuedAt="Text_b65e423567bd420c87de3738ba69996e4">
<div><span style="font-size: 10pt;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e4" continuedAt="Text_b65e423567bd420c87de3738ba69996e5">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e5" continuedAt="Text_b65e423567bd420c87de3738ba69996e6">
<div><span style="font-size: 10pt;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e6" continuedAt="Text_b65e423567bd420c87de3738ba69996e7">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"><span style="font-size: 10pt;">On January 1, 2024, Sanjeev Luther was appointed as President, Chief Executive Officer and a director of the Company. Upon his appointment, he was granted
            a non-qualified stock option to purchase approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_55dbcd9bb3d54cd89c7a36f4a4910543" contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember" unitRef="U002" decimals="0" scale="0" format="ixt:num-dot-decimal">1,685,000</ix:nonFraction> shares of the Company&#8217;s common stock. The stock option has an
            exercise price of $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" id="Fact_bcf227d7f17a446194a8ed7747e6f2aa" contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember" unitRef="U003" decimals="2" scale="0" format="ixt:num-dot-decimal">1.80</ix:nonFraction> per share, which was equal to the fair market value of the Company&#8217;s common stock on the date of grant, will
            vest over <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_bfd5d72d016541b1a7fe607c0ab0c2b3" contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric>, with <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="Fact_3273a08432344abdac1517f0ca97a467" contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">25</ix:nonFraction>%
            of the shares vesting on the first anniversary of the grant date and the remaining <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="Fact_0a994114f7f74815b08efc666414c80c" contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember" unitRef="U008" decimals="2" scale="-2" format="ixt:num-dot-decimal">75</ix:nonFraction>% of the shares vesting in equal <ix:nonNumeric name="erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" id="Fact_8d1f9d607967471cada98b0141ef75fd" contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember">monthly</ix:nonNumeric> installments over the <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_3db61c96148b465cac40dfbf9e198a89" contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>
            thereafter, in each case, subject to continued service. The stock option was granted pursuant to the terms of Mr. Luther&#8217;s employment agreement and as a material inducement to his joining the Company in accordance with Nasdaq Listing Rule
            5635(c)(4).</span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e7" continuedAt="Text_b65e423567bd420c87de3738ba69996e8">
<div><span style="font-size: 10pt;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e8" continuedAt="Text_b65e423567bd420c87de3738ba69996e9">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e9" continuedAt="Text_b65e423567bd420c87de3738ba69996e10">
<div><span style="font-size: 10pt;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e10" continuedAt="Text_b65e423567bd420c87de3738ba69996e11">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.2pt; margin-left: 0.2pt; font-style: italic;">Remaining Funding Received from December
          2023 Financing</div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e11" continuedAt="Text_b65e423567bd420c87de3738ba69996e12">
<div><span style="font-size: 10pt;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e12" continuedAt="Text_b65e423567bd420c87de3738ba69996e13">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e13" continuedAt="Text_b65e423567bd420c87de3738ba69996e14">
<div><span style="font-size: 10pt;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e14" continuedAt="Text_b65e423567bd420c87de3738ba69996e15">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">On January 11, 2024, the second and final
          closing of the December 2023 convertible note financing occurred. At this closing, the Company received approximately $<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" id="Fact_3d6406fcd10e4a7a9f2c708620409bd0" contextRef="c20240111to20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction> million and
          issued an aggregate of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_3aa56454ae1c48809499116dd6ffb00f" contextRef="c20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction> million of December 2023 convertible notes and note warrants to purchase approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_7e668534fb8f4de6a47f05b6cdeb8a34" contextRef="c20240111_ClassOfWarrantOrRightAxis_WarrantMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction> million shares of common stock.</div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e15" continuedAt="Text_b65e423567bd420c87de3738ba69996e16">
<div><span style="font-size: 10pt;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e16" continuedAt="Text_b65e423567bd420c87de3738ba69996e17">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageFooter" style="width: 100%;"></div>

          <div class="BRPFPageNumberArea" style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">F-34</span></div>

          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div style="text-align: left; font-weight: normal; font-style: italic; font-size: 8pt;"> <a href="#TABLEOFCONTENTS">Table of Contents</a><a href="#TABLEOFCONTENTS"><br/>
                </a></div>

            </div>

          </div>

        </div>

        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e17" continuedAt="Text_b65e423567bd420c87de3738ba69996e18">
<div><span style="font-size: 10pt;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_b65e423567bd420c87de3738ba69996e18">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">The December 2023 convertible notes
          issued on January 11, 2024 have the same terms as those issued on December 15, 2023, except that the one issued on January 11, 2024 expire on <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_619450d195814d1ba2e3125218e1c850" contextRef="c20240111to20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember" format="ixt:date-monthname-day-year-en">January 11, 2029</ix:nonNumeric>. The note warrants issued on January 11, 2024 have the same terms as the note warrants issued on December 15, 2023, except that the one issued on January 11, 2024 expire on <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_873269ecba5240e4baf59725ccc53248" contextRef="c20240111to20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember" format="ixt:date-monthname-day-year-en">January 11, 2029</ix:nonNumeric>. See Note 6 for more information regarding the December 2023 convertible note financing, the December 2023 convertible notes and the note warrants.</div>
</ix:continuation>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      </div>

      <div><br/>
      </div>

    </div>

    <div style="text-align: center;"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">F-35</span></div>

    <div style="text-align: center;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
<div><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;"> </span></div>
</div>

  </div>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ef20015352_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 3.1</font><br>
  </div>
  <div><br>
  </div>
  <div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">THIS COMPOSITE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ETERNA THERAPEUTICS INC. (THE &#8220;CORPORATION&#8221;) REFLECTS THE PROVISIONS OF THE CORPORATION&#8217;S CERTIFICATE
      OF INCORPORATION AND ALL AMENDMENTS THERETO FILED WITH THE DELAWARE SECRETARY OF STATE THEREAFTER ON OR PRIOR TO OCTOBER 17, 2022, BUT IS NOT AN AMENDMENT AND/OR RESTATEMENT THEREOF.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMPOSITE</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RESTATED CERTIFICATE</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INCORPORATION</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics Inc., a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1. The name of the corporation is Eterna Therapeutics Inc. The corporation was originally incorporated under the name Alroy
      Industries, Inc. The original certificate of incorporation of the corporation was filed with the Secretary of State of the State of Delaware on April 13, 1984 (the &#8220;Original Certificate&#8221;). The Original Certificate was amended and restated by a
      restated certificate of incorporation of the corporation filed with the Secretary of State of the State of Delaware on June 14, 1991 (the &#8220;Amended and Restated Certificate&#8221;).</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2. This Restated Certificate of Incorporation was duly adopted in accordance with Section 245 of the General Corporation Law of
      Delaware.</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3. Pursuant to Section 245(c) of the General Corporation Law of Delaware, this Restated Certificate of Incorporation only restates
      and integrates and does not further amend the provisions of the Amended and Restated Certificate as heretofore amended or supplemented, and there is no discrepancy between those provisions and the provisions of this Restated Certificate of
      Incorporation.</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4. The text of the Amended and Restated Certificate as heretofore amended or supplemented is hereby restated to read in its entirety
      as follows:</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE I</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The name of the corporation (the &#8220;Corporation&#8221;) is Eterna Therapeutics Inc.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE II</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The address of the corporation&#8217;s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, county
      of New Castle, Delaware. The name of the Corporation&#8217;s registered agent at such address is The Corporation Trust Company.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE III</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The nature of the business or purpose to be conducted or promoted is to be engaged in any lawful act or activity for which
      corporations may be organized under the General Corporation Law of the State of Delaware.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE IV</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;The total number of shares of stock which the Corporation shall have
        authority to issue is 101,000,000 shares, of which 100,000,000 shares shall be Common Stock, par value $.005 per share, and 1,000,000 shall be Preferred Stock, par value $.005 per share</font>.&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(a)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Series A Preferred Stock</u></font>. This corporation is
      authorized to issue a series of Preferred Stock designated &#8220;Series A Convertible Preferred Stock&#8221; consisting of 156,112 shares.</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Dividend Rights</u></font>.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(i)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Rights to Cash Dividends.</u></font>&#160;In the absence of any
      action pursuant to part (ii) of this subdivision (a)(l), the holders of the Series A Preferred shall be entitled to receive cumulative dividends of ten cents per share per annum, payable semiannually in equal installments of five cents per share on
      December 1 and June 1 of each year. The dividends so payable on any December 1 or June 1 will be paid by check or draft to the person (the &#8220;Registered Holder&#8221;) in whose name the Series A Preferred is registered as of the close of business on November
      15 or May 15 next preceding the interest payment date (whether or not a business day), at such person&#8217;s address as it appears on the registration books of the Corporation.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(ii)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Rights to Stock Dividends.</u></font>&#160;At the Corporation&#8217;s
      option, the Corporation may declare and pay a dividend for any dividend payment date(s) in the form of its common stock, $.005 par value per share (the &#8220;Common Stock&#8221;), such stock dividend to be in lieu of the dividend provided for by part (i) of
      this subdivision (a)(l). To determine the amount of Common Stock to be issued as a substitute dividend on the Series A Preferred, the Common Stock will be valued at its market value. Market value is defined for this purpose as the average closing bid
      price for the twentieth through eleventh trading days preceding the date on which interest is due.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Voting Rights</u></font>. The Series A Preferred shall have
      no voting rights.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Rights on Liquidation, Dissolution and Winding Up</u></font>.
      Upon liquidation, dissolution and winding up, each share of the Series A Preferred shall have preference over the Common Stock to the extent of $1.00 per share, but shall not otherwise be entitled to share in the proceeds of any liquidation,
      dissolution or winding up. The preference or subordination of the rights of the Series A Preferred with respect to any other class of stock, or any other series of preferred stock, shall be as stated in the instrument defining the rights of such
      other class or series. Neither the merger or consolidation of the Corporation into or with any other corporation or any other corporation into or with the Corporation, nor a sale, transfer or lease of all or any part of the assets of the Corporation,
      shall be deemed to be a liquidation, dissolution or winding up of the Corporation within the meaning of this subdivision (3).</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Conversion Rights</u></font>. Commencing on the date of the
      issuance of the Series A Preferred, the Series A Preferred shall at any time be convertible at the option of the holder thereof into duly authorized, validly issued, fully paid and nonassessable shares of Common Stock at a conversion rate (the
      &#8220;Conversion Rate&#8221;) as set forth below (subject to adjustment as provided in subdivision (5) hereof).</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(i) The Registered Holder shall have the right at any time to convert shares of Series A Preferred into that number of fully paid
      and nonassessable shares of Common Stock of the Corporation that equals the number of shares of Series A Preferred that are surrendered for conversion divided by the Conversion Rate. The Conversion Rate shall initially be 100%, and shall be subject
      to adjustment pursuant to subdivision (5) hereof. Upon the surrender of the Series A Preferred accompanied by the written request for conversion from the Registered Holder, the Corporation shall issue and deliver to such Registered Holder
      certificates evidencing such shares of Common Stock.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(ii) In order to exercise the conversion privileges, the Registered Holder shall surrender the Series A Preferred to the
      Corporation at its principal address, accompanied by written notice to the Corporation that such holder elects to convert all or a portion of the same. Such notice shall also state the name or names (with address) in which the certificate or
      certificates for shares of Common Stock and any re-issued Series A Preferred shall be issued upon such conversion. As promptly as practicable after the receipt of such notice and surrender of the Series A Preferred, the Corporation shall issue and
      deliver to such holder, or to his assignee or assignees on his written order, a certificate or certificates for the number of full shares of Common Stock and any re-issued Series A Preferred issuable upon the conversion of the Series A Preferred.
      Such conversion shall be deemed to have been effected at the close of business of the first business day after the date on which such notice shall have been received by the Corporation and such Series A Preferred shall have been surrendered.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(iii) No fractional shares shall be issued upon conversion of the Series A Preferred and any portion of the same which would
      otherwise be convertible into a fractional share shall be paid in cash in the amount of the liquidation preference of the fractional share. No payment or adjustment shall be made upon any conversion on account of any cash dividends on the Common
      Stock issued upon such conversion.</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(5)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Adjustments to Conversion Rate.</u></font></div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Conversion Rate shall be subject to adjustment as provided in this subdivision (5).</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(i) In case the Corporation shall (A) pay a dividend, or make a distribution, in shares of its Common Stock (the &#8220;Shares&#8221;), (B)
      subdivide its outstanding Shares into a greater number of Shares, (C) combine its outstanding Shares into a smaller number of Shares, or (D) issue by reclassification of its Shares any shares of Common Stock of the Corporation (other than a change in
      par value, or from par value to no par value, or from no par value to par value), the Conversion Rate in effect immediately prior thereto shall be adjusted so that the Registered Holder shall be entitled to receive the number of Shares which he would
      have owned or have been entitled to receive immediately following the happening of any of the events described above, had the Series A Preferred been converted immediately prior to the record or effective date thereof.</div>
    <div style="text-align: left; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">An adjustment made pursuant to subparts (i)(A)-(D) above shall become effective immediately after the record date in the case of a
      dividend or distribution in Shares and shall become effective immediately after the effective date in the case of a subdivision, combination or reclassification. If, as a result of an adjustment made pursuant to this paragraph, the Registered Holder
      shall become entitled to receive shares of two or more classes of Common Stock of the Corporation, the Board of Directors (whose determination shall be conclusive and shall be evidenced by a resolution) shall determine the allocation of the adjusted
      Conversion Rate between or among the shares of such classes of Common Stock.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(ii) In case of any reclassification of the outstanding Shares (other than a change in par value, or from par value to no par
      value, or from no par value to par value, or as a result of a subdivision, combination or stock dividend), or in case of any consolidation of the Corporation with, or merger of the Corporation into, another corporation wherein the Corporation is not
      the surviving entity, or in case of any sale of all, or substantially all, of the property, assets, business and goodwill of the Corporation, the Corporation, or such successor or purchasing corporation, as the case may be, shall provide, by a
      written instrument delivered to the Registered Holder, that the Registered Holder shall thereafter be entitled upon conversion to the kind and amount of shares of stock or other equity securities, or other property or assets which would have been
      receivable by such Registered Holder upon such reclassification, consolidation, merger or sale, if the Series A Preferred had been converted immediately prior thereto. Such corporation, which thereafter shall be deemed to be the &#8220;Corporation&#8221; for
      purposes of the Series A Preferred, shall provide in such written instrument for adjustments to the Conversion Rate which shall be as nearly equivalent as may be practicable to the adjustments provided for in this subdivision (5).</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(iii)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Common Stock Issued at Less Than the Conversion Price</u></font>.
      If the Corporation shall issue any Common Stock without consideration or for a consideration per share less than the then applicable Equivalent Preference Amount, the Equivalent Preference Amount shall immediately be reduced to the amount determined
      by dividing (A) an amount equal to the sum of (1) the number of shares of Common Stock outstanding immediately prior to such issuance multiplied by the Equivalent Preference Amount in effect immediately prior to such issuance and (2) the
      consideration, if any, received by the Corporation upon such issuance, by (B) the total number of shares of Common Stock outstanding immediately after such issuance. The Equivalent Preference Amount at any time shall be the value that results when
      the liquidation preference of one share of Series A Preferred is multiplied by the Conversion Rate in effect at that time; thus the Conversion Rate applicable after the adjustment in the Equivalent Preference Amount provided by this part (iii) shall
      be the figure that results when the adjusted Equivalent Preference Amount is divided by the liquidation preference of one share of Series A Preferred.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the purpose of determining the date on which an adjustment to the Conversion Rate pursuant to this part (iii) shall take effect,
      the Conversion Rate shall be adjusted as of the earlier of (x) the date, if any, on which the Corporation shall enter into a firm contract for the issuance of such shares of Common Stock, or securities convertible into or exchangeable or exercisable
      for shares of Common Stock, or (y) the date of actual issuance of such shares of Common Stock or such other securities.</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the purposes of any adjustment of the Conversion Rate pursuant to this part (iii), the following provisions shall also be
      applicable:</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(A)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cash</u></font>. In the case of the issuance of Common Stock
      for cash, the amount of the consideration received by the Corporation shall be deemed to be the amount of the cash proceeds received by the Corporation for such Common Stock before deducting therefrom any discounts, commissions, taxes or other
      expenses allowed, paid or incurred by the Corporation for any underwriting or otherwise in connection with the issuance and sale thereof.</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(B)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Consideration Other Than Cash</u></font>. In the case of the
      issuance of Common Stock (otherwise than upon the conversion of shares of capital stock or other securities of the Corporation) for a consideration in whole or in part other than cash, including securities acquired in exchange therefor (other than
      securities by their terms so exchangeable), the consideration other than cash shall be deemed to be the fair value thereof as determined by the Board of Directors, irrespective of any accounting treatment; provided that such fair value as determined
      by the Board of Directors shall not exceed the aggregate current market price of the shares of Common Stock being issued as of the date the Board of Directors authorizes the issuance of such shares.</div>
    <div style="text-align: left; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(C)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Options and Convertible Securities</u></font>. In the case
      of the issuance of (x) options, warrants or other rights to purchase or acquire Common Stock (whether or not at the time exercisable), (y) securities by their terms convertible into or exchangeable for Common Stock (whether or not at the time so
      convertible or exchangeable) or (z) options, warrants or rights to purchase such convertible or exchangeable securities (whether or not at the time exercisable):</div>
    <div style="text-align: justify; text-indent: 104.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1) the aggregate maximum number of shares of Common Stock deliverable upon exercise of such options, warrants or other rights to
      purchase or acquire Common Stock shall be deemed to have been issued at the time such options, warrants or rights were issued and for a consideration equal to the consideration (determined in the manner provided in subparts (A) and (B) above), if
      any, received by the Corporation upon the issuance of such options, warrants or rights plus the minimum purchase price provided in such options, warrants or rights for the Common Stock covered thereby;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2) the aggregate maximum number of shares of Common Stock deliverable upon conversion of or in exchange for any such convertible
      or exchangeable securities, or upon the exercise of options, warrants or other rights to purchase or acquire such convertible or exchangeable securities and the subsequent conversion or exchange thereof, shall be deemed to have been issued at the
      time such securities were issued or such options, warrants or rights were issued and for a consideration equal to the consideration, if any, received by the Corporation for any such securities and related options, warrants or rights (excluding any
      cash received on account of accrued interest or accrued dividends), plus the additional consideration (determined in the manner provided in subparts (A) and (B) above), if any, to be received by the Corporation upon the conversion or exchange of such
      securities, or upon the exercise of any related options, warrants or rights to purchase or acquire such convertible or exchangeable securities and the subsequent conversion or exchange thereof.</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3) on any change in the number of shares of Common Stock deliverable upon exercise of any such options, warrants or rights or
      conversion or exchange of such convertible or exchangeable securities or any change in the consideration to be received by the Corporation upon such exercise, conversion or exchange (the &#8220;Change in Number or Consideration&#8221;), including, but not
      limited to, a change resulting from the anti-dilution provisions thereof, the Conversion Rate as then in effect shall forthwith be readjusted to such Conversion Rate as would have been obtained had an adjustment been made upon the issuance of such
      options, warrants or rights not exercised prior to the Change in Number or Consideration, or of such convertible or exchangeable securities not converted or exchanged prior to the Change in Number or Consideration, upon the basis of the Change in
      Number or Consideration;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4) on the expiration or cancellation of any such options, warrants or rights, or the termination of the right to convert or
      exchange such convertible or exchangeable securities, if the Conversion Rate shall have been adjusted upon the issuance thereof, the Conversion Rate shall forthwith be readjusted to such Conversion Rate as would have been obtained had an adjustment
      been made upon the issuance of such options, warrants, rights or such convertible or exchangeable securities on the basis of the issuance of only the number of shares of Common Stock actually issued upon the exercise of such options, warrants or
      rights, or upon the conversion or exchange of such convertible or exchangeable securities; and</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(5) if the Conversion Rate shall have been adjusted upon the issuance of any such options, warrants, rights or convertible or
      exchangeable securities, no further adjustment of the Conversion Rate shall be made for the actual issuance of Common Stock upon the exercise, conversion or exchange thereof.</div>
    <div style="text-align: justify; text-indent: 128.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(iv) Whenever the Conversion Rate shall be adjusted as herein provided, the Corporation shall compute the adjusted Conversion Rate
      in accordance with such provisions and shall prepare a certificate signed by its President, any Vice-President or the Chief Financial Officer setting forth the adjusted Conversion Rate and showing in reasonable detail the facts upon which such
      adjustment was based and shall mail such certificate to the Registered Holders of the Series A Preferred.</div>
    <div style="text-align: justify; text-indent: 79.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(6)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Reservation of Shares</u></font>. The Corporation shall at
      all times reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the conversion of the Series A Preferred, such number of shares as shall from time to time be sufficient to effect the
      conversion of all shares of Series A Preferred from time to time outstanding, and, if at any time the number of shares of Common Stock remaining unissued are not sufficient to permit the conversion of all the then-outstanding shares of Series A
      Preferred, the Corporation shall take such action as is necessary to increase the authorized amount of Common Stock to such number of shares as shall be sufficient for such purposes.</div>
    <div style="text-align: left; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(b)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Other Series or Classes of Preferred Stock</u></font>. Shares
      of an additional Preferred Stock may be issued from time to time in one or more series, each such series to have such distinctive designation or title as may be stated and expressed in this Article IV or as may be fixed by the Board of Directors
      prior to the issuance of any shares thereof. Each such series of Preferred Stock shall have such voting powers, full or limited, or no voting powers, and such designations, preferences and such relative, participating, optional or other special
      rights (including, without limitation, the right to convert the shares of such Preferred Stock into shares of the Corporation&#8217;s Common Stock at such rate and upon such terms and conditions as may be fixed by the Corporation&#8217;s Board of Directors),
      with such qualifications, limitations, or restrictions of such preferences or rights as shall be stated and expressed in this Article IV or in the resolution or resolutions providing for the issue of such series of Preferred Stock as may be adopted
      from time to time by the Board of Directors prior to the issuance of any shares thereof, in accordance with the laws of the State of Delaware.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Except as may be otherwise provided in this Article IV or in the resolution or resolutions providing for the issue of a particular
      series, the Board of Directors may from time to time increase the number of shares of any series already created by providing that any unissued shares of Preferred Stock shall constitute part of such series, or may decrease (but not below the number
      of shares thereof then outstanding) the number of shares of any series already created by providing that any unissued shares previously assigned to such series shall no longer constitute part thereof.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">All shares of Preferred Stock of all series shall be of equal rank and be identical in all respects except in respect to the
      particulars which may be fixed by the Board of Directors as provided in this Article IV.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(c)&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Common Stock</u></font>.</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1) After the requirements with respect to the preferential dividends of the Preferred Stock shall be met, and after the
      Corporation shall have complied with all of the requirements, if any, with respect to the setting aside of sums for redemption, the holders of Common Stock shall be entitled to receive such dividends as may be declared from time to time by the Board
      of Directors.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2) After distribution in full of the preferential amounts required to be distributed to the holders of the Preferred Stock and to
      the holders of any class of stock of the Corporation ranking as to distribution of assets senior to the Common Stock, in the event of voluntary or involuntary liquidation or dissolution or winding-up of the Corporation, the holders of the Common
      Stock shall be entitled to receive all of the remaining assets of the Corporation, tangible and intangible, of whatever kind available to distribution to stockholders ratably in proportion to the number of shares of Common Stock held by them,
      respectively.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3) Each holder of record of Common Stock shall have the right to vote each share of Common Stock standing in his name on the
      record books of the Corporation. Except as otherwise provided herein or in any Certificate of Designations, Preferences and Rights of Preferred Stock filed in the Office of the Secretary of State of the State of Delaware, or otherwise as required by
      law, the holders of Preferred Stock and the holders of Common Stock shall vote together as one class on all matters.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Effective immediately upon the effectiveness of the Certificate of Amendment adding this paragraph to Article IV of this
        Certificate of Incorporation on October 16, 2022 at 11:59 p.m. Eastern Time (the &#8220;Effective Time&#8221;), each ten (10) to twenty (20) shares of Common Stock that are issued and outstanding immediately prior to the Effective Time shall be reclassified
        and combined into one (1) validly issued, fully paid and non-assessable share of Common Stock, with the exact ratio within such range to be determined by the Board of Directors prior to the Effective Time and publicly announced by the Corporation,
        subject to the treatment of fractional share interests as described below (the &#8220;Reverse Stock Split&#8221;). The Reverse Stock Split shall occur automatically without any further action by the Corporation or its stockholders and whether or not any
        certificate representing such shares immediately prior to the Effective Time (the &#8220;Old Certificate&#8221;) is surrendered to the Corporation. The Reverse Stock Split shall also apply to any outstanding securities or rights convertible into, or
        exchangeable or exercisable for, Common Stock. The Reverse Stock Split shall be effected on a certificate-by-certificate basis and no fractional shares shall be issued upon the reclassification and combination. In lieu of any fractional shares to
        which the holder would otherwise be entitled, the Corporation shall pay an amount of cash equal to the product of (i) the fractional share to which the holder would otherwise be entitled and (ii) the then fair value of a share as determined in good
        faith by the Board of Directors. Following the Effective Time, each Old Certificate shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been
        reclassified and combined, subject to the elimination of fractional share interests as described above, until such time as such Old Certificate has been surrendered to the Corporation.</div>
    <div style="text-align: justify; text-indent: 48.95pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE V</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation is to have perpetual existence.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VI</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors is authorized to make, alter or repeal the Bylaws of the Corporation, to fix the amount reserved as working
      capital, and to authorize and cause to be executed, mortgages and liens without limit as to the amount upon the property and franchise of this corporation.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">With the consent in writing, and pursuant to a vote of the holders of a majority of the capital stock issued and outstanding, the
      Directors shall have the authority to dispose, in any manner, of the whole property of the Corporation.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VII</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation shall indemnify, in the manner and to the full extent permitted by law, any person (or the estate of any person) who
      was or is a party, or is threatened to be made a party to, any threatened, pending or completed action, suit or proceeding, whether or not by or in the right of the Corporation, and whether civil, criminal, administrative, investigative or otherwise,
      by reason of the fact that such person is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint
      venture, trust or other enterprise. Where required by law, the indemnification provided for herein shall be made only as authorized in the specific case upon a determination in the manner provided by law, that indemnification of the director,
      officer, employee or agent is proper under the circumstances. The Corporation may, to the full extent permitted by law, purchase and maintain insurance on behalf of any such person against any liability which may be asserted against him. To the full
      extent permitted by law, the indemnification provided herein shall include expenses (including attorneys&#8217; fees) in any action, suit or proceeding, or in connection with any appeal therein, judgments, fines and amounts paid in settlement, and in the
      manner provided by law any such expenses may be paid by the Corporation in advance of the final disposition of such action, suit or proceeding. The indemnification provided herein shall not be deemed to limit the right of the Corporation to indemnify
      any other person for any such expense to the full extent permitted by law, nor shall it be deemed exclusive of any other rights to which any person seeking indemnification from the Corporation may be entitled under any agreement, vote of stockholders
      or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office.</div>
    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To the extent permitted by law, no director of the Corporation shall be liable to the Corporation or its stockholders for monetary
      damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director&#8217;s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct
      or a knowing violation of law; (iii) under section 174 of the Delaware General Corporation Law; or (iv) for any transaction from which the director derived an improper personal benefit.</div>
    <div style="text-align: left; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VIII</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation in
      the manner now or hereafter prescribed by law.</div>
    <div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE IX</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">A.&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Number, Election and Term of Directors</u></font>. The number of
      Directors of the Corporation shall be fixed from time to time by or pursuant to the By-laws. Each director who is serving as a director on the date of this Amendment (October 20, 2005) shall hold office until the next annual meeting of stockholders
      after such date and until his or her successor has been duly elected and qualified, notwithstanding that such director may have been elected for a term that extended beyond the date of such next annual meeting of stockholders. At each annual meeting
      of stockholders after the date of this Amendment (October 20, 2005), the Directors elected at such annual meeting shall hold office for a term expiring at the next annual meeting of stockholders to be held in the year following the year of their
      election, with the members to hold office until their successors are elected and qualified.</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">B.&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Newly Created Directorship and Vacancies</u></font>. Newly
      created directorships resulting from any increase in the number of Directors and any vacancies on the Board of Directors resulting from the death, resignation, disqualification, or removal of a director shall be filled solely by the affirmative vote
      of the majority of the remaining Directors then in office, even though less than a quorum of the Board of Directors. Any Director elected (a) to fill any vacancy resulting from the death, resignation, disqualification or removal of a Director shall
      hold office for the remainder of the full term of the Director whose death, resignation, disqualification or removal created such vacancy or (b) to fill any vacancy resulting from a newly created directorship shall hold office until the next annual
      meeting of stockholders and, in each case, until such Director&#8217;s successors shall have become elected and qualified. No decrease in the number of Directors constituting the Board of Directors shall shorten the term of any incumbent Director.</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">C.&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Removal</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160;</font>Subject to the rights of any Preferred Stock to elect directors under specified circumstances, any director may be removed from office, with or without cause, and only by the affirmative vote of the
      holders of 80% of the combined voting power of the then outstanding shares of stock entitled to vote generally in the election of directors, voting together as a single class.</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE X</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or
      special meeting of such holders and may not be effected by any consent in writing by such holders. Except as otherwise required by law and subject to the rights of the holders of Preferred Stock, special meetings of stockholders of the Corporation
      may be called only by the Board of Directors pursuant to a resolution approved by a majority of the entire Board of Directors. Notwithstanding anything contained in this Restated Certificate of Incorporation to the contrary, the affirmative vote of
      the holders of at least 80% of the voting power of all shares of the Corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required to after, amend, adopt any provision inconsistent with or
      repeal this Article X.</div>
    <div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE XI</div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(a) Except as otherwise provided in this Article XI, no purchase by the Corporation from any Controlling Person (as hereinafter
      defined) of shares of any stock of the Corporation owned by such Controlling Person shall be made at a price exceeding the average price paid by such Controlling Person for all shares of stock of the Corporation acquired by such Controlling Person
      during the two-year period preceding the date of such proposed purchase unless such purchase is approved by the affirmative vote of not less than a majority of the voting power of the shares of stock of the Corporation entitled to vote held by
      Disinterested Stockholders (as hereinafter defined).</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(b) The provisions of this Article XI shall not apply to (i) any offer to purchase made by the Corporation which is made on the same
      terms and conditions to the holders of all shares of stock of the Corporation, (ii) any purchase by the Corporation of shares owned by a Controlling Person occurring after the end of two years following the date of the last acquisition by such
      Controlling Person of stock of the Corporation, (iii) any transaction which may be deemed to be a purchase by the Corporation of shares of its stock which is made in accordance with the terms of any stock option or other employee benefit plan now or
      hereafter maintained by the Corporation, or (iv) any purchase by the Corporation of shares of its stock at prevailing market prices pursuant to a stock repurchase program.</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(c) This Article XI shall not be amended without the affirmative vote of not less than a majority of the stock of the Corporation
      entitled to vote thereon; provided, however, that if, at the time of such vote, there shall be one or more Controlling Persons, such affirmative vote shall include the affirmative vote in favor of such amendment of not less than a majority of the
      voting power of the shares of stock of the Corporation entitled to vote thereon held by Disinterested Stockholders.</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(d) For purposes of this Article XI: (i) the term &#8220;Controlling Person&#8221; means any individual, corporation, partnership, trust,
      association or other organization or entity (including any group formed for the purpose of acquiring, voting or holding securities of the Corporation) which either directly, or indirectly through one or more intermediaries, owns, beneficially or of
      record, or controls by agreement, voting trust or otherwise, at least 10% of the voting power of the stock of the Corporation, and such term also includes any corporation, partnership, trust, association or other organization or entity in which one
      or more Controlling Persons have the power, through the ownership of voting securities, by contract, or otherwise, to influence significantly any of the management, activities or policies of such corporation, partnership, trust, association, other
      organization or entity and (ii) the term &#8220;Disinterested Stockholders&#8221; means those holders of the stock of the Corporation entitled to vote on any matter, none of which is a &#8220;Controlling Person.&#8221;</div>
    <div style="text-align: justify; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Corporation has caused this Restated Certificate of Incorporation to be duly executed by its authorized
      officer this 9th day of August, 2013.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13(B)
<SEQUENCE>3
<FILENAME>ef20015352_ex10-13b.htm
<DESCRIPTION>EXHIBIT 10.13(B)
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 10.13b<br>
      </font></div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div style="text-align: center; font-weight: bold;">2021 INDUCEMENT STOCK INCENTIVE PLAN</div>
    <div style="text-align: center; font-weight: bold;">TEMPLATE AWARD AGREEMENT</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;"><u>Notice of Stock Option Grant</u></div>
    <div>&#160;</div>
    <div style="text-align: justify;">Eterna Therapeutics Inc. (the &#8220;<u>Company</u>&#8221;) has awarded to you (&#8220;<u>Participant</u>&#8221;) an option to purchase up to the number of shares (&#8220;<u>Shares</u>&#8221;) of Common Stock set forth below (this &#8220;<u>Option</u>&#8221;) under
      the Company&#8217;s 2021 Inducement Stock Incentive Plan (the &#8220;<u>Plan</u>&#8221;).</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za9ea4f08bf074367aa96340295a39e09">

        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Participant Name</font><font style="font-size: 10pt;">:</font></div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Grant ID:</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Grant Date:</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Exercise Price per Share:</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Number of Shares:</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Type of Option:</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">Non-Qualified Stock Option</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Expiration Date:</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Vesting Commencement Date:</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Vesting Schedule:</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 52.26%; vertical-align: top;">
            <div style="text-align: justify;">[<font style="font-style: italic;">insert applicable vesting schedule</font>]</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">Capitalized terms used but not defined in this Notice of Stock Option Grant (this &#8220;<u>Notice</u>&#8221;) or the attached Option Terms and Conditions (including any appendices and exhibits) will have the same meanings
      specified in the Plan. The Notice and the Option Terms and Conditions are collectively referred to as the &#8220;<u>Award Agreement</u>&#8221; applicable to this Option.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">By accepting this Option (whether electronically or otherwise), Participant acknowledges and agrees to the following:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z21725de57c284d468777cf3c0ecad553">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>This Option is governed by all the terms and conditions of the Plan applicable to this Option, whether or not such terms and conditions are stated in the Award Agreement. This Option is governed by the terms and conditions of this Award
              Agreement. In the event of a conflict between the terms of the Plan and this Award Agreement, the terms of the Plan will prevail.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0a7b0e7b30e141d29cf47b4a4c77c1bd">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant has received a copy of the Plan, this Award Agreement, the Plan prospectus (if required under applicable law), and the Company&#8217;s insider trading policy, and represents that he or she has read these documents and is familiar
              with their terms. Participant further agrees to accept as binding, conclusive, and final all decisions and interpretations of the Committee regarding any questions relating to this Option and the Plan.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z47fe79aa1c3b405588b549e991b68c8d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Vesting of this Option is subject to Participant&#8217;s continued employment as an employee, which is for an unspecified duration and may be terminated at any time, with or without Cause, and nothing in this Award Agreement or the Plan changes
              the nature of that relationship.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z29aa59993f954139956b26fad5eca5e4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company is not providing any tax, legal, or financial advice, nor is the Company making any recommendations regarding participation in the Plan. <font style="font-weight: bold; font-style: italic;">Participant should consult with his
                or her own personal tax, legal, and financial advisors regarding participation in the Plan before taking any action related to the Plan</font>.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z76954341c3204c5f84d9d92fb5f5efc4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant consents to electronic delivery and participation as set forth in this Award Agreement.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zae9f7763926644b1be59f0018a36c5f6">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">If Participant does not accept or decline this Option within 60 days of the Grant Date or by such other date that may be communicated to Participant by the Company,
                the Company will accept this Option on Participant&#8217;s behalf and Participant will be deemed to have accepted the terms and conditions of this Option set forth in the Plan and this Award Agreement. If Participant wishes to decline this
                Option, Participant should promptly notify </font><font style="font-size: 10pt;">[&#9679;]<font style="font-weight: bold;"> at </font>[&#9679;]<font style="font-weight: bold;">. If Participant declines this Option, this Option will be cancelled and
                  no benefits from this Option nor any compensation or benefits in lieu of this Option will be provided to Participant</font>.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z19b91a95e07d438786a9f9e062935e17">

        <tr>
          <td colspan="2" style="vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Eterna Therapeutics Inc.</div>
          </td>
          <td style="width: 4%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Participant</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 4%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify;">By:</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 7%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify;">Signature</div>
          </td>
          <td style="width: 41%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify;">:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify;">Title:</div>
          </td>
          <td rowspan="1" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="vertical-align: top; padding-bottom: 2px;">&#160;Date:</td>
          <td rowspan="1" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div style="text-align: center; font-weight: bold;">2021 INDUCEMENT STOCK INCENTIVE PLAN</div>
    <div style="text-align: center; font-weight: bold;">TEMPLATE AWARD AGREEMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;"><u>Option Terms and Conditions</u></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z37699adaaabd485db29df09bbc5514eb">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Grant of Option</u></font><font style="font-size: 10pt;">. Capitalized terms used in the Award Agreement but not defined in the Award Agreement will have the
                same meanings specified in the Plan. Participant has been granted an Option to purchase up to the number of Shares set forth in the Notice at the Exercise Price set forth in the Notice.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6ebe546b1d6f46ec8b7288dd1aa037e9">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Exercise of Option</u></font><font style="font-size: 10pt;">. This Option is exercisable during its term in accordance with the Vesting Schedule contained in the
                Notice and the applicable provisions of the Plan and the Award Agreement. Participant may exercise the vested portion of this Option only by following the option exercise procedures established by the Committee and payment of the aggregate
                Exercise Price for the Shares to be purchased, together with any applicable taxes that the Company or any member of the Company Group is required by any law or regulation of any governmental authority, whether federal, state or local,
                domestic or foreign (&#8220;<u>Taxes</u>&#8221;), to withhold in connection with the exercise of the Option.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3d747062e17844ff88f155dc692cb29d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Method of Payment</u></font><font style="font-size: 10pt;">. Participant may always pay the Exercise Price by personal check (or readily available funds), wire
                transfer, or cashier&#8217;s check. The Committee may also allow any other method of payment permitted by Section 6(g) of the Plan in its discretion at the time of exercise, and any restrictions deemed necessary or appropriate to facilitate
                compliance with applicable law or administration of the Plan (including to avoid the recognition of additional compensation expenses for financial reporting purposes).</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z43659f73673645a4a477678b0148750a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Option Term</u></font><font style="font-size: 10pt;">.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7c84a15fa74f45d4bf1e8fc2f1c8cd89">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Maximum Term</u></font><font style="font-size: 10pt;">. This Option will in all events expire at the close of business at Company headquarters on the Expiration
                Date specified in the Notice, unless it terminates earlier in connection with the termination of Participant&#8217;s employment (as provided below) or a Change in Control (as provided in the Plan).</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb4d308af2e0c4034979939c0968ec36a">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Post-Termination Exercise Period</u></font><font style="font-size: 10pt;">. If Participant&#8217;s employment terminates prior to the Expiration Date of this Option
                other than for Cause, the unvested portion of this Option will automatically expire on Participant&#8217;s date of termination, and the vested portion of this Option will remain outstanding and exercisable for the following periods, unless
                otherwise determined by the Committee and in no event after the Expiration Date of this Option:</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d9867d7f77a41e9a229e7828db73b4e">

        <tr>
          <td style="width: 99pt;">&#160;</td>
          <td style="width: 18pt; vertical-align: top;">i.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>ninety (90) days following a termination for any reason other than Cause, Disability, or death;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z72ce3aae39db4a808d46f1c4b116fd45">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">ii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>twelve (12) months following a termination due to Disability; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1dbe797107d443191b8875dc4f79718">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>twelve (12) months following the date of Participant&#8217;s death, if Participant dies while in employment, or during the period provided in clause (ii) above.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z366b7d29d355487aa4f177792ac375f3">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">c.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>&#160;<font style="font-weight: bold;"><u>Termination for Cause</u></font>. If Participant&#8217;s employment is terminated for Cause, this Option will terminate and be forfeited immediately upon such Participant&#8217;s termination of employment, and
              Participant will be prohibited from exercising any portion (including any vested portion) of this Option on or after the date of such termination. If Participant&#8217;s employment is suspended pending an investigation of whether Participant&#8217;s
              employment will be terminated for Cause, all of Participant&#8217;s rights under this Option, including the right to exercise the Option, shall be suspended during the investigation period.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8069a40d5b424a45a31016bdba673348">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">d.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Determination of Termination Date</u></font><font style="font-size: 10pt;">. For purposes of this Option, Participant&#8217;s employment will be considered terminated
                as of the date Participant is no longer actively providing services to the Company Group (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where
                Participant is employed or the terms of Participant&#8217;s employment agreement, if any). The Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of this Option
                (including whether Participant may still be considered to be providing services while on a leave of absence).</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d7af15e6f2e4f11a10b6109040193c7">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">e.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>No Notice of Option Expiration</u></font><font style="font-size: 10pt;">. Participant is responsible for keeping track of the Expiration Date and the
                post-termination exercise periods following Participant&#8217;s termination of employment for any reason. The Company is not obligated to provide further notice of such periods. In no event will this Option be exercised later than the Expiration
                Date set forth in the Notice.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z78ead3c2e334415aa177b30ad1f1d381">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Transferability of Option</u></font><font style="font-size: 10pt;">. This Option may not be transferred in any manner other than by will or by the laws of
                descent or distribution or court order and may be exercised during the lifetime of Participant only by Participant. The terms of the Plan and this Award Agreement will be binding upon the executors, administrators, heirs, successors, and
                assigns of Participant.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1ab9a09528f24c00b7459ee44396801f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Taxes</u></font><font style="font-size: 10pt;">.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdf9ee9c72bab4b0da706f7434bf3b193">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Responsibility for Taxes</u></font><font style="font-size: 10pt;">. By accepting this Option, Participant acknowledges that, regardless of any action taken by
                the Company or, if different, any member of the Company Group that employs Participant (the &#8220;<u>Employer</u>&#8221;), the ultimate liability for all Taxes is and remains Participant&#8217;s responsibility and may exceed the amount actually withheld by
                the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Taxes in connection with any aspect of this Option, including, but
                not limited to, the grant, vesting, or exercise of this Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms
                of the grant or any aspect of this Option to reduce or eliminate Participant&#8217;s liability for Taxes or achieve any particular tax result. Further, if Participant is subject to Taxes in more than one jurisdiction, as applicable, Participant
                acknowledges that the Company and/or the Employer may be required to withhold or account for Taxes in more than one jurisdiction. Participant agrees to pay to the Company or the Employer any amount of Taxes that the Company or the Employer
                may be required to withhold or account for as a result of Participant&#8217;s participation in the Plan that cannot be satisfied by the means described in this Section. The Company may refuse to issue or deliver the Shares or the proceeds of the
                sale of Shares, if Participant fails to comply with Participant&#8217;s obligations in connection with the Taxes.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z03ef1c78f5274b82951088b515c80866">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Withholding</u></font><font style="font-size: 10pt;">. Prior to the relevant taxable or tax withholding event, as applicable, Participant agrees to make adequate
                arrangements satisfactory to the Company and/or the Employer to satisfy all Taxes. In this regard, Participant authorizes the Company or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard
                to all Taxes by one or a combination of the following:</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaac4bc9623c148b5a97b98d4a6f42f1b">

        <tr>
          <td style="width: 99pt;">&#160;</td>
          <td style="width: 18pt; vertical-align: top;">i.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding from Participant&#8217;s wages or other cash compensation paid to Participant by the Company and/or the Employer or any member of the Company Group;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zedf2a98f18ca4e559ff625ce0ed7890c">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">ii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding from proceeds of the sale of Shares acquired at exercise of this Option either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant&#8217;s behalf pursuant to this authorization and without
              further consent);</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z174758b8fd1043e4b9399563a139795d">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding Shares to be issued upon exercise of this Option, provided the Company only withholds a number of Shares necessary to satisfy no more than the withholding amounts determined based on the maximum permitted statutory rate
              applicable in Participant&#8217;s jurisdiction;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z663bfd5436f8431d88540df222050035">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iv.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant&#8217;s payment of a cash amount (including by check representing readily available funds or a wire transfer); or</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7ede38234bd341a9a0bb1d075e6de10d">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">v.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any other arrangement approved by the Committee and permitted under applicable law.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">Withholding for Taxes will be made in accordance with Section 13(c) of the Plan and such rules and procedures as may be established by the Committee, and in compliance with the Company&#8217;s insider trading policy, if
      applicable. In the event the Company or the Employer withholds more than the Taxes using one of the methods described above, Participant may receive a refund of any over-withheld amount in cash but will have no entitlement to the Shares sold or
      withheld.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za5d43a6f49124ccd8a0d10bf3c105ff1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Nature of Grant</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. In accepting this Option, Participant acknowledges,
                understands and agrees that: (a) the Plan is established voluntarily by the Company, is discretionary in nature, and may be amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan; (b) the grant of
                this Option is voluntary and occasional and does not create any contractual or other right to receive future grants, or benefits in lieu of grants, even if grants have been made in the past; (c) all decisions with respect to future grants,
                if any, will be at the sole discretion of the Company; (d) Participant is voluntarily receiving this Option; (e) this Option and the Shares allocated to this Option are not intended to replace any pension rights or compensation and are
                outside the scope of Participant&#8217;s employment contract, if any; (f) this Option and the Shares allocated to this Option, and the income and value of same, are not part of normal or expected compensation for any purpose, including, without
                limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of- service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments; (g) unless otherwise provided in
                the Plan or by the Company in its discretion, this Option and the benefits evidenced by this Award Agreement do not create any entitlement to have this Option or any such benefits transferred to, or assumed by, another company nor to be
                exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; and (h) neither the Company nor any member of the Company Group shall be liable for any foreign exchange rate fluctuation between
                Participant&#8217;s local currency and the United States Dollar or the selection by the Company or any member of the Company Group in its sole discretion of an applicable foreign exchange rate that may affect the value of this Option (or the
                calculation of income or Taxes thereunder) or of any amounts due to Participant pursuant to the settlement of this Option or the subsequent sale of the Shares allocated to this Option.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z951d82fbadd6400c8c31a27f5cce5424">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Code Section 409A</u></font><font style="font-size: 10pt;">. It is intended that the terms of this Option will not result in the imposition of any tax liability
                pursuant to Section 409A of the Code, and this Award Agreement shall be construed and interpreted consistent with that intent. Notwithstanding the foregoing, no member of the Company Group shall be liable for any costs incurred by
                Participant under Section 409A of the Code and similar state laws.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z83b395398ca9478789a9873748834d2c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Data Privacy</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. </font><font style="font-size: 10pt; font-weight: bold; font-style: italic; color: rgb(0, 0, 0);">Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant&#8217;s personal data as described in this Award Agreement and any
                other grant materials by and among the Company and the members of the Company Group for the purpose of implementing, administering and managing Participant&#8217;s participation in the Plan. Participant understands that the Company and the
                members of the Company Group may hold certain personal information about Participant, including, but not limited to, Participant&#8217;s name, home address and telephone number, date of birth, social insurance number or other identification
                number, salary, nationality, job title, any Shares or directorships held in the Company, details of all grants, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor (&#8220;<u>Data</u>&#8221;),
                for the purpose of implementing, administering and managing the Plan. Participant understands that Data will be transferred to such stock plan service provider as may be selected by the Company, presently or in the future, which may be
                assisting the Company with the implementation, administration and management of the Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country (e.g., the
                United States) may have different data privacy laws and protections than Participant&#8217;s country. Participant authorizes the Company, the stock plan service provider as may be selected by the Company, and any other possible recipients which
                may assist the Company, presently or in the future, with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering
                and managing the Plan. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, or instructs
                the Company to cease the processing of the Data, his or her employment or service will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant&#8217;s consent or instructing the Company to cease processing,
                is that the Company would not be able to grant Participant the Option or any other equity awards or administer or maintain such awards. Therefore, Participant understands that refusing or withdrawing his or her consent may affect
                Participant&#8217;s ability to participate in the Plan. For more information on the consequences of Participant&#8217;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources
                representative.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf4489bdeefc94d849e6f8890ea88af98">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Governing Law and Venue</u></font><font style="font-size: 10pt;">. This Award Agreement shall be governed by and construed and interpreted in accordance with the
                laws of the State of Delaware, without giving effect to principles of conflicts of law. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this grant or this Award
                Agreement, the parties hereby submit to the exclusive jurisdiction of the State of Delaware and agree that such litigation shall be conducted only in the courts of the State of Delaware, or the federal courts for the United States for the
                District of Delaware, and no other courts, where this grant is made and/or to be performed.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8947537e8b59403a90c95bdfecc721ed">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Addendum and Sub-Plans</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. Notwithstanding any provisions in this Award
                Agreement, this Option shall be subject to any special terms and conditions set forth in any Addendum to this Award Agreement for Participant&#8217;s country. Moreover, if Participant relocates to one of the countries included in the Addendum (if
                any), the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The
                Addendum (if any) constitutes part of this Award Agreement. Further, the Plan shall be deemed to include any special terms and conditions set forth in any applicable sub-plan for Participant&#8217;s country, and, if Participant relocates to a
                country for which the Company has established a sub-plan, the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or
                advisable for legal or administrative reasons.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z22129af6e1c9485692a5ebb846d86a7d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">12.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Entire Agreement; Enforcement of Rights; Amendment</u></font><font style="font-size: 10pt;">. This Award Agreement, together with the Plan, sets forth the entire
                agreement and understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, agreements, commitments, negotiations and arrangements between them. Except as contemplated by the
                Plan, no modification of or amendment to this Award Agreement, nor any waiver of any rights under this Award Agreement, shall be effective unless in writing signed by the parties to this Award Agreement to the extent it would alter or
                impair rights or obligations under the Option. The failure by either party to enforce any rights under this Award Agreement shall not be construed as a waiver of any rights of such party. Notwithstanding anything to the contrary in the Plan
                or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Section 409A of the Code or to
                otherwise avoid imposition of any additional tax or income recognition or costs under Section 409A of the Code in connection with this Option.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1733e1b015d4ad68daf9ab0312c2d64">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">13.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Severability</u></font><font style="font-size: 10pt;">. If one or more provisions of this Award Agreement are held to be unenforceable under applicable laws, the
                parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Award Agreement,
                (b) the balance of this Award Agreement shall be interpreted as if such provision were so excluded, and (c) the balance of this Award Agreement shall be enforceable in accordance with its terms.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z38f018c0fc904aeead3071a2ab1682ce">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">14.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Language</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. If Participant has received this Award Agreement, the Plan or any
                other document related to this Option and/or the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24bdad77bef44f6aa104deebcdf5a9b8">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">15.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Imposition of Other Requirements</u></font><font style="font-size: 10pt;">. The Company reserves the right to impose other requirements on Participant&#8217;s
                participation in the Plan, on this Option and on any Shares purchased upon exercise of this Option, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to accept
                any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3e3585f3033046d78b153f5a5d0e5965">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">16.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Notices</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. Any notice, demand or request required or permitted to be given
                under this Award Agreement shall be in writing and shall be deemed sufficient when delivered personally or by overnight courier or sent by email or fax, or forty-eight (48) hours after being deposited in the U.S. mail or a comparable
                foreign mail service, as certified or registered mail with postage or shipping charges prepaid, addressed to the party to be notified at such party&#8217;s address as set forth on the signature page, as subsequently modified by written notice, or
                if no address is specified on the signature page, at the most recent address, email or fax number set forth in the Company&#8217;s books and records.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf84a2f7670f0412d952d5a8c5b616cf4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">17.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Counterparts</u>. </font><font style="font-size: 10pt; color: rgb(0, 0, 0);">This Award Agreement may be executed in two or more
                counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. Facsimile, email or other electronic execution and delivery of this Award Agreement (including but not limited to execution
                by electronic signature or click-through electronic acceptance) shall constitute valid and binding execution and delivery for all purposes and shall be deemed to be, and have the effect of, an original signature.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za27c27d18c944334afa86c8fdb2acf98">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">18.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Successors and Assigns</u></font><font style="font-size: 10pt;">. The rights and benefits of this Award Agreement shall inure to the benefit of, and be
                enforceable by the Company&#8217;s successors and assigns.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc883b25c0cf8469f8a4498c137708926">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">19.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Consent to Electronic Delivery and Participation</u></font><font style="font-size: 10pt;">. By accepting this Option, Participant agrees to participate in the
                Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company, and consents to the electronic delivery of the Award Agreement, the Plan, account statements, Plan
                prospectuses (if any), and all other documents, communications, or information related to this Option and current or future participation in the Plan. Electronic delivery may include the delivery of a link to the Company intranet or the
                internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other delivery determined at the Company&#8217;s discretion. Participant acknowledges that Participant may receive from the Company
                a paper copy of any documents delivered electronically at no cost if Participant contacts the Company by telephone, through a postal service, or electronic mail to Company&#8217;s stock plan administration.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div> <br>
    </div>
    <div style="text-align: center;"> <font class="BRPFPageNumber" style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">9</font></div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13(C)
<SEQUENCE>4
<FILENAME>ef20015352_ex10-13c.htm
<DESCRIPTION>EXHIBIT 10.13(C)
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 10.13c<br>
      </font></div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div style="text-align: center; font-weight: bold;">2021 INDUCEMENT STOCK INCENTIVE PLAN</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">TEMPLATE AWARD AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;"><u>Notice of RSU Grant</u></div>
    <div>&#160;</div>
    <div style="text-align: justify;">Eterna Therapeutics Inc. (the &#8220;<u>Company</u>&#8221;) has awarded to you (&#8220;<u>Participant</u>&#8221;) the number of RSUs (&#8220;<u>RSUs</u>&#8221;) set forth below (the &#8220;<u>RSU Grant</u>&#8221;) under the Company&#8217;s 2021 Inducement Stock Incentive
      Plan (the &#8220;<u>Plan</u>&#8221;).</div>
    <div style="text-align: justify;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zebf4e8f9045f4955bf8cdfb5173c29eb">

        <tr>
          <td style="width: 47.66%; vertical-align: top;">
            <div style="text-align: justify; text-indent: -12pt; margin-left: 12pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Participant Name</font><font style="font-size: 10pt;">:</font></div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: bottom;">
            <div style="text-align: justify; font-weight: bold;">Grant ID:</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: bottom;">
            <div style="text-align: justify; font-weight: bold;">Grant Date:</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: bottom;">
            <div style="text-align: justify; font-weight: bold;">Number of RSUs:</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: bottom;">
            <div style="text-align: justify; font-weight: bold;">Country at Grant:</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: bottom;">
            <div style="text-align: justify; font-weight: bold;">Vesting Commencement Date:</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom;">
            <div style="text-align: justify;">[&#9679;]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: middle;">&#160;</td>
          <td colspan="2" style="vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47.66%; vertical-align: bottom;">
            <div style="text-align: justify; font-weight: bold;">Vesting Schedule:</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom;">
            <div style="text-align: justify;">[<font style="font-style: italic;">insert applicable vesting schedule</font>]</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">Capitalized terms used but not defined in this Notice of RSU Grant (this &#8220;<u>Notice</u>&#8221;) or the attached RSU Terms and Conditions (including any appendices and exhibits attached thereto) will have the same meanings
      specified in the Plan. The Notice and the RSU Terms and Conditions are collectively referred to as the &#8220;<u>Award Agreement</u>&#8221; applicable to the RSUs.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">By accepting (whether electronically or otherwise) the RSU Grant, Participant acknowledges and agrees to the following:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0141dc5b42d24cc38de48defcea7db66">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>This RSU Grant is governed by all the terms and conditions of the Plan applicable to the RSU Grant, whether or not such terms and conditions are stated in the Award Agreement. The RSU Grant is governed by the terms and conditions of this
              Award Agreement. In the event of a conflict between the terms of the Plan and this Award Agreement, the terms of the Plan will prevail.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc28097932c044099a5b7b33d99cf7cc4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant has received a copy of the Plan, this Award Agreement, the Plan prospectus (if required under applicable law), and the Company&#8217;s insider trading policy, and represents that he or she has read these documents and is familiar
              with their terms. Participant further agrees to accept as binding, conclusive, and final all decisions and interpretations of the Committee regarding any questions relating to the RSU Grant and the Plan.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdd3f8acbb1e84f68a6a7febb334fde7d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Vesting of the RSUs is subject to Participant&#8217;s continued employment as an employee, which is for an unspecified duration and may be terminated at any time, with or without Cause, and nothing in this Award Agreement or the Plan changes the
              nature of that relationship.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfb1347847c8344548491ebbe09793d20">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company is not providing any tax, legal, or financial advice, nor is the Company making any recommendations regarding participation in the Plan. <font style="font-weight: bold; font-style: italic;">Participant should consult with his
                or her own personal tax, legal, and financial advisors regarding participation in the Plan before taking any action related to the Plan</font>.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze3ec4bbc57534bb8b00ad1b35fa0291d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant consents to electronic delivery and participation as set forth in this Award Agreement.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z49d3b2eca89b45d4ad331cb20d72ef8a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">If Participant does not accept or decline the RSUs within 60 days of the Grant Date or by such other date that may be communicated to Participant by the Company,
                the Company will accept the RSUs on Participant&#8217;s behalf and Participant will be deemed to have accepted the terms and conditions of the RSUs set forth in the Plan and this Award Agreement. If Participant wishes to decline the RSUs,
                Participant should promptly notify </font><font style="font-size: 10pt;">[&#9679;]<font style="font-weight: bold;"> at </font>[&#9679;]<font style="font-weight: bold;">. If Participant declines the RSUs, the RSUs will be cancelled and no benefits
                  from the RSUs nor any compensation or benefits in lieu of the RSUs will be provided to Participant</font>.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6ca749c524574c18a7f04e3210e47f66">

        <tr>
          <td colspan="2" style="vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Eterna Therapeutics Inc.</div>
          </td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Participant</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify;">By:</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 8%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify;">Signature:</div>
          </td>
          <td style="width: 41%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify;">Title:</div>
          </td>
          <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: justify;">Date:</div>
          </td>
          <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div style="text-align: center; font-weight: bold;">2021 INDUCEMENT STOCK INCENTIVE PLAN</div>
    <div style="text-align: center; font-weight: bold;">TEMPLATE AWARD AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: justify; font-weight: bold;"><u>RSU Terms and Conditions</u></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d9a30311db7486aa78fbcf391225dcd">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Grant of RSUs</u></font><font style="font-size: 10pt;">. Capitalized terms used in the Award Agreement but not defined in the Award Agreement will have the same
                meanings specified in the Plan. An RSU is a non-voting unit of measurement which is deemed solely for bookkeeping purposes to be equivalent to one outstanding share of Common Stock (a &#8220;<u>Share</u>&#8221;). The RSUs are used solely as a device to
                determine the number of Shares to eventually be issued to Participant if such RSUs vest. The RSUs shall not be treated as property or as a trust fund of any kind.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3172bd93f9bd4daab531846ae91c7735">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Settlement</u></font><font style="font-size: 10pt;">. On or as soon as administratively practical (and within thirty (30) days) following the applicable date of
                vesting under the Vesting Schedule set forth in the Notice (a &#8220;<u>Vesting Date</u>&#8221;), the Company will deliver to Participant a number of Shares (either by delivering one or more certificates for such Shares or by entering such Shares in
                book entry form, as determined by the Company in its discretion) equal to the number of RSUs subject to the RSU Grant that vest on the applicable Vesting Date, subject to payment by Participant of any applicable taxes that the Company or
                any member of the Company Group is required by any law or regulation of any governmental authority, whether federal, state or local, domestic or foreign (&#8220;<u>Taxes</u>&#8221;) to withhold in connection with such delivery. No fractional RSUs or
                rights for fractional Shares shall be created pursuant to this Award Agreement.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb8408dc96421495983e060682e115e4a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Dividend and Voting Rights</u></font><font style="font-size: 10pt;">. Unless and until such time as Shares are issued in settlement of vested RSUs, Participant
                will have no ownership of the Shares allocated to the RSUs, and will have no rights to vote such Shares and no rights to dividends.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3c69f4bc30ca4a16857ce50592755ec1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Transferability of RSUs</u></font><font style="font-size: 10pt;">. The RSUs and any interest therein will not be sold, assigned, transferred, pledged,
                hypothecated, or otherwise disposed of in any manner other than by will or by the laws of descent or distribution or court order. The terms of the Plan and this Award Agreement will be binding upon the executors, administrators, heirs,
                successors, and assigns of Participant.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1b79c51645ee48b5ae431065a7b6725b">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Termination.</u></font><font style="font-size: 10pt;"> If Participant&#8217;s employment terminates for any reason, all unvested RSUs will be forfeited to the Company,
                and all rights of Participant to such RSUs will immediately terminate without payment of any consideration to Participant. The Committee shall have the exclusive discretion to determine when Participant is no longer actively providing
                services for purposes of this RSU Grant (including whether Participant may still be considered to be providing services while on a leave of absence).</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdfbd944b924341f69fe933ed3fd271a2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Taxes</u></font><font style="font-size: 10pt;">.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf4c4ff345d164e32bbdf31dd9993bafa">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Responsibility for Taxes</u></font><font style="font-size: 10pt;">. By accepting this RSU Grant, Participant acknowledges that, regardless of any action taken by
                the Company or, if different, any member of the Company Group that employs Participant (the &#8220;<font style="font-weight: bold; font-style: italic;">Employer</font>&#8221;), the ultimate liability for all Taxes is and remains Participant&#8217;s
                responsibility and may exceed the amount actually withheld by the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any
                Taxes in connection with any aspect of the RSU Grant, including, but not limited to, the grant, vesting, or settlement of the RSU Grant, the subsequent sale of Shares acquired pursuant to such settlement, and the receipt of any dividends;
                and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSU Grant to reduce or eliminate Participant&#8217;s liability for Taxes or achieve any particular tax result. Further, if Participant
                is subject to Taxes in more than one jurisdiction, as applicable, Participant acknowledges that the Company and/or the Employer may be required to withhold or account for Taxes in more than one jurisdiction. Participant agrees to pay to the
                Company or the Employer any amount of Taxes that the Company or the Employer may be required to withhold or account for as a result of the RSUs that cannot be satisfied by the means described in this Section. The Company may refuse to issue
                or deliver the Shares, or the proceeds of the sale of Shares, if Participant fails to comply with Participant&#8217;s obligations in connection with the Taxes.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z68ea9bbbe5534c40919533a3cc61d59d">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Withholding</u></font><font style="font-size: 10pt;">. Prior to the relevant taxable or Taxes withholding event, as applicable, Participant agrees to make
                adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Taxes. In this regard, Participant authorizes the Company or the Employer, or their respective agents, at their discretion, to satisfy the obligations with
                regard to all Taxes by one or a combination of the following:</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z78bd5fe8117140b899260839ed440404">

        <tr>
          <td style="width: 99pt;">&#160;</td>
          <td style="width: 18pt; vertical-align: top;">i.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding from Participant&#8217;s wages or other cash compensation paid to Participant by the Company and/or the Employer or any member of the Company Group;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zba62d71dc352419fb85fb445822be8e7">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">ii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding from proceeds of the sale of Shares acquired on settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant&#8217;s behalf pursuant to this authorization and without
              further consent);</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2f3e3d167b774585ae957b6d52481d05">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding Shares to be issued upon settlement of the RSUs, provided the Company only withholds a number of Shares necessary to satisfy no more than the withholding amounts determined based on the maximum permitted statutory rate
              applicable in Participant&#8217;s jurisdiction;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6a86c46677a74775a3a4efdf53e9046d">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iv.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant&#8217;s payment of a cash amount (including by check representing readily available funds or a wire transfer); or</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2534560ba42a414781f55e6ecd462fd3">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">v.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any other arrangement approved by the Committee and permitted under applicable law.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify;">Withholding for Taxes will be made in accordance with Section 13(c) of the Plan and such rules and procedures as may be established by the Committee, and in compliance with the Company&#8217;s insider trading policy, if
      applicable. In the event the Company or the Employer withholds more than the Taxes using one of the methods described above, Participant may receive a refund of any over-withheld amount in cash but will have no entitlement to the Shares sold or
      withheld.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1f5f8be63a4485c8bab43cfd39871a3">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Nature of Grant</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. In accepting the RSUs, Participant acknowledges, understands
                and agrees that: (a) the Plan is established voluntarily by the Company, is discretionary in nature, and may be amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan; (b) the grant of the RSUs is
                voluntary and occasional and does not create any contractual or other right to receive future grants, or benefits in lieu of grants, even if grants have been made in the past; (c) all decisions with respect to future grants, if any, will be
                at the sole discretion of the Company; (d) Participant is voluntarily receiving the RSUs; (e) the RSUs and the Shares allocated to the RSUs are not intended to replace any pension rights or compensation and are outside the scope of
                Participant&#8217;s employment contract, if any; (f) the RSUs and the Shares allocated to the RSUs, and the income and value of same, are not part of normal or expected compensation for any purpose, including, without limitation, calculating any
                severance, resignation, termination, redundancy, dismissal, end-of- service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments; (g) unless otherwise provided in the Plan or by the Company
                in its discretion, the RSUs and the benefits evidenced by this Award Agreement do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted
                for, in connection with any corporate transaction affecting the Shares; and (h) neither the Company nor any member of the Company Group shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the
                United States Dollar or the selection by the Company or any member of the Company Group in its sole discretion of an applicable foreign exchange rate that may affect the value of the RSUs (or the calculation of income or Taxes thereunder)
                or of any amounts due to Participant pursuant to the settlement of the RSUs or the subsequent sale of the Shares allocated to the RSUs.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc1e7967d4011476891abf17d2223f6e7">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Code Section 409A</u></font><font style="font-size: 10pt;">. It is intended that the terms of the RSUs will not result in the imposition of any tax liability
                pursuant to Section 409A of the Code, and this Award Agreement shall be construed and interpreted consistent with that intent. Payments pursuant to this Restricted Stock Unit Grant are intended to constitute separate payments for purposes
                of Section 409A of the Code. Notwithstanding the foregoing, no member of the Company Group shall be liable for any costs incurred by Participant under Section 409A of the Code and similar state laws.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcfc48547d0e34fb3855e7a8041a206cb">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Data Privacy</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. </font><font style="font-size: 10pt; font-weight: bold; font-style: italic; color: rgb(0, 0, 0);">Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant&#8217;s personal data as described in this Award Agreement and any
                other grant materials by and among the Company and the members of the Company Group for the purpose of implementing, administering and managing Participant&#8217;s participation in the Plan. Participant understands that the Company and the
                members of the Company Group may hold certain personal information about Participant, including, but not limited to, Participant&#8217;s name, home address and telephone number, date of birth, social insurance number or other identification
                number, salary, nationality, job title, any Shares or directorships held in the Company, details of all grants, or any other entitlement to Shares awarded, canceled, received, vested, unvested or outstanding in Participant&#8217;s favor (&#8220;<u>Data</u>&#8221;),
                for the purpose of implementing, administering and managing the Plan. Participant understands that Data will be transferred to such stock plan service provider as may be selected by the Company, presently or in the future, which may be
                assisting the Company with the implementation, administration and management of the Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country (e.g., the
                United States) may have different data privacy laws and protections than Participant&#8217;s country. Participant authorizes the Company, the stock plan service provider as may be selected by the Company, and any other possible recipients which
                may assist the Company, presently or in the future, with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering
                and managing the Plan. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, or instructs
                the Company to cease the processing of the Data, his or her employment or service will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant&#8217;s consent or instructing the Company to cease processing,
                is that the Company would not be able to grant Participant the RSUs or any other equity awards or administer or maintain such awards. Therefore, Participant understands that refusing or withdrawing his or her consent may affect
                Participant&#8217;s ability to participate in the Plan. For more information on the consequences of Participant&#8217;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources
                representative.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8b22c766dbd4efca8b1ba5bd39013f9">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Governing Law and Venue</u></font><font style="font-size: 10pt;">. This Award Agreement shall be governed by and construed and interpreted in accordance with the
                laws of the State of Delaware, without giving effect to principles of conflicts of law. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this grant or this Award
                Agreement, the parties hereby submit to the exclusive jurisdiction of the State of Delaware and agree that such litigation shall be conducted only in the courts of the State of Delaware, or the federal courts for the United States for the
                District of Delaware, and no other courts, where this grant is made and/or to be performed.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zebaaa9e9e3124272ae43cd53f9c8bd45">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Addendum and Sub-Plans</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. Notwithstanding any provisions in this Award
                Agreement, the RSUs shall be subject to any special terms and conditions set forth in any Addendum to this Award Agreement for Participant&#8217;s country. Moreover, if Participant relocates to one of the countries included in the Addendum (if
                any), the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The
                Addendum (if any) constitutes part of this Award Agreement. Further, the Plan shall be deemed to include any special terms and conditions set forth in any applicable sub-plan for Participant&#8217;s country, and, if Participant relocates to a
                country for which the Company has established a sub-plan, the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or
                advisable for legal or administrative reasons.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeb762a2bc23343f7889c34f72bf256d1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">12.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Entire Agreement; Enforcement of Rights; Amendment</u></font><font style="font-size: 10pt;">. This Award Agreement, together with the Plan, sets forth the entire
                agreement and understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, agreements, commitments, negotiations and arrangements between them. Except as contemplated by the
                Plan, no modification of or amendment to this Award Agreement, nor any waiver of any rights under this Award Agreement, shall be effective unless in writing signed by the parties to this Award Agreement to the extent it would alter or
                impair rights or obligations under the RSUs. The failure by either party to enforce any rights under this Award Agreement shall not be construed as a waiver of any rights of such party. Notwithstanding anything to the contrary in the Plan
                or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Section 409A of the Code or to
                otherwise avoid imposition of any additional tax or income recognition or costs under Section 409A of the Code in connection with the RSUs.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f0a7c9f503a45dd98ac2f2f6638c9b2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">13.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Severability</u></font><font style="font-size: 10pt;">. If one or more provisions of this Award Agreement are held to be unenforceable under applicable laws, the
                parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Award Agreement,
                (b) the balance of this Award Agreement shall be interpreted as if such provision were so excluded, and (c) the balance of this Award Agreement shall be enforceable in accordance with its terms.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z949e8635b8c5424eb6ab2641659d9d4f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">14.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Language</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. If Participant has received this Award Agreement, the Plan or any
                other document related to the RSUs and/or the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfa0eae0d526e4c55ae4f74d4019720db">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">15.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Imposition of Other Requirements</u></font><font style="font-size: 10pt;">. The Company reserves the right to impose other requirements on Participant&#8217;s
                participation in the Plan, on the RSUs and on any Shares received under the RSUs, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to accept any additional
                agreements or undertakings that may be necessary to accomplish the foregoing.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfa425e365f3b4c12a429f62cdb733448">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">16.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Notices</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. Any notice, demand or request required or permitted to be given
                under this Award Agreement shall be in writing and shall be deemed sufficient when delivered personally or by overnight courier or sent by email or fax, or forty-eight (48) hours after being deposited in the U.S. mail or a comparable
                foreign mail service, as certified or registered mail with postage or shipping charges prepaid, addressed to the party to be notified at such party&#8217;s address as set forth on the signature page, as subsequently modified by written notice, or
                if no address is specified on the signature page, at the most recent address, email or fax number set forth in the Company&#8217;s books and records.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z18cbd52c10944327a1bd5d6d64a7c3d1">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">17.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Counterparts</u>. </font><font style="font-size: 10pt; color: rgb(0, 0, 0);">This Award Agreement may be executed in two or more
                counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. Facsimile, email or other electronic execution and delivery of this Award Agreement (including but not limited to execution
                by electronic signature or click-through electronic acceptance) shall constitute valid and binding execution and delivery for all purposes and shall be deemed to be, and have the effect of, an original signature.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zea4cc15e903042c28b9d9a98f790c7a3">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">18.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Successors and Assigns</u></font><font style="font-size: 10pt;">. The rights and benefits of this Award Agreement shall inure to the benefit of, and be
                enforceable by the Company&#8217;s successors and assigns.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb1a254bbeb99403b995d96f8bdaead62">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">19.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Consent to Electronic Delivery and Participation</u></font><font style="font-size: 10pt;">. By accepting the RSUs, Participant agrees to participate in the Plan
                through an on-line or electronic system established and maintained by the Company or a third party designated by the Company, and consents to the electronic delivery of the Award Agreement, the Plan, account statements, Plan prospectuses
                (if any), and all other documents, communications, or information related to the RSUs and current or future participation in the Plan. Electronic delivery may include the delivery of a link to the Company intranet or the internet site of a
                third party involved in administering the Plan, the delivery of the document via e-mail or such other delivery determined at the Company&#8217;s discretion. Participant acknowledges that Participant may receive from the Company a paper copy of
                any documents delivered electronically at no cost if Participant contacts the Company by telephone, through a postal service, or electronic mail to Company&#8217;s stock administration.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div><br>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
  <div class="BRPFPageNumberArea" style="text-align: center;">
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14(B)
<SEQUENCE>5
<FILENAME>ef20015352_ex10-14b.htm
<DESCRIPTION>EXHIBIT 10.14(B)
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 10.14b<br>
      </font></div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div style="text-align: center; font-weight: bold;">RESTATED 2020 STOCK INCENTIVE PLAN</div>
    <div style="text-align: center; font-weight: bold;">AWARD AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;"><u>Notice of Stock Option Grant</u></div>
    <div>&#160;</div>
    <div style="text-align: justify;">Eterna Therapeutics Inc. (the &#8220;<u>Company</u>&#8221;) has awarded to you (&#8220;<u>Participant</u>&#8221;) an option to purchase up to the number of shares (&#8220;<u>Shares</u>&#8221;) of Common Stock set forth below (this &#8220;<u>Option</u>&#8221;) under
      its Restated 2020 Stock Incentive Plan (the &#8220;<u>Plan</u>&#8221;).</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z823af8fcfc8b4cd0b9cebab81841436f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Participant Name</font><font style="font-size: 10pt;">:</font></div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Grant ID:</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Grant Date:</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Exercise Price per Share:</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Number of Shares:</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Type of Option:</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Expiration Date:</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Vesting Commencement Date:</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: middle;">&#160;</td>
          <td style="vertical-align: middle;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 53%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Vesting Schedule:</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: justify;">&#160;&#160;</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; ]</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">Capitalized terms used but not defined in this Notice of Stock Option Grant (this &#8220;<font style="font-weight: bold; font-style: italic;">Notice</font>&#8221;) or the attached Option Terms and Conditions (including any
      appendices and exhibits) will have the same meanings specified in the Plan. The Notice and the Option Terms and Conditions are collectively referred to as the &#8220;<u>Award Agreement&#8221;</u> applicable to this Option.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">By accepting this Option (whether electronically or otherwise), Participant acknowledges and agrees to the following:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9c1ea2f7b2fd465cb3297d06810bfaa2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>This Option is governed by all the terms and conditions of the Plan applicable to this Option, whether or not such terms and conditions are stated in the Award Agreement. This Option is governed by the terms and conditions of this Award
              Agreement. In the event of a conflict between the terms of the Plan and this Award Agreement, the terms of the Plan will prevail.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z62d4e1f2e0c0400e9c8b96136b99057c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant has received a copy of the Plan, this Award Agreement, the Plan prospectus (if required under applicable law), and the Company&#8217;s insider trading policy, and represents that he or she has read these documents and is familiar
              with their terms. Participant further agrees to accept as binding, conclusive, and final all decisions and interpretations of the Committee regarding any questions relating to this Option and the Plan.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z56364c6d02694da587d4f5c1ff18c8cc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Vesting of this Option is subject to Participant&#8217;s continued [employment] [service] as an [employee] [director] [consultant], which is for an unspecified duration and may be terminated at any time, with or without Cause, and nothing in
              this Award Agreement or the Plan changes the nature of that relationship.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z61e55294e55b491d889bea9620110631" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company is not providing any tax, legal, or financial advice, nor is the Company making any recommendations regarding participation in the Plan. <font style="font-weight: bold; font-style: italic;">Participant should consult with his
                or her own personal tax, legal, and financial advisors regarding participation in the Plan before taking any action related to the Plan</font>.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zad93dd24edea46be86f48d005d991cc4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant consents to electronic delivery and participation as set forth in this Award Agreement.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z656f741bc2ae4661a030d1efa4f83fbf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">If Participant does not accept or decline this Option within 60 days of the Grant Date or by such other date that may be communicated to Participant by the Company,
                the Company will accept this Option on Participant&#8217;s behalf and Participant will be deemed to have accepted the terms and conditions of this Option set forth in the Plan and this Award Agreement. If Participant wishes to decline this
                Option, Participant should promptly notify </font><font style="font-size: 10pt;">[&#9679;]<font style="font-weight: bold;"> at </font>[&#9679;]<font style="font-weight: bold;">. If Participant declines this Option, this Option will be cancelled and
                  no benefits from this Option nor any compensation or benefits in lieu of this Option will be provided to Participant</font>.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; font-weight: bold;">Eterna Therapeutics Inc.</div>
            </td>
            <td style="width: 2%; vertical-align: top;">&#160;</td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; font-weight: bold;">Participant</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify;">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 8%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify;">Signature:</div>
            </td>
            <td style="width: 41%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify;">Title:</div>
            </td>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify;">Date:</div>
            </td>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
    </div>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div style="text-align: center; font-weight: bold;">RESTATED 2020 STOCK INCENTIVE PLAN</div>
    <div style="text-align: center; font-weight: bold;">TEMPLATE AWARD AGREEMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-weight: bold;"><u>Option Terms and Conditions</u></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0f76d485745f4bc3b2d5bf2f48acddad" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Grant of Option</u></font><font style="font-size: 10pt;">. Capitalized terms used in the Award Agreement but not defined in the Award Agreement will have the
                same meanings specified in the Plan. Participant has been granted an Option to purchase up to the number of Shares set forth in the Notice at the Exercise Price set forth in the Notice. If designated in the Notice as an Incentive Stock
                Option, this Option is intended to qualify as an Incentive Stock Option under Section 422 of the Code. However, even if this Option is intended to be an Incentive Stock Option, it will be treated as a Non-Qualified Stock Option to the
                extent that it exceeds the $100,000 limit contained in Section 422(d) of Code, as provided in the Plan.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z39e8e30706bb4e25a88a7110ef848cab" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Exercise of Option</u></font><font style="font-size: 10pt;">. This Option is exercisable during its term in accordance with the Vesting Schedule contained in the
                Notice and the applicable provisions of the Plan and the Award Agreement. Participant may exercise the vested portion of this Option only by following the option exercise procedures established by the Committee and payment of the aggregate
                Exercise Price for the Shares to be purchased, together with any applicable taxes that the Company is required by any law or regulation of any governmental authority, whether federal, state or local, domestic or foreign (&#8220;<u>Taxes</u>&#8221;), to
                withhold in connection with the exercise of the Option.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zc9551b39f9554d0f824b8b217d442cfd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Method of Payment</u></font><font style="font-size: 10pt;">. Participant may always pay the Exercise Price by personal check (or readily available funds), wire
                transfer, or cashier&#8217;s check. The Committee may also allow any other method of payment permitted by Section 6(h) of the Plan in its discretion at the time of exercise, and any restrictions deemed necessary or appropriate to facilitate
                compliance with applicable law or administration of the Plan (including to avoid the recognition of additional compensation expenses for financial reporting purposes).</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z27bf771c7d2f451b8293ab46bdf693ee" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Option Term</u></font><font style="font-size: 10pt;">.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z57f90fdda79c4a9aa64148528ac02674" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Maximum Term</u></font><font style="font-size: 10pt;">. This Option will in all events expire at the close of business at Company headquarters on the Expiration
                Date specified in the Notice, unless it terminates earlier in connection with the termination of Participant&#8217;s [employment] [service] (as provided below) or a Change in Control (as provided in the Plan).</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb334da21b7f246268511b3e0442d0afb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Post-Termination Exercise Period</u></font><font style="font-size: 10pt;">. If Participant&#8217;s [employment] [service] terminates prior to the Expiration Date of
                this Option other than for Cause, the unvested portion of this Option will automatically expire on Participant&#8217;s date of termination, and the vested portion of this Option will remain outstanding and exercisable for the following periods,
                unless otherwise determined by the Committee and in no event after the Expiration Date of this Option:</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z01b384a33e4948358588b13ff574f9a1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90pt;">&#160;</td>
          <td style="width: 18pt; vertical-align: top;">i.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>ninety (90) days following a termination for any reason other than Cause, Disability, or death;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z96426aa7c55c462387bae71c1e301775" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">ii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>twelve (12) months following a termination due to Disability; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z03835caa37c24f508740bed29767c46f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>twelve (12) months following the date of Participant&#8217;s death, if Participant dies while in [employment] [service], or during the period provided in clause (ii) above.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za5ba1e0dd8c8414ca5c93908350f965e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">c.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>&#160;<font style="font-weight: bold;"><u>Termination for Cause</u></font>. If Participant&#8217;s [employment] [service] is terminated for Cause, this Option will terminate and be forfeited immediately upon such Participant&#8217;s termination of
              [employment] [service], and Participant will be prohibited from exercising any portion (including any vested portion) of this Option on or after the date of such termination. If Participant&#8217;s [employment] [service] is suspended pending an
              investigation of whether Participant&#8217;s [employment] [service] will be terminated for Cause, all of Participant&#8217;s rights under this Option, including the right to exercise the Option, shall be suspended during the investigation period.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z83af4deee85d4080ba598f984fb5185c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">d.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Determination of Termination Date</u></font><font style="font-size: 10pt;">. For purposes of this Option, Participant&#8217;s [employment] [service] will be considered
                terminated as of the date Participant is no longer actively providing services to the Company Group (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the
                jurisdiction where Participant is employed or the terms of Participant&#8217;s employment agreement, if any). The Committee shall have the exclusive discretion to determine when Participant is no longer actively providing services for purposes of
                this Option (including whether Participant may still be considered to be providing services while on a leave of absence).</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zbb95667a9e464730b359bf7324c8012d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">e.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>No Notice of Option Expiration</u></font><font style="font-size: 10pt;">. Participant is responsible for keeping track of the Expiration Date and the
                post-termination exercise periods following Participant&#8217;s termination of [employment] [service] for any reason. The Company is not obligated to provide further notice of such periods. In no event will this Option be exercised later than the
                Expiration Date set forth in the Notice.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2888f7c99ee149f996f2dd45079ba8f4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Transferability of Option</u></font><font style="font-size: 10pt;">. This Option may not be transferred in any manner other than by will or by the laws of
                descent or distribution or court order and may be exercised during the lifetime of Participant only by Participant. The terms of the Plan and this Award Agreement will be binding upon the executors, administrators, heirs, successors, and
                assigns of Participant.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd98ee180cb2c4b1581ed8c3d3617687e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Taxes</u></font><font style="font-size: 10pt;">.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z0f26d01703c2440b9bd04c049a00a29b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Responsibility for Taxes</u></font><font style="font-size: 10pt;">. By accepting this Option, Participant acknowledges that, regardless of any action taken by
                the Company or, if different, any member of the Company Group that employs Participant (the &#8220;<u>Employer</u>&#8221;), the ultimate liability for all Taxes is and remains Participant&#8217;s responsibility and may exceed the amount actually withheld by
                the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Taxes in connection with any aspect of this Option, including, but
                not limited to, the grant, vesting, or exercise of this Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms
                of the grant or any aspect of this Option to reduce or eliminate Participant&#8217;s liability for Taxes or achieve any particular tax result. Further, if Participant is subject to Taxes in more than one jurisdiction, as applicable, Participant
                acknowledges that the Company and/or the Employer may be required to withhold or account for Taxes in more than one jurisdiction. Participant agrees to pay to the Company or the Employer any amount of Taxes that the Company or the Employer
                may be required to withhold or account for as a result of Participant&#8217;s participation in the Plan that cannot be satisfied by the means described in this Section. The Company may refuse to issue or deliver the Shares or the proceeds of the
                sale of Shares, if Participant fails to comply with Participant&#8217;s obligations in connection with the Taxes.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zbf38a1e5a9f64ef899cb3ecba9fb1d46" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Withholding</u></font><font style="font-size: 10pt;">. Prior to the relevant taxable or tax withholding event, as applicable, Participant agrees to make adequate
                arrangements satisfactory to the Company and/or the Employer to satisfy all Taxes. In this regard, Participant authorizes the Company or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard
                to all Taxes by one or a combination of the following:</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z90c1978bc5e545a1beca4fbf410f2edc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">i.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding from Participant&#8217;s wages or other cash compensation paid to Participant by the Company and/or the Employer or any member of the Company Group;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z25cbbeb8b8ba4a28a27d04ebd1e10b3b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">ii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding from proceeds of the sale of Shares acquired at exercise of this Option either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant&#8217;s behalf pursuant to this authorization and without
              further consent);</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfee4ab4d05494ed2b06a5cdda6b50715" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding Shares to be issued upon exercise of this Option, provided the Company only withholds a number of Shares necessary to satisfy no more than the withholding amounts determined based on the maximum permitted statutory rate
              applicable in Participant&#8217;s jurisdiction;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9945cb20aa7e4a2f98cc8ad3a749d037" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iv.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant&#8217;s payment of a cash amount (including by check representing readily available funds or a wire transfer); or</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z18d1ab9a6143404eb414341e9b7ceb6a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">v.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any other arrangement approved by the Committee and permitted under applicable law.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">Withholding for Taxes will be made in accordance with Section 14(c) of the Plan and such rules and procedures as may be established by the Committee, and in compliance with the Company&#8217;s insider trading policy, if
      applicable. In the event the Company or the Employer withholds more than the Taxes using one of the methods described above, Participant may receive a refund of any over-withheld amount in cash but will have no entitlement to the Shares sold or
      withheld.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf3fe841453f4496c8bad151f696bfb9b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Notice of Disqualifying Disposition of Incentive Stock Option Shares</u></font><font style="font-size: 10pt;">. If Participant is subject to Taxes in the United
                States and sells or otherwise disposes of any of the Shares acquired pursuant to an Incentive Stock Option on or before the later of (a) two years after the Grant Date, or (b) one year after the exercise date, Participant will immediately
                notify the Company in writing of such disposition.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z32d8a5313c24416abf7f18583937baee" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Nature of Grant</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. In accepting this Option, Participant acknowledges,
                understands and agrees that: (a) the Plan is established voluntarily by the Company, is discretionary in nature, and may be amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan; (b) the grant of
                this Option is voluntary and occasional and does not create any contractual or other right to receive future grants, or benefits in lieu of grants, even if grants have been made in the past; (c) all decisions with respect to future grants,
                if any, will be at the sole discretion of the Company; (d) Participant is voluntarily participating in the Plan; (e) this Option and the Shares allocated to this Option are not intended to replace any pension rights or compensation and are
                outside the scope of Participant&#8217;s employment contract, if any; (f) this Option and the Shares allocated to this Option, and the income and value of same, are not part of normal or expected compensation for any purpose, including, without
                limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of- service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments; (g) unless otherwise provided in
                the Plan or by the Company in its discretion, this Option and the benefits evidenced by this Award Agreement do not create any entitlement to have this Option or any such benefits transferred to, or assumed by, another company nor to be
                exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; and (h) neither the Company nor any member of the Company Group shall be liable for any foreign exchange rate fluctuation between
                Participant&#8217;s local currency and the United States Dollar or the selection by the Company or any member of the Company Group in its sole discretion of an applicable foreign exchange rate that may affect the value of this Option (or the
                calculation of income or Taxes thereunder) or of any amounts due to Participant pursuant to the settlement of this Option or the subsequent sale of the Shares allocated to this Option.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za8d9ce5b73ca41afa1d61004b0a66ede" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Code Section 409A</u></font><font style="font-size: 10pt;">. It is intended that the terms of this Option will not result in the imposition of any tax liability
                pursuant to Section 409A of the Code, and this Award Agreement shall be construed and interpreted consistent with that intent. Notwithstanding the foregoing, no member of the Company Group shall be liable for any costs incurred by
                Participant under Section 409A of the Code and similar state laws.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z5240aaf55cc3402aa9315d4a6267d61c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Data Privacy</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. </font><font style="font-size: 10pt; font-weight: bold; font-style: italic; color: rgb(0, 0, 0);">Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant&#8217;s personal data as described in this Award Agreement and any
                other grant materials by and among the Company and the members of the Company Group for the purpose of implementing, administering and managing Participant&#8217;s participation in the Plan. Participant understands that the Company and the
                members of the Company Group may hold certain personal information about Participant, including, but not limited to, Participant&#8217;s name, home address and telephone number, date of birth, social insurance number or other identification
                number, salary, nationality, job title, any Shares or directorships held in the Company, details of all grants, or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor (&#8220;<u>Data</u>&#8221;),

                for the purpose of implementing, administering and managing the Plan. Participant understands that Data will be transferred to such stock plan service provider as may be selected by the Company, presently or in the future, which may be
                assisting the Company with the implementation, administration and management of the Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country (e.g., the
                United States) may have different data privacy laws and protections than Participant&#8217;s country. Participant authorizes the Company, the stock plan service provider as may be selected by the Company, and any other possible recipients which
                may assist the Company, presently or in the future, with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering
                and managing Participant&#8217;s participation in the Plan. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his
                or her consent, or instructs the Company to cease the processing of the Data, his or her employment or service will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant&#8217;s consent or instructing the
                Company to cease processing, is that the Company would not be able to grant Participant the Option or any other equity awards or administer or maintain such awards. Therefore, Participant understands that refusing or withdrawing his or her
                consent may affect Participant&#8217;s ability to participate in the Plan. For more information on the consequences of Participant&#8217;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local
                human resources representative.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf20a695bba434ebf912e63d698a71bb9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Governing Law and Venue</u></font><font style="font-size: 10pt;">. This Award Agreement shall be governed by and construed and interpreted in accordance with the
                laws of the State of Delaware, without giving effect to principles of conflicts of law. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this grant or this Award
                Agreement, the parties hereby submit to the exclusive jurisdiction of the State of Delaware and agree that such litigation shall be conducted only in the courts of the State of Delaware, or the federal courts for the United States for the
                District of Delaware, and no other courts, where this grant is made and/or to be performed.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z559c991ac158494fb614ee55bf832ec2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">12.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Addendum and Sub-Plans</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. Notwithstanding any provisions in this Award
                Agreement, this Option shall be subject to any special terms and conditions set forth in any Addendum to this Award Agreement for Participant&#8217;s country. Moreover, if Participant relocates to one of the countries included in the Addendum (if
                any), the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The
                Addendum (if any) constitutes part of this Award Agreement. Further, the Plan shall be deemed to include any special terms and conditions set forth in any applicable sub-plan for Participant&#8217;s country, and, if Participant relocates to a
                country for which the Company has established a sub-plan, the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or
                advisable for legal or administrative reasons.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z016265ba261b41ac9573de3acf51567d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">13.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Entire Agreement; Enforcement of Rights; Amendment</u></font><font style="font-size: 10pt;">. This Award Agreement, together with the Plan, sets forth the entire
                agreement and understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, agreements, commitments, negotiations and arrangements between them. Except as contemplated by the
                Plan, no modification of or amendment to this Award Agreement, nor any waiver of any rights under this Award Agreement, shall be effective unless in writing signed by the parties to this Award Agreement to the extent it would alter or
                impair rights or obligations under the Option. The failure by either party to enforce any rights under this Award Agreement shall not be construed as a waiver of any rights of such party. Notwithstanding anything to the contrary in the Plan
                or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Section 409A of the Code or to
                otherwise avoid imposition of any additional tax or income recognition or costs under Section 409A of the Code in connection with this Option.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zcea329bcc2ae42a28334296213985474" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">14.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Severability</u></font><font style="font-size: 10pt;">. If one or more provisions of this Award Agreement are held to be unenforceable under applicable laws, the
                parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Award Agreement,
                (b) the balance of this Award Agreement shall be interpreted as if such provision were so excluded, and (c) the balance of this Award Agreement shall be enforceable in accordance with its terms.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3e8b25359fc841338f094cb96df4467f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">15.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Language</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. If Participant has received this Award Agreement, the Plan or any
                other document related to this Option and/or the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5208241659db40adbf18f3a951f9918f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">16.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Imposition of Other Requirements</u></font><font style="font-size: 10pt;">. The Company reserves the right to impose other requirements on Participant&#8217;s
                participation in the Plan, on this Option and on any Shares purchased upon exercise of this Option, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to accept
                any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zc70e18c751c247b0a4869df2ffff5f3d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">17.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Notices</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. Any notice, demand or request required or permitted to be given
                under this Award Agreement shall be in writing and shall be deemed sufficient when delivered personally or by overnight courier or sent by email or fax, or forty-eight (48) hours after being deposited in the U.S. mail or a comparable
                foreign mail service, as certified or registered mail with postage or shipping charges prepaid, addressed to the party to be notified at such party&#8217;s address as set forth on the signature page, as subsequently modified by written notice, or
                if no address is specified on the signature page, at the most recent address, email or fax number set forth in the Company&#8217;s books and records.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf3c8cae141e347acb4917eaa497e4717" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">18.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Counterparts</u>.&#160;</font><font style="font-size: 10pt; color: rgb(0, 0, 0);">This Award Agreement may be executed in two or more
                counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. Facsimile, email or other electronic execution and delivery of this Award Agreement (including but not limited to execution
                by electronic signature or click-through electronic acceptance) shall constitute valid and binding execution and delivery for all purposes and shall be deemed to be, and have the effect of, an original signature.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z136cf36d49994208a49b7cb4aa0982cc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">19.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Successors and Assigns</u></font><font style="font-size: 10pt;">. The rights and benefits of this Award Agreement shall inure to the benefit of, and be
                enforceable by the Company&#8217;s successors and assigns.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1e2b8ff69a8a4804aada2041ed9a9f68" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">20.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Consent to Electronic Delivery and Participation</u></font><font style="font-size: 10pt;">. By accepting this Option, Participant agrees to participate in the
                Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company, and consents to the electronic delivery of the Award Agreement, the Plan, account statements, Plan
                prospectuses (if any), and all other documents, communications, or information related to this Option and current or future participation in the Plan. Electronic delivery may include the delivery of a link to the Company intranet or the
                internet site of a third party involved in administering the Plan, the delivery of the document via e-mail or such other delivery determined at the Company&#8217;s discretion. Participant acknowledges that Participant may receive from the Company
                a paper copy of any documents delivered electronically at no cost if Participant contacts the Company by telephone, through a postal service, or electronic mail to Company&#8217;s stock plan administration.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div> <br>
    </div>
  </div>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
  <div style="text-align: center;" class="BRPFPageNumberArea">
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.14(C)
<SEQUENCE>6
<FILENAME>ef20015352_ex10-14c.htm
<DESCRIPTION>EXHIBIT 10.14(C)
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 10.14c<br>
      </font></div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div style="text-align: center; font-weight: bold;">RESTATED 2020 STOCK INCENTIVE PLAN</div>
    <div style="text-align: center; font-weight: bold;">AWARD AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;"><u>Notice of RSU Grant</u></div>
    <div>&#160;</div>
    <div style="text-align: justify;">Eterna Therapeutics Inc. (the &#8220;<u>Company</u>&#8221;) has awarded to you (&#8220;<u>Participant</u>&#8221;) the number of RSUs (&#8220;<u>RSUs</u>&#8221;) set forth below (the &#8220;<u>RSU Grant</u>&#8221;) under the Company&#8217;s Restated 2020 Stock Incentive
      Plan (the &#8220;<u>Plan</u>&#8221;).</div>
    <div style="text-align: justify;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z95c4bee03919466182ac90c997f8980a">

        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Participant Name:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 70%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Grant ID:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 70%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Grant Date:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 70%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Number of RSUs:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 70%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Country at Grant:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 70%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Vesting</div>
            <div style="text-align: justify; font-weight: bold;">Commencement Date:</div>
          </td>
          <td style="width: 70%; vertical-align: bottom;">
            <div>[&#160; &#160;&#160; ]</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 70%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: justify; font-weight: bold;">Vesting Schedule:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify;">[&#160; &#160;&#160; ]</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">Capitalized terms used but not defined in this Notice of RSU Grant (this &#8220;<u>Notice</u>&#8221;) or the attached RSU Terms and Conditions (including any appendices and exhibits attached thereto) will have the same meanings
      specified in the Plan. The Notice and the RSU Terms and Conditions are collectively referred to as the &#8220;<u>Award Agreement</u>&#8221; applicable to the RSUs.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">By accepting (whether electronically or otherwise) the RSU Grant, Participant acknowledges and agrees to the following:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3df88da5e57a4d04ab6fc138931d1411">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>This RSU Grant is governed by all the terms and conditions of the Plan applicable to the RSU Grant, whether or not such terms and conditions are stated in the Award Agreement. The RSU Grant is governed by the terms and conditions of this
              Award Agreement. In the event of a conflict between the terms of the Plan and this Award Agreement, the terms of the Plan will prevail.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcb761abfd76b4a0e82fe5bcc15b51aef">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant has received a copy of the Plan, this Award Agreement, the Plan prospectus (if required under applicable law), and the Company&#8217;s insider trading policy, and represents that he or she has read these documents and is familiar
              with their terms. Participant further agrees to accept as binding, conclusive, and final all decisions and interpretations of the Committee regarding any questions relating to the RSU Grant and the Plan.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9998fbd9387f4676900523b63e845474">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Vesting of the RSUs is subject to Participant&#8217;s continued employment as an [employment] [service] as an [employee] [director] [consultant], which is for an unspecified duration and may be terminated at any time, with or without Cause, and
              nothing in this Award Agreement or the Plan changes the nature of that relationship.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd16f2e97889d47959aa14989630b2291">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Company is not providing any tax, legal, or financial advice, nor is the Company making any recommendations regarding participation in the Plan. <font style="font-weight: bold; font-style: italic;">Participant should consult with his
                or her own personal tax, legal, and financial advisors regarding participation in the Plan before taking any action related to the Plan</font>.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3698c3c495494db9af85058c8c5ae14d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant consents to electronic delivery and participation as set forth in this Award Agreement.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc4c6634b2d434d6794e83ea0d851a407">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">If Participant does not accept or decline the RSUs within 60 days of the Grant Date or by such other date that may be communicated to Participant by the Company,
                the Company will accept the RSUs on Participant&#8217;s behalf and Participant will be deemed to have accepted the terms and conditions of the RSUs set forth in the Plan and this Award Agreement. If Participant wishes to decline the RSUs,
                Participant should promptly notify </font><font style="font-size: 10pt;">[&#9679;]<font style="font-weight: bold;"> at </font>[&#9679;]<font style="font-weight: bold;">.&#160; If Participant declines the RSUs, the RSUs will be cancelled and no benefits
                  from the RSUs nor any compensation or benefits in lieu of the RSUs will be provided to Participant</font>.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td colspan="2" style="vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">Eterna Therapeutics Inc.</div>
              </td>
              <td style="width: 2%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div style="text-align: justify; font-weight: bold;">Participant</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 2%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: justify;">By:</div>
              </td>
              <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 8%; vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: justify;">Signature:</div>
              </td>
              <td style="width: 41%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: justify;">Title: <br>
                </div>
              </td>
              <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: justify;">Date:</div>
              </td>
              <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div style="text-align: center; font-weight: bold;">RESTATED 2020 STOCK INCENTIVE PLAN</div>
    <div style="text-align: center; font-weight: bold;">AWARD AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: justify; font-weight: bold;"><u>RSU Terms and Conditions</u></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze9aa901101464362bc1da0ced29e3e37">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Grant of RSUs</u></font><font style="font-size: 10pt;">. Capitalized terms used in the Award Agreement but not defined in the Award Agreement will have the same
                meanings specified in the Plan. An RSU is a non-voting unit of measurement which is deemed solely for bookkeeping purposes to be equivalent to one outstanding share of Common Stock (a &#8220;<u>Share</u>&#8221;). The RSUs are used solely as a device to
                determine the number of Shares to eventually be issued to Participant if such RSUs vest. The RSUs shall not be treated as property or as a trust fund of any kind.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z409bed984f004c638ad0161f75c6a5f5">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Settlement</u></font><font style="font-size: 10pt;">. On or as soon as administratively practical (and within thirty (30) days) following the applicable date of
                vesting under the Vesting Schedule set forth in the Notice (a &#8220;<u>Vesting Date</u>&#8221;), the Company will deliver to Participant a number of Shares (either by delivering one or more certificates for such Shares or by entering such Shares in
                book entry form, as determined by the Company in its discretion) equal to the number of RSUs subject to the RSU Grant that vest on the applicable Vesting Date, subject to payment by Participant of any applicable taxes that the Company or
                any member of the Company Group is required by any law or regulation of any governmental authority, whether federal, state or local, domestic or foreign (&#8220;<u>Taxes</u>&#8221;) to withhold in connection with such delivery. No fractional RSUs or
                rights for fractional Shares shall be created pursuant to this Award Agreement.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze59284eb4841414e991cfa18760bd615">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Dividend and Voting Rights</u></font><font style="font-size: 10pt;">. Unless and until such time as Shares are issued in settlement of vested RSUs, Participant
                will have no ownership of the Shares allocated to the RSUs, and will have no rights to vote such Shares and no rights to dividends.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcff8992541414552b6b12da571ffadc5">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Non-Transferability of RSUs</u></font><font style="font-size: 10pt;">. The RSUs and any interest therein will not be sold, assigned, transferred, pledged,
                hypothecated, or otherwise disposed of in any manner other than by will or by the laws of descent or distribution or court order. The terms of the Plan and this Award Agreement will be binding upon the executors, administrators, heirs,
                successors, and assigns of Participant.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z238564173f79455698756ef638d3af41">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Termination.</u></font><font style="font-size: 10pt;"> If Participant&#8217;s [employment][service] terminates for any reason, all unvested RSUs will be forfeited to
                the Company, and all rights of Participant to such RSUs will immediately terminate without payment of any consideration to Participant. The Committee shall have the exclusive discretion to determine when Participant is no longer actively
                providing services for purposes of this RSU Grant (including whether Participant may still be considered to be providing services while on a leave of absence).</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf189b200a5954c4f8f4efefddb1b6366">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Taxes</u></font><font style="font-size: 10pt;">.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z82fcb7e6dbff4510a2b6819edcac6c49">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Responsibility for Taxes</u></font><font style="font-size: 10pt;">. By accepting this RSU Grant, Participant acknowledges that, regardless of any action taken by
                the Company or, if different, any member of the Company Group that employs Participant (the &#8220;<font style="font-weight: bold; font-style: italic;">Employer</font>&#8221;), the ultimate liability for all Taxes is and remains Participant&#8217;s
                responsibility and may exceed the amount actually withheld by the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any
                Taxes in connection with any aspect of the RSU Grant, including, but not limited to, the grant, vesting, or settlement of the RSU Grant, the subsequent sale of Shares acquired pursuant to such settlement, and the receipt of any dividends;
                and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSU Grant to reduce or eliminate Participant&#8217;s liability for Taxes or achieve any particular tax result. Further, if Participant
                is subject to Taxes in more than one jurisdiction, as applicable, Participant acknowledges that the Company and/or the Employer may be required to withhold or account for Taxes in more than one jurisdiction. Participant agrees to pay to the
                Company or the Employer any amount of Taxes that the Company or the Employer may be required to withhold or account for as a result of the RSUs that cannot be satisfied by the means described in this Section. The Company may refuse to issue
                or deliver the Shares, or the proceeds of the sale of Shares, if Participant fails to comply with Participant&#8217;s obligations in connection with the Taxes.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z69582667b13943c291b573ceb10561db">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Withholding</u></font><font style="font-size: 10pt;">. Prior to the relevant taxable or Taxes withholding event, as applicable, Participant agrees to make
                adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Taxes. In this regard, Participant authorizes the Company or the Employer, or their respective agents, at their discretion, to satisfy the obligations with
                regard to all Taxes by one or a combination of the following:</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zecda632b36b642649eb541357d7e4359">

        <tr>
          <td style="width: 99pt;">&#160;</td>
          <td style="width: 18pt; vertical-align: top;">i.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding from Participant&#8217;s wages or other cash compensation paid to Participant by the Company and/or the Employer or any member of the Company Group;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6f0c8ec5c7f745599347ab368a7b737d">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">ii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding from proceeds of the sale of Shares acquired on settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on Participant&#8217;s behalf pursuant to this authorization and without
              further consent);</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z893b24eac5124779aa1cbf00539a596c">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iii.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>withholding Shares to be issued upon settlement of the RSUs, provided the Company only withholds a number of Shares necessary to satisfy no more than the withholding amounts determined based on the maximum permitted statutory rate
              applicable in Participant&#8217;s jurisdiction;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8da9ea5ed52c455f87a402dd832d0393">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">iv.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Participant&#8217;s payment of a cash amount (including by check representing readily available funds or a wire transfer); or</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za6b8074877d745c09e51cfb9616a2eca">

        <tr>
          <td style="width: 99pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">v.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any other arrangement approved by the Committee and permitted under applicable law.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">Withholding for Taxes will be made in accordance with Section 13(c) of the Plan and such rules and procedures as may be established by the Committee, and in compliance with the Company&#8217;s insider trading policy, if
      applicable. In the event the Company or the Employer withholds more than the Taxes using one of the methods described above, Participant may receive a refund of any over-withheld amount in cash but will have no entitlement to the Shares sold or
      withheld.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z87b15b186cb548e1a2f70fab099d09ad">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Nature of Grant</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. In accepting the RSUs, Participant acknowledges, understands
                and agrees that: (a) the Plan is established voluntarily by the Company, is discretionary in nature, and may be amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan; (b) the grant of the RSUs is
                voluntary and occasional and does not create any contractual or other right to receive future grants, or benefits in lieu of grants, even if grants have been made in the past; (c) all decisions with respect to future grants, if any, will be
                at the sole discretion of the Company; (d) Participant is voluntarily receiving the RSUs; (e) the RSUs and the Shares allocated to the RSUs are not intended to replace any pension rights or compensation and are outside the scope of
                Participant&#8217;s employment contract, if any; (f) the RSUs and the Shares allocated to the RSUs, and the income and value of same, are not part of normal or expected compensation for any purpose, including, without limitation, calculating any
                severance, resignation, termination, redundancy, dismissal, end-of- service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments; (g) unless otherwise provided in the Plan or by the Company
                in its discretion, the RSUs and the benefits evidenced by this Award Agreement do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted
                for, in connection with any corporate transaction affecting the Shares; and (h) neither the Company nor any member of the Company Group shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the
                United States Dollar or the selection by the Company or any member of the Company Group in its sole discretion of an applicable foreign exchange rate that may affect the value of the RSUs (or the calculation of income or Taxes thereunder)
                or of any amounts due to Participant pursuant to the settlement of the RSUs or the subsequent sale of the Shares allocated to the RSUs.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5af16d6952de4bcbaf156e2500756690">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Code Section 409A</u></font><font style="font-size: 10pt;">. It is intended that the terms of the RSUs will not result in the imposition of any tax liability
                pursuant to Section 409A of the Code, and this Award Agreement shall be construed and interpreted consistent with that intent. Payments pursuant to this Restricted Stock Unit Grant are intended to constitute separate payments for purposes
                of Section 409A of the Code. Notwithstanding the foregoing, no member of the Company Group shall be liable for any costs incurred by Participant under Section 409A of the Code and similar state laws.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbe655414caee43f2b719b1b87fdd9186">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Data Privacy</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. </font><font style="font-size: 10pt; font-weight: bold; font-style: italic; color: rgb(0, 0, 0);">Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant&#8217;s personal data as described in this Award Agreement and any
                other grant materials by and among the Company and the members of the Company Group for the purpose of implementing, administering and managing Participant&#8217;s participation in the Plan. Participant understands that the Company and the
                members of the Company Group may hold certain personal information about Participant, including, but not limited to, Participant&#8217;s name, home address and telephone number, date of birth, social insurance number or other identification
                number, salary, nationality, job title, any Shares or directorships held in the Company, details of all grants, or any other entitlement to Shares awarded, canceled, received, vested, unvested or outstanding in Participant&#8217;s favor (&#8220;<u>Data</u>&#8221;),
                for the purpose of implementing, administering and managing the Plan. Participant understands that Data will be transferred to such stock plan service provider as may be selected by the Company, presently or in the future, which may be
                assisting the Company with the implementation, administration and management of the Plan. Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipient&#8217;s country (e.g., the
                United States) may have different data privacy laws and protections than Participant&#8217;s country. Participant authorizes the Company, the stock plan service provider as may be selected by the Company, and any other possible recipients which
                may assist the Company, presently or in the future, with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering
                and managing the Plan. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, or instructs
                the Company to cease the processing of the Data, his or her employment or service will not be adversely affected; the only adverse consequence of refusing or withdrawing Participant&#8217;s consent or instructing the Company to cease processing,
                is that the Company would not be able to grant Participant the RSUs or any other equity awards or administer or maintain such awards. Therefore, Participant understands that refusing or withdrawing his or her consent may affect
                Participant&#8217;s ability to participate in the Plan. For more information on the consequences of Participant&#8217;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources
                representative.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z387b008b938d49f0bad970bef0fde99f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Governing Law and Venue</u></font><font style="font-size: 10pt;">. This Award Agreement shall be governed by and construed and interpreted in accordance with the
                laws of the State of Delaware, without giving effect to principles of conflicts of law. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this grant or this Award
                Agreement, the parties hereby submit to the exclusive jurisdiction of the State of Delaware and agree that such litigation shall be conducted only in the courts of the State of Delaware, or the federal courts for the United States for the
                District of Delaware, and no other courts, where this grant is made and/or to be performed.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zba6ef39e2f6c4cd88b0e9df614d75650">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Addendum and Sub-Plans</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. Notwithstanding any provisions in this Award
                Agreement, the RSUs shall be subject to any special terms and conditions set forth in any Addendum to this Award Agreement for Participant&#8217;s country. Moreover, if Participant relocates to one of the countries included in the Addendum (if
                any), the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The
                Addendum (if any) constitutes part of this Award Agreement. Further, the Plan shall be deemed to include any special terms and conditions set forth in any applicable sub-plan for Participant&#8217;s country, and, if Participant relocates to a
                country for which the Company has established a sub-plan, the special terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or
                advisable for legal or administrative reasons.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc469f19e4b4341868a03240adc448a4e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">12.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Entire Agreement; Enforcement of Rights; Amendment</u></font><font style="font-size: 10pt;">. This Award Agreement, together with the Plan, sets forth the entire
                agreement and understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, agreements, commitments, negotiations and arrangements between them. Except as contemplated by the
                Plan, no modification of or amendment to this Award Agreement, nor any waiver of any rights under this Award Agreement, shall be effective unless in writing signed by the parties to this Award Agreement to the extent it would alter or
                impair rights or obligations under the RSUs. The failure by either party to enforce any rights under this Award Agreement shall not be construed as a waiver of any rights of such party. Notwithstanding anything to the contrary in the Plan
                or this Award Agreement, the Company reserves the right to revise this Award Agreement as it deems necessary or advisable, in its sole discretion and without the consent of Participant, to comply with Section 409A of the Code or to
                otherwise avoid imposition of any additional tax or income recognition or costs under Section 409A of the Code in connection with the RSUs.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfa6c6b3954f94982ab29ee93a0bfd20d">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">13.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Severability</u></font><font style="font-size: 10pt;">. If one or more provisions of this Award Agreement are held to be unenforceable under applicable laws, the
                parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Award Agreement,
                (b) the balance of this Award Agreement shall be interpreted as if such provision were so excluded, and (c) the balance of this Award Agreement shall be enforceable in accordance with its terms.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11bb09fbf3b942e5b5abb920ef81ac85">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">14.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Language</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. If Participant has received this Award Agreement, the Plan or any
                other document related to the RSUs and/or the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z84aa7e20f77944c09cf92e0b9fe4ce8c">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">15.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Imposition of Other Requirements</u></font><font style="font-size: 10pt;">. The Company reserves the right to impose other requirements on Participant&#8217;s
                participation in the Plan, on the RSUs and on any Shares received under the RSUs, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require Participant to accept any additional
                agreements or undertakings that may be necessary to accomplish the foregoing.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z261f5410edf040d185811c075ed34664">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">16.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Notices</u></font><font style="font-size: 10pt; color: rgb(0, 0, 0);">. Any notice, demand or request required or permitted to be given
                under this Award Agreement shall be in writing and shall be deemed sufficient when delivered personally or by overnight courier or sent by email or fax, or forty-eight (48) hours after being deposited in the U.S. mail or a comparable
                foreign mail service, as certified or registered mail with postage or shipping charges prepaid, addressed to the party to be notified at such party&#8217;s address as set forth on the signature page, as subsequently modified by written notice, or
                if no address is specified on the signature page, at the most recent address, email or fax number set forth in the Company&#8217;s books and records.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ef076cae6ed42688bea6f1dfedeb022">

        <tr>
          <td style="width: 18pt;">&#160;</td>
          <td style="width: 18pt; vertical-align: top;">17.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);"><u>Counterparts</u>. </font><font style="font-size: 10pt; color: rgb(0, 0, 0);">This Award Agreement may be executed in two or more
                counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. Facsimile, email or other electronic execution and delivery of this Award Agreement (including but not limited to execution
                by electronic signature or click-through electronic acceptance) shall constitute valid and binding execution and delivery for all purposes and shall be deemed to be, and have the effect of, an original signature.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4d2e98bc5d554b269deecc5fbfa312f4">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">18.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Successors and Assigns</u></font><font style="font-size: 10pt;">. The rights and benefits of this Award Agreement shall inure to the benefit of, and be
                enforceable by the Company&#8217;s successors and assigns.</font></div>
          </td>
        </tr>

    </table>
    <br>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9f22e18d8a5f4efe95511fb6b6672be3">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">19.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"><u>Consent to Electronic Delivery and Participation</u></font><font style="font-size: 10pt;">. By accepting the RSUs, Participant agrees to participate in the Plan
                through an on-line or electronic system established and maintained by the Company or a third party designated by the Company, and consents to the electronic delivery of the Award Agreement, the Plan, account statements, Plan prospectuses
                (if any), and all other documents, communications, or information related to the RSUs and current or future participation in the Plan. Electronic delivery may include the delivery of a link to the Company intranet or the internet site of a
                third party involved in administering the Plan, the delivery of the document via e-mail or such other delivery determined at the Company&#8217;s discretion. Participant acknowledges that Participant may receive from the Company a paper copy of
                any documents delivered electronically at no cost if Participant contacts the Company by telephone, through a postal service, or electronic mail to the Company&#8217;s stock plan administrator.</font></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div><br>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
  <div class="BRPFPageNumberArea" style="text-align: center;">
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>7
<FILENAME>ef20015352_ex10-16.htm
<DESCRIPTION>EXHIBIT 10.16
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;"> Exhibit 10.16<br>
    </div>
    <div> <br>
    </div>
    <div>Execution version</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">EMPLOYMENT AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">This EMPLOYMENT AGREEMENT (this &#8220;Agreement&#8221;) is made as of the 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> day of January, 2024 (the &#8220;Effective Date&#8221;) between
      Eterna Therapeutics, Inc. f/k/a Brooklyn Immuno Therapeutics, Inc. (the &#8220;Company&#8221;) and Dorothy Clarke (&#8220;Executive&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Employment Term</font>.&#160; The Company shall employ
        Executive, and Executive accepts employment with the Company, upon the terms and subject to the conditions set forth in this Agreement, commencing on the Effective Date and ending on the Date of Termination (as defined in Section 4(e) of this
        Agreement) (the &#8220;Term&#8221;).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Terms of Employment</font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Position and Duties</u>.&#160; During the Term, Executive shall be employed by the Company as General Counsel
        and shall have such duties, responsibilities and authorities as are customarily associated with Executive&#8217;s position and such additional duties and responsibilities consistent with Executive&#8217;s position as may, from time to time, be properly and
        lawfully assigned to Executive.&#160; Executive shall report to the Company&#8217;s Chief Executive Officer (the &#8220;CEO&#8221;).&#160; Executive shall act at all times in compliance in all respects with the policies, rules and decisions adopted from time to time by the
        Company and perform all of the duties and obligations required of Executive by this Agreement in a loyal and conscientious manner.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Engaging in Other Activities</u>.&#160; During the Term, Executive shall devote Executive&#8217;s full time and
        attention to the Company and its affiliates and shall not be employed by or provide services to any other person or entity.&#160; During the Term, it shall not be a violation of this Agreement for Executive, subject to the requirements of Section 8
        hereof, to (i) serve on civic, charitable or religious boards or engage in other activities for such organizations, (ii) with the consent of the Board, which consent shall not be unreasonably withheld, serve on up to two corporate boards unrelated
        to the Company (and retain all compensation in whatever form for such service), and (iii) manage personal investments, so long as such activities (individually or in the aggregate) do not interfere with the performance of Executive's
        responsibilities as set forth in Sections 2(a) or 2(b) of this Agreement or Executive's fiduciary duties to the Company. The Company is aware of Executive&#8217;s activities with Comera and consents to same, provided such activities do not interfere with
        Executive&#8217;s duties to the Company pursuant to this Agreement.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Location</u>.&#160; Executive&#8217;s primary work location shall be from Executive&#8217;s home in the Commonwealth of
        Pennsylvania.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="color: rgb(0, 0, 0);"><u>Board Service</u>.</font> Executive currently serves as a member of the
        Company&#8217;s Board of Directors (the &#8220;Board&#8221;). The compensation described herein shall not be interpreted to apply to remuneration for Executive&#8217;s Board service.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Compensation and Benefits</font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Base Salary</u>.&#160; During the Term, the Company shall pay Executive an annualized base salary (&#8220;Annual Base
        Salary&#8221;) of $350,000, payable in regular installments in accordance with the Company's normal payroll practices, and subject to usual payroll deductions.&#160; During the Term, the Annual Base Salary shall be reviewed by the Compensation Committee of
        the Board (the &#8220;Compensation Committee&#8221;), but no less frequently than once a year.&#160; If so increased or reduced, then such adjusted salary will thereafter be the Annual Base Salary for all purposes under this Agreement. Commencing in 2024, Executive
        will be eligible to receive annual salary increases based upon achievement of reasonable performance targets to be agreed to between Executive and the Company, as determined by the Compensation Committee of the Board in its discretion.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u></u><font style="color: rgb(0, 0, 0);"><u>Signing Bonus</u>. In recognition of services provided by Executive from September 10, 2023 to the
        Effective Date, Company shall pay a Signing Bonus of $89,100, less applicable payroll withholdings, in the first Company payroll after January 1, 2024.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Performance Bonus</u>. Commencing on January 1, 2024, Executive shall be eligible to receive an annual cash
        bonus award in an amount up to a target of forty percent (40%) of Executive's Annual Base Salary (the &#8220;Performance Bonus&#8221;) based upon achievement of reasonable performance targets to be agreed to between Executive and the Company. Such performance
        targets shall be based in part upon performance of the Company, and in part on Executive's individual performance. The Performance Bonus shall be determined by the Compensation Committee in its sole discretion and paid annually no later than March
        15 of the year following the year on which such Performance Bonus is based. Executive's receipt of the Performance Bonus, if any, is conditioned on Executive's continued employment in good standing as of January 31 of the year following the year to
        which such Performance Bonus is based, and any such Performance Bonus will not be considered earned until such date.&#160; Executive's Performance Bonus opportunity shall be reviewed annually by the Compensation Committee and subject to adjustment to
        reflect Executive's performance in the Compensation Committee's sole discretion.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Equity</u>. The Company shall recommend to the Compensation Committee that Executive be granted an equity
        award representing 0.5% of the Company&#8217;s fully diluted shares, which shall be equivalent to an option to purchase 168,521 shares of Company common stock (the &#8220;Option&#8221;), which Option shall, to the extent possible, be treated as an Incentive Stock
        Option, with a strike price equivalent to the fair market value of the Company common stock as of the date of the Option grant (which date of grant shall coincide with the Effective Date of this Agreement). The Option shall vest over a period of
        four (4) years from the date of grant, with 25% of the Option fully vesting on the nine (9) month anniversary of the date of Grant, which vesting shall continue on a monthly basis thereafter for the following three (3) year period, until fully
        vested, subject to the Executive&#8217;s continued employment and further subject to Section 5(c) of this Agreement. With respect to the Option, 50% of it (84,261 shares) shall be in consideration for Executive&#8217;s service as a Company Director (the &#8220;Board
        Service Option&#8221;) and 50% of the Option (84,260 shares) shall be in consideration for Executive&#8217;s service as an employee (the &#8220;Employment Service Option&#8221;). The Board Service Option and Employment Service Option shall be reflected in written award
        agreements which shall be subject to the Brooklyn ImmunoTherapeutics, Inc. Restated 2020 Stock Incentive Plan (the &#8220;Plan&#8221;), which may be amended and modified from time to time. The Board Service Option shall immediately accelerate and vest upon the
        Executive&#8217;s removal as a Company Director (for reasons other than for cause or for voluntary resignation, except that a request for resignation by the Board shall not be considered a voluntary resignation).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160; <u></u><font style="color: rgb(0, 0, 0);"><u>Additional Equity Grants</u>. Commencing in 2024, Executive will be eligible to receive annual equity
        awards under an applicable equity incentive plan of the Company as then in effect, as determined by the Compensation Committee of the Board in its discretion.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>PTO</u>.&#160; During the Term, Executive shall be eligible to participate in the Company&#8217;s flexible paid time
        off (&#8220;PTO&#8221;) policy and paid holidays in connection with the Company&#8217;s holiday policy. PTO is not accrued and is not paid at termination.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160; &#160; <font style="color: rgb(0, 0, 0);"><u>Expense Reimbursement</u>.&#160; Executive shall be reimbursed for all reasonable travel and other out-of-pocket
        expenses actually and properly incurred by Executive prior to and during the Term in connection with carrying out Executive&#8217;s duties hereunder in accordance with the Company's policies in effect from time to time for its senior executives
        generally.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Benefits</u>.&#160; During the Term, Executive shall be eligible to participate in all welfare, perquisite, fringe
        benefit, insurance, retirement and other benefit plans, practices, policies and programs, maintained by the Company and its affiliates applicable to senior executives of the Company generally, in each case as amended from time to time. The Company
        shall reimburse Executive for the costs of Executive's health, dental and vision insurance obtained through Executive's retiree health insurance plan from her previous employer up to but no more than the costs of the Company-provided health, dental
        and vision plan.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Termination of Employment</font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160; &#160; <font style="color: rgb(0, 0, 0);"><u>Death and Disability</u>.&#160; Executive's employment shall terminate automatically upon Executive's death.&#160; If
        the Company determines in good faith that the Disability (as defined below) of Executive has occurred during the Term, it may give to Executive written notice in accordance with Section 11 of this Agreement of its intention to terminate Executive's
        employment; provided that (i) such notice is provided no later than 150 calendar days following the determination of Executive's Disability, and (ii) Executive has not returned to full-time employment during the period between such determination
        and the giving of such notice.&#160; In such event, Executive's employment shall terminate effective on the 30th calendar day after receipt of such notice by Executive (the &#8220;Disability Effective Date&#8221;), provided that, within the thirty (30) calendar
        days after such receipt, Executive shall not have returned to full-time performance of Executive's duties.&#160; For purposes of this Agreement, &#8220;<u>Disability</u>&#8221; shall mean the inability of Executive to perform the essential duties of the position
        held by Executive by reason of any medically determined physical or mental impairment that is reasonably expected to result in death or lasts for 120 calendar days in any one-year period, all as determined by an independent licensed physician
        mutually acceptable to the Company and Executive or Executive's legal representative.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Cause</u>.&#160; Executive's employment with the Company may be terminated by the Company with or without Cause.&#160;
        For purposes of this Agreement, &#8220;Cause&#8221; shall mean: (i) the continued failure of Executive to perform Executive's duties as set forth in Section 2 hereof or Executive's material disregard of the reasonable and lawful directives of the Company (in
        each case other than any such failure resulting from any medically determined physical or mental impairment) that is not cured by Executive within twenty (20) calendar days after a written demand for performance is delivered to Executive by the
        Company which specifically identifies the manner in which the Company believes that Executive has not performed Executive's duties or disregarded a directive of the Board; (ii) Executive's commission of any material act of fraud, misappropriation
        or embezzlement against or in connection with the Company or any of its affiliates or their respective businesses or operations; (iii) Executive's commission of, or indictment for or otherwise being formally charged with, any crime involving
        dishonesty or for any felony; (iv) the engaging by Executive in misconduct that is materially detrimental to the financial condition or business reputation of the Company or any of its affiliates, including due to any adverse publicity; or (v) a
        material breach by Executive of Executive&#8217;s obligations under Section 8, or Executive&#8217;s representations under Section 9, of this Agreement.&#160; In addition to the notice and opportunity to cure set forth in subsection (i) above, to the extent that any
        of the grounds set forth in subsections (iv) or (v) above is capable of being cured, the Company shall not have Cause unless it has furnished Executive with written notice specifically identifying the conduct allegedly giving rise to Cause, and
        Executive has failed to cure such ground within twenty (20) days of the delivery of such notice.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Good Reason</u>.&#160; Executive's employment with the Company may be terminated by Executive with or without Good
        Reason.&#160; For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the occurrence of any of the following without Executive's consent:&#160; (i) a material reduction by the Company of Executive's title, duties, responsibilities, authority or reporting
        relationship set forth in Section 2(a); (ii) a material reduction by the Company of Executive's Annual Base Salary; (iii) a material breach of the Company of this Agreement; or (iv) a material change in geographic location at which Executive must
        principally perform services under this Agreement from the location at which Executive was principally employed.&#160; A termination of Executive's employment by Executive under Sections 4(c)(i), (ii),(iii) or (iv) shall not be deemed to be for Good
        Reason unless (x) Executive gives notice to the Company of the existence of the event or condition constituting Good Reason within thirty (30) calendar days after becoming aware of the initial occurrence or existence of such event or condition, and
        (y) the Company fails to cure such event or condition within thirty (30) calendar days after receiving such notice.&#160; Additionally, Executive must terminate Executive&#8217;s employment within ninety (90) calendar days after the initial occurrence of the
        circumstance constituting Good Reason for such termination to be &#8220;Good Reason&#8221; hereunder.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Notice of Termination</u>.&#160; Any termination by the Company for Cause, or by Executive for Good Reason, shall
        be communicated by Notice of Termination to the other party in accordance with Section 11.&#160; For purposes of this Agreement, a &#8220;Notice of Termination&#8221; means a written notice which (i) indicates the specific termination provision in this Agreement
        relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive's employment under the provision so indicated, and (iii) if the Date of Termination (as
        defined below) is other than the date of receipt of such notice, specifies the Date of Termination.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Date of Termination</u>.&#160; &#8220;Date of Termination&#8221; means, as applicable, the date of Executive's death, the
        Disability Effective Date, or the date on which the termination of Executive's employment by the Company for Cause or without Cause or by Executive for Good Reason or without Good Reason is effective.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Resignation from All Positions</u>.&#160; Notwithstanding any other provision of this Agreement, upon the
        termination of Executive's employment for any reason, unless otherwise requested by the Board, Executive shall immediately resign from all positions that Executive holds or has ever held with the Company and its affiliates, including the boards of
        directors or committees of the Company's affiliates.&#160; Executive hereby agrees to execute any and all documentation to effectuate such resignations upon request by the Company, but Executive shall be treated for all purposes as having so resigned
        upon termination of Executive&#8217;s employment, regardless of when or whether Executive executes any such documentation. Any unvested Board Service Options shall vest in accordance with Section 3(d) of this Agreement.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Severance Payments</font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Any Termination of Employment</u>.&#160; If, during or at the expiration of the Term, Executive's employment with
        the Company and its affiliates shall terminate for any reason or no reason, then:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Accrued Benefits</u>.&#160; The Company shall pay, or cause to be paid, to Executive the sum of:&#160; (A) the
        portion of Executive's Annual Base Salary earned through the Date of Termination, to the extent not previously paid, (B) the amount of the Performance Bonus that the Compensation Committee of the Board has decided has been earned by Executive
        preceding the Date of Termination, but has not yet been paid to Executive, and (C) any unreimbursed business expenses to the extent reimbursable in accordance with the Company's reimbursement policies (the sum of the amounts described in clauses
        (A) through and including (C) shall be referred to as the &#8220;Accrued Benefits&#8221;).&#160; The Accrued Benefits shall be paid to Executive in a single lump sum within thirty (30) calendar days after the Date of Termination or such earlier date if required by
        law.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Other Benefits</u>.&#160; To the extent not previously paid or provided, the Company shall pay or provide, or
        cause to be paid or provided, to Executive (or Executive&#8217;s estate) any other amounts or benefits (including, as applicable, any payment of long-term incentive awards) required to be paid or provided or which Executive is eligible to receive under
        any plan, program, policy or practice or contract or agreement of the Company, including any benefits to which Executive is entitled under COBRA (such other amounts and benefits described in this Section 5(a)(ii) shall be hereinafter referred to as
        the &#8220;Other Benefits&#8221;) in accordance with the terms and normal procedures of each such plan, program, policy or practice or contract or agreement, based on accrued and vested benefits through the Date of Termination.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Good Reason, Other than for Cause</u>.&#160; If, during the Term, the Company shall terminate Executive's
        employment other than for Disability or Cause, or if Executive shall terminate employment for Good Reason, then, in addition to providing the Accrued Benefits and Other Benefits, as set forth in Section 5(a) above, and subject to Sections 6 and
        8(f) below, the Company shall pay or provide the following amounts and benefits to Executive:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><u>Severance</u>.&#160; The Company shall pay to Executive severance equivalent to six (6) months of Executive&#8217;s
        Annual Base Salary as of the Date of Termination (the &#8220;Severance&#8221;),&#160; which Severance payments shall be made over a period of six (6) months (the &#8220;Severance Period&#8221;), in regular installments in accordance with the Company's normal payroll practices.
        The Severance payments shall begin on the date the Release described in Section 6 becomes effective and irrevocable in accordance with its terms (the &#8220;Release Effective Date&#8221;) and shall continue for the Severance Period until the Severance is fully
        paid.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Continued Health Insurance</u>.&#160; If Executive elects COBRA coverage under the applicable medical and
        dental plans of the Company, the Company will subsidize a portion of the applicable monthly COBRA premium during the Severance Period, so that Executive will only be required to pay the premiums applicable to continuing employees during that time;
        provided that such subsidy shall cease on the date on which Executive becomes eligible for medical and dental coverage from a third party.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Good Reason, Other than for Cause During the Change in Control Protection Period</u>.&#160; If, during the Term
        and during the period beginning upon the occurrence of a &#8220;Change in Control&#8221; (as defined in the Equity Plan) and ending on the first anniversary of the occurrence of the Change in Control (the &#8220;Change in Control Protection Period&#8221;), the Company
        shall terminate Executive's employment other than for Disability or Cause, or if Executive shall terminate employment for Good Reason, then, in addition to providing the Accrued Benefits and Other Benefits, as set forth in Section 5(a) above, and
        subject to Sections 6 and 8(f) below, the Company shall pay or provide the benefits set forth in Section 5(b) except that Executive shall receive a lump sum amount equivalent to twelve (12) months of Executive&#8217;s Annual Base Salary (in lieu of the
        amount paid during the Severance Period as provided in Section 5(b)), and the Performance Bonus, which shall not be pro-rated, within fourteen (14) business days of the effective date of the Release provided for in Section 6 and Executive shall
        thereafter be entitled to twelve (12) months of subsidized COBRA premiums. In addition, and notwithstanding anything contained in the applicable Company equity plan and award agreements to the contrary, all outstanding and unvested equity awards of
        the Company granted to Executive shall become immediately vested and exercisable upon such Date of Termination.&#160; In addition, all outstanding and vested Company stock options (including those that vest pursuant to the operation of the immediately
        preceding sentence) will remain exercisable for a period of twelve (12) months following the Date of Termination pursuant to this Section 5(c).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Section 280G</u>.&#160; Notwithstanding anything in this Agreement to the contrary, in the event it shall be
        determined that any accrual, acceleration, payment, benefit or distribution by the Company or any of its affiliated companies to or for the benefit of Executive (whether paid or payable or distributed or distributable pursuant to the terms of this
        Agreement or otherwise) (a &#8220;Payment&#8221;) would be an excess parachute payment within the meaning of section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) (such excess only, an &#8220;Excess Payment&#8221;), then Executive shall forfeit all
        Excess Payments if the after-tax value to Executive of the Payments, as reduced by such forfeiture, would be greater than the after-tax value to Executive of the Payments absent such forfeiture.&#160; The forfeiture of Excess Payments, if applicable,
        shall be applied to the severance described in Section 5(c) hereof, then to cancellation of accelerated vesting of performance-based equity awards (based on the reverse order of the date of grant), then to cancellation of accelerated vesting of
        other equity awards (based on the reverse order of the date of grant), and then to any other Payments on a pro-rata basis.&#160; All determinations required to be made under this Section 5(d), including whether and when a Payment is subject to section
        280G of the Code, and the value of a Payment for purposes of section 280G of the Code, and the assumptions to be utilized in arriving at such determination, shall be made by an accounting firm with expertise in such matters designated by the
        Company (the &#8220;Accounting Firm&#8221;).&#160; The Company will direct the Accounting Firm to provide its determination and detailed supporting calculations both to the Company and Executive within fifteen (15) business days after the date of the event giving
        rise to the Payment or such other time as is requested by the Company.&#160; Any determination by the Accounting Firm shall be binding upon the Company and Executive.&#160; All fees and expenses of the Accounting Firm for services performed pursuant to this
        Section 5(d) shall be borne solely by the Company.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">6.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Release</font>.&#160; Notwithstanding anything contained herein
        to the contrary, the Company shall not be obligated to make any payment or provide any benefit under Section 5(b) or 5(c) hereof unless:&#160; (a) Executive or Executive's legal representative first executes within twenty-one (21) calendar days after
        the Date of Termination (or such longer period as required by applicable law) a release of claims in a form the Company approves (the &#8220;Release&#8221;); (b) Executive does not revoke the Release; and (c) the Release becomes effective and irrevocable in
        accordance with its terms.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">7.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Full Settlement</font>.&#160; The Company's obligation to make
        the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company or any of its affiliates may
        have against Executive or others, except as otherwise may be provided in Section 8 hereof.&#160; In no event shall Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to Executive under
        any of the provisions of this Agreement and such amounts shall not be reduced whether or not Executive obtains other employment.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Executive&#8217;s Covenants</font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Confidentiality</u>.&#160; During the Term and thereafter, Executive agrees to keep secret and confidential, and
        not to use or disclose to any third parties, except as directly required for Executive to perform Executive's responsibilities for the Company under this Agreement, any of the Company's Confidential Information (as defined in paragraph (i) below)
        acquired by Executive during the course of, or in connection with, Executive's employment with the Company.&#160; Executive acknowledges that the Confidential Information is the exclusive property of the Company.&#160; Upon termination of Executive's
        employment with the Company, for any reason, or at the request of the Company at any time, Executive shall promptly return to the Company all property then in Executive's possession, custody or control belonging to the Company, including all
        Confidential Information.&#160; Executive shall not retain any copies of correspondence, memoranda, reports, notebooks, drawings, photographs or other documents in any form whatsoever (including information contained in computer or other electronic
        memory or on any computer or electronic storage device) relating in any way to the affairs of the Company and which were entrusted to Executive or obtained by Executive at any time during the Term.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Assignment of Rights</u>.&#160; Executive shall promptly disclose to the Company and hereby assigns and transfers
        to the Company all of Executive's right, title and interest in and to:</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">any and all patents, inventions, discoveries, concepts, processes, methods, formulas, techniques, trade
        secrets, know-how, and related rights, whether or not patentable; and</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">any and all copyrights and works of authorship, whether or not copyrightable, if and only to the extent that
        such intellectual property was conceived, created or reduced to tangible form by Executive in the course of performing her duties for the Company, and either relates to the business of the Company, or was conceived, created or reduced to tangible
        form with the use or assistance of the Company's facilities, materials or personnel.&#160; Without limiting the generality of the foregoing, this assignment requirement applies to applications for U.S. or foreign letters patent and copyright
        registration granted upon such inventions, discoveries, and works of authorship and similar items as hereinabove set forth.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">Executive shall deliver to the Company any and all instruments necessary to confirm complete ownership by the
        Company of any and all rights as described above, and upon the failure of Executive to furnish such documents, this Agreement shall constitute such documentation for all purposes.&#160; Executive further agrees during and after Executive's employment by
        the Company, to cooperate fully, including giving testimony in support of Executive's inventorship, as may be necessary in the opinion of the Company to obtain and/or maintain letters patent and to vest the entire ownership of such letters patent
        with the Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Non-Disparagement</u>.&#160; Executive agrees that Executive will not do or say anything that could reasonably be
        expected to disparage or impact negatively the name or reputation in the marketplace of the Company or any of its affiliates, employees, officers, directors, stockholders, members, principals or assigns.&#160; Subject to Executive's continuing
        obligations to comply with Section 8(a) (Confidential Information) hereof, nothing in this Section 8(d) shall preclude Executive from responding truthfully to any legal process or truthfully testifying in a legal or regulatory proceeding, provided
        that, to the extent permitted by law and Section 8(g) hereof, Executive promptly informs the Company of any such obligation prior to participating in any such proceedings.&#160; The Company, defined for purposes of this Section 8(d) as the Board,
        Company executives, and its individual members, agrees in turn that it will not do or say anything that could reasonably be expected to disparage or impact negatively the name or reputation in the marketplace of Executive, provided that nothing in
        this Section 8(d) shall prevent the Company from responding truthfully to any legal process or truthfully testifying in a legal or regulatory proceeding.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Divisible Provisions</u>.&#160; The individual terms and provisions of this Section 8 are intended to be
        separate and divisible provisions and if, for any reason, any one or more of them is held to be invalid or unenforceable, neither the validity nor the enforceability of any other provision of this Section 8 shall thereby be affected.&#160; It is the
        intention of Executive and the Company that the potential restrictions on Executive's solicitation and future employment imposed by this Section 8 be reasonable in both duration and geographic scope and in all other respects.&#160; If for any reason any
        court of competent jurisdiction shall find any provisions of this Section 8 unreasonable in duration or geographic scope or otherwise, Executive and the Company agree that the restrictions and prohibitions contained herein may be modified by a
        court of competent jurisdiction and shall be effective to the fullest extent allowed under applicable law in such jurisdiction.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160; &#160; &#160; <font style="color: rgb(0, 0, 0);"><u>Injunctive Relief and Remedies</u>.&#160; In event of a breach or threatened breach of any of Executive's duties
        and obligations under this Section 8, the Company shall be entitled, in addition to any other legal or equitable remedies it may have in connection therewith (including any right to damages it may suffer), to (i) seek temporary, preliminary and
        permanent injunctive relief restraining such breach or threatened breach, (ii) cease making payments or providing benefits under Section 5 of this Agreement (other than paragraph 5(a) thereof), and (iii) seek any other relief obtainable through
        statutory or common law means (including, but not limited to, applicable trade secrets law).&#160; Executive hereby expressly acknowledges that the harm that might result to the Company's business as a result of any noncompliance by Executive with the
        provisions of this Section 8 may be largely irreparable.&#160; The restrictions stated in this Section 8 are in addition to and not in lieu of protections afforded to trade secrets and confidential information under applicable law.&#160; Nothing in this
        Section 8 is intended to or shall be interpreted as diminishing or otherwise limiting the Company's right under applicable law to protect its trade secrets and confidential information.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Protected Activity</u>.&#160; Nothing contained in this Agreement, or any other agreement, policy, practice,
        procedure, directive or instruction maintained by the Company shall prohibit Executive from reporting possible violations of federal, state or local laws or regulations to any federal, state or local governmental agency or commission (a &#8220;Government
        Agency&#8221;) or from making other disclosures that are protected under the whistleblower provisions of federal, state or local laws or regulations.&#160; Executive does not need prior authorization of any kind to make any such reports or disclosures to any
        Government Agency and Executive is not required to notify the Company that Executive has made such reports or disclosures.&#160; Nothing in this Agreement limits any right Executive may have to receive a whistleblower award or bounty for information
        provided to any Government Agency.&#160; Executive hereby acknowledges that the Company has informed Executive, in accordance with 18 U.S.C. &#167; 1833(b), that Executive may not be held criminally or civilly liable under any federal or state trade secret
        law for the disclosure of a trade secret where the disclosure:&#160; (i) is made in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating
        a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Notification/Survival</u>.&#160; To enable the Company to monitor Executive's compliance with the obligations
        imposed by this Section 8, Executive agrees to inform the Company of the identity of any subsequent employer and Executive's new job title.&#160; Executive agrees that he will disclose the existence of this Section 8 to any subsequent employer.&#160;
        Following the expiration of the Term or this Agreement, this Section 8 shall survive and be of full force and effect.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Definitions</u>.&#160; As used in this Section 8, the following definitions shall apply</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">&#8220;<u>Company</u>&#8221; means the Company and its subsidiaries and affiliates.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">&#160;&#8220;<u>Confidential Information</u>&#8221; means information pertaining to the business of the Company that is generally not known to or readily ascertainable to the industry in which the Company competes,
      and that gives or tends to give the Company a competitive advantage over persons who do not possess such information or the secrecy of which is otherwise of value to the Company in the conduct of its business regardless of when and by whom such
      information was developed or acquired, and regardless of whether any of these are described in writing, copyrightable or considered copyrightable, patentable or considered patentable.&#160; Confidential Information includes, but is not limited to, the
      Company's trade secrets, financial information or plans, pricing and profit information, sales and marketing information or plans, business or strategic plans, information concerning methods of operation, proprietary systems or software, legal or
      regulatory information, cost and pricing information or policies, information concerning new or potential products or markets, clinical data, medical or other data relating to participants in clinical trials, or research and/or analysis, information
      related to present and potential customers, vendors and suppliers (including, but not limited to, lists, contact information, requirements, contract terms, and pricing), methods of operations, research and development, product information, business
      technical information, including technical data, techniques, solutions, test methods, quality control systems, processes, design specifications, technical formulas, procedures and information, all agreements, schematics, manuals, studies, reports,
      and statistical information relating to the Company, all formulations, database files, information technology, strategic alliances, products, services, programs and processes used or sold, and all software licensed or developed by the Company,
      computer programs, systems and/or software, ideas, inventions, business information, know-how, improvements, designs, redesigns, creations, discoveries and developments of the Company.&#160; Confidential Information includes all forms of the information,
      whether oral, written or contained in electronic or any other format.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">9.</font>&#160;&#160;&#160; &#160;&#160; &#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Representations</font>.&#160; Executive hereby represents and
        warrants to the Company that Executive is not party to any contract, understanding, agreement or policy, whether or not written, with Executive&#8217;s current employer (or any other previous employer) or otherwise, that would be breached by Executive's
        entering into, or performing services under, this Agreement.&#160; Executive further represents that Executive has disclosed to the Company in writing all material threatened, pending, or actual claims against Executive that are unresolved and still
        outstanding as of the Effective Date, in each case of which Executive is aware, resulting or arising from Executive&#8217;s service with Executive&#8217;s current employer (or any other previous employer) or Executive&#8217;s membership on any boards of directors.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">10.</font>&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Cooperation</font>.&#160; During the Term and thereafter,
        Executive shall cooperate with the Company and its affiliates, without additional consideration, in any internal investigation or administrative, regulatory, or judicial proceeding as reasonably requested by the Company including, without
        limitation, Executive's being available to the Company and its affiliates upon reasonable notice for interviews and factual investigations, appearing at the Company's request to give testimony without requiring service of a subpoena or other legal
        process, volunteering to the Company all pertinent information, and turning over to the Company all relevant documents that are or may come into Executive's possession, all at times and on schedules that are reasonably consistent with Executive's
        other permitted activities and commitments and otherwise taking into account Executive's reasonable business obligations.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">11.</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Notices</font>.&#160; Any notice provided for in this Agreement
        shall be in writing and shall be either personally delivered, sent by electronic mail, or sent by reputable overnight carrier, in each case with proof of receipt, to the recipient.&#160; Notices to Executive shall be sent to the address of Executive
        most recently provided to the Company.&#160; Notices to the Company should be sent to the attention of the Company&#8217;s Chief Executive Officer.&#160; Any notice under this Agreement will be deemed to have been given when so delivered or sent (subject to proof
        of delivery and receipt).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">12.</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Severability</font>.&#160; The invalidity or unenforceability of
        any particular provision in this Agreement shall not affect the other provisions hereof, and this Agreement shall be construed in all respects as if the invalid or unenforceable provision were omitted.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">13.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Complete Agreement</font>.&#160; This Agreement embodies the
        complete agreement and understanding between the parties with respect to the subject matter hereof and effective as of its date supersedes and preempts any prior understandings, agreements or representations by or between the parties, written or
        oral, which may have related to the subject matter hereof in any way.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">14.</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Withholding of Taxes</font>.&#160; The Company and its affiliates
        may withhold from any amounts payable under this Agreement all federal, state, city or other taxes as the Company and its affiliates are required to withhold pursuant to any law or government regulation or ruling.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Successors and Assigns</font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">This Agreement is personal to Executive, and, without the prior written consent of the Company, shall not be
        assignable by Executive other than by will or the laws of descent and distribution.&#160; This Agreement shall inure to the benefit of and be enforceable by Executive&#8217;s legal representatives.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);">This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.&#160;
        Except as provided in Section 15(c), without the prior written consent of Executive this Agreement shall not be assignable by the Company, except to an affiliate.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160; &#160; &#160; &#160; <font style="color: rgb(0, 0, 0);">The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or
        otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such
        succession had taken place.&#160; &#8220;Company&#8221; means the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid that assumes and agrees to perform this Agreement by operation of law or otherwise.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">16.</font>&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Choice of Law/Dispute Resolution</font>.&#160; This Agreement
        shall be governed, construed, interpreted and enforced in accordance with the substantive laws of the Commonwealth of Pennsylvania, without regard to conflicts of law principles.&#160; The parties shall execute simultaneously herewith a mutual agreement
        to arbitrate claims, which arbitration shall take place in Pennsylvania.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">17.</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Amendment and Waiver</font>.&#160; The provisions of this
        Agreement may be amended or waived only with the prior written consent of the Company and Executive, and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall affect the validity, binding effect or
        enforceability of this Agreement.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Section 409A Compliance</font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>In General</u>.&#160; The intent of the parties is that payments and benefits under this Agreement comply with
        Section 409A of the Code (&#8220;Section 409A&#8221;) or are exempt therefrom and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted and administered so as to be in compliance therewith.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Separation from Service</u>.&#160; A termination of employment shall not be deemed to have occurred for purposes
        of any provision of this Agreement providing for the payment of any amounts or benefits subject to Section 409A upon or following a termination of employment un-less such termination is also a &#8220;separation from service&#8221; within the meaning of Section
        409A, and for purposes of any such provision of this Agreement, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms shall mean &#8220;separation from service&#8221; within the meaning of Section 409A.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Reimbursements or In-Kind Benefits</u>.&#160; With regard to any provision herein that provides for reimbursement
        of costs and expenses or in-kind benefits, except as permitted by Section 409A:&#160; (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit; (ii) the amount of expenses eligible for
        reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year; and (iii) such payments shall be made on or before the
        last day of Executive's taxable year following the taxable year in which the expense occurred, or such earlier date as required hereunder.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Six Month Delay</u>.&#160; Notwithstanding anything contained in this Agreement to the contrary, if Executive is
        a &#8220;specified employee,&#8221; as determined under the Company's policy for identifying specified employees on the Date of Termination, then to the extent required in order to comply with Section 409A, all payments, benefits or reimbursements paid or
        provided under this Agreement that constitute a &#8220;deferral of compensation&#8221; within the meaning of Section 409A, that are provided as a result of a &#8220;separation from service&#8221; within the meaning of Section 409A and that would otherwise be paid or
        provided during the first six (6) months following such Date of Termination shall be accumulated through and paid or provided (without interest), within twenty (20 )calendar days after the first business day that is more than six (6) months after
        the date of her separation from service (or, if Executive dies during such six-month period, within twenty (20) calendar days after Executive's death).</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Payment Dates</u>.&#160; In the event the payment period under this Agreement for any nonqualified deferred
        compensation commences in one calendar year and ends in a second calendar year, the payments shall not be paid (or installments commenced) until the later of the first payroll date of the second calendar year, or the date that such Release becomes
        effective and irrevocable, to the extent necessary to comply with Section 409A.&#160; For purposes of Section 409A, Executive&#8217;s right to receive any &#8220;installment&#8221; payments pursuant to this Agreement shall be treated as a right to receive a series of
        separate and distinct payments.</font></div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">19.</font>&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><font style="font-weight: bold;">Counterparts</font>.&#160; This Agreement may be executed in
        counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement.&#160; A signed copy of this Agreement delivered by electronic mail or other means of electronic transmission shall be
        deemed to have the same legal effect as delivery of an original signed copy of this Agreement.</font></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z164401c129cd4a2a9472bb7d04b9cba7" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="text-align: justify;">ETERNA THERAPEUTICS, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top; border-bottom: 2px solid black;" colspan="2">
            <div style="text-align: justify; font-style: italic;">/s/ Sandra M. Gurrola</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="text-align: justify;">By:</div>
          </td>
          <td style="width: 47%; vertical-align: top;">
            <div style="text-align: justify;">&#160;&#160;Sandra Gurrola</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 3%; vertical-align: top;">
            <div style="text-align: justify;">Its:</div>
          </td>
          <td style="width: 47%; vertical-align: top;">
            <div style="text-align: justify;">&#160;&#160;Sr. VP of Finance</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="text-align: justify;">EXECUTIVE</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top; border-bottom: 2px solid black;" colspan="2">
            <div style="text-align: justify; font-style: italic;">/s/ Dorothy Clarke</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="text-align: justify;">Dorothy Clarke</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">12</font></div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>8
<FILENAME>ef20015352_ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 21.1</div>

    <div>&#160;</div>

    <div style="text-align: center; font-weight: bold;">SUBSIDIARIES OF THE REGISTRANT</div>

    <div>&#160;<br>
       </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td nowrap="nowrap" style="width: 49%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="font-weight: bold;">Subsidiary</div>
          </td>
          <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td nowrap="nowrap" style="width: 49%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>State Or Country of Organization <br>
               </div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: justify; text-indent: -12pt; margin-left: 12pt;">Eterna Therapeutics LLC</div>
          </td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: justify;">Delaware</div>
          </td>
        </tr>

    </table>

    <div> <br>
       </div>

    <div>*Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of the registrant are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of
      the year covered by this report.</div>
    <br>

    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>9
<FILENAME>ef20015352_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 23.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div><br>
    </div>
    <div>We have issued our report dated March 15, 2024, with respect to the consolidated financial statements included in the Annual Report of Eterna Therapeutics Inc. on Form 10-K for the year ended December 31, 2023.&#160; We consent to the incorporation by
      reference of said report in the Registration Statements of Eterna Therapeutics Inc. on Forms S-1 (File No. 333-261185, File No. 333-256570 and File No. 333-271279), on Forms S-3 (File No. 333-264585, File No. 333-273977 and File No. 333-276493) and
      on Forms S-8 (File No. 333-260200, File No. 333-256760 and File No. 333-276521).</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>/s/ Grant Thornton LLP</div>
          </td>
          <td style="width: 50%; vertical-align: top;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>New York, New York</div>
          </td>
          <td style="width: 50%; vertical-align: top;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>March 14, 2024</div>
          </td>
          <td style="width: 50%; vertical-align: top;"><br>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <br>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>ef20015352_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 31.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</div>
    <div style="text-align: center; font-weight: bold;">SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a), AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; font-weight: bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div>&#160;</div>
    <div>I, Sanjeev Luther, certify that:</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">1. I have reviewed this annual report on Form 10-K of Eterna Therapeutics Inc. (the &#8220;Company&#8221;);</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
      statements were made, not misleading with respect to the period covered by this report;</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this report;</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
      over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;">&#160;</td>
          <td style="width: 20.55pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
              subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
              the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(c)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
              report based on such evaluation; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(d)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report)
              that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the
      registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report
              financial information; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div>Dated: March 14, 2024</div>
          </td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-style: italic;">/s/ <font style="font-variant: small-caps;">Sanjeev Luther</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
          <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">Sanjeev Luther</div>
            <div style="text-align: center; font-weight: bold;">President and Chief Executive Officer</div>
            <div style="text-align: center; font-weight: bold;">Eterna Therapeutics Inc.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>ef20015352_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 31.2</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</div>
    <div style="text-align: center; font-weight: bold;">SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a), AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; font-weight: bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div>&#160;</div>
    <div>I, Sandra Gurrola, certify that:</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">1. I have reviewed this annual report on Form 10-K of Eterna Therapeutics Inc. (the &#8220;Company&#8221;);</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
      statements were made, not misleading with respect to the period covered by this report;</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this report;</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
      over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
              subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
              the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(c)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
              report based on such evaluation; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(d)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report)
              that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the
      registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report
              financial information; and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 20.55pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div>Dated: March 14, 2024</div>
          </td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center;">/s/ <font style="font-style: italic; font-variant: small-caps;">Sandra Gurrola</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
          <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">Sandra Gurrola</div>
            <div style="text-align: center; font-weight: bold;">Senior Vice President of Finance</div>
            <div style="text-align: center; font-weight: bold;">Eterna Therapeutics Inc.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>ef20015352_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 32.1</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</div>
    <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">In connection with the Annual Report of Eterna Therapeutics Inc. (the &#8220;Registrant&#8221;) on Form 10-K for the year ended December 31, 2023 (the &#8220;Report&#8221;), I, Sanjeev Luther, President and Chief Executive Officer of the
      Registrant, do hereby certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</div>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z6f3a2efb73864b11966b8666429f33f9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div>Dated: March 14, 2024</div>
          </td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center;">/s/ <font style="font-style: italic; font-variant: small-caps;">Sanjeev Luther</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">Sanjeev Luther</div>
            <div style="text-align: center; font-weight: bold;">President and Chief Executive Officer</div>
            <div style="text-align: center; font-weight: bold;">Eterna Therapeutics Inc.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>ef20015352_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 32.2</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</div>
    <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">In connection with the Annual Report of Eterna Therapeutics Inc. (the &#8220;Registrant&#8221;) on Form 10-K for the year ended December 31, 2023 (the &#8220;Report&#8221;), I, Sandra Gurrola, Senior Vice President of Finance of the
      Registrant, do hereby certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div>&#160;</div>
    <div style="text-indent: 24.5pt;">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</div>
    <div>&#160;<br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div>Dated: March 14, 2024</div>
          </td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-style: italic;">/s/ <font style="font-variant: small-caps;">Sandra Gurrola</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 49%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">&#160;</td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: bottom;">
            <div style="text-align: center; font-weight: bold;">Sandra Gurrola</div>
            <div style="text-align: center; font-weight: bold;">Senior Vice President of Finance</div>
            <div style="text-align: center; font-weight: bold;">Eterna Therapeutics Inc.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97
<SEQUENCE>14
<FILENAME>ef20015352_ex97.htm
<DESCRIPTION>EXHIBIT 97
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">

  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; color: rgb(37, 37, 37); font-weight: bold;"> Exhibit 97<br>
    </div>
    <div style="text-align: center; color: #252525; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; color: #252525; font-weight: bold;">ETERNA THERAPEUTICS INC.</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #252525; font-weight: bold;">CLAWBACK POLICY</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z98386d5eedf0442793d8b606f61d5ad9" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">I.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Introduction</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">The Board of Directors (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;) of Eterna Therapeutics Inc. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) believes that it is
        in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company&#8217;s pay-for-performance compensation philosophy.&#160; The Board has therefore adopted
        this policy which provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws (the &#8220;<font style="font-weight: bold;">Policy</font>&#8221;).&#160; This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221;) and final rules and amendments adopted
        by the Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;) to implement the aforementioned legislation.</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zabc83311d2424272a707b4ea7600f4c0" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">II.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Administration</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #252525;">This Policy shall be administered by the Board or, if so designated by the Board, the Compensation Committee of the Board, in which case references herein to the Board shall be deemed
      references to the Compensation Committee. Any determinations made by the Board shall be final and binding on all affected individuals.</div>
    <div>&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z528e64031bc54e4a9a27367ef044b3cb" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">III.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Covered Executives</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">This Policy applies to the Company&#8217;s current and former executive officers, as determined by the Board in accordance with the requirements of Section 10D of the Exchange Act and any
        applicable rules or standards adopted by the SEC and any national securities exchange on which the Company&#8217;s securities are listed, and such other employees who may from time to time be deemed subject to the Policy by the Board (&#8220;<font style="font-weight: bold;">Covered Executives</font>&#8221;).</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z672c35722981477d8313280087447df8" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">IV.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Incentive-Based Compensation</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">For purposes of this Policy, incentive-based compensation (&#8220;<font style="font-weight: bold;">Incentive-Based Compensation</font>&#8221;) includes any compensation that is granted, earned,
        or vested based wholly or in part upon the attainment of any financial reporting measures that are determined and presented in accordance with the accounting principles (&#8220;<font style="font-weight: bold;">GAAP Measures</font>&#8221;) used in preparing the
        Company&#8217;s financial statements and any measures derived wholly or in part from such measures, as well as non-GAAP Measures, stock price, and total shareholder return (collectively, &#8220;<font style="font-weight: bold;">Financial Reporting Measures</font>&#8221;);
        however, it does not include: (i) base salaries; (ii) discretionary cash bonuses; (iii) awards (either cash or equity) that are solely based upon subjective, strategic or operational standards or standards unrelated to Financial Reporting Measures,
        and (iv) equity awards that vest solely on completion of a specified employment period or without any performance condition.&#160; Incentive-Based Compensation is considered received in the fiscal period during which the applicable reporting measure is
        attained, even if the payment or grant of such award occurs after the end of that period.&#160; If an award is subject to both time-based and performance-based vesting conditions, the award is considered received upon satisfaction of the
        performance-based conditions, even if such an award continues to be subject to the time-based vesting conditions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">For the purposes of this Policy, Incentive-Based Compensation may include, among other things, any of the following:</div>
      <div><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd38160a0227447508f7bea48985c26a5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Annual bonuses and other short- and long-term cash incentives.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z19ba1923343c4a46a34520c07f0520c6">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Stock options.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z70492f3e22df48c48c8dcea7503e2bfe">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Stock appreciation rights.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c866234402a463abd0a9532cfd05c55">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Restricted stock or restricted stock units.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z52ab14f873fe48d4a93f1149182e8d13">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Performance shares or performance units.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">For purposes of this Policy, Financial Reporting Measures may include, among other things, any of the following:</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z83d4a622657a4aad98c2d2a6eaf2d30b">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Company stock price.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeaf2a8a701244f1384a73ba3d012c833">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Total shareholder return.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8cf6dea51bb74194b0b70edd4552f59d">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Revenues.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7709dc4737454aef9f5dd72382aee2fb">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Net income.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z948274ec4e3546da94fb05053bce39b5">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Earnings before interest, taxes, depreciation, and amortization (EBITDA).</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbca2a6b6ce58449099c927a349a14f62">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Funds from operations.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z963defb872954c32acb491098d8e1621">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Liquidity measures such as working capital or operating cash flow.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z14d92b0d7ddc4a39af2ee257fac6111a">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Return measures such as return on invested capital or return on assets.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ea4a49a9f8b4365baa51b11a53f186f">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">Earnings measures such as earnings per share.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z7a1a43a0f4ab43e1a9bf8c1189705ac0" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">V.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Recoupment; Accounting Restatement</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">In the event the Company is required to prepare an accounting restatement of its financial statements due to the Company&#8217;s material noncompliance with any financial reporting
        requirement under U.S. securities laws, including any required accounting restatement to correct an error in previously issued financial statements that (i) is material to the previously issued financial statements or (ii) is not material to
        previously issued financial statements, but that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, the Board will require reimbursement or forfeiture of any excess
        Incentive-Based Compensation received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the Company is required to prepare the accounting restatement (the &#8220;<font style="font-weight: bold;">Look-Back
          Period</font>&#8221;).&#160; For the purposes of this Policy, the date on which the Company is required to prepare an accounting restatement is the earlier of (i) the date the Board concludes or reasonably should have concluded that the Company is required
        to prepare a restatement to correct a material error, and (ii) the date a court, regulator, or other legally authorized body directs the Company to restate its previously issued financial statements to correct a material error. The Company&#8217;s
        obligation to recover erroneously awarded compensation is not dependent on if or when the restated financial statements are filed.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #252525;">Recovery of the Incentive-Based Compensation is only required when the excess award is received by a Covered Executive (i) after the beginning of their service as a
          Covered Executive, (ii)</font><font style="color: #000000;">&#160;</font><font style="color: #252525;">who served as an executive officer at any time during the performance period for that Incentive-Based Compensation, (iii) while the Company has a
          class of securities listed on a national securities exchange or a national securities association, and (iv) during the Look-Back Period immediately preceding the date on which the Company is required to prepare an accounting restatement.</font></div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z47a858005f23482ca464c4a2d7fe3dc5" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">VI.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Excess Incentive Compensation: Amount Subject to Recovery</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">The amount of Incentive-Based Compensation subject to recovery is the amount the Covered Executive received in excess of the amount of Incentive-Based Compensation that would have
        been paid to the Covered Executive had it been based on the restated financial statements, as determined by the Board.&#160; The amount subject to recovery will be calculated on a pre-tax basis.</div>
      <div>&#160;</div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">For Incentive-Based Compensation received as cash awards, the erroneously awarded compensation is the difference between the amount of the cash award that was received (whether
        payable in a lump sum or over time) and the amount that should have been received applying the restated Financial Reporting Measure.&#160; For cash awards paid from bonus pools, the erroneously awarded Incentive-Based Compensation is the pro rata
        portion of any deficiency that results from the aggregate bonus pool that is reduced based on applying the restated Financial Reporting Measure.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">For Incentive-Based Compensation received as equity awards that are still held at the time of recovery, the amount subject to recovery is the number of shares or other equity awards
        received or vested in excess of the number that should have been received or vested applying the restated Financial Reporting Measure.&#160; If the equity award has been exercised, but the underlying shares have not been sold, the erroneously awarded
        compensation is the number of shares underlying the award.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">In instances where the Company is not able to determine the amount of erroneously awarded Incentive-Based Compensation directly from the information in the accounting restatement,
        the amount will be based on the Company&#8217;s reasonable estimate of the effect of the accounting restatement on the applicable measure.&#160; In such instances, the Company will maintain documentation of the determination of that reasonable estimate.</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zced2a253f9a24c1fabefa91c3cf4fc6a" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">VII.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Method of Recoupment</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">The Board will determine, in its sole discretion, subject to applicable law, the method for recouping Incentive-Based Compensation hereunder, which may include, without limitation:</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd270b71bdc3d4490b0a836a068a415ca">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">requiring reimbursement of cash Incentive-Based Compensation previously paid;</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z01a0f7691aab43d1919f2d6b9459183e">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb67788629c6743d282b50addbd5d005a">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">offsetting the recouped amount from any compensation otherwise owed by the Company to the Covered Executive;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfd1e4959380143a5aad731f522037a4e">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">cancelling outstanding vested or unvested equity awards; and/or</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z72f91f84a99046279e2f6664b62b5514">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #252525;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #252525;">taking any other remedial and recovery action permitted by law, as determined by the Board.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z7b87619b386f4b2a9cb5a4be2ed2bac7" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">VIII.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>No Indemnification; Successors</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">The Company shall not indemnify any Covered Executives against the loss of any incorrectly awarded Incentive-Based Compensation.&#160; This Policy shall be binding and enforceable
        against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.</div>
      <div><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z5e4e042429c74d16bf342c33db367e48" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">IX.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Exception to Enforcement</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">The Board shall recover any excess Incentive-Based Compensation in accordance with this Policy unless such recovery would be impracticable, as determined by the Board in accordance
        with Rule 10D-1 of the Exchange Act and any applicable rules or standards adopted by the SEC and the listing standards of any national securities exchange on which the Company&#8217;s securities are listed.</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z444db75a89084b4283f47b8597b6e28f" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">X.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Interpretation</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">The Board is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy.&#160; It is
        intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act and any applicable rules or standards adopted by the SEC and any national securities exchange on which the Company&#8217;s
        securities are listed.</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z3df4f789793f48bfa7bdf722771d3e66" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">XI.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Effective Date</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">This Policy shall be effective as of the date it is adopted by the Board (the &#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;) and shall apply to Incentive-Based
        Compensation that is received by a Covered Executive on or after that date, as determined by the Board in accordance with applicable rules or standards adopted by the SEC and the listing standards of any national securities exchange on which the
        Company&#8217;s securities are listed.</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z21ea27f2790043e6a9878529fb89a077" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">XII.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Amendment; Termination</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; color: #252525;">The Board may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary to comply with any rules or standards adopted by the SEC and
        the listing standards of any national securities exchange on which the Company&#8217;s securities are listed. The Board may terminate this Policy at any time.</div>
      <div>&#160;</div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="za3b41b415bea4eadb6b660964400902b" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;">XIII.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify;"><font style="font-weight: bold; color: #000000;"><u>Other Recoupment Rights</u></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #252525;">Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms
      of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #252525; font-weight: bold;">COVERED EXECUTIVE ACKNOWLEDGMENT AND AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #252525; font-weight: bold;">PERTAINING TO THE ETERNA THERAPEUTICS INC. CLAWBACK POLICY</div>
    <div>&#160;</div>
    <div style="text-align: justify; color: #252525;">This Acknowledgment &amp; Agreement (the &#8220;Acknowledgment&#8221;) is delivered by the undersigned employee (&#8220;Covered Executive&#8221;), as of the date set forth below, to Eterna Therapeutics Inc. (the &#8220;Company&#8221;).
      Effective as of [___], 2023 (the &#8220;Effective Date&#8221;), the Board of Directors (the &#8220;Board&#8221;) of the Company adopted the Eterna Therapeutics Inc. Clawback Policy, attached as <u>Exhibit A</u> hereto (as amended, restated, supplemented or otherwise
      modified from time to time by the Board, the &#8220;Clawback Policy&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: justify; color: #252525;">In consideration of the continued benefits to be received from the Company (and/or any subsidiary of the Company) and Covered Executive&#8217;s right to participate in, and as a condition to the receipt of,
      Incentive-Based Compensation (as defined in the Clawback Policy), Covered Executive hereby acknowledges and agrees to the following:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf5890940e8094d4ea6c675359011eff0">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: #252525;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: #252525;">Covered Executive has read and understands the Clawback Policy and has had an opportunity to ask questions to the Company regarding the Clawback Policy.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z902496b144a943cfb092a21ed07cdd20">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: #252525;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: #252525;">Covered Executive is bound by and to abide by the terms of the Clawback Policy and intends for the Clawback Policy to be applied to the fullest extent of the law.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc1b7935f06b94463b4ecb6eaac7f7429">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: #252525;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: #252525;">The Clawback Policy shall apply to any and all Incentive-Based Compensation that is approved, awarded or granted to Covered Executive on or after the Effective Date or received by Covered Executive during the
              Look-Back Period (as defined in the Clawback Policy).</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z05a59b03a990485b803b204ebcdcc093">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: #252525;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: #252525;">Covered Executive is not entitled to indemnification or right of advancement of expenses in connection with any enforcement of the Clawback Policy by the Company.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0571164e22cf4499ba4e88d30be963d6">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: #252525;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="color: #252525;">In the event of any inconsistency between the provisions of the Clawback Policy and this Acknowledgment or any applicable incentive-based compensation arrangements, employment agreement, equity agreement,
              indemnification agreement or similar agreement or arrangement setting forth the terms and conditions of any Incentive-Based Compensation, the terms of the Clawback Policy shall govern.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; color: #252525;">No modifications, waivers or amendments of the terms of this Acknowledgment shall be effective unless signed in writing by Covered Executive and the Company. The provisions of this Acknowledgment shall
      inure to the benefit of the Company, and shall be binding upon, the successors, administrators, heirs, legal representatives and assigns of Covered Executive.</div>
    <div>&#160;</div>
    <div style="text-align: justify; color: #252525;">By signing below, Covered Executive agrees to the application of the Clawback Policy and the other terms of this Acknowledgment.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd6a60a22766546f0823de7504ce38b54">

        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 70%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: justify; color: #252525;">Name:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>erna-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<xs:schema targetNamespace="http://eternatx.com/20231231" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:erna="http://eternatx.com/20231231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://eternatx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>010000 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <!--Parent Role: CONSOLIDATED BALANCE SHEETS-->
        <link:definition>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
        <link:definition>020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity" id="ConsolidatedStatementsOfStockholdersEquity">
        <link:definition>030000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations" id="OrganizationAndDescriptionOfBusinessOperations">
        <link:definition>060100 - Disclosure - Organization and Description of Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LiquidityAndCapitalResources" id="LiquidityAndCapitalResources">
        <link:definition>060200 - Disclosure - Liquidity and Capital Resources</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>060300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AssetAcquisition" id="AssetAcquisition">
        <link:definition>060400 - Disclosure - Asset Acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ContractWithCustomer" id="ContractWithCustomer">
        <link:definition>060500 - Disclosure - Contract with Customer</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings" id="PromissoryNoteAndConvertibleNoteFinancings">
        <link:definition>060600 - Disclosure - Promissory Note and Convertible Note Financings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
        <link:definition>060700 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/Leases" id="Leases">
        <link:definition>060800 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
        <link:definition>060900 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment" id="GoodwillAndInprocessResearchDevelopment">
        <link:definition>061000 - Disclosure - Goodwill and In-Process Research &amp; Development</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>061100 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>061200 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>061300 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare" id="BasicAndDilutedNetLossPerCommonShare">
        <link:definition>061400 - Disclosure - Basic and Diluted Net Loss per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensation" id="StockbasedCompensation">
        <link:definition>061500 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrants" id="EquityAndWarrants">
        <link:definition>061600 - Disclosure - Equity and Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>061700 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/SubsequentEvent" id="SubsequentEvent">
        <link:definition>061800 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/InsiderTradingArrangements" id="InsiderTradingArrangements">
        <link:definition>061900 - Disclosure - Insider Trading Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>070300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AssetAcquisitionTables" id="AssetAcquisitionTables">
        <!--Parent Role: Asset Acquisition-->
        <link:definition>080400 - Disclosure - Asset Acquisition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables" id="PromissoryNoteAndConvertibleNoteFinancingsTables">
        <!--Parent Role: Promissory Note and Convertible Note Financings-->
        <link:definition>080600 - Disclosure - Promissory Note and Convertible Note Financings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
        <!--Parent Role: Property and Equipment-->
        <link:definition>080700 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesTables" id="LeasesTables">
        <!--Parent Role: Leases-->
        <link:definition>080800 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables" id="FairValueOfFinancialInstrumentsTables">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>080900 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>081200 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables" id="BasicAndDilutedNetLossPerCommonShareTables">
        <!--Parent Role: Basic and Diluted Net Loss per Common Share-->
        <link:definition>081400 - Disclosure - Basic and Diluted Net Loss per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationTables" id="StockbasedCompensationTables">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>081500 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsTables" id="EquityAndWarrantsTables">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>081600 - Disclosure - Equity and Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <!--Parent Role: Income Taxes-->
        <link:definition>081700 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails" id="OrganizationAndDescriptionOfBusinessOperationsDetails">
        <!--Parent Role: Organization and Description of Business Operations-->
        <link:definition>090100 - Disclosure - Organization and Description of Business Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails" id="LiquidityAndCapitalResourcesDetails">
        <!--Parent Role: Liquidity and Capital Resources-->
        <link:definition>090200 - Disclosure - Liquidity and Capital Resources (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090304 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090306 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090308 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" id="BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails">
        <!--Parent Role: Basis of Accounting Presentation and Summary of Significant Accounting Policies-->
        <link:definition>090310 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails" id="AssetAcquisitionSummaryOfAssetAcquisitionDetails">
        <!--Parent Role: Asset Acquisition-->
        <link:definition>090400 - Disclosure - Asset Acquisition, Summary of Asset Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails" id="AssetAcquisitionFairValuationOfAssumptionsDetails">
        <!--Parent Role: Asset Acquisition-->
        <link:definition>090402 - Disclosure - Asset Acquisition, Fair Valuation of Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails" id="AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails">
        <!--Parent Role: Asset Acquisition-->
        <link:definition>090404 - Disclosure - Asset Acquisition, Fair Value Measurement of Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/ContractWithCustomerDetails" id="ContractWithCustomerDetails">
        <!--Parent Role: Contract with Customer-->
        <link:definition>090500 - Disclosure - Contract with Customer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails" id="PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails">
        <!--Parent Role: Promissory Note and Convertible Note Financings-->
        <link:definition>090600 - Disclosure - Promissory Note and Convertible Note Financings, Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails" id="PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails">
        <!--Parent Role: Promissory Note and Convertible Note Financings-->
        <link:definition>090602 - Disclosure - Promissory Note and Convertible Note Financings, Based on Relative Fair Value Allocation of Proceeds and Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails" id="PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails">
        <!--Parent Role: Promissory Note and Convertible Note Financings-->
        <link:definition>090604 - Disclosure - Promissory Note and Convertible Note Financings, Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails" id="PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails">
        <!--Parent Role: Promissory Note and Convertible Note Financings-->
        <link:definition>090606 - Disclosure - Promissory Note and Convertible Note Financings, Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
        <!--Parent Role: Property and Equipment-->
        <link:definition>090700 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesOperatingLeaseDetails" id="LeasesOperatingLeaseDetails">
        <!--Parent Role: Leases-->
        <link:definition>090800 - Disclosure - Leases, Operating Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" id="LeasesNetOperatingLeaseExpensesDetails">
        <!--Parent Role: Leases-->
        <link:definition>090802 - Disclosure - Leases, Net Operating Lease Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" id="LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails">
        <!--Parent Role: Leases-->
        <link:definition>090804 - Disclosure - Leases, Operating Lease Right-of-use Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" id="LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
        <!--Parent Role: Leases-->
        <link:definition>090806 - Disclosure - Leases, Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" id="LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01">
        <!--Parent Role: Leases, Maturities of Operating Lease Liabilities (Details)-->
        <link:definition>090808 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details) CALC 01</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/LeasesManhattanSubleaseDetails" id="LeasesManhattanSubleaseDetails">
        <!--Parent Role: Leases-->
        <link:definition>090808 - Disclosure - Leases, Manhattan Sublease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" id="FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>090900 - Disclosure - Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" id="FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>090902 - Disclosure - Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails" id="FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails">
        <!--Parent Role: Fair Value of Financial Instruments-->
        <link:definition>090904 - Disclosure - Fair Value of Financial Instruments, Carrying Value and Fair Value of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails" id="GoodwillAndInprocessResearchDevelopmentDetails">
        <!--Parent Role: Goodwill and In-Process Research & Development-->
        <link:definition>091000 - Disclosure - Goodwill and In-Process Research &amp; Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
        <!--Parent Role: Related Party Transactions-->
        <link:definition>091100 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>091200 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails" id="CommitmentsAndContingenciesLegalMattersDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091300 - Disclosure - Commitments and Contingencies, Legal Matters (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" id="CommitmentsAndContingenciesLicensingAgreementsDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091302 - Disclosure - Commitments and Contingencies, Licensing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails" id="CommitmentsAndContingenciesRetirementSavingsPlanDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091308 - Disclosure - Commitments and Contingencies, Retirement Savings Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails" id="BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails">
        <!--Parent Role: Basic and Diluted Net Loss per Common Share-->
        <link:definition>091400 - Disclosure - Basic and Diluted Net Loss per Common Share, Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" id="BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails">
        <!--Parent Role: Basic and Diluted Net Loss per Common Share-->
        <link:definition>091402 - Disclosure - Basic and Diluted Net Loss per Common Share, Securities Excluded from Calculation of Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails" id="StockbasedCompensationEquityIncentivePlansDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091500 - Disclosure - Stock-Based Compensation, Equity Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" id="StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091502 - Disclosure - Stock-Based Compensation, Weighted-Average Assumptions Used for Stock Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails" id="StockbasedCompensationStockOptionActivityDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091504 - Disclosure - Stock-Based Compensation, Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" id="StockbasedCompensationSummaryOfStockOptionsDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091506 - Disclosure - Stock-Based Compensation, Summary of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails" id="StockbasedCompensationRestrictedStockUnitsDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091508 - Disclosure - Stock-Based Compensation, Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" id="StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091510 - Disclosure - Stock-Based Compensation, Number of RSUs Vested and Settled (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" id="StockbasedCompensationStockbasedCompensationExpenseDetails">
        <!--Parent Role: Stock-Based Compensation-->
        <link:definition>091514 - Disclosure - Stock-Based Compensation, Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails" id="EquityAndWarrantsPrivatePlacementOfEquityDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091600 - Disclosure - Equity and Warrants, Private Placement of Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails" id="EquityAndWarrantsNoteWarrantsDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091602 - Disclosure - Equity and Warrants, Note Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsSepaDetails" id="EquityAndWarrantsSepaDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091610 - Disclosure - Equity and Warrants, SEPA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" id="EquityAndWarrantsCumulativeConvertiblePreferredStockDetails">
        <!--Parent Role: Equity and Warrants-->
        <link:definition>091612 - Disclosure - Equity and Warrants, Cumulative Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" id="IncomeTaxesLossBeforeIncomeTaxesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091700 - Disclosure - Income Taxes, Loss before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" id="IncomeTaxesComponentsOfIncomeTaxProvisionDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091702 - Disclosure - Income Taxes, Components of Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" id="IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091704 - Disclosure - Income Taxes, Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" id="IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091706 - Disclosure - Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails" id="IncomeTaxesUncertainTaxPositionsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091708 - Disclosure - Income Taxes, Uncertain Tax Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://eternatx.com/role/SubsequentEventDetails" id="SubsequentEventDetails">
        <!--Parent Role: Subsequent Event-->
        <link:definition>091800 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" />
  <xs:element name="December2023ConvertibleNotesMember" id="erna_December2023ConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="July2023ConvertibleNotesMember" id="erna_July2023ConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="July2023WarrantsMember" id="erna_July2023WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="December2023WarrantsMember" id="erna_December2023WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ConvertibleNotesAbstract" id="erna_ConvertibleNotesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PaidInKindInterestAddedToConvertibleNotesPrincipal" id="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PromissoryNoteAndConvertibleNoteFinancingAbstract" id="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" id="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="AccruedSomervilleFacilityCurrent" id="erna_AccruedSomervilleFacilityCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AccruedClinicalCurrent" id="erna_AccruedClinicalCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AccruedLegalFeesAndRelatedCurrent" id="erna_AccruedLegalFeesAndRelatedCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ContingentConsiderationMember" id="erna_ContingentConsiderationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ChangeInFairValueOfContingentConsideration" id="erna_ChangeInFairValueOfContingentConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ConvertibleDebtMeasurementInput" id="erna_ConvertibleDebtMeasurementInput" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="MarketCapContingentConsiderationMember" id="erna_MarketCapContingentConsiderationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommonWarrantsMember" id="erna_CommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExacisAssetPurchaseAgreementMember" id="erna_ExacisAssetPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployeeContributionAtThresholdTwo" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" id="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployeeContributionAtThresholdOne" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RetirementPlan401KMember" id="erna_RetirementPlan401KMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NoteWarrantsAbstract" id="erna_NoteWarrantsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommonWarrantsOneMember" id="erna_CommonWarrantsOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightGrantsInPeriod" id="erna_ClassOfWarrantOrRightGrantsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="July2023AndDecember2023ConvertibleNotesMember" id="erna_July2023AndDecember2023ConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LegalMattersAbstract" id="erna_LegalMattersAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LitigationSettlementAmountPayable" id="erna_LitigationSettlementAmountPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ContractWithCustomersAbstract" id="erna_ContractWithCustomersAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromCellLineCustomizationActivities" id="erna_ProceedsFromCellLineCustomizationActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="OptionFeeObligationPaymentPercentage" id="erna_OptionFeeObligationPaymentPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromOptionAndLicenseAgreement" id="erna_ProceedsFromOptionAndLicenseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LiquidityAndCapitalResourcesAbstract" id="erna_LiquidityAndCapitalResourcesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LiquidityAndCapitalResourcesTextBlock" id="erna_LiquidityAndCapitalResourcesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LicensingAgreementsAbstract" id="erna_LicensingAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NoticePeriodToAssumeControlPatents" id="erna_NoticePeriodToAssumeControlPatents" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LiquidityAndCapitalResourcesTable" id="erna_LiquidityAndCapitalResourcesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LiquidityAndCapitalResourcesLineItems" id="erna_LiquidityAndCapitalResourcesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PrivatePlacementOfferingsAbstract" id="erna_PrivatePlacementOfferingsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NewFacilityLeaseAbstract" id="erna_NewFacilityLeaseAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LincolnParkCapitalFundLLCMember" id="erna_LincolnParkCapitalFundLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" id="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AssetAcquisitionFairValueOfConsiderationPaid" id="erna_AssetAcquisitionFairValueOfConsiderationPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ResearchAndDevelopmentInProcessAssetAcquisition" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LaboratoryAndManufacturingEquipmentMember" id="erna_LaboratoryAndManufacturingEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WarrantLiabilitiesExpense" id="erna_WarrantLiabilitiesExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LossOnNonControllingInvestment" id="erna_LossOnNonControllingInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="CommitmentSharesIssueExpense" id="erna_CommitmentSharesIssueExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NonCashResearchAndDevelopmentInProcessAssetAcquisition" id="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="GainLossOnChangeInFairValueOfContingentConsideration" id="erna_GainLossOnChangeInFairValueOfContingentConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" id="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ContingentConsiderationForAssetAcquisition" id="erna_ContingentConsiderationForAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="InitialMeasurementOfRightOfUseAssets" id="erna_InitialMeasurementOfRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="InitialMeasurementOfLeaseLiabilities" id="erna_InitialMeasurementOfLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="WarrantsIssued" id="erna_WarrantsIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" id="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="RepricingOfWarrantsInConnectionWithFinancing" id="erna_RepricingOfWarrantsInConnectionWithFinancing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" id="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AccrualForPurchasesOfPropertyAndEquipment" id="erna_AccrualForPurchasesOfPropertyAndEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ExpensesPaidInConnectionWithPrivateOffering" id="erna_ExpensesPaidInConnectionWithPrivateOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IssuanceOfCommonStockForAssetAcquisition" id="erna_IssuanceOfCommonStockForAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="UnpaidFeesIncurredInConnectionWithPrivateOffering" id="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ConversionOfWarrantLiabilityToEquity" id="erna_ConversionOfWarrantLiabilityToEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" id="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CashPaidDuringThePeriodForAbstract" id="erna_CashPaidDuringThePeriodForAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" id="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InitialMeasurementOfFinanceLeaseLiabilities" id="erna_InitialMeasurementOfFinanceLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncreaseDecreaseInOperatingLeaseLiabilities" id="erna_IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" id="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="GainOnTerminationOfLease" id="erna_GainOnTerminationOfLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="GainLossOnDisposalOfFixedAssets" id="erna_GainLossOnDisposalOfFixedAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="OperatingLeaseAssestAbstract" id="erna_OperatingLeaseAssestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InitialMeasurementOfOperatingLeaseROUAssets" id="erna_InitialMeasurementOfOperatingLeaseROUAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" id="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InitialMeasurementOfOperatingLeaseLiabilities" id="erna_InitialMeasurementOfOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PrincipalPaymentsOnOperatingLeaseLiabilities" id="erna_PrincipalPaymentsOnOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" id="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AccretionOfInterestSublease" id="erna_AccretionOfInterestSublease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" id="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValuePrivateOffering" id="erna_StockIssuedDuringPeriodValuePrivateOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesPrivateOffering" id="erna_StockIssuedDuringPeriodSharesPrivateOffering" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" id="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesAcquisitions2" id="erna_StockIssuedDuringPeriodSharesAcquisitions2" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueAcquisitions2" id="erna_StockIssuedDuringPeriodValueAcquisitions2" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="StockIssuedDuringPeriodValueStockPurchaseAgreement" id="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="OperatingLeasesMonthlyBaseRent" id="erna_OperatingLeasesMonthlyBaseRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="OperatingLeasesIncreaseInBaseRentPercentage" id="erna_OperatingLeasesIncreaseInBaseRentPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TenantImprovementAllowance" id="erna_TenantImprovementAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="OperatingLeaseIncrementalBorrowingRate" id="erna_OperatingLeaseIncrementalBorrowingRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReceivedAmountOfTenantImprovementAllowance" id="erna_ReceivedAmountOfTenantImprovementAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="TenantImprovementAllowancePerRentableSquareFoot" id="erna_TenantImprovementAllowancePerRentableSquareFoot" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" id="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="OutOfPocketExpenses" id="erna_OutOfPocketExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ERSquibbSonsLLCMember" id="erna_ERSquibbSonsLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SanDiegoLeaseMember" id="erna_SanDiegoLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="UnpaidOutOfPocketCostsTenantImprovementAllowance" id="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="LesseeCommitmentToPurchaseProperty" id="erna_LesseeCommitmentToPurchaseProperty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="RemainingNetBookValueOfFixedAssets" id="erna_RemainingNetBookValueOfFixedAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="CEOInducementGrantAbstract" id="erna_CEOInducementGrantAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RemainingFundingReceivedFromDecember2023FinancingAbstract" id="erna_RemainingFundingReceivedFromDecember2023FinancingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PresidentChiefExecutiveOfficerAndDirectorMember" id="erna_PresidentChiefExecutiveOfficerAndDirectorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NonQualifiedStockOptionMember" id="erna_NonQualifiedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfAwardsVestedAndSettledAbstract" id="erna_NumberOfAwardsVestedAndSettledAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RestrictedStockUnitesWithheldToCoverTaxes" id="erna_RestrictedStockUnitesWithheldToCoverTaxes" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AggregateIntrinsicValueAbstract" id="erna_AggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InducementPlan2021Member" id="erna_InducementPlan2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EquityIncentivePlan2020Member" id="erna_EquityIncentivePlan2020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfSharesOfCommonStockOutstanding" id="erna_PercentageOfSharesOfCommonStockOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="IncentiveStockOptionsMember" id="erna_IncentiveStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StandbyEquityPurchaseAgreementMember" id="erna_StandbyEquityPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StandbySecuritiesPurchaseAgreementAbstract" id="erna_StandbySecuritiesPurchaseAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SaleOfStockNumberOfSharesToIssuedInTransaction" id="erna_SaleOfStockNumberOfSharesToIssuedInTransaction" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" id="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EquityLineOfCreditConsiderationSharesOfCommonStock" id="erna_EquityLineOfCreditConsiderationSharesOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PreFundedWarrantsMember" id="erna_PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FactorBioscienceIncMember" id="erna_FactorBioscienceIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PIPEInvestorMember" id="erna_PIPEInvestorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RelatedPartyTransactionAbstract" id="erna_RelatedPartyTransactionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfMonthlyInstallmentsForFeesPayable" id="erna_NumberOfMonthlyInstallmentsForFeesPayable" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NoticePeriodForFirstTerminationOfContract" id="erna_NoticePeriodForFirstTerminationOfContract" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RemainingUnamortizedLicenseFeeObligation" id="erna_RemainingUnamortizedLicenseFeeObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="Q422PIPETransactionAbstract" id="erna_Q422PIPETransactionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="UnitPriceOfWarrants" id="erna_UnitPriceOfWarrants" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" id="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="MasterServiceAgreementInitialFeesPayable" id="erna_MasterServiceAgreementInitialFeesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="InitialLicenseFeeObligation" id="erna_InitialLicenseFeeObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="RelatedPartyTransactionPeriodicFeesPaymentAmount" id="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LicenseAgreementAutomaticRenewalTerm" id="erna_LicenseAgreementAutomaticRenewalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SublicenseFees" id="erna_SublicenseFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="AgreedWaivePayment" id="erna_AgreedWaivePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NoticePeriodForSupersedingTerminationProvisions" id="erna_NoticePeriodForSupersedingTerminationProvisions" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MonthlyMasterServicesAgreementFeesPayable" id="erna_MonthlyMasterServicesAgreementFeesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" id="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ExacisOptionAgreementAbstract" id="erna_ExacisOptionAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PaymentOfOptionFee" id="erna_PaymentOfOptionFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NoveCiteINCMember" id="erna_NoveCiteINCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" id="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AreaOfSubleaseSpaceCurrentlyRented" id="erna_AreaOfSubleaseSpaceCurrentlyRented" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" id="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="FutureLeasePaymentsSubleaseAgreementTableTextBlock" id="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfInLicensedPortfolioPatents" id="erna_NumberOfInLicensedPortfolioPatents" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PerformanceBasedStockOptionMember" id="erna_PerformanceBasedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TimeBasedStockOptionMember" id="erna_TimeBasedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IncomeTaxAbstract" id="erna_IncomeTaxAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TaxCutsAndJobsActOperatingLossCarryforwards" id="erna_TaxCutsAndJobsActOperatingLossCarryforwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="TaxCreditCarryforwardExpirationYear" id="erna_TaxCreditCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" id="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" id="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" id="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DeferredTaxLiabilitiesConvertibleDebt" id="erna_DeferredTaxLiabilitiesConvertibleDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DeferredTaxAssetsRightOfUseLiabilities" id="erna_DeferredTaxAssetsRightOfUseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" id="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" id="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxAssetsRightOfUseAssets" id="erna_DeferredTaxAssetsRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ContingentConsiderationTwoMember" id="erna_ContingentConsiderationTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContingentConsiderationThreeMember" id="erna_ContingentConsiderationThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ExacisAssetPurchaseAbstract" id="erna_ExacisAssetPurchaseAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfCashConsideration" id="erna_PercentageOfCashConsideration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CommencementPeriodOfCommonStockInPurchaseAgreement" id="erna_CommencementPeriodOfCommonStockInPurchaseAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionSharePrice" id="erna_AssetAcquisitionSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="MinimumCapitalizationRequirementAmount" id="erna_MinimumCapitalizationRequirementAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="LockUpPeriodForCommonStock" id="erna_LockUpPeriodForCommonStock" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ContingentConsiderationOneMember" id="erna_ContingentConsiderationOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumeratorValueForStockIssuance" id="erna_NumeratorValueForStockIssuance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="EstimatedEquityValueOfStockIssuedInAssetAcquisition" id="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="NumberOfConsecutiveTradingDays" id="erna_NumberOfConsecutiveTradingDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ConvertibleNotesBeneficialConversionFeaturePercentage" id="erna_ConvertibleNotesBeneficialConversionFeaturePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="RepurchasePricePercentageToPrincipalAmount" id="erna_RepurchasePricePercentageToPrincipalAmount" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DebtInstrumentAccruedInterestRate" id="erna_DebtInstrumentAccruedInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="December2022ConvertibleNotesMember" id="erna_December2022ConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TransactionFeesRelatedToDebtIssuanceAndWarrants" id="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="EffectOfReductionOfExercisePriceOfWarrants" id="erna_EffectOfReductionOfExercisePriceOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NumberOfRevenueGeneratingContracts" id="erna_NumberOfRevenueGeneratingContracts" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AllocationOfProceedsAndCostsAbstract" id="erna_AllocationOfProceedsAndCostsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromConvertibleDebtNet" id="erna_ProceedsFromConvertibleDebtNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="AllocationPercentageOfFairValue" id="erna_AllocationPercentageOfFairValue" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="WarrantRepricing" id="erna_WarrantRepricing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PrivatePlacementOfEquityAbstract" id="erna_PrivatePlacementOfEquityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightsExercisableTerm" id="erna_ClassOfWarrantOrRightsExercisableTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TransactionFeesPayable" id="erna_TransactionFeesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" id="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NumberOfWarrantsInEachUnit" id="erna_NumberOfWarrantsInEachUnit" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ObligationToPayLiquidatedDamagesPercentage" id="erna_ObligationToPayLiquidatedDamagesPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="OverSubscriptionAmountReceived" id="erna_OverSubscriptionAmountReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ClassOfWarrantOrRightExercised" id="erna_ClassOfWarrantOrRightExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PIPEInvestorOneMember" id="erna_PIPEInvestorOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>erna-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesComponentsOfIncomeTaxProvisionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesLossBeforeIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesManhattanSubleaseDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesManhattanSubleaseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedBalanceSheets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="RestrictedCashNoncurrent" xlink:title="RestrictedCashNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="RestrictedCashNoncurrent" xlink:title="calculation: Assets to RestrictedCashNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="EquityMethodInvestments" xlink:title="calculation: Assets to EquityMethodInvestments" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to PrepaidExpenseAndOtherAssetsCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherReceivablesNetCurrent" xlink:title="calculation: AssetsCurrent to OtherReceivablesNetCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="Cash" xlink:title="calculation: AssetsCurrent to Cash" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: Assets to OtherAssetsNoncurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="calculation: Assets to OperatingLeaseRightOfUseAsset" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to DerivativeLiabilitiesNoncurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: Liabilities to OperatingLeaseLiabilityNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="TaxesPayableCurrent" xlink:title="calculation: LiabilitiesCurrent to TaxesPayableCurrent" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OtherLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to OtherLiabilitiesCurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="DeferredRevenueCurrent" xlink:title="DeferredRevenueCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="DeferredRevenueCurrent" xlink:title="calculation: LiabilitiesCurrent to DeferredRevenueCurrent" order="6.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="DeferredRevenueNoncurrent" xlink:title="DeferredRevenueNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DeferredRevenueNoncurrent" xlink:title="calculation: Liabilities to DeferredRevenueNoncurrent" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:title="BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:title="calculation: Liabilities to BusinessCombinationContingentConsiderationLiabilityNoncurrent" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="ConvertibleLongTermNotesPayable" xlink:title="ConvertibleLongTermNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="ConvertibleLongTermNotesPayable" xlink:title="calculation: Liabilities to ConvertibleLongTermNotesPayable" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="PreferredStockValue" xlink:title="calculation: StockholdersEquity to PreferredStockValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquity" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquity" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="PreferredStockDividendsAndOtherAdjustments" xlink:title="calculation: NetIncomeLossAvailableToCommonStockholdersBasic to PreferredStockDividendsAndOtherAdjustments" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: NetIncomeLoss to IncomeTaxExpenseBenefit" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="LossOnNonControllingInvestment" xlink:title="calculation: NonoperatingIncomeExpense to LossOnNonControllingInvestment" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="WarrantLiabilitiesExpense" xlink:title="calculation: NonoperatingIncomeExpense to WarrantLiabilitiesExpense" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ChangeInFairValueOfContingentConsideration" xlink:label="ChangeInFairValueOfContingentConsideration" xlink:title="ChangeInFairValueOfContingentConsideration" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="ChangeInFairValueOfContingentConsideration" xlink:title="calculation: NonoperatingIncomeExpense to ChangeInFairValueOfContingentConsideration" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="calculation: NonoperatingIncomeExpense to OtherNonoperatingIncomeExpense" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="InvestmentIncomeNet" xlink:title="InvestmentIncomeNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InvestmentIncomeNet" xlink:title="calculation: NonoperatingIncomeExpense to InvestmentIncomeNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InterestExpense" xlink:title="calculation: NonoperatingIncomeExpense to InterestExpense" order="4.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="NonoperatingIncomeExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to NonoperatingIncomeExpense" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="GeneralAndAdministrativeExpense" xlink:title="calculation: OperatingExpenses to GeneralAndAdministrativeExpense" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="calculation: OperatingExpenses to ResearchAndDevelopmentInProcessAssetAcquisition" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="calculation: OperatingExpenses to ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ImpairmentOfOngoingProject" xlink:title="calculation: OperatingExpenses to ImpairmentOfOngoingProject" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="OperatingExpenses" xlink:title="calculation: OperatingIncomeLoss to OperatingExpenses" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="Revenues" xlink:title="calculation: GrossProfit to Revenues" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="CostOfRevenue" xlink:title="CostOfRevenue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="CostOfRevenue" xlink:title="calculation: GrossProfit to CostOfRevenue" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="GrossProfit" xlink:title="calculation: OperatingIncomeLoss to GrossProfit" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="NetIncomeLoss" xlink:title="calculation: NetIncomeLossAvailableToCommonStockholdersBasic to NetIncomeLoss" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="FinanceLeasePrincipalPayments" xlink:title="FinanceLeasePrincipalPayments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="FinanceLeasePrincipalPayments" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to FinanceLeasePrincipalPayments" order="9.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:label="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:label="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to CashPaidForFractionalSharesInConnectionWithReverseStockSplit" order="11.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExpensesPaidInConnectionWithPrivateOffering" xlink:label="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="ExpensesPaidInConnectionWithPrivateOffering" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ExpensesPaidInConnectionWithPrivateOffering" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsPreferredStockAndPreferenceStock" order="10.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfNotesPayable" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfNotesPayable" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="ProceedsFromNotesPayable" xlink:title="ProceedsFromNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromNotesPayable" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromNotesPayable" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfCommonStock" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:label="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:title="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromConvertibleDebt" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromConvertibleDebt" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="PaymentOfFinancingAndStockIssuanceCosts" xlink:title="PaymentOfFinancingAndStockIssuanceCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentOfFinancingAndStockIssuanceCosts" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentOfFinancingAndStockIssuanceCosts" order="8.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationDepletionAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationDepletionAndAmortization" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnDisposalOfFixedAssets" order="16.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:label="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" order="13.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="IncreaseDecreaseInDueToRelatedParties" xlink:title="IncreaseDecreaseInDueToRelatedParties" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInDueToRelatedParties" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInDueToRelatedParties" order="27.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NetIncomeLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NetIncomeLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to AmortizationOfFinancingCostsAndDiscounts" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OperatingLeaseImpairmentLoss" order="12.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="LossOnNonControllingInvestment" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to LossOnNonControllingInvestment" order="19.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainOnTerminationOfLease" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainOnTerminationOfLease" order="17.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="26.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOperatingLeaseLiabilities" order="28.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OperatingLeaseRightOfUseAssetAmortizationExpense" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherReceivables" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherReceivables" order="23.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingLiabilities" order="29.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherNoncurrentAssets" order="25.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest" xlink:label="PaidInKindInterest" xlink:title="PaidInKindInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="PaidInKindInterest" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to PaidInKindInterest" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="FairValueAdjustmentOfWarrants" xlink:title="FairValueAdjustmentOfWarrants" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="FairValueAdjustmentOfWarrants" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to FairValueAdjustmentOfWarrants" order="18.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="24.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="InterestExpenseDebt" xlink:title="InterestExpenseDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="InterestExpenseDebt" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to InterestExpenseDebt" order="15.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ImpairmentOfOngoingProject" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ImpairmentOfOngoingProject" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to EquityMethodInvestmentRealizedGainLossOnDisposal" order="11.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommitmentSharesIssueExpense" xlink:label="CommitmentSharesIssueExpense" xlink:title="CommitmentSharesIssueExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="CommitmentSharesIssueExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to CommitmentSharesIssueExpense" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="NonCashResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NonCashResearchAndDevelopmentInProcessAssetAcquisition" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="GainLossOnChangeInFairValueOfContingentConsideration" xlink:title="GainLossOnChangeInFairValueOfContingentConsideration" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnChangeInFairValueOfContingentConsideration" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnChangeInFairValueOfContingentConsideration" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInDeferredRevenue" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInDeferredRevenue" order="5.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSaleOfPropertyPlantAndEquipment" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="calculation: ResearchAndDevelopmentInProcessAssetAcquisition to AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:title="AssetAcquisitionConsiderationTransferredTransactionCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:title="calculation: ResearchAndDevelopmentInProcessAssetAcquisition to AssetAcquisitionConsiderationTransferredTransactionCost" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="calculation: ResearchAndDevelopmentInProcessAssetAcquisition to AssetAcquisitionFairValueOfConsiderationPaid" order="1.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="calculation: PropertyPlantAndEquipmentNet to PropertyPlantAndEquipmentGross" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: PropertyPlantAndEquipmentNet to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="VariableLeaseCost" xlink:title="calculation: LeaseCost to VariableLeaseCost" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="OperatingLeaseCost" xlink:title="calculation: LeaseCost to OperatingLeaseCost" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="SubleaseIncome" xlink:title="calculation: LeaseCost to SubleaseIncome" order="2.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="4.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesManhattanSubleaseDetails">
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="calculation: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="calculation: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="calculation: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedLegalFeesAndRelatedCurrent" xlink:label="AccruedLegalFeesAndRelatedCurrent" xlink:title="AccruedLegalFeesAndRelatedCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedLegalFeesAndRelatedCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedLegalFeesAndRelatedCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="InterestPayableCurrent" xlink:title="InterestPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="InterestPayableCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to InterestPayableCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedClinicalCurrent" xlink:label="AccruedClinicalCurrent" xlink:title="AccruedClinicalCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedClinicalCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedClinicalCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedSomervilleFacilityCurrent" xlink:label="AccruedSomervilleFacilityCurrent" xlink:title="AccruedSomervilleFacilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedSomervilleFacilityCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedSomervilleFacilityCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to OtherAccruedLiabilitiesCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedProfessionalFeesCurrent" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="CurrentForeignTaxExpenseBenefit" xlink:title="CurrentForeignTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentForeignTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentForeignTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentFederalTaxExpenseBenefit" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentStateAndLocalTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="calculation: IncomeTaxExpenseBenefit to CurrentIncomeTaxExpenseBenefit" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="DeferredForeignIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredForeignIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredFederalIncomeTaxExpenseBenefit" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: IncomeTaxExpenseBenefit to DeferredIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:label="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="calculation: IncomeTaxExpenseBenefit to EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxLiabilitiesConvertibleDebt" xlink:label="DeferredTaxLiabilitiesConvertibleDebt" xlink:title="DeferredTaxLiabilitiesConvertibleDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesConvertibleDebt" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesConvertibleDebt" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsRightOfUseAssets" xlink:label="DeferredTaxAssetsRightOfUseAssets" xlink:title="DeferredTaxAssetsRightOfUseAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxAssetsRightOfUseAssets" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxAssetsRightOfUseAssets" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="calculation: DeferredTaxLiabilities to DeferredIncomeTaxLiabilities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="DeferredTaxAssetsNet" xlink:title="DeferredTaxAssetsNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseOther" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="DeferredTaxAssetsRightOfUseLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsRightOfUseLiabilities" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsInProcessResearchAndDevelopment" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsNet" xlink:to="DeferredTaxAssetsGross" xlink:title="calculation: DeferredTaxAssetsNet to DeferredTaxAssetsGross" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsNet" xlink:to="DeferredTaxAssetsValuationAllowance" xlink:title="calculation: DeferredTaxAssetsNet to DeferredTaxAssetsValuationAllowance" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="DeferredTaxAssetsNet" xlink:title="calculation: DeferredTaxLiabilities to DeferredTaxAssetsNet" order="0.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:label="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:title="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationTaxCredits" order="8.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>erna-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm" />
  <link:roleRef roleURI="http://eternatx.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#SubsequentEventDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesUncertainTaxPositionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesComponentsOfIncomeTaxProvisionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesLossBeforeIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsSepaDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsSepaDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsNoteWarrantsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsPrivatePlacementOfEquityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationStockbasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationNumberOfRsusVestedAndSettledDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationRestrictedStockUnitsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationSummaryOfStockOptionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationStockOptionActivityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationEquityIncentivePlansDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#CommitmentsAndContingenciesRetirementSavingsPlanDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#CommitmentsAndContingenciesLegalMattersDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#RelatedPartyTransactionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#GoodwillAndInprocessResearchDevelopmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesManhattanSubleaseDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesManhattanSubleaseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesOperatingLeaseDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesOperatingLeaseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/ContractWithCustomerDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#ContractWithCustomerDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionFairValuationOfAssumptionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionSummaryOfAssetAcquisitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LiquidityAndCapitalResourcesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#OrganizationAndDescriptionOfBusinessOperationsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsTables" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationTables" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables" xlink:type="simple" xlink:href="erna-20231231.xsd#BasicAndDilutedNetLossPerCommonShareTables" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="erna-20231231.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesTables" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentTables" xlink:type="simple" xlink:href="erna-20231231.xsd#PropertyAndEquipmentTables" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionTables" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionTables" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://eternatx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="erna-20231231.xsd#SubsequentEvent" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrants" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrants" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensation" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare" xlink:type="simple" xlink:href="erna-20231231.xsd#BasicAndDilutedNetLossPerCommonShare" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="erna-20231231.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="erna-20231231.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://eternatx.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="erna-20231231.xsd#RelatedPartyTransactions" />
  <link:roleRef roleURI="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment" xlink:type="simple" xlink:href="erna-20231231.xsd#GoodwillAndInprocessResearchDevelopment" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://eternatx.com/role/Leases" xlink:type="simple" xlink:href="erna-20231231.xsd#Leases" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipment" xlink:type="simple" xlink:href="erna-20231231.xsd#PropertyAndEquipment" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancings" />
  <link:roleRef roleURI="http://eternatx.com/role/ContractWithCustomer" xlink:type="simple" xlink:href="erna-20231231.xsd#ContractWithCustomer" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisition" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisition" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://eternatx.com/role/LiquidityAndCapitalResources" xlink:type="simple" xlink:href="erna-20231231.xsd#LiquidityAndCapitalResources" />
  <link:roleRef roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations" xlink:type="simple" xlink:href="erna-20231231.xsd#OrganizationAndDescriptionOfBusinessOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedStatementsOfStockholdersEquity" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://eternatx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="erna-20231231.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsAbstract" xlink:title="definition: StatementLineItems to AssetsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="definition: StatementLineItems to LiabilitiesAndStockholdersEquityAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesCurrentAbstract" xlink:title="definition: StatementLineItems to LiabilitiesCurrentAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="ConvertibleLongTermNotesPayable" xlink:title="ConvertibleLongTermNotesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ConvertibleLongTermNotesPayable" xlink:title="definition: StatementLineItems to ConvertibleLongTermNotesPayable" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="definition: StatementLineItems to DerivativeLiabilitiesNoncurrent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="definition: StatementLineItems to OperatingLeaseLiabilityNoncurrent" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="definition: StatementLineItems to OtherLiabilitiesNoncurrent" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="DeferredRevenueNoncurrent" xlink:title="DeferredRevenueNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DeferredRevenueNoncurrent" xlink:title="definition: StatementLineItems to DeferredRevenueNoncurrent" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:title="BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:title="definition: StatementLineItems to BusinessCombinationContingentConsiderationLiabilityNoncurrent" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Liabilities" xlink:title="definition: StatementLineItems to Liabilities" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityAbstract" xlink:title="definition: StatementLineItems to StockholdersEquityAbstract" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="definition: StatementLineItems to LiabilitiesAndStockholdersEquity" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PreferredStockValue" xlink:title="definition: StatementLineItems to PreferredStockValue" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockValue" xlink:title="definition: StatementLineItems to CommonStockValue" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdditionalPaidInCapital" xlink:title="definition: StatementLineItems to AdditionalPaidInCapital" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="definition: StatementLineItems to RetainedEarningsAccumulatedDeficit" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AccountsPayableCurrent" xlink:title="definition: StatementLineItems to AccountsPayableCurrent" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AccruedLiabilitiesCurrent" xlink:title="definition: StatementLineItems to AccruedLiabilitiesCurrent" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="TaxesPayableCurrent" xlink:title="definition: StatementLineItems to TaxesPayableCurrent" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="definition: StatementLineItems to OperatingLeaseLiabilityCurrent" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="DeferredRevenueCurrent" xlink:title="DeferredRevenueCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DeferredRevenueCurrent" xlink:title="definition: StatementLineItems to DeferredRevenueCurrent" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherLiabilitiesCurrent" xlink:title="definition: StatementLineItems to OtherLiabilitiesCurrent" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesCurrent" xlink:title="definition: StatementLineItems to LiabilitiesCurrent" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsCurrentAbstract" xlink:title="definition: StatementLineItems to AssetsCurrentAbstract" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="RestrictedCashNoncurrent" xlink:title="RestrictedCashNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RestrictedCashNoncurrent" xlink:title="definition: StatementLineItems to RestrictedCashNoncurrent" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="definition: StatementLineItems to PropertyPlantAndEquipmentNet" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: StatementLineItems to OperatingLeaseRightOfUseAsset" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Goodwill" xlink:title="definition: StatementLineItems to Goodwill" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EquityMethodInvestments" xlink:title="definition: StatementLineItems to EquityMethodInvestments" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherAssetsNoncurrent" xlink:title="definition: StatementLineItems to OtherAssetsNoncurrent" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Assets" xlink:title="definition: StatementLineItems to Assets" order="32.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Cash" xlink:title="definition: StatementLineItems to Cash" order="33.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherReceivablesNetCurrent" xlink:title="definition: StatementLineItems to OtherReceivablesNetCurrent" order="34.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="definition: StatementLineItems to PrepaidExpenseAndOtherAssetsCurrent" order="35.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsCurrent" xlink:title="definition: StatementLineItems to AssetsCurrent" order="36.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="37.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: StatementTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: StatementTable to RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="RelatedPartyMember" xlink:title="RelatedPartyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="RelatedPartyMember" xlink:title="definition: RelatedPartyDomain to RelatedPartyMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="NonrelatedPartyMember" xlink:title="NonrelatedPartyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NonrelatedPartyMember" xlink:title="definition: RelatedPartyDomain to NonrelatedPartyMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfOperations" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValuePrivateOffering" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesPrivateOffering" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="definition: StatementLineItems to SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions2" xlink:label="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="StockIssuedDuringPeriodValueAcquisitions2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueAcquisitions2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions2" xlink:label="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="StockIssuedDuringPeriodSharesAcquisitions2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesAcquisitions2" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueStockPurchaseAgreement" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesStockPurchaseAgreement" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalMarkToMarket" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DividendsPreferredStockCash" xlink:title="definition: StatementLineItems to DividendsPreferredStockCash" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PreferredStockDividendsShares" xlink:title="definition: StatementLineItems to PreferredStockDividendsShares" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="22.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="PreferredStockMember" xlink:title="definition: EquityComponentDomain to PreferredStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: StatementTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LiquidityAndCapitalResources" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisition" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ContractWithCustomer" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipment" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/Leases" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstruments" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/RelatedPartyTransactions" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrants" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxes" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/SubsequentEvent" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails">
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesLineItems" xlink:label="LiquidityAndCapitalResourcesLineItems" xlink:title="LiquidityAndCapitalResourcesLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NewFacilityLeaseAbstract" xlink:label="NewFacilityLeaseAbstract" xlink:title="NewFacilityLeaseAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="NewFacilityLeaseAbstract" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to NewFacilityLeaseAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PrivatePlacementOfferingsAbstract" xlink:label="PrivatePlacementOfferingsAbstract" xlink:title="PrivatePlacementOfferingsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="PrivatePlacementOfferingsAbstract" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to PrivatePlacementOfferingsAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="ProceedsFromConvertibleDebt" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to ProceedsFromConvertibleDebt" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="AreaOfRealEstateProperty" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to AreaOfRealEstateProperty" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="LineOfCredit" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to LineOfCredit" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="RestrictedCash" xlink:title="RestrictedCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="RestrictedCash" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to RestrictedCash" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to StockRepurchaseProgramAuthorizedAmount1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to SaleOfStockNumberOfSharesIssuedInTransaction" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="ProceedsFromIssuanceOrSaleOfEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to ProceedsFromIssuanceOrSaleOfEquity" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesTable" xlink:label="LiquidityAndCapitalResourcesTable" xlink:title="LiquidityAndCapitalResourcesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="LiquidityAndCapitalResourcesTable" xlink:title="definition: LiquidityAndCapitalResourcesLineItems to LiquidityAndCapitalResourcesTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="LegalEntityAxis" xlink:title="definition: LiquidityAndCapitalResourcesTable to LegalEntityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="EntityDomain_2" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain_2" xlink:title="definition: LegalEntityAxis to EntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LincolnParkCapitalFundLLCMember" xlink:label="LincolnParkCapitalFundLLCMember" xlink:title="LincolnParkCapitalFundLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityDomain" xlink:to="LincolnParkCapitalFundLLCMember" xlink:title="definition: EntityDomain to LincolnParkCapitalFundLLCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="definition: LiquidityAndCapitalResourcesTable to ShortTermDebtTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain_2" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain_2" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="definition: ShortTermDebtTypeDomain to ConvertibleDebtMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="RangeAxis" xlink:title="definition: LiquidityAndCapitalResourcesTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: LiquidityAndCapitalResourcesTable to SubsequentEventTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="PropertyPlantAndEquipmentNetByTypeAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNetByTypeAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ScheduleOfPropertyPlantAndEquipmentTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LaboratoryAndManufacturingEquipmentMember" xlink:label="LaboratoryAndManufacturingEquipmentMember" xlink:title="LaboratoryAndManufacturingEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LaboratoryAndManufacturingEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LaboratoryAndManufacturingEquipmentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:label="AssetAcquisitionContingentConsiderationLineItems" xlink:title="AssetAcquisitionContingentConsiderationLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAbstract" xlink:label="ExacisAssetPurchaseAbstract" xlink:title="ExacisAssetPurchaseAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="ExacisAssetPurchaseAbstract" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to ExacisAssetPurchaseAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to StockIssuedDuringPeriodSharesAcquisitions" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LockUpPeriodForCommonStock" xlink:label="LockUpPeriodForCommonStock" xlink:title="LockUpPeriodForCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="LockUpPeriodForCommonStock" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to LockUpPeriodForCommonStock" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:label="EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:title="EstimatedEquityValueOfStockIssuedInAssetAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to EstimatedEquityValueOfStockIssuedInAssetAcquisition" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionSharePrice" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionSharePrice" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:label="CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:title="CommencementPeriodOfCommonStockInPurchaseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to CommencementPeriodOfCommonStockInPurchaseAgreement" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MinimumCapitalizationRequirementAmount" xlink:label="MinimumCapitalizationRequirementAmount" xlink:title="MinimumCapitalizationRequirementAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="MinimumCapitalizationRequirementAmount" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to MinimumCapitalizationRequirementAmount" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfConsecutiveTradingDays" xlink:label="NumberOfConsecutiveTradingDays" xlink:title="NumberOfConsecutiveTradingDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="NumberOfConsecutiveTradingDays" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to NumberOfConsecutiveTradingDays" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumeratorValueForStockIssuance" xlink:label="NumeratorValueForStockIssuance" xlink:title="NumeratorValueForStockIssuance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="NumeratorValueForStockIssuance" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to NumeratorValueForStockIssuance" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfCashConsideration" xlink:label="PercentageOfCashConsideration" xlink:title="PercentageOfCashConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="PercentageOfCashConsideration" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to PercentageOfCashConsideration" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:label="AssetAcquisitionContingentConsiderationTable" xlink:title="AssetAcquisitionContingentConsiderationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionContingentConsiderationTable" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionContingentConsiderationTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: AssetAcquisitionContingentConsiderationTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAgreementMember" xlink:label="ExacisAssetPurchaseAgreementMember" xlink:title="ExacisAssetPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="ExacisAssetPurchaseAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to ExacisAssetPurchaseAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="ContingentConsiderationByTypeAxis" xlink:title="ContingentConsiderationByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="ContingentConsiderationByTypeAxis" xlink:title="definition: AssetAcquisitionContingentConsiderationTable to ContingentConsiderationByTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain" xlink:title="ContingentConsiderationTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain" xlink:title="definition: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain_2" xlink:title="ContingentConsiderationTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain_2" xlink:title="definition: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationOneMember" xlink:label="ContingentConsiderationOneMember" xlink:title="ContingentConsiderationOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ContingentConsiderationTypeDomain" xlink:to="ContingentConsiderationOneMember" xlink:title="definition: ContingentConsiderationTypeDomain to ContingentConsiderationOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationTwoMember" xlink:label="ContingentConsiderationTwoMember" xlink:title="ContingentConsiderationTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ContingentConsiderationTypeDomain" xlink:to="ContingentConsiderationTwoMember" xlink:title="definition: ContingentConsiderationTypeDomain to ContingentConsiderationTwoMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationThreeMember" xlink:label="ContingentConsiderationThreeMember" xlink:title="ContingentConsiderationThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ContingentConsiderationTypeDomain" xlink:to="ContingentConsiderationThreeMember" xlink:title="definition: ContingentConsiderationTypeDomain to ContingentConsiderationThreeMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="RangeAxis" xlink:title="definition: AssetAcquisitionContingentConsiderationTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:label="AssetAcquisitionContingentConsiderationLineItems" xlink:title="AssetAcquisitionContingentConsiderationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to LiabilitiesFairValueDisclosureAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to ValuationTechniqueAndInputDescriptionAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="WarrantsAndRightsOutstandingMeasurementInput" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to WarrantsAndRightsOutstandingMeasurementInput" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to WarrantsAndRightsOutstandingTerm" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="BusinessCombinationContingentConsiderationLiability" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to BusinessCombinationContingentConsiderationLiability" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:label="AssetAcquisitionContingentConsiderationTable" xlink:title="AssetAcquisitionContingentConsiderationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionContingentConsiderationTable" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionContingentConsiderationTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="MeasurementInputTypeAxis" xlink:title="definition: AssetAcquisitionContingentConsiderationTable to MeasurementInputTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain_2" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain_2" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputSharePriceMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputSharePriceMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputRiskFreeInterestRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputRiskFreeInterestRateMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="MeasurementInputExpectedDividendRateMember" xlink:title="MeasurementInputExpectedDividendRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedDividendRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputExpectedDividendRateMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="MeasurementInputExpectedTermMember" xlink:title="MeasurementInputExpectedTermMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedTermMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputExpectedTermMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: AssetAcquisitionContingentConsiderationTable to TypeOfArrangementAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAgreementMember" xlink:label="ExacisAssetPurchaseAgreementMember" xlink:title="ExacisAssetPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="ExacisAssetPurchaseAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to ExacisAssetPurchaseAgreementMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:label="AssetAcquisitionContingentConsiderationLineItems" xlink:title="AssetAcquisitionContingentConsiderationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:label="AssetAcquisitionConsiderationTransferredAbstract" xlink:title="AssetAcquisitionConsiderationTransferredAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionConsiderationTransferredAbstract" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionConsiderationTransferredAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:label="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:title="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionFairValueOfConsiderationPaid" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:title="AssetAcquisitionConsiderationTransferredTransactionCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionConsiderationTransferredTransactionCost" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to ResearchAndDevelopmentInProcessAssetAcquisition" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:label="AssetAcquisitionContingentConsiderationTable" xlink:title="AssetAcquisitionContingentConsiderationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionContingentConsiderationTable" xlink:title="definition: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionContingentConsiderationTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: AssetAcquisitionContingentConsiderationTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAgreementMember" xlink:label="ExacisAssetPurchaseAgreementMember" xlink:title="ExacisAssetPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="ExacisAssetPurchaseAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to ExacisAssetPurchaseAgreementMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/ContractWithCustomerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContractWithCustomersAbstract" xlink:label="ContractWithCustomersAbstract" xlink:title="ContractWithCustomersAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomersAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractWithCustomersAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromOptionAndLicenseAgreement" xlink:label="ProceedsFromOptionAndLicenseAgreement" xlink:title="ProceedsFromOptionAndLicenseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ProceedsFromOptionAndLicenseAgreement" xlink:title="definition: DisaggregationOfRevenueLineItems to ProceedsFromOptionAndLicenseAgreement" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromCellLineCustomizationActivities" xlink:label="ProceedsFromCellLineCustomizationActivities" xlink:title="ProceedsFromCellLineCustomizationActivities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ProceedsFromCellLineCustomizationActivities" xlink:title="definition: DisaggregationOfRevenueLineItems to ProceedsFromCellLineCustomizationActivities" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="RevenueRemainingPerformanceObligationPercentage" xlink:title="RevenueRemainingPerformanceObligationPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="RevenueRemainingPerformanceObligationPercentage" xlink:title="definition: DisaggregationOfRevenueLineItems to RevenueRemainingPerformanceObligationPercentage" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:label="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:title="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:title="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="ContractWithCustomerLiabilityRevenueRecognized" xlink:title="ContractWithCustomerLiabilityRevenueRecognized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomerLiabilityRevenueRecognized" xlink:title="definition: DisaggregationOfRevenueLineItems to ContractWithCustomerLiabilityRevenueRecognized" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OptionFeeObligationPaymentPercentage" xlink:label="OptionFeeObligationPaymentPercentage" xlink:title="OptionFeeObligationPaymentPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="OptionFeeObligationPaymentPercentage" xlink:title="definition: DisaggregationOfRevenueLineItems to OptionFeeObligationPaymentPercentage" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueTable" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="TimingOfTransferOfGoodOrServiceAxis" xlink:title="TimingOfTransferOfGoodOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="TimingOfTransferOfGoodOrServiceAxis" xlink:title="definition: DisaggregationOfRevenueTable to TimingOfTransferOfGoodOrServiceAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="TimingOfTransferOfGoodOrServiceDomain" xlink:title="TimingOfTransferOfGoodOrServiceDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TimingOfTransferOfGoodOrServiceAxis" xlink:to="TimingOfTransferOfGoodOrServiceDomain" xlink:title="definition: TimingOfTransferOfGoodOrServiceAxis to TimingOfTransferOfGoodOrServiceDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="TimingOfTransferOfGoodOrServiceDomain_2" xlink:title="TimingOfTransferOfGoodOrServiceDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TimingOfTransferOfGoodOrServiceAxis" xlink:to="TimingOfTransferOfGoodOrServiceDomain_2" xlink:title="definition: TimingOfTransferOfGoodOrServiceAxis to TimingOfTransferOfGoodOrServiceDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember" xlink:label="TransferredOverTimeMember" xlink:title="TransferredOverTimeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TimingOfTransferOfGoodOrServiceDomain" xlink:to="TransferredOverTimeMember" xlink:title="definition: TimingOfTransferOfGoodOrServiceDomain to TransferredOverTimeMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:label="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:title="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:title="definition: DebtInstrumentLineItems to LongtermConvertibleDebtCurrentAndNoncurrentAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="ConvertibleLongTermNotesPayable" xlink:title="ConvertibleLongTermNotesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ConvertibleLongTermNotesPayable" xlink:title="definition: DebtInstrumentLineItems to ConvertibleLongTermNotesPayable" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentFaceAmount" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: DebtInstrumentLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:label="TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:title="TransactionFeesRelatedToDebtIssuanceAndWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:title="definition: DebtInstrumentLineItems to TransactionFeesRelatedToDebtIssuanceAndWarrants" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentInterestRateStatedPercentage" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DebtInstrumentAccruedInterestRate" xlink:label="DebtInstrumentAccruedInterestRate" xlink:title="DebtInstrumentAccruedInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAccruedInterestRate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentAccruedInterestRate" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="DebtInstrumentRepaidPrincipal" xlink:title="DebtInstrumentRepaidPrincipal" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentRepaidPrincipal" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentRepaidPrincipal" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="InterestExpenseDebtExcludingAmortization" xlink:title="InterestExpenseDebtExcludingAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="InterestExpenseDebtExcludingAmortization" xlink:title="definition: DebtInstrumentLineItems to InterestExpenseDebtExcludingAmortization" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentMaturityDate" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="DebtInstrumentConvertibleConversionPrice1" xlink:title="DebtInstrumentConvertibleConversionPrice1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentConvertibleConversionPrice1" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentConvertibleConversionPrice1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="definition: DebtInstrumentLineItems to StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:label="ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:title="ConvertibleNotesBeneficialConversionFeaturePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:title="definition: DebtInstrumentLineItems to ConvertibleNotesBeneficialConversionFeaturePercentage" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RepurchasePricePercentageToPrincipalAmount" xlink:label="RepurchasePricePercentageToPrincipalAmount" xlink:title="RepurchasePricePercentageToPrincipalAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="RepurchasePricePercentageToPrincipalAmount" xlink:title="definition: DebtInstrumentLineItems to RepurchasePricePercentageToPrincipalAmount" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: DebtInstrumentLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectOfReductionOfExercisePriceOfWarrants" xlink:label="EffectOfReductionOfExercisePriceOfWarrants" xlink:title="EffectOfReductionOfExercisePriceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="EffectOfReductionOfExercisePriceOfWarrants" xlink:title="definition: DebtInstrumentLineItems to EffectOfReductionOfExercisePriceOfWarrants" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="17.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023ConvertibleNotesMember" xlink:label="July2023ConvertibleNotesMember" xlink:title="July2023ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="July2023ConvertibleNotesMember" xlink:title="definition: DebtInstrumentNameDomain to July2023ConvertibleNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="December2023ConvertibleNotesMember" xlink:title="definition: DebtInstrumentNameDomain to December2023ConvertibleNotesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2022ConvertibleNotesMember" xlink:label="December2022ConvertibleNotesMember" xlink:title="December2022ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="December2022ConvertibleNotesMember" xlink:title="definition: DebtInstrumentNameDomain to December2022ConvertibleNotesMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="LongtermDebtTypeAxis" xlink:title="definition: DebtInstrumentTable to LongtermDebtTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain_2" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain_2" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="definition: LongtermDebtTypeDomain to ConvertibleDebtMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: DebtInstrumentTable to ClassOfWarrantOrRightAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="July2023WarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to July2023WarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="December2023WarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to December2023WarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: DebtInstrumentTable to StatementEquityComponentsAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="DebtInstrumentRedemptionPeriodAxis" xlink:title="DebtInstrumentRedemptionPeriodAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentRedemptionPeriodAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentRedemptionPeriodAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="DebtInstrumentRedemptionPeriodDomain" xlink:title="DebtInstrumentRedemptionPeriodDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentRedemptionPeriodAxis" xlink:to="DebtInstrumentRedemptionPeriodDomain" xlink:title="definition: DebtInstrumentRedemptionPeriodAxis to DebtInstrumentRedemptionPeriodDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="DebtInstrumentRedemptionPeriodDomain_2" xlink:title="DebtInstrumentRedemptionPeriodDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentRedemptionPeriodAxis" xlink:to="DebtInstrumentRedemptionPeriodDomain_2" xlink:title="definition: DebtInstrumentRedemptionPeriodAxis to DebtInstrumentRedemptionPeriodDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:label="DebtInstrumentRedemptionPeriodOneMember" xlink:title="DebtInstrumentRedemptionPeriodOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentRedemptionPeriodDomain" xlink:to="DebtInstrumentRedemptionPeriodOneMember" xlink:title="definition: DebtInstrumentRedemptionPeriodDomain to DebtInstrumentRedemptionPeriodOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:label="DebtInstrumentRedemptionPeriodTwoMember" xlink:title="DebtInstrumentRedemptionPeriodTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentRedemptionPeriodDomain" xlink:to="DebtInstrumentRedemptionPeriodTwoMember" xlink:title="definition: DebtInstrumentRedemptionPeriodDomain to DebtInstrumentRedemptionPeriodTwoMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:label="DebtInstrumentRedemptionPeriodThreeMember" xlink:title="DebtInstrumentRedemptionPeriodThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentRedemptionPeriodDomain" xlink:to="DebtInstrumentRedemptionPeriodThreeMember" xlink:title="definition: DebtInstrumentRedemptionPeriodDomain to DebtInstrumentRedemptionPeriodThreeMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: DebtInstrumentTable to SubsequentEventTypeAxis" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocationOfProceedsAndCostsAbstract" xlink:label="AllocationOfProceedsAndCostsAbstract" xlink:title="AllocationOfProceedsAndCostsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="AllocationOfProceedsAndCostsAbstract" xlink:title="definition: DebtInstrumentLineItems to AllocationOfProceedsAndCostsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="ConvertibleDebtFairValueDisclosures" xlink:title="ConvertibleDebtFairValueDisclosures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ConvertibleDebtFairValueDisclosures" xlink:title="definition: DebtInstrumentLineItems to ConvertibleDebtFairValueDisclosures" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocationPercentageOfFairValue" xlink:label="AllocationPercentageOfFairValue" xlink:title="AllocationPercentageOfFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="AllocationPercentageOfFairValue" xlink:title="definition: DebtInstrumentLineItems to AllocationPercentageOfFairValue" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ProceedsFromConvertibleDebt" xlink:title="definition: DebtInstrumentLineItems to ProceedsFromConvertibleDebt" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="PaymentsOfDebtIssuanceCosts" xlink:title="PaymentsOfDebtIssuanceCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="PaymentsOfDebtIssuanceCosts" xlink:title="definition: DebtInstrumentLineItems to PaymentsOfDebtIssuanceCosts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_WarrantRepricing" xlink:label="WarrantRepricing" xlink:title="WarrantRepricing" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="WarrantRepricing" xlink:title="definition: DebtInstrumentLineItems to WarrantRepricing" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromConvertibleDebtNet" xlink:label="ProceedsFromConvertibleDebtNet" xlink:title="ProceedsFromConvertibleDebtNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ProceedsFromConvertibleDebtNet" xlink:title="definition: DebtInstrumentLineItems to ProceedsFromConvertibleDebtNet" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="LongtermDebtTypeAxis" xlink:title="definition: DebtInstrumentTable to LongtermDebtTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain_2" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain_2" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023ConvertibleNotesMember" xlink:label="July2023ConvertibleNotesMember" xlink:title="July2023ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="July2023ConvertibleNotesMember" xlink:title="definition: LongtermDebtTypeDomain to July2023ConvertibleNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="July2023WarrantsMember" xlink:title="definition: LongtermDebtTypeDomain to July2023WarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="December2023ConvertibleNotesMember" xlink:title="definition: LongtermDebtTypeDomain to December2023ConvertibleNotesMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="December2023WarrantsMember" xlink:title="definition: LongtermDebtTypeDomain to December2023WarrantsMember" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="definition: DebtInstrumentLineItems to ValuationTechniqueAndInputDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMeasurementInput" xlink:label="LongTermDebtMeasurementInput" xlink:title="LongTermDebtMeasurementInput" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMeasurementInput" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMeasurementInput" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="WarrantsAndRightsOutstandingMeasurementInput" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="definition: DebtInstrumentLineItems to WarrantsAndRightsOutstandingMeasurementInput" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="definition: DebtInstrumentLineItems to WarrantsAndRightsOutstandingTerm" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="LongtermDebtTypeAxis" xlink:title="definition: DebtInstrumentTable to LongtermDebtTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain_2" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain_2" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023ConvertibleNotesMember" xlink:label="July2023ConvertibleNotesMember" xlink:title="July2023ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="July2023ConvertibleNotesMember" xlink:title="definition: LongtermDebtTypeDomain to July2023ConvertibleNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="July2023WarrantsMember" xlink:title="definition: LongtermDebtTypeDomain to July2023WarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="December2023ConvertibleNotesMember" xlink:title="definition: LongtermDebtTypeDomain to December2023ConvertibleNotesMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="December2023WarrantsMember" xlink:title="definition: LongtermDebtTypeDomain to December2023WarrantsMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="MeasurementInputTypeAxis" xlink:title="definition: DebtInstrumentTable to MeasurementInputTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain_2" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain_2" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputSharePriceMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputSharePriceMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="MeasurementInputCreditSpreadMember" xlink:title="MeasurementInputCreditSpreadMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputCreditSpreadMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputCreditSpreadMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="MeasurementInputExercisePriceMember" xlink:title="MeasurementInputExercisePriceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExercisePriceMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputExercisePriceMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="MeasurementInputExpectedTermMember" xlink:title="MeasurementInputExpectedTermMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedTermMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputExpectedTermMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="MeasurementInputExpectedDividendRateMember" xlink:title="MeasurementInputExpectedDividendRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedDividendRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputExpectedDividendRateMember" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputRiskFreeInterestRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputRiskFreeInterestRateMember" order="7.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleNotesAbstract" xlink:label="ConvertibleNotesAbstract" xlink:title="ConvertibleNotesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ConvertibleNotesAbstract" xlink:title="definition: DebtInstrumentLineItems to ConvertibleNotesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:label="MaturitiesOfLongTermDebtAbstract" xlink:title="MaturitiesOfLongTermDebtAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="MaturitiesOfLongTermDebtAbstract" xlink:title="definition: DebtInstrumentLineItems to MaturitiesOfLongTermDebtAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:label="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:title="PromissoryNoteAndConvertibleNoteFinancingAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:title="definition: DebtInstrumentLineItems to PromissoryNoteAndConvertibleNoteFinancingAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="InterestExpenseDebt" xlink:title="InterestExpenseDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="InterestExpenseDebt" xlink:title="definition: DebtInstrumentLineItems to InterestExpenseDebt" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="definition: DebtInstrumentLineItems to AmortizationOfFinancingCostsAndDiscounts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest" xlink:label="PaidInKindInterest" xlink:title="PaidInKindInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="PaidInKindInterest" xlink:title="definition: DebtInstrumentLineItems to PaidInKindInterest" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:label="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:title="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:title="definition: DebtInstrumentLineItems to InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="AccruedLiabilitiesCurrent" xlink:title="definition: DebtInstrumentLineItems to AccruedLiabilitiesCurrent" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ProceedsFromConvertibleDebt" xlink:title="definition: DebtInstrumentLineItems to ProceedsFromConvertibleDebt" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:label="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:title="PaidInKindInterestAddedToConvertibleNotesPrincipal" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:title="definition: DebtInstrumentLineItems to PaidInKindInterestAddedToConvertibleNotesPrincipal" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="ConvertibleLongTermNotesPayable" xlink:title="ConvertibleLongTermNotesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="ConvertibleLongTermNotesPayable" xlink:title="definition: DebtInstrumentLineItems to ConvertibleLongTermNotesPayable" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="19.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="LongtermDebtTypeAxis" xlink:title="definition: DebtInstrumentTable to LongtermDebtTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain_2" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain_2" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="definition: LongtermDebtTypeDomain to ConvertibleDebtMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:label="PropertyPlantAndEquipmentGrossAbstract" xlink:title="PropertyPlantAndEquipmentGrossAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGrossAbstract" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGrossAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="definition: PropertyPlantAndEquipmentLineItems to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNet" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="definition: PropertyPlantAndEquipmentLineItems to GainLossOnDisposalOfFixedAssets" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingNetBookValueOfFixedAssets" xlink:label="RemainingNetBookValueOfFixedAssets" xlink:title="RemainingNetBookValueOfFixedAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="RemainingNetBookValueOfFixedAssets" xlink:title="definition: PropertyPlantAndEquipmentLineItems to RemainingNetBookValueOfFixedAssets" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ProceedsFromSaleOfPropertyPlantAndEquipment" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="Depreciation" xlink:title="definition: PropertyPlantAndEquipmentLineItems to Depreciation" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ScheduleOfPropertyPlantAndEquipmentTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="EquipmentMember" xlink:title="EquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="EquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to EquipmentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesOperatingLeaseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeCommitmentToPurchaseProperty" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeCommitmentToPurchaseProperty" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="DepositsAssetsNoncurrent" xlink:title="DepositsAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="DepositsAssetsNoncurrent" xlink:title="definition: LesseeLeaseDescriptionLineItems to DepositsAssetsNoncurrent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseRightOfUseAsset" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiability" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseImpairmentLoss" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="definition: LesseeLeaseDescriptionLineItems to InitialMeasurementOfOperatingLeaseROUAssets" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="definition: LesseeLeaseDescriptionLineItems to InitialMeasurementOfOperatingLeaseLiabilities" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AreaOfRealEstateProperty" xlink:title="definition: LesseeLeaseDescriptionLineItems to AreaOfRealEstateProperty" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseRenewalTerm" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseRenewalTerm" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeasesMonthlyBaseRent" xlink:label="OperatingLeasesMonthlyBaseRent" xlink:title="OperatingLeasesMonthlyBaseRent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeasesMonthlyBaseRent" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeasesMonthlyBaseRent" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeasesIncreaseInBaseRentPercentage" xlink:label="OperatingLeasesIncreaseInBaseRentPercentage" xlink:title="OperatingLeasesIncreaseInBaseRentPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeasesIncreaseInBaseRentPercentage" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeasesIncreaseInBaseRentPercentage" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LineOfCredit" xlink:title="definition: LesseeLeaseDescriptionLineItems to LineOfCredit" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TenantImprovementAllowancePerRentableSquareFoot" xlink:label="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="TenantImprovementAllowancePerRentableSquareFoot" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="definition: LesseeLeaseDescriptionLineItems to TenantImprovementAllowancePerRentableSquareFoot" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TenantImprovementAllowance" xlink:label="TenantImprovementAllowance" xlink:title="TenantImprovementAllowance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="TenantImprovementAllowance" xlink:title="definition: LesseeLeaseDescriptionLineItems to TenantImprovementAllowance" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseholdImprovementsGross" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseholdImprovementsGross" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ReceivedAmountOfTenantImprovementAllowance" xlink:label="ReceivedAmountOfTenantImprovementAllowance" xlink:title="ReceivedAmountOfTenantImprovementAllowance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="ReceivedAmountOfTenantImprovementAllowance" xlink:title="definition: LesseeLeaseDescriptionLineItems to ReceivedAmountOfTenantImprovementAllowance" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:label="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:title="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OutOfPocketExpenses" xlink:label="OutOfPocketExpenses" xlink:title="OutOfPocketExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OutOfPocketExpenses" xlink:title="definition: LesseeLeaseDescriptionLineItems to OutOfPocketExpenses" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:label="UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:title="UnpaidOutOfPocketCostsTenantImprovementAllowance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:title="definition: LesseeLeaseDescriptionLineItems to UnpaidOutOfPocketCostsTenantImprovementAllowance" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeaseIncrementalBorrowingRate" xlink:label="OperatingLeaseIncrementalBorrowingRate" xlink:title="OperatingLeaseIncrementalBorrowingRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseIncrementalBorrowingRate" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseIncrementalBorrowingRate" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:label="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:title="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:title="definition: LesseeLeaseDescriptionLineItems to AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeLeaseDescriptionTable" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeLeaseDescriptionTable" order="23.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: LesseeLeaseDescriptionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ERSquibbSonsLLCMember" xlink:label="ERSquibbSonsLLCMember" xlink:title="ERSquibbSonsLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="ERSquibbSonsLLCMember" xlink:title="definition: RelatedPartyDomain to ERSquibbSonsLLCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SanDiegoLeaseMember" xlink:label="SanDiegoLeaseMember" xlink:title="SanDiegoLeaseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="SanDiegoLeaseMember" xlink:title="definition: RelatedPartyDomain to SanDiegoLeaseMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="definition: LesseeLeaseDescriptionTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesManhattanSubleaseDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueNetAssetLiabilityAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueNetAssetLiabilityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueDisclosureAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueDisclosure" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueDisclosure" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="ContingentConsiderationByTypeAxis" xlink:title="ContingentConsiderationByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ContingentConsiderationByTypeAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ContingentConsiderationByTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain" xlink:title="ContingentConsiderationTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain" xlink:title="definition: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain_2" xlink:title="ContingentConsiderationTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain_2" xlink:title="definition: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MarketCapContingentConsiderationMember" xlink:label="MarketCapContingentConsiderationMember" xlink:title="MarketCapContingentConsiderationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ContingentConsiderationTypeDomain" xlink:to="MarketCapContingentConsiderationMember" xlink:title="definition: ContingentConsiderationTypeDomain to MarketCapContingentConsiderationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByLiabilityClassAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to ValuationTechniqueAndInputDescriptionAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:title="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ChangeInFairValueOfContingentConsideration" xlink:label="ChangeInFairValueOfContingentConsideration" xlink:title="ChangeInFairValueOfContingentConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ChangeInFairValueOfContingentConsideration" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to ChangeInFairValueOfContingentConsideration" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to WarrantsAndRightsOutstandingTerm" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="WarrantsAndRightsOutstandingMeasurementInput" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to WarrantsAndRightsOutstandingMeasurementInput" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="LiabilitiesFairValueAdjustment" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to LiabilitiesFairValueAdjustment" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to FairValueByLiabilityClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="ContingentConsiderationByTypeAxis" xlink:title="ContingentConsiderationByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="ContingentConsiderationByTypeAxis" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to ContingentConsiderationByTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain" xlink:title="ContingentConsiderationTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain" xlink:title="definition: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain_2" xlink:title="ContingentConsiderationTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain_2" xlink:title="definition: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationMember" xlink:label="ContingentConsiderationMember" xlink:title="ContingentConsiderationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ContingentConsiderationTypeDomain" xlink:to="ContingentConsiderationMember" xlink:title="definition: ContingentConsiderationTypeDomain to ContingentConsiderationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="MeasurementInputTypeAxis" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to MeasurementInputTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain_2" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain_2" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="MeasurementInputExpectedTermMember" xlink:title="MeasurementInputExpectedTermMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedTermMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputExpectedTermMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputRiskFreeInterestRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputRiskFreeInterestRateMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="MeasurementInputExpectedDividendRateMember" xlink:title="MeasurementInputExpectedDividendRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedDividendRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputExpectedDividendRateMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputSharePriceMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputSharePriceMember" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:title="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:label="DebtInstrumentFairValueDisclosureAbstract" xlink:title="DebtInstrumentFairValueDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="DebtInstrumentFairValueDisclosureAbstract" xlink:title="definition: FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems to DebtInstrumentFairValueDisclosureAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="definition: FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems to ValuationTechniqueAndInputDescriptionAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleDebtMeasurementInput" xlink:label="ConvertibleDebtMeasurementInput" xlink:title="ConvertibleDebtMeasurementInput" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ConvertibleDebtMeasurementInput" xlink:title="definition: FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems to ConvertibleDebtMeasurementInput" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="ConvertibleDebtFairValueDisclosures" xlink:title="ConvertibleDebtFairValueDisclosures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ConvertibleDebtFairValueDisclosures" xlink:title="definition: FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems to ConvertibleDebtFairValueDisclosures" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="FairValueByBalanceSheetGroupingTable" xlink:title="FairValueByBalanceSheetGroupingTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="FairValueByBalanceSheetGroupingTable" xlink:title="definition: FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems to FairValueByBalanceSheetGroupingTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="FairValueByMeasurementBasisAxis" xlink:title="FairValueByMeasurementBasisAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="FairValueByMeasurementBasisAxis" xlink:title="definition: FairValueByBalanceSheetGroupingTable to FairValueByMeasurementBasisAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="FairValueDisclosureItemAmountsDomain" xlink:title="FairValueDisclosureItemAmountsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByMeasurementBasisAxis" xlink:to="FairValueDisclosureItemAmountsDomain" xlink:title="definition: FairValueByMeasurementBasisAxis to FairValueDisclosureItemAmountsDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="PortionAtFairValueFairValueDisclosureMember" xlink:title="PortionAtFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueDisclosureItemAmountsDomain" xlink:to="PortionAtFairValueFairValueDisclosureMember" xlink:title="definition: FairValueDisclosureItemAmountsDomain to PortionAtFairValueFairValueDisclosureMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="PortionAtFairValueFairValueDisclosureMember_2" xlink:title="PortionAtFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByMeasurementBasisAxis" xlink:to="PortionAtFairValueFairValueDisclosureMember_2" xlink:title="definition: FairValueByMeasurementBasisAxis to PortionAtFairValueFairValueDisclosureMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="CarryingReportedAmountFairValueDisclosureMember" xlink:title="CarryingReportedAmountFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueDisclosureItemAmountsDomain" xlink:to="CarryingReportedAmountFairValueDisclosureMember" xlink:title="definition: FairValueDisclosureItemAmountsDomain to CarryingReportedAmountFairValueDisclosureMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="EstimateOfFairValueFairValueDisclosureMember" xlink:title="EstimateOfFairValueFairValueDisclosureMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueDisclosureItemAmountsDomain" xlink:to="EstimateOfFairValueFairValueDisclosureMember" xlink:title="definition: FairValueDisclosureItemAmountsDomain to EstimateOfFairValueFairValueDisclosureMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueByBalanceSheetGroupingTable to FairValueByFairValueHierarchyLevelAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="MeasurementInputTypeAxis" xlink:title="definition: FairValueByBalanceSheetGroupingTable to MeasurementInputTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain_2" xlink:title="MeasurementInputTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain_2" xlink:title="definition: MeasurementInputTypeAxis to MeasurementInputTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputSharePriceMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputSharePriceMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="MeasurementInputCreditSpreadMember" xlink:title="MeasurementInputCreditSpreadMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputCreditSpreadMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputCreditSpreadMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputRiskFreeInterestRateMember" xlink:title="definition: MeasurementInputTypeDomain to MeasurementInputRiskFreeInterestRateMember" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="RelatedPartyTransactionLineItems" xlink:title="RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RelatedPartyTransactionAbstract" xlink:label="RelatedPartyTransactionAbstract" xlink:title="RelatedPartyTransactionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="RelatedPartyTransactionAbstract" xlink:title="definition: RelatedPartyTransactionLineItems to RelatedPartyTransactionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisOptionAgreementAbstract" xlink:label="ExacisOptionAgreementAbstract" xlink:title="ExacisOptionAgreementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ExacisOptionAgreementAbstract" xlink:title="definition: RelatedPartyTransactionLineItems to ExacisOptionAgreementAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_Q422PIPETransactionAbstract" xlink:label="Q422PIPETransactionAbstract" xlink:title="Q422PIPETransactionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="Q422PIPETransactionAbstract" xlink:title="definition: RelatedPartyTransactionLineItems to Q422PIPETransactionAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: RelatedPartyTransactionLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="definition: RelatedPartyTransactionLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="UnitPriceOfWarrants" xlink:title="definition: RelatedPartyTransactionLineItems to UnitPriceOfWarrants" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PaymentOfOptionFee" xlink:label="PaymentOfOptionFee" xlink:title="PaymentOfOptionFee" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="PaymentOfOptionFee" xlink:title="definition: RelatedPartyTransactionLineItems to PaymentOfOptionFee" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoticePeriodForSupersedingTerminationProvisions" xlink:label="NoticePeriodForSupersedingTerminationProvisions" xlink:title="NoticePeriodForSupersedingTerminationProvisions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="NoticePeriodForSupersedingTerminationProvisions" xlink:title="definition: RelatedPartyTransactionLineItems to NoticePeriodForSupersedingTerminationProvisions" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MasterServiceAgreementInitialFeesPayable" xlink:label="MasterServiceAgreementInitialFeesPayable" xlink:title="MasterServiceAgreementInitialFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="MasterServiceAgreementInitialFeesPayable" xlink:title="definition: RelatedPartyTransactionLineItems to MasterServiceAgreementInitialFeesPayable" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfMonthlyInstallmentsForFeesPayable" xlink:label="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="NumberOfMonthlyInstallmentsForFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="definition: RelatedPartyTransactionLineItems to NumberOfMonthlyInstallmentsForFeesPayable" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:label="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="RelatedPartyTransactionPeriodicFeesPaymentAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="definition: RelatedPartyTransactionLineItems to RelatedPartyTransactionPeriodicFeesPaymentAmount" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MonthlyMasterServicesAgreementFeesPayable" xlink:label="MonthlyMasterServicesAgreementFeesPayable" xlink:title="MonthlyMasterServicesAgreementFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="MonthlyMasterServicesAgreementFeesPayable" xlink:title="definition: RelatedPartyTransactionLineItems to MonthlyMasterServicesAgreementFeesPayable" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialLicenseFeeObligation" xlink:label="InitialLicenseFeeObligation" xlink:title="InitialLicenseFeeObligation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="InitialLicenseFeeObligation" xlink:title="definition: RelatedPartyTransactionLineItems to InitialLicenseFeeObligation" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:label="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="definition: RelatedPartyTransactionLineItems to DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoticePeriodForFirstTerminationOfContract" xlink:label="NoticePeriodForFirstTerminationOfContract" xlink:title="NoticePeriodForFirstTerminationOfContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="NoticePeriodForFirstTerminationOfContract" xlink:title="definition: RelatedPartyTransactionLineItems to NoticePeriodForFirstTerminationOfContract" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AgreedWaivePayment" xlink:label="AgreedWaivePayment" xlink:title="AgreedWaivePayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="AgreedWaivePayment" xlink:title="definition: RelatedPartyTransactionLineItems to AgreedWaivePayment" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="definition: RelatedPartyTransactionLineItems to ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingUnamortizedLicenseFeeObligation" xlink:label="RemainingUnamortizedLicenseFeeObligation" xlink:title="RemainingUnamortizedLicenseFeeObligation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="RemainingUnamortizedLicenseFeeObligation" xlink:title="definition: RelatedPartyTransactionLineItems to RemainingUnamortizedLicenseFeeObligation" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="MinorityInterestOwnershipPercentageByParent" xlink:title="definition: RelatedPartyTransactionLineItems to MinorityInterestOwnershipPercentageByParent" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LicenseAgreementAutomaticRenewalTerm" xlink:label="LicenseAgreementAutomaticRenewalTerm" xlink:title="LicenseAgreementAutomaticRenewalTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="LicenseAgreementAutomaticRenewalTerm" xlink:title="definition: RelatedPartyTransactionLineItems to LicenseAgreementAutomaticRenewalTerm" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SublicenseFees" xlink:label="SublicenseFees" xlink:title="SublicenseFees" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="SublicenseFees" xlink:title="definition: RelatedPartyTransactionLineItems to SublicenseFees" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:label="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:title="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyTransactionLineItems" xlink:to="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:title="definition: RelatedPartyTransactionLineItems to PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="definition: RelatedPartyTransactionLineItems to ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="23.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_FactorBioscienceIncMember" xlink:label="FactorBioscienceIncMember" xlink:title="FactorBioscienceIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="FactorBioscienceIncMember" xlink:title="definition: RelatedPartyDomain to FactorBioscienceIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="PIPEInvestorMember" xlink:title="definition: RelatedPartyDomain to PIPEInvestorMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to TitleOfIndividualAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="DirectorMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to DirectorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="OwnershipAxis" xlink:title="definition: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to OwnershipAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: OwnershipDomain to NoveCiteINCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to ClassOfWarrantOrRightAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="DefinedContributionPlanDisclosureLineItems" xlink:title="DefinedContributionPlanDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="DefinedContributionPlanAbstract" xlink:title="DefinedContributionPlanAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanAbstract" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:label="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployeeContributionAtThresholdOne" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployeeContributionAtThresholdTwo" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="DefinedContributionPlanTable" xlink:title="DefinedContributionPlanTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanTable" xlink:title="definition: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="RetirementPlanNameAxis" xlink:title="RetirementPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DefinedContributionPlanTable" xlink:to="RetirementPlanNameAxis" xlink:title="definition: DefinedContributionPlanTable to RetirementPlanNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="RetirementPlanNameDomain" xlink:title="RetirementPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RetirementPlanNameAxis" xlink:to="RetirementPlanNameDomain" xlink:title="definition: RetirementPlanNameAxis to RetirementPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="RetirementPlanNameDomain_2" xlink:title="RetirementPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RetirementPlanNameAxis" xlink:to="RetirementPlanNameDomain_2" xlink:title="definition: RetirementPlanNameAxis to RetirementPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RetirementPlan401KMember" xlink:label="RetirementPlan401KMember" xlink:title="RetirementPlan401KMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RetirementPlanNameDomain" xlink:to="RetirementPlan401KMember" xlink:title="definition: RetirementPlanNameDomain to RetirementPlan401KMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DefinedContributionPlanTable" xlink:to="RangeAxis" xlink:title="definition: DefinedContributionPlanTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to EarningsPerShareDilutedOtherDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain_2" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain_2" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to WarrantMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="ConvertibleCommonStockMember" xlink:title="ConvertibleCommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertibleCommonStockMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to ConvertibleCommonStockMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertiblePreferredStockMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to ConvertiblePreferredStockMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfSharesOfCommonStockOutstanding" xlink:label="PercentageOfSharesOfCommonStockOutstanding" xlink:title="PercentageOfSharesOfCommonStockOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="PercentageOfSharesOfCommonStockOutstanding" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to PercentageOfSharesOfCommonStockOutstanding" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="11.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="definition: PlanNameAxis to PlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EquityIncentivePlan2020Member" xlink:label="EquityIncentivePlan2020Member" xlink:title="EquityIncentivePlan2020Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="EquityIncentivePlan2020Member" xlink:title="definition: PlanNameDomain to EquityIncentivePlan2020Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InducementPlan2021Member" xlink:label="InducementPlan2021Member" xlink:title="InducementPlan2021Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="InducementPlan2021Member" xlink:title="definition: PlanNameDomain to InducementPlan2021Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncentiveStockOptionsMember" xlink:label="IncentiveStockOptionsMember" xlink:title="IncentiveStockOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="IncentiveStockOptionsMember" xlink:title="definition: EmployeeStockOptionMember to IncentiveStockOptionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="NonQualifiedStockOptionMember" xlink:title="definition: EmployeeStockOptionMember to NonQualifiedStockOptionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to SubsequentEventTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AggregateIntrinsicValueAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AggregateIntrinsicValueAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="19.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TimeBasedStockOptionMember" xlink:label="TimeBasedStockOptionMember" xlink:title="TimeBasedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="TimeBasedStockOptionMember" xlink:title="definition: EmployeeStockOptionMember to TimeBasedStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PerformanceBasedStockOptionMember" xlink:label="PerformanceBasedStockOptionMember" xlink:title="PerformanceBasedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="PerformanceBasedStockOptionMember" xlink:title="definition: EmployeeStockOptionMember to PerformanceBasedStockOptionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfAwardsVestedAndSettledAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfAwardsVestedAndSettledAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RestrictedStockUnitesWithheldToCoverTaxes" xlink:label="RestrictedStockUnitesWithheldToCoverTaxes" xlink:title="RestrictedStockUnitesWithheldToCoverTaxes" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="RestrictedStockUnitesWithheldToCoverTaxes" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to RestrictedStockUnitesWithheldToCoverTaxes" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain_2" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain_2" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfEquityAbstract" xlink:title="definition: SubsidiarySaleOfStockLineItems to PrivatePlacementOfEquityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: SubsidiarySaleOfStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfWarrantsInEachUnit" xlink:label="NumberOfWarrantsInEachUnit" xlink:title="NumberOfWarrantsInEachUnit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="NumberOfWarrantsInEachUnit" xlink:title="definition: SubsidiarySaleOfStockLineItems to NumberOfWarrantsInEachUnit" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="UnitPriceOfWarrants" xlink:title="definition: SubsidiarySaleOfStockLineItems to UnitPriceOfWarrants" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="definition: SubsidiarySaleOfStockLineItems to ProceedsFromIssuanceOfWarrants" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: SubsidiarySaleOfStockLineItems to StockRepurchaseProgramAuthorizedAmount1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightsExercisableTerm" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: SubsidiarySaleOfStockLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightExercised" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightExercised" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="definition: SubsidiarySaleOfStockLineItems to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="OverSubscriptionAmountReceived" xlink:title="definition: SubsidiarySaleOfStockLineItems to OverSubscriptionAmountReceived" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="definition: SubsidiarySaleOfStockLineItems to ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ObligationToPayLiquidatedDamagesPercentage" xlink:title="definition: SubsidiarySaleOfStockLineItems to ObligationToPayLiquidatedDamagesPercentage" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="TransactionFeesPayable" xlink:title="definition: SubsidiarySaleOfStockLineItems to TransactionFeesPayable" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="LossContingencyEstimateOfPossibleLoss" xlink:title="definition: SubsidiarySaleOfStockLineItems to LossContingencyEstimateOfPossibleLoss" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="LossContingencyDamagesPaidValue" xlink:title="definition: SubsidiarySaleOfStockLineItems to LossContingencyDamagesPaidValue" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="definition: SubsidiarySaleOfStockLineItems to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="19.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PIPEInvestorOneMember" xlink:label="PIPEInvestorOneMember" xlink:title="PIPEInvestorOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="PIPEInvestorOneMember" xlink:title="definition: RelatedPartyDomain to PIPEInvestorOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="PIPEInvestorMember" xlink:title="definition: RelatedPartyDomain to PIPEInvestorMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="definition: ClassOfWarrantOrRightDomain to WarrantMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsOneMember" xlink:label="CommonWarrantsOneMember" xlink:title="CommonWarrantsOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="CommonWarrantsOneMember" xlink:title="definition: WarrantMember to CommonWarrantsOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="CommonWarrantsMember" xlink:title="definition: WarrantMember to CommonWarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="PreFundedWarrantsMember" xlink:title="definition: WarrantMember to PreFundedWarrantsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to StatementEquityComponentsAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoteWarrantsAbstract" xlink:label="NoteWarrantsAbstract" xlink:title="NoteWarrantsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="NoteWarrantsAbstract" xlink:title="definition: ClassOfWarrantOrRightLineItems to NoteWarrantsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="definition: ClassOfWarrantOrRightLineItems to WarrantsAndRightsNoteDisclosureAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="ClassOfWarrantOrRightGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightGrantsInPeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="definition: ClassOfWarrantOrRightLineItems to WarrantsAndRightsOutstandingTerm" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="ClassOfWarrantOrRightTable" xlink:title="definition: ClassOfWarrantOrRightLineItems to ClassOfWarrantOrRightTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfWarrantOrRightTable" xlink:to="LongtermDebtTypeAxis" xlink:title="definition: ClassOfWarrantOrRightTable to LongtermDebtTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain_2" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain_2" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="definition: LongtermDebtTypeDomain to ConvertibleDebtMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023AndDecember2023ConvertibleNotesMember" xlink:label="July2023AndDecember2023ConvertibleNotesMember" xlink:title="July2023AndDecember2023ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConvertibleDebtMember" xlink:to="July2023AndDecember2023ConvertibleNotesMember" xlink:title="definition: ConvertibleDebtMember to July2023AndDecember2023ConvertibleNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfWarrantOrRightTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: ClassOfWarrantOrRightTable to StatementEquityComponentsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfWarrantOrRightTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: ClassOfWarrantOrRightTable to ClassOfWarrantOrRightAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="definition: ClassOfWarrantOrRightDomain to WarrantMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="CommonWarrantsMember" xlink:title="definition: WarrantMember to CommonWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsOneMember" xlink:label="CommonWarrantsOneMember" xlink:title="CommonWarrantsOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="CommonWarrantsOneMember" xlink:title="definition: WarrantMember to CommonWarrantsOneMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="July2023WarrantsMember" xlink:title="definition: WarrantMember to July2023WarrantsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="WarrantMember" xlink:to="December2023WarrantsMember" xlink:title="definition: WarrantMember to December2023WarrantsMember" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsSepaDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StandbySecuritiesPurchaseAgreementAbstract" xlink:label="StandbySecuritiesPurchaseAgreementAbstract" xlink:title="StandbySecuritiesPurchaseAgreementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="StandbySecuritiesPurchaseAgreementAbstract" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to StandbySecuritiesPurchaseAgreementAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to StockRepurchaseProgramAuthorizedAmount1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:label="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:title="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:label="EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:title="EquityLineOfCreditConsiderationSharesOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to EquityLineOfCreditConsiderationSharesOfCommonStock" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to SaleOfStockNumberOfSharesIssuedInTransaction" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="ProceedsFromIssuanceOrSaleOfEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to ProceedsFromIssuanceOrSaleOfEquity" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesToIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to SaleOfStockNumberOfSharesToIssuedInTransaction" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="definition: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StandbyEquityPurchaseAgreementMember" xlink:label="StandbyEquityPurchaseAgreementMember" xlink:title="StandbyEquityPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="StandbyEquityPurchaseAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to StandbyEquityPurchaseAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="LegalEntityAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to LegalEntityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="EntityDomain_2" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain_2" xlink:title="definition: LegalEntityAxis to EntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LincolnParkCapitalFundLLCMember" xlink:label="LincolnParkCapitalFundLLCMember" xlink:title="LincolnParkCapitalFundLLCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityDomain" xlink:to="LincolnParkCapitalFundLLCMember" xlink:title="definition: EntityDomain to LincolnParkCapitalFundLLCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="FeaturesOfConvertiblePreferredStockAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="definition: ClassOfStockLineItems to FeaturesOfConvertiblePreferredStockAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockSharesAuthorized" xlink:title="definition: ClassOfStockLineItems to PreferredStockSharesAuthorized" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockSharesIssued" xlink:title="definition: ClassOfStockLineItems to PreferredStockSharesIssued" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockSharesOutstanding" xlink:title="definition: ClassOfStockLineItems to PreferredStockSharesOutstanding" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="DividendsPayableAmountPerShare" xlink:title="DividendsPayableAmountPerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="DividendsPayableAmountPerShare" xlink:title="definition: ClassOfStockLineItems to DividendsPayableAmountPerShare" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="DividendsPreferredStockCash" xlink:title="definition: ClassOfStockLineItems to DividendsPreferredStockCash" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="PreferredStockLiquidationPreference" xlink:title="PreferredStockLiquidationPreference" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockLiquidationPreference" xlink:title="definition: ClassOfStockLineItems to PreferredStockLiquidationPreference" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleConversionRatio" xlink:label="PreferredStockConvertibleConversionRatio" xlink:title="PreferredStockConvertibleConversionRatio" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockConvertibleConversionRatio" xlink:title="definition: ClassOfStockLineItems to PreferredStockConvertibleConversionRatio" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="definition: ClassOfStockLineItems to ConvertiblePreferredStockSharesIssuedUponConversion" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="PreferredStockConvertibleSharesIssuable" xlink:title="PreferredStockConvertibleSharesIssuable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PreferredStockConvertibleSharesIssuable" xlink:title="definition: ClassOfStockLineItems to PreferredStockConvertibleSharesIssuable" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfStockLineItems" xlink:to="ScheduleOfStockByClassTable" xlink:title="definition: ClassOfStockLineItems to ScheduleOfStockByClassTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncomeTaxAbstract" xlink:label="IncomeTaxAbstract" xlink:title="IncomeTaxAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="IncomeTaxAbstract" xlink:title="definition: OperatingLossCarryforwardsLineItems to IncomeTaxAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="definition: OperatingLossCarryforwardsLineItems to ValuationAllowanceDeferredTaxAssetChangeInAmount" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwards" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwards" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TaxCutsAndJobsActOperatingLossCarryforwards" xlink:label="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="TaxCutsAndJobsActOperatingLossCarryforwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="definition: OperatingLossCarryforwardsLineItems to TaxCutsAndJobsActOperatingLossCarryforwards" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="TaxCreditCarryforwardAmount" xlink:title="definition: OperatingLossCarryforwardsLineItems to TaxCreditCarryforwardAmount" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TaxCreditCarryforwardExpirationYear" xlink:label="TaxCreditCarryforwardExpirationYear" xlink:title="TaxCreditCarryforwardExpirationYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="TaxCreditCarryforwardExpirationYear" xlink:title="definition: OperatingLossCarryforwardsLineItems to TaxCreditCarryforwardExpirationYear" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="definition: OperatingLossCarryforwardsLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OpenTaxYear" xlink:label="OpenTaxYear" xlink:title="OpenTaxYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OpenTaxYear" xlink:title="definition: OperatingLossCarryforwardsLineItems to OpenTaxYear" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsTable" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="definition: OperatingLossCarryforwardsTable to IncomeTaxAuthorityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain_2" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain_2" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="DomesticCountryMember" xlink:title="definition: IncomeTaxAuthorityDomain to DomesticCountryMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="definition: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="ForeignCountryMember" xlink:title="definition: IncomeTaxAuthorityDomain to ForeignCountryMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://eternatx.com/role/SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CEOInducementGrantAbstract" xlink:label="CEOInducementGrantAbstract" xlink:title="CEOInducementGrantAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="CEOInducementGrantAbstract" xlink:title="definition: SubsequentEventLineItems to CEOInducementGrantAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:label="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:title="RemainingFundingReceivedFromDecember2023FinancingAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:title="definition: SubsequentEventLineItems to RemainingFundingReceivedFromDecember2023FinancingAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ProceedsFromConvertibleDebt" xlink:title="definition: SubsequentEventLineItems to ProceedsFromConvertibleDebt" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: SubsequentEventLineItems to DebtInstrumentFaceAmount" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: SubsequentEventLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="definition: SubsequentEventLineItems to DebtInstrumentMaturityDate" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: SubsequentEventLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="definition: SubsequentEventLineItems to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="definition: SubsequentEventLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="definition: SubsequentEventLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:title="definition: SubsequentEventLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsequentEventLineItems" xlink:to="SubsequentEventTable" xlink:title="definition: SubsequentEventLineItems to SubsequentEventTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="AwardTypeAxis" xlink:title="definition: SubsequentEventTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="NonQualifiedStockOptionMember" xlink:title="definition: EmployeeStockOptionMember to NonQualifiedStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: SubsequentEventTable to TitleOfIndividualAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PresidentChiefExecutiveOfficerAndDirectorMember" xlink:label="PresidentChiefExecutiveOfficerAndDirectorMember" xlink:title="PresidentChiefExecutiveOfficerAndDirectorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="PresidentChiefExecutiveOfficerAndDirectorMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to PresidentChiefExecutiveOfficerAndDirectorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="VestingAxis" xlink:title="definition: SubsequentEventTable to VestingAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="definition: VestingAxis to VestingDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain_2" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="VestingAxis" xlink:to="VestingDomain_2" xlink:title="definition: VestingAxis to VestingDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheOneMember" xlink:title="definition: VestingDomain to ShareBasedCompensationAwardTrancheOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="ShareBasedCompensationAwardTrancheTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="definition: VestingDomain to ShareBasedCompensationAwardTrancheTwoMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="LongtermDebtTypeAxis" xlink:title="definition: SubsequentEventTable to LongtermDebtTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain_2" xlink:title="LongtermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain_2" xlink:title="definition: LongtermDebtTypeAxis to LongtermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LongtermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="definition: LongtermDebtTypeDomain to ConvertibleDebtMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConvertibleDebtMember" xlink:to="December2023ConvertibleNotesMember" xlink:title="definition: ConvertibleDebtMember to December2023ConvertibleNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: SubsequentEventTable to ClassOfWarrantOrRightAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="definition: ClassOfWarrantOrRightDomain to WarrantMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: SubsequentEventTable to SubsequentEventTypeAxis" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>erna-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems" xlink:label="InsiderTradingArrLineItems" xlink:title="InsiderTradingArrLineItems" />
    <link:label xlink:type="resource" xlink:label="ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="ecd_InsiderTradingArrLineItems" xml:lang="en-US" id="ecd_InsiderTradingArrLineItems">Insider Trading Arrangements [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems" xlink:title="label: InsiderTradingArrLineItems to ecd_InsiderTradingArrLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="Rule10b51ArrAdoptedFlag" xlink:title="Rule10b51ArrAdoptedFlag" />
    <link:label xlink:type="resource" xlink:label="ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="ecd_Rule10b51ArrAdoptedFlag" xml:lang="en-US" id="ecd_Rule10b51ArrAdoptedFlag">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag" xlink:title="label: Rule10b51ArrAdoptedFlag to ecd_Rule10b51ArrAdoptedFlag" />
    <link:label xlink:type="resource" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="ecd_Rule10b51ArrAdoptedFlag_lbl1" xml:lang="en-US" id="ecd_Rule10b51ArrAdoptedFlag_lbl1">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl1" xlink:title="label: Rule10b51ArrAdoptedFlag to ecd_Rule10b51ArrAdoptedFlag_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="Rule10b51ArrTrmntdFlag" xlink:title="Rule10b51ArrTrmntdFlag" />
    <link:label xlink:type="resource" xlink:label="ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="ecd_Rule10b51ArrTrmntdFlag" xml:lang="en-US" id="ecd_Rule10b51ArrTrmntdFlag">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag" xlink:title="label: Rule10b51ArrTrmntdFlag to ecd_Rule10b51ArrTrmntdFlag" />
    <link:label xlink:type="resource" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="ecd_Rule10b51ArrTrmntdFlag_lbl1" xml:lang="en-US" id="ecd_Rule10b51ArrTrmntdFlag_lbl1">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl1" xlink:title="label: Rule10b51ArrTrmntdFlag to ecd_Rule10b51ArrTrmntdFlag_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="NonRule10b51ArrAdoptedFlag" xlink:title="NonRule10b51ArrAdoptedFlag" />
    <link:label xlink:type="resource" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="ecd_NonRule10b51ArrAdoptedFlag" xml:lang="en-US" id="ecd_NonRule10b51ArrAdoptedFlag">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag" xlink:title="label: NonRule10b51ArrAdoptedFlag to ecd_NonRule10b51ArrAdoptedFlag" />
    <link:label xlink:type="resource" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="ecd_NonRule10b51ArrAdoptedFlag_lbl1" xml:lang="en-US" id="ecd_NonRule10b51ArrAdoptedFlag_lbl1">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl1" xlink:title="label: NonRule10b51ArrAdoptedFlag to ecd_NonRule10b51ArrAdoptedFlag_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="NonRule10b51ArrTrmntdFlag" xlink:title="NonRule10b51ArrTrmntdFlag" />
    <link:label xlink:type="resource" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="ecd_NonRule10b51ArrTrmntdFlag" xml:lang="en-US" id="ecd_NonRule10b51ArrTrmntdFlag">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag" xlink:title="label: NonRule10b51ArrTrmntdFlag to ecd_NonRule10b51ArrTrmntdFlag" />
    <link:label xlink:type="resource" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="ecd_NonRule10b51ArrTrmntdFlag_lbl1" xml:lang="en-US" id="ecd_NonRule10b51ArrTrmntdFlag_lbl1">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl1" xlink:title="label: NonRule10b51ArrTrmntdFlag to ecd_NonRule10b51ArrTrmntdFlag_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">Less accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapital" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl1">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket">Repricing of warrants in connection with December 2023 financing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalMarkToMarket to us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xml:lang="en-US" id="us-gaap_AmortizationOfFinancingCostsAndDiscounts">Amortization of debt discount and debt issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:title="label: AmortizationOfFinancingCostsAndDiscounts to us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AmortizationOfFinancingCostsAndDiscounts1" xml:lang="en-US" id="us-gaap_AmortizationOfFinancingCostsAndDiscounts1">Amortization of debt discount and debt issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts1" xlink:title="label: AmortizationOfFinancingCostsAndDiscounts to us-gaap_AmortizationOfFinancingCostsAndDiscounts1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AmortizationOfFinancingCostsAndDiscounts2" xml:lang="en-US" id="us-gaap_AmortizationOfFinancingCostsAndDiscounts2">Amortization of the debt discount and debt issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts2" xlink:title="label: AmortizationOfFinancingCostsAndDiscounts to us-gaap_AmortizationOfFinancingCostsAndDiscounts2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Depreciation" xml:lang="en-US" id="us-gaap_Depreciation">Depreciation expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Depreciation" xlink:to="us-gaap_Depreciation" xlink:title="label: Depreciation to us-gaap_Depreciation" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract">CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasic" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic">Net loss per common share - basic (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl1">Earnings Per Share, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:label="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:title="CashAndCashEquivalentsAtCarryingValueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract">Cash and Cash Equivalents [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:title="label: CashAndCashEquivalentsAtCarryingValueAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1">Cash and Cash Equivalents, at Carrying Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1" xlink:title="label: CashAndCashEquivalentsAtCarryingValueAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="label: CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy to us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1" xlink:title="label: CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy to us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="CashEquivalentsAtCarryingValue" xlink:title="CashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashEquivalentsAtCarryingValue" xml:lang="en-US" id="us-gaap_CashEquivalentsAtCarryingValue">Cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" xlink:title="label: CashEquivalentsAtCarryingValue to us-gaap_CashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US" id="us-gaap_CashEquivalentsAtCarryingValue_lbl1">Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xlink:title="label: CashEquivalentsAtCarryingValue to us-gaap_CashEquivalentsAtCarryingValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet" xml:lang="en-US" id="us-gaap_InterestPaidNet">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xml:lang="en-US" id="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">Increase in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="label: ValuationAllowanceDeferredTaxAssetChangeInAmount to us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1" xml:lang="en-US" id="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1" xlink:title="label: ValuationAllowanceDeferredTaxAssetChangeInAmount to us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherReceivables" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherReceivables">Other receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:title="label: IncreaseDecreaseInOtherReceivables to us-gaap_IncreaseDecreaseInOtherReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1">Increase (Decrease) in Other Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xlink:title="label: IncreaseDecreaseInOtherReceivables to us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="IncreaseDecreaseInDueToRelatedParties" xlink:title="IncreaseDecreaseInDueToRelatedParties" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInDueToRelatedParties" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInDueToRelatedParties">Due to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:title="label: IncreaseDecreaseInDueToRelatedParties to us-gaap_IncreaseDecreaseInDueToRelatedParties" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesOutstanding" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding">Common stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue" xml:lang="en-US" id="us-gaap_CommonStockValue">Common stock, $0.005 par value, 100,000 shares authorized at December 31, 2023 and 2022; 5,410 and 5,127 issued and outstanding at December 31, 2023 and 2022, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">Current Tax Provision [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">Deferred Tax Provision [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="label: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US" id="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract">Components of Income Tax Provision [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="label: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComputerEquipmentMember" xml:lang="en-US" id="us-gaap_ComputerEquipmentMember">Computer Equipment and Programs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember" xlink:title="label: ComputerEquipmentMember to us-gaap_ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComputerEquipmentMember1" xml:lang="en-US" id="us-gaap_ComputerEquipmentMember1">Computer Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember1" xlink:title="label: ComputerEquipmentMember to us-gaap_ComputerEquipmentMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="ContingentConsiderationByTypeAxis" xlink:title="ContingentConsiderationByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContingentConsiderationByTypeAxis" xml:lang="en-US" id="us-gaap_ContingentConsiderationByTypeAxis">Contingent Consideration by Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" xlink:title="label: ContingentConsiderationByTypeAxis to us-gaap_ContingentConsiderationByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain" xlink:title="ContingentConsiderationTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContingentConsiderationTypeDomain" xml:lang="en-US" id="us-gaap_ContingentConsiderationTypeDomain">Contingent Consideration Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationTypeDomain" xlink:to="us-gaap_ContingentConsiderationTypeDomain" xlink:title="label: ContingentConsiderationTypeDomain to us-gaap_ContingentConsiderationTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConvertibleDebtMember" xml:lang="en-US" id="us-gaap_ConvertibleDebtMember">Convertible Debt [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember" xlink:title="label: ConvertibleDebtMember to us-gaap_ConvertibleDebtMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertibleDebtMember1" xml:lang="en-US" id="us-gaap_ConvertibleDebtMember1">Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember1" xlink:title="label: ConvertibleDebtMember to us-gaap_ConvertibleDebtMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="ConvertibleLongTermNotesPayable" xlink:title="ConvertibleLongTermNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertibleLongTermNotesPayable" xml:lang="en-US" id="us-gaap_ConvertibleLongTermNotesPayable">Convertible notes, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable" xlink:title="label: ConvertibleLongTermNotesPayable to us-gaap_ConvertibleLongTermNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleLongTermNotesPayable1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ConvertibleLongTermNotesPayable1" xml:lang="en-US" id="us-gaap_ConvertibleLongTermNotesPayable1">Convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable1" xlink:title="label: ConvertibleLongTermNotesPayable to us-gaap_ConvertibleLongTermNotesPayable1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleLongTermNotesPayable2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConvertibleLongTermNotesPayable2" xml:lang="en-US" id="us-gaap_ConvertibleLongTermNotesPayable2">Convertible notes, net, at December 31, 2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable2" xlink:title="label: ConvertibleLongTermNotesPayable to us-gaap_ConvertibleLongTermNotesPayable2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xml:lang="en-US" id="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">Each preferred stock converted into common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="label: ConvertiblePreferredStockSharesIssuedUponConversion to us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertiblePreferredStockMember" xml:lang="en-US" id="us-gaap_ConvertiblePreferredStockMember">Preferred Stock Converted into Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember" xlink:title="label: ConvertiblePreferredStockMember to us-gaap_ConvertiblePreferredStockMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="CostOfRevenue" xlink:title="CostOfRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostOfRevenue" xml:lang="en-US" id="us-gaap_CostOfRevenue">Cost of revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostOfRevenue" xlink:to="us-gaap_CostOfRevenue" xlink:title="label: CostOfRevenue to us-gaap_CostOfRevenue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1">Current Federal Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="CurrentForeignTaxExpenseBenefit" xlink:title="CurrentForeignTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentForeignTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_CurrentForeignTaxExpenseBenefit">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:title="label: CurrentForeignTaxExpenseBenefit to us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentForeignTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentForeignTaxExpenseBenefit_lbl1">Current Foreign Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl1" xlink:title="label: CurrentForeignTaxExpenseBenefit to us-gaap_CurrentForeignTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit">Current income tax provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1">Current Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_CurrentStateAndLocalTaxExpenseBenefit">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:title="label: CurrentStateAndLocalTaxExpenseBenefit to us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureTextBlock" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock">Promissory Note and Convertible Note Financings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount">Aggregate principal amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl1">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage">Interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentMaturityDate" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate">Expiration date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentMaturityDate1" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate1">Debt maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate1" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentNameDomain" xml:lang="en-US" id="us-gaap_DebtInstrumentNameDomain">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:title="label: DebtInstrumentNameDomain to us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAxis" xml:lang="en-US" id="us-gaap_DebtInstrumentAxis">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis" xlink:title="label: DebtInstrumentAxis to us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentLineItems" xml:lang="en-US" id="us-gaap_DebtInstrumentLineItems">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems" xlink:title="label: DebtInstrumentLineItems to us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentTable" xml:lang="en-US" id="us-gaap_DebtInstrumentTable">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable" xlink:title="label: DebtInstrumentTable to us-gaap_DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="PaymentsOfDebtIssuanceCosts" xlink:title="PaymentsOfDebtIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDebtIssuanceCosts" xml:lang="en-US" id="us-gaap_PaymentsOfDebtIssuanceCosts">Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:title="label: PaymentsOfDebtIssuanceCosts to us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDebtIssuanceCosts_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDebtIssuanceCosts_lbl1">Payments of Debt Issuance Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl1" xlink:title="label: PaymentsOfDebtIssuanceCosts to us-gaap_PaymentsOfDebtIssuanceCosts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="DeferredForeignIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_DeferredForeignIncomeTaxExpenseBenefit">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:title="label: DeferredForeignIncomeTaxExpenseBenefit to us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredForeignIncomeTaxExpenseBenefit to us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit">Deferred Income tax provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1">Deferred Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredIncomeTaxLiabilities" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities">Total deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl1">Deferred Tax Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredTaxAssetsGross" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross">Total gross deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl1">Deferred Tax Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="label: DeferredTaxAssetsInProcessResearchAndDevelopment to us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1" xlink:title="label: DeferredTaxAssetsInProcessResearchAndDevelopment to us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="DeferredTaxAssetsNet" xlink:title="DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredTaxAssetsNet" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsNet">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet" xlink:title="label: DeferredTaxAssetsNet to us-gaap_DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsNet_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsNet_lbl1">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl1" xlink:title="label: DeferredTaxAssetsNet to us-gaap_DeferredTaxAssetsNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">Foreign net operating losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsForeign to us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">R&amp;D credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="label: DeferredTaxAssetsTaxCreditCarryforwardsResearch to us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences">Compensation accrual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">Stock compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseOther to us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseOther to us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsValuationAllowance">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="label: DeferredTaxAssetsValuationAllowance to us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xlink:title="label: DeferredTaxAssetsValuationAllowance to us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">Intangibles - goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="label: DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill to us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1">Deferred Tax Liabilities, Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1" xlink:title="label: DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill to us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredTaxLiabilities" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilities">Net deferred taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities" xlink:title="label: DeferredTaxLiabilities to us-gaap_DeferredTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilities_lbl1">Deferred Tax Liabilities, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl1" xlink:title="label: DeferredTaxLiabilities to us-gaap_DeferredTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="DeferredRevenueCurrent" xlink:title="DeferredRevenueCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredRevenueCurrent" xml:lang="en-US" id="us-gaap_DeferredRevenueCurrent">Deferred revenue, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" xlink:title="label: DeferredRevenueCurrent to us-gaap_DeferredRevenueCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="DeferredRevenueNoncurrent" xlink:title="DeferredRevenueNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredRevenueNoncurrent" xml:lang="en-US" id="us-gaap_DeferredRevenueNoncurrent">Deferred revenue, non-current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent" xlink:title="label: DeferredRevenueNoncurrent to us-gaap_DeferredRevenueNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredRevenueNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_DeferredRevenueNoncurrent_lbl1">Deferred Revenue, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl1" xlink:title="label: DeferredRevenueNoncurrent to us-gaap_DeferredRevenueNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="DepositsAssetsNoncurrent" xlink:title="DepositsAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepositsAssetsNoncurrent" xml:lang="en-US" id="us-gaap_DepositsAssetsNoncurrent">Security deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:title="label: DepositsAssetsNoncurrent to us-gaap_DepositsAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepositsAssetsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_DepositsAssetsNoncurrent_lbl1">Deposits Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl1" xlink:title="label: DepositsAssetsNoncurrent to us-gaap_DepositsAssetsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativeLiabilitiesNoncurrent" xml:lang="en-US" id="us-gaap_DerivativeLiabilitiesNoncurrent">Warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:title="label: DerivativeLiabilitiesNoncurrent to us-gaap_DerivativeLiabilitiesNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:label="DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:title="DerivativesMethodsOfAccountingNonhedgingDerivatives" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives" xml:lang="en-US" id="us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives">Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:to="us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:title="label: DerivativesMethodsOfAccountingNonhedgingDerivatives to us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDiluted" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted">Net loss per common share - diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="DividendsPayableAmountPerShare" xlink:title="DividendsPayableAmountPerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsPayableAmountPerShare" xml:lang="en-US" id="us-gaap_DividendsPayableAmountPerShare">Cumulative annual dividend payable per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPayableAmountPerShare" xlink:to="us-gaap_DividendsPayableAmountPerShare" xlink:title="label: DividendsPayableAmountPerShare to us-gaap_DividendsPayableAmountPerShare" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">Domestic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateContinuingOperations">Benefit (provision) for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:title="label: EffectiveIncomeTaxRateContinuingOperations to us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xlink:title="label: EffectiveIncomeTaxRateContinuingOperations to us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="label: EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance to us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance to us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">Tax at federal income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">Foreign tax differential</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="label: EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential to us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">Non-deductible expenses/excludable items</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="label: EffectiveIncomeTaxRateReconciliationNondeductibleExpense to us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">State income tax, net of federal tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="label: EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes to us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">Credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="label: EffectiveIncomeTaxRateReconciliationTaxCredits to us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl1">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationTaxCredits to us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense1" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense1">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense1" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl2">Share-Based Payment Arrangement, Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensation" xml:lang="en-US" id="us-gaap_ShareBasedCompensation">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl1">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="EquipmentMember" xlink:title="EquipmentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquipmentMember" xml:lang="en-US" id="us-gaap_EquipmentMember">Laboratory and Manufacturing Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquipmentMember" xlink:to="us-gaap_EquipmentMember" xlink:title="label: EquipmentMember to us-gaap_EquipmentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquipmentMember_lbl1" xml:lang="en-US" id="us-gaap_EquipmentMember_lbl1">Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl1" xlink:title="label: EquipmentMember to us-gaap_EquipmentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EquityMethodInvestments" xml:lang="en-US" id="us-gaap_EquityMethodInvestments">Investment in non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestments_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestments_lbl1">Equity Method Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl1" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DomesticCountryMember" xml:lang="en-US" id="us-gaap_DomesticCountryMember">Federal [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember" xlink:title="label: DomesticCountryMember to us-gaap_DomesticCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DomesticCountryMember_lbl1" xml:lang="en-US" id="us-gaap_DomesticCountryMember_lbl1">Domestic Tax Authority [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl1" xlink:title="label: DomesticCountryMember to us-gaap_DomesticCountryMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ForeignCountryMember" xml:lang="en-US" id="us-gaap_ForeignCountryMember">Foreign [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember" xlink:title="label: ForeignCountryMember to us-gaap_ForeignCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ForeignCountryMember_lbl1" xml:lang="en-US" id="us-gaap_ForeignCountryMember_lbl1">Foreign Tax Authority [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl1" xlink:title="label: ForeignCountryMember to us-gaap_ForeignCountryMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesMember" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:title="label: GeneralAndAdministrativeExpense to us-gaap_GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl1">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl1" xlink:title="label: GeneralAndAdministrativeExpense to us-gaap_GeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpenseMember" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember">General and Administrative [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:title="label: GeneralAndAdministrativeExpenseMember to us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="label: GoodwillAndIntangibleAssetsGoodwillPolicy to us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsGoodwillPolicy to us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_GrossProfit" xml:lang="en-US" id="us-gaap_GrossProfit">Gross loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit" xlink:title="label: GrossProfit to us-gaap_GrossProfit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrossProfit_lbl1" xml:lang="en-US" id="us-gaap_GrossProfit_lbl1">Gross Profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl1" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillImpairmentLoss" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss">Goodwill impairment loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl1" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl1">Goodwill, Impairment Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl1" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="InProcessResearchAndDevelopmentPolicy" xlink:title="InProcessResearchAndDevelopmentPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InProcessResearchAndDevelopmentPolicy" xml:lang="en-US" id="us-gaap_InProcessResearchAndDevelopmentPolicy">In-Process Research &amp; Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InProcessResearchAndDevelopmentPolicy" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:title="label: InProcessResearchAndDevelopmentPolicy to us-gaap_InProcessResearchAndDevelopmentPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1" xml:lang="en-US" id="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1">In Process Research and Development, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InProcessResearchAndDevelopmentPolicy" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1" xlink:title="label: InProcessResearchAndDevelopmentPolicy to us-gaap_InProcessResearchAndDevelopmentPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract">CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl1">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">Accrued interest and penalties related to uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl1">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">Reconciliation of Computed Expected Income Taxes to Effective Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxesPaidNet" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl1">Income Taxes Paid, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Goodwill" xml:lang="en-US" id="us-gaap_Goodwill">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill" xlink:title="label: Goodwill to us-gaap_Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Goodwill_lbl1" xml:lang="en-US" id="us-gaap_Goodwill_lbl1">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl1" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xml:lang="en-US" id="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xml:lang="en-US" id="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_InterestExpense" xml:lang="en-US" id="us-gaap_InterestExpense">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpense" xlink:to="us-gaap_InterestExpense" xlink:title="label: InterestExpense to us-gaap_InterestExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpense_lbl1" xml:lang="en-US" id="us-gaap_InterestExpense_lbl1">Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpense" xlink:to="us-gaap_InterestExpense_lbl1" xlink:title="label: InterestExpense to us-gaap_InterestExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="InterestExpenseDebt" xlink:title="InterestExpenseDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestExpenseDebt" xml:lang="en-US" id="us-gaap_InterestExpenseDebt">Accrued interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt" xlink:title="label: InterestExpenseDebt to us-gaap_InterestExpenseDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_InterestExpenseDebt1" xml:lang="en-US" id="us-gaap_InterestExpenseDebt1">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt1" xlink:title="label: InterestExpenseDebt to us-gaap_InterestExpenseDebt1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpenseDebt_lbl2" xml:lang="en-US" id="us-gaap_InterestExpenseDebt_lbl2">Interest Expense, Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl2" xlink:title="label: InterestExpenseDebt to us-gaap_InterestExpenseDebt_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="InvestmentIncomeNet" xlink:title="InvestmentIncomeNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InvestmentIncomeNet" xml:lang="en-US" id="us-gaap_InvestmentIncomeNet">Interest income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet" xlink:title="label: InvestmentIncomeNet to us-gaap_InvestmentIncomeNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentIncomeNet_lbl1" xml:lang="en-US" id="us-gaap_InvestmentIncomeNet_lbl1">Investment Income, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl1" xlink:title="label: InvestmentIncomeNet to us-gaap_InvestmentIncomeNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsGross" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross">Cost improvement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl1">Leasehold Improvements, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsMember" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl1">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities" xml:lang="en-US" id="us-gaap_Liabilities">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities" xlink:title="label: Liabilities to us-gaap_Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity">Total liabilities and stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCredit" xml:lang="en-US" id="us-gaap_LineOfCredit">Letter of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCredit" xlink:to="us-gaap_LineOfCredit" xlink:title="label: LineOfCredit to us-gaap_LineOfCredit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1">Long-Term Debt, Maturity, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">2028</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1">Long-Term Debt, Maturity, Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">2027</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1">Long-Term Debt, Maturity, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1">Long-Term Debt, Maturity, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1">Long-Term Debt, Maturity, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebt" xml:lang="en-US" id="us-gaap_LongTermDebt">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebt_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl1">Long-Term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyEstimateOfPossibleLoss" xml:lang="en-US" id="us-gaap_LossContingencyEstimateOfPossibleLoss">Estimated contingent loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyEstimateOfPossibleLoss" xlink:to="us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:title="label: LossContingencyEstimateOfPossibleLoss to us-gaap_LossContingencyEstimateOfPossibleLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:label="MaturitiesOfLongTermDebtAbstract" xlink:title="MaturitiesOfLongTermDebtAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MaturitiesOfLongTermDebtAbstract" xml:lang="en-US" id="us-gaap_MaturitiesOfLongTermDebtAbstract">Future Minimum Principal Payments under Convertible Notes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:title="label: MaturitiesOfLongTermDebtAbstract to us-gaap_MaturitiesOfLongTermDebtAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MaturitiesOfLongTermDebtAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MaturitiesOfLongTermDebtAbstract_lbl1" xml:lang="en-US" id="us-gaap_MaturitiesOfLongTermDebtAbstract_lbl1">Maturities of Long-Term Debt [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="us-gaap_MaturitiesOfLongTermDebtAbstract_lbl1" xlink:title="label: MaturitiesOfLongTermDebtAbstract to us-gaap_MaturitiesOfLongTermDebtAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestOwnershipPercentageByParent" xml:lang="en-US" id="us-gaap_MinorityInterestOwnershipPercentageByParent">Percentage of non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:title="label: MinorityInterestOwnershipPercentageByParent to us-gaap_MinorityInterestOwnershipPercentageByParent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis">Related Party, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="label: RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis1" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis1">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis1" xlink:title="label: RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">Cash flows from investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities1">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">Cash flows from operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLoss" xml:lang="en-US" id="us-gaap_NetIncomeLoss">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss1" xml:lang="en-US" id="us-gaap_NetIncomeLoss1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl2">Net Income (Loss) Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">Net loss attributable to common stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic1" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic1">Net loss attributable to common stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic1" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl2" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl2">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl2" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NonoperatingIncomeExpense" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense">Total other (expense) income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl1">Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwards" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwards">Operating loss carry forward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards" xlink:title="label: OperatingLossCarryforwards to us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Revenues" xml:lang="en-US" id="us-gaap_Revenues">Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Revenues" xlink:to="us-gaap_Revenues" xlink:title="label: Revenues to us-gaap_Revenues" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">Organization and Description of Business Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense">Other expense, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:title="label: OtherNonoperatingIncomeExpense to us-gaap_OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl1">Other Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xlink:title="label: OtherNonoperatingIncomeExpense to us-gaap_OtherNonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpenseAbstract">Other expense, net:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:title="label: OtherNonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xlink:title="label: OtherNonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">Dividends paid to Series A convertible preferred stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="label: PaymentsOfDividendsPreferredStockAndPreferenceStock to us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1">Payments of Ordinary Dividends, Preferred Stock and Preference Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xlink:title="label: PaymentsOfDividendsPreferredStockAndPreferenceStock to us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized">Preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued">Preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding">Preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PreferredStockDividendsAndOtherAdjustments" xml:lang="en-US" id="us-gaap_PreferredStockDividendsAndOtherAdjustments">Series A convertible preferred stock dividend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:title="label: PreferredStockDividendsAndOtherAdjustments to us-gaap_PreferredStockDividendsAndOtherAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1">Preferred Stock Dividends and Other Adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xlink:title="label: PreferredStockDividendsAndOtherAdjustments to us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromConvertibleDebt" xml:lang="en-US" id="us-gaap_ProceedsFromConvertibleDebt">Proceeds received from the convertible notes financings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt" xlink:title="label: ProceedsFromConvertibleDebt to us-gaap_ProceedsFromConvertibleDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromConvertibleDebt1" xml:lang="en-US" id="us-gaap_ProceedsFromConvertibleDebt1">Proceeds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt1" xlink:title="label: ProceedsFromConvertibleDebt to us-gaap_ProceedsFromConvertibleDebt1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromConvertibleDebt2" xml:lang="en-US" id="us-gaap_ProceedsFromConvertibleDebt2">Gross convertible notes at issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt2" xlink:title="label: ProceedsFromConvertibleDebt to us-gaap_ProceedsFromConvertibleDebt2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock">Proceeds from issuance of common stock and warrants in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="ProceedsFromIssuanceOrSaleOfEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOrSaleOfEquity">Gross proceeds from sale of equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="label: ProceedsFromIssuanceOrSaleOfEquity to us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfWarrants">Proceeds from issuance of warrants to purchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:title="label: ProceedsFromIssuanceOfWarrants to us-gaap_ProceedsFromIssuanceOfWarrants" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1">Proceeds from Issuance of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xlink:title="label: ProceedsFromIssuanceOfWarrants to us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="ProceedsFromNotesPayable" xlink:title="ProceedsFromNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromNotesPayable" xml:lang="en-US" id="us-gaap_ProceedsFromNotesPayable">Proceeds received under promissory note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable" xlink:title="label: ProceedsFromNotesPayable to us-gaap_ProceedsFromNotesPayable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">Proceeds from sales of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="label: ProceedsFromSaleOfPropertyPlantAndEquipment to us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment1" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment1">Proceeds from the sale of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment1" xlink:title="label: ProceedsFromSaleOfPropertyPlantAndEquipment to us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross">Property and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet1">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet1" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl2">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentAbstract">Property and Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="label: PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="label: PropertyPlantAndEquipmentPolicyTextBlock to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xlink:title="label: PropertyPlantAndEquipmentPolicyTextBlock to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">Purchase of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:title="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xml:lang="en-US" id="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:title="label: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RelatedPartyDomain" xml:lang="en-US" id="us-gaap_RelatedPartyDomain">Related Party, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="label: RelatedPartyDomain to us-gaap_RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyDomain1" xml:lang="en-US" id="us-gaap_RelatedPartyDomain1">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain1" xlink:title="label: RelatedPartyDomain to us-gaap_RelatedPartyDomain1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="RelatedPartyTransactionLineItems" xlink:title="RelatedPartyTransactionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionLineItems">Related Party Transaction [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems" xlink:title="label: RelatedPartyTransactionLineItems to us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsDisclosureTextBlock">Related Party Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="label: RelatedPartyTransactionsDisclosureTextBlock to us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US" id="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="label: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfNotesPayable" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable">Principal payment made on promissory note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl1">Repayments of Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpensePolicy">Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="label: ResearchAndDevelopmentExpensePolicy to us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xlink:title="label: ResearchAndDevelopmentExpensePolicy to us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="label: ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost to us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost1">Research and development expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost1" xlink:title="label: ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost to us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2" xlink:title="label: ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost to us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="RevenueRecognitionPolicyTextBlock" xlink:title="RevenueRecognitionPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US" id="us-gaap_RevenueRecognitionPolicyTextBlock">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:title="label: RevenueRecognitionPolicyTextBlock to us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xml:lang="en-US" id="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">Common stock shares issued and sold (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="label: SaleOfStockNumberOfSharesIssuedInTransaction to us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction1" xml:lang="en-US" id="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction1">Common stock shares issued and sold (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction1" xlink:title="label: SaleOfStockNumberOfSharesIssuedInTransaction to us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">Stock-Based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTextBlock">Schedule of Property, Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="label: PropertyPlantAndEquipmentTextBlock to us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_SeriesAPreferredStockMember" xml:lang="en-US" id="us-gaap_SeriesAPreferredStockMember">Series A Convertible Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember" xlink:title="label: SeriesAPreferredStockMember to us-gaap_SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SeriesAPreferredStockMember1" xml:lang="en-US" id="us-gaap_SeriesAPreferredStockMember1">Series A Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember1" xlink:title="label: SeriesAPreferredStockMember to us-gaap_SeriesAPreferredStockMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">Cancelled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">Restricted stock units, granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">Restricted stock units, outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber1">Outstanding, Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber2">Outstanding, Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">Outstanding, Beginning balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue1">Outstanding, Ending balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">RSUs vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1">Released (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">Released (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">Stock-based compensation shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">Number of common stock shares to be issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">Cancelled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">Outstanding, beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1">Outstanding, ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">Outstanding, beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1">Outstanding, ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber2">Stock option outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">Outstanding, ending balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">Dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">Weighted average volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">Weighted average risk-free rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain">Award Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems1">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable1">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable1" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeDomain" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeDomain">Short-Term Debt, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain" xlink:title="label: ShortTermDebtTypeDomain to us-gaap_ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeAxis" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeAxis">Short-Term Debt, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis" xlink:title="label: ShortTermDebtTypeAxis to us-gaap_ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StateAndLocalJurisdictionMember" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember">State [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl1" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl1">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US" id="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="label: ShareBasedCompensationOptionAndIncentivePlansPolicy to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xlink:title="label: ShareBasedCompensationOptionAndIncentivePlansPolicy to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityAbstract" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract">Stockholder's equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl1">Equity, Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl1" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteAbstract">Equity and Warrants [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract" xlink:title="label: StockholdersEquityNoteAbstract to us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding">Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:title="label: ClassOfWarrantOrRightOutstanding to us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding1">Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding1" xlink:title="label: ClassOfWarrantOrRightOutstanding to us-gaap_ClassOfWarrantOrRightOutstanding1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding_lbl2" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding_lbl2">Class of Warrant or Right, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl2" xlink:title="label: ClassOfWarrantOrRightOutstanding to us-gaap_ClassOfWarrantOrRightOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock">Equity and Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1">Equity [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">Warrants to purchase common shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights1">Warrants to purchase common shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights2" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights2">Warrants to purchase common shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights2" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeAxis" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventLineItems" xml:lang="en-US" id="us-gaap_SubsequentEventLineItems">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems" xlink:title="label: SubsequentEventLineItems to us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTable" xml:lang="en-US" id="us-gaap_SubsequentEventTable">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable" xlink:title="label: SubsequentEventTable to us-gaap_SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeDomain" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiarySaleOfStockLineItems" xml:lang="en-US" id="us-gaap_SubsidiarySaleOfStockLineItems">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" xlink:title="label: SubsidiarySaleOfStockLineItems to us-gaap_SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">Goodwill and In-Process Research &amp; Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract">Supplemental disclosures of cash flow information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US" id="us-gaap_TaxCreditCarryforwardAmount">Federal and state income tax credit carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount" xlink:title="label: TaxCreditCarryforwardAmount to us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent" xml:lang="en-US" id="us-gaap_AssetsCurrent">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsCurrentAbstract" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="UnrecognizedTaxBenefits" xlink:title="UnrecognizedTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefits">Beginning balance of uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits" xlink:title="label: UnrecognizedTaxBenefits to us-gaap_UnrecognizedTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_UnrecognizedTaxBenefits1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefits1">Ending balance of uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits1" xlink:title="label: UnrecognizedTaxBenefits to us-gaap_UnrecognizedTaxBenefits1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefits_lbl2" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefits_lbl2">Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl2" xlink:title="label: UnrecognizedTaxBenefits to us-gaap_UnrecognizedTaxBenefits_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:title="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">Additions based on current year's tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:title="label: UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions to us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:title="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">Net changes based on prior year's tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:title="label: UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions to us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantMember" xml:lang="en-US" id="us-gaap_WarrantMember">Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember" xlink:title="label: WarrantMember to us-gaap_WarrantMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantMember1" xml:lang="en-US" id="us-gaap_WarrantMember1">Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember1" xlink:title="label: WarrantMember to us-gaap_WarrantMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">Weighted average shares outstanding - diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">Weighted average shares outstanding - basic (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockMember" xml:lang="en-US" id="us-gaap_CommonStockMember">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="label: PropertyPlantAndEquipmentDisclosureTextBlock to us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain">Long-Lived Tangible Asset [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Cash" xml:lang="en-US" id="us-gaap_Cash">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Cash" xlink:to="us-gaap_Cash" xlink:title="label: Cash to us-gaap_Cash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Cash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Cash_lbl1" xml:lang="en-US" id="us-gaap_Cash_lbl1">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Cash" xlink:to="us-gaap_Cash_lbl1" xlink:title="label: Cash to us-gaap_Cash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockMember" xml:lang="en-US" id="us-gaap_PreferredStockMember">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockMember" xlink:to="us-gaap_PreferredStockMember" xlink:title="label: PreferredStockMember to us-gaap_PreferredStockMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets" xml:lang="en-US" id="us-gaap_Assets">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets" xlink:title="label: Assets to us-gaap_Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US" id="us-gaap_OtherLiabilitiesCurrent">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:title="label: OtherLiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesCurrent_lbl1">Other Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl1" xlink:title="label: OtherLiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent">Other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityDomain" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityDomain">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:title="label: IncomeTaxAuthorityDomain to us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="ConvertibleCommonStockMember" xlink:title="ConvertibleCommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertibleCommonStockMember" xml:lang="en-US" id="us-gaap_ConvertibleCommonStockMember">Convertible Notes Converted into Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleCommonStockMember" xlink:to="us-gaap_ConvertibleCommonStockMember" xlink:title="label: ConvertibleCommonStockMember to us-gaap_ConvertibleCommonStockMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">Loss on shares sold to Lincoln Park Capital, LLC</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="label: EquityMethodInvestmentRealizedGainLossOnDisposal to us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl1">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl1" xlink:title="label: EquityMethodInvestmentRealizedGainLossOnDisposal to us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="FairValueByBalanceSheetGroupingTable" xlink:title="FairValueByBalanceSheetGroupingTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByBalanceSheetGroupingTable" xml:lang="en-US" id="us-gaap_FairValueByBalanceSheetGroupingTable">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:title="label: FairValueByBalanceSheetGroupingTable to us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="FairValueDisclosureItemAmountsDomain" xlink:title="FairValueDisclosureItemAmountsDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosureItemAmountsDomain" xml:lang="en-US" id="us-gaap_FairValueDisclosureItemAmountsDomain">Fair Value Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:title="label: FairValueDisclosureItemAmountsDomain to us-gaap_FairValueDisclosureItemAmountsDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="CarryingReportedAmountFairValueDisclosureMember" xlink:title="CarryingReportedAmountFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xml:lang="en-US" id="us-gaap_CarryingReportedAmountFairValueDisclosureMember">Carrying Value [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingReportedAmountFairValueDisclosureMember" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:title="label: CarryingReportedAmountFairValueDisclosureMember to us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="PortionAtFairValueFairValueDisclosureMember" xlink:title="PortionAtFairValueFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PortionAtFairValueFairValueDisclosureMember" xml:lang="en-US" id="us-gaap_PortionAtFairValueFairValueDisclosureMember">Portion at Fair Value Measurement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:title="label: PortionAtFairValueFairValueDisclosureMember to us-gaap_PortionAtFairValueFairValueDisclosureMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="EstimateOfFairValueFairValueDisclosureMember" xlink:title="EstimateOfFairValueFairValueDisclosureMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xml:lang="en-US" id="us-gaap_EstimateOfFairValueFairValueDisclosureMember">Fair Value [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimateOfFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:title="label: EstimateOfFairValueFairValueDisclosureMember to us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:title="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xml:lang="en-US" id="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:title="label: FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems to us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:label="PropertyPlantAndEquipmentGrossAbstract" xlink:title="PropertyPlantAndEquipmentGrossAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGrossAbstract">Property, Plant and Equipment, Gross [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:title="label: PropertyPlantAndEquipmentGrossAbstract to us-gaap_PropertyPlantAndEquipmentGrossAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable" xml:lang="en-US" id="us-gaap_StatementTable">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable" xlink:title="label: StatementTable to us-gaap_StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesNameDomain">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="label: AntidilutiveSecuritiesNameDomain to us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract" xml:lang="en-US" id="us-gaap_AssetsAbstract">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems" xml:lang="en-US" id="us-gaap_StatementLineItems">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">Changes in Fair Value of Warrant Liabilities [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">Warrant activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="label: ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock to us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1" xlink:title="label: ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock to us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightTable">Class of Warrant or Right [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable" xlink:title="label: ClassOfWarrantOrRightTable to us-gaap_ClassOfWarrantOrRightTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightAxis">Class of Warrant or Right [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" xlink:title="label: ClassOfWarrantOrRightAxis to us-gaap_ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightDomain">Class of Warrant or Right [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" xlink:title="label: ClassOfWarrantOrRightDomain to us-gaap_ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOfOngoingProject" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ImpairmentOfOngoingProject" xml:lang="en-US" id="us-gaap_ImpairmentOfOngoingProject">Non-cash impairment charges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfOngoingProject" xlink:to="us-gaap_ImpairmentOfOngoingProject" xlink:title="label: ImpairmentOfOngoingProject to us-gaap_ImpairmentOfOngoingProject" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOfOngoingProject1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOfOngoingProject1" xml:lang="en-US" id="us-gaap_ImpairmentOfOngoingProject1">Impairment of in-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfOngoingProject" xlink:to="us-gaap_ImpairmentOfOngoingProject1" xlink:title="label: ImpairmentOfOngoingProject to us-gaap_ImpairmentOfOngoingProject1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwardsTable" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsTable">Operating Loss Carryforwards [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable" xlink:title="label: OperatingLossCarryforwardsTable to us-gaap_OperatingLossCarryforwardsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwardsLineItems" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsLineItems">Operating Loss Carryforwards [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems" xlink:title="label: OperatingLossCarryforwardsLineItems to us-gaap_OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel3Member" xml:lang="en-US" id="us-gaap_FairValueInputsLevel3Member">Level 3 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member" xlink:title="label: FairValueInputsLevel3Member to us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:label="FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:title="FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xml:lang="en-US" id="us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock">Fair Value Assumptions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:title="label: FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock to us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl1">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="FairValueByBalanceSheetGroupingTextBlock" xlink:title="FairValueByBalanceSheetGroupingTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xml:lang="en-US" id="us-gaap_FairValueByBalanceSheetGroupingTextBlock">Fair Value and Carrying Values of Convertible Notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByBalanceSheetGroupingTextBlock" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:title="label: FairValueByBalanceSheetGroupingTextBlock to us-gaap_FairValueByBalanceSheetGroupingTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="PreferredStockLiquidationPreference" xlink:title="PreferredStockLiquidationPreference" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockLiquidationPreference" xml:lang="en-US" id="us-gaap_PreferredStockLiquidationPreference">Preferred stock, liquidation preference per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreference" xlink:to="us-gaap_PreferredStockLiquidationPreference" xlink:title="label: PreferredStockLiquidationPreference to us-gaap_PreferredStockLiquidationPreference" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xml:lang="en-US" id="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="label: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightLineItems">Class of Warrant or Right [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" xlink:title="label: ClassOfWarrantOrRightLineItems to us-gaap_ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain" xml:lang="en-US" id="us-gaap_ClassOfStockDomain">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xml:lang="en-US" id="us-gaap_WarrantsAndRightsNoteDisclosureAbstract">Warrant Activity Abstract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="label: WarrantsAndRightsNoteDisclosureAbstract to us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="DeferredTaxAssetsNetAbstract" xlink:title="DeferredTaxAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsNetAbstract" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsNetAbstract">Deferred Tax Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" xlink:title="label: DeferredTaxAssetsNetAbstract to us-gaap_DeferredTaxAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsNetAbstract_lbl1">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl1" xlink:title="label: DeferredTaxAssetsNetAbstract to us-gaap_DeferredTaxAssetsNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="PropertyPlantAndEquipmentNetByTypeAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract">Property and Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="label: PropertyPlantAndEquipmentNetByTypeAbstract to us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1">Property, Plant and Equipment, Net, by Type [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1" xlink:title="label: PropertyPlantAndEquipmentNetByTypeAbstract to us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">Issuance of note warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalWarrantIssued to us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInDeferredRevenue">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:title="label: IncreaseDecreaseInDeferredRevenue to us-gaap_IncreaseDecreaseInDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1">Increase (Decrease) in Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1" xlink:title="label: IncreaseDecreaseInDeferredRevenue to us-gaap_IncreaseDecreaseInDeferredRevenue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="DeferredRevenue" xlink:title="DeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredRevenue" xml:lang="en-US" id="us-gaap_DeferredRevenue">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRevenue" xlink:to="us-gaap_DeferredRevenue" xlink:title="label: DeferredRevenue to us-gaap_DeferredRevenue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsNoncurrent" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl1">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingExpensesAbstract" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl1">Operating Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl1" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingExpenses" xml:lang="en-US" id="us-gaap_OperatingExpenses">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpenses_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl1">Operating Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl1" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">Total potential shares of common stock excluded from computation (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract">Basic and Diluted Net Loss per Common Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">Securities Excluded from the Computation of Diluted Net Loss per Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US" id="us-gaap_EarningsPerSharePolicyTextBlock">Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="label: EarningsPerSharePolicyTextBlock to us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerSharePolicyTextBlock_lbl1">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xlink:title="label: EarningsPerSharePolicyTextBlock to us-gaap_EarningsPerSharePolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xml:lang="en-US" id="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">Anti-dilutive Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="label: EarningsPerShareDilutedOtherDisclosuresAbstract to us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">Other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US" id="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="label: ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis">Long-Lived Tangible Asset [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentLineItems">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="label: PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="DebtPolicyTextBlock" xlink:title="DebtPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtPolicyTextBlock" xml:lang="en-US" id="us-gaap_DebtPolicyTextBlock">Convertible Notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock" xlink:title="label: DebtPolicyTextBlock to us-gaap_DebtPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">Loss before Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquity" xml:lang="en-US" id="us-gaap_StockholdersEquity">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquity1" xml:lang="en-US" id="us-gaap_StockholdersEquity1">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity2" xml:lang="en-US" id="us-gaap_StockholdersEquity2">Total stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity2" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl3">Equity, Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl3" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">Fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="label: DeferredTaxLiabilitiesPropertyPlantAndEquipment to us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xlink:title="label: DeferredTaxLiabilitiesPropertyPlantAndEquipment to us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit">Benefit (provision) for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit1">Total tax (benefit) provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit1" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl2" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl2">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockValue" xml:lang="en-US" id="us-gaap_PreferredStockValue">Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at December 31, 2023 and 2022, $156 liquidation preference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl1">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl1" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xml:lang="en-US" id="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">Warrant Liabilities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="label: DerivativeFinancialInstrumentsLiabilitiesMember to us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember" xml:lang="en-US" id="us-gaap_RetainedEarningsMember">Accumulated Deficit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain" xml:lang="en-US" id="us-gaap_EquityComponentDomain">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xml:lang="en-US" id="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract">Weighted Average Remaining Contractual Life [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="label: ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeStockOptionMember" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember">Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest" xlink:label="PaidInKindInterest" xlink:title="PaidInKindInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_PaidInKindInterest" xml:lang="en-US" id="us-gaap_PaidInKindInterest">Paid-in-kind interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest" xlink:title="label: PaidInKindInterest to us-gaap_PaidInKindInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaidInKindInterest1" xml:lang="en-US" id="us-gaap_PaidInKindInterest1">Paid in-kind</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest1" xlink:title="label: PaidInKindInterest to us-gaap_PaidInKindInterest1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">Issuance of common stock from vested restricted stock units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">Issuance of common stock from vested restricted stock units (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">Shares were issued upon settlement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesAcquisitions">Asset acquisition of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">Number of shares converted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="label: StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities to us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities1">Number of convertible notes converted into shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities1" xlink:title="label: StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities to us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="CommitmentsAndContingenciesPolicyTextBlock" xlink:title="CommitmentsAndContingenciesPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesPolicyTextBlock">Commitment and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:title="label: CommitmentsAndContingenciesPolicyTextBlock to us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1" xlink:title="label: CommitmentsAndContingenciesPolicyTextBlock to us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="PaymentOfFinancingAndStockIssuanceCosts" xlink:title="PaymentOfFinancingAndStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xml:lang="en-US" id="us-gaap_PaymentOfFinancingAndStockIssuanceCosts">Fees paid related to the Convertible Notes Financings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfFinancingAndStockIssuanceCosts" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:title="label: PaymentOfFinancingAndStockIssuanceCosts to us-gaap_PaymentOfFinancingAndStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl1" xml:lang="en-US" id="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl1">Payment of Financing and Stock Issuance Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfFinancingAndStockIssuanceCosts" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl1" xlink:title="label: PaymentOfFinancingAndStockIssuanceCosts to us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">Number of Option Share [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">Outstanding Restricted Stock Units [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">Options Vested and Exercisable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">Options vested and exercisable, weighted average exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">Options vested and exercisable, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">Options vested and exercisable, outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">Weightage-Average Assumptions Used for Stock Options Granted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">Stock-based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="ConvertibleDebtFairValueDisclosures" xlink:title="ConvertibleDebtFairValueDisclosures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConvertibleDebtFairValueDisclosures" xml:lang="en-US" id="us-gaap_ConvertibleDebtFairValueDisclosures">Convertible Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:title="label: ConvertibleDebtFairValueDisclosures to us-gaap_ConvertibleDebtFairValueDisclosures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertibleDebtFairValueDisclosures1" xml:lang="en-US" id="us-gaap_ConvertibleDebtFairValueDisclosures1">Relative Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures1" xlink:title="label: ConvertibleDebtFairValueDisclosures to us-gaap_ConvertibleDebtFairValueDisclosures1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract">Description of Business [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl1">Business Combination, Description [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock">Basic and Diluted Net Loss per Common Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">Denominator [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl1">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockLineItems" xml:lang="en-US" id="us-gaap_ClassOfStockLineItems">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems" xlink:title="label: ClassOfStockLineItems to us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US" id="us-gaap_ScheduleOfStockByClassTable">Schedule of Stock by Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable" xlink:title="label: ScheduleOfStockByClassTable to us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract" xml:lang="en-US" id="us-gaap_LeasesAbstract">Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DividendsPreferredStockCash" xml:lang="en-US" id="us-gaap_DividendsPreferredStockCash">Cash dividends to Series A convertible preferred stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash" xlink:title="label: DividendsPreferredStockCash to us-gaap_DividendsPreferredStockCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DividendsPreferredStockCash1" xml:lang="en-US" id="us-gaap_DividendsPreferredStockCash1">Dividend paid in cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash1" xlink:title="label: DividendsPreferredStockCash to us-gaap_DividendsPreferredStockCash1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsPreferredStockCash_lbl2" xml:lang="en-US" id="us-gaap_DividendsPreferredStockCash_lbl2">Dividends, Preferred Stock, Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl2" xlink:title="label: DividendsPreferredStockCash to us-gaap_DividendsPreferredStockCash_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:label="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:title="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xml:lang="en-US" id="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract">Convertible Notes Payable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:title="label: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl1">Convertible Debt [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl1" xlink:title="label: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongtermDebtTypeAxis" xml:lang="en-US" id="us-gaap_LongtermDebtTypeAxis">Long-Term Debt, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis" xlink:title="label: LongtermDebtTypeAxis to us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableCurrent" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl1">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl1" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent1">Total accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent2">Interest in accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US" id="us-gaap_AccruedProfessionalFeesCurrent">Professional fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" xlink:title="label: AccruedProfessionalFeesCurrent to us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent">Accrued compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="InterestPayableCurrent" xlink:title="InterestPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPayableCurrent" xml:lang="en-US" id="us-gaap_InterestPayableCurrent">Convertible Notes interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent" xlink:title="label: InterestPayableCurrent to us-gaap_InterestPayableCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1">Other Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TaxesPayableCurrent" xml:lang="en-US" id="us-gaap_TaxesPayableCurrent">Income taxes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent" xlink:title="label: TaxesPayableCurrent to us-gaap_TaxesPayableCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongtermDebtTypeDomain" xml:lang="en-US" id="us-gaap_LongtermDebtTypeDomain">Long-Term Debt, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain" xlink:title="label: LongtermDebtTypeDomain to us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="NetIncomeLossAbstract" xlink:title="NetIncomeLossAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLossAbstract" xml:lang="en-US" id="us-gaap_NetIncomeLossAbstract">Numerator [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract" xlink:title="label: NetIncomeLossAbstract to us-gaap_NetIncomeLossAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAbstract_lbl1">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl1" xlink:title="label: NetIncomeLossAbstract to us-gaap_NetIncomeLossAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">Loss before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1">Prepaid Expense and Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosure">Liabilities, fair value disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" xlink:title="label: LiabilitiesFairValueDisclosure to us-gaap_LiabilitiesFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosure_lbl1">Liabilities, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xlink:title="label: LiabilitiesFairValueDisclosure to us-gaap_LiabilitiesFairValueDisclosure_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="InterestExpenseDebtExcludingAmortization" xlink:title="InterestExpenseDebtExcludingAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpenseDebtExcludingAmortization" xml:lang="en-US" id="us-gaap_InterestExpenseDebtExcludingAmortization">Accrued interest due under the promissory note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:title="label: InterestExpenseDebtExcludingAmortization to us-gaap_InterestExpenseDebtExcludingAmortization" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfArrangementAxis" xml:lang="en-US" id="us-gaap_TypeOfArrangementAxis">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis" xlink:title="label: TypeOfArrangementAxis to us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US" id="us-gaap_FairValueMeasurementsFairValueHierarchyDomain">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="label: FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockDividendsShares" xml:lang="en-US" id="us-gaap_PreferredStockDividendsShares">Cash dividends to Series A convertible preferred stockholders (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares" xlink:title="label: PreferredStockDividendsShares to us-gaap_PreferredStockDividendsShares" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">Payroll tax remitted on net share settlement of equity awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">Initial measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues1" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues1">Warrants fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues1" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain">Fair Value by Liability Class [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:title="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xml:lang="en-US" id="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">Basis of Accounting Presentation and Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:title="label: BasisOfPresentationAndSignificantAccountingPoliciesTextBlock to us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract">Accrued Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">Organization and Description of Business Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding" xml:lang="en-US" id="us-gaap_SharesOutstanding">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding1" xml:lang="en-US" id="us-gaap_SharesOutstanding1">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">Fair value, end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue1" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue1">Fair value, beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue1" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByLiabilityClassAxis" xml:lang="en-US" id="us-gaap_FairValueByLiabilityClassAxis">Liability Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis" xlink:title="label: FairValueByLiabilityClassAxis to us-gaap_FairValueByLiabilityClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US" id="us-gaap_FairValueByFairValueHierarchyLevelAxis">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="label: FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">Principal Payments under Convertible Notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">Deferred Tax Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">Income Tax Provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">Reconciliation of Computed Expected Income Taxes to Effective Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">Loss before Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="label: ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock to us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xlink:title="label: ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock to us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureAbstract">Commitments and Contingencies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">Goodwill and In-Process Research &amp; Development [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract">Fair Value of Financial Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventsTextBlock" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock">Subsequent Event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl1">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureAbstract" xml:lang="en-US" id="us-gaap_DebtDisclosureAbstract">Promissory Note and Convertible Note Financings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract" xlink:title="label: DebtDisclosureAbstract to us-gaap_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">Summarizes of Stock Option Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">Weighted-Average Assumptions Used for Stock Options Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">Stock-Based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UseOfEstimates" xml:lang="en-US" id="us-gaap_UseOfEstimates">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UseOfEstimates_lbl1" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl1">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl1" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock">Segment Reporting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="ScheduleOfDebtTableTextBlock" xlink:title="ScheduleOfDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDebtTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfDebtTableTextBlock">Based on Relative Fair Value Allocation of Proceeds and Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" xlink:title="label: ScheduleOfDebtTableTextBlock to us-gaap_ScheduleOfDebtTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RestrictedStockUnitsRSUMember" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember">RSUs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockUnitsRSUMember1" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember1">RSU [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember1" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">Fair Valuation of Assumptions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LiabilitiesFairValueDisclosureAbstract" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosureAbstract">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:title="label: LiabilitiesFairValueDisclosureAbstract to us-gaap_LiabilitiesFairValueDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueDisclosureAbstract1" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosureAbstract1">Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract1" xlink:title="label: LiabilitiesFairValueDisclosureAbstract to us-gaap_LiabilitiesFairValueDisclosureAbstract1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember">Research and Development [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:title="label: ResearchAndDevelopmentExpenseMember to us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingPoliciesAbstract" xml:lang="en-US" id="us-gaap_AccountingPoliciesAbstract">Basis of Accounting Presentation and Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract" xlink:title="label: AccountingPoliciesAbstract to us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingAbstract" xml:lang="en-US" id="us-gaap_SegmentReportingAbstract">Segment Reporting [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract" xlink:title="label: SegmentReportingAbstract to us-gaap_SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsAbstract">Related Party Transactions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract" xlink:title="label: RelatedPartyTransactionsAbstract to us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsAbstract" xml:lang="en-US" id="us-gaap_SubsequentEventsAbstract">Subsequent Event [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract" xlink:title="label: SubsequentEventsAbstract to us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">Private placement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherReceivablesNetCurrent" xml:lang="en-US" id="us-gaap_OtherReceivablesNetCurrent">Other receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent" xlink:title="label: OtherReceivablesNetCurrent to us-gaap_OtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherReceivablesNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherReceivablesNetCurrent_lbl1">Other Receivables, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl1" xlink:title="label: OtherReceivablesNetCurrent to us-gaap_OtherReceivablesNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="FairValueByMeasurementBasisAxis" xlink:title="FairValueByMeasurementBasisAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByMeasurementBasisAxis" xml:lang="en-US" id="us-gaap_FairValueByMeasurementBasisAxis">Measurement Basis [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" xlink:title="label: FairValueByMeasurementBasisAxis to us-gaap_FairValueByMeasurementBasisAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">Other non-current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="label: IncreaseDecreaseInOtherNoncurrentAssets to us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1" xlink:title="label: IncreaseDecreaseInOtherNoncurrentAssets to us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xml:lang="en-US" id="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="label: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US" id="us-gaap_ArrangementsAndNonarrangementTransactionsMember">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:title="label: ArrangementsAndNonarrangementTransactionsMember to us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xml:lang="en-US" id="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="label: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityAxis" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityAxis">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:title="label: IncomeTaxAuthorityAxis to us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross1">Stock options granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">Changes in Warrant Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="label: ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock to us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1" xlink:title="label: ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock to us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">Computation of Net Loss per Share Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="FeaturesOfConvertiblePreferredStockAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xml:lang="en-US" id="us-gaap_FeaturesOfConvertiblePreferredStockAbstract">Cumulative Convertible Preferred Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:title="label: FeaturesOfConvertiblePreferredStockAbstract to us-gaap_FeaturesOfConvertiblePreferredStockAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1" xml:lang="en-US" id="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1">Features of Convertible Preferred Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1" xlink:title="label: FeaturesOfConvertiblePreferredStockAbstract to us-gaap_FeaturesOfConvertiblePreferredStockAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">Summarizes of RSU Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="label: ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionAbstract" xlink:label="RevenueRecognitionAbstract" xlink:title="RevenueRecognitionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueRecognitionAbstract" xml:lang="en-US" id="us-gaap_RevenueRecognitionAbstract">Revenue Recognition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueRecognitionAbstract" xlink:to="us-gaap_RevenueRecognitionAbstract" xlink:title="label: RevenueRecognitionAbstract to us-gaap_RevenueRecognitionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock">Basis of Accounting Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">Liabilities Measured at Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">Employer matching contributions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="label: DefinedContributionPlanEmployerDiscretionaryContributionAmount to us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="DeferredTaxLiabilitiesNetAbstract" xlink:title="DeferredTaxLiabilitiesNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesNetAbstract" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesNetAbstract">Deferred Tax Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:title="label: DeferredTaxLiabilitiesNetAbstract to us-gaap_DeferredTaxLiabilitiesNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1" xlink:title="label: DeferredTaxLiabilitiesNetAbstract to us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">Weighted Average Fair Value Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">Cancelled (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">Unamortized stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">Weighted Average Exercise Price per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice1">Exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">Cancelled (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameAxis" xml:lang="en-US" id="us-gaap_PlanNameAxis">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameAxis" xlink:to="us-gaap_PlanNameAxis" xlink:title="label: PlanNameAxis to us-gaap_PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameDomain" xml:lang="en-US" id="us-gaap_PlanNameDomain">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="us-gaap_PlanNameDomain" xlink:title="label: PlanNameDomain to us-gaap_PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AwardTypeAxis" xml:lang="en-US" id="us-gaap_AwardTypeAxis">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyDamagesPaidValue" xml:lang="en-US" id="us-gaap_LossContingencyDamagesPaidValue">Liquidated damages payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesPaidValue" xlink:to="us-gaap_LossContingencyDamagesPaidValue" xlink:title="label: LossContingencyDamagesPaidValue to us-gaap_LossContingencyDamagesPaidValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventMember" xml:lang="en-US" id="us-gaap_SubsequentEventMember">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationAxis" xml:lang="en-US" id="us-gaap_IncomeStatementLocationAxis">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:title="label: IncomeStatementLocationAxis to us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationDomain" xml:lang="en-US" id="us-gaap_IncomeStatementLocationDomain">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:title="label: IncomeStatementLocationDomain to us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">Increase in stock-based compensation shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="PreferredStockLiquidationPreferenceValue" xlink:title="PreferredStockLiquidationPreferenceValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockLiquidationPreferenceValue" xml:lang="en-US" id="us-gaap_PreferredStockLiquidationPreferenceValue">Preferred stock, liquidation preference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:title="label: PreferredStockLiquidationPreferenceValue to us-gaap_PreferredStockLiquidationPreferenceValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">Recent Accounting Standards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US" id="us-gaap_ConcentrationRiskCreditRisk">Concentration of Credit Risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:title="label: ConcentrationRiskCreditRisk to us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskCreditRisk_lbl1" xml:lang="en-US" id="us-gaap_ConcentrationRiskCreditRisk_lbl1">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl1" xlink:title="label: ConcentrationRiskCreditRisk to us-gaap_ConcentrationRiskCreditRisk_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife">Estimated useful life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">Options vested and exercisable, weighted average remaining contractual life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">Weighted-average remaining contractual life, outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">Expected term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">Weighted average remaining requisite service period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfOperatingSegments" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments">Number of operating segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments" xlink:title="label: NumberOfOperatingSegments to us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AreaOfRealEstateProperty" xml:lang="en-US" id="us-gaap_AreaOfRealEstateProperty">Area of premises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty" xlink:title="label: AreaOfRealEstateProperty to us-gaap_AreaOfRealEstateProperty" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueAdjustment" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueAdjustment">Change in fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueAdjustment" xlink:to="us-gaap_LiabilitiesFairValueAdjustment" xlink:title="label: LiabilitiesFairValueAdjustment to us-gaap_LiabilitiesFairValueAdjustment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xml:lang="en-US" id="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">Uncertain Tax Positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="label: ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock to us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="DebtInstrumentConvertibleConversionPrice1" xlink:title="DebtInstrumentConvertibleConversionPrice1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US" id="us-gaap_DebtInstrumentConvertibleConversionPrice1">Initial conversion rate (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="label: DebtInstrumentConvertibleConversionPrice1 to us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:label="DebtInstrumentFairValueDisclosureAbstract" xlink:title="DebtInstrumentFairValueDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFairValueDisclosureAbstract" xml:lang="en-US" id="us-gaap_DebtInstrumentFairValueDisclosureAbstract">Debt Instrument, Fair Value Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFairValueDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:title="label: DebtInstrumentFairValueDisclosureAbstract to us-gaap_DebtInstrumentFairValueDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueNetAssetLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueNetAssetLiabilityAbstract" xml:lang="en-US" id="us-gaap_FairValueNetAssetLiabilityAbstract">Fair Value Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueNetAssetLiabilityAbstract" xlink:to="us-gaap_FairValueNetAssetLiabilityAbstract" xlink:title="label: FairValueNetAssetLiabilityAbstract to us-gaap_FairValueNetAssetLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="label: EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent to us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">Number of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="DebtInstrumentRedemptionPeriodAxis" xlink:title="DebtInstrumentRedemptionPeriodAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodAxis" xml:lang="en-US" id="us-gaap_DebtInstrumentRedemptionPeriodAxis">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:title="label: DebtInstrumentRedemptionPeriodAxis to us-gaap_DebtInstrumentRedemptionPeriodAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="DebtInstrumentRedemptionPeriodDomain" xlink:title="DebtInstrumentRedemptionPeriodDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodDomain" xml:lang="en-US" id="us-gaap_DebtInstrumentRedemptionPeriodDomain">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:title="label: DebtInstrumentRedemptionPeriodDomain to us-gaap_DebtInstrumentRedemptionPeriodDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:label="DebtInstrumentRedemptionPeriodOneMember" xlink:title="DebtInstrumentRedemptionPeriodOneMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodOneMember" xml:lang="en-US" id="us-gaap_DebtInstrumentRedemptionPeriodOneMember">Condition One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRedemptionPeriodOneMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:title="label: DebtInstrumentRedemptionPeriodOneMember to us-gaap_DebtInstrumentRedemptionPeriodOneMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodOneMember_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentRedemptionPeriodOneMember_lbl1">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRedemptionPeriodOneMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodOneMember_lbl1" xlink:title="label: DebtInstrumentRedemptionPeriodOneMember to us-gaap_DebtInstrumentRedemptionPeriodOneMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:label="DebtInstrumentRedemptionPeriodTwoMember" xlink:title="DebtInstrumentRedemptionPeriodTwoMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xml:lang="en-US" id="us-gaap_DebtInstrumentRedemptionPeriodTwoMember">Condition Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRedemptionPeriodTwoMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:title="label: DebtInstrumentRedemptionPeriodTwoMember to us-gaap_DebtInstrumentRedemptionPeriodTwoMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodTwoMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodTwoMember_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentRedemptionPeriodTwoMember_lbl1">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRedemptionPeriodTwoMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodTwoMember_lbl1" xlink:title="label: DebtInstrumentRedemptionPeriodTwoMember to us-gaap_DebtInstrumentRedemptionPeriodTwoMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:label="DebtInstrumentRedemptionPeriodThreeMember" xlink:title="DebtInstrumentRedemptionPeriodThreeMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xml:lang="en-US" id="us-gaap_DebtInstrumentRedemptionPeriodThreeMember">Condition Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRedemptionPeriodThreeMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:title="label: DebtInstrumentRedemptionPeriodThreeMember to us-gaap_DebtInstrumentRedemptionPeriodThreeMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodThreeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentRedemptionPeriodThreeMember_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentRedemptionPeriodThreeMember_lbl1">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRedemptionPeriodThreeMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodThreeMember_lbl1" xlink:title="label: DebtInstrumentRedemptionPeriodThreeMember to us-gaap_DebtInstrumentRedemptionPeriodThreeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="FairValueAdjustmentOfWarrants" xlink:title="FairValueAdjustmentOfWarrants" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US" id="us-gaap_FairValueAdjustmentOfWarrants">Change in fair value of warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" xlink:title="label: FairValueAdjustmentOfWarrants to us-gaap_FairValueAdjustmentOfWarrants" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAdjustmentOfWarrants_lbl1" xml:lang="en-US" id="us-gaap_FairValueAdjustmentOfWarrants_lbl1">Fair Value Adjustment of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl1" xlink:title="label: FairValueAdjustmentOfWarrants to us-gaap_FairValueAdjustmentOfWarrants_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="ConvertibleDebtTableTextBlock" xlink:title="ConvertibleDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConvertibleDebtTableTextBlock" xml:lang="en-US" id="us-gaap_ConvertibleDebtTableTextBlock">Activity of Convertible Notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" xlink:title="label: ConvertibleDebtTableTextBlock to us-gaap_ConvertibleDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertibleDebtTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ConvertibleDebtTableTextBlock_lbl1">Convertible Debt [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl1" xlink:title="label: ConvertibleDebtTableTextBlock to us-gaap_ConvertibleDebtTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationContingentConsiderationLiability" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationLiability">Market capitalization of monetary amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:title="label: BusinessCombinationContingentConsiderationLiability to us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">Incremental fair value of stock options recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VestingAxis" xml:lang="en-US" id="us-gaap_VestingAxis">Vesting [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingAxis" xlink:to="us-gaap_VestingAxis" xlink:title="label: VestingAxis to us-gaap_VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VestingDomain" xml:lang="en-US" id="us-gaap_VestingDomain">Vesting [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingDomain" xlink:to="us-gaap_VestingDomain" xlink:title="label: VestingDomain to us-gaap_VestingDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">Stock based compensation stock option term period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod1">Warrant expiration term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">Vesting percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:title="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">Remeasurement of contingent consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:title="label: BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 to us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">Number of accelerated vesting stock option (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:title="BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">Contingent consideration liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:title="label: BusinessCombinationContingentConsiderationLiabilityNoncurrent to us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl1">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl1" xlink:title="label: BusinessCombinationContingentConsiderationLiabilityNoncurrent to us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheOneMember">Vesting on First Anniversary [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:title="label: ShareBasedCompensationAwardTrancheOneMember to us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="ShareBasedCompensationAwardTrancheTwoMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheTwoMember">Vesting on Three Years Thereafter [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:title="label: ShareBasedCompensationAwardTrancheTwoMember to us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount1">Aggregate gross purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount2" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount2">Aggregate gross purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount2" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount3" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount3">Aggregate gross purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount3" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="DefinedContributionPlanTable" xlink:title="DefinedContributionPlanTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanTable" xml:lang="en-US" id="us-gaap_DefinedContributionPlanTable">Defined Contribution Plan [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanTable" xlink:title="label: DefinedContributionPlanTable to us-gaap_DefinedContributionPlanTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="DefinedContributionPlanDisclosureLineItems" xlink:title="DefinedContributionPlanDisclosureLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanDisclosureLineItems" xml:lang="en-US" id="us-gaap_DefinedContributionPlanDisclosureLineItems">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:title="label: DefinedContributionPlanDisclosureLineItems to us-gaap_DefinedContributionPlanDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">Warrant exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights2" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights2">Warrant exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights2" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights3" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights3">Warrant exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights3" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xml:lang="en-US" id="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">Debt discount and debt issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="label: DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet to us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" xlink:title="label: DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet to us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLeasePayments" xlink:label="ProceedsFromLeasePayments" xlink:title="ProceedsFromLeasePayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromLeasePayments" xml:lang="en-US" id="us-gaap_ProceedsFromLeasePayments">Sublease payments received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLeasePayments" xlink:to="us-gaap_ProceedsFromLeasePayments" xlink:title="label: ProceedsFromLeasePayments to us-gaap_ProceedsFromLeasePayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLeasePayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromLeasePayments_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromLeasePayments_lbl1">Proceeds from Lease Payment, Operating Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLeasePayments" xlink:to="us-gaap_ProceedsFromLeasePayments_lbl1" xlink:title="label: ProceedsFromLeasePayments to us-gaap_ProceedsFromLeasePayments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_SubleaseIncome" xml:lang="en-US" id="us-gaap_SubleaseIncome">Sublease income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseIncome" xlink:to="us-gaap_SubleaseIncome" xlink:title="label: SubleaseIncome to us-gaap_SubleaseIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubleaseIncome_lbl1" xml:lang="en-US" id="us-gaap_SubleaseIncome_lbl1">Sublease Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl1" xlink:title="label: SubleaseIncome to us-gaap_SubleaseIncome_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostAbstract" xml:lang="en-US" id="us-gaap_LeaseCostAbstract">Net Operating Lease Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract" xlink:title="label: LeaseCostAbstract to us-gaap_LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LeaseCost" xml:lang="en-US" id="us-gaap_LeaseCost">Total lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost" xlink:title="label: LeaseCost to us-gaap_LeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCost_lbl1" xml:lang="en-US" id="us-gaap_LeaseCost_lbl1">Lease, Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl1" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseCost" xml:lang="en-US" id="us-gaap_OperatingLeaseCost">Operating lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost" xlink:title="label: OperatingLeaseCost to us-gaap_OperatingLeaseCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableLeaseCost" xml:lang="en-US" id="us-gaap_VariableLeaseCost">Variable lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost" xlink:title="label: VariableLeaseCost to us-gaap_VariableLeaseCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTable" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTable">Disaggregation of Revenue [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable" xlink:title="label: DisaggregationOfRevenueTable to us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember" xlink:label="TransferredOverTimeMember" xlink:title="TransferredOverTimeMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TransferredOverTimeMember" xml:lang="en-US" id="us-gaap_TransferredOverTimeMember">Revenue Recognized Over Time [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferredOverTimeMember" xlink:to="us-gaap_TransferredOverTimeMember" xlink:title="label: TransferredOverTimeMember to us-gaap_TransferredOverTimeMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TransferredOverTimeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TransferredOverTimeMember_lbl1" xml:lang="en-US" id="us-gaap_TransferredOverTimeMember_lbl1">Transferred over Time [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferredOverTimeMember" xlink:to="us-gaap_TransferredOverTimeMember_lbl1" xlink:title="label: TransferredOverTimeMember to us-gaap_TransferredOverTimeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueLineItems" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueLineItems">Disaggregation of Revenue [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" xlink:title="label: DisaggregationOfRevenueLineItems to us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="TimingOfTransferOfGoodOrServiceAxis" xlink:title="TimingOfTransferOfGoodOrServiceAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xml:lang="en-US" id="us-gaap_TimingOfTransferOfGoodOrServiceAxis">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:title="label: TimingOfTransferOfGoodOrServiceAxis to us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="TimingOfTransferOfGoodOrServiceDomain" xlink:title="TimingOfTransferOfGoodOrServiceDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xml:lang="en-US" id="us-gaap_TimingOfTransferOfGoodOrServiceDomain">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:title="label: TimingOfTransferOfGoodOrServiceDomain to us-gaap_TimingOfTransferOfGoodOrServiceDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="ContractWithCustomerLiabilityRevenueRecognized" xlink:title="ContractWithCustomerLiabilityRevenueRecognized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xml:lang="en-US" id="us-gaap_ContractWithCustomerLiabilityRevenueRecognized">Revenue recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:title="label: ContractWithCustomerLiabilityRevenueRecognized to us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="ContractWithCustomerAssetNet" xlink:title="ContractWithCustomerAssetNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerAssetNet" xml:lang="en-US" id="us-gaap_ContractWithCustomerAssetNet">Contract assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerAssetNet" xlink:to="us-gaap_ContractWithCustomerAssetNet" xlink:title="label: ContractWithCustomerAssetNet to us-gaap_ContractWithCustomerAssetNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerAbstract" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerAbstract">Contract with Customer [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:title="label: RevenueFromContractWithCustomerAbstract to us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="RevenueFromContractWithCustomerTextBlock" xlink:title="RevenueFromContractWithCustomerTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerTextBlock" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerTextBlock">Contract with Customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:title="label: RevenueFromContractWithCustomerTextBlock to us-gaap_RevenueFromContractWithCustomerTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="AssetsAndLiabilitiesLesseeAbstract" xlink:title="AssetsAndLiabilitiesLesseeAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAndLiabilitiesLesseeAbstract" xml:lang="en-US" id="us-gaap_AssetsAndLiabilitiesLesseeAbstract">Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:title="label: AssetsAndLiabilitiesLesseeAbstract to us-gaap_AssetsAndLiabilitiesLesseeAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="ContractWithCustomerLiability" xlink:title="ContractWithCustomerLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerLiability" xml:lang="en-US" id="us-gaap_ContractWithCustomerLiability">Contract liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability" xlink:title="label: ContractWithCustomerLiability to us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset">Operating lease ROU assets, Ending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset1">Operating lease ROU assets, Beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset1" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset2" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset2">ROU asset balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset2" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset3" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset3">Right-of-use assets - operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset3" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset3" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl4" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl4">Operating Lease, Right-of-Use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl4" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">Maturities of Operating Lease Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="RetirementPlanNameAxis" xlink:title="RetirementPlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetirementPlanNameAxis" xml:lang="en-US" id="us-gaap_RetirementPlanNameAxis">Retirement Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlanNameAxis" xlink:to="us-gaap_RetirementPlanNameAxis" xlink:title="label: RetirementPlanNameAxis to us-gaap_RetirementPlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="RetirementPlanNameDomain" xlink:title="RetirementPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetirementPlanNameDomain" xml:lang="en-US" id="us-gaap_RetirementPlanNameDomain">Retirement Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlanNameDomain" xlink:to="us-gaap_RetirementPlanNameDomain" xlink:title="label: RetirementPlanNameDomain to us-gaap_RetirementPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionTable" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionTable">Lessee, Lease, Description [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable" xlink:title="label: LesseeLeaseDescriptionTable to us-gaap_LesseeLeaseDescriptionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionLineItems" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionLineItems">Lessee, Lease, Description [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" xlink:title="label: LesseeLeaseDescriptionLineItems to us-gaap_LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseDescriptionAbstract" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseDescriptionAbstract">Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:title="label: LesseeOperatingLeaseDescriptionAbstract to us-gaap_LesseeOperatingLeaseDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1">Lessee, Operating Lease, Description [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1" xlink:title="label: LesseeOperatingLeaseDescriptionAbstract to us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="RestrictedCashCurrent" xlink:title="RestrictedCashCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedCashCurrent" xml:lang="en-US" id="us-gaap_RestrictedCashCurrent">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent" xlink:title="label: RestrictedCashCurrent to us-gaap_RestrictedCashCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedCashCurrent_lbl1" xml:lang="en-US" id="us-gaap_RestrictedCashCurrent_lbl1">Restricted Cash, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl1" xlink:title="label: RestrictedCashCurrent to us-gaap_RestrictedCashCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="RestrictedCashNoncurrent" xlink:title="RestrictedCashNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedCashNoncurrent" xml:lang="en-US" id="us-gaap_RestrictedCashNoncurrent">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent" xlink:title="label: RestrictedCashNoncurrent to us-gaap_RestrictedCashNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedCashNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_RestrictedCashNoncurrent_lbl1">Restricted Cash, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl1" xlink:title="label: RestrictedCashNoncurrent to us-gaap_RestrictedCashNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="RestrictedCash" xlink:title="RestrictedCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedCash" xml:lang="en-US" id="us-gaap_RestrictedCash">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCash" xlink:to="us-gaap_RestrictedCash" xlink:title="label: RestrictedCash to us-gaap_RestrictedCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedCash1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedCash1" xml:lang="en-US" id="us-gaap_RestrictedCash1">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedCash" xlink:to="us-gaap_RestrictedCash1" xlink:title="label: RestrictedCash to us-gaap_RestrictedCash1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">Net decrease in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2">Total cash, cash equivalents and restricted cash at end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="FinanceLeasePrincipalPayments" xlink:title="FinanceLeasePrincipalPayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_FinanceLeasePrincipalPayments" xml:lang="en-US" id="us-gaap_FinanceLeasePrincipalPayments">Principal payments on finance leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinanceLeasePrincipalPayments" xlink:to="us-gaap_FinanceLeasePrincipalPayments" xlink:title="label: FinanceLeasePrincipalPayments to us-gaap_FinanceLeasePrincipalPayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FinanceLeasePrincipalPayments_lbl1" xml:lang="en-US" id="us-gaap_FinanceLeasePrincipalPayments_lbl1">Finance Lease, Principal Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinanceLeasePrincipalPayments" xlink:to="us-gaap_FinanceLeasePrincipalPayments_lbl1" xlink:title="label: FinanceLeasePrincipalPayments to us-gaap_FinanceLeasePrincipalPayments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">Weighted average discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">Total payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">2028</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">2027</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">Maturities of Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseImpairmentLoss" xml:lang="en-US" id="us-gaap_OperatingLeaseImpairmentLoss">Impairment of ROU asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss" xlink:title="label: OperatingLeaseImpairmentLoss to us-gaap_OperatingLeaseImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseImpairmentLoss1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseImpairmentLoss1" xml:lang="en-US" id="us-gaap_OperatingLeaseImpairmentLoss1">Impairment of right-of-use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss1" xlink:title="label: OperatingLeaseImpairmentLoss to us-gaap_OperatingLeaseImpairmentLoss1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseLiability" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability">Operating lease liabilities, Ending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_OperatingLeaseLiability1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability1">Operating lease liabilities, Beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability2">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability2" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiability3" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability3">Lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability3" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent">Current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent1">Operating lease liabilities, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent1" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl2">Operating Lease, Liability, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">Less: Imputed interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent">Less non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent1">Operating lease liabilities, non-current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent1" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:label="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:title="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xml:lang="en-US" id="us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">Revenue recognized in previous periods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:title="label: ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod to us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:title="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xml:lang="en-US" id="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract">Catch-up adjustment to revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:to="us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:title="label: ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract to us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostTableTextBlock" xml:lang="en-US" id="us-gaap_LeaseCostTableTextBlock">Net Operating Lease Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock" xlink:title="label: LeaseCostTableTextBlock to us-gaap_LeaseCostTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="LesseeLeasesPolicyTextBlock" xlink:title="LesseeLeasesPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeLeasesPolicyTextBlock" xml:lang="en-US" id="us-gaap_LesseeLeasesPolicyTextBlock">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" xlink:title="label: LesseeLeasesPolicyTextBlock to us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeasesPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_LesseeLeasesPolicyTextBlock_lbl1">Lessee, Leases [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl1" xlink:title="label: LesseeLeasesPolicyTextBlock to us-gaap_LesseeLeasesPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LitigationSettlementAmountAwardedToOtherParty" xml:lang="en-US" id="us-gaap_LitigationSettlementAmountAwardedToOtherParty">Litigation settlement, amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountAwardedToOtherParty" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:title="label: LitigationSettlementAmountAwardedToOtherParty to us-gaap_LitigationSettlementAmountAwardedToOtherParty" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputTypeAxis" xml:lang="en-US" id="us-gaap_MeasurementInputTypeAxis">Measurement Input Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis" xlink:title="label: MeasurementInputTypeAxis to us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="MeasurementInputCreditSpreadMember" xlink:title="MeasurementInputCreditSpreadMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputCreditSpreadMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputCreditSpreadMember" xml:lang="en-US" id="us-gaap_MeasurementInputCreditSpreadMember">Credit Spread [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputCreditSpreadMember" xlink:to="us-gaap_MeasurementInputCreditSpreadMember" xlink:title="label: MeasurementInputCreditSpreadMember to us-gaap_MeasurementInputCreditSpreadMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="MeasurementInputExercisePriceMember" xlink:title="MeasurementInputExercisePriceMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputExercisePriceMember" xml:lang="en-US" id="us-gaap_MeasurementInputExercisePriceMember">Exercise Price [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember" xlink:title="label: MeasurementInputExercisePriceMember to us-gaap_MeasurementInputExercisePriceMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="MeasurementInputExpectedDividendRateMember" xlink:title="MeasurementInputExpectedDividendRateMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MeasurementInputExpectedDividendRateMember" xml:lang="en-US" id="us-gaap_MeasurementInputExpectedDividendRateMember">Dividend Yield [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:title="label: MeasurementInputExpectedDividendRateMember to us-gaap_MeasurementInputExpectedDividendRateMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputExpectedDividendRateMember1" xml:lang="en-US" id="us-gaap_MeasurementInputExpectedDividendRateMember1">Dividend [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember1" xlink:title="label: MeasurementInputExpectedDividendRateMember to us-gaap_MeasurementInputExpectedDividendRateMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="MeasurementInputExpectedTermMember" xlink:title="MeasurementInputExpectedTermMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MeasurementInputExpectedTermMember" xml:lang="en-US" id="us-gaap_MeasurementInputExpectedTermMember">Expected Term [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember" xlink:title="label: MeasurementInputExpectedTermMember to us-gaap_MeasurementInputExpectedTermMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputExpectedTermMember1" xml:lang="en-US" id="us-gaap_MeasurementInputExpectedTermMember1">Expected Life [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember1" xlink:title="label: MeasurementInputExpectedTermMember to us-gaap_MeasurementInputExpectedTermMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US" id="us-gaap_MeasurementInputPriceVolatilityMember">Volatility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" xlink:title="label: MeasurementInputPriceVolatilityMember to us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputPriceVolatilityMember1" xml:lang="en-US" id="us-gaap_MeasurementInputPriceVolatilityMember1">Volatility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember1" xlink:title="label: MeasurementInputPriceVolatilityMember to us-gaap_MeasurementInputPriceVolatilityMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US" id="us-gaap_MeasurementInputRiskFreeInterestRateMember">Risk Free Rate [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:title="label: MeasurementInputRiskFreeInterestRateMember to us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputRiskFreeInterestRateMember1" xml:lang="en-US" id="us-gaap_MeasurementInputRiskFreeInterestRateMember1">Risk Free Rate [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember1" xlink:title="label: MeasurementInputRiskFreeInterestRateMember to us-gaap_MeasurementInputRiskFreeInterestRateMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US" id="us-gaap_MeasurementInputSharePriceMember">Stock Price [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember" xlink:title="label: MeasurementInputSharePriceMember to us-gaap_MeasurementInputSharePriceMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputSharePriceMember1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputSharePriceMember1" xml:lang="en-US" id="us-gaap_MeasurementInputSharePriceMember1">Stock Price [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember1" xlink:title="label: MeasurementInputSharePriceMember to us-gaap_MeasurementInputSharePriceMember1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MeasurementInputTypeDomain" xml:lang="en-US" id="us-gaap_MeasurementInputTypeDomain">Measurement Input Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain" xlink:title="label: MeasurementInputTypeDomain to us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xml:lang="en-US" id="us-gaap_ValuationTechniqueAndInputDescriptionAbstract">Valuation Technique and Input, Description [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:title="label: ValuationTechniqueAndInputDescriptionAbstract to us-gaap_ValuationTechniqueAndInputDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueAndInputDescriptionAbstract1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ValuationTechniqueAndInputDescriptionAbstract1" xml:lang="en-US" id="us-gaap_ValuationTechniqueAndInputDescriptionAbstract1">Valuation Technique and Input, Description [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="us-gaap_ValuationTechniqueAndInputDescriptionAbstract1" xlink:title="label: ValuationTechniqueAndInputDescriptionAbstract to us-gaap_ValuationTechniqueAndInputDescriptionAbstract1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueAndInputDescriptionAbstract2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationTechniqueAndInputDescriptionAbstract2" xml:lang="en-US" id="us-gaap_ValuationTechniqueAndInputDescriptionAbstract2">Fair Value Assumptions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="us-gaap_ValuationTechniqueAndInputDescriptionAbstract2" xlink:title="label: ValuationTechniqueAndInputDescriptionAbstract to us-gaap_ValuationTechniqueAndInputDescriptionAbstract2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="WarrantsAndRightsOutstandingMeasurementInput" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingMeasurementInput">Measurement input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:title="label: WarrantsAndRightsOutstandingMeasurementInput to us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsOutstandingMeasurementInput1" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingMeasurementInput1">Warrants , measurement input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput1" xlink:title="label: WarrantsAndRightsOutstandingMeasurementInput to us-gaap_WarrantsAndRightsOutstandingMeasurementInput1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OpenTaxYear" xlink:label="OpenTaxYear" xlink:title="OpenTaxYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OpenTaxYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OpenTaxYear" xml:lang="en-US" id="us-gaap_OpenTaxYear">Open tax year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OpenTaxYear" xlink:to="us-gaap_OpenTaxYear" xlink:title="label: OpenTaxYear to us-gaap_OpenTaxYear" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">Weighted average remaining lease term (years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseRenewalTerm" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseRenewalTerm">Extension term of sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:title="label: LesseeOperatingLeaseRenewalTerm to us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1">Lessee, Operating Lease, Renewal Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1" xlink:title="label: LesseeOperatingLeaseRenewalTerm to us-gaap_LesseeOperatingLeaseRenewalTerm_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="RevenueRemainingPerformanceObligationPercentage" xlink:title="RevenueRemainingPerformanceObligationPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueRemainingPerformanceObligationPercentage" xml:lang="en-US" id="us-gaap_RevenueRemainingPerformanceObligationPercentage">Performance obligation, percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:title="label: RevenueRemainingPerformanceObligationPercentage to us-gaap_RevenueRemainingPerformanceObligationPercentage" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMeasurementInput" xlink:label="LongTermDebtMeasurementInput" xlink:title="LongTermDebtMeasurementInput" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMeasurementInput" xml:lang="en-US" id="us-gaap_LongTermDebtMeasurementInput">Convertible note, measurement input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMeasurementInput" xlink:to="us-gaap_LongTermDebtMeasurementInput" xlink:title="label: LongTermDebtMeasurementInput to us-gaap_LongTermDebtMeasurementInput" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingTerm">Expected life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:title="label: WarrantsAndRightsOutstandingTerm to us-gaap_WarrantsAndRightsOutstandingTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_WarrantsAndRightsOutstandingTerm1" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingTerm1">Warrants expiration term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm1" xlink:title="label: WarrantsAndRightsOutstandingTerm to us-gaap_WarrantsAndRightsOutstandingTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsOutstandingTerm_lbl2" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingTerm_lbl2">Warrants and Rights Outstanding, Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl2" xlink:title="label: WarrantsAndRightsOutstandingTerm to us-gaap_WarrantsAndRightsOutstandingTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityAbstract" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityAbstract">Operating Lease, Liability [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract" xlink:title="label: OperatingLeaseLiabilityAbstract to us-gaap_OperatingLeaseLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">Amortization of operating lease ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense1">Amortization of right-of-use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense1" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract" xlink:label="AssetAcquisitionAbstract" xlink:title="AssetAcquisitionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionAbstract" xml:lang="en-US" id="us-gaap_AssetAcquisitionAbstract">Asset Acquisition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionAbstract" xlink:to="us-gaap_AssetAcquisitionAbstract" xlink:title="label: AssetAcquisitionAbstract to us-gaap_AssetAcquisitionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="AssetAcquisitionTableTextBlock" xlink:title="AssetAcquisitionTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionTableTextBlock" xml:lang="en-US" id="us-gaap_AssetAcquisitionTableTextBlock">Fair Value Measurement of Assets Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionTableTextBlock" xlink:to="us-gaap_AssetAcquisitionTableTextBlock" xlink:title="label: AssetAcquisitionTableTextBlock to us-gaap_AssetAcquisitionTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:label="AssetAcquisitionConsiderationTransferredAbstract" xlink:title="AssetAcquisitionConsiderationTransferredAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xml:lang="en-US" id="us-gaap_AssetAcquisitionConsiderationTransferredAbstract">Fair Value Consideration of Assets Acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionConsiderationTransferredAbstract" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:title="label: AssetAcquisitionConsiderationTransferredAbstract to us-gaap_AssetAcquisitionConsiderationTransferredAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xml:lang="en-US" id="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">Shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="label: AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable to us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable1" xml:lang="en-US" id="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable1">Cash or other consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable1" xlink:title="label: AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable to us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:title="AssetAcquisitionConsiderationTransferredTransactionCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xml:lang="en-US" id="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost">Direct costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:title="label: AssetAcquisitionConsiderationTransferredTransactionCost to us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl1" xml:lang="en-US" id="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl1">Asset Acquisition, Consideration Transferred, Transaction Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl1" xlink:title="label: AssetAcquisitionConsiderationTransferredTransactionCost to us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:label="AssetAcquisitionContingentConsiderationTable" xlink:title="AssetAcquisitionContingentConsiderationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionContingentConsiderationTable" xml:lang="en-US" id="us-gaap_AssetAcquisitionContingentConsiderationTable">Asset Acquisition, Contingent Consideration [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:title="label: AssetAcquisitionContingentConsiderationTable to us-gaap_AssetAcquisitionContingentConsiderationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:label="AssetAcquisitionContingentConsiderationLineItems" xlink:title="AssetAcquisitionContingentConsiderationLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionContingentConsiderationLineItems" xml:lang="en-US" id="us-gaap_AssetAcquisitionContingentConsiderationLineItems">Asset Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:title="label: AssetAcquisitionContingentConsiderationLineItems to us-gaap_AssetAcquisitionContingentConsiderationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleConversionRatio" xlink:label="PreferredStockConvertibleConversionRatio" xlink:title="PreferredStockConvertibleConversionRatio" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockConvertibleConversionRatio" xml:lang="en-US" id="us-gaap_PreferredStockConvertibleConversionRatio">Preferred stock, conversion rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockConvertibleConversionRatio" xlink:to="us-gaap_PreferredStockConvertibleConversionRatio" xlink:title="label: PreferredStockConvertibleConversionRatio to us-gaap_PreferredStockConvertibleConversionRatio" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="PreferredStockConvertibleSharesIssuable" xlink:title="PreferredStockConvertibleSharesIssuable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockConvertibleSharesIssuable" xml:lang="en-US" id="us-gaap_PreferredStockConvertibleSharesIssuable">Aggregate preferred stock to be convert into common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:title="label: PreferredStockConvertibleSharesIssuable to us-gaap_PreferredStockConvertibleSharesIssuable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTextBlock" xlink:label="AssetAcquisitionTextBlock" xlink:title="AssetAcquisitionTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionTextBlock" xml:lang="en-US" id="us-gaap_AssetAcquisitionTextBlock">Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionTextBlock" xlink:to="us-gaap_AssetAcquisitionTextBlock" xlink:title="label: AssetAcquisitionTextBlock to us-gaap_AssetAcquisitionTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xml:lang="en-US" id="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract">Stock-Based Compensation Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="label: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xlink:title="label: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="DefinedContributionPlanAbstract" xlink:title="DefinedContributionPlanAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanAbstract" xml:lang="en-US" id="us-gaap_DefinedContributionPlanAbstract">Defined Contribution Plan [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanAbstract" xlink:to="us-gaap_DefinedContributionPlanAbstract" xlink:title="label: DefinedContributionPlanAbstract to us-gaap_DefinedContributionPlanAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="DebtInstrumentRepaidPrincipal" xlink:title="DebtInstrumentRepaidPrincipal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentRepaidPrincipal" xml:lang="en-US" id="us-gaap_DebtInstrumentRepaidPrincipal">Repaid principal amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentRepaidPrincipal" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal" xlink:title="label: DebtInstrumentRepaidPrincipal to us-gaap_DebtInstrumentRepaidPrincipal" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="RelatedPartyMember" xlink:title="RelatedPartyMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyMember" xml:lang="en-US" id="us-gaap_RelatedPartyMember">Related Party [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember" xlink:title="label: RelatedPartyMember to us-gaap_RelatedPartyMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="NonrelatedPartyMember" xlink:title="NonrelatedPartyMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonrelatedPartyMember" xml:lang="en-US" id="us-gaap_NonrelatedPartyMember">Nonrelated Party [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonrelatedPartyMember" xlink:to="us-gaap_NonrelatedPartyMember" xlink:title="label: NonrelatedPartyMember to us-gaap_NonrelatedPartyMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US" id="srt_TitleOfIndividualWithRelationshipToEntityDomain">Title of Individual [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="label: TitleOfIndividualWithRelationshipToEntityDomain to srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:label xlink:type="resource" xlink:label="srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_DirectorMember" xml:lang="en-US" id="srt_DirectorMember">Dr. Fiore [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DirectorMember" xlink:to="srt_DirectorMember" xlink:title="label: DirectorMember to srt_DirectorMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis" xml:lang="en-US" id="srt_RangeAxis">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis" xlink:title="label: RangeAxis to srt_RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_RangeAxis1" xml:lang="en-US" id="srt_RangeAxis1">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis1" xlink:title="label: RangeAxis to srt_RangeAxis1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember" xml:lang="en-US" id="srt_RangeMember">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember" xlink:title="label: RangeMember to srt_RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember" xml:lang="en-US" id="srt_MaximumMember">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember" xlink:title="label: MaximumMember to srt_MaximumMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember" xml:lang="en-US" id="srt_MinimumMember">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember" xlink:title="label: MinimumMember to srt_MinimumMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualAxis" xml:lang="en-US" id="srt_TitleOfIndividualAxis">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis" xlink:title="label: TitleOfIndividualAxis to srt_TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipAxis" xml:lang="en-US" id="srt_OwnershipAxis">Ownership [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipAxis" xlink:to="srt_OwnershipAxis" xlink:title="label: OwnershipAxis to srt_OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipDomain" xml:lang="en-US" id="srt_OwnershipDomain">Ownership [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipDomain" xlink:to="srt_OwnershipDomain" xlink:title="label: OwnershipDomain to srt_OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="DocumentAnnualReport" xlink:title="DocumentAnnualReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentAnnualReport" xml:lang="en-US" id="dei_DocumentAnnualReport">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport" xlink:title="label: DocumentAnnualReport to dei_DocumentAnnualReport" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentTransitionReport" xml:lang="en-US" id="dei_DocumentTransitionReport">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport" xlink:title="label: DocumentTransitionReport to dei_DocumentTransitionReport" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="DocumentFinStmtErrorCorrectionFlag" xlink:title="DocumentFinStmtErrorCorrectionFlag" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFinStmtErrorCorrectionFlag" xml:lang="en-US" id="dei_DocumentFinStmtErrorCorrectionFlag">Document Financial Statement Error Correction [Flag]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" xlink:title="label: DocumentFinStmtErrorCorrectionFlag to dei_DocumentFinStmtErrorCorrectionFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:label="DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:title="DocumentFinStmtRestatementRecoveryAnalysisFlag" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xml:lang="en-US" id="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:title="label: DocumentFinStmtRestatementRecoveryAnalysisFlag to dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInteractiveDataCurrent" xml:lang="en-US" id="dei_EntityInteractiveDataCurrent">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent" xlink:title="label: EntityInteractiveDataCurrent to dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="IcfrAuditorAttestationFlag" xlink:title="IcfrAuditorAttestationFlag" />
    <link:label xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_IcfrAuditorAttestationFlag" xml:lang="en-US" id="dei_IcfrAuditorAttestationFlag">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag" xlink:title="label: IcfrAuditorAttestationFlag to dei_IcfrAuditorAttestationFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:label xlink:type="resource" xlink:label="dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LegalEntityAxis" xml:lang="en-US" id="dei_LegalEntityAxis">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalEntityAxis" xlink:to="dei_LegalEntityAxis" xlink:title="label: LegalEntityAxis to dei_LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:label xlink:type="resource" xlink:label="dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityDomain" xml:lang="en-US" id="dei_EntityDomain">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityDomain" xlink:to="dei_EntityDomain" xlink:title="label: EntityDomain to dei_EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityWellKnownSeasonedIssuer" xml:lang="en-US" id="dei_EntityWellKnownSeasonedIssuer">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:title="label: EntityWellKnownSeasonedIssuer to dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityVoluntaryFilers" xml:lang="en-US" id="dei_EntityVoluntaryFilers">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers" xlink:title="label: EntityVoluntaryFilers to dei_EntityVoluntaryFilers" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus" xml:lang="en-US" id="dei_EntityCurrentReportingStatus">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityShellCompany" xml:lang="en-US" id="dei_EntityShellCompany">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityShellCompany" xlink:to="dei_EntityShellCompany" xlink:title="label: EntityShellCompany to dei_EntityShellCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory" xml:lang="en-US" id="dei_EntityFilerCategory">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness" xml:lang="en-US" id="dei_EntitySmallBusiness">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityPublicFloat" xml:lang="en-US" id="dei_EntityPublicFloat">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityPublicFloat" xlink:to="dei_EntityPublicFloat" xlink:title="label: EntityPublicFloat to dei_EntityPublicFloat" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="AuditorName" xlink:title="AuditorName" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorName" xml:lang="en-US" id="dei_AuditorName">Auditor Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorName" xlink:to="dei_AuditorName" xlink:title="label: AuditorName to dei_AuditorName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="AuditorLocation" xlink:title="AuditorLocation" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorLocation" xml:lang="en-US" id="dei_AuditorLocation">Auditor Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorLocation" xlink:to="dei_AuditorLocation" xlink:title="label: AuditorLocation to dei_AuditorLocation" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="AuditorFirmId" xlink:title="AuditorFirmId" />
    <link:label xlink:type="resource" xlink:label="dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AuditorFirmId" xml:lang="en-US" id="dei_AuditorFirmId">Auditor Firm ID</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AuditorFirmId" xlink:to="dei_AuditorFirmId" xlink:title="label: AuditorFirmId to dei_AuditorFirmId" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:label="EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:title="EquityLineOfCreditConsiderationSharesOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl" xml:lang="en-US" id="erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl">Number of shares of stock issued during the period pursuant to equity line of credit consideration shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:to="erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl" xlink:title="label: EquityLineOfCreditConsiderationSharesOfCommonStock to erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl1" xml:lang="en-US" id="erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl1">Equity Line of Credit Consideration Shares of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:to="erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl1" xlink:title="label: EquityLineOfCreditConsiderationSharesOfCommonStock to erna_EquityLineOfCreditConsiderationSharesOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EquityLineOfCreditConsiderationSharesOfCommonStock" xml:lang="en-US" id="erna_EquityLineOfCreditConsiderationSharesOfCommonStock">Consideration shares of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:to="erna_EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:title="label: EquityLineOfCreditConsiderationSharesOfCommonStock to erna_EquityLineOfCreditConsiderationSharesOfCommonStock" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:label="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:title="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl" xml:lang="en-US" id="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl">The equity interest of shareholders, partners or other equity holders in consolidated entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:to="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl" xlink:title="label: BeneficialOwnershipPercentageOfIssuedAndOutstandingShares to erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl1" xml:lang="en-US" id="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl1">Beneficial Ownership Percentage of Issued and Outstanding Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:to="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl1" xlink:title="label: BeneficialOwnershipPercentageOfIssuedAndOutstandingShares to erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xml:lang="en-US" id="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares">Beneficial owning percentage on issued and outstanding shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:to="erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:title="label: BeneficialOwnershipPercentageOfIssuedAndOutstandingShares to erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesToIssuedInTransaction" />
    <link:label xlink:type="resource" xlink:label="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl" xml:lang="en-US" id="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl">The number of shares to be issued by the subsidiary or equity method investee per stock transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:to="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl" xlink:title="label: SaleOfStockNumberOfSharesToIssuedInTransaction to erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1" xml:lang="en-US" id="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1">Sale of Stock, Number of Shares to Issued in Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:to="erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1" xlink:title="label: SaleOfStockNumberOfSharesToIssuedInTransaction to erna_SaleOfStockNumberOfSharesToIssuedInTransaction_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xml:lang="en-US" id="erna_SaleOfStockNumberOfSharesToIssuedInTransaction">Number of remaining shares to be sold (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:to="erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="label: SaleOfStockNumberOfSharesToIssuedInTransaction to erna_SaleOfStockNumberOfSharesToIssuedInTransaction" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StandbySecuritiesPurchaseAgreementAbstract" xlink:label="StandbySecuritiesPurchaseAgreementAbstract" xlink:title="StandbySecuritiesPurchaseAgreementAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_StandbySecuritiesPurchaseAgreementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StandbySecuritiesPurchaseAgreementAbstract_lbl1" xml:lang="en-US" id="erna_StandbySecuritiesPurchaseAgreementAbstract_lbl1">Standby Securities Purchase Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StandbySecuritiesPurchaseAgreementAbstract" xlink:to="erna_StandbySecuritiesPurchaseAgreementAbstract_lbl1" xlink:title="label: StandbySecuritiesPurchaseAgreementAbstract to erna_StandbySecuritiesPurchaseAgreementAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StandbyEquityPurchaseAgreementMember" xlink:label="StandbyEquityPurchaseAgreementMember" xlink:title="StandbyEquityPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="erna_StandbyEquityPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StandbyEquityPurchaseAgreementMember_lbl" xml:lang="en-US" id="erna_StandbyEquityPurchaseAgreementMember_lbl">Name of agreement information about standby equity purchase agreement between the entities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StandbyEquityPurchaseAgreementMember" xlink:to="erna_StandbyEquityPurchaseAgreementMember_lbl" xlink:title="label: StandbyEquityPurchaseAgreementMember to erna_StandbyEquityPurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StandbyEquityPurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StandbyEquityPurchaseAgreementMember_lbl1" xml:lang="en-US" id="erna_StandbyEquityPurchaseAgreementMember_lbl1">Standby Equity Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StandbyEquityPurchaseAgreementMember" xlink:to="erna_StandbyEquityPurchaseAgreementMember_lbl1" xlink:title="label: StandbyEquityPurchaseAgreementMember to erna_StandbyEquityPurchaseAgreementMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl">Number of shares issuable under share-based payment arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl1" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issuable in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod">Number of shares issuable (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncentiveStockOptionsMember" xlink:label="IncentiveStockOptionsMember" xlink:title="IncentiveStockOptionsMember" />
    <link:label xlink:type="resource" xlink:label="erna_IncentiveStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IncentiveStockOptionsMember_lbl" xml:lang="en-US" id="erna_IncentiveStockOptionsMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on incentive basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncentiveStockOptionsMember" xlink:to="erna_IncentiveStockOptionsMember_lbl" xlink:title="label: IncentiveStockOptionsMember to erna_IncentiveStockOptionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IncentiveStockOptionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IncentiveStockOptionsMember_lbl1" xml:lang="en-US" id="erna_IncentiveStockOptionsMember_lbl1">Incentive Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncentiveStockOptionsMember" xlink:to="erna_IncentiveStockOptionsMember_lbl1" xlink:title="label: IncentiveStockOptionsMember to erna_IncentiveStockOptionsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IncentiveStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IncentiveStockOptionsMember" xml:lang="en-US" id="erna_IncentiveStockOptionsMember">Incentive Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncentiveStockOptionsMember" xlink:to="erna_IncentiveStockOptionsMember" xlink:title="label: IncentiveStockOptionsMember to erna_IncentiveStockOptionsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfSharesOfCommonStockOutstanding" xlink:label="PercentageOfSharesOfCommonStockOutstanding" xlink:title="PercentageOfSharesOfCommonStockOutstanding" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSharesOfCommonStockOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfSharesOfCommonStockOutstanding_lbl" xml:lang="en-US" id="erna_PercentageOfSharesOfCommonStockOutstanding_lbl">Percentage of common stock shares outstanding considered for equity number of shares under equity incentive plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSharesOfCommonStockOutstanding" xlink:to="erna_PercentageOfSharesOfCommonStockOutstanding_lbl" xlink:title="label: PercentageOfSharesOfCommonStockOutstanding to erna_PercentageOfSharesOfCommonStockOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSharesOfCommonStockOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfSharesOfCommonStockOutstanding_lbl1" xml:lang="en-US" id="erna_PercentageOfSharesOfCommonStockOutstanding_lbl1">Percentage of Shares of Common Stock Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSharesOfCommonStockOutstanding" xlink:to="erna_PercentageOfSharesOfCommonStockOutstanding_lbl1" xlink:title="label: PercentageOfSharesOfCommonStockOutstanding to erna_PercentageOfSharesOfCommonStockOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSharesOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfSharesOfCommonStockOutstanding" xml:lang="en-US" id="erna_PercentageOfSharesOfCommonStockOutstanding">Percentage of number of shares of common stock outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSharesOfCommonStockOutstanding" xlink:to="erna_PercentageOfSharesOfCommonStockOutstanding" xlink:title="label: PercentageOfSharesOfCommonStockOutstanding to erna_PercentageOfSharesOfCommonStockOutstanding" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EquityIncentivePlan2020Member" xlink:label="EquityIncentivePlan2020Member" xlink:title="EquityIncentivePlan2020Member" />
    <link:label xlink:type="resource" xlink:label="erna_EquityIncentivePlan2020Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EquityIncentivePlan2020Member_lbl" xml:lang="en-US" id="erna_EquityIncentivePlan2020Member_lbl">Share-based compensation equity incentive plan 2020.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentivePlan2020Member" xlink:to="erna_EquityIncentivePlan2020Member_lbl" xlink:title="label: EquityIncentivePlan2020Member to erna_EquityIncentivePlan2020Member_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EquityIncentivePlan2020Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EquityIncentivePlan2020Member_lbl1" xml:lang="en-US" id="erna_EquityIncentivePlan2020Member_lbl1">Equity Incentive Plan 2020 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentivePlan2020Member" xlink:to="erna_EquityIncentivePlan2020Member_lbl1" xlink:title="label: EquityIncentivePlan2020Member to erna_EquityIncentivePlan2020Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EquityIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EquityIncentivePlan2020Member" xml:lang="en-US" id="erna_EquityIncentivePlan2020Member">2020 Equity Incentive Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentivePlan2020Member" xlink:to="erna_EquityIncentivePlan2020Member" xlink:title="label: EquityIncentivePlan2020Member to erna_EquityIncentivePlan2020Member" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InducementPlan2021Member" xlink:label="InducementPlan2021Member" xlink:title="InducementPlan2021Member" />
    <link:label xlink:type="resource" xlink:label="erna_InducementPlan2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InducementPlan2021Member_lbl" xml:lang="en-US" id="erna_InducementPlan2021Member_lbl">Share-based payment arrangement award inducement plan 2021.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InducementPlan2021Member" xlink:to="erna_InducementPlan2021Member_lbl" xlink:title="label: InducementPlan2021Member to erna_InducementPlan2021Member_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InducementPlan2021Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InducementPlan2021Member_lbl1" xml:lang="en-US" id="erna_InducementPlan2021Member_lbl1">Inducement Plan 2021 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InducementPlan2021Member" xlink:to="erna_InducementPlan2021Member_lbl1" xlink:title="label: InducementPlan2021Member to erna_InducementPlan2021Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InducementPlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InducementPlan2021Member" xml:lang="en-US" id="erna_InducementPlan2021Member">2021 Inducement Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InducementPlan2021Member" xlink:to="erna_InducementPlan2021Member" xlink:title="label: InducementPlan2021Member to erna_InducementPlan2021Member" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_AggregateIntrinsicValueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AggregateIntrinsicValueAbstract_lbl1" xml:lang="en-US" id="erna_AggregateIntrinsicValueAbstract_lbl1">Aggregate Intrinsic Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="erna_AggregateIntrinsicValueAbstract_lbl1" xlink:title="label: AggregateIntrinsicValueAbstract to erna_AggregateIntrinsicValueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RestrictedStockUnitesWithheldToCoverTaxes" xlink:label="RestrictedStockUnitesWithheldToCoverTaxes" xlink:title="RestrictedStockUnitesWithheldToCoverTaxes" />
    <link:label xlink:type="resource" xlink:label="erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl" xml:lang="en-US" id="erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl">The number of shares of restricted stock withheld to cover the withholding taxes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitesWithheldToCoverTaxes" xlink:to="erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl" xlink:title="label: RestrictedStockUnitesWithheldToCoverTaxes to erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl1" xml:lang="en-US" id="erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl1">Restricted Stock Unites, Withheld to Cover Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitesWithheldToCoverTaxes" xlink:to="erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl1" xlink:title="label: RestrictedStockUnitesWithheldToCoverTaxes to erna_RestrictedStockUnitesWithheldToCoverTaxes_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RestrictedStockUnitesWithheldToCoverTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RestrictedStockUnitesWithheldToCoverTaxes" xml:lang="en-US" id="erna_RestrictedStockUnitesWithheldToCoverTaxes">Restricted stock units, withheld to cover taxes (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitesWithheldToCoverTaxes" xlink:to="erna_RestrictedStockUnitesWithheldToCoverTaxes" xlink:title="label: RestrictedStockUnitesWithheldToCoverTaxes to erna_RestrictedStockUnitesWithheldToCoverTaxes" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfAwardsVestedAndSettledAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfAwardsVestedAndSettledAbstract_lbl1" xml:lang="en-US" id="erna_NumberOfAwardsVestedAndSettledAbstract_lbl1">Number of Awards Vested and Settled [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="erna_NumberOfAwardsVestedAndSettledAbstract_lbl1" xlink:title="label: NumberOfAwardsVestedAndSettledAbstract to erna_NumberOfAwardsVestedAndSettledAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfAwardsVestedAndSettledAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfAwardsVestedAndSettledAbstract" xml:lang="en-US" id="erna_NumberOfAwardsVestedAndSettledAbstract">Number of RSUs Vested and Settled [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="erna_NumberOfAwardsVestedAndSettledAbstract" xlink:title="label: NumberOfAwardsVestedAndSettledAbstract to erna_NumberOfAwardsVestedAndSettledAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="erna_NonQualifiedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NonQualifiedStockOptionMember_lbl" xml:lang="en-US" id="erna_NonQualifiedStockOptionMember_lbl">Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="erna_NonQualifiedStockOptionMember_lbl" xlink:title="label: NonQualifiedStockOptionMember to erna_NonQualifiedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NonQualifiedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NonQualifiedStockOptionMember_lbl1" xml:lang="en-US" id="erna_NonQualifiedStockOptionMember_lbl1">Non-qualified Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="erna_NonQualifiedStockOptionMember_lbl1" xlink:title="label: NonQualifiedStockOptionMember to erna_NonQualifiedStockOptionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NonQualifiedStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NonQualifiedStockOptionMember" xml:lang="en-US" id="erna_NonQualifiedStockOptionMember">Nonqualified Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="erna_NonQualifiedStockOptionMember" xlink:title="label: NonQualifiedStockOptionMember to erna_NonQualifiedStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PresidentChiefExecutiveOfficerAndDirectorMember" xlink:label="PresidentChiefExecutiveOfficerAndDirectorMember" xlink:title="PresidentChiefExecutiveOfficerAndDirectorMember" />
    <link:label xlink:type="resource" xlink:label="erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl" xml:lang="en-US" id="erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl">Person with designation of president, chief executive officer and person serving on board of director.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PresidentChiefExecutiveOfficerAndDirectorMember" xlink:to="erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl" xlink:title="label: PresidentChiefExecutiveOfficerAndDirectorMember to erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl1" xml:lang="en-US" id="erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl1">President, Chief Executive Officer and Director [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PresidentChiefExecutiveOfficerAndDirectorMember" xlink:to="erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl1" xlink:title="label: PresidentChiefExecutiveOfficerAndDirectorMember to erna_PresidentChiefExecutiveOfficerAndDirectorMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PresidentChiefExecutiveOfficerAndDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PresidentChiefExecutiveOfficerAndDirectorMember" xml:lang="en-US" id="erna_PresidentChiefExecutiveOfficerAndDirectorMember">Sanjeev Luther [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PresidentChiefExecutiveOfficerAndDirectorMember" xlink:to="erna_PresidentChiefExecutiveOfficerAndDirectorMember" xlink:title="label: PresidentChiefExecutiveOfficerAndDirectorMember to erna_PresidentChiefExecutiveOfficerAndDirectorMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl">Description of the frequency of periodic stock vesting, which may be presented in a variety of ways (for example, monthly, quarterly, annually).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl1" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Frequency of Periodic Installment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment">Frequency of stock vesting installments over three years thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:label="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:title="RemainingFundingReceivedFromDecember2023FinancingAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingFundingReceivedFromDecember2023FinancingAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RemainingFundingReceivedFromDecember2023FinancingAbstract_lbl1" xml:lang="en-US" id="erna_RemainingFundingReceivedFromDecember2023FinancingAbstract_lbl1">Remaining Funding Received from December 2023 Financing [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:to="erna_RemainingFundingReceivedFromDecember2023FinancingAbstract_lbl1" xlink:title="label: RemainingFundingReceivedFromDecember2023FinancingAbstract to erna_RemainingFundingReceivedFromDecember2023FinancingAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CEOInducementGrantAbstract" xlink:label="CEOInducementGrantAbstract" xlink:title="CEOInducementGrantAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_CEOInducementGrantAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CEOInducementGrantAbstract_lbl1" xml:lang="en-US" id="erna_CEOInducementGrantAbstract_lbl1">CEO Inducement Grant [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CEOInducementGrantAbstract" xlink:to="erna_CEOInducementGrantAbstract_lbl1" xlink:title="label: CEOInducementGrantAbstract to erna_CEOInducementGrantAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CEOInducementGrantAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CEOInducementGrantAbstract" xml:lang="en-US" id="erna_CEOInducementGrantAbstract">CEO Inducement Grant [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CEOInducementGrantAbstract" xlink:to="erna_CEOInducementGrantAbstract" xlink:title="label: CEOInducementGrantAbstract to erna_CEOInducementGrantAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingNetBookValueOfFixedAssets" xlink:label="RemainingNetBookValueOfFixedAssets" xlink:title="RemainingNetBookValueOfFixedAssets" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingNetBookValueOfFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RemainingNetBookValueOfFixedAssets_lbl" xml:lang="en-US" id="erna_RemainingNetBookValueOfFixedAssets_lbl">Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingNetBookValueOfFixedAssets" xlink:to="erna_RemainingNetBookValueOfFixedAssets_lbl" xlink:title="label: RemainingNetBookValueOfFixedAssets to erna_RemainingNetBookValueOfFixedAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingNetBookValueOfFixedAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RemainingNetBookValueOfFixedAssets_lbl1" xml:lang="en-US" id="erna_RemainingNetBookValueOfFixedAssets_lbl1">Remaining Net Book Value of Fixed Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingNetBookValueOfFixedAssets" xlink:to="erna_RemainingNetBookValueOfFixedAssets_lbl1" xlink:title="label: RemainingNetBookValueOfFixedAssets to erna_RemainingNetBookValueOfFixedAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingNetBookValueOfFixedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RemainingNetBookValueOfFixedAssets" xml:lang="en-US" id="erna_RemainingNetBookValueOfFixedAssets">Net book value of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingNetBookValueOfFixedAssets" xlink:to="erna_RemainingNetBookValueOfFixedAssets" xlink:title="label: RemainingNetBookValueOfFixedAssets to erna_RemainingNetBookValueOfFixedAssets" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeCommitmentToPurchaseProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LesseeCommitmentToPurchaseProperty_lbl" xml:lang="en-US" id="erna_LesseeCommitmentToPurchaseProperty_lbl">The amount of property for which lessee committed to purchase.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="erna_LesseeCommitmentToPurchaseProperty_lbl" xlink:title="label: LesseeCommitmentToPurchaseProperty to erna_LesseeCommitmentToPurchaseProperty_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeCommitmentToPurchaseProperty_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LesseeCommitmentToPurchaseProperty_lbl1" xml:lang="en-US" id="erna_LesseeCommitmentToPurchaseProperty_lbl1">Lessee, Commitment to Purchase Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="erna_LesseeCommitmentToPurchaseProperty_lbl1" xlink:title="label: LesseeCommitmentToPurchaseProperty to erna_LesseeCommitmentToPurchaseProperty_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeCommitmentToPurchaseProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LesseeCommitmentToPurchaseProperty" xml:lang="en-US" id="erna_LesseeCommitmentToPurchaseProperty">Commitment to purchase equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="erna_LesseeCommitmentToPurchaseProperty" xlink:title="label: LesseeCommitmentToPurchaseProperty to erna_LesseeCommitmentToPurchaseProperty" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:label="UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:title="UnpaidOutOfPocketCostsTenantImprovementAllowance" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl" xml:lang="en-US" id="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl">The company has to pay sublease for owned assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:to="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl" xlink:title="label: UnpaidOutOfPocketCostsTenantImprovementAllowance to erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl1" xml:lang="en-US" id="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl1">Unpaid Out of Pocket Costs Tenant Improvement Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:to="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl1" xlink:title="label: UnpaidOutOfPocketCostsTenantImprovementAllowance to erna_UnpaidOutOfPocketCostsTenantImprovementAllowance_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance" xml:lang="en-US" id="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance">Unpaid out of pocket costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:to="erna_UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:title="label: UnpaidOutOfPocketCostsTenantImprovementAllowance to erna_UnpaidOutOfPocketCostsTenantImprovementAllowance" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SanDiegoLeaseMember" xlink:label="SanDiegoLeaseMember" xlink:title="SanDiegoLeaseMember" />
    <link:label xlink:type="resource" xlink:label="erna_SanDiegoLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SanDiegoLeaseMember_lbl" xml:lang="en-US" id="erna_SanDiegoLeaseMember_lbl">Represents the San Diego Lease agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SanDiegoLeaseMember" xlink:to="erna_SanDiegoLeaseMember_lbl" xlink:title="label: SanDiegoLeaseMember to erna_SanDiegoLeaseMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SanDiegoLeaseMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SanDiegoLeaseMember_lbl1" xml:lang="en-US" id="erna_SanDiegoLeaseMember_lbl1">San Diego Lease [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SanDiegoLeaseMember" xlink:to="erna_SanDiegoLeaseMember_lbl1" xlink:title="label: SanDiegoLeaseMember to erna_SanDiegoLeaseMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SanDiegoLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SanDiegoLeaseMember" xml:lang="en-US" id="erna_SanDiegoLeaseMember">San Diego Lease [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SanDiegoLeaseMember" xlink:to="erna_SanDiegoLeaseMember" xlink:title="label: SanDiegoLeaseMember to erna_SanDiegoLeaseMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ERSquibbSonsLLCMember" xlink:label="ERSquibbSonsLLCMember" xlink:title="ERSquibbSonsLLCMember" />
    <link:label xlink:type="resource" xlink:label="erna_ERSquibbSonsLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ERSquibbSonsLLCMember_lbl" xml:lang="en-US" id="erna_ERSquibbSonsLLCMember_lbl">A Delaware limited liability company ("Sublessor"), for office, laboratory and research and development space (the "Premises").</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ERSquibbSonsLLCMember" xlink:to="erna_ERSquibbSonsLLCMember_lbl" xlink:title="label: ERSquibbSonsLLCMember to erna_ERSquibbSonsLLCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ERSquibbSonsLLCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ERSquibbSonsLLCMember_lbl1" xml:lang="en-US" id="erna_ERSquibbSonsLLCMember_lbl1">E.R. Squibb &amp; Sons, L.L.C. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ERSquibbSonsLLCMember" xlink:to="erna_ERSquibbSonsLLCMember_lbl1" xlink:title="label: ERSquibbSonsLLCMember to erna_ERSquibbSonsLLCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ERSquibbSonsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ERSquibbSonsLLCMember" xml:lang="en-US" id="erna_ERSquibbSonsLLCMember">E.R. Squibb &amp; Sons, L.L.C. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ERSquibbSonsLLCMember" xlink:to="erna_ERSquibbSonsLLCMember" xlink:title="label: ERSquibbSonsLLCMember to erna_ERSquibbSonsLLCMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OutOfPocketExpenses" xlink:label="OutOfPocketExpenses" xlink:title="OutOfPocketExpenses" />
    <link:label xlink:type="resource" xlink:label="erna_OutOfPocketExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OutOfPocketExpenses_lbl" xml:lang="en-US" id="erna_OutOfPocketExpenses_lbl">The company incurred additional out-of-pocket expenses for sublessor/lessor owned assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OutOfPocketExpenses" xlink:to="erna_OutOfPocketExpenses_lbl" xlink:title="label: OutOfPocketExpenses to erna_OutOfPocketExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OutOfPocketExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OutOfPocketExpenses_lbl1" xml:lang="en-US" id="erna_OutOfPocketExpenses_lbl1">Out-of-pocket Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OutOfPocketExpenses" xlink:to="erna_OutOfPocketExpenses_lbl1" xlink:title="label: OutOfPocketExpenses to erna_OutOfPocketExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OutOfPocketExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OutOfPocketExpenses" xml:lang="en-US" id="erna_OutOfPocketExpenses">Out-of-pocket expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OutOfPocketExpenses" xlink:to="erna_OutOfPocketExpenses" xlink:title="label: OutOfPocketExpenses to erna_OutOfPocketExpenses" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:label="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:title="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl" xml:lang="en-US" id="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl">Incremental costs incurred in connection with Tenant Improvement Allowance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:to="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl" xlink:title="label: LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance to erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl1" xml:lang="en-US" id="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl1">Lease Liability incremental Amount Above Tenant Improvement Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:to="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl1" xlink:title="label: LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance to erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xml:lang="en-US" id="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance">Lease liability incremental amount Above Tenant Improvement Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:to="erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:title="label: LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance to erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TenantImprovementAllowancePerRentableSquareFoot" xlink:label="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="TenantImprovementAllowancePerRentableSquareFoot" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl" xml:lang="en-US" id="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl">Amount of tenant improvement allowance per rentable square foot for the improvements of premises.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowancePerRentableSquareFoot" xlink:to="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl" xlink:title="label: TenantImprovementAllowancePerRentableSquareFoot to erna_TenantImprovementAllowancePerRentableSquareFoot_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1" xml:lang="en-US" id="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1">Tenant Improvement Allowance, per Rentable Square Foot</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowancePerRentableSquareFoot" xlink:to="erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1" xlink:title="label: TenantImprovementAllowancePerRentableSquareFoot to erna_TenantImprovementAllowancePerRentableSquareFoot_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowancePerRentableSquareFoot" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TenantImprovementAllowancePerRentableSquareFoot" xml:lang="en-US" id="erna_TenantImprovementAllowancePerRentableSquareFoot">Tenant improvement allowance per rentable square foot</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowancePerRentableSquareFoot" xlink:to="erna_TenantImprovementAllowancePerRentableSquareFoot" xlink:title="label: TenantImprovementAllowancePerRentableSquareFoot to erna_TenantImprovementAllowancePerRentableSquareFoot" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ReceivedAmountOfTenantImprovementAllowance" xlink:label="ReceivedAmountOfTenantImprovementAllowance" xlink:title="ReceivedAmountOfTenantImprovementAllowance" />
    <link:label xlink:type="resource" xlink:label="erna_ReceivedAmountOfTenantImprovementAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ReceivedAmountOfTenantImprovementAllowance_lbl" xml:lang="en-US" id="erna_ReceivedAmountOfTenantImprovementAllowance_lbl">Amount of tenant improvement allowance received.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReceivedAmountOfTenantImprovementAllowance" xlink:to="erna_ReceivedAmountOfTenantImprovementAllowance_lbl" xlink:title="label: ReceivedAmountOfTenantImprovementAllowance to erna_ReceivedAmountOfTenantImprovementAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ReceivedAmountOfTenantImprovementAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ReceivedAmountOfTenantImprovementAllowance_lbl1" xml:lang="en-US" id="erna_ReceivedAmountOfTenantImprovementAllowance_lbl1">Received Amount of Tenant Improvement Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReceivedAmountOfTenantImprovementAllowance" xlink:to="erna_ReceivedAmountOfTenantImprovementAllowance_lbl1" xlink:title="label: ReceivedAmountOfTenantImprovementAllowance to erna_ReceivedAmountOfTenantImprovementAllowance_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ReceivedAmountOfTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ReceivedAmountOfTenantImprovementAllowance" xml:lang="en-US" id="erna_ReceivedAmountOfTenantImprovementAllowance">Company received tenant improvement allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReceivedAmountOfTenantImprovementAllowance" xlink:to="erna_ReceivedAmountOfTenantImprovementAllowance" xlink:title="label: ReceivedAmountOfTenantImprovementAllowance to erna_ReceivedAmountOfTenantImprovementAllowance" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeaseIncrementalBorrowingRate" xlink:label="OperatingLeaseIncrementalBorrowingRate" xlink:title="OperatingLeaseIncrementalBorrowingRate" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseIncrementalBorrowingRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLeaseIncrementalBorrowingRate_lbl" xml:lang="en-US" id="erna_OperatingLeaseIncrementalBorrowingRate_lbl">Weighted average incremental borrowing rate for operating lease calculated at point in time.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseIncrementalBorrowingRate" xlink:to="erna_OperatingLeaseIncrementalBorrowingRate_lbl" xlink:title="label: OperatingLeaseIncrementalBorrowingRate to erna_OperatingLeaseIncrementalBorrowingRate_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseIncrementalBorrowingRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeaseIncrementalBorrowingRate_lbl1" xml:lang="en-US" id="erna_OperatingLeaseIncrementalBorrowingRate_lbl1">Operating Lease Incremental Borrowing Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseIncrementalBorrowingRate" xlink:to="erna_OperatingLeaseIncrementalBorrowingRate_lbl1" xlink:title="label: OperatingLeaseIncrementalBorrowingRate to erna_OperatingLeaseIncrementalBorrowingRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLeaseIncrementalBorrowingRate" xml:lang="en-US" id="erna_OperatingLeaseIncrementalBorrowingRate">Incremental borrowing rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseIncrementalBorrowingRate" xlink:to="erna_OperatingLeaseIncrementalBorrowingRate" xlink:title="label: OperatingLeaseIncrementalBorrowingRate to erna_OperatingLeaseIncrementalBorrowingRate" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TenantImprovementAllowance" xlink:label="TenantImprovementAllowance" xlink:title="TenantImprovementAllowance" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TenantImprovementAllowance_lbl" xml:lang="en-US" id="erna_TenantImprovementAllowance_lbl">Amount of tenant improvement allowance to improvements of the Premises.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowance" xlink:to="erna_TenantImprovementAllowance_lbl" xlink:title="label: TenantImprovementAllowance to erna_TenantImprovementAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TenantImprovementAllowance_lbl1" xml:lang="en-US" id="erna_TenantImprovementAllowance_lbl1">Tenant Improvement Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowance" xlink:to="erna_TenantImprovementAllowance_lbl1" xlink:title="label: TenantImprovementAllowance to erna_TenantImprovementAllowance_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TenantImprovementAllowance" xml:lang="en-US" id="erna_TenantImprovementAllowance">Tenant improvement allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TenantImprovementAllowance" xlink:to="erna_TenantImprovementAllowance" xlink:title="label: TenantImprovementAllowance to erna_TenantImprovementAllowance" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeasesIncreaseInBaseRentPercentage" xlink:label="OperatingLeasesIncreaseInBaseRentPercentage" xlink:title="OperatingLeasesIncreaseInBaseRentPercentage" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl" xml:lang="en-US" id="erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl">The percentage increase in base rent per year after first year for operating leases.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesIncreaseInBaseRentPercentage" xlink:to="erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl" xlink:title="label: OperatingLeasesIncreaseInBaseRentPercentage to erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl1" xml:lang="en-US" id="erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl1">Operating Leases Increase In Base Rent Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesIncreaseInBaseRentPercentage" xlink:to="erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl1" xlink:title="label: OperatingLeasesIncreaseInBaseRentPercentage to erna_OperatingLeasesIncreaseInBaseRentPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesIncreaseInBaseRentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLeasesIncreaseInBaseRentPercentage" xml:lang="en-US" id="erna_OperatingLeasesIncreaseInBaseRentPercentage">Percentage increase in base rent after first year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesIncreaseInBaseRentPercentage" xlink:to="erna_OperatingLeasesIncreaseInBaseRentPercentage" xlink:title="label: OperatingLeasesIncreaseInBaseRentPercentage to erna_OperatingLeasesIncreaseInBaseRentPercentage" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeasesMonthlyBaseRent" xlink:label="OperatingLeasesMonthlyBaseRent" xlink:title="OperatingLeasesMonthlyBaseRent" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesMonthlyBaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLeasesMonthlyBaseRent_lbl" xml:lang="en-US" id="erna_OperatingLeasesMonthlyBaseRent_lbl">The amount of rental expense payable per month for operating leases.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesMonthlyBaseRent" xlink:to="erna_OperatingLeasesMonthlyBaseRent_lbl" xlink:title="label: OperatingLeasesMonthlyBaseRent to erna_OperatingLeasesMonthlyBaseRent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesMonthlyBaseRent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeasesMonthlyBaseRent_lbl1" xml:lang="en-US" id="erna_OperatingLeasesMonthlyBaseRent_lbl1">Operating Leases, Monthly Base Rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesMonthlyBaseRent" xlink:to="erna_OperatingLeasesMonthlyBaseRent_lbl1" xlink:title="label: OperatingLeasesMonthlyBaseRent to erna_OperatingLeasesMonthlyBaseRent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeasesMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLeasesMonthlyBaseRent" xml:lang="en-US" id="erna_OperatingLeasesMonthlyBaseRent">Monthly base rent payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasesMonthlyBaseRent" xlink:to="erna_OperatingLeasesMonthlyBaseRent" xlink:title="label: OperatingLeasesMonthlyBaseRent to erna_OperatingLeasesMonthlyBaseRent" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:label xlink:type="resource" xlink:label="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xml:lang="en-US" id="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl">Number of shares Forfeiture of unvested restricted stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xml:lang="en-US" id="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1">Shares Issued, Shares, Forfeiture of unvested restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xml:lang="en-US" id="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock">Forfeiture of unvested restricted stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl">Number of shares that have been issued in a stock purchase agreement during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1">Stock Issued During Period, Shares, Stock Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl">Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1">Stock Issued During Period, Value, Stock Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to erna_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl">Value of stock related to Forfeiture of unvested restricted stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1">Stock Issued During Period, Value, Forfeiture of Unvested Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock">Forfeiture of unvested restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions2" xlink:label="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="StockIssuedDuringPeriodValueAcquisitions2" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl">Value of stock issued pursuant to acquisitions during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions2 to erna_StockIssuedDuringPeriodValueAcquisitions2_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1">Stock Issued During Period, Value, Acquisitions2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions2 to erna_StockIssuedDuringPeriodValueAcquisitions2_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValueAcquisitions2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValueAcquisitions2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValueAcquisitions2">Issuance of common stock in connection with Exacis asset acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodValueAcquisitions2" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions2 to erna_StockIssuedDuringPeriodValueAcquisitions2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions2" xlink:label="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="StockIssuedDuringPeriodSharesAcquisitions2" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl">Number of shares of stock issued during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions2 to erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1">Stock Issued During Period, Shares, Acquisitions2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions2 to erna_StockIssuedDuringPeriodSharesAcquisitions2_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesAcquisitions2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesAcquisitions2" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesAcquisitions2">Issuance of common stock in connection with Exacis asset acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions2" xlink:to="erna_StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions2 to erna_StockIssuedDuringPeriodSharesAcquisitions2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl">Value of stock issued common stock and warrants in connection with private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:title="label: StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1">Stock Issued During Period Value 0f Common Stock and Warrants in Connection with Private Offering Net of Offering Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:title="label: StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts">Issuance of common stock and warrants in connection with November 2022 private offering, net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="label: StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl">Number of shares that have been issued in private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl1">Stock Issued During Period, Shares, Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to erna_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesPrivateOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesPrivateOffering" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesPrivateOffering">Issuance of common stock in connection with private offering (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="erna_StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to erna_StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl">Shares of stock issued common stock and warrants in connection with private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1">Stock Issued During Period Shares of Common Stock and Warrants in Connection with Private Offering Net of Offering Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xml:lang="en-US" id="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts">Issuance of common stock and warrants in connection with November 2022 private offering, net. (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:to="erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="label: StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts to erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValuePrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_StockIssuedDuringPeriodValuePrivateOffering_lbl" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValuePrivateOffering_lbl">Equity impact of the value of stock that has been issued in private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="erna_StockIssuedDuringPeriodValuePrivateOffering_lbl" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to erna_StockIssuedDuringPeriodValuePrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValuePrivateOffering_lbl1">Stock Issued During Period, Value, Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="erna_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to erna_StockIssuedDuringPeriodValuePrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_StockIssuedDuringPeriodValuePrivateOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_StockIssuedDuringPeriodValuePrivateOffering" xml:lang="en-US" id="erna_StockIssuedDuringPeriodValuePrivateOffering">Issuance of common stock in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="erna_StockIssuedDuringPeriodValuePrivateOffering" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to erna_StockIssuedDuringPeriodValuePrivateOffering" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:label="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xml:lang="en-US" id="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1">Lessee Operating Lease Weighted Average Remaining Lease Term And Discount Rate Abstract [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xml:lang="en-US" id="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract">Weighted Average Remaining Lease Term and Discount Rate [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccretionOfInterestSublease" xlink:label="AccretionOfInterestSublease" xlink:title="AccretionOfInterestSublease" />
    <link:label xlink:type="resource" xlink:label="erna_AccretionOfInterestSublease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AccretionOfInterestSublease_lbl" xml:lang="en-US" id="erna_AccretionOfInterestSublease_lbl">The fair value of accretion of interest for sublease of operating lease liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccretionOfInterestSublease" xlink:to="erna_AccretionOfInterestSublease_lbl" xlink:title="label: AccretionOfInterestSublease to erna_AccretionOfInterestSublease_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AccretionOfInterestSublease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AccretionOfInterestSublease_lbl1" xml:lang="en-US" id="erna_AccretionOfInterestSublease_lbl1">Accretion of Interest, Sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccretionOfInterestSublease" xlink:to="erna_AccretionOfInterestSublease_lbl1" xlink:title="label: AccretionOfInterestSublease to erna_AccretionOfInterestSublease_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AccretionOfInterestSublease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AccretionOfInterestSublease" xml:lang="en-US" id="erna_AccretionOfInterestSublease">Accretion of interest for Somerville Sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccretionOfInterestSublease" xlink:to="erna_AccretionOfInterestSublease" xlink:title="label: AccretionOfInterestSublease to erna_AccretionOfInterestSublease" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:label="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:title="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl" xml:lang="en-US" id="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl">The adjustment to lease liability due to remeasurement of sublease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:to="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl" xlink:title="label: AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease to erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl1" xml:lang="en-US" id="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl1">Adjustment to Lease Liability Due to Remeasurement of Sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:to="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl1" xlink:title="label: AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease to erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xml:lang="en-US" id="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease">Adjustment to lease liability due to remeasurement of Somerville Sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:to="erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:title="label: AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease to erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:label="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl">Principal payments on operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1">Principal payments on operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to erna_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_PrincipalPaymentsOnOperatingLeaseLiabilities" xml:lang="en-US" id="erna_PrincipalPaymentsOnOperatingLeaseLiabilities">Principal payments on operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="erna_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to erna_PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl">The fair value of initial measurement of operating lease liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1">Initial Measurement of Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfOperatingLeaseLiabilities" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseLiabilities">Recognition of lease liability for Somerville Sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to erna_InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2">Initial measurement of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to erna_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:label="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:title="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl" xml:lang="en-US" id="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl">The adjustment to remeasurement of operating lease ROU assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:to="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl" xlink:title="label: AdjustmentToRemeasurementOfOperatingLeaseROUAssets to erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl1" xml:lang="en-US" id="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl1">Adjustment to Remeasurement of Operating Lease ROU Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:to="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl1" xlink:title="label: AdjustmentToRemeasurementOfOperatingLeaseROUAssets to erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xml:lang="en-US" id="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets">Adjustment to ROU asset for remeasurement of Somvervile Sublease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:to="erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:title="label: AdjustmentToRemeasurementOfOperatingLeaseROUAssets to erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl">The fair value of initial measurement of operating lease ROU assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1">Initial Measurement of Operating Lease ROU Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_InitialMeasurementOfOperatingLeaseROUAssets" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseROUAssets">Recognition of ROU asset for Somerville Sublease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to erna_InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xml:lang="en-US" id="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2">Initial measurement of operating lease ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to erna_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeaseAssestAbstract" xlink:label="OperatingLeaseAssestAbstract" xlink:title="OperatingLeaseAssestAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseAssestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeaseAssestAbstract_lbl1" xml:lang="en-US" id="erna_OperatingLeaseAssestAbstract_lbl1">Operating Lease, Asset [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseAssestAbstract" xlink:to="erna_OperatingLeaseAssestAbstract_lbl1" xlink:title="label: OperatingLeaseAssestAbstract to erna_OperatingLeaseAssestAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnDisposalOfFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_GainLossOnDisposalOfFixedAssets_lbl" xml:lang="en-US" id="erna_GainLossOnDisposalOfFixedAssets_lbl">Amount of gain (loss) on sale or disposal of fixed assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="erna_GainLossOnDisposalOfFixedAssets_lbl" xlink:title="label: GainLossOnDisposalOfFixedAssets to erna_GainLossOnDisposalOfFixedAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnDisposalOfFixedAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_GainLossOnDisposalOfFixedAssets_lbl1" xml:lang="en-US" id="erna_GainLossOnDisposalOfFixedAssets_lbl1">Gain (Loss) on Disposal of Fixed Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="erna_GainLossOnDisposalOfFixedAssets_lbl1" xlink:title="label: GainLossOnDisposalOfFixedAssets to erna_GainLossOnDisposalOfFixedAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnDisposalOfFixedAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_GainLossOnDisposalOfFixedAssets" xml:lang="en-US" id="erna_GainLossOnDisposalOfFixedAssets">Loss on disposal of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="erna_GainLossOnDisposalOfFixedAssets" xlink:title="label: GainLossOnDisposalOfFixedAssets to erna_GainLossOnDisposalOfFixedAssets" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnDisposalOfFixedAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_GainLossOnDisposalOfFixedAssets_lbl2" xml:lang="en-US" id="erna_GainLossOnDisposalOfFixedAssets_lbl2">Loss on disposal of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="erna_GainLossOnDisposalOfFixedAssets_lbl2" xlink:title="label: GainLossOnDisposalOfFixedAssets to erna_GainLossOnDisposalOfFixedAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:label xlink:type="resource" xlink:label="erna_GainOnTerminationOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_GainOnTerminationOfLease_lbl" xml:lang="en-US" id="erna_GainOnTerminationOfLease_lbl">Amount of gain on termination of lease before expiration of lease term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="erna_GainOnTerminationOfLease_lbl" xlink:title="label: GainOnTerminationOfLease to erna_GainOnTerminationOfLease_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_GainOnTerminationOfLease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_GainOnTerminationOfLease_lbl1" xml:lang="en-US" id="erna_GainOnTerminationOfLease_lbl1">Gain on Termination of Lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="erna_GainOnTerminationOfLease_lbl1" xlink:title="label: GainOnTerminationOfLease to erna_GainOnTerminationOfLease_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_GainOnTerminationOfLease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_GainOnTerminationOfLease" xml:lang="en-US" id="erna_GainOnTerminationOfLease">Gain on lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="erna_GainOnTerminationOfLease" xlink:title="label: GainOnTerminationOfLease to erna_GainOnTerminationOfLease" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:label="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl" xml:lang="en-US" id="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl">Amount of cash flows from issuance of common stock from exercise of pre-funded warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:to="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl" xlink:title="label: IssuanceOfCommonStockFromExerciseOfPreFundedWarrants to erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1" xml:lang="en-US" id="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1">Issuance of Common Stock from Exercise of Pre-funded Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:to="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1" xlink:title="label: IssuanceOfCommonStockFromExerciseOfPreFundedWarrants to erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xml:lang="en-US" id="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants">Issuance of common stock from exercise of pre-funded warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:to="erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="label: IssuanceOfCommonStockFromExerciseOfPreFundedWarrants to erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl">The increase (decrease) during the reporting period in the operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to erna_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IncreaseDecreaseInOperatingLeaseLiabilities" xml:lang="en-US" id="erna_IncreaseDecreaseInOperatingLeaseLiabilities">Operating lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="erna_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to erna_IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfFinanceLeaseLiabilities" xlink:label="InitialMeasurementOfFinanceLeaseLiabilities" xlink:title="InitialMeasurementOfFinanceLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl">The fair value of initial measurement of finance lease liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfFinanceLeaseLiabilities" xlink:to="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl" xlink:title="label: InitialMeasurementOfFinanceLeaseLiabilities to erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1">Initial Measurement of Finance Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfFinanceLeaseLiabilities" xlink:to="erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1" xlink:title="label: InitialMeasurementOfFinanceLeaseLiabilities to erna_InitialMeasurementOfFinanceLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfFinanceLeaseLiabilities" xml:lang="en-US" id="erna_InitialMeasurementOfFinanceLeaseLiabilities">Initial measurement of finance lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfFinanceLeaseLiabilities" xlink:to="erna_InitialMeasurementOfFinanceLeaseLiabilities" xlink:title="label: InitialMeasurementOfFinanceLeaseLiabilities to erna_InitialMeasurementOfFinanceLeaseLiabilities" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:label="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:title="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1" xml:lang="en-US" id="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1">Reconciliation of Cash Cash Equivalents and Restricted Cash in Condensed Consolidated Statements Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1" xlink:title="label: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xml:lang="en-US" id="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract">Reconciliation of cash, cash equivalents and restricted cash at end of period:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:title="label: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CashPaidDuringThePeriodForAbstract" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:title="CashPaidDuringThePeriodForAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidDuringThePeriodForAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CashPaidDuringThePeriodForAbstract_lbl1" xml:lang="en-US" id="erna_CashPaidDuringThePeriodForAbstract_lbl1">Cash Paid During the Period for [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="erna_CashPaidDuringThePeriodForAbstract_lbl1" xlink:title="label: CashPaidDuringThePeriodForAbstract to erna_CashPaidDuringThePeriodForAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidDuringThePeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CashPaidDuringThePeriodForAbstract" xml:lang="en-US" id="erna_CashPaidDuringThePeriodForAbstract">Cash paid during the period for:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="erna_CashPaidDuringThePeriodForAbstract" xlink:title="label: CashPaidDuringThePeriodForAbstract to erna_CashPaidDuringThePeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:label="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl" xml:lang="en-US" id="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl">Amount of gain (loss) on remeasurement of right-of-use asset obtained in exchange for operating lease liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:to="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl" xlink:title="label: GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset to erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1" xml:lang="en-US" id="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1">Gain (Loss) on Remeasurement of Operating Lease Liability and Right-of-Use-Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:to="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1" xlink:title="label: GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset to erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xml:lang="en-US" id="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset">Gain on remeasurement of operating lease liability and right-of-use-asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:to="erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="label: GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset to erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConversionOfWarrantLiabilityToEquity" xlink:label="ConversionOfWarrantLiabilityToEquity" xlink:title="ConversionOfWarrantLiabilityToEquity" />
    <link:label xlink:type="resource" xlink:label="erna_ConversionOfWarrantLiabilityToEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ConversionOfWarrantLiabilityToEquity_lbl" xml:lang="en-US" id="erna_ConversionOfWarrantLiabilityToEquity_lbl">The conversion of warrant liability to equity in non-cash investing and financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfWarrantLiabilityToEquity" xlink:to="erna_ConversionOfWarrantLiabilityToEquity_lbl" xlink:title="label: ConversionOfWarrantLiabilityToEquity to erna_ConversionOfWarrantLiabilityToEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ConversionOfWarrantLiabilityToEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ConversionOfWarrantLiabilityToEquity_lbl1" xml:lang="en-US" id="erna_ConversionOfWarrantLiabilityToEquity_lbl1">Conversion of Warrant Liability to Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfWarrantLiabilityToEquity" xlink:to="erna_ConversionOfWarrantLiabilityToEquity_lbl1" xlink:title="label: ConversionOfWarrantLiabilityToEquity to erna_ConversionOfWarrantLiabilityToEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:label="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:title="UnpaidFeesIncurredInConnectionWithPrivateOffering" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl">Value of unpaid fees incurred in connection with private offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:to="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl" xlink:title="label: UnpaidFeesIncurredInConnectionWithPrivateOffering to erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1">Unpaid Fees Incurred in Connection with Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:to="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1" xlink:title="label: UnpaidFeesIncurredInConnectionWithPrivateOffering to erna_UnpaidFeesIncurredInConnectionWithPrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering">Unpaid fees incurred in connection with November 2022 private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:to="erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:title="label: UnpaidFeesIncurredInConnectionWithPrivateOffering to erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IssuanceOfCommonStockForAssetAcquisition" xlink:label="IssuanceOfCommonStockForAssetAcquisition" xlink:title="IssuanceOfCommonStockForAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_IssuanceOfCommonStockForAssetAcquisition_lbl" xml:lang="en-US" id="erna_IssuanceOfCommonStockForAssetAcquisition_lbl">The issuance of common stock for asset acquisition in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForAssetAcquisition" xlink:to="erna_IssuanceOfCommonStockForAssetAcquisition_lbl" xlink:title="label: IssuanceOfCommonStockForAssetAcquisition to erna_IssuanceOfCommonStockForAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IssuanceOfCommonStockForAssetAcquisition_lbl1" xml:lang="en-US" id="erna_IssuanceOfCommonStockForAssetAcquisition_lbl1">Issuance of Common Stock for Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForAssetAcquisition" xlink:to="erna_IssuanceOfCommonStockForAssetAcquisition_lbl1" xlink:title="label: IssuanceOfCommonStockForAssetAcquisition to erna_IssuanceOfCommonStockForAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IssuanceOfCommonStockForAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IssuanceOfCommonStockForAssetAcquisition" xml:lang="en-US" id="erna_IssuanceOfCommonStockForAssetAcquisition">Issuance of common stock for Exacis asset acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfCommonStockForAssetAcquisition" xlink:to="erna_IssuanceOfCommonStockForAssetAcquisition" xlink:title="label: IssuanceOfCommonStockForAssetAcquisition to erna_IssuanceOfCommonStockForAssetAcquisition" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:label="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl" xml:lang="en-US" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl">Amount of cash outflow for fractional shares in connection with reverse stock split.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:to="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl" xlink:title="label: CashPaidForFractionalSharesInConnectionWithReverseStockSplit to erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1" xml:lang="en-US" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1">Cash Paid for Fractional Shares in Connection with Reverse Stock Split</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:to="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1" xlink:title="label: CashPaidForFractionalSharesInConnectionWithReverseStockSplit to erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xml:lang="en-US" id="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit">Cash paid for fractional shares in connection with reverse stock split</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:to="erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="label: CashPaidForFractionalSharesInConnectionWithReverseStockSplit to erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExpensesPaidInConnectionWithPrivateOffering" xlink:label="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="ExpensesPaidInConnectionWithPrivateOffering" />
    <link:label xlink:type="resource" xlink:label="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl" xml:lang="en-US" id="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl">The amount of expenses paid in connection with private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpensesPaidInConnectionWithPrivateOffering" xlink:to="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl" xlink:title="label: ExpensesPaidInConnectionWithPrivateOffering to erna_ExpensesPaidInConnectionWithPrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1" xml:lang="en-US" id="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1">Expenses Paid In Connection with Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpensesPaidInConnectionWithPrivateOffering" xlink:to="erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1" xlink:title="label: ExpensesPaidInConnectionWithPrivateOffering to erna_ExpensesPaidInConnectionWithPrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ExpensesPaidInConnectionWithPrivateOffering" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_ExpensesPaidInConnectionWithPrivateOffering" xml:lang="en-US" id="erna_ExpensesPaidInConnectionWithPrivateOffering">Fees paid in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpensesPaidInConnectionWithPrivateOffering" xlink:to="erna_ExpensesPaidInConnectionWithPrivateOffering" xlink:title="label: ExpensesPaidInConnectionWithPrivateOffering to erna_ExpensesPaidInConnectionWithPrivateOffering" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccrualForPurchasesOfPropertyAndEquipment" xlink:label="AccrualForPurchasesOfPropertyAndEquipment" xlink:title="AccrualForPurchasesOfPropertyAndEquipment" />
    <link:label xlink:type="resource" xlink:label="erna_AccrualForPurchasesOfPropertyAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AccrualForPurchasesOfPropertyAndEquipment_lbl" xml:lang="en-US" id="erna_AccrualForPurchasesOfPropertyAndEquipment_lbl">The accrual for purchases of property and equipment noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccrualForPurchasesOfPropertyAndEquipment" xlink:to="erna_AccrualForPurchasesOfPropertyAndEquipment_lbl" xlink:title="label: AccrualForPurchasesOfPropertyAndEquipment to erna_AccrualForPurchasesOfPropertyAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AccrualForPurchasesOfPropertyAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AccrualForPurchasesOfPropertyAndEquipment_lbl1" xml:lang="en-US" id="erna_AccrualForPurchasesOfPropertyAndEquipment_lbl1">Accrual for Purchases of Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccrualForPurchasesOfPropertyAndEquipment" xlink:to="erna_AccrualForPurchasesOfPropertyAndEquipment_lbl1" xlink:title="label: AccrualForPurchasesOfPropertyAndEquipment to erna_AccrualForPurchasesOfPropertyAndEquipment_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AccrualForPurchasesOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AccrualForPurchasesOfPropertyAndEquipment" xml:lang="en-US" id="erna_AccrualForPurchasesOfPropertyAndEquipment">Accrual for purchases of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccrualForPurchasesOfPropertyAndEquipment" xlink:to="erna_AccrualForPurchasesOfPropertyAndEquipment" xlink:title="label: AccrualForPurchasesOfPropertyAndEquipment to erna_AccrualForPurchasesOfPropertyAndEquipment" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:label="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:title="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl" xml:lang="en-US" id="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl">The adjustment to lease liability and right of use asset due to remeasurement in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:to="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl" xlink:title="label: AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement to erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl1" xml:lang="en-US" id="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl1">Adjustment to Lease Liability and Right of Use Asset Due to Remeasurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:to="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl1" xlink:title="label: AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement to erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xml:lang="en-US" id="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement">Adjustment to lease liability and ROU asset due to remeasurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:to="erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:title="label: AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement to erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RepricingOfWarrantsInConnectionWithFinancing" xlink:label="RepricingOfWarrantsInConnectionWithFinancing" xlink:title="RepricingOfWarrantsInConnectionWithFinancing" />
    <link:label xlink:type="resource" xlink:label="erna_RepricingOfWarrantsInConnectionWithFinancing_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RepricingOfWarrantsInConnectionWithFinancing_lbl" xml:lang="en-US" id="erna_RepricingOfWarrantsInConnectionWithFinancing_lbl">The repricing of warrants in connection with financing in noncash financing activities..</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepricingOfWarrantsInConnectionWithFinancing" xlink:to="erna_RepricingOfWarrantsInConnectionWithFinancing_lbl" xlink:title="label: RepricingOfWarrantsInConnectionWithFinancing to erna_RepricingOfWarrantsInConnectionWithFinancing_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RepricingOfWarrantsInConnectionWithFinancing_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RepricingOfWarrantsInConnectionWithFinancing_lbl1" xml:lang="en-US" id="erna_RepricingOfWarrantsInConnectionWithFinancing_lbl1">Repricing of Warrants in Connection with Financing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepricingOfWarrantsInConnectionWithFinancing" xlink:to="erna_RepricingOfWarrantsInConnectionWithFinancing_lbl1" xlink:title="label: RepricingOfWarrantsInConnectionWithFinancing to erna_RepricingOfWarrantsInConnectionWithFinancing_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RepricingOfWarrantsInConnectionWithFinancing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RepricingOfWarrantsInConnectionWithFinancing" xml:lang="en-US" id="erna_RepricingOfWarrantsInConnectionWithFinancing">Repricing of warrants in connection with December 2023 financing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepricingOfWarrantsInConnectionWithFinancing" xlink:to="erna_RepricingOfWarrantsInConnectionWithFinancing" xlink:title="label: RepricingOfWarrantsInConnectionWithFinancing to erna_RepricingOfWarrantsInConnectionWithFinancing" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:label="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:title="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl">The value of unpaid fees incurred in connection with the issuance of convertible notes and warrants in noncash financing activities..</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:to="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl" xlink:title="label: UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants to erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl1" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl1">Unpaid Fees Incurred in Connection with the Issuance of Convertible Notes and Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:to="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl1" xlink:title="label: UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants to erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xml:lang="en-US" id="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants">Unpaid fees incurred in connection with the December 2023 financing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:to="erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:title="label: UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants to erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_WarrantsIssued" xlink:label="WarrantsIssued" xlink:title="WarrantsIssued" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_WarrantsIssued_lbl" xml:lang="en-US" id="erna_WarrantsIssued_lbl">Value of warrants issued to purchase common stock of the company together with convertible notes in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsIssued" xlink:to="erna_WarrantsIssued_lbl" xlink:title="label: WarrantsIssued to erna_WarrantsIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantsIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_WarrantsIssued_lbl1" xml:lang="en-US" id="erna_WarrantsIssued_lbl1">Warrants Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsIssued" xlink:to="erna_WarrantsIssued_lbl1" xlink:title="label: WarrantsIssued to erna_WarrantsIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_WarrantsIssued" xml:lang="en-US" id="erna_WarrantsIssued">Note warrants issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsIssued" xlink:to="erna_WarrantsIssued" xlink:title="label: WarrantsIssued to erna_WarrantsIssued" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfLeaseLiabilities" xlink:label="InitialMeasurementOfLeaseLiabilities" xlink:title="InitialMeasurementOfLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfLeaseLiabilities_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfLeaseLiabilities_lbl">The fair value of Initial measurement of lease liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfLeaseLiabilities" xlink:to="erna_InitialMeasurementOfLeaseLiabilities_lbl" xlink:title="label: InitialMeasurementOfLeaseLiabilities to erna_InitialMeasurementOfLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfLeaseLiabilities_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfLeaseLiabilities_lbl1">Initial measurement of lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfLeaseLiabilities" xlink:to="erna_InitialMeasurementOfLeaseLiabilities_lbl1" xlink:title="label: InitialMeasurementOfLeaseLiabilities to erna_InitialMeasurementOfLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfLeaseLiabilities" xml:lang="en-US" id="erna_InitialMeasurementOfLeaseLiabilities">Initial measurement of lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfLeaseLiabilities" xlink:to="erna_InitialMeasurementOfLeaseLiabilities" xlink:title="label: InitialMeasurementOfLeaseLiabilities to erna_InitialMeasurementOfLeaseLiabilities" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfRightOfUseAssets" xlink:label="InitialMeasurementOfRightOfUseAssets" xlink:title="InitialMeasurementOfRightOfUseAssets" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialMeasurementOfRightOfUseAssets_lbl" xml:lang="en-US" id="erna_InitialMeasurementOfRightOfUseAssets_lbl">The fair value of Initial measurement of ROU assets in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssets" xlink:to="erna_InitialMeasurementOfRightOfUseAssets_lbl" xlink:title="label: InitialMeasurementOfRightOfUseAssets to erna_InitialMeasurementOfRightOfUseAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfRightOfUseAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialMeasurementOfRightOfUseAssets_lbl1" xml:lang="en-US" id="erna_InitialMeasurementOfRightOfUseAssets_lbl1">Initial Measurement of Right of Use Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssets" xlink:to="erna_InitialMeasurementOfRightOfUseAssets_lbl1" xlink:title="label: InitialMeasurementOfRightOfUseAssets to erna_InitialMeasurementOfRightOfUseAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialMeasurementOfRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialMeasurementOfRightOfUseAssets" xml:lang="en-US" id="erna_InitialMeasurementOfRightOfUseAssets">Initial measurement of ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssets" xlink:to="erna_InitialMeasurementOfRightOfUseAssets" xlink:title="label: InitialMeasurementOfRightOfUseAssets to erna_InitialMeasurementOfRightOfUseAssets" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationForAssetAcquisition" xlink:label="ContingentConsiderationForAssetAcquisition" xlink:title="ContingentConsiderationForAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationForAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ContingentConsiderationForAssetAcquisition_lbl" xml:lang="en-US" id="erna_ContingentConsiderationForAssetAcquisition_lbl">Accrued payment of contingent consideration in noncash investing and financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationForAssetAcquisition" xlink:to="erna_ContingentConsiderationForAssetAcquisition_lbl" xlink:title="label: ContingentConsiderationForAssetAcquisition to erna_ContingentConsiderationForAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationForAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ContingentConsiderationForAssetAcquisition_lbl1" xml:lang="en-US" id="erna_ContingentConsiderationForAssetAcquisition_lbl1">Contingent Consideration for Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationForAssetAcquisition" xlink:to="erna_ContingentConsiderationForAssetAcquisition_lbl1" xlink:title="label: ContingentConsiderationForAssetAcquisition to erna_ContingentConsiderationForAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationForAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ContingentConsiderationForAssetAcquisition" xml:lang="en-US" id="erna_ContingentConsiderationForAssetAcquisition">Contingent consideration for Exacis asset acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationForAssetAcquisition" xlink:to="erna_ContingentConsiderationForAssetAcquisition" xlink:title="label: ContingentConsiderationForAssetAcquisition to erna_ContingentConsiderationForAssetAcquisition" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:label="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:title="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl" xml:lang="en-US" id="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl">The cash inflow from the additional capital contribution to the entity pursuant to stock purchase agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:to="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl" xlink:title="label: ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement to erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl1" xml:lang="en-US" id="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl1">Proceeds from Issuance of Common Stock Pursuant to Stock Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:to="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl1" xlink:title="label: ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement to erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xml:lang="en-US" id="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement">Proceeds from sale of common stock pursuant to stock purchase agreement with Lincoln Park Capital Fund, LLC</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:to="erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:title="label: ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement to erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="GainLossOnChangeInFairValueOfContingentConsideration" xlink:title="GainLossOnChangeInFairValueOfContingentConsideration" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl" xml:lang="en-US" id="erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl">The amount of gain (loss) on change in fair value of contingent consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnChangeInFairValueOfContingentConsideration" xlink:to="erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl" xlink:title="label: GainLossOnChangeInFairValueOfContingentConsideration to erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl1" xml:lang="en-US" id="erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl1">Gain (Loss) on Change in Fair Value of Contingent Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnChangeInFairValueOfContingentConsideration" xlink:to="erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl1" xlink:title="label: GainLossOnChangeInFairValueOfContingentConsideration to erna_GainLossOnChangeInFairValueOfContingentConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_GainLossOnChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_GainLossOnChangeInFairValueOfContingentConsideration" xml:lang="en-US" id="erna_GainLossOnChangeInFairValueOfContingentConsideration">Change in fair value of contingent consideration liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnChangeInFairValueOfContingentConsideration" xlink:to="erna_GainLossOnChangeInFairValueOfContingentConsideration" xlink:title="label: GainLossOnChangeInFairValueOfContingentConsideration to erna_GainLossOnChangeInFairValueOfContingentConsideration" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="NonCashResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl" xml:lang="en-US" id="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl">The non cash amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:title="label: NonCashResearchAndDevelopmentInProcessAssetAcquisition to erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xml:lang="en-US" id="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl1">Non Cash Research and Development in Process, Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:title="label: NonCashResearchAndDevelopmentInProcessAssetAcquisition to erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition" xml:lang="en-US" id="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition">Non-cash component of acquisition of Exacis in-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="label: NonCashResearchAndDevelopmentInProcessAssetAcquisition to erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommitmentSharesIssueExpense" xlink:label="CommitmentSharesIssueExpense" xlink:title="CommitmentSharesIssueExpense" />
    <link:label xlink:type="resource" xlink:label="erna_CommitmentSharesIssueExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommitmentSharesIssueExpense_lbl" xml:lang="en-US" id="erna_CommitmentSharesIssueExpense_lbl">Amount of noncash expense for commitment shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentSharesIssueExpense" xlink:to="erna_CommitmentSharesIssueExpense_lbl" xlink:title="label: CommitmentSharesIssueExpense to erna_CommitmentSharesIssueExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommitmentSharesIssueExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommitmentSharesIssueExpense_lbl1" xml:lang="en-US" id="erna_CommitmentSharesIssueExpense_lbl1">Commitment Shares Issue Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentSharesIssueExpense" xlink:to="erna_CommitmentSharesIssueExpense_lbl1" xlink:title="label: CommitmentSharesIssueExpense to erna_CommitmentSharesIssueExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommitmentSharesIssueExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CommitmentSharesIssueExpense" xml:lang="en-US" id="erna_CommitmentSharesIssueExpense">Commitment shares issued to Lincoln Park Capital, LLC</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentSharesIssueExpense" xlink:to="erna_CommitmentSharesIssueExpense" xlink:title="label: CommitmentSharesIssueExpense to erna_CommitmentSharesIssueExpense" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:label xlink:type="resource" xlink:label="erna_LossOnNonControllingInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LossOnNonControllingInvestment_lbl" xml:lang="en-US" id="erna_LossOnNonControllingInvestment_lbl">Amount of loss on non-controlling investment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="erna_LossOnNonControllingInvestment_lbl" xlink:title="label: LossOnNonControllingInvestment to erna_LossOnNonControllingInvestment_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LossOnNonControllingInvestment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LossOnNonControllingInvestment_lbl1" xml:lang="en-US" id="erna_LossOnNonControllingInvestment_lbl1">Loss on Non-controlling Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="erna_LossOnNonControllingInvestment_lbl1" xlink:title="label: LossOnNonControllingInvestment to erna_LossOnNonControllingInvestment_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LossOnNonControllingInvestment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_LossOnNonControllingInvestment" xml:lang="en-US" id="erna_LossOnNonControllingInvestment">Loss on non-controlling investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="erna_LossOnNonControllingInvestment" xlink:title="label: LossOnNonControllingInvestment to erna_LossOnNonControllingInvestment" />
    <link:label xlink:type="resource" xlink:label="erna_LossOnNonControllingInvestment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LossOnNonControllingInvestment_lbl2" xml:lang="en-US" id="erna_LossOnNonControllingInvestment_lbl2">Loss on non-controlling investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="erna_LossOnNonControllingInvestment_lbl2" xlink:title="label: LossOnNonControllingInvestment to erna_LossOnNonControllingInvestment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantLiabilitiesExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_WarrantLiabilitiesExpense_lbl" xml:lang="en-US" id="erna_WarrantLiabilitiesExpense_lbl">Amount of expenses related to warrant liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="erna_WarrantLiabilitiesExpense_lbl" xlink:title="label: WarrantLiabilitiesExpense to erna_WarrantLiabilitiesExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantLiabilitiesExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_WarrantLiabilitiesExpense_lbl1" xml:lang="en-US" id="erna_WarrantLiabilitiesExpense_lbl1">Warrant Liabilities Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="erna_WarrantLiabilitiesExpense_lbl1" xlink:title="label: WarrantLiabilitiesExpense to erna_WarrantLiabilitiesExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantLiabilitiesExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_WarrantLiabilitiesExpense" xml:lang="en-US" id="erna_WarrantLiabilitiesExpense">Change in fair value of warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="erna_WarrantLiabilitiesExpense" xlink:title="label: WarrantLiabilitiesExpense to erna_WarrantLiabilitiesExpense" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LaboratoryAndManufacturingEquipmentMember" xlink:label="LaboratoryAndManufacturingEquipmentMember" xlink:title="LaboratoryAndManufacturingEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="erna_LaboratoryAndManufacturingEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LaboratoryAndManufacturingEquipmentMember_lbl" xml:lang="en-US" id="erna_LaboratoryAndManufacturingEquipmentMember_lbl">Tangible personal property used to produce goods and service.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaboratoryAndManufacturingEquipmentMember" xlink:to="erna_LaboratoryAndManufacturingEquipmentMember_lbl" xlink:title="label: LaboratoryAndManufacturingEquipmentMember to erna_LaboratoryAndManufacturingEquipmentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LaboratoryAndManufacturingEquipmentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LaboratoryAndManufacturingEquipmentMember_lbl1" xml:lang="en-US" id="erna_LaboratoryAndManufacturingEquipmentMember_lbl1">Laboratory and Manufacturing Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaboratoryAndManufacturingEquipmentMember" xlink:to="erna_LaboratoryAndManufacturingEquipmentMember_lbl1" xlink:title="label: LaboratoryAndManufacturingEquipmentMember to erna_LaboratoryAndManufacturingEquipmentMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LaboratoryAndManufacturingEquipmentMember" xml:lang="en-US" id="erna_LaboratoryAndManufacturingEquipmentMember">Laboratory and Manufacturing Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaboratoryAndManufacturingEquipmentMember" xlink:to="erna_LaboratoryAndManufacturingEquipmentMember" xlink:title="label: LaboratoryAndManufacturingEquipmentMember to erna_LaboratoryAndManufacturingEquipmentMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xml:lang="en-US" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl">The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xml:lang="en-US" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1">Research and Development in Process, Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ResearchAndDevelopmentInProcessAssetAcquisition" xml:lang="en-US" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition">Acquisition of Exacis in-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to erna_ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xml:lang="en-US" id="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2">Total fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to erna_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xml:lang="en-US" id="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl">Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xml:lang="en-US" id="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1">Asset Acquisition, Fair Value of Consideration Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to erna_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_AssetAcquisitionFairValueOfConsiderationPaid" xml:lang="en-US" id="erna_AssetAcquisitionFairValueOfConsiderationPaid">Contingent consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to erna_AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:label="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:title="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" />
    <link:label xlink:type="resource" xlink:label="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl" xml:lang="en-US" id="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl">The allocated percentage of fair value of consideration to the purchased license.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:to="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl" xlink:title="label: AllocatedPercentageOfFairValueConsiderationToPurchasedLicense to erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl1" xml:lang="en-US" id="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl1">Allocated Percentage of Fair Value Consideration to Purchased License</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:to="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl1" xlink:title="label: AllocatedPercentageOfFairValueConsiderationToPurchasedLicense to erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xml:lang="en-US" id="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense">Allocated percentage of fair value of consideration to purchased license</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:to="erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:title="label: AllocatedPercentageOfFairValueConsiderationToPurchasedLicense to erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LincolnParkCapitalFundLLCMember" xlink:label="LincolnParkCapitalFundLLCMember" xlink:title="LincolnParkCapitalFundLLCMember" />
    <link:label xlink:type="resource" xlink:label="erna_LincolnParkCapitalFundLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LincolnParkCapitalFundLLCMember_lbl" xml:lang="en-US" id="erna_LincolnParkCapitalFundLLCMember_lbl">Name of entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkCapitalFundLLCMember" xlink:to="erna_LincolnParkCapitalFundLLCMember_lbl" xlink:title="label: LincolnParkCapitalFundLLCMember to erna_LincolnParkCapitalFundLLCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LincolnParkCapitalFundLLCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LincolnParkCapitalFundLLCMember_lbl1" xml:lang="en-US" id="erna_LincolnParkCapitalFundLLCMember_lbl1">Lincoln Park Capital Fund, LLC [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkCapitalFundLLCMember" xlink:to="erna_LincolnParkCapitalFundLLCMember_lbl1" xlink:title="label: LincolnParkCapitalFundLLCMember to erna_LincolnParkCapitalFundLLCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LincolnParkCapitalFundLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LincolnParkCapitalFundLLCMember" xml:lang="en-US" id="erna_LincolnParkCapitalFundLLCMember">Lincoln Park [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkCapitalFundLLCMember" xlink:to="erna_LincolnParkCapitalFundLLCMember" xlink:title="label: LincolnParkCapitalFundLLCMember to erna_LincolnParkCapitalFundLLCMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NewFacilityLeaseAbstract" xlink:label="NewFacilityLeaseAbstract" xlink:title="NewFacilityLeaseAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_NewFacilityLeaseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NewFacilityLeaseAbstract_lbl1" xml:lang="en-US" id="erna_NewFacilityLeaseAbstract_lbl1">New Facility Lease [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewFacilityLeaseAbstract" xlink:to="erna_NewFacilityLeaseAbstract_lbl1" xlink:title="label: NewFacilityLeaseAbstract to erna_NewFacilityLeaseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PrivatePlacementOfferingsAbstract" xlink:label="PrivatePlacementOfferingsAbstract" xlink:title="PrivatePlacementOfferingsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_PrivatePlacementOfferingsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PrivatePlacementOfferingsAbstract_lbl1" xml:lang="en-US" id="erna_PrivatePlacementOfferingsAbstract_lbl1">Private Placement Offerings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="erna_PrivatePlacementOfferingsAbstract_lbl1" xlink:title="label: PrivatePlacementOfferingsAbstract to erna_PrivatePlacementOfferingsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesLineItems" xlink:label="LiquidityAndCapitalResourcesLineItems" xlink:title="LiquidityAndCapitalResourcesLineItems" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LiquidityAndCapitalResourcesLineItems_lbl" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesLineItems_lbl">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="erna_LiquidityAndCapitalResourcesLineItems_lbl" xlink:title="label: LiquidityAndCapitalResourcesLineItems to erna_LiquidityAndCapitalResourcesLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LiquidityAndCapitalResourcesLineItems_lbl1" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesLineItems_lbl1">Liquidity and Capital Resources [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="erna_LiquidityAndCapitalResourcesLineItems_lbl1" xlink:title="label: LiquidityAndCapitalResourcesLineItems to erna_LiquidityAndCapitalResourcesLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesTable" xlink:label="LiquidityAndCapitalResourcesTable" xlink:title="LiquidityAndCapitalResourcesTable" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LiquidityAndCapitalResourcesTable_lbl" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTable_lbl">Disclosure of information about liquidity and capital resources.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="erna_LiquidityAndCapitalResourcesTable_lbl" xlink:title="label: LiquidityAndCapitalResourcesTable to erna_LiquidityAndCapitalResourcesTable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LiquidityAndCapitalResourcesTable_lbl1" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTable_lbl1">Liquidity and Capital Resources [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="erna_LiquidityAndCapitalResourcesTable_lbl1" xlink:title="label: LiquidityAndCapitalResourcesTable to erna_LiquidityAndCapitalResourcesTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoticePeriodToAssumeControlPatents" xlink:label="NoticePeriodToAssumeControlPatents" xlink:title="NoticePeriodToAssumeControlPatents" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodToAssumeControlPatents_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoticePeriodToAssumeControlPatents_lbl" xml:lang="en-US" id="erna_NoticePeriodToAssumeControlPatents_lbl">The number of days to provide notice to assume control of such patents in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodToAssumeControlPatents" xlink:to="erna_NoticePeriodToAssumeControlPatents_lbl" xlink:title="label: NoticePeriodToAssumeControlPatents to erna_NoticePeriodToAssumeControlPatents_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodToAssumeControlPatents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoticePeriodToAssumeControlPatents_lbl1" xml:lang="en-US" id="erna_NoticePeriodToAssumeControlPatents_lbl1">Notice Period to Assume Control Patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodToAssumeControlPatents" xlink:to="erna_NoticePeriodToAssumeControlPatents_lbl1" xlink:title="label: NoticePeriodToAssumeControlPatents to erna_NoticePeriodToAssumeControlPatents_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodToAssumeControlPatents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoticePeriodToAssumeControlPatents" xml:lang="en-US" id="erna_NoticePeriodToAssumeControlPatents">Notice period to assume control patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodToAssumeControlPatents" xlink:to="erna_NoticePeriodToAssumeControlPatents" xlink:title="label: NoticePeriodToAssumeControlPatents to erna_NoticePeriodToAssumeControlPatents" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LicensingAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LicensingAgreementsAbstract_lbl1" xml:lang="en-US" id="erna_LicensingAgreementsAbstract_lbl1">Licensing Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicensingAgreementsAbstract" xlink:to="erna_LicensingAgreementsAbstract_lbl1" xlink:title="label: LicensingAgreementsAbstract to erna_LicensingAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LicensingAgreementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LicensingAgreementsAbstract" xml:lang="en-US" id="erna_LicensingAgreementsAbstract">Licensing Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicensingAgreementsAbstract" xlink:to="erna_LicensingAgreementsAbstract" xlink:title="label: LicensingAgreementsAbstract to erna_LicensingAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesTextBlock" xlink:label="LiquidityAndCapitalResourcesTextBlock" xlink:title="LiquidityAndCapitalResourcesTextBlock" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LiquidityAndCapitalResourcesTextBlock_lbl" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTextBlock_lbl">The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="erna_LiquidityAndCapitalResourcesTextBlock_lbl" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to erna_LiquidityAndCapitalResourcesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LiquidityAndCapitalResourcesTextBlock_lbl1" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTextBlock_lbl1">Liquidity And Capital Resources [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="erna_LiquidityAndCapitalResourcesTextBlock_lbl1" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to erna_LiquidityAndCapitalResourcesTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LiquidityAndCapitalResourcesTextBlock" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesTextBlock">Liquidity and Capital Resources</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="erna_LiquidityAndCapitalResourcesTextBlock" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to erna_LiquidityAndCapitalResourcesTextBlock" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesAbstract" xlink:label="LiquidityAndCapitalResourcesAbstract" xlink:title="LiquidityAndCapitalResourcesAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LiquidityAndCapitalResourcesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LiquidityAndCapitalResourcesAbstract_lbl1" xml:lang="en-US" id="erna_LiquidityAndCapitalResourcesAbstract_lbl1">Liquidity and Capital Resources [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesAbstract" xlink:to="erna_LiquidityAndCapitalResourcesAbstract_lbl1" xlink:title="label: LiquidityAndCapitalResourcesAbstract to erna_LiquidityAndCapitalResourcesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromOptionAndLicenseAgreement" xlink:label="ProceedsFromOptionAndLicenseAgreement" xlink:title="ProceedsFromOptionAndLicenseAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromOptionAndLicenseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ProceedsFromOptionAndLicenseAgreement_lbl" xml:lang="en-US" id="erna_ProceedsFromOptionAndLicenseAgreement_lbl">The cash inflow from exclusive option and license agreement as a non-refundable up-front payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOptionAndLicenseAgreement" xlink:to="erna_ProceedsFromOptionAndLicenseAgreement_lbl" xlink:title="label: ProceedsFromOptionAndLicenseAgreement to erna_ProceedsFromOptionAndLicenseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromOptionAndLicenseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProceedsFromOptionAndLicenseAgreement_lbl1" xml:lang="en-US" id="erna_ProceedsFromOptionAndLicenseAgreement_lbl1">Proceeds from Option and License Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOptionAndLicenseAgreement" xlink:to="erna_ProceedsFromOptionAndLicenseAgreement_lbl1" xlink:title="label: ProceedsFromOptionAndLicenseAgreement to erna_ProceedsFromOptionAndLicenseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromOptionAndLicenseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ProceedsFromOptionAndLicenseAgreement" xml:lang="en-US" id="erna_ProceedsFromOptionAndLicenseAgreement">Proceeds from option and license agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOptionAndLicenseAgreement" xlink:to="erna_ProceedsFromOptionAndLicenseAgreement" xlink:title="label: ProceedsFromOptionAndLicenseAgreement to erna_ProceedsFromOptionAndLicenseAgreement" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OptionFeeObligationPaymentPercentage" xlink:label="OptionFeeObligationPaymentPercentage" xlink:title="OptionFeeObligationPaymentPercentage" />
    <link:label xlink:type="resource" xlink:label="erna_OptionFeeObligationPaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OptionFeeObligationPaymentPercentage_lbl" xml:lang="en-US" id="erna_OptionFeeObligationPaymentPercentage_lbl">Percentage of obligated to payments of the option fees.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OptionFeeObligationPaymentPercentage" xlink:to="erna_OptionFeeObligationPaymentPercentage_lbl" xlink:title="label: OptionFeeObligationPaymentPercentage to erna_OptionFeeObligationPaymentPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OptionFeeObligationPaymentPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OptionFeeObligationPaymentPercentage_lbl1" xml:lang="en-US" id="erna_OptionFeeObligationPaymentPercentage_lbl1">Option Fee Obligation Payment Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OptionFeeObligationPaymentPercentage" xlink:to="erna_OptionFeeObligationPaymentPercentage_lbl1" xlink:title="label: OptionFeeObligationPaymentPercentage to erna_OptionFeeObligationPaymentPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OptionFeeObligationPaymentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OptionFeeObligationPaymentPercentage" xml:lang="en-US" id="erna_OptionFeeObligationPaymentPercentage">Option fee obligation payment percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OptionFeeObligationPaymentPercentage" xlink:to="erna_OptionFeeObligationPaymentPercentage" xlink:title="label: OptionFeeObligationPaymentPercentage to erna_OptionFeeObligationPaymentPercentage" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromCellLineCustomizationActivities" xlink:label="ProceedsFromCellLineCustomizationActivities" xlink:title="ProceedsFromCellLineCustomizationActivities" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromCellLineCustomizationActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ProceedsFromCellLineCustomizationActivities_lbl" xml:lang="en-US" id="erna_ProceedsFromCellLineCustomizationActivities_lbl">The cash inflow from cell line customization activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromCellLineCustomizationActivities" xlink:to="erna_ProceedsFromCellLineCustomizationActivities_lbl" xlink:title="label: ProceedsFromCellLineCustomizationActivities to erna_ProceedsFromCellLineCustomizationActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromCellLineCustomizationActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProceedsFromCellLineCustomizationActivities_lbl1" xml:lang="en-US" id="erna_ProceedsFromCellLineCustomizationActivities_lbl1">Proceeds from Cell Line Customization Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromCellLineCustomizationActivities" xlink:to="erna_ProceedsFromCellLineCustomizationActivities_lbl1" xlink:title="label: ProceedsFromCellLineCustomizationActivities to erna_ProceedsFromCellLineCustomizationActivities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromCellLineCustomizationActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ProceedsFromCellLineCustomizationActivities" xml:lang="en-US" id="erna_ProceedsFromCellLineCustomizationActivities">Proceeds from cell line customization activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromCellLineCustomizationActivities" xlink:to="erna_ProceedsFromCellLineCustomizationActivities" xlink:title="label: ProceedsFromCellLineCustomizationActivities to erna_ProceedsFromCellLineCustomizationActivities" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContractWithCustomersAbstract" xlink:label="ContractWithCustomersAbstract" xlink:title="ContractWithCustomersAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ContractWithCustomersAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ContractWithCustomersAbstract_lbl1" xml:lang="en-US" id="erna_ContractWithCustomersAbstract_lbl1">Contract with Customers [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomersAbstract" xlink:to="erna_ContractWithCustomersAbstract_lbl1" xlink:title="label: ContractWithCustomersAbstract to erna_ContractWithCustomersAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ContractWithCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ContractWithCustomersAbstract" xml:lang="en-US" id="erna_ContractWithCustomersAbstract">Contract with Customers [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractWithCustomersAbstract" xlink:to="erna_ContractWithCustomersAbstract" xlink:title="label: ContractWithCustomersAbstract to erna_ContractWithCustomersAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LitigationSettlementAmountPayable" xlink:label="LitigationSettlementAmountPayable" xlink:title="LitigationSettlementAmountPayable" />
    <link:label xlink:type="resource" xlink:label="erna_LitigationSettlementAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LitigationSettlementAmountPayable_lbl" xml:lang="en-US" id="erna_LitigationSettlementAmountPayable_lbl">Amount payable to other party in judgment or settlement of litigation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountPayable" xlink:to="erna_LitigationSettlementAmountPayable_lbl" xlink:title="label: LitigationSettlementAmountPayable to erna_LitigationSettlementAmountPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LitigationSettlementAmountPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LitigationSettlementAmountPayable_lbl1" xml:lang="en-US" id="erna_LitigationSettlementAmountPayable_lbl1">Litigation Settlement, Amount Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountPayable" xlink:to="erna_LitigationSettlementAmountPayable_lbl1" xlink:title="label: LitigationSettlementAmountPayable to erna_LitigationSettlementAmountPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LitigationSettlementAmountPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LitigationSettlementAmountPayable" xml:lang="en-US" id="erna_LitigationSettlementAmountPayable">Aggregate settlement amount payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountPayable" xlink:to="erna_LitigationSettlementAmountPayable" xlink:title="label: LitigationSettlementAmountPayable to erna_LitigationSettlementAmountPayable" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_LegalMattersAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LegalMattersAbstract_lbl1" xml:lang="en-US" id="erna_LegalMattersAbstract_lbl1">Legal Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalMattersAbstract" xlink:to="erna_LegalMattersAbstract_lbl1" xlink:title="label: LegalMattersAbstract to erna_LegalMattersAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LegalMattersAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LegalMattersAbstract" xml:lang="en-US" id="erna_LegalMattersAbstract">Legal Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalMattersAbstract" xlink:to="erna_LegalMattersAbstract" xlink:title="label: LegalMattersAbstract to erna_LegalMattersAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023AndDecember2023ConvertibleNotesMember" xlink:label="July2023AndDecember2023ConvertibleNotesMember" xlink:title="July2023AndDecember2023ConvertibleNotesMember" />
    <link:label xlink:type="resource" xlink:label="erna_July2023AndDecember2023ConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_July2023AndDecember2023ConvertibleNotesMember_lbl" xml:lang="en-US" id="erna_July2023AndDecember2023ConvertibleNotesMember_lbl">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023AndDecember2023ConvertibleNotesMember" xlink:to="erna_July2023AndDecember2023ConvertibleNotesMember_lbl" xlink:title="label: July2023AndDecember2023ConvertibleNotesMember to erna_July2023AndDecember2023ConvertibleNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_July2023AndDecember2023ConvertibleNotesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_July2023AndDecember2023ConvertibleNotesMember_lbl1" xml:lang="en-US" id="erna_July2023AndDecember2023ConvertibleNotesMember_lbl1">July 2023 and December 2023 Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023AndDecember2023ConvertibleNotesMember" xlink:to="erna_July2023AndDecember2023ConvertibleNotesMember_lbl1" xlink:title="label: July2023AndDecember2023ConvertibleNotesMember to erna_July2023AndDecember2023ConvertibleNotesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_July2023AndDecember2023ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_July2023AndDecember2023ConvertibleNotesMember" xml:lang="en-US" id="erna_July2023AndDecember2023ConvertibleNotesMember">July 2023 and December 2023 Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023AndDecember2023ConvertibleNotesMember" xlink:to="erna_July2023AndDecember2023ConvertibleNotesMember" xlink:title="label: July2023AndDecember2023ConvertibleNotesMember to erna_July2023AndDecember2023ConvertibleNotesMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="ClassOfWarrantOrRightGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl">The number of grants made during the period on warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightGrantsInPeriod" xlink:to="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl" xlink:title="label: ClassOfWarrantOrRightGrantsInPeriod to erna_ClassOfWarrantOrRightGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1">Class of Warrant or Right Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightGrantsInPeriod" xlink:to="erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1" xlink:title="label: ClassOfWarrantOrRightGrantsInPeriod to erna_ClassOfWarrantOrRightGrantsInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ClassOfWarrantOrRightGrantsInPeriod" xml:lang="en-US" id="erna_ClassOfWarrantOrRightGrantsInPeriod">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightGrantsInPeriod" xlink:to="erna_ClassOfWarrantOrRightGrantsInPeriod" xlink:title="label: ClassOfWarrantOrRightGrantsInPeriod to erna_ClassOfWarrantOrRightGrantsInPeriod" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsOneMember" xlink:label="CommonWarrantsOneMember" xlink:title="CommonWarrantsOneMember" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommonWarrantsOneMember_lbl" xml:lang="en-US" id="erna_CommonWarrantsOneMember_lbl">A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsOneMember" xlink:to="erna_CommonWarrantsOneMember_lbl" xlink:title="label: CommonWarrantsOneMember to erna_CommonWarrantsOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommonWarrantsOneMember_lbl1" xml:lang="en-US" id="erna_CommonWarrantsOneMember_lbl1">Common Warrants One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsOneMember" xlink:to="erna_CommonWarrantsOneMember_lbl1" xlink:title="label: CommonWarrantsOneMember to erna_CommonWarrantsOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CommonWarrantsOneMember" xml:lang="en-US" id="erna_CommonWarrantsOneMember">Q4-22 Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsOneMember" xlink:to="erna_CommonWarrantsOneMember" xlink:title="label: CommonWarrantsOneMember to erna_CommonWarrantsOneMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoteWarrantsAbstract" xlink:label="NoteWarrantsAbstract" xlink:title="NoteWarrantsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_NoteWarrantsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoteWarrantsAbstract_lbl1" xml:lang="en-US" id="erna_NoteWarrantsAbstract_lbl1">Note Warrants [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoteWarrantsAbstract" xlink:to="erna_NoteWarrantsAbstract_lbl1" xlink:title="label: NoteWarrantsAbstract to erna_NoteWarrantsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RetirementPlan401KMember" xlink:label="RetirementPlan401KMember" xlink:title="RetirementPlan401KMember" />
    <link:label xlink:type="resource" xlink:label="erna_RetirementPlan401KMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RetirementPlan401KMember_lbl" xml:lang="en-US" id="erna_RetirementPlan401KMember_lbl">A defined-contribution retirement account which allows employees to save a portion of their salary in a tax-advantaged manner. The money earned in a 401(k) Plan is not taxed until after the employee retires, at which time their income will typically be lower than during their working years.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlan401KMember" xlink:to="erna_RetirementPlan401KMember_lbl" xlink:title="label: RetirementPlan401KMember to erna_RetirementPlan401KMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RetirementPlan401KMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RetirementPlan401KMember_lbl1" xml:lang="en-US" id="erna_RetirementPlan401KMember_lbl1">Retirement Plan, 401K [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlan401KMember" xlink:to="erna_RetirementPlan401KMember_lbl1" xlink:title="label: RetirementPlan401KMember to erna_RetirementPlan401KMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RetirementPlan401KMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RetirementPlan401KMember" xml:lang="en-US" id="erna_RetirementPlan401KMember">401K [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetirementPlan401KMember" xlink:to="erna_RetirementPlan401KMember" xlink:title="label: RetirementPlan401KMember to erna_RetirementPlan401KMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdOne" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl">Percentage of employee contribution to the plan that is fully matched by the employer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdOne to erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1">Defined Contribution Plan Employee Contribution at Threshold One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdOne to erna_DefinedContributionPlanEmployeeContributionAtThresholdOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne">Employee contribution threshold for matching percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdOne to erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:label="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl">Defined contribution plan, deferral percentage of employee on their pay on pre-tax basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:to="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl" xlink:title="label: DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis to erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1">Defined Contribution Plan, Deferral Percent of Their Pay on Pre-tax Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:to="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1" xlink:title="label: DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis to erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xml:lang="en-US" id="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis">Employees contribution, deferral percentage of their pay on a pre-tax basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:to="erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="label: DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis to erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl">Percentage employer matches of the employee's percentage contribution up to a certain percentage matched.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1">Defined Contribution Plan Employer Matching Contribution Percent of Match One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne">Employer matching contribution up to first 3%</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl">Percentage employer matches of the employee's percentage contribution in excess of certain percentage matched.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1">Defined Contribution Plan Employer Matching Contribution Percent of Match Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xml:lang="en-US" id="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo">Employer matching contribution in excess of first 2%</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:to="erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo to erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdTwo" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl">Percentage of employee contribution to the plan that is fully matched by the employer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdTwo to erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1">Defined Contribution Plan Employee Contribution At Threshold Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdTwo to erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xml:lang="en-US" id="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo">Deferred compensation matched by employer, next match</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:to="erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="label: DefinedContributionPlanEmployeeContributionAtThresholdTwo to erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAgreementMember" xlink:label="ExacisAssetPurchaseAgreementMember" xlink:title="ExacisAssetPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisAssetPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ExacisAssetPurchaseAgreementMember_lbl" xml:lang="en-US" id="erna_ExacisAssetPurchaseAgreementMember_lbl">Information about asset purchase agreement (the "Purchase Agreement"), together with Exacis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisAssetPurchaseAgreementMember" xlink:to="erna_ExacisAssetPurchaseAgreementMember_lbl" xlink:title="label: ExacisAssetPurchaseAgreementMember to erna_ExacisAssetPurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisAssetPurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ExacisAssetPurchaseAgreementMember_lbl1" xml:lang="en-US" id="erna_ExacisAssetPurchaseAgreementMember_lbl1">Exacis Asset Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisAssetPurchaseAgreementMember" xlink:to="erna_ExacisAssetPurchaseAgreementMember_lbl1" xlink:title="label: ExacisAssetPurchaseAgreementMember to erna_ExacisAssetPurchaseAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisAssetPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ExacisAssetPurchaseAgreementMember" xml:lang="en-US" id="erna_ExacisAssetPurchaseAgreementMember">Exacis Asset Purchase [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisAssetPurchaseAgreementMember" xlink:to="erna_ExacisAssetPurchaseAgreementMember" xlink:title="label: ExacisAssetPurchaseAgreementMember to erna_ExacisAssetPurchaseAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommonWarrantsMember_lbl" xml:lang="en-US" id="erna_CommonWarrantsMember_lbl">A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="erna_CommonWarrantsMember_lbl" xlink:title="label: CommonWarrantsMember to erna_CommonWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommonWarrantsMember_lbl1" xml:lang="en-US" id="erna_CommonWarrantsMember_lbl1">Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="erna_CommonWarrantsMember_lbl1" xlink:title="label: CommonWarrantsMember to erna_CommonWarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_CommonWarrantsMember" xml:lang="en-US" id="erna_CommonWarrantsMember">Q1-22 Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="erna_CommonWarrantsMember" xlink:title="label: CommonWarrantsMember to erna_CommonWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_CommonWarrantsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CommonWarrantsMember_lbl2" xml:lang="en-US" id="erna_CommonWarrantsMember_lbl2">Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="erna_CommonWarrantsMember_lbl2" xlink:title="label: CommonWarrantsMember to erna_CommonWarrantsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MarketCapContingentConsiderationMember" xlink:label="MarketCapContingentConsiderationMember" xlink:title="MarketCapContingentConsiderationMember" />
    <link:label xlink:type="resource" xlink:label="erna_MarketCapContingentConsiderationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_MarketCapContingentConsiderationMember_lbl" xml:lang="en-US" id="erna_MarketCapContingentConsiderationMember_lbl">The Market Cap Contingent Consideration is indexed to or settled in the Company's own shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketCapContingentConsiderationMember" xlink:to="erna_MarketCapContingentConsiderationMember_lbl" xlink:title="label: MarketCapContingentConsiderationMember to erna_MarketCapContingentConsiderationMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_MarketCapContingentConsiderationMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_MarketCapContingentConsiderationMember_lbl1" xml:lang="en-US" id="erna_MarketCapContingentConsiderationMember_lbl1">Market Cap Contingent Consideration [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketCapContingentConsiderationMember" xlink:to="erna_MarketCapContingentConsiderationMember_lbl1" xlink:title="label: MarketCapContingentConsiderationMember to erna_MarketCapContingentConsiderationMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_MarketCapContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_MarketCapContingentConsiderationMember" xml:lang="en-US" id="erna_MarketCapContingentConsiderationMember">Market Cap Contingent Consideration [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketCapContingentConsiderationMember" xlink:to="erna_MarketCapContingentConsiderationMember" xlink:title="label: MarketCapContingentConsiderationMember to erna_MarketCapContingentConsiderationMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleDebtMeasurementInput" xlink:label="ConvertibleDebtMeasurementInput" xlink:title="ConvertibleDebtMeasurementInput" />
    <link:label xlink:type="resource" xlink:label="erna_ConvertibleDebtMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ConvertibleDebtMeasurementInput_lbl" xml:lang="en-US" id="erna_ConvertibleDebtMeasurementInput_lbl">Value of input used to measure fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtMeasurementInput" xlink:to="erna_ConvertibleDebtMeasurementInput_lbl" xlink:title="label: ConvertibleDebtMeasurementInput to erna_ConvertibleDebtMeasurementInput_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ConvertibleDebtMeasurementInput_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ConvertibleDebtMeasurementInput_lbl1" xml:lang="en-US" id="erna_ConvertibleDebtMeasurementInput_lbl1">Convertible Debt Measurement Input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtMeasurementInput" xlink:to="erna_ConvertibleDebtMeasurementInput_lbl1" xlink:title="label: ConvertibleDebtMeasurementInput to erna_ConvertibleDebtMeasurementInput_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ConvertibleDebtMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ConvertibleDebtMeasurementInput" xml:lang="en-US" id="erna_ConvertibleDebtMeasurementInput">Measurement input</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleDebtMeasurementInput" xlink:to="erna_ConvertibleDebtMeasurementInput" xlink:title="label: ConvertibleDebtMeasurementInput to erna_ConvertibleDebtMeasurementInput" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ChangeInFairValueOfContingentConsideration" xlink:label="ChangeInFairValueOfContingentConsideration" xlink:title="ChangeInFairValueOfContingentConsideration" />
    <link:label xlink:type="resource" xlink:label="erna_ChangeInFairValueOfContingentConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ChangeInFairValueOfContingentConsideration_lbl" xml:lang="en-US" id="erna_ChangeInFairValueOfContingentConsideration_lbl">Amount of change in fair value of contingent consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChangeInFairValueOfContingentConsideration" xlink:to="erna_ChangeInFairValueOfContingentConsideration_lbl" xlink:title="label: ChangeInFairValueOfContingentConsideration to erna_ChangeInFairValueOfContingentConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ChangeInFairValueOfContingentConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ChangeInFairValueOfContingentConsideration_lbl1" xml:lang="en-US" id="erna_ChangeInFairValueOfContingentConsideration_lbl1">Change in Fair Value of Contingent Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChangeInFairValueOfContingentConsideration" xlink:to="erna_ChangeInFairValueOfContingentConsideration_lbl1" xlink:title="label: ChangeInFairValueOfContingentConsideration to erna_ChangeInFairValueOfContingentConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ChangeInFairValueOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ChangeInFairValueOfContingentConsideration" xml:lang="en-US" id="erna_ChangeInFairValueOfContingentConsideration">Change in fair value of contingent consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChangeInFairValueOfContingentConsideration" xlink:to="erna_ChangeInFairValueOfContingentConsideration" xlink:title="label: ChangeInFairValueOfContingentConsideration to erna_ChangeInFairValueOfContingentConsideration" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationMember" xlink:label="ContingentConsiderationMember" xlink:title="ContingentConsiderationMember" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ContingentConsiderationMember_lbl" xml:lang="en-US" id="erna_ContingentConsiderationMember_lbl">Description of contingent payment arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationMember" xlink:to="erna_ContingentConsiderationMember_lbl" xlink:title="label: ContingentConsiderationMember to erna_ContingentConsiderationMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ContingentConsiderationMember_lbl1" xml:lang="en-US" id="erna_ContingentConsiderationMember_lbl1">Contingent Consideration [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationMember" xlink:to="erna_ContingentConsiderationMember_lbl1" xlink:title="label: ContingentConsiderationMember to erna_ContingentConsiderationMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ContingentConsiderationMember" xml:lang="en-US" id="erna_ContingentConsiderationMember">Contingent Consideration [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationMember" xlink:to="erna_ContingentConsiderationMember" xlink:title="label: ContingentConsiderationMember to erna_ContingentConsiderationMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedLegalFeesAndRelatedCurrent" xlink:label="AccruedLegalFeesAndRelatedCurrent" xlink:title="AccruedLegalFeesAndRelatedCurrent" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedLegalFeesAndRelatedCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AccruedLegalFeesAndRelatedCurrent_lbl" xml:lang="en-US" id="erna_AccruedLegalFeesAndRelatedCurrent_lbl">Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal fees and related. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLegalFeesAndRelatedCurrent" xlink:to="erna_AccruedLegalFeesAndRelatedCurrent_lbl" xlink:title="label: AccruedLegalFeesAndRelatedCurrent to erna_AccruedLegalFeesAndRelatedCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedLegalFeesAndRelatedCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AccruedLegalFeesAndRelatedCurrent_lbl1" xml:lang="en-US" id="erna_AccruedLegalFeesAndRelatedCurrent_lbl1">Accrued Legal Fees and Related, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLegalFeesAndRelatedCurrent" xlink:to="erna_AccruedLegalFeesAndRelatedCurrent_lbl1" xlink:title="label: AccruedLegalFeesAndRelatedCurrent to erna_AccruedLegalFeesAndRelatedCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedLegalFeesAndRelatedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AccruedLegalFeesAndRelatedCurrent" xml:lang="en-US" id="erna_AccruedLegalFeesAndRelatedCurrent">Legal fees and related</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLegalFeesAndRelatedCurrent" xlink:to="erna_AccruedLegalFeesAndRelatedCurrent" xlink:title="label: AccruedLegalFeesAndRelatedCurrent to erna_AccruedLegalFeesAndRelatedCurrent" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedClinicalCurrent" xlink:label="AccruedClinicalCurrent" xlink:title="AccruedClinicalCurrent" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedClinicalCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AccruedClinicalCurrent_lbl" xml:lang="en-US" id="erna_AccruedClinicalCurrent_lbl">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical trail cost (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalCurrent" xlink:to="erna_AccruedClinicalCurrent_lbl" xlink:title="label: AccruedClinicalCurrent to erna_AccruedClinicalCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedClinicalCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AccruedClinicalCurrent_lbl1" xml:lang="en-US" id="erna_AccruedClinicalCurrent_lbl1">Accrued Clinical, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalCurrent" xlink:to="erna_AccruedClinicalCurrent_lbl1" xlink:title="label: AccruedClinicalCurrent to erna_AccruedClinicalCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedClinicalCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AccruedClinicalCurrent" xml:lang="en-US" id="erna_AccruedClinicalCurrent">Clinical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedClinicalCurrent" xlink:to="erna_AccruedClinicalCurrent" xlink:title="label: AccruedClinicalCurrent to erna_AccruedClinicalCurrent" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedSomervilleFacilityCurrent" xlink:label="AccruedSomervilleFacilityCurrent" xlink:title="AccruedSomervilleFacilityCurrent" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedSomervilleFacilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AccruedSomervilleFacilityCurrent_lbl" xml:lang="en-US" id="erna_AccruedSomervilleFacilityCurrent_lbl">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to somerville facility (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedSomervilleFacilityCurrent" xlink:to="erna_AccruedSomervilleFacilityCurrent_lbl" xlink:title="label: AccruedSomervilleFacilityCurrent to erna_AccruedSomervilleFacilityCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedSomervilleFacilityCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AccruedSomervilleFacilityCurrent_lbl1" xml:lang="en-US" id="erna_AccruedSomervilleFacilityCurrent_lbl1">Accrued Somerville Facility, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedSomervilleFacilityCurrent" xlink:to="erna_AccruedSomervilleFacilityCurrent_lbl1" xlink:title="label: AccruedSomervilleFacilityCurrent to erna_AccruedSomervilleFacilityCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AccruedSomervilleFacilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AccruedSomervilleFacilityCurrent" xml:lang="en-US" id="erna_AccruedSomervilleFacilityCurrent">Somerville facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedSomervilleFacilityCurrent" xlink:to="erna_AccruedSomervilleFacilityCurrent" xlink:title="label: AccruedSomervilleFacilityCurrent to erna_AccruedSomervilleFacilityCurrent" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:label="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:title="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" />
    <link:label xlink:type="resource" xlink:label="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US" id="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl">The amount of interest expense debt excluding amortization of financing costs and discounts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:to="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl" xlink:title="label: InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts to erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl1" xml:lang="en-US" id="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl1">Interest Expense Debt Excluding Amortization Of Financing Costs And Discounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:to="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl1" xlink:title="label: InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts to erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xml:lang="en-US" id="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts">Remaining of interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:to="erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:title="label: InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts to erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:label="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:title="PromissoryNoteAndConvertibleNoteFinancingAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract_lbl1" xml:lang="en-US" id="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract_lbl1">Promissory Note and Convertible Note Financing [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:to="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract_lbl1" xlink:title="label: PromissoryNoteAndConvertibleNoteFinancingAbstract to erna_PromissoryNoteAndConvertibleNoteFinancingAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract" xml:lang="en-US" id="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract">Promissory Note and Convertible Note Financing [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:to="erna_PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:title="label: PromissoryNoteAndConvertibleNoteFinancingAbstract to erna_PromissoryNoteAndConvertibleNoteFinancingAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:label="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:title="PaidInKindInterestAddedToConvertibleNotesPrincipal" />
    <link:label xlink:type="resource" xlink:label="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl" xml:lang="en-US" id="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl">The paid-in-kind interest added to convertible notes principal in noncash financing activities..</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:to="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl" xlink:title="label: PaidInKindInterestAddedToConvertibleNotesPrincipal to erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl1" xml:lang="en-US" id="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl1">Paid-in-Kind Interest Added to Convertible Notes Principal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:to="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl1" xlink:title="label: PaidInKindInterestAddedToConvertibleNotesPrincipal to erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" xml:lang="en-US" id="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal">Paid-in-kind interest added to convertible notes principal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:to="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:title="label: PaidInKindInterestAddedToConvertibleNotesPrincipal to erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" />
    <link:label xlink:type="resource" xlink:label="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl2" xml:lang="en-US" id="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl2">Paid-in-kind interest added to principal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:to="erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl2" xlink:title="label: PaidInKindInterestAddedToConvertibleNotesPrincipal to erna_PaidInKindInterestAddedToConvertibleNotesPrincipal_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleNotesAbstract" xlink:label="ConvertibleNotesAbstract" xlink:title="ConvertibleNotesAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ConvertibleNotesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ConvertibleNotesAbstract_lbl1" xml:lang="en-US" id="erna_ConvertibleNotesAbstract_lbl1">Convertible Notes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleNotesAbstract" xlink:to="erna_ConvertibleNotesAbstract_lbl1" xlink:title="label: ConvertibleNotesAbstract to erna_ConvertibleNotesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_December2023WarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_December2023WarrantsMember_lbl" xml:lang="en-US" id="erna_December2023WarrantsMember_lbl">Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount issued in December 2023.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2023WarrantsMember" xlink:to="erna_December2023WarrantsMember_lbl" xlink:title="label: December2023WarrantsMember to erna_December2023WarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_December2023WarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_December2023WarrantsMember_lbl1" xml:lang="en-US" id="erna_December2023WarrantsMember_lbl1">December 2023 Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2023WarrantsMember" xlink:to="erna_December2023WarrantsMember_lbl1" xlink:title="label: December2023WarrantsMember to erna_December2023WarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_December2023WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_December2023WarrantsMember" xml:lang="en-US" id="erna_December2023WarrantsMember">December 2023 Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2023WarrantsMember" xlink:to="erna_December2023WarrantsMember" xlink:title="label: December2023WarrantsMember to erna_December2023WarrantsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_July2023WarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_July2023WarrantsMember_lbl" xml:lang="en-US" id="erna_July2023WarrantsMember_lbl">Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount issued in July 2023.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023WarrantsMember" xlink:to="erna_July2023WarrantsMember_lbl" xlink:title="label: July2023WarrantsMember to erna_July2023WarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_July2023WarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_July2023WarrantsMember_lbl1" xml:lang="en-US" id="erna_July2023WarrantsMember_lbl1">July 2023 Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023WarrantsMember" xlink:to="erna_July2023WarrantsMember_lbl1" xlink:title="label: July2023WarrantsMember to erna_July2023WarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_July2023WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_July2023WarrantsMember" xml:lang="en-US" id="erna_July2023WarrantsMember">July 2023 Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023WarrantsMember" xlink:to="erna_July2023WarrantsMember" xlink:title="label: July2023WarrantsMember to erna_July2023WarrantsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023ConvertibleNotesMember" xlink:label="July2023ConvertibleNotesMember" xlink:title="July2023ConvertibleNotesMember" />
    <link:label xlink:type="resource" xlink:label="erna_July2023ConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_July2023ConvertibleNotesMember_lbl" xml:lang="en-US" id="erna_July2023ConvertibleNotesMember_lbl">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock issued in July 2023.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023ConvertibleNotesMember" xlink:to="erna_July2023ConvertibleNotesMember_lbl" xlink:title="label: July2023ConvertibleNotesMember to erna_July2023ConvertibleNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_July2023ConvertibleNotesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_July2023ConvertibleNotesMember_lbl1" xml:lang="en-US" id="erna_July2023ConvertibleNotesMember_lbl1">July 2023 Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023ConvertibleNotesMember" xlink:to="erna_July2023ConvertibleNotesMember_lbl1" xlink:title="label: July2023ConvertibleNotesMember to erna_July2023ConvertibleNotesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_July2023ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_July2023ConvertibleNotesMember" xml:lang="en-US" id="erna_July2023ConvertibleNotesMember">July 2023 Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="July2023ConvertibleNotesMember" xlink:to="erna_July2023ConvertibleNotesMember" xlink:title="label: July2023ConvertibleNotesMember to erna_July2023ConvertibleNotesMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:label xlink:type="resource" xlink:label="erna_December2023ConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_December2023ConvertibleNotesMember_lbl" xml:lang="en-US" id="erna_December2023ConvertibleNotesMember_lbl">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock issued in December 2023.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2023ConvertibleNotesMember" xlink:to="erna_December2023ConvertibleNotesMember_lbl" xlink:title="label: December2023ConvertibleNotesMember to erna_December2023ConvertibleNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_December2023ConvertibleNotesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_December2023ConvertibleNotesMember_lbl1" xml:lang="en-US" id="erna_December2023ConvertibleNotesMember_lbl1">December 2023 Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2023ConvertibleNotesMember" xlink:to="erna_December2023ConvertibleNotesMember_lbl1" xlink:title="label: December2023ConvertibleNotesMember to erna_December2023ConvertibleNotesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_December2023ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_December2023ConvertibleNotesMember" xml:lang="en-US" id="erna_December2023ConvertibleNotesMember">December 2023 Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2023ConvertibleNotesMember" xlink:to="erna_December2023ConvertibleNotesMember" xlink:title="label: December2023ConvertibleNotesMember to erna_December2023ConvertibleNotesMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="erna_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PreFundedWarrantsMember_lbl" xml:lang="en-US" id="erna_PreFundedWarrantsMember_lbl">A pre-funded warrant that allows the warrant holder to purchase a specified number of a company's securities at a nominal exercise price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="erna_PreFundedWarrantsMember_lbl" xlink:title="label: PreFundedWarrantsMember to erna_PreFundedWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PreFundedWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PreFundedWarrantsMember_lbl1" xml:lang="en-US" id="erna_PreFundedWarrantsMember_lbl1">Pre-funded Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="erna_PreFundedWarrantsMember_lbl1" xlink:title="label: PreFundedWarrantsMember to erna_PreFundedWarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PreFundedWarrantsMember" xml:lang="en-US" id="erna_PreFundedWarrantsMember">Pre-funded Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="erna_PreFundedWarrantsMember" xlink:title="label: PreFundedWarrantsMember to erna_PreFundedWarrantsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_FactorBioscienceIncMember" xlink:label="FactorBioscienceIncMember" xlink:title="FactorBioscienceIncMember" />
    <link:label xlink:type="resource" xlink:label="erna_FactorBioscienceIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_FactorBioscienceIncMember_lbl" xml:lang="en-US" id="erna_FactorBioscienceIncMember_lbl">A corporation the company entered into agreement to provide the Company with MRNA cell engineering research support services, including access to certain facilities, equipment, materials and training, and the Company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FactorBioscienceIncMember" xlink:to="erna_FactorBioscienceIncMember_lbl" xlink:title="label: FactorBioscienceIncMember to erna_FactorBioscienceIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_FactorBioscienceIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_FactorBioscienceIncMember_lbl1" xml:lang="en-US" id="erna_FactorBioscienceIncMember_lbl1">Factor Bioscience Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FactorBioscienceIncMember" xlink:to="erna_FactorBioscienceIncMember_lbl1" xlink:title="label: FactorBioscienceIncMember to erna_FactorBioscienceIncMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_FactorBioscienceIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_FactorBioscienceIncMember" xml:lang="en-US" id="erna_FactorBioscienceIncMember">Factor Bioscience Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FactorBioscienceIncMember" xlink:to="erna_FactorBioscienceIncMember" xlink:title="label: FactorBioscienceIncMember to erna_FactorBioscienceIncMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PIPEInvestorMember_lbl" xml:lang="en-US" id="erna_PIPEInvestorMember_lbl">A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="erna_PIPEInvestorMember_lbl" xlink:title="label: PIPEInvestorMember to erna_PIPEInvestorMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PIPEInvestorMember_lbl1" xml:lang="en-US" id="erna_PIPEInvestorMember_lbl1">PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="erna_PIPEInvestorMember_lbl1" xlink:title="label: PIPEInvestorMember to erna_PIPEInvestorMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PIPEInvestorMember" xml:lang="en-US" id="erna_PIPEInvestorMember">PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="erna_PIPEInvestorMember" xlink:title="label: PIPEInvestorMember to erna_PIPEInvestorMember" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_PIPEInvestorMember_lbl2" xml:lang="en-US" id="erna_PIPEInvestorMember_lbl2">Q1-22 PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="erna_PIPEInvestorMember_lbl2" xlink:title="label: PIPEInvestorMember to erna_PIPEInvestorMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RelatedPartyTransactionAbstract" xlink:label="RelatedPartyTransactionAbstract" xlink:title="RelatedPartyTransactionAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_RelatedPartyTransactionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RelatedPartyTransactionAbstract_lbl1" xml:lang="en-US" id="erna_RelatedPartyTransactionAbstract_lbl1">Related Party Transaction [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionAbstract" xlink:to="erna_RelatedPartyTransactionAbstract_lbl1" xlink:title="label: RelatedPartyTransactionAbstract to erna_RelatedPartyTransactionAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RelatedPartyTransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RelatedPartyTransactionAbstract" xml:lang="en-US" id="erna_RelatedPartyTransactionAbstract">Related Party Transaction [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionAbstract" xlink:to="erna_RelatedPartyTransactionAbstract" xlink:title="label: RelatedPartyTransactionAbstract to erna_RelatedPartyTransactionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfMonthlyInstallmentsForFeesPayable" xlink:label="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="NumberOfMonthlyInstallmentsForFeesPayable" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl" xml:lang="en-US" id="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl">The number of equal monthly installments for initial fees payable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfMonthlyInstallmentsForFeesPayable" xlink:to="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl" xlink:title="label: NumberOfMonthlyInstallmentsForFeesPayable to erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1" xml:lang="en-US" id="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1">Number of Monthly Installments for Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfMonthlyInstallmentsForFeesPayable" xlink:to="erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1" xlink:title="label: NumberOfMonthlyInstallmentsForFeesPayable to erna_NumberOfMonthlyInstallmentsForFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfMonthlyInstallmentsForFeesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfMonthlyInstallmentsForFeesPayable" xml:lang="en-US" id="erna_NumberOfMonthlyInstallmentsForFeesPayable">Number of monthly installments for fees payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfMonthlyInstallmentsForFeesPayable" xlink:to="erna_NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="label: NumberOfMonthlyInstallmentsForFeesPayable to erna_NumberOfMonthlyInstallmentsForFeesPayable" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoticePeriodForFirstTerminationOfContract" xlink:label="NoticePeriodForFirstTerminationOfContract" xlink:title="NoticePeriodForFirstTerminationOfContract" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForFirstTerminationOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoticePeriodForFirstTerminationOfContract_lbl" xml:lang="en-US" id="erna_NoticePeriodForFirstTerminationOfContract_lbl">The Company may terminate the first work under the MSA on or after the second anniversary of the date of the MSA, subject to providing Factor with prior notice, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForFirstTerminationOfContract" xlink:to="erna_NoticePeriodForFirstTerminationOfContract_lbl" xlink:title="label: NoticePeriodForFirstTerminationOfContract to erna_NoticePeriodForFirstTerminationOfContract_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForFirstTerminationOfContract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoticePeriodForFirstTerminationOfContract_lbl1" xml:lang="en-US" id="erna_NoticePeriodForFirstTerminationOfContract_lbl1">Notice Period for First Termination of Contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForFirstTerminationOfContract" xlink:to="erna_NoticePeriodForFirstTerminationOfContract_lbl1" xlink:title="label: NoticePeriodForFirstTerminationOfContract to erna_NoticePeriodForFirstTerminationOfContract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForFirstTerminationOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoticePeriodForFirstTerminationOfContract" xml:lang="en-US" id="erna_NoticePeriodForFirstTerminationOfContract">Notice period for first termination of contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForFirstTerminationOfContract" xlink:to="erna_NoticePeriodForFirstTerminationOfContract" xlink:title="label: NoticePeriodForFirstTerminationOfContract to erna_NoticePeriodForFirstTerminationOfContract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingUnamortizedLicenseFeeObligation" xlink:label="RemainingUnamortizedLicenseFeeObligation" xlink:title="RemainingUnamortizedLicenseFeeObligation" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingUnamortizedLicenseFeeObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RemainingUnamortizedLicenseFeeObligation_lbl" xml:lang="en-US" id="erna_RemainingUnamortizedLicenseFeeObligation_lbl">The amount of remaining unamortized license fee obligation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingUnamortizedLicenseFeeObligation" xlink:to="erna_RemainingUnamortizedLicenseFeeObligation_lbl" xlink:title="label: RemainingUnamortizedLicenseFeeObligation to erna_RemainingUnamortizedLicenseFeeObligation_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingUnamortizedLicenseFeeObligation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RemainingUnamortizedLicenseFeeObligation_lbl1" xml:lang="en-US" id="erna_RemainingUnamortizedLicenseFeeObligation_lbl1">Remaining Unamortized License Fee Obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingUnamortizedLicenseFeeObligation" xlink:to="erna_RemainingUnamortizedLicenseFeeObligation_lbl1" xlink:title="label: RemainingUnamortizedLicenseFeeObligation to erna_RemainingUnamortizedLicenseFeeObligation_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RemainingUnamortizedLicenseFeeObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RemainingUnamortizedLicenseFeeObligation" xml:lang="en-US" id="erna_RemainingUnamortizedLicenseFeeObligation">Remaining unamortized license fee obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingUnamortizedLicenseFeeObligation" xlink:to="erna_RemainingUnamortizedLicenseFeeObligation" xlink:title="label: RemainingUnamortizedLicenseFeeObligation to erna_RemainingUnamortizedLicenseFeeObligation" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_Q422PIPETransactionAbstract" xlink:label="Q422PIPETransactionAbstract" xlink:title="Q422PIPETransactionAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_Q422PIPETransactionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_Q422PIPETransactionAbstract_lbl1" xml:lang="en-US" id="erna_Q422PIPETransactionAbstract_lbl1">Q4-22 PIPE Transaction [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Q422PIPETransactionAbstract" xlink:to="erna_Q422PIPETransactionAbstract_lbl1" xlink:title="label: Q422PIPETransactionAbstract to erna_Q422PIPETransactionAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_Q422PIPETransactionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_Q422PIPETransactionAbstract" xml:lang="en-US" id="erna_Q422PIPETransactionAbstract">Q4-22 PIPE [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Q422PIPETransactionAbstract" xlink:to="erna_Q422PIPETransactionAbstract" xlink:title="label: Q422PIPETransactionAbstract to erna_Q422PIPETransactionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_UnitPriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_UnitPriceOfWarrants_lbl" xml:lang="en-US" id="erna_UnitPriceOfWarrants_lbl">Exercise price of prefunded and common warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnitPriceOfWarrants" xlink:to="erna_UnitPriceOfWarrants_lbl" xlink:title="label: UnitPriceOfWarrants to erna_UnitPriceOfWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_UnitPriceOfWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_UnitPriceOfWarrants_lbl1" xml:lang="en-US" id="erna_UnitPriceOfWarrants_lbl1">Unit Price of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnitPriceOfWarrants" xlink:to="erna_UnitPriceOfWarrants_lbl1" xlink:title="label: UnitPriceOfWarrants to erna_UnitPriceOfWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_UnitPriceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_UnitPriceOfWarrants" xml:lang="en-US" id="erna_UnitPriceOfWarrants">Unit price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnitPriceOfWarrants" xlink:to="erna_UnitPriceOfWarrants" xlink:title="label: UnitPriceOfWarrants to erna_UnitPriceOfWarrants" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:label="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:title="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl" xml:lang="en-US" id="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl">Company will pay to Factor of sublicense fees paid before license expiration date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:to="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl" xlink:title="label: PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate to erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl1" xml:lang="en-US" id="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl1">Percentage of Sublicense Fees Paid Before License Expiration Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:to="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl1" xlink:title="label: PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate to erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xml:lang="en-US" id="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate">Percentage of sublicense fees paid before license expiration date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:to="erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:title="label: PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate to erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MasterServiceAgreementInitialFeesPayable" xlink:label="MasterServiceAgreementInitialFeesPayable" xlink:title="MasterServiceAgreementInitialFeesPayable" />
    <link:label xlink:type="resource" xlink:label="erna_MasterServiceAgreementInitialFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_MasterServiceAgreementInitialFeesPayable_lbl" xml:lang="en-US" id="erna_MasterServiceAgreementInitialFeesPayable_lbl">The amount agreed to pay an initial fee under Master Services Agreement (or "MSA").</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MasterServiceAgreementInitialFeesPayable" xlink:to="erna_MasterServiceAgreementInitialFeesPayable_lbl" xlink:title="label: MasterServiceAgreementInitialFeesPayable to erna_MasterServiceAgreementInitialFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_MasterServiceAgreementInitialFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_MasterServiceAgreementInitialFeesPayable_lbl1" xml:lang="en-US" id="erna_MasterServiceAgreementInitialFeesPayable_lbl1">Master Service Agreement, Initial Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MasterServiceAgreementInitialFeesPayable" xlink:to="erna_MasterServiceAgreementInitialFeesPayable_lbl1" xlink:title="label: MasterServiceAgreementInitialFeesPayable to erna_MasterServiceAgreementInitialFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_MasterServiceAgreementInitialFeesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_MasterServiceAgreementInitialFeesPayable" xml:lang="en-US" id="erna_MasterServiceAgreementInitialFeesPayable">Master services agreement, initial fees payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MasterServiceAgreementInitialFeesPayable" xlink:to="erna_MasterServiceAgreementInitialFeesPayable" xlink:title="label: MasterServiceAgreementInitialFeesPayable to erna_MasterServiceAgreementInitialFeesPayable" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialLicenseFeeObligation" xlink:label="InitialLicenseFeeObligation" xlink:title="InitialLicenseFeeObligation" />
    <link:label xlink:type="resource" xlink:label="erna_InitialLicenseFeeObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_InitialLicenseFeeObligation_lbl" xml:lang="en-US" id="erna_InitialLicenseFeeObligation_lbl">The amount of initial license fees required to pay including non-refundable fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFeeObligation" xlink:to="erna_InitialLicenseFeeObligation_lbl" xlink:title="label: InitialLicenseFeeObligation to erna_InitialLicenseFeeObligation_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_InitialLicenseFeeObligation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_InitialLicenseFeeObligation_lbl1" xml:lang="en-US" id="erna_InitialLicenseFeeObligation_lbl1">Initial License Fee Obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFeeObligation" xlink:to="erna_InitialLicenseFeeObligation_lbl1" xlink:title="label: InitialLicenseFeeObligation to erna_InitialLicenseFeeObligation_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_InitialLicenseFeeObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_InitialLicenseFeeObligation" xml:lang="en-US" id="erna_InitialLicenseFeeObligation">Initial license fees obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFeeObligation" xlink:to="erna_InitialLicenseFeeObligation" xlink:title="label: InitialLicenseFeeObligation to erna_InitialLicenseFeeObligation" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:label="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="RelatedPartyTransactionPeriodicFeesPaymentAmount" />
    <link:label xlink:type="resource" xlink:label="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl" xml:lang="en-US" id="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl">The amount of required periodic fees payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:to="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl" xlink:title="label: RelatedPartyTransactionPeriodicFeesPaymentAmount to erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1" xml:lang="en-US" id="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1">Related Party Transaction, Periodic Fees Payment, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:to="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1" xlink:title="label: RelatedPartyTransactionPeriodicFeesPaymentAmount to erna_RelatedPartyTransactionPeriodicFeesPaymentAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xml:lang="en-US" id="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount">Monthly installment fees amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:to="erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="label: RelatedPartyTransactionPeriodicFeesPaymentAmount to erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LicenseAgreementAutomaticRenewalTerm" xlink:label="LicenseAgreementAutomaticRenewalTerm" xlink:title="LicenseAgreementAutomaticRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementAutomaticRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LicenseAgreementAutomaticRenewalTerm_lbl" xml:lang="en-US" id="erna_LicenseAgreementAutomaticRenewalTerm_lbl">The automatic renewal term of license agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementAutomaticRenewalTerm" xlink:to="erna_LicenseAgreementAutomaticRenewalTerm_lbl" xlink:title="label: LicenseAgreementAutomaticRenewalTerm to erna_LicenseAgreementAutomaticRenewalTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementAutomaticRenewalTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LicenseAgreementAutomaticRenewalTerm_lbl1" xml:lang="en-US" id="erna_LicenseAgreementAutomaticRenewalTerm_lbl1">License Agreement Automatic Renewal Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementAutomaticRenewalTerm" xlink:to="erna_LicenseAgreementAutomaticRenewalTerm_lbl1" xlink:title="label: LicenseAgreementAutomaticRenewalTerm to erna_LicenseAgreementAutomaticRenewalTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LicenseAgreementAutomaticRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LicenseAgreementAutomaticRenewalTerm" xml:lang="en-US" id="erna_LicenseAgreementAutomaticRenewalTerm">License agreement automatic renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicenseAgreementAutomaticRenewalTerm" xlink:to="erna_LicenseAgreementAutomaticRenewalTerm" xlink:title="label: LicenseAgreementAutomaticRenewalTerm to erna_LicenseAgreementAutomaticRenewalTerm" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SublicenseFees" xlink:label="SublicenseFees" xlink:title="SublicenseFees" />
    <link:label xlink:type="resource" xlink:label="erna_SublicenseFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SublicenseFees_lbl" xml:lang="en-US" id="erna_SublicenseFees_lbl">Sublicense fees required to pay including non-refundable fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SublicenseFees" xlink:to="erna_SublicenseFees_lbl" xlink:title="label: SublicenseFees to erna_SublicenseFees_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SublicenseFees_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SublicenseFees_lbl1" xml:lang="en-US" id="erna_SublicenseFees_lbl1">Sublicense Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SublicenseFees" xlink:to="erna_SublicenseFees_lbl1" xlink:title="label: SublicenseFees to erna_SublicenseFees_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SublicenseFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SublicenseFees" xml:lang="en-US" id="erna_SublicenseFees">Sublicense fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SublicenseFees" xlink:to="erna_SublicenseFees" xlink:title="label: SublicenseFees to erna_SublicenseFees" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AgreedWaivePayment" xlink:label="AgreedWaivePayment" xlink:title="AgreedWaivePayment" />
    <link:label xlink:type="resource" xlink:label="erna_AgreedWaivePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AgreedWaivePayment_lbl" xml:lang="en-US" id="erna_AgreedWaivePayment_lbl">The amount agreed to waive payment as per waiver agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreedWaivePayment" xlink:to="erna_AgreedWaivePayment_lbl" xlink:title="label: AgreedWaivePayment to erna_AgreedWaivePayment_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AgreedWaivePayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AgreedWaivePayment_lbl1" xml:lang="en-US" id="erna_AgreedWaivePayment_lbl1">Agreed Waive Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreedWaivePayment" xlink:to="erna_AgreedWaivePayment_lbl1" xlink:title="label: AgreedWaivePayment to erna_AgreedWaivePayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AgreedWaivePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AgreedWaivePayment" xml:lang="en-US" id="erna_AgreedWaivePayment">Agreed waive payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreedWaivePayment" xlink:to="erna_AgreedWaivePayment" xlink:title="label: AgreedWaivePayment to erna_AgreedWaivePayment" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoticePeriodForSupersedingTerminationProvisions" xlink:label="NoticePeriodForSupersedingTerminationProvisions" xlink:title="NoticePeriodForSupersedingTerminationProvisions" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForSupersedingTerminationProvisions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoticePeriodForSupersedingTerminationProvisions_lbl" xml:lang="en-US" id="erna_NoticePeriodForSupersedingTerminationProvisions_lbl">The Master Services Agreement (or "MSA") contains customary confidentiality provisions and representations and warranties of the parties, and the Master Services Agreement (or "MSA") may be terminated by ether party prior notice, subject to any superseding termination provisions contained in a particular work order, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForSupersedingTerminationProvisions" xlink:to="erna_NoticePeriodForSupersedingTerminationProvisions_lbl" xlink:title="label: NoticePeriodForSupersedingTerminationProvisions to erna_NoticePeriodForSupersedingTerminationProvisions_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForSupersedingTerminationProvisions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoticePeriodForSupersedingTerminationProvisions_lbl1" xml:lang="en-US" id="erna_NoticePeriodForSupersedingTerminationProvisions_lbl1">Notice Period for Superseding Termination Provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForSupersedingTerminationProvisions" xlink:to="erna_NoticePeriodForSupersedingTerminationProvisions_lbl1" xlink:title="label: NoticePeriodForSupersedingTerminationProvisions to erna_NoticePeriodForSupersedingTerminationProvisions_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoticePeriodForSupersedingTerminationProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoticePeriodForSupersedingTerminationProvisions" xml:lang="en-US" id="erna_NoticePeriodForSupersedingTerminationProvisions">Notice period for superseding termination provisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoticePeriodForSupersedingTerminationProvisions" xlink:to="erna_NoticePeriodForSupersedingTerminationProvisions" xlink:title="label: NoticePeriodForSupersedingTerminationProvisions to erna_NoticePeriodForSupersedingTerminationProvisions" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MonthlyMasterServicesAgreementFeesPayable" xlink:label="MonthlyMasterServicesAgreementFeesPayable" xlink:title="MonthlyMasterServicesAgreementFeesPayable" />
    <link:label xlink:type="resource" xlink:label="erna_MonthlyMasterServicesAgreementFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_MonthlyMasterServicesAgreementFeesPayable_lbl" xml:lang="en-US" id="erna_MonthlyMasterServicesAgreementFeesPayable_lbl">The monthly master service agreement ("MSA") fees payable to related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MonthlyMasterServicesAgreementFeesPayable" xlink:to="erna_MonthlyMasterServicesAgreementFeesPayable_lbl" xlink:title="label: MonthlyMasterServicesAgreementFeesPayable to erna_MonthlyMasterServicesAgreementFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_MonthlyMasterServicesAgreementFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_MonthlyMasterServicesAgreementFeesPayable_lbl1" xml:lang="en-US" id="erna_MonthlyMasterServicesAgreementFeesPayable_lbl1">Monthly Master Services Agreement Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MonthlyMasterServicesAgreementFeesPayable" xlink:to="erna_MonthlyMasterServicesAgreementFeesPayable_lbl1" xlink:title="label: MonthlyMasterServicesAgreementFeesPayable to erna_MonthlyMasterServicesAgreementFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_MonthlyMasterServicesAgreementFeesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_MonthlyMasterServicesAgreementFeesPayable" xml:lang="en-US" id="erna_MonthlyMasterServicesAgreementFeesPayable">Monthly master services agreement fees payable initial 12-month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MonthlyMasterServicesAgreementFeesPayable" xlink:to="erna_MonthlyMasterServicesAgreementFeesPayable" xlink:title="label: MonthlyMasterServicesAgreementFeesPayable to erna_MonthlyMasterServicesAgreementFeesPayable" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:label="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" />
    <link:label xlink:type="resource" xlink:label="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl" xml:lang="en-US" id="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl">Amount of deposit paid which will be applied to the last month of the first work order.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:to="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl" xlink:title="label: DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder to erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1" xml:lang="en-US" id="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1">Deposit Paid to be Applied to Last Month of First Work Order</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:to="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1" xlink:title="label: DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder to erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xml:lang="en-US" id="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder">Deposit paid to be applied to last month of first work order</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:to="erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="label: DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder to erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisOptionAgreementAbstract" xlink:label="ExacisOptionAgreementAbstract" xlink:title="ExacisOptionAgreementAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisOptionAgreementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ExacisOptionAgreementAbstract_lbl1" xml:lang="en-US" id="erna_ExacisOptionAgreementAbstract_lbl1">Exacis Option Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisOptionAgreementAbstract" xlink:to="erna_ExacisOptionAgreementAbstract_lbl1" xlink:title="label: ExacisOptionAgreementAbstract to erna_ExacisOptionAgreementAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PaymentOfOptionFee" xlink:label="PaymentOfOptionFee" xlink:title="PaymentOfOptionFee" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfOptionFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PaymentOfOptionFee_lbl" xml:lang="en-US" id="erna_PaymentOfOptionFee_lbl">Payment of option fee related to licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfOptionFee" xlink:to="erna_PaymentOfOptionFee_lbl" xlink:title="label: PaymentOfOptionFee to erna_PaymentOfOptionFee_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfOptionFee_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PaymentOfOptionFee_lbl1" xml:lang="en-US" id="erna_PaymentOfOptionFee_lbl1">Payment of Option Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfOptionFee" xlink:to="erna_PaymentOfOptionFee_lbl1" xlink:title="label: PaymentOfOptionFee to erna_PaymentOfOptionFee_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PaymentOfOptionFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PaymentOfOptionFee" xml:lang="en-US" id="erna_PaymentOfOptionFee">Payment of option fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentOfOptionFee" xlink:to="erna_PaymentOfOptionFee" xlink:title="label: PaymentOfOptionFee to erna_PaymentOfOptionFee" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:label xlink:type="resource" xlink:label="erna_NoveCiteINCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NoveCiteINCMember_lbl" xml:lang="en-US" id="erna_NoveCiteINCMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="erna_NoveCiteINCMember_lbl" xlink:title="label: NoveCiteINCMember to erna_NoveCiteINCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NoveCiteINCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NoveCiteINCMember_lbl1" xml:lang="en-US" id="erna_NoveCiteINCMember_lbl1">NoveCite, INC. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="erna_NoveCiteINCMember_lbl1" xlink:title="label: NoveCiteINCMember to erna_NoveCiteINCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NoveCiteINCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NoveCiteINCMember" xml:lang="en-US" id="erna_NoveCiteINCMember">NoveCite, INC. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="erna_NoveCiteINCMember" xlink:title="label: NoveCiteINCMember to erna_NoveCiteINCMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:label="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:title="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl" xml:lang="en-US" id="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl">Percentage of increase in annual lease payment for subleases for each year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:to="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl" xlink:title="label: PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments to erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1" xml:lang="en-US" id="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1">Percentage of Lessee Sublease, Increase In Annual Lease Rent Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:to="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1" xlink:title="label: PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments to erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xml:lang="en-US" id="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments">Percentage of annual rent increase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:to="erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:title="label: PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments to erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract">Future Lease Payments, Sublease Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl">Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Three Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AreaOfSubleaseSpaceCurrentlyRented" xlink:label="AreaOfSubleaseSpaceCurrentlyRented" xlink:title="AreaOfSubleaseSpaceCurrentlyRented" />
    <link:label xlink:type="resource" xlink:label="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl" xml:lang="en-US" id="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl">The subleases rentable area for properties currently rented.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfSubleaseSpaceCurrentlyRented" xlink:to="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl" xlink:title="label: AreaOfSubleaseSpaceCurrentlyRented to erna_AreaOfSubleaseSpaceCurrentlyRented_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1" xml:lang="en-US" id="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1">Area of Sublease, Space Currently Rented</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfSubleaseSpaceCurrentlyRented" xlink:to="erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1" xlink:title="label: AreaOfSubleaseSpaceCurrentlyRented to erna_AreaOfSubleaseSpaceCurrentlyRented_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AreaOfSubleaseSpaceCurrentlyRented" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AreaOfSubleaseSpaceCurrentlyRented" xml:lang="en-US" id="erna_AreaOfSubleaseSpaceCurrentlyRented">Currently rented area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AreaOfSubleaseSpaceCurrentlyRented" xlink:to="erna_AreaOfSubleaseSpaceCurrentlyRented" xlink:title="label: AreaOfSubleaseSpaceCurrentlyRented to erna_AreaOfSubleaseSpaceCurrentlyRented" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl">Amount of minimum sublease rentals to be received by the seller-lessee for sale-leaseback transactions accounted for using the deposit method or as a financing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals">Total payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentals to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl">Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl">Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1">Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Two Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xml:lang="en-US" id="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:to="erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="label: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears to erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:label="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl">Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1">Operating Lease Right-of-use Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US" id="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock">Operating Lease Right-of-use Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:label="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:title="FutureLeasePaymentsSubleaseAgreementTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl" xml:lang="en-US" id="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl">Tabular disclosure of future lease payments of sublease agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:to="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl" xlink:title="label: FutureLeasePaymentsSubleaseAgreementTableTextBlock to erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1" xml:lang="en-US" id="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1">Future Lease Payments, Sublease Agreement [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:to="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1" xlink:title="label: FutureLeasePaymentsSubleaseAgreementTableTextBlock to erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" xml:lang="en-US" id="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock">Future Lease Payments from Sublease Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:to="erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:title="label: FutureLeasePaymentsSubleaseAgreementTableTextBlock to erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfInLicensedPortfolioPatents" xlink:label="NumberOfInLicensedPortfolioPatents" xlink:title="NumberOfInLicensedPortfolioPatents" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfInLicensedPortfolioPatents_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfInLicensedPortfolioPatents_lbl" xml:lang="en-US" id="erna_NumberOfInLicensedPortfolioPatents_lbl">The number of in-licensed portfolio patents covering key mRNA cell engineering technologies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInLicensedPortfolioPatents" xlink:to="erna_NumberOfInLicensedPortfolioPatents_lbl" xlink:title="label: NumberOfInLicensedPortfolioPatents to erna_NumberOfInLicensedPortfolioPatents_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfInLicensedPortfolioPatents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfInLicensedPortfolioPatents_lbl1" xml:lang="en-US" id="erna_NumberOfInLicensedPortfolioPatents_lbl1">Number of In-licensed Portfolio Patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInLicensedPortfolioPatents" xlink:to="erna_NumberOfInLicensedPortfolioPatents_lbl1" xlink:title="label: NumberOfInLicensedPortfolioPatents to erna_NumberOfInLicensedPortfolioPatents_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfInLicensedPortfolioPatents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfInLicensedPortfolioPatents" xml:lang="en-US" id="erna_NumberOfInLicensedPortfolioPatents">Number of patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInLicensedPortfolioPatents" xlink:to="erna_NumberOfInLicensedPortfolioPatents" xlink:title="label: NumberOfInLicensedPortfolioPatents to erna_NumberOfInLicensedPortfolioPatents" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl">Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Expected share and unit options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl1" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl1">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Expected To Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue">Balance expected to vest (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl">The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber">Balance expected to vest (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl">The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1">Share-based Compensation Arrangement By Share-based Payment Award, Extended Post-Termination, Exercise Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xml:lang="en-US" id="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod">Exercise period of extended post-termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PerformanceBasedStockOptionMember" xlink:label="PerformanceBasedStockOptionMember" xlink:title="PerformanceBasedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="erna_PerformanceBasedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PerformanceBasedStockOptionMember_lbl" xml:lang="en-US" id="erna_PerformanceBasedStockOptionMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedStockOptionMember" xlink:to="erna_PerformanceBasedStockOptionMember_lbl" xlink:title="label: PerformanceBasedStockOptionMember to erna_PerformanceBasedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PerformanceBasedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PerformanceBasedStockOptionMember_lbl1" xml:lang="en-US" id="erna_PerformanceBasedStockOptionMember_lbl1">Performance Based Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedStockOptionMember" xlink:to="erna_PerformanceBasedStockOptionMember_lbl1" xlink:title="label: PerformanceBasedStockOptionMember to erna_PerformanceBasedStockOptionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TimeBasedStockOptionMember" xlink:label="TimeBasedStockOptionMember" xlink:title="TimeBasedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="erna_TimeBasedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TimeBasedStockOptionMember_lbl" xml:lang="en-US" id="erna_TimeBasedStockOptionMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on time basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedStockOptionMember" xlink:to="erna_TimeBasedStockOptionMember_lbl" xlink:title="label: TimeBasedStockOptionMember to erna_TimeBasedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TimeBasedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TimeBasedStockOptionMember_lbl1" xml:lang="en-US" id="erna_TimeBasedStockOptionMember_lbl1">Time Based Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedStockOptionMember" xlink:to="erna_TimeBasedStockOptionMember_lbl1" xlink:title="label: TimeBasedStockOptionMember to erna_TimeBasedStockOptionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncomeTaxAbstract" xlink:label="IncomeTaxAbstract" xlink:title="IncomeTaxAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_IncomeTaxAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_IncomeTaxAbstract_lbl1" xml:lang="en-US" id="erna_IncomeTaxAbstract_lbl1">Income Tax [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAbstract" xlink:to="erna_IncomeTaxAbstract_lbl1" xlink:title="label: IncomeTaxAbstract to erna_IncomeTaxAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_IncomeTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_IncomeTaxAbstract" xml:lang="en-US" id="erna_IncomeTaxAbstract">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAbstract" xlink:to="erna_IncomeTaxAbstract" xlink:title="label: IncomeTaxAbstract to erna_IncomeTaxAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TaxCutsAndJobsActOperatingLossCarryforwards" xlink:label="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="TaxCutsAndJobsActOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl" xml:lang="en-US" id="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl">Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws from effect of Tax Cuts and Jobs Act.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:to="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl" xlink:title="label: TaxCutsAndJobsActOperatingLossCarryforwards to erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1" xml:lang="en-US" id="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1">Tax Cuts and Jobs Act, Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:to="erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1" xlink:title="label: TaxCutsAndJobsActOperatingLossCarryforwards to erna_TaxCutsAndJobsActOperatingLossCarryforwards_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCutsAndJobsActOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TaxCutsAndJobsActOperatingLossCarryforwards" xml:lang="en-US" id="erna_TaxCutsAndJobsActOperatingLossCarryforwards">Net operating loss carryforwards under Tax Cuts and Jobs Act</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:to="erna_TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="label: TaxCutsAndJobsActOperatingLossCarryforwards to erna_TaxCutsAndJobsActOperatingLossCarryforwards" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TaxCreditCarryforwardExpirationYear" xlink:label="TaxCreditCarryforwardExpirationYear" xlink:title="TaxCreditCarryforwardExpirationYear" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TaxCreditCarryforwardExpirationYear_lbl" xml:lang="en-US" id="erna_TaxCreditCarryforwardExpirationYear_lbl">Expiration beginning year of the tax credit carryforward, in YYYY format.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCreditCarryforwardExpirationYear" xlink:to="erna_TaxCreditCarryforwardExpirationYear_lbl" xlink:title="label: TaxCreditCarryforwardExpirationYear to erna_TaxCreditCarryforwardExpirationYear_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCreditCarryforwardExpirationYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TaxCreditCarryforwardExpirationYear_lbl1" xml:lang="en-US" id="erna_TaxCreditCarryforwardExpirationYear_lbl1">Tax Credit Carryforward Expiration Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCreditCarryforwardExpirationYear" xlink:to="erna_TaxCreditCarryforwardExpirationYear_lbl1" xlink:title="label: TaxCreditCarryforwardExpirationYear to erna_TaxCreditCarryforwardExpirationYear_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TaxCreditCarryforwardExpirationYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TaxCreditCarryforwardExpirationYear" xml:lang="en-US" id="erna_TaxCreditCarryforwardExpirationYear">Tax credits begin to expire</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxCreditCarryforwardExpirationYear" xlink:to="erna_TaxCreditCarryforwardExpirationYear" xlink:title="label: TaxCreditCarryforwardExpirationYear to erna_TaxCreditCarryforwardExpirationYear" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax positions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent to erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1">Effective Income Tax Rate Reconciliation Uncertain Tax Positions Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent to erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent">Uncertain tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="label: EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent to erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:label="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:title="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to convertible debt.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent to erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl1" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl1">Effective Income Tax Rate Reconciliation, Convertible Debt, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent to erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent">Convertible debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:to="erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:title="label: EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent to erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:label="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to decrease in the valuation allowance for deferred tax assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:to="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount to erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1">Effective Income Tax Rate Reconciliation, Decrease in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:to="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount to erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xml:lang="en-US" id="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:to="erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="label: EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount to erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxLiabilitiesConvertibleDebt" xlink:label="DeferredTaxLiabilitiesConvertibleDebt" xlink:title="DeferredTaxLiabilitiesConvertibleDebt" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxLiabilitiesConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxLiabilitiesConvertibleDebt_lbl" xml:lang="en-US" id="erna_DeferredTaxLiabilitiesConvertibleDebt_lbl">Amount of deferred tax liability attributable to taxable temporary differences from convertible debt.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesConvertibleDebt" xlink:to="erna_DeferredTaxLiabilitiesConvertibleDebt_lbl" xlink:title="label: DeferredTaxLiabilitiesConvertibleDebt to erna_DeferredTaxLiabilitiesConvertibleDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxLiabilitiesConvertibleDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxLiabilitiesConvertibleDebt_lbl1" xml:lang="en-US" id="erna_DeferredTaxLiabilitiesConvertibleDebt_lbl1">Deferred Tax Liabilities, Convertible Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesConvertibleDebt" xlink:to="erna_DeferredTaxLiabilitiesConvertibleDebt_lbl1" xlink:title="label: DeferredTaxLiabilitiesConvertibleDebt to erna_DeferredTaxLiabilitiesConvertibleDebt_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxLiabilitiesConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_DeferredTaxLiabilitiesConvertibleDebt" xml:lang="en-US" id="erna_DeferredTaxLiabilitiesConvertibleDebt">Convertible debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesConvertibleDebt" xlink:to="erna_DeferredTaxLiabilitiesConvertibleDebt" xlink:title="label: DeferredTaxLiabilitiesConvertibleDebt to erna_DeferredTaxLiabilitiesConvertibleDebt" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="DeferredTaxAssetsRightOfUseLiabilities" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiabilities" xlink:to="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl" xlink:title="label: DeferredTaxAssetsRightOfUseLiabilities to erna_DeferredTaxAssetsRightOfUseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1">Deferred Tax Assets Right Of Use Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiabilities" xlink:to="erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1" xlink:title="label: DeferredTaxAssetsRightOfUseLiabilities to erna_DeferredTaxAssetsRightOfUseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DeferredTaxAssetsRightOfUseLiabilities" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseLiabilities">ROU Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiabilities" xlink:to="erna_DeferredTaxAssetsRightOfUseLiabilities" xlink:title="label: DeferredTaxAssetsRightOfUseLiabilities to erna_DeferredTaxAssetsRightOfUseLiabilities" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl" xml:lang="en-US" id="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards excluding foreign purpose.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:to="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign to erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1" xml:lang="en-US" id="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1">Deferred Tax Assets, Operating Loss Carryforwards Excluding Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:to="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign to erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xml:lang="en-US" id="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign">Net operating losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:to="erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign to erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xml:lang="en-US" id="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl">Amount of deferred tax assets attributable to taxable temporary differences from research and development costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xlink:title="label: DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts to erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1" xml:lang="en-US" id="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1">Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1" xlink:title="label: DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts to erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xml:lang="en-US" id="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts">Capitalized research and development expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="label: DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts to erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsRightOfUseAssets" xlink:label="DeferredTaxAssetsRightOfUseAssets" xlink:title="DeferredTaxAssetsRightOfUseAssets" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DeferredTaxAssetsRightOfUseAssets_lbl" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseAssets_lbl">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseAssets" xlink:to="erna_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:title="label: DeferredTaxAssetsRightOfUseAssets to erna_DeferredTaxAssetsRightOfUseAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DeferredTaxAssetsRightOfUseAssets_lbl1" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseAssets_lbl1">Deferred Tax Assets Right of Use Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseAssets" xlink:to="erna_DeferredTaxAssetsRightOfUseAssets_lbl1" xlink:title="label: DeferredTaxAssetsRightOfUseAssets to erna_DeferredTaxAssetsRightOfUseAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DeferredTaxAssetsRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_DeferredTaxAssetsRightOfUseAssets" xml:lang="en-US" id="erna_DeferredTaxAssetsRightOfUseAssets">ROU Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseAssets" xlink:to="erna_DeferredTaxAssetsRightOfUseAssets" xlink:title="label: DeferredTaxAssetsRightOfUseAssets to erna_DeferredTaxAssetsRightOfUseAssets" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationTwoMember" xlink:label="ContingentConsiderationTwoMember" xlink:title="ContingentConsiderationTwoMember" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ContingentConsiderationTwoMember_lbl" xml:lang="en-US" id="erna_ContingentConsiderationTwoMember_lbl">Description of contingent payment two arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationTwoMember" xlink:to="erna_ContingentConsiderationTwoMember_lbl" xlink:title="label: ContingentConsiderationTwoMember to erna_ContingentConsiderationTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationTwoMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ContingentConsiderationTwoMember_lbl1" xml:lang="en-US" id="erna_ContingentConsiderationTwoMember_lbl1">Contingent Consideration Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationTwoMember" xlink:to="erna_ContingentConsiderationTwoMember_lbl1" xlink:title="label: ContingentConsiderationTwoMember to erna_ContingentConsiderationTwoMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ContingentConsiderationTwoMember" xml:lang="en-US" id="erna_ContingentConsiderationTwoMember">Contingent Consideration Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationTwoMember" xlink:to="erna_ContingentConsiderationTwoMember" xlink:title="label: ContingentConsiderationTwoMember to erna_ContingentConsiderationTwoMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationThreeMember" xlink:label="ContingentConsiderationThreeMember" xlink:title="ContingentConsiderationThreeMember" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ContingentConsiderationThreeMember_lbl" xml:lang="en-US" id="erna_ContingentConsiderationThreeMember_lbl">Description of contingent payment three arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationThreeMember" xlink:to="erna_ContingentConsiderationThreeMember_lbl" xlink:title="label: ContingentConsiderationThreeMember to erna_ContingentConsiderationThreeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationThreeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ContingentConsiderationThreeMember_lbl1" xml:lang="en-US" id="erna_ContingentConsiderationThreeMember_lbl1">Contingent Consideration Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationThreeMember" xlink:to="erna_ContingentConsiderationThreeMember_lbl1" xlink:title="label: ContingentConsiderationThreeMember to erna_ContingentConsiderationThreeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAbstract" xlink:label="ExacisAssetPurchaseAbstract" xlink:title="ExacisAssetPurchaseAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisAssetPurchaseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ExacisAssetPurchaseAbstract_lbl1" xml:lang="en-US" id="erna_ExacisAssetPurchaseAbstract_lbl1">Exacis Asset Purchase [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="erna_ExacisAssetPurchaseAbstract_lbl1" xlink:title="label: ExacisAssetPurchaseAbstract to erna_ExacisAssetPurchaseAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ExacisAssetPurchaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ExacisAssetPurchaseAbstract" xml:lang="en-US" id="erna_ExacisAssetPurchaseAbstract">Exacis Asset Purchase [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="erna_ExacisAssetPurchaseAbstract" xlink:title="label: ExacisAssetPurchaseAbstract to erna_ExacisAssetPurchaseAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfCashConsideration" xlink:label="PercentageOfCashConsideration" xlink:title="PercentageOfCashConsideration" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfCashConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PercentageOfCashConsideration_lbl" xml:lang="en-US" id="erna_PercentageOfCashConsideration_lbl">Percentage of all cash or other consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCashConsideration" xlink:to="erna_PercentageOfCashConsideration_lbl" xlink:title="label: PercentageOfCashConsideration to erna_PercentageOfCashConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfCashConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PercentageOfCashConsideration_lbl1" xml:lang="en-US" id="erna_PercentageOfCashConsideration_lbl1">Percentage of Cash Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCashConsideration" xlink:to="erna_PercentageOfCashConsideration_lbl1" xlink:title="label: PercentageOfCashConsideration to erna_PercentageOfCashConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PercentageOfCashConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PercentageOfCashConsideration" xml:lang="en-US" id="erna_PercentageOfCashConsideration">Percentage of cash consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCashConsideration" xlink:to="erna_PercentageOfCashConsideration" xlink:title="label: PercentageOfCashConsideration to erna_PercentageOfCashConsideration" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:label="CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:title="CommencementPeriodOfCommonStockInPurchaseAgreement" />
    <link:label xlink:type="resource" xlink:label="erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl" xml:lang="en-US" id="erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl">Period for common stock purchase agreement commencement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:to="erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl" xlink:title="label: CommencementPeriodOfCommonStockInPurchaseAgreement to erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl1" xml:lang="en-US" id="erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl1">Commencement Period of Common Stock in Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:to="erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl1" xlink:title="label: CommencementPeriodOfCommonStockInPurchaseAgreement to erna_CommencementPeriodOfCommonStockInPurchaseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_CommencementPeriodOfCommonStockInPurchaseAgreement" xml:lang="en-US" id="erna_CommencementPeriodOfCommonStockInPurchaseAgreement">Common stock purchase agreement commencement period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:to="erna_CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:title="label: CommencementPeriodOfCommonStockInPurchaseAgreement to erna_CommencementPeriodOfCommonStockInPurchaseAgreement" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AssetAcquisitionSharePrice_lbl" xml:lang="en-US" id="erna_AssetAcquisitionSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="erna_AssetAcquisitionSharePrice_lbl" xlink:title="label: AssetAcquisitionSharePrice to erna_AssetAcquisitionSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AssetAcquisitionSharePrice_lbl1" xml:lang="en-US" id="erna_AssetAcquisitionSharePrice_lbl1">Asset Acquisition, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="erna_AssetAcquisitionSharePrice_lbl1" xlink:title="label: AssetAcquisitionSharePrice to erna_AssetAcquisitionSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AssetAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AssetAcquisitionSharePrice" xml:lang="en-US" id="erna_AssetAcquisitionSharePrice">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="erna_AssetAcquisitionSharePrice" xlink:title="label: AssetAcquisitionSharePrice to erna_AssetAcquisitionSharePrice" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MinimumCapitalizationRequirementAmount" xlink:label="MinimumCapitalizationRequirementAmount" xlink:title="MinimumCapitalizationRequirementAmount" />
    <link:label xlink:type="resource" xlink:label="erna_MinimumCapitalizationRequirementAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_MinimumCapitalizationRequirementAmount_lbl" xml:lang="en-US" id="erna_MinimumCapitalizationRequirementAmount_lbl">The amount required for numerator value of stock issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumCapitalizationRequirementAmount" xlink:to="erna_MinimumCapitalizationRequirementAmount_lbl" xlink:title="label: MinimumCapitalizationRequirementAmount to erna_MinimumCapitalizationRequirementAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_MinimumCapitalizationRequirementAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_MinimumCapitalizationRequirementAmount_lbl1" xml:lang="en-US" id="erna_MinimumCapitalizationRequirementAmount_lbl1">Minimum Market Capitalization Requirement, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumCapitalizationRequirementAmount" xlink:to="erna_MinimumCapitalizationRequirementAmount_lbl1" xlink:title="label: MinimumCapitalizationRequirementAmount to erna_MinimumCapitalizationRequirementAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_MinimumCapitalizationRequirementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_MinimumCapitalizationRequirementAmount" xml:lang="en-US" id="erna_MinimumCapitalizationRequirementAmount">Minimum market capitalization requirement, amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumCapitalizationRequirementAmount" xlink:to="erna_MinimumCapitalizationRequirementAmount" xlink:title="label: MinimumCapitalizationRequirementAmount to erna_MinimumCapitalizationRequirementAmount" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LockUpPeriodForCommonStock" xlink:label="LockUpPeriodForCommonStock" xlink:title="LockUpPeriodForCommonStock" />
    <link:label xlink:type="resource" xlink:label="erna_LockUpPeriodForCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_LockUpPeriodForCommonStock_lbl" xml:lang="en-US" id="erna_LockUpPeriodForCommonStock_lbl">The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForCommonStock" xlink:to="erna_LockUpPeriodForCommonStock_lbl" xlink:title="label: LockUpPeriodForCommonStock to erna_LockUpPeriodForCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_LockUpPeriodForCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_LockUpPeriodForCommonStock_lbl1" xml:lang="en-US" id="erna_LockUpPeriodForCommonStock_lbl1">Lock-up Period for Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForCommonStock" xlink:to="erna_LockUpPeriodForCommonStock_lbl1" xlink:title="label: LockUpPeriodForCommonStock to erna_LockUpPeriodForCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_LockUpPeriodForCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_LockUpPeriodForCommonStock" xml:lang="en-US" id="erna_LockUpPeriodForCommonStock">Lock-up period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForCommonStock" xlink:to="erna_LockUpPeriodForCommonStock" xlink:title="label: LockUpPeriodForCommonStock to erna_LockUpPeriodForCommonStock" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationOneMember" xlink:label="ContingentConsiderationOneMember" xlink:title="ContingentConsiderationOneMember" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ContingentConsiderationOneMember_lbl" xml:lang="en-US" id="erna_ContingentConsiderationOneMember_lbl">Description of contingent payment one arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationOneMember" xlink:to="erna_ContingentConsiderationOneMember_lbl" xlink:title="label: ContingentConsiderationOneMember to erna_ContingentConsiderationOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ContingentConsiderationOneMember_lbl1" xml:lang="en-US" id="erna_ContingentConsiderationOneMember_lbl1">Contingent Consideration One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationOneMember" xlink:to="erna_ContingentConsiderationOneMember_lbl1" xlink:title="label: ContingentConsiderationOneMember to erna_ContingentConsiderationOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ContingentConsiderationOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ContingentConsiderationOneMember" xml:lang="en-US" id="erna_ContingentConsiderationOneMember">Contingent Consideration One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContingentConsiderationOneMember" xlink:to="erna_ContingentConsiderationOneMember" xlink:title="label: ContingentConsiderationOneMember to erna_ContingentConsiderationOneMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumeratorValueForStockIssuance" xlink:label="NumeratorValueForStockIssuance" xlink:title="NumeratorValueForStockIssuance" />
    <link:label xlink:type="resource" xlink:label="erna_NumeratorValueForStockIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumeratorValueForStockIssuance_lbl" xml:lang="en-US" id="erna_NumeratorValueForStockIssuance_lbl">The amount of numerator value for stock issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumeratorValueForStockIssuance" xlink:to="erna_NumeratorValueForStockIssuance_lbl" xlink:title="label: NumeratorValueForStockIssuance to erna_NumeratorValueForStockIssuance_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumeratorValueForStockIssuance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumeratorValueForStockIssuance_lbl1" xml:lang="en-US" id="erna_NumeratorValueForStockIssuance_lbl1">Numerator Value for Stock Issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumeratorValueForStockIssuance" xlink:to="erna_NumeratorValueForStockIssuance_lbl1" xlink:title="label: NumeratorValueForStockIssuance to erna_NumeratorValueForStockIssuance_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumeratorValueForStockIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumeratorValueForStockIssuance" xml:lang="en-US" id="erna_NumeratorValueForStockIssuance">Numerator value for stock issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumeratorValueForStockIssuance" xlink:to="erna_NumeratorValueForStockIssuance" xlink:title="label: NumeratorValueForStockIssuance to erna_NumeratorValueForStockIssuance" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:label="EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:title="EstimatedEquityValueOfStockIssuedInAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl" xml:lang="en-US" id="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl">Assumed amount of stock issued in connection with calculation of share price in asset purchase transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:to="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl" xlink:title="label: EstimatedEquityValueOfStockIssuedInAssetAcquisition to erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl1" xml:lang="en-US" id="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl1">Estimated Equity Value of Stock Issued in Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:to="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl1" xlink:title="label: EstimatedEquityValueOfStockIssuedInAssetAcquisition to erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition" xml:lang="en-US" id="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition">Estimated equity value of stock issued in asset acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:to="erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:title="label: EstimatedEquityValueOfStockIssuedInAssetAcquisition to erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfConsecutiveTradingDays" xlink:label="NumberOfConsecutiveTradingDays" xlink:title="NumberOfConsecutiveTradingDays" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfConsecutiveTradingDays_lbl" xml:lang="en-US" id="erna_NumberOfConsecutiveTradingDays_lbl">Number of consecutive trading days in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfConsecutiveTradingDays" xlink:to="erna_NumberOfConsecutiveTradingDays_lbl" xlink:title="label: NumberOfConsecutiveTradingDays to erna_NumberOfConsecutiveTradingDays_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfConsecutiveTradingDays_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfConsecutiveTradingDays_lbl1" xml:lang="en-US" id="erna_NumberOfConsecutiveTradingDays_lbl1">Number of Consecutive Trading Days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfConsecutiveTradingDays" xlink:to="erna_NumberOfConsecutiveTradingDays_lbl1" xlink:title="label: NumberOfConsecutiveTradingDays to erna_NumberOfConsecutiveTradingDays_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfConsecutiveTradingDays" xml:lang="en-US" id="erna_NumberOfConsecutiveTradingDays">Number of consecutive trading days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfConsecutiveTradingDays" xlink:to="erna_NumberOfConsecutiveTradingDays" xlink:title="label: NumberOfConsecutiveTradingDays to erna_NumberOfConsecutiveTradingDays" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:label="ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:title="ConvertibleNotesBeneficialConversionFeaturePercentage" />
    <link:label xlink:type="resource" xlink:label="erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl" xml:lang="en-US" id="erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl">The conversion limitations percentage on the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed immediately after conversion rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:to="erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl" xlink:title="label: ConvertibleNotesBeneficialConversionFeaturePercentage to erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl1" xml:lang="en-US" id="erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl1">Convertible Notes, Beneficial Conversion Feature Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:to="erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl1" xlink:title="label: ConvertibleNotesBeneficialConversionFeaturePercentage to erna_ConvertibleNotesBeneficialConversionFeaturePercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ConvertibleNotesBeneficialConversionFeaturePercentage" xml:lang="en-US" id="erna_ConvertibleNotesBeneficialConversionFeaturePercentage">Beneficial conversion feature percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:to="erna_ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:title="label: ConvertibleNotesBeneficialConversionFeaturePercentage to erna_ConvertibleNotesBeneficialConversionFeaturePercentage" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RepurchasePricePercentageToPrincipalAmount" xlink:label="RepurchasePricePercentageToPrincipalAmount" xlink:title="RepurchasePricePercentageToPrincipalAmount" />
    <link:label xlink:type="resource" xlink:label="erna_RepurchasePricePercentageToPrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_RepurchasePricePercentageToPrincipalAmount_lbl" xml:lang="en-US" id="erna_RepurchasePricePercentageToPrincipalAmount_lbl">Percentage of notes repurchase price to principal amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepurchasePricePercentageToPrincipalAmount" xlink:to="erna_RepurchasePricePercentageToPrincipalAmount_lbl" xlink:title="label: RepurchasePricePercentageToPrincipalAmount to erna_RepurchasePricePercentageToPrincipalAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_RepurchasePricePercentageToPrincipalAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_RepurchasePricePercentageToPrincipalAmount_lbl1" xml:lang="en-US" id="erna_RepurchasePricePercentageToPrincipalAmount_lbl1">Repurchase Price Percentage to Principal Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepurchasePricePercentageToPrincipalAmount" xlink:to="erna_RepurchasePricePercentageToPrincipalAmount_lbl1" xlink:title="label: RepurchasePricePercentageToPrincipalAmount to erna_RepurchasePricePercentageToPrincipalAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_RepurchasePricePercentageToPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_RepurchasePricePercentageToPrincipalAmount" xml:lang="en-US" id="erna_RepurchasePricePercentageToPrincipalAmount">Repurchase price percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepurchasePricePercentageToPrincipalAmount" xlink:to="erna_RepurchasePricePercentageToPrincipalAmount" xlink:title="label: RepurchasePricePercentageToPrincipalAmount to erna_RepurchasePricePercentageToPrincipalAmount" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DebtInstrumentAccruedInterestRate" xlink:label="DebtInstrumentAccruedInterestRate" xlink:title="DebtInstrumentAccruedInterestRate" />
    <link:label xlink:type="resource" xlink:label="erna_DebtInstrumentAccruedInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_DebtInstrumentAccruedInterestRate_lbl" xml:lang="en-US" id="erna_DebtInstrumentAccruedInterestRate_lbl">Interest rate accrued per annum.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAccruedInterestRate" xlink:to="erna_DebtInstrumentAccruedInterestRate_lbl" xlink:title="label: DebtInstrumentAccruedInterestRate to erna_DebtInstrumentAccruedInterestRate_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_DebtInstrumentAccruedInterestRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_DebtInstrumentAccruedInterestRate_lbl1" xml:lang="en-US" id="erna_DebtInstrumentAccruedInterestRate_lbl1">Debt Instrument, Accrued Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAccruedInterestRate" xlink:to="erna_DebtInstrumentAccruedInterestRate_lbl1" xlink:title="label: DebtInstrumentAccruedInterestRate to erna_DebtInstrumentAccruedInterestRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_DebtInstrumentAccruedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_DebtInstrumentAccruedInterestRate" xml:lang="en-US" id="erna_DebtInstrumentAccruedInterestRate">Accrued interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAccruedInterestRate" xlink:to="erna_DebtInstrumentAccruedInterestRate" xlink:title="label: DebtInstrumentAccruedInterestRate to erna_DebtInstrumentAccruedInterestRate" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2022ConvertibleNotesMember" xlink:label="December2022ConvertibleNotesMember" xlink:title="December2022ConvertibleNotesMember" />
    <link:label xlink:type="resource" xlink:label="erna_December2022ConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_December2022ConvertibleNotesMember_lbl" xml:lang="en-US" id="erna_December2022ConvertibleNotesMember_lbl">Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2022ConvertibleNotesMember" xlink:to="erna_December2022ConvertibleNotesMember_lbl" xlink:title="label: December2022ConvertibleNotesMember to erna_December2022ConvertibleNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_December2022ConvertibleNotesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_December2022ConvertibleNotesMember_lbl1" xml:lang="en-US" id="erna_December2022ConvertibleNotesMember_lbl1">December 2022 Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2022ConvertibleNotesMember" xlink:to="erna_December2022ConvertibleNotesMember_lbl1" xlink:title="label: December2022ConvertibleNotesMember to erna_December2022ConvertibleNotesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_December2022ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_December2022ConvertibleNotesMember" xml:lang="en-US" id="erna_December2022ConvertibleNotesMember">December 2022 Convertible Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="December2022ConvertibleNotesMember" xlink:to="erna_December2022ConvertibleNotesMember" xlink:title="label: December2022ConvertibleNotesMember to erna_December2022ConvertibleNotesMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:label="TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:title="TransactionFeesRelatedToDebtIssuanceAndWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl" xml:lang="en-US" id="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl">The amount of transaction fees related to debt issuance and warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:to="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl" xlink:title="label: TransactionFeesRelatedToDebtIssuanceAndWarrants to erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl1" xml:lang="en-US" id="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl1">Transaction Fees Related to Debt Issuance and Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:to="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl1" xlink:title="label: TransactionFeesRelatedToDebtIssuanceAndWarrants to erna_TransactionFeesRelatedToDebtIssuanceAndWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants" xml:lang="en-US" id="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants">Transaction fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:to="erna_TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:title="label: TransactionFeesRelatedToDebtIssuanceAndWarrants to erna_TransactionFeesRelatedToDebtIssuanceAndWarrants" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectOfReductionOfExercisePriceOfWarrants" xlink:label="EffectOfReductionOfExercisePriceOfWarrants" xlink:title="EffectOfReductionOfExercisePriceOfWarrants" />
    <link:label xlink:type="resource" xlink:label="erna_EffectOfReductionOfExercisePriceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_EffectOfReductionOfExercisePriceOfWarrants_lbl" xml:lang="en-US" id="erna_EffectOfReductionOfExercisePriceOfWarrants_lbl">Amount of effect of the reduction of the exercise price of the warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectOfReductionOfExercisePriceOfWarrants" xlink:to="erna_EffectOfReductionOfExercisePriceOfWarrants_lbl" xlink:title="label: EffectOfReductionOfExercisePriceOfWarrants to erna_EffectOfReductionOfExercisePriceOfWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_EffectOfReductionOfExercisePriceOfWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_EffectOfReductionOfExercisePriceOfWarrants_lbl1" xml:lang="en-US" id="erna_EffectOfReductionOfExercisePriceOfWarrants_lbl1">Effect of Reduction of Exercise Price of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectOfReductionOfExercisePriceOfWarrants" xlink:to="erna_EffectOfReductionOfExercisePriceOfWarrants_lbl1" xlink:title="label: EffectOfReductionOfExercisePriceOfWarrants to erna_EffectOfReductionOfExercisePriceOfWarrants_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_EffectOfReductionOfExercisePriceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_EffectOfReductionOfExercisePriceOfWarrants" xml:lang="en-US" id="erna_EffectOfReductionOfExercisePriceOfWarrants">Effect of reduction of exercise price of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectOfReductionOfExercisePriceOfWarrants" xlink:to="erna_EffectOfReductionOfExercisePriceOfWarrants" xlink:title="label: EffectOfReductionOfExercisePriceOfWarrants to erna_EffectOfReductionOfExercisePriceOfWarrants" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfRevenueGeneratingContracts" xlink:label="NumberOfRevenueGeneratingContracts" xlink:title="NumberOfRevenueGeneratingContracts" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfRevenueGeneratingContracts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfRevenueGeneratingContracts_lbl" xml:lang="en-US" id="erna_NumberOfRevenueGeneratingContracts_lbl">Number of revenue generating contracts of the organization.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRevenueGeneratingContracts" xlink:to="erna_NumberOfRevenueGeneratingContracts_lbl" xlink:title="label: NumberOfRevenueGeneratingContracts to erna_NumberOfRevenueGeneratingContracts_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfRevenueGeneratingContracts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfRevenueGeneratingContracts_lbl1" xml:lang="en-US" id="erna_NumberOfRevenueGeneratingContracts_lbl1">Number of Revenue Generating Contracts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRevenueGeneratingContracts" xlink:to="erna_NumberOfRevenueGeneratingContracts_lbl1" xlink:title="label: NumberOfRevenueGeneratingContracts to erna_NumberOfRevenueGeneratingContracts_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfRevenueGeneratingContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_NumberOfRevenueGeneratingContracts" xml:lang="en-US" id="erna_NumberOfRevenueGeneratingContracts">Number of revenue generating contracts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRevenueGeneratingContracts" xlink:to="erna_NumberOfRevenueGeneratingContracts" xlink:title="label: NumberOfRevenueGeneratingContracts to erna_NumberOfRevenueGeneratingContracts" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocationOfProceedsAndCostsAbstract" xlink:label="AllocationOfProceedsAndCostsAbstract" xlink:title="AllocationOfProceedsAndCostsAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_AllocationOfProceedsAndCostsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AllocationOfProceedsAndCostsAbstract_lbl1" xml:lang="en-US" id="erna_AllocationOfProceedsAndCostsAbstract_lbl1">Allocation of Proceeds and Costs [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocationOfProceedsAndCostsAbstract" xlink:to="erna_AllocationOfProceedsAndCostsAbstract_lbl1" xlink:title="label: AllocationOfProceedsAndCostsAbstract to erna_AllocationOfProceedsAndCostsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromConvertibleDebtNet" xlink:label="ProceedsFromConvertibleDebtNet" xlink:title="ProceedsFromConvertibleDebtNet" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromConvertibleDebtNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ProceedsFromConvertibleDebtNet_lbl" xml:lang="en-US" id="erna_ProceedsFromConvertibleDebtNet_lbl">The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromConvertibleDebtNet" xlink:to="erna_ProceedsFromConvertibleDebtNet_lbl" xlink:title="label: ProceedsFromConvertibleDebtNet to erna_ProceedsFromConvertibleDebtNet_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ProceedsFromConvertibleDebtNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ProceedsFromConvertibleDebtNet_lbl1" xml:lang="en-US" id="erna_ProceedsFromConvertibleDebtNet_lbl1">Proceeds from Convertible Debt Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromConvertibleDebtNet" xlink:to="erna_ProceedsFromConvertibleDebtNet_lbl1" xlink:title="label: ProceedsFromConvertibleDebtNet to erna_ProceedsFromConvertibleDebtNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocationPercentageOfFairValue" xlink:label="AllocationPercentageOfFairValue" xlink:title="AllocationPercentageOfFairValue" />
    <link:label xlink:type="resource" xlink:label="erna_AllocationPercentageOfFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_AllocationPercentageOfFairValue_lbl" xml:lang="en-US" id="erna_AllocationPercentageOfFairValue_lbl">The allocated percentage of fair value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocationPercentageOfFairValue" xlink:to="erna_AllocationPercentageOfFairValue_lbl" xlink:title="label: AllocationPercentageOfFairValue to erna_AllocationPercentageOfFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_AllocationPercentageOfFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_AllocationPercentageOfFairValue_lbl1" xml:lang="en-US" id="erna_AllocationPercentageOfFairValue_lbl1">Allocation Percentage of Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocationPercentageOfFairValue" xlink:to="erna_AllocationPercentageOfFairValue_lbl1" xlink:title="label: AllocationPercentageOfFairValue to erna_AllocationPercentageOfFairValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_AllocationPercentageOfFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_AllocationPercentageOfFairValue" xml:lang="en-US" id="erna_AllocationPercentageOfFairValue">Allocation Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocationPercentageOfFairValue" xlink:to="erna_AllocationPercentageOfFairValue" xlink:title="label: AllocationPercentageOfFairValue to erna_AllocationPercentageOfFairValue" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_WarrantRepricing" xlink:label="WarrantRepricing" xlink:title="WarrantRepricing" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantRepricing_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_WarrantRepricing_lbl" xml:lang="en-US" id="erna_WarrantRepricing_lbl">The amount of warrant repricing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantRepricing" xlink:to="erna_WarrantRepricing_lbl" xlink:title="label: WarrantRepricing to erna_WarrantRepricing_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantRepricing_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_WarrantRepricing_lbl1" xml:lang="en-US" id="erna_WarrantRepricing_lbl1">Warrant Repricing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantRepricing" xlink:to="erna_WarrantRepricing_lbl1" xlink:title="label: WarrantRepricing to erna_WarrantRepricing_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_WarrantRepricing" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="erna_WarrantRepricing" xml:lang="en-US" id="erna_WarrantRepricing">Warrant Repricing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantRepricing" xlink:to="erna_WarrantRepricing" xlink:title="label: WarrantRepricing to erna_WarrantRepricing" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="erna_PrivatePlacementOfEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PrivatePlacementOfEquityAbstract_lbl1" xml:lang="en-US" id="erna_PrivatePlacementOfEquityAbstract_lbl1">Private Placement of Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="erna_PrivatePlacementOfEquityAbstract_lbl1" xlink:title="label: PrivatePlacementOfEquityAbstract to erna_PrivatePlacementOfEquityAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PrivatePlacementOfEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PrivatePlacementOfEquityAbstract" xml:lang="en-US" id="erna_PrivatePlacementOfEquityAbstract">Private Placement of Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="erna_PrivatePlacementOfEquityAbstract" xlink:title="label: PrivatePlacementOfEquityAbstract to erna_PrivatePlacementOfEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightsExercisableTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightsExercisableTerm_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightsExercisableTerm_lbl">Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="erna_ClassOfWarrantOrRightsExercisableTerm_lbl" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to erna_ClassOfWarrantOrRightsExercisableTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightsExercisableTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightsExercisableTerm_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightsExercisableTerm_lbl1">Class of Warrant or Rights Exercisable Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="erna_ClassOfWarrantOrRightsExercisableTerm_lbl1" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to erna_ClassOfWarrantOrRightsExercisableTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightsExercisableTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ClassOfWarrantOrRightsExercisableTerm" xml:lang="en-US" id="erna_ClassOfWarrantOrRightsExercisableTerm">Warrant exercisable term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="erna_ClassOfWarrantOrRightsExercisableTerm" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to erna_ClassOfWarrantOrRightsExercisableTerm" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_TransactionFeesPayable_lbl" xml:lang="en-US" id="erna_TransactionFeesPayable_lbl">Fees incurred related to PIPE transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="erna_TransactionFeesPayable_lbl" xlink:title="label: TransactionFeesPayable to erna_TransactionFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_TransactionFeesPayable_lbl1" xml:lang="en-US" id="erna_TransactionFeesPayable_lbl1">Transaction Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="erna_TransactionFeesPayable_lbl1" xlink:title="label: TransactionFeesPayable to erna_TransactionFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_TransactionFeesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_TransactionFeesPayable" xml:lang="en-US" id="erna_TransactionFeesPayable">Transaction fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="erna_TransactionFeesPayable" xlink:title="label: TransactionFeesPayable to erna_TransactionFeesPayable" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl">Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1">Obligation to Pay Liquidated Damages Percentage on Subscription Amount per Month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth">Obligation to pay liquidated damages per month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfWarrantsInEachUnit" xlink:label="NumberOfWarrantsInEachUnit" xlink:title="NumberOfWarrantsInEachUnit" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfWarrantsInEachUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_NumberOfWarrantsInEachUnit_lbl" xml:lang="en-US" id="erna_NumberOfWarrantsInEachUnit_lbl">Number of warrant consist in each unit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfWarrantsInEachUnit" xlink:to="erna_NumberOfWarrantsInEachUnit_lbl" xlink:title="label: NumberOfWarrantsInEachUnit to erna_NumberOfWarrantsInEachUnit_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_NumberOfWarrantsInEachUnit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_NumberOfWarrantsInEachUnit_lbl1" xml:lang="en-US" id="erna_NumberOfWarrantsInEachUnit_lbl1">Number of warrants in each unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfWarrantsInEachUnit" xlink:to="erna_NumberOfWarrantsInEachUnit_lbl1" xlink:title="label: NumberOfWarrantsInEachUnit to erna_NumberOfWarrantsInEachUnit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentage_lbl" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentage_lbl">Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentage_lbl" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to erna_ObligationToPayLiquidatedDamagesPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentage_lbl1" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentage_lbl1">Obligation to Pay Liquidated Damages Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentage_lbl1" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to erna_ObligationToPayLiquidatedDamagesPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ObligationToPayLiquidatedDamagesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_ObligationToPayLiquidatedDamagesPercentage" xml:lang="en-US" id="erna_ObligationToPayLiquidatedDamagesPercentage">Obligated to pay liquidated damages percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="erna_ObligationToPayLiquidatedDamagesPercentage" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to erna_ObligationToPayLiquidatedDamagesPercentage" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:label xlink:type="resource" xlink:label="erna_OverSubscriptionAmountReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_OverSubscriptionAmountReceived_lbl" xml:lang="en-US" id="erna_OverSubscriptionAmountReceived_lbl">Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="erna_OverSubscriptionAmountReceived_lbl" xlink:title="label: OverSubscriptionAmountReceived to erna_OverSubscriptionAmountReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_OverSubscriptionAmountReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_OverSubscriptionAmountReceived_lbl1" xml:lang="en-US" id="erna_OverSubscriptionAmountReceived_lbl1">Over-Subscription Amount Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="erna_OverSubscriptionAmountReceived_lbl1" xlink:title="label: OverSubscriptionAmountReceived to erna_OverSubscriptionAmountReceived_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_OverSubscriptionAmountReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_OverSubscriptionAmountReceived" xml:lang="en-US" id="erna_OverSubscriptionAmountReceived">Over-subscription amount received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="erna_OverSubscriptionAmountReceived" xlink:title="label: OverSubscriptionAmountReceived to erna_OverSubscriptionAmountReceived" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercised_lbl">Number of warrants or rights exercised during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="erna_ClassOfWarrantOrRightExercised_lbl" xlink:title="label: ClassOfWarrantOrRightExercised to erna_ClassOfWarrantOrRightExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_ClassOfWarrantOrRightExercised_lbl1" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercised_lbl1">Class of Warrant or Right Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="erna_ClassOfWarrantOrRightExercised_lbl1" xlink:title="label: ClassOfWarrantOrRightExercised to erna_ClassOfWarrantOrRightExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_ClassOfWarrantOrRightExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="erna_ClassOfWarrantOrRightExercised" xml:lang="en-US" id="erna_ClassOfWarrantOrRightExercised">Warrants exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="erna_ClassOfWarrantOrRightExercised" xlink:title="label: ClassOfWarrantOrRightExercised to erna_ClassOfWarrantOrRightExercised" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PIPEInvestorOneMember" xlink:label="PIPEInvestorOneMember" xlink:title="PIPEInvestorOneMember" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="erna_PIPEInvestorOneMember_lbl" xml:lang="en-US" id="erna_PIPEInvestorOneMember_lbl">A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorOneMember" xlink:to="erna_PIPEInvestorOneMember_lbl" xlink:title="label: PIPEInvestorOneMember to erna_PIPEInvestorOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="erna_PIPEInvestorOneMember_lbl1" xml:lang="en-US" id="erna_PIPEInvestorOneMember_lbl1">PIPE Investor One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorOneMember" xlink:to="erna_PIPEInvestorOneMember_lbl1" xlink:title="label: PIPEInvestorOneMember to erna_PIPEInvestorOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="erna_PIPEInvestorOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="erna_PIPEInvestorOneMember" xml:lang="en-US" id="erna_PIPEInvestorOneMember">Q4-22 PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorOneMember" xlink:to="erna_PIPEInvestorOneMember" xlink:title="label: PIPEInvestorOneMember to erna_PIPEInvestorOneMember" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>erna-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://eternatx.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#SubsequentEventDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesUncertainTaxPositionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesComponentsOfIncomeTaxProvisionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesLossBeforeIncomeTaxesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsCumulativeConvertiblePreferredStockDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsSepaDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsSepaDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsNoteWarrantsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsPrivatePlacementOfEquityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationStockbasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationNumberOfRsusVestedAndSettledDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationRestrictedStockUnitsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationSummaryOfStockOptionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationStockOptionActivityDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationEquityIncentivePlansDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#CommitmentsAndContingenciesRetirementSavingsPlanDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#CommitmentsAndContingenciesLegalMattersDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#RelatedPartyTransactionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#GoodwillAndInprocessResearchDevelopmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesManhattanSubleaseDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesManhattanSubleaseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesOperatingLeaseDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesOperatingLeaseDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/ContractWithCustomerDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#ContractWithCustomerDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionFairValuationOfAssumptionsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionSummaryOfAssetAcquisitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#LiquidityAndCapitalResourcesDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails" xlink:type="simple" xlink:href="erna-20231231.xsd#OrganizationAndDescriptionOfBusinessOperationsDetails" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrantsTables" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrantsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensationTables" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables" xlink:type="simple" xlink:href="erna-20231231.xsd#BasicAndDilutedNetLossPerCommonShareTables" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="erna-20231231.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/LeasesTables" xlink:type="simple" xlink:href="erna-20231231.xsd#LeasesTables" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipmentTables" xlink:type="simple" xlink:href="erna-20231231.xsd#PropertyAndEquipmentTables" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancingsTables" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisitionTables" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisitionTables" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://eternatx.com/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="erna-20231231.xsd#InsiderTradingArrangements" />
  <link:roleRef roleURI="http://eternatx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="erna-20231231.xsd#SubsequentEvent" />
  <link:roleRef roleURI="http://eternatx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="erna-20231231.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://eternatx.com/role/EquityAndWarrants" xlink:type="simple" xlink:href="erna-20231231.xsd#EquityAndWarrants" />
  <link:roleRef roleURI="http://eternatx.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="erna-20231231.xsd#StockbasedCompensation" />
  <link:roleRef roleURI="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare" xlink:type="simple" xlink:href="erna-20231231.xsd#BasicAndDilutedNetLossPerCommonShare" />
  <link:roleRef roleURI="http://eternatx.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="erna-20231231.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://eternatx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="erna-20231231.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://eternatx.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="erna-20231231.xsd#RelatedPartyTransactions" />
  <link:roleRef roleURI="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment" xlink:type="simple" xlink:href="erna-20231231.xsd#GoodwillAndInprocessResearchDevelopment" />
  <link:roleRef roleURI="http://eternatx.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="erna-20231231.xsd#FairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://eternatx.com/role/Leases" xlink:type="simple" xlink:href="erna-20231231.xsd#Leases" />
  <link:roleRef roleURI="http://eternatx.com/role/PropertyAndEquipment" xlink:type="simple" xlink:href="erna-20231231.xsd#PropertyAndEquipment" />
  <link:roleRef roleURI="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings" xlink:type="simple" xlink:href="erna-20231231.xsd#PromissoryNoteAndConvertibleNoteFinancings" />
  <link:roleRef roleURI="http://eternatx.com/role/ContractWithCustomer" xlink:type="simple" xlink:href="erna-20231231.xsd#ContractWithCustomer" />
  <link:roleRef roleURI="http://eternatx.com/role/AssetAcquisition" xlink:type="simple" xlink:href="erna-20231231.xsd#AssetAcquisition" />
  <link:roleRef roleURI="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="erna-20231231.xsd#BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://eternatx.com/role/LiquidityAndCapitalResources" xlink:type="simple" xlink:href="erna-20231231.xsd#LiquidityAndCapitalResources" />
  <link:roleRef roleURI="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations" xlink:type="simple" xlink:href="erna-20231231.xsd#OrganizationAndDescriptionOfBusinessOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedStatementsOfStockholdersEquity" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://eternatx.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="erna-20231231.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://eternatx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="erna-20231231.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="DocumentAnnualReport" xlink:title="DocumentAnnualReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentAnnualReport" xlink:title="presentation: CoverAbstract to DocumentAnnualReport" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentTransitionReport" xlink:title="presentation: CoverAbstract to DocumentTransitionReport" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityWellKnownSeasonedIssuer" xlink:title="presentation: CoverAbstract to EntityWellKnownSeasonedIssuer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityVoluntaryFilers" xlink:title="presentation: CoverAbstract to EntityVoluntaryFilers" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: CoverAbstract to EntityCurrentReportingStatus" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityInteractiveDataCurrent" xlink:title="presentation: CoverAbstract to EntityInteractiveDataCurrent" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="IcfrAuditorAttestationFlag" xlink:title="IcfrAuditorAttestationFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="IcfrAuditorAttestationFlag" xlink:title="presentation: CoverAbstract to IcfrAuditorAttestationFlag" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="DocumentFinStmtErrorCorrectionFlag" xlink:title="DocumentFinStmtErrorCorrectionFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFinStmtErrorCorrectionFlag" xlink:title="presentation: CoverAbstract to DocumentFinStmtErrorCorrectionFlag" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:label="DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:title="DocumentFinStmtRestatementRecoveryAnalysisFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:title="presentation: CoverAbstract to DocumentFinStmtRestatementRecoveryAnalysisFlag" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityShellCompany" xlink:title="presentation: CoverAbstract to EntityShellCompany" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityPublicFloat" xlink:title="presentation: CoverAbstract to EntityPublicFloat" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: CoverAbstract to EntityCommonStockSharesOutstanding" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="AuditorFirmId" xlink:title="AuditorFirmId" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorFirmId" xlink:title="presentation: CoverAbstract to AuditorFirmId" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="AuditorName" xlink:title="AuditorName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorName" xlink:title="presentation: CoverAbstract to AuditorName" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="AuditorLocation" xlink:title="AuditorLocation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AuditorLocation" xlink:title="presentation: CoverAbstract to AuditorLocation" order="41.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: StatementTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="RelatedPartyMember" xlink:title="RelatedPartyMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="RelatedPartyMember" xlink:title="presentation: RelatedPartyDomain to RelatedPartyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="NonrelatedPartyMember" xlink:title="NonrelatedPartyMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NonrelatedPartyMember" xlink:title="presentation: RelatedPartyDomain to NonrelatedPartyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: StatementTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="Cash" xlink:title="presentation: AssetsCurrentAbstract to Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherReceivablesNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherReceivablesNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="RestrictedCashNoncurrent" xlink:title="RestrictedCashNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="RestrictedCashNoncurrent" xlink:title="presentation: AssetsAbstract to RestrictedCashNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: AssetsAbstract to OperatingLeaseRightOfUseAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsAbstract to Goodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="EquityMethodInvestments" xlink:title="presentation: AssetsAbstract to EquityMethodInvestments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="AssetsAbstract" xlink:title="presentation: StatementLineItems to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="TaxesPayableCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to TaxesPayableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="DeferredRevenueCurrent" xlink:title="DeferredRevenueCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="DeferredRevenueCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to DeferredRevenueCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OtherLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OtherLiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="ConvertibleLongTermNotesPayable" xlink:title="ConvertibleLongTermNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="ConvertibleLongTermNotesPayable" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to ConvertibleLongTermNotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DerivativeLiabilitiesNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OperatingLeaseLiabilityNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="DeferredRevenueNoncurrent" xlink:title="DeferredRevenueNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DeferredRevenueNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DeferredRevenueNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:title="BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to BusinessCombinationContingentConsiderationLiabilityNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementLineItems to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfFinancialPositionAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="PreferredStockLiquidationPreferenceValue" xlink:title="PreferredStockLiquidationPreferenceValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockLiquidationPreferenceValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockLiquidationPreferenceValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to StockholdersEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="Revenues" xlink:title="presentation: IncomeStatementAbstract to Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="CostOfRevenue" xlink:title="CostOfRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="CostOfRevenue" xlink:title="presentation: IncomeStatementAbstract to CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="GrossProfit" xlink:title="presentation: IncomeStatementAbstract to GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="GeneralAndAdministrativeExpense" xlink:title="presentation: OperatingExpensesAbstract to GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentInProcessAssetAcquisition" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: OperatingExpensesAbstract to ImpairmentOfOngoingProject" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="OperatingExpenses" xlink:title="presentation: OperatingExpensesAbstract to OperatingExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OperatingExpensesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="WarrantLiabilitiesExpense" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to WarrantLiabilitiesExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ChangeInFairValueOfContingentConsideration" xlink:label="ChangeInFairValueOfContingentConsideration" xlink:title="ChangeInFairValueOfContingentConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="ChangeInFairValueOfContingentConsideration" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to ChangeInFairValueOfContingentConsideration" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="LossOnNonControllingInvestment" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to LossOnNonControllingInvestment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="InvestmentIncomeNet" xlink:title="InvestmentIncomeNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="InvestmentIncomeNet" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to InvestmentIncomeNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="InterestExpense" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to InterestExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to OtherNonoperatingIncomeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to NonoperatingIncomeExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OtherNonoperatingIncomeExpenseAbstract" xlink:title="presentation: IncomeStatementAbstract to OtherNonoperatingIncomeExpenseAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeStatementAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeStatementAbstract to IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="PreferredStockDividendsAndOtherAdjustments" xlink:title="presentation: IncomeStatementAbstract to PreferredStockDividendsAndOtherAdjustments" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLossAvailableToCommonStockholdersBasic" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasic" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareDiluted" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="PreferredStockMember" xlink:title="presentation: StatementEquityComponentsAxis to PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: StatementTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValuePrivateOffering" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesPrivateOffering" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:label="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueAcquisitions2" xlink:label="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="StockIssuedDuringPeriodValueAcquisitions2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueAcquisitions2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueAcquisitions2" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesAcquisitions2" xlink:label="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="StockIssuedDuringPeriodSharesAcquisitions2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesAcquisitions2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesAcquisitions2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueStockPurchaseAgreement" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesStockPurchaseAgreement" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalMarkToMarket" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="DividendsPreferredStockCash" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to DividendsPreferredStockCash" order="16.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PreferredStockDividendsShares" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PreferredStockDividendsShares" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLoss" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity_2" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationDepletionAndAmortization" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommitmentSharesIssueExpense" xlink:label="CommitmentSharesIssueExpense" xlink:title="CommitmentSharesIssueExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="CommitmentSharesIssueExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to CommitmentSharesIssueExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to EquityMethodInvestmentRealizedGainLossOnDisposal" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OperatingLeaseRightOfUseAssetAmortizationExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OperatingLeaseImpairmentLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="NonCashResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NonCashResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to NonCashResearchAndDevelopmentInProcessAssetAcquisition" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:label="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ImpairmentOfOngoingProject" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnDisposalOfFixedAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainOnTerminationOfLease" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainOnTerminationOfLease" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="InterestExpenseDebt" xlink:title="InterestExpenseDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="InterestExpenseDebt" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to InterestExpenseDebt" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest" xlink:label="PaidInKindInterest" xlink:title="PaidInKindInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="PaidInKindInterest" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to PaidInKindInterest" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to AmortizationOfFinancingCostsAndDiscounts" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="FairValueAdjustmentOfWarrants" xlink:title="FairValueAdjustmentOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="FairValueAdjustmentOfWarrants" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to FairValueAdjustmentOfWarrants" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnChangeInFairValueOfContingentConsideration" xlink:label="GainLossOnChangeInFairValueOfContingentConsideration" xlink:title="GainLossOnChangeInFairValueOfContingentConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnChangeInFairValueOfContingentConsideration" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnChangeInFairValueOfContingentConsideration" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="LossOnNonControllingInvestment" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to LossOnNonControllingInvestment" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherReceivables" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="IncreaseDecreaseInOtherNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherNoncurrentAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherNoncurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOperatingLeaseLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="IncreaseDecreaseInDueToRelatedParties" xlink:title="IncreaseDecreaseInDueToRelatedParties" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInDueToRelatedParties" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInDueToRelatedParties" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="IncreaseDecreaseInDeferredRevenue" xlink:title="IncreaseDecreaseInDeferredRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInDeferredRevenue" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInDeferredRevenue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromConvertibleDebt" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromConvertibleDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="PaymentOfFinancingAndStockIssuanceCosts" xlink:title="PaymentOfFinancingAndStockIssuanceCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentOfFinancingAndStockIssuanceCosts" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentOfFinancingAndStockIssuanceCosts" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="ProceedsFromNotesPayable" xlink:title="ProceedsFromNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromNotesPayable" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromNotesPayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfNotesPayable" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfNotesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:label="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:title="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExpensesPaidInConnectionWithPrivateOffering" xlink:label="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="ExpensesPaidInConnectionWithPrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ExpensesPaidInConnectionWithPrivateOffering" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ExpensesPaidInConnectionWithPrivateOffering" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:label="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to IssuanceOfCommonStockFromExerciseOfPreFundedWarrants" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsPreferredStockAndPreferenceStock" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:label="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="CashPaidForFractionalSharesInConnectionWithReverseStockSplit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to CashPaidForFractionalSharesInConnectionWithReverseStockSplit" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="FinanceLeasePrincipalPayments" xlink:title="FinanceLeasePrincipalPayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="FinanceLeasePrincipalPayments" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to FinanceLeasePrincipalPayments" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CashPaidDuringThePeriodForAbstract" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:title="CashPaidDuringThePeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: CashPaidDuringThePeriodForAbstract to InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="IncomeTaxesPaidNet" xlink:title="presentation: CashPaidDuringThePeriodForAbstract to IncomeTaxesPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashPaidDuringThePeriodForAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashPaidDuringThePeriodForAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationForAssetAcquisition" xlink:label="ContingentConsiderationForAssetAcquisition" xlink:title="ContingentConsiderationForAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ContingentConsiderationForAssetAcquisition" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to ContingentConsiderationForAssetAcquisition" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IssuanceOfCommonStockForAssetAcquisition" xlink:label="IssuanceOfCommonStockForAssetAcquisition" xlink:title="IssuanceOfCommonStockForAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="IssuanceOfCommonStockForAssetAcquisition" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to IssuanceOfCommonStockForAssetAcquisition" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_WarrantsIssued" xlink:label="WarrantsIssued" xlink:title="WarrantsIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="WarrantsIssued" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to WarrantsIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RepricingOfWarrantsInConnectionWithFinancing" xlink:label="RepricingOfWarrantsInConnectionWithFinancing" xlink:title="RepricingOfWarrantsInConnectionWithFinancing" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="RepricingOfWarrantsInConnectionWithFinancing" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to RepricingOfWarrantsInConnectionWithFinancing" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:label="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:title="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:label="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:title="PaidInKindInterestAddedToConvertibleNotesPrincipal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PaidInKindInterestAddedToConvertibleNotesPrincipal" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfRightOfUseAssets" xlink:label="InitialMeasurementOfRightOfUseAssets" xlink:title="InitialMeasurementOfRightOfUseAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="InitialMeasurementOfRightOfUseAssets" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to InitialMeasurementOfRightOfUseAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfLeaseLiabilities" xlink:label="InitialMeasurementOfLeaseLiabilities" xlink:title="InitialMeasurementOfLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="InitialMeasurementOfLeaseLiabilities" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to InitialMeasurementOfLeaseLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:label="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:title="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccrualForPurchasesOfPropertyAndEquipment" xlink:label="AccrualForPurchasesOfPropertyAndEquipment" xlink:title="AccrualForPurchasesOfPropertyAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="AccrualForPurchasesOfPropertyAndEquipment" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to AccrualForPurchasesOfPropertyAndEquipment" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConversionOfWarrantLiabilityToEquity" xlink:label="ConversionOfWarrantLiabilityToEquity" xlink:title="ConversionOfWarrantLiabilityToEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ConversionOfWarrantLiabilityToEquity" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to ConversionOfWarrantLiabilityToEquity" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:label="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:title="UnpaidFeesIncurredInConnectionWithPrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="UnpaidFeesIncurredInConnectionWithPrivateOffering" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to UnpaidFeesIncurredInConnectionWithPrivateOffering" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfFinanceLeaseLiabilities" xlink:label="InitialMeasurementOfFinanceLeaseLiabilities" xlink:title="InitialMeasurementOfFinanceLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="InitialMeasurementOfFinanceLeaseLiabilities" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to InitialMeasurementOfFinanceLeaseLiabilities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:label="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:title="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent" xlink:label="RestrictedCashCurrent" xlink:title="RestrictedCashCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="RestrictedCashCurrent" xlink:title="presentation: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to RestrictedCashCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LiquidityAndCapitalResources">
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesAbstract" xlink:label="LiquidityAndCapitalResourcesAbstract" xlink:title="LiquidityAndCapitalResourcesAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesTextBlock" xlink:label="LiquidityAndCapitalResourcesTextBlock" xlink:title="LiquidityAndCapitalResourcesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesAbstract" xlink:to="LiquidityAndCapitalResourcesTextBlock" xlink:title="presentation: LiquidityAndCapitalResourcesAbstract to LiquidityAndCapitalResourcesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:title="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisition">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract" xlink:label="AssetAcquisitionAbstract" xlink:title="AssetAcquisitionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTextBlock" xlink:label="AssetAcquisitionTextBlock" xlink:title="AssetAcquisitionTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAbstract" xlink:to="AssetAcquisitionTextBlock" xlink:title="presentation: AssetAcquisitionAbstract to AssetAcquisitionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ContractWithCustomer">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="RevenueFromContractWithCustomerTextBlock" xlink:title="RevenueFromContractWithCustomerTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="RevenueFromContractWithCustomerTextBlock" xlink:title="presentation: RevenueFromContractWithCustomerAbstract to RevenueFromContractWithCustomerTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtDisclosureTextBlock" xlink:title="presentation: DebtDisclosureAbstract to DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipment">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/Leases">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstruments">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueDisclosuresTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/RelatedPartyTransactions">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="presentation: RelatedPartyTransactionsAbstract to RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrants">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: StockholdersEquityNoteAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxes">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxDisclosureTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/SubsequentEvent">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventsTextBlock" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/InsiderTradingArrangements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems" xlink:label="InsiderTradingArrLineItems" xlink:title="InsiderTradingArrLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="Rule10b51ArrAdoptedFlag" xlink:title="Rule10b51ArrAdoptedFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InsiderTradingArrLineItems" xlink:to="Rule10b51ArrAdoptedFlag" xlink:title="presentation: InsiderTradingArrLineItems to Rule10b51ArrAdoptedFlag" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="NonRule10b51ArrAdoptedFlag" xlink:title="NonRule10b51ArrAdoptedFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InsiderTradingArrLineItems" xlink:to="NonRule10b51ArrAdoptedFlag" xlink:title="presentation: InsiderTradingArrLineItems to NonRule10b51ArrAdoptedFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="Rule10b51ArrTrmntdFlag" xlink:title="Rule10b51ArrTrmntdFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InsiderTradingArrLineItems" xlink:to="Rule10b51ArrTrmntdFlag" xlink:title="presentation: InsiderTradingArrLineItems to Rule10b51ArrTrmntdFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="NonRule10b51ArrTrmntdFlag" xlink:title="NonRule10b51ArrTrmntdFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InsiderTradingArrLineItems" xlink:to="NonRule10b51ArrTrmntdFlag" xlink:title="presentation: InsiderTradingArrLineItems to NonRule10b51ArrTrmntdFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to PropertyPlantAndEquipmentPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:title="presentation: AccountingPoliciesAbstract to GoodwillAndIntangibleAssetsGoodwillPolicy" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="InProcessResearchAndDevelopmentPolicy" xlink:title="InProcessResearchAndDevelopmentPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="InProcessResearchAndDevelopmentPolicy" xlink:title="presentation: AccountingPoliciesAbstract to InProcessResearchAndDevelopmentPolicy" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="RevenueRecognitionPolicyTextBlock" xlink:title="RevenueRecognitionPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RevenueRecognitionPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RevenueRecognitionPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ResearchAndDevelopmentExpensePolicy" xlink:title="presentation: AccountingPoliciesAbstract to ResearchAndDevelopmentExpensePolicy" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="IncomeTaxPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to IncomeTaxPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="EarningsPerSharePolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to EarningsPerSharePolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingPolicyPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ConcentrationRiskCreditRisk" xlink:title="presentation: AccountingPoliciesAbstract to ConcentrationRiskCreditRisk" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FairValueOfFinancialInstrumentsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to FairValueOfFinancialInstrumentsPolicy" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="LesseeLeasesPolicyTextBlock" xlink:title="LesseeLeasesPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="LesseeLeasesPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to LesseeLeasesPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="CommitmentsAndContingenciesPolicyTextBlock" xlink:title="CommitmentsAndContingenciesPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CommitmentsAndContingenciesPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to CommitmentsAndContingenciesPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="presentation: AccountingPoliciesAbstract to ShareBasedCompensationOptionAndIncentivePlansPolicy" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:label="DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:title="DerivativesMethodsOfAccountingNonhedgingDerivatives" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DerivativesMethodsOfAccountingNonhedgingDerivatives" xlink:title="presentation: AccountingPoliciesAbstract to DerivativesMethodsOfAccountingNonhedgingDerivatives" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="DebtPolicyTextBlock" xlink:title="DebtPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DebtPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to DebtPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract" xlink:label="AssetAcquisitionAbstract" xlink:title="AssetAcquisitionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:title="presentation: AssetAcquisitionAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="AssetAcquisitionTableTextBlock" xlink:title="AssetAcquisitionTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAbstract" xlink:to="AssetAcquisitionTableTextBlock" xlink:title="presentation: AssetAcquisitionAbstract to AssetAcquisitionTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="ScheduleOfDebtTableTextBlock" xlink:title="ScheduleOfDebtTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfDebtTableTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfDebtTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:label="FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:title="FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:title="presentation: DebtDisclosureAbstract to FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="ConvertibleDebtTableTextBlock" xlink:title="ConvertibleDebtTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ConvertibleDebtTableTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ConvertibleDebtTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentTextBlock" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostTableTextBlock" xlink:title="presentation: LeasesAbstract to LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:label="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: LeasesAbstract to OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:label="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:title="FutureLeasePaymentsSubleaseAgreementTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="FutureLeasePaymentsSubleaseAgreementTableTextBlock" xlink:title="presentation: LeasesAbstract to FutureLeasePaymentsSubleaseAgreementTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="FairValueByBalanceSheetGroupingTextBlock" xlink:title="FairValueByBalanceSheetGroupingTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueByBalanceSheetGroupingTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueByBalanceSheetGroupingTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfInLicensedPortfolioPatents" xlink:label="NumberOfInLicensedPortfolioPatents" xlink:title="NumberOfInLicensedPortfolioPatents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfInLicensedPortfolioPatents" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfInLicensedPortfolioPatents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LiquidityAndCapitalResourcesDetails">
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesAbstract" xlink:label="LiquidityAndCapitalResourcesAbstract" xlink:title="LiquidityAndCapitalResourcesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesAbstract" xlink:to="Cash" xlink:title="presentation: LiquidityAndCapitalResourcesAbstract to Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: LiquidityAndCapitalResourcesAbstract to RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: LiquidityAndCapitalResourcesAbstract to NetIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: LiquidityAndCapitalResourcesAbstract to NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesTable" xlink:label="LiquidityAndCapitalResourcesTable" xlink:title="LiquidityAndCapitalResourcesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LincolnParkCapitalFundLLCMember" xlink:label="LincolnParkCapitalFundLLCMember" xlink:title="LincolnParkCapitalFundLLCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityDomain" xlink:to="LincolnParkCapitalFundLLCMember" xlink:title="presentation: EntityDomain to LincolnParkCapitalFundLLCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="presentation: LegalEntityAxis to EntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="LegalEntityAxis" xlink:title="presentation: LiquidityAndCapitalResourcesTable to LegalEntityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="presentation: ShortTermDebtTypeDomain to ConvertibleDebtMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="presentation: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="presentation: LiquidityAndCapitalResourcesTable to ShortTermDebtTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="RangeAxis" xlink:title="presentation: LiquidityAndCapitalResourcesTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: LiquidityAndCapitalResourcesTable to SubsequentEventTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LiquidityAndCapitalResourcesLineItems" xlink:label="LiquidityAndCapitalResourcesLineItems" xlink:title="LiquidityAndCapitalResourcesLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NewFacilityLeaseAbstract" xlink:label="NewFacilityLeaseAbstract" xlink:title="NewFacilityLeaseAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="AreaOfRealEstateProperty" xlink:title="presentation: NewFacilityLeaseAbstract to AreaOfRealEstateProperty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="LineOfCredit" xlink:title="presentation: NewFacilityLeaseAbstract to LineOfCredit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="RestrictedCash" xlink:title="RestrictedCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="RestrictedCash" xlink:title="presentation: NewFacilityLeaseAbstract to RestrictedCash" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: NewFacilityLeaseAbstract to StockRepurchaseProgramAuthorizedAmount1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="presentation: NewFacilityLeaseAbstract to SaleOfStockNumberOfSharesIssuedInTransaction" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="ProceedsFromIssuanceOrSaleOfEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewFacilityLeaseAbstract" xlink:to="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="presentation: NewFacilityLeaseAbstract to ProceedsFromIssuanceOrSaleOfEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="NewFacilityLeaseAbstract" xlink:title="presentation: LiquidityAndCapitalResourcesLineItems to NewFacilityLeaseAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PrivatePlacementOfferingsAbstract" xlink:label="PrivatePlacementOfferingsAbstract" xlink:title="PrivatePlacementOfferingsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfferingsAbstract" xlink:to="ProceedsFromConvertibleDebt" xlink:title="presentation: PrivatePlacementOfferingsAbstract to ProceedsFromConvertibleDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesLineItems" xlink:to="PrivatePlacementOfferingsAbstract" xlink:title="presentation: LiquidityAndCapitalResourcesLineItems to PrivatePlacementOfferingsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesTable" xlink:to="LiquidityAndCapitalResourcesLineItems" xlink:title="presentation: LiquidityAndCapitalResourcesTable to LiquidityAndCapitalResourcesLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiquidityAndCapitalResourcesAbstract" xlink:to="LiquidityAndCapitalResourcesTable" xlink:title="presentation: LiquidityAndCapitalResourcesAbstract to LiquidityAndCapitalResourcesTable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:label="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:title="CashAndCashEquivalentsAtCarryingValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="CashEquivalentsAtCarryingValue" xlink:title="CashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="CashEquivalentsAtCarryingValue" xlink:title="presentation: CashAndCashEquivalentsAtCarryingValueAbstract to CashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="RestrictedCash" xlink:title="RestrictedCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="RestrictedCash" xlink:title="presentation: CashAndCashEquivalentsAtCarryingValueAbstract to RestrictedCash" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValueAbstract" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsAtCarryingValueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LaboratoryAndManufacturingEquipmentMember" xlink:label="LaboratoryAndManufacturingEquipmentMember" xlink:title="LaboratoryAndManufacturingEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LaboratoryAndManufacturingEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LaboratoryAndManufacturingEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="PropertyPlantAndEquipmentNetByTypeAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="presentation: PropertyPlantAndEquipmentNetByTypeAbstract to PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNetByTypeAbstract" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNetByTypeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentLineItems" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfPropertyPlantAndEquipmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionAbstract" xlink:label="RevenueRecognitionAbstract" xlink:title="RevenueRecognitionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfRevenueGeneratingContracts" xlink:label="NumberOfRevenueGeneratingContracts" xlink:title="NumberOfRevenueGeneratingContracts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueRecognitionAbstract" xlink:to="NumberOfRevenueGeneratingContracts" xlink:title="presentation: RevenueRecognitionAbstract to NumberOfRevenueGeneratingContracts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet" xlink:label="ContractWithCustomerAssetNet" xlink:title="ContractWithCustomerAssetNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueRecognitionAbstract" xlink:to="ContractWithCustomerAssetNet" xlink:title="presentation: RevenueRecognitionAbstract to ContractWithCustomerAssetNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="DeferredRevenue" xlink:title="DeferredRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueRecognitionAbstract" xlink:to="DeferredRevenue" xlink:title="presentation: RevenueRecognitionAbstract to DeferredRevenue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="ContractWithCustomerLiability" xlink:title="ContractWithCustomerLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueRecognitionAbstract" xlink:to="ContractWithCustomerLiability" xlink:title="presentation: RevenueRecognitionAbstract to ContractWithCustomerLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RevenueRecognitionAbstract" xlink:title="presentation: AccountingPoliciesAbstract to RevenueRecognitionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="NumberOfOperatingSegments" xlink:title="presentation: SegmentReportingAbstract to NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingAbstract" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract" xlink:label="AssetAcquisitionAbstract" xlink:title="AssetAcquisitionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:label="AssetAcquisitionContingentConsiderationTable" xlink:title="AssetAcquisitionContingentConsiderationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAgreementMember" xlink:label="ExacisAssetPurchaseAgreementMember" xlink:title="ExacisAssetPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="ExacisAssetPurchaseAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to ExacisAssetPurchaseAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="ContingentConsiderationByTypeAxis" xlink:title="ContingentConsiderationByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain" xlink:title="ContingentConsiderationTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationOneMember" xlink:label="ContingentConsiderationOneMember" xlink:title="ContingentConsiderationOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentConsiderationTypeDomain" xlink:to="ContingentConsiderationOneMember" xlink:title="presentation: ContingentConsiderationTypeDomain to ContingentConsiderationOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationTwoMember" xlink:label="ContingentConsiderationTwoMember" xlink:title="ContingentConsiderationTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentConsiderationTypeDomain" xlink:to="ContingentConsiderationTwoMember" xlink:title="presentation: ContingentConsiderationTypeDomain to ContingentConsiderationTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationThreeMember" xlink:label="ContingentConsiderationThreeMember" xlink:title="ContingentConsiderationThreeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentConsiderationTypeDomain" xlink:to="ContingentConsiderationThreeMember" xlink:title="presentation: ContingentConsiderationTypeDomain to ContingentConsiderationThreeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain" xlink:title="presentation: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="ContingentConsiderationByTypeAxis" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to ContingentConsiderationByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="RangeAxis" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:label="AssetAcquisitionContingentConsiderationLineItems" xlink:title="AssetAcquisitionContingentConsiderationLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAbstract" xlink:label="ExacisAssetPurchaseAbstract" xlink:title="ExacisAssetPurchaseAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="presentation: ExacisAssetPurchaseAbstract to StockIssuedDuringPeriodSharesAcquisitions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LockUpPeriodForCommonStock" xlink:label="LockUpPeriodForCommonStock" xlink:title="LockUpPeriodForCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="LockUpPeriodForCommonStock" xlink:title="presentation: ExacisAssetPurchaseAbstract to LockUpPeriodForCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:label="EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:title="EstimatedEquityValueOfStockIssuedInAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="EstimatedEquityValueOfStockIssuedInAssetAcquisition" xlink:title="presentation: ExacisAssetPurchaseAbstract to EstimatedEquityValueOfStockIssuedInAssetAcquisition" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="AssetAcquisitionSharePrice" xlink:title="presentation: ExacisAssetPurchaseAbstract to AssetAcquisitionSharePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:label="CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:title="CommencementPeriodOfCommonStockInPurchaseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="CommencementPeriodOfCommonStockInPurchaseAgreement" xlink:title="presentation: ExacisAssetPurchaseAbstract to CommencementPeriodOfCommonStockInPurchaseAgreement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MinimumCapitalizationRequirementAmount" xlink:label="MinimumCapitalizationRequirementAmount" xlink:title="MinimumCapitalizationRequirementAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="MinimumCapitalizationRequirementAmount" xlink:title="presentation: ExacisAssetPurchaseAbstract to MinimumCapitalizationRequirementAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfConsecutiveTradingDays" xlink:label="NumberOfConsecutiveTradingDays" xlink:title="NumberOfConsecutiveTradingDays" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="NumberOfConsecutiveTradingDays" xlink:title="presentation: ExacisAssetPurchaseAbstract to NumberOfConsecutiveTradingDays" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumeratorValueForStockIssuance" xlink:label="NumeratorValueForStockIssuance" xlink:title="NumeratorValueForStockIssuance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="NumeratorValueForStockIssuance" xlink:title="presentation: ExacisAssetPurchaseAbstract to NumeratorValueForStockIssuance" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfCashConsideration" xlink:label="PercentageOfCashConsideration" xlink:title="PercentageOfCashConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="PercentageOfCashConsideration" xlink:title="presentation: ExacisAssetPurchaseAbstract to PercentageOfCashConsideration" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisAssetPurchaseAbstract" xlink:to="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="presentation: ExacisAssetPurchaseAbstract to AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="ExacisAssetPurchaseAbstract" xlink:title="presentation: AssetAcquisitionContingentConsiderationLineItems to ExacisAssetPurchaseAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="AssetAcquisitionContingentConsiderationLineItems" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to AssetAcquisitionContingentConsiderationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAbstract" xlink:to="AssetAcquisitionContingentConsiderationTable" xlink:title="presentation: AssetAcquisitionAbstract to AssetAcquisitionContingentConsiderationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract" xlink:label="AssetAcquisitionAbstract" xlink:title="AssetAcquisitionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:label="AssetAcquisitionContingentConsiderationTable" xlink:title="AssetAcquisitionContingentConsiderationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputSharePriceMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputSharePriceMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputRiskFreeInterestRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputRiskFreeInterestRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="MeasurementInputExpectedDividendRateMember" xlink:title="MeasurementInputExpectedDividendRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedDividendRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputExpectedDividendRateMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="MeasurementInputExpectedTermMember" xlink:title="MeasurementInputExpectedTermMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedTermMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputExpectedTermMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="presentation: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="MeasurementInputTypeAxis" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to MeasurementInputTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAgreementMember" xlink:label="ExacisAssetPurchaseAgreementMember" xlink:title="ExacisAssetPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="ExacisAssetPurchaseAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to ExacisAssetPurchaseAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to TypeOfArrangementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:label="AssetAcquisitionContingentConsiderationLineItems" xlink:title="AssetAcquisitionContingentConsiderationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="BusinessCombinationContingentConsiderationLiability" xlink:title="BusinessCombinationContingentConsiderationLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="BusinessCombinationContingentConsiderationLiability" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to BusinessCombinationContingentConsiderationLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="presentation: AssetAcquisitionContingentConsiderationLineItems to LiabilitiesFairValueDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="WarrantsAndRightsOutstandingMeasurementInput" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="presentation: ValuationTechniqueAndInputDescriptionAbstract to WarrantsAndRightsOutstandingMeasurementInput" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="presentation: ValuationTechniqueAndInputDescriptionAbstract to WarrantsAndRightsOutstandingTerm" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="presentation: AssetAcquisitionContingentConsiderationLineItems to ValuationTechniqueAndInputDescriptionAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="AssetAcquisitionContingentConsiderationLineItems" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to AssetAcquisitionContingentConsiderationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAbstract" xlink:to="AssetAcquisitionContingentConsiderationTable" xlink:title="presentation: AssetAcquisitionAbstract to AssetAcquisitionContingentConsiderationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract" xlink:label="AssetAcquisitionAbstract" xlink:title="AssetAcquisitionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTable" xlink:label="AssetAcquisitionContingentConsiderationTable" xlink:title="AssetAcquisitionContingentConsiderationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisAssetPurchaseAgreementMember" xlink:label="ExacisAssetPurchaseAgreementMember" xlink:title="ExacisAssetPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="ExacisAssetPurchaseAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to ExacisAssetPurchaseAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLineItems" xlink:label="AssetAcquisitionContingentConsiderationLineItems" xlink:title="AssetAcquisitionContingentConsiderationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:label="AssetAcquisitionConsiderationTransferredAbstract" xlink:title="AssetAcquisitionConsiderationTransferredAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:label="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionConsiderationTransferredAbstract" xlink:to="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:title="presentation: AssetAcquisitionConsiderationTransferredAbstract to AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionConsiderationTransferredAbstract" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="presentation: AssetAcquisitionConsiderationTransferredAbstract to AssetAcquisitionFairValueOfConsiderationPaid" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:label="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:title="AssetAcquisitionConsiderationTransferredTransactionCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionConsiderationTransferredAbstract" xlink:to="AssetAcquisitionConsiderationTransferredTransactionCost" xlink:title="presentation: AssetAcquisitionConsiderationTransferredAbstract to AssetAcquisitionConsiderationTransferredTransactionCost" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionConsiderationTransferredAbstract" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="presentation: AssetAcquisitionConsiderationTransferredAbstract to ResearchAndDevelopmentInProcessAssetAcquisition" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AssetAcquisitionConsiderationTransferredAbstract" xlink:title="presentation: AssetAcquisitionContingentConsiderationLineItems to AssetAcquisitionConsiderationTransferredAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:label="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:title="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationLineItems" xlink:to="AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" xlink:title="presentation: AssetAcquisitionContingentConsiderationLineItems to AllocatedPercentageOfFairValueConsiderationToPurchasedLicense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionContingentConsiderationTable" xlink:to="AssetAcquisitionContingentConsiderationLineItems" xlink:title="presentation: AssetAcquisitionContingentConsiderationTable to AssetAcquisitionContingentConsiderationLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAbstract" xlink:to="AssetAcquisitionContingentConsiderationTable" xlink:title="presentation: AssetAcquisitionAbstract to AssetAcquisitionContingentConsiderationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/ContractWithCustomerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="TimingOfTransferOfGoodOrServiceAxis" xlink:title="TimingOfTransferOfGoodOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="TimingOfTransferOfGoodOrServiceDomain" xlink:title="TimingOfTransferOfGoodOrServiceDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember" xlink:label="TransferredOverTimeMember" xlink:title="TransferredOverTimeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TimingOfTransferOfGoodOrServiceDomain" xlink:to="TransferredOverTimeMember" xlink:title="presentation: TimingOfTransferOfGoodOrServiceDomain to TransferredOverTimeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TimingOfTransferOfGoodOrServiceAxis" xlink:to="TimingOfTransferOfGoodOrServiceDomain" xlink:title="presentation: TimingOfTransferOfGoodOrServiceAxis to TimingOfTransferOfGoodOrServiceDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="TimingOfTransferOfGoodOrServiceAxis" xlink:title="presentation: DisaggregationOfRevenueTable to TimingOfTransferOfGoodOrServiceAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContractWithCustomersAbstract" xlink:label="ContractWithCustomersAbstract" xlink:title="ContractWithCustomersAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromOptionAndLicenseAgreement" xlink:label="ProceedsFromOptionAndLicenseAgreement" xlink:title="ProceedsFromOptionAndLicenseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomersAbstract" xlink:to="ProceedsFromOptionAndLicenseAgreement" xlink:title="presentation: ContractWithCustomersAbstract to ProceedsFromOptionAndLicenseAgreement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromCellLineCustomizationActivities" xlink:label="ProceedsFromCellLineCustomizationActivities" xlink:title="ProceedsFromCellLineCustomizationActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomersAbstract" xlink:to="ProceedsFromCellLineCustomizationActivities" xlink:title="presentation: ContractWithCustomersAbstract to ProceedsFromCellLineCustomizationActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="RevenueRemainingPerformanceObligationPercentage" xlink:title="RevenueRemainingPerformanceObligationPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomersAbstract" xlink:to="RevenueRemainingPerformanceObligationPercentage" xlink:title="presentation: ContractWithCustomersAbstract to RevenueRemainingPerformanceObligationPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:label="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:title="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomersAbstract" xlink:to="ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:title="presentation: ContractWithCustomersAbstract to ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:label="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:title="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomersAbstract" xlink:to="ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:title="presentation: ContractWithCustomersAbstract to ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="ContractWithCustomerLiabilityRevenueRecognized" xlink:title="ContractWithCustomerLiabilityRevenueRecognized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomersAbstract" xlink:to="ContractWithCustomerLiabilityRevenueRecognized" xlink:title="presentation: ContractWithCustomersAbstract to ContractWithCustomerLiabilityRevenueRecognized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OptionFeeObligationPaymentPercentage" xlink:label="OptionFeeObligationPaymentPercentage" xlink:title="OptionFeeObligationPaymentPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContractWithCustomersAbstract" xlink:to="OptionFeeObligationPaymentPercentage" xlink:title="presentation: ContractWithCustomersAbstract to OptionFeeObligationPaymentPercentage" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="ContractWithCustomersAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to ContractWithCustomersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="DisaggregationOfRevenueLineItems" xlink:title="presentation: DisaggregationOfRevenueTable to DisaggregationOfRevenueLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="DisaggregationOfRevenueTable" xlink:title="presentation: RevenueFromContractWithCustomerAbstract to DisaggregationOfRevenueTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023ConvertibleNotesMember" xlink:label="July2023ConvertibleNotesMember" xlink:title="July2023ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="July2023ConvertibleNotesMember" xlink:title="presentation: DebtInstrumentNameDomain to July2023ConvertibleNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="December2023ConvertibleNotesMember" xlink:title="presentation: DebtInstrumentNameDomain to December2023ConvertibleNotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2022ConvertibleNotesMember" xlink:label="December2022ConvertibleNotesMember" xlink:title="December2022ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="December2022ConvertibleNotesMember" xlink:title="presentation: DebtInstrumentNameDomain to December2022ConvertibleNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="presentation: LongtermDebtTypeDomain to ConvertibleDebtMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="presentation: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="LongtermDebtTypeAxis" xlink:title="presentation: DebtInstrumentTable to LongtermDebtTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="July2023WarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to July2023WarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="December2023WarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to December2023WarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: DebtInstrumentTable to ClassOfWarrantOrRightAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: DebtInstrumentTable to StatementEquityComponentsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="DebtInstrumentRedemptionPeriodAxis" xlink:title="DebtInstrumentRedemptionPeriodAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="DebtInstrumentRedemptionPeriodDomain" xlink:title="DebtInstrumentRedemptionPeriodDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:label="DebtInstrumentRedemptionPeriodOneMember" xlink:title="DebtInstrumentRedemptionPeriodOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentRedemptionPeriodDomain" xlink:to="DebtInstrumentRedemptionPeriodOneMember" xlink:title="presentation: DebtInstrumentRedemptionPeriodDomain to DebtInstrumentRedemptionPeriodOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:label="DebtInstrumentRedemptionPeriodTwoMember" xlink:title="DebtInstrumentRedemptionPeriodTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentRedemptionPeriodDomain" xlink:to="DebtInstrumentRedemptionPeriodTwoMember" xlink:title="presentation: DebtInstrumentRedemptionPeriodDomain to DebtInstrumentRedemptionPeriodTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:label="DebtInstrumentRedemptionPeriodThreeMember" xlink:title="DebtInstrumentRedemptionPeriodThreeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentRedemptionPeriodDomain" xlink:to="DebtInstrumentRedemptionPeriodThreeMember" xlink:title="presentation: DebtInstrumentRedemptionPeriodDomain to DebtInstrumentRedemptionPeriodThreeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentRedemptionPeriodAxis" xlink:to="DebtInstrumentRedemptionPeriodDomain" xlink:title="presentation: DebtInstrumentRedemptionPeriodAxis to DebtInstrumentRedemptionPeriodDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentRedemptionPeriodAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentRedemptionPeriodAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: DebtInstrumentTable to SubsequentEventTypeAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:label="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:title="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="ConvertibleLongTermNotesPayable" xlink:title="ConvertibleLongTermNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="ConvertibleLongTermNotesPayable" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to ConvertibleLongTermNotesPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to DebtInstrumentFaceAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:label="TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:title="TransactionFeesRelatedToDebtIssuanceAndWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="TransactionFeesRelatedToDebtIssuanceAndWarrants" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to TransactionFeesRelatedToDebtIssuanceAndWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to DebtInstrumentInterestRateStatedPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DebtInstrumentAccruedInterestRate" xlink:label="DebtInstrumentAccruedInterestRate" xlink:title="DebtInstrumentAccruedInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="DebtInstrumentAccruedInterestRate" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to DebtInstrumentAccruedInterestRate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="DebtInstrumentRepaidPrincipal" xlink:title="DebtInstrumentRepaidPrincipal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="DebtInstrumentRepaidPrincipal" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to DebtInstrumentRepaidPrincipal" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="InterestExpenseDebtExcludingAmortization" xlink:title="InterestExpenseDebtExcludingAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="InterestExpenseDebtExcludingAmortization" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to InterestExpenseDebtExcludingAmortization" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="DebtInstrumentMaturityDate" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to DebtInstrumentMaturityDate" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="DebtInstrumentConvertibleConversionPrice1" xlink:title="DebtInstrumentConvertibleConversionPrice1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="DebtInstrumentConvertibleConversionPrice1" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to DebtInstrumentConvertibleConversionPrice1" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:label="ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:title="ConvertibleNotesBeneficialConversionFeaturePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="ConvertibleNotesBeneficialConversionFeaturePercentage" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to ConvertibleNotesBeneficialConversionFeaturePercentage" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RepurchasePricePercentageToPrincipalAmount" xlink:label="RepurchasePricePercentageToPrincipalAmount" xlink:title="RepurchasePricePercentageToPrincipalAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="RepurchasePricePercentageToPrincipalAmount" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to RepurchasePricePercentageToPrincipalAmount" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectOfReductionOfExercisePriceOfWarrants" xlink:label="EffectOfReductionOfExercisePriceOfWarrants" xlink:title="EffectOfReductionOfExercisePriceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="EffectOfReductionOfExercisePriceOfWarrants" xlink:title="presentation: LongtermConvertibleDebtCurrentAndNoncurrentAbstract to EffectOfReductionOfExercisePriceOfWarrants" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:title="presentation: DebtInstrumentLineItems to LongtermConvertibleDebtCurrentAndNoncurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023ConvertibleNotesMember" xlink:label="July2023ConvertibleNotesMember" xlink:title="July2023ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="July2023ConvertibleNotesMember" xlink:title="presentation: LongtermDebtTypeDomain to July2023ConvertibleNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="July2023WarrantsMember" xlink:title="presentation: LongtermDebtTypeDomain to July2023WarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="December2023ConvertibleNotesMember" xlink:title="presentation: LongtermDebtTypeDomain to December2023ConvertibleNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="December2023WarrantsMember" xlink:title="presentation: LongtermDebtTypeDomain to December2023WarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="presentation: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="LongtermDebtTypeAxis" xlink:title="presentation: DebtInstrumentTable to LongtermDebtTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocationOfProceedsAndCostsAbstract" xlink:label="AllocationOfProceedsAndCostsAbstract" xlink:title="AllocationOfProceedsAndCostsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="ConvertibleDebtFairValueDisclosures" xlink:title="ConvertibleDebtFairValueDisclosures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllocationOfProceedsAndCostsAbstract" xlink:to="ConvertibleDebtFairValueDisclosures" xlink:title="presentation: AllocationOfProceedsAndCostsAbstract to ConvertibleDebtFairValueDisclosures" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AllocationPercentageOfFairValue" xlink:label="AllocationPercentageOfFairValue" xlink:title="AllocationPercentageOfFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllocationOfProceedsAndCostsAbstract" xlink:to="AllocationPercentageOfFairValue" xlink:title="presentation: AllocationOfProceedsAndCostsAbstract to AllocationPercentageOfFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllocationOfProceedsAndCostsAbstract" xlink:to="ProceedsFromConvertibleDebt" xlink:title="presentation: AllocationOfProceedsAndCostsAbstract to ProceedsFromConvertibleDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="PaymentsOfDebtIssuanceCosts" xlink:title="PaymentsOfDebtIssuanceCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllocationOfProceedsAndCostsAbstract" xlink:to="PaymentsOfDebtIssuanceCosts" xlink:title="presentation: AllocationOfProceedsAndCostsAbstract to PaymentsOfDebtIssuanceCosts" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_WarrantRepricing" xlink:label="WarrantRepricing" xlink:title="WarrantRepricing" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllocationOfProceedsAndCostsAbstract" xlink:to="WarrantRepricing" xlink:title="presentation: AllocationOfProceedsAndCostsAbstract to WarrantRepricing" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ProceedsFromConvertibleDebtNet" xlink:label="ProceedsFromConvertibleDebtNet" xlink:title="ProceedsFromConvertibleDebtNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllocationOfProceedsAndCostsAbstract" xlink:to="ProceedsFromConvertibleDebtNet" xlink:title="presentation: AllocationOfProceedsAndCostsAbstract to ProceedsFromConvertibleDebtNet" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="AllocationOfProceedsAndCostsAbstract" xlink:title="presentation: DebtInstrumentLineItems to AllocationOfProceedsAndCostsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023ConvertibleNotesMember" xlink:label="July2023ConvertibleNotesMember" xlink:title="July2023ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="July2023ConvertibleNotesMember" xlink:title="presentation: LongtermDebtTypeDomain to July2023ConvertibleNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="July2023WarrantsMember" xlink:title="presentation: LongtermDebtTypeDomain to July2023WarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="December2023ConvertibleNotesMember" xlink:title="presentation: LongtermDebtTypeDomain to December2023ConvertibleNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="December2023WarrantsMember" xlink:title="presentation: LongtermDebtTypeDomain to December2023WarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="presentation: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="LongtermDebtTypeAxis" xlink:title="presentation: DebtInstrumentTable to LongtermDebtTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputSharePriceMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputSharePriceMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="MeasurementInputCreditSpreadMember" xlink:title="MeasurementInputCreditSpreadMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputCreditSpreadMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputCreditSpreadMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="MeasurementInputExercisePriceMember" xlink:title="MeasurementInputExercisePriceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExercisePriceMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputExercisePriceMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="MeasurementInputExpectedTermMember" xlink:title="MeasurementInputExpectedTermMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedTermMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputExpectedTermMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="MeasurementInputExpectedDividendRateMember" xlink:title="MeasurementInputExpectedDividendRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedDividendRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputExpectedDividendRateMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputRiskFreeInterestRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputRiskFreeInterestRateMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="presentation: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="MeasurementInputTypeAxis" xlink:title="presentation: DebtInstrumentTable to MeasurementInputTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMeasurementInput" xlink:label="LongTermDebtMeasurementInput" xlink:title="LongTermDebtMeasurementInput" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="LongTermDebtMeasurementInput" xlink:title="presentation: ValuationTechniqueAndInputDescriptionAbstract to LongTermDebtMeasurementInput" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="WarrantsAndRightsOutstandingMeasurementInput" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="presentation: ValuationTechniqueAndInputDescriptionAbstract to WarrantsAndRightsOutstandingMeasurementInput" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="presentation: ValuationTechniqueAndInputDescriptionAbstract to WarrantsAndRightsOutstandingTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="presentation: DebtInstrumentLineItems to ValuationTechniqueAndInputDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="presentation: LongtermDebtTypeDomain to ConvertibleDebtMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="presentation: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="LongtermDebtTypeAxis" xlink:title="presentation: DebtInstrumentTable to LongtermDebtTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleNotesAbstract" xlink:label="ConvertibleNotesAbstract" xlink:title="ConvertibleNotesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesAbstract" xlink:to="ProceedsFromConvertibleDebt" xlink:title="presentation: ConvertibleNotesAbstract to ProceedsFromConvertibleDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesAbstract" xlink:to="DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:title="presentation: ConvertibleNotesAbstract to DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="AmortizationOfFinancingCostsAndDiscounts" xlink:title="AmortizationOfFinancingCostsAndDiscounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesAbstract" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="presentation: ConvertibleNotesAbstract to AmortizationOfFinancingCostsAndDiscounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:label="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:title="PaidInKindInterestAddedToConvertibleNotesPrincipal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesAbstract" xlink:to="PaidInKindInterestAddedToConvertibleNotesPrincipal" xlink:title="presentation: ConvertibleNotesAbstract to PaidInKindInterestAddedToConvertibleNotesPrincipal" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="ConvertibleLongTermNotesPayable" xlink:title="ConvertibleLongTermNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesAbstract" xlink:to="ConvertibleLongTermNotesPayable" xlink:title="presentation: ConvertibleNotesAbstract to ConvertibleLongTermNotesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="ConvertibleNotesAbstract" xlink:title="presentation: DebtInstrumentLineItems to ConvertibleNotesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:label="MaturitiesOfLongTermDebtAbstract" xlink:title="MaturitiesOfLongTermDebtAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MaturitiesOfLongTermDebtAbstract" xlink:to="LongTermDebt" xlink:title="presentation: MaturitiesOfLongTermDebtAbstract to LongTermDebt" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="MaturitiesOfLongTermDebtAbstract" xlink:title="presentation: DebtInstrumentLineItems to MaturitiesOfLongTermDebtAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:label="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:title="PromissoryNoteAndConvertibleNoteFinancingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="InterestExpenseDebt" xlink:title="InterestExpenseDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:to="InterestExpenseDebt" xlink:title="presentation: PromissoryNoteAndConvertibleNoteFinancingAbstract to InterestExpenseDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:to="AmortizationOfFinancingCostsAndDiscounts" xlink:title="presentation: PromissoryNoteAndConvertibleNoteFinancingAbstract to AmortizationOfFinancingCostsAndDiscounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaidInKindInterest" xlink:label="PaidInKindInterest" xlink:title="PaidInKindInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:to="PaidInKindInterest" xlink:title="presentation: PromissoryNoteAndConvertibleNoteFinancingAbstract to PaidInKindInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:label="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:title="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:to="InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" xlink:title="presentation: PromissoryNoteAndConvertibleNoteFinancingAbstract to InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: PromissoryNoteAndConvertibleNoteFinancingAbstract to AccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="PromissoryNoteAndConvertibleNoteFinancingAbstract" xlink:title="presentation: DebtInstrumentLineItems to PromissoryNoteAndConvertibleNoteFinancingAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/PropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="EquipmentMember" xlink:title="EquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="EquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to EquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:label="PropertyPlantAndEquipmentGrossAbstract" xlink:title="PropertyPlantAndEquipmentGrossAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to GainLossOnDisposalOfFixedAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingNetBookValueOfFixedAssets" xlink:label="RemainingNetBookValueOfFixedAssets" xlink:title="RemainingNetBookValueOfFixedAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="RemainingNetBookValueOfFixedAssets" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to RemainingNetBookValueOfFixedAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to ProceedsFromSaleOfPropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentGrossAbstract" xlink:to="Depreciation" xlink:title="presentation: PropertyPlantAndEquipmentGrossAbstract to Depreciation" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGrossAbstract" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGrossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentLineItems" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to ScheduleOfPropertyPlantAndEquipmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesOperatingLeaseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ERSquibbSonsLLCMember" xlink:label="ERSquibbSonsLLCMember" xlink:title="ERSquibbSonsLLCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="ERSquibbSonsLLCMember" xlink:title="presentation: RelatedPartyDomain to ERSquibbSonsLLCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SanDiegoLeaseMember" xlink:label="SanDiegoLeaseMember" xlink:title="SanDiegoLeaseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="SanDiegoLeaseMember" xlink:title="presentation: RelatedPartyDomain to SanDiegoLeaseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeCommitmentToPurchaseProperty" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeCommitmentToPurchaseProperty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="DepositsAssetsNoncurrent" xlink:title="DepositsAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="DepositsAssetsNoncurrent" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to DepositsAssetsNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeaseImpairmentLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to InitialMeasurementOfOperatingLeaseROUAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to InitialMeasurementOfOperatingLeaseLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="AreaOfRealEstateProperty" xlink:title="AreaOfRealEstateProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="AreaOfRealEstateProperty" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to AreaOfRealEstateProperty" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeOperatingLeaseRenewalTerm" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeOperatingLeaseRenewalTerm" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeasesMonthlyBaseRent" xlink:label="OperatingLeasesMonthlyBaseRent" xlink:title="OperatingLeasesMonthlyBaseRent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeasesMonthlyBaseRent" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeasesMonthlyBaseRent" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeasesIncreaseInBaseRentPercentage" xlink:label="OperatingLeasesIncreaseInBaseRentPercentage" xlink:title="OperatingLeasesIncreaseInBaseRentPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeasesIncreaseInBaseRentPercentage" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeasesIncreaseInBaseRentPercentage" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="LineOfCredit" xlink:title="LineOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LineOfCredit" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LineOfCredit" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TenantImprovementAllowancePerRentableSquareFoot" xlink:label="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="TenantImprovementAllowancePerRentableSquareFoot" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="TenantImprovementAllowancePerRentableSquareFoot" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to TenantImprovementAllowancePerRentableSquareFoot" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TenantImprovementAllowance" xlink:label="TenantImprovementAllowance" xlink:title="TenantImprovementAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="TenantImprovementAllowance" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to TenantImprovementAllowance" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LeaseholdImprovementsGross" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LeaseholdImprovementsGross" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ReceivedAmountOfTenantImprovementAllowance" xlink:label="ReceivedAmountOfTenantImprovementAllowance" xlink:title="ReceivedAmountOfTenantImprovementAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="ReceivedAmountOfTenantImprovementAllowance" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to ReceivedAmountOfTenantImprovementAllowance" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:label="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:title="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OutOfPocketExpenses" xlink:label="OutOfPocketExpenses" xlink:title="OutOfPocketExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OutOfPocketExpenses" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OutOfPocketExpenses" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:label="UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:title="UnpaidOutOfPocketCostsTenantImprovementAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="UnpaidOutOfPocketCostsTenantImprovementAllowance" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to UnpaidOutOfPocketCostsTenantImprovementAllowance" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeaseIncrementalBorrowingRate" xlink:label="OperatingLeaseIncrementalBorrowingRate" xlink:title="OperatingLeaseIncrementalBorrowingRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="OperatingLeaseIncrementalBorrowingRate" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to OperatingLeaseIncrementalBorrowingRate" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:label="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:title="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="LesseeLeaseDescriptionLineItems" xlink:title="presentation: LesseeLeaseDescriptionTable to LesseeLeaseDescriptionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeLeaseDescriptionTable" xlink:title="presentation: LeasesAbstract to LesseeLeaseDescriptionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseCost" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="SubleaseIncome" xlink:title="presentation: LeaseCostAbstract to SubleaseIncome" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="VariableLeaseCost" xlink:title="presentation: LeaseCostAbstract to VariableLeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="LeaseCost" xlink:title="presentation: LeaseCostAbstract to LeaseCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostAbstract" xlink:title="presentation: LeasesAbstract to LeaseCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="AssetsAndLiabilitiesLesseeAbstract" xlink:title="AssetsAndLiabilitiesLesseeAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OperatingLeaseAssestAbstract" xlink:label="OperatingLeaseAssestAbstract" xlink:title="OperatingLeaseAssestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="presentation: OperatingLeaseAssestAbstract to InitialMeasurementOfOperatingLeaseROUAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:label="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:title="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="AdjustmentToRemeasurementOfOperatingLeaseROUAssets" xlink:title="presentation: OperatingLeaseAssestAbstract to AdjustmentToRemeasurementOfOperatingLeaseROUAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAssetAmortizationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset_2" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAsset_2" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAsset" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="OperatingLeaseAssestAbstract" xlink:title="presentation: AssetsAndLiabilitiesLesseeAbstract to OperatingLeaseAssestAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="presentation: OperatingLeaseLiabilityAbstract to InitialMeasurementOfOperatingLeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccretionOfInterestSublease" xlink:label="AccretionOfInterestSublease" xlink:title="AccretionOfInterestSublease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="AccretionOfInterestSublease" xlink:title="presentation: OperatingLeaseLiabilityAbstract to AccretionOfInterestSublease" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:label="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:title="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" xlink:title="presentation: OperatingLeaseLiabilityAbstract to AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:label="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="presentation: OperatingLeaseLiabilityAbstract to PrincipalPaymentsOnOperatingLeaseLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability_2" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability_2" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="OperatingLeaseLiabilityAbstract" xlink:title="presentation: AssetsAndLiabilitiesLesseeAbstract to OperatingLeaseLiabilityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="AssetsAndLiabilitiesLesseeAbstract" xlink:title="presentation: LeasesAbstract to AssetsAndLiabilitiesLesseeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:label="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01" />
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/LeasesManhattanSubleaseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AreaOfSubleaseSpaceCurrentlyRented" xlink:label="AreaOfSubleaseSpaceCurrentlyRented" xlink:title="AreaOfSubleaseSpaceCurrentlyRented" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="AreaOfSubleaseSpaceCurrentlyRented" xlink:title="presentation: LeasesAbstract to AreaOfSubleaseSpaceCurrentlyRented" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:label="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:title="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" xlink:title="presentation: LeasesAbstract to PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:label="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentals" xlink:title="presentation: SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentals" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" xlink:title="presentation: LeasesAbstract to SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLeasePayments" xlink:label="ProceedsFromLeasePayments" xlink:title="ProceedsFromLeasePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="ProceedsFromLeasePayments" xlink:title="presentation: LeasesAbstract to ProceedsFromLeasePayments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="ContingentConsiderationByTypeAxis" xlink:title="ContingentConsiderationByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain" xlink:title="ContingentConsiderationTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MarketCapContingentConsiderationMember" xlink:label="MarketCapContingentConsiderationMember" xlink:title="MarketCapContingentConsiderationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentConsiderationTypeDomain" xlink:to="MarketCapContingentConsiderationMember" xlink:title="presentation: ContingentConsiderationTypeDomain to MarketCapContingentConsiderationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain" xlink:title="presentation: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ContingentConsiderationByTypeAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ContingentConsiderationByTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="presentation: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByLiabilityClassAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="LiabilitiesFairValueDisclosure" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to LiabilitiesFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueNetAssetLiabilityAbstract" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="presentation: FairValueNetAssetLiabilityAbstract to LiabilitiesFairValueDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueNetAssetLiabilityAbstract" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueNetAssetLiabilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="presentation: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to FairValueByLiabilityClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="ContingentConsiderationByTypeAxis" xlink:title="ContingentConsiderationByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="ContingentConsiderationTypeDomain" xlink:title="ContingentConsiderationTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ContingentConsiderationMember" xlink:label="ContingentConsiderationMember" xlink:title="ContingentConsiderationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentConsiderationTypeDomain" xlink:to="ContingentConsiderationMember" xlink:title="presentation: ContingentConsiderationTypeDomain to ContingentConsiderationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentConsiderationByTypeAxis" xlink:to="ContingentConsiderationTypeDomain" xlink:title="presentation: ContingentConsiderationByTypeAxis to ContingentConsiderationTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="ContingentConsiderationByTypeAxis" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to ContingentConsiderationByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="MeasurementInputExpectedTermMember" xlink:title="MeasurementInputExpectedTermMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedTermMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputExpectedTermMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputRiskFreeInterestRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputRiskFreeInterestRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="MeasurementInputExpectedDividendRateMember" xlink:title="MeasurementInputExpectedDividendRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputExpectedDividendRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputExpectedDividendRateMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputSharePriceMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputSharePriceMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="presentation: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="MeasurementInputTypeAxis" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to MeasurementInputTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="LiabilitiesFairValueAdjustment" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to LiabilitiesFairValueAdjustment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="presentation: ValuationTechniqueAndInputDescriptionAbstract to WarrantsAndRightsOutstandingTerm" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="WarrantsAndRightsOutstandingMeasurementInput" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="WarrantsAndRightsOutstandingMeasurementInput" xlink:title="presentation: ValuationTechniqueAndInputDescriptionAbstract to WarrantsAndRightsOutstandingMeasurementInput" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to ValuationTechniqueAndInputDescriptionAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:title="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ChangeInFairValueOfContingentConsideration" xlink:label="ChangeInFairValueOfContingentConsideration" xlink:title="ChangeInFairValueOfContingentConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ChangeInFairValueOfContingentConsideration" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems to ChangeInFairValueOfContingentConsideration" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="FairValueByBalanceSheetGroupingTable" xlink:title="FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="FairValueByMeasurementBasisAxis" xlink:title="FairValueByMeasurementBasisAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="FairValueDisclosureItemAmountsDomain" xlink:title="FairValueDisclosureItemAmountsDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="PortionAtFairValueFairValueDisclosureMember" xlink:title="PortionAtFairValueFairValueDisclosureMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosureItemAmountsDomain" xlink:to="PortionAtFairValueFairValueDisclosureMember" xlink:title="presentation: FairValueDisclosureItemAmountsDomain to PortionAtFairValueFairValueDisclosureMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="CarryingReportedAmountFairValueDisclosureMember" xlink:title="CarryingReportedAmountFairValueDisclosureMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosureItemAmountsDomain" xlink:to="CarryingReportedAmountFairValueDisclosureMember" xlink:title="presentation: FairValueDisclosureItemAmountsDomain to CarryingReportedAmountFairValueDisclosureMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="EstimateOfFairValueFairValueDisclosureMember" xlink:title="EstimateOfFairValueFairValueDisclosureMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosureItemAmountsDomain" xlink:to="EstimateOfFairValueFairValueDisclosureMember" xlink:title="presentation: FairValueDisclosureItemAmountsDomain to EstimateOfFairValueFairValueDisclosureMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByMeasurementBasisAxis" xlink:to="FairValueDisclosureItemAmountsDomain" xlink:title="presentation: FairValueByMeasurementBasisAxis to FairValueDisclosureItemAmountsDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="FairValueByMeasurementBasisAxis" xlink:title="presentation: FairValueByBalanceSheetGroupingTable to FairValueByMeasurementBasisAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueByBalanceSheetGroupingTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="MeasurementInputTypeAxis" xlink:title="MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="MeasurementInputTypeDomain" xlink:title="MeasurementInputTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="MeasurementInputSharePriceMember" xlink:title="MeasurementInputSharePriceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputSharePriceMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputSharePriceMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="MeasurementInputCreditSpreadMember" xlink:title="MeasurementInputCreditSpreadMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputCreditSpreadMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputCreditSpreadMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="MeasurementInputPriceVolatilityMember" xlink:title="MeasurementInputPriceVolatilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputPriceVolatilityMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputPriceVolatilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="MeasurementInputRiskFreeInterestRateMember" xlink:title="MeasurementInputRiskFreeInterestRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeDomain" xlink:to="MeasurementInputRiskFreeInterestRateMember" xlink:title="presentation: MeasurementInputTypeDomain to MeasurementInputRiskFreeInterestRateMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasurementInputTypeAxis" xlink:to="MeasurementInputTypeDomain" xlink:title="presentation: MeasurementInputTypeAxis to MeasurementInputTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="MeasurementInputTypeAxis" xlink:title="presentation: FairValueByBalanceSheetGroupingTable to MeasurementInputTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:title="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:label="DebtInstrumentFairValueDisclosureAbstract" xlink:title="DebtInstrumentFairValueDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="ConvertibleDebtFairValueDisclosures" xlink:title="ConvertibleDebtFairValueDisclosures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentFairValueDisclosureAbstract" xlink:to="ConvertibleDebtFairValueDisclosures" xlink:title="presentation: DebtInstrumentFairValueDisclosureAbstract to ConvertibleDebtFairValueDisclosures" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="DebtInstrumentFairValueDisclosureAbstract" xlink:title="presentation: FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems to DebtInstrumentFairValueDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAndInputDescriptionAbstract" xlink:label="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="ValuationTechniqueAndInputDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ConvertibleDebtMeasurementInput" xlink:label="ConvertibleDebtMeasurementInput" xlink:title="ConvertibleDebtMeasurementInput" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationTechniqueAndInputDescriptionAbstract" xlink:to="ConvertibleDebtMeasurementInput" xlink:title="presentation: ValuationTechniqueAndInputDescriptionAbstract to ConvertibleDebtMeasurementInput" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ValuationTechniqueAndInputDescriptionAbstract" xlink:title="presentation: FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems to ValuationTechniqueAndInputDescriptionAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByBalanceSheetGroupingTable" xlink:to="FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:title="presentation: FairValueByBalanceSheetGroupingTable to FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueByBalanceSheetGroupingTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueByBalanceSheetGroupingTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="Goodwill" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillImpairmentLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ImpairmentOfOngoingProject" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="RelatedPartyTransactionsAbstract" xlink:title="RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_FactorBioscienceIncMember" xlink:label="FactorBioscienceIncMember" xlink:title="FactorBioscienceIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="FactorBioscienceIncMember" xlink:title="presentation: RelatedPartyDomain to FactorBioscienceIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="PIPEInvestorMember" xlink:title="presentation: RelatedPartyDomain to PIPEInvestorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to RelatedPartyTransactionsByRelatedPartyAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="DirectorMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to DirectorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: OwnershipDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="OwnershipAxis" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to OwnershipAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to ClassOfWarrantOrRightAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="RelatedPartyTransactionLineItems" xlink:title="RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RelatedPartyTransactionAbstract" xlink:label="RelatedPartyTransactionAbstract" xlink:title="RelatedPartyTransactionAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoticePeriodForSupersedingTerminationProvisions" xlink:label="NoticePeriodForSupersedingTerminationProvisions" xlink:title="NoticePeriodForSupersedingTerminationProvisions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="NoticePeriodForSupersedingTerminationProvisions" xlink:title="presentation: RelatedPartyTransactionAbstract to NoticePeriodForSupersedingTerminationProvisions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MasterServiceAgreementInitialFeesPayable" xlink:label="MasterServiceAgreementInitialFeesPayable" xlink:title="MasterServiceAgreementInitialFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="MasterServiceAgreementInitialFeesPayable" xlink:title="presentation: RelatedPartyTransactionAbstract to MasterServiceAgreementInitialFeesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfMonthlyInstallmentsForFeesPayable" xlink:label="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="NumberOfMonthlyInstallmentsForFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="NumberOfMonthlyInstallmentsForFeesPayable" xlink:title="presentation: RelatedPartyTransactionAbstract to NumberOfMonthlyInstallmentsForFeesPayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:label="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="RelatedPartyTransactionPeriodicFeesPaymentAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="RelatedPartyTransactionPeriodicFeesPaymentAmount" xlink:title="presentation: RelatedPartyTransactionAbstract to RelatedPartyTransactionPeriodicFeesPaymentAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_MonthlyMasterServicesAgreementFeesPayable" xlink:label="MonthlyMasterServicesAgreementFeesPayable" xlink:title="MonthlyMasterServicesAgreementFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="MonthlyMasterServicesAgreementFeesPayable" xlink:title="presentation: RelatedPartyTransactionAbstract to MonthlyMasterServicesAgreementFeesPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InitialLicenseFeeObligation" xlink:label="InitialLicenseFeeObligation" xlink:title="InitialLicenseFeeObligation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="InitialLicenseFeeObligation" xlink:title="presentation: RelatedPartyTransactionAbstract to InitialLicenseFeeObligation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:label="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" xlink:title="presentation: RelatedPartyTransactionAbstract to DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoticePeriodForFirstTerminationOfContract" xlink:label="NoticePeriodForFirstTerminationOfContract" xlink:title="NoticePeriodForFirstTerminationOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="NoticePeriodForFirstTerminationOfContract" xlink:title="presentation: RelatedPartyTransactionAbstract to NoticePeriodForFirstTerminationOfContract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AgreedWaivePayment" xlink:label="AgreedWaivePayment" xlink:title="AgreedWaivePayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="AgreedWaivePayment" xlink:title="presentation: RelatedPartyTransactionAbstract to AgreedWaivePayment" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:title="presentation: RelatedPartyTransactionAbstract to ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingUnamortizedLicenseFeeObligation" xlink:label="RemainingUnamortizedLicenseFeeObligation" xlink:title="RemainingUnamortizedLicenseFeeObligation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="RemainingUnamortizedLicenseFeeObligation" xlink:title="presentation: RelatedPartyTransactionAbstract to RemainingUnamortizedLicenseFeeObligation" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="MinorityInterestOwnershipPercentageByParent" xlink:title="presentation: RelatedPartyTransactionAbstract to MinorityInterestOwnershipPercentageByParent" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LicenseAgreementAutomaticRenewalTerm" xlink:label="LicenseAgreementAutomaticRenewalTerm" xlink:title="LicenseAgreementAutomaticRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="LicenseAgreementAutomaticRenewalTerm" xlink:title="presentation: RelatedPartyTransactionAbstract to LicenseAgreementAutomaticRenewalTerm" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SublicenseFees" xlink:label="SublicenseFees" xlink:title="SublicenseFees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="SublicenseFees" xlink:title="presentation: RelatedPartyTransactionAbstract to SublicenseFees" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:label="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:title="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionAbstract" xlink:to="PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" xlink:title="presentation: RelatedPartyTransactionAbstract to PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionLineItems" xlink:to="RelatedPartyTransactionAbstract" xlink:title="presentation: RelatedPartyTransactionLineItems to RelatedPartyTransactionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ExacisOptionAgreementAbstract" xlink:label="ExacisOptionAgreementAbstract" xlink:title="ExacisOptionAgreementAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PaymentOfOptionFee" xlink:label="PaymentOfOptionFee" xlink:title="PaymentOfOptionFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExacisOptionAgreementAbstract" xlink:to="PaymentOfOptionFee" xlink:title="presentation: ExacisOptionAgreementAbstract to PaymentOfOptionFee" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionLineItems" xlink:to="ExacisOptionAgreementAbstract" xlink:title="presentation: RelatedPartyTransactionLineItems to ExacisOptionAgreementAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_Q422PIPETransactionAbstract" xlink:label="Q422PIPETransactionAbstract" xlink:title="Q422PIPETransactionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: Q422PIPETransactionAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="presentation: Q422PIPETransactionAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Q422PIPETransactionAbstract" xlink:to="UnitPriceOfWarrants" xlink:title="presentation: Q422PIPETransactionAbstract to UnitPriceOfWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionLineItems" xlink:to="Q422PIPETransactionAbstract" xlink:title="presentation: RelatedPartyTransactionLineItems to Q422PIPETransactionAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="RelatedPartyTransactionLineItems" xlink:title="presentation: ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to RelatedPartyTransactionLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsAbstract" xlink:to="ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="presentation: RelatedPartyTransactionsAbstract to ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedLegalFeesAndRelatedCurrent" xlink:label="AccruedLegalFeesAndRelatedCurrent" xlink:title="AccruedLegalFeesAndRelatedCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedLegalFeesAndRelatedCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedLegalFeesAndRelatedCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedProfessionalFeesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedSomervilleFacilityCurrent" xlink:label="AccruedSomervilleFacilityCurrent" xlink:title="AccruedSomervilleFacilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedSomervilleFacilityCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedSomervilleFacilityCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrent" xlink:label="InterestPayableCurrent" xlink:title="InterestPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="InterestPayableCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to InterestPayableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to EmployeeRelatedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AccruedClinicalCurrent" xlink:label="AccruedClinicalCurrent" xlink:title="AccruedClinicalCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedClinicalCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedClinicalCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to OtherAccruedLiabilitiesCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedLiabilitiesCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LitigationSettlementAmountPayable" xlink:label="LitigationSettlementAmountPayable" xlink:title="LitigationSettlementAmountPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LitigationSettlementAmountPayable" xlink:title="presentation: LegalMattersAbstract to LitigationSettlementAmountPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LitigationSettlementAmountAwardedToOtherParty" xlink:title="presentation: LegalMattersAbstract to LitigationSettlementAmountAwardedToOtherParty" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LegalMattersAbstract" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LegalMattersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoticePeriodToAssumeControlPatents" xlink:label="NoticePeriodToAssumeControlPatents" xlink:title="NoticePeriodToAssumeControlPatents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="NoticePeriodToAssumeControlPatents" xlink:title="presentation: LicensingAgreementsAbstract to NoticePeriodToAssumeControlPatents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LicensingAgreementsAbstract" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LicensingAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="DefinedContributionPlanTable" xlink:title="DefinedContributionPlanTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="RetirementPlanNameAxis" xlink:title="RetirementPlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="RetirementPlanNameDomain" xlink:title="RetirementPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RetirementPlan401KMember" xlink:label="RetirementPlan401KMember" xlink:title="RetirementPlan401KMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RetirementPlanNameDomain" xlink:to="RetirementPlan401KMember" xlink:title="presentation: RetirementPlanNameDomain to RetirementPlan401KMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RetirementPlanNameAxis" xlink:to="RetirementPlanNameDomain" xlink:title="presentation: RetirementPlanNameAxis to RetirementPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanTable" xlink:to="RetirementPlanNameAxis" xlink:title="presentation: DefinedContributionPlanTable to RetirementPlanNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanTable" xlink:to="RangeAxis" xlink:title="presentation: DefinedContributionPlanTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="DefinedContributionPlanDisclosureLineItems" xlink:title="DefinedContributionPlanDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="DefinedContributionPlanAbstract" xlink:title="DefinedContributionPlanAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:label="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployeeContributionAtThresholdOne" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployeeContributionAtThresholdOne" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:label="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="DefinedContributionPlanEmployeeContributionAtThresholdTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployeeContributionAtThresholdTwo" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployeeContributionAtThresholdTwo" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanAbstract" xlink:to="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="presentation: DefinedContributionPlanAbstract to DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanDisclosureLineItems" xlink:to="DefinedContributionPlanAbstract" xlink:title="presentation: DefinedContributionPlanDisclosureLineItems to DefinedContributionPlanAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DefinedContributionPlanTable" xlink:to="DefinedContributionPlanDisclosureLineItems" xlink:title="presentation: DefinedContributionPlanTable to DefinedContributionPlanDisclosureLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="DefinedContributionPlanTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to DefinedContributionPlanTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="NetIncomeLossAbstract" xlink:title="NetIncomeLossAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetIncomeLossAbstract" xlink:to="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="presentation: NetIncomeLossAbstract to NetIncomeLossAvailableToCommonStockholdersBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="NetIncomeLossAbstract" xlink:title="presentation: EarningsPerShareAbstract to NetIncomeLossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to EarningsPerShareBasic" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to EarningsPerShareDiluted" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="presentation: EarningsPerShareAbstract to WeightedAverageNumberOfSharesOutstandingAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="ConvertibleCommonStockMember" xlink:title="ConvertibleCommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertibleCommonStockMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to ConvertibleCommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertiblePreferredStockMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to ConvertiblePreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="presentation: EarningsPerShareDilutedOtherDisclosuresAbstract to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to EarningsPerShareDilutedOtherDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EquityIncentivePlan2020Member" xlink:label="EquityIncentivePlan2020Member" xlink:title="EquityIncentivePlan2020Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="EquityIncentivePlan2020Member" xlink:title="presentation: PlanNameDomain to EquityIncentivePlan2020Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_InducementPlan2021Member" xlink:label="InducementPlan2021Member" xlink:title="InducementPlan2021Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="InducementPlan2021Member" xlink:title="presentation: PlanNameDomain to InducementPlan2021Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="presentation: PlanNameAxis to PlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncentiveStockOptionsMember" xlink:label="IncentiveStockOptionsMember" xlink:title="IncentiveStockOptionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="IncentiveStockOptionsMember" xlink:title="presentation: EmployeeStockOptionMember to IncentiveStockOptionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="NonQualifiedStockOptionMember" xlink:title="presentation: EmployeeStockOptionMember to NonQualifiedStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to SubsequentEventTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PercentageOfSharesOfCommonStockOutstanding" xlink:label="PercentageOfSharesOfCommonStockOutstanding" xlink:title="PercentageOfSharesOfCommonStockOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="PercentageOfSharesOfCommonStockOutstanding" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to PercentageOfSharesOfCommonStockOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="presentation: ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="presentation: AggregateIntrinsicValueAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:title="presentation: AggregateIntrinsicValueAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AggregateIntrinsicValueAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AggregateIntrinsicValueAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TimeBasedStockOptionMember" xlink:label="TimeBasedStockOptionMember" xlink:title="TimeBasedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="TimeBasedStockOptionMember" xlink:title="presentation: EmployeeStockOptionMember to TimeBasedStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PerformanceBasedStockOptionMember" xlink:label="PerformanceBasedStockOptionMember" xlink:title="PerformanceBasedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="PerformanceBasedStockOptionMember" xlink:title="presentation: EmployeeStockOptionMember to PerformanceBasedStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AllocatedShareBasedCompensationExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RestrictedStockUnitesWithheldToCoverTaxes" xlink:label="RestrictedStockUnitesWithheldToCoverTaxes" xlink:title="RestrictedStockUnitesWithheldToCoverTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="RestrictedStockUnitesWithheldToCoverTaxes" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to RestrictedStockUnitesWithheldToCoverTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfAwardsVestedAndSettledAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfAwardsVestedAndSettledAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="presentation: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PIPEInvestorOneMember" xlink:label="PIPEInvestorOneMember" xlink:title="PIPEInvestorOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="PIPEInvestorOneMember" xlink:title="presentation: RelatedPartyDomain to PIPEInvestorOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="PIPEInvestorMember" xlink:title="presentation: RelatedPartyDomain to PIPEInvestorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RelatedPartyTransactionsByRelatedPartyAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsOneMember" xlink:label="CommonWarrantsOneMember" xlink:title="CommonWarrantsOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="CommonWarrantsOneMember" xlink:title="presentation: WarrantMember to CommonWarrantsOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="CommonWarrantsMember" xlink:title="presentation: WarrantMember to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: WarrantMember to PreFundedWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: PrivatePlacementOfEquityAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NumberOfWarrantsInEachUnit" xlink:label="NumberOfWarrantsInEachUnit" xlink:title="NumberOfWarrantsInEachUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="NumberOfWarrantsInEachUnit" xlink:title="presentation: PrivatePlacementOfEquityAbstract to NumberOfWarrantsInEachUnit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_UnitPriceOfWarrants" xlink:label="UnitPriceOfWarrants" xlink:title="UnitPriceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="UnitPriceOfWarrants" xlink:title="presentation: PrivatePlacementOfEquityAbstract to UnitPriceOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ProceedsFromIssuanceOfWarrants" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: PrivatePlacementOfEquityAbstract to StockRepurchaseProgramAuthorizedAmount1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightsExercisableTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: PrivatePlacementOfEquityAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightExercised" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="presentation: PrivatePlacementOfEquityAbstract to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="OverSubscriptionAmountReceived" xlink:title="presentation: PrivatePlacementOfEquityAbstract to OverSubscriptionAmountReceived" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ObligationToPayLiquidatedDamagesPercentage" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ObligationToPayLiquidatedDamagesPercentage" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="TransactionFeesPayable" xlink:title="presentation: PrivatePlacementOfEquityAbstract to TransactionFeesPayable" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="LossContingencyEstimateOfPossibleLoss" xlink:title="presentation: PrivatePlacementOfEquityAbstract to LossContingencyEstimateOfPossibleLoss" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="LossContingencyDamagesPaidValue" xlink:title="presentation: PrivatePlacementOfEquityAbstract to LossContingencyDamagesPaidValue" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfEquityAbstract" xlink:title="presentation: SubsidiarySaleOfStockLineItems to PrivatePlacementOfEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="SubsidiarySaleOfStockLineItems" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to SubsidiarySaleOfStockLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="presentation: StockholdersEquityNoteAbstract to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="ClassOfWarrantOrRightTable" xlink:title="ClassOfWarrantOrRightTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023AndDecember2023ConvertibleNotesMember" xlink:label="July2023AndDecember2023ConvertibleNotesMember" xlink:title="July2023AndDecember2023ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleDebtMember" xlink:to="July2023AndDecember2023ConvertibleNotesMember" xlink:title="presentation: ConvertibleDebtMember to July2023AndDecember2023ConvertibleNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="presentation: LongtermDebtTypeDomain to ConvertibleDebtMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="presentation: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="LongtermDebtTypeAxis" xlink:title="presentation: ClassOfWarrantOrRightTable to LongtermDebtTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: ClassOfWarrantOrRightTable to StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="CommonWarrantsMember" xlink:title="presentation: WarrantMember to CommonWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CommonWarrantsOneMember" xlink:label="CommonWarrantsOneMember" xlink:title="CommonWarrantsOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="CommonWarrantsOneMember" xlink:title="presentation: WarrantMember to CommonWarrantsOneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_July2023WarrantsMember" xlink:label="July2023WarrantsMember" xlink:title="July2023WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="July2023WarrantsMember" xlink:title="presentation: WarrantMember to July2023WarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023WarrantsMember" xlink:label="December2023WarrantsMember" xlink:title="December2023WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantMember" xlink:to="December2023WarrantsMember" xlink:title="presentation: WarrantMember to December2023WarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: ClassOfWarrantOrRightTable to ClassOfWarrantOrRightAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="ClassOfWarrantOrRightLineItems" xlink:title="ClassOfWarrantOrRightLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NoteWarrantsAbstract" xlink:label="NoteWarrantsAbstract" xlink:title="NoteWarrantsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NoteWarrantsAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: NoteWarrantsAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NoteWarrantsAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: NoteWarrantsAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NoteWarrantsAbstract" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="presentation: NoteWarrantsAbstract to WarrantsAndRightsOutstandingTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="NoteWarrantsAbstract" xlink:title="presentation: ClassOfWarrantOrRightLineItems to NoteWarrantsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ClassOfWarrantOrRightGrantsInPeriod" xlink:label="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="ClassOfWarrantOrRightGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightGrantsInPeriod" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightGrantsInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding_2" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightOutstanding_2" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightLineItems" xlink:to="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="presentation: ClassOfWarrantOrRightLineItems to WarrantsAndRightsNoteDisclosureAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightTable" xlink:to="ClassOfWarrantOrRightLineItems" xlink:title="presentation: ClassOfWarrantOrRightTable to ClassOfWarrantOrRightLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ClassOfWarrantOrRightTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ClassOfWarrantOrRightTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsSepaDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StandbyEquityPurchaseAgreementMember" xlink:label="StandbyEquityPurchaseAgreementMember" xlink:title="StandbyEquityPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="StandbyEquityPurchaseAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to StandbyEquityPurchaseAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_LincolnParkCapitalFundLLCMember" xlink:label="LincolnParkCapitalFundLLCMember" xlink:title="LincolnParkCapitalFundLLCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityDomain" xlink:to="LincolnParkCapitalFundLLCMember" xlink:title="presentation: EntityDomain to LincolnParkCapitalFundLLCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="presentation: LegalEntityAxis to EntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="LegalEntityAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to LegalEntityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_StandbySecuritiesPurchaseAgreementAbstract" xlink:label="StandbySecuritiesPurchaseAgreementAbstract" xlink:title="StandbySecuritiesPurchaseAgreementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbySecuritiesPurchaseAgreementAbstract" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: StandbySecuritiesPurchaseAgreementAbstract to StockRepurchaseProgramAuthorizedAmount1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:label="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:title="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbySecuritiesPurchaseAgreementAbstract" xlink:to="BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" xlink:title="presentation: StandbySecuritiesPurchaseAgreementAbstract to BeneficialOwnershipPercentageOfIssuedAndOutstandingShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:label="EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:title="EquityLineOfCreditConsiderationSharesOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbySecuritiesPurchaseAgreementAbstract" xlink:to="EquityLineOfCreditConsiderationSharesOfCommonStock" xlink:title="presentation: StandbySecuritiesPurchaseAgreementAbstract to EquityLineOfCreditConsiderationSharesOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbySecuritiesPurchaseAgreementAbstract" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="presentation: StandbySecuritiesPurchaseAgreementAbstract to SaleOfStockNumberOfSharesIssuedInTransaction" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="ProceedsFromIssuanceOrSaleOfEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbySecuritiesPurchaseAgreementAbstract" xlink:to="ProceedsFromIssuanceOrSaleOfEquity" xlink:title="presentation: StandbySecuritiesPurchaseAgreementAbstract to ProceedsFromIssuanceOrSaleOfEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesToIssuedInTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbySecuritiesPurchaseAgreementAbstract" xlink:to="SaleOfStockNumberOfSharesToIssuedInTransaction" xlink:title="presentation: StandbySecuritiesPurchaseAgreementAbstract to SaleOfStockNumberOfSharesToIssuedInTransaction" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="StandbySecuritiesPurchaseAgreementAbstract" xlink:title="presentation: CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems to StandbySecuritiesPurchaseAgreementAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:title="presentation: ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable to CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FeaturesOfConvertiblePreferredStockAbstract" xlink:label="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="FeaturesOfConvertiblePreferredStockAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare" xlink:label="DividendsPayableAmountPerShare" xlink:title="DividendsPayableAmountPerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="DividendsPayableAmountPerShare" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to DividendsPayableAmountPerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="DividendsPreferredStockCash" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to DividendsPreferredStockCash" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference" xlink:label="PreferredStockLiquidationPreference" xlink:title="PreferredStockLiquidationPreference" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockLiquidationPreference" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockLiquidationPreference" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleConversionRatio" xlink:label="PreferredStockConvertibleConversionRatio" xlink:title="PreferredStockConvertibleConversionRatio" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockConvertibleConversionRatio" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockConvertibleConversionRatio" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="ConvertiblePreferredStockSharesIssuedUponConversion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="ConvertiblePreferredStockSharesIssuedUponConversion" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to ConvertiblePreferredStockSharesIssuedUponConversion" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="PreferredStockConvertibleSharesIssuable" xlink:title="PreferredStockConvertibleSharesIssuable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="PreferredStockConvertibleSharesIssuable" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to PreferredStockConvertibleSharesIssuable" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FeaturesOfConvertiblePreferredStockAbstract" xlink:to="StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="presentation: FeaturesOfConvertiblePreferredStockAbstract to StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="FeaturesOfConvertiblePreferredStockAbstract" xlink:title="presentation: ClassOfStockLineItems to FeaturesOfConvertiblePreferredStockAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="ClassOfStockLineItems" xlink:title="presentation: ScheduleOfStockByClassTable to ClassOfStockLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfStockByClassTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfStockByClassTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="presentation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="presentation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="CurrentForeignTaxExpenseBenefit" xlink:title="CurrentForeignTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentForeignTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentForeignTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredFederalIncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="DeferredForeignIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredForeignIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredForeignIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:label="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" xlink:title="presentation: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract to IncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="DeferredTaxAssetsNetAbstract" xlink:title="DeferredTaxAssetsNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsInProcessResearchAndDevelopment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="DeferredTaxAssetsRightOfUseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsRightOfUseLiabilities" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsRightOfUseLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseOther" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsTaxDeferredExpenseOther" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsGross" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsGross" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsValuationAllowance" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsValuationAllowance" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="DeferredTaxAssetsNet" xlink:title="DeferredTaxAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsNet" xlink:title="presentation: DeferredTaxAssetsNetAbstract to DeferredTaxAssetsNet" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxAssetsNetAbstract" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxAssetsNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="DeferredTaxLiabilitiesNetAbstract" xlink:title="DeferredTaxLiabilitiesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxAssetsRightOfUseAssets" xlink:label="DeferredTaxAssetsRightOfUseAssets" xlink:title="DeferredTaxAssetsRightOfUseAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredTaxAssetsRightOfUseAssets" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredTaxAssetsRightOfUseAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_DeferredTaxLiabilitiesConvertibleDebt" xlink:label="DeferredTaxLiabilitiesConvertibleDebt" xlink:title="DeferredTaxLiabilitiesConvertibleDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredTaxLiabilitiesConvertibleDebt" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredTaxLiabilitiesConvertibleDebt" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesNetAbstract" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="presentation: DeferredTaxLiabilitiesNetAbstract to DeferredIncomeTaxLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesNetAbstract" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxLiabilitiesNetAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxLiabilities" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:label="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:title="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="EffectiveIncomeTaxRateReconciliationTaxCredits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationTaxCredits" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateContinuingOperations" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateContinuingOperations" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="DomesticCountryMember" xlink:title="presentation: IncomeTaxAuthorityDomain to DomesticCountryMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="presentation: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="ForeignCountryMember" xlink:title="presentation: IncomeTaxAuthorityDomain to ForeignCountryMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="presentation: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="presentation: OperatingLossCarryforwardsTable to IncomeTaxAuthorityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_IncomeTaxAbstract" xlink:label="IncomeTaxAbstract" xlink:title="IncomeTaxAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="presentation: IncomeTaxAbstract to ValuationAllowanceDeferredTaxAssetChangeInAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="OperatingLossCarryforwards" xlink:title="presentation: IncomeTaxAbstract to OperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TaxCutsAndJobsActOperatingLossCarryforwards" xlink:label="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="TaxCutsAndJobsActOperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="TaxCutsAndJobsActOperatingLossCarryforwards" xlink:title="presentation: IncomeTaxAbstract to TaxCutsAndJobsActOperatingLossCarryforwards" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="TaxCreditCarryforwardAmount" xlink:title="TaxCreditCarryforwardAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="TaxCreditCarryforwardAmount" xlink:title="presentation: IncomeTaxAbstract to TaxCreditCarryforwardAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_TaxCreditCarryforwardExpirationYear" xlink:label="TaxCreditCarryforwardExpirationYear" xlink:title="TaxCreditCarryforwardExpirationYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="TaxCreditCarryforwardExpirationYear" xlink:title="presentation: IncomeTaxAbstract to TaxCreditCarryforwardExpirationYear" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="presentation: IncomeTaxAbstract to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OpenTaxYear" xlink:label="OpenTaxYear" xlink:title="OpenTaxYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAbstract" xlink:to="OpenTaxYear" xlink:title="presentation: IncomeTaxAbstract to OpenTaxYear" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="IncomeTaxAbstract" xlink:title="presentation: OperatingLossCarryforwardsLineItems to IncomeTaxAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="OperatingLossCarryforwardsLineItems" xlink:title="presentation: OperatingLossCarryforwardsTable to OperatingLossCarryforwardsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="OperatingLossCarryforwardsTable" xlink:title="presentation: IncomeTaxDisclosureAbstract to OperatingLossCarryforwardsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:title="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="UnrecognizedTaxBenefits" xlink:title="UnrecognizedTaxBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="UnrecognizedTaxBenefits" xlink:title="presentation: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to UnrecognizedTaxBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:title="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:title="presentation: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:title="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:title="presentation: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="UnrecognizedTaxBenefits_2" xlink:title="UnrecognizedTaxBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="UnrecognizedTaxBenefits_2" xlink:title="presentation: ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward to UnrecognizedTaxBenefits" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:title="presentation: IncomeTaxDisclosureAbstract to ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="NonQualifiedStockOptionMember" xlink:title="presentation: EmployeeStockOptionMember to NonQualifiedStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="AwardTypeAxis" xlink:title="presentation: SubsequentEventTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_PresidentChiefExecutiveOfficerAndDirectorMember" xlink:label="PresidentChiefExecutiveOfficerAndDirectorMember" xlink:title="PresidentChiefExecutiveOfficerAndDirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="PresidentChiefExecutiveOfficerAndDirectorMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to PresidentChiefExecutiveOfficerAndDirectorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: SubsequentEventTable to TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheOneMember" xlink:title="presentation: VestingDomain to ShareBasedCompensationAwardTrancheOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="ShareBasedCompensationAwardTrancheTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="presentation: VestingDomain to ShareBasedCompensationAwardTrancheTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="presentation: VestingAxis to VestingDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="VestingAxis" xlink:title="presentation: SubsequentEventTable to VestingAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="LongtermDebtTypeAxis" xlink:title="LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="LongtermDebtTypeDomain" xlink:title="LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember" xlink:label="ConvertibleDebtMember" xlink:title="ConvertibleDebtMember" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_December2023ConvertibleNotesMember" xlink:label="December2023ConvertibleNotesMember" xlink:title="December2023ConvertibleNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleDebtMember" xlink:to="December2023ConvertibleNotesMember" xlink:title="presentation: ConvertibleDebtMember to December2023ConvertibleNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeDomain" xlink:to="ConvertibleDebtMember" xlink:title="presentation: LongtermDebtTypeDomain to ConvertibleDebtMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongtermDebtTypeAxis" xlink:to="LongtermDebtTypeDomain" xlink:title="presentation: LongtermDebtTypeAxis to LongtermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="LongtermDebtTypeAxis" xlink:title="presentation: SubsequentEventTable to LongtermDebtTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="WarrantMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: SubsequentEventTable to ClassOfWarrantOrRightAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: SubsequentEventTable to SubsequentEventTypeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_CEOInducementGrantAbstract" xlink:label="CEOInducementGrantAbstract" xlink:title="CEOInducementGrantAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CEOInducementGrantAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: CEOInducementGrantAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CEOInducementGrantAbstract" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: CEOInducementGrantAbstract to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CEOInducementGrantAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="presentation: CEOInducementGrantAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CEOInducementGrantAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="presentation: CEOInducementGrantAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CEOInducementGrantAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" xlink:title="presentation: CEOInducementGrantAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="CEOInducementGrantAbstract" xlink:title="presentation: SubsequentEventLineItems to CEOInducementGrantAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="erna-20231231.xsd#erna_RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:label="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:title="RemainingFundingReceivedFromDecember2023FinancingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="ProceedsFromConvertibleDebt" xlink:title="ProceedsFromConvertibleDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:to="ProceedsFromConvertibleDebt" xlink:title="presentation: RemainingFundingReceivedFromDecember2023FinancingAbstract to ProceedsFromConvertibleDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: RemainingFundingReceivedFromDecember2023FinancingAbstract to DebtInstrumentFaceAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: RemainingFundingReceivedFromDecember2023FinancingAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:to="DebtInstrumentMaturityDate" xlink:title="presentation: RemainingFundingReceivedFromDecember2023FinancingAbstract to DebtInstrumentMaturityDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="RemainingFundingReceivedFromDecember2023FinancingAbstract" xlink:title="presentation: SubsequentEventLineItems to RemainingFundingReceivedFromDecember2023FinancingAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventLineItems" xlink:title="presentation: SubsequentEventTable to SubsequentEventLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventTable" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image00007.jpg
<TEXT>
begin 644 image00007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !4 'X# 2(  A$! Q$!_\0
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M  TFE94B&HS(78X 9D4*/Q-+^T=975[\+;W[*LCQP3Q3W*QC+&%6^8CZ<'Z
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M=L]&TUIFM+4,L9F8,YRQ8Y( [D]JS_"VC72W<NM:X5?5;A<*@^[;I_<7^O\
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7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231231200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 12, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Eterna Therapeutics Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1103425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1035 Cambridge Street, Suite 18A,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-1199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.005 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ERNA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,410,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">GRANT THORNTON LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231460656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 7,575<span></span>
</td>
<td class="nump">$ 11,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">425<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,599<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">9,599<span></span>
</td>
<td class="nump">13,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">4,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets - operating leases</a></td>
<td class="nump">32,781<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="nump">2,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment in non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">49,132<span></span>
</td>
<td class="nump">22,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,067<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,893<span></span>
</td>
<td class="nump">3,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">2,216<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,573<span></span>
</td>
<td class="nump">7,654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes, net</a></td>
<td class="nump">6,773<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant liabilities</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">32,854<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, non-current</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration liability</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">46,899<span></span>
</td>
<td class="nump">10,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholder's equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.005 par value, 100,000 shares authorized at December 31, 2023 and 2022; 5,410 and 5,127 issued and outstanding at December 31, 2023 and 2022, respectively</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">189,186<span></span>
</td>
<td class="nump">177,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(186,981)<span></span>
</td>
<td class="num">(165,297)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">2,233<span></span>
</td>
<td class="nump">12,107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">49,132<span></span>
</td>
<td class="nump">22,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,205<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholder's equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at December 31, 2023 and 2022, $156 liquidation preference</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231127232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholder's equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation preference</a></td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">5,410<span></span>
</td>
<td class="nump">5,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">5,410<span></span>
</td>
<td class="nump">5,127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064232170736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross loss</a></td>
<td class="num">(168)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">5,920<span></span>
</td>
<td class="nump">10,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,587<span></span>
</td>
<td class="nump">16,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition', window );">Acquisition of Exacis in-process research and development</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Impairment of in-process research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,990<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">20,967<span></span>
</td>
<td class="nump">33,217<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(21,135)<span></span>
</td>
<td class="num">(33,217)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other expense, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WarrantLiabilitiesExpense', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">10,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LossOnNonControllingInvestment', window );">Loss on non-controlling investment</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(941)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Interest income</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(614)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(334)<span></span>
</td>
<td class="num">(1,141)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income, net</a></td>
<td class="num">(536)<span></span>
</td>
<td class="nump">8,683<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(21,671)<span></span>
</td>
<td class="num">(24,534)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit (provision) for income taxes</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(21,668)<span></span>
</td>
<td class="num">(24,579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Series A convertible preferred stock dividend</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (21,684)<span></span>
</td>
<td class="num">$ (24,595)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (4.08)<span></span>
</td>
<td class="num">$ (8.06)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (4.08)<span></span>
</td>
<td class="num">$ (8.06)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic (in shares)</a></td>
<td class="nump">5,314<span></span>
</td>
<td class="nump">3,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted (in shares)</a></td>
<td class="nump">5,314<span></span>
</td>
<td class="nump">3,051<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of change in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LossOnNonControllingInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss on non-controlling investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LossOnNonControllingInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ResearchAndDevelopmentInProcessAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_WarrantLiabilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_WarrantLiabilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231396512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Preferred Stock [Member] </div>
<div>Series A Convertible Preferred Stock [Member]</div>
</th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A Convertible Preferred Stock [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 166,191<span></span>
</td>
<td class="num">$ (140,702)<span></span>
</td>
<td class="nump">$ 25,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">2,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValuePrivateOffering', window );">Issuance of common stock in connection with private offering</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesPrivateOffering', window );">Issuance of common stock in connection with private offering (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts', window );">Issuance of common stock and warrants in connection with November 2022 private offering, net.</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">7,383<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts', window );">Issuance of common stock and warrants in connection with November 2022 private offering, net. (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividends to Series A convertible preferred stockholders</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Cash dividends to Series A convertible preferred stockholders (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,579)<span></span>
</td>
<td class="num">(24,579)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">177,377<span></span>
</td>
<td class="num">(165,297)<span></span>
</td>
<td class="nump">12,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">5,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueAcquisitions2', window );">Issuance of common stock in connection with Exacis asset acquisition</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesAcquisitions2', window );">Issuance of common stock in connection with Exacis asset acquisition (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodValueStockPurchaseAgreement', window );">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement', window );">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of note warrants</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">9,014<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket', window );">Repricing of warrants in connection with December 2023 financing</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividends to Series A convertible preferred stockholders</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Cash dividends to Series A convertible preferred stockholders (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,668)<span></span>
</td>
<td class="num">(21,668)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 189,186<span></span>
</td>
<td class="num">$ (186,981)<span></span>
</td>
<td class="nump">$ 2,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">5,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares Forfeiture of unvested restricted stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesAcquisitions2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesAcquisitions2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of stock issued common stock and warrants in connection with private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesPrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been issued in private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesPrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been issued in a stock purchase agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued common stock and warrants in connection with private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueAcquisitions2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueAcquisitions2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Forfeiture of unvested restricted stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValuePrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been issued in private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValuePrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StockIssuedDuringPeriodValueStockPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StockIssuedDuringPeriodValueStockPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to additional paid in capital (APIC) resulting from changes in fair value of common and preferred stock issued to employee benefit trust but unearned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231300144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (21,668)<span></span>
</td>
<td class="num">$ (24,579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,242<span></span>
</td>
<td class="nump">2,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CommitmentSharesIssueExpense', window );">Commitment shares issued to Lincoln Park Capital, LLC</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on shares sold to Lincoln Park Capital, LLC</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use asset</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of right-of-use asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition', window );">Non-cash component of acquisition of Exacis in-process research and development</a></td>
<td class="nump">433<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset', window );">Gain on remeasurement of operating lease liability and right-of-use-asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(642)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Impairment of in-process research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainLossOnDisposalOfFixedAssets', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainOnTerminationOfLease', window );">Gain on lease termination</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Accrued interest expense</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Paid-in-kind interest expense</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(215)<span></span>
</td>
<td class="num">(10,795)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainLossOnChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration liability</a></td>
<td class="num">(118)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LossOnNonControllingInvestment', window );">Loss on non-controlling investment</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">527<span></span>
</td>
<td class="num">(262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(556)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">1,014<span></span>
</td>
<td class="num">(646)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(2,898)<span></span>
</td>
<td class="nump">2,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liability</a></td>
<td class="nump">1,338<span></span>
</td>
<td class="num">(340)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Due to related party</a></td>
<td class="num">(1,750)<span></span>
</td>
<td class="nump">2,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(374)<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(20,408)<span></span>
</td>
<td class="num">(20,976)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from the sale of fixed assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds received from the convertible notes financings</a></td>
<td class="nump">16,503<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Fees paid related to the Convertible Notes Financings</a></td>
<td class="num">(251)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds received under promissory note</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payment made on promissory note</a></td>
<td class="num">(1,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement', window );">Proceeds from sale of common stock pursuant to stock purchase agreement with Lincoln Park Capital Fund, LLC</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock and warrants in connection with private offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExpensesPaidInConnectionWithPrivateOffering', window );">Fees paid in connection with private offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants', window );">Issuance of common stock from exercise of pre-funded warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payroll tax remitted on net share settlement of equity awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Dividends paid to Series A convertible preferred stockholders</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit', window );">Cash paid for fractional shares in connection with reverse stock split</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal payments on finance leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">16,556<span></span>
</td>
<td class="nump">19,579<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(3,871)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">15,541<span></span>
</td>
<td class="nump">16,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">11,670<span></span>
</td>
<td class="nump">15,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CashPaidDuringThePeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ContingentConsiderationForAssetAcquisition', window );">Contingent consideration for Exacis asset acquisition</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IssuanceOfCommonStockForAssetAcquisition', window );">Issuance of common stock for Exacis asset acquisition</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WarrantsIssued', window );">Note warrants issued</a></td>
<td class="nump">9,219<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RepricingOfWarrantsInConnectionWithFinancing', window );">Repricing of warrants in connection with December 2023 financing</a></td>
<td class="nump">766<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants', window );">Unpaid fees incurred in connection with the December 2023 financing</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaidInKindInterestAddedToConvertibleNotesPrincipal', window );">Paid-in-kind interest added to convertible notes principal</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfRightOfUseAssets', window );">Initial measurement of ROU assets</a></td>
<td class="nump">34,410<span></span>
</td>
<td class="nump">1,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfLeaseLiabilities', window );">Initial measurement of lease liabilities</a></td>
<td class="nump">34,170<span></span>
</td>
<td class="nump">1,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement', window );">Adjustment to lease liability and ROU asset due to remeasurement</a></td>
<td class="num">(1,620)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AccrualForPurchasesOfPropertyAndEquipment', window );">Accrual for purchases of property and equipment</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConversionOfWarrantLiabilityToEquity', window );">Conversion of Warrant Liability to Equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnpaidFeesIncurredInConnectionWithPrivateOffering', window );">Unpaid fees incurred in connection with November 2022 private offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfFinanceLeaseLiabilities', window );">Initial measurement of finance lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash at end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">7,575<span></span>
</td>
<td class="nump">11,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">4,095<span></span>
</td>
<td class="nump">4,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 11,670<span></span>
</td>
<td class="nump">$ 15,541<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AccrualForPurchasesOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The accrual for purchases of property and equipment noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AccrualForPurchasesOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to lease liability and right of use asset due to remeasurement in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CashPaidDuringThePeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CashPaidDuringThePeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for fractional shares in connection with reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CommitmentSharesIssueExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for commitment shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CommitmentSharesIssueExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ContingentConsiderationForAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued payment of contingent consideration in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ContingentConsiderationForAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ConversionOfWarrantLiabilityToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The conversion of warrant liability to equity in non-cash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ConversionOfWarrantLiabilityToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ExpensesPaidInConnectionWithPrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses paid in connection with private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ExpensesPaidInConnectionWithPrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainLossOnChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gain (loss) on change in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainLossOnChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainLossOnDisposalOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of fixed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainLossOnDisposalOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on remeasurement of right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of finance lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of Initial measurement of lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of Initial measurement of ROU assets in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IssuanceOfCommonStockForAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The issuance of common stock for asset acquisition in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IssuanceOfCommonStockForAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash flows from issuance of common stock from exercise of pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LossOnNonControllingInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss on non-controlling investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LossOnNonControllingInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non cash amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PaidInKindInterestAddedToConvertibleNotesPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The paid-in-kind interest added to convertible notes principal in noncash financing activities..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PaidInKindInterestAddedToConvertibleNotesPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity pursuant to stock purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RepricingOfWarrantsInConnectionWithFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The repricing of warrants in connection with financing in noncash financing activities..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RepricingOfWarrantsInConnectionWithFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnpaidFeesIncurredInConnectionWithPrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of unpaid fees incurred in connection with private offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnpaidFeesIncurredInConnectionWithPrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of unpaid fees incurred in connection with the issuance of convertible notes and warrants in noncash financing activities..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of warrants issued to purchase common stock of the company together with convertible notes in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentOfFinancingAndStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226837424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization and Description of Business Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Description of Business Operations</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">1)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Organization and Description of Business Operations</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics Inc. is a life science company committed to realizing the potential of mRNA cell engineering to provide
            patients with transformational new medicines.&#160; Eterna has in-licensed a portfolio of over 100 patents covering key mRNA cell
            engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSliceTM and UltraSliceTM gene-editing proteins, and the ToRNAdoTM mRNA delivery system, which Eterna collectively refers to as our &#8220;mRNA
            technology platform.&#8221; Eterna refers to aspects of its mRNA technology platform as &#8220;mRNA delivery,&#8221; &#8220;mRNA gene editing&#8221; and &#8220;mRNA cell reprogramming.&#8221; Eterna licenses its mRNA technology platform from Factor Bioscience Limited (&#8220;Factor Limited&#8221;)
            under an exclusive license agreement. As used herein, the &#8220;Company&#8221; or &#8220;Eterna&#8221; refers collectively to Eterna and its consolidated subsidiaries (Eterna LLC, Novellus, Inc. and Novellus Therapeutics Limited) unless otherwise stated or the
            context otherwise requires.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226415104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity and Capital Resources<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LiquidityAndCapitalResourcesTextBlock', window );">Liquidity and Capital Resources</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">2)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Liquidity and Capital Resources</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has incurred significant operating losses and has an accumulated deficit as a result of its efforts to develop
        product candidates, including conducting clinical trials and providing general and administrative support for operations. As of December 31, 2023, the Company had an unrestricted cash balance of approximately $7.6 million and an accumulated deficit of approximately $187.0
        million. For the year ended December 31, 2023, the Company incurred a net loss of $21.7 million, and the Company used cash of $20.4 million in operating activities.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;In October 2022, the Company entered into a sublease for approximately 45,500 square feet of office and laboratory space in Somerville, Massachusetts.&#160; Pursuant to the sublease, the Company delivered to the sublessor a security deposit in the form of a letter
          of credit in the amount of $4.1 million, which will be reduced on an incremental basis throughout the term of the sublease.&#160; The letter
          of credit was issued by the Company&#8217;s commercial bank, which required that the Company cash collateralize the letter of credit by depositing $4.1
          million in a restricted cash account with such bank.&#160; The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the sublease.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In April 2023, the Company entered into a standby equity purchase agreement (the &#8220;SEPA&#8221;) and a registration rights agreement with Lincoln Park Capital Fund, LLC (&#8220;Lincoln Park&#8221;), pursuant to which
            Lincoln Park committed to purchase up to $10.0 million of the Company&#8217;s common stock in an &#8220;equity line&#8221; financing arrangement.
            During the year ended December 31, 2023, the Company issued and sold approximately 214,000 shares of common stock under the SEPA for
            gross proceeds of $0.3 million<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">.</span></span></span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </span></span></span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In July and December 2023, the Company received $16.5 million in gross proceeds from the
            issuance of convertible notes and in January 2024 received an additional $1.4 million in gross proceeds from the issuance of
            additional convertible notes. See Notes 6 and 18 for additional information regarding these financings.</span></span></div>

<div><br/></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">In










            connection with preparing the accompanying consolidated financial statements as of and for the year ended December 31, 2023, the Company&#8217;s management concluded that there is substantial doubt regarding the Company&#8217;s ability to continue as a
            going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these consolidated financial statements. The Company will need to
            raise additional capital, which could be through the sales of shares of its common stock under the SEPA, public or private equity offerings, debt financings, out-licensing the Company&#8217;s intellectual property, strategic partnerships or other
            means. Other than the SEPA, the Company currently has no arrangements for capital, and no assurances can be given that it will be able to raise capital when needed, on acceptable terms, or at all.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The
        accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying consolidated financial
        statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company&#8217;s ability
        to continue as a going concern.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LiquidityAndCapitalResourcesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LiquidityAndCapitalResourcesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LiquidityAndCapitalResourcesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LiquidityAndCapitalResourcesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064229035024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Accounting Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">3)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Basis of Accounting Presentation and Summary of Significant Accounting Policies</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Basis of Accounting Presentation</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). All
        significant intercompany balances and transactions have been eliminated in consolidation.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-style: italic;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-style: italic;">Summary of Significant Accounting Policies</div>

<div><br class="Apple-interchange-newline"/></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Use of Estimates</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; contingent consideration and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of
        historical experience and various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Cash, Cash Equivalents and Restricted Cash</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had no cash equivalents as of December 31, 2023 or 2022.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Restricted cash consists of a cash collateralization of $4.1 million for a security deposit in the form of a letter of credit issued by the Company&#8217;s commercial bank and delivered to the sublessor of office and laboratory space the Company
        subleases in Somerville, Massachusetts. The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the sublease.<br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Property and Equipment</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of seven years. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Furniture and fixtures are depreciated over an estimated useful life of five years.&#160; Computer equipment are depreciated over an estimated useful life of three years. Upon retirement or other
        disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of operations. Expenditures for maintenance and repairs are
        charged to operations. Renewals and betterments are capitalized.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Goodwill</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#8220;IRX&#8221;) in November 2018, which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events occur or circumstances indicate it is more likely
        than not that the fair value of a reporting unit is less than&#160; its carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, macroeconomic conditions, industry and market
        considerations, cost factors, overall financial performance and other relevant events.&#160; Management evaluates the Company as a single reporting unit, therefore, goodwill is tested for impairment at the entity level. Goodwill is tested for impairment
        as of December 31st of each year, or more frequently as warranted by events or changes in circumstances mentioned above.&#160; Accounting guidance also permits an optional qualitative assessment for goodwill to determine whether it is more likely than
        not that the carrying value of a reporting unit exceeds its fair value. If, after this qualitative assessment, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then
        no further quantitative testing would be necessary. A quantitative assessment is performed if the qualitative assessment results in a more likely than not determination or if a qualitative assessment is not performed. The quantitative assessment
        considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#8217;s carrying value exceeds its fair value.<br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">In-Process Research &amp; Development</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In-process research and development (&#8220;IPR&amp;D&#8221;) assets represent the fair value assigned to technologies that were acquired
        in connection with the acquisition of IRX in November 2018, which have not reached technological feasibility and have no alternative future use. IPR&amp;D assets are considered to be indefinite lived until the completion or abandonment of the
        associated research and development projects. During the period that the IPR&amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or
        changes in circumstances that indicate that the fair value of the IPR&amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize
        products associated with the IPR&amp;D assets, these assets are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a
        full or partial impairment charge related to the IPR&amp;D assets, calculated as the excess of carrying value of the IPR&amp;D assets over fair value.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: left;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Revenue
              Recognition</span></span><br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company recognizes the related revenue under ASC 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). Under ASC 606, the Company recognizes revenue when a customer obtains
            control of promised services or goods in an amount that reflects the consideration to which the Company expects to receive in exchange for those goods or services. </span></div>

<div>
        &#160; <br/></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In general, the Company applies the following steps when recognizing revenue from contracts with customers: (i) identify the contract, (ii) identify the performance obligations,
          (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations and (v) recognize revenue when a performance obligation is satisfied. Recognition of revenue is driven by satisfaction of the performance
          obligations using one of two methods: revenue is either recognized over time or at a point in time. Contracts containing multiple performance obligations classify those performance obligations into separate units of account either as standalone
          or combined units of account. Allocation of revenue to individual elements that qualify for separate accounting is based on the separate selling prices determined for each component, and total contract consideration is then allocated across the
          components of the arrangement. If separate selling prices are not available, the Company will use its best estimate of such selling prices, consistent with the overall pricing strategy and after consideration of relevant market factors.</span><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company estimates the amount of consideration it expects to recognize as revenue that is not probable of having a significant reversal of such recognized revenue, and it places
          a constraint on the remaining contractual consideration. As it becomes evident that the constrained amounts are no longer at risk of a significant reversal of revenue, the Company will remove the constraint from the related revenue and recognize
          a cumulative catch-up adjustment to revenue in the period in which the constraint was removed.</span><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has one revenue generating contract. Such contract
          relates to an option and license agreement as well as certain development activities.&#160; See Note 5.</span><br/>
        <br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt; text-align: justify;"> Contract Assets:<br/>
      </div>

<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> A contract asset is an entity&#8217;s right to payment for goods and services already transferred to a customer if that right to payment is conditional on something other than the passage of time.
          Generally, an entity will recognize a contract asset when it has fulfilled a contract obligation but must perform other obligations before being entitled to payment. Contract assets consist primarily of the cost of project contract work performed
          by third parties whereby the Company expects to recognize any related revenue at a later date, upon satisfaction of the contract obligations. The Company had no contract assets as of December 31, 2023 or 2022.</span></div>

<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contract Liabilities:</span></div>

<div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contract liabilities consist primarily of consideration received, usually in the form of payment, on project work to be performed whereby the Company expects to recognize any related revenue at a later date, upon
            satisfaction of the contract obligations. As of December 31, 2023, contract liabilities were $0.6 million and are recognized as
            deferred revenue in the accompanying consolidated balance sheet. The Company recognized $0.1 million of revenue during the year ended
            December 31, 2023 from contract liabilities that arose in 2023. There were no contract liabilities as of December 31, 2022.</span><br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Research and Development</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The major components of research and development costs include salaries and employee benefits, stock-based compensation expense, supplies and
        materials, preclinical study costs, expensed licensed technology, consulting, scientific advisors and other third-party costs, and allocations of various overhead costs related to our product development efforts. </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has contracted with third parties to perform various studies. The financial terms of these agreements vary from
        contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts expended during the reporting period. If the actual timing of the performance of the
        services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a straight-line basis if the expected costs are expected to be incurred ratably during
        the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the allocation of responsibilities among the parties to the agreement, and the completion of
        portions of the clinical study or trial or similar conditions.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Income Taxes</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Loss Per Share</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the
        two-class method required for participating securities.&#160; The Company&#8217;s convertible notes contractually entitle the holders of such notes to participate in dividends but does not contractually require the holders to participate in the Company&#8217;s
        losses.&#160; As such, the two-class method is not applicable during periods with a net loss.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number
        of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of
        shares of common stock outstanding plus dilutive securities.&#160; Shares of common stock issuable upon exercise, conversion or vesting of stock options, restricted stock units, warrants and the outstanding Series A convertible preferred stock are
        considered potential shares of common stock and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. The Company&#8217;s convertible notes are also considered potential shares of common
        stock and are included in the calculation of diluted net loss per share using the &#8220;if-converted&#8221; method, and the more dilutive of either the two-class method or the if-converted method is reported.&#160; Diluted net loss per share is the same as basic
        net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Segment Reporting</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, <span style="font-style: italic;">Segment Reporting,</span> the Company has determined that it operates as one operating segment.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Concentration of Credit Risk</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000. The Company&#8217;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In the Company&#8217;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#8217;s supply chain, which
        could ultimately impact the Company&#8217;s ability to continue its research and development activities. For the years ended December 31, 2023 and 2022, there was no vendor concentration related to the Company&#8217;s research and development activities.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Fair Value of Financial Instruments</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 1 Inputs &#8211; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 2 Inputs &#8211; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 3 Inputs &#8211; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The carrying amounts reported on the balance sheet for cash and cash equivalents, other receivables, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value due to their short maturities.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Leases</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company accounts for its leases under
        ASC Topic 842, <span style="font-style: italic;">Leases.</span> Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less. </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for lease modifications as a separate contract when the modification (i) grants the lessee an additional
          right of use not included in the original lease contract, and (ii) increases the lease payments commensurate with the stand-alone price for the additional right of use.&#160; In this case, the Company would be treated as a new lease and measured in
          accordance with ASC 842 at the commencement date of the new lease without any impact on the existing lease.&#160; Otherwise, the Company accounts for lease modifications as a continuance of the existing lease, in which case, the Company reassesses the
          lease classification, remeasures the lease liability using an updated discount rate, and unless there is a full or partial termination of the lease, adjusts the ROU asset by the amount of change to the lease liability.&#160; For a full or partial
          lease termination, the lessee reduces the carrying amount of the ROU asset on a basis proportionate to the full or partial termination of the lease, and any difference between the adjustment to the ROU asset and the lease liability is recognized
          as a gain or loss in the current period.</div>

<div><br/>
        </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Commitment and Contingencies</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company follows ASC No.450-20, <span style="font-style: italic;">Loss Contingencies,</span> to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock-Based Compensation</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-line basis.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Warrants</span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, <span style="font-style: italic;">Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.</span> The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#8217;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.<span style="text-decoration: underline;"><br/>
        </span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div><span style="text-decoration: underline;">Convertible Notes</span></div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The Company accounts for its convertible
          notes as a long-term liability equal to the proceeds received from issuance, including the embedded conversion feature, plus any interest paid-in-kind, net of the unamortized debt issuance costs and debt discount on the consolidated balance
          sheets. The Company evaluates all embedded features contained in the convertible notes, such as the conversion feature, the paid-in-kind feature and the redemption feature in the event of a default, to determine if such features require
          bifurcation as a derivative. The conversion feature included in the convertible notes is not required to be accounted for separately as an embedded derivative because the conversion feature is considered both indexed to the Company&#8217;s own stock
          and qualifies to be classified in stockholders&#8217; equity. The paid-in-kind feature is considered to be a commitment to originate a loan, and the terms of the additional loans have the same terms as the original debt instrument. Therefore, the
          paid-in-kind feature qualifies for the scope exception under the applicable accounting guidance and is not required to be bifurcated as a derivative. The redemption feature in the event of a default was determined to be clearly and closely
          related to the convertible notes and not required to be bifurcated as a derivative.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Proceeds from the sale of convertible
          notes with stock purchase warrants are allocated to the two elements based on their relative fair values. The portion of the proceeds allocated to warrants are recorded as a debt discount to the convertible note proceeds and presented on a net
          basis in the consolidated balance sheet. Debt issuance costs directly attributable to the transaction are capitalized and allocated to the convertible notes and warrants in the same manner as the proceeds. The amount of debt issuance costs
          allocated to the convertible notes represent a reduction of the face value of the convertible note proceeds. The Company amortizes debt issuance costs and debt discounts over the contractual term of the convertible notes, using the effective
          interest method, as interest expense on the consolidated statements of operations.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Recent Accounting Standards</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br/>
          </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>  <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> In June 2022, the Financial Accounting
          Standard Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#8220;ASU 2022-03&#8221;). The FASB issued ASU
          2022-03 to (1) clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative
          example, and (3) to introduce new disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on
          the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and
          interim periods within those fiscal years with early adoption permitted. The Company does not expect a material impact to its consolidated financial statements as a result of adopting this ASU.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In October 2023, the FASB issued ASU No.
          2023-06, Disclosure Improvements &#8211; Codification Amendment in Response to the SEC&#8217;s Disclosure Update and Simplification Initiative. This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning
          them with the SEC&#8217;s regulations.&#160; The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC&#8217;s removal of the related
          disclosure.&#160; If the SEC has not removed the applicable requirements from Regulation S-X or Regulation S-K by June 30, 2027, then this ASU will not become effective.&#160; Early adoption is prohibited.&#160; The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In November 2023, the FASB issued ASU
          No. 2023-07, Segment Reporting &#8211; Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses
          and increased interim disclosure requirements, among others. ASU No. 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. Early adoption is permitted, and
          the amendments should be applied retrospectively. The Company does not expect the amendments in this ASU to have a material impact on its consolidated financial statements.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In December 2023, the FASB issued ASU
          No. 2023-09, Improvements to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related
          disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064230413104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAbstract', window );"><strong>Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTextBlock', window );">Asset Acquisition</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">

      <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 36pt; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.4pt; margin-left: 0.4pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">4)</span></div>
            </td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.4pt; margin-left: 0.4pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Asset Acquisition</span></div>
            </td>

  </tr>


</table>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">In April 2023, the Company entered into an
      asset purchase agreement (the &#8220;Exacis Purchase Agreement&#8221;), with Exacis Biotherapeutics Inc. (&#8220;Exacis&#8221;), the stockholders party thereto and, with respect to specified provisions therein, Factor Limited (the &#8220;Exacis Acquisition&#8221;). Pursuant to the
      Exacis Purchase Agreement, the Company acquired from Exacis substantially all of Exacis&#8217; intellectual property assets (the &#8220;Exacis Assets&#8221;), including all of Exacis&#8217; right, title and interest in and to an exclusive license agreement by and between
      Exacis and Factor Limited (the &#8220;Purchased License&#8221;).&#160; The Company assumed none of Exacis&#8217; liabilities, other than liabilities under the Purchased License that accrue subsequent to the closing date.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">In consideration for the Exacis Assets, on
      the closing date of the transaction, the Company issued to Exacis an aggregate of approximately 69,000 shares of the Company&#8217;s common
      stock, which shares are subject to a 12-month lockup, pursuant to which Exacis may not sell or otherwise transfer such shares.&#160; The shares
      were issued to Exacis at a price based on the Company having an assumed equity valuation of $75.0 million, divided by the number of issued
      and outstanding shares of common stock as of the close of business two trading days prior to the closing date.&#160; For accounting purposes, the shares issued were valued at $3.00 per share, which was the closing price of the Company&#8217;s common stock on the date of issuance.&#160; The Company additionally agreed to make the following contingent payments:</div>

<div style="font-size: 10pt;">&#160;</div>

<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt; text-align: left;">(i)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;">if, at any time during the three-year
                    period commencing on the closing date and ending on the three-year anniversary of the closing date, the Company&#8217;s market
                    capitalization equals or exceeds $100.0 million for at least <span style="-sec-ix-hidden:Fact_35ada709acde4da985c53db06fba5394">ten</span> consecutive trading days, then the Company will issue to Exacis a number of shares of common stock equal to (x) $2.0 million divided by (y) the quotient of $100.00
                    million divided by the number of the Company&#8217;s then issued and outstanding shares of common stock;</div>
                </td>

  </tr>


</table>
        </div>

<div style="font-size: 10pt;">&#160;</div>

<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt; text-align: left;">(ii)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;">if, at any time during the three-year
                    period commencing on the closing date and ending on the three-year anniversary of the closing date, the Company&#8217;s market capitalization equals or exceeds $200.0 million for at least <span style="-sec-ix-hidden:Fact_fe2e977747fa41309cc95a33766e6e30">ten</span> consecutive trading days, then the Company will issue to
                    Exacis a number of additional shares of common stock equal to (x) $2.0 million divided by (y) the quotient of $200.00 million divided by the number of the Company&#8217;s then issued and outstanding shares of common stock (collectively with (i) above, the
                    &#8220;Market Cap Contingent Consideration&#8221;); and</div>
                </td>

  </tr>


</table>
        </div>

<div style="font-size: 10pt;">&#160;</div>

<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="text-align: right; vertical-align: top; width: 36pt;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: left;">(iii)</div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto; font-family: 'Times New Roman';">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;">during the five-year period commencing on the closing date and ending on the five-year anniversary of the closing date, the Company will pay or deliver to Exacis 20% of all cash or other consideration (collectively, &#8220;License Contingent Consideration&#8221;) actually received by the Company during such five-year period from (i) third-party licensees or sublicensees of
                    the intellectual property rights acquired by the Company from Exacis pursuant to the Exacis Purchase Agreement, or (ii) subject to certain exceptions, the sale of such intellectual property rights; provided, that the License Contingent
                    Consideration shall not in any event exceed $45.0 million.</div>
                </td>

  </tr>


</table>
        </div>

<div style="font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">The Company accounted for the Exacis
      Acquisition as an asset acquisition because it determined that substantially all of the fair value of the assets acquired was concentrated in the Purchased License.&#160; Assets acquired in an asset acquisition are recognized based on their cost to the
      acquirer and generally allocated to the assets on a relative fair value basis.&#160; The Company&#8217;s cost for acquiring the Exacis Assets includes the issuance of the shares of the Company&#8217;s common stock, direct acquisition-related costs and contingent
      consideration.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">The Market Cap Contingent Consideration is
      indexed to or settled in the Company&#8217;s own shares.&#160; As a result, the Company classified the Market Cap Contingent Consideration as a liability measured at fair value because the financial instrument embodies a conditional obligation (the Company
      would only issue the shares on the condition that the market capitalization thresholds are met), and at inception, the monetary value of the obligation is based solely on a fixed monetary amount ($2.0 million of shares for each target), which will be settleable with a variable number of the Company&#8217;s shares.&#160; <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;">The Company used a Monte Carlo simulation model to estimate the fair value of the Market
      Cap Contingent Consideration as of the acquisition date using the following assumptions:</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">
      <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Stock price</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3.00</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Risk-free rate</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3.58</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Volatility</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">100</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">0</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: right; color: rgb(0, 0, 0);">3.0 years</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;">The License Contingent Consideration is to be
      settled in cash and is generally recognized when the liability is probable and estimable.&#160; As of the acquisition date and as of December 31, 2023, the Company concluded that paying the License Contingent Consideration was not probable or estimable.&#160;
      Therefore, there was no applicable contingent consideration liability recognized.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="text-align: justify;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The table below shows the total fair value of
          the consideration paid for the Exacis Assets (in thousands).</span><br/>
      </div>

<div><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value of<br/>
              Consideration</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Shares issued</div>
          </td>

    <td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">208</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 88%; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Contingent consideration</div>
          </td>

    <td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">225</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Direct costs</div>
          </td>

    <td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">27</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Total fair value</div>
          </td>

    <td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">460</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.4pt;">The Company allocated 100% of the fair value of the consideration to the Purchased License, which the Company determined is an IPR&amp;D asset.&#160; IPR&amp;D assets acquired
      through an asset purchase that have no alternative future uses and no separate economic values from their original intended purpose are expensed in the period the cost is incurred.&#160; As a result, the Company expensed the fair value of the Purchased
      License during the year ended December 31, 2023.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064227024224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract with Customer<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Contract with Customer</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">5)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Contract with Customer</div>
            </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt; margin-left: 0.5pt;">On February 21, 2023, the Company and
        Lineage Cell Therapeutics, Inc. (&#8220;Lineage&#8221;) entered into an exclusive option and license agreement (the &#8220;Lineage Agreement&#8221;), which provided Lineage with the option (the &#8220;Option Right&#8221;) to obtain an exclusive sublicense of intellectual property
        from the Company and to request the Company to develop a customized cell line.&#160; The Lineage Agreement was amended in August 2023 to provide for changes specifically related to the cell line customization activities such as (i) payment terms, (ii)
        certain definitions, (iii) certain courses of action if the customized cell line selected by Lineage is not successful and (iv) documentation requirements.&#160; Lineage paid the Company a $0.3 million non-refundable up-front payment (the &#8220;Option Fee&#8221;) for the Option Right and paid an initial payment of $0.4 million to commence the cell line customization activities, per the amended payment terms. If Lineage obtains the sublicense, the Company would be entitled to receive
        additional license fees, including milestone payments and royalties.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">Pursuant to ASC 606, the Company determined
        that the Option Right was an unexercised right held by Lineage under the Lineage Agreement at contract inception, as the cell line customization activities and the sublicense were optional purchases at contract inception. These optional purchases
        of goods and services would be treated as separate contracts if and when Lineage determines that it will make such purchases. Therefore, 100%
        of the Option Fee was allocated to the Option Right.&#160; The Option Fee will remain in deferred revenue until such time that Lineage enters into the sublicense or when the Option Right expires.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">The Option Right and the cell line
        customization activities are accounted for as separate contracts, and the Company has determined that the amended terms discussed above represent a modification to the cell line customization contract.&#160; Because there were no goods or services
        transferred to Lineage before entering into the amendment, and therefore, no previously recognized revenue, there was no catch-up adjustment to revenue required at the time of the amendment.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">Lineage will make payments to the Company
        for the cell line customization activities over the development period.&#160; The Company will only earn the remaining full amount of the cell line customization fee if it makes certain progress towards delivery of the customized cell line.&#160; The Company
        has determined that $0.4 million of consideration received could be recognized without the probability of being reversed, and it has
        placed a constraint on the remaining contractual customization fee.&#160; The $0.4 million is being recognized equally over the development
        period, which is expected to be approximately 20 to 25 months, as the level of effort to perform the services is happening at the same rate over time.&#160; If the development period is expected to be longer or shorter than originally planned, the
        Company will recognize a cumulative catch-up adjustment in the period that such determination is made. For the year ended December 31, 2023, the Company recognized approximately $0.1 million of revenue for the customization activities.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">The granting of the license that the
        Company may provide to Lineage if Lineage exercises the Option Right is not considered a performance obligation at this time, as it is an optional request that the customer may make in the future and will be accounted for as a separate contract
        when the customer exercises the Option Right.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">The Company recognizes direct labor and
        supplies used in the customization activities as incurred and are recorded as a cost of revenue.&#160; As provided for in the A&amp;R Factor License Agreement discussed in Note 11, the Company is obligated to pay Factor Limited 20% of any amounts the Company receives from a customer that is related to the licensed technology under the A&amp;R Factor License Agreement, which is
        also recorded as a cost of revenue.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064229792032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Promissory Note and Convertible Note Financings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Promissory Note and Convertible Note Financings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Promissory Note and Convertible Note Financings</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">6)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Promissory Note and Convertible Note Financings</span></div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">&#160;</span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On



            <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">July 14, 2023, the Company received $8.7 million from a private placement in which the Company issued $8.7
              million in aggregate principal amount of convertible notes (the &#8220;July 2023 convertible notes&#8221;) and warrants to purchase an aggregate of approximately 6.1 million shares of its common stock (the &#8220;July 2023 warrants&#8221;). The Company recognized approximately $0.2 million in fees associated with the transaction</span>.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On



            <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">December 8, 2023, the Company received $1.5 million in exchange for the issuance of 6% promissory note with an
              aggregate principal amount of $1.5 million to Charles Cherington. The promissory note was to mature on January 8, 2024, and interest accrued at a rate of 6.0%
              per annum, payable at maturity. On December 14, 2023, the Company repaid the $1.5 million of principal and $1,500 of accrued interest due under the promissory note. There are no further obligations under the promissory note</span>.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On



            <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">December 14, 2023, the Company entered into a purchase agreement with certain purchasers for the private placement
              of $9.2 million of convertible notes (the &#8220;December 2023 convertible notes&#8221; and together with the July 2023 convertible notes, the
              &#8220;convertible notes&#8221;) and warrants to purchase an aggregate of approximately 9.6 million shares of the Company&#8217;s common stock (the
              &#8220;December 2023 warrants&#8221; and together with the July 2023 warrants, the &#8220;note warrants&#8221;). There were two closings under this purchase agreement. The first closing occurred on December 15, 2023, and the Company received $7.8 million and issued $7.8 million
              of December 2023 convertible notes and December 2023 warrants to purchase approximately 8.1 million shares of our common stock.
              The second closing, in which the Company received the reaming $1.4 million under the purchase agreement, occurred in January 2024.
              See Note 18 for additional information regarding the second closing</span>.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: #FFFFFF; display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;">See Note 16 for more information on the note
              warrants</span><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">.</span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">July 2023 convertible notes bear interest at 6% per annum, and the December 2023 convertible notes bear interest at 12%
                per annum, both of which are payable quarterly in arrears. At the Company&#8217;s election, it may pay interest either in cash or in-kind by increasing the outstanding principal amount of the convertible notes. The July 2023 convertible notes
                mature on July 14, 2028, and the December 2023 convertible notes issued on December 15, 2023 mature on December 15, 2028, unless earlier converted or repurchased.&#160; The Company does not have the option to redeem any of the convertible notes prior
                to maturity</span>.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">At <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">the option of the holders, the convertible notes may be converted from time-to-time in whole or in
                part into shares of the Company&#8217;s common stock at an initial conversion rate of, with respect to the July 2023 convertible notes, $2.86
                per share and, with respect to the December 2023 convertible notes, $1.9194 per share, subject to customary adjustments for stock
                splits, stock dividends, recapitalization and the like.&#160; As of December 31, 2023, none of the convertible notes were converted
                into shares of common stock</span>.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;">convertible notes do not contain any ratchet or other financial antidilution provisions.&#160; The
                  convertible notes contain conversion limitations such that no conversion may be made if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99%, 9.99% or 19.99% immediately after conversion thereof, subject to certain increases not in excess of either 9.99% or 19.99% at the option of such holder</span>.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">convertible notes provide for customary events of default which include (subject in certain cases to customary grace and cure periods), among others: nonpayment of principal or interest, breach
                  of covenants or other agreements in the convertible notes; the occurrence of a material adverse effect event (as defined in the related securities purchase agreement) and certain events of bankruptcy. Generally, if an event of default
                  occurs and is continuing under the convertible notes, the holder thereof may require the Company to repurchase some or all of their convertible notes at a repurchase price equal to 100% of the principal amount of the convertible notes being repurchased, plus accrued and unpaid interest thereon</span>.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
              </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">In <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">connection with the issuance of the December 2023 convertible notes, the Company agreed to reduce the exercise price of the warrants the Company issued in a private placement in December 2022
                    (see Note 16) to purchase an aggregate of approximately 4.4 million shares of the Company&#8217;s common stock from $3.28 to $1.43 per share and
                    of the July 2023 warrants from $2.61 to $1.43 per share. The effect of the reduction of the exercise price of these warrants was approximately $1.6 million and measured as the excess of the fair value of the modified instruments over the fair value of the instruments immediately before they were modified. The change in
                    the fair value of the repriced warrants is considered an issuance cost to the December 2023 convertible notes and December 2023 warrants. As such, the $1.6 million was allocated to each of those respective instruments based on their relative fair values, or approximately $0.8 million to each of the December 2023 convertible notes and December 2023 warrants</span>.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
                </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The Company determined that there were no embedded derivatives within the convertible
                      notes that required bifurcation from the host agreement.&#160; The Company allocated the gross proceeds received, the fees incurred, and as applicable, the impact of repricing the warrants discussed above, over the July 2023 convertible
                      notes and July 2023 warrants and over the December 2023 convertible notes and December 2023 warrants, as applicable, based on their relative fair values as follows (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of Proceeds and Costs:</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Relative<br/>
                              Fair Value</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation<br/>
                              Percentage</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Costs</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds,<br/>
                              Net</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">July 2023 convertible notes</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">8,715</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">39.94</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,481</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(80</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,401</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">July 2023 warrants</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">13,103</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">60.06</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">5,234</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(121</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">5,113</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">21,818</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">100.00</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">8,715</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(201</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">8,514</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
                      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of Proceeds and Costs:</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Relative<br/>
                              Fair Value</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation<br/>
                              Percentage</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Costs</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrant<br/>
                              Repricing</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds,<br/>
                              Net</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">December 2023 convertible notes</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">9,059</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">48.83</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,803</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(81</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(766</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">2,956</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">December 2023 warrants</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">9,495</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">51.17</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,985</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(85</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(802</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,098</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">18,554</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">100.00</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">7,788</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(166</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(1,568</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">6,054</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
                      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Company estimated the fair values of the convertible notes as of July 14, 2023 and December 15, 2023 based off a valuation
                      performed by a third-party specialist using a binomial tree model and the following assumptions:</div>

<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
                    </div>

<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">
                      <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                              <div>&#160;</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Stock<br/>
                                Price</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Credit<br/>
                                Spread</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">Volatility</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Risk-Free<br/>
                                Rate</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>July 2023 convertible notes</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>2.81</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>2,500</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>108</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>4.60</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; white-space: nowrap;" valign="bottom">
                              <div>December 2023 convertible notes</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>1.51</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>2,000</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>109</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>3.90</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

  </tr>


</table>
                    </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The fair value of the note warrants, all of which qualified for equity classification, was determined using the Black-Scholes pricing model as of each
                      of July 14, 2023 and December 15, 2023 using the following assumptions:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
                    </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">
                      <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                              <div>&#160;</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Stock<br/>
                                Price</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Exercise<br/>
                                Price</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                              <div style="text-align: center;">Expected<br/>
                                Life</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">Volatility</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">Dividend</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Risk-Free<br/>
                                Rate</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>July 2023 warrants</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>2.81</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>2.61</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">5 years</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>98</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>0.00</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>4.04</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;" valign="bottom">
                              <div>December 2023 warrants</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>1.51</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>1.43</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">5 years</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>101</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>0.00</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>3.91</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

  </tr>


</table>
                    </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span>
                    </div>

<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div><span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The amount of proceeds
                          allocated to the note warrants resulted in a corresponding reduction in the carrying value of the respective convertible notes as a debt discount, which is amortized with the debt issuance costs as a component of interest expense
                          based on the effective interest rate method over the contractual terms of the convertible notes.</span><br/>
                      </div>

<div><br/>
                      </div>

<div>&#160;<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;">
                    </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The following table shows the activity that occurred during the year ended December 31,
                      2023 for the convertible notes on the accompanying consolidated balance sheet:</div>

<div> <br/>
                    </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">Gross convertible notes at issuance</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">16,503</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">Debt discount and debt issuance costs</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(10,146</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">
                              <div style="color: rgb(0, 0, 0);">Amortization of debt discount and debt issuance costs</div>
                            </div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">303</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">Paid-in-kind interest added to principal</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">113</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">Convertible notes, net, at December 31, 2023</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">6,773</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
                      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The future minimum principal payments under the convertible notes as of December 31, 2023
                          are as follows:</div>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ending December 31,</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Principal</div>
                              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Payments</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2027</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2028</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">16,616</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom">
                              <div style="text-align: left; color: rgb(33, 37, 41); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">16,616</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
                        </div>

<div>&#160;</div>

<div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has recognized approximately $0.6 million in interest expense for the year ended December 31, 2023
                          for the convertible notes, which includes $0.3 million for the amortization of the debt discount and debt issuance
                          costs.&#160; Of the remaining $0.3 million in interest expense, $0.1 million was paid in-kind and added to the principal of the respective notes and $0.2 million of interest is in accrued expenses in the accompanying consolidated balance sheet.</span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064228776192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">7)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Property and Equipment</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment consist of the following (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Laboratory and manufacturing equipment</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">40</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">28</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">Furniture and fixtures<br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">19</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Leasehold improvements<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">274</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">Computer equipment and programs</div>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">274</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">240</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">607</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">268</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less accumulated depreciation and amortization</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(114</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(32</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">493</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">236</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December 31, 2023, the Company recognized a <span style="font-style: italic;">de minimis</span> loss on
        disposal of fixed assets. During the year ended December 31, 2022, the Company consolidated its research and development activities in Cambridge, Massachusetts and entered into lease termination agreements for its Brooklyn, New York and San Diego,
        California facilities. As a result, the Company disposed of certain assets it would no longer use and recognized a loss on disposal of fixed assets of approximately $0.3 million, which was composed of $0.6 million in remaining net book value of
        such assets, offset by proceeds received from selling certain fixed assets for approximately $0.3 million. </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Depreciation expense totaled $0.1
        million and $0.2 million for the years ended December 31, 2023 and 2022, respectively. No depreciation expense is recorded on fixed
        assets in process until such time as the assets are completed and are placed into service.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226887152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">8)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Leases</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Operating Leases</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he </span>Company currently has operating leases for office
        and laboratory space in (a) the borough of Manhattan in New York, New York, (b) Cambridge, Massachusetts, and (c) Somerville, Massachusetts, which expire in 2026, 2028, and 2033, respectively<span style="font-size: 10pt; font-family: 'Times New Roman';">.</span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Until March 2022, the Company also leased a facility in Brooklyn, New York. In March 2022, the Company entered into an
        agreement to assign that lease to an unaffiliated third party, who also agreed to purchase certain equipment from the Company for $50,000,
        which partially reimbursed the Company for certain existing unamortized leasehold improvements, and to reimburse the Company for the approximately $63,000
        security deposit under the lease. Under the assignment agreement, the unaffiliated third party assumed all of the obligations, liabilities, covenants and conditions of the Company as tenant under the lease.&#160; As a result of the lease assignment, the
        Company wrote off the remaining ROU asset balance of approximately $1.4 million and the corresponding lease liability of approximately $1.5 million.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company had also leased a facility in San Diego, California. During the second quarter of 2022, the Company determined to consolidate its research and
          development efforts in Cambridge, Massachusetts and sublease its San Diego lab and office space.&#160; As a result, the Company recognized an impairment charge of approximately $0.8 million on the San Diego lease ROU asset during the year ended December 31, 2022.&#160; In November 2022, the Company entered into a lease termination agreement, effective January 31, 2023;
          and as of December 31, 2023, there was no lease liability or ROU asset balances remaining for the San Diego lease.</span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In October 2022, the Company entered into a sublease with a subsidiary of Bristol-Myers Squibb Company, as sublessor (&#8220;Sublessor&#8221;), for office, laboratory and
          research and development space of approximately 45,500 square feet in Somerville, Massachusetts.&#160; The lease expires in November 2033
          and is subject to a five-year extension. Rent payments under the sublease began on November 29, 2023. The Company pays base rent of
          approximately $0.5 million per month during the first year of the term, which will increase 3% per year thereafter.&#160; The Company also makes monthly payments for parking, which are based on market rates that can change from time to time, and pay its share of
          traditional lease expenses, including certain taxes, operating expenses and utilities.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company paid the Sublessor a security deposit in the form of a letter of credit in the amount of approximately $4.1 million. Provided there are no events of default by the Company under the sublease, the letter of credit will be reduced on an incremental basis throughout the term.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Sublessor agreed to provide the Company with a tenant improvement allowance (&#8220;TIA&#8221;) of $190 per rentable square foot, or $8.6 million.&#160; Tenant improvements in excess
          of this amount will be at the Company&#8217;s own cost.&#160; Construction was substantially complete in January 2024 and the total out-of-pocket costs for the improvements is estimated to be approximately $2.1 million.&#160; As of December 31, 2023, the Company received the entire $8.6
          million TIA.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company obtained access and control of the premises on June 21, 2023, and as such, the Company determined that the commencement date for accounting purposes was
          June 21, 2023.&#160; The Company also performed an analysis on the accounting ownership of the tenant improvement assets and determined that such assets were sublessor/lessor owned.&#160; As a result, TIA payments made by the Sublessor to the Company for
          the tenant improvement assets are considered a reimbursement rather than a lease incentive and not included as part of the consideration of the contract.&#160; Amounts paid by the Company for sublessor/lessor owned assets in excess of the TIA are
          considered non-cash lease payments and are added to the consideration in the contract.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company measured the lease liability and corresponding ROU asset for the sublease as of June 21, 2023, which includes lease payments the Company must make over
          the ten-year lease term.&#160; The Company did not include the option to extend the lease for an additional five years in the initial measurement because the Company was not reasonably certain as of June 21, 2023 that it would exercise its right to
          extend the lease term. As a result, the Company recorded a lease liability of $34.4 million, which included $0.6 million for the incremental amount above the TIA that the Company expected to pay for sublessor/lessor owned assets as of the initial measurement
          date, and a corresponding ROU asset of $34.7 million as of June 30, 2023.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In December 2023, the Company incurred additional out-of-pocket expenses of approximately $0.4 million for sublessor/lessor owned assets as a result of out-of-scope changes.&#160; These cost changes were accounted for as a lease modification of the existing lease.&#160; The Company
          determined that the lease continued to be classified as an operating lease after modification and remeasured the liability for the remaining unpaid lease payments, including the aggregate $1.0 million of unpaid out-of-pocket costs above the TIA that the Company will pay for sublessor/lessor owned assets, as well as remeasuring any variable lease payment that is based on an
          index or rate.&#160; The Company also requested a third-party specialist to reassess the incremental borrowing rate, which is the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal
          to the lease payments in a similar economic environment.&#160; This reassessment resulted in an increased incremental borrowing rate from 12.7%
          as of the initial measurement date to 14.4% as of the modification date.&#160; The remeasurement resulted in a decrease to the lease
          liability of approximately $1.6 million with a corresponding adjustment to the ROU asset.<br/>
        </span></div>

<div> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2023 and 2022, the net operating lease expenses were as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-weight: bold;">2023</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,399</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">595</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(84</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(84</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">136</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">150</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,451</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">661</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2023 and
            the ending balances as of December 31 2023, including the changes during the period (in thousands).</div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating Lease</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ROU Assets</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at January 1, 2023</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,030</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Recognition of ROU asset for Somerville Sublease</div>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">34,410</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Adjustment to ROU asset for remeasurement of Somvervile Sublease liability</div>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(1,620</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Amortization of operating lease ROU assets</div>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(1,039</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at December 31, 2023</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">32,781</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating Lease</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Liabilities</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at January 1, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">1,182</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Recognition of lease liability for Somerville Sublease</div>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">34,169</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accretion of interest for Somerville Sublease</div>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">1,858</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Adjustment to lease liablity due to remeasurement of Somerville Sublease</div>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(1,620</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Principal payments on operating lease liabilities</div>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(519</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at December 31, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">35,070</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Less non-current portion</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">32,854</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Current portion at December 31, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">2,216</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2023, the Company&#8217;s operating leases had a weighted-average remaining life of 9.8 years with a weighted-average discount rate of 14.24%.
          <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of the
          operating lease liabilities are as follows (in thousands):</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2024</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,972</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2025</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,075</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2026</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,238</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2027</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,308</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2028</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,406</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">33,879</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total payments</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">65,878</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less imputed interest</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(30,808</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total operating lease liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">35,070</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
          </div>

<div><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Manhattan Sublease</span>
          <br/></div>

<div> <br/>
              </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">In April 2019, the Company entered into a sublease with an unaffiliated third party (the
              &#8220;Subtenant&#8221;), whereby the Subtenant agreed to sublease approximately 999 square feet of space rented by the Company in the borough
              of Manhattan in New York, New York commencing on May 15, 2019. The term of this sublease expires on October 31, 2026 with no option to extend. Rent payments by the Subtenant under the sublease began on September 1, 2019. The sublease
              stipulates an annual rent increase of 2.25%. The Subtenant is also responsible for paying to the Company all tenant energy costs,
              annual operating costs, and annual tax costs attributable to the subleased space during the term of the sublease.</div>

<div><br/>
              </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company received sublease payments of approximately $0.1 million for each of the years ended December 31, 2023 and 2022, respectively. In accordance with ASC Topic 842, the Company treats the sublease as a separate
              lease, as the Company was not relieved of the primary obligation under the related lease. The Company continues to account for the related lease as a lessee and in the same manner as prior to the commencement date of the sublease. The Company
              accounts for the sublease as a lessor of the lease. The sublease is classified as an operating lease, as it does not meet the criteria of a sale-type or direct financing lease.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The following tables shows the future payments the Company expects to receive from the Subtenant over
              the remaining term of the sublease (in thousands):</div>

<div><br/>
              </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2023</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">86</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">88<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">75<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total payments <br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">249</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226971872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">9)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Fair Value of Financial Instruments</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The following tables summarize the liabilities that are measured at fair value as of December 31, 2023 and, 2022 (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-weight: bold;">As of December 31,</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-weight: bold;">Description</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-weight: bold;">Level</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-weight: bold;">2023<br/>
                </div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-weight: bold;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-style: italic;">Liabilities:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Warrant liabilities - Common Warrants</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">3</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">116</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">331</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Market Cap Contingent Consideration</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">3</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">107</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">-</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
         </div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company uses a Black-Scholes option pricing model to estimate the fair value of its warrant liabilities and a Monte Carlo simulation model to
        estimate the fair value of the Market Cap Contingent Consideration, both of which are considered a Level 3 fair value measurement. The Company remeasures the fair value of the warrant liabilities and the Market Cap Contingent Consideration at each
        reporting period and changes in the fair values are recognized in the statement of operations.<br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">Certain inputs used in Black-Scholes and Monte Carlo models may fluctuate in future periods based upon factors that are outside of the Company&#8217;s
        control.&#160; A significant change in one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the Company&#8217;s warrant liabilities or contingent consideration liabilities, which could also
        result in material non-cash gains or losses being reported in the Company&#8217;s consolidated statement of operations<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">.</span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span></span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal;"> </span> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following table presents the changes in the liabilities
                measured at fair value from January 1, 2023, or from the initial measurement date if later than January 1, 2023, through December 31, 2023 (in thousands): </span></span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Warrant<br/>
                    Liabilities</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contingent<br/>
                    Consideration</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>
                </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Fair value at January 1, <span style="text-indent: 0pt;">2023</span></div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">331</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Initial measurement</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">225</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Change in fair value</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">(215</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">(118</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Fair value at December 31, <span style="text-indent: 0pt;">2023</span></div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">116</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">107</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div>
           <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
              </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; margin-left: 0.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Black-Scholes valuation assumptions used at December 31, 2023 for the warrant liabilities were 3.69 years expected term,
            3.93% risk-free rate, 103%
            volatility and 0% dividend yield.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">With the assistance of a third-party specialist, the Company assesses the fair value of the Market Cap Contingent Consideration at each quarterly reporting period using the Monte Carlo model, and as of June 30, 2023, determined that the
            fair value of the contingent consideration had been reduced by approximately $0.1 million from the initial measurement.&#160; The Company
            assessed the fair value of the Market Cap Contingent Consideration as of September 30, 2023 and as of December 31, 2023, and determined that there was no material change to the Market Cap Contingent Consideration for either period, and
            therefore, did not recognize a change in the fair value of the Market Cap Contingent Consideration since the June 30, 2023
            remeasurement. The Company assessed the fair value as of December 31, 2023, and the inputs used for that assessment was risk-free rate of 4.07%,
            expected term of 2.3 years, stock price of $1.80, volatility of 108% and dividend yield of 0%.</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: -9pt; margin-left: 9pt;"> <br/>
          </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The table below is provided for comparative purposes only and presents information about the fair value of the convertible notes relative to the carrying values recognized in the consolidated balance sheet as of December 31, 2023 (in
            thousands).&#160; The Company did not have any of the convertible notes or similar instruments outstanding as of December 31, 2022.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">December 31,<br/>
                    </span> <span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2023</span></div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Carrying<br/>
                    Value</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Fair<br/>
                    Value</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Convertible Notes</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">16,616<br/>
                    </span> </div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">17,594<br/>
                    </span> </div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
          <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The carrying value in the table above is shown before the allocation of the proceeds to the note warrants. The Company assesses the fair value of the convertible notes using the binomial model, which is considered a Level 3 measurement.&#160;
            The weighted average inputs used in the binomial model as of December 31, 2023 was stock price of $1.80, credit spread of 1,891, volatility of 109% and
            risk-free rate of 3.87%.</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226914112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and In-Process Research &amp; Development<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and In-Process Research &amp; Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and In-Process Research &amp; Development</a></td>
<td class="text">
<div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">10)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">Goodwill and In-Process Research &amp; Development</div>
                </td>

  </tr>


</table>
        </div>

<div><br/>
        </div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Goodwill</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          November 2018, the Company acquired IRX, which was accounted for as a business combination.&#160; The Company recorded goodwill in the amount of $2.0
          million related to the acquisition. The Company performed its annual qualitative assessment as of December 31, 2023 and 2022, and based on the assessments, the Company determined that it was more likely than not that the fair value of the entity
          exceeded its carrying value for such years and that the performance of the quantitative impairment test was not required.&#160; Therefore, no
          impairment was required for any of the periods presented.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> In-Process Research &amp; Development</span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          In 2018, Company recorded IPR&amp;D in the amount of $6.0 million, which represented the fair value assigned to technologies that were
          acquired in connection with the acquisition of IRX in November 2018 and which had not reached technological feasibility and had no alternative future use.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral cavity. The IRX-2 multi-cytokine
          biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE trial did not meet its primary
          endpoint of event-free survival. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate the treatment effect of IRX-2 in patient subgroups and in
          combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial was the only Company-sponsored study of IRX-2.&#160; Based on the totality of available information, the Company decided not to further develop IRX-2. As such, the Company determined
          that the carrying value of the IPR&amp;D asset was impaired and recognized a non-cash impairment charge of approximately $6.0 million
          on the consolidated statement of operations during 2022, which reduced the value of the asset to zero.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226906752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">
<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="align: right; vertical-align: top; width: 9pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: -36pt; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">11)</span></div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold; color: rgb(0, 0, 0);">Related Party Transactions</span></span></div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Agreements with
          Factor Bioscience Inc. and Affiliates</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As
          of December 31, 2023, the Company had the agreements described below with Factor Bioscience Inc. and/or Dr. Matthew Angel. These agreements have been deemed related party transactions because the Company&#8217;s former chief executive officer, Dr.
          Angel, is the chairman and chief executive officer of Factor Bioscience Inc. and a director of its subsidiary, Factor Bioscience Limited (&#8220;Factor Limited&#8221; and together with Factor Bioscience Inc. and its other affiliates, &#8220;Factor Bioscience&#8221;).
          Dr. Angel resigned as the Company&#8217;s chief executive officer effective December 31, 2023.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In
          September 2022, the Company entered into a Master Services Agreement (the &#8220;MSA&#8221;) with Factor Bioscience, pursuant to which Factor Bioscience agreed to provide services to the Company as agreed between the Company and Factor Bioscience and as set
          forth in one or more work orders under the MSA, including the first work order included in the MSA (&#8220;WO1&#8221;). The MSA contains customary confidentiality provisions and representations and warranties of the parties, and the MSA may be terminated by
          either party upon 30 days&#8217; prior notice, subject to any superseding termination provisions contained in a particular work order. </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Under
























          WO1, Factor Bioscience agreed to provide the Company with mRNA cell engineering research support services, including access to certain facilities, equipment, materials and training, and the Company agreed to pay Factor Bioscience an initial fee
          of $5.0 million, payable in 12
          equal monthly installments of approximately $0.4 million. Of the $5.0 million, the Company allocated $3.5 million to the License Fee Obligation
          (as defined below). Following the initial 12-month period, the Company agreed to continue paying Factor Bioscience the monthly fee of $0.4
          million until such time as WO1 is terminated. Upon entering into the MSA, the Company paid a deposit of $0.4 million, which will be
          applied to the last month of WO1. The Company may terminate WO1 on or after the second anniversary of the date of the MSA, subject to providing Factor Bioscience with 120 days&#8217; prior notice.&#160; Factor Bioscience may terminate WO1 only on and after the fourth anniversary of the date of the MSA, subject to providing the Company with 120 days&#8217; prior notice.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In connection with entering into the MSA, Factor Limited entered into a waiver agreement with Eterna LLC, pursuant to which
          Factor Limited agreed to waive payment of $3.5 million otherwise payable to it (the &#8220;License Fee Obligation&#8221;) in October 2022 by Eterna
          LLC under the exclusive license agreement entered into in April 2021 by and among Eterna LLC, Novellus Limited and Factor Limited (the &#8220;Original Factor License Agreement&#8221;).&#160; Under the terms of the waiver agreement, the License Fee Obligation is
          waived conditionally on the Company paying Factor Bioscience a minimum of $3.5 million due under the MSA.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Because the License Fee Obligation was conditionally waived until the Company paid Factor Bioscience a minimum of $3.5 million under the MSA, the Company recorded a liability of $3.5 million.&#160; As of December 31, 2023, there was approximately $1.2 million
          of the unamortized License Fee Obligation remaining, which is recorded on the accompanying consolidated balance sheet in the &#8220;due to related party, current&#8221; line item.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In September 2022, Novellus Inc. (&#8220;Novellus&#8221;) and the Company entered into a Second
        Amendment to the Limited Waiver and Assignment Agreement (the &#8220;Waiver and Assignment Agreement&#8221;) with Drs. Matthew Angel and Christopher Rohde (the &#8220;Founders&#8221;) whereby the Company agreed to be responsible for all future, reasonable and
        substantiated legal fees, costs, settlements and judgments incurred by the Founders, the Company or Novellus. for certain claims and actions and any pending or future litigation brought against the Founders, Novellus and/or the Company by or on
        behalf of the Westman and Sowyrda legal matters described in Note 13 (the &#8220;Covered Claims&#8221;).&#160; The Founders will continue to be solely responsible for any payments made to satisfy a judgement or settlement of any pending or future wage act claims.&#160;
        Under the Waiver and Assignment Agreement, the Founders agreed that they are not entitled to, and waived any right to, indemnification or advancement of past, present or future legal fees, costs, judgments, settlement or other liabilities they may
        have been entitled to receive from the Company or Novellus in respect of the Covered Claims. The Company and the Founders will share in any recoveries up to the point at which the parties have been fully compensated for legal fees, costs and
        expenses incurred, with the Company retaining any excess recoveries. The Company has the sole authority to direct and control the prosecution, defense and settlement of the Covered Claims.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> In November 2022, following the expiration of one of the milestone deadlines for
        certain regulatory filings required under the Third Amended and Restated Exclusive License Agreement between Novellus Limited and Factor Limited entered into in November 2020 (the &#8220;Novellus-Factor License Agreement&#8221;), which permitted Factor Limited
        to terminate the license granted to Novellus Limited thereunder, the Company entered into the first amendment to the Original Factor License Agreement (as amended, the &#8220;2021 Factor License Agreement&#8221;), pursuant to which, among other things, Factor
        Limited granted to Eterna LLC an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#8220;Factor Patents&#8221;) for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the
        Factor Patents. The Original Factor License Agreement also (i) terminated the Novellus-Factor License Agreement, (ii) confirmed Factor Limited&#8217;s grant to Eterna LLC of the rights and licenses Novellus Limited previously granted to Eterna LLC under
        the Novellus-Factor License Agreement on the same terms and conditions as granted by Novellus Limited to Eterna LLC under such agreement, (iii) confirmed that the sublicense granted by Novellus Limited in accordance with the Novellus-Factor License
        Agreement to NoveCite, Inc., a company which the Company has a 25% non-controlling interest (&#8220;NoveCite&#8221;), survived termination of the
        Novellus-Factor License Agreement; and (iv) removed Novellus Limited from the Original Factor License Agreement and the license agreement entered into on October 6, 2020 between Novellus Limited and NoveCite, Inc, as amended, and replaced Novellus
        Limited with Factor Limited as the direct licensor to Eterna LLC and NoveCite under such agreements, respectively.<br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> On February 20, 2023, the Company, entered into an exclusive license agreement (the
        &#8220;Feb 2023 Factor Exclusive License Agreement&#8221;) with Factor Limited, pursuant to which Factor Limited granted to the Company an exclusive, sublicensable, worldwide license under certain patents owned by Factor Limited for the purpose of, among other
        things, identifying and pursuing certain opportunities to develop products in respect of such patents and to otherwise grant to third parties sublicenses to such patents. The Feb 2023 Factor Exclusive License Agreement, which terminated and
        superseded the Amended Factor License Agreement, was subsequently terminated and superseded by the A&amp;R Factor License Agreement (as defined below).</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On November 14, 2023, the Company entered into an amended and restated exclusive
        license agreement (the &#8220;A&amp;R Factor License Agreement&#8221;) with Factor Limited to replace in its entirety the exclusive license agreement between the parties dated February 20, 2023 and the amendment thereto.&#160; Under the terms of the A&amp;R Factor
        License Agreement, Factor Limited granted to the Company an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#8220;Factor Patents&#8221;).&#160; The A&amp;R Factor License Agreement also provides for, among other things, the
        expansion of the Company&#8217;s license rights to include (i) the field of use of the Factor Patents to include veterinary uses (ii) know-how that is necessary or reasonably useful to practice to the licensed patents, (iii) the ability to sublicense
        through multiple tiers (as opposed to only permitting a direct sublicense) and (iv) the transfer of technology to the Company, subject to the use restrictions in the A&amp;R Factor License Agreement.&#160; The term of the A&amp;R Factor License
        Agreement expires on November 22, 2027, but will be automatically extended for an additional five years (such period, the &#8220;Renewal
        Term&#8221;) if the Company pays at least $6.0 million to Factor Limited from fees from sublicenses to the Factor Patents (&#8220;Sublicense Fees&#8221;),
        other cash on hand or a combination of both sources of funds.&#160; The Company will pay to Factor Limited 20% of any Sublicense Fee received
        by the Company during the term of the A&amp;R Factor License Agreement.&#160; Beginning in September 2024, the Company will also begin paying Factor Limited a monthly maintenance fee of approximately $0.4 million until the expiration of the A&amp;R Factor License Agreement, including any Renewal Term. The Company may terminate the A&amp;R Factor License Agreement upon 120 days&#8217; written notice to Factor Limited, and both parties have additional customary termination rights.&#160; Under the A&amp;R Factor License Agreement,
        the Company is obligated to pay the expenses incurred by Factor Limited in preparing, filing, prosecuting and maintaining the Factor Patents and the Company agreed to bear all costs and expenses associated with enforcing and defending the Factor
        Patents in any action or proceeding arising from pursuit of sublicensing opportunities under the license granted under the A&amp;R Factor License Agreement.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Exacis Asset Acquisition</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On April 26, 2023, the Company entered into the Exacis Purchase Agreement to acquire
        the Exacis Assets, including all of Exacis&#8217; right, title and interest in the Purchased License. The Company assumed none of Exacis&#8217; liabilities, other than liabilities under the Purchased License that accrue subsequent to the closing date. See Note
        4.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Exacis Acquisition was deemed a related party transaction because Dr. Gregory
        Fiore, who was the chief executive officer of Exacis at the time of the Exacis Acquisition, was also a member of the Company&#8217;s board of directors at the time of the Exacis Acquisition.&#160; Additionally, Dr. Angel, who was the Company&#8217;s chief executive
        officer at the time of the Exacis Acquisition, was chairman of Exacis&#8217; scientific advisory board, and an affiliate of Factor Bioscience was the majority stockholder of Exacis at the time of the Exacis Acquisition.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> In October 2022, the Company entered into an Option Agreement on October 8, 2022 with
        Exacis (the &#8220;Exacis Option Agreement&#8221;), pursuant to which Exacis granted the Company the option to negotiate and enter into an exclusive worldwide license to certain of the technology licensed by Exacis for the treatment of cancer in humans. The
        Exacis Option Agreement provided for the Company paying Exacis a fee of $250,000 for the option, which would be creditable against the
        fees or purchase price payable under any such license if entered into by the Company in accordance with Exacis Option Agreement. The Company did not exercise the option, and the Exacis Option Agreement terminated on December 31, 2022. </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Consulting Agreement with Former Director</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In May 2023, the Company entered into a consulting agreement with Dr. Fiore, whereby
        Dr. Fiore agreed to provide business development consulting services to the Company for a monthly retainer of $20,000.&#160; The consulting
        agreement was terminable for any reason by either party upon 15 days&#8217; written notice. The Company terminated the consulting agreement,
        effective July 31, 2023. Dr. Fiore served on the Company&#8217;s board of directors from June 2022 to October 4, 2023.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">July 2023 and December 2023 Financings</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Investors in the July 2023 convertible note financing included Brant Binder, Richard
        Wagner, Charles Cherington and Nicholas Singer, and investors in the December 2023 convertible note financing included Messrs. Cherington and Singer. Each of them participated in the applicable financing under the same terms and subject to the same
        conditions as all the other investors. See Note 6 for additional information regarding the financings. Mr. Binder served on the Company&#8217;s board of directors from July 6, 2023 to August 8, 2023, Mr. Wagner served on the Company&#8217;s board of directors
        from July 6, 2023 to August 8, 2023, Mr. Cherington served on the Company&#8217;s board of directors from March 2021 to July 6, 2023, and Mr. Singer served on the Company&#8217;s board of directors from June 2022 to July 6, 2023.</div>

<div><br/></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Q4-22 PIPE </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In November 2022, the Company entered into a securities purchase agreement with certain investors providing for the
              issuance of approximately of 2,185,000 units, each unit consisting of (i) one share of the Company&#8217;s common stock and (ii) two warrants to
              purchase shares of the Company&#8217;s common stock, at a purchase price of $3.53 per unit. The financing closed in December 2022.
              Messrs. Cherington and Singer invested in the financing on the same terms and subject to the same conditions as all other investors in the financing. Mr. Cherington served on the Company&#8217;s board of directors from March 2021 to July 6, 2023,
              and Mr. Singer served on the Company&#8217;s board of directors from June 2022 to July 6, 2023.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226920272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">12)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Accrued Expenses</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;">Accrued expenses consisted of the following (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Legal fees and related</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">643</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,139</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Professional fees</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">239</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">124</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">Somerville facility <br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">218</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">138</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">Convertible Notes interest <br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">176</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Accrued compensation</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">109</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,065</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Clinical</span></td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">18</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">570</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">Other<br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">490</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">590</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total accrued expenses</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,893</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,626</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226847072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">13)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Commitments and Contingencies</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The










          Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a
          liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the amount can be reasonably estimated.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Novellus, Inc. v.
            Sowyrda et al., C.A. No. 2184CV02436-BLS2</span><br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;"> <br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On October 25, 2021 Novellus, Inc. filed a
            complaint in the Superior Court of Massachusetts, Suffolk County, against former Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#8217;s former parent company prior to the
            Company&#8217;s acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract and civil conspiracy. The Company acquired Novellus, Inc. on July 16, 2021.&#160; On May 27, 2022, Novellus, Inc. amended the complaint to withdraw all
            claims against all defendants except Messrs. Sowyrda and Westman.&#160; On July 1, 2022, Mr. Westman filed a motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain litigation in the Court of
            Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr. Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned Zelickson et al., v. Angel et al., C.A. 2021-1014-JRS and by Mr. Westman
            against Novellus LLC captioned Westman v. Novellus LLC, C.A. No. 2021-0882-NAC (together, the &#8220;Delaware Actions&#8221;).&#160; On July 1, 2022, Mr. Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants
            Dr. Angel and Dr. Rohde alleging violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit.&#160; Mr. Sowyrda also joined in Mr. Westman&#8217;s
            motion to stay the case pending the Delaware Actions.&#160; Novellus, Inc.&#8217;s claims and Mr. Sowyrda&#8217;s counterclaims relate to alleged conduct that took place before the Company acquired Novellus, Inc.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"><br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On November 15, 2022, prior to a decision
            on Messrs. Westman&#8217;s and Sowyrda&#8217;s motion to compel or stay, the parties agreed to voluntarily dismiss and consolidate the Delaware Actions with this action.&#160; On December 15, 2022, Mr. Sowyrda filed an Amended Answer to the Amended Complaint,
            asserted affirmative defenses and filed Amended Counterclaims against Dr. Angel, Dr. Rohde, Novellus LLC, Novellus Inc., Factor Bioscience Inc., and the Company (collectively, the &#8220;Counterclaim Defendants&#8221;) alleging against various Counterclaim
            Defendants breach of contract, breaches of the implied duty of good faith and fair dealing, breaches of fiduciary duty, breaches of the operating agreement, aiding and abetting breaches of fiduciary duty, tortious interference with contract,
            equitable accounting, violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, unjust enrichment, and quantum meruit.&#160; Also on December 15, 2022, Mr. Westman filed an answer to the Amended
            Complaint and asserted similar counterclaims against the same Counterclaim Defendants.&#160; Messrs. Westman and Sowyrda each asserted claims for indemnification and/or advancement against Novellus, Inc.&#160; On January 11, 2023, Messrs. Westman and
            Sowyrda served a joint motion to enforce their advancement and/or indemnification rights against Novellus Inc.&#160; Novellus Inc. vigorously opposes this motion and served its opposition on January 27, 2023.&#160; On February 8, 2023, Messrs. Westman
            and Sowyrda served a reply in support of their motion to enforce indemnification/advancement rights, and submitted the motion to the Court.&#160; Novellus Inc. answered Messrs. Westman and Sowyrda&#8217;s counterclaims on January 27, 2023, denying
            liability.&#160; The remaining Counterclaim Defendants served a motion to dismiss most of the remaining counterclaims on January 27, 2023.&#160; The Court entered an order granting the Counterclaim Defendants&#8217; motion to dismiss and denying Messrs.&#160;
            Sowyrda and Westman&#8217;s motion to enforce on June 15, 2023.&#160; The Court&#8217;s order dismissed all of Mr. Westman&#8217;s claims against Counterclaim Defendants except his claim for indemnification, and all of Mr. Sowyrda&#8217;s claims except his claim for
            indemnification and his employment-related claims, which Counterclaim Defendants did not move to dismiss.&#160; On July 6, 2023, Messrs. Westman and Sowyrda filed a petition for interlocutory review with a single justice of the Massachusetts Appeals
            Court, seeking to overturn the judge&#8217;s decision granting the Counterclaim Defendants&#8217; motion to dismiss most of the remaining counterclaims, but not the decision denying Messrs. Westman and Sowyrda&#8217;s motion to enforce advancement rights.&#160; On
            July 25, 2023, the parties to the appeal filed a joint motion to the single justice in the appellate court to stay the appeal to allow for amended counterclaims to be filed by Counterclaim Plaintiffs and a motion to dismiss to be filed by
            Counterclaim Defendants.&#160; Counterclaim Plaintiffs filed an initial set of amended counterclaims on August 15, 2023.&#160; Counterclaim Plaintiffs amended and refiled their amended counterclaims on September 29, 2023.&#160; Counterclaim Defendants served
            their motion to dismiss all of the amended counterclaims, except for Mr. Sowyrda&#8217;s employment-related claims, on October 13, 2023.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"><br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Under applicable Delaware law and Novellus
            Inc.&#8217;s organizational documents, the Company may be required to advance or reimburse certain legal expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing matters. However, a future advance or
            reimbursement is not currently probable nor can it be reasonably estimated.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"><br/>
          </span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">eTheRNA
            Immunotherapies NV and eTheRNA Inc. v. Eterna Therapeutics Inc. C.A. No. 123CV11732</span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;"> <br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On July 31, 2023, eTheRNA Immunotherapies
            NV and eTheRNA Inc. filed a complaint in court against the Company alleging: (1) federal trademark infringement; (2) federal unfair competition; (3) Massachusetts state common law trademark infringement; (4) Massachusetts state unfair
            competition.&#160; Service of process for the complaint was completed on August 1, 2023. The Company&#8217;s answer was filed on October 10, 2023. At this stage in the litigation, the Company is not able to predict the probability of a favorable or
            unfavorable outcome.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"><br/>
          </span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Dhesh Govender v. Eterna Therapeutics LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On










            or about February 5, 2021, Dhesh Govender, a former short-term consultant of Eterna LLC, filed a complaint against Eterna LLC and certain individuals that plaintiff alleged were directors of Eterna LLC. Plaintiff alleged that Eterna LLC and
            certain of its officers and directors engaged in unlawful and discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserted various breach of contract, fraud and quantum meruit claims based on an
            alleged oral agreement pursuant to which he alleged Eterna LLC agreed to hire him as an executive once the merger involving the Company and NTN Buzztime, Inc. was completed. On December 15, 2022, the parties executed a Confidential Settlement
            Agreement and Release of All Claims. On January 11, 2023, the parties filed a Stipulation to Discontinue in the Court action. Also on January 11, 2023, plaintiff voluntarily dismissed the arbitration.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">John Westman v.
              Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949 (Middlesex County (Massachusetts) Superior Court)</span></div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On or about September 7, 2021, John Westman, a former employee of Novellus, Inc.
          filed a complaint in Middlesex County (Massachusetts) Superior Court against Novellus, Inc. and Novellus, Inc.&#8217;s founders and former executives, Dr. Rohde and Dr. Angel.&#160; The case includes allegations that Novellus, Inc. violated the
          Massachusetts Wage Act.&#160; The Company acquired Novellus, Inc. on July 16, 2021.&#160; Mr. Westman&#8217;s claims relate to alleged conduct that took place before the Company acquired Novellus, Inc.&#160;&#160; Mr. Westman agreed to dismiss the lawsuit and proceed with
          his claims in arbitration.&#160; Following mediation, the parties settled this dispute in December 2022.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The aggregate settlement amount payable by the Company for the Westman and Govender
          matters discussed above was approximately $0.5 million, both of which were recognized as expense in the consolidated statement of
          operations for the year ended December 31, 2022 and were fully <span style="-sec-ix-hidden:Fact_1686a4286739492e851a84f95f37d027">paid</span> during the year ended December 31, 2023.<br/>
          <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"> <span style="text-decoration: underline;">Emerald Private Equity Fund, LLC Matter</span></div>

<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"><span style="text-decoration: underline;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#8220;Emerald&#8221;), a stockholder of the Company, made a demand
            pursuant to 8 Del. C. 220 to inspect certain books and records of the Company. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the merger involving the Company and NTN
            Buzztime, Inc. and the issuance of paper stock certificates, including investigating whether: (i) the Company&#8217;s stock certificates were issued in accordance with the merger agreement; (ii) certain restrictions on the sale of the Company&#8217;s
            common stock following the merger were proper and applied without favor; (iii) anyone received priority in post-merger issuances of the Company&#8217;s stock certificates that allowed them to benefit from an increase in the trading price of the
            Company&#8217;s common stock; and (iv) it should pursue remedial measures and/or report alleged misconduct to the SEC. The Company responded to the demand letter and produced certain information to Emerald in connection with the demand, which is
            subject to the terms of a confidentiality agreement entered into among the parties, including certain additional stockholders who subsequently joined as parties to such agreement.&#160; Following discussions, with no admission of wrongdoing, the
            Company and Emerald entered into a confidential settlement agreement, pursuant to which the Company paid $1.2 million in 2022 in full
            settlement of all of the Emerald&#8217;s purported claims, including a release by the Emerald in favor of the Company in respect of any and all such claims.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Licensing
            Agreements</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Factor Limited</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">On










            November 14, 2023, the Company and Factor Limited entered into the A&amp;R Factor License Agreement, which terminated and superseded the exclusive license agreement between the parties dated February 20, 2023 and the amendment thereto.&#160; See
            Note 11 for additional information regarding the A&amp;R Factor License Agreement.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has other license, collaboration and royalty agreements with third parties related to IRX-2, including
            an agreement entered into with University of South Florida Research Association, Inc. (&#8220;USFRF&#8221;) in February 2024 to revoke certain license agreements with USFRF related to IRX-2.&#160; The Company does not intend to further develop IRX-2 and has
            provided USFRF with notice that the Company intends to abandon the IRX-2 patents. USFRF has 30 days to provide the Company with its
            notice to assume control of such patents.&#160; As a result of abandoning the IRX-2 patents, the Company will no longer have any obligations under the existing related agreements. existing related agreements.</span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;">Retirement Savings
            Plan</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company established a defined contribution plan, organized under Section 401(k) of the Internal Revenue Code, which allows
        employees to defer up to 90% of their pay on a pre-tax basis. Beginning on January 1, 2023, the Company began matching employees&#8217;
        contributions at a rate of 100% of the first 3% of the employee&#8217;s contribution and 50% of the next 2% of the employee&#8217;s contribution, for a maximum Company match of 4%.
        <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">For the year ended December 31, 2023, the
          Company matched less than $0.1 million towards employees&#8217; 401k contributions.</span><br/>
      </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064227219712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Common Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic and Diluted Net Loss per Common Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Basic and Diluted Net Loss per Common Share</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">14)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">
                <div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">B</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">asic and Diluted Net Loss per
                    Common Share</span></div>
              </div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;">The following table sets forth the computation of the net loss per share attributable to common stockholders, basic and diluted (in thousands, except per share data):</div>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years Ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2023</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Numerator:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net loss attributable to common stockholders</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(21,684</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(24,595</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Denominator</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted average shares outstanding - basic and diluted</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,314</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,051</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net loss per common share - basic and diluted</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4.08</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(8.06</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>

<div>&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Since the Company was in a net loss position for all periods presented, the net loss per share
          attributable to common stockholders was the same on a basic and diluted basis, as the inclusion of all potential common equivalent shares outstanding would have been anti-dilutive.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="font-size: 10pt;">The <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 48px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">following table presents the amount of warrants, stock options, convertible preferred stock, convertible notes and restricted stock units (&#8220;RSUs&#8221;) that were excluded
            from the computation of diluted net loss per share of common stock for the years ended December 31, 2023 and 2022, as their effect was anti-dilutive (in thousands):</span></span> </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; font-size: 10pt;"><span style="font-weight: bold;">Years ended December 31,<br/>
                  </span></div>
              </td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">2023</div>
              </td>

    <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; font-size: 10pt;"><span style="font-weight: bold;">2022</span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt; font-size: 10pt;">Warrants</div>
              </td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">18,922</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">4,713</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; width: 76%; font-size: 10pt; white-space: nowrap;" valign="bottom">C<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: -9.6px; text-transform: none; word-spacing: 0px; white-space: nowrap; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">onvertible Notes converted into common stock</span></td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">7,877</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Stock options</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">389</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">359</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock converted into common stock</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">7</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">RSUs</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total potential common shares excluded from computation</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,207</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">5,083</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

      </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226959952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">15)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Stock-Based Compensation</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Incentive Plans</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s stock-based compensation plans consist of the Restated 2020 Equity Incentive Plan (the &#8220;Restated 2020 Plan&#8221;) and
        the 2021 Inducement Equity Incentive Plan (the &#8220;2021 Inducement Plan&#8221;). The Company&#8217;s board of directors has designated its compensation committee as the administrator of the foregoing plans (the &#8220;Plan Administrator&#8221;). Among other things, the Plan
        Administrator selects persons to receive awards under the foregoing plans and determines the number of shares subject to each award and the terms, conditions, performance measures, if any, and other provisions of the award.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The
        Restated 2020 Plan provides for (a) approximately 724,000 shares of common stock that can be issued under the Restated 2020 Plan, which
        includes an increase to the Restated 2020 Plan of 300,000 that was approved by the Company&#8217;s stockholders at the 2023 annual meeting of
        stockholders on June 16, 2023, and (b) an annual increase in the number of shares reserved for issuance on January 1 of each year from 2022 through 2031 equal to the lesser of (i) 5% of the number of shares of common stock outstanding on the immediately preceding December 31 and (ii) such smaller number of shares of common stock as may be determine by
        the board of directors (the provision providing for the increase described in clause (b) is referred to as the &#8220;evergreen provision&#8221;). As of January 1, 2023, pursuant to the evergreen provision, the number of shares issuable under the Restated 2020
        Plan was increased by approximately 256,000. Based on the number of shares of common stock outstanding on December 31, 2023, as of
        January 1, 2024, pursuant to the evergreen provision, the number of shares issuable under the Restated 2020 Plan was increased by approximately 271,000.<br/>
      </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Awards under the Restated 2020 Plan may be granted to officers, directors, employees and consultants of the Company.&#160; Stock
        options granted under the Restated 2020 Plan may either be incentive stock options or nonqualified stock options, may have a term of up to ten years,
        and are exercisable at a price per share not less than the fair market value, as defined in the Restated 2020 Plan, on the date of grant. </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">As of December 31, 2023, there was approximately 684,000 shares of common stock remaining to be issued under the Restated 2020 Plan. As of December 31, 2023, there were approximately 296,000 stock options outstanding under the Restated 2020 Plan and no
        RSUs granted under the Restated 2020 Plan were outstanding.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The 2021 Inducement Plan provides for the grant of up to 75,000 share-based awards as material inducement awards to new employees in accordance with the employment inducement grant rules set forth in Section 711(a) of the NYSE
        American LLC Company Guide (the Company&#8217;s common stock was listed on the NYSE American at the time the 2021 Inducement Plan was adopted). The 2021 Inducement Plan expires in May 2031. As of December 31, 2023, there was approximately 68,000 shares of common stock remaining to be issued under the 2021 Inducement Plan. As of December 31, 2022, there were approximately 4,000 stock options outstanding and approximately 1,000
        RSUs outstanding that were granted under the 2021 Inducement Plan.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Equity Awards</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock Options</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records stock-based compensation in accordance with ASC Topic 718, Compensation &#8211; Stock Compensation.&#160; The Company
        estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The risk-free rate is based on the observed interest rates appropriate for the expected life. The expected life (estimated
        period of time outstanding) of the stock options granted is estimated using the &#8220;<span style="font-style: normal;">simplified</span>&#8221; method as permitted by the SEC&#8217;s Staff Accounting Bulletin No. 110, <span style="font-style: italic;">Share-Based
          Payment</span>. Expected volatility is based on the volatility of the Company&#8217;s peer group over the expected life of the stock option granted, and the Company assumes no dividends. Forfeitures are recognized as incurred.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The
        following weighted-average assumptions were used for stock options granted during the years ended December 31, 2023 and 2022: </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">Year ended</span> <span style="font-weight: bold;">December 31,</span></td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" valign="bottom">2022</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Weighted average risk-free rate</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3.82</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2.52</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Weighted average volatility</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">95.15</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">90.49</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">0</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">0</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">5.44 years </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">5.79 years <br/>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes stock option activity for the years ended December 31, 2023 and 2022 (in thousands except for
        per-share and remaining contractual life data):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold;">Outstanding</span></div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">
                <div>Weighted </div>
                <div>Average </div>
                <div>Exercise</div>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Price per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Remaining </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Contractual </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Life (in</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">years)</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Aggregate</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Intrinsic</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding January 1, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">199<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">168</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">9.38</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">287</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">17</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(127</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">141</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding December 31, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">359</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);"><br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">57</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">7.57</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);"><br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">237</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">4</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">(207</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">19</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Outstanding December 31, 2023</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">389</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">45</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">7.04</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Options vested and exercisable at December 31, 2023</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">331</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">50</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6.69<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;">The per-share weighted average grant-date fair value of stock options granted during the year ended December 31, 2022 and 2021
        was $2.99 and $12.91,
        respectively.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As of December 31, 2023, the unamortized stock-based compensation expense related to outstanding unvested options was approximately $0.6 million with a weighted average remaining requisite service period of 1.91 years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.</span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Vesting of all stock options is subject to continuous service with the Company through their applicable vesting dates.<br/>
        </span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">During
























          the year ended December 31, 2022, the Company accelerated the vesting of approximately 40,000 stock options under certain time-based
          vesting stock option grants previously awarded to Dr. Howard Federoff, the Company&#8217;s former chief executive officer, pursuant to a separation agreement entered into with Dr. Federoff. The Company also waived a performance condition under a
          performance-based stock option grant and accelerated the vesting of approximately 21,000 stock options under such grant.&#160; Lastly, the
          Company extended the post-termination exercise period from 90 days to 36 months immediately following his separation date for any options that were vested, including the options that accelerating in vesting, as described above.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The above modifications to Dr. Federoff&#8217;s stock options grants resulted in modification accounting under ASC 718, <span style="font-style: italic;">Compensation









              &#8211; Stock Compensation</span>. As a result, the Company immediately recognized approximately $0.1 million during 2022 for the
            incremental fair value of stock options that were vested prior to the modification by calculating the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For
            stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and
            immediately recognized approximately $0.1 million during 2022 of stock compensation expense in full since there was no future service
            period required to be provided.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>

<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Restricted Stock Units</span></span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes RSU activity for the years ended December 31, 2023 and 2022 (in thousands except for per-share data):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Outstanding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Restricted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock Units</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">January 1, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">12<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">276</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">55</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">39</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="margin-left: 9pt;">Released<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(3</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">271</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">(60</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">61</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">December 31, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">236</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">(3</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">199</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">December 31, 2023</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">1</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">322</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Balance expected to vest at December 31, 2023</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$<br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">322</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The










          Company recognizes the fair value of RSUs granted as expense on a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal
          is determined to be probable.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Outstanding




















































          RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the
          respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date,
          which is the grant date.</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In lieu of paying cash to satisfy withholding taxes due upon the settlement of vested RSUs, at the Company&#8217;s discretion, an employee may elect to have shares of
            common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable. During the year ended December 31, 2023, less than 1,000 RSUs vested. During the year ended December 31, 2022, approximately 3,000
            RSUs vested. The Company withheld approximately 1,000 RSUs to cover withholding taxes, and the net 2,000 shares were issued upon settlement.</span></div>

<div><br/></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Stock-Based Compensation Expense</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For the years ended December 31, 2023 and 2022, the Company recognized stock-based compensation expense as follows (in
        thousands): <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2023
                </div>
              </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2022
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">234</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,249</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">General and administrative</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,008</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,686</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,242</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,935</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
         </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226917840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Equity and Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity and Warrants</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">16)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Equity and Warrants</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-style: italic;">Private Placements<br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Q4-22 PIPE Transaction<br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On November 23, 2022, the Company entered into a purchase agreement with certain
            investors pursuant to which the Company issued an aggregate of approximately 2.2 million units, with each unit consisting of (i) one share of common stock and (ii) two
            warrants, each exercisable to purchase one share of common stock at an exercise price of $3.28 per, at a purchase price of $3.53 per unit (inclusive of
            $0.125 per warrant). The transaction closed on December 2, 2022. The Company received aggregate gross proceeds of approximately $7.7 million. The Company incurred fees of approximately $0.3 million through December 31, 2022 related to the transaction.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each warrant had an exercise price
              of $3.28 per share (subject to customary adjustments), became exercisable six months from the date of issuance, and expires <span style="-sec-ix-hidden:Fact_e3ad1a6b59fa4c388062e2bab91b442b">five-and-one-half</span>
              years from the date of issuance. The warrants meet the criteria for equity classification.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 27pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;">As discussed in Note 6, in connection with the December 2023
              convertible note financing, the exercise price of the warrants was reduced from $3.28 per share to $1.43 per share.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;">Q1-22 Private Placement</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On March 6, 2022, the Company entered into a purchase agreement with an investor
            pursuant to which the Company issued approximately 343,000 units, each unit consisting of (i) one share of the Company&#8217;s common stock (or, in lieu thereof, one pre-funded warrant to purchase one share of common stock) and (ii) one warrant to
            purchase one share of common stock, for an aggregate gross purchase price of approximately $12.0 million. The transaction closed on March 9, 2022. The Company issued 275,000
            shares of common stock, approximately 68,000 pre-funded warrants and warrants to purchase approximately 343,000 shares of common stock. The Company incurred fees of approximately $1.0 million through December 31, 2022 related to this transaction, which were allocated to the fair value of the pre-funded warrants and warrants and Each pre-funded
            warrant had an exercise price of $0.10 per share (subject to customary adjustments), was immediately exercisable, could be exercised
            at any time, and had no expiration date.<span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
              </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each warrant has an exercise price of $38.20 per share (subject to customary adjustments), became exercisable six months following the date of issuance, and expires <span style="-sec-ix-hidden:Fact_5269f7037c524c0e8f946b93d07e4c92">five-and-one-half</span>
              years from the date of issuance.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The pre-funded warrants and warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet
            the requirements of the indexation guidance under ASC 815-40. These warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations. (See Note 9 for
            more information related to changes in fair value.) Upon exercise, the fair value of the pre-funded warrants and/or warrants on the exercise date is reclassified from warrant liabilities to equity.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The fair values of the pre-funded warrants and warrants
              at the issuance date totaled $12.6 million in the aggregate, or $0.6 million more than the aggregate gross purchase price of the units sold in the offering. The $0.6 million represents an inducement to the investor to enter into the purchase agreement and was recorded in warrant liabilities expense in the accompanying consolidated statement of
              operations.<br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On July 12, 2022, all the pre-funded warrants were exercised. The Company issued approximately 68,000 shares of common stock upon exercise and received approximately $7,000
            of proceeds. The fair value of the pre-funded warrants as of the exercise date (approximately $0.7 million) was reclassified from
            warrant liabilities to equity.<br/>
          </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In connection with the transaction, the Company and the investor also entered into a registration rights agreement pursuant to which the Company agreed to prepare and file a registration statement
              with the SEC to register the resale of the shares of common stock issued in the offering and issuable upon exercise of the pre-funded warrants and warrants. The resale registration statement became effective on May 11, 2022.</span><br/>
          </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0);">Pursuant to the registration rights agreement, the Company is obligated to pay the investor
            liquidated damages equal to 2% of the purchase price for the units per month, with a maximum aggregate payment of 12 of the purchase price for the units, in the event the investor is not permitted to use the registration statement to resell the securities
            registered for resale thereunder for more than a specified period of time.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span> </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On May 24, 2022, the Company notified the investor that the investor was not able to use the registration agreement because the Company had not timely
            filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 with the SEC, and that the investor could not use the registration statement until the Company filed that quarterly report, which was filed on June 30, 2022. The
            Company accrued $0.2 million during 2022 for the contingent loss the Company incurred as liquidated damages as a result of the late
            filing, which is recorded in other expense, net for the year ended December 31, 2022 in the accompanying consolidated statements of operations. The Company paid the $0.2 million liquidated damages to the investor in June 2022.</div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"> <br/>
          </div>

<div><span style="text-decoration: underline;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Note&#160;Warrants</span></span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration: underline;"></span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">As discussed in Note 6, in connection with the July
              2023 and December 2023 convertible note financings, the Company issued note warrants to purchase an aggregate of approximately 14.2
              million shares of common stock.&#160; The exercise price of all such warrants is currently $1.43 per share (subject to customary
              adjustments), are expire five years following the date of issuance. All such warrants qualified for equity classification.</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following table shows the Company&#8217;s warrant activity for the year ended
            December 31, 2023 (in thousands except for per-share data):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Q1-22 Common<br/>
                  </div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Q4-22</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;">July 2023 <br/>
                  </div>
                  <div style="text-align: center;"><span style="font-weight: bold;">Warrants</span><br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 2023</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Balance as of January 1, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">343</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,370</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,713</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Granted</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">6,094</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">8,115</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">14,209</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Balance as of December 31, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">343</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,370</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">6,094</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">8,115</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">18,922</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
              </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As of December 31, 2023, the weighted average remaining
              contractual life of the warrants outstanding was 4.68 years and the weighted average exercise price was $2.10 per share.</div>

<div><br/>
            </div>

<div style="margin: 0px 0.3pt 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; font-weight: normal; text-align: left; text-transform: none;">SEPA</div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">On April 5, 2023, the
            Company entered into the SEPA with Lincoln Park, pursuant to which Lincoln Park committed to purchase up to $10.0 million of the
            Company&#8217;s common stock. Such sales of common stock by the Company, if any, are subject to certain conditions and limitations set forth in the SEPA, including a condition that the Company may not direct Lincoln Park to purchase any shares of
            common stock under the SEPA if such purchase would result in Lincoln Park beneficially owning more than 4.99% of the Company&#8217;s
            issued and outstanding shares of common stock. Sales under the SEPA may occur from time to time, at the Company&#8217;s sole discretion, through April 2025.</div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">In consideration of
            Lincoln Park&#8217;s entry into the SEPA, the Company issued to Lincoln Park approximately 74,000 shares of common stock (the &#8220;Commitment
            Shares&#8221;).&#160; The value of the Commitment Shares was recorded as a period expense and included in other expense, net, in the accompanying consolidated statements of operations for year ended December 31, 2023.</div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The Company evaluated the contract that includes the right to require Lincoln Park to purchase shares of common stock in the future (&#8220;put right&#8221;) considering the
              guidance in ASC 815-40, Derivatives and Hedging &#8212; Contracts on an Entity&#8217;s Own Equity and concluded that it is an equity-linked contract that does not qualify for equity classification, and therefore requires fair value accounting. The
              Company analyzed the terms of the freestanding put right and concluded that it has an immaterial value as of December 31, 2023.</span></div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">During the year ended
            December 31, 2023, the Company issued and sold approximately 214,000 shares of common stock under the SEPA, including the 74,000 Commitment Shares, for gross proceeds of approximately $0.3 million.&#160; As of December 31, 2023, there were approximately 2,860,000 shares remaining to be
            sold under the SEPA.</div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">In connection with entry
            into the SEPA, the Company terminated its prior purchase agreements with Lincoln Park entered into during 2021.</div>

<div style="display:none;"><br/></div>
<div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"> <br/>
          </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Cumulative Convertible Preferred Stock </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has authorized 156,000 shares of preferred stock, all of which is designated as Series A Cumulative Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;), and all of which were issued and
            outstanding as of December 31, 2023.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Series A Preferred Stock provides for a cumulative annual dividend of $0.10 per share, payable in semi-annual installments in June and December. Dividends may be paid in cash or with shares of common stock.<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company paid approximately $16,000 in cash for payment of dividends during the years ended December 31, 2023 and 2022</span>.</span><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: #FFFFFF; margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">The Series A Preferred Stock has no voting rights and has a $1.00 per share liquidation preference over the Company&#8217;s common
              stock. The holder of shares of Series A Preferred Stock has the right at any time to convert such shares into that number of shares of common stock that equals the number of shares of Series A Preferred Stock that are surrendered for
              conversion divided by the conversion rate.&#160; At December 31, 2023, the conversion rate was 8.8016 and, based on that conversion
              rate, one share of Series A Preferred Stock would have converted into approximately 0.11 shares of common stock, and all the
              outstanding shares of the Series A Preferred Stock would have converted into approximately 18,000 shares of common stock in the
              aggregate. There were no conversions during the years ended December 31, 2023 and 2022. There is no mandatory conversion term,
              date or any redemption features associated with the Series A Preferred Stock. The conversion rate will adjust under the following circumstances:</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">1.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0);">If the Company (a) pays a dividend or makes a distribution in shares of its common stock, (b) subdivides its outstanding shares of common stock into a greater number of shares, (c) combines its
                    outstanding shares of common stock into a smaller number of shares, or (d) issues by reclassification of its shares of common stock any shares of its common stock (other than a change in par value, or from par value to no par value, or
                    from no par value to par value), then the conversion rate in effect immediately prior to the applicable event will be adjusted so that the holders of the Series A Preferred Stock will be entitled to receive the number of shares of
                    common stock which they would have owned or have been entitled to receive immediately following the happening of the event, had the Series A Preferred Stock been converted immediately prior to the record or effective date of the
                    applicable event.</div>
                </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">2.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0);">If the outstanding shares of the Company&#8217;s common stock are reclassified (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a
                    subdivision, combination or stock dividend), or if the Company consolidates with or merge into another corporation and the Company is not the surviving entity, or if the Company sells all or substantially all of its property, assets,
                    business and goodwill, then the holders of the Series A Preferred Stock will thereafter be entitled upon conversion to the kind and amount of shares of stock or other equity securities, or other property or assets which would have been
                    receivable by such holders upon such reclassification, consolidation, merger or sale, if the Series A Preferred Stock had been converted immediately prior thereto.</div>
                </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="color: rgb(0, 0, 0);">If the Company issues common stock without consideration or for a consideration per share less than the then applicable Equivalent Preference Amount (as defined below), then the Equivalent Preference
                    Amount will immediately be reduced to the amount determined by dividing (A) an amount equal to the sum of (1) the number of shares of common stock outstanding immediately prior to such issuance multiplied by the Equivalent Preference
                    Amount in effect immediately prior to such issuance and (2) the consideration, if any, received by the Company upon such issuance, by (B) the total number of shares of common stock outstanding immediately after such issuance. The
                    &#8220;Equivalent Preference Amount&#8221; is the value that results when the liquidation preference of one share of Series A Preferred Stock (which is $1.00)
                    is multiplied by the conversion rate in effect at that time; thus the conversion rate applicable after the adjustment in the Equivalent Preference Amount as described herein will be the figure that results when the adjusted Equivalent
                    Preference Amount is divided by the liquidation preference of one share of Series A Preferred Stock.</div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226896560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">17)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Income Taxes</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Loss before income taxes consist of the following (in thousands):</div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px; width: 76%;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px; width: 76%;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"><span style="font-weight: bold;">&#160;<span style="font-style: italic;">(in thousands)</span></span><br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Domestic</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21,654</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,513</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(17</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total loss before income taxes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21,671</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,534</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For each of the years ended December 31, 2023 and 2022, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Current Tax Provision</div>
            </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">1</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Deferred Tax Provision<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(2,155</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(6,851</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1,602</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">(2</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(187</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(2,149</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(8,640</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Change in valuation allowance</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">2,145</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">8,681</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total tax<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: -9.6px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: nowrap; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> (benefit) </span>provision for income taxes</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(3</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">45</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Assets:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Net operating losses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,740</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,382</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign net operating losses<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">784</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">782</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Stock compensation</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,141</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,173</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">&#160; &#160; In-process research and development</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,009</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,233</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Capitalized rearch and development expenses</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">3,105</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1,502</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">R&amp;D credit carryforwards</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">437</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">517</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Compensation accrual</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">81</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" valign="bottom">ROU Liabilities<br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">8,932</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">334</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Other<br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">132</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">549</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total gross deferred tax assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">29,283</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,553</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18,302</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(16,157</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,981</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">396</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Liabilities:</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Fixed assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt;">ROU Assets<br/>
                </div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(8,349</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(291</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt;">Convertible debt<br/>
                </div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(2,507</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Intangibles - goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(179</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(160</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,041</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(461</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred taxes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(60</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(65</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
         </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">The reconciliation of computed expected
          income taxes to effective income taxes by applying the federal statutory rate of 21% is as follows:</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 27pt;">&#160;<br/>
        </div>

<div>
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
                </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom">2023</td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom">2022</td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax at federal income tax rate</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.00</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">21.00</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income tax, net of federal tax</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.92</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">6.52</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Foreign tax differential</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.01</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.01</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses/excludable items</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.74</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">6.09</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in valuation allowance</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(9.90</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(35.38</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; font-size: 10pt;">Convertible debt</div>
                </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(11.92</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">0.00</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%<br/>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credits</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.00</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">0.98</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">Uncertain tax positions<br/>
                </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">0.00</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(0.49</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(3.34</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1.11</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Benefit (provision) for income taxes</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.01</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">(0.18</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">%)</td>

  </tr>


</table>
          </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 18pt;">&#160; <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The net increase in the total valuation allowance for the year ended December 31, 2023 was an increase of approximately $2.1
              million. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets
              is dependent upon the generation of future taxable income during periods in which those temporary difference become deductible. Management considered the scheduled reversal of deferred tax liabilities, projected future taxable income and
              planning strategies in making this assessment.&#160; Based on the level of historical operating results and projections for the taxable income for the future, management has determined that it is more likely than not that the deferred taxes assets
              will not be utilized. Accordingly, the Company has recorded a full valuation allowance. The net deferred tax liability represents an indefinite life intangible liability related to tax deductible goodwill, partially offset by an indefinite
              life deferred tax asset.</span> </div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">At December 31, 2023 and 2022, the Company has available net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $48.4 million and $35.6 million for
          federal income tax purposes, respectively, of which approximately $48.4 million can be carried forward indefinitely. The Company has
          available $39.6 million and $28.8
          million state NOLs for the years ended December 31, 2023 and 2022, respectively. The Company also has foreign NOL carryforwards of approximately $6.3
          million for each of the years ended December 31, 2023 and 2022, which carry forward indefinitely. Section 382 of the Internal Revenue Code (&#8220;IRC&#8221;) imposes limits on the ability to use NOL carryforwards that existed prior to a change in control to
          offset future taxable income. Such limitations would reduce, potentially significantly, the gross deferred tax assets disclosed in the table above related to the NOL carryforwards.&#160; The Company continues to disclose the NOL carryforwards at their
          original amount in the table above as no potential limitation has been quantified. The Company has also established a full valuation allowance for all deferred tax assets, including the NOL carryforwards, since the Company could not conclude that
          it was more likely than not able to generate future taxable income to realize these assets.&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">At December 31, 2023 and 2022 the Company has federal and state income tax credit carryforwards of approximately $0.4 million and $0.5 million,
          respectively. The credits begin to expire in 2041.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">In accordance with authoritative guidance, the impact of an uncertain income tax position on the income tax return must be
          recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2023 and 2022 (in thousands):</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br/>
        </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;"> 2023<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;">2022<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Beginning balance of uncertain tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">121</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Additions based on current year&#8217;s tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">45</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Net changes based on prior year&#8217;s tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">272</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">76</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Ending balance of uncertain tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">393</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">121</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
           </div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">It
          is reasonably possible that unrecognized tax benefits may increase or decrease within the next twelve months due to tax examination changes, expiration of statute of limitations, or changes in tax law.&#160; The Company does not anticipate any
          significant changes to unrecognized tax benefits over the next 12 months. </div>

<div> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company recognizes interest and penalties related to unrecognized tax positions within the income tax expense line in the
          accompanying consolidated statements of operations. There were no accrued interest and penalties associated with uncertain tax
          positions as of December 31, 2023 or December 31, 2022.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The Company is subject to U.S. federal, state, and foreign income tax. The Company&#8217;s income tax returns are subject to
          examination by the relevant taxing authorities. As of December 31, 2023, the <span style="-sec-ix-hidden:Fact_27587e86962c450fb8de5335527ed5c8">2020 &#8211; 2023</span> tax years remain subject to examination in
          the U.S. federal tax, various state, and foreign tax jurisdictions. The Company is not currently under examination by federal state, or foreign jurisdictions.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) was enacted into law. Among other changes to the tax code, the IRA imposes a 1% excise tax on
            certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022.&#160; A number of exceptions to
            the stock buyback tax are available including exceptions to certain reorganizations. However, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more
            guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.<br/>
          </span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226819888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Event [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">18)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Subsequent Event</div>
            </td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.2pt; margin-left: 0.2pt; font-style: italic;">CEO Inducement Grant</div>

<div><span style="font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div><span style="font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"><span style="font-size: 10pt;">On January 1, 2024, Sanjeev Luther was appointed as President, Chief Executive Officer and a director of the Company. Upon his appointment, he was granted
            a non-qualified stock option to purchase approximately 1,685,000 shares of the Company&#8217;s common stock. The stock option has an
            exercise price of $1.80 per share, which was equal to the fair market value of the Company&#8217;s common stock on the date of grant, will
            vest over four years, with 25%
            of the shares vesting on the first anniversary of the grant date and the remaining 75% of the shares vesting in equal monthly installments over the three years
            thereafter, in each case, subject to continued service. The stock option was granted pursuant to the terms of Mr. Luther&#8217;s employment agreement and as a material inducement to his joining the Company in accordance with Nasdaq Listing Rule
            5635(c)(4).</span></div>

<div><span style="font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div><span style="font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.2pt; margin-left: 0.2pt; font-style: italic;">Remaining Funding Received from December
          2023 Financing</div>

<div><span style="font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div><span style="font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">On January 11, 2024, the second and final
          closing of the December 2023 convertible note financing occurred. At this closing, the Company received approximately $1.4 million and
          issued an aggregate of $1.4 million of December 2023 convertible notes and note warrants to purchase approximately 1.5 million shares of common stock.</div>

<div><span style="font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div><span style="font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;">The December 2023 convertible notes
          issued on January 11, 2024 have the same terms as those issued on December 15, 2023, except that the one issued on January 11, 2024 expire on January 11, 2029. The note warrants issued on January 11, 2024 have the same terms as the note warrants issued on December 15, 2023, except that the one issued on January 11, 2024 expire on January 11, 2029. See Note 6 for more information regarding the December 2023 convertible note financing, the December 2023 convertible notes and the note warrants.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231228976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064230890784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting Presentation</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;">Basis of Accounting Presentation</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Updates (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). All
        significant intercompany balances and transactions have been eliminated in consolidation.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Use of Estimates</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; contingent consideration and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of
        historical experience and various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Cash, Cash Equivalents and Restricted Cash</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had no cash equivalents as of December 31, 2023 or 2022.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Restricted cash consists of a cash collateralization of $4.1 million for a security deposit in the form of a letter of credit issued by the Company&#8217;s commercial bank and delivered to the sublessor of office and laboratory space the Company
        subleases in Somerville, Massachusetts. The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the sublease.<br/>
      </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Property and Equipment</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of seven years. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Furniture and fixtures are depreciated over an estimated useful life of five years.&#160; Computer equipment are depreciated over an estimated useful life of three years. Upon retirement or other
        disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of operations. Expenditures for maintenance and repairs are
        charged to operations. Renewals and betterments are capitalized.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Goodwill</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#8220;IRX&#8221;) in November 2018, which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events occur or circumstances indicate it is more likely
        than not that the fair value of a reporting unit is less than&#160; its carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, macroeconomic conditions, industry and market
        considerations, cost factors, overall financial performance and other relevant events.&#160; Management evaluates the Company as a single reporting unit, therefore, goodwill is tested for impairment at the entity level. Goodwill is tested for impairment
        as of December 31st of each year, or more frequently as warranted by events or changes in circumstances mentioned above.&#160; Accounting guidance also permits an optional qualitative assessment for goodwill to determine whether it is more likely than
        not that the carrying value of a reporting unit exceeds its fair value. If, after this qualitative assessment, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then
        no further quantitative testing would be necessary. A quantitative assessment is performed if the qualitative assessment results in a more likely than not determination or if a qualitative assessment is not performed. The quantitative assessment
        considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#8217;s carrying value exceeds its fair value.<br/>
      </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">In-Process Research &amp; Development</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">In-Process Research &amp; Development</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In-process research and development (&#8220;IPR&amp;D&#8221;) assets represent the fair value assigned to technologies that were acquired
        in connection with the acquisition of IRX in November 2018, which have not reached technological feasibility and have no alternative future use. IPR&amp;D assets are considered to be indefinite lived until the completion or abandonment of the
        associated research and development projects. During the period that the IPR&amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or
        changes in circumstances that indicate that the fair value of the IPR&amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize
        products associated with the IPR&amp;D assets, these assets are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a
        full or partial impairment charge related to the IPR&amp;D assets, calculated as the excess of carrying value of the IPR&amp;D assets over fair value.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<div style="text-align: left;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Revenue
              Recognition</span></span><br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company recognizes the related revenue under ASC 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). Under ASC 606, the Company recognizes revenue when a customer obtains
            control of promised services or goods in an amount that reflects the consideration to which the Company expects to receive in exchange for those goods or services. </span></div>

<div>
        &#160; <br/></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In general, the Company applies the following steps when recognizing revenue from contracts with customers: (i) identify the contract, (ii) identify the performance obligations,
          (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations and (v) recognize revenue when a performance obligation is satisfied. Recognition of revenue is driven by satisfaction of the performance
          obligations using one of two methods: revenue is either recognized over time or at a point in time. Contracts containing multiple performance obligations classify those performance obligations into separate units of account either as standalone
          or combined units of account. Allocation of revenue to individual elements that qualify for separate accounting is based on the separate selling prices determined for each component, and total contract consideration is then allocated across the
          components of the arrangement. If separate selling prices are not available, the Company will use its best estimate of such selling prices, consistent with the overall pricing strategy and after consideration of relevant market factors.</span><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company estimates the amount of consideration it expects to recognize as revenue that is not probable of having a significant reversal of such recognized revenue, and it places
          a constraint on the remaining contractual consideration. As it becomes evident that the constrained amounts are no longer at risk of a significant reversal of revenue, the Company will remove the constraint from the related revenue and recognize
          a cumulative catch-up adjustment to revenue in the period in which the constraint was removed.</span><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has one revenue generating contract. Such contract
          relates to an option and license agreement as well as certain development activities.&#160; See Note 5.</span><br/>
        <br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt; text-align: justify;"> Contract Assets:<br/>
      </div>

<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> A contract asset is an entity&#8217;s right to payment for goods and services already transferred to a customer if that right to payment is conditional on something other than the passage of time.
          Generally, an entity will recognize a contract asset when it has fulfilled a contract obligation but must perform other obligations before being entitled to payment. Contract assets consist primarily of the cost of project contract work performed
          by third parties whereby the Company expects to recognize any related revenue at a later date, upon satisfaction of the contract obligations. The Company had no contract assets as of December 31, 2023 or 2022.</span></div>

<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contract Liabilities:</span></div>

<div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
          </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contract liabilities consist primarily of consideration received, usually in the form of payment, on project work to be performed whereby the Company expects to recognize any related revenue at a later date, upon
            satisfaction of the contract obligations. As of December 31, 2023, contract liabilities were $0.6 million and are recognized as
            deferred revenue in the accompanying consolidated balance sheet. The Company recognized $0.1 million of revenue during the year ended
            December 31, 2023 from contract liabilities that arose in 2023. There were no contract liabilities as of December 31, 2022.</span><br/>
        </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Research and Development</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended.</div>

<div><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The major components of research and development costs include salaries and employee benefits, stock-based compensation expense, supplies and
        materials, preclinical study costs, expensed licensed technology, consulting, scientific advisors and other third-party costs, and allocations of various overhead costs related to our product development efforts. </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has contracted with third parties to perform various studies. The financial terms of these agreements vary from
        contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts expended during the reporting period. If the actual timing of the performance of the
        services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a straight-line basis if the expected costs are expected to be incurred ratably during
        the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the allocation of responsibilities among the parties to the agreement, and the completion of
        portions of the clinical study or trial or similar conditions.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Income Taxes</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Loss Per Share</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the
        two-class method required for participating securities.&#160; The Company&#8217;s convertible notes contractually entitle the holders of such notes to participate in dividends but does not contractually require the holders to participate in the Company&#8217;s
        losses.&#160; As such, the two-class method is not applicable during periods with a net loss.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number
        of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of
        shares of common stock outstanding plus dilutive securities.&#160; Shares of common stock issuable upon exercise, conversion or vesting of stock options, restricted stock units, warrants and the outstanding Series A convertible preferred stock are
        considered potential shares of common stock and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. The Company&#8217;s convertible notes are also considered potential shares of common
        stock and are included in the calculation of diluted net loss per share using the &#8220;if-converted&#8221; method, and the more dilutive of either the two-class method or the if-converted method is reported.&#160; Diluted net loss per share is the same as basic
        net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Segment Reporting</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company&#8217;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, <span style="font-style: italic;">Segment Reporting,</span> the Company has determined that it operates as one operating segment.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Concentration of Credit Risk</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to $250,000. The Company&#8217;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In the Company&#8217;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#8217;s supply chain, which
        could ultimately impact the Company&#8217;s ability to continue its research and development activities. For the years ended December 31, 2023 and 2022, there was no vendor concentration related to the Company&#8217;s research and development activities.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Fair Value of Financial Instruments</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 1 Inputs &#8211; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 2 Inputs &#8211; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"><span style="color: rgb(0, 0, 0);">&#8226;</span>&#160;&#160;&#160;&#160; <span style="color: rgb(0, 0, 0);">Level 3 Inputs &#8211; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The carrying amounts reported on the balance sheet for cash and cash equivalents, other receivables, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value due to their short maturities.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Leases</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company accounts for its leases under
        ASC Topic 842, <span style="font-style: italic;">Leases.</span> Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#8220;ROU&#8221;) assets represent the Company&#8217;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.</div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less. </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for lease modifications as a separate contract when the modification (i) grants the lessee an additional
          right of use not included in the original lease contract, and (ii) increases the lease payments commensurate with the stand-alone price for the additional right of use.&#160; In this case, the Company would be treated as a new lease and measured in
          accordance with ASC 842 at the commencement date of the new lease without any impact on the existing lease.&#160; Otherwise, the Company accounts for lease modifications as a continuance of the existing lease, in which case, the Company reassesses the
          lease classification, remeasures the lease liability using an updated discount rate, and unless there is a full or partial termination of the lease, adjusts the ROU asset by the amount of change to the lease liability.&#160; For a full or partial
          lease termination, the lessee reduces the carrying amount of the ROU asset on a basis proportionate to the full or partial termination of the lease, and any difference between the adjustment to the ROU asset and the lease liability is recognized
          as a gain or loss in the current period.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitment and Contingencies</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Commitment and Contingencies</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company follows ASC No.450-20, <span style="font-style: italic;">Loss Contingencies,</span> to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Stock-Based Compensation</span></div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-line basis.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives', window );">Warrants</a></td>
<td class="text">
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Warrants</span><br/>
      </div>

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, <span style="font-style: italic;">Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.</span> The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#8217;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.<span style="text-decoration: underline;"><br/>
        </span></div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Convertible Notes</a></td>
<td class="text">
<div><span style="text-decoration: underline;">Convertible Notes</span></div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The Company accounts for its convertible
          notes as a long-term liability equal to the proceeds received from issuance, including the embedded conversion feature, plus any interest paid-in-kind, net of the unamortized debt issuance costs and debt discount on the consolidated balance
          sheets. The Company evaluates all embedded features contained in the convertible notes, such as the conversion feature, the paid-in-kind feature and the redemption feature in the event of a default, to determine if such features require
          bifurcation as a derivative. The conversion feature included in the convertible notes is not required to be accounted for separately as an embedded derivative because the conversion feature is considered both indexed to the Company&#8217;s own stock
          and qualifies to be classified in stockholders&#8217; equity. The paid-in-kind feature is considered to be a commitment to originate a loan, and the terms of the additional loans have the same terms as the original debt instrument. Therefore, the
          paid-in-kind feature qualifies for the scope exception under the applicable accounting guidance and is not required to be bifurcated as a derivative. The redemption feature in the event of a default was determined to be clearly and closely
          related to the convertible notes and not required to be bifurcated as a derivative.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Proceeds from the sale of convertible
          notes with stock purchase warrants are allocated to the two elements based on their relative fair values. The portion of the proceeds allocated to warrants are recorded as a debt discount to the convertible note proceeds and presented on a net
          basis in the consolidated balance sheet. Debt issuance costs directly attributable to the transaction are capitalized and allocated to the convertible notes and warrants in the same manner as the proceeds. The amount of debt issuance costs
          allocated to the convertible notes represent a reduction of the face value of the convertible note proceeds. The Company amortizes debt issuance costs and debt discounts over the contractual term of the convertible notes, using the effective
          interest method, as interest expense on the consolidated statements of operations.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Recent Accounting Standards</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;"> <br/>
          </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>  <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> In June 2022, the Financial Accounting
          Standard Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#8220;ASU 2022-03&#8221;). The FASB issued ASU
          2022-03 to (1) clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative
          example, and (3) to introduce new disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on
          the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and
          interim periods within those fiscal years with early adoption permitted. The Company does not expect a material impact to its consolidated financial statements as a result of adopting this ASU.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In October 2023, the FASB issued ASU No.
          2023-06, Disclosure Improvements &#8211; Codification Amendment in Response to the SEC&#8217;s Disclosure Update and Simplification Initiative. This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning
          them with the SEC&#8217;s regulations.&#160; The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC&#8217;s removal of the related
          disclosure.&#160; If the SEC has not removed the applicable requirements from Regulation S-X or Regulation S-K by June 30, 2027, then this ASU will not become effective.&#160; Early adoption is prohibited.&#160; The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In November 2023, the FASB issued ASU
          No. 2023-07, Segment Reporting &#8211; Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses
          and increased interim disclosure requirements, among others. ASU No. 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. Early adoption is permitted, and
          the amendments should be applied retrospectively. The Company does not expect the amendments in this ASU to have a material impact on its consolidated financial statements.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In December 2023, the FASB issued ASU
          No. 2023-09, Improvements to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related
          disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives that either were not designated as hedging instruments or do not qualify for hedge accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226824384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAbstract', window );"><strong>Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Valuation of Assumptions</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;">The Company used a Monte Carlo simulation model to estimate the fair value of the Market
      Cap Contingent Consideration as of the acquisition date using the following assumptions:</span>
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">
      <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Stock price</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3.00</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Risk-free rate</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3.58</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Volatility</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">100</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 88%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">0</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: right; color: rgb(0, 0, 0);">3.0 years</div>
            </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
      </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTableTextBlock', window );">Fair Value Measurement of Assets Acquired</a></td>
<td class="text">
<div style="text-align: justify;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The table below shows the total fair value of
          the consideration paid for the Exacis Assets (in thousands).</span><br/>
      </div>

<div><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair Value of<br/>
              Consideration</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Shares issued</div>
          </td>

    <td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">208</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 88%; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Contingent consideration</div>
          </td>

    <td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">225</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Direct costs</div>
          </td>

    <td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">27</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);">Total fair value</div>
          </td>

    <td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">460</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231110384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Promissory Note and Convertible Note Financings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Promissory Note and Convertible Note Financings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Based on Relative Fair Value Allocation of Proceeds and Costs</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The Company determined that there were no embedded derivatives within the convertible
                      notes that required bifurcation from the host agreement.&#160; The Company allocated the gross proceeds received, the fees incurred, and as applicable, the impact of repricing the warrants discussed above, over the July 2023 convertible
                      notes and July 2023 warrants and over the December 2023 convertible notes and December 2023 warrants, as applicable, based on their relative fair values as follows (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of Proceeds and Costs:</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Relative<br/>
                              Fair Value</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation<br/>
                              Percentage</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Costs</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds,<br/>
                              Net</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">July 2023 convertible notes</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">8,715</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">39.94</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,481</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(80</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,401</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">July 2023 warrants</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">13,103</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">60.06</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">5,234</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(121</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">5,113</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">21,818</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">100.00</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">8,715</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(201</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">8,514</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
                      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of Proceeds and Costs:</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation of</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Relative<br/>
                              Fair Value</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Allocation<br/>
                              Percentage</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Costs</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrant<br/>
                              Repricing</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proceeds,<br/>
                              Net</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">December 2023 convertible notes</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">9,059</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">48.83</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,803</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(81</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(766</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">2,956</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">December 2023 warrants</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">9,495</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">51.17</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,985</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(85</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(802</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">3,098</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">&#160;</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">18,554</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">100.00</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">%</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">7,788</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(166</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(1,568</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">6,054</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock', window );">Fair Value Assumptions</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Company estimated the fair values of the convertible notes as of July 14, 2023 and December 15, 2023 based off a valuation
                      performed by a third-party specialist using a binomial tree model and the following assumptions:</div>

<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
                    </div>

<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">
                      <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                              <div>&#160;</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Stock<br/>
                                Price</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Credit<br/>
                                Spread</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">Volatility</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Risk-Free<br/>
                                Rate</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>July 2023 convertible notes</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>2.81</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>2,500</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>108</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>4.60</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; white-space: nowrap;" valign="bottom">
                              <div>December 2023 convertible notes</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>1.51</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>2,000</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>109</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>3.90</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

  </tr>


</table>
                    </div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div><span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The fair value of the note warrants, all of which qualified for equity classification, was determined using the Black-Scholes pricing model as of each
                      of July 14, 2023 and December 15, 2023 using the following assumptions:</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
                    </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">
                      <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                              <div>&#160;</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Stock<br/>
                                Price</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Exercise<br/>
                                Price</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                              <div style="text-align: center;">Expected<br/>
                                Life</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">Volatility</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">Dividend</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                              <div style="text-align: center;">Risk-Free<br/>
                                Rate</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>July 2023 warrants</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>2.81</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>2.61</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">5 years</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>98</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>0.00</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>4.04</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;" valign="bottom">
                              <div>December 2023 warrants</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>1.51</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>$</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>1.43</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;" valign="bottom">
                              <div style="text-align: center;">5 years</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>101</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>0.00</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div>3.91</div>
                            </td>

    <td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                              <div>%</div>
                            </td>

  </tr>


</table>
                    </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Activity of Convertible Notes</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;">
                    </span>
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The following table shows the activity that occurred during the year ended December 31,
                      2023 for the convertible notes on the accompanying consolidated balance sheet:</div>

<div> <br/>
                    </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">Gross convertible notes at issuance</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">16,503</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">Debt discount and debt issuance costs</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">(10,146</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">)</div>
                          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">
                              <div style="color: rgb(0, 0, 0);">Amortization of debt discount and debt issuance costs</div>
                            </div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">303</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">Paid-in-kind interest added to principal</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">113</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">Convertible notes, net, at December 31, 2023</div>
                          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">$</div>
                          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                            <div style="color: rgb(0, 0, 0);">6,773</div>
                          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Principal Payments under Convertible Notes</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The future minimum principal payments under the convertible notes as of December 31, 2023
                          are as follows:</div>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ending December 31,</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Principal</div>
                              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Payments</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2027</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                              <div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">2028</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">16,616</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom">
                              <div style="text-align: left; color: rgb(33, 37, 41); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                              <div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">16,616</div>
                            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226819888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Equipment</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Property and equipment consist of the following (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Laboratory and manufacturing equipment</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">40</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">28</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">Furniture and fixtures<br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">19</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Leasehold improvements<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">274</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">Computer equipment and programs</div>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">274</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">240</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">607</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">268</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less accumulated depreciation and amortization</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(114</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(32</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Property and equipment, net</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">493</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="color: rgb(0, 0, 0);">236</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064228398480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Net Operating Lease Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2023 and 2022, the net operating lease expenses were as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-weight: bold;">2023</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,399</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">595</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(84</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(84</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">136</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">150</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,451</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">661</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock', window );">Operating Lease Right-of-use Assets and Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2023 and
            the ending balances as of December 31 2023, including the changes during the period (in thousands).</div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating Lease</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">ROU Assets</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at January 1, 2023</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">1,030</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Recognition of ROU asset for Somerville Sublease</div>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">34,410</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Adjustment to ROU asset for remeasurement of Somvervile Sublease liability</div>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(1,620</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Amortization of operating lease ROU assets</div>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(1,039</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">Operating lease ROU assets at December 31, 2023</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">32,781</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Operating Lease</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Liabilities</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at January 1, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">1,182</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Recognition of lease liability for Somerville Sublease</div>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">34,169</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accretion of interest for Somerville Sublease</div>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">1,858</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Adjustment to lease liablity due to remeasurement of Somerville Sublease</div>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(1,620</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">
                    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Principal payments on operating lease liabilities</div>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">(519</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Operating lease liabilities at December 31, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">35,070</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); text-indent: 10pt;">Less non-current portion</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">32,854</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Current portion at December 31, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">2,216</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
        </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Lease Liabilities</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The maturities of the
          operating lease liabilities are as follows (in thousands):</span>
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2024</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,972</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2025</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,075</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2026</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,238</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2027</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,308</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">2028</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6,406</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">33,879</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total payments</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">65,878</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Less imputed interest</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(30,808</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total operating lease liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">35,070</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock', window );">Future Lease Payments from Sublease Agreement</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;">The following tables shows the future payments the Company expects to receive from the Subtenant over
              the remaining term of the sublease (in thousands):</div>

<div><br/>
              </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div>
                    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2023</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">86</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">88<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">75<br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total payments <br/>
                    </div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">249</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future lease payments of sublease agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231524368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value of Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Liabilities Measured at Fair Value</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;">The following tables summarize the liabilities that are measured at fair value as of December 31, 2023 and, 2022 (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-weight: bold;">As of December 31,</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-weight: bold;">Description</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-weight: bold;">Level</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-weight: bold;">2023<br/>
                </div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-weight: bold;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-style: italic;">Liabilities:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Warrant liabilities - Common Warrants</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">3</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">116</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">331</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;">Market Cap Contingent Consideration</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">3</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">107</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: #000000;">-</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
         </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Changes in Warrant Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following table presents the changes in the liabilities
                measured at fair value from January 1, 2023, or from the initial measurement date if later than January 1, 2023, through December 31, 2023 (in thousands): </span></span><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Warrant<br/>
                    Liabilities</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Contingent<br/>
                    Consideration</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">&#160;</div>
                </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Fair value at January 1, <span style="text-indent: 0pt;">2023</span></div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">331</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Initial measurement</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">225</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Change in fair value</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">(215</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">(118</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">Fair value at December 31, <span style="text-indent: 0pt;">2023</span></div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">116</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">107</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value and Carrying Values of Convertible Notes</a></td>
<td class="text">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The table below is provided for comparative purposes only and presents information about the fair value of the convertible notes relative to the carrying values recognized in the consolidated balance sheet as of December 31, 2023 (in
            thousands).&#160; The Company did not have any of the convertible notes or similar instruments outstanding as of December 31, 2022.</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">December 31,<br/>
                    </span> <span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2023</span></div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Carrying<br/>
                    Value</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Fair<br/>
                    Value</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Convertible Notes</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">16,616<br/>
                    </span> </div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">17,594<br/>
                    </span> </div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226959952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;">Accrued expenses consisted of the following (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Legal fees and related</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">643</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,139</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Professional fees</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">239</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">124</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">Somerville facility <br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">218</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">138</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">Convertible Notes interest <br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">176</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Accrued compensation</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">109</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,065</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Clinical</span></td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">18</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">570</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">Other<br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">490</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">590</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Total accrued expenses</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,893</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,626</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231310928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic and Diluted Net Loss per Common Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Net Loss per Share Basic and Diluted</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;">The following table sets forth the computation of the net loss per share attributable to common stockholders, basic and diluted (in thousands, except per share data):</div>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years Ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2023</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Numerator:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net loss attributable to common stockholders</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(21,684</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(24,595</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Denominator</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted average shares outstanding - basic and diluted</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,314</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,051</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net loss per common share - basic and diluted</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4.08</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(8.06</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Securities Excluded from the Computation of Diluted Net Loss per Common Stock</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"><span style="font-size: 10pt;">The <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 48px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">following table presents the amount of warrants, stock options, convertible preferred stock, convertible notes and restricted stock units (&#8220;RSUs&#8221;) that were excluded
            from the computation of diluted net loss per share of common stock for the years ended December 31, 2023 and 2022, as their effect was anti-dilutive (in thousands):</span></span> </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"> <br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; font-size: 10pt;"><span style="font-weight: bold;">Years ended December 31,<br/>
                  </span></div>
              </td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">2023</div>
              </td>

    <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; font-size: 10pt;"><span style="font-weight: bold;">2022</span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt; font-size: 10pt;">Warrants</div>
              </td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">18,922</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">4,713</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; width: 76%; font-size: 10pt; white-space: nowrap;" valign="bottom">C<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: -9.6px; text-transform: none; word-spacing: 0px; white-space: nowrap; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">onvertible Notes converted into common stock</span></td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">7,877</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Stock options</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">389</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">359</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock converted into common stock</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">18</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">7</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">RSUs</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Total potential common shares excluded from computation</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">27,207</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">5,083</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

      </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231395760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Used for Stock Options Granted</a></td>
<td class="text">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">The
        following weighted-average assumptions were used for stock options granted during the years ended December 31, 2023 and 2022: </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0);"> </span><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">Year ended</span> <span style="font-weight: bold;">December 31,</span></td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" valign="bottom">2022</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Weighted average risk-free rate</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3.82</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2.52</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Weighted average volatility</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">95.15</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">90.49</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Dividend yield</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">0</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">%</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">0</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Expected term</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">5.44 years </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom">5.79 years <br/>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summarizes of Stock Option Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes stock option activity for the years ended December 31, 2023 and 2022 (in thousands except for
        per-share and remaining contractual life data):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="font-weight: bold;">Outstanding</span></div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Options</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">
                <div>Weighted </div>
                <div>Average </div>
                <div>Exercise</div>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Price per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Remaining </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Contractual </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Life (in</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">years)</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Aggregate</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Intrinsic</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding January 1, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">199<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">168</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">9.38</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">287</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">17</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">(127</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">141</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Outstanding December 31, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">359</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);"><br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">57</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">7.57</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);"><br/>
              </div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">237</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">4</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">(207</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">19</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Outstanding December 31, 2023</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">389</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">45</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">7.04</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Options vested and exercisable at December 31, 2023</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">331</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">50</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">6.69<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summarizes of RSU Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following table summarizes RSU activity for the years ended December 31, 2023 and 2022 (in thousands except for per-share data):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Outstanding</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> Restricted</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Stock Units</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Weighted </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Average</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fair</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Value per</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Share</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">January 1, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">12<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">276</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">55</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">39</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="margin-left: 9pt;">Released<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(3</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">271</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">(60</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">61</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">December 31, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">236</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Cancelled<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">(3</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">199</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">December 31, 2023</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">1</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">322</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Balance expected to vest at December 31, 2023</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$<br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">322</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For the years ended December 31, 2023 and 2022, the Company recognized stock-based compensation expense as follows (in
        thousands): <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"> <br/>
      </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
        <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: top; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2023
                </div>
              </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2022
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Research and development</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">234</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,249</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">General and administrative</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,008</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,686</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,242</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">$<br/>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,935</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
         </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231097888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Equity and Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Warrant activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following table shows the Company&#8217;s warrant activity for the year ended
            December 31, 2023 (in thousands except for per-share data):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Q1-22 Common<br/>
                  </div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Q4-22</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;">July 2023 <br/>
                  </div>
                  <div style="text-align: center;"><span style="font-weight: bold;">Warrants</span><br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 2023</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Total</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Warrants</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Balance as of January 1, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">343</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,370</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,713</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Granted</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">6,094</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">8,115</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">14,209</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Balance as of December 31, 2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">343</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">4,370</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">6,094</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">8,115</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">18,922</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064227365696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Loss before Income Taxes</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Loss before income taxes consist of the following (in thousands):</div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px; width: 76%;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years ended December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px; width: 76%;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"><span style="font-weight: bold;">&#160;<span style="font-style: italic;">(in thousands)</span></span><br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"><br/>
              </td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Domestic</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21,654</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,513</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(17</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total loss before income taxes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(21,671</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(24,534</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Income Tax Provision</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">For each of the years ended December 31, 2023 and 2022, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Years ended December 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2023<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Current Tax Provision</div>
            </td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">4</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">-</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">1</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">4</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Deferred Tax Provision<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Federal<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(2,155</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(6,851</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0); margin-left: 9pt;">State<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">8</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(1,602</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="margin-left: 9pt;">Foreign <br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">(2</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(187</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(2,149</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">(8,640</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Change in valuation allowance</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">2,145</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">8,681</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">Total tax<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: -9.6px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: nowrap; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> (benefit) </span>provision for income taxes</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(3</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">45</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred Tax Assets and Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

<div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Assets:</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Net operating losses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,740</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,382</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Foreign net operating losses<br/>
                </div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">784</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">782</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Stock compensation</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,141</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,173</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">&#160; &#160; In-process research and development</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,009</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,233</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Capitalized rearch and development expenses</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">3,105</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1,502</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">R&amp;D credit carryforwards</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">437</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">517</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Compensation accrual</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">3</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">81</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" valign="bottom">ROU Liabilities<br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">8,932</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">334</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;&#160;&#160; Other<br/>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">132</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">549</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total gross deferred tax assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">29,283</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">16,553</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Valuation allowance</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(18,302</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(16,157</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,981</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">396</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Deferred Tax Liabilities:</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Fixed assets</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(6</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt;">ROU Assets<br/>
                </div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(8,349</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(291</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="margin-left: 9pt;">Convertible debt<br/>
                </div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(2,507</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">-</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Intangibles - goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(179</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(160</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total deferred tax liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(11,041</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(461</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Net deferred taxes</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(60</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(65</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>

  </tr>


</table>
         </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Computed Expected Income Taxes to Effective Income Taxes</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">The reconciliation of computed expected
          income taxes to effective income taxes by applying the federal statutory rate of 21% is as follows:</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 27pt;">&#160;<br/>
        </div>

<div>
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of December 31,</div>
                </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom">2023</td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom">2022</td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Tax at federal income tax rate</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">21.00</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">21.00</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">State income tax, net of federal tax</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">4.92</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">6.52</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Foreign tax differential</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.01</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(0.01</td>

    <td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses/excludable items</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(0.74</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">6.09</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in valuation allowance</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(9.90</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">(35.38</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; font-size: 10pt;">Convertible debt</div>
                </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(11.92</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%)</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">0.00</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%<br/>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Credits</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.00</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">0.98</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">Uncertain tax positions<br/>
                </td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">0.00</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(0.49</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">%)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(3.34</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%)</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">1.11</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">%</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Benefit (provision) for income taxes</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">0.01</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">%</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">(0.18</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">%)</td>

  </tr>


</table>
          </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Uncertain Tax Positions</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2023 and 2022 (in thousands):</span>
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br/>
        </div>

<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of December 31,</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;"> 2023<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; font-weight: bold;">2022<br/>
                  </div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Beginning balance of uncertain tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">121</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Additions based on current year&#8217;s tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">45</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Net changes based on prior year&#8217;s tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">272</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">76</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">Ending balance of uncertain tax positions</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">393</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0);">121</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
           </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226942064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business Operations (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>Patents</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Description of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfInLicensedPortfolioPatents', window );">Number of patents</a></td>
<td class="nump">100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfInLicensedPortfolioPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of in-licensed portfolio patents covering key mRNA cell engineering technologies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfInLicensedPortfolioPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224269328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity and Capital Resources (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 14, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 05, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,575<span></span>
</td>
<td class="nump">$ 7,575<span></span>
</td>
<td class="nump">$ 11,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(186,981)<span></span>
</td>
<td class="num">(186,981)<span></span>
</td>
<td class="num">(165,297)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,668)<span></span>
</td>
<td class="num">(24,579)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,408)<span></span>
</td>
<td class="num">(20,976)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NewFacilityLeaseAbstract', window );"><strong>New Facility Lease [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of premises | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letter of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds received from the convertible notes financings</a></td>
<td class="nump">$ 7,788<span></span>
</td>
<td class="nump">$ 8,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,503<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds received from the convertible notes financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfferingsAbstract', window );"><strong>Private Placement Offerings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds received from the convertible notes financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember', window );">Lincoln Park [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NewFacilityLeaseAbstract', window );"><strong>New Facility Lease [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock shares issued and sold (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember', window );">Lincoln Park [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NewFacilityLeaseAbstract', window );"><strong>New Facility Lease [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LiquidityAndCapitalResourcesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LiquidityAndCapitalResourcesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NewFacilityLeaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NewFacilityLeaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PrivatePlacementOfferingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PrivatePlacementOfferingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064228311120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231193360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=erna_LaboratoryAndManufacturingEquipmentMember', window );">Laboratory and Manufacturing Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=erna_LaboratoryAndManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=erna_LaboratoryAndManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224685600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Revenue Recognition (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Contract</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfRevenueGeneratingContracts', window );">Number of revenue generating contracts | Contract</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfRevenueGeneratingContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of revenue generating contracts of the organization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfRevenueGeneratingContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226887152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>Segments</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064230855792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition, Summary of Asset Acquisition (Details) - Exacis Asset Purchase [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExacisAssetPurchaseAbstract', window );"><strong>Exacis Asset Purchase [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Asset acquisition of common stock (in shares)</a></td>
<td class="nump">69,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LockUpPeriodForCommonStock', window );">Lock-up period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition', window );">Estimated equity value of stock issued in asset acquisition</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AssetAcquisitionSharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfCashConsideration', window );">Percentage of cash consideration</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Cash or other consideration</a></td>
<td class="num">$ (208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExacisAssetPurchaseAbstract', window );"><strong>Exacis Asset Purchase [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Cash or other consideration</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember', window );">Contingent Consideration One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExacisAssetPurchaseAbstract', window );"><strong>Exacis Asset Purchase [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CommencementPeriodOfCommonStockInPurchaseAgreement', window );">Common stock purchase agreement commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MinimumCapitalizationRequirementAmount', window );">Minimum market capitalization requirement, amount</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfConsecutiveTradingDays', window );">Number of consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumeratorValueForStockIssuance', window );">Numerator value for stock issuance</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember', window );">Contingent Consideration Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExacisAssetPurchaseAbstract', window );"><strong>Exacis Asset Purchase [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CommencementPeriodOfCommonStockInPurchaseAgreement', window );">Common stock purchase agreement commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MinimumCapitalizationRequirementAmount', window );">Minimum market capitalization requirement, amount</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfConsecutiveTradingDays', window );">Number of consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumeratorValueForStockIssuance', window );">Numerator value for stock issuance</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember', window );">Contingent Consideration Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExacisAssetPurchaseAbstract', window );"><strong>Exacis Asset Purchase [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CommencementPeriodOfCommonStockInPurchaseAgreement', window );">Common stock purchase agreement commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AssetAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AssetAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CommencementPeriodOfCommonStockInPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for common stock purchase agreement commencement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CommencementPeriodOfCommonStockInPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assumed amount of stock issued in connection with calculation of share price in asset purchase transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ExacisAssetPurchaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ExacisAssetPurchaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LockUpPeriodForCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LockUpPeriodForCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_MinimumCapitalizationRequirementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount required for numerator value of stock issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_MinimumCapitalizationRequirementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of consecutive trading days in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumeratorValueForStockIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of numerator value for stock issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumeratorValueForStockIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of all cash or other consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231336672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Asset Acquisition, Fair Valuation of Assumptions (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Apr. 26, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember', window );">Exacis Asset Purchase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Market capitalization of monetary amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend Yield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAndInputDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064230920976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition, Fair Value Measurement of Assets Acquired (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredAbstract', window );"><strong>Fair Value Consideration of Assets Acquired [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition', window );">Total fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 460<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense', window );">Allocated percentage of fair value of consideration to purchased license</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember', window );">Exacis Asset Purchase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredAbstract', window );"><strong>Fair Value Consideration of Assets Acquired [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Shares issued</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AssetAcquisitionFairValueOfConsiderationPaid', window );">Contingent consideration</a></td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost', window );">Direct costs</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition', window );">Total fair value</a></td>
<td class="nump">$ 460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The allocated percentage of fair value of consideration to the purchased license.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AssetAcquisitionFairValueOfConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AssetAcquisitionFairValueOfConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ResearchAndDevelopmentInProcessAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ResearchAndDevelopmentInProcessAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction cost incurred as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_ExacisAssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064232437824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract with Customer (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 21, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ContractWithCustomersAbstract', window );"><strong>Contract with Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromOptionAndLicenseAgreement', window );">Proceeds from option and license agreement</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromCellLineCustomizationActivities', window );">Proceeds from cell line customization activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Performance obligation, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Revenue recognized in previous periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract', window );">Catch-up adjustment to revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OptionFeeObligationPaymentPercentage', window );">Option fee obligation payment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Revenue Recognized Over Time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ContractWithCustomersAbstract', window );"><strong>Contract with Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ContractWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ContractWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OptionFeeObligationPaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of obligated to payments of the option fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OptionFeeObligationPaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ProceedsFromCellLineCustomizationActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from cell line customization activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ProceedsFromCellLineCustomizationActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ProceedsFromOptionAndLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from exclusive option and license agreement as a non-refundable up-front payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ProceedsFromOptionAndLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064220151008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Promissory Note and Convertible Note Financings, Summary (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 14, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Dec. 15, 2023</div></th>
<th class="th"><div>Dec. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,773,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of convertible notes converted into shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EffectOfReductionOfExercisePriceOfWarrants', window );">Effect of reduction of exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of convertible notes converted into shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EffectOfReductionOfExercisePriceOfWarrants', window );">Effect of reduction of exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DebtInstrumentAccruedInterestRate', window );">Accrued interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepaidPrincipal', window );">Repaid principal amount</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Accrued interest due under the promissory note</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  08,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RepurchasePricePercentageToPrincipalAmount', window );">Repurchase price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member] | Condition One [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleNotesBeneficialConversionFeaturePercentage', window );">Beneficial conversion feature percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member] | Condition One [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleNotesBeneficialConversionFeaturePercentage', window );">Beneficial conversion feature percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member] | Condition Two [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleNotesBeneficialConversionFeaturePercentage', window );">Beneficial conversion feature percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member] | Condition Two [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleNotesBeneficialConversionFeaturePercentage', window );">Beneficial conversion feature percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member] | Condition Three [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleNotesBeneficialConversionFeaturePercentage', window );">Beneficial conversion feature percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=erna_July2023ConvertibleNotesMember', window );">July 2023 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TransactionFeesRelatedToDebtIssuanceAndWarrants', window );">Transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 14,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion rate (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common shares (in shares)</a></td>
<td class="nump">9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 15,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion rate (in dollars per share)</a></td>
<td class="nump">$ 1.9194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=erna_December2022ConvertibleNotesMember', window );">December 2022 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EffectOfReductionOfExercisePriceOfWarrants', window );">Effect of reduction of exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=erna_December2022ConvertibleNotesMember', window );">December 2022 Convertible Notes [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ConvertibleNotesBeneficialConversionFeaturePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The conversion limitations percentage on the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed immediately after conversion rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ConvertibleNotesBeneficialConversionFeaturePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DebtInstrumentAccruedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate accrued per annum.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DebtInstrumentAccruedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EffectOfReductionOfExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of effect of the reduction of the exercise price of the warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EffectOfReductionOfExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RepurchasePricePercentageToPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of notes repurchase price to principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RepurchasePricePercentageToPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TransactionFeesRelatedToDebtIssuanceAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of transaction fees related to debt issuance and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TransactionFeesRelatedToDebtIssuanceAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepaidPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt repaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepaidPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_July2023WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_July2023WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_December2023WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_December2023WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=erna_July2023ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=erna_July2023ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=erna_December2023ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=erna_December2023ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=erna_December2022ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=erna_December2022ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224667008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Promissory Note and Convertible Note Financings, Based on Relative Fair Value Allocation of Proceeds and Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationOfProceedsAndCostsAbstract', window );"><strong>Allocation of Proceeds and Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Relative Fair Value</a></td>
<td class="nump">$ 18,554<span></span>
</td>
<td class="nump">$ 21,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationPercentageOfFairValue', window );">Allocation Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds</a></td>
<td class="nump">$ 7,788<span></span>
</td>
<td class="nump">$ 8,715<span></span>
</td>
<td class="nump">$ 16,503<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Costs</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WarrantRepricing', window );">Warrant Repricing</a></td>
<td class="num">(1,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromConvertibleDebtNet', window );">Proceeds from Convertible Debt Net</a></td>
<td class="nump">6,054<span></span>
</td>
<td class="nump">8,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember', window );">July 2023 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationOfProceedsAndCostsAbstract', window );"><strong>Allocation of Proceeds and Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Relative Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationPercentageOfFairValue', window );">Allocation Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromConvertibleDebtNet', window );">Proceeds from Convertible Debt Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationOfProceedsAndCostsAbstract', window );"><strong>Allocation of Proceeds and Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Relative Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationPercentageOfFairValue', window );">Allocation Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.06%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromConvertibleDebtNet', window );">Proceeds from Convertible Debt Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationOfProceedsAndCostsAbstract', window );"><strong>Allocation of Proceeds and Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Relative Fair Value</a></td>
<td class="nump">$ 9,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationPercentageOfFairValue', window );">Allocation Percentage</a></td>
<td class="nump">48.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds</a></td>
<td class="nump">$ 3,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Costs</a></td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WarrantRepricing', window );">Warrant Repricing</a></td>
<td class="num">(766)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromConvertibleDebtNet', window );">Proceeds from Convertible Debt Net</a></td>
<td class="nump">2,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationOfProceedsAndCostsAbstract', window );"><strong>Allocation of Proceeds and Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Relative Fair Value</a></td>
<td class="nump">$ 9,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AllocationPercentageOfFairValue', window );">Allocation Percentage</a></td>
<td class="nump">51.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds</a></td>
<td class="nump">$ 3,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Costs</a></td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_WarrantRepricing', window );">Warrant Repricing</a></td>
<td class="num">(802)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ProceedsFromConvertibleDebtNet', window );">Proceeds from Convertible Debt Net</a></td>
<td class="nump">$ 3,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AllocationOfProceedsAndCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AllocationOfProceedsAndCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AllocationPercentageOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The allocated percentage of fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AllocationPercentageOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ProceedsFromConvertibleDebtNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ProceedsFromConvertibleDebtNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_WarrantRepricing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of warrant repricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_WarrantRepricing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064219030576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Promissory Note and Convertible Note Financings, Fair Value Assumptions (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th">
<div>Dec. 15, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 14, 2023 </div>
<div>$ / shares </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 26, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Life [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember', window );">July 2023 Convertible Notes [Member] | Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Convertible note, measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember', window );">July 2023 Convertible Notes [Member] | Credit Spread [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Convertible note, measurement input | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember', window );">July 2023 Convertible Notes [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Convertible note, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember', window );">July 2023 Convertible Notes [Member] | Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Convertible note, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member] | Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member] | Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member] | Expected Life [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member] | Dividend [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member] | Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member] | Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Convertible note, measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member] | Credit Spread [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Convertible note, measurement input | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Convertible note, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member] | Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Convertible note, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member] | Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member] | Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member] | Expected Life [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member] | Dividend [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member] | Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Fair Value Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants , measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAndInputDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_July2023ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_July2023WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_December2023WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224659120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Promissory Note and Convertible Note Financings, Convertible Notes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleNotesAbstract', window );"><strong>Convertible Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Gross convertible notes at issuance</a></td>
<td class="nump">$ 7,788<span></span>
</td>
<td class="nump">$ 8,715<span></span>
</td>
<td class="nump">$ 16,503<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaidInKindInterestAddedToConvertibleNotesPrincipal', window );">Paid-in-kind interest added to principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes, net, at December 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,773<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PromissoryNoteAndConvertibleNoteFinancingAbstract', window );"><strong>Promissory Note and Convertible Note Financing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of the debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Paid in-kind</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Interest in accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,893<span></span>
</td>
<td class="nump">$ 3,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleNotesAbstract', window );"><strong>Convertible Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes, net, at December 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Future Minimum Principal Payments under Convertible Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PromissoryNoteAndConvertibleNoteFinancingAbstract', window );"><strong>Promissory Note and Convertible Note Financing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of the debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Paid in-kind</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts', window );">Remaining of interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Interest in accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ConvertibleNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ConvertibleNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense debt excluding amortization of financing costs and discounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PaidInKindInterestAddedToConvertibleNotesPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The paid-in-kind interest added to convertible notes principal in noncash financing activities..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PaidInKindInterestAddedToConvertibleNotesPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PromissoryNoteAndConvertibleNoteFinancingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PromissoryNoteAndConvertibleNoteFinancingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064220059584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 607<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_GainLossOnDisposalOfFixedAssets', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingNetBookValueOfFixedAssets', window );">Net book value of fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sales of fixed assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expenses</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory and Manufacturing Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment and Programs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Property, Plant and Equipment, Gross [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 274<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_GainLossOnDisposalOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of fixed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_GainLossOnDisposalOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RemainingNetBookValueOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RemainingNetBookValueOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064220332944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Operating Lease (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LesseeCommitmentToPurchaseProperty', window );">Commitment to purchase equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU asset balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,781,000<span></span>
</td>
<td class="nump">$ 1,030,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,070,000<span></span>
</td>
<td class="nump">1,182,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of ROU asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">772,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseROUAssets', window );">Initial measurement of operating lease ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseLiabilities', window );">Initial measurement of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,169,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of premises | ft&#178;</a></td>
<td class="nump">45,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letter of credit</a></td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance', window );">Lease liability incremental amount Above Tenant Improvement Allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OutOfPocketExpenses', window );">Out-of-pocket expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnpaidOutOfPocketCostsTenantImprovementAllowance', window );">Unpaid out of pocket costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement', window );">Adjustment to lease liability and ROU asset due to remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,620,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeaseIncrementalBorrowingRate', window );">Incremental borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeaseIncrementalBorrowingRate', window );">Incremental borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ERSquibbSonsLLCMember', window );">E.R. Squibb &amp; Sons, L.L.C. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU asset balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of premises | ft&#178;</a></td>
<td class="nump">45,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extension term of sublease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeasesMonthlyBaseRent', window );">Monthly base rent payable</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeasesIncreaseInBaseRentPercentage', window );">Percentage increase in base rent after first year</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Letter of credit</a></td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TenantImprovementAllowancePerRentableSquareFoot', window );">Tenant improvement allowance per rentable square foot</a></td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TenantImprovementAllowance', window );">Tenant improvement allowance</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Cost improvement</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ReceivedAmountOfTenantImprovementAllowance', window );">Company received tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_SanDiegoLeaseMember', window );">San Diego Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseROUAssets', window );">Initial measurement of operating lease ROU assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseLiabilities', window );">Initial measurement of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to lease liability and right of use asset due to remeasurement in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfOperatingLeaseROUAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease ROU assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfOperatingLeaseROUAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental costs incurred in connection with Tenant Improvement Allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LesseeCommitmentToPurchaseProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property for which lessee committed to purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LesseeCommitmentToPurchaseProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeaseIncrementalBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average incremental borrowing rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeaseIncrementalBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeasesIncreaseInBaseRentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage increase in base rent per year after first year for operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeasesIncreaseInBaseRentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeasesMonthlyBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of rental expense payable per month for operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeasesMonthlyBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OutOfPocketExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The company incurred additional out-of-pocket expenses for sublessor/lessor owned assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OutOfPocketExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ReceivedAmountOfTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tenant improvement allowance received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ReceivedAmountOfTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tenant improvement allowance to improvements of the Premises.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TenantImprovementAllowancePerRentableSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tenant improvement allowance per rentable square foot for the improvements of premises.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TenantImprovementAllowancePerRentableSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnpaidOutOfPocketCostsTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The company has to pay sublease for owned assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnpaidOutOfPocketCostsTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ERSquibbSonsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_ERSquibbSonsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_SanDiegoLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_SanDiegoLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064232517840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Net Operating Lease Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Net Operating Lease Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 3,399<span></span>
</td>
<td class="nump">$ 595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">$ 3,451<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231194496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Operating Lease Right-of-use Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OperatingLeaseAssestAbstract', window );"><strong>Operating Lease, Asset [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU assets, Beginning</a></td>
<td class="nump">$ 1,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseROUAssets', window );">Recognition of ROU asset for Somerville Sublease</a></td>
<td class="nump">34,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets', window );">Adjustment to ROU asset for remeasurement of Somvervile Sublease liability</a></td>
<td class="num">(1,620)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease ROU assets</a></td>
<td class="num">(1,039)<span></span>
</td>
<td class="num">$ (336)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU assets, Ending</a></td>
<td class="nump">32,781<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, Beginning</a></td>
<td class="nump">1,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialMeasurementOfOperatingLeaseLiabilities', window );">Recognition of lease liability for Somerville Sublease</a></td>
<td class="nump">34,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AccretionOfInterestSublease', window );">Accretion of interest for Somerville Sublease</a></td>
<td class="nump">1,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease', window );">Adjustment to lease liability due to remeasurement of Somerville Sublease</a></td>
<td class="num">(1,620)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrincipalPaymentsOnOperatingLeaseLiabilities', window );">Principal payments on operating lease liabilities</a></td>
<td class="num">(519)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, Ending</a></td>
<td class="nump">35,070<span></span>
</td>
<td class="nump">1,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Less non-current portion</a></td>
<td class="nump">32,854<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion</a></td>
<td class="nump">$ 2,216<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AccretionOfInterestSublease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of accretion of interest for sublease of operating lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AccretionOfInterestSublease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to lease liability due to remeasurement of sublease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to remeasurement of operating lease ROU assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialMeasurementOfOperatingLeaseROUAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease ROU assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialMeasurementOfOperatingLeaseROUAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OperatingLeaseAssestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OperatingLeaseAssestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PrincipalPaymentsOnOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal payments on operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PrincipalPaymentsOnOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224092976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases, Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract', window );"><strong>Weighted Average Remaining Lease Term and Discount Rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years)</a></td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">14.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturities of Operating Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 6,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">6,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">6,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">6,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">6,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">33,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total payments</a></td>
<td class="nump">65,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(30,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 35,070<span></span>
</td>
<td class="nump">$ 1,182<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231194496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Manhattan Sublease (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 18, 2019 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AreaOfSubleaseSpaceCurrentlyRented', window );">Currently rented area | ft&#178;</a></td>
<td class="nump">999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments', window );">Percentage of annual rent increase</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract', window );"><strong>Future Lease Payments, Sublease Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals', window );">Total payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePayments', window );">Sublease payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AreaOfSubleaseSpaceCurrentlyRented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The subleases rentable area for properties currently rented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AreaOfSubleaseSpaceCurrentlyRented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase in annual lease payment for subleases for each year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals to be received by the seller-lessee for sale-leaseback transactions accounted for using the deposit method or as a financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from lease payment, classified as operating activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479016/842-30-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479016/842-30-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064228287584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details) - Level 3 [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Market Cap Contingent Consideration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=erna_MarketCapContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=erna_MarketCapContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064220594928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 26, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Remeasurement of contingent consideration</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 118,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend Yield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationMember', window );">Contingent Consideration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationMember', window );">Contingent Consideration [Member] | Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationMember', window );">Contingent Consideration [Member] | Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationMember', window );">Contingent Consideration [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationMember', window );">Contingent Consideration [Member] | Dividend Yield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationMember', window );">Contingent Consideration [Member] | Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">$ 331,000<span></span>
</td>
<td class="nump">$ 331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(215,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,000<span></span>
</td>
<td class="nump">$ 331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Warrant Liabilities [Member] | Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Warrant Liabilities [Member] | Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Warrant Liabilities [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Warrant Liabilities [Member] | Dividend Yield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of change in fair value of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAndInputDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=erna_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224145856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments, Carrying Value and Fair Value of Convertible Notes (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 14, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,554<span></span>
</td>
<td class="nump">$ 21,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Stock Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleDebtMeasurementInput', window );">Measurement input | $ / shares</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Credit Spread [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleDebtMeasurementInput', window );">Measurement input</a></td>
<td class="nump">1,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleDebtMeasurementInput', window );">Measurement input</a></td>
<td class="nump">1.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Risk Free Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract', window );"><strong>Valuation Technique and Input, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ConvertibleDebtMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.0387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible Debt</a></td>
<td class="nump">$ 16,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible Debt</a></td>
<td class="nump">$ 17,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ConvertibleDebtMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ConvertibleDebtMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAndInputDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAndInputDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231407376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and In-Process Research &amp; Development (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and In-Process Research &amp; Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Non-cash impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064225086208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 20, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 23, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>Installment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th">
<div>Sep. 09, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 06, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionAbstract', window );"><strong>Related Party Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionPeriodicFeesPaymentAmount', window );">Monthly installment fees amount</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoticePeriodForFirstTerminationOfContract', window );">Notice period for first termination of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,920,000<span></span>
</td>
<td class="nump">$ 10,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LicenseAgreementAutomaticRenewalTerm', window );">License agreement automatic renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate', window );">Percentage of sublicense fees paid before license expiration date</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ExacisOptionAgreementAbstract', window );"><strong>Exacis Option Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PaymentOfOptionFee', window );">Payment of option fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=erna_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionAbstract', window );"><strong>Related Party Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of non-controlling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionAbstract', window );"><strong>Related Party Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SublicenseFees', window );">Sublicense fees</a></td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Dr. Fiore [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionAbstract', window );"><strong>Related Party Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionPeriodicFeesPaymentAmount', window );">Monthly installment fees amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoticePeriodForFirstTerminationOfContract', window );">Notice period for first termination of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_FactorBioscienceIncMember', window );">Factor Bioscience Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionAbstract', window );"><strong>Related Party Transaction [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoticePeriodForSupersedingTerminationProvisions', window );">Notice period for superseding termination provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MasterServiceAgreementInitialFeesPayable', window );">Master services agreement, initial fees payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfMonthlyInstallmentsForFeesPayable', window );">Number of monthly installments for fees payable | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RelatedPartyTransactionPeriodicFeesPaymentAmount', window );">Monthly installment fees amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_MonthlyMasterServicesAgreementFeesPayable', window );">Monthly master services agreement fees payable initial 12-month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_InitialLicenseFeeObligation', window );">Initial license fees obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder', window );">Deposit paid to be applied to last month of first work order</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoticePeriodForFirstTerminationOfContract', window );">Notice period for first termination of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AgreedWaivePayment', window );">Agreed waive payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingUnamortizedLicenseFeeObligation', window );">Remaining unamortized license fee obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_Q422PIPETransactionAbstract', window );"><strong>Q4-22 PIPE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnitPriceOfWarrants', window );">Unit price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_Q422PIPETransactionAbstract', window );"><strong>Q4-22 PIPE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember', window );">PIPE Investor [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_Q422PIPETransactionAbstract', window );"><strong>Q4-22 PIPE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AgreedWaivePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount agreed to waive payment as per waiver agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AgreedWaivePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deposit paid which will be applied to the last month of the first work order.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ExacisOptionAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ExacisOptionAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_InitialLicenseFeeObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of initial license fees required to pay including non-refundable fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_InitialLicenseFeeObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LicenseAgreementAutomaticRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The automatic renewal term of license agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LicenseAgreementAutomaticRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_MasterServiceAgreementInitialFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount agreed to pay an initial fee under Master Services Agreement (or "MSA").</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_MasterServiceAgreementInitialFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_MonthlyMasterServicesAgreementFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The monthly master service agreement ("MSA") fees payable to related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_MonthlyMasterServicesAgreementFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NoticePeriodForFirstTerminationOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company may terminate the first work under the MSA on or after the second anniversary of the date of the MSA, subject to providing Factor with prior notice, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NoticePeriodForFirstTerminationOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NoticePeriodForSupersedingTerminationProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Master Services Agreement (or "MSA") contains customary confidentiality provisions and representations and warranties of the parties, and the Master Services Agreement (or "MSA") may be terminated by ether party prior notice, subject to any superseding termination provisions contained in a particular work order, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NoticePeriodForSupersedingTerminationProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfMonthlyInstallmentsForFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equal monthly installments for initial fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfMonthlyInstallmentsForFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PaymentOfOptionFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of option fee related to licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PaymentOfOptionFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Company will pay to Factor of sublicense fees paid before license expiration date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_Q422PIPETransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_Q422PIPETransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RelatedPartyTransactionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RelatedPartyTransactionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RelatedPartyTransactionPeriodicFeesPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of required periodic fees payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RelatedPartyTransactionPeriodicFeesPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RemainingUnamortizedLicenseFeeObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remaining unamortized license fee obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RemainingUnamortizedLicenseFeeObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SublicenseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sublicense fees required to pay including non-refundable fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SublicenseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnitPriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price of prefunded and common warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnitPriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=erna_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=erna_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_FactorBioscienceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_FactorBioscienceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064228126912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AccruedLegalFeesAndRelatedCurrent', window );">Legal fees and related</a></td>
<td class="nump">$ 643<span></span>
</td>
<td class="nump">$ 1,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AccruedSomervilleFacilityCurrent', window );">Somerville facility</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Convertible Notes interest</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">1,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AccruedClinicalCurrent', window );">Clinical</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 1,893<span></span>
</td>
<td class="nump">$ 3,626<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AccruedClinicalCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical trail cost (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AccruedClinicalCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AccruedLegalFeesAndRelatedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal fees and related. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AccruedLegalFeesAndRelatedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AccruedSomervilleFacilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to somerville facility (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AccruedSomervilleFacilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226242208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies, Legal Matters (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LitigationSettlementAmountPayable', window );">Aggregate settlement amount payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement, amount</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LegalMattersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LegalMattersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LitigationSettlementAmountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount payable to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LitigationSettlementAmountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064227132752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies, Licensing Agreements (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoticePeriodToAssumeControlPatents', window );">Notice period to assume control patents</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_LicensingAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_LicensingAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NoticePeriodToAssumeControlPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of days to provide notice to assume control of such patents in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NoticePeriodToAssumeControlPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064232170784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies, Retirement Savings Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis', window );">Employees contribution, deferral percentage of their pay on a pre-tax basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=erna_RetirementPlan401KMember', window );">401K [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis', window );">Employees contribution, deferral percentage of their pay on a pre-tax basis</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne', window );">Employer matching contribution up to first 3%</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanEmployeeContributionAtThresholdOne', window );">Employee contribution threshold for matching percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo', window );">Employer matching contribution in excess of first 2%</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo', window );">Deferred compensation matched by employer, next match</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=erna_RetirementPlan401KMember', window );">401K [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer matching contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, deferral percentage of employee on their pay on pre-tax basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanEmployeeContributionAtThresholdOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employee contribution to the plan that is fully matched by the employer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanEmployeeContributionAtThresholdOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employee contribution to the plan that is fully matched by the employer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution up to a certain percentage matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution in excess of certain percentage matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=erna_RetirementPlan401KMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=erna_RetirementPlan401KMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064228236016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Common Share, Computation of Net Loss per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (21,684)<span></span>
</td>
<td class="num">$ (24,595)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic (in shares)</a></td>
<td class="nump">5,314<span></span>
</td>
<td class="nump">3,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted (in shares)</a></td>
<td class="nump">5,314<span></span>
</td>
<td class="nump">3,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (4.08)<span></span>
</td>
<td class="num">$ (8.06)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (4.08)<span></span>
</td>
<td class="num">$ (8.06)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064220045712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Common Share, Securities Excluded from Calculation of Diluted Net Loss per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential shares of common stock excluded from computation (in shares)</a></td>
<td class="nump">27,207<span></span>
</td>
<td class="nump">5,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential shares of common stock excluded from computation (in shares)</a></td>
<td class="nump">18,922<span></span>
</td>
<td class="nump">4,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleCommonStockMember', window );">Convertible Notes Converted into Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential shares of common stock excluded from computation (in shares)</a></td>
<td class="nump">7,877<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential shares of common stock excluded from computation (in shares)</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Preferred Stock Converted into Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential shares of common stock excluded from computation (in shares)</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential shares of common stock excluded from computation (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064219777472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Equity Incentive Plans (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,000<span></span>
</td>
<td class="nump">359,000<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PercentageOfSharesOfCommonStockOutstanding', window );">Percentage of number of shares of common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod', window );">Number of shares issuable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common stock shares to be issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">684,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units, granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod', window );">Number of shares issuable (in shares)</a></td>
<td class="nump">271,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member] | Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock-based compensation shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">724,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in stock-based compensation shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member] | Incentive Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock based compensation stock option term period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan [Member] | Nonqualified Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock based compensation stock option term period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_InducementPlan2021Member', window );">2021 Inducement Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common stock shares to be issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=erna_InducementPlan2021Member', window );">2021 Inducement Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock-based compensation shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PercentageOfSharesOfCommonStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock shares outstanding considered for equity number of shares under equity incentive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PercentageOfSharesOfCommonStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=erna_EquityIncentivePlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_IncentiveStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_IncentiveStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=erna_InducementPlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=erna_InducementPlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064231110512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Weighted-Average Assumptions Used for Stock Options Granted (Details) - Stock Options [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Weightage-Average Assumptions Used for Stock Options Granted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free rate</a></td>
<td class="nump">3.82%<span></span>
</td>
<td class="nump">2.52%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average volatility</a></td>
<td class="nump">95.15%<span></span>
</td>
<td class="nump">90.49%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years 5 months 8 days<span></span>
</td>
<td class="text">5 years 9 months 14 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224058432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Stock Option Activity (Details) - Stock Options [Member] - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Option Share [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(207)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract', window );"><strong>Weighted Average Remaining Contractual Life [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life, outstanding</a></td>
<td class="text">7 years 14 days<span></span>
</td>
<td class="text">7 years 6 months 25 days<span></span>
</td>
<td class="text">9 years 4 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract', window );"><strong>Options Vested and Exercisable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options vested and exercisable, outstanding (in shares)</a></td>
<td class="nump">331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Options vested and exercisable, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and exercisable, weighted average remaining contractual life</a></td>
<td class="text">6 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options vested and exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224675616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Summary of Stock Options (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,242,000<span></span>
</td>
<td class="nump">$ 2,935,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
<td class="nump">$ 12.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized stock-based compensation expense</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average remaining requisite service period</a></td>
<td class="text">1 year 10 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Incremental fair value of stock options recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod', window );">Exercise period of extended post-termination</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod', window );">Exercise period of extended post-termination</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=erna_TimeBasedStockOptionMember', window );">Time Based Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vesting stock option (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=erna_PerformanceBasedStockOptionMember', window );">Performance Based Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vesting stock option (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_TimeBasedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_TimeBasedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_PerformanceBasedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_PerformanceBasedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064219776064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Restricted Stock Units (Details) - RSU [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding Restricted Stock Units [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, Beginning balance (in shares)</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, Ending balance (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber', window );">Balance expected to vest (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 236<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, Ending balance (in dollars per share)</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">$ 236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue', window );">Balance expected to vest (in dollars per share)</a></td>
<td class="nump">$ 322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Expected share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064230922800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Number of RSUs Vested and Settled (Details) - RSUs [Member] - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfAwardsVestedAndSettledAbstract', window );"><strong>Number of RSUs Vested and Settled [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RestrictedStockUnitesWithheldToCoverTaxes', window );">Restricted stock units, withheld to cover taxes (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Shares were issued upon settlement (in shares)</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfAwardsVestedAndSettledAbstract', window );"><strong>Number of RSUs Vested and Settled [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (in shares)</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfAwardsVestedAndSettledAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfAwardsVestedAndSettledAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RestrictedStockUnitesWithheldToCoverTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares of restricted stock withheld to cover the withholding taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RestrictedStockUnitesWithheldToCoverTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224977792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation, Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,242<span></span>
</td>
<td class="nump">$ 2,935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">1,249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,008<span></span>
</td>
<td class="nump">$ 1,686<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064220404368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants, Private Placement of Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 02, 2022</div></th>
<th class="th"><div>Nov. 23, 2022</div></th>
<th class="th"><div>Jul. 12, 2022</div></th>
<th class="th"><div>Mar. 06, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightExercised', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorOneMember', window );">Q4-22 PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnitPriceOfWarrants', window );">Unit price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants to purchase of common stock</a></td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TransactionFeesPayable', window );">Transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorOneMember', window );">Q4-22 PIPE Investor [Member] | Q4-22 Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NumberOfWarrantsInEachUnit', window );">Number of warrants in each unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,185,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_UnitPriceOfWarrants', window );">Unit price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth', window );">Obligation to pay liquidated damages per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TransactionFeesPayable', window );">Transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimated contingent loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Liquidated damages payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ObligationToPayLiquidatedDamagesPercentage', window );">Obligated to pay liquidated damages percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember', window );">Q1-22 PIPE Investor [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightsExercisableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightsExercisableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NumberOfWarrantsInEachUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrant consist in each unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NumberOfWarrantsInEachUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ObligationToPayLiquidatedDamagesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ObligationToPayLiquidatedDamagesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_OverSubscriptionAmountReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_OverSubscriptionAmountReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_PrivatePlacementOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_PrivatePlacementOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TransactionFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees incurred related to PIPE transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TransactionFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_UnitPriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price of prefunded and common warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_UnitPriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=erna_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064225287008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants, Note Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 15, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Mar. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">4,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">14,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">18,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoteWarrantsAbstract', window );"><strong>Note Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration term</a></td>
<td class="text">4 years 8 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember', window );">Q1-22 Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoteWarrantsAbstract', window );"><strong>Note Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsOneMember', window );">Q4-22 Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">4,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">4,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_July2023WarrantsMember', window );">July 2023 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoteWarrantsAbstract', window );"><strong>Note Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">6,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">6,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=erna_December2023WarrantsMember', window );">December 2023 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant Activity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ClassOfWarrantOrRightGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">8,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">8,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | December 2023 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoteWarrantsAbstract', window );"><strong>Note Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023AndDecember2023ConvertibleNotesMember', window );">July 2023 and December 2023 Convertible Notes [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoteWarrantsAbstract', window );"><strong>Note Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_July2023AndDecember2023ConvertibleNotesMember', window );">July 2023 and December 2023 Convertible Notes [Member] | Common Stock [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_NoteWarrantsAbstract', window );"><strong>Note Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common shares (in shares)</a></td>
<td class="nump">14,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ClassOfWarrantOrRightGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ClassOfWarrantOrRightGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_NoteWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_NoteWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_CommonWarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_July2023WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_July2023WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=erna_December2023WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=erna_December2023WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_July2023AndDecember2023ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_July2023AndDecember2023ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224758816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants, SEPA (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 05, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember', window );">Lincoln Park Capital Fund, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StandbySecuritiesPurchaseAgreementAbstract', window );"><strong>Standby Securities Purchase Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock shares issued and sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember', window );">Lincoln Park Capital Fund, LLC [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StandbySecuritiesPurchaseAgreementAbstract', window );"><strong>Standby Securities Purchase Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares', window );">Beneficial owning percentage on issued and outstanding shares</a></td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StandbySecuritiesPurchaseAgreementAbstract', window );"><strong>Standby Securities Purchase Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock shares issued and sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_SaleOfStockNumberOfSharesToIssuedInTransaction', window );">Number of remaining shares to be sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=erna_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | Lincoln Park Capital Fund, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_StandbySecuritiesPurchaseAgreementAbstract', window );"><strong>Standby Securities Purchase Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EquityLineOfCreditConsiderationSharesOfCommonStock', window );">Consideration shares of common stock (in shares)</a></td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EquityLineOfCreditConsiderationSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to equity line of credit consideration shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EquityLineOfCreditConsiderationSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_SaleOfStockNumberOfSharesToIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares to be issued by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_SaleOfStockNumberOfSharesToIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_StandbySecuritiesPurchaseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_StandbySecuritiesPurchaseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=erna_LincolnParkCapitalFundLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=erna_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=erna_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064225271680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity and Warrants, Cumulative Convertible Preferred Stock (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Cumulative Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="nump">156,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividend paid in cash | $</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Cumulative Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Cumulative annual dividend payable per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividend paid in cash | $</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, liquidation preference per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Preferred stock, conversion rate</a></td>
<td class="nump">8.8016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract', window );"><strong>Cumulative Convertible Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividend paid in cash | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Each preferred stock converted into common stock (in shares)</a></td>
<td class="nump">0.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Aggregate preferred stock to be convert into common stock (in shares)</a></td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares converted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FeaturesOfConvertiblePreferredStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FeaturesOfConvertiblePreferredStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064226879152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes, Loss before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Loss before Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (21,654)<span></span>
</td>
<td class="num">$ (24,513)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (21,671)<span></span>
</td>
<td class="num">$ (24,534)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224532240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes, Components of Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current Tax Provision [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax provision</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred Tax Provision [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(2,155)<span></span>
</td>
<td class="num">(6,851)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(1,602)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income tax provision</a></td>
<td class="num">(2,149)<span></span>
</td>
<td class="num">(8,640)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount', window );">Change in valuation allowance</a></td>
<td class="nump">2,145<span></span>
</td>
<td class="nump">8,681<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total tax (benefit) provision for income taxes</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to decrease in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064224085056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes, Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred Tax Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign', window );">Net operating losses</a></td>
<td class="nump">$ 12,740<span></span>
</td>
<td class="nump">$ 9,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Foreign net operating losses</a></td>
<td class="nump">784<span></span>
</td>
<td class="nump">782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">2,141<span></span>
</td>
<td class="nump">2,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">In-process research and development</a></td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts', window );">Capitalized research and development expenses</a></td>
<td class="nump">3,105<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D credit carryforwards</a></td>
<td class="nump">437<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences', window );">Compensation accrual</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxAssetsRightOfUseLiabilities', window );">ROU Liabilities</a></td>
<td class="nump">8,932<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">29,283<span></span>
</td>
<td class="nump">16,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(18,302)<span></span>
</td>
<td class="num">(16,157)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">10,981<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred Tax Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxAssetsRightOfUseAssets', window );">ROU Assets</a></td>
<td class="num">(8,349)<span></span>
</td>
<td class="num">(291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_DeferredTaxLiabilitiesConvertibleDebt', window );">Convertible debt</a></td>
<td class="num">(2,507)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Intangibles - goodwill</a></td>
<td class="num">(179)<span></span>
</td>
<td class="num">(160)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(11,041)<span></span>
</td>
<td class="num">(461)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred taxes</a></td>
<td class="num">$ (60)<span></span>
</td>
<td class="num">$ (65)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets attributable to taxable temporary differences from research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards excluding foreign purpose.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxAssetsRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxAssetsRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxAssetsRightOfUseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxAssetsRightOfUseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_DeferredTaxLiabilitiesConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_DeferredTaxLiabilitiesConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479692/805-740-25-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064232552208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Reconciliation of Computed Expected Income Taxes to Effective Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax at federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal tax</a></td>
<td class="nump">4.92%<span></span>
</td>
<td class="nump">6.52%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax differential</a></td>
<td class="num">(0.01%)<span></span>
</td>
<td class="num">(0.01%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible expenses/excludable items</a></td>
<td class="num">(0.74%)<span></span>
</td>
<td class="nump">6.09%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(9.90%)<span></span>
</td>
<td class="num">(35.38%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent', window );">Convertible debt</a></td>
<td class="num">(11.92%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Credits</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.98%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent', window );">Uncertain tax positions</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.49%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="num">(3.34%)<span></span>
</td>
<td class="nump">1.11%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Benefit (provision) for income taxes</a></td>
<td class="nump">0.01%<span></span>
</td>
<td class="num">(0.18%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncomeTaxAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Federal and state income tax credit carryforwards</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TaxCreditCarryforwardExpirationYear', window );">Tax credits begin to expire</a></td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax year</a></td>
<td class="text">2020 2021 2022 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncomeTaxAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">$ 48,400,000<span></span>
</td>
<td class="nump">35,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_TaxCutsAndJobsActOperatingLossCarryforwards', window );">Net operating loss carryforwards under Tax Cuts and Jobs Act</a></td>
<td class="nump">48,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncomeTaxAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">39,600,000<span></span>
</td>
<td class="nump">28,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_IncomeTaxAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_IncomeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_IncomeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TaxCreditCarryforwardExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration beginning year of the tax credit carryforward, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TaxCreditCarryforwardExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_TaxCutsAndJobsActOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws from effect of Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_TaxCutsAndJobsActOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064228184496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes, Uncertain Tax Positions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance of uncertain tax positions</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on current year's tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Net changes based on prior year's tax positions</a></td>
<td class="nump">272<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance of uncertain tax positions</a></td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140064220711648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 11, 2024</div></th>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Dec. 15, 2023</div></th>
<th class="th"><div>Jul. 14, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingFundingReceivedFromDecember2023FinancingAbstract', window );"><strong>Remaining Funding Received from December 2023 Financing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds received from the convertible notes financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,788<span></span>
</td>
<td class="nump">$ 8,715<span></span>
</td>
<td class="nump">$ 16,503<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingFundingReceivedFromDecember2023FinancingAbstract', window );"><strong>Remaining Funding Received from December 2023 Financing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common shares (in shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingFundingReceivedFromDecember2023FinancingAbstract', window );"><strong>Remaining Funding Received from December 2023 Financing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  08,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingFundingReceivedFromDecember2023FinancingAbstract', window );"><strong>Remaining Funding Received from December 2023 Financing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds received from the convertible notes financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember', window );">December 2023 Convertible Notes [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_RemainingFundingReceivedFromDecember2023FinancingAbstract', window );"><strong>Remaining Funding Received from December 2023 Financing [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds received from the convertible notes financings</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Expiration date</a></td>
<td class="text">Jan. 11,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CEOInducementGrantAbstract', window );"><strong>CEO Inducement Grant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,000<span></span>
</td>
<td class="nump">287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember', window );">Nonqualified Stock Options [Member] | Sanjeev Luther [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CEOInducementGrantAbstract', window );"><strong>CEO Inducement Grant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment', window );">Frequency of stock vesting installments over three years thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember', window );">Nonqualified Stock Options [Member] | Sanjeev Luther [Member] | Vesting on First Anniversary [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CEOInducementGrantAbstract', window );"><strong>CEO Inducement Grant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember', window );">Nonqualified Stock Options [Member] | Sanjeev Luther [Member] | Vesting on Three Years Thereafter [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_erna_CEOInducementGrantAbstract', window );"><strong>CEO Inducement Grant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_CEOInducementGrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_CEOInducementGrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_RemainingFundingReceivedFromDecember2023FinancingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_RemainingFundingReceivedFromDecember2023FinancingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic stock vesting, which may be presented in a variety of ways (for example, monthly, quarterly, annually).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>erna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=erna_December2023ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=erna_NonQualifiedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=erna_PresidentChiefExecutiveOfficerAndDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=erna_PresidentChiefExecutiveOfficerAndDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>106
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MG@ ,^P %"#N63_9?CIK+!\K>K=%H:S2J].$NHU=E20L)B!!4BE.7/;6"T*U
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MZOLYY_+U1K_"L'UE9?P_4$L#!!0    ( )*$;EA7VF/$$0,   ,+   8
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MCHJ!I@%M9M%XVM_LD]LF06UQ@#.L<89>G"NA-!(+Z$D%EK-\2P_1WD-)&+7
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M6M]5[&JT9TG2'!<D+0M0X>7EX!U\&]J-08/X=XJ?R<%G4 _EL2P_UQ?7R>7
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MQ+?4R*>8>OJ'IGF60=C[3_7C)3AS,-DE<>VFL:%NX3'HY/-_J3/F8>QDFN;
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M0%[K_9=W^)IQO6B[?=N-+V>^??TNWLX<]CB!WY\]/UV<GIX>$?H14BQ]C8<
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MEA^]MA?3,6&[0YW0F3[5"E_)Q/EOS<0!Q_LP\1\7!ZP:[UC-L6CX P7C/Q=
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M$O080'7[^O\D5/'S4!<_#16Q#F);P9?HU_\:6F_AOXD,0Q[4@VHC[PME:..
M3Q;S9TR86)-+O^XX:HN\]Z&1^1!P"T*=MD.IG0N7?5E?#K>U,XK.#0UWAU.Y
M@HV.:EHG$U#,A0^08@6 +L$.[8J74<BDN:HX*V#GP?6*)\IN(<#SV_?J8LN/
MH=BHQ\)%/"%<X +5]G!*Y'@=SG-<,#6!T?*7-$PE'.I3/IY$$09>GL;!2[L?
M(IZ-$"?>0RIIY+ >@3"]I;3$LA5[QP/>WR*Q2+@DN$:#.AL*8.G39%$A0ICN
M+U4N&[BE TH,>@B'+.) \GJG9.-REMI%ZF[O))'6Y89H&V6(B#$Y HOKW<)D
MEM1$OY6#W^$HC7+4H+VN]%^4_<$(U53SOI.IR93C1@30 #@%8'-V)E5%<IIL
MP[*1U"+#V/ *[4=0#R8-7L?,P>]JF6(DD)(>57& M?.G1>Q7)(U(DJ9 -/D(
MC9?LKRK8D:A ^P&5C0@@!O!G),=+63_:\G QTY"0=Q$AZDT5H)6[Y&T[:3=5
MIWXN/(/H&[-U&,@-8(XGD_"+?E"I=L+V7I1@YL9%E3#,3BK<R*\5L$6=PE4<
M;!L6ZZI<VH)TL21LVCDO+/CF.E'CP-%L8QM#!6622!UE*;%\:Z;OZMU#AT:9
MI]-;5*"E"CB>4)(D-7=BE8@3TJP"38-1/PV<1#W%6O?6D"3F<EUIRE*W5Y9$
M &)_;S$8;,14T7TJ5"5!6EA\S;XD<47S9:E2GN42],;G2@EGG.;K7E#NJH"A
M]FT3WI"ODK^)X*9T!H=3738F1E-:##(J+YR[6.0_0BBQ3K*?U4E+/P.>X!'<
M^&YX=PJ.577D\W?95]:(K":SO8RT9_9%^YN7*PP&092%>Z_>9L^R[Y8\IT+,
M()%PXXH5-W)YKY4I,KKUX8Z.X53AX$\R)F@&>H;E9X.6\@LXEBH;=!O/<SZB
M^@&!#=AOLU:Q)/LVH;'G[)*SQ@J$ <85-^=C0'%1\N,KS'?.=?OE::N/;62S
M-!N@2EJ$?QHA#0,::YU[5(Z==]DW^DJ!$HWB!^T2U]-)$,J -PS$]UC<].'W
MX,1R#+QQ29]=4:9V$UDX6'3IN-RRU-D#J[74V[.TY?1]YD+;> #G7\RRCV3J
M>VOJZ_"$@[I:S-]FEX_XGBT6KU!,S.S,XMGB3?9MRS_8.'X]'T_[;HRA'I\]
M/I+'(:61]V#^ME0P4G2]#H@']$^?OSR797UR%4?F;/M&/[T!IK/-];H?X=UW
M-"X;G'$5Y];@%56:N$T O1-OQ$&&QUY!*5)Y(JF5+74>0_-1Y,6);Z&U=,64
M#]5.A9E.FTRY"BU9^7YV)3T:@:%//CR>&^>H7AX=7IV5W1!W:&9M#PQ.#2R#
MHV,/6FNVZTOIP> S=JE U/2QGJ0 J#U^T>[N=G\/N(B?P?OE\8\)8$]@XW&H
M66'K?/;FU21*T_8BV)H_BB]M"+;DGVLE42VT ,]7UH;V@E[0_97D_#]02P,$
M%     @ DH1N6*BYY+/4!P  :10  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&ULE5C;;MPX$GWOKR!Z=@(;</IF)QLDM@''L\8&F-D)DKT\+/:!+;%;
MW%"DAJ3<[OWZ/<5;2W;;DWFQ6Q)9=:KJU"E*ESMCO[E&",\>6J7=U;3QOGL_
MG[NJ$2UW,],)C2<;8UON<6FW<]=9P>NPJ57SU6+Q=MYRJ:?7E^'>9WM]:7JO
MI!:?+7-]VW*[_RB4V5U-E]-\XXO<-IYNS*\O.[X57X7_1_?9XFI>K-2R%=I)
MHYD5FZOIS?+]QPM:'Q;\4XJ=&_QF%,G:F&]T\:F^FBX(D%"B\F2!X]^]N!5*
MD2' ^"W9G!:7M''X.UN_"[$CEC5WXM:H?\G:-U?3=U-6BPWOE?]B=G\5*9XW
M9*\RRH6_;!?7GE],6=4[;]JT&0A:J>-__I#R,-CP;O',AE7:L JXHZ. \B?N
M^?6E-3MF:36LT8\0:M@-<%)34;YZBZ<2^_SUK='>(C5PZQMV&QP*>SGWL$TK
MYE6R\S':63UC9[EBO\!4X]A?="WJL8$Y0!5DJXSLX^I%BS^):L;.EV=LM5B=
MOV#OO$1Z'NR=_Z%(V;]OUB[<_\^QH*/)B^,FJ6'>NXY7XFJ*CG#"WHOI]:L?
MEF\7'UX ?%$ 7[QD_0^4YF4[;TXGS\3^JV9W8FU[="-;I4R?,=\(=FO:CNL]
MX[J>_ Q[Z$]&K</^W@C+.]%[6;DS]DFC1B>O?GBW6BT^I'7A:OGAE GMA14U
MD]H;&&+BH5*]0P\RT\6.U#53LD*'"\:W5@@TNV<GY']LDMWDI]GX&=LULFI8
M9\V]!-]87AD") O)Q]#:K_%6$)Z"$MC,VD.]QA!=O\[0S(9"0/ 0DIXK\MD)
MZ_>3C37MXVR1/2M^ZX7SHT>X78M[:&#'>.IK^3_@KBBI5+$9I98]"9CMN&,<
MO^J027;3;[$Y5(ILIO@9U)E5#==;X9CK1"4WLN)*[8%%<2\"+()3W!4,_"".
MTDO:WB.O<'HB3UG']P$$"MFBW"=2GDXJQ$[I@O1)+6EW?(+E^5%E>NM@"IGC
M47SE)KH_$CB+$HU;ZWV)7SJFC2<LE7!NTZN0VQ-Y?\IJ4_4$*@*G7$L;4N5F
M97O'93VN#/O38G8. 56*=FFC7T/]>UWSM1*L[UZCEH@SQWN$-7?BP&S*-JT8
M$BH #'[!HY 8HDJRAT3 _T7QCVI4IL6C2GQG6<X8.!?69C*,:C-CGS8E^LAG
M%U8?>#QN[)WI%3(NJ$NE5R(1MQ(@_X37=2@L5Z4_-X(P2(W^J*7>4B2@N-$B
MXW A =;LN2*\,_89'.@Y 33LYNLM>[MX.X90"X(.S/7$-]P_S6B@OF:]%@_"
M5M(!I T/&J%&;$$=4W*>]@\,5UG] %\$!V=$\._LA]#4HTRR'70M"0P5N;=H
M/>+[45^AL=VQ]1/08FM,'7W0^(!]=RB-QRF+^@)8G>BXQ46Q[ZBE:-NN$;J$
M75)*T0&-),5'A"W_)F)C%^<!%GK 6#!CN5C\2&@&)0#?8P&4,M500H8EBJ(U
MW$'>T(ZD E$CA*498*%]NJ=*>:DB$H^S7429T8>!X>*\>)1Q-%P(] E'Q$.'
M]G<C((=^')5X\GR)44Y>0;4TQ4G=?33E9\5FIC R.: Q*S3./1IZD]72P371
MEZ\-9HL5X;1 Y&2MJ8-6^R0++Y$R YFQCZ+BO0O:81,=M4E< OI,I0F6:Y=*
M .,YT>M0]IAO:N:2\8";VJ:$FAFB:=:(>VEZ%Z9*9;8ZZ'BJ[%G&PDFY&0*J
MFM<]AEW]7\00A<H4&B35KEG*5^!"XE_!,!L,]<SA(C8)<"K$)"OR=_0S*A#7
MIGD<L$%<I:DCBXI$DE>C$:[@-E(O,IM2AI&$F=0293+PYWQ#.JE9T8L4@BM3
M$K,;*N4HEAVW-3%)07UQ%C//3\L1Q,DQ_HT&#2R!-0Y'!)OG99#XFF9T5)E!
M+>GPA!>WX!SHUGPME?0!SUI0U%0_3/8ZT@,1 <"D4S@!UW2L@2<P3E)*'N<K
M<Y<.4$_2$X,: <<!(+LL\$":<*8Y5L%)K& ^%V([E"$>*T 5A,D[1/0@\1XG
M8&*UH-NK-^@_>FDI\T"118I7;$"IP%D8IG??J$A9HV&_@4418DLD=F N"XH1
M 8+382P?Y]H1B,K@_&9# S=P'H+$_#,8>E*'R)%JK2G]L#D9\;2D*1POVQZG
M/CK&'NM#&6N38 3.!$'.1(IE ;R6UXC@+K76'EW HJSAU4RT:^ [/_K2,"C9
M..NH\')(S2P'I7N?Z=G(CRW$S%.^4WODV9!5MR2DY?MR,!ZHGCR<D/*!PCT=
M*.GDF;LF$#M1@--QS6 F;1- <HOU5.G (!FV4\GRK#^\"B225/G=BT &24OE
MV/2^IS%$(YT*NCXRDOC3H30I8[%8?CZXL;Z5,M&$PH5G"O/)AG<^UW>=(K7L
M77SO>*D\(71=]6',4  T3\FZK>/IA:3!^4'%9^S&'=[=*+KDXN85;[L/7]@=
MK./NSZG$A^/<899BQ]\,,K%<CMF'"J0:Q<;"R#B8:R7=72U^#.\F]&(0)-P]
MYB]II&/A!8\?,AO/5.[Q2U4B(HW[JM%&F>U^<"3]O9 .DC7ARIG?2=RQ[PKS
MP><?P-R&CUR.!?+$+T'E;OF.=A,_'QV6QX]POW"[I5<')3;8NIC]^<TTGKGS
MA3==^)BT-AXY"3\; 9VPM #/-P8U21?DH'Q=O/X_4$L#!!0    ( )*$;EAX
MY5.O_ P  ,(F   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;+5:6V_;
M1A9^YZ\@W*1P )HF=;.4&Y"DEVV!;HVDVV*QV(<1.9*F)CDJA[3C_OK]SIGA
M3:)E9[?[(I'4S+E\YS[BZSM=WIB=E)7_.<\*\^9L5U7[EY>7)MG)7)A0[V6!
M7S:ZS$6%VW)[:?:E%"EORK/+210M+G.ABK.WK_G9=?GVM:ZK3!7RNO1-G>>B
MO'\O,WWWYBP^:QY\5-M=10\NW[[>BZW\)*M_[*]+W%VV5%*5R\(H7?BEW+PY
M>Q>_?#^C];S@5R7O3._:)TW66M_0S0_IF[.(!)*93"JB(/!U*S_(+"-"$.,/
M1_.L94D;^]<-]>]8=^BR%D9^T-EO*JUV;\Z69WXJ-Z+.JH_Z[F_2Z3,G>HG.
M#'_Z=W;M?'7F)[6I=.XV0X)<%?9;?'8X]#8LHP<V3-R&"<MM&;&4WXA*O'U=
MZCN_I-6@1A>L*N^&<*H@HWRJ2ORJL*]Z>UWJ7!FCRWO_[[J2OBA2_X,N;F59
MJ74F[</O5"&*1!5;\_JR E/:>IDX!N\M@\D##.*)_Y,NJIWQORU2F0X)7$+:
M5N1)(_+[R4F*W\@D]*=QX$^BR?0$O6D+P93I3?\:"/Q_O5N;JH0[_7L,#<MK
M-LZ+0NREV8M$OCE##!E9WLJSMU]_%2^B5R<TF;6:S$Y1_RN,>9K!XH7WI6C]
M7'@_UMF]'\^LP0*_VDGLR/>BN$=8)Q)1F?K/EN$5_#O+*%0WX.$+?U^J6P%J
M^PR (1%4OBK\NYU*=@,:D*9V%+R& A:*[;:46]Y?*@BS%YDO<EV#C-[X24_D
M B(;_YQH?OW5<C*)7K'$).WQ.EX1OWK!BM^)LA1%9?Q*^_NZ3';(#_BAQQNL
MQ'Y?ZL\*&42"ZB*,6SW-3L ):(T"C43G.3VL='+S@#0-OT:(T/]E"*;>%NI/
M@#'D^2P*)WX/FHT$5P$C)@H+H(:J+*1PZ\((FR]A.$2:S->R])>G;1>'\SYY
M^1E %%OIHV;P#K(0_('16#R'/5H7(D@M>U%XIRTVX *\/P"\#'I\V$FLWE:Z
ML&@<41=L'D!1EY"@\'\418WZXY2"6Y(E55%)V*)"F4A*<B>!2[]T)ER$T7-O
M#R!$4=1YX._%O2"/P"*FJZK[$(#Y+6 />?M>J)0?#;0!AY[&!2$:S*.(G<>)
MT\J7UM*OD4DML@?*,@+0$FZ%>W]3EUA4^GJ=*> *5N;AO0.#C\LO60@61E-\
MMAX/N]D 95,F"!BT ^WOI6D]X2BD/;+LJN>>C\9F*^/)^&08*[V5#$#KX"<"
MFU7U')._/.Q7X6(D['O@$H/XZM5(&O!&%3](!8_JVZRW%G4D78",)!4XT!U]
M5'?:3S)M.)<WOJ/,B.UM]&U4"2=U.WR=)'5)'J/[L3%O?(ME'LTH5^&RA8O#
MT^7XWG/RG$=\@;>.PS8TW<!4R]$,K>MR8)K0(W4-4BYX.'V#\0+5JD4/T3GG
M! T2P*QETPO*(UR##D75)2_*7*'W2;J"&R\YQ$2:*@ISI!%5V([=-L];4:;$
MM3J2V>]H+)A&KF'V_FY*MSN+J-?"9ZU](IS\M11E+ZU6G/F[%-K8_C$3'I&)
M)X-4O-9P==C'PDZ)KTG.?P H;(.$U T 0%&:T']7C49=,R; A)33[XE*QU8J
M#BO0280!.[J\N%%084VK$M V#;R8?$P%[>A^K([1FB,U'X73Z]6O7CNU?#J0
M+H3&(K%7' ]_ X.Z0)D%0BBW2I8-92)54D5S#IL.>Y%4@R48^SMQ*RTN^\I5
M;K@R7-NG90_A0<CITFOJ-NIK8SA'QFW<Z0R1XY+:,14RY%KV1.;.LL)4>5'I
M"_JV$:NQ@XWJ[>$SMKY]09:F7H$Z'\0>3&VYV:G5UH+ )F20V\/+"()':]&S
M2;A<L)^S'&3E<2J/F#V@1+.*5S._I15@ E__[DC8$9,RBDA_QS5E'%NN637/
M[#-%1<,JFJI;E<HBQ0,D-;%7E<C4GS9--'Z8J1OT(>\8N5:X9EP+(%4A'S8[
MUYS67-Z!(0:@_S)*(-7L=?B!6Q!.OZ)*=K(B VL.XXV=3KC7JE2JLIH50 VX
M560V&XW>,?&&:L_"F<H!@FVM3,V)']Z WJNWQGEA+E*XF]6\ZQ20Q @@:/>
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M[E<@&R6[?2">]N]:<T/;H%ZUEOD;R8S'\Y/A26P9I\/C\Z.@?==-*]?$2"(
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M<VAE971S+W-H965T,38N>&ULK5=M;]LV$/[N7T%X0X$!CM^2=D6;&$B:;O.
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MWYC=+Y3R><G^,E.Y\"MVT?8EC+/6>5.GQ4!0*QW_R_M4A]Z"U]-O+)BG!?.
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M/\\V'J^.FI_:V$W.8Y$;@Z>N41YX6P\5._"ED%N3-!"@F2]DO>1"X2D500"
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M"AO/^_'&FR:<L=?&X\0>+DM\(I%E [POC/&'&P[0?70M_@%02P,$%     @
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M0#/(^5:Z&[U[#XV>GL=+M;352G>U+T/G=&N=+IM@9% *57_Y0Y.'@X!!]$0
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M\0YXGVO,3'/P#[03?OH;4$L#!!0    ( )*$;EA\NV!2=!(  /$S   9
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M5H<;,E.',7VI=JR2;C5#X^!YF2<@Z)W$/"'02'X>4:S\!0]Q1%F(:VCF FR
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MIN(_EPI-D*4%^'YND +"!SH@_<KGW?\ 4$L#!!0    ( )*$;EBAFV.#-00
M $$*   9    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;*56;6_B.!#^GE\Q
MRIY6K91"$J#0%I!*>Z<[:;>JRNY5I]-],,E K#IVUG9*^^]W[ 06KA2MM%_
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M4?R.0MHJI)YW8\BSO&663<=:K4$[:4)S"^^JUR9R7+JDS*VF6TYZ=CICAF?
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M$/62?M"+XD'R@Y1S;D/$^WA(DYCT._&HX33JQ.?!*<RYS-#'GU)8,?D*:V:
M LAV$J(,]YFB_ $3PEGC*J<+5R.2H*-W,AC\1+"\0:=N6(G@'N\#*74GE,I6
MDCB+VK2UXPDI2SPX$QL#^*WFSTS0X:&PKE4M<B@H\+! )(ND>^9-T5>C<[!^
M6U<;^ZQ4-2&3\373FK2)FG<)5.4"1=M,24JKY:WN$K4F-[S0_J4DZL;[2A8H
M6)G=R$$M.1D\^?AAE*;QU</\J_'+Y.J46# +:Z1$4W6+FDHX6&I5'NJM30@/
M]!?=[B;$Y]<AO/K.P#>=X5]BS]5UQR8=7 ,NE_3E]9G<B^5^*VY[[BWR3L\]
MMB&%9!1=I"GTHV'2"VY@)V9W/F9M% F)R_^5%@RCT7 (9\%\-RM!;W0!O<%%
M<+^?D&-(03*"8>!B#PGT@R_*L@/EUM;8)A?@<[&3AR =1FD\A$$4CWIPZ"O0
MW?FLTYNS\L.+\Y$*K?G";T^W\]%U,Q;\$&^&J\],K[@T('!)JG%G2..(;@:6
M9F-5Y8>$A;(T<OAE03,>:B= ]TM%_K4;9V [-4Z_ U!+ P04    " "2A&Y8
M;4:&V.8,  #9)0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6RU6EES
MVS@2?N>O0'DR4W&5+(O49>5PE>T<DZW,3BJ>HZ:V]@$B(0D;BE (TH[VU^_7
M#?"RZ&-V=E]LB@0:?7Q]DJ]N3?[%;I0JQ+=MFMG71YNBV+TX/;7Q1FVE'9J=
MRO!D9?*M+/ S7Y_:7:YDPINVZ6DT&LU.MU)G1^>O^-ZG_/R5*8M49^I3+FRY
MW<I\?ZE2<_OZ*#RJ;GS6ZTU!-T[/7^WD6EVKXM?=IQR_3FLJB=ZJS&J3B5RM
M7A]=A"\N)[2>%_RFU:UM70N29&G,%_KQ(7E]-"*&5*KB@BA(_+M15RI-B1#8
M^.II'M5'TL;V=47]'<L.69;2JBN3_JZ38O/ZZ.Q()&HER[3X;&Y_5%Z>*=&+
M36KYK[AU:\>S(Q&7MC!;OQD<;'7F_LMO7@^M#6>C>S9$?D/$?+N#F,LWLI#G
MKW)S*W):#6ITP:+R;C"G,S+*=9'CJ<:^XORZ,/&7DTO(E8@KLX6MK21UO3HM
M0)W6G,:>TJ6C%-U#*8S$3R8K-E:\S1*5= F<@JV:MZCB[3)ZD.(;%0_%.!R(
M:!2-'Z WKF4=,[WQGY15_.-B:8L< /EGG]B.Z*2?*#G-"[N3L7I]!*^P*K]1
M1^<_?!?.1B\?8'E2LSQYB/J?,L^#E/KY#*?'P;U:>?NUU,5>?,ABE9'KB$^I
MS*SX9:-XG<SV/WQW%H7SEU98IK%D&G&;QHZWQ 9.; MA5J+ [L_*%K+ 4MAU
MU'^,>$X+B7XT>ME=3X_Y0?CR6,@L"6@EGH0@D92Q0L0HGD#T[HXVV6&OD$LC
M\X1D2'2.F&)R*S;2(@18O<Z8/UW8KOCXL=5%H93 0CI<)O!A36##_DH?"*UJ
M;72V]NIJL\E\7[1W-4Q>; WV&*S.00?[[8#IT9Z@LT>X,&C%3N46QA"%042-
M%6E&WD(L*THX;=[+#G0,(0N5@Z!R8F3E=JF8?[N10!-B^O)?.(#H*AEO'%'>
M2<MI+W@##!)->L$U&.&, @.)K9*V!)6!T"OLV0]XHY-KEYL;31G 5MIBTFRA
MX! 8;CU,0E*(YQ((V>'6-XWXK=*]F$>3P6@TJM@&23(1+,4(!GU9B!ADEDIH
M:TN0;O1R>-I W&YTO ET%J<E'8J=N$9RM(I4T;^+3AV/1LP''W@+<#";-UBV
MW/.V7@_;F!3,8'$A/.C'.#(K90H=JH),9E9!9RE$^UN9*1'.7!AUNGV^)->I
M]M8LZZS?NCY>)*Q4T@N;C4A+$,CW(J3%;/B]DKE8Y69+IT4@EYMRO<&/<2C4
M5SK-ZR55UKI#GNMC,?V^,N_!X7=MA,H"&@622%K'L-YN5:*=A7>$:WZ(]*&8
M%HYFH34.LB68M%N9IGCPZ%DPS%;N"0VU \! ''%ZH@'[;0U8#T7BA-3&?%:*
M!E;B7"\I9"!(I++$/;*))EVO5)[C"?3D@X8/!>I&Y>M<J:PYHQ4+F/G:'I6Q
M=V5.UBHJK??0&/2KG<V\3-5]#A PE FZE52,W:Z[1=,9P7PH7'HQ]^#K$1.W
M#%F#F#8%77$G_T]QQ9/$G8=.W(N[,;6'E@?6.@>_SMQFM=(QG';08&H@U':7
MFKU2+@Y3)D6]B2UU//218B@XD0=FQQ&VIOLH#TISH%TR/'VV]&;PI(#>S&3D
MO'JEL;_S=,!$-I(R"0=ZXJO<L06@=XH'=A 0[]"S4-]4'FO+FD84D[ +1*9L
MX R!@PH.#109'5I64N<X(_^"#N5&IJ5BZZ/PAC,F5<CJB\T>;0GN$T^LD,I1
M>B!%6E!-+*Z-.CM[,&7DBEH?0BHD?EK:>)P)^G,'6HN9XZ)KF9:C/&AHTG]F
M@L_7OSX1&<Q"B[PKB?J*IF[*)7)\0 .#^;31GZ\1?<W!X168T9R$:JK^*;9F
MZ.H:!]#4Q,4F3SC]W *WSLEY >]L$7%,Y&5*U0F@ ^:P'B2N?3\X#T.J#[P7
M_?V/Z[?!Q1:\4/K_^/&J\BOQOH1P+K;?3<H=(!!R4A1<39PCFJ*FZ9-V@9:V
MRMZ'NF3X)3"O2HX?4+GZMM.YT\A/\#[*KO\5LO\2L/LXNX^+Z %H3QX!-L>.
MS@Z.L@[,[86NF*(##B'>SZQO$WRXY@ J?O8LM%H JI4-K;BWS^F!YL7UE?C%
M['0,I)T-NJT5(RA\Z4]L/^JT'@'\DF6V323D$,B)JZ.PTCH-*'&92O!X':,"
M)*ON7!\&#-*"K4E4ZLYXB%JE/ZY'8K/.]+_):RT!#YQBQXW7:XZB#GD5(99*
M1!_+M6$?D(+:#QJ+G*0<K*$X;=WIN;9?3E9(S2*G^(R#ENT2P2Q]Q:G!!]!9
M\#(/8 A#>ZIP0SS%Q"W2DW+4.[?$\TJ-25 QMW)^V$)/'0GNU41-I:5L7YH)
MJQ&$7':\YCC'!4_P2;JX1,W*RJ2IN:6-MSPJ4LD)DF8NU]0<VG+K#V3\EM87
MV_W,)&5>,<#Y52B:N!RZ/KL.>=^+X ^JRP^7!;R,E@2_>ZY$Q5771,%X>!8%
MWXMH.(W$]X>K;TP* *=PIV Q'893+%V,AI,%UK[1E!_ REZK- E&>#3"[;>5
MD;AJF XG$R_-=#A?^$L&:JVX@NL&-S\$(FU'/6[ 1^Y< >-IND%?0)@SI<4=
M0GBL=IPN""PGKBJAM4T\1!'&TR+J9AA@*#'D\8O@YU8L\E&DT=.%U]-;5P&A
M2Z\K'T;,X<K/]8%7K0,_,J*UKZR.@XLU"MPU^<,'+-*91<#YC;RZPTZW4HZ"
M<+$(G@7A[$PLAN,S7)X$[QVX@NAL'H3SX(HB&;HD]$UA-!?'(IR$'9('(3X8
M3Q?!=![,A_A3TQ/1>"XF;7+1B,DM'J0V%N.SA7@F)E,Q'XXFN#H)JLA\HSC+
MDE'NU),'5(+Q.(1TTU$P&\Y(Y!.&5&/9V[LX9A\[X:+Q*1'RCBO>@[:H0EL8
M4!I^%@T7"[[U+,0EW! ACIP!M7>Z?SB3(Z?)+6H9CLCWYJ,J3N<JE55WT:D5
MO0XK<0Z+@V>CX4QL=9H2.4YH\E!9C4_<GP=6(H2(#JZ=[.:C-!=ZE4@TQ^K-
M,D\Y!ROMG?@]%+]1V.;!B$#3?\>*NC.Y(K_668E(4!.OB\R*YVJ@@7L !U26
MHK@C]-WX<P@Y./8-XR)X#!>##G&4$"I5N;/8IJ%)O'=+IE%/S>2*'320A:2(
MAOSFD!%49#K1D@%L:5QRHR$QB'+9[;#R)A^*'PW/\-XI4$5GVN&TKH!IAD>'
M;K1:D3/&)?>/OI/M-N0H!]1.Y@Z@DMIRSHV*,SQG>N/T3:=7QW81(U.+-5)3
M92 [,\1ZMNC5((/64^\AA_*[VO*I6H_">[7.8R7?87Z4MDCWK*^@@7KA$, C
M(F.+$S=.JKS5YP2/99Z?+4; TIZ]8PQ/=*]6VI.N)B^2S[1TFU35$9U<\=D4
MQ\[U!\)-+:OHU5E7JX2> DQ>);[SKF97<@D'=0;B2ZHN40/%TE,R'4MV1YG=
M0,HCQC(M7$/?)L-E=9D538=+=?5!11W<7U%S=XM<2\3=TU\S&M0_4EJ@N_B?
M5Q2MO--3,O3S>5@7O*.TQ"F^53T<)/@(R2Z:S^JT/IT&XT7P&69E7W@^1@Z.
MYF$[,<]&N#<+@\/,/@FB\:R]=,P9?'&P="Q"I.HQMES*E!VS+L4!!X)1?YKV
MN[A0;C==W'GT=3^=24:[,3EH.US7\7C' J0Z"]4QQ44-.JD;II=JC3JKYJ_R
MH(:%V'7XDL+BC8MROKFH\G'[F+61::!M,V).?,>-V+,D6 Y%"R:N[24(6544
MJ?,8&@GP</WQT6K6B7'5<*SU8N4B<]CGZ,^!Q1UC,L2<:JY*X:SPD:3)L6N5
M :)ING=*SKWE?%X%C=:HAE]*.?W[5Q[N1&A5[S2M:*7:5GW487TH+E7,T_._
MIA5*.ZB/7,!<K8@&O__R[9MGL&;-P<&_MJK,&R.J'_2Q7TM#YO;C2S?L[/29
M?BK4ID6"#0)^LT3TFHF:D_A#AJ9#E40&_'$_(NV&+$/QSJ[V+ V]_W%Q[1OD
M3> TY<[SY#14L>T+08=RS\W=+)]HA'Q5\/2<E.HG<FY\G/KJB4? M7Z# _UN
MT/OY+&3*U+_?NZ6LUPR7\+#ASFFY]OA:(9W72"@<2R?(H=10CW.?-T\JTE%?
M-Y-GE^H9517*GT8%)5VW:A@WPZJ*4KNDJ573,^)RYW-E2M'K0,)!_88U [JB
M]C2/,WTULB/+-WKU;PIZ7_G[$/;N3^6[;G1L#8P>;4^D]2G84LX,ZIQY[ 86
M?4?SQ"+@K(2$B47TMIG?4*-W,CN&-3+?&"UC$ ZBR2)X[Z*2J_6:M^*()0%I
M^0Q_9V>SX!=38)';%!&)P6(\%7W?<)RV/K=!];OFCXIH&@PDNB]OZKOU=TL7
M[G.=9KG[Z.DGF7,N2=4*6T?#^?1(Y.Y#(O>C,#O^>&=IBL)L^7*C).H@6H#G
M*X, XW_0 ?777.?_ 5!+ P04    " "2A&Y8>TBF0ML0  #O-@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970R,BYX;6RM6UMSVSB6?N>O0'DR4U:5+.MFQ[E6
M.>[L3D]M[[C;/3L/6_, D9"%"4DH!&G'\^OG7  0D"C9R>Y+(E' P;E^YP+Z
M_:-IOMB-4JWX5I6U_7"R:=OMV_-SFV]4)>W$;%4-OZQ-4\D6OC;WYW;;*%G0
MIJH\GT^GE^>5U/7)Q_?T[+;Y^-YT;:EK==L(VU65;)X^J=(\?CB9G?@'O^G[
M38L/SC^^W\I[=:?:OVUO&_AV'J@4NE*UU:86C5I_.+F>O?VTQ/6TX'^T>K31
M9X&2K(SY@E]^+CZ<3)$A5:J\10H2_GM0-ZHLD1"P\=71/ E'XL;XLZ?^'R0[
MR+*25MV8\N^Z:#<?3JY.1*'6LBO;W\SCGY63YP+IY::T]*]XY+4+.#'O;&LJ
MMQF^5[KF_^4WIX=HP]7TP(:YVS GOOD@XO(GV<J/[QOS*!I<#=3P XE*NX$Y
M7:-1[MH&?M6PK_WX^6NGVR<AZT+\73:-K%O[_KP%POCS>>Z(?&(B\P-$9G/Q
MBZG;C16?ZT(5*8%SX"BP-?=L?9H?I?B3RB=B,1N+^72^.$)O$<1<$+W%R\44
M_WN]LFT#;O&/(8F9WG*8'H;*6[N5N?IP K%@5?.@3C[^Z0^SR^F[(]PN [?+
M8]1?:I3C1&:7HVQ([-M&/\A6B=L2V(?P@D>_+L_F<W'[\^UG\3LLLI(CYJ^U
M^&_SH*J5:L1\0;:8CT6[4>+&5%M9/PG8K1I5"%VW1DBQ[9I\ R$BY'VCB#9X
M<[L1N6I:P(=,UP\*/+JQN-)VP(Z ?8\;G6\2LMK:#JA*"-I[H'2/[)JUD-MM
M8[YI"$55/HGY9 X!49;(:5?KUH[Y,"6!&CX0N0'LL*VN[W'WJ1X)4RMA-[(A
M<KFI*M@+#.5?2$6G&I:TCR9[=+H:,S'U336YMG)5*N0W2'F$6HO,NWU*;!N=
MTZ)7B\G\2FQ5,Z8E/:EXQ<4"5[ (I[K.R\X"<,&/V:OI9#:_H%\=BZ.)^!T4
MUT96RTMC07GP"8+(&8]MQVN]DAOX%>@6D8[O&V/!-HW)E2KLOLI?O9Z\]CI/
MB0&;78.>L%9J:.-TL@C&:C>-Z>XW/7LNSN? 4@GK"U1RFTHU$9_1$DYJL9'%
MOH*S6,'.,*>V6_T3$@"29#2%S"-D\4_X3+X_&HN5RF6E$BM;_4U4C&CKQE3$
M3>&\$)U3UKD:D\^H;UL- "#6H,HS>' &3G&VD>5:7%M1: N'6@H0""78?SG&
MC^"8M<M*Y+)(OC<6(%X&*QX@:#0R4^/&M:[A4'!E#L!]U\*GWF_A@P5E%EV.
M%D$!=O4"ZG@UFRP7_:.)^'5&*+ +#P@#OTCP4V3^AR$ K.6C/WM9\"<.M%@N
MQM/IU ?ZBV,\(ORG/US-9Z_?V3123TU#)BFUZG!UH\QZ3#0 U\_6'>:SX'8O
M"OY1CR6XIM^;/;]W+*#,2G'/Q>0>4.P$V&P^F::A.8P);,DW0X#@%#]_?8&J
MSHA!N\]A>O#E%=EE7UF6U!"^Q*H;-NWP>=\',[->"2^%&6UC38V=0SZ"(PA9
MEB:/ 6DM=2,>9-D%WWI6;OQ"T-6OS(ZB&"4!P/GI=Z(8AKRN*E5HUD4$9V/0
M:%<6 '3AK"*C%/4D6JBP&<F0F]HPH$GR&D2\/>"UAS+;U63^O3P_@[P&]/^(
MD?TC\/O[2ZS#9LY!/36:F8+/ A;(E2YUJX$P[F[$]=V-N)I=G"VG8UP _-@(
M;<$%'W2A>+O(I=V4"F+6JK8M&0)IA66O!,47!B@#K(L*RO8,I6L45&J-*\><
M;VDX^AM;XK[3!0J]QPZ%1\]+PCI:H5+2=A@P<&KDO? -0DEMN3&J"1DD5@00
M7:APZ'.TKZ<@9NM[( <@&5&@JI>4AHMT31S;%HQ$ H,(T#>R']F).+U3BA/@
M&]125ID&Y>.>DMN[$)*#YTU&XF];TSO>^/OB\=PT_7=3IRF4/$MCPLQ+::U>
M:Y\UA[0*'"JJJAF9>A;L2S$!0X_LZSR9&6A-*TO8@DA^&4#,*3:D TA-#<)#
MOX)4"5ZUL_!@WL!5E$6%-67A#S#KM4++LU#) 8URMK:<Q+&J(!L[4/1IG32#
MQ0"7 J2)_6* %4'*-DW!E=&0FB&PH?-700$0HY0"T#LQYYM2%^0QL<]EL<]!
MV?*7#H!P-O=E"^#Y00,1$@1T'$R,@XEO.&N)+G96$KHOMW=*:DJVL-^7W;M^
M==2M@M.EWGRZ5WZ'NGWDU9_Z>O:,K_\\7+4FJ3.NXE#DQ#MD:<UNL0BNJK$%
M9PC ^8F-7.5XF4CK"#! ,5O$.CQRK2&'[! .'I(%MN\^W^!.7@8>RQ!L(0"]
M/@_8U;G"3M30T13.F,)2V[\0%-CJCH=A]D.ZA%-IEL7U''CXS)=SMY'*6*8C
M"DX-!@!H5J6^]S"\!<*Q ;-2?^U<S!6RD@C1X!RRQ,7S/P8Y4\#!E-@C#E8'
ME-Q=:I$XR=)55T6X!>?Z##*;OX3JV%M#/1 JQ4ZG.<W"N95NG6"=5?NZZ95,
M;F&5@PJ+*9&"(?/.XNH$9RIJ&3@KX],>C:6P6Y5S@,'YVA0D#)1;$^ZHGL1\
M.=10 <.\*P77C=R1#<,8A?-CB4&Y^FA"Y_%+_%%<\K7$5?F48?" '^- J),-
MB K0\9O:FJ9%3\,AJ)A-SWX-ZO_*JR"JT:VYLPA%=AQK8P<'NR)P68H</&,4
M*,]TF;#.O!+)KX'9AI@--;RT;IG!5  ]UV(:]3U90)(\;S"H 27[B5+146"3
M*%Y> $!L-)&A$I-K$CZ^,Z'Z<2]2L&Q&E^G*UOLT%CRH<NKIF6.=YD6#SN4S
MX5C4J@VL/"GI];[?W[P\9]K=0BU.>UNIV0D3Q0P(MUL(:*=N5C65?6'Z^)U3
M$<S@&4Y$R(.2&8DX/".QN]!&H$UKAAO2HX/&V7(RS[SXQ[K4_:X(*P[;]?V3
M11.3H]0M]ZOQ"&:X9\K2GDE2G8)=#S4]Y G/]4H3<;W'"$*W2_]@,D[SPA<%
MN6S#'"$BS1W:QCPFOA\&*[Z$H)L6)+?OK=FNMRYPQ F+3&?!PECW85M".T$O
M9ZP7D$>.WF8\H+IAO7N/RGAX';Y2S4>$PZ/4;<+CW['B[K]^DB55XUQ3_476
M'3:LCLMLL5QDR_'B]52<96?PZ?5LD?TG;@29X FX\/3-,KL:SV87V6PYGD_?
M[!#<$SPBF6R^&K\!>:Z'-[%C/])=$X(-! "$(* &WK^!C7!P2'<:F)C!OONC
M0=.U$/YU@09%A%Q.+J^<$_F:;8_\CF/CME?S9$0Q 9B_O<;$=@UK2G$1L9L-
MC@HY-< >BO7_ OPT92UN9?-E/%#YQ;]3Y(5T'H*XV_)4<QK-@%CX[-@$$#C'
MN,!DOE_NK9YB1P>46@OZ'YTRCE6^WT!$*C0A*>FRU, F(RL. ]"I052'SB@[
MPEY>=F0+V>_N,Z777"6I+@#H;/#(1!LID#WU")6E'0G5*$'K( GA0=CZ2+G8
MI2C@,3ECI6H%J* !SYZ$>41/BTJ=Y>3-FU  [N@Z"W<Y1>)ZAW#TCNRPPRR*
M;W+ 33>-AW*%D@[/KMI!,()LIRC5-,IW)SP/9 <%[[SP78W5A<N J+58\$ -
M7+=Y2AUW,,? [XGBTDSR>GFL9SQ%>GCB?/KNAER<FI8[6DW/9^_<?4_2&/9K
M!:]-&VPJ/5P%ZKMJZE?(]0Y5&N,?KR((O(\4*(NTS% H#'<=KL9"_.(8<#QR
MNJ'^A>MS&I8=#H-#S1M+M.[:#I.M4_6V:YFT5W%P"9=.LS!] P+Q)/ G17<E
MD(4YWO^LBGO<0UXS?P<2LBPT<H(X^0SE8]M[Z%\?X5%_00NG.H.PZ"W6"CAK
MI25G4"=^4<6.?L(@D;/YT^%<[DMP . U!J[3H4VF@CP(]6.@OD"N9?GT+V<@
M@/ J3!W6T%V$D Z*/"".FQWK"J.A 2SQQPZGNHGXJ?,F.%I!# 8BLD #KIU+
MX]G1$$QQ)X9G?.;"=R_>^-;FV<O3Z YT<C2_-\H-IE/6QU>7TYCYD/31]U<J
M(W%3"0;G-H1EV1$L0Q-#*=VZ9A#P$JNQO5F>W4_=:8KO>ZC91-QT55=2L&!<
MA,+]%OQ14>-T1Q:(D8$<IH/:L-'H?;.+RQW;;<-F?S<%92X\#]T40(>^9TF
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M#1NY_1.%9SUM U#Q2E,,Y,941=FG!>!4F(.%'2\PU'CW]U<%:V%T4T2/R(!
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MU>C8@/932W3K!0=H[NF3OP%02P,$%     @ DH1N6,&K>(I# @  D 8  !D
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MPGJ#%?E,;"6A!#4-P./HMSW_'0":&"XTM05 JZ"4U%_Q06>S,L.S7X-\1L#
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MG8[A-EMRB](##7YT8J]2;+159!SPI)=F;1L*616BX7:M;3B28[>D5\>84MV
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M3QX^><27<W34&,9AN>07!D0+Q=B]+*DSQ[+-0[LA</>W-"AK+[H461,%5>$
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M4N/3X.7>2,N?DA,YWXG2T-]C"K]#DY".9"J.DN3_IX2<\@4?)[_-N#5N3;]
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M9O)&E*Q,1;G1Y.0#@VG]YGQF8'?$F*7M3E?-3OY7=J(^>2]+L]7D79GQ["G
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M?<J)XTO^+^7?LZ4V"G\E?_8EW5&F^REMYXQU0W.8^M@:&M03^-FG#]$P_'Q
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MP$%9 -Z74IKMP0;H_Q*R?U!+ P04    " "2A&Y87=ZCT_P$  #.#0  &0
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M@W1 %[!D56X>Y>9GV*XGMGB9S+6[TDT]-@X'-*NTD<4V&!D47-1W]K+-PUY
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M07#A5Y1Q=S&S:_=R,1.-+AF'>TE44U54?E]"*;9S-W1W"P]L4VBSX"]F-=W
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MYW 5<<VEM2_ SI6TA6.#=,0R(.SMKI4RS^T2S9<RM,/]']]WZY*/HTF:\!3
M^@<JPG*!IVPP6;?-HR5P+MZ6 DLF43).F1A&69:R/]^FGGHW2D-+=T$E,FID
M2L<A:2*.)C NG0SWT[ACZ3G[K)\#O@6.[C (CG$EE]9=!WQ(&Z!()H)@PM1/
MRGI-95ZHJ<=[!'$$@C,DS -#Z),#?#T:4U#1T08U:6R.VRUJS^3=!NP*I'1
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M>2'V BSK1(#5!%B7!@R:@,&E <,F8'AIP*@)&!T&3$\$V$V ?>D6QDW ^-*
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M-!<?2)M@U@LA]$-@6V5_E::_ 5!+ P04    " "2A&Y8DB\A5)L"   1"0
M&0   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6RUEEUKVS 4AO^*\&!L4.JO
M?+1=8FC:A@U6" W;+LHN%/LX$94E5SINDG\_27;=%!)WE/3&EF2]KYYSCH4T
M6DOUH%< 2#8%%WKLK1#+"]_7Z0H*JD]E"<)\R:4J*)JN6OJZ5$ S)RJX'P7!
MP"\H$UXR<F,SE8QDA9P)F"FBJZ*@:CL!+M=C+_2>!^[8<H5VP$]&)5W"'/!7
M.5.FY[<N&2M :"8%49"/O<OP8A(&5N!F_&:PUCMM8D-92/E@.S^RL1=8(N"0
MHK6@YO4$5\"Y=3(<CXVIUZYIA;OM9_>I"]X$LZ :KB3_PS)<C;TSCV20TXKC
MG5Q_AR:@OO5+)=?N2=;-W, C::51%HW8$!1,U&^Z:1*Q(PA[!P11(X@<=[V0
MH[RF2).1DFNB[&SC9ALN5*<V<$S8JLQ1F:_,Z#"94,TTD3FY3%-9"61B268*
M- BD==I$1N9UR>RT.5L*EK.4"GPED9RE#/2)$9L_1N'6"6\>*U::&B+Y<@U(
M&==?1SX:;+NXGS:(DQHQ.H!X#>DIB<,3$@51_%KNFVC;D*,VY,CY]0[X_:0+
MJ2A*53/>4E'EYN>HE WDA?C^%HH%J+_[@#L7L!OI0I<TA;%7VE2J)_"2SY_"
M0?"M S]N\6/G'A_ /Y#@^\N%1F7BV L<?P!PKP7N=>;[1B,SVP<R4FG(*TXX
MRV$?9+?-D&R!*MT!U&^!^IU.TTH)9NH-+H53MK%MW5GP3L-WYF_0X@Z.7_#!
M!P /6^#A<0K>;=-_L^!G+=!9I].5+,H*0?WG[NXT>V?NSEO4\^,7^_P#@,/@
MY00)CE/N-WSBP_7V=PXX>UFXI6K)A"8<<F,5G [-_E3U^5MW4);NS%M(-">H
M:Z[,G064G6"^YU+B<\<>H^TM*/D'4$L#!!0    ( )*$;EAF(GJDT0(  "4(
M   9    >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;*U676_3,!3]*U:8T"9-
MS=?:HM%&Z@<('HJJ58,'Q(.;W"36'#O8;CLD?CRV\T%;I6&:>&ELYYYSS[EV
MKCLY</$D<P"%G@O*Y-3)E2KO75?&.118#G@)3+])N2BPTE.1N;(4@!,+*J@;
M>-[(+3!A3C2Q:VL13?A.4<)@+9#<%046O^9 ^6'J^$ZS\$"R7)D%-YJ4.(,-
MJ,=R+?3,;5D24@"3A#,D()TZ,_]^,3;Q-N K@8,\&B/C9,OYDYE\3J:.9P0!
MA5@9!JP?>U@ I89(R_A9<SIM2@,\'C?L'ZUW[66+)2PX_482E4^==PY*(,4[
MJA[XX1/4?H:&+^94VE]TJ&,]!\4[J7A1@[6"@K#JB9_K.AP!0O\"(*@!P1D@
M""X PAH06J.5,FMKB16.)H(?D##1FLT,;&TL6KLAS.SB1@G]EFB<BN98$HEX
MBF9QS'=,$9:AM0 )3.&JSBQ!FVJ+3=B&9(RD),9,G4 X)3$!>8L>8 ]L!_H9
M<QUJ.:Z7H#"A\@9=(<+0BE"JE^7$5=J!T>'&M=IYI3:XH-8/T(HSE4OT@260
MG!*XVGKK/VC\SX->QB7$ Q3ZMRCP@A ];I;H^NH&+702H4]8A\+%R_F"AJ]'
M9]CN4VAYPPN\767]/MM**_-'5R4KOKMN/M,<[F6)8Y@ZI=ENL0<G>OO&'WGO
MNTS_)[(3ZW>M];L^]NC+KMB",(=/U$7(@(' ]N#%]4Y)]+MOU^95BI%-83K;
M/O(G[O[88J^(5UH<MA:'O18;Y0A+":KSPZ@(QD<&O#,#?1$GJD:MJE&OJB6D
M( 0D3=V[9%4,OG><=3 Z4]:;YI6E';<FQB\K+25X2ZC^<J"SOA7+\,3'^1$9
M_[/"[E$G+D!D]H*2R/;)JBFWJ^T=.+.MW_T;7EV@*RPRPB2BD&JH-QAK;:*Z
ME*J)XJ7MZUNN]"UAA[F^QT&8 /T^Y5PU$Y.@_6<0_0%02P,$%     @ DH1N
M6##L3Y-  @  [ 0  !D   !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL?51=
MC],P$/PKEI$02*<F37L%E312>P7!PZ&J%?" >'"336*=8P=[VQS_'G^DH2?:
MOB1>>V<\8^\Z[91^,C4 DN=&2+.@-6([CR*3U] P,U(M2+M2*MTPM*&N(M-J
M8(4'-2)*XG@6-8Q+FJ5^;J.S5!U0< D;3<RA:9C^LP*AN@4=T]/$EE<UNHDH
M2UM6P0[P6[O1-HH&EH(W( U7DF@H%W0YGJ^F+M\G?.?0F;,Q<4[V2CVYX$NQ
MH+$3! )R= S,_H[P $(X(BOC=\])ART=\'Q\8O_DO5LO>V;@08D?O,!Z0=]3
M4D#)#@*WJOL,O9][QY<K8?R7='UN3$E^,*B:'FP5-%R&/WONS^$,D$RN )(>
MD'C=82.O<LV09:E6'=$NV[*Y@;?JT58<E^Y2=JCM*K<XS%;,<$-4299YK@X2
MN:S(1H,!B2P<FRS(+MR82]OQ2O*2YTSB"X@2/.=@[L@.*GMG2+;0*NW7WJP!
M&1?F;1JA5>SVC?)>W2JH2ZZH&R?D44FL#?DH"RA>$D36ZN W.?E=)3<9UY"/
MR&1\1Y(XF9S$FAO$D^$@)YYX<H7X?]\_EWN#VI;=KTO& ]OT,IMKQ;EI60X+
MVKK;T$>@V>M7XUG\X8;6Z:!U>HL]^WIH]J#===KFULRK-1>/(F@-;#//YKK\
MF(W3Z'@N(#JKP 9TY?O,$%\?H1B'V:&5EZ&"_Z6'=^"1Z8I+0P24%AJ/WMU3
MHD-OA0!5Z^MYK]!VAQ_6]CD"[1+L>JD4G@*WP?# 97\!4$L#!!0    ( )*$
M;EA3M+-=&@4  / ;   9    >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;+59
M74_K.!#]*U;V:@42D,2%%MBV$A16N]*RBRZ7W8?5?3")VU@D<:[M4-A?O^,D
M)"E-IVH57EKG8X[GS(S'I_5X*=6SCC@WY#6)4SUQ(F.R2]?50<03ID]DQE-X
M,I<J808NU<+5F>(L+(R2V*6>-W03)E)G.B[NW:OI6.8F%BF_5T3G2<+4VS6/
MY7+B^,[[C:]B$1E[PYV.,[;@#]P\9O<*KMP:)10)3[60*5%\/G&N_,L9'5F#
MXHV_!5_JUIA8*D]2/MN+W\.)XUF/>,P#8R$8?+WP&8]CBP1^_*A G7I.:]@>
MOZ/_6I ',D],\YF,_Q&AB2;.N4-"/F=Y;+[*Y6^\(G1F\0(9Z^*3+*MW/8<$
MN38RJ8S!@T2DY3=[K0+1,@"<;@-:&="/!L,-!H/*8% 0+3TK:-TPPZ9C)9=$
MV;<!S0Z*V!36P$:D-HT/1L%3 79F>J4UU,I5\",76MC 'I&',J-$SLG:4W)P
MPPT3L3XDQ^3VE05"5R_=YRJ(()[DWSN>/''U'5YX?+@A!U\.R1?B$ATQQ341
M*7E,A=%'<!/&WR*9:Y:&>NP:8&-]<H/*\^O2<[K!<Y_<R=1$FMRF(0\[[&=;
M["D"X$(8ZUC2]UA>4Q3Q*E,G9. =$>K109=#N/D-#\#<[S)?<6=0IW90X TV
MX&U(S]63-@I6S_>ND)>(I]V(MJ5<ZHP%?.) S]!<O7!G^O-/_M#[I8MN3V K
MY$]K\J<8>E77K%6Y4,Z!3!(8P:(*GLD!E%]9E(==D2CAAP6\[84OT^&%YWEC
M]Z5-$75B3XIG-<4SE.(?P.(XSTC&E9!="^ :M=\UF[@SL)J28C4AQ(8UL2&*
M=:N-@ ;-0\(A?>:-O+ XYS:!9>:$UCD\A/RQCUGNBD(YV:B5R='9>B91E_;,
MY*@F/$()/]@R))D2 2_*,I1QS)2VF2U+M+-"1VN\!A\XH;/NR>F\YG2.<KKG
M*N"I 2E0K#RF(UA^L/N'7+%-F2H1?;]%R3NA'TBAT^Y)ZJ(F=8&2FED:4A%I
M(DC-5CX7:QDZIM[Y!S[HC'OR\;UF^_=01G?L521Y4N_:G?LP"K%K'^D+;95P
M2^_XO>^*%61? >@);34 M D [;.&*[3V1GC:T3[Q2?<EU4@='Q43TQGL/2)=
M0,,ALS8C\E?*\=KN5?'TA;8:A4;S^*?]UW9/$J8*P&<((K]11#ZN0F9M@9>]
M!X M%.>)K0TK 'D:E!>;=1,^R\XQP7T>D#<.FSW&OQ%./JZ<[D1:='/X_?8,
M)1"P3!@6B__*M:"LG%(%^2/"$IFGII/]<&W%^Y[7L>0_0S+YC6;R<='T9VX7
M=2GK4\V#W/X?0*#00V@$)&1OW;\I>])$50AP%WVOPX]5NHV<\G$]!71M3X/&
M7:KA.8P:.<R@J#OIGJ_EDG9D\C,TE=^(*G^+JMK4O+\M)=Z\>]).510^0XG1
M1HE1K_?F37M59GVAK0:@4684%3Y]-6]\EIUC@ON\O7G31IA17)CUTKSINERC
M7<T;]V7?7#=ZC>)Z;;_FC8/NG%K<Q>W-FS;"C.+_1NW7O"O0$=Z\\:GWS60C
MN>@VR;6I>4>P<-'VC2/OG,Z>T%;CT$@O.NR_??>DH*H ?(8>HXT>H[C8Z:M]
M]RK0MOA\MKE]NZTS%5B\B^*H20,+:+SE\4I]MS[.NBH.<=SF]?(L[(ZIA4@U
MB?D<3+V3$52J*H^7R@LCL^*$YDD:(Y-B&'$&*\F^ ,_G4IKW"SM!?<@W_1]0
M2P,$%     @ DH1N6+;;]JG/ P  ?10  !D   !X;"]W;W)K<VAE971S+W-H
M965T-#0N>&ULO5C_;^(V'/U7K.PTW4D]$B>%0@=(7+EJ)^TDU.XZ3=-^,,F'
M8N'$J>U N[]^=DCS10I>T:SR \2)/R]^SR_.P],#%SNY!5#H.669G'E;I?)K
MWY?Q%E(B!SR'3%_9<)$2I9OBT9>Y )*412GSPR 8^2FAF3>?EN=68C[EA6(T
M@Y5 LDA3(EZ^ ..'F8>]UQ-W]'&KS E_/LW)(]R#^I&OA&[Y-4I"4\@DY1D2
ML)EY"WQ]@R>FH.SQ0.$@6\?(4%ESOC.-;\G,"\R(@$&L# 31/WNX <8,DA['
M4P7JU?<TA>WC5_3;DKPFLR82;CC[@R9J._/&'DI@0PJF[OCA5Z@(#0U>S)DL
MO]'AV'<T\5!<2,73JEB/(*79\9<\5T*T"O#EB8*P*@C?6A!5!5%)]#BRDM:2
M*#*?"GY PO36:.:@U*:LUFQH9J;Q7@E]E>HZ-5](J;VRB)\**JD1]@+=$BK0
M V$%*87F&Z0[%6EN6A)]7((BE,E/Z#/Z<;]$'S]\FOI*C\3@^7%UUR_'NX8G
M[KJ$>( B?('"((QZRF_LY8M<#% XZBOW-?]:A+ 6(2SQ+D_@?7TF,97HJ,6J
M$/%6&P/]]1W2-8B_^^A9\<RC=RUS$L/,T\^6!+$';_[S3W@4_-)'UA%8AWI4
M4X]*].@$]=\H65.F9QYD:^8!+:F,&9>%T#HLUE()_;SU*A&Y5,(16$>)RUJ)
M2ZL)OA.QT],?DYPJPN@_M?M3GFG+BQ=$4EYDJD\$*_*Y(AS!KDHPLPKOYWI-
M-I^IO^_A-ZSY#:W\[A6/=V@E:&RWMA7E7"Z.P#J$1S7AD=7:S1+V.\3;C#YI
M6Y,L0=^RO% 7: DR%K1<U?[#XB.7BC@"ZRAR52MR9;<X$/-$Z[>P0M2HT,?6
M"G$NVR/8J.7EJ-_%XYK"V$KACLH=NA4 Z(XHNY&M0.<2<036X3RI.4_>Q\@3
MEXHX NLH@H,FM@3_W\IVC',)5V@X;+DY& 31<-QO:=S*8-A*YH$S/;_Z+?QB
M-;0=Y6PZCM"ZG)O(A</W,35VFL5<H755:=(8MD:<-]K::>:JT-IK-#YAZ"9*
M87N66M(]34#/YI\46&(WM=/LY JMR[N)6'CX3J9VFL)<H755:7(8MH::-YK:
M:<JJT-JF/A&?<1.>L#T]?7W.(5:0Z+D5J=W33C.4*[0N[29PX?$[>=II('.%
MUE6EB638FF\:,S"Z@5ZV]OH(O0 1LI>9TV3EM_:&S,:<_IO[2#.)&&PT?#"X
MTFN#..YU'1N*Y^5VT9HKQ=/R< LD 6$ZZ.L;SM5KP^Q U3N.\W\!4$L#!!0
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M(@Q"-\#W.\[54T%WT*;6X3]02P,$%     @ DH1N6+GP/B>" P  K T  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#8N>&ULM9?;;MLX$(9?A= 6BQ9HK9/M
M'-86$#M;="^"!DF[>U'T@I;&%EN)5$G:;OOT.Z0466YE(BK2&^O$^6>^&0\/
ML[V0GU4.H,G7LN!J[N5:5Y>^K](<2JI&H@*.7]9"EE3CH]SXJI) ,VM4%GX4
M!%._I(Q[R<R^NY7)3&QUP3C<2J*V94GEMP448C_W0N_AQ1W;Y-J\\)-913=P
M#_I]=2OQR6]5,E8"5TQP(F$]]Z["RV48&P,[XE\&>]6Y)P9E)<1G\_!/-O<"
M$Q$4D&HC0?&R@R44A5'".+XTHE[KTQAV[Q_47UMXA%E1!4M1_,<RG<^]<X]D
ML*;;0M^)_1MH@"9&+Q6%LK]D7X^=X.!TJ[0H&V.,H&2\OM*O32(Z!N'XA$'4
M&$0_&DQ/&,2-@<V<7T=FL:ZIILE,BCV19C2JF1N;&VN--(R;,MYKB5\9VNED
M*;B6F$MTJW.RM Y!DN?7H"DKU ORBKR_OR;/G[T@SPCCY%TNMHKR3,U\C>Z-
MB)\VKI:UJ^B$JS B-^@M5^1OGD%V+.!CW&WPT4/PB\BI^!I6(Q*%+TD41'%?
M0&[S:TA').XU/PHG;G,96[UX4"X5^7"U4O;#QYX8%[7FN%_3=/&EJF@*<P_;
M5('<@9?\^4<X#?[J WXBL2/\<8L_=JDGMU*D )DB:RE*(JJZ37E&"I9BWP.A
M&PF 4X#N2T.M?6:US=RS2^(@F/F[+IW3_R_235JZR0"Z%.<=8H8T/<J^T\.L
MQ#2#OOY8.#T,+?7DIX2-.PD[8IRVC%,W(TB[,/ 4B%@5;&.A7I(*)%90X[3>
M1U5KAF$GDO"'PCG=_F+ASEJH,R?4'>R ;P'7G%1L./L.F9G'T-&.X51FV)CH
MG<X63MVAY:K%IITDG2C6><MU[N1:4IWFK[85H=DG_ ^:OB):(*;%[>-QZ@WE
M.7\LST7+<S&P3GT,3HVA#!<_M5!XJH7"X+"@!DZ.M_7$MX9N#Y&*?K,5<K>2
M6WHH7J-VU)G!*#H!V-DQA(\JU-VAH=[N<,_P#K=WY,,-E"N0O2N=6W<PW1.I
M'6<A.F0A^@V+?2/Z5"EX(K7C%!RV.Z%S._'(CG6+#$:.'['L^9W],!9E8X\)
MBJ1BRW6]-6[?MD>1*[L!]P_#ZW/,#94;QA4I8(VFP>@,EUU9'PWJ!RTJN[M>
M"8W_ 'N;XW$*I!F W]="Z(<'XZ ]H"7_ U!+ P04    " "2A&Y8;/M@2Y0,
M  "=K0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6R]W>UOVD@"!O!_
MQ>).IZZT%_ KT$N0VLQ;5^I>U>S>?EC=!P<&L HV:YNDE?:/7]LX# -FL)N'
M_=(F-/X--(\\9AYLWSXGZ9=L*65N?5VOXNRNM\SSS=M^/YLNY3K,;I*-C(M_
MF2?I.LR+;]-%/]ND,IQ5&ZU7?6<P"/KK,(I[D]OJL4_IY#;9YJLHEI]2*]NN
MUV'Z[;U<)<]W/;OW\L#G:+',RP?ZD]M-N) /,O]U\RDMONOOE5FTEG$6);&5
MROE=[YW]5@P'Y0;53_PODL_9P==6^5(>D^1+^<V'V5UO4#XCN9+3O"3"XJ\G
M>2]7JU(JGL<?-=K;CUEN>/CUB\ZJ%U^\F,<PD_?)ZK=HEB_O>J.>-9/S<+O*
M/R?/0M8OR"^]:;+*JC^MY]W/#H<]:[K-\F1=;UP\@W44[_X.O];_$0<;V-Z9
M#9QZ Z?M!FZ]@7N\07!F Z_>P&L[@E]OX+?=(*@W"-IN,*PW&+;=8%1O,*I^
MN[M?1_6[)&$>3F[3Y-E*RY\NM/*+*A#5UL6O,(K+[#[D:?&O4;%=/OF4)NLH
MRY+TF_5SDDLKC&?6?1(_R32/'E=R]R"+XC">1O$B^]%ZV(7<>D-D'D:K[ ?K
MW]:O#\1Z\\\?;OMY\8Q*MS^M1R>[T9TSH]N.]3&)\V5FT7@F9SK0+U[*_O4X
M+Z_GO6,4B9S>6+;WH^4,'+?A"=V;-_]INS)N3EJ,[MIG-Z?M-W<:-F<7GGP8
M[S?W&C;G;?[K_+-/7K38?#!JVES[3;K[9+J5YY[QCE.869_";V'YW>_O'K,\
M+?9Z_V]XEN]WJM>LEE/!VVP33N5=K]C79S)]DKW)O_YA!X/_-*4%B1$D1I$8
M0V(<B0D0IB70VR?0,^E: N,R@4UQ,Q)=XX;$R X;5EAY"/,T"89#=S 8W/:?
M#I-T^G-'/\&03XLC,0'"M'CX^WCXQGC\O%T_RM1*YM;T."@OC\B9%<5Y8F7+
ML!C?>A/%]9=-<^5[XW!=HX3$"!*C.RPPY TY'$=B H1I>0OV>0N,>:/S>7'
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M,:C&H9I :7I45:D0.%=96 N@50)4(U"-0C4&U3A4$RA-CZ*J' +D/2;,6.<
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MBEUL_4TYP'.2?JF>]N0O4$L#!!0    ( )*$;EC;35 OM08  /TY   9
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MO['S'F_G.Y:UCKD]/YFU(E"C#Z4I%(W*9C(!+^BAID'3 2A-0FD*1:/JF'3
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M8=!#78.F!%":A-(4BD;5V;GF7B^=_SS56I_V7OW3_8J&O;I>'P% : * D \
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M8<8M_?ONT-EWE]!)%8I&5]R8^_&1Z_@?K6"==@3PLU@+ >T"@-(4BD;U,FG
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MP7I!TFA%LY<9/8TZ>@'URM2+-'J1HZ4&JDJ-7@FLX8,E@*31BF:O*'H:=20
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MC[?H[9MWZ UB"?IKS3.I;>7$57IZ ^(&NZENBJG(D:DP0?<\46N)/B0AA'4
M5_,NR9-G\C?$BG@+P27JX0M$/-)K(31_N3NQT.F56O9RO-X)+2_00T2UB#5)
M+]!'P:5$7Z\74@F=O?^V*5A,T&^?P&SI*YG2 *:.WK,2Q :<V:^_8-_[K2WZ
MCL!J6O1++?HV]'I>027"RHC0%GD!-\SAS-FSF?G><.)N]@-JVA!_5-K4> Y*
MG@,KSS] KPD-@BS.(JH@U$> 5B-@M#AD-'D:<Z'8?_E &_$"W]\C]1[C_@'S
M%J,>:6?NE\S]GU(X =5&TV\PZ(][!RR;-J3GM[,<EBR'=GU-SFLE0R93+FF$
M^!(MV9,6FDH)JC45A@T:^(!HTX*,O':BHY+HR$KT3UTR3;5!&QIE\!*:5KQS
M]^JH$9'O'8EH7$8T/I4@ 4 HT5+P&&GM0;XDK'&#B7>@?M."#(YPQ5Y5ASPK
MV]O]?0=/NDV1T%YDO&9Z>(<46XS(,3WQ7JW$]F2F"RZHXJ+8=/<TR9;Z),\$
M2U9[Q?/K/<0+$*T'O'V&<[.F*[2Z'J32@[QVP=O-T)4>':'5]:CJ/[:6U/.+
MW@ZO=BHW4KEI0XX4/5Q59VPOSW>92)A.7,BIWK$G\RSMF6M%/'NE.D*KQU]5
M?3QX]<RU-A9GZ]$16EV/JI? /]=,',_<9J^ QX>9V[0Y=@17[00^T4^ _I]M
MS:,0?8I3P3=@>)Y(7"OBV0O5$5H]_JI+P:-73]Q.&Y>NT.IZ5#T./MGDG)FX
M+=W+\+!=;S$ZDKFD:G"(O<&9\SC-%(B]1L%PU@&L!(WM*6R'/G?)ND*K"U%U
M402_=@J33KNHKM#J>E1=%+%V)>>G\ YO:$WA-J/^81*[>Q=',8A5?I\F4<"S
M1!77,.5H>6=WG=]4'8S?X*MY<?-6P107@?=4K%@B401+#>E=#G6A$\7=6O&B
M>)I?3RVX4CS.']= 0Q#&0']?<JZ>7\P$Y0WG[']02P,$%     @ DH1N6+6E
M$JF=!P  6#L  !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULM9M=;]LV
M%(;_"N$-10NTMD7Y*VEB(+$TK$"#!,FR712[H&4ZX2J)*D7E ]B/'RDIDFDQ
M=(2>]:*Q9/*A^![ZB*](G3QR\3V_IU2BIR1.\]/!O939\6B41_<T(?F09S15
MWVRY2(A4A^)NE&>"DDU9*8E'>#R>C1+"TL'RI#QW)98GO) Q2^F50'F1)$0\
MG].8/YX.O,'+B6MV=R_UB='R)"-W](;*V^Q*J*-10]FPA*8YXRD2='LZ./..
M0_](5RA+_,GH8[[S&>FNK#G_K@^^;$X'8WU%-*:1U BB_CS0%8UC35+7\:.&
M#IHV=<7=SR_TW\K.J\ZL24Y7//Z+;>3]Z6 Q0!NZ)44LK_GC[[3NT%3S(A[G
MY?_HL2H['P]05.22)W5E=04)2ZN_Y*D68J<"GKU2 =<5\'X%_$H%OZ[@O[7"
MI*XP>6N%:5VA[/JHZGLI7$ D69X(_HB$+JUH^D.I?EE;Z<52/5!NI%#?,E5/
M+K]2I7+^$5UF5!#)TCM4GD'O RH)B_,/)R.IFM&%1U&-/*^0^!6DARYX*N]S
M%*8;NK'47QVHCQV D>I?TTG\TLES["1>1G*(?.\CPF.,T>U-@-[_^@%MY;M?
MO/GBL^T*W;R 1@W/?^%9,,';,=B!"=V8"R(.80S5_&9H^"77=PX-].ULG4NA
M?M!_VX9"A9C8$3K+'><9B>CI0*6QG(H'.E@JU6=CJ^J0L  2%@+!C#A,FCA,
M7/3EBB<)DRHY2R0YR@H1W>M?*/U1L$R?M87%2>P;%DA8  D+*]B\A.E;XL-R
M.E;_3D8/%KVGC=Y3I]XW-"H$D\_J?I/QG%GU=1+ZZ@L)"R!A806;[>@[\U_5
M=];H.W/J>WUYBTB>JTG0FL0DC:A-8">BK\"SSC#Q\7SA[?:D$J];T!O[XTZY
M<-;1Q9N,7Q]Y\T:9N5.9ZM8;,[)FL1J -EV<@+ZZS#O=\*?C>;>_0;>@YRUP
M5Y=Y5[^I0Y=%H\O"J<N7)"-,E!F0;U$S?FSZ.$%]]5ETNKTO3+?$?&[1!>BJ
M#/&.&O&.W.*E3#(2HT0-KD+0%Q5Y,^&+RU'7J)K;9'4VT5?6H^ZPFTP\R["#
M;#4$@ADQ\,;M-'L,$867WSZCUC"X&^D;AYIF!L*;'74# =IN"$4S0['C>#QG
M*,Z4H=;:*WC"] SW7Y<5.*]INRI-IM-]B5;N1OO>Q4%I(13-%!RW@N,#MS4I
MJ="21X)N[!.J&K%[ZZA20D=G9UN]=8:DA5 T4^?6KWE.&[(_?4 LC:I,H_(.
M27BA4L[9FC]0] =-B3I0MU6A#LM<=!;'_/&UR9B[W=YIQ^_.*BV1#D!;#:%H
M9FQ:#^>Y3=QE(3_Q[:>,1]_5Q)<^933-7\GQH-ZMIAG9RRHVJ"^#HIEBMP;.
M<SNXVU3-%S>(%^4]MM8\XKE];N.&]1:\ZYFJ/-91'-2I0=%,Q5M+Y[D]W=GF
MGR)OGE'$>XF(I)MV?HDV!=6%=&IJYD+6N(!Z0*_K[3YY,VP+3+?D_GP>ZM),
MM5N;Z+E]X@5+65(DZ-L%3=946!_,N1&]U8.D!:"T$(IF!J/UIM[BYQ^3>J"^
M%)06@-)"*)H9C=;L>H?<;COG67.AZFMSI3R6?6(#ZFMKFN?O9HZAA^?["0;4
MUT+1S)65UMABM[&]($\'<Y$;T5=F4%H 2@NA:&8P6FN+O9_/11C26ZY :0$H
M+82BF=%H?2]V^]Y^N<@-ZQT6;,U%D\E>+@)M-82BF8*W!AB[#7 XO!ZBFQ\%
M6Z_1.Y)DG]$-3_./Z.OPZW U=*<H4(L+2@M :2$4S8Q1:X3Q!"!%@7I@4%H
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M1P,;[P(>*"Y5:PQ6R42(9SNYS(=>8!-"AIFV#,3<%CA"QBR12>-GS>DUK[3
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M<@=48U MA&H<I>D9:\H=MKG<\1U'\LUBYQ1!&R%0S8-JU-XMR;1=,\N'CAI
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M9R7LQ+[!>]-]AH.?6\]7F,:%)^OZW%G"6;%W:-0!3 J4U/U;/!_NX00PGET
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MDAS>A2@)3<5[^ "?GT-X]^8]O &:PYRFJ7J?8NQ*Y9T>PXTJ3V:E)\$)3_P
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MI,%&P0US;.5 60'<WTIICA-[0-L<)O\ 4$L#!!0    ( )*$;E@4S0.$^@,
M (@4   9    >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;,5848^C-A#^*Q:5
MJCOI;L&0A&2;1-K-MFJE[G6UN>L]5'UP8))8"YC:)MG^^XZ!A9 0VE1$]Q+
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MTM'ZO1FSY;.B&J:8T3TRN>'8NT2P1DCGQL<31A9CK^)!BS2?'*V$UB+.;[?
M0I#& -^O!2:Q?# ;5,/'^3]02P,$%     @ DH1N6!W# E^2!@  VC\  !D
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M*BIX;]_?GF[P@(:Z5E!: *4Q%,WL!K5SY1[%NG*AWA64YD-I 93&4#13[=K
M<NT.5E/M55/MJIJ'N=J*+/JWQ\,XU+Z"TOR*UKS7G-*NMV2HA86BF=+6)I9K
M=[%T#<^X%I9$E?>!D1GJ<4%IOMNVS#S'Z9 9:G.A:.:4AMKGHG:?J]]MN_ZF
M^P:N#[D.OT1)GECOZ?9S&:H^E.9#:0&4QE TLX_4AAEUCW%/IU"_#$KSH;0
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M4P0PI0:I$"@1XA9I$2UB7X$NO "H@[HU"<V/'XYJAEO'#X<:-MUT6KLA7O<
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MZ$85<;I-K4V*';LS8R[1 E=H35XKU8"/(ANP4]W@%"UPA=9DM)(.V*X=/AR
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M/.W\TH%D6],\+9E4K9AYW*AN&;@V4-]7C,G7@9X@[[\G_P)02P,$%     @
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MKU]GY>^N/:@:Z.X@,_\/4$L#!!0    ( )*$;EA0OJ[E?00  ,T8   9
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MJZYGS(E2<]O,6H]8*V[-65;(0R4=":RF'GKE/NM]?@[/QSA20(Z%5H](Q7G
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MXB3F;(^XCE9L>F!J8]#*#:'Z7UQ*KG:)PLGDD::L!/2"#R#NT5<F!%J!.AR
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M=K6M8Z%XPP4M:F=)4&2D^L5/=2):#F[0X^#5#E[78=3CX-<.O@ZT(M-A+;#
MT931'6+*6JJI!YT;[2VCR8C:Q@?!Y-M,^HGHCL2T /2(GX"_17-:E)0 $1S1
M%3J\0_>,;C.]=6<+$#C+^3FZ0%\>%NCL]3EZC3*"'E.ZX9@D?&H+":;D[;B&
MN*T@O!X(UT.?*!$I1^]) LFQ@"TC:L+R]F'=>H.*"X@OD>^^19[C^0:@^;^[
M>P,X?I-E7^OY/7KS#6,RJYU4?K]9<L'D0?YA2EFE.#(KJNJ^YB6.86;)\N7
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MN9S(VXE5/6LU$+34;=^2"ME$ZL=4]OG E(%\OZ)4[ =J@>8_A^@/4$L#!!0
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MEX1K _7[BC'Y,M!OQ^V_(=/_ %!+ P04    " "2A&Y8AZ/C7),%  #)&@
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MCAF [V="Z.V-F: ZO1K_#U!+ P04    " "2A&Y8#11C40@#  ! "   &0
M 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6RM5FUOVC 0_BM65FVMU#600-@Z
M0.*ET_JA$Z+K]F':!Y,<Q*IC9[8#=+]^9R=DE+=5T[X0^WSW^+D7W]%=2?6H
M4P!#UAD7NN>EQN37OJ_C%#*JKV0. D_F4F74X%8M?)TKH(DSRK@?-!J1GU$F
MO'[7R2:JWY6%X4S 1!%=9!E53T/@<M7SFMY&,&6+U%B!W^_F= 'W8![RB<*=
M7Z,D+ .AF11$P;SG#9K7HX[5=PI?&:STUII83V92/MK-;=+S&I80<(B-1:#X
M6<((.+= 2.-GA>G55UK#[?4&_:/S'7V940TCR;^QQ*0][YU'$IC3@INI7'V"
MRI^VQ8LEU^Z7K"K=AD?B0AN95<;((&.B_-)U%8<M@V9TQ""H#()=@]81@[ R
M")VC)3/GUI@:VN\JN2+*:B.:7;C8.&OTA@F;Q7NC\)2AG>G?BEAF0+[0->A+
M\B!B4 9S;P5D(C6SL=;D? PHY?J"O"4/]V-R?G9!SHA52V6AJ4ATUS?(QF+Z
M<77SL+PY.')S,R!W4IA4DQN10/(<P$<W:E^"C2_#X"3B&.(K$C8O2= (P@.$
M1B\W#T[0">O0A@XO/((WA5B*F'%&7<'*.897H6PAV"](7(2'(&#.#$;^9AWS
M(F%B00:9+(319%)FPHJ,Q'.*V:_,IF *A6GY/I6<$RSG%57)CT,I*!FV#C.T
M'>):YS2&GH<M0(-:@M=__:H9-3X<"M]_ GL6S%8=S-8I]/X0%DRX8,PHIUBF
M-IY%7:X&HY)ORO50($KTCD.WG6V)]=?L^LMM__9U&K7&,]+MFG3[).E!DE0/
MR'::A& 5Q(52( QY JK>Z+_S+B^(#G(J6>]KM-J':4<U[>@D[<\X/.*4B@5L
M$<\5D^K%M*,]4D$GV"&^K].)#A/OU,0[)XEC(_GW"NGL93]\'^Y0WM?9KJ*2
ML[_5C#-0"S>C-(GMJRY[62VMQ^# =?\=^1#'8SG-_L"4L_6.*GP-FG"8(V3C
MJH,UH,IY56Z,S%W+GTF# \0M4QSQH*P"GL^E-)N-O:#^T]#_#5!+ P04
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M:0]PZP#W,&!X(L"K [QS X9UP/#<@%$=,#H,&)\(&-<!XW-KF-0!DW,#IG7
MM+J[V]M1W4L_5.'5A<SOB2Q+:UIY4 FBBM:W,,Y*[=XJJ;^-=9RZNEW?%>++
M6F2*!)OR]84O5!@GQ4OR+_+IUB<OOGM)OB-]4BQ#*0H29^13%JOB>WU2'W]<
MYNLBS&;%15_IUI3,?E373+<UNR=J=ESR+L_4LB!!-A,S$]#7E[&[%O?Q6MZZ
M5N)_PNP5<9SOB3MPART-NCDC?' ZW+>'^R+2M8^J<*\E/'BB]G6BPX<GP^D9
MM7O.R7!V?KC;$L[/"!],VVHW[J2W4Z57\;P3O ^B[';C;$'H.IN5[Q]$)'0G
M-R-SF:=$UR?2.R&K^@B-LS"+RE*_7=\52NK^\/>6:WB[K7/87F<Y2+PI5F$D
M+GMZ%"B$W(C>U3__X8P'_V[3$A+F(V$!$D:1,(:$<1#,T.=PI\^AC7[U7N:1
M$+-"C][[LE1+0:(\VPBIXKM$D"Q7NLN</\JSK9-\:ZVHJRB1,'\+FU2P,@7:
M7$TFT^E%?[,OMN-"TXDS,@O1XT+.>#3PS%+LN-3 +,%!EV?<\M'NEH^LM_R7
M4,HP4P7Y[5W5]?Q._B!'@^?C=VTWVHKO>J.1,!\)"Y PBH0Q)(R#8(84QSLI
MCK_!Z#A&ZA,)\Y&P  FC2!A#PC@(9NASLM/GY+RN4N5DM9;14L\M];B8IGJN
M6D\C7L2/AR_;M+CEC_<'C-&@_#,'A!MK.[K*# D+D#"*A#$DC(-@ALRF.YE-
MK3*[V<NT?JPR+=OP:V5U[=Z0,!\)"Y PBH0Q)(R#8(;N7N]T]_H;#+^OD?I$
MPGPD+$#"*!+&D# .@AGZ= ;-FM[ VC->+Q92+$(ER$K&6GRK,"%AFJ\SU:8\
M.ZRK]* T'TH+H#0*I3$HC=>TR4$&M4N?3&'M+18[5F$%7U>Q#"O38:;EU:HF
M*Z&SFI T'TH+H#3ZQ'^^6IRNEEA/+4\S:'LXBF8JS6V4YEJOUQQ$NZ5Z=G1G
M"2)I/I060&D42F-0&D?13#DV?H3S+0P)!^I(0&D^E!9 :11*8U :1]%,H3;&
MA/.W.1/VFCJK$^I-.,=F@3<]=!0":)T42F-0&D?13-4UWHAC-T?.':V[>B;V
M:CM+$.J:0&D!E$:A- :E<13-E&KCG3C?PCQQH.X)E.9#:0&41J$T!J5Q%,T4
M:F.B.'87!3F23XY7 X9'9HJ]/9U5![53H#0*I3$HC:-HINH:3\6QFRH=EPZG
M9PD+:I= :0&41J$T!J5Q%,T45F.:.-8U[[.6#NV$W>.=Y=#\NG7<A/H>4%H
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MA !&%P-DK^8\@.PAD+TS0BZ6\./3> J LQLVFX_O L@8@8PO!KE8SH8!9()
M)A>#' X6'P/(%(%,:2%GYIXK^:M^4(_ND;"YD;OZ6F\"R R!S&@A;^7W2JY]
MT/&$0[Z3$'[9G;"Z,KFP 60?@>S30G[@5EJH,C;(<UU!C%3W;&Z$A;_R+P>0
M;Q#(-[20 VNAY$$.]6GE\]!]A<7N*^+! DHUX#_V*-V6#2OK="E,2(>:A5@M
MD$"4TEIM?K(II!+[;JC5@U=^3?('$_-+EU@P@+D#I/TP&4,;[_P?A'286+K$
M9KD5W#8&:Q<S2)=8(3=<&O:9%Y7P8_9&*JYR"5%EHJPS51EB8@[I$DOD'ZW7
MC[(HZB:=J-?0Q!#QK ]^@IL\Q,0LTB76R)V_*=9LSGWW6QJN+*\3[D9[8PKI
M$CL$HK*I@'#\ PIYU@\Q:W2)M3'492F=?\D>PHI7AX#>V(3$K-$EUH9W6[Y/
M#V11^8:>PG^ZU= 1(>"P,+W&)!(12V3A=/[M-< *7X^E;^CG\Y,(TTA$K!$?
MDI^B\Q=N8)"XL(4C=&I"K(Z)RD&X;,E_-'I=A DC(A;&HEI9\;WR\\[Q0U-D
M$::.B%@=H BYAFX/86[ML[R!;\I[48_AD!'S1D3L#30;_1J%F)@W(F)OO,A'
MV:LE!P3[5TB(>2,B]@::^C4K$M-(1*R1XZG?T=K$1!(1BV2? Q[#ZF'BZ!&+
M TT&&XW<P_S1(_;'\QSF:#UB%ND16P3-$YKUB"YQ48OE1)[P5)\A)N:9'K%G
MCJ0+1UL<\TR/V#-AWG 4#K-+[Y*+6\WNB"FF=\GEK28FIIC>)1>XOO9"3$PQ
MO3/,54YCQN$"-J:<F%@Y.&828F+*B8F5@V.F(28FGIA8/"_RR#9;5&7)(6OS
M["$F)IZ86#Q','^G'O!VB(GNKA"+!\,4[%.(B;DGIMY@.;IFS%Z-A..R"*=B
M,6:AF-A"^ PBC)LQ9J'XHA.=1MS$+!333W00S$;<Q"P4$UL(QPSC9H)9*"&V
MT*EIX\LAE& 62H@MM)\VMMD,8'GMH/K.@3/$Q"R4$%OH@.DG/<]18<X68F(6
M2LZR$?.R-N_D_=:]#G<J$\Q"";&%#IB?N*L,:$C4><AOZ! 3W>4GMM ?3+7E
MSG$%F0<0'+IGB(E9*"&V$+[$$5HHP2R4$%L(QPPME& 62H@MA&.&%DHP"R7$
M%D)W#QLSRQ2S4$ILH=.[A\^'4(I9*#W[\MN3)L,%CQ034$I]P@S;3&R'^W0I
M)J"4^HP9AMGLEIB 4NI39BAF&#)33$#I&;9Z3B^Z-C#1@V;$ L(QP\B>8@)*
MB05T:FVX7:?'C5B$"2@E%M!IS"\"TK@0$Q-02BR@TYCUD_!X(2:@[$('!YY6
MD4),3$ 9L8!.8X+077A:+L,LE!%;Z#3FM"I7X?9*AEDHN] N4-TW&Q;*, ME
MY]\%:K.YD0_ P^;AW#?#+)016^@H9KWT45^&F)B%,F(+'<5<C.>#?3(78J('
MGHDM=!1S6)65?_>A,80P"V7$%@IW_]I[EZ\$E"18_23$Q"R4$5NHB>G'NE9U
M5@=S-W@68/8Q"_6)+=3$'(F-, 9B$UPSOR(?8F(6ZA-;J(EY)W(-"7$A^<NO
M#/0Q"_7/>**MS?Y5N3 P65-U=<YUXTL#F(7Z9S[D=G12V<<$U*\%U*E?MN_?
MK<5&*K&>0ND6[N>\R.>&^1^^I&X4)_XHZ:8JBB'<FZE;S=>'+Y4=OA#W_C]0
M2P,$%     @ DH1N6),QO/V  @  DS$  !H   !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<\W:36ZC0!"&X:M8'"#MKNJJ[HSBK&:3[2@70$[[1[&-!8PF
MN?U8SL+^T"QF$_&M4(,HW@5ZA("G7_70COON-.SVYV'Q<3R<AE6S&\?SCQ"&
M]:X>V^&A.]?3Y<BFZX_M>%GVVW!NU^_MM@99+CWT]S.:YZ?[F8O7SW/]GXG=
M9K-?UY_=^O>QGL9_# Y_NOY]V-4Z-HO7MM_6<=6$C\-M]Q"NF_APF=PL7MY6
M3?_R%ILP=Y! D,P?I!"D\P<E"$KS!QD$V?Q!#D$^?U"&H#Q_4(&@,G_0(P0]
MSA\4ERCCDB!I@C6!UA&YC@1>1P0[$H@=D>Q(8'9$M".!VA'9C@1N1X0[$L@=
MD>Y(8'=$O".!WH)Z"X'>@GH+@=XR>=@FT%M0;R'06U!O(=!;4&\AT%M0;R'0
M6U!O(=!;4&\AT%M0;R'06U%O)=!;46\ET%M1;R706R<O2PCT5M1;"?16U%L)
M]%;46PGT5M1;"?16U%L)]%;46PGT3JAW(M [H=Z)0.^$>B<"O1/JG0CT3I.7
MW01Z)]0[$>B=4.]$H'="O1.!W@GU3@1Z)]0[$>AMJ+<1Z&VHMQ'H;:BW$>AM
MJ+<1Z&VHMQ'H;9./E01Z&^IM!'H;ZFT$>AOJ;01Z&^IM!'H[ZNT$>COJ[01Z
M.^KM!'H[ZNT$>COJ[01Z.^KM!'K[Y&<3 KT=]78"O1WU=@*]'?5V KTSZIT)
M],ZH=R;0.Z/>F4#OC'IG KTSZIT)],ZH=R;0.Z/>F4#O//E9D$#OC'IG KTS
MZIT)]"ZH=R'0NZ#>A4#O@GH7 KT+ZET(]"ZH=_E.O8?Q\U"'6\_7&J__G52/
MEW/K[?+7Y=?.R=U[Q3G<5PS/?P%02P,$%     @ DH1N6/<P)@8G @  ,C
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M;5!D;5!D;5!D;5!D;?ZGK#^\/_SC^.59CZZ?GO/9\E>!FU]02P$"% ,4
M" "2A&Y8!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( )*$;ECTWJ<)[@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )*$;EB97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ DH1N6.%'GRJJ!P  &S(  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( )*$;E@2S KD
M( <  +XB   8              " @>T/  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    " "2A&Y85]ICQ!$#   #"P  &
M@(%#%P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ DH1N
M6,F4Q&?T!0  6A@  !@              ("!BAH  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( )*$;E@P#]K@)0@  !0Y   8
M      " @;0@  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M" "2A&Y82"AW[O(+   O.P  &               @($/*0  >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ DH1N6!O49[3Z P  9@D  !@
M             ("!-S4  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( )*$;EAL<D6OP@<  !X3   8              " @6<Y  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "2A&Y8\1NSD,0A  #9
M:@  &               @(%?00  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ DH1N6%'"T.,["0  ,1D  !D              ("!66,
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " "2A&Y8J+GD
ML]0'  !I%   &0              @('+;   >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( )*$;EAXY5.O_ P  ,(F   9
M  " @=9T  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
MDH1N6#B"G)5< P  7@<  !D              ("!"8(  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    " "2A&Y88C/:L"8.  #G)P  &0
M            @(&<A0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( )*$;E@?=+8 #P<  &43   9              " @?F3  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ DH1N6(L*63FQ!0
M@ T  !D              ("!/YL  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    " "2A&Y8[8$,1C42  #!.@  &0              @($G
MH0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( )*$;EC=
MX55ZNP(  .T%   9              " @9.S  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ DH1N6'R[8%)T$@  \3,  !D
M     ("!A;8  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )*$;EA)/BCBP00  +,+   9              "
M@9/X  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ DH1N
M6,&K>(I# @  D 8  !D              ("!B_T  'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    " "2A&Y8%=AW9/DB   '=   &0
M        @($%  $ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( )*$;E@%&$;_+0,  %('   9              " @34C 0!X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ DH1N6%1[2NU3!@  B!
M !D              ("!F28! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    " "2A&Y8&)B#]] "   >!@  &0              @($C+0$
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( )*$;EA=WJ/3
M_ 0  ,X-   9              " @2HP 0!X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ DH1N6.=1V&0=!   E0H  !D
M ("!734! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " "2
MA&Y85E6Z1;\"  #A!0  &0              @(&Q.0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( )*$;EA VTCJ!00  ,X)   9
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M970S-RYX;6Q02P$"% ,4    " "2A&Y8GZ"W8; '   X3P  &0
M    @(%D4@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M )*$;EA3(-=T?@(  %8'   9              " @4M: 0!X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ DH1N6)(O(52; @  $0D  !D
M             ("! %T! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    " "2A&Y89B)ZI-$"   E"   &0              @('27P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( )*$;E@P[$^30 (
M .P$   9              " @=IB 0!X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ DH1N6%.TLUT:!0  \!L  !D              ("!
M464! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " "2A&Y8
MMMOVJ<\#  !]%   &0              @(&B:@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( )*$;EAQGG",D0,  &8/   9
M      " @:AN 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%
M  @ DH1N6+GP/B>" P  K T  !D              ("!<'(! 'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "2A&Y8;/M@2Y0,  "=K0
M&0              @($I=@$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+
M 0(4 Q0    ( )*$;EC;35 OM08  /TY   9              " @?2" 0!X
M;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ DH1N6&0(H3"B
M"0  D7L  !D              ("!X(D! 'AL+W=O<FMS:&5E=',O<VAE970T
M.2YX;6Q02P$"% ,4    " "2A&Y8%U5:?',&  "V-0  &0
M@(&YDP$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( )*$
M;E@QHQQE6P0  .T4   9              " @6.: 0!X;"]W;W)K<VAE971S
M+W-H965T-3$N>&UL4$L! A0#%     @ DH1N6+6E$JF=!P  6#L  !D
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M 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " "2A&Y8=&]
M97T#  "'#@  &0              @($JL@$ >&PO=V]R:W-H965T<R]S:&5E
M=#4V+GAM;%!+ 0(4 Q0    ( )*$;EC\@/Q;PP(   4)   9
M  " @=ZU 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @
MDH1N6/F(6I?6"   ]%T  !D              ("!V+@! 'AL+W=O<FMS:&5E
M=',O<VAE970U."YX;6Q02P$"% ,4    " "2A&Y8IJ:*\W$$  !5'0  &0
M            @('EP0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4
M Q0    ( )*$;EB$6(,#Y0(  +@)   9              " @8W& 0!X;"]W
M;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ DH1N6$'LU^_X"P
M_)L  !D              ("!J<D! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX
M;6Q02P$"% ,4    " "2A&Y8UI%R9_T"  !!"0  &0              @('8
MU0$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( )*$;EC%
MH?T>B (  )0&   9              " @0S9 0!X;"]W;W)K<VAE971S+W-H
M965T-C,N>&UL4$L! A0#%     @ DH1N6+&],4,P @  V00  !D
M     ("!R]L! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )*$;E@WEUYVYP(  $@(   9              "
M@>[P 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ DH1N
M6$"+AL X!0  >QL  !D              ("!#/0! 'AL+W=O<FMS:&5E=',O
M<VAE970W,"YX;6Q02P$"% ,4    " "2A&Y8);Z?H>X$   /'P  &0
M        @(%[^0$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0
M   ( )*$;EB"$/JFSP,  (L/   9              " @:#^ 0!X;"]W;W)K
M<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ DH1N6,P/0P(! P  G H
M !D              ("!I@(" 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q0
M2P$"% ,4    " "2A&Y8N\SW8OT"  !0"P  &0              @('>!0(
M>&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( )*$;EA5<A H
M. H  %9Y   9              " @1() @!X;"]W;W)K<VAE971S+W-H965T
M-S4N>&UL4$L! A0#%     @ DH1N6%9P99\<!P  348  !D
M ("!@1," 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " "2
MA&Y84+ZNY7T$  #-&   &0              @('4&@( >&PO=V]R:W-H965T
M<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( )*$;EB#; ^CC00   X7   9
M          " @8@? @!X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#
M%     @ DH1N6#5Z8TZ1 @  [P8  !D              ("!3"0" 'AL+W=O
M<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    " "2A&Y8+Q26N7,#  !%
M#   &0              @($4)P( >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM
M;%!+ 0(4 Q0    ( )*$;EA4?W'^= 0  !D1   9              " @;XJ
M @!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ DH1N6(>C
MXUR3!0  R1H  !D              ("!:2\" 'AL+W=O<FMS:&5E=',O<VAE
M970X,BYX;6Q02P$"% ,4    " "2A&Y8#11C40@#  ! "   &0
M    @($S-0( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    (
M )*$;EA(E")U8 @  .1:   9              " @7(X @!X;"]W;W)K<VAE
M971S+W-H965T.#0N>&UL4$L! A0#%     @ DH1N6,;$75UG P  E1<   T
M             ( !"4$" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "2A&Y8
MEXJ[',     3 @  "P              @ &;1 ( 7W)E;',O+G)E;'-02P$"
M% ,4    " "2A&Y86*M(,W@&  "4-P  #P              @ &$10( >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ DH1N6),QO/V  @  DS$  !H
M         ( !*4P" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ DH1N6/<P)@8G @  ,C   !,              ( !X4X" %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     %P 7  [&0  .5$"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>266</ContextCount>
  <ElementCount>513</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>83</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - Organization and Description of Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations</Role>
      <ShortName>Organization and Description of Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - Liquidity and Capital Resources</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LiquidityAndCapitalResources</Role>
      <ShortName>Liquidity and Capital Resources</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - Asset Acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AssetAcquisition</Role>
      <ShortName>Asset Acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - Contract with Customer</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ContractWithCustomer</Role>
      <ShortName>Contract with Customer</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - Promissory Note and Convertible Note Financings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings</Role>
      <ShortName>Promissory Note and Convertible Note Financings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>061000 - Disclosure - Goodwill and In-Process Research &amp; Development</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment</Role>
      <ShortName>Goodwill and In-Process Research &amp; Development</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>061100 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>061200 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>061300 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>061400 - Disclosure - Basic and Diluted Net Loss per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare</Role>
      <ShortName>Basic and Diluted Net Loss per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>061500 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>061600 - Disclosure - Equity and Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrants</Role>
      <ShortName>Equity and Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>061700 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>061800 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>061900 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>070300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>080400 - Disclosure - Asset Acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AssetAcquisitionTables</Role>
      <ShortName>Asset Acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/AssetAcquisition</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>080600 - Disclosure - Promissory Note and Convertible Note Financings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables</Role>
      <ShortName>Promissory Note and Convertible Note Financings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>080700 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/PropertyAndEquipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>080800 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>080900 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/FairValueOfFinancialInstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>081200 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/AccruedExpenses</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>081400 - Disclosure - Basic and Diluted Net Loss per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables</Role>
      <ShortName>Basic and Diluted Net Loss per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>081500 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/StockbasedCompensation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>081600 - Disclosure - Equity and Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsTables</Role>
      <ShortName>Equity and Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/EquityAndWarrants</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>081700 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://eternatx.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>090100 - Disclosure - Organization and Description of Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails</Role>
      <ShortName>Organization and Description of Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>090200 - Disclosure - Liquidity and Capital Resources (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LiquidityAndCapitalResourcesDetails</Role>
      <ShortName>Liquidity and Capital Resources (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/LiquidityAndCapitalResources</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>090304 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>090306 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>090308 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>090310 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails</Role>
      <ShortName>Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>090400 - Disclosure - Asset Acquisition, Summary of Asset Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails</Role>
      <ShortName>Asset Acquisition, Summary of Asset Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>090402 - Disclosure - Asset Acquisition, Fair Valuation of Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails</Role>
      <ShortName>Asset Acquisition, Fair Valuation of Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>090404 - Disclosure - Asset Acquisition, Fair Value Measurement of Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails</Role>
      <ShortName>Asset Acquisition, Fair Value Measurement of Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>090500 - Disclosure - Contract with Customer (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/ContractWithCustomerDetails</Role>
      <ShortName>Contract with Customer (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/ContractWithCustomer</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>090600 - Disclosure - Promissory Note and Convertible Note Financings, Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails</Role>
      <ShortName>Promissory Note and Convertible Note Financings, Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>090602 - Disclosure - Promissory Note and Convertible Note Financings, Based on Relative Fair Value Allocation of Proceeds and Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails</Role>
      <ShortName>Promissory Note and Convertible Note Financings, Based on Relative Fair Value Allocation of Proceeds and Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>090604 - Disclosure - Promissory Note and Convertible Note Financings, Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails</Role>
      <ShortName>Promissory Note and Convertible Note Financings, Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>090606 - Disclosure - Promissory Note and Convertible Note Financings, Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails</Role>
      <ShortName>Promissory Note and Convertible Note Financings, Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>090700 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>090800 - Disclosure - Leases, Operating Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesOperatingLeaseDetails</Role>
      <ShortName>Leases, Operating Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>090802 - Disclosure - Leases, Net Operating Lease Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails</Role>
      <ShortName>Leases, Net Operating Lease Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>090804 - Disclosure - Leases, Operating Lease Right-of-use Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails</Role>
      <ShortName>Leases, Operating Lease Right-of-use Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>090806 - Disclosure - Leases, Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases, Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>090808 - Disclosure - Leases, Manhattan Sublease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/LeasesManhattanSubleaseDetails</Role>
      <ShortName>Leases, Manhattan Sublease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>090900 - Disclosure - Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails</Role>
      <ShortName>Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>090902 - Disclosure - Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails</Role>
      <ShortName>Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>090904 - Disclosure - Fair Value of Financial Instruments, Carrying Value and Fair Value of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails</Role>
      <ShortName>Fair Value of Financial Instruments, Carrying Value and Fair Value of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>091000 - Disclosure - Goodwill and In-Process Research &amp; Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails</Role>
      <ShortName>Goodwill and In-Process Research &amp; Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>091100 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/RelatedPartyTransactions</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>091200 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/AccruedExpensesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>091300 - Disclosure - Commitments and Contingencies, Legal Matters (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails</Role>
      <ShortName>Commitments and Contingencies, Legal Matters (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>091302 - Disclosure - Commitments and Contingencies, Licensing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails</Role>
      <ShortName>Commitments and Contingencies, Licensing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>091308 - Disclosure - Commitments and Contingencies, Retirement Savings Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails</Role>
      <ShortName>Commitments and Contingencies, Retirement Savings Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>091400 - Disclosure - Basic and Diluted Net Loss per Common Share, Computation of Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Common Share, Computation of Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>091402 - Disclosure - Basic and Diluted Net Loss per Common Share, Securities Excluded from Calculation of Diluted Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Common Share, Securities Excluded from Calculation of Diluted Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>091500 - Disclosure - Stock-Based Compensation, Equity Incentive Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails</Role>
      <ShortName>Stock-Based Compensation, Equity Incentive Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>091502 - Disclosure - Stock-Based Compensation, Weighted-Average Assumptions Used for Stock Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails</Role>
      <ShortName>Stock-Based Compensation, Weighted-Average Assumptions Used for Stock Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>091504 - Disclosure - Stock-Based Compensation, Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation, Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>091506 - Disclosure - Stock-Based Compensation, Summary of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation, Summary of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>091508 - Disclosure - Stock-Based Compensation, Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails</Role>
      <ShortName>Stock-Based Compensation, Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>091510 - Disclosure - Stock-Based Compensation, Number of RSUs Vested and Settled (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails</Role>
      <ShortName>Stock-Based Compensation, Number of RSUs Vested and Settled (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>091514 - Disclosure - Stock-Based Compensation, Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation, Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>091600 - Disclosure - Equity and Warrants, Private Placement of Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails</Role>
      <ShortName>Equity and Warrants, Private Placement of Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>091602 - Disclosure - Equity and Warrants, Note Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails</Role>
      <ShortName>Equity and Warrants, Note Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>091610 - Disclosure - Equity and Warrants, SEPA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsSepaDetails</Role>
      <ShortName>Equity and Warrants, SEPA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>091612 - Disclosure - Equity and Warrants, Cumulative Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails</Role>
      <ShortName>Equity and Warrants, Cumulative Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>091700 - Disclosure - Income Taxes, Loss before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes, Loss before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>091702 - Disclosure - Income Taxes, Components of Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes, Components of Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>091704 - Disclosure - Income Taxes, Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes, Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>091706 - Disclosure - Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails</Role>
      <ShortName>Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>091708 - Disclosure - Income Taxes, Uncertain Tax Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails</Role>
      <ShortName>Income Taxes, Uncertain Tax Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ef20015352_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>091800 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://eternatx.com/role/SubsequentEvent</ParentRole>
      <Position>84</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="ef20015352_10k.htm">ef20015352_10k.htm</File>
    <File>erna-20231231.xsd</File>
    <File>erna-20231231_cal.xml</File>
    <File>erna-20231231_def.xml</File>
    <File>erna-20231231_lab.xml</File>
    <File>erna-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image00007.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="811">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>113
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20015352_10k.htm": {
   "nsprefix": "erna",
   "nsuri": "http://eternatx.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "ef20015352_10k.htm"
     ]
    },
    "schema": {
     "local": [
      "erna-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "erna-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "erna-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "erna-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "erna-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 371,
   "keyCustom": 142,
   "axisStandard": 28,
   "axisCustom": 0,
   "memberStandard": 43,
   "memberCustom": 32,
   "hidden": {
    "total": 13,
    "http://xbrl.sec.gov/dei/2023": 7,
    "http://fasb.org/us-gaap/2023": 4,
    "http://eternatx.com/20231231": 2
   },
   "contextCount": 266,
   "entityCount": 1,
   "segmentCount": 83,
   "elementCount": 797,
   "unitCount": 9,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 811,
    "http://xbrl.sec.gov/dei/2023": 37,
    "http://xbrl.sec.gov/ecd/2023": 4
   },
   "report": {
    "R1": {
     "role": "http://eternatx.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://eternatx.com/role/ConsolidatedBalanceSheets",
     "longName": "010000 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:Cash",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U003",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U003",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
     "longName": "020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:Revenues",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:Revenues",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
     "longName": "030000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations",
     "longName": "060100 - Disclosure - Organization and Description of Business Operations",
     "shortName": "Organization and Description of Business Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://eternatx.com/role/LiquidityAndCapitalResources",
     "longName": "060200 - Disclosure - Liquidity and Capital Resources",
     "shortName": "Liquidity and Capital Resources",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:LiquidityAndCapitalResourcesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:LiquidityAndCapitalResourcesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies",
     "longName": "060300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://eternatx.com/role/AssetAcquisition",
     "longName": "060400 - Disclosure - Asset Acquisition",
     "shortName": "Asset Acquisition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:AssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:AssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://eternatx.com/role/ContractWithCustomer",
     "longName": "060500 - Disclosure - Contract with Customer",
     "shortName": "Contract with Customer",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings",
     "longName": "060600 - Disclosure - Promissory Note and Convertible Note Financings",
     "shortName": "Promissory Note and Convertible Note Financings",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://eternatx.com/role/PropertyAndEquipment",
     "longName": "060700 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://eternatx.com/role/Leases",
     "longName": "060800 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://eternatx.com/role/FairValueOfFinancialInstruments",
     "longName": "060900 - Disclosure - Fair Value of Financial Instruments",
     "shortName": "Fair Value of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment",
     "longName": "061000 - Disclosure - Goodwill and In-Process Research & Development",
     "shortName": "Goodwill and In-Process Research & Development",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://eternatx.com/role/RelatedPartyTransactions",
     "longName": "061100 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://eternatx.com/role/AccruedExpenses",
     "longName": "061200 - Disclosure - Accrued Expenses",
     "shortName": "Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://eternatx.com/role/CommitmentsAndContingencies",
     "longName": "061300 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare",
     "longName": "061400 - Disclosure - Basic and Diluted Net Loss per Common Share",
     "shortName": "Basic and Diluted Net Loss per Common Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://eternatx.com/role/StockbasedCompensation",
     "longName": "061500 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://eternatx.com/role/EquityAndWarrants",
     "longName": "061600 - Disclosure - Equity and Warrants",
     "shortName": "Equity and Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://eternatx.com/role/IncomeTaxes",
     "longName": "061700 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://eternatx.com/role/SubsequentEvent",
     "longName": "061800 - Disclosure - Subsequent Event",
     "shortName": "Subsequent Event",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://eternatx.com/role/InsiderTradingArrangements",
     "longName": "061900 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c20231001to20231231",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231001to20231231",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "070300 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://eternatx.com/role/AssetAcquisitionTables",
     "longName": "080400 - Disclosure - Asset Acquisition (Tables)",
     "shortName": "Asset Acquisition (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables",
     "longName": "080600 - Disclosure - Promissory Note and Convertible Note Financings (Tables)",
     "shortName": "Promissory Note and Convertible Note Financings (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://eternatx.com/role/PropertyAndEquipmentTables",
     "longName": "080700 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://eternatx.com/role/LeasesTables",
     "longName": "080800 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://eternatx.com/role/FairValueOfFinancialInstrumentsTables",
     "longName": "080900 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://eternatx.com/role/AccruedExpensesTables",
     "longName": "081200 - Disclosure - Accrued Expenses (Tables)",
     "shortName": "Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables",
     "longName": "081400 - Disclosure - Basic and Diluted Net Loss per Common Share (Tables)",
     "shortName": "Basic and Diluted Net Loss per Common Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://eternatx.com/role/StockbasedCompensationTables",
     "longName": "081500 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://eternatx.com/role/EquityAndWarrantsTables",
     "longName": "081600 - Disclosure - Equity and Warrants (Tables)",
     "shortName": "Equity and Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://eternatx.com/role/IncomeTaxesTables",
     "longName": "081700 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails",
     "longName": "090100 - Disclosure - Organization and Description of Business Operations (Details)",
     "shortName": "Organization and Description of Business Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:NumberOfInLicensedPortfolioPatents",
      "unitRef": "U004",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:NumberOfInLicensedPortfolioPatents",
      "unitRef": "U004",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
     "longName": "090200 - Disclosure - Liquidity and Capital Resources (Details)",
     "shortName": "Liquidity and Capital Resources (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:Cash",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230701to20231231_ShortTermDebtTypeAxis_ConvertibleDebtMember",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails",
     "longName": "090304 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Cash, Cash Equivalents and Restricted Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
     "longName": "090306 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c20231231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails",
     "longName": "090308 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Revenue Recognition (Details)",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Revenue Recognition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:NumberOfRevenueGeneratingContracts",
      "unitRef": "U006",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:NumberOfRevenueGeneratingContracts",
      "unitRef": "U006",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails",
     "longName": "090310 - Disclosure - Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)",
     "shortName": "Basis of Accounting Presentation and Summary of Significant Accounting Policies, Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "U007",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "U007",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails",
     "longName": "090400 - Disclosure - Asset Acquisition, Summary of Asset Acquisition (Details)",
     "shortName": "Asset Acquisition, Summary of Asset Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
     "longName": "090402 - Disclosure - Asset Acquisition, Fair Valuation of Assumptions (Details)",
     "shortName": "Asset Acquisition, Fair Valuation of Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c20230426_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230426_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails",
     "longName": "090404 - Disclosure - Asset Acquisition, Fair Value Measurement of Assets Acquired (Details)",
     "shortName": "Asset Acquisition, Fair Value Measurement of Assets Acquired (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:ResearchAndDevelopmentInProcessAssetAcquisition",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230430",
      "name": "erna:AllocatedPercentageOfFairValueConsiderationToPurchasedLicense",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://eternatx.com/role/ContractWithCustomerDetails",
     "longName": "090500 - Disclosure - Contract with Customer (Details)",
     "shortName": "Contract with Customer (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c20230221to20230221",
      "name": "erna:ProceedsFromOptionAndLicenseAgreement",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230221to20230221",
      "name": "erna:ProceedsFromOptionAndLicenseAgreement",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
     "longName": "090600 - Disclosure - Promissory Note and Convertible Note Financings, Summary (Details)",
     "shortName": "Promissory Note and Convertible Note Financings, Summary (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:ConvertibleLongTermNotesPayable",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "erna:EffectOfReductionOfExercisePriceOfWarrants",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
     "longName": "090602 - Disclosure - Promissory Note and Convertible Note Financings, Based on Relative Fair Value Allocation of Proceeds and Costs (Details)",
     "shortName": "Promissory Note and Convertible Note Financings, Based on Relative Fair Value Allocation of Proceeds and Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c20231215",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231215",
      "name": "erna:AllocationPercentageOfFairValue",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
     "longName": "090604 - Disclosure - Promissory Note and Convertible Note Financings, Fair Value Assumptions (Details)",
     "shortName": "Promissory Note and Convertible Note Financings, Fair Value Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c20230426_MeasurementInputTypeAxis_MeasurementInputSharePriceMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember",
      "name": "us-gaap:LongTermDebtMeasurementInput",
      "unitRef": "U003",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails",
     "longName": "090606 - Disclosure - Promissory Note and Convertible Note Financings, Convertible Notes (Details)",
     "shortName": "Promissory Note and Convertible Note Financings, Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c20231215to20231215",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://eternatx.com/role/PropertyAndEquipmentDetails",
     "longName": "090700 - Disclosure - Property and Equipment (Details)",
     "shortName": "Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://eternatx.com/role/LeasesOperatingLeaseDetails",
     "longName": "090800 - Disclosure - Leases, Operating Lease (Details)",
     "shortName": "Leases, Operating Lease (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c20220331",
      "name": "erna:LesseeCommitmentToPurchaseProperty",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20220331",
      "name": "erna:LesseeCommitmentToPurchaseProperty",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails",
     "longName": "090802 - Disclosure - Leases, Net Operating Lease Expenses (Details)",
     "shortName": "Leases, Net Operating Lease Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails",
     "longName": "090804 - Disclosure - Leases, Operating Lease Right-of-use Assets and Liabilities (Details)",
     "shortName": "Leases, Operating Lease Right-of-use Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c20221231",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:AdjustmentToRemeasurementOfOperatingLeaseROUAssets",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
     "longName": "090806 - Disclosure - Leases, Maturities of Operating Lease Liabilities (Details)",
     "shortName": "Leases, Maturities of Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://eternatx.com/role/LeasesManhattanSubleaseDetails",
     "longName": "090808 - Disclosure - Leases, Manhattan Sublease (Details)",
     "shortName": "Leases, Manhattan Sublease (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c20190418",
      "name": "erna:AreaOfSubleaseSpaceCurrentlyRented",
      "unitRef": "U005",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20190418",
      "name": "erna:AreaOfSubleaseSpaceCurrentlyRented",
      "unitRef": "U005",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
     "longName": "090900 - Disclosure - Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)",
     "shortName": "Fair Value of Financial Instruments, Liabilities Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c20231231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
     "longName": "090902 - Disclosure - Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)",
     "shortName": "Fair Value of Financial Instruments, Changes in Warrant Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c20230101to20230630",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20230630",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
     "longName": "090904 - Disclosure - Fair Value of Financial Instruments, Carrying Value and Fair Value of Convertible Notes (Details)",
     "shortName": "Fair Value of Financial Instruments, Carrying Value and Fair Value of Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c20231215",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputSharePriceMember",
      "name": "erna:ConvertibleDebtMeasurementInput",
      "unitRef": "U003",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails",
     "longName": "091000 - Disclosure - Goodwill and In-Process Research & Development (Details)",
     "shortName": "Goodwill and In-Process Research & Development (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:Goodwill",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://eternatx.com/role/RelatedPartyTransactionsDetails",
     "longName": "091100 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c20230219to20230220",
      "name": "erna:RelatedPartyTransactionPeriodicFeesPaymentAmount",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230219to20230220",
      "name": "erna:RelatedPartyTransactionPeriodicFeesPaymentAmount",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://eternatx.com/role/AccruedExpensesDetails",
     "longName": "091200 - Disclosure - Accrued Expenses (Details)",
     "shortName": "Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "erna:AccruedLegalFeesAndRelatedCurrent",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "erna:AccruedLegalFeesAndRelatedCurrent",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
     "longName": "091300 - Disclosure - Commitments and Contingencies, Legal Matters (Details)",
     "shortName": "Commitments and Contingencies, Legal Matters (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c20221231",
      "name": "erna:LitigationSettlementAmountPayable",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20221231",
      "name": "erna:LitigationSettlementAmountPayable",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
     "longName": "091302 - Disclosure - Commitments and Contingencies, Licensing Agreements (Details)",
     "shortName": "Commitments and Contingencies, Licensing Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:NoticePeriodToAssumeControlPatents",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "erna:NoticePeriodToAssumeControlPatents",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
     "longName": "091308 - Disclosure - Commitments and Contingencies, Retirement Savings Plan (Details)",
     "shortName": "Commitments and Contingencies, Retirement Savings Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c20220101to20221231_RangeAxis_MaximumMember",
      "name": "erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20220101to20221231_RangeAxis_MaximumMember",
      "name": "erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails",
     "longName": "091400 - Disclosure - Basic and Diluted Net Loss per Common Share, Computation of Net Loss per Share (Details)",
     "shortName": "Basic and Diluted Net Loss per Common Share, Computation of Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R67": {
     "role": "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails",
     "longName": "091402 - Disclosure - Basic and Diluted Net Loss per Common Share, Securities Excluded from Calculation of Diluted Net Loss per Share (Details)",
     "shortName": "Basic and Diluted Net Loss per Common Share, Securities Excluded from Calculation of Diluted Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
     "longName": "091500 - Disclosure - Stock-Based Compensation, Equity Incentive Plans (Details)",
     "shortName": "Stock-Based Compensation, Equity Incentive Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c20231231_AwardTypeAxis_EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231_PlanNameAxis_EquityIncentivePlan2020Member",
      "name": "erna:PercentageOfSharesOfCommonStockOutstanding",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails",
     "longName": "091502 - Disclosure - Stock-Based Compensation, Weighted-Average Assumptions Used for Stock Options Granted (Details)",
     "shortName": "Stock-Based Compensation, Weighted-Average Assumptions Used for Stock Options Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
     "longName": "091504 - Disclosure - Stock-Based Compensation, Stock Option Activity (Details)",
     "shortName": "Stock-Based Compensation, Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c20221231_AwardTypeAxis_EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
     "longName": "091506 - Disclosure - Stock-Based Compensation, Summary of Stock Options (Details)",
     "shortName": "Stock-Based Compensation, Summary of Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "U003",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails",
     "longName": "091508 - Disclosure - Stock-Based Compensation, Restricted Stock Units (Details)",
     "shortName": "Stock-Based Compensation, Restricted Stock Units (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
     "longName": "091510 - Disclosure - Stock-Based Compensation, Number of RSUs Vested and Settled (Details)",
     "shortName": "Stock-Based Compensation, Number of RSUs Vested and Settled (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "name": "erna:RestrictedStockUnitesWithheldToCoverTaxes",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
     "longName": "091514 - Disclosure - Stock-Based Compensation, Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation, Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
     "longName": "091600 - Disclosure - Equity and Warrants, Private Placement of Equity (Details)",
     "shortName": "Equity and Warrants, Private Placement of Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c20231231_ClassOfWarrantOrRightAxis_WarrantMember",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "U003",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20220712to20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
     "longName": "091602 - Disclosure - Equity and Warrants, Note Warrants (Details)",
     "shortName": "Equity and Warrants, Note Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c20221231",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20221231",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
     "longName": "091610 - Disclosure - Equity and Warrants, SEPA (Details)",
     "shortName": "Equity and Warrants, SEPA (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c20230101to20231231_LegalEntityAxis_LincolnParkCapitalFundLLCMember",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember",
      "name": "erna:BeneficialOwnershipPercentageOfIssuedAndOutstandingShares",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
     "longName": "091612 - Disclosure - Equity and Warrants, Cumulative Convertible Preferred Stock (Details)",
     "shortName": "Equity and Warrants, Cumulative Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:PreferredStockSharesOutstanding",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails",
     "longName": "091700 - Disclosure - Income Taxes, Loss before Income Taxes (Details)",
     "shortName": "Income Taxes, Loss before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails",
     "longName": "091702 - Disclosure - Income Taxes, Components of Income Tax Provision (Details)",
     "shortName": "Income Taxes, Components of Income Tax Provision (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "091704 - Disclosure - Income Taxes, Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes, Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c20231231",
      "name": "erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231231",
      "name": "erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails",
     "longName": "091706 - Disclosure - Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)",
     "shortName": "Income Taxes, Reconciliation of Computed Expected Income Taxes to Effective Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20230101to20231231",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U008",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails",
     "longName": "091708 - Disclosure - Income Taxes, Uncertain Tax Positions (Details)",
     "shortName": "Income Taxes, Uncertain Tax Positions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c20221231",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20211231",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://eternatx.com/role/SubsequentEventDetails",
     "longName": "091800 - Disclosure - Subsequent Event (Details)",
     "shortName": "Subsequent Event (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c20231215to20231215",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "U001",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c20240111_ClassOfWarrantOrRightAxis_WarrantMember_SubsequentEventTypeAxis_SubsequentEventMember",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "U002",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20015352_10k.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting Presentation and Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/AccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r698"
     ]
    },
    "erna_AccretionOfInterestSublease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AccretionOfInterestSublease",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of accretion of interest for sublease of operating lease liabilities in noncash financing activities.",
        "label": "Accretion of Interest, Sublease",
        "terseLabel": "Accretion of interest for Somerville Sublease"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AccrualForPurchasesOfPropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AccrualForPurchasesOfPropertyAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The accrual for purchases of property and equipment noncash financing activities.",
        "label": "Accrual for Purchases of Property and Equipment",
        "terseLabel": "Accrual for purchases of property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AccruedClinicalCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AccruedClinicalCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical trail cost (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Clinical, Current",
        "terseLabel": "Clinical"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AccruedLegalFeesAndRelatedCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AccruedLegalFeesAndRelatedCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal fees and related. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Legal Fees and Related, Current",
        "terseLabel": "Legal fees and related"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails",
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses",
        "label": "Interest in accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "erna_AccruedSomervilleFacilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AccruedSomervilleFacilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to somerville facility (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Somerville Facility, Current",
        "terseLabel": "Somerville facility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/PropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r174",
      "r549"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r698",
      "r891"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital [Member]",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r574",
      "r746",
      "r747",
      "r748",
      "r868",
      "r893"
     ]
    },
    "erna_AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment to lease liability and right of use asset due to remeasurement in noncash financing activities.",
        "label": "Adjustment to Lease Liability and Right of Use Asset Due to Remeasurement",
        "terseLabel": "Adjustment to lease liability and ROU asset due to remeasurement"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment to lease liability due to remeasurement of sublease.",
        "label": "Adjustment to Lease Liability Due to Remeasurement of Sublease",
        "terseLabel": "Adjustment to lease liability due to remeasurement of Somerville Sublease"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AdjustmentToRemeasurementOfOperatingLeaseROUAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AdjustmentToRemeasurementOfOperatingLeaseROUAssets",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment to remeasurement of operating lease ROU assets.",
        "label": "Adjustment to Remeasurement of Operating Lease ROU Assets",
        "negatedLabel": "Adjustment to ROU asset for remeasurement of Somvervile Sublease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalMarkToMarket",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repricing of warrants in connection with December 2023 financing",
        "documentation": "Amount of increase (decrease) to additional paid in capital (APIC) resulting from changes in fair value of common and preferred stock issued to employee benefit trust but unearned."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r133"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r377"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of note warrants",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r56",
      "r133"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AggregateIntrinsicValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AggregateIntrinsicValueAbstract",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AgreedWaivePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AgreedWaivePayment",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount agreed to waive payment as per waiver agreement.",
        "label": "Agreed Waive Payment",
        "terseLabel": "Agreed waive payment"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AllocatedPercentageOfFairValueConsiderationToPurchasedLicense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AllocatedPercentageOfFairValueConsiderationToPurchasedLicense",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The allocated percentage of fair value of consideration to the purchased license.",
        "label": "Allocated Percentage of Fair Value Consideration to Purchased License",
        "terseLabel": "Allocated percentage of fair value of consideration to purchased license"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r421"
     ]
    },
    "erna_AllocationOfProceedsAndCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AllocationOfProceedsAndCostsAbstract",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation of Proceeds and Costs [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AllocationPercentageOfFairValue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AllocationPercentageOfFairValue",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The allocated percentage of fair value.",
        "label": "Allocation Percentage of Fair Value",
        "terseLabel": "Allocation Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of debt discount and debt issuance costs",
        "verboseLabel": "Amortization of debt discount and debt issuance costs",
        "terseLabel": "Amortization of the debt discount and debt issuance costs",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r490",
      "r677",
      "r678",
      "r738"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total potential shares of common stock excluded from computation (in shares)",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Area of premises",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "erna_AreaOfSubleaseSpaceCurrentlyRented": {
     "xbrltype": "integerItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AreaOfSubleaseSpaceCurrentlyRented",
     "presentation": [
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The subleases rentable area for properties currently rented.",
        "label": "Area of Sublease, Space Currently Rented",
        "terseLabel": "Currently rented area"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails",
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_AssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferredAbstract",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Consideration of Assets Acquired [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails": {
       "parentTag": "erna_ResearchAndDevelopmentInProcessAssetAcquisition",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails",
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares issued",
        "label": "Cash or other consideration",
        "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r865",
      "r866",
      "r867"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferredTransactionCost",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails": {
       "parentTag": "erna_ResearchAndDevelopmentInProcessAssetAcquisition",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Direct costs",
        "label": "Asset Acquisition, Consideration Transferred, Transaction Cost",
        "documentation": "Amount of transaction cost incurred as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r865",
      "r866",
      "r867"
     ]
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionContingentConsiderationLineItems",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails",
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition, Contingent Consideration [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_AssetAcquisitionContingentConsiderationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionContingentConsiderationTable",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails",
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition, Contingent Consideration [Table]",
        "documentation": "Disclosure of information about contingent consideration in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "erna_AssetAcquisitionFairValueOfConsiderationPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AssetAcquisitionFairValueOfConsiderationPaid",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails": {
       "parentTag": "erna_ResearchAndDevelopmentInProcessAssetAcquisition",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Fair Value of Consideration Paid",
        "negatedLabel": "Contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "erna_AssetAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "AssetAcquisitionSharePrice",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.",
        "label": "Asset Acquisition, Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement of Assets Acquired",
        "documentation": "Tabular disclosure of asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_AssetAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionTextBlock",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition",
        "documentation": "The entire disclosure for asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r177",
      "r202",
      "r239",
      "r254",
      "r258",
      "r264",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r459",
      "r461",
      "r481",
      "r542",
      "r609",
      "r698",
      "r709",
      "r763",
      "r764",
      "r878"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsAndLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAndLiabilitiesLesseeAbstract",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and Liabilities, Lessee [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r181",
      "r202",
      "r264",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r459",
      "r461",
      "r481",
      "r698",
      "r763",
      "r764",
      "r878"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r713",
      "r714",
      "r715"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r713",
      "r714",
      "r715"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r713",
      "r714",
      "r715"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Accounting Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting Presentation and Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "erna_BeneficialOwnershipPercentageOfIssuedAndOutstandingShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "BeneficialOwnershipPercentageOfIssuedAndOutstandingShares",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of shareholders, partners or other equity holders in consolidated entity.",
        "label": "Beneficial Ownership Percentage of Issued and Outstanding Shares",
        "terseLabel": "Beneficial owning percentage on issued and outstanding shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement of contingent consideration",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r737"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market capitalization of monetary amount",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r74",
      "r456"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liability",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r74"
     ]
    },
    "us-gaap_BusinessCombinationDescriptionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDescriptionAbstract",
     "presentation": [
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business [Abstract]",
        "label": "Business Combination, Description [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_CEOInducementGrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "CEOInducementGrantAbstract",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CEO Inducement Grant [Abstract]",
        "terseLabel": "CEO Inducement Grant [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Value [Member]",
        "documentation": "Measured as reported on the statement of financial position (balance sheet)."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r543",
      "r585",
      "r604",
      "r698",
      "r709",
      "r727"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r172",
      "r666"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValueAbstract",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Abstract]",
        "label": "Cash and Cash Equivalents, at Carrying Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r143"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "verboseLabel": "Total cash, cash equivalents and restricted cash at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r116",
      "r198"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net decrease in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r116"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r888"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_CashPaidDuringThePeriodForAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "CashPaidDuringThePeriodForAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During the Period for [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "auth_ref": []
    },
    "erna_CashPaidForFractionalSharesInConnectionWithReverseStockSplit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "CashPaidForFractionalSharesInConnectionWithReverseStockSplit",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for fractional shares in connection with reverse stock split.",
        "label": "Cash Paid for Fractional Shares in Connection with Reverse Stock Split",
        "negatedLabel": "Cash paid for fractional shares in connection with reverse stock split"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ChangeInFairValueOfContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ChangeInFairValueOfContingentConsideration",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of change in fair value of contingent consideration.",
        "label": "Change in Fair Value of Contingent Consideration",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r178",
      "r179",
      "r180",
      "r202",
      "r225",
      "r226",
      "r229",
      "r231",
      "r237",
      "r238",
      "r264",
      "r282",
      "r284",
      "r285",
      "r286",
      "r289",
      "r290",
      "r322",
      "r323",
      "r327",
      "r330",
      "r338",
      "r481",
      "r565",
      "r566",
      "r567",
      "r568",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r586",
      "r596",
      "r618",
      "r641",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r723",
      "r740",
      "r749"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r237",
      "r322",
      "r323",
      "r325",
      "r327",
      "r330",
      "r336",
      "r338",
      "r565",
      "r566",
      "r567",
      "r568",
      "r679",
      "r723",
      "r740"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrant exercise price (in dollars per share)",
        "terseLabel": "Warrant exercise price (in dollars per share)",
        "label": "Warrant exercise price (in dollars per share)",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "erna_ClassOfWarrantOrRightExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ClassOfWarrantOrRightExercised",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights exercised during the period.",
        "label": "Class of Warrant or Right Exercised",
        "verboseLabel": "Warrants exercised (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ClassOfWarrantOrRightGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ClassOfWarrantOrRightGrantsInPeriod",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on warrants.",
        "label": "Class of Warrant or Right Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of common stock (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants to purchase common shares (in shares)",
        "label": "Warrants to purchase common shares (in shares)",
        "terseLabel": "Warrants to purchase common shares (in shares)",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "erna_ClassOfWarrantOrRightsExercisableTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ClassOfWarrantOrRightsExercisableTerm",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Class of Warrant or Rights Exercisable Term",
        "terseLabel": "Warrant exercisable term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "erna_CommencementPeriodOfCommonStockInPurchaseAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "CommencementPeriodOfCommonStockInPurchaseAgreement",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for common stock purchase agreement commencement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Commencement Period of Common Stock in Purchase Agreement",
        "terseLabel": "Common stock purchase agreement commencement period"
       }
      }
     },
     "auth_ref": []
    },
    "erna_CommitmentSharesIssueExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "CommitmentSharesIssueExpense",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for commitment shares.",
        "label": "Commitment Shares Issue Expense",
        "terseLabel": "Commitment shares issued to Lincoln Park Capital, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r274",
      "r275",
      "r660",
      "r759"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment and Contingencies",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r661"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock [Member]",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r746",
      "r747",
      "r868",
      "r889",
      "r893"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized (in shares)",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r596"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued (in shares)",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding (in shares)",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r97",
      "r596",
      "r615",
      "r893",
      "r894"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $0.005 par value, 100,000 shares authorized at December 31, 2023 and 2022; 5,410 and 5,127 issued and outstanding at December 31, 2023 and 2022, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r545",
      "r698"
     ]
    },
    "erna_CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "CommonWarrantsMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.",
        "label": "Common Warrants [Member]",
        "verboseLabel": "Q1-22 Common Warrants [Member]",
        "terseLabel": "Common Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_CommonWarrantsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "CommonWarrantsOneMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.",
        "label": "Common Warrants One [Member]",
        "terseLabel": "Q4-22 Common Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of Income Tax Provision [Abstract]",
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment and Programs [Member]",
        "terseLabel": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r157"
     ]
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContingentConsiderationByTypeAxis",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration by Type [Axis]",
        "documentation": "Information by type of contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "erna_ContingentConsiderationForAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ContingentConsiderationForAssetAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued payment of contingent consideration in noncash investing and financing activities.",
        "label": "Contingent Consideration for Asset Acquisition",
        "terseLabel": "Contingent consideration for Exacis asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ContingentConsiderationMember",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ContingentConsiderationOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ContingentConsiderationOneMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment one arrangement.",
        "label": "Contingent Consideration One [Member]",
        "terseLabel": "Contingent Consideration One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ContingentConsiderationThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ContingentConsiderationThreeMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment three arrangement.",
        "label": "Contingent Consideration Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ContingentConsiderationTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ContingentConsiderationTwoMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment two arrangement.",
        "label": "Contingent Consideration Two [Member]",
        "terseLabel": "Contingent Consideration Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContingentConsiderationTypeDomain",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration Type [Domain]",
        "documentation": "Description of contingent payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract assets",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r343",
      "r354"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r342",
      "r354"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Catch-up adjustment to revenue",
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r355"
     ]
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue recognized in previous periods",
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "erna_ContractWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ContractWithCustomersAbstract",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customers [Abstract]",
        "terseLabel": "Contract with Customers [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ConversionOfWarrantLiabilityToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ConversionOfWarrantLiabilityToEquity",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The conversion of warrant liability to equity in non-cash investing and financing activities.",
        "label": "Conversion of Warrant Liability to Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleCommonStockMember",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes Converted into Common Stock [Member]",
        "documentation": "Common stock securities that may be converted to another form of security."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Debt",
        "label": "Relative Fair Value",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": []
    },
    "erna_ConvertibleDebtMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ConvertibleDebtMeasurementInput",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt Measurement Input",
        "terseLabel": "Measurement input"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Debt [Member]",
        "label": "Convertible Notes [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r292",
      "r293",
      "r303",
      "r304",
      "r305",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678"
     ]
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Activity of Convertible Notes",
        "label": "Convertible Debt [Table Text Block]",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleLongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible notes, net",
        "verboseLabel": "Convertible notes",
        "terseLabel": "Convertible notes, net, at December 31, 2023",
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "erna_ConvertibleNotesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ConvertibleNotesAbstract",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ConvertibleNotesBeneficialConversionFeaturePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ConvertibleNotesBeneficialConversionFeaturePercentage",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The conversion limitations percentage on the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed immediately after conversion rate.",
        "label": "Convertible Notes, Beneficial Conversion Feature Percentage",
        "terseLabel": "Beneficial conversion feature percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Converted into Common Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r323",
      "r327",
      "r704",
      "r705",
      "r706",
      "r707"
     ]
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Each preferred stock converted into common stock (in shares)",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r60",
      "r96",
      "r131",
      "r333"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenues",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r202",
      "r264",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r481",
      "r763"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r726",
      "r743",
      "r862"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r726",
      "r743"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current income tax provision",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r444",
      "r450",
      "r743"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Tax Provision [Abstract]",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r726",
      "r743",
      "r862"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Note and Convertible Note Financings [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Note and Convertible Note Financings",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r199",
      "r291",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r307",
      "r314",
      "r315",
      "r317"
     ]
    },
    "erna_DebtInstrumentAccruedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DebtInstrumentAccruedInterestRate",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate accrued per annum.",
        "label": "Debt Instrument, Accrued Interest Rate",
        "terseLabel": "Accrued interest rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r92",
      "r93",
      "r145",
      "r147",
      "r207",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r491",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r741"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial conversion rate (in dollars per share)",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r294"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r86",
      "r292",
      "r491",
      "r675",
      "r676"
     ]
    },
    "us-gaap_DebtInstrumentFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFairValueDisclosureAbstract",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r293"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r316",
      "r491",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r741"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration date",
        "label": "Debt maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r674",
      "r870"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r207",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r491",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r741"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condition One [Member]",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condition Three [Member]",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condition Two [Member]",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_DebtInstrumentRepaidPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRepaidPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repaid principal amount",
        "documentation": "Amount of principal of debt repaid."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r60",
      "r63",
      "r83",
      "r84",
      "r86",
      "r89",
      "r130",
      "r132",
      "r207",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r316",
      "r491",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r741"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Debt discount and debt issuance costs",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r303",
      "r318",
      "r675",
      "r676"
     ]
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "erna_December2022ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "December2022ConvertibleNotesMember",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "December 2022 Convertible Notes [Member]",
        "terseLabel": "December 2022 Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_December2023ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "December2023ConvertibleNotesMember",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock issued in December 2023.",
        "label": "December 2023 Convertible Notes [Member]",
        "terseLabel": "December 2023 Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_December2023WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "December2023WarrantsMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount issued in December 2023.",
        "label": "December 2023 Warrants [Member]",
        "terseLabel": "December 2023 Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r743",
      "r861",
      "r862"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r743",
      "r861"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Income tax provision",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r139",
      "r163",
      "r449",
      "r450",
      "r743"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Provision [Abstract]",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r146",
      "r438"
     ]
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue, current",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, non-current",
        "label": "Deferred Revenue, Noncurrent",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r743",
      "r861",
      "r862"
     ]
    },
    "erna_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets attributable to taxable temporary differences from research and development costs.",
        "label": "Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs",
        "terseLabel": "Capitalized research and development expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-process research and development",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r860"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Assets [Abstract]",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards excluding foreign purpose.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards Excluding Foreign",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign net operating losses",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r860"
     ]
    },
    "erna_DeferredTaxAssetsRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DeferredTaxAssetsRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use assets.",
        "label": "Deferred Tax Assets Right of Use Assets",
        "negatedLabel": "ROU Assets"
       }
      }
     },
     "auth_ref": []
    },
    "erna_DeferredTaxAssetsRightOfUseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DeferredTaxAssetsRightOfUseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from right-of-use liabilities.",
        "label": "Deferred Tax Assets Right Of Use Liabilities",
        "terseLabel": "ROU Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "R&amp;D credit carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73",
      "r860"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation accrual",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days)."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r860"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r860"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r860"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred taxes",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r859"
     ]
    },
    "erna_DeferredTaxLiabilitiesConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DeferredTaxLiabilitiesConvertibleDebt",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from convertible debt.",
        "label": "Deferred Tax Liabilities, Convertible Debt",
        "negatedLabel": "Convertible debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Intangibles - goodwill",
        "label": "Deferred Tax Liabilities, Goodwill",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r75",
      "r76",
      "r860"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Liabilities [Abstract]",
        "label": "Deferred Tax Liabilities, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fixed assets",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r860"
     ]
    },
    "us-gaap_DefinedContributionPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanAbstract",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan, deferral percentage of employee on their pay on pre-tax basis.",
        "label": "Defined Contribution Plan, Deferral Percent of Their Pay on Pre-tax Basis",
        "terseLabel": "Employees contribution, deferral percentage of their pay on a pre-tax basis"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "erna_DefinedContributionPlanEmployeeContributionAtThresholdOne": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DefinedContributionPlanEmployeeContributionAtThresholdOne",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employee contribution to the plan that is fully matched by the employer.",
        "label": "Defined Contribution Plan Employee Contribution at Threshold One",
        "terseLabel": "Employee contribution threshold for matching percentage"
       }
      }
     },
     "auth_ref": []
    },
    "erna_DefinedContributionPlanEmployeeContributionAtThresholdTwo": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DefinedContributionPlanEmployeeContributionAtThresholdTwo",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employee contribution to the plan that is fully matched by the employer.",
        "label": "Defined Contribution Plan Employee Contribution At Threshold Two",
        "terseLabel": "Deferred compensation matched by employer, next match"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employer matching contributions",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution up to a certain percentage matched.",
        "label": "Defined Contribution Plan Employer Matching Contribution Percent of Match One",
        "terseLabel": "Employer matching contribution up to first 3%"
       }
      }
     },
     "auth_ref": []
    },
    "erna_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution in excess of certain percentage matched.",
        "label": "Defined Contribution Plan Employer Matching Contribution Percent of Match Two",
        "terseLabel": "Employer matching contribution in excess of first 2%"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanTable",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Table]",
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "erna_DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deposit paid which will be applied to the last month of the first work order.",
        "label": "Deposit Paid to be Applied to Last Month of First Work Order",
        "terseLabel": "Deposit paid to be applied to last month of first work order"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security deposit",
        "label": "Deposits Assets, Noncurrent",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expenses",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r52"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r243"
     ]
    },
    "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFinancialInstrumentsLiabilitiesMember",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liabilities [Member]",
        "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_DerivativesMethodsOfAccountingNonhedgingDerivatives": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesMethodsOfAccountingNonhedgingDerivatives",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "documentation": "Disclosure of accounting policy for derivatives that either were not designated as hedging instruments or do not qualify for hedge accounting."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "DirectorMember",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dr. Fiore [Member]"
       }
      }
     },
     "auth_ref": [
      "r753",
      "r890"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r379",
      "r410",
      "r411",
      "r413",
      "r692"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableAmountPerShare",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative annual dividend payable per share (in dollars per share)",
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_DividendsPreferredStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPreferredStockCash",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash dividends to Series A convertible preferred stockholders",
        "terseLabel": "Dividend paid in cash",
        "label": "Dividends, Preferred Stock, Cash",
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r133"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r714",
      "r715"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r714",
      "r715",
      "r717"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r714",
      "r715",
      "r717"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal [Member]",
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "erna_ERSquibbSonsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ERSquibbSonsLLCMember",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A Delaware limited liability company (\"Sublessor\"), for office, laboratory and research and development space (the \"Premises\").",
        "label": "E.R. Squibb &amp; Sons, L.L.C. [Member]",
        "terseLabel": "E.R. Squibb &amp; Sons, L.L.C. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Net Loss per Common Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share - basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r222",
      "r225",
      "r229",
      "r230",
      "r231",
      "r235",
      "r471",
      "r472",
      "r539",
      "r553",
      "r668"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per common share - diluted (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r225",
      "r229",
      "r230",
      "r231",
      "r235",
      "r471",
      "r472",
      "r539",
      "r553",
      "r668"
     ]
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Anti-dilutive Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Net Loss per Common Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r232",
      "r233",
      "r234"
     ]
    },
    "erna_EffectOfReductionOfExercisePriceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "EffectOfReductionOfExercisePriceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of effect of the reduction of the exercise price of the warrants.",
        "label": "Effect of Reduction of Exercise Price of Warrants",
        "terseLabel": "Effect of reduction of exercise price of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Benefit (provision) for income taxes",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax at federal income tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r428",
      "r452"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r863"
     ]
    },
    "erna_EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to convertible debt.",
        "label": "Effective Income Tax Rate Reconciliation, Convertible Debt, Percent",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "auth_ref": []
    },
    "erna_EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to decrease in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Decrease in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign tax differential",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r863"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-deductible expenses/excludable items",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r863"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State income tax, net of federal tax",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r863"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r863"
     ]
    },
    "erna_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to uncertain tax positions.",
        "label": "Effective Income Tax Rate Reconciliation Uncertain Tax Positions Percent",
        "negatedLabel": "Uncertain tax positions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued compensation",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining requisite service period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquipmentMember",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory and Manufacturing Equipment [Member]",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r168",
      "r186",
      "r187",
      "r188",
      "r208",
      "r209",
      "r210",
      "r212",
      "r218",
      "r220",
      "r236",
      "r265",
      "r266",
      "r340",
      "r414",
      "r415",
      "r416",
      "r445",
      "r446",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r508",
      "r556",
      "r557",
      "r558",
      "r574",
      "r641"
     ]
    },
    "erna_EquityIncentivePlan2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "EquityIncentivePlan2020Member",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation equity incentive plan 2020.",
        "label": "Equity Incentive Plan 2020 [Member]",
        "terseLabel": "2020 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_EquityLineOfCreditConsiderationSharesOfCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "EquityLineOfCreditConsiderationSharesOfCommonStock",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to equity line of credit consideration shares.",
        "label": "Equity Line of Credit Consideration Shares of Common Stock",
        "terseLabel": "Consideration shares of common stock (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on shares sold to Lincoln Park Capital, LLC",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r736",
      "r738"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment in non-controlling interest",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r263",
      "r728",
      "r754"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r480",
      "r675",
      "r676"
     ]
    },
    "erna_EstimatedEquityValueOfStockIssuedInAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "EstimatedEquityValueOfStockIssuedInAssetAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed amount of stock issued in connection with calculation of share price in asset purchase transaction.",
        "label": "Estimated Equity Value of Stock Issued in Asset Acquisition",
        "terseLabel": "Estimated equity value of stock issued in asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ExacisAssetPurchaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ExacisAssetPurchaseAbstract",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exacis Asset Purchase [Abstract]",
        "terseLabel": "Exacis Asset Purchase [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ExacisAssetPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ExacisAssetPurchaseAgreementMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails",
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about asset purchase agreement (the \"Purchase Agreement\"), together with Exacis.",
        "label": "Exacis Asset Purchase Agreement [Member]",
        "terseLabel": "Exacis Asset Purchase [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ExacisOptionAgreementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ExacisOptionAgreementAbstract",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exacis Option Agreement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ExpensesPaidInConnectionWithPrivateOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ExpensesPaidInConnectionWithPrivateOffering",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expenses paid in connection with private offering during the period.",
        "label": "Expenses Paid In Connection with Private Offering",
        "negatedLabel": "Fees paid in connection with private offering"
       }
      }
     },
     "auth_ref": []
    },
    "erna_FactorBioscienceIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "FactorBioscienceIncMember",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A corporation the company entered into agreement to provide the Company with MRNA cell engineering research support services, including access to certain facilities, equipment, materials and training, and the Company.",
        "label": "Factor Bioscience Inc. [Member]",
        "terseLabel": "Factor Bioscience Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrant liabilities",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r8"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r475",
      "r478"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r475",
      "r478"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Measured at Fair Value",
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r78",
      "r80",
      "r142"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Valuation of Assumptions",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Assumptions",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r81",
      "r82"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value and Carrying Values of Convertible Notes",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r81"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r475",
      "r520",
      "r521",
      "r522",
      "r675",
      "r676",
      "r688",
      "r689",
      "r690"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r141"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r78",
      "r305",
      "r675",
      "r676"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r675",
      "r676"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r473"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r475",
      "r522",
      "r675",
      "r676",
      "r688",
      "r689",
      "r690"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in Fair Value of Warrant Liabilities [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r80"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial measurement",
        "terseLabel": "Warrants fair value",
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Fair value, end of period",
        "periodStartLabel": "Fair value, beginning of period",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r520",
      "r521",
      "r522",
      "r675",
      "r676",
      "r688",
      "r689",
      "r690"
     ]
    },
    "us-gaap_FairValueNetAssetLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueNetAssetLiabilityAbstract",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r21"
     ]
    },
    "us-gaap_FeaturesOfConvertiblePreferredStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FeaturesOfConvertiblePreferredStockAbstract",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Convertible Preferred Stock [Abstract]",
        "label": "Features of Convertible Preferred Stock [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payments on finance leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r502"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign [Member]",
        "label": "Foreign Tax Authority [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "erna_FutureLeasePaymentsSubleaseAgreementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "FutureLeasePaymentsSubleaseAgreementTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future lease payments of sublease agreements.",
        "label": "Future Lease Payments, Sublease Agreement [Table Text Block]",
        "terseLabel": "Future Lease Payments from Sublease Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "erna_GainLossOnChangeInFairValueOfContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "GainLossOnChangeInFairValueOfContingentConsideration",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gain (loss) on change in fair value of contingent consideration.",
        "label": "Gain (Loss) on Change in Fair Value of Contingent Consideration",
        "terseLabel": "Change in fair value of contingent consideration liability"
       }
      }
     },
     "auth_ref": []
    },
    "erna_GainLossOnDisposalOfFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "GainLossOnDisposalOfFixedAssets",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of fixed assets.",
        "label": "Gain (Loss) on Disposal of Fixed Assets",
        "verboseLabel": "Loss on disposal of fixed assets",
        "terseLabel": "Loss on disposal of fixed assets"
       }
      }
     },
     "auth_ref": []
    },
    "erna_GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on remeasurement of right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Gain (Loss) on Remeasurement of Operating Lease Liability and Right-of-Use-Asset",
        "negatedLabel": "Gain on remeasurement of operating lease liability and right-of-use-asset"
       }
      }
     },
     "auth_ref": []
    },
    "erna_GainOnTerminationOfLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "GainOnTerminationOfLease",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain on termination of lease before expiration of lease term.",
        "label": "Gain on Termination of Lease",
        "negatedLabel": "Gain on lease termination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r620"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r268",
      "r538",
      "r673",
      "r698",
      "r756",
      "r757"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and In-Process Research &amp; Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/GoodwillAndInprocessResearchDevelopment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and In-Process Research &amp; Development",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r271",
      "r673"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment loss",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r269",
      "r270",
      "r271",
      "r673"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross loss",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r202",
      "r239",
      "r253",
      "r257",
      "r259",
      "r264",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r481",
      "r670",
      "r763"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r713",
      "r714",
      "r715"
     ]
    },
    "us-gaap_ImpairmentOfOngoingProject": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfOngoingProject",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      },
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-cash impairment charges",
        "label": "Impairment of in-process research and development",
        "documentation": "Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51"
     ]
    },
    "us-gaap_InProcessResearchAndDevelopmentPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InProcessResearchAndDevelopmentPolicy",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-Process Research &amp; Development",
        "label": "In Process Research and Development, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets."
       }
      }
     },
     "auth_ref": []
    },
    "erna_IncentiveStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "IncentiveStockOptionsMember",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on incentive basis.",
        "label": "Incentive Stock Options [Member]",
        "terseLabel": "Incentive Stock Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r451"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r103",
      "r149",
      "r239",
      "r253",
      "r257",
      "r259",
      "r540",
      "r551",
      "r670"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r451"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss before Income Taxes [Abstract]",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r625"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r625"
     ]
    },
    "erna_IncomeTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "IncomeTaxAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Domain]",
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r423",
      "r429",
      "r435",
      "r442",
      "r447",
      "r453",
      "r454",
      "r455",
      "r570"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/IncomeTaxesComponentsOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Benefit (provision) for income taxes",
        "totalLabel": "Total tax (benefit) provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r164",
      "r219",
      "r220",
      "r244",
      "r427",
      "r448",
      "r554"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Computed Expected Income Taxes to Effective Income Taxes [Abstract]",
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r425",
      "r426",
      "r435",
      "r436",
      "r441",
      "r443",
      "r564"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Taxes Paid, Net",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDueToRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related party",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 28.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the operating lease liabilities.",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other non-current assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other receivables",
        "label": "Increase (Decrease) in Other Receivables",
        "documentation": "Amount of increase (decrease) in receivables classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/GoodwillAndInprocessResearchDevelopmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-process research and development",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "erna_InducementPlan2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "InducementPlan2021Member",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement award inducement plan 2021.",
        "label": "Inducement Plan 2021 [Member]",
        "terseLabel": "2021 Inducement Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_InitialLicenseFeeObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "InitialLicenseFeeObligation",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of initial license fees required to pay including non-refundable fee.",
        "label": "Initial License Fee Obligation",
        "terseLabel": "Initial license fees obligation"
       }
      }
     },
     "auth_ref": []
    },
    "erna_InitialMeasurementOfFinanceLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "InitialMeasurementOfFinanceLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of initial measurement of finance lease liabilities in noncash financing activities.",
        "label": "Initial Measurement of Finance Lease Liabilities",
        "terseLabel": "Initial measurement of finance lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "erna_InitialMeasurementOfLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "InitialMeasurementOfLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of Initial measurement of lease liabilities in noncash financing activities.",
        "label": "Initial measurement of lease liabilities",
        "terseLabel": "Initial measurement of lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "erna_InitialMeasurementOfOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "InitialMeasurementOfOperatingLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of initial measurement of operating lease liabilities in noncash financing activities.",
        "label": "Initial Measurement of Operating Lease Liabilities",
        "terseLabel": "Recognition of lease liability for Somerville Sublease",
        "verboseLabel": "Initial measurement of operating lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "erna_InitialMeasurementOfOperatingLeaseROUAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "InitialMeasurementOfOperatingLeaseROUAssets",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of initial measurement of operating lease ROU assets.",
        "label": "Initial Measurement of Operating Lease ROU Assets",
        "verboseLabel": "Recognition of ROU asset for Somerville Sublease",
        "terseLabel": "Initial measurement of operating lease ROU assets"
       }
      }
     },
     "auth_ref": []
    },
    "erna_InitialMeasurementOfRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "InitialMeasurementOfRightOfUseAssets",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of Initial measurement of ROU assets in noncash financing activities.",
        "label": "Initial Measurement of Right of Use Assets",
        "terseLabel": "Initial measurement of ROU assets"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r151",
      "r189",
      "r242",
      "r489",
      "r626",
      "r708",
      "r892"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest expense",
        "verboseLabel": "Interest expense",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r311",
      "r320",
      "r677",
      "r678"
     ]
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebtExcludingAmortization",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest due under the promissory note",
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r312",
      "r677",
      "r678"
     ]
    },
    "erna_InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest expense debt excluding amortization of financing costs and discounts.",
        "label": "Interest Expense Debt Excluding Amortization Of Financing Costs And Discounts",
        "terseLabel": "Remaining of interest expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r196",
      "r197"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes interest",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r111"
     ]
    },
    "erna_IssuanceOfCommonStockForAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "IssuanceOfCommonStockForAssetAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The issuance of common stock for asset acquisition in noncash financing activities.",
        "label": "Issuance of Common Stock for Asset Acquisition",
        "terseLabel": "Issuance of common stock for Exacis asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "erna_IssuanceOfCommonStockFromExerciseOfPreFundedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "IssuanceOfCommonStockFromExerciseOfPreFundedWarrants",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash flows from issuance of common stock from exercise of pre-funded warrants.",
        "label": "Issuance of Common Stock from Exercise of Pre-funded Warrants",
        "terseLabel": "Issuance of common stock from exercise of pre-funded warrants"
       }
      }
     },
     "auth_ref": []
    },
    "erna_July2023AndDecember2023ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "July2023AndDecember2023ConvertibleNotesMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "July 2023 and December 2023 Convertible Notes [Member]",
        "terseLabel": "July 2023 and December 2023 Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_July2023ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "July2023ConvertibleNotesMember",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock issued in July 2023.",
        "label": "July 2023 Convertible Notes [Member]",
        "terseLabel": "July 2023 Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_July2023WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "July2023WarrantsMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount issued in July 2023.",
        "label": "July 2023 Warrants [Member]",
        "terseLabel": "July 2023 Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_LaboratoryAndManufacturingEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LaboratoryAndManufacturingEquipmentMember",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and service.",
        "label": "Laboratory and Manufacturing Equipment [Member]",
        "terseLabel": "Laboratory and Manufacturing Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease expense",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r697"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Operating Lease Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Operating Lease Expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "erna_LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental costs incurred in connection with Tenant Improvement Allowance.",
        "label": "Lease Liability incremental Amount Above Tenant Improvement Allowance",
        "terseLabel": "Lease liability incremental amount Above Tenant Improvement Allowance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsGross",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost improvement",
        "label": "Leasehold Improvements, Gross",
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold Improvements [Member]",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "erna_LegalMattersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LegalMattersAbstract",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Matters [Abstract]",
        "terseLabel": "Legal Matters [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_LesseeCommitmentToPurchaseProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LesseeCommitmentToPurchaseProperty",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property for which lessee committed to purchase.",
        "label": "Lessee, Commitment to Purchase Property",
        "terseLabel": "Commitment to purchase equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_LesseeOperatingLeaseDescriptionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseDescriptionAbstract",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Lessee, Operating Lease, Description [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Operating Lease Liabilities",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extension term of sublease",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "erna_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Operating Lease Weighted Average Remaining Lease Term And Discount Rate Abstract [Abstract]",
        "terseLabel": "Weighted Average Remaining Lease Term and Discount Rate [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://eternatx.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r202",
      "r264",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r460",
      "r461",
      "r462",
      "r481",
      "r595",
      "r669",
      "r709",
      "r763",
      "r878",
      "r879"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r148",
      "r547",
      "r698",
      "r742",
      "r755",
      "r871"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r171",
      "r202",
      "r264",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r460",
      "r461",
      "r462",
      "r481",
      "r698",
      "r763",
      "r878",
      "r879"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value",
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, fair value disclosure",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities, Fair Value Disclosure [Abstract]",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_LicenseAgreementAutomaticRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LicenseAgreementAutomaticRenewalTerm",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The automatic renewal term of license agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "License Agreement Automatic Renewal Term",
        "terseLabel": "License agreement automatic renewal term"
       }
      }
     },
     "auth_ref": []
    },
    "erna_LicensingAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LicensingAgreementsAbstract",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing Agreements [Abstract]",
        "terseLabel": "Licensing Agreements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_LincolnParkCapitalFundLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LincolnParkCapitalFundLLCMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity.",
        "label": "Lincoln Park Capital Fund, LLC [Member]",
        "terseLabel": "Lincoln Park [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Letter of credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r147",
      "r887"
     ]
    },
    "erna_LiquidityAndCapitalResourcesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LiquidityAndCapitalResourcesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity and Capital Resources [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_LiquidityAndCapitalResourcesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LiquidityAndCapitalResourcesLineItems",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liquidity and Capital Resources [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_LiquidityAndCapitalResourcesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LiquidityAndCapitalResourcesTable",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about liquidity and capital resources.",
        "label": "Liquidity and Capital Resources [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_LiquidityAndCapitalResourcesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LiquidityAndCapitalResourcesTextBlock",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResources"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.",
        "label": "Liquidity And Capital Resources [Text Block]",
        "terseLabel": "Liquidity and Capital Resources"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation settlement, amount",
        "documentation": "Amount awarded to other party in judgment or settlement of litigation."
       }
      }
     },
     "auth_ref": []
    },
    "erna_LitigationSettlementAmountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LitigationSettlementAmountPayable",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Payable",
        "terseLabel": "Aggregate settlement amount payable"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "erna_LockUpPeriodForCommonStock": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LockUpPeriodForCommonStock",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Lock-up Period for Common Stock",
        "terseLabel": "Lock-up period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r147",
      "r304",
      "r319",
      "r675",
      "r676",
      "r887"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r207",
      "r309"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r207",
      "r309"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r207",
      "r309"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r207",
      "r309"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r207",
      "r309"
     ]
    },
    "us-gaap_LongTermDebtMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMeasurementInput",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible note, measurement input",
        "documentation": "Value of input used to measure long-term debt."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermConvertibleDebtCurrentAndNoncurrentAbstract",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes Payable [Abstract]",
        "label": "Convertible Debt [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r55"
     ]
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyDamagesPaidValue",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidated damages payment",
        "documentation": "Amount of damages paid to the plaintiff in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ]
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated contingent loss",
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r280",
      "r281"
     ]
    },
    "erna_LossOnNonControllingInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "LossOnNonControllingInvestment",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      },
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss on non-controlling investment.",
        "label": "Loss on Non-controlling Investment",
        "negatedLabel": "Loss on non-controlling investment",
        "terseLabel": "Loss on non-controlling investment"
       }
      }
     },
     "auth_ref": []
    },
    "erna_MarketCapContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "MarketCapContingentConsiderationMember",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Market Cap Contingent Consideration is indexed to or settled in the Company's own shares.",
        "label": "Market Cap Contingent Consideration [Member]",
        "terseLabel": "Market Cap Contingent Consideration [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_MasterServiceAgreementInitialFeesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "MasterServiceAgreementInitialFeesPayable",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount agreed to pay an initial fee under Master Services Agreement (or \"MSA\").",
        "label": "Master Service Agreement, Initial Fees Payable",
        "terseLabel": "Master services agreement, initial fees payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future Minimum Principal Payments under Convertible Notes [Abstract]",
        "label": "Maturities of Long-Term Debt [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails",
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r279",
      "r369",
      "r524",
      "r555",
      "r587",
      "r588",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r662",
      "r663",
      "r672",
      "r679",
      "r691",
      "r699",
      "r765",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885"
     ]
    },
    "us-gaap_MeasurementInputCreditSpreadMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputCreditSpreadMember",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Spread [Member]",
        "documentation": "Measurement input using amount above (below) yield between two debt instruments similar in maturity, but different in credit quality."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend Yield [Member]",
        "label": "Dividend [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Term [Member]",
        "label": "Expected Life [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility [Member]",
        "label": "Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk Free Rate [Member]",
        "label": "Risk Free Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price [Member]",
        "label": "Stock Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "erna_MinimumCapitalizationRequirementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "MinimumCapitalizationRequirementAmount",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount required for numerator value of stock issuance.",
        "label": "Minimum Market Capitalization Requirement, Amount",
        "terseLabel": "Minimum market capitalization requirement, amount"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r279",
      "r369",
      "r524",
      "r555",
      "r587",
      "r588",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r662",
      "r663",
      "r672",
      "r679",
      "r691",
      "r699",
      "r765",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of non-controlling interest",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "erna_MonthlyMasterServicesAgreementFeesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "MonthlyMasterServicesAgreementFeesPayable",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The monthly master service agreement (\"MSA\") fees payable to related party.",
        "label": "Monthly Master Services Agreement Fees Payable",
        "terseLabel": "Monthly master services agreement fees payable initial 12-month"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net cash used in operating activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r118"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 0.0
      },
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r118",
      "r150",
      "r169",
      "r183",
      "r184",
      "r188",
      "r202",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r219",
      "r220",
      "r227",
      "r239",
      "r253",
      "r257",
      "r259",
      "r264",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r472",
      "r481",
      "r552",
      "r617",
      "r639",
      "r640",
      "r670",
      "r708",
      "r763"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator [Abstract]",
        "label": "Net Income (Loss) Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss attributable to common stockholders",
        "verboseLabel": "Net loss attributable to common stockholders",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r213",
      "r214",
      "r215",
      "r216",
      "r222",
      "r223",
      "r228",
      "r231",
      "r239",
      "r253",
      "r257",
      "r259",
      "r670"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "erna_NewFacilityLeaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NewFacilityLeaseAbstract",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Facility Lease [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "erna_NonCashResearchAndDevelopmentInProcessAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NonCashResearchAndDevelopmentInProcessAssetAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The non cash amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Non Cash Research and Development in Process, Asset Acquisition",
        "verboseLabel": "Non-cash component of acquisition of Exacis in-process research and development"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NonQualifiedStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NonQualifiedStockOptionMember",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Non-qualified Stock Option [Member]",
        "terseLabel": "Nonqualified Stock Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://eternatx.com/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://eternatx.com/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other (expense) income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r744",
      "r745"
     ]
    },
    "erna_NoteWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NoteWarrantsAbstract",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Warrants [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NoticePeriodForFirstTerminationOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NoticePeriodForFirstTerminationOfContract",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company may terminate the first work under the MSA on or after the second anniversary of the date of the MSA, subject to providing Factor with prior notice, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Notice Period for First Termination of Contract",
        "terseLabel": "Notice period for first termination of contract"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NoticePeriodForSupersedingTerminationProvisions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NoticePeriodForSupersedingTerminationProvisions",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Master Services Agreement (or \"MSA\") contains customary confidentiality provisions and representations and warranties of the parties, and the Master Services Agreement (or \"MSA\") may be terminated by ether party prior notice, subject to any superseding termination provisions contained in a particular work order, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Notice Period for Superseding Termination Provisions",
        "terseLabel": "Notice period for superseding termination provisions"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NoticePeriodToAssumeControlPatents": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NoticePeriodToAssumeControlPatents",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of days to provide notice to assume control of such patents in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Notice Period to Assume Control Patents",
        "terseLabel": "Notice period to assume control patents"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NoveCiteINCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NoveCiteINCMember",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "NoveCite, INC. [Member]",
        "terseLabel": "NoveCite, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NumberOfAwardsVestedAndSettledAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NumberOfAwardsVestedAndSettledAbstract",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Awards Vested and Settled [Abstract]",
        "terseLabel": "Number of RSUs Vested and Settled [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NumberOfConsecutiveTradingDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NumberOfConsecutiveTradingDays",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of consecutive trading days in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Number of Consecutive Trading Days",
        "terseLabel": "Number of consecutive trading days"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NumberOfInLicensedPortfolioPatents": {
     "xbrltype": "integerItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NumberOfInLicensedPortfolioPatents",
     "presentation": [
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of in-licensed portfolio patents covering key mRNA cell engineering technologies.",
        "label": "Number of In-licensed Portfolio Patents",
        "terseLabel": "Number of patents"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NumberOfMonthlyInstallmentsForFeesPayable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NumberOfMonthlyInstallmentsForFeesPayable",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equal monthly installments for initial fees payable.",
        "label": "Number of Monthly Installments for Fees Payable",
        "terseLabel": "Number of monthly installments for fees payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of operating segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "erna_NumberOfRevenueGeneratingContracts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NumberOfRevenueGeneratingContracts",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of revenue generating contracts of the organization.",
        "label": "Number of Revenue Generating Contracts",
        "terseLabel": "Number of revenue generating contracts"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NumberOfWarrantsInEachUnit": {
     "xbrltype": "integerItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NumberOfWarrantsInEachUnit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrant consist in each unit.",
        "label": "Number of warrants in each unit"
       }
      }
     },
     "auth_ref": []
    },
    "erna_NumeratorValueForStockIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "NumeratorValueForStockIssuance",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of numerator value for stock issuance.",
        "label": "Numerator Value for Stock Issuance",
        "terseLabel": "Numerator value for stock issuance"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ObligationToPayLiquidatedDamagesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ObligationToPayLiquidatedDamagesPercentage",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.",
        "label": "Obligation to Pay Liquidated Damages Percentage",
        "terseLabel": "Obligated to pay liquidated damages percentage"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.",
        "label": "Obligation to Pay Liquidated Damages Percentage on Subscription Amount per Month",
        "terseLabel": "Obligation to pay liquidated damages per month"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OpenTaxYear": {
     "xbrltype": "gYearListItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OpenTaxYear",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Open tax year",
        "documentation": "Tax year that remains open to examination under enacted tax laws, in YYYY format."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r253",
      "r257",
      "r259",
      "r670"
     ]
    },
    "erna_OperatingLeaseAssestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "OperatingLeaseAssestAbstract",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Asset [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease expense",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r697"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of ROU asset",
        "label": "Impairment of right-of-use asset",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "erna_OperatingLeaseIncrementalBorrowingRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "OperatingLeaseIncrementalBorrowingRate",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average incremental borrowing rate for operating lease calculated at point in time.",
        "label": "Operating Lease Incremental Borrowing Rate",
        "terseLabel": "Incremental borrowing rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Operating Lease Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc01": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Operating lease liabilities, Ending",
        "periodStartLabel": "Operating lease liabilities, Beginning",
        "label": "Total operating lease liabilities",
        "terseLabel": "Lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityAbstract",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Current portion",
        "terseLabel": "Operating lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less non-current portion",
        "terseLabel": "Operating lease liabilities, non-current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Operating lease ROU assets, Ending",
        "periodStartLabel": "Operating lease ROU assets, Beginning",
        "verboseLabel": "ROU asset balance",
        "terseLabel": "Right-of-use assets - operating leases",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of operating lease ROU assets",
        "terseLabel": "Amortization of right-of-use asset",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "erna_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.",
        "label": "Operating Lease Right-of-use Assets and Liabilities [Table Text Block]",
        "terseLabel": "Operating Lease Right-of-use Assets and Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r697"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://eternatx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining lease term (years)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r697"
     ]
    },
    "erna_OperatingLeasesIncreaseInBaseRentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "OperatingLeasesIncreaseInBaseRentPercentage",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage increase in base rent per year after first year for operating leases.",
        "label": "Operating Leases Increase In Base Rent Percentage",
        "terseLabel": "Percentage increase in base rent after first year"
       }
      }
     },
     "auth_ref": []
    },
    "erna_OperatingLeasesMonthlyBaseRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "OperatingLeasesMonthlyBaseRent",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of rental expense payable per month for operating leases.",
        "label": "Operating Leases, Monthly Base Rent",
        "terseLabel": "Monthly base rent payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carry forward",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "erna_OptionFeeObligationPaymentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "OptionFeeObligationPaymentPercentage",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of obligated to payments of the option fees.",
        "label": "Option Fee Obligation Payment Percentage",
        "terseLabel": "Option fee obligation payment percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and Description of Business Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/OrganizationAndDescriptionOfBusinessOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and Description of Business Operations",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r140",
      "r561",
      "r562"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r698"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense, net:",
        "label": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "erna_OutOfPocketExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "OutOfPocketExpenses",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The company incurred additional out-of-pocket expenses for sublessor/lessor owned assets.",
        "label": "Out-of-pocket Expenses",
        "terseLabel": "Out-of-pocket expenses"
       }
      }
     },
     "auth_ref": []
    },
    "erna_OverSubscriptionAmountReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "OverSubscriptionAmountReceived",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.",
        "label": "Over-Subscription Amount Received",
        "terseLabel": "Over-subscription amount received"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PIPEInvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PIPEInvestorMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.",
        "label": "PIPE Investor [Member]",
        "terseLabel": "PIPE Investor [Member]",
        "verboseLabel": "Q1-22 PIPE Investor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PIPEInvestorOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PIPEInvestorOneMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.",
        "label": "PIPE Investor One [Member]",
        "terseLabel": "Q4-22 PIPE Investor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaidInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaidInKindInterest",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Paid-in-kind interest expense",
        "label": "Paid in-kind",
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "erna_PaidInKindInterestAddedToConvertibleNotesPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PaidInKindInterestAddedToConvertibleNotesPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The paid-in-kind interest added to convertible notes principal in noncash financing activities..",
        "label": "Paid-in-Kind Interest Added to Convertible Notes Principal",
        "terseLabel": "Paid-in-kind interest added to convertible notes principal",
        "verboseLabel": "Paid-in-kind interest added to principal"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentOfFinancingAndStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fees paid related to the Convertible Notes Financings",
        "label": "Payment of Financing and Stock Issuance Costs",
        "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "erna_PaymentOfOptionFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PaymentOfOptionFee",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of option fee related to licensing agreement.",
        "label": "Payment of Option Fee",
        "terseLabel": "Payment of option fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends paid to Series A convertible preferred stockholders",
        "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payroll tax remitted on net share settlement of equity awards",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "erna_PercentageOfCashConsideration": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PercentageOfCashConsideration",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of all cash or other consideration.",
        "label": "Percentage of Cash Consideration",
        "terseLabel": "Percentage of cash consideration"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments",
     "presentation": [
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in annual lease payment for subleases for each year.",
        "label": "Percentage of Lessee Sublease, Increase In Annual Lease Rent Payments",
        "terseLabel": "Percentage of annual rent increase"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PercentageOfSharesOfCommonStockOutstanding": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PercentageOfSharesOfCommonStockOutstanding",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of common stock shares outstanding considered for equity number of shares under equity incentive plan.",
        "label": "Percentage of Shares of Common Stock Outstanding",
        "terseLabel": "Percentage of number of shares of common stock outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company will pay to Factor of sublicense fees paid before license expiration date.",
        "label": "Percentage of Sublicense Fees Paid Before License Expiration Date",
        "terseLabel": "Percentage of sublicense fees paid before license expiration date"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PerformanceBasedStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PerformanceBasedStockOptionMember",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.",
        "label": "Performance Based Stock Option [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "erna_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A pre-funded warrant that allows the warrant holder to purchase a specified number of a company's securities at a nominal exercise price.",
        "label": "Pre-funded Warrants [Member]",
        "terseLabel": "Pre-funded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockConvertibleConversionRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockConvertibleConversionRatio",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, conversion rate",
        "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted."
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockConvertibleSharesIssuable",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate preferred stock to be convert into common stock (in shares)",
        "documentation": "Number of common shares issuable upon conversion of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r324"
     ]
    },
    "us-gaap_PreferredStockDividendsAndOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockDividendsAndOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Series A convertible preferred stock dividend",
        "label": "Preferred Stock Dividends and Other Adjustments",
        "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r722",
      "r751"
     ]
    },
    "us-gaap_PreferredStockDividendsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockDividendsShares",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash dividends to Series A convertible preferred stockholders (in shares)",
        "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, liquidation preference per share (in dollars per share)",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r96",
      "r740",
      "r766"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreferenceValue",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, liquidation preference",
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r327"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r701",
      "r704",
      "r705",
      "r706",
      "r707",
      "r889",
      "r893"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r322"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r596"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r322"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r596",
      "r615",
      "r893",
      "r894"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at December 31, 2023 and 2022, $156 liquidation preference",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r544",
      "r698"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r734"
     ]
    },
    "erna_PresidentChiefExecutiveOfficerAndDirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PresidentChiefExecutiveOfficerAndDirectorMember",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of president, chief executive officer and person serving on board of director.",
        "label": "President, Chief Executive Officer and Director [Member]",
        "terseLabel": "Sanjeev Luther [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PrincipalPaymentsOnOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PrincipalPaymentsOnOperatingLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal payments on operating lease liabilities.",
        "label": "Principal payments on operating lease liabilities",
        "negatedLabel": "Principal payments on operating lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PrivatePlacementOfEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PrivatePlacementOfEquityAbstract",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement of Equity [Abstract]",
        "terseLabel": "Private Placement of Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_PrivatePlacementOfferingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PrivatePlacementOfferingsAbstract",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Offerings [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ProceedsFromCellLineCustomizationActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ProceedsFromCellLineCustomizationActivities",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from cell line customization activities.",
        "label": "Proceeds from Cell Line Customization Activities",
        "terseLabel": "Proceeds from cell line customization activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds received from the convertible notes financings",
        "label": "Proceeds",
        "verboseLabel": "Gross convertible notes at issuance",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "erna_ProceedsFromConvertibleDebtNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ProceedsFromConvertibleDebtNet",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock and warrants in connection with private offering",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "erna_ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity pursuant to stock purchase agreement.",
        "label": "Proceeds from Issuance of Common Stock Pursuant to Stock Purchase Agreement",
        "terseLabel": "Proceeds from sale of common stock pursuant to stock purchase agreement with Lincoln Park Capital Fund, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from issuance of warrants to purchase of common stock",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds from sale of equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r565"
     ]
    },
    "us-gaap_ProceedsFromLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLeasePayments",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease payments received",
        "label": "Proceeds from Lease Payment, Operating Activity",
        "documentation": "Amount of cash inflow from lease payment, classified as operating activity."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r507"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds received under promissory note",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "erna_ProceedsFromOptionAndLicenseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ProceedsFromOptionAndLicenseAgreement",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from exclusive option and license agreement as a non-refundable up-front payment.",
        "label": "Proceeds from Option and License Agreement",
        "terseLabel": "Proceeds from option and license agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sales of fixed assets",
        "label": "Proceeds from the sale of fixed assets",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "erna_PromissoryNoteAndConvertibleNoteFinancingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "PromissoryNoteAndConvertibleNoteFinancingAbstract",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Note and Convertible Note Financing [Abstract]",
        "terseLabel": "Promissory Note and Convertible Note Financing [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r158",
      "r161",
      "r162"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/PropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r173",
      "r550"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGrossAbstract",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://eternatx.com/role/PropertyAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r541",
      "r550",
      "r698"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNetByTypeAbstract",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment [Abstract]",
        "label": "Property, Plant and Equipment, Net, by Type [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r158",
      "r161",
      "r548"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property, Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "erna_Q422PIPETransactionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "Q422PIPETransactionAbstract",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Q4-22 PIPE Transaction [Abstract]",
        "terseLabel": "Q4-22 PIPE [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails",
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r279",
      "r357",
      "r369",
      "r405",
      "r406",
      "r407",
      "r523",
      "r524",
      "r555",
      "r587",
      "r588",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r662",
      "r663",
      "r672",
      "r679",
      "r691",
      "r699",
      "r702",
      "r758",
      "r765",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails",
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r279",
      "r357",
      "r369",
      "r405",
      "r406",
      "r407",
      "r523",
      "r524",
      "r555",
      "r587",
      "r588",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r662",
      "r663",
      "r672",
      "r679",
      "r691",
      "r699",
      "r702",
      "r758",
      "r765",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885"
     ]
    },
    "erna_ReceivedAmountOfTenantImprovementAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ReceivedAmountOfTenantImprovementAllowance",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tenant improvement allowance received.",
        "label": "Received Amount of Tenant Improvement Allowance",
        "terseLabel": "Company received tenant improvement allowance"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ReconciliationOfCashCashEquivalentsAndRestrictedCashInCondensedConsolidatedStatementsOfCashFlowsAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Cash Cash Equivalents and Restricted Cash in Condensed Consolidated Statements Of Cash Flows [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash at end of period:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party, Type [Domain]",
        "label": "Related Party [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r512",
      "r513",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r614",
      "r616",
      "r648"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r206",
      "r512",
      "r513",
      "r514",
      "r515",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r614",
      "r616",
      "r648"
     ]
    },
    "erna_RelatedPartyTransactionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RelatedPartyTransactionAbstract",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Abstract]",
        "terseLabel": "Related Party Transaction [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r621",
      "r622",
      "r625"
     ]
    },
    "erna_RelatedPartyTransactionPeriodicFeesPaymentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RelatedPartyTransactionPeriodicFeesPaymentAmount",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of required periodic fees payment.",
        "label": "Related Party Transaction, Periodic Fees Payment, Amount",
        "terseLabel": "Monthly installment fees amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/LeasesOperatingLeaseDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party, Type [Axis]",
        "label": "Related Party [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r512",
      "r513",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r614",
      "r616",
      "r648",
      "r877"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r510",
      "r511",
      "r513",
      "r516",
      "r571",
      "r572",
      "r573",
      "r623",
      "r624",
      "r625",
      "r645",
      "r647"
     ]
    },
    "erna_RemainingFundingReceivedFromDecember2023FinancingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RemainingFundingReceivedFromDecember2023FinancingAbstract",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining Funding Received from December 2023 Financing [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_RemainingNetBookValueOfFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RemainingNetBookValueOfFixedAssets",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Remaining Net Book Value of Fixed Assets",
        "terseLabel": "Net book value of fixed assets"
       }
      }
     },
     "auth_ref": []
    },
    "erna_RemainingUnamortizedLicenseFeeObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RemainingUnamortizedLicenseFeeObligation",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of remaining unamortized license fee obligation.",
        "label": "Remaining Unamortized License Fee Obligation",
        "terseLabel": "Remaining unamortized license fee obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payment made on promissory note",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "erna_RepricingOfWarrantsInConnectionWithFinancing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RepricingOfWarrantsInConnectionWithFinancing",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The repricing of warrants in connection with financing in noncash financing activities..",
        "label": "Repricing of Warrants in Connection with Financing",
        "terseLabel": "Repricing of warrants in connection with December 2023 financing"
       }
      }
     },
     "auth_ref": []
    },
    "erna_RepurchasePricePercentageToPrincipalAmount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RepurchasePricePercentageToPrincipalAmount",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of notes repurchase price to principal amount.",
        "label": "Repurchase Price Percentage to Principal Amount",
        "terseLabel": "Repurchase price percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "verboseLabel": "Research and development expense",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept."
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "erna_ResearchAndDevelopmentInProcessAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ResearchAndDevelopmentInProcessAssetAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      },
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process, Asset Acquisition",
        "terseLabel": "Acquisition of Exacis in-process research and development",
        "totalLabel": "Total fair value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted cash",
        "terseLabel": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r739",
      "r886",
      "r888"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r739"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r729",
      "r739"
     ]
    },
    "erna_RestrictedStockUnitesWithheldToCoverTaxes": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RestrictedStockUnitesWithheldToCoverTaxes",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares of restricted stock withheld to cover the withholding taxes.",
        "label": "Restricted Stock Unites, Withheld to Cover Taxes",
        "terseLabel": "Restricted stock units, withheld to cover taxes (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "RSUs [Member]",
        "label": "RSU [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r133",
      "r546",
      "r559",
      "r560",
      "r569",
      "r597",
      "r698"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit [Member]",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r208",
      "r209",
      "r210",
      "r212",
      "r218",
      "r220",
      "r265",
      "r266",
      "r414",
      "r415",
      "r416",
      "r445",
      "r446",
      "r463",
      "r465",
      "r466",
      "r468",
      "r470",
      "r556",
      "r558",
      "r574",
      "r893"
     ]
    },
    "erna_RetirementPlan401KMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "RetirementPlan401KMember",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A defined-contribution retirement account which allows employees to save a portion of their salary in a tax-advantaged manner. The money earned in a 401(k) Plan is not taxed until after the employee retires, at which time their income will typically be lower than during their working years.",
        "label": "Retirement Plan, 401K [Member]",
        "terseLabel": "401K [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetirementPlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanNameAxis",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Plan Name [Axis]",
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r691",
      "r724",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828"
     ]
    },
    "us-gaap_RetirementPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanNameDomain",
     "presentation": [
      "http://eternatx.com/role/CommitmentsAndContingenciesRetirementSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Plan Name [Domain]",
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r691",
      "r724",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomer"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r356"
     ]
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionAbstract",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r619",
      "r665",
      "r667"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance obligation, percentage",
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r202",
      "r240",
      "r241",
      "r252",
      "r255",
      "r256",
      "r260",
      "r261",
      "r262",
      "r264",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r481",
      "r540",
      "r763"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://eternatx.com/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://eternatx.com/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals to be received by the seller-lessee for sale-leaseback transactions accounted for using the deposit method or as a financing.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals",
        "totalLabel": "Total payments"
       }
      }
     },
     "auth_ref": []
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsFiscalYearMaturityAbstract",
     "presentation": [
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Future Lease Payments, Sublease Agreement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails": {
       "parentTag": "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, Next Twelve Months",
        "terseLabel": "2024"
       }
      }
     },
     "auth_ref": []
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails": {
       "parentTag": "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Three Years",
        "terseLabel": "2026"
       }
      }
     },
     "auth_ref": []
    },
    "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails": {
       "parentTag": "erna_SaleLeasebackTransactionsFutureMinimumSubleaseRentals",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesManhattanSubleaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of minimum sublease rentals for sale-leaseback transactions accounted for using the deposit method or as a financing to be received by the seller-lessee in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Sale Leaseback Transactions, Future Minimum Sublease Rentals, within Two Years",
        "terseLabel": "2025"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock shares issued and sold (in shares)",
        "terseLabel": "Common stock shares issued and sold (in shares)",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "erna_SaleOfStockNumberOfSharesToIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SaleOfStockNumberOfSharesToIssuedInTransaction",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares to be issued by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares to Issued in Transaction",
        "terseLabel": "Number of remaining shares to be sold (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "erna_SanDiegoLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SanDiegoLeaseMember",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the San Diego Lease agreement.",
        "label": "San Diego Lease [Member]",
        "terseLabel": "San Diego Lease [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/AccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Excluded from the Computation of Diluted Net Loss per Common Stock",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Provision",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Based on Relative Fair Value Allocation of Proceeds and Costs",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in Warrant Liabilities",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of derivative liabilities at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computation of Net Loss per Share Basic and Diluted",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Computed Expected Income Taxes to Effective Income Taxes",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation Expense",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss before Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal Payments under Convertible Notes",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails",
      "http://eternatx.com/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r621",
      "r622",
      "r625"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r378",
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summarizes of Stock Option Activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r66"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-Average Assumptions Used for Stock Options Granted",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summarizes of RSU Activity",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r130",
      "r132",
      "r133",
      "r178",
      "r179",
      "r180",
      "r237",
      "r322",
      "r323",
      "r325",
      "r327",
      "r330",
      "r336",
      "r338",
      "r565",
      "r566",
      "r567",
      "r568",
      "r679",
      "r723",
      "r740"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant activity",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uncertain Tax Positions",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r695",
      "r858"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesSegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r261",
      "r671"
     ]
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Series A Convertible Preferred Stock [Member]",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r733",
      "r767"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based Compensation [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r692"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted stock units, granted (in shares)",
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted (in dollars per share)",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock units, outstanding (in shares)",
        "periodEndLabel": "Outstanding, Ending balance (in shares)",
        "periodStartLabel": "Outstanding, Beginning balance (in shares)",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Restricted Stock Units [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, Beginning balance (in dollars per share)",
        "periodEndLabel": "Outstanding, Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Fair Value Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Expected share and unit options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Expected To Date Fair Value",
        "terseLabel": "Balance expected to vest (in dollars per share)"
       }
      }
     },
     "auth_ref": []
    },
    "erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Number",
        "terseLabel": "Balance expected to vest (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "RSUs vested (in shares)",
        "negatedLabel": "Released (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Released (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Extended Post-Termination, Exercise Period",
        "terseLabel": "Exercise period of extended post-termination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weightage-Average Assumptions Used for Stock Options Granted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average risk-free rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic stock vesting, which may be presented in a variety of ways (for example, monthly, quarterly, annually).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Frequency of Periodic Installment",
        "terseLabel": "Frequency of stock vesting installments over three years thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r378",
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in stock-based compensation shares authorized (in shares)",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation shares authorized (in shares)",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r694"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of common stock shares to be issued (in shares)",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Stock options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average grant date fair value (in dollars per share)",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance",
        "periodEndLabel": "Outstanding, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "label": "Stock option outstanding (in shares)",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r385"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Option Share [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r385"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Vested and Exercisable [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options vested and exercisable, aggregate intrinsic value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, outstanding (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options vested and exercisable, weighted average exercise price (in dollars per share)",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "erna_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuable under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issuable in Period",
        "terseLabel": "Number of shares issuable (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://eternatx.com/role/StockbasedCompensationRestrictedStockUnitsDetails",
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r381",
      "r382",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancelled (in dollars per share)",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "verboseLabel": "Exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting on First Anniversary [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting on Three Years Thereafter [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r383",
      "r402",
      "r403",
      "r404",
      "r405",
      "r408",
      "r417",
      "r418",
      "r419",
      "r420"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation Expense [Abstract]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of accelerated vesting stock option (in shares)",
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation stock option term period",
        "terseLabel": "Warrant expiration term",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r693"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average remaining contractual life, outstanding",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options vested and exercisable, weighted average remaining contractual life",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental fair value of stock options recognized",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "erna_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SharesIssuedSharesForfeitureOfUnvestedRestrictedStock",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares Forfeiture of unvested restricted stock during the period.",
        "label": "Shares Issued, Shares, Forfeiture of unvested restricted stock",
        "negatedLabel": "Forfeiture of unvested restricted stock (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "erna_StandbyEquityPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StandbyEquityPurchaseAgreementMember",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of agreement information about standby equity purchase agreement between the entities.",
        "label": "Standby Equity Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "erna_StandbySecuritiesPurchaseAgreementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StandbySecuritiesPurchaseAgreementAbstract",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standby Securities Purchase Agreement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State [Member]",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r178",
      "r179",
      "r180",
      "r202",
      "r225",
      "r226",
      "r229",
      "r231",
      "r237",
      "r238",
      "r264",
      "r282",
      "r284",
      "r285",
      "r286",
      "r289",
      "r290",
      "r322",
      "r323",
      "r327",
      "r330",
      "r338",
      "r481",
      "r565",
      "r566",
      "r567",
      "r568",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r586",
      "r596",
      "r618",
      "r641",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r723",
      "r740",
      "r749"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r35",
      "r168",
      "r186",
      "r187",
      "r188",
      "r208",
      "r209",
      "r210",
      "r212",
      "r218",
      "r220",
      "r236",
      "r265",
      "r266",
      "r340",
      "r414",
      "r415",
      "r416",
      "r445",
      "r446",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r470",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r508",
      "r556",
      "r557",
      "r558",
      "r574",
      "r641"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209",
      "r210",
      "r236",
      "r525",
      "r563",
      "r586",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605",
      "r606",
      "r607",
      "r608",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r616",
      "r619",
      "r620",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r641",
      "r703"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED BALANCE SHEETS [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209",
      "r210",
      "r236",
      "r525",
      "r563",
      "r586",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r605",
      "r606",
      "r607",
      "r608",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r616",
      "r619",
      "r620",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r641",
      "r703"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition of common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97",
      "r133"
     ]
    },
    "erna_StockIssuedDuringPeriodSharesAcquisitions2": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions2",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions2",
        "terseLabel": "Issuance of common stock in connection with Exacis asset acquisition (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsCumulativeConvertiblePreferredStockDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares converted (in shares)",
        "verboseLabel": "Number of convertible notes converted into shares (in shares)",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r34",
      "r60",
      "r133",
      "r308"
     ]
    },
    "erna_StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of stock issued common stock and warrants in connection with private offering during the period.",
        "label": "Stock Issued During Period Shares of Common Stock and Warrants in Connection with Private Offering Net of Offering Costs",
        "terseLabel": "Issuance of common stock and warrants in connection with November 2022 private offering, net. (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "erna_StockIssuedDuringPeriodSharesPrivateOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesPrivateOffering",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been issued in private offering during the period.",
        "label": "Stock Issued During Period, Shares, Private Offering",
        "terseLabel": "Issuance of common stock in connection with private offering (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from vested restricted stock units (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r133"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares were issued upon settlement (in shares)",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r96",
      "r97",
      "r133"
     ]
    },
    "erna_StockIssuedDuringPeriodSharesStockPurchaseAgreement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesStockPurchaseAgreement",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been issued in a stock purchase agreement during the period.",
        "label": "Stock Issued During Period, Shares, Stock Purchase Agreement",
        "terseLabel": "Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "erna_StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued common stock and warrants in connection with private offering during the period.",
        "label": "Stock Issued During Period Value 0f Common Stock and Warrants in Connection with Private Offering Net of Offering Costs",
        "terseLabel": "Issuance of common stock and warrants in connection with November 2022 private offering, net."
       }
      }
     },
     "auth_ref": []
    },
    "erna_StockIssuedDuringPeriodValueAcquisitions2": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodValueAcquisitions2",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions2",
        "terseLabel": "Issuance of common stock in connection with Exacis asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "erna_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Forfeiture of unvested restricted stock during the period.",
        "label": "Stock Issued During Period, Value, Forfeiture of Unvested Restricted Stock",
        "terseLabel": "Forfeiture of unvested restricted stock"
       }
      }
     },
     "auth_ref": []
    },
    "erna_StockIssuedDuringPeriodValuePrivateOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodValuePrivateOffering",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been issued in private offering during the period.",
        "label": "Stock Issued During Period, Value, Private Offering",
        "terseLabel": "Issuance of common stock in connection with private offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock from vested restricted stock units",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r96",
      "r97",
      "r133"
     ]
    },
    "erna_StockIssuedDuringPeriodValueStockPurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "StockIssuedDuringPeriodValueStockPurchaseAgreement",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.",
        "label": "Stock Issued During Period, Value, Stock Purchase Agreement",
        "terseLabel": "Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails",
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate gross purchase price",
        "verboseLabel": "Aggregate gross purchase price",
        "terseLabel": "Aggregate gross purchase price",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private placement (in shares)",
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "totalLabel": "Total stockholders' equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r100",
      "r101",
      "r120",
      "r598",
      "r615",
      "r642",
      "r643",
      "r698",
      "r709",
      "r742",
      "r755",
      "r871",
      "r893"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets",
      "http://eternatx.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholder's equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and Warrants [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity and Warrants",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r201",
      "r321",
      "r323",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r337",
      "r340",
      "r469",
      "r644",
      "r646",
      "r659"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r697"
     ]
    },
    "erna_SublicenseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "SublicenseFees",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sublicense fees required to pay including non-refundable fee.",
        "label": "Sublicense Fees",
        "terseLabel": "Sublicense fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r518"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r518"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r518"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r518"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://eternatx.com/role/LiquidityAndCapitalResourcesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails",
      "http://eternatx.com/role/StockbasedCompensationEquityIncentivePlansDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r518"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://eternatx.com/role/SubsequentEvent"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r519"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "documentation": "Different names of stock transactions and the different attributes of each transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal and state income tax credit carryforwards",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "erna_TaxCreditCarryforwardExpirationYear": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "TaxCreditCarryforwardExpirationYear",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration beginning year of the tax credit carryforward, in YYYY format.",
        "label": "Tax Credit Carryforward Expiration Year",
        "terseLabel": "Tax credits begin to expire"
       }
      }
     },
     "auth_ref": []
    },
    "erna_TaxCutsAndJobsActOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "TaxCutsAndJobsActOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws from effect of Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards under Tax Cuts and Jobs Act"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "erna_TenantImprovementAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "TenantImprovementAllowance",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tenant improvement allowance to improvements of the Premises.",
        "label": "Tenant Improvement Allowance",
        "terseLabel": "Tenant improvement allowance"
       }
      }
     },
     "auth_ref": []
    },
    "erna_TenantImprovementAllowancePerRentableSquareFoot": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "TenantImprovementAllowancePerRentableSquareFoot",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tenant improvement allowance per rentable square foot for the improvements of premises.",
        "label": "Tenant Improvement Allowance, per Rentable Square Foot",
        "terseLabel": "Tenant improvement allowance per rentable square foot"
       }
      }
     },
     "auth_ref": []
    },
    "erna_TimeBasedStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "TimeBasedStockOptionMember",
     "presentation": [
      "http://eternatx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on time basis.",
        "label": "Time Based Stock Option [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of Transfer of Good or Service [Axis]",
        "documentation": "Information by timing of transfer of good or service to customer."
       }
      }
     },
     "auth_ref": [
      "r686",
      "r768"
     ]
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of Transfer of Good or Service [Domain]",
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "auth_ref": [
      "r686",
      "r768"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r753",
      "r876"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://eternatx.com/role/RelatedPartyTransactionsDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "erna_TransactionFeesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "TransactionFeesPayable",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees incurred related to PIPE transaction.",
        "label": "Transaction Fees Payable",
        "terseLabel": "Transaction fees"
       }
      }
     },
     "auth_ref": []
    },
    "erna_TransactionFeesRelatedToDebtIssuanceAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "TransactionFeesRelatedToDebtIssuanceAndWarrants",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of transaction fees related to debt issuance and warrants.",
        "label": "Transaction Fees Related to Debt Issuance and Warrants",
        "terseLabel": "Transaction fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransferredOverTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransferredOverTimeMember",
     "presentation": [
      "http://eternatx.com/role/ContractWithCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognized Over Time [Member]",
        "label": "Transferred over Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred over time."
       }
      }
     },
     "auth_ref": [
      "r686"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/AssetAcquisitionFairValueMeasurementOfAssetsAcquiredDetails",
      "http://eternatx.com/role/AssetAcquisitionSummaryOfAssetAcquisitionDetails",
      "http://eternatx.com/role/EquityAndWarrantsSepaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "erna_UnitPriceOfWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "UnitPriceOfWarrants",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price of prefunded and common warrants.",
        "label": "Unit Price of Warrants",
        "verboseLabel": "Unit price (in dollars per share)"
       }
      }
     },
     "auth_ref": []
    },
    "erna_UnpaidFeesIncurredInConnectionWithPrivateOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "UnpaidFeesIncurredInConnectionWithPrivateOffering",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of unpaid fees incurred in connection with private offering.",
        "label": "Unpaid Fees Incurred in Connection with Private Offering",
        "terseLabel": "Unpaid fees incurred in connection with November 2022 private offering"
       }
      }
     },
     "auth_ref": []
    },
    "erna_UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of unpaid fees incurred in connection with the issuance of convertible notes and warrants in noncash financing activities..",
        "label": "Unpaid Fees Incurred in Connection with the Issuance of Convertible Notes and Warrants",
        "terseLabel": "Unpaid fees incurred in connection with the December 2023 financing"
       }
      }
     },
     "auth_ref": []
    },
    "erna_UnpaidOutOfPocketCostsTenantImprovementAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "UnpaidOutOfPocketCostsTenantImprovementAllowance",
     "crdr": "debit",
     "presentation": [
      "http://eternatx.com/role/LeasesOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The company has to pay sublease for owned assets.",
        "label": "Unpaid Out of Pocket Costs Tenant Improvement Allowance",
        "terseLabel": "Unpaid out of pocket costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance of uncertain tax positions",
        "periodEndLabel": "Ending balance of uncertain tax positions",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r432"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest and penalties related to uncertain tax positions",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions based on current year's tax positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesUncertainTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net changes based on prior year's tax positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://eternatx.com/role/BasisOfAccountingPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r155",
      "r156",
      "r159",
      "r160"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/IncomeTaxesReconciliationOfComputedExpectedIncomeTaxesToEffectiveIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in valuation allowance",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_ValuationTechniqueAndInputDescriptionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueAndInputDescriptionAbstract",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsCarryingValueAndFairValueOfConvertibleNotesDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Technique and Input, Description [Abstract]",
        "verboseLabel": "Valuation Technique and Input, Description [Abstract]",
        "label": "Fair Value Assumptions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable lease expense",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r697"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854"
     ]
    },
    "erna_WarrantLiabilitiesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "WarrantLiabilitiesExpense",
     "crdr": "debit",
     "calculation": {
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to warrant liabilities.",
        "label": "Warrant Liabilities Expense",
        "negatedLabel": "Change in fair value of warrant liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/EquityAndWarrantsPrivatePlacementOfEquityDetails",
      "http://eternatx.com/role/SubsequentEventDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Member]",
        "terseLabel": "Warrants [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r701",
      "r704",
      "r705",
      "r706",
      "r707"
     ]
    },
    "erna_WarrantRepricing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "WarrantRepricing",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsBasedOnRelativeFairValueAllocationOfProceedsAndCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of warrant repricing.",
        "label": "Warrant Repricing",
        "negatedLabel": "Warrant Repricing"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "presentation": [
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Activity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement input",
        "label": "Warrants , measurement input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://eternatx.com/role/AssetAcquisitionFairValuationOfAssumptionsDetails",
      "http://eternatx.com/role/EquityAndWarrantsNoteWarrantsDetails",
      "http://eternatx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://eternatx.com/role/PromissoryNoteAndConvertibleNoteFinancingsFairValueAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life",
        "verboseLabel": "Warrants expiration term",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "erna_WarrantsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://eternatx.com/20231231",
     "localname": "WarrantsIssued",
     "crdr": "credit",
     "presentation": [
      "http://eternatx.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of warrants issued to purchase common stock of the company together with convertible notes in noncash financing activities.",
        "label": "Warrants Issued",
        "terseLabel": "Note warrants issued"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding - diluted (in shares)",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r231"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator [Abstract]",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://eternatx.com/role/BasicAndDilutedNetLossPerCommonShareComputationOfNetLossPerShareDetails",
      "http://eternatx.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding - basic (in shares)",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r231"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "b",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2C",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-8"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479692/805-740-25-9"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350/tableOfContent"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12A"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-5"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-7"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>114
<FILENAME>0001140361-24-013254-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-013254-xbrl.zip
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M0.L+H",?^JY]-AH'_AWA9<E/#ZVPK!2$"]:W)4!NM-K/ZH!,KNT1\*;6M L
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M1B,-AV>?.8]'/&"@P#QR]C/OX\7/W/-'CE<T[*KKR WQ+C_[)<MMSFR>4.5
MY'C1VIO7FADMCH+WX5^#:-V1VL7S FX9!<Q:>[A.\7#7@@[67F=W#LJ-X>>Z
M8_6*IW:&Q.6Z.+W%([YS'MX#?OAQ8/%0_#GDS"9J!R3X^+>_:1K\_X_P6PNC
MB0M,<P"[6!^PD>-.WFM_OP&N$VKG_%Z[\D?,^_L'C>Z'SG_X>\W0Q]$'#>FX
M#@;%K?=><_D KEB^ZP?OM?_6Z9\/!Q_A$^(CXA?\'@;J>WT_@/F\USS?XQ\T
M\5>][T>1/X(OC!^TT'<=6^N[S/J>W(_\\7NM.7USR)'ETKP>TED,Z!]X%9ZY
M#?S8L^O3M[)+L&!3>?!!&['@UO'JN*+W&HLC/[D4B*_0M8-WF9V<6F-F4XL^
M("<1W/;?Z#4-__]M?G>;N+MTX5XNK.^[MKPT'T(''[^=G]V<?-:N;XYN3JY_
M[ ?ODBEEIOJ2$[P^.?YV=79S=G*M'9U_UDY^/_[EZ/SG$^WXXNO7L^OKLXOS
M#<_4?.Q,?V/AT %=S?=JVN?#XT/-U%O-WNSLU X_C9: VC/0FH;7])?R9#2#
MW?G=D(1S[]C1\+TVXK83CY*K-,84"<I1ZB/_/_4XY'7:=[JH".&]!G0F24.1
MGHF4)S]BM'Z8 YJ-T=MV-WS#2-A]+!*>^L%(^Q%X-P"(U 3'TCR&&BZF''_V
MK7@DU;\#$ARG( 3_[!FVU6M:O;[5[C99K]LS==9H&ZVF;AEZOV<?:%('N^*#
MPA3.@X^&7O^59$;ZW8_:8GY2T<&+TL'''\,Q\W+;GL.U X#?.WQDTU2T[+-O
MOK+@NW;A\;?J^VO17>;)B($U#+OENC".!;SYIP/]@/X>,]M._D9C[*>#S]>7
MIU^<,+K!EP[4!!5<=/V'I=17L-@,XF5^"D4J2A"1#'>+N0J^H++DWTW>_S&R
M%[VDT,CL3']],5_*Z6(%7&DM)K06S#W@5\S%1Y;QK"//BYE[Q<=^$&5X5[O5
MZP^:@U8?^%!ST&L"'[.-KFZ9=H_IO79_.>^"^<(<HI\.'-@0,/[?]WW?[8/.
M[$=]_^'@X__Y[UZGV?XPS=WRQ#&US^\B^RGP$W1;'O@=G9]_._JB79U<7ES=
M:)??KJZ_'9W?:#<7&JAG-Z"#:49#N[@"]O7&?JM=G&HWOYQH&<TMT=J.CF_P
MMM%K-%?<N+_1Q:"0DOX&=Y!:-ZVS/AG=MZ!'/W5.?R/>".J!%@VY=NJ$@'K:
M'YP%V@FV4UBN,UR25^9$N)$S!,@&C8[>;AK-KL6:';O5Y:;>;/1!F^BUK&;7
M7(\ W]LP.@A0+QKB%.HVF]0G,,LZ]PX^*G^GUC!J&KX^2Y-%<FZY?G!QM<)#
M6B6'DO<W*(?6=B(4Z0R;$#!4P-3! .>,D-$MJ\?;_1YC_5ZS;9N]!B!\KSWH
MZJ PM\TU<7RND&F63LAL!#@W5T?GUV<D)G97@CR!YA[/])^Z\PM9UDM.3,FA
M**$Y37C]M4'@C[0_Y3^ K\GO\DQ^34'P,O(>*Q<X(0:!0-B#] &.@I)S+A<\
MH= -/BJ>S+H'@.MUS6:[Q?1&DQF<=?4FT\VVU0+NUFET5W$/U VCV=87R^O-
M.06*K&64 *-;+0PL8,(C=LLIM'?X[_'M@<9<X,RW 1L/'0O,Y<J)L*XS;<'
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M*[R*SO%ZX8T0E'WX*9DHX&""UI8_ L5V@OP?1@6.B3[G6^TV\.^CH;I[".*
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M._%31K>9)_F[%H_1]<6\B88BWP]RF@#1[&2<8>."*D++%Q>=*!L@MT#U"$"
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MKX7[X_H&0([9WJ>PQHA0,H)?7?I\@N=-QHBT=[WUO^;@Q>!G?!NDL?R(4AD
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M4QE*N1C'C<(B;^=]N*=AZ5P3N"'X Q2$PFAQM!CP(/_)ET^UUW]GLW5]0VS
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MRFI%Q3)) V"#[8&P6[F'D8HD 'YX>\\!AU@V=E01D]]O)5RG O^/2%2E[%;
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MX\2;?'E_T8?#PI=U%26N%*QS:+#X3OZ"J Q"\2*RB*U=])N<<D#:?74DQ?B
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MNS<+NAV.+19_C,TC2?3 0I!_TKFG![@VR5FJ*<*8W<Q1ZA(&N.TW5R2P][&
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MJMD1.SJ81T3WOQZME/4=6&UZ+NN:&RD]#KG?"7]+'(D. ;1..D4\NN!M+B*
M3G5R;*.<1^9MS42K+J'K+<.'A"NJ:H^Y<R1S5))#K(^:>.[;V6VKKNP7,8H5
MA3*6IR,PI.D>NLE6^750^&"^'JYEYH/&#&YI>EX? R: /K_1C -]2P9HT2C)
M[<RX$X3#IGFU? >4FNLX%=U?=]H$^2<+;4'7%/YQ'UB<>V&X%8N-<*3'[,L
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M]I_UNIH]/Y_].=^$_0O?^%-1$X',:TJL54'GO*2&#=\U13$G?K;7BA+Y_O6
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MN#<AQF$I@S@@=$)=*ZH)93[A8[D8P'5>;KB#<ZW-G?&BW2 >@25TTW_I6%6
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MUT7>-/MP.&^0B>.6]^_I1"Z)NCKYHQ):1",#[OCA<I8'547#:0JB6ATH4&7
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MH540&4>M]2@>?6U)JZDBF!"@G05_](0CIEF!>C<4=4_N E<&UR5M[J_2:!V
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M] A4U 0=83(,AN$*8,U[.,@DMD?XU)9O07_@QV,ADTNI:QWM/]("9CW1<K\
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M'KU^]^%W^''GEW?O_B_^^^.G$Y!AC->;K@L><6>@KY>^W+7 .,IW$A_Q/T+
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M:;)<I%=R>_0=:\XF31WW%HH417%H2I-TFB#ZYQ-="=Q^68DQK4(@BZ=E(K
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M?-=_]@(0S/:77Q<%;/9W/_;-Y0HHJ\YSWC9X2G@4?T55J%^^!:KG\T4/A&<
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M*8@TJD-0=GDQS\9HJ(!RH&W"M2I@L3*\K'"-Z )<-"4H\N",@P4"\H6'CH_
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M(V94%L2031!<4,S(+J+KWNZQQ2#T"#M+<% =ZE</)*OBL3((C^ '%%>"G#L
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M;N18+%RG"(\3WBVGG/,K);$6=U1Q%C,%5+-(,"/!KAW=&2\VYW$EGDPQ#[4
MC-0^\%CX%9^44B740)^,%TN:?1PWPAW+U)?\QM--L=/=EEDQ^#,>FBJ /-V(
M9K;ZC%]23!^N*J/O)X8R,E-8VSD M+7>"9^&QJ)$6O@R5S7-(TUS2!]"CCG*
MR^Z@A&)252;#6NVJAG$\.S$BN3+4!P);,5CXUBS@@63POO;?:4(ZWC^0% UQ
M(U5<RWUX:WQG--@F/HK3[3/3Z#DUEG^E819,,O2(,LL8$@K7:Y>_ E@[2Y"O
M?K#PQ!B],CP)"WW > :?=DS3_,B[-W>E%QW12.U%30%343!^6XC3 ,8,)-5D
MW'09X\YTW$Q+X/L!K@0DW5V0F3MGW@6"_X;\6V'V!D ?6 YX.S/#O6)&/.:H
MH&LD)?$L9K'PS+*.A=!5*&+,UTH QOQM #;E.-OI=0N:244"=V*5I4  F8^Q
MC!86-X! FH%\/5;  )VC$+5ZA$T4J=%!6W23IPDWG(&$GL-Q(C+/'<O*IQI9
M@3$/[,I0SSX%U-T>3WVI)ZK52/_LU2'A2UD ?CKV2@[HBM3 :F.B&V@K#!Q#
MD\3Y6G>$Y3/4!F$EV+G@GR\-O1'M&(L36GB8G9+.#U.:6!A\0_45=L@E2'2#
M&8: ?F_'K)L=;'!71K?93M-M=O-NLYV=ZC:;6H(H2@4(A(J!3O54T&_(""ZP
M_F3,LRD>PE]6 ,CG6PQ"B\76U7L,L8P%C^J@$:!Y449B0-V(K>=-ZL@X?!OX
M;%^B<,5_AY0[(6?RF1=J:'YJTJ6J:^-YL5&:5I/:R,NW9,;]DO 63,ZQ$SO(
MVJ0 )],9GH]=6L/\+9A]HZ_.#9FG3DP9E5+S);D-"&[!'5'JLA'+]GGZ)AP3
MY9>'67&D:("Q@:EX(-K)  4&*H=U#@,_D18O2W!DKC[N!O6:NSD2%08/$:[W
M@LLXBW'T&96LHUHWFN+?# 2>&'N#4T$-*&+,!*P+/8CSGE>COX(R4X'/C7EZ
M[0W"+$ABO#,5I%4F/:KQ["F*T'+C@!\^(I:])/#5\&09N>#)W^FFS6M#NR.3
M$4RSDZH7Y^L4C+B4W3%BW? 2M";/^BCNT/7$F>32\HNS>)(6ZMG&U&C92WEJ
M7FT5>@T)>TF9QL*[M"G!7(744?T!Q I<7U=#+W&5;;WX]7/UNQ5E1=G3:@4C
M#?8MN112#63W:O5HV70K A*IQ5-W%@EOPEZ>BE4U(\FP!;( ,INS.>3K_RDK
MI7D[\P!PEMUR\R1.2Y'+7V9HMRN@#>7E?E6I)/J1L1@I1UQ8!4'R8I*29G@U
M66E#OQ68<7-5T2#YA)PVEC4X%%>JGB5F2TU>9KDLP8!Q(-B79FP (]I^FMMC
M\"Q$;3@>H;NQ#^D-I64DKY839&\#GD*,B5$>J)FAML+4=)>*)8-*X9";S;XR
MW321S>U$-CM-9+.);&XMLKF"BFTR]7V*V8!L_H*-&$ZP<TB$0OA1A&RY)'-H
M$U(_EC/BT5\D>+QZFLB1U3@".*^<]X V^4WHS")*#2F=HRU=^]JO0%Z:2$V3
M5^&34U6HGA>\9C9[NG'<;YJA,PZ(P0^!CX.FS))%R50\A>3\L)\9*&FHJ$45
M1\(F,#)U4,4E-S^7L04MQW-=.$B8D%_.4-B5E9-X8\Y9BP,#"B@^(^IL1'$$
MTTZ@Q6/6 (9W:?"4G.CPEM&4A;:+QT=C(R)[:XD&I70=#.%ZGFF)E6(&(X.L
M""+<&A,:P3^"D<NIQ[#':*E^1:E[QHNS2H8N7Y4I[PI[X8K(?R0/33$U4I[-
MI%IX TZ]E5XGW(IA=?UH[;FOZ3<83,7C#L'<(B4"6^[<TE8HZ99.GO" $\
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M!24 $P42N84)O&V>A'-XC61(HQ@AWNGMC5\KN)]]&X%B#IAZ H0S#N!)@#0
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M]IFXWP6 A98S!CP'5--\X<(?)R,F[7N)-?^#(KF6/6$MG$B_5XU7,EB-Y#3
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MW8$&.0^\O=[_+.GN!YR9!MR&M<R4Y-2:-,/MH25;6TGX%4G0\F+R>/='1)*
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M8*(A$59XKR!&#BGIS&9KR:"0+2A2Y5N[)K",Y8SEE; L*1-0(2B55"3V$#<
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M,*2"$(ZXLAIZ+QW0$@4UHF'8R!U&T CIJ3:0Z]0 4(N!C.F,Z:P#+(O\^W0
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M$1FL:(^@M$8YQ)TFPCC(&OH!YD!BAF]J6_1LX1O[?A.+G)-($,VT@-Y@;YB
M$!,K_6;J,)LDJCP< W>[(;S-#4U<+OKWOE=ZUQX,RRK^-^PNJ,O,J4\Y^6$-
M_+%R#=8,LGY]2W[G_M<1\=U)@9BNQC2..D<!T@ 09[EBAA.ML%/:".Q(JD[_
M XCS)8# S"Z>&[NX1YU:D7$$O@& ";8.((0:H 6S#&H9&T$1P!M&IJ3!. [
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M( PQ83A%&NB8_F?H2M7]SS2HEB&7(;>:3LH T,& !(Q;(BB44,7Z/HB0L-2
M)_NNGU<<*\/O&<'O@79_R^%/ ,2LEI1ZI0G&5!BF7(2@,4IRF])@P_GR>+9W
M\$LSNRR#-'&0$@LU80X:1XAS2(>?/ 0(:V YP-LJN'MV>-MNL&?7-7D5Y1UI
MU7<V=N2\<=V^BH><4U]SI'M)8!T=8,0WTW6FZ_N%^+']^[ _B"IP_[*WP."L
MW+L5;SV98JV?7="9^V%-%Z[\VC:NSO[X[$SO2[>Z2I4(,CT"V3,>Y#XQ$ ."
MC%!"<Z8Q5X PB>C#(Y!S"&?/,)"9RZ$SERPT,UT?(ETG(S0Q)EAY8)F,0=38
MLD8HC*P@B@"YVFS<9QK620!VF4=D'K%!'F&XI\8IS""7!.'8JH$+%[N[("L%
M9.G%H1H:/DN<6C^L!+"8&4=F'!MD',12[ V1&F%# D>05BL19V,ICYGE.*$
M6M8P,J/(C&)7C )I@[B5P1#1@% "E51(8F0DQ=98\G#3VZPE)%RI]9BPW%20
M#[2*^.?5"" /QNH^ND'1Z?5S>=;!)@[LV"N8GM#-M+:C1,[ :\ZZIG?M/LS.
M@T7&0@^,<RR8S)Q X1#5V'(G$+',K=*M+,>BTB&]C,[$T)DE0::UM"6!8DA+
M)35F)D@"C0074EG,,,?&2+SI4K7,T#/(#A]DAO  %FZ,P9H Y*2F&"OFA=#
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M1 4SC"!!& :.:I,8BA_=;C1C.)$5);%%2:'S'A%K&,8&,L8(\<09*+32@'O
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M68UWEK4XYUE_\V*7>J3JD:K/;:G/.3.EK)OZ,K^_=YA^;.+)M!"3K)A#>3D
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MUTC(F '$S+%ZR)$X>78<?&IM94 >K$UH#PVPAX_9MQKH(82ZQ6]L!FCU6N6
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MI[-J;FVT);=N16KLOU2L;"RP!/-N<S@:_O7KU2\?WEZ_>WW]\>O;CU^_&&D
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MUU=7:"3+!IV<Y[5!5R@H2X6:[6)9=)DEAK/_%C 8TSMPZU<UW_EB-[KVUBL
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MO<[*L2Z2V$HYL3S:WLS:9E,70;"#:"Z I^>Y7:I_0#./:M1 .G#3]PI&;*I
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MWK/G8WWA+$>C=-R$*%F!XFPVWZV]KG+T1&_$?] U&_[==$U/UXP#A"&1**5
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MF5&KV2]713UOK1UIPPCNS:W^W5FXVUQNN*T*LIUG.C!:43JYD4X[.98'01.
MG= $(-J'9F[Y)ZL+W-M8W]?B/FAA8CT\\=>UN.2]8I!% &7M_?(-*#MK84"Y
MA6*N:[*S!!U.K^":^Y!_%HZG-<R.S4&FHT0L0\O?$C7J'*G<2/^\@;;V?-LO
M943P"I&V$[_9?+Q#^S"?3:1M%+9JX>^Y6ECO*UW!YCGN%NT>!;P'SX9V,A3]
M.];QVE[MX:S#"!O#$)'".CSMV?M<GUMXT/T-A--W/I5;L]N[$ZWK,3Y^AOX
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M&&%DIPJ,I\+<.RN,^=ERD2T,$]A_AXH+\NG(36[P,:<M!W&-!(=,M1.61(@
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MA$@M?.B[3G*_/><]IS[K9:=!)9K5U*C%?MP=-?J->]H'_:EXS@>]@?KU+"J
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M;U_<1;=^4K?SL0U_#QPY<.3ZG@\ST1YIM"!/)$'RL#/17BOA6JR'N6B'6<.
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M8I)3%3&5XD2F\4X";AB9V[^!8KU-)P^RLZ?R9# _>Y,>CP7AE&%!%4LP@H3
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M/TS?SZ9S)9;SN6&BERP;9_97[IV_*'$]'?]SJ3+["B\G,_''LVH=,8P50T0
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MKT8:?6=WV;:L\E^OY\7E.7IHOC-.70:8PNCFVQ^Y,JWMX>@Z7ZQ#LRSJP3T
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M<SG6C0]X>5>F7,O/#EFQB*-=JA7[RLA'=  &\3"(AX.+!X(B"&*9$O,?G"2
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M&L0NW_0]+_1%:,:$6)8?N<1U(H\3$L61:Q\6]#T8C/A^#&UPY)W_3)KB1'2
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M[KM[ +6P\#DTL"PO#HD=>]2+3-OU73?F411[\>1 +:;)TCU5/5&;3@,)8CR
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M[O6DJ;H?<HZ"6+6=<;B8 V$NRSACIA;&U 0?S4W!Q^?'8D&PR78S!8Q$%HU
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MH6D+85LA%T1;4')<ZF\5O;*O''WPZ@+,JI3](9LV2U;>H"M'\K)%P1.WJ"N
M3B2T>63:EDM,UPHI"T.V,DYR-&I^NJ.9D.$1'0<[>O_;W!03N0KZ'OA%,Q!R
M*-D1N#3R ]>G2&8@=N 05S "O_A>$+NZ.N#CTON@D:A^)OQWRC)HA3X.1GP[
MYD!QZ@>A[1'AA!$#C@>>#R,2QZ#!GYWXSQ!V.G2<:53JA-WM'S["!5W36642
M/F3;-;X,>UYP*//4C7[?S8V-!3O'L9)"1?>:5Q\_O/U ;\6K3- _KN&O&CIX
M!FI'YO+<50-9I _E;(M/RGP>2V71=W) NF]YFZ8+Y-WB%>V.-II38\TC0"L"
M^[=&JFG:H&LG.VPM@Q&1AO:B?_OSVTO;; =T-DQ*4K^:SP-\<AGA1Y<TAMG\
M:-#9(WW*N^E]?[O+JI:A*FFP(*CL3ZM9/Y5-*+]MDMZX*R8E"WV*N?_%E']T
MA3_E5]_^=>#T_BXH7[GL[2EI<M;6;^B-JY(LX'K67^.AVXT:=QF*V;]\OG[U
M_LW-V]<WOWU^\]OG3]_^+!M9?O/--YWQXA_06*@",/SPM[_2G]<\1-^W0][4
MHVU_*VLVMVZSKXG(;6CKV3AO>45G&-;Z="?$XC^!(1ZD+=YOX^F+('!#S_+C
M.  'F(8QB4(P;V+;]UQ:]GA=4["WN8UG0#BZ6L*GC) H,D-A.]P,_( PESNN
M9^W2A=8>E7UFZ[//3CKHW/5$!ED F]=FQ(+:.RWHJ.PWQSR'O0?EO*C&>9&8
MI8]&DH.#FJ*QJJ(R#,,\F3R1-1Z6V4.*4>YT/E,GRU4KUF2NS%093XS2Y6)%
M0 I64>8:XPOG8$KD1B9FZNE%?)"!)_"$<6YY7UZ'NW@9YL*8-%9I4PQ&1$JF
M&3D*M55!)^RWVHD>EKU7-?%5&5"$P1EW%(:%'ZP</! H3V"U: :#JXZIC;1V
M7E8,R5YMI8^TVS=OP!&[UMEEUSJCTBF=%YE.>9 EU9[X;[J)[+2DHW(YG6X?
MW"DOYF'ZX&Y>E1%+N;:A\8!%&;.4YSZX0Y=TM]49E<WCD%%]<+?WL<>WO>TU
MW5U9"U3\.M$^N%.VZ?;9^6\,0:<K#?1KW:R1&U?#NX%*ITL0^S $.;/-"Z32
MX0DRL$=P/0[O0/V"HW3&M2'JU@4369:?F\[GZB[#597=:4QJ[W _+VLS[B2R
MCH2#=;;&SCSZ#&IU(.KC9LOH<*KE&=CTO?@B9A/AT@DIFLF:?A.BT52V[ O>
MG:^+4Y'5YMM_[P\__R7QYGG_GO?O!/8O9F&<QMY].1;BD;R8(KSMD>=J&_K\
M+L[KQL'X;W@P?A1>WKK#Y0OE\S,%GX^"&Y @QXN#ULA/6#0X9U%P$HQ\IN#1
M*?BB]_V>0'E/5?RN.QN:U&;9A-K;,.U^$=&BRB;_)<G9+,5:IV93S,BS7>9$
MML>$1:*0A+8;,L>*3=^V2>BNK,=J)*E7/_X]$1G-V-V3C$S*ZJKJ.X43++]P
MBI*LQB,:15@2,E@5=!41E(\254%P!2:@F<]>87V]"T^'Q+[Y$.ZL-5^DS#]3
M\*PUSUKSK#5;6M-V+<<$Q2EX'!/3"R(KBB++-)GO^6;@L&?4FF_RA83VN8FK
M*P^M,OT+-R1GE3EM@:^-K39^.1:0OS,*IL]Q3S:+O9F:?FIC/RPP@3,*:M Y
M/:C!OBC<!B!_!P*/ A]T_),C\)'X=120AK,'((T_15%KNXZTK!U5M3$T2K\(
M+'7-[]+'N1%)(#D%_CB;I4PM9%'T^9"E3 B>E_6I6/A9XKOG6BBT52B0_?+1
M&M Q2N;IO83^4VB.H)O9'8ZP!&!$Q'E#FFZ&H\$';(D#')-:!+P+WDEOVW!K
M!3':+UU9/(M ;,.@JQ3>7MOV78/>$T=N)"(3C%S!2>BR*/!CW[0BL(8=$GGA
M >W>2:)5,5CE9&'D#YF@:S"3MJ1RY%+3]!@G+L(9QD$4$]>#SP*3!0S\CBE0
M^;6<^2<Y\;TZ$Q=!V ?>'(8+MBV9D8-]*Q9.#,P;!H$(@HA'U+)=,^3<G *9
M#PH%%NJAP%J2:2B>XY:T#T/PG2V$"Z0V\;V0$M>-HEA0CYBQX_E3H/WA>S,$
M&@C' 6!@/;R9\19-H#7U=K;JG"L'_E292FLL@TLP<.@"PRLKOF?TH?M5::X0
MQ$J:B04LSV51.-LQ--::3R3  0[RM-4C$>6U?I&YID6[Z\IH0AE2D.^ =4\5
M)%T%DZ3 @_O?%X^JOB\M1OADELR%\6]&<H]G(D ?(,DLI8OAEG";>=K@3_*W
M#GOUKQ];?=SV@YK/K7^N?_IFMY<-+'5&@ND]G=7OZA'YFRXEMQAX(^JZ%A3J
M/].4/R:SV?6<@SRB\UL4LM=@NR[R.JJG@X8"#4=B/V)N& ?$M.(HC&W.+3#C
M/.&X%MD#-!0Q/<]S>$ ]EQ.3^-07E)DD$(YP/1/T^;<#/)O5,J?G:'1J^II1
MK(&E]$5)^R^?/KQ]G^0+B2HVOJJ^!>RVDN\J"+?=ZN?;@&[*!>S&/A?IPQ8U
MD9;YPX:0:_N==+E(5[Q3CW:V\_%.,=!R#T@@HW?SRP_HZ.6Y\5'D @T XS_H
M/0SB%]3VZ0/J\2TBS,/CH_53:A';1^P:+3<[$D&OV#=ON1'[M&[@UXI7;3)(
MQFN(8=ISR\#3JKA$"Y1P:%QB#TNA16W9=%.W^9]69!Z$?&/#/J/(6^[H@['8
M7E90B^RRZ2;RHC?3J"#?'I9">WBTZ:9NBZ<]!V GM0U'+<R[)M;>;^D7%4ZT
M32OH-,UA_UHF&-A\]_'_+R.>&&NDC&%J5@% B!\84=$W!N$(R\8Q.N0^! O,
M$+KPME3N1:B3RFRO :C[I0QI11=,\&^Y;[J^3R(>AH[KQX$E?,89"5U-+Q!;
M6;K[:!RS]6A-F]+0"X(HBD-"& \LX&&7>=P-G)B%JV(A^QFM?=6/:_8^:'!'
MV0%'@D!B:PD58Y><D2=RE5OK^R R?#^&L!? %W/8\3/LF#0#?2%!)!O]0U:%
ML]'<PS52G4@BB@'Q=%ZV?BKNSMNLVFUTDZCV)/=X;#!+_L#.1_#Y',/Z52<<
MS0D /#A9-/OWB*]XME!,IW-B@<R?+V%/J-:GJFU*\>B"#F63*OP(J(!/5V0
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MX>-?LBOC5[J !ST:U_-;,9/GMWGKL7?TBX GBCF\0-S+TVD5,WB0,8-%(V8
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M@$1Z-R^@2%^G>7.W"SMF#@TLC]@N['5!W=ARPCCRP2V,J*V!9C[1W=Y))^O
M<BEX1PIZAT95_\+1(A0!NETG]GT16L3E(N+"]N)(Q"*(N&^NB'R='E%+-7BM
MAX275,:L/DP:W.+HZ5Z=P/X.'Z;9 C&0-D3^8QY%U!6FY0J?6"8)N>\X+'(]
MGUNV%6H.]?89P=@'E:VK_K&>#NI(V1?+FC*K9%%64K'1\[;B\Q*6GS&U ]"<
M:,$G170FT<7R.PETIBXOC"14FV""M8H$+@RVS++:0#)D SRPK^[/89FS\RMU
M_!C+8!?@^GV&9<;/>U0IE36RENHE;)AI;X8!>#0%O[V;][+]*V]4U@N5R>GE
MIY7;W$T[ZH1(/LG3H(J3K\'TX*HA27DJK/S:?Q0^*!8.2RQ->9&^C&##M>T2
M@U^RO%-3)F]\?9<E^2)]P$3VC^D=%ZTWO$VE_57/\A$M@^AIQ4&S!+N4<(^R
MJ[MLN3&;%8C,%PCIG(.%+5O.-VA1@XHB 6;B5F5BY:"=P.B%?W+@O%E1]89C
M_M\EOU6_)7.IP# O7PZI'&_;4(1AE,MU)0=59I:Q&4WNU3/+2CGYLVRM,Y?'
M.7!U 2B-*6B%EHZ 86%CP,RQ%&'1>77%,$4Q7W,HD1Q-PSB(Q!V=Q:6%\ ^1
M+\IRND_IXU/&:4$0L$$66%Y1%Q-*#.V%,"RGM62OX>U(D==R;MW(Q^?&2-49
M:)4<H-8/C FT]'K+J (8BNKWE,O+<Z!&'@,#R!4I<!NSQG+)Y"4M,1\1S19H
M7BQ!,;R**G6 9@./7[1H7[%B@>()0X-W(3:H;#4TDUQZ452 2!=/^A$HY.07
M* SN%<JK0BO/2L#6<C8/-(=W%@4E3>;H<VW%I1<MBF1%J6'ILBA4=2%/E*OY
MU[6=C8&7.,0U_+"&P9$M</$*%%AU59,CVL?8I=1J\T1^AW3#6HO"S8('X#B7
M#Z6X4MBPB 4OK=1&!4UC[/$2G6DT5L'4I64'LQZI6L) *$>XWMH7-9!\[?@M
ME)$LQX=-H_*\,<SV#.^*0DQD;,1?NTLS]!-A'JKN5)6NXD%KJGQ]<'AR69V)
MR0(<G#\9T(2+VGRMH>SA@("L466:UL@ZS9=@D+P$"WXK3(?QO#6J@M0:64+Z
M$GAKVGPSW-C%CBF--AQH[,:M/$,0QDE6J,)857PJP0<K!98*?L %Y1@UD#@"
ME10O#:Q,W"YG=)%F3P86UL]O&PW9ZLC>Y[LDX\HD+@Y[/@J)!,V--]714N]0
MIZID'7)<U#V&:D[;;-E/Y=,N-QTFE1&:!\S86>!+VN^LB"%[J)2)1S*UK'CD
M+=:@*M7>FX,,P4D2K:DWKDMJ:=>?V'@F)M-,J:+Y13-0),_F-D^^=Z)[49SD
M*?-F<8>K71X<5[0HI]>8>GWRAZ48U5FB3*]2E)(>0TDTQ395!P"Z4%GRCW/E
M!:PY)BR^^J!NJ5R:N##184(/H/DE"H6L)HZ?E(G!U5QEM*UX;2KK5S""6,#R
MR_DHVB,OE[90-86J(KNB1'LTRF;9O&ATEJ?&]\D/S9ID'/Q&KKV N^ V62LM
M.X;V<3,D/D4UD<:R%)M>VLG*0ZHFU>-;,(V_).DR!\-/O\9R_>J],63L9> S
M!W8M3FP+HTV=V>286UN^#7B@OYGZ(U")N;1%GA9]JDX ]1JN?0=:RPP#M;1*
MU5PSN3H04$VRD *OX6D7,M: [4-8F4E8F=E-NY9NP+C_-9E+:_>=%!KYX@9V
M29;?)0\?1(:%J%B<^?2!9NUC$&;3*!1^X 0V(<0* Y=&K@7:/[+@4Z([6[(L
MQ_QG]709>2_G\NZWU[J(>]",N-M5P/W2WM12MW^L\9UJM*!,^%F1NR+GVXK6
MX&!J\:4:>\C^4G7)N6+T:FTV,J;"F?D^^?(#!NY3?%R/+RIG;<#F+IRQ#5D4
M:9V@X5TH!;96%;:XZL)HBOT"'V%&66/H/6'=A*BH'JR\JL*'4B-&0=J1Y_7;
MM=LNORB=55B+V=/5D2S>4=7\]LAJ_K/%.R&+]S@,9H\J7+9'%BZ?&6Q"#'8S
M-]Z**%MBW8!M:A#B+CHG _.UZ7/?-_51:<>*2+5N+T3R&A])BS)4B/ U$$,:
M*[T-%[323+_ -9KQ1ZP*'V>Q]\WQEF/1L!R5@[&]K5XVAWK(4KYDBV[(5&JH
M<I0*1ZZ15CG,T&\^0YGV6RQ:Z5@V3/SV<8G"RRDL_])M7FWX8QX'GK& XPV_
MSYXZ#VX^L#A&N99-KCZN]QT[)8H'E*;C.@?\B5L'O!AI.AK5]D#00#L# YTP
M+)"] A9H7Z! $X0$V@40J \'=*I@0'HHH/6P/_O*Q+%'E=_8(\MOSK)_.K+_
MIA&DMX@.:KEK1]/& 4)6'B!4AFK%J'HCNS2N-YD^ZRQJ=48OHREH4R*L,-JF
MF5@\;:R3:<)RED:E2NKLN1-5G*@1],?3@D6ZH;ZE/;=&F*=G,N[L!QPL7-],
M9-EHILIH>0%2)0^H]&<431]+?(6IY74PL ?@7$ZLB(;+XR2)8:K"\O)$1LPX
MWK[,JP.S]F2:=WT1LN .%WB)WH,,T_\Q3Q\O[])'%85.<F,N,,E!%J-G=1Z5
MO"5>SE0%.H9#F:CP"]0X>4GS,L(M&:=(EI>>2NFX-#PKF=ZD^D0_8 E9@IDA
M:/.C+Y4K1I#5\\79E_2]REA@_<0?ZO"HY$4IF10@>-47^JG#5*VJ>IDTG<ND
MLD66%!E:15KSIL5O,@KN OTF6!./EX>?"!#;/"VTY1;T+XQHN2@Q)&17/VQ.
MS&3Q",@R)8=4WE2SJ_-J*(!B&-7;K\M'?A1S\4AG" O01 &@,67<MWP!6H\$
M=N"8E%#/(=3T8^+I,N>[#4C7%?#'**.>P.#JE? ;WRO7MH$W4VS78J 5(7'$
M=4UA:R]A)EF.R4-@T^6+M54%GRIF0M"E9NU 9 9.[(B0,ILX?AQ$@45]+S:=
MV.)5XG*; K85*@I@N<8_/]+YK9!'%;^JXIU]%@:LZX&,G-T->N A :9$J9_Z
MQX9= 5(>;-3TP4J"2DI>5,N@))WL0@UOOL,-B6S9:OD-.P/M:B-/EQE3D,@Q
MR.U6G^\:T@)X'H'T^I-8LXSU>=--W%Y2A*AY)8"6HM@";ZJ<@U]@KDVHDI 3
M8'N7>*%#@L"AB/LFK) ZH<^<,-:N.$9B]W+LU%_.[\KLQO8:E%EZ=<"FDRY;
M]+)>#))+?7GV2H#K,U>G7.U<9=(VC^1*20T8X2V=^M/J'*?"?<+"$V N>7Q9
M8$ =!7C.Y3YSP7IW_!!DF3 C.[0(+')LAR[GEGY=FSOY\*!!C4K =DK,D(5K
M@5O"NA2"4@K(=9A"@P)QVZ&.#T288:[E!C'S79^$Q(Z8&WN18T=4N-QV-,>_
M0W0+IT\2&*:G4! HI@2&><PPD69>0,/T18PZL)2RJI5MVE"Q-2Q\\V!7&6M]
M\WCCVK42%<IU GLL525;-:YHP1OMW%6-A8L;$7P$FLD:+Y44=5'GG!9!;+D7
MBQQ7C?1?#7$:@=*6.?=59FT]*IKG*5-)]@74 ZP3*U\I,UUY^X75[,L7%RG!
MQ?Z'$3U@=:K";H<IY?BOU& J"E_$TPOQ*#/ 6\'X.@6LFV&Q'+Q$APP\CZK]
MMKNUW^?@P\D%'XYU3CRJ\M[N5MZ?.>=9. ?9Y&7U%WWS%2B;8Z&-6!@2@B"7
M>G5HY]WQ&V%4H:G])^Y9>8+[Y5DE[:B*7OM<T7OR#'9384YY&P\1\(M"!GY8
M9NR.MGPM/&50L"PMKZ I--N=#, ,!_M7?5^Z.-(3@2%@49]J/ECFJA9QS?+%
M%41$IV OSY>8GCPOJC':3V\4%5Y406[04,UBP]JT[KU*A9LI8]E2-%)&RA@4
MFZ72B,=SB2OCDQ"R +4B!CFD*3ZJ ,[^$Q? O93]>RP%,:H*SCY7P9T\@WUN
MR/#:Y)59<T5C7;JZM6[561<[P/YG)F[3K*[B?IND"'OP>)?*ITD1NKI';C&&
MHNI$0L87$<;^Z%12GPSN4N->18!7G%=&*<WD:6399G?@*RJ0*%X#HUW4C6[;
MT]K0Y;8^C2BFN\4DJQ;#/64G(9T66*V/5?I)CE6&<K87!8I#W<Y7WX.X'/T]
M_5]5%)XO4O;'73KCVZ_((77?J'(%YURN</*BZ4BZSQE5KN"<RQ5.G\'>M<%^
MUR=8W3Q(OFK5999W!Q<*+1A/%BIQ7XC)9E9/\5'W46OJBLNG5$E(C1'BSZEZ
M%%P^!_4K4834N0>.7E-DT2]0:/2:*^1[(SVERJ-!'&0UDK)$89$)NBCQ0!@>
MG.+[C+LE\*Q*^^]2HD?!(CFI+GOHH 67*FA(5Y[B@/4F5F]Y*YJGYPX1L?!"
M-Q""$'"G(M^V7<]V.+/@<Z;KLF29);:E9>*IWLI3UN%=T&S7O#!-36I$.7VU
MF%63EG0YPP(#@P$;)@N%'%5C+E74E9D3>!I5.NW@\+,: EMYO*K7,#RU7/8D
M;G-XYYQ>4]"[8A7;'CI/N((<^BHREA30L^6\RI.[5?S0*,V S[O0G/;F)L<[
M:(%191;.N<SB]+7 D<R,4;G<3C>7^\PYY].NO9QVO4[G.::X@IJM!;!*ZX;+
M0.K^4GC,!S_^<D8E&CCG1(-3VD#/*GI')1HX(R'^SPPV'08#!^]7^K2Q>D;B
MB!?"L-/&!T-^5213HK]6=G?UE:8G> 3>UAR!&7G=Y:#YEK+W=[>H1&;-5TFI
M"NI1A>,.E'\J I>:OO!(S&(2<09&O^<QC]HD"EU7G^_HEOF.INM8__R,AWDW
M\;LY[(&$+^E,9I67VF-C6OD6[I/>>VKF:=<4KE:IL9ZT:C[:!'95]23H_XA$
MGAFJ,/<!<DO=@(9FX-B!Y]H$_HTL%E'.@8IV& D^H-WD,%JO3$!UM\@_;;MU
M'< MW7ZILT5%'"M,&^._EL#%96>%J\:.0?ZO,?T'1.UE7N5_+>="!5I@VY2Q
MEZ(Z[H A:&=4?HYSSL\Y>?UQ+ -E5'Z.T\W/.7/.V3?<BV\HQ795;%O%X12"
M2X)%,E@Z>GC'<%3:BW-.>SFEW?.L<G=4VHMS3GLY>09[-_^"$,Y955!=BSQ@
MB"\B6\CF#W-L,1&7$J^L6N?&*XF#]2I1",4?$W8'!FME__Z#WL[Q\]?PZ0S6
M\_6=;"J[*+JM_P:7IS-P1C[!AWB=2H3L#*@M=8<,ZE?P-['-2>=UZBU7QAO*
M[HH3OGM50,:2!UI49<FZ^(<'4!7*-ZJ>7N=+=O!G.X7J^&T-@-W"IL5,4'D*
M)+VK:J)U#J7A*6>LKF-+YLJ'D=5KXA:(6Y9F52/#?BXP*[4&H_T)6/0B,18G
M<KV\!:8I3G.="_D"M9A;OZ ^G1OZHL:RC9O-K]A84367A5<T7ZE8#%^BF&$?
M[E?S^9M]KW./\"G*2]!5XW7GJ+PL4N9EM;7DFL:NFYJG[D>KZG1$!\[J):GQ
ME\"Z;72QT7Q,1J5_D6[ZUY:\V?'.=G 9QW'>4$_P_R.7(.X_O/OP9D 3YAT7
M8E0&!NEF8.RT$!W/8YC_T;CF4"+CK/*F)S=&IOX<68GUF]RL.09#%(9,U4E5
MR62=\[ R5;#V5]21E\0^4&EL'0#%),>,1J:!5($/UG=P^(09Z1]%.98/67J;
MT7N%"GH3?\(^;?FU:FKV?X)_3E^)^F+>!,]AENE3$5 >4>+Z9A13;O,8/"R3
MDB!FVIX.MK--JV44D:53J3OSLD>>>5U8@:M/&L2GYQ>&0+<.?Y:',DDN#V6
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MS(#Z81 (*S!MRXN8#CQD?S+:GI2$GI@A==X4S[8IXL .0A+'+G@?).)1%/"
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M0(=E^O3(\,<VI0Q)+NI^W7?9;%;Y9(OG-&ZVG4B-)[>&M5;X A8R78"NFCZ
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M<>DV0?ZD)_P\^_(",P=+F.XD-5*C2Z%@4&8"9.+83ZNL2U,54E=MJB-/=_H
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M^TDO5B2MM_AN"^2V?K5I>'\G37W*Y7QV7:GRPJFNU,T7ZK;@>FCYK&KL7;U
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M.'%9Q".6!&'L,^D1$C,1)8*EEDC$(T4P&UD\>!"3V.I$/*:A^11-R/';B4_
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M/"&N,>O)$>N],1M,OWFRG;GMS&UG;ALYV<[<=N:V,[<]Y?S6C57$AUG,:]#
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M-0SK"5;+D5L(S04&Z24OYX5<1:)E6G97_@#"> V&CD"GQFX@OC$S:(L6"T1
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M>LU@#\J-U?"#,>0GF=:8'\'2*#($<E<F^%]AGRL;D3GRT18;!#EC R%GUEW
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M-C! 7<6@NU)/T#$_[,R>X(X0!"0FD50LBB7S4AHI&E+I^B12,F#IYE+ZAW/
M;247QJ+/ARO!L9F NZCOL\XYZYQC6*$J)2I0B1OPA*F()1RL3)$F*?&"( C#
MC5;H@0X++F+/'['.&6O0K_FX*!73(M3..,M^Z85VIL/B\^+3[[HL?C@ 8@VQ
MK&1*#ZP-75\-(T?(,2;.R*(TB5KO\IG\,2O%),<T<QLLW*<D84E*0P+_&P=A
M(GW"$N6G7))8V +G.\/"%:<R9#*)%(]8#!^(KR01@L*>KSPA-"Q\)_3GCY\^
MO/T9W+K/^T% V]C.K9>CPWD;2F56 ZO>H_'E2P*G_9S5^K$',R3!NB8XW??Q
M^2Q?\;X-6-Q=%'AO@(;O=(SZ[QSS"6?E%D7UEJ3[=WW)[N/>VU+;W+4:[;R9
M!P<P;A\BO5_RRE:E7O9Z6XO@PREE+4^PZ29O&%)_;[/!N_+@/[0TVTGFE\#X
M7.?ZV9/0+T&?]7^JV9PA]GTB9S,PG2I-U<M9K^'_;@.@6ZH9T]OZS,U?P1Y;
M/-)=8Q[WTO7U.\":R N]E$T6&9@F63.JUN_5H[J_]_,A+/EHSUY^*+(O6$/F
MPP1&KM-_ERMD;&+A?7C/6J=ATTT#RS0<FO?6%#TX+C]V]K0GR:&V0BS'9#-K
M:NJFFWQ[OLS3YY]Q\\8*4Z93]:3WB!_ :P,3&6O:P97_S2XI=3[\].&-\QEG
M:MPO6[G6+>O0[,-YUJSC33?UDX[/"NZLX#9QS  VZZ=JGXK-MJH;=%:!?0/.
M6I=PZKS+OYC<-"SRLYS K+,/=!F]6>YPYWY>B%N.R<HWA31%D[ X!_CEQ8RW
MDI;QOTQ79,Z+$N\JYUBO#IYA:A6U7U$7.)K"0^&I-U51PIW*UV"@XZ.L1_>A
MR&\*?F<*T;]7IM3']7QVFQ>8BOTY?R47%[=KTB@>!&[L2Y'X'+A <!H+"@PO
MF4JYC"UMYR@AU/O'1U-]] ,O9@^M3:-\]=#^19]%X\;R4T69]U/KV7.W?+W?
MQ V#37'#J^63"@=$:H($PQ>4%V:U)(<EP"]P.F5FZB@"R9]G+S80^C7&6]ZK
MRI-_7WQ$B6GH+,6\ !:4Y6N.#;M?/;R!%W6O;4.[:2 \%F+]%- N41P)5PGX
M0T51$,21!=I]=&+_].[MBLHJEZ442'&4Z5).G[T$L5]15F6IJB3&/IYG*VFK
MJ_W4-*QC)#]-D798$*9-,:8"RHATPRAE-(YXE,H8&\9*Y7E P544LZZ:)M!K
M/<[ZI0V)1D+CV==\?;FEK]7 +PQ+RV^R$%FI(X>@:AIE=3J>CM.8!E'@QT1Q
M6"@1D91[RO<IA1V4>_[WP],S7?K.$%PN*IK^?@"MWU1/^8 /68A ]6M)V@WW
M%'!](B+/)0ES?<)!<RC)_9"10/K,AA,Z GT[Q?OI]O7#KN@R3A K5NM*@ZW-
M=1,UM<9 W="C6.<H"SB.BL"7D63$]WB:T(!['H%=C BV:B>KCK)&1#)_N4$]
MDLQL7\^SJ9C,2RP'W*NQ>&0^]+V(@/9U9900EI(PC@*@K%**L#",$S963=Q9
M!F_K97"O"%T^D=3K4*G@%Z;<W6PQ0@</F4P%Y*;^ 34F9K<T7@&_P@JF+?,/
M3.2RQ.+L0LJT7+8&-ZSNA^K&MT5^AY7?L!J\54K S@@"T,PBBD(64#]RPY3%
M'O=DD*8\L8!,*(%_Z@-?EQYX><A RR^\"E=:?EUB@\#,"S3HE93;$U8KG-;T
MWL+-'TP)T?;FY_I)X*K(]8.8!;[/TS *.)C14:B(4)8ZG,?0-$-IZ%Y9-$UM
M/=?5R)?*;#:-!ZJBJRT!V*(P]SX^N[7RV*:;^NU)SJ&AWTAHZ+R8XUS,;DAY
ML#*P5FC;=-,A&^DL1Y>VP#!TUOVD5</1B:M-%^>6I\O.3 _[<'S7QF4L2A,5
MIF!JL5 E2<JEQV@2NYZ;^.)$N^>A79O*?7Q>SI-_5I71!? ,+&SQX/ 4^4>?
M&[^X<!(I@* =)]Z*;M+&B)7:Y9O%O9]E<==V'*D?NZX;IXD7L22,$D\E/DU4
MZA&5A'(SG/@ =.Z[WNF\:%SO,OOF@/T_NRW[P!9'@16K;8NZ74M6F;2F"K+\
M=J][K71.N/#YE]FWR]LL!9'\P23<@1-(>)#XL>),>%'D!E32A"<Q^-+ :,]>
M*C##+^&9ER DE[=\HJHSKIXLF$*8*X=E#,XZ-./<26G*Z(L"-"^()](!*]4C
M+$CCMS*5F62=K2RF?=2DM1'31BC0HA%3F\1C;HJP\7"R6[5Y/Z(2:].HC7>1
M[X^JAR'G(.@9&5C[]&P,CL@8/%OVW]%B'FC+(H/PE60@P+)#:QHNU:=[+(L=
M.Z?=9--+Y(@?G%@?7E^;3CSSLC1MWA#;[@07^!$(-I7&2-<'GFA^+(*0R]4@
M!78/+F89VIQ3?(S*IF#* ,]<5!WO^N<<L[:)\Y5CT\IT+C"NAF;1D5V%B'F^
M]-+4)2)@"48O/3#J:!A$J1?2U-)0_0FY"N A')E\)!),4"(D2U(&HA*',O%#
M&<9^PI5*;37%#N0!'(!\Y(JM.!'1Y-LNZ'A(ZV\0!I><0;A/?X<;;*Y463NO
M/GYX^X'?R%>%Y+]>PS]-YHZ8@(NI<\]N&]4_R^_KS:3ZILY47,YFL+_G;0ZJ
MO6A>TJWDOBP3]H<88$!GM.T%;<JU+GLUVW%H-"!TUN7B9R_?7M*XZZMLG)9>
M@V9&]_#-98)?77(%\_G!X9.O_*&TY 3=%DTO09,_6I%5,Z)E'4UBJ?ZUDVYU
M6TU,5Z?I]Q:PM)FOD[#^N/44_U/R=.7R6U*==BT2L7%].FU\%JN-CB5W;@O<
M%_[C\_6KG]^\?_OZ_;O/;]Y]_O3LI4YI0XOC->Y).GN*OUQSO2V?V @GMU+*
MMAM8=XA#[AF# /7DC*@?#YQT)T0]T8CZ?J[0::(I@Q#TY RA_XV:)\,9;1"&
MGIQ!]"/EGYU ]+_HBNS!'@!Z4*4U7KZS$6\'G7\$J+R7!+X*E.?2A#,WC&/F
MQ@G\P6(0!6HKS$U=SPVV1L#M!W_; Q5KB5@P>^?7&E,_#CA]1$,:2C]U?>(R
MP>/$%V$2IU'D1HRDL;5X"2[(Z2F\(^[8UH*[@T5^GA<ZZJ?[@&/[89FK"P<>
MZMP7\E+-=0^F^K"_C0O'2ZSPYA<+S#Y>L[BW+YNGQI?[810F,I11K'S&8Q7+
M0#"5QD31. A]]\E*W1Y8] M]H-Q)'ZKPHTMXZIU0I'9-N="-U[J_>@?"(6"[
M)TG,>!2S5']*>>*2B#(/%LW2'OBQ5V<H6)+0*XL^["!.[5!@LU/&-AQPM9F=
M9ON*4I?$7N(S+XY8H%1$6!S+A 8J$4FHK-W']]:6_VC*DYJJ*#ASX'-8V=9B
MZQD>L@-TZ&_N6U[U@UZ2K$=)P@N(5"Z/_-1S&1413P(9$Y\'E :AYT:[2]&'
M0K[5N\")U-SVBQ-$=LMB>>,J]9;4_-'>QAYCD1@))?>DEX#"8XF4"?,X)TR1
M).!NZ-F.H)[&1K2#^6<7FM/A[1D1@: D((D(F4IDXGI)*KGT? 3@A]8>%P>V
M^ ;O'VNVCVW!]EG9WF,N*O=(M[3G=>6_&I:O>%9@/;QY8U%NE##\0\-$%U?:
M<@_MZ-$3X$4Y#2.F&"QVQ%@:A+%B/@$/0"4>DX+;<E<>7TT.//1TKXA-2>X$
M+\5#^NSN3J:9$;T6SO0"2#6?I$ZR..GOKK7.=GQP9ME=!;K$19_F!GMI D6(
M@KS:#&5[/-2:,^[!G:%.3S?2>BBHTZ"4)A)M#R0]/8/;R_ONP/.'/'8;E"5"
MXC'3=R=,[EE_?-_Z8Q"\G[K'38,:B:#T,I[*Q[%914@]&:614(HE*HJX#&7@
M!\QGRI/NRJC+;E[C86"*T17=V^8\:DJ3"N+0I0(< $:Q"@8(*W8]3"GA 8UB
M"S$/E-*T;SY3#M[95SPC.4!2DT^#6(6N%PJ?,N'*2,4L2&(O=4/)1$P/EM1T
MZLV:#LJJH3MDU8Q\LQY.N6&UF\\)-$_?D!@CTZ^L''ID0 H=E#A"O;,"H8,@
M[70@I/V(5+2NVG$P.2=#VWS>)G9K@L!"X $MQM[Q?+AT)AE/LHD^;#?X1.?Z
MTVLG(OXE [T-%\#&7[;2>NZ+_$N62G.[(WAY.Y%EZ91 P(F![N@K2A.SYC,G
MS>')TWRF<YX[(H\F18$YSX4IDUY'H7%RWPQ[WLRS%"V-I:'I X7%N#K30$/T
M3G)LYI%BE+(5YX:_,GC<O7XX4@?_!XLMS8L"C:^$EUE=$%+<\ND-/"Z;MI\
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MA <G//A!\&!GK*V-(*E$ L$DQK&20J=:"4E33922<:!OW>:LO3MCYF+3NG/
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M"CS4X!2GU%AQAV,3$R$EYL+0.$UHJFDP5Q(#\H]W^IH/7UNR&M][,:>:@9O
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MMM9"NHH )_;[P=C/: 841%APK'&*#*<IB2TW&B8ATP(=^IBGYPD&3X_]>JO
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ML9*8,BA2+:TLKF62 ,I(0"3?X3$=GT/4PV/ZT9S%NS CO.)W/AOQWUJYC*/
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M)GFTJ4M-CUO$I<PG?-@C,>5))PL<$SH?4>#^PQW,TZ^UNA*%K^'4Q%S-D":
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M/=ULJZP%[K)@^$B>PM0>E]GQT9D:2^)[.UKH2_._-2U>U:38!$.HO),S(3'
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MI4K?[(QJ,G^;3.U@,W]LF:HPNGW^(4XD3(FF:0P@PP2G3#*&$BHX5T!#$X-
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M4YVJ&#(E4_*P>B:; SE,0UU(^X3DCX*Y3UAUPJJGBU6&,0T4QBE1&AO A89
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M-9T,@0"/J?ND71,6D4MV%_"/C+.[+4JAQ#30G'+)&ZTZEBUYW]H:1_-0LO$
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M 2E0=."WGT6F[MV/-^/;X8O_#U!+ P04    " "3A&Y8M7:80D0J  "%_
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M+S3G+K;2! >*0;IS1TC/O3A@ )6T&1O &:>B;:'X_ /R><?W\.&J@!%1/L1
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M@G(/G0VP>ZYEJ[9K]FD"FWW%L@G*IM2 %AW&KV4"0@T8 N^T3!]@_H_F=C#
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MPA 1:%O_;:F6Y1EHM(61X*H_]M@4I%TD1L8_O.<V+TC'Q]L^@3KS03??5'[
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M/P,G%!PI\*WD\GV$[%!*2?\<Y<68\0?<VD)<0*:"57-"7,LXD(?%$&9/A)F
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M/0ZJ0_M)6X6C%B.JLQDFX'N5%BF\F>LUGAF6YA/VL=2&,@F(3Y%F8,]E!&(
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ML>M"QU8G\"YJ6B!K,5H)9KY$O@SU,D494N ZU2L,_]I>W"9+Y5T=<HABN[*
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MG[F)UF 3GW\7%?R&?EG7FPQ^^3]02P,$%     @ DX1N6( =^?3&)@  )=<
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M)P*JHZO14',V)Z^6;=,#2H.AG'P#&JW)L=4R)FW8/$M72HWCK;K@)U6<@(S
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MMTA9_B$:.L90;DR9&9ME3A;YDBSU."YU894:R&.]Q& &0PDFNDJ7%:9EO9R
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M%^ TM26%6C0V<UC=I>V#AL_%,HT-U!/!0$72D>^>!Q#GB=$5$=7F,K"C=MG
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MI_6W!2H4-K?0DQY>[\5E)@96]0XWW.;E&&WV*B@8O:I[J%Y@Z:**#>HV3^O
M:+I+^GPG\5S'EG%BNW;L++R%XT3VW)/QS/5]]U$QFJ=WQ]6.@BUT:_JW1XQ?
M4]H[MH5Y&"LZ_<Q@\/+/]JH*A,RTE4S8OKJ 0SKB];O1+4GF0NN#)6_V($Q8
M-4D")YSR.]&^4?=/R+A-JV$D3L@%MW+BD0@&21D+6ZG+S/&Z'^(LB?@R47>
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MM.V&#(FAWYX]@LH_WRM7!OM<9F*X1B;2$)$JY/*R-4[7NG%51L\YY[56F[O
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M<'<N5TMAKW !)?;7N@F-E2.TE)!PR?GOG'A&E3,,=#I^9^>Z?D\TW0Q-QON
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MH)[_#$&S&_]1RX/P9WQ.<$6UC>("[J<7]^=-L:$?EOVJ@A_^/U!+ P04
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MLJQ852\> QS^\T_'/QZ]? PK.3[$TU"Y7A@+S_ @TDH-G1E]%[Z[ B 7(,9
M/\FRM4IS^R/J(^[D:*;3K"S6ENE>Y ELLH1C&OF![4#V#"=RQGY4PI/NBG$5
MJ.DD:I76<T80 VI1K<LUON^PI1=U%(QPNBS33!W_, )EZ,_/U!Z^*)+GTJ[J
MS*_*BB!>=]\;M";8-L" $;HT54U@ 1S5%@SNX7UW_+#=_D^3&W7\##?[\W&T
MV=-@Q5=V<7T;_WP\_N'';XV>3A -@&KZ (:@O\C;R)HT0"PZ*9;X=IHK/8$W
M$E#Q#9\IG">]>_+LN3W(_S8Y$"/@6##4.[V"GRTRV1-^.IM@)3\<J@]-634:
M%.RZ" &[-]F_&[:!?*FW/^(BA^,5VJ[L\2!)I: #S) [5O3/I( _\J)6TZ:$
M=93,,&A)R[*X32L8S(F\NT@3Y1W*P+J8%D#FEO<4I:J:Y3(S:"N:9$3?XV0&
M&7U>J"2M@'DL ?G N#/URI@<?B^J: UZ8%G#(/&</H#,$VH&*WG&T@-'W^T9
MX\&*-N0$#.!^"68\,INTKA2\E\(P3A[O1%?Z\D=DE>J'SMFK9)^"27'V[EQ=
M?/65/!Z<W:0WAGI$P$F=N;Y!K]QF:^PB^NK*^9=!N2><BW%.)PFPLJH'[<2U
M4P%[FX')"&P/^.$4V*5!7M>O @,F'I\<_0R*N\YG^$)I3#VR[Y^E->G1OZ?9
M BS0NLA',&&3>VX)/^*2SW159Z 9.,6K8U:=;5ZGGJ'_5M? O2=SMT=8W4W\
MK;HI <;P9 %B>OU$+1UJ>2*7-HNNF])AX1@C T0]I5HV@%6@VX$^,$8Z CM\
M4K,* ;K=HA#U@7\V^0Q0E"V4?(T.F&F3@;%2X^OP_]);)!501=1JGD[FECP"
MZJS40J-:&7AWO%M@@]K=2[=/B-]&_-^^^E(>#]YW@RB=M0^/9S=""GE1 U+F
MS6(,> KH5\T!]TCT5'4Q^<BXWF;O^%:6J;F^-3[&IALPI$JD$:"GM*H:%CU'
MQR/8(_Y7QA[AX#SL,?\0_"@CCW&ZQ0)FNL95C-12E^I69S#FOQ\>'3U72U@M
M?<$F7C0'?_^A-%-3HN"Y:P@),AT^GM-5C\NIO:?W!38/P[I7S2_7!MV@ZK1]
M/*^^;WZQY\#^I=A)ZTPW1K)_L9''6*95Q:,"7K6&58FI $1D%(JR[E9P5N2W
M:&R.LPZRB!:/$J,2SSR,??S\Q]'Q\8E@ZOVL>SF$<C;>.QHI_+_]W;/D269T
MB<RJGKN8;5TL[?G($_BY+A9V2#7)=%7]Y;O75Q_>?@#Y]QH,YX^G\#_?_6)A
M'DZQA%<.QOC.@9[6&/_5V4JOJX&!_"!#\6P9EZ/)!ZLTJ><OU!&%L;N[H0 W
M_RIO @?YCY?*AK]/[A?^#J/6#Z&T9W\^_'E7I':\,U)[ PI+@AZV*P1.%5+8
MH]CJ0]GM3S\?/M\5U-.=09V!C<P)#*:YLH> [,+!G^>Z8 -,CRN#KG!@,*!V
M.C['GMMEX,T%^56KO33==\[(JAD#Q,A#J8!'[V7[(QIR#MJ**7WXL,MSG91$
MUUB=69?9Q*2WH"<WBR8#Q@M_)G;Y-);)2;VJO.BDOW0.Z@/*U[5&7EJ918J/
M)$:FS#_A3_BC D4C6]#W,-B49FJ-5N3>O3\QI)(<DWSG& Y^9S3H#6O@#&Q_
M^@56A5M!P1I\, 8H[3+$*N6-+W5*T:G)W("8@-^3$A@:@H$\OP"^EI/GRENR
MOQ)\O:LG!W4&S0PRA@<@GL:VL#?N,_P2_N'MEER]+VYIY18:Q\]QA7\%XP+^
MRM&%NL3#2E PX2#H:4?G)T* LJ02-";V5G-#CO:B)+^[]G,D>@VX8FUQWJVS
MV:UI#HM,X:OE$J!-R\*I>!,BE\=%\;'J,?\?P&!V2-4[T:)VRF7^"#;#>LX&
M/G-:#WEGG(=GB4]''2T?K=G$@%Q'[SM0(6 7()$E.3*%D<[<@Q#[]JI]ZV*"
M]Q84YZU1JR.MOF*57!1QIYA[3A"[5[TE8(ENQ)C+-HI; !OR,&V6FL;BI5\>
MAG,P@H +!](7AKH?Q&\&V"KPF@(@ 42V /IAMKU )QG.$2[/K@#U4J)RC:,!
M7M5-':Q$:*G+)NP9!"-:AD402I!F$8Z@#WTT-3\\!,[@_X6<)C%36"=OE+9D
M'2&P(EH\*+Z@HA'S01XR3A,+@66)SD3^$':Z0@%A*/ .*M1LKDQF;N$9/"@U
M\1]@)56+'1'WP> O&7F..>'"FH<$;'=(BP]5/G:I\IWLC"O\5I"MTE7X2%8.
MZ@&A'9\7ZI9'H7S->YHYCU57W.5Q_;!K)HZ.P/2?39IH9L-O@'T464,L&-GN
M[[ +/)"_+<,CM0?VMV6!_"[X/FE]OY+OF^6(U2=1MN[0#A$KD+#A(2NHM^+)
M;#,\? ; -LP.__T8F'KHGQDWM8R(2DB!&LDJ!5[4TCYY42(R@%5/C&&UDYRQ
MP?[LQL-MHE/6[9*Q/5PY1HS1PDSS*,>H%/@/ H+24X!W+<V$5$-<"FV C5WG
M)1LI$87\HW='+#U,^3VG> ,GEF"U;!D5Y))SW(E]6V;J%XD2SXGL<!5VQD/
ML)1^P \7IIRQ\H=NC"(3^/6H:\BB"X8A[#?89)2P./!#]&UKX!$<>8DR4&/D
M""1&7DUY26#;L]J+X)"Q21[+ZF!?INY3+=WQ.T@FQBR,E?UZF!0B'.F# NY
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MZFFQRCDO/E"R>X8-5\\E=#9,,<<\$>LSIT@!'P5%BS$B74T =U$E&Q>WV,!
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M7:1\:<G(Y]QQI!(YD:L;Q[RP@R25;B:![]FQ]MZ0:\69"#Y6RP* 6D"05XY
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M:_]Z]?VX2-;TQ[Q>9/#'_P=02P,$%     @ DX1N6 [_;.EA"   CR0  !4
M  !E9C(P,#$U,S4R7V5X,S$M,2YH=&WM6FU/XT@2_G[2_8>ZC'87I 22 +LW
M"2!E(-Q$QP*"S&GN8\=N)WW3<7N[[83LK[^GVG;(&TM@X':DFP@)NUU=;UWU
M5'7;QZ-TK$__^A>BXY$4H;_"=:I2+4^/]_/_Q>#?:C6Z5(&,G0PI-2VZR\9C
ME=*%BD4<**%S.O\[-T$VEG%*@94B!7WF5#RD#]:(T*IP*.GF]CI26E+S<.]@
MK[%WU&P>+LP_,\G,JN$HI<;[]T=4HV:]>;@XO5;+M=XOU#X>F'!&@V%@M+$G
ME7>1_U7(I3,M3RJ1B=-:),9*SUKT4U^-I:,K.:5;,Q;Q3VWRSYWZ7;:H44_2
M-J7R/JT)K89QB[2,,.(YM^A=W?_:E<)KEF+C1B*$D.*B0G[>206N2J6=ZS"2
M;%"+#I/[-6XT$,&7H359'-96'RVJDK-LTUC8H8IKK%F+1)::^9#-A>1C V-#
M"5ZQB66I<:@FY8KBLE1N48AG4?AD6B@],#H$A^[GC[T/O3X=-/8:Q_O+K$Z/
M![:\W7]:2FG*)C%GW=M^[Z)WUNGWKJ_H^@+1TKLZZ]UT+JG[N7OVJ=_[5Q?#
MH.C>TLVGV[M/G:L^]:^_5NX=>-_V^KWN'>2<?>Q<_:-+G;,^W7ZZQ%#C0-0:
MASMBESI7Y]0XV@EW\_LJ=>ZH<WY]T^^>O[(ZW@$']28[H?^Q2W>=VP^=J^Y=
M[?KS9???7CD\:=;KS;7E^/%=X^=Z>VVX5Z4[$?]'R@E=9NE(VBITL*F*9I2.
M1-K:DL^2+2H.84:+D_D(V5,Y;>Q1CT9B(LG*B9)31HR1<B3B.!,:@XFQ*9F8
M+HP=(^5J_R0341>>B 7UH91(9):JP%$O#O9H!WK2C^_^WFS6VV=FG(AXYN\:
M[=UU U^B;W.//@C&-:@TGM&7V$RU!,Y4<[4+?4,#V(@-4 V+)50,<V:4Q:G-
M)-@#YSSDP1"!;(0MP$2*1( A2X:A,C4YW1I!+ /IG+ S)AF++Y+8XCE/A[$0
MRD"D]J@(&4P0* N<!5F,Z= $R4[3D0I&Y+)@5.+I INIM++@Q7:,E=/ 3X;F
MJ4I'L-,E,O!Z,OL$&IH0UDXP+:3!;-$;K^/X@S]PO*2H+"T+-E3A=9!SY"X\
M5W&$2!*I A\5!SH+P1/N6E"X"E<KJV>4P$Q>*%Y K1]6HK#>K8C&8H>*&5>9
M(M,@@/L-G./%.:]/(-R((FVFKEB;TOE6#I5+K8 \P<]R]:%L=<'%KM1I3>G7
M\?+A'B?5@BZ</8U?VJ[P8P$ ' <FBE#CK=>R1\)*[Q:8J0:HUM";)-9BH)4;
M,3F3C9$*G Y\'RH7:.,RS.,DL4;G_DFL"62(84<[\$,HX=_<V.Y],!(Q2GH'
M@7>;:5!XH#W:D;M^:N,HS._R6Q5[E- E_]+1'*0+JY:[CU7:6EZT)"^"/#8W
M77*<IV!@VPHGV5%PA-3:)2* ,B>5>L7?)R(,Y_=:.'=2.;^[N;B$F#Y/>GGG
M,E5A.N*;^@];MS'\>^B^CE-[NM"+X3XLM2F8'_SLPZJT. V?H&_6]XXX$FG"
M@18(7>J4F@1\4$*W8)*W-)LY+,XLEN-<.A!@S1D*MXC+*J-T(#*W_13&R8%$
M<!62<@ VF04#)/9$.8\:H$+3S'RXP#[@S2)F6:F%C]8">A\BKEK@&3]4P![H
MXHQ6(;?5RV8#Z;.!4Z$25K$]*B\;'E1C9IPYQG"?\LX#OL<:XR3T0ZOO)R6"
M_9MIP4@)*[U.#[4 ,_("LU@7<3603 @4PWP9+F5!L2;+"XQ;NQ)Z&.+(__].
MJ8<>>J/;7I)<@S=/KE5(?A2+UW)LZYG;IQK2<Z)"SB#A3.RC!;&06>Z1.*V$
M#<N81M(I,5!:I3.NVIO$(N%7D\QG@P_T/'679B[T6KY6WA?V)9E-D&C.-QU!
M@'V9U\=W74,9HY?0R#<\D0DW 4R"QC+/*>2_2E"GOF?5-Y15P1MD57<B=.:/
M2SC&9!2A&U431(<KN\I-+=P6=2J_W=QA^B3"1-08E[>S Y.ECVNP3245<VK)
MO7KT![N)U>PJE!J4FP(/$S)W#-1KLZSO>?#MY$'X%M4E#['U4.7]=M&]^R<;
M\^$9-87;,1,$F>6 7&AV-G =&Y=BG(]KP,O!#/HM0Z\$UCN/3(F068#W%>I"
M<6P8I3\JB)</17;7RPV4' DW[QNY3OC$E*&OI]X]1:V;D59?I"Z.$5;HJU_M
ML3?.OB?WL4<OW<?ZHZBP#*OJ [PP^"TN[0/2\.(\H[%9Z]OGJ@GT[JFQ.4HR
MC1\ 2SX]3Z5\],!@SF%@T+0P6:B@IN>U@X4'H#H&;/SGC409O/*W3,$*'ZA9
M'/@SBMWOV]4W0;^WV+AV--I(D"@$,)\X\-E%H"0BKJCD\PWD5(HO7)KSMM(7
M9]\?^_/&\GSJ67%<;.[R8Y\-F")"3'1R#BF/QGS156,*(A;=;C7O#QR: Y>-
MQ]BA_BZ],;GH5=#;>+#WO?9_8]'_%CO+#DI\9 &15<2B]*AN;'Y8781]-2^)
M*IX8/9%<%V,Q+([>;5$(Y#C19B;Q=#HR.?J+I:1"$KQ*#['W9\=C_HK/7[Y*
M$.;\^"6D%HD#37GU9O%Y^/Z'Y_2&O#]JT:_" J<:AU7_9OC)1=@8W8^*W?I<
M\UFJ/_GVSS]OD4KQ, "+?;=/Q_QD:64GP$[!79$;H[>K!5@;?E6X]$KO>)])
M3Y\7FU^U5E3$9&U@TM2,X=WDOEU!FDT1O/%)I?&<T^+_@8S'#2D28$$&^?-6
MLL/!3KU*_+>[C=C7<^XK^.YK79.[XV5QO?I6>R545V/T95QO+%H?WB[XKN)L
MI&1$W7L99'Q^0=?Y;N"UA#WVHOJ5BL'C'U(L5?&7?'S2_-,^/GDPI;PZWN>/
M=OQ%\1G2?P%02P,$%     @ DX1N6#SBM*)<"   J20  !4   !E9C(P,#$U
M,S4R7V5X,S$M,BYH=&WM6FU/(SD2_G[2_8>ZC'87I 22 'LWX47*0-B)C@,$
MF=/<1Z?;22R<=J_=G9#]]?N4NSMT7A@" ]HYB0@)VUTN5Y6KGBJ[^VB4C/7)
MW_]&=#22(O0MM!.5:'ERM)O]SP?_4:O1A0IDY&1(B6G1;3H>JX3.522B0 F=
MT?G?F0G2L8P2"JP4">A3IZ(A?;)&A%:%0TG7-U<#I24U]W?V=AH[!\WF?FG^
MJ8EG5@U'"34^?CR@&C7KS?WR]%HMDWHW%_NH;\(9]8>!T<8>5SX,_*]"+IEI
M>5P9F"BI#<18Z5F+?NFIL71T*:=T8\8B^N60_'.G_I M:M3CY) 2>9_4A%;#
MJ$5:#C#B.;?H0]W_#BNYU2Q%QHU$B$7R1H7\O.,*3)5(.Y=A)%FA%NW']RO<
MJ"^"NZ$U:136EA^51<E8'M)8V*&*:BQ9BT2:F/F0S1;)QOK&AA*\(A/)0N)0
M38H=1;,0KKR(9Y';9)H+W3<Z!(?.U\_=3]T>[35VFD>[BZQ.COJVZ.X^O4JA
MRKIE3CLWO>YY][3=ZUY=TM4YO*5[>=J];E_0>?>RC29:5^>@Z-S0]9>;VR_M
MRQ[UKKYWW=O.Z9>;;J_;N:7.U]//[<O?.M0^[='-EPL,-?9$K;&_);:I?7E&
MC8.M<#OK5ZE]2^VSJ^M>Y^R5Q?$&V*LWV0B]SQVZ;=]\:E]V;FM77R\Z__/"
MX4FS7E_=CI\_-'ZM'ZX,=ZMT*Z+0"OHMM=9H484,-E&#&24CD;0VY+.@BXI"
MJ-'B8#Y ]%1.&CO4I9&82+)RHN24$6.D'(DH2H7&8&QL0B:B<V/'"+G:O\D,
MJ -+1()Z(VE%+--$!8ZZ4;!#6\E(TL\?_M5LU@]/S3@6T<SW&H?;JPJ^1-[F
M#GT2C&L0:3RCN\A,M03.5#.Q<WE# ]B(#% -FR54!'5FE$:)3278 ^<\Y$$1
M@6B$+L!$&H@ 0Y8,0V5B,KH5@D@&TCEA9TPR%G>26.,Y3X>Q$,)@2>U1$6LP
M0: L<!9D$:9#$@0[34<J&)%+@U&!IR4V4VEESHOU&"NG@9\,S5.5C*"GBV7@
MY63V,20T(;2=8%I(_5G9&J]C^+UO&%[2H$@M)1VJL#K(\=B6GJMH $\2B0(?
M%04Z#<$3YBH)7(6IE=4SBJ$F;Q1OH-8/.Y%K[Y:6QF:'BAE7F2+5((#Y#8SC
MEW->GD"X$0VTF;I\;PKC6SE4+K$"ZPE^EHD/8:LE$[M"IA6A7\?*^SL<5"59
M.'H:_SQTN1US & _,(,!<KSU4G9)6.G- C55']D:<I/$7O2U<B,F9[(Q0H'#
M@?NA<H$V+L4\#A+@2V:?V)I AAAVM 4[A!+VS93MW <C$2&EM^%X-ZD&A0?:
M@RVY[:<V#L*LEW55Y%%"%_P+0[.3EG8M,Q^+M/%Z@X7U!EB/U4T6#.<I&-@V
MPDDV% PAM7:Q""#,<:5>\?U8A.&\KX5SQY6SV^OS"RS3XTDOKURF*DQ&W*G_
MM'$9P[^'ZNLHL2>E6@S]L) F9[[WJW>KAX2?$^XFX1,SF_6= _9)FK#+!4(7
MTB4F!D<DTPV89,7->@[EF?G&G$D' NP^@^(&'EIEO Y$ZC:?PHC9EW"S?*4,
MBDUJP0 A/E'.XP>H4#XS'TZU#\A31B\KM?!^FX/P@^]5<V3CAPHH!%F<T2KD
M GM1;6!^VG<J5,(JUD=E"<3#:\2,4\=H[H/?>>CWJ&.<A'PH^OVD6+!]4RT8
M,Z&EE^DA*V!&EFK*&1*MOF1"X!GFRW A'M9Z";IVR0DQQ#'P'ERO'%S]-P^N
M97!^%)578FSCF9N'&L)SHD*.(.%,Y+T%OI!:KI8XK(0-"Y]&T"G15UHE,\[?
MZY9%P"\'F8\&[^A9Z"[,+%5=/FO>Y_K%J8T1:,Z7'T& $YJ7Q]=?0QFAJM"(
M-SR1,9<#3((2,XLIQ+^*D;'>H^H'BJK@#:*J,Q$Z]1<G[&-R,$!=JB;P#E?4
ME^N*N0WR5-9=7VOZ(,)$Y!B7%;9]DR:/2[!))A5S:LE5^^ ;YXKEZ,J%ZA?'
M P\3,C,,Q#ODM=[CX,>)@_ MLDOF8JNNRB?OO([W3];&PS-R"I=C)@A2RPY9
M*G;6<!T;EV"<+V[ RT$-^CU%K0366X],&2"R .]+U+G@.#I*?VD0+5Z/;*^F
M&P@Y$FY>-W*>\($I0Y]/O7GR7#<CK>ZDSB\4ENBKWVVQ-XZ^)T^T!R\]T?I+
MJ;!PJ^H#O##XE;?V 6EX<YY1V*S4[7/1!&KWQ-@,)9G&#X EWZ,G4CYZ=3#G
MT#<H6I@L5!#3\]K"Q@-0'0,V_O-!HG!>^7NJH(5WU#0*_&W%]OO!]?_FX-K6
M*"-!HN# ?/? MQB!DO"X/)//#Y!3*>XX-6=EI4_.OC[V-X_%3=6S_#@_W&47
M0&LP1828Z.0<4A[U^;RJQA1X+*K=:E8?.!0'+AV/<4+]0WIELJ6706_M%=][
M[O_!O/\M3I9MI/B!!416X8O2H[JQV;5U[O;5+"6J:&+T1')>C,0POX2W>2*0
MXUB;F<33Z<ADZ"\6@@I!\"HUQ,Y?[8_9RS[??!4GS/CQZT@M8@>:HO5F_KG_
M\:?GU(9\/FK1?X0%3C7VJ_X=\9.;L-:['UVVV(PG63Q+]&^\!ZR<[+I=.N*=
M6=A%WVZ12D >Y#LW 78*KHK<&+5=+<#>\$O#A9=[1[M,>O(\W_RNO:+<)VM]
MDR1F#.O&]X<5A-D4SAL=5QK/L.IC&_.::SRN2!X I37(W[>2'?:WZE7BO^U-
MEGT]X[Z"[;[7-)DYGNO7Z]]O+[GJLH^^D*N,%.#_ORCZZ=JB# KSM[+9ARKR
MM=9Y[&WUFYZ*3NCQKRSF/%_R54KS+_LJI:1'T3K:Y<]Y?"/_0.E/4$L#!!0
M   ( ).$;EA;C-3VNP0  $0.   5    968R,# Q-3,U,E]E>#,R+3$N:'1M
MQ5=M;^(X$/Y^TOV'.:K;;24")%"VO!2)TE2+KE<JH*?>1R=QP+>.G76< OOK
M;YR7-NVVUU?I(B3\,IYYYIGQ3#)<ZXB/?OT%8+BF),A&.-9,<SH:-O/_8O$W
MRX)SYE.1T "T[,,BC2*FX8P)(GQ&>"Z7/:?23R,J-/B*$HWR:<+$"DZ4)(%B
MP8K"Y7P6,D[!Z33:#;MQZ#B=ROF)C'>*K=8:[%[O$"QP6DZG>MRR<M3- O;0
MD\$.O)4ON53'M;TP>VJ0Z!VGQ[50"FV%)&)\UX?/2Q;1!"[H!N8R(N+S ++]
MA/V@?;!;L1Z IEMM$<Y6H@^<AKB2:>[#7BM[!K6"-05")FL2H)%B4(/LW'$-
MJ=)4W6)84^-0'SKQ]B=MX!'_VTK)5 36PZTJE%SE "*B5DQ8!ED?2*KE[9+*
MC>1KGE0!15U""EHB#MA-&5$<EN"J1C(5!2>; K0G>8 :W.NOTY/I$MI.PQXV
M[ZL:?=JSNZW!P^7'+)1N/&9BXLZ7T[/I9+R<SBY@=H:9,KV83"_'Y^!>NY.K
MY?0O%Y=1PIW#Y=5\<36^6,)R!O817#46C4D#%NXD.VRW#UMU&"]@?#J[7+JG
M[X56M5;:Z+6Z!N3RJPN+\?QD?.$NK-GUN?LWC"=+L^.T6LY;J&(B0"A]<T$.
M,2-KHZG K!&"^II) 1NFUZ#7%,9"I(3#G,92:9 AN(A?$%BNJ2(Q337S$Y@*
MOP'[1OS3WI'CM 9SNF*)5D3H;,$>'  J/9,JP@M@_8'NJTS[CA(%%*$$<$I]
M&GE40=NNF_O8?J#0V"^5U6%:AP41_U!Z ^<IRJDZ7"J:,.,4$!' 9,TH@MU2
M'R'>4)B%(18793Q \;(6W.&L0R !]5!OAT%2FH6[.L2I2E+<Q'I4B;]A]\L@
MCSY)@ 0R-C6H*IR+F.#E]A"L\HB@B37;<KJ#L9]Q:8)7QWV"YO%4M(-O0FXX
MQ1+4_Y"@[ML'F?F<O@RN*8O!77P72)!BFF'%,K2Y6W]-!%; B<3JFR28"W4(
M4\Z1%1G%W,C=GE7T>\H4-94X,>XD1?+8[7V" 5=@'^X'![<4W%FZM5+P8/?:
MG8&Q_S%..[G33&":122#A*FM"1/H.1,51B D3*%O,>:.\:)NM@GG6.XPS;'I
MH(])C&XE]>Q46#8CHS!@F6I#&TJE/"=!QG@QS$92.GZ79(V?_(.AI\IY=4\3
M#[N73SE/8N)C<SNNM6K9/"9!4,[S IP-67!<^]$-V\2AH?>E?=3M>+;=ZW:]
MHVZWVW%Z8;L=]M[>L#8LT&LS:?U>UGW323B)$Y0I1R]N;.:YZ\=#K4:5[HSS
MH 1:V.WTT.R-N98^X:5^+>.*NN*HX?#4O!/TX4^B_#78G:R<=*KT%K)-'3QC
MUWG2;)F8SZIX%?3_:!FU43-IPM!$YEX4LW$?F$9QOXC<#<'<-7<BB3"9+1]C
M@^?O%\QATXB.GJ4%I]7HO"=6H.0&TQG?7>Q7$/AD#-ZF[DEX95I[4FL9H=UX
M"XGD#&_WRMO'6F]^!R\Q^X&4?0!-[Z0FI^.UV?KH"\[#!'R8>6]\;7I)W_\H
M8T^]_;SN&I4%/ZOR+VD'S^V5BM_RP>#\;Q\,%3_*T;!IOK2R0?'M^"]02P,$
M%     @ DX1N6)&%>CF0!   &0X  !4   !E9C(P,#$U,S4R7V5X,S(M,BYH
M=&W%5VUOXC@0_G[2_8<YJMMM)0))H'M;H$B4PBVZ'E3 GO8^.HD!:QT[9SNE
MW*^_<5Y*VMTN?9,N0F+L&<\\\^*9I+<Q,>___!- ;T-)E%%(&V8X[?>:^7^Q
M^8OCP!4+J= T B,[L$CCF!D8,T%$R C/Y;+G4H9I3(6!4%%B4#[53*SA0DD2
M*1:M*5S/9RO&*?CM1JOA-4Y]OUTY/Y3)3K'UQH!W=G8*#OBNWZX>=YP<=;.
MW0MDM(-@'4HNU7GM:)4]-=!FQ^EY;26%<58D9GS7@?=+%E,-4[J%N8R)>-^%
MC*_9O[0#GIN8+AAZ:QS"V5IT@-,5[F2:.W#D9D^W5D1-@9!Z0R(T4A UR,Z=
MUS!4AJH[#!MJ'>I .[G]1AL$)/RZ5C(5D?.05862J^Q"3-2:"<<BZP!)C;S;
M4KF1?"^0*J*H2TA!2\01NRDSBF0)KFHD4U'$9%N #B2/4,/HRZ?)Q60)+;_A
M]YKW5?5[@2J7S<-62E>^9V8XFB\GX\EPL)S,IC ;8[5,IL/)]> *QI/I $FD
M9F.4&,WA^O-\\7DP7<)R!MY'^-Q8-(8-6(R&V6&O=>K68;" P>7L>CFZ?"VT
MJK72QIG[P8)<?AK!8C"_&$Q'"V?VY6KT-PR&2\OQ7??;<+T[\CZXW1_B82)"
M*!U[24ZQ*FO]B<#*$8*&ADD!6V8V8#84!D*DA,.<)E(9D"L8(7Y!8+FABB0T
M-2S4,!%A XZM^+NCC[[O=N=TS;111)ALP^N> "H=2Q7C)7#^0/=5IGU'B0**
M4"*XI"&- ZJ@Y=7MG6P]4&CME\KJ,*G#@HA($?@]54IR@FLJ&*K]"_L(7"NJ
MF770(LZ["+4D:BQ;P1YB'2()Z X-=I@?9=AJ5X<D53I%)K:C2NIM8'_KYHDG
M&D@D$]N"JL*YB,U;;@]QJH (JIW9+:<[&(09*)NW.O()FL=3\0Z^"KGE%#M0
MYTWR>>R=9.;SR&5P;5>,]JE=T#!5S#!L6!A*&-V&&R*P 0XE-E^ML0SJL$HY
MQZC(..%6[NZLHO^D3%';B+5U1Q=UX[6.">9:@7=Z')W<A6!OZ<Y*$0?OK-7N
M6OMOX[2?.\T$5EA,,DA8U88P@9XS48D(K A3Z%N"I6*]J%LVX1R['58XSAST
M42?HEJYGIU;E++(*(Y:IMF%#J93G09 )W@G+T*7C^R)K/.;?]SN;(0%.L)!R
MKA,2XH [K[FU;)V0*"K7>1/.R)=.HRV+S,8NW%_+IF['!">)1IF2>O+4LL]^
MV/:,ZE=&+ZZC$FAAMWV&9F_LI0L)+_4;F534%4=M<"[MP._ GT2%&_#:69]H
M5^-6R#9-=,"N_ZC9LNP.JG@6](.S(.-W@!EDAJBBJ9O0LYQ[F;TA6)FVXG6,
MI>J$F!N4O=\)>TTKVC\8%EQ6L_.:7(&26ZQ3?#'QGA' 1W/P,G6/PBO+.I#&
MR!CM)K>@)6=X=]?!,79R^SMYBMDW#-D;A.F5H<G#\;)J??#F\K  'U;>"[4>
M&.AO9>>Q-YKGW:"RB6>=^VGOKC]BE6I?\AG@_V^? 7LW2JK7M)]/&5%\$/X'
M4$L#!!0    ( ).$;EC0;[(+8!L  (FO   3    968R,# Q-3,U,E]E>#DW
M+FAT;>T]:7/;R+'?7]7[#Q-M;>*MHK2X#\OK*EGF;E1Q;)>L))MZ]2HUP Q$
MQ"#  *!D[:]/=\_@(D&*]+&V9?JD0&"FN]'3UW3W/)G5\^SI__X/8T]FD@OZ
M!)_KM,[DTR<_JO_UQ3\<'[,7:2SS2@I6%X_9F^5\GM;LYS3G>9SR3-U'OYX7
M\7(N\YK%I>0UW+^LTOR:/2L++LI47$OV^O)5DF:26<Z)?6*>N);E])X_+Q9W
M97H]JYD9ABX[9I9A.?W'CX\5U#]JL)]$A;ACT75<9$7YT]%W"?TZ8E5]E\F?
MCI(BKX\3/D^SN\?L3U?I7%;LI;QEE\6<YW\Z9?1]E?XF'S/36-2GK);OZF.>
MI=?Y8Y;)!*[0R(_9=P;].CVB^17E2I87U8P+F$A_.&+T[$]'0*Y:EBT<,XE(
M/6;.XMW:B"SB\=OKLECFXGCUJSXX:LA3-N?E=9H?(W2/&5_617NI5).H:U%1
M"@ECY44N-=1/1'K3O%7XV #7GX2&:$$LKZ-'MC]AZN\/FEZW&IFHR 2,S*;O
M9FD$#!'Z3Z*R&?_'^^=J$&J0MES\O6&23S?T]&IZ^?*,7?UY>GGV>OJWJXOS
M-^SBY?G)ZCQ/__B=Z1FG'WOZ\Q=G_WAV=OX7]OK5BXOS?Z[-VJR.)S6/8-W$
M,LNJ!8]A6?UT9!S1SPLN1//S^S+^;2KJ&?Y@?']ZQ%+QT]%O86 'GG"E%(GA
M.)8?VB*(/,-+/%.X7(0P><:KZJ>CYV]>__PBK>HKA/#H:;>>>RL;X"\;X&YD
M6:<QSQIRU<7BM/^8NEULX<^Q$1H4; _P61UN\[OZ][*JT^0.GGB"1!D0</"J
MUB7!!? (WO>T_]+:^7ZLQ6XX*3FS#25:T;\+2D^63R_RNBS$,J[3(G_RX_+I
M/CC"A7+D_<-E9(T-"WC#PNHX_QXTE91,<P&K3K_^U95W]/1J)MFS@I>"%0E[
MGI8RKHNR8H]JN/['[P++ @"V$^OH*3VOR4'/F*<_X'!36.PY9S!%R1=R":^Q
M8A=Y?++?Z.?%?,'SN]7Q(YFE\@:6;SWC-0,QFU8=@=.<X121K. ZRASX4"%(
M>%4/R'@NX+F*@88JY0PFDX!X76@=35_/.3P-?QEG\3*KEZ54T\GY8L913%0T
M_'69UFH\'L>@L."MIEESB1XH99HG11D3O"T(B(SIGU9LP>^.X>OCA2SA/Q!%
M,4@TN >,"X[\QA:S-"NJ8C&[.U%<P;H7!Y#@H*6$1P%L42S PNAH4<]2F*#(
MTOB.W<[2>,8697&3"@ %'B!PX*T7RP49*$"C&%8<XBS?R1A>VLT**)JV0'MU
M.\\;K-&D04H#]6@L^ Q$PZM)6<R!F/ BP"Y"U8LC9BGA>9O6,Y8T1A,\M"A*
M/=1_EL"0.%3%P J0"MA$PB>XL0+H@.XIX)'QVSU9]C718X6G.M("Q=0=P%4,
M* 7KBHP\HD1VIV!^(TD6@&YXWK#6FPZFZ;MXQG,PS<YB(I,9VLZ$P:OB@)"
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MBZF0);RH,=J1 B$5T]Q,*O=6HF%=84SH> #N!.8IXK>(=RR5@JJ+&J?OPG5
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MO:V*W-[8'/I2J291UQ0'XF9E+@=[=\VG)S_B 0CT85;/,_CP7U!+ P04
M" "3A&Y8,G((UH\@  #:@ $ $0   &5R;F$M,C R,S$R,S$N>'-D[3UK<^,X
M<M]3E?_ ^$.RJ5J/'S.[MY[L;$JVY3W=>2R=I+G-?;J"24ABAB*U .G'_?J@
M 3[ )T!*\H 75NU#)KH;:'0#:#0:C9__^V7K64^84#?P/YU<O#L_L;!O!X[K
MKS^=1/044=MU3_[[EW_]EY__[?3T5^QC@D+L6(^OUC4)D$-<9XVMV7RZ<CUL
M77YX]_[=Q;L?+B\_2,6GIX#^0C]2>X.WR H16>/P 6TQW2$;?SK9A.'NX]D9
M#C'Q4?CRS@ZV9Y?GE^\OV#^L/1[>8C^\"\CV%J]0Y(6?3GZ/D.>N7.R<6(P!
MGWY\H2F9Y^?G=\_OWP5DS8B<7YS]S^?[!:\X@85:5)4*2,_UO^;HOCP2+Z'\
M_@R*'Q'%:2-*\'$[+JZNKLYX:0K*"+D-I%V?ALBWL0SOA"F"#/S#F2A,0!WL
MYN$HMM^M@Z<S5L Y3 %#<AJ^[C"M;@<K/H-BP+D\/7]_FO4+4XP\X@K11XZ4
ME.0JHB2L@T^+! )3%,L"54&^'X0H9%K)/\4?=SO77P7Q%_8->O1C(H4Y7EF\
MCS\"P4\GU-WN/.A _FU#\.K3"<CZ-)'RWW<$OV,M3$!(X.$&D4#Q&4.A3!EY
MR^ZSBA,2B-@E*B4=8$2"'2:AR[C.5.CL8&S9R&O+%D.Q(\]HKAR\:LL50W%]
MUV2F//38EBF&@KWC\@-TEHP#"WY\F4^J)TO>FMO CF!V'OG.V _=\'7"!BC9
M<DTZL5SGTTDC1%IQ4G4FLE_.V>1]?FZ=6@D%^2?R'4N0LR1Z/Y\5B13I1Q0[
M4_\7_KLXEF/L&*0)LS!<]!'S&EF-%W]-A-!=-C>!3P//=6#!OD8>+">+#<8A
M%8*I+VZ4"I,)E\J"=1R.Q7(S?5A,[R>WH^7XUKH>W8\>;L;6XH_C\7(QB$1+
M)#-$&-\;'+J,$85\\K R<\Q$$X76G-7VL4DNW"AKDO)%&RE;W^4:]9^#U.ND
MGG8HG:ZF.["F61LJ1F0-7*/0+E5#<[%D__L\?F "F]Y9T]EX/EI.&, @+AUQ
M+<+ _KH)/(=ME\:_1VSM:19;!7RC^-ZW$]]B.;WY\Q^G][?C^>(_K/%?ODR6
M?QL$J2/(&T0W=U[PK!AV&5BCV#ZT$]O-:/%'Z^Y^^MLPZG+"FI(U\MU_\&8R
M6_$64YNX._AKNKJ.J.MC2HL39DN<1C'^F%B;+K6]@$8$LS_D"KC-*55A!2LK
MJ<3*:AFD*DOUWF43G\.F/B:>&[1S0^3-,0TB8N-8AHT0"HE=EB66DN/BB@E:
M*<5!.K)TKA%UV40WLNT@8ILI?SV3&&;R6$3;+2*O;"ESU[Z[8J8=V\=EP&S2
MM-U$C@>BI9#X^[+$><4P&#-JEEPW5X2X=@"3ZL^AQ"T8-$36D!&EF(F)C2GJ
M9GOZTE>%U#Z4I<9)6!*-H=\+IDM(D!W^YH:;FXB&P1:3U%HIERCZ_X=R_R=D
MK&=&QTH(#4*0A3 CP=:E-""O#T&(87T*_"?PGCUZ&+[<N3[;E;/)(YX"6\ K
M!/9C66 9<0MHB>4MHR\^9C4,DBQ($MR>8&/ 3FP'9GHJLW*)0CI_J)0.)R,<
MDPFA00@Y6Q CFEI]XK>BHW^JL.\XXM"Q<L?>(9?\%7D1GJ[B"0!Y$Y^&A/O*
MXQY7 2E$<546!5"T.$DPJU*BED1UD),LIU^#P'EV/8_--1-_1P*V'Z%L9X(1
ML3>W^ E[@30QZ0(WR^WBO"RWA#*?JR;^Z4P0MQ+JUK^C[>Z_+*F208RR&.?8
M U?1#+'Y?DF03YD9E?DD:DL5@JKP/L2D+$[+DHD- LEM4FR;1-@9O^RPGZXP
MQ8^*[J]P)<04K(3$T.GY'<IVZX9\EA>6+NRBL9\Y!)H %,*HV.5+U!+3-Z,W
M2*;HU;'!'>IZ$9L^'G!X'U ZPP3Z,/ 7&T1PYK-10BID5;&WYV2%NU00MAAE
M"TA;S$BV!'&+4Q\D)TN.GQA!3 8;+EN8=*0XBIHRA70J=OZ<T.DU4+)D4H,H
M9%&( SLV-GY#A"V\B15=_JP00,5.7M#@XR.A,O2]W/<3G_W$2_22+"7R!T5_
M5^S-!;;%T8>.SLTWT2/%OT>,Q?%3NO$H?E1T>,4>/:-@<1)#I^>UF[H.)LR<
MARCK$4P :RQMU!O*%:*HV*/'Q*R8FB63&\1R^+.P8YR)59Z-%4.]#GP*I@@/
M^\,;',19WR6_AG"RQC.Y)7KTTEUO=5F3YI1.XA2R_TGK.,_Z3E0]R*[CD9(L
MU=983?)N>9"DU(;]SZH&7=$^M"IH15VY0OX51U5*,6L?>@W2;#C]DN67^](D
M,0&HE%#M:=D@D2['9K*H]$";9*AQ6*84<+<SN$'Z.H<&.2.JLJC1ABH<%:A$
MJ7/<,,BMLW=;%F8+>-7^2M.GK13^?B[S02]:^,YE36B$:))]G<=<*>@6WO=!
MJGIN>%F@=85-LJQPOBO%J.?#'R2H<N;+LBM_;I*:[,)7BDMQ!##(Z0#W;VYQ
MB%ROTS6<!+5)WAWNW2C4XNI UWNL[^+V#^JC?=$GIRPZ@(V;X>8+/DHU:']G
M:!#Y,4],X)8E_ LKZA/RXG AUODA<6UF"$-93H'>OEISSEVNSM^??SCRN<OW
M%O N_FM)W</)9!TDRH>A<<S#Q H'[Q&&0E,U9JG^CT=7_3J7]J#FQU/S.7["
M?H3GV [6HNE'4/+Z2LQ2\9^.KN)Q3UA25PSZ?4S]7N U3")SO L(?#^"=M=5
M891N7QP[8N1[*^X'*^V(0;/U8DA2-2L6Y)2U-=8AXTZNM.).OI?UI2(J95 '
M'75(SCN1<.*PXFB[*SM^VJ,=6B$N-10B/2-%B5]':MB@$>TT G_&"+H:IMEX
MW%,.1K"CI1LZ! ZM):4M<Y.68$MJ83J+4"MIY* Q^BDK<AK1!- D\>I4%4JQ
M:R>]& 2Z;ZQBO.3FI-T96Q&[=L#8Q:L#Q"YF]L:@17MJ$3\4G_K\UK/[A-,%
M8^1Y@1V;%/RN.G;$C5(:THXJMT]5;ZN?)0.GM7Z*6 -F^"3<RDM=QC"L= G+
M,5$:#N;1WEJ=Z5:-$7T84F^KE26#JK56RCHX6..'4[="05=5JR/SMFI6\O>W
M5K-BX:!A+2X;%'6GTRE1I^L&5VVN&PP"K;]O$ >N^&O^9SX0HP&@,0!#YS;"
M5?UMA.^MM$[Q99!@DP0?<)B741(?7B%,)>Q!Y%HR21.Y0LAR4;99-/L@9-UA
M.G?7FS!8L2IC]YCOW+OHT?5<>+A%.8CUT ^B"B4[L&Z(\S:=!JM3UJK$H0;3
MN-2P04.:-.0S"B/"^RE]#R(6=[-JM,([B$Z4C+9$)[*FP%ZSJ"&#)AQ!$VX8
M7^<77?4AQE9K12?9:JA2*1CB?CQ:C!>=JK-N1O<WUOG%H%)5*N5O4!@B?Q&Q
MC5*UH5@+<Y!)HRSI5+'B:JVDWF%VZ'2=51H4\?F6,PI3G)S #T*I22WVOPQ[
MU?$R[/>YR2%IOH5"&7E0L"X*=K.!S$)TXL<7HNKLDOW)'%^U2EL<+=6*FVZY
M?G(I;+!J]E<KUI.O;&T7CF_?D< ;?9V')WM\M2MMI_34+F8E!H1M51YO<((>
M-D%W3L]:XC0ID3HQMYR46Z5/ATG]/:A*NR3@.=U0 34I0WWR;Z7@6Z42'P2L
ME1\D']M67=88MM8N0\B57H:0070M4Y/?XS7R/K,-)29YD;;$:8Y7:TA5KI1[
MV]SG;$<#[;/B!@XZT5XG7)L-)\BUNB98I$;55HUZU&-J2&E[HM*0I)E6ULY!
M45HKRAR'K@@+7J GB"^8><C7595&Y&,J2\FUIE"6K*%6W%(+FCKH2_=\5)#H
M)PKCN,(,@I>5;H,=@EB3/ATND]75GIFLOK<D7F"CFH.,DUT-6M=5ZQ;8C@])
MQB^V%SG8N2/!]B;C;[HJH7=3R;UK>CM]+2V=K?0U8]1*.+56C%5+XA44N9+4
MH-"MT[>)-%L3GYDO$+D,ZU#>-FN/UJ1J'1.]7;5)]/9]DCLL;1Y?7@=[K)5B
M_(8AH 0[Z D3M)8#HK\PR+N <+2I^/0KN.(+U],.3_9(BE6:L.H5*VG]Z4@T
M/Q=9#0Q8JX (?"OFP8J9&+2OC?9)6C"RV1!FPUE#N1JPCJ0[I?.$>MV1M<)*
MFC=H12NM2%,U2).$CEXTX1U),TI!6@V:(>5?R$T=@W*T4(XL<18O_\*:HZ,;
M36A'4HV2OZ!>-:1L8$(U>/L&Q6BC& _1]A&3Z6I.(_I7UI_8@:PO. P]+8M%
M!_TXBE).YU*O***5,(7,%U^H)1HJLKN(I@XZT]K^*.]ZQ+&0KB6BPC^2UK2U
M2:IR9<<M'91&,VGVC+A/*(1]L!WGW1 @.55IC=6D(.W3;%]IIMF&''V\75;:
M,)A78LA!(_0T L* DM_-6E %>7C)EW:YE9+GUSNS?.N#K+5DO< [U"QC&>+@
MLBW;"96R78QGHT&DFB*]B;:12.8@Q?;-"%YA0N*M0K/$6Q XO$+H#?:LB;D
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M+Z#'ME@]=D&+C=&[H-*=SFEC_R]=R5_B)U?#2'E86JG#8\PN;8D&XL=0'<<
M8\B3IKE5'M35":@.WZG?NG]&R1/Z1M)BT=T"&,K&$K-]-OL)6X.YMH[<?OU!
MI9J%JC'0RPYTL/ON6\=RJSV/&L:]11OQ[Y_) $PV2CM DI?>7T3VC;,30/)J
M@UJN6W4GLLZ&.,E&<1<GR8OO+R0EYMF-D^3U!O6NL567HG4.&;I;Y5T<95E^
M?W$I,]!NG&59L2'G3MC;+>>T\K<G_]IT"7C3Y4<ZJ][*8$E0>(S$DOUE8Q@3
M#XB5U#SVR+< #;4=_Z*N/*AUJT)Z[3%*CTIZEM*@FA:F8,HZHT;)/J"0=C'V
MI(NH**)4G$IXCUIG]SIX70]1_'LCQ#"_7--A#WW#*5ZNEZ+Z6VK%*.GN]PWB
M(0Z3W'CXBW1T$L"P$>J5YQ!#A;1%.@PM9#M6;?D2IPKXV:$?R7P.3S[1_ALN
M%CCE\W0V8?>"=A7/(6CO\_S9T&ZPZHAH[TOF<[]V"VA_)KZQWN'H >DUQY\4
MYW*+CH_R6B[#'O!.[TJ6[^,$$*78?ZGGO,S!W0\"UM-MHGI5=!XOQ%25H,<H
MN40HYU=P>62K7G@C?4<)#?UXG=S<$L1>XU8W5=90A1&;. <5%/]YN4K(*T*5
MD$:@@^E%KDDS?>!8L=48CA4 YZ"RNXOKJM5#9G* Z(DZ^8Z[1(%# :0;O/U5
M['R>QNJ'B'-*B:G VG%!0=0>#'I$@3<E2#=KM]]CMX.%0U7U'5FB[ DG";J,
M8KY7J&U4(WF[>37DTVAHJ+[63:YA'-86/D^A#YS.PHC%AKZ!.'" 6.D*AX>)
M;5#1#96<-QF9HSRGRI635ZT',1"W_8>2.'!P6.EJ[3N4; ,ZY"GOF-Q'+RAG
MV5O/T)QDJ/%QQ,5Y*063BF7_*E/(KG'Z6)V=D;0O[>>7(HNH=7$:9:]7%!,Y
M>U:K^82X].6J'=2T20&[O9I&RIEKJ] %_4=>X'AX(W0YN1MYPVD\C[4+%!*?
M=FXYQ"U*7V7_=9<ZJ"T9!TTNZ9_XL9NO;3@C]_Y2,_I7=X%:.?#>4@L=YN3D
MG"Q7)&41--?S^C-/$LGF5Z//4J@PU7'&&4K1',MG&$JJ5D>44(WAIZK9*DP_
M&+%X5\9 /**V52\ JFNB;NNKIAXQ/RVLW8BMRNTDLMI*^*LY)N9![;4(:1%+
M4Y9 L6*@[F!%23TEK,!4=L2*DGE0L[U*VKLB*MA+EU]I)5#$P,JT<6,J,R'T
M6*GOAB%3%< L*;N?]4+L!QN+);-2G<643(/J=.)A&-C<!4A=&<Q(/:;"+4#;
M:6]3M&,*6-'Q^@RT@<D@:[1ZDJ%*UJ/LJ@HJ89,0O9JOV0$-5J@#,5.A28'+
MR@*NL#)5$M2,NA:ZG-19 @I4J LH0Z%I <K& LZ ,E0"G $$-EFR&_RALR4C
MUQW<KRB?5,%/FTT^]M#*+8I)R@(9N!+]M_0H6?E("4O'7;92DI#G*(V1])+J
MEFL188;;JB5H;.[&ME!,;TV:,#><>PJP*5H0R0T;DC4$4@R.<J+.8-@E"F+-
M9M9-1ZI:K0W54^%LY98\)^D3R@K\D* +]*":OX#*:%NL5R:@V8NL;8B;\OJ9
M2X--<P@V5+"#8-R>)[EEU5S/?^2H_%N-"SU]'Q,J^DGA :2T*Q94S(/<OVIK
M\H60V3-.$O:05%I$Z2-#<2F_^ GD82SX:+T.B,^DD#?(2!Z\$ZC2(!?N;3V@
M;VLXEM:B,LB7,H9AT>E!##<$6KY[,?+ZWC#)E2WOU5-%J?74=I-S#'*;MA[V
M^H]"Z4A4TXO1'H'J22)[_$E/I-))^MC32%K1?XAOU2J<7S8PZ6DHIM)<62R(
M;BUK0MEL$::\JHLW:I%.%Y7<P^[NFR135+'S*,M>YR1[CK*9(J#4G8$*7  &
MDX*9K4%< 0>HQ^?58?N%*VCC"5#(O(35;-@$#A:(XJX 4?"N0/&7,/U1WXVR
MJ%[ZW[()TUFUVYS7G]'L]"%':6Q&F0_>\"'2AO>D,.O1C/X&6QL1JA[P(=@>
M<$[_QD7+IXL'= $8!Y36H%A;>FHXA9MB !*UE>S@]K_%S.#S2YRL9_27P9,[
M%2?[65Z?TZ10YFPB__.^?H6A[EA;>O&[192ALRA'LR:!Y!7';58Q>.3753$I
MR/LWZM;G 3I)@DK#T%/QBKTSS+*"BS&%:G6!GE!"#+OE5L55X#86GQ1P[8SA
M"DIC+3L([.H)U>TFT0H748+_0#.YE*QK&!=4@YBJ(.?(=%) ]&$X5W@ZU@T,
M@AC5\)TWY4';_'HS5B_#JSB%/;_JA].9.K2ZA*JWRDI,"!%&A=W@(6,K.P<X
M"J<'06-N^H=_EH>B;4ZR'C36N]6-R,YVR.KUG,T:UT7I-..B<;*+\GO2CWH=
M-?93'H0K2_#0<0?V!;6AU_*"HV2X!80E=^_",(H+3 NR*XTXZH9-^61I$<!N
M9CF>,W& #S" W=*0+8<$EPH:P&Z6)JCP*XA*WPESD^N8![U6$T,'P.O86(!<
MSF8?@0TPV);!+)=@!Q'/$.$ZD=@W*(LEZ<@',[* IHK1/H(39+0MPU,E0U"O
M9X,4643I(^S.DPN^[;G;@-Z&^U[V!&?S;KM[V A6]9D_3Z;/G(H$/BS]P9K*
M\-HB=N@G0(X6?</(<1_[@YT9M]P'C,+XW*0;,)GY03MA5D28I2Z[(3GF2KI/
M:2#L+'"L9[>/(+8PX)81K)=$=CPIVS<,QV_SP.?Z4_K($Y&Z(QW"S@+I>G;[
MB'0+ VX9Z7I)@HK+@ZA3!W_!=E)-A2U W"R\CY!5&F?+ &W6*PN4#MOQRM.$
M]0*C?;"RP*J:U3XB%VBX+>-8+85K)I7J!_9_#U&._OK_4$L#!!0    ( ).$
M;ECCJBILAVD  $U8!P 5    97)N82TR,#(S,3(S,5]D968N>&UL[;W9=B0W
MDB9\/^?\[Z!?<ZTEI:J>5IVNF<-5PQYF!CO(E*:OZC@]$*2W/!R4+TRRGGX
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M/C N;[,_CO.*/+B_FMW+N 0+'!+(#0D:&A;OC%1OQY0?_A:GN$";OW];YC0
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MHAY8QMZML$_HRW44)RFILA[YSAZ+>H4T"><3D^TC^WADGC9;U&R P8KV-U]
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M%,OUDRK RLT05+JM8@HQA7H=K>M(_9]?FEJO<9?VDDHU7LA)";N5FX!PAL@
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M?17+SA!V)JUCBC[%NGWOMO]>'STU"7B3I^>R6%5E4489#87^B"+:8^@94ZW
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M3AT6CIA']0Z )#ZNMPBE$#+2]0*$5Z\H)W*SL_U(Z3K(\.D\><-J@P>&JZH
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M;)YAI1,8RP@(-!$7 :'#_R2O8'TI5A3CCUB5R<$3BC/@"#Z2F"7/ )+'+]E
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M3>CW 9R'+&ZK[5X"[K@@I)X,"1SJ<$VMIJCR0,!AZON23S<Z79-F&F%R! 0
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M\PD8"/&?;T##OAB@9-_Z\"K&8 @EMX"&T2?7YCV:G94HP);=A>D!3"UO(2D
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M+L?"E^@%%V05'"7U7MS9RTN:T&VY6P*Z&G\T?V1>E+_C_(\5%6%D=^WR^_2
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M1>!,,--;!PX$.YT1)I &/<9H$XBJLWUZ$MP6G-V2H[LL$CF.YJUPY3B=820
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M;8QYVW(_$]1@J9\Q:UCZ&:CMP^MG3)F[?N8O &Q)1KDDHYQ5,LH/ORS9*.V
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MK@\K7K15Q>0@>XF &2*J;A5-Y/"0<:6EH22,"DUSLT9XF%KR>,@.H+.N$G^
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M%FL^*<8*=4(>XR0UH]A07DVQMOPT%!N6:"**=1R-H%A+7TZQDE^E6)@,$R!
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M)VO6=0U47:UMAW<YE6"<PUPF0+:)(:"CFPHX*JIU]+1<4Z/-8Q_LMZIM-^J
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MT2'A<"/YKV1#S6R2XF6N6"[V.&4T[WL,,9Z+OTJ0$7U0U-EC>J\$P_-A3XW
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M>6Z)X0O6/%9<QME%QJ/(FM][68_V>DRPT*COD3'1<+U8QKQ4KI0T<Z6\>L;
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MEEYL<187G5N()-W4*5U4-3&-"T>.3_G>(*W*1 54!91)7$8MJXQQ66T7I;A
M&[;E@_[*_N9WH>W8<1/:U)':9#@7#4Y*%3(/-+O!<0I/[:CZ9I@/NFPQ90'G
MIG^U+-*+ 8UQONVK-(_>,0??L\>\<:Z=L+FP=[^44>%[U+AJ7XX8RB3#(0<(
MQ;+-(48)C\M"YR2]IZW[8^]TQ/&.]BK38IFNV:V1U3\D4X?C+=3SBV,LN$Y"
MCB\U2(=IG'_EG.8(BYVS:I])0</39?P2U+TC+O B(/7=FU6U-]29>CT,K(-V
M$1S\ P.^OM6X=T+S&]A5+>K\B ^@/61%O*%^EL])?Y>$2J37HG5%@&@L\@M%
MT9YM$_IU5"+VZ]$-_9D3:X'8$THO^BP0:@EK3< =1>WV>-&6% %?"8)Y9N96
M*[*C'=:J;:^HUY];4PK5LV,2(==1KM(WS R5S(5RD"E6BNK?T;9\X'DDIZXY
M8OJ=>P,IH6QG*#0G&& G+90N[!%13QS4L*B>+E#U_+#QH1IMCP2)QQ:>%BC;
MX?5Y$M\F&SX,E\9#M=P^),KDW(F@+@%48)1ZT3!!HA=5CQ!^9EEWL.?= _J*
M)!;??(!_L7B/ G,CQ&[/ "GBS2B(&$1+F6)TP[RB^!5"11XK';#BOE% :AIL
MBX#2PRB<?/@N.DMI",-YP=;97B-:)%L!W-#B:PM 69[+C-SA/.<9U#YA30.K
M$>ZVLE)A&&YHR@+$#[D7 X[(E*/V W2' R&'KG:'##'#0Y<E$AT!54P!-$_:
MCL?MAKQ@S'-Y&71)C>7K-!YZ>==T'J8E<D[K8>!(F=Y#J]_T6E>M9)&>\WD8
MUS<9426]_!XZM4Z>#VM@S<*GNJN@G.=2"U4?12;D2!>U;U>.2*VKB"%1$JP,
M)I6D7TYHJH^8?NPN^L6R;<@;(F(6G%\4#S@SG<<P$ZX^AT[8$?]F90&9UM"Z
M4I%"HQSQYWYY8%BMQ/;C=WFAUFGSPRMR0">'S5R-AT\U6<R%Z@XL:HD%,FL,
M#3#%+#(4RCS.*M_$SUB]OJ:0J+Z&4,*1-PJOKCP1FU;Q0J0151LJ"_8LC/4T
M54T1HT_;A;= L(UIDVKWLO?AA#S&23]7D%I(LO^A%@+> ='U#;T'HK%NLPNB
M4I+L@RB?!K83HE>#BKT0PKJ6[(8H957[(22@F/^LTOZZA\LX69^EQ_$V*>(-
M3^YUV[\^X@K_?9?D28&O<?:4K/ ESA*R9AN![U-NI7/M?#W5.9,[T1FF2=Q!
MGFJ8\'N 'FZ8IIS&9QRF<-^Y>2N<>:_9Z"([IC ]146G%2;P*CVY,$=4F"62
M=TY>2(XH*&6J"I'(. 8ZI6>0>0Z9!U5<$>M$GW>/[(A*0/ESU15'#+]SEW)"
MT39/9D0"Z+R%TH,U'*I9BN&1MV519,GMKJ@3'EW&?$#S.B"CF*08AQN/4Q+[
MPGRB7^:8I$62[I+TOCJ(1M+\([XC&2[E^"CT])D6FF3K)(VS%Y[-C6W.IYKT
MJ].BW=>3X(,EE<D]->LR$WIR7MR9_"N [.::MISJM:;I/$?\/H9;KH^2UIR2
M[^6JZ:E!9L5@?^%L,H?=U;<WR7O0_L$,Y?1$_JJOTNVG,/ZAO1NT]U-'B4J>
MNUJ@KNEF1?A;^)@ RJ\MAGCLY5UFF"5<.RUWQ"[3=;E$EN>XD&P(L-"HZLE(
MPS&*6I0*9-QLYD\5T$PL1)50LV.9YU8G?.FW.O2*8J[A-\[88(*,JK0NY0T4
MV]0-!("@S;&%/T<45LUC#<5*E".QVH3 I0/9=S =%!5-$#P>?9YAWV^,$-QR
MVU_/-1*NUW4UPJ[KNT9E@<F_HG.E7/15*T>=S3QW['[F)SX9OVYD/*\ F]4Y
ML:V9WHJP4J>S,NP35K"I3HQ<C<=6%<H[ -M? (Y.7BG 5-E)@%#F=:*V'$54
MS0G;'W'ZO-KL^(5B\EN[;-5Z6]OU:D";W4W+![7]W<"?R89XK9GFP$B],1ZM
M*05WZ9KVJ&AW &TI%9(\)]D+2DGAF9'68!%LI+<$6F]KO4Y;M-G>&J/S[/6D
MMB_NEEE&(839>KH@29!2IM[O*99QW?&I\NR\YU-B7+GK4Z@3'9,-]438U,L3
M1JW'Y?5CK7^7@Y3B(4Y15RF$O$+JBB:&]=+;,"H2[6P9-4+.+&1HFM*?<<S:
M4;Z_I/GQ+PG.Z$=\>!'N)1VE6WTJ2UU'4HTJJ2O9;)VJ2&AG*VKU*9MGG)>?
ME[\&LHUU''B(8YUVB6IEHDU@-_3.-;'<NEN@N7*@O/)V.*6LE]U/)JMDW6?Q
M]"4!F+I3.M',URETW6[I0>\HRG)NZ7OODW@&@""6]3:8LY.K]&;K+! W#[GB
M%T[YZ@#U#;F)GW]+B@=6D;2/^XEDO'0?^SLQ^[QS-%-3<K095[8ZEE\)5/,;
MMQR*H:3Z6+,1U60KC&P#"Z*-0U*P:]WI$(E=/,'YC7)<T%?@W6-RA]C^W((V
MT%_C;.U[)<D5D@0.'KUX,=):)Y0<&E-@EZP<"S$%6>K%K5)]P79SH);> G&U
M(ZY70Z ]NOS&%M6RF$?*>)R0%?7.69%_2<EMCK,GMO7Y+-WNV$N5%T DU3D)
MMJ9/7XJ^3)+7\\TO9WF^&W29)_6A&",#^)A@+ WVYE.,N2$*9SLV=_<9G;&S
M.?$&/>ZMAC=BAX.\9F0/S2W%#("S*]U,P2OE,.Q%IY,5<78JT^[-;S'KL11Y
M:S?!-RX#(.TUD-EW)ZFUKEZ]UOJB5^+!^W5?[^-+\TK'FSC/U8L%4_OK=YZF
M\P<5A*?^(F"=J@D+:A25)_/?7C"Y?6DVI;P@+A3:BLGD#!+%[YEHVP_E4[D5
MAO790L4L$9Z7]^+NDH8AVD[QXBW3]?_/WKOW1HXC>Z)?A>@_%MV :_94]=Z]
M=W:!!-RNJH&Q[K*ORSV-N8V# SF3:6LF4\R6E*[R?/I+4F^);P8EIFW@G.ER
M*AZ4^(M@D P&OZ8/6;I-US0<J>]VH*]V0W;IFK[U'?Y>_D);\Z^1RX(057>P
MGRA/EPOQ'K[>U+,-*D?I)7K%N=ER=$>%^J+X!O+7XWZ?Y,^,K"=WP%)+7M99
M@B"6P")GZ.)\)/:]%ZA!S;5[QMQG09O)<_"2G:SRAP%EMP<FI_1?O->U F!I
M7J%"L_ NY6Q3'#\UQY=B*?-@TK'$J@<F*]\RAM'BMC%JYBD-G#\D69T=>4&R
M@AKLIC'IOH5?;S^G64+CCF3WE?Y2):!(C A49E-H&$:F;U59R#?SKCL+U!AE
M95H0':N^&#ZJ?\3%.D\/_&\ZLO]R+-(,TXE/[]!U+)X#%LTD$)A&!7(A1 _J
MZ 8QOUD\7)6V<WTLBY(BCP8E(]N6/J\_J>"YIQ>1:C3Q" =>2^U3IDQ0$6E0
MF?F4G@;GE'J-XTD1D_<3,?BT0_N8D/6Q/D.'6^U<5#U.S2DOK?I<M_<@8'@I
MO2Y9K[?K=O\;U"8B68X"V.UI4NE6G5XQK:K?SU#OR2EV_. #^W1^+>B4LDD*
MR:Z/J,!P4!V>V20:'0OM1!N].=@ 'JJ5(?:BU3JKG0Z^ WV&,"MFLD75)XAD
M<R.(!0!L2-N8FN=^M%(5Q'[T"9ITB! M6$-G-^OW0[N^QP]IEK$Q]<VZ(;'W
M$LS;/XP.TBS04#QH"V<W[GI*T*4HG*&>>/2-RD=]!:C2@(8JSE"KH]IZ.NNE
M.?S]=#/2XG 1BHG.:;J)&"9<XV0*09T&(]KQ!$A,"^4552T!<VP2)4:^2<B[
MZIQ!G?,407$&L]X5V;8!',;F*6(1FID1?.:VE.GA\RO\1'M(:3(&3%/;43+!
M&9%!VP"M2:W-T*Q40C0E&>(R-A-<B*W.'%%3\U/P2NS0!HKS;&ZM'_'FN,/7
MVU^3\ICS3,+K+;LY[:ZY.8V-QK(T.U?V9FO,FMUW0=VQO2 '1!R4*U?B;<6M
M;FCHM$X/R:X]9UE7#[L8W[V]\-*]*ZJ(?T^/UOPMI0RV!&('-^A1;5?ED BO
MCV8W;&PMJ6-D?PTOR41_<';$^!$7L/" M@3N%8>QYP3_@H>ONZ9^K,NVW"7?
MJ]+*YUG_TF?#D=!)RF1 M)0"YCJ<6@\\/-JVP<R'V$E=->2\P$/%P*/?'DLL
MWL(-<4*GX0/>B=NP$B;V'B=A!H$&4J<V!+ %P;!J8!P1CZY+V8O16#NWT40Q
M\K(Z+"1C,Y+K;7L=3GT&X!><X6UJ.@]UEC09@1TD@;D?Y[> \SXN33!S/O:2
M5]W-6>@F)T]ID2Y]930$XH0>Q1? $X=B+5#L5/S-86:?\FF[Q6M6MKEM[6U2
MXN&.DJ%3<1<U\2HNHL#<BOM[ $?X3@TQ\RX.HE?#IRS 86@_EO5!M#7[1__R
M/F8AK9[!DUB<D@=BA5[)VP(F;LE>HM@OG9A!!9HKN#<DE%4)9@TBDT%,SBCS
M(^*IP_)V932)6,ZXHIA.5*T=W:[YD?ZG*-,UG0Q]IK^G#Z:COY>T20#@* W,
M97F]#7 8X-H6,Y_E)GUPKW>,0[L?'(5>" +A$Q_D)%3LAD[29@*-]%YM"6@X
M@O&^MIZ)+9VA1AA?-*S%13SJQV)R1F/_TG871010UQ&QW[TS99R,ZWI&,'=D
MVD;@T=I K9E_T0J:E(&)Q1$8HT-H\Y;8FEBVCE]LQ!$!,]"0:*H6!IV"@:Z!
MZVEL?X4%L=$8%0;)"XX\%V2_3\NJ6DFVN2"\>AG.6.VR[LI72;DC)][ZRUKR
M>EJZ4TM][=Q6J<K*[62M>N0\4ATP1%-@R T_Q+-;AZ9M):)OW7X GNFZY";R
MU5FR 65[*;*"TOL>9&TK?&U2K4)]V[&<<]5?;HG&O$PZE5A]_?%]Q5*&X17%
MYHB9Q2S^1LCF6[K;4;.]S$K:WRQ]O,HWT1J*$V_]V2QY/8W)J:6^YF6K5&5P
M=K)6#3D?[RZS=S<Y6;/">K>XP.S "OIOR?[PO]%'=FR%'/AYWE@,U0U4Q+.O
MA\9L):)OWGZHGO?P7M<@605/$]+Q03TA*=3Q/$4[P [EB748'<43L?8/X-$Y
M9EL7D5HEI3A646DLMF?4X:(3>'J C,_="3B$I^U,\#3/JN3QOL!_'FE_?7IB
MG29=A-31-6N.<CK?E1Q="V!6%!5:E$LT4KY5]PCQ9PLOM6@[DEA\\]$:BHQ\
ML&0R/T)@E_9T6IQ@TBS<C;#"ENJB6:0#08YJ"<X+/@LNL+$C8]IIA9JH_A(R
M(D_+4.OVM0BI=)4E2)A6-*;?IT5!\F=^VK=9VAH< 6[BC>PAGB!#T[W$M#.&
M)B&F[=N#(6)FWN(4WV++KYR_YH71BW.6NI66SX9;G[X")UNB[@+!=J1\WPEN
MD\JC)6;[5LX*5M45.>F_JT/2G -5+*AAB67ORANCPCTM(.1/MKE<Y8JWO\#,
M:3%'59>=./^6Y)M^N]E\K;H-H"B.^^HW:Z?E+USAP'R$!W!F_N\:PK%YM<K6
MR7DH6_V.TX?'$F_>G=.8)WG J$>+?J/"T9;D T=8H+^Q^W#QPF5) ^%>XQ3!
M+$OA(-UUZ)PEH.G.,]-I(\WJT%WCZ&_Q+BF9[R_*@K_=?>_M9 NQ,,*:F9.G
M,-\9%LB[>,_$?%NAG+'Y"5]Q?+_CL$=]_GBF<#!X)-"H&$T)O60.IHZP)C.+
M Z(#X/7V4U&F>]K$<3%&\</Z\XT?>AJ\6!?(&O1$M,HJ1\0K^C<_SM;\LJQ)
M27J$Z+[C$/)#FCZ$@W8JZ+*Q6+1YS]8+Q./N/:MNB'U&?]3_C6:YV+;K%0O#
MIOV_9'8_?F#>\18?2-Y>#OM<_:]THFC#T\S_S'A\IW4V+8/9=S/4J)R)&<E8
MU62HI5MXVF2% N+82:-)C@GK8.X2#^Q@-_-L-'ICK]GD&P,P7B<>%IRJO< @
M"(WB^)=%X6*+(L5!:[;Z%1\V6ZKSJ#$LJB=<S3/I[)+/9EA=AU[*TOF.=W)=
M3X6G$>)-DT9/9SVQ+*39EE6U+QUL6BG5 %ZSF-$MIK//E!6]X<L)OV5I6=Q^
M_>U7O+_'^0C'1K3UA]'0>EJ244M,3.D)Y_=$'4GI=*E,2LV[HO\LT!_57PL/
M3&9]2RR[8&@E2I:^F2P('K!(2*O%&3?O.7!>)&XDP0L,<!8*5-H<55%YSOI2
MI,UUUEYW1 F^D"P?W'[$1XH1G,'ECG.T_>5")71#O2%8]C= @XQ2Q;WU#.YE
MZZY8XS>[]#CJ \RQY)6#(5J4A YL+N.,=5_QPO1V<%,\&<_7;MS>X?5CEOYY
MU!3WF%4GH,<TT!F!-S7^,C%X6I/&AO;"^C9T'KJ=/_=R%$[?(9L;$["SMK5B
M0$>N50WMY.V]Q\D, %=IAB]+O)=>% @I&]"A]V1'X+@G;QJ#@^XW*K0C[G0-
M0F+)=1:-T&J]4QHU<\GH#R8;<>$O((">V@2P7Y89':#_;55 ^UFY4<_B3WL-
M%IQ\E60%VC'5G6'*Y.G:[-H&M*!KK%3EDPR%K'IT9_T=DXXVFG0]2Z 0UVX<
MVKL9;]^0H\(FV'JQN3I_6+X?X/+5 %"RNAP*@0NM-S?%6^CXU2O<4A?7E.WK
MF7)TNWMZ#O]M&M-6 >S5&*C2;-AH):S:LCHLD!P4U8EE*\<8!L2IGR:[.CK&
MT=Z.->9F,;CS]9H<LS9')I46RM$3UA](1>AI5?HV^!J34H/*AA2,JVJF555?
MK8G0#7U5BH!JV8R95'6T]9F?:TT?LG2;KA-J77V66G T0YX!)(A-YPTM3$[?
M-RP+M"V2^BNQ)AV9),$7S))T^J%3*0VM2,HV39.,Q@JT7:E(A%1;@(Q:E>FX
M+/KKPT(W25X^W^5)5M"6\./>8BLP)6\#-QVY=]1FUA[_D$VK1QVO:=A7-07B
M)*A/$XW9&/<]L>^?<:BFYAK&:9806Z0NFVQ0T9!)JK+!#2H:_=#%MDP'%1G;
MI,!6-,:A[4E%<2W-F"*A5E756AC\+!F.CF\4>(])@6]R\I G^R]'-F>J3\\7
MY\?RD;"Z,)L[\@ONB#=C"X&0U9B1GRQ?6X-X$V^#]&R$TFJ]9*]N\O2)W==X
MV"5KS"/''],,%9SMIX6-&P2$!!@+(S?A(W+@2T"M9!:'<UT^XOP6KS%%T/T.
M%U]P>7',<XJAD2WJ">N/JB+T] /Z-H"<R%2J49FQ@G'%GZ&\>[BL71IT)['Y
M\$.+DM/WS641I( >HM2K<8-+?5RRPDR/X@Q1FC-44[T,!"F.0OK":,%#C^UN
MTR_/=<8"&Y?YXNCY]U2:(J6F'B<]R:BATIC4K0%+3)*J,4HUDG"O>K\VZ3_L
M02R)/YJ>%J7R&(%CG)PC9A*FVQC"::[;?7+:&/P15_^]S+B9?Z%?MK+M*C=H
MA&!+KN[6'S,N_QN ;%JG!-M?*_O*\ -;PE%%,^9:-1<$&4FIQZR,9._J!RCA
M3Q:_+<@*&,2YUR:W")DPCVX4B@F-H/&2I4X 0-:15$.-?FSH?T)TBER!M>.I
MLTQ?.E85(5<XP$91@>*"[.B+DIS713C/<XHNW-QRQQHL>=Q?'1>=\ RG8%+M
M DX!6(T,Z'>&JZP!V#*S>AQ@"E<#2:A'RQ,H^G]73JQ\3#(T9(KBJ&A TQ 6
M @ED@,U2(;@><=&18%8^3Y[5I,&)N(W")$='[B8CRY;;-TW+K;7>N5O6:I4)
M79;20+S31[)/TFSIM"Y'L!%O!(P2P.R$#++"/!$_TTW<W@[M2G*^,(3H]AYO
M2-'>UWS#OZ>O&P)ND_J2<$!5( [L*I;3A$$L@(1%WOBB<C@-PWO, QKPO-><
MUQO'Y;-@_T!--+[<?$0$=:^Y4#? BI%8NM%MYD.FWD7FJ'T2Q:Z IO]$]YBK
M>KI;RQ'0"F\O5T-BGD4:X3U*/:/\Y5E\>TA]<0B_"::XS&YPGI+-WW)2C*TD
MH(9FF2:$!M]UFG!O#5/_.DC[E,LU 32NZHN((LJ\"HAV,@N\1DLO\(H&:R^O
MPW2MMG(,CN@':N+,YON^OJ,'D?I:L8<W:P9'W*F;\W3S*@)[9KMJ'\ V3L*U
M;V:#KM2N.)OHXJW^!/_^&?7I:@6(:SAK+AH\JVX:+-BN<:6'_4(UO;D% .">
MNFNH7V;IVQ7X,8#T"?>J7IR7;7J7\<T++F($MS+8B0&\L<&E_3!3&?=&F%[W
M8"5V=?'(,,V=UN]\4Z#LUU")96/8$7&2>R \T#O9Y+63)KL_XB0, ?9R(<]&
MA+"&Y@JBFIW5GN@$#&H*)F6__E>511'1Q401V(WJ^J(%C2>*%+-/29ZEV4-!
MPX,FC$C7K!1.NCO2*:7A*.PD93((6TH!<SU.K0<>@FW;8.9S[*2N6(1Y+-MZ
MT5\P'8!9.'K >17F\J,)ZZK.5"4B%N_BAD"A<_$!\\2M6 D3>Y63,(M  [)3
M&P+8AF X;OC9!+NRCK.I>40\'B]E,4:C\=QFL^39.YR41VJ4+(TR>\)YF=*&
MW5#9.,_K^X8D144<.)LS>3:<ON?S[%L),K;:Z54>WK.0M+HX[H_U188]:M22
M5^?WHREGXH(AXM6YHY-_Y@(&IP#C!##H*.B@%PC%]6C7<+#1[@W+TGZ>&]!1
MS!OYD'H_7I8>W9-'1UO1S7GG:^H>T_+9<'(93M5D!AI"%5@\'NX[P,7K0=IH
M%L\'4+VJ*K^F_ZY\(+L=LZ&,)8H/:!S"4#^X,4ZF O :Q?.%&6Q_ID*?3S@[
MXEN\)@^T;6RS4%;B4T?8%O>4$WJ7]=2UP;^@IT*#NI2GE'%5/T.]A]%$00;=
M2FPZ8%RQ4T8_K-5IC)A9;(*7![G>CBI2/U?_*XM [)CJSV3*Y&DW=FT#F4\;
MJU09E:$0;5WV94W,$AG$M=^&IF?&VS?#J, (.C>V4^F/R'I&+(#E657\_QG]
M4?\WFJ7>T"A53()#036&$FF^=R:'O&$X^'7"$=X='.]%P;/?"CR>O@JOGASD
MBT127@X>\B%N:)_AAM^PU_G&,#W]B+=IQN;8&9U%WQ]9,'=#C>+3_K CSSAG
MUYWEF/V:Y,]]HO,]&QA&?@1&6-V-OL(\?2',N_CZ/>]6J'R<I_!50XCV2;E^
M9'."=8]JX0Q1("P2:$0,G92?S+Y# C:7N9P/WT^Y2[[WO.<77$J6R(SI.Q>B
MH_?W$F8M IGSFVC3&+R&?]60\'/N,=X>:HX!XM!-$^M4LXT,<&FP@<[IC;5Y
M(:Z>R<M@QVN6OW#L*2;NL !<<J?:]=C4IS^/:?E\F=$W./+:*[RBSMUCDM4'
MJKZP_?FBQ)O?<?KP2/][_H3SY 'S@U8?DQ*WD?HMV>T^DYQ)'6]NQ]DZW[H0
MH5JWU$'6L%][L?.OP5XKR+'90*U=-=2H)N^?HFE3>J,9"6+[?*(D@4B;"'-:
M-TPC04[ZSN1V3WS<IJ^UQ2E/LM-^AMF&:Y=&!1^E[1H5[>#L\FV7K1$%_4K+
MC,=6C5Q=)'3,V^WJZC4;5N(PKTZ<\4HVIUK()HSESS+:>OBDX(.L3=OF&5M?
MH;.$/>L7U2O%[S&;DXC^M8*J9J%>N_K5@]M*0KW&G:')I(DW$+$61K.K'$<_
MQ>NS50<PHVA@?(Y[P87,>C\-?\7Y4[K&XN_13O#XJQ=WI$QV_><7I"B_D/(?
MN*Q3<O]=9Z_7WV(TW,RJLT;@3#H]!^!9OPS(9&2N%JM&SGG:L/HM2_8D+]D#
M5+ G[_AQ#K3NCX_X._OWPD/4O 9&%L+O<&R9175_Z'CS*&TK02/V65N\N%L1
MQ-MM'-U%(6>HU3,LQ7F&F +ZM$3/N$2=CC-4)<*\.:*98/\:O-$I;KC73;\^
MED699)LT>QB%XY^^XWR=%O@FI]^-;5!L8??4O1L =)V"2P,6+O'L_LV6+O[L
MU/*09:$=&C3=PFY($:?MU6T[^6UL?R,%+!#M[2I\EUN<VP%961K 7\4Q,A56
M);15[VH[),%K-AV+(#6''H3@O](\V[R@[?8:>P!;,K@ZZ.2V:P,8G,VX$LS>
M30<4N 98C22OT]O,?GL1;-,C\3CO?UBU8>V!(^_-\RSI>5RW#D_>]<QPHQ)<
M8^>]:0F^W9$X'XN;F0KWJYDT\_@WS[: S;PV[[;DI5"^;]E+Y5ABENZH'FJJ
M;JU^Z5',\7LM/HK9MSOH*&;;G%-/M0YEAI"#C9\K@!IL+%L!.N+X>J-91AQ6
MJ.)+LL?]V^AK+R=Z5'?/\)&G%Q7I\?5P(YDJ[S,@7;&_$/L3_<%^6'B32-@%
M1/WIAA;4I^BC6]F#LR+O(]DG:2;!WO#A"'W-0R#\#75!(;"5:H+!FKB/PNJG
M2' XZ@X!$H4=-L)B12-"HZ1'9\$C=]UW5(' %0J?U2\W>N8)1J$F7RR.A:J@
M.*1=\3\1^SL*ARCN"*+Y?D,8#DCZ*%3WY"P@9)?,L1)1*8TQLO7SQV1/PX3B
M)DDWHM.XAM3UZVNI/:%KV!I?,.O5J."MXUY=I7\>TTW"UJ VU4-TJ&*[99%O
MVM?$ND.&UJ%AZMN++:#F64(YWA?XSR/MKT]/]']^Q?M[G(\0JZ1I%B/$-+XK
M!BK-WM-ZB7#EW%O(L^I^1OQW]$?U9.FD*67'$</O/)ICBD@'$T$C),P"[LML
M3?;X:TG=$_-(5TP)FY1.(Q8#ROHS*"D]X6[0"E_0JU6HH*_B7%4/4?L4-8^C
M"(-,>I=8=</0)A0,?<NP@<Z2]B&<8AK1JFT$: )JU)) =F(T/57SJFPEBMFK
M64_K[44UMU6R&-C,DC-?Y_37+T<V%%YOSS<;?K5-LN-TQ?FQ?"3LLC"PDPGF
MFGR/()AH6NJL@?E76.Q0@5$3@YP>,-#,/%6.*2-+.9">B^5;0 5*6CZ^253]
M&OO.$(#]0)P.L#97WV, >H4@^?X.SF&>M?3!]:C-$@9M8/6 SLZQ:/W(EJU9
M?S=F\UV9MVR?]YJ]N3[E:KZIF%5W?S#W1F=HUQ&C0TN]\.*_+4J(>P^.-@P,
MN0=;":[@G,50O^!OO8N=<I+1?ZZKW623B_A<V>O/:L_N:<"N[04YE>*@7&75
MUN)6MWC-LQZ[B_N^LE-B[#SSLA;M#"/BW[5#"[>5TK?TZ-$,6FO"53DDI.L*
M$)1M>!MEGS'>6P"70+VB[L*<T%^P&L(%ZY"LS/D8?)L6_[J@8W-:LG^-S,R
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M["R_OZ!F/\5#D._NB?<[>.^5^+1 N3/B+GCU&[6PO&2%OR@]NB$%C_ 7'O8
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M.*0=V2N8O*9XF;\\WS)54&\$4P@-H#7*:E?>\GL[N-0.]J2N'1Y/67 XB)(
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MF:=2CWDG6=6WU[_52Q]GB+:*/H@IP5K6Y=)<:S5&A&G7(Q9Y!O:LF++*3*I
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M36C@:>DDQM)<_(06Z5%Y"<_@VC.NGCWD<(FF(;P < S=A<^TX_^?T[!ZB*
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MA$IY0>9SH+LPGVTLXV!2/4*NQ_ZJR^?I=>N[+K Y0[0I:5R7K4][57M?Y1@
M0G-HB?6W4 :#2HC:" I5#G!YK\'++TWY@E.'C)$+M<&,?W$ B6"K8__F0^]
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M74(.8/-2M K:OL2J; Q,)&'5_(CXKY&:F*KS%3:FQXS$R 2,*BLS0=I"9G;
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MP5)O=47;=BP1%AJG/Z[I?(:..2.\.W+7W]&:V],J'5OK:Z#V:E6V:BMMU2-
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MF<L;*G0A ]^V!#;1:3D$;;GD5F*UNM;8+97ZCHM]LT$UL"(W0K :#K[?'^H
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MV7(<YJWZ>MBELG15'U&C1%8W41 IABZ:X;==_!NCS5!TECVN.4F.)2L[R?W
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M2S=\K 71'+GI^TNOHK)6#H.T]#0L/]G0%H_8'/E-E<-CM7'GQ@&AG(!C;>2
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M0.OB&AA$[N:8=KQNKJCJ')QV)L2^4AOG[HI*[)G.5W?L1]<+\,>IB7VE'69
M[$5MG/IB+[&OC8>"WW]\Z?S>E;>]$$>;?G^V*:G7T&.U/]LQ?>\P.Y/]V=9$
MO4_QZ_[L5M#:;:.SX-L=*BVWTHW K'M,3[D_VYY#]VHVWI]]7MV?/7.N/)K3
MH.[/1O.:2?9GCTAZNZN [S'<66B2\*V4FRV-4G'11F4\R<>24Q+1ITP\.7H/
MF9US8'+6+T^>'Z3G:4JS:YD+Z?P^H?PD8VOR 7T!^;UT!&S\O%\_.J_4-JET
M8DT-B\MH%2<;>9WD7;S+B <RE;Q5N11Y"V3P)-=&"G4G[TX9Y.XI3T/.KT03
MQB?FBP8XB@>U=-U=^V4+O]0UXQZT..1-WY8E7!D=$P4)+TGVL3B30^+.L*<@
M4NC@LZ1&^N]OSX&T;%D 3X6Y T;:""!SE^E2(\VE1HY+_ 27HV2W')+:\C6O
M91LHVI/2F66T[$Q)YR:7I=M$EH.R6':FL)Q'+VJ%!*W$E9I00$U9:3[2/M#D
M+M;.6&F:KK+(5?GAI>2J-$ "$@C<] 4?\>A6EPGC#N'C078('Q$[A(^81.F[
ME_RBV86WA=!/$-VS89W]*PV6-.'\HI4ZF0G)5]85L@&[G@UTPF5D5ND1!EKX
ME2.B/&$"I)0@-1%8P NB)7WBE[>55VKS')! WBX*HA8_YLGZ)Z9@AN"*!S=]
MW17UY OG-#$W#J)QR)V9/00L,P*H ^1YC '.L:D@CL[ :4DNS;Z'/=/0MF<)
MS%=,MH_A+N&(&_XI+F;[3.^R[]1+=R)3YF6TW34SLFN6+H)"/:7MV'JG<@>A
M(AU['22^7WSQ3R_<\4U' ?Q&=JD@(QM1F*R\("$/O$PEN_7=Z_6WAK,3/0S'
MYD!K3EDZ!2NS%PT#CET%*]ZE9<C&27@4K+RQ$XJ12CG""QX<P)11,C2$6<?.
MM-X9(X+29V@HNAB3J> H.#@<.840*B7AX]9E])4-=WQ$O%HIZ%"3G1@+YD3%
M0-#*2[3MX-,74]-J-S+3M#C?\ L[X(PBEX2 2H7)P._EM,&ORD]-%,SA%%LU
M=,,SM7643FIH=CPL(_$+8YM(* ;648 71$A!U55SWB/!KHJ9N :O+5\Q_CX(
MU,7$)@)PJYC5ZW"/ +,3P!4Y7*.]]F02KC*+-YE.#49<8-*QUC5#Z%M.^DQ3
M/PF*^$C%D[;>L[BA#%8A[SDUGIK &(4YM=MI;P*A$=C44.X48VCQ#8N5'@WI
MQ<PCZ,B(4H<U,"!E'](88Z&FS\PP.!T3DIR!"'/@/O?]9$>7W^B]%WZE-#V/
MEC<T]#*ZO-@E";/?@*!V>?G6&N5MG*%7/?I KFM1Z1]Z"A87;+Q^AM43P8Z]
M(@/3G<?T^I2D:THSON,6GL1W87#/*PW[1?P=/["7K9-X=[\6)\%Y2=BRRPB!
M!S%J6"D)H19D!:FFX5$B*O*>_":7>!AT0NJ+U1=?5*]Q@RD) ^\N"(,L8#K>
M+G>4GQ9BU#Z.*+\:%!9HY$]0/(*322&)MQS2D"OCV6>5"58DC!G@DW<3DQ-]
M@,=#,%CO#'I%BPY!TXAS7\(A+-JF[+R($1=9CO""Y&L.=%GVE,C2!XDY!8U!
M!ITEG=%^=WM*HV-J..!.%M]:.].#@Y9S5#G@-Q>L)-QHW4EJ%(7J3&:O$ +X
M&SI=<99V,WV(;Y-"82<5+G(*^2$A3R2H9#CQI4V2)5X0$C].LP/B%BJ<Q=JH
M:'6]1OFFO[6J<P->5)*@T#\ MA4ZD#^=%P$8#HSNH=X<&3B#NN)]T$;R??V&
MJ& =F?SA!;<_8M,[&'E_QAN:/ 1A2+]Z/LP3GSO'X-[B]=&XHS@"?I7:78W0
M?0;[X-TM[WK43@OK9"7-']"HW8_,> !Z6IU6*=ETWQX3KET =9SOM60%_LK8
M7Y8C><%YT0!<I'53 QRHX="%WO=&(PY=E@;#[&3Q<[\#/#! .<82)O^XC!@4
M:)I]>8*D=7QWZ)<G/]PMV1!SOH$8]G_YV':U^AI$;/3C.7_3#,(1GX/4A\V!
MS8ND,57*+XBCTL;Y,&J SH<0*Z7T9S0;_"RO5VPG#:1>0H5BLH3# #17#24+
MW2(EN-3.XQPB=KC,#4S,?5 1'SM"7+TSPM!>=%AX59V#B^+P-<S:.'?.#Y -
M4?JCU"4.YQ3:2%4=N5J10B'A&@E320J=K^[8CZX7X(^6A!6S'>Q)+5)MG/KB
MR>*&;F2HH&6,?'4K';(X5X_"I.W7K$6"-(V3YQ]Q1IF5R@DO^*6HQ?E=FB6>
MWXPC#I:7WWB O$U/8FP.;QP?;%K940S4N"CE"!3C#+@B*GXLA^5_Y>(3[Q4<
M#K48I?7KO8*QKJ(+&%J+47&/-UP.,8T'^5>T#^Z:QP<ZZL#F!<O+Z'^#:)D/
MN>?+)5W>QHU*I-=)P"JQ]<+FR#9803ZT#5!@Y>/&]M#C2(.KH';X81IYC&C+
M9,^"Z.P7DRXIL ?R?-=+I1.(0 7DV14ZX*Q<Q'S32]>5>!%#:/# =]Z^GSA.
M9('-& 4MC2["6%?91PRLQOB.@L0"!]M&=A'@@=(_0+28Y9#SW#^:@V1*"@5'
MBGX5%1P;_K9D</#W0V"#0VPC0K]$O?FH<(2HGP'@I^CKC7(]]R7\'EX%Y"[_
M8R_XCQGJ'5FG1^_@43-6-RTI(GE]Q?:S.3:*(24.JVEUDI2NU8).OK 6P<4^
M2YI+!*&W05LRAJD_OC)?6$VD+5%8FT[,^YQ]?DH7GG1>7]-?L+B165W0[JY+
ME5[T>7BOJ8Z+*SLE%S_S'*'\D.M]\$#32CY0Q?TV(DTZ+$2)VVW8[-KS_3A9
M\EVP_+H[$&3]XZ;8(QM$###\+4_)+MUY<*GR;AM'18(-2%Q:26<J-X3P+*4\
M6WO^)@1>9?)[EWNQ%QNAI'G-I4JF<H]EMUIWP,:ZW+C/QD!(\^N)*TB9VRT:
M:-!1WA]LB1WK&X#[WL]^TMEI8P!NC@$R#M"".>S_?1<^]P[YW87DFZD*V8"Z
M72?Z,-]I1HGK#JD7-+S#6\QA:._!6*R-B+JCM9<OG*Q+G1O@X@SCW?H'0)8-
MWP42YM8/6T-#,60/QH;E4-W]/O;#M%*_(2X.%1*(:' Q%#>G_)U#<G?AQM"L
M*HP!YG;=SH;J3G.]..^07GQZ:1> S'@P[T%GTTW[,=3NLNUR>Z[;I=ZM"^ .
M^MUV+,!?(P$M =E9=?UHV.IA!];@0F(+W>^+QQJ4=@8"Z^@PY1!.K@+^6I1#
M7Z!E < %]>C7[W1!8!@%T=3PHFG(7)<,--W;#%?JP%Z/J^N:<>\B^$L+ RF*
MKHI&W'BNPXHS[&FL0:" #W%-PC5]T;)E ;RCQMP(<,,]C$>_[J(E77:N:O24
M*@[6*4K9'2-J58I_CJ#33L?I(+78XIQL$WJVXL_)HR@@ECF\,(P?Q3I'_GN^
MWE%9Y5!P%N 2\D9XR5L@,S=H911D$T1>R'@)3?R J=@F@4^G/CK0@YY8OZF;
MYX1:!2JG@3H4.@(EULG-3@-#X,A/819HG%F0&@$BRD.3@S%B?0"R\YTPCCFJ
M#)CBXX"A@8H*S)'WJ^>SHI^"./4#RM[^,O);Q][><O+-.LK9H%BI%GT$[K.D
M!'6W(!N%_3C9QODM:G#/A1@_87).$SX/9^WNW2=4W,#+=Z7'#\&2\M(7LC3?
M5?#]Y@?31T,VQ$;W041I G$']@$I@_*:I+LM7)[!QN7D@0V\Z2FDU<RS0OGL
M!YZ6P1=)-?,4<@&4H__9!5NQ.6'CL6H%7B@214&";$BJ<2K^*BLT\:C>C\O8
M!$)U_U2*%![:H]09Y''&]UX3P\#.QGCQG)0%""OQ?B9].1)F%$.])6@LA_O>
M=[,?\+M,F /F\+&"#A/4F??E]9=+-KU/F4#[I%M9()]OMQ2P(JQ[^O!GV2H3
M:L;:+L'GUL$#Y+$.^%,^<K,Q=;N["P.?#Z>0]3=>930B/IMOPXX^ MK(DL*U
M $PL#O/-ABD;T67B*J$@?(:!%^AP'KB7.PX3G@0;@O\;7IHU,>5ILT5DGSVO
M'N<LUA7$2;=*?>,D?4\N87LA&]=Y/, O\D5*6["I,7^?G++ &D-^Z5?Q,%ZM
M! _A$J(B^>K'^_*=F:4$4A0D6;ZPP:JT\9)GQCB27S1C]1'\Z+?W/]^?YE^K
M4+[QGF%9):'W02IX4['/\F<E#,%(RA=I&Y@*I./@KP55$[*2B:4,)H)PL8\F
ME<-KAA064#S^7791Q5S^ ;>AY\_AEM,.!XVU7*HQ)]DK6TY'%&KPO1TI?*'4
M;>CG$+0 $.9/9C(V#6YY59#"M.EM0Q/*^B-$)=IT&S3[ ;4X0F.[\''<H^9*
M$X:N_O%D\8\/9Q\_DH-I_J[CW:8.CWH\6U[&=LV8P/-MXD4II!F*(\4I;<W2
M\@5[2]O@N4<YW@"F:4@)<2WYA2Q%>#%2*3>; ]VZ;1\/:*"Z1_1(%NZA9\$A
MR/!&RGY#0_%UA-!RBBK,SO<'7\B]6GV/HVP=/E]&;!X4AC"=2;_&"5R7>2TN
M7VI@TUA.?@D#.1NOT3:#'E,PM:QT*C-%/-]?N2I/_[/S0K(1HORL82[+-PH&
M$9L>YW?'RMNU)IZ^F@,JMFGKNF-JJRA<U-#H:%C&(1S&)G%0S$C(CP+"4H)<
M-L'++]664D>!605'<0Q:2]YB_&WL&8R)27O 5K&J[&BK'>S!8W5TF*(2H3@+
M?'I-DR!>@I4@2;-;FL &-G$=P06K3<M\U%@N)T+Z<E9NJ&L&GP@96E9[I)$B
M3H3R31(0Q\]D4;%]8@72Y#%.?A'842/.4'S_>0XK G N8Y7)WU+*G FN'XV"
M!];KP+J$7*;(KRN5DJ<DW=W]F_J5G1JP/B%7,_FBQ)95/8'%$O8>L-1#WEQ'
M?T3?H\^WT=_8?WZ^X0LX7M8XQ?'F^L,??_G^X4^?WY"$;F%7!W0K[)]Q I.I
M%4P9X-I4><TIDV95%7U1FN_/"%A1&K$Z/T]]M9>YH\0V&&YT0KHJRD[(S.AH
M/HI$\$Q-XG@G$#Q>G@@!P>>X2U9D -2YU%%@5D7PW(+6EN"9?AL$@F=@TAZP
M!5:W)5;%\)'5L>H?"U9'ARGN,H.\#^RW2-Z(29??6#6BE#)*>57</;ZWWF F
M5BP\Z(K9!8?UK*"3.T/#'9%C SV->T^3XH*W72E,0B$-,Z_*A?(3<Q]C$,46
M#=R,.>MIJ 2?34R.A5ZLA30SBRBX_5"]B[!2GD@!"&B14N0(D*I<=',(5>ME
M.+/O@K$>IVW1&J95A/9WI@>.T)'!B<EQ_O'GCQ]AQT;_-@J-DO+].TO:N%2'
M8KP>7\.(TGMZ91?_^'.Q16B.B]HZC1P;MD;=*SJD"D?HU^P(17A]<;>1(0"J
M8>? \.($*IC=Y&]1D%W#4?2K57ZBL@&MCA+RK5I+V "Y12'ZM$UM0XEAE<CB
M2^U0?W[Z0!S:A=BS/*D@$PI,'7WN:M!8KP7J<&XI7,!8J<@!/G"&R0[EILA@
MPR(\(=<Y+/*'+Q8 BK%O  (LQ[J.=\#8/-VNWJ3]9=.+'N%M$)%E'(9>DD((
M59PC>O<B48 " -3C>JSOA8[^GNG_R8]=R7E%"O=M?:*K.*%RLO'E:1N(,TZ?
MO:P)*VL]^>&_X7JL3A0,-8M_E-"R)NKC"5:*%V6Z@#"$C2@ 4+DT#4?["H7Y
M3I5@2>ZXSF+N3PNM?.5[ZE-NUH"-,;'3.$<Q5&5YW,*N4I/Y$M)!/=LJN/$B
M./97R(/;E!KRS8C,;822(JA;JB&@Y]5K.LX;3NLVMJ<7;;\MPB%'BRK@NTS3
M6P8,,D?O+;-S%$SR^MV#(_0_15*B\SS1T:4XDZ ^<F(J)K^=OIA-+Z!K!9UX
M&AI6NKN1GNI*/,]4)2Y/9O32BZJ'2^0>2Z&;2.4I*=23MXR'GGS_>7[R;F)>
M:0RNV*+AZUZMJZ%P8C.38Z$:AP*:6D3!,R-X=8B6"#TE4F1&QTY&P:J"JSD%
MJR43,_TN]L3+P*(U4 N,YMG\RAR!IZT'^@X<I"/C$Y, 2>T:NP\U2LKW[RQI
MXU4=BM')3+\MI1OUB38V#^8.4YN9))"G*RG)3)DM,XJC,[&ZQ<'#2D_,5W2
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M=#CPV8%(YZQ5CB)&S[,^=4?[HT_^]:Z@Z;(C_%')+D+'9Y\@?=DQO7W&&?L
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MQ3!%XR0Y87&>NUXZCH$F9.AWY4Q<<+_/<PR%@PB94(IP8+ +-Y$PY_DQ)CA
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MPZ_T-4 H* A9<1\O#.6*67;ERP&B-WF[18.H_G9;Y?$S4<3J*4>(D<M;GP'
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M$N2%='?&X)C?2=_C:]JN29\ #8(6EYEU4.3B]0OL=G0S-AJB]]FUZPLW+__
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M1&$=1W ]#K(]P*IK:JZZN75-4N*QZPARN3"0JO_S?R4H)WWT_'Z#7E$JWL(
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MCG.@0?94+,(N,YJ'*MXD:8!KP!"A-/N9CY8EQIB?.ENJ*O597*HJ+565HEM
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M@K6MUS)&;>,Q;JQM/<3Q!B>SE@TL-LM,P74>S*CA^?HG_/46YI4,VD<99/"
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MM4Y\'JR-^&3O5B50G)A(O[&%4V+8 8(R.#YS7H_?A^2PCSY%,&RVO"\N\N'
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MK[^X*R/:?J'_H8>:__/_4$L#!!0    ( ).$;E@STYS\80D  !P*   .
M:6UA9V4P,# P-RYJ<&>=E'DTU'L?QW_#C#%#%QE+TS5D'5FBLI1E0M8N[D@C
M7(;FEICD6F>R)E'<00C7TE1DN[*,-9J1P2"*2M'(-I0U6]%H+'-USW/O<\YS
MGC_N\[P_Y_W]Y_TYW_-Y?3_G?/EO^1. N)V5K14  H$ K]T"^.\ "T (#!&"
M@(6$($)0J) P7!P.A\'@B._$1,5E$+*R,@AI::2<BCQRO]+WTM(*F@I*JFKJ
M!]7WR6OI:*%U5-#JZ&^7@*!0*%P8+@F'2Z*1TDCT_RQ^*R A##@#T8(@14!
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M+FAT;5!+ 0(4 Q0    ( ).$;EBU=IA"1"H  (7\   7              "
M 3@$! !E9C(P,#$U,S4R7V5X,3 M,3-B+FAT;5!+ 0(4 Q0    ( ).$;EA5
MX>0JS"8   ?;   7              "  ;$N! !E9C(P,#$U,S4R7V5X,3 M
M,3-C+FAT;5!+ 0(4 Q0    ( ).$;EB4GEMK>BL  "P( 0 7
M  "  ;)5! !E9C(P,#$U,S4R7V5X,3 M,31B+FAT;5!+ 0(4 Q0    ( ).$
M;EB '?GTQB8  "77   7              "  6&!! !E9C(P,#$U,S4R7V5X
M,3 M,31C+FAT;5!+ 0(4 Q0    ( ).$;EA_&(:??SL  " 4 0 6
M      "  5RH! !E9C(P,#$U,S4R7V5X,3 M,38N:'1M4$L! A0#%     @
MDX1N6%O"F8I7 P  U@D  !4              ( !#^0$ &5F,C P,34S-3)?
M97@R,2TQ+FAT;5!+ 0(4 Q0    ( ).$;EBW7]N[: ,  (X*   5
M      "  9GG! !E9C(P,#$U,S4R7V5X,C,M,2YH=&U02P$"% ,4    " "3
MA&Y8UH#8X8\K  !UZ0  %               @ $TZP0 968R,# Q-3,U,E]E
M>#,M,2YH=&U02P$"% ,4    " "3A&Y8#O]LZ6$(  "/)   %0
M    @ 'U%@4 968R,# Q-3,U,E]E>#,Q+3$N:'1M4$L! A0#%     @ DX1N
M6#SBM*)<"   J20  !4              ( !B1\% &5F,C P,34S-3)?97@S
M,2TR+FAT;5!+ 0(4 Q0    ( ).$;EA;C-3VNP0  $0.   5
M  "  1@H!0!E9C(P,#$U,S4R7V5X,S(M,2YH=&U02P$"% ,4    " "3A&Y8
MD85Z.9 $   9#@  %0              @ $&+04 968R,# Q-3,U,E]E>#,R
M+3(N:'1M4$L! A0#%     @ DX1N6-!OL@M@&P  B:\  !,
M ( !R3$% &5F,C P,34S-3)?97@Y-RYH=&U02P$"% ,4    " "3A&Y8,G((
MUH\@  #:@ $ $0              @ %:304 97)N82TR,#(S,3(S,2YX<V10
M2P$"% ,4    " "3A&Y8"^?JT'4:  "?B $ %0              @ $8;@4
M97)N82TR,#(S,3(S,5]C86PN>&UL4$L! A0#%     @ DX1N6..J*FR':0
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B86=E,# P,#<N:G!G4$L%!@     4 !0 - 4  .':!P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>ef20015352_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:erna="http://eternatx.com/20231231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="erna-20231231.xsd" xlink:type="simple"/>
    <context id="c20230101to20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c20240312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2024-03-12</instant>
        </period>
    </context>
    <context id="c20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231001to20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c20230430_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c20230101to20231231_LegalEntityAxis_LincolnParkCapitalFundLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20240101to20240131_ShortTermDebtTypeAxis_ConvertibleDebtMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="c20230701to20231231_ShortTermDebtTypeAxis_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">erna:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationThreeMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c20230401to20230430_RangeAxis_MaximumMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c20230426_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:ExacisAssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="c20230426_MeasurementInputTypeAxis_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="c20230426_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="c20230426_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="c20230426_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="c20231231_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c20230221to20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2023-02-21</startDate>
            <endDate>2023-02-21</endDate>
        </period>
    </context>
    <context id="c20230221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="c20230101to20231231_TimingOfTransferOfGoodOrServiceAxis_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_DebtInstrumentAxis_December2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-08</instant>
        </period>
    </context>
    <context id="c20240131_DebtInstrumentAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="c20231215_ClassOfWarrantOrRightAxis_December2023WarrantsMember_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20221231_DebtInstrumentAxis_December2022ConvertibleNotesMember_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2022ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20230714_ClassOfWarrantOrRightAxis_July2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714to20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="c20231214to20231214_LongtermDebtTypeAxis_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_DebtInstrumentAxis_July2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_DebtInstrumentAxis_December2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodOneMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodTwoMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodTwoMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodThreeMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodOneMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231231_DebtInstrumentAxis_December2022ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2022ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_DebtInstrumentAxis_December2022ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">erna:December2022ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20230714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714to20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="c20230714to20230714_LongtermDebtTypeAxis_July2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="c20231215to20231215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2023-12-15</startDate>
            <endDate>2023-12-15</endDate>
        </period>
    </context>
    <context id="c20230714to20230714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2023-07-14</startDate>
            <endDate>2023-07-14</endDate>
        </period>
    </context>
    <context id="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-15</startDate>
            <endDate>2023-12-15</endDate>
        </period>
    </context>
    <context id="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-15</startDate>
            <endDate>2023-12-15</endDate>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-14</instant>
        </period>
    </context>
    <context id="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_SanDiegoLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:SanDiegoLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:ERSquibbSonsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="c20190418to20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="c20221231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:MarketCapContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:MarketCapContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">erna:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementBasisAxis_EstimateOfFairValueFairValueDisclosureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementBasisAxis_CarryingReportedAmountFairValueDisclosureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c20230219to20230220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2023-02-19</startDate>
            <endDate>2023-02-20</endDate>
        </period>
    </context>
    <context id="c20230501to20230531_TitleOfIndividualAxis_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c20220909_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-09</instant>
        </period>
    </context>
    <context id="c20230101to20231231_TitleOfIndividualAxis_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:FactorBioscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221130_OwnershipAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">erna:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="c20230219to20230220_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-19</startDate>
            <endDate>2023-02-20</endDate>
        </period>
    </context>
    <context id="c20230220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2023-02-20</instant>
        </period>
    </context>
    <context id="c20221001to20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20221123to20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-23</startDate>
            <endDate>2022-11-23</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">erna:RetirementPlan401KMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_RangeAxis_MaximumMember_RetirementPlanNameAxis_RetirementPlan401KMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">erna:RetirementPlan401KMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_PlanNameAxis_InducementPlan2021Member_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20230101_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="c20240101to20240101_PlanNameAxis_EquityIncentivePlan2020Member_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AwardTypeAxis_NonQualifiedStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AwardTypeAxis_IncentiveStockOptionsMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:IncentiveStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_PlanNameAxis_InducementPlan2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_PlanNameAxis_InducementPlan2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:InducementPlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20231231_PlanNameAxis_EquityIncentivePlan2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">erna:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20221231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_TimeBasedStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:TimeBasedStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_PerformanceBasedStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:PerformanceBasedStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221123to20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-23</startDate>
            <endDate>2022-11-23</endDate>
        </period>
    </context>
    <context id="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-12</endDate>
        </period>
    </context>
    <context id="c20221202to20221202_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-02</startDate>
            <endDate>2022-12-02</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220712to20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-12</endDate>
        </period>
    </context>
    <context id="c20220306to20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-06</startDate>
            <endDate>2022-03-06</endDate>
        </period>
    </context>
    <context id="c20231231_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20220601to20220630_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">erna:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023AndDecember2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:July2023AndDecember2023ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ClassOfWarrantOrRightAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_December2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_July2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20230101to20231231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:July2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:December2023WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">erna:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-05</instant>
        </period>
    </context>
    <context id="c20230405to20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">erna:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-05</startDate>
            <endDate>2023-04-05</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">erna:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20231231_IncomeTaxAuthorityAxis_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20231231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_IncomeTaxAuthorityAxis_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20231231_IncomeTaxAuthorityAxis_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20221231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">erna:PresidentChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">erna:PresidentChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">erna:PresidentChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">erna:NonQualifiedStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="c20240111to20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-11</startDate>
            <endDate>2024-01-11</endDate>
        </period>
    </context>
    <context id="c20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">erna:December2023ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-11</instant>
        </period>
    </context>
    <context id="c20240111_ClassOfWarrantOrRightAxis_WarrantMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-11</instant>
        </period>
    </context>
    <unit id="U001">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U002">
        <measure>shares</measure>
    </unit>
    <unit id="U003">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U004">
        <measure>erna:Patents</measure>
    </unit>
    <unit id="U005">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U006">
        <measure>erna:Contract</measure>
    </unit>
    <unit id="U007">
        <measure>erna:Segments</measure>
    </unit>
    <unit id="U008">
        <measure>pure</measure>
    </unit>
    <unit id="U009">
        <measure>erna:Installment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="c20230101to20231231"
      id="Fact_629cc0c7d07b4e578787a6de4aa918a0">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20230101to20231231"
      id="Fact_99e4d27530914e4bbc045d6727e85b94">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="c20230101to20231231"
      id="Fact_60d02b68a361407c944f1e068a03541a">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="c20230101to20231231"
      id="Fact_0c3de09103e447dfb2642e4d0c1cbf35">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="c20230101to20231231"
      id="Fact_960200065d13403f95244e3870700475">0000748592</dei:EntityCentralIndexKey>
    <erna:NumberOfConsecutiveTradingDays
      contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      id="Fact_35ada709acde4da985c53db06fba5394">P10D</erna:NumberOfConsecutiveTradingDays>
    <erna:NumberOfConsecutiveTradingDays
      contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      id="Fact_fe2e977747fa41309cc95a33766e6e30">P10D</erna:NumberOfConsecutiveTradingDays>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_1686a4286739492e851a84f95f37d027"
      unitRef="U001">500000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      id="Fact_5269f7037c524c0e8f946b93d07e4c92">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      id="Fact_e3ad1a6b59fa4c388062e2bab91b442b">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:OpenTaxYear
      contextRef="c20230101to20231231"
      id="Fact_27587e86962c450fb8de5335527ed5c8">2020 2021 2022 2023</us-gaap:OpenTaxYear>
    <dei:SecurityExchangeName
      contextRef="c20230101to20231231"
      id="Fact_a18828d7e3b54c4d80f7f0a71c4d08d7">NASDAQ</dei:SecurityExchangeName>
    <dei:AuditorFirmId
      contextRef="c20230101to20231231"
      id="Fact_bb4f95767a444ec094e91a06596f509d">248</dei:AuditorFirmId>
    <dei:DocumentType
      contextRef="c20230101to20231231"
      id="Fact_91dc94c9bc684a98920a361540c10b9d">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="c20230101to20231231"
      id="Fact_659bf4f5b1234f9494cd180c2d9a096b">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="c20230101to20231231"
      id="Fact_af37064148ca47d58e2043bc9b95c482">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="c20230101to20231231"
      id="Fact_0cc9e6b9aab946d29364196f80684622">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="c20230101to20231231"
      id="Fact_9ab982465a034a1ea804a026c5023738">1-11460</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="c20230101to20231231"
      id="Fact_073cca32bf90494b86a206a43bcea367">Eterna Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230101to20231231"
      id="Fact_da7a04f44135437295da943eb4212429">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230101to20231231"
      id="Fact_5cedbaa61dd24d959516ad4079c9fcdc">31-1103425</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230101to20231231"
      id="Fact_b6c8d27c669a48a1ab15d08e5346f780">1035 Cambridge Street, Suite 18A,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20230101to20231231"
      id="Fact_33ad2fa07c384e12bcf49e2b7138ec96">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230101to20231231"
      id="Fact_dca17a9e23d1419f8ba4e0c6f3e25dc0">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230101to20231231"
      id="Fact_2dea8d0e321240219bdbc047196c8b66">02141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230101to20231231"
      id="Fact_34977c76abbf47f2829712552a60ae3d">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230101to20231231"
      id="Fact_bf7eccb8472a47a28e2a0939ab6b4dea">582-1199</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20230101to20231231"
      id="Fact_bad5b8f702004fa58571d6a704444939">Common Stock, $0.005 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230101to20231231"
      id="Fact_7e416b1f7db4474d9a660057de321cb1">ERNA</dei:TradingSymbol>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="c20230101to20231231"
      id="Fact_2cf6c0d4894b4223b1c85fcfd23ae3d0">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="c20230101to20231231"
      id="Fact_ab24b0c62ddc472b89f614df2ebeacea">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="c20230101to20231231"
      id="Fact_8422077ac14d4d3880fe721d23300d6c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="c20230101to20231231"
      id="Fact_eaed3623a1c94a79898929981e7298b1">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="c20230101to20231231"
      id="Fact_a3b6a223b415410b83a4997416156479">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="c20230101to20231231"
      id="Fact_a22d019a8c43455388e2349bfa0c64e5">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230101to20231231"
      id="Fact_99693850800b48179ffd8e3bfd6882bc">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="c20230101to20231231"
      id="Fact_d971d201374f4d9998a35b221fe82f83">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="c20230101to20231231"
      id="Fact_fdd8c221fc814a188093d10fe246869f">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="c20230101to20231231"
      id="Fact_6b4aa3d47ae942d08a734b41ddc2b640">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="c20230630"
      decimals="-5"
      id="Fact_58d033db59ea44bcb29736da431f9868"
      unitRef="U001">9700000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c20240312"
      decimals="INF"
      id="Fact_c60f6e92ea4140a286f2d94a8f836ce9"
      unitRef="U002">5410331</dei:EntityCommonStockSharesOutstanding>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="c20231001to20231231"
      id="Fact_9c0b66bdc7934a46812cb864f7b44f7e">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="c20231001to20231231"
      id="Fact_3040567776b9490284ef343a16fc2f5c">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="c20231001to20231231"
      id="Fact_a0c0f2d4513e42e7aca101d0819f83da">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="c20231001to20231231"
      id="Fact_9c8f65c57b004657aa064db7efcb08d4">false</ecd:NonRule10b51ArrTrmntdFlag>
    <dei:AuditorName
      contextRef="c20230101to20231231"
      id="Fact_369a0c9c16e34d95a6bfafd8cadddb42">GRANT THORNTON LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="c20230101to20231231"
      id="Fact_9b7d245530af4b0f8cac403f52f0186c">New York, New York</dei:AuditorLocation>
    <us-gaap:Cash
      contextRef="c20231231"
      decimals="-3"
      id="Fact_4d6c08d38c45460aab422d206980b6c5"
      unitRef="U001">7575000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="c20221231"
      decimals="-3"
      id="Fact_fa4216fe2b2545c18eefd83f63559cdf"
      unitRef="U001">11446000</us-gaap:Cash>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_a25c429eac74421cb7f11979dda690ff"
      unitRef="U001">425000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_d129541be24b45569d87311250fca146"
      unitRef="U001">951000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_096caa837e3e47b9a586941facf1705a"
      unitRef="U001">1599000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_e0518ad7e2d54eeb985bb5394968b0c7"
      unitRef="U001">1284000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_2a4e0cdd20ae47febb93a9d36cd2dddb"
      unitRef="U001">9599000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_0199ec07a3364086886bbbb1afe041ff"
      unitRef="U001">13681000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_dca6b6e7e7064a239705de6adcf6a8dd"
      unitRef="U001">4095000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_bddc55d04fc442c1a5f7b4ea0399372b"
      unitRef="U001">4095000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20231231"
      decimals="-3"
      id="Fact_559b8bffd03f4eb1a2b2b85006f96050"
      unitRef="U001">493000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20221231"
      decimals="-3"
      id="Fact_3441247eb41549809a8dc9e1c5376d7c"
      unitRef="U001">236000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20231231"
      decimals="-3"
      id="Fact_4780d8a0e2ec4d32965bddd68e4e64ae"
      unitRef="U001">32781000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c92593d9d4fd45fcac546968ae47d2fc"
      unitRef="U001">1030000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="c20231231"
      decimals="-3"
      id="Fact_8c6a8be77f4a43ab95cc31b6b00b6f04"
      unitRef="U001">2044000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20221231"
      decimals="-3"
      id="Fact_e12ac8776c5f44f38d3565680fd35230"
      unitRef="U001">2044000</us-gaap:Goodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="c20231231"
      decimals="-3"
      id="Fact_b4df2b38209c469b8048584daf03b517"
      unitRef="U001">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="c20221231"
      decimals="-3"
      id="Fact_4b806e181fe34a728a1fa10e374ff550"
      unitRef="U001">59000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_56ea93ebfa0f404bbfdda81aab753ac8"
      unitRef="U001">120000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_5deba22fb82547adbecd9cd94a3e9769"
      unitRef="U001">1134000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="c20231231"
      decimals="-3"
      id="Fact_d55ddb17f75940899552f5dbcbe5ca6f"
      unitRef="U001">49132000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20221231"
      decimals="-3"
      id="Fact_cc07c99f4d094a4e99e49cc445468ac2"
      unitRef="U001">22279000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_6a87d02e2e2d404aa79d6d048e45787d"
      unitRef="U001">1067000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_9428a2a24e3b446fad63385cb95718f4"
      unitRef="U001">1620000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_72c80b0d4bb941f0b4836b6667b5ee24"
      unitRef="U001">1893000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_e40d068275154c51a5e9d01fe8faa47e"
      unitRef="U001">3626000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_87187394fae3414587c9c95fc1ec03a2"
      unitRef="U001">2000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_a02a482625314393900860c7601335e6"
      unitRef="U001">0</us-gaap:TaxesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_e10e8616a5ed4ae5b87d8b7699d72721"
      unitRef="U001">2216000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_590c6510b9434bdfb4a886e9bce523cf"
      unitRef="U001">295000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember"
      decimals="-3"
      id="Fact_333b50c41dfc49faa328d65d9bbd0ccf"
      unitRef="U001">1205000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember"
      decimals="-3"
      id="Fact_59bca42bfb394f129d7d5879c6fd6fa0"
      unitRef="U001">1750000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_e3a7479c0e0944aa80c490955a4213a4"
      unitRef="U001">190000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_8672c9422bc54bee8626d50e2eff6d5d"
      unitRef="U001">0</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember"
      decimals="-3"
      id="Fact_c56446bf1ace474295302e5f8a648d60"
      unitRef="U001">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember"
      decimals="-3"
      id="Fact_d3968758f9ba457da226f88119bcb149"
      unitRef="U001">363000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_d0db517431d2467cb7580a76e24a20c3"
      unitRef="U001">6573000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_8d75bf20760843a187d08b822efe95e0"
      unitRef="U001">7654000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="c20231231"
      decimals="-3"
      id="Fact_9832126f6970407495942c4b276f545a"
      unitRef="U001">6773000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="c20221231"
      decimals="-3"
      id="Fact_bd03911c773c4a0f87e5e02d93f3ad19"
      unitRef="U001">0</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_f15c1d79cdb642f5bc96ea7740575be2"
      unitRef="U001">116000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_74f42e7b69664793ba9d6ff733e7d8c6"
      unitRef="U001">331000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_be38b114bd654c7ea4f5d4039d3e6c66"
      unitRef="U001">32854000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_d97446b97d524f5b9261d9c5c1a178d4"
      unitRef="U001">887000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember"
      decimals="-3"
      id="Fact_1610bb952e1141f79622ac5d79796654"
      unitRef="U001">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_RelatedPartyMember"
      decimals="-3"
      id="Fact_caa93de4a46b4eed9c16d777cba3a9d5"
      unitRef="U001">1206000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_baf621403ef347febd9a503e24078626"
      unitRef="U001">392000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_68fcfb1a3de04524910a125118630a66"
      unitRef="U001">0</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_2854743a8e654962878e2fee5daf853a"
      unitRef="U001">107000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_073a5957ecf445eba84b9bb96c08b7de"
      unitRef="U001">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember"
      decimals="-3"
      id="Fact_337cf3c0c30d4e8b913900f2cb147051"
      unitRef="U001">84000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20221231_RelatedPartyTransactionsByRelatedPartyAxis_NonrelatedPartyMember"
      decimals="-3"
      id="Fact_ab4d1647afa147459fae6e9c70bac40e"
      unitRef="U001">94000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20231231"
      decimals="-3"
      id="Fact_ef521011624d46799d0cf8b010d7197c"
      unitRef="U001">46899000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20221231"
      decimals="-3"
      id="Fact_8d467db2bc084f999dc7508255130ebd"
      unitRef="U001">10172000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20231231"
      decimals="3"
      id="Fact_6017e08797084dbfb77816978f71608b"
      unitRef="U003">0.005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20221231"
      decimals="3"
      id="Fact_01b245be86134eddb7d3627cdf857083"
      unitRef="U003">0.005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20231231"
      decimals="-3"
      id="Fact_b13bb3bbe0074a339df9a7874070a235"
      unitRef="U002">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20221231"
      decimals="-3"
      id="Fact_26ac4c14d9ee40a4baafd8848ce3d3af"
      unitRef="U002">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20221231"
      decimals="-3"
      id="Fact_9f8016c60a574428b4a2d6230f579b82"
      unitRef="U002">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20231231"
      decimals="-3"
      id="Fact_0a12f4ff50a547f98b1bf23e79ee5680"
      unitRef="U002">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20221231"
      decimals="-3"
      id="Fact_1aef977bd5eb4c0cbea66703048adbf2"
      unitRef="U002">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20231231"
      decimals="-3"
      id="Fact_95ae1f1607154928ba9eea571e7003c3"
      unitRef="U002">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_3358e6fbe7f34ff093a12aa3764fa44b"
      unitRef="U001">156000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c20231231"
      decimals="-3"
      id="Fact_2a2feaef5eb24c0caa2217eca6afb3d8"
      unitRef="U001">156000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockValue
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_f176c9300f714c2f943a1bb6848ef5b8"
      unitRef="U001">1000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_dffbc502186f44c9b9deb741760727e7"
      unitRef="U001">1000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20231231"
      decimals="3"
      id="Fact_b7792e63291c4405998a0ea8bfc06a71"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20221231"
      decimals="3"
      id="Fact_1c2ec87765df47cfa1d8ce04b5530d75"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20231231"
      decimals="-3"
      id="Fact_547e1fc06cd24abbb539c716a0b0fc06"
      unitRef="U002">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20221231"
      decimals="-3"
      id="Fact_3478ab00207149648f759d42c5b616e5"
      unitRef="U002">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20231231"
      decimals="-3"
      id="Fact_4fba1a51450b4c8183fe0e0196c35f84"
      unitRef="U002">5410000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20231231"
      decimals="-3"
      id="Fact_0e42136741c54654b4eecfd28f57782b"
      unitRef="U002">5410000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20221231"
      decimals="-3"
      id="Fact_7ed27b6fb585414a9210c78b3ef181e5"
      unitRef="U002">5127000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20221231"
      decimals="-3"
      id="Fact_196458a81c2b4582914a2cff08cac4bc"
      unitRef="U002">5127000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="c20231231"
      decimals="-3"
      id="Fact_c58b9481d58b468881661ee656eefb3f"
      unitRef="U001">27000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c332b82d7dae4a078de9fd062293dbe1"
      unitRef="U001">26000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20231231"
      decimals="-3"
      id="Fact_5090af07b5034b148d8ffa132e2a9ecc"
      unitRef="U001">189186000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20221231"
      decimals="-3"
      id="Fact_95681a219a9a47979c03c08b575d789c"
      unitRef="U001">177377000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20231231"
      decimals="-3"
      id="Fact_c28db29db75b40a880d6198d633d7fd0"
      unitRef="U001">-186981000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20221231"
      decimals="-3"
      id="Fact_52e29e084d914b47b6303c262fae77ae"
      unitRef="U001">-165297000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="c20231231"
      decimals="-3"
      id="Fact_c285b2393179401f96e4ce6c810451a2"
      unitRef="U001">2233000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231"
      decimals="-3"
      id="Fact_1a665a92419c435797a1de8c6d1b94df"
      unitRef="U001">12107000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20231231"
      decimals="-3"
      id="Fact_9df133542e254975a181acb894863bfe"
      unitRef="U001">49132000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20221231"
      decimals="-3"
      id="Fact_bc8d9fd8f24249baac8b53a73f617996"
      unitRef="U001">22279000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_9c57d2961c5243c7804758446362d266"
      unitRef="U001">68000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f386c10dcce744e39578dc2f4265ff80"
      unitRef="U001">0</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_dff85eb0c53845f0b56614c88e7aa3f8"
      unitRef="U001">236000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_151245f3eeac4fb0bf9c7e9ca07860ef"
      unitRef="U001">0</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_ca23458ba2ce4654beb67954643a9aa8"
      unitRef="U001">-168000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2454edeef3664b6281bd71abcb4d23a6"
      unitRef="U001">0</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_e08c059fff1b43a49e57b359cc17b951"
      unitRef="U001">5920000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_aab2b0e229d743aba3cdcc2faf44c529"
      unitRef="U001">10392000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_2a45a6a9d773439e87e292dee93cbefd"
      unitRef="U001">14587000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_78610be6d0674883880ee22dff2bff21"
      unitRef="U001">16835000</us-gaap:GeneralAndAdministrativeExpense>
    <erna:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_5e3387f7b736452285b7da2a371f6d4c"
      unitRef="U001">460000</erna:ResearchAndDevelopmentInProcessAssetAcquisition>
    <erna:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_0815c84b2d75471bbc463e53dce935a6"
      unitRef="U001">0</erna:ResearchAndDevelopmentInProcessAssetAcquisition>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_7c7aa666ea354e329f9c35236e03b195"
      unitRef="U001">0</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_b6f1995c60cb49eebeb16ef074a42ca2"
      unitRef="U001">5990000</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:OperatingExpenses
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_4cda2738666e4360959c8b057cff78e6"
      unitRef="U001">20967000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c15733253f69402ca202fe690eeee00d"
      unitRef="U001">33217000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_48275537a4a34b6db026e3e25b12b70b"
      unitRef="U001">-21135000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_b38d7d3e579d48169c4183f281689e51"
      unitRef="U001">-33217000</us-gaap:OperatingIncomeLoss>
    <erna:WarrantLiabilitiesExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_fc6da15ada4348e8a309b3ad6a9c7275"
      unitRef="U001">-215000</erna:WarrantLiabilitiesExpense>
    <erna:WarrantLiabilitiesExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_06229dfc8e8d486bb2137bd5f13e3727"
      unitRef="U001">-10795000</erna:WarrantLiabilitiesExpense>
    <erna:ChangeInFairValueOfContingentConsideration
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_acacfc0fc3d9400cbf287cea4a5a4072"
      unitRef="U001">118000</erna:ChangeInFairValueOfContingentConsideration>
    <erna:ChangeInFairValueOfContingentConsideration
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_b1e8f0144f114a5e9c775fc61d109ad9"
      unitRef="U001">0</erna:ChangeInFairValueOfContingentConsideration>
    <erna:LossOnNonControllingInvestment
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_97e7c5792e974d9c9225dbff32550d1e"
      unitRef="U001">59000</erna:LossOnNonControllingInvestment>
    <erna:LossOnNonControllingInvestment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_dc4b07ac9918405ca4f440a30cb96348"
      unitRef="U001">941000</erna:LossOnNonControllingInvestment>
    <us-gaap:InvestmentIncomeNet
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_f450109cd64045b380466c5debe2a3a3"
      unitRef="U001">138000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f579855643a84be2ba58e8410c557f89"
      unitRef="U001">0</us-gaap:InvestmentIncomeNet>
    <us-gaap:InterestExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_9bcefda45dbc4f6980d30f9a6d3bebf5"
      unitRef="U001">614000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8c493381b0f4410f991beaef18bfed4e"
      unitRef="U001">30000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_8c0ce0f37a73416cb33c96937b38d7de"
      unitRef="U001">-334000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_29162345e1cd4b6a93506063bc7a1bd0"
      unitRef="U001">-1141000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_bf2a073d681a42abbb145f8abede3091"
      unitRef="U001">-536000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_073cba25519842ebb94d23d4746ba362"
      unitRef="U001">8683000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_3aff42effc934babab2dbbc0f79e5c12"
      unitRef="U001">-21671000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_fd97bac0eeb645569a5a5cdfa2afcd65"
      unitRef="U001">-24534000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_576b5a3f691e45ed8072acdb21caff56"
      unitRef="U001">-3000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_90ac2edb68364de58268c75cd6d613ad"
      unitRef="U001">45000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_30f4f222aef1474ba5f920642b307c8b"
      unitRef="U001">-21668000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a947ba21d25742d696a8801454066227"
      unitRef="U001">-24579000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_e8a3181d92e542c1a94e2e32ab82284b"
      unitRef="U001">16000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_de336daaa0cf428b830dd8464c2fb306"
      unitRef="U001">16000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_9c8af24a963c43e38d9b1e1c77db81c2"
      unitRef="U001">-21684000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_bc8a68ba0f68485badd4349e983cddbd"
      unitRef="U001">-24595000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20230101to20231231"
      decimals="2"
      id="Fact_d0cb27a84d6849a38ec7b70a107483dc"
      unitRef="U003">-4.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20230101to20231231"
      decimals="2"
      id="Fact_cb074f5d46c240a6ae4f00ddbdfd2ffd"
      unitRef="U003">-4.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220101to20221231"
      decimals="2"
      id="Fact_4b52e655a03b4ddbbdb856ea1053491d"
      unitRef="U003">-8.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220101to20221231"
      decimals="2"
      id="Fact_cf4e3640668d451f94234ac5951e5d1d"
      unitRef="U003">-8.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_c24a68b1ab2c4f4ea6c344f353e0ae8a"
      unitRef="U002">5314000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_aa3530300c8046619c4360e8eb819a8d"
      unitRef="U002">5314000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_662dd55fb5df4136a1dbd807f4a5f671"
      unitRef="U002">3051000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_37a45672ef3f4b438e836d7a976bd2ec"
      unitRef="U002">3051000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_8348917587ba4810878a412b4a887a4a"
      unitRef="U002">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_ba76188cc9b14422b0d55838dae3af0a"
      unitRef="U001">1000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c85635a315844727adb1ff9e0b928787"
      unitRef="U002">2601000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_018ead85e3804b93b702b72592a77c41"
      unitRef="U001">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b592fb5b8ad3436ca48151c64ba07dd5"
      unitRef="U001">166191000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_9164b3e768214b4f8f8a88cae91855a2"
      unitRef="U001">-140702000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_933106efa6d14ab59fcd764e5a3656a2"
      unitRef="U001">25503000</us-gaap:StockholdersEquity>
    <erna:StockIssuedDuringPeriodSharesPrivateOffering
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_33e586a587664fa1a4a76bcf0a0168e6"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesPrivateOffering>
    <erna:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_e49f948bf476465aa8fa1b9e66df184b"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValuePrivateOffering>
    <erna:StockIssuedDuringPeriodSharesPrivateOffering
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1dd35f5c7e534623bfd3be526b97569a"
      unitRef="U002">275000</erna:StockIssuedDuringPeriodSharesPrivateOffering>
    <erna:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9dd5c8a05fd64732942a16c8ce6ea3e3"
      unitRef="U001">1000</erna:StockIssuedDuringPeriodValuePrivateOffering>
    <erna:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_40a54a2a866c473bbd8c79088fed3678"
      unitRef="U001">-1000</erna:StockIssuedDuringPeriodValuePrivateOffering>
    <erna:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_96006f93258c46a8a2350f45958a06b8"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValuePrivateOffering>
    <erna:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f25d88b881ae4ff88629fb3fc981e57c"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValuePrivateOffering>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_29056b643ad74d2a84f291f637178618"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_e94b9352eb6a4274935555dffab53b8d"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_edc1578484d44993b5b4c7b5bb3ace9b"
      unitRef="U002">2000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_95c8201d26b34effb4a6f04e189a89a9"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_01e2ce28ebd943d0840b2e19b80ad2ed"
      unitRef="U001">-5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_bba16ca166c24e1892efed2b646e0937"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7d8edbe8ea90477aabf6fdf0ccdb021e"
      unitRef="U001">-5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_cde2d1689e364178a315ec0a93b94f28"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_6e6992bf082f4b899120820b0e35791d"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_992901fe2c294012b9d0a66bdea035bd"
      unitRef="U002">2185000</erna:StockIssuedDuringPeriodSharesOfCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ca67442d7e69427b96f4a8729eb52209"
      unitRef="U001">12000</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_c516ddb4c2d243f4b326870dc4e495f1"
      unitRef="U001">7383000</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_b988ace2492f4f219dcae27eb48ce162"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_81514d2ee9284b6b81fc3fc681134d9f"
      unitRef="U001">7395000</erna:StockIssuedDuringPeriodValue0fCommonStockAndWarrantsInConnectionWithPrivateOfferingNetOfOfferingCosts>
    <erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2ce5ee502b004ed7a6c74ba3eabc83e4"
      unitRef="U002">0</erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2e5e00c8ac0445c0b86d61b9a2a84075"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b6a8cb9d97d2498d930893f7fa26b7c9"
      unitRef="U002">4000</erna:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2a5c3c890a90471bbb1b9458137f37a4"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_65927fb628f5401db91cad319353eb91"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_5d770ef83d5447e5a2e8b62827fd0380"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_b2a887a5c6994e5484cf5bf77f77c03d"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_d9c5baee224d4043906367e4cc071dd0"
      unitRef="U002">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_71a706d8ff99483b971b0e8ab9c5018b"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9c77b7e90f9c4648a4c6c4c770fac6d1"
      unitRef="U002">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_39ac8950d1d846268c752b0be5eec51d"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7600bbae067d485191a3f4b1228d5c00"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_8026db955fab43358c6aea3f4cca97d8"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_84d1b46e1ce44ee2b1b4f1023b0d703f"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_ff670234c13042c8a8b76b37a046925c"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_3343af0d698a4c84b68a32d84a409b8d"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_c7f5cea361794230b8678e83e42d9816"
      unitRef="U001">2935000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_4d53fc49b23c41019dba8aabfaf36d73"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2bc27d9af0b04541a9a2932c953dcd42"
      unitRef="U001">2935000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2cd1f0cee67947418e25b3d7e824d6e9"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a62b9a9b36c947b28789ad36373cc931"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_c472217ccc3b402e9b533a6f88b0dbc3"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_641b5b235b6742b18c716bef53a5ece8"
      unitRef="U001">-24579000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_15ecd4241e52472795b405bf576b7a6d"
      unitRef="U001">-24579000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_22e5cb46b0354cb4992a423417b80874"
      unitRef="U002">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_49f696e51be3482586c64284630e5bc4"
      unitRef="U001">1000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c633c166644f4ec18bab07f070a4041f"
      unitRef="U002">5127000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_560027aefa094d37ab03b8fbba00f3fc"
      unitRef="U001">26000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_3d63221e8c0548f1b4d435a8fd93ec89"
      unitRef="U001">177377000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_442615502b6643c68aa5640665b55d8c"
      unitRef="U001">-165297000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20221231"
      decimals="-3"
      id="Fact_edce8ae476f14097b3fcb9528126e4e6"
      unitRef="U001">12107000</us-gaap:StockholdersEquity>
    <erna:StockIssuedDuringPeriodSharesAcquisitions2
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_d3a08f033dc8403da02a790114bb847f"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_33b476afbd2c4d85b523ad02a0e3d098"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodSharesAcquisitions2
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e22f2f7e607d4565971bdd9e68bebaf2"
      unitRef="U002">69000</erna:StockIssuedDuringPeriodSharesAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e82b42b71cb04134a668049f78d9c3c1"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_9fcea42ca4344e2b81bba89832af6725"
      unitRef="U001">208000</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_eb6d9f7c2a5f40ce81445a4c6329ee3d"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodValueAcquisitions2
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_8c520435a4a345a2bf113208ee951652"
      unitRef="U001">208000</erna:StockIssuedDuringPeriodValueAcquisitions2>
    <erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_98d746f5509d4327831c48f943d2981f"
      unitRef="U002">0</erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_d45ab070eb1a4ae49a814ff1699375a4"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_aca1ebaa845c4e56804dc7403db3278a"
      unitRef="U002">214000</erna:StockIssuedDuringPeriodSharesStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_efdd30749a2141779161db39b28c55ae"
      unitRef="U001">1000</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_9c8ae0030f0245eeb7bee3788ad55b39"
      unitRef="U001">579000</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d40e5974e18f44e59c13ac33e3f2ba84"
      unitRef="U001">0</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <erna:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_6608d341fe754c69bb40832d34e4818e"
      unitRef="U001">580000</erna:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_dc13c4ccc8c84395a3e874eebdca6931"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ea54172070af499f8e7df63f40b98a9e"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4f295e2413e247e292629736c7157a3d"
      unitRef="U001">9014000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_4cbff6bb2fbc411ead439529d1673b3e"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_c4b71a18a2d343c8b9449b27ca453292"
      unitRef="U001">9014000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_79b1c93997f949c78e7ae017d4f27a89"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4d0d7b5219994eaf9bc51c8e6eecfa27"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_8e5c8e7a6c794d2eb366c2ff58a96598"
      unitRef="U001">766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_1d9dd94f0cb54024bba065c6f004069a"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_da258e7ed0604091a7081d2efc9006fc"
      unitRef="U001">766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2e9dedaaa3fe420ab25ad2cd69e4d5db"
      unitRef="U002">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_0e3b916ae6314eeabe8ead0c5cd1343d"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_38e62dab9f2b4a3b95fc9e6164b68cd4"
      unitRef="U002">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_59d4d3ebf85544da83a84dbeaedc7fb4"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f396b9f0a0db449297aa682819526263"
      unitRef="U001">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_85e53a1fe16e47cab54f8b91efd35f62"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_3f22bb0b93ca414eae31a4670e1c3938"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_40056182a31541258deabac920659082"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4f82f6f3e7ed43ddbcc2f9fb7cb55342"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_157729159f4546a189daee09b479e6df"
      unitRef="U001">1242000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_da6939322d834dd3b1e027c16486805f"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_ef68120875804bcd9a3748e633623060"
      unitRef="U001">1242000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_5e94de285e064f50be9c10e61dd7da25"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7abbb59cda7c46d9aa99a43b9fb0e030"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_fbce8fb74045404bbfbbc65e22f97fb5"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_858dba46c6614942b001493f1c1253a3"
      unitRef="U001">-21668000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_64753e1bff954cb2a5a50061e64d886d"
      unitRef="U001">-21668000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_eb18778a4ae047a0baba0751762bb02c"
      unitRef="U002">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_f0773f4aa1c74a28982353be9e8e9e59"
      unitRef="U001">1000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ef5fe7f3c8374d70ab9a3385c4c45940"
      unitRef="U002">5410000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2cb7328ae4c54103a38674559f332b1d"
      unitRef="U001">27000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20231231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4cd6e60cad4d4d2c93a0be60106046d0"
      unitRef="U001">189186000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20231231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0c36973b2ef94a0588b4e7933368cff7"
      unitRef="U001">-186981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20231231"
      decimals="-3"
      id="Fact_394836c6103a46fcb32c7fbb3519808b"
      unitRef="U001">2233000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_97ae97b0f746486ab74dd483d3309d3f"
      unitRef="U001">-21668000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_521cc7943d01464ca6e251e21eff2472"
      unitRef="U001">-24579000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_995212e6d7184a7cbbae0e9179dd308c"
      unitRef="U001">84000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2c406f47175c4a5484cc73223f49329b"
      unitRef="U001">161000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_8f2be070befa432c884fbc3e24a49e0a"
      unitRef="U001">1242000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_6b2077a4216a428e82fd850c11a0e4a5"
      unitRef="U001">2935000</us-gaap:ShareBasedCompensation>
    <erna:CommitmentSharesIssueExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_cf85527266df43538e27a032b5d8835c"
      unitRef="U001">249000</erna:CommitmentSharesIssueExpense>
    <erna:CommitmentSharesIssueExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f9ac5d02e120443f8efdc9a95ac9ac12"
      unitRef="U001">0</erna:CommitmentSharesIssueExpense>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_4a2c27993dec4a55a7635e92989aab68"
      unitRef="U001">-11000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_dc2c03e02af449db8a3c08b3337e4669"
      unitRef="U001">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_229dec39c4e4464fad5ca19ecd0e4621"
      unitRef="U001">1039000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d4da1ffadf11438db601c99e73c91571"
      unitRef="U001">336000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_7f6bdbe4830f42d69639e2febca59529"
      unitRef="U001">0</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_6b180a0afa2e433a8674f35779cea118"
      unitRef="U001">772000</us-gaap:OperatingLeaseImpairmentLoss>
    <erna:NonCashResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_5e3389237711425b92d385cb4d62ec9f"
      unitRef="U001">433000</erna:NonCashResearchAndDevelopmentInProcessAssetAcquisition>
    <erna:NonCashResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ee4ae2603a4f49e9a02dc80a56d8085f"
      unitRef="U001">0</erna:NonCashResearchAndDevelopmentInProcessAssetAcquisition>
    <erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_2fe99dcba24c4aa5ab24f7ae577af80f"
      unitRef="U001">0</erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset>
    <erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f3f2e3219e8649bd9f2860f26f21cf41"
      unitRef="U001">642000</erna:GainLossOnRemeasurementOfOperatingLeaseLiabilityAndRightOfUseAsset>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_d993c1127ba14c158d937fc6f1a48e3d"
      unitRef="U001">0</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_5f3bc78ff44d45fc9fb3dcf7afe18214"
      unitRef="U001">5990000</us-gaap:ImpairmentOfOngoingProject>
    <erna:GainLossOnDisposalOfFixedAssets
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_b0854ac69a594f3e86a8baf811ae16aa"
      unitRef="U001">1000</erna:GainLossOnDisposalOfFixedAssets>
    <erna:GainLossOnDisposalOfFixedAssets
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8caa3400228d4360962cd19c51b3a98f"
      unitRef="U001">280000</erna:GainLossOnDisposalOfFixedAssets>
    <erna:GainOnTerminationOfLease
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_322e5d7f53e34b69b33f8d566347b33e"
      unitRef="U001">0</erna:GainOnTerminationOfLease>
    <erna:GainOnTerminationOfLease
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8c1b1221683f42d6a528b240ca8970f0"
      unitRef="U001">85000</erna:GainOnTerminationOfLease>
    <us-gaap:InterestExpenseDebt
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_d222a91c9d57454b8959bfab7a7970aa"
      unitRef="U001">176000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_50d65e4dbe11445b8c7896f49b3581ba"
      unitRef="U001">0</us-gaap:InterestExpenseDebt>
    <us-gaap:PaidInKindInterest
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_b9da2ae50407461b9d1703cfb25600fb"
      unitRef="U001">113000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_567113df8c08417b9d259975b62a58c8"
      unitRef="U001">0</us-gaap:PaidInKindInterest>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_d1e7e5c582e84181951243cf7268842c"
      unitRef="U001">303000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_5f6f45a572754b31bae77f3ea32a7abf"
      unitRef="U001">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_5f906708b2954ed2aafcd7f1dbffbbd7"
      unitRef="U001">-215000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d900b71a9de74a88a48cbf187fa216e6"
      unitRef="U001">-10795000</us-gaap:FairValueAdjustmentOfWarrants>
    <erna:GainLossOnChangeInFairValueOfContingentConsideration
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_b8ccee90e6ab499fac4e959644ca9201"
      unitRef="U001">-118000</erna:GainLossOnChangeInFairValueOfContingentConsideration>
    <erna:GainLossOnChangeInFairValueOfContingentConsideration
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_0a8b61e6ef6d42b6bdbf54c2b1d61e4e"
      unitRef="U001">0</erna:GainLossOnChangeInFairValueOfContingentConsideration>
    <erna:LossOnNonControllingInvestment
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_91b436d942aa41f39f7bc2971c76346d"
      unitRef="U001">59000</erna:LossOnNonControllingInvestment>
    <erna:LossOnNonControllingInvestment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_593d0fba8f1649159ddae3202cfd14cb"
      unitRef="U001">941000</erna:LossOnNonControllingInvestment>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_76a60c2b18354f0cb755833b2c05e689"
      unitRef="U001">-527000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_9cc65d45214d45218d8cdf13cdabaea9"
      unitRef="U001">262000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_a04557f2838f4eb7a8bfc2f2a0d84f04"
      unitRef="U001">556000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_6a2c7e939cba4cb281f91a8ff6e524b8"
      unitRef="U001">187000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_dcbcd166c4494d61b3e6a9e0b857c3f6"
      unitRef="U001">-1014000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a1001d16b9194180b215a3d4496f0f5e"
      unitRef="U001">646000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_4926bf6ac3ce4d5fb8df01210c228472"
      unitRef="U001">-2898000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_64b9a54055c149ed8bde7b198f49c0d7"
      unitRef="U001">2034000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <erna:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_6bb2bd76db7245288e1f4d882e122027"
      unitRef="U001">1338000</erna:IncreaseDecreaseInOperatingLeaseLiabilities>
    <erna:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c076d51c96214f50a9ca001259b8f5a5"
      unitRef="U001">-340000</erna:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_943554a8fe4940fc90383cff1cbcb60d"
      unitRef="U001">-1750000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_d9e14488e5f34146bdb7a9be2479b537"
      unitRef="U001">2956000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_d2df18fde0b94446977e1e42c6c24403"
      unitRef="U001">582000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2292c750ef3b4ff98cf33bba34810c06"
      unitRef="U001">0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_a0e003339978464d98080c31e4ebd301"
      unitRef="U001">-374000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7580c48d09f5451bac3101db0d8e187d"
      unitRef="U001">155000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_9438c6d8a00446beb4803abe7545c1a0"
      unitRef="U001">-20408000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c218a9208bd54844b95c96b7b03c7b6c"
      unitRef="U001">-20976000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_90c2b0f080d442ddaa45704c187d7964"
      unitRef="U001">19000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_9967ecc016e945adb3b34ec01ac26e53"
      unitRef="U001">297000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_4ef1ec54c5004d99ae288f0465d1be67"
      unitRef="U001">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_1fdf53e94a394869bd943ac9046e6256"
      unitRef="U001">250000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_91a9d98a2e8a4770a5e4b6bfc676b5eb"
      unitRef="U001">-19000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2518c08135a642b3864b8d85c80c0620"
      unitRef="U001">-47000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_180ed5d0467d4662addc634b110fe91d"
      unitRef="U001">16503000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c76c1c6a48af434796b3d79f161ac7f6"
      unitRef="U001">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_3a336cffc7714ab7bd39a34f13ccf6e6"
      unitRef="U001">251000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ceb4dcd105f24c02ad824c11b4dab357"
      unitRef="U001">0</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_93a8c06761f641459cc9fe2b459a0bfe"
      unitRef="U001">1500000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_b933481b31284c839ba51dd0d700442f"
      unitRef="U001">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_f8476d8d26cc48a38fb0831e7dcbf90d"
      unitRef="U001">1500000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_9b7a65f3ae0f4612888ec6d442e6553f"
      unitRef="U001">0</us-gaap:RepaymentsOfNotesPayable>
    <erna:ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_c84e6240a8634cbdbea425c584d0cbf0"
      unitRef="U001">320000</erna:ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement>
    <erna:ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_55d291f0a1b2409592402b809f2aadec"
      unitRef="U001">0</erna:ProceedsFromIssuanceOfCommonStockPursuantToStockPurchaseAgreement>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_8a33d494f58d43208c34c609ac7be65c"
      unitRef="U001">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_0f6c1d2e96094d949ec039dd1d4b0d63"
      unitRef="U001">19706000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <erna:ExpensesPaidInConnectionWithPrivateOffering
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_68c2ff06f92e4ca7a0ca676d92ce0f7f"
      unitRef="U001">0</erna:ExpensesPaidInConnectionWithPrivateOffering>
    <erna:ExpensesPaidInConnectionWithPrivateOffering
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_fd8289819c8c4464947d59b8bb2fe795"
      unitRef="U001">110000</erna:ExpensesPaidInConnectionWithPrivateOffering>
    <erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_2acea41995d247f384e727bea044204c"
      unitRef="U001">0</erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants>
    <erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_eedd1a24d03d46e1a9cdc589b7de8408"
      unitRef="U001">7000</erna:IssuanceOfCommonStockFromExerciseOfPreFundedWarrants>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_19dd11c31af54ac780a62a9e50798fe0"
      unitRef="U001">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7bbeefe3a4b541db9419da5adb62c51f"
      unitRef="U001">5000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_2cd5d320c4b3447bbdf10524202f3909"
      unitRef="U001">16000</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_3a8f9dd656d34990a21318d03cae1789"
      unitRef="U001">16000</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_d80f39083e844ef88135cba101b4e409"
      unitRef="U001">0</erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit>
    <erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_5286e282163b489ea6b1eebec9060420"
      unitRef="U001">1000</erna:CashPaidForFractionalSharesInConnectionWithReverseStockSplit>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_46256f2dbc4643e59164b07c033e807c"
      unitRef="U001">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_4523452ea396420fb4aa5df88ffc392d"
      unitRef="U001">2000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_7e0935250a9d425586ca9850bc3d79fe"
      unitRef="U001">16556000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ebb648f21fe448009b43ff11e100ee12"
      unitRef="U001">19579000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_a392c83c1f964fe4a1ebef3bf636d557"
      unitRef="U001">-3871000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_e6da942c86bc4f1fa36e6c1e89b89acb"
      unitRef="U001">-1444000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20221231"
      decimals="-3"
      id="Fact_cd16d33f438845489c4a507bbec427d4"
      unitRef="U001">15541000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a3a7542fb7124aba941849042f4847da"
      unitRef="U001">16985000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20231231"
      decimals="-3"
      id="Fact_0e1a65aa80df482d84072238ea16f061"
      unitRef="U001">11670000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20221231"
      decimals="-3"
      id="Fact_55d5dbdf0bda431cb015e1b474c98ff6"
      unitRef="U001">15541000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_16158331690542da9563876126fe224c"
      unitRef="U001">20000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_6036a4ad6cb147e1bf0cb91113e13497"
      unitRef="U001">30000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_ce5e6271ff3b45c5956e0cd02e8fc7d1"
      unitRef="U001">4000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_107a4b9de5944a26a6c1dd7619ff65b2"
      unitRef="U001">15000</us-gaap:IncomeTaxesPaidNet>
    <erna:ContingentConsiderationForAssetAcquisition
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_92bbd2ca144c494c8d25d2cd02955e36"
      unitRef="U001">225000</erna:ContingentConsiderationForAssetAcquisition>
    <erna:ContingentConsiderationForAssetAcquisition
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_01563fd66f7949f09c3d5b147526e11f"
      unitRef="U001">0</erna:ContingentConsiderationForAssetAcquisition>
    <erna:IssuanceOfCommonStockForAssetAcquisition
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_a919ef802c904454bc7af39116fbeee6"
      unitRef="U001">208000</erna:IssuanceOfCommonStockForAssetAcquisition>
    <erna:IssuanceOfCommonStockForAssetAcquisition
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_92d9f75828124e74850e4d4fca63d94d"
      unitRef="U001">0</erna:IssuanceOfCommonStockForAssetAcquisition>
    <erna:WarrantsIssued
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_b7636f6653d24ab78c57e9c6cb490fbb"
      unitRef="U001">9219000</erna:WarrantsIssued>
    <erna:WarrantsIssued
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f96804be5a2d4443852d39402727d754"
      unitRef="U001">0</erna:WarrantsIssued>
    <erna:RepricingOfWarrantsInConnectionWithFinancing
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_e05578449fae4de5afd6d4f920c37039"
      unitRef="U001">766000</erna:RepricingOfWarrantsInConnectionWithFinancing>
    <erna:RepricingOfWarrantsInConnectionWithFinancing
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c19c0618a479479caf7806b01356b3a1"
      unitRef="U001">0</erna:RepricingOfWarrantsInConnectionWithFinancing>
    <erna:UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_ad5c1fe86bfa41ef8da28276b803f2d8"
      unitRef="U001">116000</erna:UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants>
    <erna:UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_c6d4cca5fa894fdcb1b5af9f7303b715"
      unitRef="U001">0</erna:UnpaidFeesIncurredInConnectionWithTheIssuanceOfConvertibleNotesAndWarrants>
    <erna:PaidInKindInterestAddedToConvertibleNotesPrincipal
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_bd80fcb5ce8240a69cdb3c07e59e3045"
      unitRef="U001">113000</erna:PaidInKindInterestAddedToConvertibleNotesPrincipal>
    <erna:PaidInKindInterestAddedToConvertibleNotesPrincipal
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f7edb9a35e1447fe9e8b17356d658671"
      unitRef="U001">0</erna:PaidInKindInterestAddedToConvertibleNotesPrincipal>
    <erna:InitialMeasurementOfRightOfUseAssets
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_72e7b001b34e4717bcead6feabcc07ea"
      unitRef="U001">34410000</erna:InitialMeasurementOfRightOfUseAssets>
    <erna:InitialMeasurementOfRightOfUseAssets
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a2f9bd4a71cf4364a030520464ec3566"
      unitRef="U001">1706000</erna:InitialMeasurementOfRightOfUseAssets>
    <erna:InitialMeasurementOfLeaseLiabilities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_d0ec4b4ccfd04365a8f92e298c745d25"
      unitRef="U001">34170000</erna:InitialMeasurementOfLeaseLiabilities>
    <erna:InitialMeasurementOfLeaseLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_1423b267e1324488a937e514d701d40b"
      unitRef="U001">1706000</erna:InitialMeasurementOfLeaseLiabilities>
    <erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_fe63a90b179641e59806015b22e33dfd"
      unitRef="U001">-1620000</erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement>
    <erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_caba6a75b70f4bb29f16d52d75d6c811"
      unitRef="U001">0</erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement>
    <erna:AccrualForPurchasesOfPropertyAndEquipment
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_a9f620f60e86444dbcbad91cf36e9f5b"
      unitRef="U001">323000</erna:AccrualForPurchasesOfPropertyAndEquipment>
    <erna:AccrualForPurchasesOfPropertyAndEquipment
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_75f584f2e2dc415696dc52f988fe947a"
      unitRef="U001">0</erna:AccrualForPurchasesOfPropertyAndEquipment>
    <erna:ConversionOfWarrantLiabilityToEquity
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_b0bf096838bb41609bc0a3d383dff436"
      unitRef="U001">0</erna:ConversionOfWarrantLiabilityToEquity>
    <erna:ConversionOfWarrantLiabilityToEquity
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_acd0f5189fb84a598451bf3cd6a05572"
      unitRef="U001">867000</erna:ConversionOfWarrantLiabilityToEquity>
    <erna:UnpaidFeesIncurredInConnectionWithPrivateOffering
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_b1be55513a314f7c8ed96e2dd373ad75"
      unitRef="U001">0</erna:UnpaidFeesIncurredInConnectionWithPrivateOffering>
    <erna:UnpaidFeesIncurredInConnectionWithPrivateOffering
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_7162d1ed923a4894a103eed6053c9584"
      unitRef="U001">208000</erna:UnpaidFeesIncurredInConnectionWithPrivateOffering>
    <erna:InitialMeasurementOfFinanceLeaseLiabilities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_7a310ed939304861aa170fcd5f120549"
      unitRef="U001">0</erna:InitialMeasurementOfFinanceLeaseLiabilities>
    <erna:InitialMeasurementOfFinanceLeaseLiabilities
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_e924fbeaf7e047b1bbbb85471febc32b"
      unitRef="U001">10000</erna:InitialMeasurementOfFinanceLeaseLiabilities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20231231"
      decimals="-3"
      id="Fact_432e2e37f14842ea8e2140377e01f649"
      unitRef="U001">7575000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_a43f6f5bbd084f9886b9485ec94b06a7"
      unitRef="U001">11446000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_616e4d25d2cd41eda1b0215c19a53d2b"
      unitRef="U001">4095000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_78d4ee5de04b465d9fb6b4a4c4ee93e0"
      unitRef="U001">4095000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20231231"
      decimals="-3"
      id="Fact_cc2d14d3c67f4c95907aee6c0af64665"
      unitRef="U001">11670000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20221231"
      decimals="-3"
      id="Fact_fbbcf0ee649d46dfaa8409b08cf1c01d"
      unitRef="U001">15541000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_e8e4b46423fc459bb75555fc7279ec7b">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;1)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Organization and Description of Business Operations&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Eterna Therapeutics Inc. is a life science company committed to realizing the potential of mRNA cell engineering to provide
            patients with transformational new medicines.&#160; Eterna has in-licensed a portfolio of over 100 patents covering key mRNA cell
            engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSliceTM and UltraSliceTM gene-editing proteins, and the ToRNAdoTM mRNA delivery system, which Eterna collectively refers to as our &#x201c;mRNA
            technology platform.&#x201d; Eterna refers to aspects of its mRNA technology platform as &#x201c;mRNA delivery,&#x201d; &#x201c;mRNA gene editing&#x201d; and &#x201c;mRNA cell reprogramming.&#x201d; Eterna licenses its mRNA technology platform from Factor Bioscience Limited (&#x201c;Factor Limited&#x201d;)
            under an exclusive license agreement. As used herein, the &#x201c;Company&#x201d; or &#x201c;Eterna&#x201d; refers collectively to Eterna and its consolidated subsidiaries (Eterna LLC, Novellus, Inc. and Novellus Therapeutics Limited) unless otherwise stated or the
            context otherwise requires.&lt;/div&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <erna:NumberOfInLicensedPortfolioPatents
      contextRef="c20230101to20231231"
      decimals="0"
      id="Fact_6599a8b890094b36aa94e1b3b27b8efd"
      unitRef="U004">100</erna:NumberOfInLicensedPortfolioPatents>
    <erna:LiquidityAndCapitalResourcesTextBlock
      contextRef="c20230101to20231231"
      id="Text_fc15066e43c442738a9103a62a510e6f">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;2)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Liquidity and Capital Resources&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has incurred significant operating losses and has an accumulated deficit as a result of its efforts to develop
        product candidates, including conducting clinical trials and providing general and administrative support for operations. As of December 31, 2023, the Company had an unrestricted cash balance of approximately $7.6 million and an accumulated deficit of approximately $187.0
        million. For the year ended December 31, 2023, the Company incurred a net loss of $21.7 million, and the Company used cash of $20.4 million in operating activities.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;In October 2022, the Company entered into a sublease for approximately 45,500 square feet of office and laboratory space in Somerville, Massachusetts.&#160; Pursuant to the sublease, the Company delivered to the sublessor a security deposit in the form of a letter
          of credit in the amount of $4.1 million, which will be reduced on an incremental basis throughout the term of the sublease.&#160; The letter
          of credit was issued by the Company&#x2019;s commercial bank, which required that the Company cash collateralize the letter of credit by depositing $4.1
          million in a restricted cash account with such bank.&#160; The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the sublease.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In April 2023, the Company entered into a standby equity purchase agreement (the &#x201c;SEPA&#x201d;) and a registration rights agreement with Lincoln Park Capital Fund, LLC (&#x201c;Lincoln Park&#x201d;), pursuant to which
            Lincoln Park committed to purchase up to $10.0 million of the Company&#x2019;s common stock in an &#x201c;equity line&#x201d; financing arrangement.
            During the year ended December 31, 2023, the Company issued and sold approximately 214,000 shares of common stock under the SEPA for
            gross proceeds of $0.3 million&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In July and December 2023, the Company received $16.5 million in gross proceeds from the
            issuance of convertible notes and in January 2024 received an additional $1.4 million in gross proceeds from the issuance of
            additional convertible notes. See Notes 6 and 18 for additional information regarding these financings.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;In










            connection with preparing the accompanying consolidated financial statements as of and for the year ended December 31, 2023, the Company&#x2019;s management concluded that there is substantial doubt regarding the Company&#x2019;s ability to continue as a
            going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these consolidated financial statements. The Company will need to
            raise additional capital, which could be through the sales of shares of its common stock under the SEPA, public or private equity offerings, debt financings, out-licensing the Company&#x2019;s intellectual property, strategic partnerships or other
            means. Other than the SEPA, the Company currently has no arrangements for capital, and no assurances can be given that it will be able to raise capital when needed, on acceptable terms, or at all.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The
        accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying consolidated financial
        statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the Company&#x2019;s ability
        to continue as a going concern.&lt;/div&gt;
</erna:LiquidityAndCapitalResourcesTextBlock>
    <us-gaap:Cash
      contextRef="c20231231"
      decimals="-5"
      id="Fact_1be9de5a8249481fab31ad1c0dd9cc17"
      unitRef="U001">7600000</us-gaap:Cash>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20231231"
      decimals="-5"
      id="Fact_4a36e72ca6b84fb3893193b0c03de336"
      unitRef="U001">-187000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_8d01e63cf4e849d8a2c1b3907d5fda31"
      unitRef="U001">-21700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_dbb602b7dfbc46b4a7eb2fb2d191acd5"
      unitRef="U001">-20400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="c20221031"
      decimals="0"
      id="Fact_f7798d76446a45ffa2d9daffa472e868"
      unitRef="U005">45500</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LineOfCredit
      contextRef="c20221031"
      decimals="-5"
      id="Fact_9f2de0426f684de499f06b79b185bd0a"
      unitRef="U001">4100000</us-gaap:LineOfCredit>
    <us-gaap:RestrictedCash
      contextRef="c20221031"
      decimals="-5"
      id="Fact_fe8e39df2eb949b499cfac5c21b5629f"
      unitRef="U001">4100000</us-gaap:RestrictedCash>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20230430_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember"
      decimals="-5"
      id="Fact_3642793f8cc2410099a58e09e1079d89"
      unitRef="U001">10000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c20230101to20231231_LegalEntityAxis_LincolnParkCapitalFundLLCMember"
      decimals="0"
      id="Fact_9f32889c32724c3587652375980b06a1"
      unitRef="U002">214000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="c20230101to20231231_LegalEntityAxis_LincolnParkCapitalFundLLCMember"
      decimals="-5"
      id="Fact_97dc4fdc29b941a38cfd5d3e0886ee6c"
      unitRef="U001">300000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20230701to20231231_ShortTermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_94751a1cd78940448727e67e44a9296c"
      unitRef="U001">16500000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20240101to20240131_ShortTermDebtTypeAxis_ConvertibleDebtMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_efff07005c12434aa651ba5eb9d063b2"
      unitRef="U001">1400000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="c20230101to20231231"
      id="Text_58dd98addd9c452ab1c0163aa9b955ed">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;3)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Basis of Accounting Presentation and Summary of Significant Accounting Policies&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basis of Accounting Presentation&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). All
        significant intercompany balances and transactions have been eliminated in consolidation.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-style: italic;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Summary of Significant Accounting Policies&lt;/div&gt;

&lt;div&gt;&lt;br class="Apple-interchange-newline"/&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; contingent consideration and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of
        historical experience and various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had no cash equivalents as of December 31, 2023 or 2022.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; Restricted cash consists of a cash collateralization of $4.1 million for a security deposit in the form of a letter of credit issued by the Company&#x2019;s commercial bank and delivered to the sublessor of office and laboratory space the Company
        subleases in Somerville, Massachusetts. The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the sublease.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of seven years. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Furniture and fixtures are depreciated over an estimated useful life of five years.&#160; Computer equipment are depreciated over an estimated useful life of three years. Upon retirement or other
        disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of operations. Expenditures for maintenance and repairs are
        charged to operations. Renewals and betterments are capitalized.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#x201c;IRX&#x201d;) in November 2018, which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events occur or circumstances indicate it is more likely
        than not that the fair value of a reporting unit is less than&#160; its carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, macroeconomic conditions, industry and market
        considerations, cost factors, overall financial performance and other relevant events.&#160; Management evaluates the Company as a single reporting unit, therefore, goodwill is tested for impairment at the entity level. Goodwill is tested for impairment
        as of December 31st of each year, or more frequently as warranted by events or changes in circumstances mentioned above.&#160; Accounting guidance also permits an optional qualitative assessment for goodwill to determine whether it is more likely than
        not that the carrying value of a reporting unit exceeds its fair value. If, after this qualitative assessment, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then
        no further quantitative testing would be necessary. A quantitative assessment is performed if the qualitative assessment results in a more likely than not determination or if a qualitative assessment is not performed. The quantitative assessment
        considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#x2019;s carrying value exceeds its fair value.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;In-Process Research &amp;amp; Development&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) assets represent the fair value assigned to technologies that were acquired
        in connection with the acquisition of IRX in November 2018, which have not reached technological feasibility and have no alternative future use. IPR&amp;amp;D assets are considered to be indefinite lived until the completion or abandonment of the
        associated research and development projects. During the period that the IPR&amp;amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or
        changes in circumstances that indicate that the fair value of the IPR&amp;amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize
        products associated with the IPR&amp;amp;D assets, these assets are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a
        full or partial impairment charge related to the IPR&amp;amp;D assets, calculated as the excess of carrying value of the IPR&amp;amp;D assets over fair value.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;Revenue
              Recognition&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company recognizes the related revenue under ASC 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). Under ASC 606, the Company recognizes revenue when a customer obtains
            control of promised services or goods in an amount that reflects the consideration to which the Company expects to receive in exchange for those goods or services. &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;
        &#160; &lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In general, the Company applies the following steps when recognizing revenue from contracts with customers: (i) identify the contract, (ii) identify the performance obligations,
          (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations and (v) recognize revenue when a performance obligation is satisfied. Recognition of revenue is driven by satisfaction of the performance
          obligations using one of two methods: revenue is either recognized over time or at a point in time. Contracts containing multiple performance obligations classify those performance obligations into separate units of account either as standalone
          or combined units of account. Allocation of revenue to individual elements that qualify for separate accounting is based on the separate selling prices determined for each component, and total contract consideration is then allocated across the
          components of the arrangement. If separate selling prices are not available, the Company will use its best estimate of such selling prices, consistent with the overall pricing strategy and after consideration of relevant market factors.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company estimates the amount of consideration it expects to recognize as revenue that is not probable of having a significant reversal of such recognized revenue, and it places
          a constraint on the remaining contractual consideration. As it becomes evident that the constrained amounts are no longer at risk of a significant reversal of revenue, the Company will remove the constraint from the related revenue and recognize
          a cumulative catch-up adjustment to revenue in the period in which the constraint was removed.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company has one revenue generating contract. Such contract
          relates to an option and license agreement as well as certain development activities.&#160; See Note 5.&lt;/span&gt;&lt;br/&gt;
        &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt; text-align: justify;"&gt; Contract Assets:&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="margin-top: 0px; margin-bottom: 0px; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; A contract asset is an entity&#x2019;s right to payment for goods and services already transferred to a customer if that right to payment is conditional on something other than the passage of time.
          Generally, an entity will recognize a contract asset when it has fulfilled a contract obligation but must perform other obligations before being entitled to payment. Contract assets consist primarily of the cost of project contract work performed
          by third parties whereby the Company expects to recognize any related revenue at a later date, upon satisfaction of the contract obligations. The Company had no contract assets as of December 31, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Contract Liabilities:&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Contract liabilities consist primarily of consideration received, usually in the form of payment, on project work to be performed whereby the Company expects to recognize any related revenue at a later date, upon
            satisfaction of the contract obligations. As of December 31, 2023, contract liabilities were $0.6 million and are recognized as
            deferred revenue in the accompanying consolidated balance sheet. The Company recognized $0.1 million of revenue during the year ended
            December 31, 2023 from contract liabilities that arose in 2023. There were no contract liabilities as of December 31, 2022.&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The major components of research and development costs include salaries and employee benefits, stock-based compensation expense, supplies and
        materials, preclinical study costs, expensed licensed technology, consulting, scientific advisors and other third-party costs, and allocations of various overhead costs related to our product development efforts. &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has contracted with third parties to perform various studies. The financial terms of these agreements vary from
        contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts expended during the reporting period. If the actual timing of the performance of the
        services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a straight-line basis if the expected costs are expected to be incurred ratably during
        the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the allocation of responsibilities among the parties to the agreement, and the completion of
        portions of the clinical study or trial or similar conditions.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Loss Per Share&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the
        two-class method required for participating securities.&#160; The Company&#x2019;s convertible notes contractually entitle the holders of such notes to participate in dividends but does not contractually require the holders to participate in the Company&#x2019;s
        losses.&#160; As such, the two-class method is not applicable during periods with a net loss.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number
        of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of
        shares of common stock outstanding plus dilutive securities.&#160; Shares of common stock issuable upon exercise, conversion or vesting of stock options, restricted stock units, warrants and the outstanding Series A convertible preferred stock are
        considered potential shares of common stock and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. The Company&#x2019;s convertible notes are also considered potential shares of common
        stock and are included in the calculation of diluted net loss per share using the &#x201c;if-converted&#x201d; method, and the more dilutive of either the two-class method or the if-converted method is reported.&#160; Diluted net loss per share is the same as basic
        net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company&#x2019;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, &lt;span style="font-style: italic;"&gt;Segment Reporting,&lt;/span&gt; the Company has determined that it operates as one operating segment.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000. The Company&#x2019;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In the Company&#x2019;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#x2019;s supply chain, which
        could ultimately impact the Company&#x2019;s ability to continue its research and development activities. For the years ended December 31, 2023 and 2022, there was no vendor concentration related to the Company&#x2019;s research and development activities.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 1 Inputs &#x2013; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 2 Inputs &#x2013; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 3 Inputs &#x2013; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The carrying amounts reported on the balance sheet for cash and cash equivalents, other receivables, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value due to their short maturities.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Leases&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The Company accounts for its leases under
        ASC Topic 842, &lt;span style="font-style: italic;"&gt;Leases.&lt;/span&gt; Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#x201c;ROU&#x201d;) assets represent the Company&#x2019;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less. &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company accounts for lease modifications as a separate contract when the modification (i) grants the lessee an additional
          right of use not included in the original lease contract, and (ii) increases the lease payments commensurate with the stand-alone price for the additional right of use.&#160; In this case, the Company would be treated as a new lease and measured in
          accordance with ASC 842 at the commencement date of the new lease without any impact on the existing lease.&#160; Otherwise, the Company accounts for lease modifications as a continuance of the existing lease, in which case, the Company reassesses the
          lease classification, remeasures the lease liability using an updated discount rate, and unless there is a full or partial termination of the lease, adjusts the ROU asset by the amount of change to the lease liability.&#160; For a full or partial
          lease termination, the lessee reduces the carrying amount of the ROU asset on a basis proportionate to the full or partial termination of the lease, and any difference between the adjustment to the ROU asset and the lease liability is recognized
          as a gain or loss in the current period.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Commitment and Contingencies&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company follows ASC No.450-20, &lt;span style="font-style: italic;"&gt;Loss Contingencies,&lt;/span&gt; to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-line basis.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Warrants&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, &lt;span style="font-style: italic;"&gt;Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.&lt;/span&gt; The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#x2019;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;span style="text-decoration: underline;"&gt;Convertible Notes&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company accounts for its convertible
          notes as a long-term liability equal to the proceeds received from issuance, including the embedded conversion feature, plus any interest paid-in-kind, net of the unamortized debt issuance costs and debt discount on the consolidated balance
          sheets. The Company evaluates all embedded features contained in the convertible notes, such as the conversion feature, the paid-in-kind feature and the redemption feature in the event of a default, to determine if such features require
          bifurcation as a derivative. The conversion feature included in the convertible notes is not required to be accounted for separately as an embedded derivative because the conversion feature is considered both indexed to the Company&#x2019;s own stock
          and qualifies to be classified in stockholders&#x2019; equity. The paid-in-kind feature is considered to be a commitment to originate a loan, and the terms of the additional loans have the same terms as the original debt instrument. Therefore, the
          paid-in-kind feature qualifies for the scope exception under the applicable accounting guidance and is not required to be bifurcated as a derivative. The redemption feature in the event of a default was determined to be clearly and closely
          related to the convertible notes and not required to be bifurcated as a derivative.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;Proceeds from the sale of convertible
          notes with stock purchase warrants are allocated to the two elements based on their relative fair values. The portion of the proceeds allocated to warrants are recorded as a debt discount to the convertible note proceeds and presented on a net
          basis in the consolidated balance sheet. Debt issuance costs directly attributable to the transaction are capitalized and allocated to the convertible notes and warrants in the same manner as the proceeds. The amount of debt issuance costs
          allocated to the convertible notes represent a reduction of the face value of the convertible note proceeds. The Company amortizes debt issuance costs and debt discounts over the contractual term of the convertible notes, using the effective
          interest method, as interest expense on the consolidated statements of operations.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;  &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; In June 2022, the Financial Accounting
          Standard Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#x201c;ASU 2022-03&#x201d;). The FASB issued ASU
          2022-03 to (1) clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative
          example, and (3) to introduce new disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on
          the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and
          interim periods within those fiscal years with early adoption permitted. The Company does not expect a material impact to its consolidated financial statements as a result of adopting this ASU.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In October 2023, the FASB issued ASU No.
          2023-06, Disclosure Improvements &#x2013; Codification Amendment in Response to the SEC&#x2019;s Disclosure Update and Simplification Initiative. This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning
          them with the SEC&#x2019;s regulations.&#160; The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC&#x2019;s removal of the related
          disclosure.&#160; If the SEC has not removed the applicable requirements from Regulation S-X or Regulation S-K by June 30, 2027, then this ASU will not become effective.&#160; Early adoption is prohibited.&#160; The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In November 2023, the FASB issued ASU
          No. 2023-07, Segment Reporting &#x2013; Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses
          and increased interim disclosure requirements, among others. ASU No. 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. Early adoption is permitted, and
          the amendments should be applied retrospectively. The Company does not expect the amendments in this ASU to have a material impact on its consolidated financial statements.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In December 2023, the FASB issued ASU
          No. 2023-09, Improvements to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related
          disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.&lt;/div&gt;
</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_fb9977bbb433498b8cfb2852a951b3a8">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basis of Accounting Presentation&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles
        (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Updates (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). All
        significant intercompany balances and transactions have been eliminated in consolidation.&lt;/div&gt;
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="c20230101to20231231"
      id="Text_6b97bb1fe89949e1ac78336d4cd3f300">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and
        assumptions that affect: (a) the reported amounts of assets and liabilities; (b) disclosure of contingent assets and liabilities at the date of the consolidated financial statements; (c) the reported amounts of expenses during the reporting period;
        and (d) the reported amount of the fair value of assets acquired in connection with business combinations. On an ongoing basis, the Company evaluates its estimates, including those related to the recoverability and useful lives of long-lived
        assets; stock-based compensation assumptions; valuation assumptions of warrants; contingencies; contingent consideration and the provision for income taxes, including the valuation allowance. The Company bases its estimates on a combination of
        historical experience and various other assumptions that it believes are reasonable under the circumstances. Actual results may differ materially from these estimates.&lt;/div&gt;
</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="c20230101to20231231"
      id="Text_48422aca8e0b4de1b6a610801a9b8cb8">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company classifies highly liquid investments with a remaining contractual maturity at date of purchase of three months or
        less as cash equivalents. The Company had no cash equivalents as of December 31, 2023 or 2022.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; Restricted cash consists of a cash collateralization of $4.1 million for a security deposit in the form of a letter of credit issued by the Company&#x2019;s commercial bank and delivered to the sublessor of office and laboratory space the Company
        subleases in Somerville, Massachusetts. The amount of required restricted cash collateral will decline in parallel with the reduction in the amount of the letter of credit over the term of the sublease.&lt;br/&gt;
      &lt;/div&gt;
</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="c20231231"
      decimals="-3"
      id="Fact_e4948a2535344e88a145a0d18fd09f3f"
      unitRef="U001">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="c20221231"
      decimals="-3"
      id="Fact_6e9be2dd6e6a4bc1b8824c1391f3ed7a"
      unitRef="U001">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="c20231231"
      decimals="-5"
      id="Fact_1917172e89074e839112de32ef2f8c3e"
      unitRef="U001">4100000</us-gaap:RestrictedCash>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_2da43536e14c489382ce5eef9701b4b4">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Property and equipment are recorded at cost and are depreciated over their estimated useful lives using the straight-line
        method. Laboratory and manufacturing equipment are depreciated over an estimated useful life of seven years. Leasehold improvements are
        depreciated over the shorter of their estimated useful life, or the lease term. Furniture and fixtures are depreciated over an estimated useful life of five years.&#160; Computer equipment are depreciated over an estimated useful life of three years. Upon retirement or other
        disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gain or losses are reflected in the results of operations. Expenditures for maintenance and repairs are
        charged to operations. Renewals and betterments are capitalized.&lt;/div&gt;
</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_LaboratoryAndManufacturingEquipmentMember"
      id="Fact_a45db9a78f024ac8a715d7bbf21da8d0">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"
      id="Fact_a6ea70cbb87448c39686dc9f469bb4aa">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      id="Fact_8acc4891053a481784f35d7da7055a3d">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="c20230101to20231231"
      id="Text_c6a6f33ca0aa4d9d911c3133c23c4c45">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in the acquisition
        of IRX Therapeutics, Inc. (&#x201c;IRX&#x201d;) in November 2018, which was accounted for as a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events occur or circumstances indicate it is more likely
        than not that the fair value of a reporting unit is less than&#160; its carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, macroeconomic conditions, industry and market
        considerations, cost factors, overall financial performance and other relevant events.&#160; Management evaluates the Company as a single reporting unit, therefore, goodwill is tested for impairment at the entity level. Goodwill is tested for impairment
        as of December 31st of each year, or more frequently as warranted by events or changes in circumstances mentioned above.&#160; Accounting guidance also permits an optional qualitative assessment for goodwill to determine whether it is more likely than
        not that the carrying value of a reporting unit exceeds its fair value. If, after this qualitative assessment, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then
        no further quantitative testing would be necessary. A quantitative assessment is performed if the qualitative assessment results in a more likely than not determination or if a qualitative assessment is not performed. The quantitative assessment
        considers whether the carrying amount of a reporting unit exceeds its fair value, in which case an impairment charge is recorded to the extent the reporting unit&#x2019;s carrying value exceeds its fair value.&lt;br/&gt;
      &lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:InProcessResearchAndDevelopmentPolicy
      contextRef="c20230101to20231231"
      id="Text_c2367262f15e42dd88fba84a270f0b9e">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;In-Process Research &amp;amp; Development&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) assets represent the fair value assigned to technologies that were acquired
        in connection with the acquisition of IRX in November 2018, which have not reached technological feasibility and have no alternative future use. IPR&amp;amp;D assets are considered to be indefinite lived until the completion or abandonment of the
        associated research and development projects. During the period that the IPR&amp;amp;D assets are considered indefinite-lived, they are tested for impairment on an annual basis or more frequently if the Company becomes aware of any events occurring or
        changes in circumstances that indicate that the fair value of the IPR&amp;amp;D assets are less than their carrying amounts. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize
        products associated with the IPR&amp;amp;D assets, these assets are then deemed definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a
        full or partial impairment charge related to the IPR&amp;amp;D assets, calculated as the excess of carrying value of the IPR&amp;amp;D assets over fair value.&lt;/div&gt;
</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_05beddd75c8246a682bc9683a3d459a6">
&lt;div style="text-align: left;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;Revenue
              Recognition&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company recognizes the related revenue under ASC 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). Under ASC 606, the Company recognizes revenue when a customer obtains
            control of promised services or goods in an amount that reflects the consideration to which the Company expects to receive in exchange for those goods or services. &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;
        &#160; &lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In general, the Company applies the following steps when recognizing revenue from contracts with customers: (i) identify the contract, (ii) identify the performance obligations,
          (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations and (v) recognize revenue when a performance obligation is satisfied. Recognition of revenue is driven by satisfaction of the performance
          obligations using one of two methods: revenue is either recognized over time or at a point in time. Contracts containing multiple performance obligations classify those performance obligations into separate units of account either as standalone
          or combined units of account. Allocation of revenue to individual elements that qualify for separate accounting is based on the separate selling prices determined for each component, and total contract consideration is then allocated across the
          components of the arrangement. If separate selling prices are not available, the Company will use its best estimate of such selling prices, consistent with the overall pricing strategy and after consideration of relevant market factors.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company estimates the amount of consideration it expects to recognize as revenue that is not probable of having a significant reversal of such recognized revenue, and it places
          a constraint on the remaining contractual consideration. As it becomes evident that the constrained amounts are no longer at risk of a significant reversal of revenue, the Company will remove the constraint from the related revenue and recognize
          a cumulative catch-up adjustment to revenue in the period in which the constraint was removed.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company has one revenue generating contract. Such contract
          relates to an option and license agreement as well as certain development activities.&#160; See Note 5.&lt;/span&gt;&lt;br/&gt;
        &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt; text-align: justify;"&gt; Contract Assets:&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="margin-top: 0px; margin-bottom: 0px; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; A contract asset is an entity&#x2019;s right to payment for goods and services already transferred to a customer if that right to payment is conditional on something other than the passage of time.
          Generally, an entity will recognize a contract asset when it has fulfilled a contract obligation but must perform other obligations before being entitled to payment. Contract assets consist primarily of the cost of project contract work performed
          by third parties whereby the Company expects to recognize any related revenue at a later date, upon satisfaction of the contract obligations. The Company had no contract assets as of December 31, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin-top: 0px; margin-bottom: 0px; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Contract Liabilities:&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Contract liabilities consist primarily of consideration received, usually in the form of payment, on project work to be performed whereby the Company expects to recognize any related revenue at a later date, upon
            satisfaction of the contract obligations. As of December 31, 2023, contract liabilities were $0.6 million and are recognized as
            deferred revenue in the accompanying consolidated balance sheet. The Company recognized $0.1 million of revenue during the year ended
            December 31, 2023 from contract liabilities that arose in 2023. There were no contract liabilities as of December 31, 2022.&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;
</us-gaap:RevenueRecognitionPolicyTextBlock>
    <erna:NumberOfRevenueGeneratingContracts
      contextRef="c20230101to20231231"
      decimals="INF"
      id="Fact_1010609b576e4bf7b61d377923a6d42e"
      unitRef="U006">1</erna:NumberOfRevenueGeneratingContracts>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="c20221231"
      decimals="-6"
      id="Fact_94e336b326ef466ab44215ea1c6e920b"
      unitRef="U001">0</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="c20231231"
      decimals="-6"
      id="Fact_05d55bba4cd14be0bc9c59f1ebd5ef1f"
      unitRef="U001">0</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:DeferredRevenue
      contextRef="c20231231"
      decimals="-5"
      id="Fact_812895507fad47329ba8c33871c3644c"
      unitRef="U001">600000</us-gaap:DeferredRevenue>
    <us-gaap:ContractWithCustomerLiability
      contextRef="c20231231"
      decimals="-5"
      id="Fact_41bf0a5629a4416ba26ee8ac3c758073"
      unitRef="U001">100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="c20221231"
      decimals="-6"
      id="Fact_0c6a1d6972e1420f8742f5b377a43a84"
      unitRef="U001">0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="c20230101to20231231"
      id="Text_3a7f085e167c4fe3adab4b68b5c77eb4">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company expenses its research and development costs as incurred. Research and development expenses consist of costs
        incurred for company-sponsored research and development activities, as well as support for selected investigator-sponsored research. Upfront payments and milestone payments made for the licensing of technology are expensed as research and
        development in the period in which they are incurred if the technology is not expected to have any alternative future uses other than the specific research and development project for which it was intended.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The major components of research and development costs include salaries and employee benefits, stock-based compensation expense, supplies and
        materials, preclinical study costs, expensed licensed technology, consulting, scientific advisors and other third-party costs, and allocations of various overhead costs related to our product development efforts. &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has contracted with third parties to perform various studies. The financial terms of these agreements vary from
        contract to contract and may result in uneven payment flows. The Company accrues for third party expenses based on estimates of the services received and efforts expended during the reporting period. If the actual timing of the performance of the
        services or the level of effort varies from the estimate, the accrual is adjusted accordingly. The expenses for some third-party services may be recognized on a straight-line basis if the expected costs are expected to be incurred ratably during
        the period. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the successful enrollment of patients, the allocation of responsibilities among the parties to the agreement, and the completion of
        portions of the clinical study or trial or similar conditions.&lt;/div&gt;
</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_498e5018dea24bdf8cc2b8a498488b16">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company records deferred tax liabilities and assets based on the differences between the consolidated financial statements
        carrying amounts and the tax basis of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse and establishing a valuation allowance when it was more likely than not that some portion or all of
        the deferred tax assets would not be realized. Income tax expense consists of the tax payable for the period and the change during the period in deferred tax assets and liabilities.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the tax position will be
        sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a
        greater than 50% likelihood of being realized upon ultimate resolution. The Company has no material uncertain tax positions for any of the reporting periods presented.&lt;/div&gt;
</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_7951f8cc83434eda9aa97204d7a1dd30">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Loss Per Share&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the
        two-class method required for participating securities.&#160; The Company&#x2019;s convertible notes contractually entitle the holders of such notes to participate in dividends but does not contractually require the holders to participate in the Company&#x2019;s
        losses.&#160; As such, the two-class method is not applicable during periods with a net loss.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number
        of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of
        shares of common stock outstanding plus dilutive securities.&#160; Shares of common stock issuable upon exercise, conversion or vesting of stock options, restricted stock units, warrants and the outstanding Series A convertible preferred stock are
        considered potential shares of common stock and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. The Company&#x2019;s convertible notes are also considered potential shares of common
        stock and are included in the calculation of diluted net loss per share using the &#x201c;if-converted&#x201d; method, and the more dilutive of either the two-class method or the if-converted method is reported.&#160; Diluted net loss per share is the same as basic
        net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive.&lt;/div&gt;
</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_eed8acfbc096446e81415cdb77dd5376">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company&#x2019;s chief operating decision maker, who is the chief executive officer, reviews operating results on a consolidated
        basis to make decisions about allocating resources and assessing performance of the Company.&#160; As a result, in accordance with ASC No. 280, &lt;span style="font-style: italic;"&gt;Segment Reporting,&lt;/span&gt; the Company has determined that it operates as one operating segment.&lt;/div&gt;
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c20230101to20231231"
      decimals="INF"
      id="Fact_7d462c41db9b4c5fba461db583183138"
      unitRef="U007">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="c20230101to20231231"
      id="Text_8b2098fc4dcc48598043cbdf4eb2f4e7">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company maintains its cash balances in financial institutions located in the United States. Accounts at each institution
        are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to $250,000. The Company&#x2019;s cash balances are uninsured for deposit accounts that exceed the FDIC insurance limit.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In the Company&#x2019;s business, vendor concentrations could be indicative of vulnerabilities in the Company&#x2019;s supply chain, which
        could ultimately impact the Company&#x2019;s ability to continue its research and development activities. For the years ended December 31, 2023 and 2022, there was no vendor concentration related to the Company&#x2019;s research and development activities.&lt;/div&gt;
</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="c20230101to20231231"
      id="Text_2791aa3d01e245a0bf8c2ac430d9635d">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly
        transaction between willing market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to
        unobservable inputs. The fair value hierarchy is as follows:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 1 Inputs &#x2013; Valued based on quoted prices in active markets
          for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 2 Inputs &#x2013; Valued based on inputs other than quoted prices
          included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
          in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or
          corroborated by market data by correlation or other means.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#x2022;&lt;/span&gt;&#160;&#160;&#160;&#160; &lt;span style="color: rgb(0, 0, 0);"&gt;Level 3 Inputs &#x2013; Valued based on inputs for which there is
          little or no market value, which require the reporting entity to develop its own assumptions.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The carrying amounts reported on the balance sheet for cash and cash equivalents, other receivables, prepaid assets and other
        current assets, accounts payable and accrued expenses, other current liabilities and other liabilities approximate fair value due to their short maturities.&lt;/div&gt;
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_50f18a33557b4d308295462934021741">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Leases&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The Company accounts for its leases under
        ASC Topic 842, &lt;span style="font-style: italic;"&gt;Leases.&lt;/span&gt; Operating lease liabilities represent the present value of lease payments not yet paid. Right-of-use (&#x201c;ROU&#x201d;) assets represent the Company&#x2019;s right to use an underlying asset and are
        based upon the operating lease liabilities adjusted for prepaid or accrued lease payments, initial direct costs, lease incentives and impairment of operating lease assets. If the interest rate implicit in the lease is not readily determinable, the
        Company uses the incremental borrowing rates for collateralized borrowings in an amount equal to the lease payments under similar terms.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The Company has elected the practical
        expedient to not separate non-lease components from the lease components to which they relate and instead account for each as a single lease component for all underlying asset classes. Some leasing arrangements require variable payments that are
        dependent on usage or may vary for other reasons, such as payments for insurance, tax payments and other miscellaneous costs. The variable portion of payments contemplated in the lease that do not depend on an index or rate are not included in the
        ROU assets or lease liabilities. Rather, variable payments that do not depend on an index or rate are expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease
        contract are accounted for as lease expenses.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has also elected not to recognize ROU and lease liabilities for short-term leases that have a term of 12 months
          or less. &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company accounts for lease modifications as a separate contract when the modification (i) grants the lessee an additional
          right of use not included in the original lease contract, and (ii) increases the lease payments commensurate with the stand-alone price for the additional right of use.&#160; In this case, the Company would be treated as a new lease and measured in
          accordance with ASC 842 at the commencement date of the new lease without any impact on the existing lease.&#160; Otherwise, the Company accounts for lease modifications as a continuance of the existing lease, in which case, the Company reassesses the
          lease classification, remeasures the lease liability using an updated discount rate, and unless there is a full or partial termination of the lease, adjusts the ROU asset by the amount of change to the lease liability.&#160; For a full or partial
          lease termination, the lessee reduces the carrying amount of the ROU asset on a basis proportionate to the full or partial termination of the lease, and any difference between the adjustment to the ROU asset and the lease liability is recognized
          as a gain or loss in the current period.&lt;/div&gt;
</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_4f18285a39af4e629713ec9c7a2a2f1d">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Commitment and Contingencies&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company follows ASC No.450-20, &lt;span style="font-style: italic;"&gt;Loss Contingencies,&lt;/span&gt; to report accounting for
        contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be
        reasonably estimated.&lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="c20230101to20231231"
      id="Text_326ab3d8fd264d64a32f3ad506798d11">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company recognizes stock-based compensation expense for equity awards granted to employees, directors and certain
        consultants. The Company estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-line basis.&lt;/div&gt;
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DerivativesMethodsOfAccountingNonhedgingDerivatives
      contextRef="c20230101to20231231"
      id="Text_80aad676cc3543da99880f689a019949">
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Warrants&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an
        assessment of the specific terms of the warrants and applicable authoritative guidance in ASC 480, &lt;span style="font-style: italic;"&gt;Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging.&lt;/span&gt; The assessment considers
        whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or meet all of the requirements for equity classification under ASC 815, including whether the warrants are
        indexed to the Company&#x2019;s own stock and whether the holders of the warrants could potentially require net cash settlement in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which
        requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;
</us-gaap:DerivativesMethodsOfAccountingNonhedgingDerivatives>
    <us-gaap:DebtPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_d3e14252f96b4f4b808b88f1facdd12d">
&lt;div&gt;&lt;span style="text-decoration: underline;"&gt;Convertible Notes&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company accounts for its convertible
          notes as a long-term liability equal to the proceeds received from issuance, including the embedded conversion feature, plus any interest paid-in-kind, net of the unamortized debt issuance costs and debt discount on the consolidated balance
          sheets. The Company evaluates all embedded features contained in the convertible notes, such as the conversion feature, the paid-in-kind feature and the redemption feature in the event of a default, to determine if such features require
          bifurcation as a derivative. The conversion feature included in the convertible notes is not required to be accounted for separately as an embedded derivative because the conversion feature is considered both indexed to the Company&#x2019;s own stock
          and qualifies to be classified in stockholders&#x2019; equity. The paid-in-kind feature is considered to be a commitment to originate a loan, and the terms of the additional loans have the same terms as the original debt instrument. Therefore, the
          paid-in-kind feature qualifies for the scope exception under the applicable accounting guidance and is not required to be bifurcated as a derivative. The redemption feature in the event of a default was determined to be clearly and closely
          related to the convertible notes and not required to be bifurcated as a derivative.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;Proceeds from the sale of convertible
          notes with stock purchase warrants are allocated to the two elements based on their relative fair values. The portion of the proceeds allocated to warrants are recorded as a debt discount to the convertible note proceeds and presented on a net
          basis in the consolidated balance sheet. Debt issuance costs directly attributable to the transaction are capitalized and allocated to the convertible notes and warrants in the same manner as the proceeds. The amount of debt issuance costs
          allocated to the convertible notes represent a reduction of the face value of the convertible note proceeds. The Company amortizes debt issuance costs and debt discounts over the contractual term of the convertible notes, using the effective
          interest method, as interest expense on the consolidated statements of operations.&lt;/div&gt;
</us-gaap:DebtPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="c20230101to20231231"
      id="Text_ebab9e05a0a34b64914cfb784e536bc2">
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Recent Accounting Standards&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;  &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; In June 2022, the Financial Accounting
          Standard Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (&#x201c;ASU 2022-03&#x201d;). The FASB issued ASU
          2022-03 to (1) clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative
          example, and (3) to introduce new disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on
          the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and
          interim periods within those fiscal years with early adoption permitted. The Company does not expect a material impact to its consolidated financial statements as a result of adopting this ASU.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In October 2023, the FASB issued ASU No.
          2023-06, Disclosure Improvements &#x2013; Codification Amendment in Response to the SEC&#x2019;s Disclosure Update and Simplification Initiative. This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning
          them with the SEC&#x2019;s regulations.&#160; The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC&#x2019;s removal of the related
          disclosure.&#160; If the SEC has not removed the applicable requirements from Regulation S-X or Regulation S-K by June 30, 2027, then this ASU will not become effective.&#160; Early adoption is prohibited.&#160; The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In November 2023, the FASB issued ASU
          No. 2023-07, Segment Reporting &#x2013; Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses
          and increased interim disclosure requirements, among others. ASU No. 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. Early adoption is permitted, and
          the amendments should be applied retrospectively. The Company does not expect the amendments in this ASU to have a material impact on its consolidated financial statements.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In December 2023, the FASB issued ASU
          No. 2023-09, Improvements to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related
          disclosures. ASU No. 2023-09 is effective for fiscal years beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. Early adoption is permitted. The Company does not expect the amendments in
          this ASU to have a material impact on its consolidated financial statements.&lt;/div&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AssetAcquisitionTextBlock
      contextRef="c20230101to20231231"
      id="Text_14b266b3119b4a67a97ab669e2d1ce15">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;

      &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="text-align: right; vertical-align: top; width: 36pt; font-size: 10pt;"&gt;
              &lt;div style="text-align: justify; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;4)&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;"&gt;
              &lt;div style="text-align: justify; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;Asset Acquisition&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;"&gt;In April 2023, the Company entered into an
      asset purchase agreement (the &#x201c;Exacis Purchase Agreement&#x201d;), with Exacis Biotherapeutics Inc. (&#x201c;Exacis&#x201d;), the stockholders party thereto and, with respect to specified provisions therein, Factor Limited (the &#x201c;Exacis Acquisition&#x201d;). Pursuant to the
      Exacis Purchase Agreement, the Company acquired from Exacis substantially all of Exacis&#x2019; intellectual property assets (the &#x201c;Exacis Assets&#x201d;), including all of Exacis&#x2019; right, title and interest in and to an exclusive license agreement by and between
      Exacis and Factor Limited (the &#x201c;Purchased License&#x201d;).&#160; The Company assumed none of Exacis&#x2019; liabilities, other than liabilities under the Purchased License that accrue subsequent to the closing date.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;"&gt;In consideration for the Exacis Assets, on
      the closing date of the transaction, the Company issued to Exacis an aggregate of approximately 69,000 shares of the Company&#x2019;s common
      stock, which shares are subject to a 12-month lockup, pursuant to which Exacis may not sell or otherwise transfer such shares.&#160; The shares
      were issued to Exacis at a price based on the Company having an assumed equity valuation of $75.0 million, divided by the number of issued
      and outstanding shares of common stock as of the close of business two trading days prior to the closing date.&#160; For accounting purposes, the shares issued were valued at $3.00 per share, which was the closing price of the Company&#x2019;s common stock on the date of issuance.&#160; The Company additionally agreed to make the following contingent payments:&lt;/div&gt;

&lt;div style="font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="width: 36pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: top; width: 36pt;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt; text-align: left;"&gt;(i)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="text-align: left; vertical-align: top; width: auto;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;"&gt;if, at any time during the three-year
                    period commencing on the closing date and ending on the three-year anniversary of the closing date, the Company&#x2019;s market
                    capitalization equals or exceeds $100.0 million for at least &lt;span style="-sec-ix-hidden:Fact_35ada709acde4da985c53db06fba5394"&gt;ten&lt;/span&gt; consecutive trading days, then the Company will issue to Exacis a number of shares of common stock equal to (x) $2.0 million divided by (y) the quotient of $100.00
                    million divided by the number of the Company&#x2019;s then issued and outstanding shares of common stock;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="width: 36pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: top; width: 36pt;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt; text-align: left;"&gt;(ii)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="text-align: left; vertical-align: top; width: auto;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;"&gt;if, at any time during the three-year
                    period commencing on the closing date and ending on the three-year anniversary of the closing date, the Company&#x2019;s market capitalization equals or exceeds $200.0 million for at least &lt;span style="-sec-ix-hidden:Fact_fe2e977747fa41309cc95a33766e6e30"&gt;ten&lt;/span&gt; consecutive trading days, then the Company will issue to
                    Exacis a number of additional shares of common stock equal to (x) $2.0 million divided by (y) the quotient of $200.00 million divided by the number of the Company&#x2019;s then issued and outstanding shares of common stock (collectively with (i) above, the
                    &#x201c;Market Cap Contingent Consideration&#x201d;); and&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="width: 36pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: top; width: 36pt;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: left;"&gt;(iii)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="text-align: left; vertical-align: top; width: auto; font-family: 'Times New Roman';"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: justify;"&gt;during the five-year period commencing on the closing date and ending on the five-year anniversary of the closing date, the Company will pay or deliver to Exacis 20% of all cash or other consideration (collectively, &#x201c;License Contingent Consideration&#x201d;) actually received by the Company during such five-year period from (i) third-party licensees or sublicensees of
                    the intellectual property rights acquired by the Company from Exacis pursuant to the Exacis Purchase Agreement, or (ii) subject to certain exceptions, the sale of such intellectual property rights; provided, that the License Contingent
                    Consideration shall not in any event exceed $45.0 million.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;"&gt;The Company accounted for the Exacis
      Acquisition as an asset acquisition because it determined that substantially all of the fair value of the assets acquired was concentrated in the Purchased License.&#160; Assets acquired in an asset acquisition are recognized based on their cost to the
      acquirer and generally allocated to the assets on a relative fair value basis.&#160; The Company&#x2019;s cost for acquiring the Exacis Assets includes the issuance of the shares of the Company&#x2019;s common stock, direct acquisition-related costs and contingent
      consideration.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;"&gt;The Market Cap Contingent Consideration is
      indexed to or settled in the Company&#x2019;s own shares.&#160; As a result, the Company classified the Market Cap Contingent Consideration as a liability measured at fair value because the financial instrument embodies a conditional obligation (the Company
      would only issue the shares on the condition that the market capitalization thresholds are met), and at inception, the monetary value of the obligation is based solely on a fixed monetary amount ($2.0 million of shares for each target), which will be settleable with a variable number of the Company&#x2019;s shares.&#160; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"&gt;The Company used a Monte Carlo simulation model to estimate the fair value of the Market
      Cap Contingent Consideration as of the acquisition date using the following assumptions:&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Stock price&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3.00&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Risk-free rate&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3.58&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Volatility&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;100&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Dividend yield&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;0&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Expected term&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: right; color: rgb(0, 0, 0);"&gt;3.0 years&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt;"&gt;The License Contingent Consideration is to be
      settled in cash and is generally recognized when the liability is probable and estimable.&#160; As of the acquisition date and as of December 31, 2023, the Company concluded that paying the License Contingent Consideration was not probable or estimable.&#160;
      Therefore, there was no applicable contingent consideration liability recognized.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align: justify;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The table below shows the total fair value of
          the consideration paid for the Exacis Assets (in thousands).&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair Value of&lt;br/&gt;
              Consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Shares issued&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;208&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 88%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Contingent consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;225&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Direct costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;27&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Total fair value&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;460&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.4pt;"&gt;The Company allocated 100% of the fair value of the consideration to the Purchased License, which the Company determined is an IPR&amp;amp;D asset.&#160; IPR&amp;amp;D assets acquired
      through an asset purchase that have no alternative future uses and no separate economic values from their original intended purpose are expensed in the period the cost is incurred.&#160; As a result, the Company expensed the fair value of the Purchased
      License during the year ended December 31, 2023.&lt;/div&gt;
</us-gaap:AssetAcquisitionTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="0"
      id="Fact_6958ac1cb915430d9ace9f6241bc6d54"
      unitRef="U002">69000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <erna:LockUpPeriodForCommonStock
      contextRef="c20230101to20231231_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      id="Fact_01772be8413e4042af59901ae0337a51">P12M</erna:LockUpPeriodForCommonStock>
    <erna:EstimatedEquityValueOfStockIssuedInAssetAcquisition
      contextRef="c20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-5"
      id="Fact_97507d7b957548d4a512dbf2344ba462"
      unitRef="U001">75000000</erna:EstimatedEquityValueOfStockIssuedInAssetAcquisition>
    <erna:AssetAcquisitionSharePrice
      contextRef="c20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="2"
      id="Fact_6c3c0b56f77843bd9983cc2e1a36835b"
      unitRef="U003">3</erna:AssetAcquisitionSharePrice>
    <erna:CommencementPeriodOfCommonStockInPurchaseAgreement
      contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      id="Fact_3428d3791c2649469e0ef5e7c312ea2b">P3Y</erna:CommencementPeriodOfCommonStockInPurchaseAgreement>
    <erna:CommencementPeriodOfCommonStockInPurchaseAgreement
      contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      id="Fact_6f37ce9820cb4875aa11fefdfa5fa7d3">P3Y</erna:CommencementPeriodOfCommonStockInPurchaseAgreement>
    <erna:MinimumCapitalizationRequirementAmount
      contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-5"
      id="Fact_897f4c89b1514843b6b6510da1d26e04"
      unitRef="U001">100000000</erna:MinimumCapitalizationRequirementAmount>
    <erna:NumeratorValueForStockIssuance
      contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-5"
      id="Fact_ad8b85c579c345138c480a7373a05f79"
      unitRef="U001">2000000</erna:NumeratorValueForStockIssuance>
    <erna:MinimumCapitalizationRequirementAmount
      contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationOneMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-4"
      id="Fact_e2689f070e8643f9806500c2406d4a2f"
      unitRef="U001">100000000</erna:MinimumCapitalizationRequirementAmount>
    <erna:CommencementPeriodOfCommonStockInPurchaseAgreement
      contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      id="Fact_602db52d29b4454c8a19480c1d5e35a4">P3Y</erna:CommencementPeriodOfCommonStockInPurchaseAgreement>
    <erna:MinimumCapitalizationRequirementAmount
      contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-5"
      id="Fact_5ea6ea6d9e6d4f67b019b88a22795ff1"
      unitRef="U001">200000000</erna:MinimumCapitalizationRequirementAmount>
    <erna:NumeratorValueForStockIssuance
      contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-5"
      id="Fact_a6bef33e356e4d64afc92249832737c6"
      unitRef="U001">2000000</erna:NumeratorValueForStockIssuance>
    <erna:MinimumCapitalizationRequirementAmount
      contextRef="c20230430_ContingentConsiderationByTypeAxis_ContingentConsiderationTwoMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-4"
      id="Fact_2b964015050748e3864402d02c46b612"
      unitRef="U001">200000000</erna:MinimumCapitalizationRequirementAmount>
    <erna:CommencementPeriodOfCommonStockInPurchaseAgreement
      contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationThreeMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      id="Fact_37709f9334ee41518846c12e81dff968">P5Y</erna:CommencementPeriodOfCommonStockInPurchaseAgreement>
    <erna:PercentageOfCashConsideration
      contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="2"
      id="Fact_136c81d2e71843848209398739330c3a"
      unitRef="U008">0.20</erna:PercentageOfCashConsideration>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
      contextRef="c20230401to20230430_RangeAxis_MaximumMember_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-5"
      id="Fact_8913641705c3434aa6d8d0f5fdb14668"
      unitRef="U001">45000000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="c20230426_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-5"
      id="Fact_5b205a1e6e364641b5b149f90c00dbc9"
      unitRef="U001">2000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_d61bc62ca1b844638e60aeab93dc6570">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"&gt;The Company used a Monte Carlo simulation model to estimate the fair value of the Market
      Cap Contingent Consideration as of the acquisition date using the following assumptions:&lt;/span&gt;
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Stock price&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3.00&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Risk-free rate&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3.58&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Volatility&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;100&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; width: 88%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Dividend yield&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;0&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Expected term&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: right; color: rgb(0, 0, 0);"&gt;3.0 years&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;
</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230426_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"
      decimals="2"
      id="Fact_621e6a1c267b4ab4aba1ded78fee713b"
      unitRef="U001">3</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230426_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="Fact_5fc65abc127449c6b741bf1b7396e8e9"
      unitRef="U001">0.0358</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230426_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_2afde1d140dc4f1bac0dec6614805f9e"
      unitRef="U001">1</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230426_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"
      decimals="2"
      id="Fact_aaf8ab313e274b25b9943e665f04c189"
      unitRef="U001">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20231231_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"
      id="Fact_313f64db450d47b09bf763181b5eb87e">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:AssetAcquisitionTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_ace078aa41c1453dba3f627ab72bb372">
&lt;div style="text-align: justify;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The table below shows the total fair value of
          the consideration paid for the Exacis Assets (in thousands).&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair Value of&lt;br/&gt;
              Consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Shares issued&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;208&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 88%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Contingent consideration&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;225&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Direct costs&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;27&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0);"&gt;Total fair value&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-size: 10pt; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;460&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
      contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-3"
      id="Fact_29d26d432f6c4c43b9d4d025e005b924"
      unitRef="U001">-208000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <erna:AssetAcquisitionFairValueOfConsiderationPaid
      contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-3"
      id="Fact_233d51666abc45e5bd5f9734b874ad6b"
      unitRef="U001">-225000</erna:AssetAcquisitionFairValueOfConsiderationPaid>
    <us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost
      contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-3"
      id="Fact_998c438b5a2f4bd9ba1176173914c72b"
      unitRef="U001">-27000</us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost>
    <erna:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20230401to20230430_TypeOfArrangementAxis_ExacisAssetPurchaseAgreementMember"
      decimals="-3"
      id="Fact_36e819e267de438788a595ba5fce6d8a"
      unitRef="U001">460000</erna:ResearchAndDevelopmentInProcessAssetAcquisition>
    <erna:AllocatedPercentageOfFairValueConsiderationToPurchasedLicense
      contextRef="c20230430"
      decimals="2"
      id="Fact_60bdfb58752142ebb4bae4eb65d3c495"
      unitRef="U008">1</erna:AllocatedPercentageOfFairValueConsiderationToPurchasedLicense>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="c20230101to20231231"
      id="Text_478532efb41e493da3d48b4476b5c000">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;5)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Contract with Customer&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt; margin-left: 0.5pt;"&gt;On February 21, 2023, the Company and
        Lineage Cell Therapeutics, Inc. (&#x201c;Lineage&#x201d;) entered into an exclusive option and license agreement (the &#x201c;Lineage Agreement&#x201d;), which provided Lineage with the option (the &#x201c;Option Right&#x201d;) to obtain an exclusive sublicense of intellectual property
        from the Company and to request the Company to develop a customized cell line.&#160; The Lineage Agreement was amended in August 2023 to provide for changes specifically related to the cell line customization activities such as (i) payment terms, (ii)
        certain definitions, (iii) certain courses of action if the customized cell line selected by Lineage is not successful and (iv) documentation requirements.&#160; Lineage paid the Company a $0.3 million non-refundable up-front payment (the &#x201c;Option Fee&#x201d;) for the Option Right and paid an initial payment of $0.4 million to commence the cell line customization activities, per the amended payment terms. If Lineage obtains the sublicense, the Company would be entitled to receive
        additional license fees, including milestone payments and royalties.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;Pursuant to ASC 606, the Company determined
        that the Option Right was an unexercised right held by Lineage under the Lineage Agreement at contract inception, as the cell line customization activities and the sublicense were optional purchases at contract inception. These optional purchases
        of goods and services would be treated as separate contracts if and when Lineage determines that it will make such purchases. Therefore, 100%
        of the Option Fee was allocated to the Option Right.&#160; The Option Fee will remain in deferred revenue until such time that Lineage enters into the sublicense or when the Option Right expires.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;The Option Right and the cell line
        customization activities are accounted for as separate contracts, and the Company has determined that the amended terms discussed above represent a modification to the cell line customization contract.&#160; Because there were no goods or services
        transferred to Lineage before entering into the amendment, and therefore, no previously recognized revenue, there was no catch-up adjustment to revenue required at the time of the amendment.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;Lineage will make payments to the Company
        for the cell line customization activities over the development period.&#160; The Company will only earn the remaining full amount of the cell line customization fee if it makes certain progress towards delivery of the customized cell line.&#160; The Company
        has determined that $0.4 million of consideration received could be recognized without the probability of being reversed, and it has
        placed a constraint on the remaining contractual customization fee.&#160; The $0.4 million is being recognized equally over the development
        period, which is expected to be approximately 20 to 25 months, as the level of effort to perform the services is happening at the same rate over time.&#160; If the development period is expected to be longer or shorter than originally planned, the
        Company will recognize a cumulative catch-up adjustment in the period that such determination is made. For the year ended December 31, 2023, the Company recognized approximately $0.1 million of revenue for the customization activities.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;The granting of the license that the
        Company may provide to Lineage if Lineage exercises the Option Right is not considered a performance obligation at this time, as it is an optional request that the customer may make in the future and will be accounted for as a separate contract
        when the customer exercises the Option Right.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;The Company recognizes direct labor and
        supplies used in the customization activities as incurred and are recorded as a cost of revenue.&#160; As provided for in the A&amp;amp;R Factor License Agreement discussed in Note 11, the Company is obligated to pay Factor Limited 20% of any amounts the Company receives from a customer that is related to the licensed technology under the A&amp;amp;R Factor License Agreement, which is
        also recorded as a cost of revenue.&lt;/div&gt;
</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <erna:ProceedsFromOptionAndLicenseAgreement
      contextRef="c20230221to20230221"
      decimals="-5"
      id="Fact_8873aaddeeaf4e5ca0631363dd4879b5"
      unitRef="U001">300000</erna:ProceedsFromOptionAndLicenseAgreement>
    <erna:ProceedsFromCellLineCustomizationActivities
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_0f884bac6f394c39b5133105fc8222b5"
      unitRef="U001">400000</erna:ProceedsFromCellLineCustomizationActivities>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c20230221"
      decimals="2"
      id="Fact_f91e6c3d5bcb4d72ab727ca3246f0578"
      unitRef="U008">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_e1b25f3251bf47ef8d8e201bb68915f2"
      unitRef="U001">0</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_d8cf53002e004d42932237f587ce0fd1"
      unitRef="U001">0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="c20230101to20231231_TimingOfTransferOfGoodOrServiceAxis_TransferredOverTimeMember"
      decimals="-5"
      id="Fact_3918f519c0c740cda6ff85da6736062f"
      unitRef="U001">400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="c20230101to20231231_TimingOfTransferOfGoodOrServiceAxis_TransferredOverTimeMember"
      decimals="-5"
      id="Fact_b373da1eab3d4d8797d0cef22912fddf"
      unitRef="U001">400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_dbebf9849df646439dbf712ae111cedf"
      unitRef="U001">100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <erna:OptionFeeObligationPaymentPercentage
      contextRef="c20230101to20231231"
      decimals="2"
      id="Fact_06f8fa53621e439c9f4eb4670b07ada5"
      unitRef="U008">0.20</erna:OptionFeeObligationPaymentPercentage>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_c2985972558d465daa662c05c9d35410">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;6)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Promissory Note and Convertible Note Financings&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;&#160;&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;On



            &lt;span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;"&gt;July 14, 2023, the Company received $8.7 million from a private placement in which the Company issued $8.7
              million in aggregate principal amount of convertible notes (the &#x201c;July 2023 convertible notes&#x201d;) and warrants to purchase an aggregate of approximately 6.1 million shares of its common stock (the &#x201c;July 2023 warrants&#x201d;). The Company recognized approximately $0.2 million in fees associated with the transaction&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;On



            &lt;span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;"&gt;December 8, 2023, the Company received $1.5 million in exchange for the issuance of 6% promissory note with an
              aggregate principal amount of $1.5 million to Charles Cherington. The promissory note was to mature on January 8, 2024, and interest accrued at a rate of 6.0%
              per annum, payable at maturity. On December 14, 2023, the Company repaid the $1.5 million of principal and $1,500 of accrued interest due under the promissory note. There are no further obligations under the promissory note&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;On



            &lt;span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;"&gt;December 14, 2023, the Company entered into a purchase agreement with certain purchasers for the private placement
              of $9.2 million of convertible notes (the &#x201c;December 2023 convertible notes&#x201d; and together with the July 2023 convertible notes, the
              &#x201c;convertible notes&#x201d;) and warrants to purchase an aggregate of approximately 9.6 million shares of the Company&#x2019;s common stock (the
              &#x201c;December 2023 warrants&#x201d; and together with the July 2023 warrants, the &#x201c;note warrants&#x201d;). There were two closings under this purchase agreement. The first closing occurred on December 15, 2023, and the Company received $7.8 million and issued $7.8 million
              of December 2023 convertible notes and December 2023 warrants to purchase approximately 8.1 million shares of our common stock.
              The second closing, in which the Company received the reaming $1.4 million under the purchase agreement, occurred in January 2024.
              See Note 18 for additional information regarding the second closing&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: #FFFFFF; display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;"&gt;See Note 16 for more information on the note
              warrants&lt;/span&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The &lt;span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;"&gt;July 2023 convertible notes bear interest at 6% per annum, and the December 2023 convertible notes bear interest at 12%
                per annum, both of which are payable quarterly in arrears. At the Company&#x2019;s election, it may pay interest either in cash or in-kind by increasing the outstanding principal amount of the convertible notes. The July 2023 convertible notes
                mature on July 14, 2028, and the December 2023 convertible notes issued on December 15, 2023 mature on December 15, 2028, unless earlier converted or repurchased.&#160; The Company does not have the option to redeem any of the convertible notes prior
                to maturity&lt;/span&gt;.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;At &lt;span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;"&gt;the option of the holders, the convertible notes may be converted from time-to-time in whole or in
                part into shares of the Company&#x2019;s common stock at an initial conversion rate of, with respect to the July 2023 convertible notes, $2.86
                per share and, with respect to the December 2023 convertible notes, $1.9194 per share, subject to customary adjustments for stock
                splits, stock dividends, recapitalization and the like.&#160; As of December 31, 2023, none of the convertible notes were converted
                into shares of common stock&lt;/span&gt;.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The &lt;span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-align: justify;"&gt;convertible notes do not contain any ratchet or other financial antidilution provisions.&#160; The
                  convertible notes contain conversion limitations such that no conversion may be made if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99%, 9.99% or 19.99% immediately after conversion thereof, subject to certain increases not in excess of either 9.99% or 19.99% at the option of such holder&lt;/span&gt;.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The &lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;convertible notes provide for customary events of default which include (subject in certain cases to customary grace and cure periods), among others: nonpayment of principal or interest, breach
                  of covenants or other agreements in the convertible notes; the occurrence of a material adverse effect event (as defined in the related securities purchase agreement) and certain events of bankruptcy. Generally, if an event of default
                  occurs and is continuing under the convertible notes, the holder thereof may require the Company to repurchase some or all of their convertible notes at a repurchase price equal to 100% of the principal amount of the convertible notes being repurchased, plus accrued and unpaid interest thereon&lt;/span&gt;.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
              &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;In &lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;connection with the issuance of the December 2023 convertible notes, the Company agreed to reduce the exercise price of the warrants the Company issued in a private placement in December 2022
                    (see Note 16) to purchase an aggregate of approximately 4.4 million shares of the Company&#x2019;s common stock from $3.28 to $1.43 per share and
                    of the July 2023 warrants from $2.61 to $1.43 per share. The effect of the reduction of the exercise price of these warrants was approximately $1.6 million and measured as the excess of the fair value of the modified instruments over the fair value of the instruments immediately before they were modified. The change in
                    the fair value of the repriced warrants is considered an issuance cost to the December 2023 convertible notes and December 2023 warrants. As such, the $1.6 million was allocated to each of those respective instruments based on their relative fair values, or approximately $0.8 million to each of the December 2023 convertible notes and December 2023 warrants&lt;/span&gt;.&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
                &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; The Company determined that there were no embedded derivatives within the convertible
                      notes that required bifurcation from the host agreement.&#160; The Company allocated the gross proceeds received, the fees incurred, and as applicable, the impact of repricing the warrants discussed above, over the July 2023 convertible
                      notes and July 2023 warrants and over the December 2023 convertible notes and December 2023 warrants, as applicable, based on their relative fair values as follows (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation of Proceeds and Costs:&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation of&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Relative&lt;br/&gt;
                              Fair Value&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation&lt;br/&gt;
                              Percentage&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Costs&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds,&lt;br/&gt;
                              Net&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;July 2023 convertible notes&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;8,715&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;39.94&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,481&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(80&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,401&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;July 2023 warrants&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;13,103&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;60.06&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;5,234&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(121&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;5,113&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;21,818&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;100.00&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;8,715&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(201&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;8,514&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
                      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation of Proceeds and Costs:&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation of&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Relative&lt;br/&gt;
                              Fair Value&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation&lt;br/&gt;
                              Percentage&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Costs&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrant&lt;br/&gt;
                              Repricing&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds,&lt;br/&gt;
                              Net&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;December 2023 convertible notes&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;9,059&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;48.83&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,803&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(81&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(766&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;2,956&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;December 2023 warrants&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;9,495&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;51.17&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,985&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(85&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(802&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,098&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;18,554&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;100.00&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;7,788&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(166&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(1,568&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;6,054&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
                      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The Company estimated the fair values of the convertible notes as of July 14, 2023 and December 15, 2023 based off a valuation
                      performed by a third-party specialist using a binomial tree model and the following assumptions:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;br/&gt;
                    &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Stock&lt;br/&gt;
                                Price&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Credit&lt;br/&gt;
                                Spread&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Volatility&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Risk-Free&lt;br/&gt;
                                Rate&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;July 2023 convertible notes&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2.81&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2,500&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;108&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;4.60&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;December 2023 convertible notes&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;1.51&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2,000&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;109&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;3.90&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
                    &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The fair value of the note warrants, all of which qualified for equity classification, was determined using the Black-Scholes pricing model as of each
                      of July 14, 2023 and December 15, 2023 using the following assumptions:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;br/&gt;
                    &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Stock&lt;br/&gt;
                                Price&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Exercise&lt;br/&gt;
                                Price&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Expected&lt;br/&gt;
                                Life&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Volatility&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Dividend&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Risk-Free&lt;br/&gt;
                                Rate&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;July 2023 warrants&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2.81&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2.61&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;5 years&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;98&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;0.00&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;4.04&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;December 2023 warrants&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;1.51&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;1.43&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;5 years&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;101&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;0.00&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;3.91&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
                    &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
                    &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;The amount of proceeds
                          allocated to the note warrants resulted in a corresponding reduction in the carrying value of the respective convertible notes as a debt discount, which is amortized with the debt issuance costs as a component of interest expense
                          based on the effective interest rate method over the contractual terms of the convertible notes.&lt;/span&gt;&lt;br/&gt;
                      &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
                      &lt;/div&gt;

&lt;div&gt;&#160;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;"&gt;
                    &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; The following table shows the activity that occurred during the year ended December 31,
                      2023 for the convertible notes on the accompanying consolidated balance sheet:&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
                    &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;Gross convertible notes at issuance&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;16,503&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;Debt discount and debt issuance costs&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(10,146&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;
                              &lt;div style="color: rgb(0, 0, 0);"&gt;Amortization of debt discount and debt issuance costs&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;303&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;Paid-in-kind interest added to principal&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;113&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;Convertible notes, net, at December 31, 2023&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;6,773&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
                      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The future minimum principal payments under the convertible notes as of December 31, 2023
                          are as follows:&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ending December 31,&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                              &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Principal&lt;/div&gt;
                              &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Payments&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2027&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2028&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,616&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: rgb(33, 37, 41); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Total&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,616&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
                        &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company has recognized approximately $0.6 million in interest expense for the year ended December 31, 2023
                          for the convertible notes, which includes $0.3 million for the amortization of the debt discount and debt issuance
                          costs.&#160; Of the remaining $0.3 million in interest expense, $0.1 million was paid in-kind and added to the principal of the respective notes and $0.2 million of interest is in accrued expenses in the accompanying consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;
</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember"
      decimals="-5"
      id="Fact_590478fe817f4319b97c8c830ed68daa"
      unitRef="U001">8700000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember"
      decimals="-5"
      id="Fact_79446ec0355249af8eb9b3ab3f530398"
      unitRef="U001">8700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20230714_ClassOfWarrantOrRightAxis_July2023WarrantsMember"
      decimals="-5"
      id="Fact_969d3ba577604d738ba3d9f3cb079bf5"
      unitRef="U002">6100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <erna:TransactionFeesRelatedToDebtIssuanceAndWarrants
      contextRef="c20230714to20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember"
      decimals="-5"
      id="Fact_ac39a840d1a04beaa8879d2ebe4237e8"
      unitRef="U001">200000</erna:TransactionFeesRelatedToDebtIssuanceAndWarrants>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_89c988ac62234037a28720aa6babd16e"
      unitRef="U001">1500000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="2"
      id="Fact_da8cc93be7bc40788f1cbdb82dac82d5"
      unitRef="U008">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_2ea51b0270b0409a99e51fe22f6c4379"
      unitRef="U001">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      id="Fact_c6f7f437e19a474a8ff4ebea1ff1ca5c">2024-01-08</us-gaap:DebtInstrumentMaturityDate>
    <erna:DebtInstrumentAccruedInterestRate
      contextRef="c20231208_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="3"
      id="Fact_2549167fd61040f7a634b88327a6b44f"
      unitRef="U008">0.06</erna:DebtInstrumentAccruedInterestRate>
    <us-gaap:DebtInstrumentRepaidPrincipal
      contextRef="c20231214to20231214_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_26ea066a814048e89794ea2570e2e94d"
      unitRef="U001">1500000</us-gaap:DebtInstrumentRepaidPrincipal>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="c20231214to20231214_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="0"
      id="Fact_b58e68a582c44b2c8bf2ca2853cf46ab"
      unitRef="U001">1500</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember"
      decimals="-5"
      id="Fact_5fc9069293344e49a1b22cde558d3091"
      unitRef="U001">9200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember"
      decimals="-5"
      id="Fact_f9d2d9c258a5426288261af053a820dd"
      unitRef="U002">9600000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="c20231215_DebtInstrumentAxis_December2023ConvertibleNotesMember"
      decimals="-5"
      id="Fact_8476d0b5eb194048913aad6271745c85"
      unitRef="U001">7800000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20231215_DebtInstrumentAxis_December2023ConvertibleNotesMember"
      decimals="-5"
      id="Fact_cb20ed0ddf5243ccad5d06454dd32235"
      unitRef="U001">7800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20231215_ClassOfWarrantOrRightAxis_December2023WarrantsMember_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-5"
      id="Fact_50476fc10f5e40feae5da468f9e0eb55"
      unitRef="U002">8100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20240131_DebtInstrumentAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_057904c6f0cb429f81571a89ac5d657f"
      unitRef="U001">1400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember"
      decimals="2"
      id="Fact_4ebfdb36cf1b4ddfb8d12293c3ca51ca"
      unitRef="U008">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember"
      decimals="2"
      id="Fact_c4653d71306c42118d04213697e1ae09"
      unitRef="U008">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20230101to20231231_DebtInstrumentAxis_July2023ConvertibleNotesMember"
      id="Fact_8a6038197b884e068354633dc032515e">2028-07-14</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20230101to20231231_DebtInstrumentAxis_December2023ConvertibleNotesMember"
      id="Fact_a0ba53eb51b748e6a26556a13a783752">2028-12-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c20230714_DebtInstrumentAxis_July2023ConvertibleNotesMember"
      decimals="2"
      id="Fact_e152273f0f934cdb9e4ed8f5f8a63331"
      unitRef="U003">2.86</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c20231214_DebtInstrumentAxis_December2023ConvertibleNotesMember"
      decimals="4"
      id="Fact_c45b58e7181f4ac2ac6005e86a09143a"
      unitRef="U003">1.9194</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="INF"
      id="Fact_9c5c0365a8b04126ac9a278534f8a19d"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <erna:ConvertibleNotesBeneficialConversionFeaturePercentage
      contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodOneMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember"
      decimals="4"
      id="Fact_67fc96e82526436bbaeff93badd0a7ae"
      unitRef="U008">0.0499</erna:ConvertibleNotesBeneficialConversionFeaturePercentage>
    <erna:ConvertibleNotesBeneficialConversionFeaturePercentage
      contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodTwoMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember"
      decimals="4"
      id="Fact_08779acf25d0487e9d979cfd5e6eb38f"
      unitRef="U008">0.0999</erna:ConvertibleNotesBeneficialConversionFeaturePercentage>
    <erna:ConvertibleNotesBeneficialConversionFeaturePercentage
      contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodThreeMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MinimumMember"
      decimals="4"
      id="Fact_c809c1bb6ccc4910b4a73d265fae0703"
      unitRef="U008">0.1999</erna:ConvertibleNotesBeneficialConversionFeaturePercentage>
    <erna:ConvertibleNotesBeneficialConversionFeaturePercentage
      contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodOneMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MaximumMember"
      decimals="4"
      id="Fact_6db4f49e6c0840aeace563ac988af677"
      unitRef="U008">0.0999</erna:ConvertibleNotesBeneficialConversionFeaturePercentage>
    <erna:ConvertibleNotesBeneficialConversionFeaturePercentage
      contextRef="c20230714_DebtInstrumentRedemptionPeriodAxis_DebtInstrumentRedemptionPeriodTwoMember_LongtermDebtTypeAxis_ConvertibleDebtMember_RangeAxis_MaximumMember"
      decimals="4"
      id="Fact_b655bc9f68784aa2a9204e6c25751d67"
      unitRef="U008">0.1999</erna:ConvertibleNotesBeneficialConversionFeaturePercentage>
    <erna:RepurchasePricePercentageToPrincipalAmount
      contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="2"
      id="Fact_8c9dd648b5e64c3091156e56faa57c9f"
      unitRef="U008">1</erna:RepurchasePricePercentageToPrincipalAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20221231_DebtInstrumentAxis_December2022ConvertibleNotesMember_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-5"
      id="Fact_be518a5c215545d993322ee329d41cdb"
      unitRef="U002">4400000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221231_DebtInstrumentAxis_December2022ConvertibleNotesMember"
      decimals="2"
      id="Fact_80ec1372eeda42639f50fdfc2dac4195"
      unitRef="U003">3.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20231231_DebtInstrumentAxis_December2022ConvertibleNotesMember"
      decimals="2"
      id="Fact_40645a86dfd04a4fbd1d8e362025336a"
      unitRef="U003">1.43</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20230714_ClassOfWarrantOrRightAxis_July2023WarrantsMember"
      decimals="2"
      id="Fact_594ae224a53344d5a38aee51c7cace1d"
      unitRef="U003">2.61</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember"
      decimals="2"
      id="Fact_26b9e2985dfb4272877bfdb68cf2581d"
      unitRef="U003">1.43</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:EffectOfReductionOfExercisePriceOfWarrants
      contextRef="c20231231"
      decimals="-5"
      id="Fact_01269721381a4aabbf49f7616343f3dd"
      unitRef="U001">1600000</erna:EffectOfReductionOfExercisePriceOfWarrants>
    <erna:EffectOfReductionOfExercisePriceOfWarrants
      contextRef="c20231231"
      decimals="-5"
      id="Fact_e5222758b0604374abaa9ca6c8da98c2"
      unitRef="U001">1600000</erna:EffectOfReductionOfExercisePriceOfWarrants>
    <erna:EffectOfReductionOfExercisePriceOfWarrants
      contextRef="c20231231_DebtInstrumentAxis_December2022ConvertibleNotesMember"
      decimals="-5"
      id="Fact_a6171d3fd2a44f70bdd3d87fbf45ea30"
      unitRef="U001">800000</erna:EffectOfReductionOfExercisePriceOfWarrants>
    <erna:EffectOfReductionOfExercisePriceOfWarrants
      contextRef="c20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember"
      decimals="-5"
      id="Fact_21751628af5346d1a92f5fb1aea6f4cd"
      unitRef="U001">800000</erna:EffectOfReductionOfExercisePriceOfWarrants>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_b0cc436d0f19469591241bb890fb0420">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; The Company determined that there were no embedded derivatives within the convertible
                      notes that required bifurcation from the host agreement.&#160; The Company allocated the gross proceeds received, the fees incurred, and as applicable, the impact of repricing the warrants discussed above, over the July 2023 convertible
                      notes and July 2023 warrants and over the December 2023 convertible notes and December 2023 warrants, as applicable, based on their relative fair values as follows (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation of Proceeds and Costs:&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation of&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Relative&lt;br/&gt;
                              Fair Value&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation&lt;br/&gt;
                              Percentage&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Costs&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds,&lt;br/&gt;
                              Net&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;July 2023 convertible notes&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;8,715&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;39.94&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,481&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(80&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,401&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;July 2023 warrants&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;13,103&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;60.06&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;5,234&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(121&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;5,113&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;21,818&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;100.00&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;8,715&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(201&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;8,514&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
                      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation of Proceeds and Costs:&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation of&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Relative&lt;br/&gt;
                              Fair Value&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Allocation&lt;br/&gt;
                              Percentage&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Costs&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrant&lt;br/&gt;
                              Repricing&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Proceeds,&lt;br/&gt;
                              Net&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;December 2023 convertible notes&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;9,059&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;48.83&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,803&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(81&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(766&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;2,956&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;December 2023 warrants&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;9,495&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;51.17&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,985&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(85&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(802&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;3,098&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;18,554&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;100.00&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;7,788&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(166&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(1,568&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;6,054&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_406b96c9e5e9411493423f69c118993a"
      unitRef="U001">8715000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <erna:AllocationPercentageOfFairValue
      contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember"
      decimals="4"
      id="Fact_f4fb500f3392464c964df6dfd536c58b"
      unitRef="U008">0.3994</erna:AllocationPercentageOfFairValue>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_5bc474e474404a6c8203946e1b97ec1d"
      unitRef="U001">3481000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_aaed2a19718647ccb7a46082e094e587"
      unitRef="U001">80000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <erna:ProceedsFromConvertibleDebtNet
      contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_f5290a88a99c42e29f9dc9616013199a"
      unitRef="U001">3401000</erna:ProceedsFromConvertibleDebtNet>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember"
      decimals="-3"
      id="Fact_bcda54632d4346af8c630b673259cc50"
      unitRef="U001">13103000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <erna:AllocationPercentageOfFairValue
      contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember"
      decimals="4"
      id="Fact_ce0f8971228f49b7aedc452715d7929f"
      unitRef="U008">0.6006</erna:AllocationPercentageOfFairValue>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023WarrantsMember"
      decimals="-3"
      id="Fact_c096ca2501034ce9bab2c0eff8febcc6"
      unitRef="U001">5234000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023WarrantsMember"
      decimals="-3"
      id="Fact_840bf69f14e54f219a1b843fa3b9c1fa"
      unitRef="U001">121000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <erna:ProceedsFromConvertibleDebtNet
      contextRef="c20230714to20230714_LongtermDebtTypeAxis_July2023WarrantsMember"
      decimals="-3"
      id="Fact_9553c5d39a7a493ba46cc3547e054bff"
      unitRef="U001">5113000</erna:ProceedsFromConvertibleDebtNet>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="c20230714"
      decimals="-3"
      id="Fact_45ae452e62514a41b4bf062e375ba4a1"
      unitRef="U001">21818000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <erna:AllocationPercentageOfFairValue
      contextRef="c20230714"
      decimals="4"
      id="Fact_1d2acca8161b467d9bc39bd4d2359107"
      unitRef="U008">1</erna:AllocationPercentageOfFairValue>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20230714to20230714"
      decimals="-3"
      id="Fact_f734b17ced6a4eebaf1a235672dc57f4"
      unitRef="U001">8715000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="c20230714to20230714"
      decimals="-3"
      id="Fact_4f5f75513a3946459eefd1a856126839"
      unitRef="U001">201000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <erna:ProceedsFromConvertibleDebtNet
      contextRef="c20230714to20230714"
      decimals="-3"
      id="Fact_8b08aaa380064f78aff42e9933c31002"
      unitRef="U001">8514000</erna:ProceedsFromConvertibleDebtNet>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_63f9658a6d29465ba7b141734d70959e"
      unitRef="U001">9059000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <erna:AllocationPercentageOfFairValue
      contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember"
      decimals="4"
      id="Fact_41edf28c959a4526a449a5eba9e17e23"
      unitRef="U008">0.4883</erna:AllocationPercentageOfFairValue>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_edcf027ee3e149cab2a2fc352b766e9f"
      unitRef="U001">3803000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_7090f9ed1df3447ca3d524b92888025a"
      unitRef="U001">81000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <erna:WarrantRepricing
      contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_a79674c75a6a4853b88f6e3e9ced0178"
      unitRef="U001">766000</erna:WarrantRepricing>
    <erna:ProceedsFromConvertibleDebtNet
      contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember"
      decimals="-3"
      id="Fact_ff550e1be5f649579a349f1b9351d530"
      unitRef="U001">2956000</erna:ProceedsFromConvertibleDebtNet>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember"
      decimals="-3"
      id="Fact_13f2c4545b8343ab96e0469b352ce4e3"
      unitRef="U001">9495000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <erna:AllocationPercentageOfFairValue
      contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember"
      decimals="4"
      id="Fact_d9beeb69fc3945f09786bdd44f128bf7"
      unitRef="U008">0.5117</erna:AllocationPercentageOfFairValue>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember"
      decimals="-3"
      id="Fact_e7302c9be32d40e3b2e5c447a737f278"
      unitRef="U001">3985000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember"
      decimals="-3"
      id="Fact_110d118421744396919421f096de40e0"
      unitRef="U001">85000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <erna:WarrantRepricing
      contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember"
      decimals="-3"
      id="Fact_764375aa72314f79904631ee51ec0f0e"
      unitRef="U001">802000</erna:WarrantRepricing>
    <erna:ProceedsFromConvertibleDebtNet
      contextRef="c20231215to20231215_LongtermDebtTypeAxis_December2023WarrantsMember"
      decimals="-3"
      id="Fact_9f9bb06df04e4e57b05d67948e44abe9"
      unitRef="U001">3098000</erna:ProceedsFromConvertibleDebtNet>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="c20231215"
      decimals="-3"
      id="Fact_b5b7688413f047c3b1a171a9b59bfcb9"
      unitRef="U001">18554000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <erna:AllocationPercentageOfFairValue
      contextRef="c20231215"
      decimals="4"
      id="Fact_f1400c2afa0e4fafaeadb9e0ae746d75"
      unitRef="U008">1</erna:AllocationPercentageOfFairValue>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20231215to20231215"
      decimals="-3"
      id="Fact_5c8b9a4c9ea6432882526b81a88d64cb"
      unitRef="U001">7788000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="c20231215to20231215"
      decimals="-3"
      id="Fact_f6c4ac296c02470bac3c9dc5849aea62"
      unitRef="U001">166000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <erna:WarrantRepricing
      contextRef="c20231215to20231215"
      decimals="-3"
      id="Fact_06d3b2a32ec84f9185c6860c4b6736d1"
      unitRef="U001">1568000</erna:WarrantRepricing>
    <erna:ProceedsFromConvertibleDebtNet
      contextRef="c20231215to20231215"
      decimals="-3"
      id="Fact_cfabf07c7952478e8c3ff1989997446a"
      unitRef="U001">6054000</erna:ProceedsFromConvertibleDebtNet>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock
      contextRef="c20230101to20231231"
      id="Text_525ea38c1d20421fb3ee03262dcd3722">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The Company estimated the fair values of the convertible notes as of July 14, 2023 and December 15, 2023 based off a valuation
                      performed by a third-party specialist using a binomial tree model and the following assumptions:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;br/&gt;
                    &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Stock&lt;br/&gt;
                                Price&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Credit&lt;br/&gt;
                                Spread&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Volatility&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Risk-Free&lt;br/&gt;
                                Rate&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;July 2023 convertible notes&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2.81&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2,500&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;108&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;4.60&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 52%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;December 2023 convertible notes&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;1.51&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2,000&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;109&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;3.90&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
                    &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The fair value of the note warrants, all of which qualified for equity classification, was determined using the Black-Scholes pricing model as of each
                      of July 14, 2023 and December 15, 2023 using the following assumptions:&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;br/&gt;
                    &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Stock&lt;br/&gt;
                                Price&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Exercise&lt;br/&gt;
                                Price&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Expected&lt;br/&gt;
                                Life&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Volatility&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Dividend&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;Risk-Free&lt;br/&gt;
                                Rate&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;July 2023 warrants&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2.81&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;2.61&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;5 years&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;98&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;0.00&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;4.04&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;December 2023 warrants&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;1.51&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;1.43&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; width: 20%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: center;"&gt;5 years&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;101&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;0.00&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;3.91&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div&gt;%&lt;/div&gt;
                            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
                    &lt;/div&gt;
</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"
      decimals="2"
      id="Fact_4da0bccfa2614636934c0b9b2d1f9abc"
      unitRef="U003">2.81</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember"
      decimals="-3"
      id="Fact_d2f7fc73eabf465b8b625fff7065a81b"
      unitRef="U001">2500000</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_3fd29de5fd6948999fab8d4fcc3ae94e"
      unitRef="U008">1.08</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="Fact_d0e90f949c834faeae0143b73214a96e"
      unitRef="U008">0.046</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"
      decimals="2"
      id="Fact_bc50df46eaa24d29b221ba19ce65d58c"
      unitRef="U003">1.51</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember"
      decimals="-3"
      id="Fact_67e6fbc6fbb643be88cd8b593fff9343"
      unitRef="U001">2000000</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_cb1d6c5c6c96461caec80c88c9e6c67a"
      unitRef="U008">1.09</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:LongTermDebtMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="Fact_406327759b1344d980d75350449b497c"
      unitRef="U008">0.039</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"
      decimals="2"
      id="Fact_7700063312824a32a33f5814b484edbb"
      unitRef="U003">2.81</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExercisePriceMember"
      decimals="2"
      id="Fact_8e09d5f07ba4421d9c384faa1a937389"
      unitRef="U003">2.61</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"
      id="Fact_875668411b8e413f86874adc05ef9c00">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_3e384afd27ec46958f74e0ade1c2fd8c"
      unitRef="U008">0.98</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"
      decimals="4"
      id="Fact_d6f0f480e4b74ba7ba9c5fd06bc8fb07"
      unitRef="U008">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20230714_LongtermDebtTypeAxis_July2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="Fact_d1a6fc144f824a8d8cd9793fb8dd3bb2"
      unitRef="U008">0.0404</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"
      decimals="2"
      id="Fact_6bb8aca3acb74bcf9a6662bbd89e384a"
      unitRef="U003">1.51</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExercisePriceMember"
      decimals="2"
      id="Fact_b4b96989e22f458b8697bbe65a7ce27f"
      unitRef="U003">1.43</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"
      id="Fact_45c0e87748c84f8c8334f09613057cb2">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_adbbe9bf43e44b3fa55850240d73e095"
      unitRef="U008">1.01</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"
      decimals="4"
      id="Fact_9d18e56c58934190bc7ba0f86b7d5f9d"
      unitRef="U008">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231215_LongtermDebtTypeAxis_December2023WarrantsMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="Fact_a7051ccecf204a81a12607509089ffc3"
      unitRef="U008">0.0391</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_70c164c86b74494bb6a9f20fe87e869d">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;"&gt;
                    &lt;/span&gt;
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; The following table shows the activity that occurred during the year ended December 31,
                      2023 for the convertible notes on the accompanying consolidated balance sheet:&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
                    &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;Gross convertible notes at issuance&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;16,503&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;Debt discount and debt issuance costs&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;(10,146&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;
                              &lt;div style="color: rgb(0, 0, 0);"&gt;Amortization of debt discount and debt issuance costs&lt;/div&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;303&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;Paid-in-kind interest added to principal&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;113&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;Convertible notes, net, at December 31, 2023&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                            &lt;div style="color: rgb(0, 0, 0);"&gt;6,773&lt;/div&gt;
                          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_63c4827cb3254fdf9de6b60fb39afaa7"
      unitRef="U001">16503000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="c20231231"
      decimals="-3"
      id="Fact_73ebc809f52d4313a49b05fff39a6b44"
      unitRef="U001">10146000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_cea4552c04f54924ad0354eb2e9b1b68"
      unitRef="U001">303000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <erna:PaidInKindInterestAddedToConvertibleNotesPrincipal
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_4c17560ffe204ed598bc533a23cceda3"
      unitRef="U001">113000</erna:PaidInKindInterestAddedToConvertibleNotesPrincipal>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="c20231231"
      decimals="-3"
      id="Fact_904b164462304a3f95d1a3732c68fabb"
      unitRef="U001">6773000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_1d727813baf8425889e1a435e38ac7fb">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The future minimum principal payments under the convertible notes as of December 31, 2023
                          are as follows:&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ending December 31,&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                              &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Principal&lt;/div&gt;
                              &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Payments&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2027&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2028&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,616&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
                              &lt;div style="text-align: left; color: rgb(33, 37, 41); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Total&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                              &lt;div style="color: #212529; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,616&lt;/div&gt;
                            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-3"
      id="Fact_2d5e6b724b794cfc8979c1e4830dddf0"
      unitRef="U001">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-3"
      id="Fact_8e1a1e7729034488a09613723162b93e"
      unitRef="U001">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-3"
      id="Fact_216a505f422e4dd1b5b04025f812f4a4"
      unitRef="U001">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-3"
      id="Fact_eefa87e3ba8e44c88d8dafc6ebbd6603"
      unitRef="U001">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-3"
      id="Fact_50e0c430948b4389b97ac865f4bf7689"
      unitRef="U001">16616000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebt
      contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-3"
      id="Fact_0f622ce394cd4519ab2d78633cbd382c"
      unitRef="U001">16616000</us-gaap:LongTermDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_66a6969eca024808bdebca30bbb664aa"
      unitRef="U001">600000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_728407b46c6e44c9a0293353d55e21b2"
      unitRef="U001">300000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:PaidInKindInterest
      contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_436c136cdffd4ff795f5cb0dbf95b438"
      unitRef="U001">300000</us-gaap:PaidInKindInterest>
    <erna:InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts
      contextRef="c20230101to20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_543fc3632359450c8a52c9fff3026276"
      unitRef="U001">100000</erna:InterestExpenseDebtExcludingAmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20231231_LongtermDebtTypeAxis_ConvertibleDebtMember"
      decimals="-5"
      id="Fact_894430f69dda4b10b3480c5abd6fc1e8"
      unitRef="U001">200000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_04f70f6d71f24cdaa97b8877306a3d65">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;7)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Property and Equipment&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Property and equipment consist of the following (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Laboratory and manufacturing equipment&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;40&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;28&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;Furniture and fixtures&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;19&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Leasehold improvements&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;274&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Computer equipment and programs&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;274&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;240&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;607&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;268&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less accumulated depreciation and amortization&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(114&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(32&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Property and equipment, net&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;493&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;236&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the year ended December 31, 2023, the Company recognized a &lt;span style="font-style: italic;"&gt;de minimis&lt;/span&gt; loss on
        disposal of fixed assets. During the year ended December 31, 2022, the Company consolidated its research and development activities in Cambridge, Massachusetts and entered into lease termination agreements for its Brooklyn, New York and San Diego,
        California facilities. As a result, the Company disposed of certain assets it would no longer use and recognized a loss on disposal of fixed assets of approximately $0.3 million, which was composed of $0.6 million in remaining net book value of
        such assets, offset by proceeds received from selling certain fixed assets for approximately $0.3 million. &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Depreciation expense totaled $0.1
        million and $0.2 million for the years ended December 31, 2023 and 2022, respectively. No depreciation expense is recorded on fixed
        assets in process until such time as the assets are completed and are placed into service.&lt;/div&gt;
</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="c20230101to20231231"
      id="Text_d6baae7027f6405f93a110b8d03de481">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Property and equipment consist of the following (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Laboratory and manufacturing equipment&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;40&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;28&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;Furniture and fixtures&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;19&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Leasehold improvements&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;274&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Computer equipment and programs&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;274&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;240&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;607&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;268&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less accumulated depreciation and amortization&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(114&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(32&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Property and equipment, net&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;493&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;236&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember"
      decimals="-3"
      id="Fact_9e2f1602d04e4242b6ede5af9e4ea321"
      unitRef="U001">40000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_EquipmentMember"
      decimals="-3"
      id="Fact_830215d7815d46618919493e4713a942"
      unitRef="U001">28000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"
      decimals="-3"
      id="Fact_a2601bd7d7e8429398852b55d2f6a7c3"
      unitRef="U001">19000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"
      decimals="-3"
      id="Fact_e4b41c4aded044ab9d608a5ba4f4f63b"
      unitRef="U001">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact_8569afc13287401f86633e2f8642cdd4"
      unitRef="U001">274000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact_18c4c83c4aac45c1b511acead67303ca"
      unitRef="U001">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20231231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      decimals="-3"
      id="Fact_2de7963b98b54e158316722fd4901cfb"
      unitRef="U001">274000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      decimals="-3"
      id="Fact_64514dc007904ebcac5a07f90f0009d3"
      unitRef="U001">240000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20231231"
      decimals="-3"
      id="Fact_3924a78dadc74a938b7d301effc64a02"
      unitRef="U001">607000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20221231"
      decimals="-3"
      id="Fact_38c008fd1d7e4a1cac1979622e88d608"
      unitRef="U001">268000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20231231"
      decimals="-3"
      id="Fact_d295ff3f811947b8a58078d587521b54"
      unitRef="U001">114000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20221231"
      decimals="-3"
      id="Fact_13bf528f25d14211a831c3a17ea2a5c4"
      unitRef="U001">32000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20231231"
      decimals="-3"
      id="Fact_4f6a503ec46a429dbc6e78f790970715"
      unitRef="U001">493000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20221231"
      decimals="-3"
      id="Fact_ec6ec274c1574efb8494f00dd8007f04"
      unitRef="U001">236000</us-gaap:PropertyPlantAndEquipmentNet>
    <erna:GainLossOnDisposalOfFixedAssets
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_048a85a1d0ce4a248fa5ec996d9a7df0"
      unitRef="U001">300000</erna:GainLossOnDisposalOfFixedAssets>
    <erna:RemainingNetBookValueOfFixedAssets
      contextRef="c20221231"
      decimals="-5"
      id="Fact_88c181d27d814ad3b15d3390a39b0b3b"
      unitRef="U001">600000</erna:RemainingNetBookValueOfFixedAssets>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_38de3bebfa1c4f5f94be48d6a10fcf4b"
      unitRef="U001">300000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:Depreciation
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_b1e739c247f74d87b78738da281742ed"
      unitRef="U001">100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_35e579f71c76407aa1256ba48bc0876a"
      unitRef="U001">200000</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20230101to20231231"
      id="Text_78e995807758407d9d97f05dc600df1c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;8)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Leases&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;Operating Leases&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he &lt;/span&gt;Company currently has operating leases for office
        and laboratory space in (a) the borough of Manhattan in New York, New York, (b) Cambridge, Massachusetts, and (c) Somerville, Massachusetts, which expire in 2026, 2028, and 2033, respectively&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Until March 2022, the Company also leased a facility in Brooklyn, New York. In March 2022, the Company entered into an
        agreement to assign that lease to an unaffiliated third party, who also agreed to purchase certain equipment from the Company for $50,000,
        which partially reimbursed the Company for certain existing unamortized leasehold improvements, and to reimburse the Company for the approximately $63,000
        security deposit under the lease. Under the assignment agreement, the unaffiliated third party assumed all of the obligations, liabilities, covenants and conditions of the Company as tenant under the lease.&#160; As a result of the lease assignment, the
        Company wrote off the remaining ROU asset balance of approximately $1.4 million and the corresponding lease liability of approximately $1.5 million.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company had also leased a facility in San Diego, California. During the second quarter of 2022, the Company determined to consolidate its research and
          development efforts in Cambridge, Massachusetts and sublease its San Diego lab and office space.&#160; As a result, the Company recognized an impairment charge of approximately $0.8 million on the San Diego lease ROU asset during the year ended December 31, 2022.&#160; In November 2022, the Company entered into a lease termination agreement, effective January 31, 2023;
          and as of December 31, 2023, there was no lease liability or ROU asset balances remaining for the San Diego lease.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In October 2022, the Company entered into a sublease with a subsidiary of Bristol-Myers Squibb Company, as sublessor (&#x201c;Sublessor&#x201d;), for office, laboratory and
          research and development space of approximately 45,500 square feet in Somerville, Massachusetts.&#160; The lease expires in November 2033
          and is subject to a five-year extension. Rent payments under the sublease began on November 29, 2023. The Company pays base rent of
          approximately $0.5 million per month during the first year of the term, which will increase 3% per year thereafter.&#160; The Company also makes monthly payments for parking, which are based on market rates that can change from time to time, and pay its share of
          traditional lease expenses, including certain taxes, operating expenses and utilities.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company paid the Sublessor a security deposit in the form of a letter of credit in the amount of approximately $4.1 million. Provided there are no events of default by the Company under the sublease, the letter of credit will be reduced on an incremental basis throughout the term.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Sublessor agreed to provide the Company with a tenant improvement allowance (&#x201c;TIA&#x201d;) of $190 per rentable square foot, or $8.6 million.&#160; Tenant improvements in excess
          of this amount will be at the Company&#x2019;s own cost.&#160; Construction was substantially complete in January 2024 and the total out-of-pocket costs for the improvements is estimated to be approximately $2.1 million.&#160; As of December 31, 2023, the Company received the entire $8.6
          million TIA.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company obtained access and control of the premises on June 21, 2023, and as such, the Company determined that the commencement date for accounting purposes was
          June 21, 2023.&#160; The Company also performed an analysis on the accounting ownership of the tenant improvement assets and determined that such assets were sublessor/lessor owned.&#160; As a result, TIA payments made by the Sublessor to the Company for
          the tenant improvement assets are considered a reimbursement rather than a lease incentive and not included as part of the consideration of the contract.&#160; Amounts paid by the Company for sublessor/lessor owned assets in excess of the TIA are
          considered non-cash lease payments and are added to the consideration in the contract.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company measured the lease liability and corresponding ROU asset for the sublease as of June 21, 2023, which includes lease payments the Company must make over
          the ten-year lease term.&#160; The Company did not include the option to extend the lease for an additional five years in the initial measurement because the Company was not reasonably certain as of June 21, 2023 that it would exercise its right to
          extend the lease term. As a result, the Company recorded a lease liability of $34.4 million, which included $0.6 million for the incremental amount above the TIA that the Company expected to pay for sublessor/lessor owned assets as of the initial measurement
          date, and a corresponding ROU asset of $34.7 million as of June 30, 2023.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In December 2023, the Company incurred additional out-of-pocket expenses of approximately $0.4 million for sublessor/lessor owned assets as a result of out-of-scope changes.&#160; These cost changes were accounted for as a lease modification of the existing lease.&#160; The Company
          determined that the lease continued to be classified as an operating lease after modification and remeasured the liability for the remaining unpaid lease payments, including the aggregate $1.0 million of unpaid out-of-pocket costs above the TIA that the Company will pay for sublessor/lessor owned assets, as well as remeasuring any variable lease payment that is based on an
          index or rate.&#160; The Company also requested a third-party specialist to reassess the incremental borrowing rate, which is the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal
          to the lease payments in a similar economic environment.&#160; This reassessment resulted in an increased incremental borrowing rate from 12.7%
          as of the initial measurement date to 14.4% as of the modification date.&#160; The remeasurement resulted in a decrease to the lease
          liability of approximately $1.6 million with a corresponding adjustment to the ROU asset.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the years ended December 31, 2023 and 2022, the net operating lease expenses were as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-weight: bold;"&gt;2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,399&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;595&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Sublease income&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(84&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(84&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Variable lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;136&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;150&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Total lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,451&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;661&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2023 and
            the ending balances as of December 31 2023, including the changes during the period (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operating Lease&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;ROU Assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease ROU assets at January 1, 2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,030&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                  &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Recognition of ROU asset for Somerville Sublease&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;34,410&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                  &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Adjustment to ROU asset for remeasurement of Somvervile Sublease liability&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(1,620&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                  &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Amortization of operating lease ROU assets&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(1,039&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease ROU assets at December 31, 2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;32,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operating Lease&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease liabilities at January 1, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;1,182&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                    &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Recognition of lease liability for Somerville Sublease&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;34,169&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                    &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Accretion of interest for Somerville Sublease&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;1,858&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                    &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Adjustment to lease liablity due to remeasurement of Somerville Sublease&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(1,620&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                    &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Principal payments on operating lease liabilities&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(519&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease liabilities at December 31, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;35,070&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Less non-current portion&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;32,854&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Current portion at December 31, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;2,216&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of December 31, 2023, the Company&#x2019;s operating leases had a weighted-average remaining life of 9.8 years with a weighted-average discount rate of 14.24%.
          &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The maturities of the
          operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2024&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,972&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2025&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,075&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2026&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,238&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2027&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,308&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2028&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,406&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Thereafter&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;33,879&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total payments&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;65,878&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less imputed interest&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(30,808&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total operating lease liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;35,070&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div&gt;&lt;span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Manhattan Sublease&lt;/span&gt;
          &lt;br/&gt;&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
              &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In April 2019, the Company entered into a sublease with an unaffiliated third party (the
              &#x201c;Subtenant&#x201d;), whereby the Subtenant agreed to sublease approximately 999 square feet of space rented by the Company in the borough
              of Manhattan in New York, New York commencing on May 15, 2019. The term of this sublease expires on October 31, 2026 with no option to extend. Rent payments by the Subtenant under the sublease began on September 1, 2019. The sublease
              stipulates an annual rent increase of 2.25%. The Subtenant is also responsible for paying to the Company all tenant energy costs,
              annual operating costs, and annual tax costs attributable to the subleased space during the term of the sublease.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company received sublease payments of approximately $0.1 million for each of the years ended December 31, 2023 and 2022, respectively. In accordance with ASC Topic 842, the Company treats the sublease as a separate
              lease, as the Company was not relieved of the primary obligation under the related lease. The Company continues to account for the related lease as a lessee and in the same manner as prior to the commencement date of the sublease. The Company
              accounts for the sublease as a lessor of the lease. The sublease is classified as an operating lease, as it does not meet the criteria of a sale-type or direct financing lease.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following tables shows the future payments the Company expects to receive from the Subtenant over
              the remaining term of the sublease (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of&lt;/div&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31,&lt;/div&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; 2023&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;86&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;88&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;75&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total payments &lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;249&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <erna:LesseeCommitmentToPurchaseProperty
      contextRef="c20220331"
      decimals="0"
      id="Fact_5327989e232b4eb4a231f51ee9dbece0"
      unitRef="U001">50000</erna:LesseeCommitmentToPurchaseProperty>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="c20220331"
      decimals="0"
      id="Fact_d7df29d81dfb4af68b52a8a0d9a4b950"
      unitRef="U001">63000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220331"
      decimals="-5"
      id="Fact_761af41158db47b285666df4c2ee54b0"
      unitRef="U001">1400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220331"
      decimals="-5"
      id="Fact_dc3213f819524457af480534c7e1916b"
      unitRef="U001">1500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_05c4747e7e7b4459bf46c409884b95c5"
      unitRef="U001">800000</us-gaap:OperatingLeaseImpairmentLoss>
    <erna:InitialMeasurementOfOperatingLeaseLiabilities
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_SanDiegoLeaseMember"
      decimals="-3"
      id="Fact_cfc19765c7284e5d8708d5ef870a6fcc"
      unitRef="U001">0</erna:InitialMeasurementOfOperatingLeaseLiabilities>
    <erna:InitialMeasurementOfOperatingLeaseROUAssets
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_SanDiegoLeaseMember"
      decimals="-3"
      id="Fact_5ea804bc06ae45fe85674f0301bd18bb"
      unitRef="U001">0</erna:InitialMeasurementOfOperatingLeaseROUAssets>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="0"
      id="Fact_50509eadbd8e4bb6abc69ffa5a5adcfe"
      unitRef="U005">45500</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      id="Fact_3ec84b04e55048eeb904df119a1801e3">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <erna:OperatingLeasesMonthlyBaseRent
      contextRef="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_4241b94a08ee4f57a5b52cfc113f02ab"
      unitRef="U001">500000</erna:OperatingLeasesMonthlyBaseRent>
    <erna:OperatingLeasesIncreaseInBaseRentPercentage
      contextRef="c20221001to20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="2"
      id="Fact_0c80cdd23fe44d8ea05adbee9094aee6"
      unitRef="U008">0.03</erna:OperatingLeasesIncreaseInBaseRentPercentage>
    <us-gaap:LineOfCredit
      contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_4b9051c968fb4274be1e4afd451481a3"
      unitRef="U001">4100000</us-gaap:LineOfCredit>
    <erna:TenantImprovementAllowancePerRentableSquareFoot
      contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="0"
      id="Fact_34057784d2964a108489817234296190"
      unitRef="U001">190</erna:TenantImprovementAllowancePerRentableSquareFoot>
    <erna:TenantImprovementAllowance
      contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_b506c2164a1b4034b747af829cbcc0c8"
      unitRef="U001">8600000</erna:TenantImprovementAllowance>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_a4ee19d7920c4db68d6b9ca6343d5942"
      unitRef="U001">2100000</us-gaap:LeaseholdImprovementsGross>
    <erna:ReceivedAmountOfTenantImprovementAllowance
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_9d06910a3c264d38b961b660088d5ec6"
      unitRef="U001">8600000</erna:ReceivedAmountOfTenantImprovementAllowance>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_a2ce54f790914a969e033da1140e0e0f"
      unitRef="U001">34400000</us-gaap:OperatingLeaseLiability>
    <erna:LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance
      contextRef="c20231231"
      decimals="-5"
      id="Fact_e3bf44242983492891371295cec29ed3"
      unitRef="U001">600000</erna:LeaseLiabilityIncrementalAmountAboveTenantImprovementAllowance>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_ERSquibbSonsLLCMember"
      decimals="-5"
      id="Fact_6a833bf6a3b0419ca03b7091158f5406"
      unitRef="U001">34700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <erna:OutOfPocketExpenses
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_66b9dc0388154035a8ba183b3c0f3f1c"
      unitRef="U001">400000</erna:OutOfPocketExpenses>
    <erna:UnpaidOutOfPocketCostsTenantImprovementAllowance
      contextRef="c20231231"
      decimals="-5"
      id="Fact_743c663f961d4331a7a404b1b8f8c29c"
      unitRef="U001">1000000</erna:UnpaidOutOfPocketCostsTenantImprovementAllowance>
    <erna:OperatingLeaseIncrementalBorrowingRate
      contextRef="c20230101to20231231_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_f062b1ea9eab491fa5a89a255415a6f0"
      unitRef="U008">0.127</erna:OperatingLeaseIncrementalBorrowingRate>
    <erna:OperatingLeaseIncrementalBorrowingRate
      contextRef="c20230101to20231231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_5403c9a4274146d8bae4845ac63c9c06"
      unitRef="U008">0.144</erna:OperatingLeaseIncrementalBorrowingRate>
    <erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_81360ae177fb4badb74a4baa50bdebca"
      unitRef="U001">-1600000</erna:AdjustmentToLeaseLiabilityAndRightOfUseAssetDueToRemeasurement>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_48e17f2ddd0d43088c17bf4695ba7c4a">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the years ended December 31, 2023 and 2022, the net operating lease expenses were as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-weight: bold;"&gt;2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,399&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;595&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Sublease income&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(84&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(84&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Variable lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;136&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;150&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Total lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,451&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;661&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_2ea39fb9e2b840bc85fa4fe3c75e4cef"
      unitRef="U001">3399000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_90565d57598f4142ad763587557526e0"
      unitRef="U001">595000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_4b20b18f8618431eabd825d76d97c6b9"
      unitRef="U001">84000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_097931b87e0f452986f25843edac987b"
      unitRef="U001">84000</us-gaap:SubleaseIncome>
    <us-gaap:VariableLeaseCost
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_42b0a21634324410bf2faa56316c7578"
      unitRef="U001">136000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_53287d19dfc6406596a25ae2c736c4cd"
      unitRef="U001">150000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_69e49c0f7f094201b70e705c740d800a"
      unitRef="U001">3451000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_9fa2016d796e4bbebbbc7c68bea0c8f9"
      unitRef="U001">661000</us-gaap:LeaseCost>
    <erna:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_a21c6faafd8b41f3b40b59e2c3ab2115">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2023 and
            the ending balances as of December 31 2023, including the changes during the period (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operating Lease&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;ROU Assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease ROU assets at January 1, 2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;1,030&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                  &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Recognition of ROU asset for Somerville Sublease&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;34,410&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                  &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Adjustment to ROU asset for remeasurement of Somvervile Sublease liability&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(1,620&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                  &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Amortization of operating lease ROU assets&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(1,039&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease ROU assets at December 31, 2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;32,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Operating Lease&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease liabilities at January 1, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;1,182&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                    &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Recognition of lease liability for Somerville Sublease&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;34,169&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                    &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Accretion of interest for Somerville Sublease&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;1,858&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                    &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Adjustment to lease liablity due to remeasurement of Somerville Sublease&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(1,620&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;
                    &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Principal payments on operating lease liabilities&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;(519&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Operating lease liabilities at December 31, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;35,070&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); text-indent: 10pt;"&gt;Less non-current portion&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;32,854&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Current portion at December 31, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;2,216&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;
</erna:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20221231"
      decimals="-3"
      id="Fact_3afc325497894aed8bc8afe3d4931dbb"
      unitRef="U001">1030000</us-gaap:OperatingLeaseRightOfUseAsset>
    <erna:InitialMeasurementOfOperatingLeaseROUAssets
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_cd128aded0684b1f8839a85bed73201c"
      unitRef="U001">34410000</erna:InitialMeasurementOfOperatingLeaseROUAssets>
    <erna:AdjustmentToRemeasurementOfOperatingLeaseROUAssets
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_28ab608491df4c09b78ef0758635647a"
      unitRef="U001">1620000</erna:AdjustmentToRemeasurementOfOperatingLeaseROUAssets>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_c033f8c345d845c99cb28e3c0667fac6"
      unitRef="U001">1039000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20231231"
      decimals="-3"
      id="Fact_a4ba3cc2dcde4eb9bd1ffd91a3d7d772"
      unitRef="U001">32781000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20221231"
      decimals="-3"
      id="Fact_5519358a61f84c94be2b1100b93320a6"
      unitRef="U001">1182000</us-gaap:OperatingLeaseLiability>
    <erna:InitialMeasurementOfOperatingLeaseLiabilities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_19b7698b26734649902ec06adbfbb6dd"
      unitRef="U001">34169000</erna:InitialMeasurementOfOperatingLeaseLiabilities>
    <erna:AccretionOfInterestSublease
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_7dfde89cef0c4a24b9f69faa463fa5e1"
      unitRef="U001">1858000</erna:AccretionOfInterestSublease>
    <erna:AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_a4c29748dab148929138f6097b1a3dd1"
      unitRef="U001">-1620000</erna:AdjustmentToLeaseLiabilityDueToRemeasurementOfSublease>
    <erna:PrincipalPaymentsOnOperatingLeaseLiabilities
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_e1d304fabfc74d1b8f3002841f88e99b"
      unitRef="U001">519000</erna:PrincipalPaymentsOnOperatingLeaseLiabilities>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20231231"
      decimals="-3"
      id="Fact_4305bd8f898f421a9694473b2bb10088"
      unitRef="U001">35070000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_f01ba5c6ded748b5ac6ab8fe0605d139"
      unitRef="U001">32854000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_30a6a9b690fe4439967d3243ab4cfd7d"
      unitRef="U001">2216000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20231231"
      id="Fact_c9fbc42a254c48faad3696acd1d7d4d7">P9Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20231231"
      decimals="4"
      id="Fact_410ab4a4d70b42a998f0a7d903f237c2"
      unitRef="U008">0.1424</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_e03d0948964e4f94bf38b0d419663594">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The maturities of the
          operating lease liabilities are as follows (in thousands):&lt;/span&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2024&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,972&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2025&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,075&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2026&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,238&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2027&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,308&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;2028&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6,406&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Thereafter&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;33,879&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total payments&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;65,878&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Less imputed interest&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(30,808&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total operating lease liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;35,070&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20231231"
      decimals="-3"
      id="Fact_091a3ac38dbd49ecb7ebd0c7e9ccbfc3"
      unitRef="U001">6972000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20231231"
      decimals="-3"
      id="Fact_94d3c32f02f4474cb10c0e0d03b41062"
      unitRef="U001">6075000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20231231"
      decimals="-3"
      id="Fact_c041c45a880f4cf1b9545566956f0ca9"
      unitRef="U001">6238000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c20231231"
      decimals="-3"
      id="Fact_ce30809a7a6c496c9d7ef205f3baede7"
      unitRef="U001">6308000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="c20231231"
      decimals="-3"
      id="Fact_1e351fc6781a4fb2a59a64f2db0651c4"
      unitRef="U001">6406000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="c20231231"
      decimals="-3"
      id="Fact_abcf3dc3658a4006b07c0dc895afee47"
      unitRef="U001">33879000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20231231"
      decimals="-3"
      id="Fact_8fc4052fe95943beb3da85605fb3beb9"
      unitRef="U001">65878000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20231231"
      decimals="-3"
      id="Fact_67d2cbae486d4c0fadbdc560a12d290c"
      unitRef="U001">30808000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20231231"
      decimals="-3"
      id="Fact_c8295a862628492689f7e71196d6bcee"
      unitRef="U001">35070000</us-gaap:OperatingLeaseLiability>
    <erna:AreaOfSubleaseSpaceCurrentlyRented
      contextRef="c20190418"
      decimals="0"
      id="Fact_b2859915796a4e2daa80d4ddb30c3671"
      unitRef="U005">999</erna:AreaOfSubleaseSpaceCurrentlyRented>
    <erna:PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments
      contextRef="c20190418to20190418"
      decimals="4"
      id="Fact_c2d09b3923ac4287a02506ef0f367d17"
      unitRef="U008">0.0225</erna:PercentageOfLesseeSubleaseIncreaseInAnnualLeaseRentPayments>
    <us-gaap:ProceedsFromLeasePayments
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_96cb6dfe73ac40ee9f3a100b6d15f672"
      unitRef="U001">100000</us-gaap:ProceedsFromLeasePayments>
    <us-gaap:ProceedsFromLeasePayments
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_17c8ea9959a2494aa63a80be2fe0ee58"
      unitRef="U001">100000</us-gaap:ProceedsFromLeasePayments>
    <erna:FutureLeasePaymentsSubleaseAgreementTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_f0a9922499d64eb99d8824582071229d">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.1pt; margin-left: 0.1pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following tables shows the future payments the Company expects to receive from the Subtenant over
              the remaining term of the sublease (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of&lt;/div&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31,&lt;/div&gt;
                    &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; 2023&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;86&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;88&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;75&lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total payments &lt;br/&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;249&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</erna:FutureLeasePaymentsSubleaseAgreementTableTextBlock>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths
      contextRef="c20231231"
      decimals="-3"
      id="Fact_7076697e90f44117b5453b6d44bfb52d"
      unitRef="U001">86000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsNextTwelveMonths>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears
      contextRef="c20231231"
      decimals="-3"
      id="Fact_4332e02d17b44cf9b1201aa122fffd9d"
      unitRef="U001">88000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinTwoYears>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears
      contextRef="c20231231"
      decimals="-3"
      id="Fact_ce1e3a837a204622af5386a606fc5ac6"
      unitRef="U001">75000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentalsWithinThreeYears>
    <erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentals
      contextRef="c20231231"
      decimals="-3"
      id="Fact_3ce3a30fa6004bac9ff68ae4aa5ab5a9"
      unitRef="U001">249000</erna:SaleLeasebackTransactionsFutureMinimumSubleaseRentals>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="c20230101to20231231"
      id="Text_37da32b66e184899b6d646f65abc294e">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;9)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The following tables summarize the liabilities that are measured at fair value as of December 31, 2023 and, 2022 (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-weight: bold;"&gt;Description&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-weight: bold;"&gt;Level&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-weight: bold;"&gt;2023&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-weight: bold;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-style: italic;"&gt;Liabilities:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;"&gt;Warrant liabilities - Common Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;116&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;"&gt;Market Cap Contingent Consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;107&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The Company uses a Black-Scholes option pricing model to estimate the fair value of its warrant liabilities and a Monte Carlo simulation model to
        estimate the fair value of the Market Cap Contingent Consideration, both of which are considered a Level 3 fair value measurement. The Company remeasures the fair value of the warrant liabilities and the Market Cap Contingent Consideration at each
        reporting period and changes in the fair values are recognized in the statement of operations.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;Certain inputs used in Black-Scholes and Monte Carlo models may fluctuate in future periods based upon factors that are outside of the Company&#x2019;s
        control.&#160; A significant change in one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the Company&#x2019;s warrant liabilities or contingent consideration liabilities, which could also
        result in material non-cash gains or losses being reported in the Company&#x2019;s consolidated statement of operations&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;.&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal;"&gt; &lt;/span&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The following table presents the changes in the liabilities
                measured at fair value from January 1, 2023, or from the initial measurement date if later than January 1, 2023, through December 31, 2023 (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Warrant&lt;br/&gt;
                    Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Contingent&lt;br/&gt;
                    Consideration&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;Fair value at January 1, &lt;span style="text-indent: 0pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;331&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;Initial measurement&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;225&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;Change in fair value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;(215&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;(118&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;Fair value at December 31, &lt;span style="text-indent: 0pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;116&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;107&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;
           &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
              &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; margin-left: 0.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Black-Scholes valuation assumptions used at December 31, 2023 for the warrant liabilities were 3.69 years expected term,
            3.93% risk-free rate, 103%
            volatility and 0% dividend yield.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;With the assistance of a third-party specialist, the Company assesses the fair value of the Market Cap Contingent Consideration at each quarterly reporting period using the Monte Carlo model, and as of June 30, 2023, determined that the
            fair value of the contingent consideration had been reduced by approximately $0.1 million from the initial measurement.&#160; The Company
            assessed the fair value of the Market Cap Contingent Consideration as of September 30, 2023 and as of December 31, 2023, and determined that there was no material change to the Market Cap Contingent Consideration for either period, and
            therefore, did not recognize a change in the fair value of the Market Cap Contingent Consideration since the June 30, 2023
            remeasurement. The Company assessed the fair value as of December 31, 2023, and the inputs used for that assessment was risk-free rate of 4.07%,
            expected term of 2.3 years, stock price of $1.80, volatility of 108% and dividend yield of 0%.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: -9pt; margin-left: 9pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The table below is provided for comparative purposes only and presents information about the fair value of the convertible notes relative to the carrying values recognized in the consolidated balance sheet as of December 31, 2023 (in
            thousands).&#160; The Company did not have any of the convertible notes or similar instruments outstanding as of December 31, 2022.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;December 31,&lt;br/&gt;
                    &lt;/span&gt; &lt;span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2023&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Level&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Carrying&lt;br/&gt;
                    Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Fair&lt;br/&gt;
                    Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Convertible Notes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;16,616&lt;br/&gt;
                    &lt;/span&gt; &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;17,594&lt;br/&gt;
                    &lt;/span&gt; &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
          &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The carrying value in the table above is shown before the allocation of the proceeds to the note warrants. The Company assesses the fair value of the convertible notes using the binomial model, which is considered a Level 3 measurement.&#160;
            The weighted average inputs used in the binomial model as of December 31, 2023 was stock price of $1.80, credit spread of 1,891, volatility of 109% and
            risk-free rate of 3.87%.&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;/span&gt;&lt;/div&gt;
</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_d9601f8f73d845b7aec21c6a48296618">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The following tables summarize the liabilities that are measured at fair value as of December 31, 2023 and, 2022 (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-weight: bold;"&gt;Description&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-weight: bold;"&gt;Level&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-weight: bold;"&gt;2023&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-weight: bold;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-style: italic;"&gt;Liabilities:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;"&gt;Warrant liabilities - Common Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;116&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;331&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000;"&gt;Market Cap Contingent Consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;107&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;
</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_340d3df0ceb348f78ad33003eebc0910"
      unitRef="U001">116000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_db2753c07889447b9ee13ed5c9ee5139"
      unitRef="U001">331000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20231231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_9881695433654ff689ad6cb92ad31a52"
      unitRef="U001">107000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20221231_ContingentConsiderationByTypeAxis_MarketCapContingentConsiderationMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_d6c5dfa6571d44a3b83ef93ea086fcfc"
      unitRef="U001">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_e5ea32809c4e478c8d0836bfcf6cad75">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The following table presents the changes in the liabilities
                measured at fair value from January 1, 2023, or from the initial measurement date if later than January 1, 2023, through December 31, 2023 (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Warrant&lt;br/&gt;
                    Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Contingent&lt;br/&gt;
                    Consideration&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;Fair value at January 1, &lt;span style="text-indent: 0pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;331&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;Initial measurement&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;225&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;Change in fair value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;(215&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;(118&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;Fair value at December 31, &lt;span style="text-indent: 0pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;116&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"&gt;107&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20221231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_567ed5610f1f44879c2a6348d465f07e"
      unitRef="U001">331000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20221231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember"
      decimals="-3"
      id="Fact_265adc9f39ad44549276a2ba8ea937ac"
      unitRef="U001">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20230101to20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_d50c3782f51d458fb443ed7e309de9e9"
      unitRef="U001">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember"
      decimals="-3"
      id="Fact_16c1fdc484ba47c2b43e9faf5567cb7b"
      unitRef="U001">225000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20230101to20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_0de70c075ca3422d88794fa1a55e81a8"
      unitRef="U001">-215000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20230101to20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember"
      decimals="-3"
      id="Fact_ba6ba6fce89540bb9445b9e07285f965"
      unitRef="U001">-118000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_2f5c966553fe41599687539d5164fd35"
      unitRef="U001">116000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember"
      decimals="-3"
      id="Fact_f02814ca6e414d24b56e024e1d0491e1"
      unitRef="U001">107000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"
      id="Fact_42346b6bb46e4ab091ed09381bb42866">P3Y8M8D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="Fact_d36726eadc6442268975df12f0539951"
      unitRef="U008">0.0393</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_9b3026904add4974a868a96728b5a66d"
      unitRef="U008">1.03</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231231_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"
      decimals="2"
      id="Fact_81f340f26ef841fd81c3c706086a0c2e"
      unitRef="U008">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="c20230101to20230630"
      decimals="-5"
      id="Fact_c46300d9582b4e49b7501a9d1f17fc1d"
      unitRef="U001">100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <erna:ChangeInFairValueOfContingentConsideration
      contextRef="c20230101to20230630"
      decimals="-3"
      id="Fact_933ff0754f354281825c26e94f233b2e"
      unitRef="U001">0</erna:ChangeInFairValueOfContingentConsideration>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="Fact_7318a33a34f9479f98016e4bf3555b11"
      unitRef="U008">0.0407</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputExpectedTermMember"
      id="Fact_3e9d603c137740f9b10902ee219de4a8">P2Y3M18D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"
      decimals="2"
      id="Fact_1a81c1a5e202492db021540519ac99cd"
      unitRef="U003">1.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_85ab7857a2154b028345ec4154768f5b"
      unitRef="U008">1.08</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c20231231_ContingentConsiderationByTypeAxis_ContingentConsiderationMember_MeasurementInputTypeAxis_MeasurementInputExpectedDividendRateMember"
      decimals="2"
      id="Fact_2fd028a789264e39bc92d2db9b4ff3ff"
      unitRef="U008">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="c20230101to20231231"
      id="Text_7e8859617ff84f3a9f4b9215f2765a12">
&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The table below is provided for comparative purposes only and presents information about the fair value of the convertible notes relative to the carrying values recognized in the consolidated balance sheet as of December 31, 2023 (in
            thousands).&#160; The Company did not have any of the convertible notes or similar instruments outstanding as of December 31, 2022.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;December 31,&lt;br/&gt;
                    &lt;/span&gt; &lt;span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2023&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Level&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Carrying&lt;br/&gt;
                    Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Fair&lt;br/&gt;
                    Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Convertible Notes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;16,616&lt;br/&gt;
                    &lt;/span&gt; &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;17,594&lt;br/&gt;
                    &lt;/span&gt; &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementBasisAxis_CarryingReportedAmountFairValueDisclosureMember"
      decimals="-3"
      id="Fact_b625c3b26ce14b949259c31f0722495f"
      unitRef="U001">16616000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementBasisAxis_EstimateOfFairValueFairValueDisclosureMember"
      decimals="-3"
      id="Fact_2513025cedff4068b1bbb100c767083c"
      unitRef="U001">17594000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <erna:ConvertibleDebtMeasurementInput
      contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputSharePriceMember"
      decimals="2"
      id="Fact_fb5beb0670ed495cb87f701b13034b69"
      unitRef="U003">1.8</erna:ConvertibleDebtMeasurementInput>
    <erna:ConvertibleDebtMeasurementInput
      contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputCreditSpreadMember"
      decimals="-3"
      id="Fact_b5a006cd45754ff8bf4565a080c8c302"
      unitRef="U001">1891000</erna:ConvertibleDebtMeasurementInput>
    <erna:ConvertibleDebtMeasurementInput
      contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputPriceVolatilityMember"
      decimals="2"
      id="Fact_b495c71fe3f34b988e88bdba12509dd0"
      unitRef="U008">1.09</erna:ConvertibleDebtMeasurementInput>
    <erna:ConvertibleDebtMeasurementInput
      contextRef="c20231231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_MeasurementInputTypeAxis_MeasurementInputRiskFreeInterestRateMember"
      decimals="4"
      id="Fact_99ced119dea24769a455bbfea640f367"
      unitRef="U008">0.0387</erna:ConvertibleDebtMeasurementInput>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_c714f7bc59f8401fb9f2dd1beb6e3514">
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;10)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Goodwill and In-Process Research &amp;amp; Development&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;Goodwill&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In
          November 2018, the Company acquired IRX, which was accounted for as a business combination.&#160; The Company recorded goodwill in the amount of $2.0
          million related to the acquisition. The Company performed its annual qualitative assessment as of December 31, 2023 and 2022, and based on the assessments, the Company determined that it was more likely than not that the fair value of the entity
          exceeded its carrying value for such years and that the performance of the quantitative impairment test was not required.&#160; Therefore, no
          impairment was required for any of the periods presented.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt; In-Process Research &amp;amp; Development&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
          In 2018, Company recorded IPR&amp;amp;D in the amount of $6.0 million, which represented the fair value assigned to technologies that were
          acquired in connection with the acquisition of IRX in November 2018 and which had not reached technological feasibility and had no alternative future use.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In
          June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral cavity. The IRX-2 multi-cytokine
          biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE trial did not meet its primary
          endpoint of event-free survival. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate the treatment effect of IRX-2 in patient subgroups and in
          combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial was the only Company-sponsored study of IRX-2.&#160; Based on the totality of available information, the Company decided not to further develop IRX-2. As such, the Company determined
          that the carrying value of the IPR&amp;amp;D asset was impaired and recognized a non-cash impairment charge of approximately $6.0 million
          on the consolidated statement of operations during 2022, which reduced the value of the asset to zero.&lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="c20221231"
      decimals="-5"
      id="Fact_9906e5d705774bd99357f81e7cdc495e"
      unitRef="U001">2000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20231231"
      decimals="-5"
      id="Fact_02aa9688bbf944cd810475c6d583fc97"
      unitRef="U001">2000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_e8c3f112af344732a14fda9d03c5d211"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_0bfeb5d4b3ab4642b8bf0beaf152a4aa"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20181231"
      decimals="-5"
      id="Fact_3ef2e8d362c349829ef982517cc1754e"
      unitRef="U001">6000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_2ecfcfe426d34ba6ae5f98692d7592e0"
      unitRef="U001">6000000</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20221231"
      decimals="-6"
      id="Fact_2187cdbd4b6b4bb5a98d8192392427d8"
      unitRef="U001">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_bc2710f125df424085bda4a398060ae7">
&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="align: right; vertical-align: top; width: 9pt;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: -36pt; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;11)&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-weight: bold; color: rgb(0, 0, 0);"&gt;Related Party Transactions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Agreements with
          Factor Bioscience Inc. and Affiliates&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As
          of December 31, 2023, the Company had the agreements described below with Factor Bioscience Inc. and/or Dr. Matthew Angel. These agreements have been deemed related party transactions because the Company&#x2019;s former chief executive officer, Dr.
          Angel, is the chairman and chief executive officer of Factor Bioscience Inc. and a director of its subsidiary, Factor Bioscience Limited (&#x201c;Factor Limited&#x201d; and together with Factor Bioscience Inc. and its other affiliates, &#x201c;Factor Bioscience&#x201d;).
          Dr. Angel resigned as the Company&#x2019;s chief executive officer effective December 31, 2023.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In
          September 2022, the Company entered into a Master Services Agreement (the &#x201c;MSA&#x201d;) with Factor Bioscience, pursuant to which Factor Bioscience agreed to provide services to the Company as agreed between the Company and Factor Bioscience and as set
          forth in one or more work orders under the MSA, including the first work order included in the MSA (&#x201c;WO1&#x201d;). The MSA contains customary confidentiality provisions and representations and warranties of the parties, and the MSA may be terminated by
          either party upon 30 days&#x2019; prior notice, subject to any superseding termination provisions contained in a particular work order. &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Under
























          WO1, Factor Bioscience agreed to provide the Company with mRNA cell engineering research support services, including access to certain facilities, equipment, materials and training, and the Company agreed to pay Factor Bioscience an initial fee
          of $5.0 million, payable in 12
          equal monthly installments of approximately $0.4 million. Of the $5.0 million, the Company allocated $3.5 million to the License Fee Obligation
          (as defined below). Following the initial 12-month period, the Company agreed to continue paying Factor Bioscience the monthly fee of $0.4
          million until such time as WO1 is terminated. Upon entering into the MSA, the Company paid a deposit of $0.4 million, which will be
          applied to the last month of WO1. The Company may terminate WO1 on or after the second anniversary of the date of the MSA, subject to providing Factor Bioscience with 120 days&#x2019; prior notice.&#160; Factor Bioscience may terminate WO1 only on and after the fourth anniversary of the date of the MSA, subject to providing the Company with 120 days&#x2019; prior notice.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;In connection with entering into the MSA, Factor Limited entered into a waiver agreement with Eterna LLC, pursuant to which
          Factor Limited agreed to waive payment of $3.5 million otherwise payable to it (the &#x201c;License Fee Obligation&#x201d;) in October 2022 by Eterna
          LLC under the exclusive license agreement entered into in April 2021 by and among Eterna LLC, Novellus Limited and Factor Limited (the &#x201c;Original Factor License Agreement&#x201d;).&#160; Under the terms of the waiver agreement, the License Fee Obligation is
          waived conditionally on the Company paying Factor Bioscience a minimum of $3.5 million due under the MSA.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Because the License Fee Obligation was conditionally waived until the Company paid Factor Bioscience a minimum of $3.5 million under the MSA, the Company recorded a liability of $3.5 million.&#160; As of December 31, 2023, there was approximately $1.2 million
          of the unamortized License Fee Obligation remaining, which is recorded on the accompanying consolidated balance sheet in the &#x201c;due to related party, current&#x201d; line item.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;In September 2022, Novellus Inc. (&#x201c;Novellus&#x201d;) and the Company entered into a Second
        Amendment to the Limited Waiver and Assignment Agreement (the &#x201c;Waiver and Assignment Agreement&#x201d;) with Drs. Matthew Angel and Christopher Rohde (the &#x201c;Founders&#x201d;) whereby the Company agreed to be responsible for all future, reasonable and
        substantiated legal fees, costs, settlements and judgments incurred by the Founders, the Company or Novellus. for certain claims and actions and any pending or future litigation brought against the Founders, Novellus and/or the Company by or on
        behalf of the Westman and Sowyrda legal matters described in Note 13 (the &#x201c;Covered Claims&#x201d;).&#160; The Founders will continue to be solely responsible for any payments made to satisfy a judgement or settlement of any pending or future wage act claims.&#160;
        Under the Waiver and Assignment Agreement, the Founders agreed that they are not entitled to, and waived any right to, indemnification or advancement of past, present or future legal fees, costs, judgments, settlement or other liabilities they may
        have been entitled to receive from the Company or Novellus in respect of the Covered Claims. The Company and the Founders will share in any recoveries up to the point at which the parties have been fully compensated for legal fees, costs and
        expenses incurred, with the Company retaining any excess recoveries. The Company has the sole authority to direct and control the prosecution, defense and settlement of the Covered Claims.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; In November 2022, following the expiration of one of the milestone deadlines for
        certain regulatory filings required under the Third Amended and Restated Exclusive License Agreement between Novellus Limited and Factor Limited entered into in November 2020 (the &#x201c;Novellus-Factor License Agreement&#x201d;), which permitted Factor Limited
        to terminate the license granted to Novellus Limited thereunder, the Company entered into the first amendment to the Original Factor License Agreement (as amended, the &#x201c;2021 Factor License Agreement&#x201d;), pursuant to which, among other things, Factor
        Limited granted to Eterna LLC an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#x201c;Factor Patents&#x201d;) for the purpose of identifying and pursuing certain opportunities to grant to third parties sublicenses to the
        Factor Patents. The Original Factor License Agreement also (i) terminated the Novellus-Factor License Agreement, (ii) confirmed Factor Limited&#x2019;s grant to Eterna LLC of the rights and licenses Novellus Limited previously granted to Eterna LLC under
        the Novellus-Factor License Agreement on the same terms and conditions as granted by Novellus Limited to Eterna LLC under such agreement, (iii) confirmed that the sublicense granted by Novellus Limited in accordance with the Novellus-Factor License
        Agreement to NoveCite, Inc., a company which the Company has a 25% non-controlling interest (&#x201c;NoveCite&#x201d;), survived termination of the
        Novellus-Factor License Agreement; and (iv) removed Novellus Limited from the Original Factor License Agreement and the license agreement entered into on October 6, 2020 between Novellus Limited and NoveCite, Inc, as amended, and replaced Novellus
        Limited with Factor Limited as the direct licensor to Eterna LLC and NoveCite under such agreements, respectively.&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; On February 20, 2023, the Company, entered into an exclusive license agreement (the
        &#x201c;Feb 2023 Factor Exclusive License Agreement&#x201d;) with Factor Limited, pursuant to which Factor Limited granted to the Company an exclusive, sublicensable, worldwide license under certain patents owned by Factor Limited for the purpose of, among other
        things, identifying and pursuing certain opportunities to develop products in respect of such patents and to otherwise grant to third parties sublicenses to such patents. The Feb 2023 Factor Exclusive License Agreement, which terminated and
        superseded the Amended Factor License Agreement, was subsequently terminated and superseded by the A&amp;amp;R Factor License Agreement (as defined below).&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On November 14, 2023, the Company entered into an amended and restated exclusive
        license agreement (the &#x201c;A&amp;amp;R Factor License Agreement&#x201d;) with Factor Limited to replace in its entirety the exclusive license agreement between the parties dated February 20, 2023 and the amendment thereto.&#160; Under the terms of the A&amp;amp;R Factor
        License Agreement, Factor Limited granted to the Company an exclusive, sublicensable license under certain patents owned by Factor Limited (the &#x201c;Factor Patents&#x201d;).&#160; The A&amp;amp;R Factor License Agreement also provides for, among other things, the
        expansion of the Company&#x2019;s license rights to include (i) the field of use of the Factor Patents to include veterinary uses (ii) know-how that is necessary or reasonably useful to practice to the licensed patents, (iii) the ability to sublicense
        through multiple tiers (as opposed to only permitting a direct sublicense) and (iv) the transfer of technology to the Company, subject to the use restrictions in the A&amp;amp;R Factor License Agreement.&#160; The term of the A&amp;amp;R Factor License
        Agreement expires on November 22, 2027, but will be automatically extended for an additional five years (such period, the &#x201c;Renewal
        Term&#x201d;) if the Company pays at least $6.0 million to Factor Limited from fees from sublicenses to the Factor Patents (&#x201c;Sublicense Fees&#x201d;),
        other cash on hand or a combination of both sources of funds.&#160; The Company will pay to Factor Limited 20% of any Sublicense Fee received
        by the Company during the term of the A&amp;amp;R Factor License Agreement.&#160; Beginning in September 2024, the Company will also begin paying Factor Limited a monthly maintenance fee of approximately $0.4 million until the expiration of the A&amp;amp;R Factor License Agreement, including any Renewal Term. The Company may terminate the A&amp;amp;R Factor License Agreement upon 120 days&#x2019; written notice to Factor Limited, and both parties have additional customary termination rights.&#160; Under the A&amp;amp;R Factor License Agreement,
        the Company is obligated to pay the expenses incurred by Factor Limited in preparing, filing, prosecuting and maintaining the Factor Patents and the Company agreed to bear all costs and expenses associated with enforcing and defending the Factor
        Patents in any action or proceeding arising from pursuit of sublicensing opportunities under the license granted under the A&amp;amp;R Factor License Agreement.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;Exacis Asset Acquisition&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On April 26, 2023, the Company entered into the Exacis Purchase Agreement to acquire
        the Exacis Assets, including all of Exacis&#x2019; right, title and interest in the Purchased License. The Company assumed none of Exacis&#x2019; liabilities, other than liabilities under the Purchased License that accrue subsequent to the closing date. See Note
        4.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The Exacis Acquisition was deemed a related party transaction because Dr. Gregory
        Fiore, who was the chief executive officer of Exacis at the time of the Exacis Acquisition, was also a member of the Company&#x2019;s board of directors at the time of the Exacis Acquisition.&#160; Additionally, Dr. Angel, who was the Company&#x2019;s chief executive
        officer at the time of the Exacis Acquisition, was chairman of Exacis&#x2019; scientific advisory board, and an affiliate of Factor Bioscience was the majority stockholder of Exacis at the time of the Exacis Acquisition.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; In October 2022, the Company entered into an Option Agreement on October 8, 2022 with
        Exacis (the &#x201c;Exacis Option Agreement&#x201d;), pursuant to which Exacis granted the Company the option to negotiate and enter into an exclusive worldwide license to certain of the technology licensed by Exacis for the treatment of cancer in humans. The
        Exacis Option Agreement provided for the Company paying Exacis a fee of $250,000 for the option, which would be creditable against the
        fees or purchase price payable under any such license if entered into by the Company in accordance with Exacis Option Agreement. The Company did not exercise the option, and the Exacis Option Agreement terminated on December 31, 2022. &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;Consulting Agreement with Former Director&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;In May 2023, the Company entered into a consulting agreement with Dr. Fiore, whereby
        Dr. Fiore agreed to provide business development consulting services to the Company for a monthly retainer of $20,000.&#160; The consulting
        agreement was terminable for any reason by either party upon 15 days&#x2019; written notice. The Company terminated the consulting agreement,
        effective July 31, 2023. Dr. Fiore served on the Company&#x2019;s board of directors from June 2022 to October 4, 2023.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;July 2023 and December 2023 Financings&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;Investors in the July 2023 convertible note financing included Brant Binder, Richard
        Wagner, Charles Cherington and Nicholas Singer, and investors in the December 2023 convertible note financing included Messrs. Cherington and Singer. Each of them participated in the applicable financing under the same terms and subject to the same
        conditions as all the other investors. See Note 6 for additional information regarding the financings. Mr. Binder served on the Company&#x2019;s board of directors from July 6, 2023 to August 8, 2023, Mr. Wagner served on the Company&#x2019;s board of directors
        from July 6, 2023 to August 8, 2023, Mr. Cherington served on the Company&#x2019;s board of directors from March 2021 to July 6, 2023, and Mr. Singer served on the Company&#x2019;s board of directors from June 2022 to July 6, 2023.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Q4-22 PIPE &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In November 2022, the Company entered into a securities purchase agreement with certain investors providing for the
              issuance of approximately of 2,185,000 units, each unit consisting of (i) one share of the Company&#x2019;s common stock and (ii) two warrants to
              purchase shares of the Company&#x2019;s common stock, at a purchase price of $3.53 per unit. The financing closed in December 2022.
              Messrs. Cherington and Singer invested in the financing on the same terms and subject to the same conditions as all other investors in the financing. Mr. Cherington served on the Company&#x2019;s board of directors from March 2021 to July 6, 2023,
              and Mr. Singer served on the Company&#x2019;s board of directors from June 2022 to July 6, 2023.&lt;/div&gt;
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <erna:NoticePeriodForSupersedingTerminationProvisions
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      id="Fact_302ca321de1344fdacca8ce8dd8969e0">P30D</erna:NoticePeriodForSupersedingTerminationProvisions>
    <erna:MasterServiceAgreementInitialFeesPayable
      contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_4a0ca25d42f44a5291a474d9ba87b204"
      unitRef="U001">5000000</erna:MasterServiceAgreementInitialFeesPayable>
    <erna:NumberOfMonthlyInstallmentsForFeesPayable
      contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="0"
      id="Fact_0143ccae4b7e4997b6b3ee521ae405b8"
      unitRef="U009">12</erna:NumberOfMonthlyInstallmentsForFeesPayable>
    <erna:RelatedPartyTransactionPeriodicFeesPaymentAmount
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_375bfb649d2644c28669ad3da8603e20"
      unitRef="U001">400000</erna:RelatedPartyTransactionPeriodicFeesPaymentAmount>
    <erna:MonthlyMasterServicesAgreementFeesPayable
      contextRef="c20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_7e71cfa286314f49bdff993d26e1e705"
      unitRef="U001">5000000</erna:MonthlyMasterServicesAgreementFeesPayable>
    <erna:InitialLicenseFeeObligation
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_c72d5883ff724da4b3b34c25eb3a6f11"
      unitRef="U001">3500000</erna:InitialLicenseFeeObligation>
    <erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder
      contextRef="c20220909_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_2229d196d83443d5a66c1b4627c5c587"
      unitRef="U001">400000</erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder>
    <erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder
      contextRef="c20220909_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_8c2daab075a64f0a9658b341b35f5777"
      unitRef="U001">400000</erna:DepositPaidToBeAppliedToLastMonthOfFirstWorkOrder>
    <erna:NoticePeriodForFirstTerminationOfContract
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      id="Fact_b07a0d59aeeb47a881f6df14da9777c9">P120D</erna:NoticePeriodForFirstTerminationOfContract>
    <erna:NoticePeriodForFirstTerminationOfContract
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      id="Fact_6597705e6d2947ee968b6f79b56f70e0">P120D</erna:NoticePeriodForFirstTerminationOfContract>
    <erna:AgreedWaivePayment
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_9456628f320e4468ba4ecc0eab25969e"
      unitRef="U001">3500000</erna:AgreedWaivePayment>
    <erna:AgreedWaivePayment
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_876bb15aceb3404d97348a00e47fe7a0"
      unitRef="U001">3500000</erna:AgreedWaivePayment>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_e2fc3a8164254d9ea5f139fb7d29ba2a"
      unitRef="U001">3500000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <erna:AgreedWaivePayment
      contextRef="c20220901to20220930_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_da9d53f77e9145debde26fbefe8bd707"
      unitRef="U001">3500000</erna:AgreedWaivePayment>
    <erna:RemainingUnamortizedLicenseFeeObligation
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_FactorBioscienceIncMember"
      decimals="-5"
      id="Fact_fdbba5e015e741049d733cb567d12198"
      unitRef="U001">1200000</erna:RemainingUnamortizedLicenseFeeObligation>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c20221130_OwnershipAxis_NoveCiteINCMember"
      decimals="2"
      id="Fact_c2ab9e783824441985ab51365b1e784a"
      unitRef="U008">0.25</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <erna:LicenseAgreementAutomaticRenewalTerm
      contextRef="c20230101to20231231"
      id="Fact_6afacd717e5c4482830a4a634a07f468">P5Y</erna:LicenseAgreementAutomaticRenewalTerm>
    <erna:SublicenseFees
      contextRef="c20230219to20230220_RangeAxis_MinimumMember"
      decimals="-5"
      id="Fact_fb083f3e9ac2437f8b81a76f03f1d715"
      unitRef="U001">6000000</erna:SublicenseFees>
    <erna:PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate
      contextRef="c20230220"
      decimals="2"
      id="Fact_b9d4afa546934883a05b8e19a397c39f"
      unitRef="U008">0.20</erna:PercentageOfSublicenseFeesPaidBeforeLicenseExpirationDate>
    <erna:RelatedPartyTransactionPeriodicFeesPaymentAmount
      contextRef="c20230219to20230220"
      decimals="-5"
      id="Fact_5d7c565c379c44e0b2914469f295dd1f"
      unitRef="U001">400000</erna:RelatedPartyTransactionPeriodicFeesPaymentAmount>
    <erna:NoticePeriodForFirstTerminationOfContract
      contextRef="c20230101to20231231"
      id="Fact_65c5158fc7574942bc5f6b32bae5d23a">P120D</erna:NoticePeriodForFirstTerminationOfContract>
    <erna:PaymentOfOptionFee
      contextRef="c20221001to20221031"
      decimals="0"
      id="Fact_34efe6958ee44727b7225623dc1fe6c1"
      unitRef="U001">250000</erna:PaymentOfOptionFee>
    <erna:RelatedPartyTransactionPeriodicFeesPaymentAmount
      contextRef="c20230501to20230531_TitleOfIndividualAxis_DirectorMember"
      decimals="0"
      id="Fact_e85a07e64fcf4bdcacc66c6a24b9553a"
      unitRef="U001">20000</erna:RelatedPartyTransactionPeriodicFeesPaymentAmount>
    <erna:NoticePeriodForFirstTerminationOfContract
      contextRef="c20230101to20231231_TitleOfIndividualAxis_DirectorMember"
      id="Fact_58a9083286524832b1cbadd05329bed9">P15D</erna:NoticePeriodForFirstTerminationOfContract>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_bc107ae8adba4570bfad2dfece0a48fc"
      unitRef="U002">2185000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_9c73259e3f17435aad9ac4ff84dc2c49"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_2eeceb43158a49ee87669fa5c04bd2ee"
      unitRef="U002">2</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <erna:UnitPriceOfWarrants
      contextRef="c20221123to20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_e567edc67eb04c0fb03cc5e7bb939cbe"
      unitRef="U003">3.53</erna:UnitPriceOfWarrants>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_09ff2d1d1d51425899784ee7a9d40e93">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;12)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Accrued Expenses&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Legal fees and related&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;643&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,139&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Professional fees&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;239&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;124&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;Somerville facility &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;218&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;138&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;Convertible Notes interest &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;176&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Accrued compensation&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;109&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,065&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Clinical&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;18&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;570&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;Other&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;490&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;590&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Total accrued expenses&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,893&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,626&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_7d93a6d21dd346b99df188153b132581">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Legal fees and related&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;643&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,139&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Professional fees&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;239&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;124&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;Somerville facility &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;218&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;138&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;Convertible Notes interest &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;176&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Accrued compensation&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;109&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,065&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Clinical&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;18&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;570&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;Other&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;490&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;590&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Total accrued expenses&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,893&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,626&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <erna:AccruedLegalFeesAndRelatedCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_edeee9c515964324b4d26b6a649f1a81"
      unitRef="U001">643000</erna:AccruedLegalFeesAndRelatedCurrent>
    <erna:AccruedLegalFeesAndRelatedCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_d5aee57682e14bedbd135d744dfb19fc"
      unitRef="U001">1139000</erna:AccruedLegalFeesAndRelatedCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_e0e71466743a4f308a7988e180216bca"
      unitRef="U001">239000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_f82894ff5e9c4bdbb8d8cb67b178eed1"
      unitRef="U001">124000</us-gaap:AccruedProfessionalFeesCurrent>
    <erna:AccruedSomervilleFacilityCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_915d3a1eaf5942ae988182349b02ae5d"
      unitRef="U001">218000</erna:AccruedSomervilleFacilityCurrent>
    <erna:AccruedSomervilleFacilityCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_7531c63a0ac34aecb9c780844b1a4c59"
      unitRef="U001">138000</erna:AccruedSomervilleFacilityCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_94017557e9bc45edae44c0d64b1d4414"
      unitRef="U001">176000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_a570c8ad2deb413d8889bafdfcc28c56"
      unitRef="U001">0</us-gaap:InterestPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_7c43cfe91990434480f609db45101412"
      unitRef="U001">109000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c9d0334ce54244ebbd574c56f0b025a1"
      unitRef="U001">1065000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <erna:AccruedClinicalCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_315e20ffbbf14a748061b95b9ad9d697"
      unitRef="U001">18000</erna:AccruedClinicalCurrent>
    <erna:AccruedClinicalCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_629416be2e9b46fb931367cd766c49e1"
      unitRef="U001">570000</erna:AccruedClinicalCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_cadb8b788ad44a15b718453064e258c2"
      unitRef="U001">490000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_805c5adaaf0a49debbce19e701227f6b"
      unitRef="U001">590000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20231231"
      decimals="-3"
      id="Fact_e5181e18f7154869ae8d5a0d35281929"
      unitRef="U001">1893000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c58a114de53349c09a52d30c4aac76ff"
      unitRef="U001">3626000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_2fde8b23a8364cbd9fe75501088788fb">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;13)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Commitments and Contingencies&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The










          Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a
          liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the amount can be reasonably estimated.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;Novellus, Inc. v.
            Sowyrda et al., C.A. No. 2184CV02436-BLS2&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On October 25, 2021 Novellus, Inc. filed a
            complaint in the Superior Court of Massachusetts, Suffolk County, against former Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#x2019;s former parent company prior to the
            Company&#x2019;s acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract and civil conspiracy. The Company acquired Novellus, Inc. on July 16, 2021.&#160; On May 27, 2022, Novellus, Inc. amended the complaint to withdraw all
            claims against all defendants except Messrs. Sowyrda and Westman.&#160; On July 1, 2022, Mr. Westman filed a motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain litigation in the Court of
            Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr. Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned Zelickson et al., v. Angel et al., C.A. 2021-1014-JRS and by Mr. Westman
            against Novellus LLC captioned Westman v. Novellus LLC, C.A. No. 2021-0882-NAC (together, the &#x201c;Delaware Actions&#x201d;).&#160; On July 1, 2022, Mr. Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants
            Dr. Angel and Dr. Rohde alleging violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit.&#160; Mr. Sowyrda also joined in Mr. Westman&#x2019;s
            motion to stay the case pending the Delaware Actions.&#160; Novellus, Inc.&#x2019;s claims and Mr. Sowyrda&#x2019;s counterclaims relate to alleged conduct that took place before the Company acquired Novellus, Inc.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On November 15, 2022, prior to a decision
            on Messrs. Westman&#x2019;s and Sowyrda&#x2019;s motion to compel or stay, the parties agreed to voluntarily dismiss and consolidate the Delaware Actions with this action.&#160; On December 15, 2022, Mr. Sowyrda filed an Amended Answer to the Amended Complaint,
            asserted affirmative defenses and filed Amended Counterclaims against Dr. Angel, Dr. Rohde, Novellus LLC, Novellus Inc., Factor Bioscience Inc., and the Company (collectively, the &#x201c;Counterclaim Defendants&#x201d;) alleging against various Counterclaim
            Defendants breach of contract, breaches of the implied duty of good faith and fair dealing, breaches of fiduciary duty, breaches of the operating agreement, aiding and abetting breaches of fiduciary duty, tortious interference with contract,
            equitable accounting, violations of the Massachusetts Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, unjust enrichment, and quantum meruit.&#160; Also on December 15, 2022, Mr. Westman filed an answer to the Amended
            Complaint and asserted similar counterclaims against the same Counterclaim Defendants.&#160; Messrs. Westman and Sowyrda each asserted claims for indemnification and/or advancement against Novellus, Inc.&#160; On January 11, 2023, Messrs. Westman and
            Sowyrda served a joint motion to enforce their advancement and/or indemnification rights against Novellus Inc.&#160; Novellus Inc. vigorously opposes this motion and served its opposition on January 27, 2023.&#160; On February 8, 2023, Messrs. Westman
            and Sowyrda served a reply in support of their motion to enforce indemnification/advancement rights, and submitted the motion to the Court.&#160; Novellus Inc. answered Messrs. Westman and Sowyrda&#x2019;s counterclaims on January 27, 2023, denying
            liability.&#160; The remaining Counterclaim Defendants served a motion to dismiss most of the remaining counterclaims on January 27, 2023.&#160; The Court entered an order granting the Counterclaim Defendants&#x2019; motion to dismiss and denying Messrs.&#160;
            Sowyrda and Westman&#x2019;s motion to enforce on June 15, 2023.&#160; The Court&#x2019;s order dismissed all of Mr. Westman&#x2019;s claims against Counterclaim Defendants except his claim for indemnification, and all of Mr. Sowyrda&#x2019;s claims except his claim for
            indemnification and his employment-related claims, which Counterclaim Defendants did not move to dismiss.&#160; On July 6, 2023, Messrs. Westman and Sowyrda filed a petition for interlocutory review with a single justice of the Massachusetts Appeals
            Court, seeking to overturn the judge&#x2019;s decision granting the Counterclaim Defendants&#x2019; motion to dismiss most of the remaining counterclaims, but not the decision denying Messrs. Westman and Sowyrda&#x2019;s motion to enforce advancement rights.&#160; On
            July 25, 2023, the parties to the appeal filed a joint motion to the single justice in the appellate court to stay the appeal to allow for amended counterclaims to be filed by Counterclaim Plaintiffs and a motion to dismiss to be filed by
            Counterclaim Defendants.&#160; Counterclaim Plaintiffs filed an initial set of amended counterclaims on August 15, 2023.&#160; Counterclaim Plaintiffs amended and refiled their amended counterclaims on September 29, 2023.&#160; Counterclaim Defendants served
            their motion to dismiss all of the amended counterclaims, except for Mr. Sowyrda&#x2019;s employment-related claims, on October 13, 2023.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Under applicable Delaware law and Novellus
            Inc.&#x2019;s organizational documents, the Company may be required to advance or reimburse certain legal expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing matters. However, a future advance or
            reimbursement is not currently probable nor can it be reasonably estimated.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;eTheRNA
            Immunotherapies NV and eTheRNA Inc. v. Eterna Therapeutics Inc. C.A. No. 123CV11732&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On July 31, 2023, eTheRNA Immunotherapies
            NV and eTheRNA Inc. filed a complaint in court against the Company alleging: (1) federal trademark infringement; (2) federal unfair competition; (3) Massachusetts state common law trademark infringement; (4) Massachusetts state unfair
            competition.&#160; Service of process for the complaint was completed on August 1, 2023. The Company&#x2019;s answer was filed on October 10, 2023. At this stage in the litigation, the Company is not able to predict the probability of a favorable or
            unfavorable outcome.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt;Dhesh Govender v. Eterna Therapeutics LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On










            or about February 5, 2021, Dhesh Govender, a former short-term consultant of Eterna LLC, filed a complaint against Eterna LLC and certain individuals that plaintiff alleged were directors of Eterna LLC. Plaintiff alleged that Eterna LLC and
            certain of its officers and directors engaged in unlawful and discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserted various breach of contract, fraud and quantum meruit claims based on an
            alleged oral agreement pursuant to which he alleged Eterna LLC agreed to hire him as an executive once the merger involving the Company and NTN Buzztime, Inc. was completed. On December 15, 2022, the parties executed a Confidential Settlement
            Agreement and Release of All Claims. On January 11, 2023, the parties filed a Stipulation to Discontinue in the Court action. Also on January 11, 2023, plaintiff voluntarily dismissed the arbitration.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;John Westman v.
              Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949 (Middlesex County (Massachusetts) Superior Court)&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On or about September 7, 2021, John Westman, a former employee of Novellus, Inc.
          filed a complaint in Middlesex County (Massachusetts) Superior Court against Novellus, Inc. and Novellus, Inc.&#x2019;s founders and former executives, Dr. Rohde and Dr. Angel.&#160; The case includes allegations that Novellus, Inc. violated the
          Massachusetts Wage Act.&#160; The Company acquired Novellus, Inc. on July 16, 2021.&#160; Mr. Westman&#x2019;s claims relate to alleged conduct that took place before the Company acquired Novellus, Inc.&#160;&#160; Mr. Westman agreed to dismiss the lawsuit and proceed with
          his claims in arbitration.&#160; Following mediation, the parties settled this dispute in December 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; The aggregate settlement amount payable by the Company for the Westman and Govender
          matters discussed above was approximately $0.5 million, both of which were recognized as expense in the consolidated statement of
          operations for the year ended December 31, 2022 and were fully &lt;span style="-sec-ix-hidden:Fact_1686a4286739492e851a84f95f37d027"&gt;paid&lt;/span&gt; during the year ended December 31, 2023.&lt;br/&gt;
          &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"&gt; &lt;span style="text-decoration: underline;"&gt;Emerald Private Equity Fund, LLC Matter&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 0px;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt; By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#x201c;Emerald&#x201d;), a stockholder of the Company, made a demand
            pursuant to 8 Del. C. 220 to inspect certain books and records of the Company. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the merger involving the Company and NTN
            Buzztime, Inc. and the issuance of paper stock certificates, including investigating whether: (i) the Company&#x2019;s stock certificates were issued in accordance with the merger agreement; (ii) certain restrictions on the sale of the Company&#x2019;s
            common stock following the merger were proper and applied without favor; (iii) anyone received priority in post-merger issuances of the Company&#x2019;s stock certificates that allowed them to benefit from an increase in the trading price of the
            Company&#x2019;s common stock; and (iv) it should pursue remedial measures and/or report alleged misconduct to the SEC. The Company responded to the demand letter and produced certain information to Emerald in connection with the demand, which is
            subject to the terms of a confidentiality agreement entered into among the parties, including certain additional stockholders who subsequently joined as parties to such agreement.&#160; Following discussions, with no admission of wrongdoing, the
            Company and Emerald entered into a confidential settlement agreement, pursuant to which the Company paid $1.2 million in 2022 in full
            settlement of all of the Emerald&#x2019;s purported claims, including a release by the Emerald in favor of the Company in respect of any and all such claims.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Licensing
            Agreements&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;Factor Limited&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;On










            November 14, 2023, the Company and Factor Limited entered into the A&amp;amp;R Factor License Agreement, which terminated and superseded the exclusive license agreement between the parties dated February 20, 2023 and the amendment thereto.&#160; See
            Note 11 for additional information regarding the A&amp;amp;R Factor License Agreement.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company has other license, collaboration and royalty agreements with third parties related to IRX-2, including
            an agreement entered into with University of South Florida Research Association, Inc. (&#x201c;USFRF&#x201d;) in February 2024 to revoke certain license agreements with USFRF related to IRX-2.&#160; The Company does not intend to further develop IRX-2 and has
            provided USFRF with notice that the Company intends to abandon the IRX-2 patents. USFRF has 30 days to provide the Company with its
            notice to assume control of such patents.&#160; As a result of abandoning the IRX-2 patents, the Company will no longer have any obligations under the existing related agreements. existing related agreements.&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; font-variant: normal; text-transform: none;"&gt;Retirement Savings
            Plan&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company established a defined contribution plan, organized under Section 401(k) of the Internal Revenue Code, which allows
        employees to defer up to 90% of their pay on a pre-tax basis. Beginning on January 1, 2023, the Company began matching employees&#x2019;
        contributions at a rate of 100% of the first 3% of the employee&#x2019;s contribution and 50% of the next 2% of the employee&#x2019;s contribution, for a maximum Company match of 4%.
        &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;For the year ended December 31, 2023, the
          Company matched less than $0.1 million towards employees&#x2019; 401k contributions.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <erna:LitigationSettlementAmountPayable
      contextRef="c20221231"
      decimals="-5"
      id="Fact_5a87d79d90644440b3aa3a76d1911965"
      unitRef="U001">500000</erna:LitigationSettlementAmountPayable>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="c20220101to20221231"
      decimals="-5"
      id="Fact_34b74c1d96664995ac3fde9a9aacc8a3"
      unitRef="U001">1200000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <erna:NoticePeriodToAssumeControlPatents
      contextRef="c20230101to20231231"
      id="Fact_31ef9ab1451d44129f8f8070dc4a4f53">P30D</erna:NoticePeriodToAssumeControlPatents>
    <erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis
      contextRef="c20220101to20221231_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_a47f18c4c61d46439822761f6e1798d3"
      unitRef="U008">0.90</erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis>
    <erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember"
      decimals="2"
      id="Fact_3f88a5c5b24f4996a81e1c1fc73f83e2"
      unitRef="U008">1</erna:DefinedContributionPlanDeferralPercentOfTheirPayOnPreTaxBasis>
    <erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember"
      decimals="2"
      id="Fact_7d973127094f49999febe2cec2e3a98a"
      unitRef="U008">0.03</erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchOne>
    <erna:DefinedContributionPlanEmployeeContributionAtThresholdOne
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember"
      decimals="2"
      id="Fact_02e84fb9e33f4350a9b05b8885557130"
      unitRef="U008">0.50</erna:DefinedContributionPlanEmployeeContributionAtThresholdOne>
    <erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember"
      decimals="2"
      id="Fact_c69074a311ae4bd39be0068cbc6e89f5"
      unitRef="U008">0.02</erna:DefinedContributionPlanEmployerMatchingContributionPercentOfMatchTwo>
    <erna:DefinedContributionPlanEmployeeContributionAtThresholdTwo
      contextRef="c20230101to20230101_RetirementPlanNameAxis_RetirementPlan401KMember"
      decimals="2"
      id="Fact_a50c542a52494c1781d6f37b46f3e53c"
      unitRef="U008">0.04</erna:DefinedContributionPlanEmployeeContributionAtThresholdTwo>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="c20230101to20231231_RangeAxis_MaximumMember_RetirementPlanNameAxis_RetirementPlan401KMember"
      decimals="-5"
      id="Fact_8461d676db074e039f16c105ae78166e"
      unitRef="U001">100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20230101to20231231"
      id="Text_73a0f143ec0e4578abb3a368832ca6c7">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;14)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;
                &lt;div&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"&gt;B&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;asic and Diluted Net Loss per
                    Common Share&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;The following table sets forth the computation of the net loss per share attributable to common stockholders, basic and diluted (in thousands, except per share data):&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years Ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; 2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Numerator:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net loss attributable to common stockholders&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,684&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,595&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Denominator&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted average shares outstanding - basic and diluted&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,314&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,051&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net loss per common share - basic and diluted&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4.08&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8.06&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; margin-right: 0.3pt; margin-left: 0.3pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;Since the Company was in a net loss position for all periods presented, the net loss per share
          attributable to common stockholders was the same on a basic and diluted basis, as the inclusion of all potential common equivalent shares outstanding would have been anti-dilutive.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="font-size: 10pt;"&gt;The &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 48px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;following table presents the amount of warrants, stock options, convertible preferred stock, convertible notes and restricted stock units (&#x201c;RSUs&#x201d;) that were excluded
            from the computation of diluted net loss per share of common stock for the years ended December 31, 2023 and 2022, as their effect was anti-dilutive (in thousands):&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;Years ended December 31,&lt;br/&gt;
                  &lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;"&gt;2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;2022&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt; font-size: 10pt;"&gt;Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;18,922&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;4,713&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; width: 76%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;C&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: -9.6px; text-transform: none; word-spacing: 0px; white-space: nowrap; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;onvertible Notes converted into common stock&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;7,877&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Stock options&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;389&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;359&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Preferred stock converted into common stock&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;18&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;7&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;RSUs&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Total potential common shares excluded from computation&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27,207&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;5,083&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

      &lt;/div&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_c19e7119e4a548ffb060bab5e55e09b5">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;The following table sets forth the computation of the net loss per share attributable to common stockholders, basic and diluted (in thousands, except per share data):&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years Ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; 2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Numerator:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net loss attributable to common stockholders&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,684&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,595&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Denominator&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted average shares outstanding - basic and diluted&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,314&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,051&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net loss per common share - basic and diluted&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4.08&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8.06&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_dfc14212ce504f3da121750cc5ed24d5"
      unitRef="U001">-21684000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_2f12390b1f35435995e0f33b2e35d17f"
      unitRef="U001">-24595000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_c194e11a8169419b8b8226cba0ad9c02"
      unitRef="U002">5314000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_731642c4ef2b43f0a53fac237d1f489b"
      unitRef="U002">5314000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_254d945cece442aaaf2198024500cd51"
      unitRef="U002">3051000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_0ae16c1267874824b1ff99a86842bc21"
      unitRef="U002">3051000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20230101to20231231"
      decimals="2"
      id="Fact_a5fab069f225441782c9568fb7ca56e1"
      unitRef="U003">-4.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20230101to20231231"
      decimals="2"
      id="Fact_2e95d737dc4c4b44a65e95e752b3f259"
      unitRef="U003">-4.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220101to20221231"
      decimals="2"
      id="Fact_206ecc49cbb44bcf9c2314ef1b293b3d"
      unitRef="U003">-8.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220101to20221231"
      decimals="2"
      id="Fact_352ba7a4502946aa9f862347bd988267"
      unitRef="U003">-8.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="c20230101to20231231"
      id="Text_30ee998ff1ad439abc28ac8cc254cf80">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="font-size: 10pt;"&gt;The &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 48px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;following table presents the amount of warrants, stock options, convertible preferred stock, convertible notes and restricted stock units (&#x201c;RSUs&#x201d;) that were excluded
            from the computation of diluted net loss per share of common stock for the years ended December 31, 2023 and 2022, as their effect was anti-dilutive (in thousands):&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; text-align: center; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;Years ended December 31,&lt;br/&gt;
                  &lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;"&gt;2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;2022&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt; font-size: 10pt;"&gt;Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;18,922&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;4,713&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; width: 76%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;C&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: -9.6px; text-transform: none; word-spacing: 0px; white-space: nowrap; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;onvertible Notes converted into common stock&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;7,877&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Stock options&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;389&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;359&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Preferred stock converted into common stock&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;18&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;7&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;RSUs&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Total potential common shares excluded from computation&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;27,207&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;5,083&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

      &lt;/div&gt;
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_a842c271d384479b90fce3abbb00960e"
      unitRef="U002">18922000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_dd6d67332dc440238eaf2d83249ad2cd"
      unitRef="U002">4713000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleCommonStockMember"
      decimals="-3"
      id="Fact_dbbe05106ac54783a91b49515937185b"
      unitRef="U002">7877000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleCommonStockMember"
      decimals="-3"
      id="Fact_8fb1eaf23b1845ee9e80f38142945d86"
      unitRef="U002">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_a2b2c79ff0d2492da4630d665ae086bb"
      unitRef="U002">389000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_2e4aa8673b514f1980fce043dd24f72f"
      unitRef="U002">359000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact_5a92d9b048a84b67954e31194c8bc4d6"
      unitRef="U002">18000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact_24930f81cc6e428787029e1ce7a7b29b"
      unitRef="U002">7000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20230101to20231231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_f36bfd7c62c84fa98d5d0f8d9c56db86"
      unitRef="U002">1000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_4a01019597704f619e8947e5d815176e"
      unitRef="U002">4000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_04068f2447dc49808ccc26dddcdfadde"
      unitRef="U002">27207000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_b6f4b333be2e4cf4afd2e78161e70f15"
      unitRef="U002">5083000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="c20230101to20231231"
      id="Text_cbefb7b6443c4b948ef2e409c69e0a9e">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;15)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Stock-Based Compensation&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Equity Incentive Plans&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company&#x2019;s stock-based compensation plans consist of the Restated 2020 Equity Incentive Plan (the &#x201c;Restated 2020 Plan&#x201d;) and
        the 2021 Inducement Equity Incentive Plan (the &#x201c;2021 Inducement Plan&#x201d;). The Company&#x2019;s board of directors has designated its compensation committee as the administrator of the foregoing plans (the &#x201c;Plan Administrator&#x201d;). Among other things, the Plan
        Administrator selects persons to receive awards under the foregoing plans and determines the number of shares subject to each award and the terms, conditions, performance measures, if any, and other provisions of the award.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The
        Restated 2020 Plan provides for (a) approximately 724,000 shares of common stock that can be issued under the Restated 2020 Plan, which
        includes an increase to the Restated 2020 Plan of 300,000 that was approved by the Company&#x2019;s stockholders at the 2023 annual meeting of
        stockholders on June 16, 2023, and (b) an annual increase in the number of shares reserved for issuance on January 1 of each year from 2022 through 2031 equal to the lesser of (i) 5% of the number of shares of common stock outstanding on the immediately preceding December 31 and (ii) such smaller number of shares of common stock as may be determine by
        the board of directors (the provision providing for the increase described in clause (b) is referred to as the &#x201c;evergreen provision&#x201d;). As of January 1, 2023, pursuant to the evergreen provision, the number of shares issuable under the Restated 2020
        Plan was increased by approximately 256,000. Based on the number of shares of common stock outstanding on December 31, 2023, as of
        January 1, 2024, pursuant to the evergreen provision, the number of shares issuable under the Restated 2020 Plan was increased by approximately 271,000.&lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Awards under the Restated 2020 Plan may be granted to officers, directors, employees and consultants of the Company.&#160; Stock
        options granted under the Restated 2020 Plan may either be incentive stock options or nonqualified stock options, may have a term of up to ten years,
        and are exercisable at a price per share not less than the fair market value, as defined in the Restated 2020 Plan, on the date of grant. &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;As of December 31, 2023, there was approximately 684,000 shares of common stock remaining to be issued under the Restated 2020 Plan. As of December 31, 2023, there were approximately 296,000 stock options outstanding under the Restated 2020 Plan and no
        RSUs granted under the Restated 2020 Plan were outstanding.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The 2021 Inducement Plan provides for the grant of up to 75,000 share-based awards as material inducement awards to new employees in accordance with the employment inducement grant rules set forth in Section 711(a) of the NYSE
        American LLC Company Guide (the Company&#x2019;s common stock was listed on the NYSE American at the time the 2021 Inducement Plan was adopted). The 2021 Inducement Plan expires in May 2031. As of December 31, 2023, there was approximately 68,000 shares of common stock remaining to be issued under the 2021 Inducement Plan. As of December 31, 2022, there were approximately 4,000 stock options outstanding and approximately 1,000
        RSUs outstanding that were granted under the 2021 Inducement Plan.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Equity Awards&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company records stock-based compensation in accordance with ASC Topic 718, Compensation &#x2013; Stock Compensation.&#160; The Company
        estimates the fair value of stock options using the Black-Scholes option pricing model. The fair value of stock options granted is recognized as expense over the requisite service period on a straight-lined basis.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The risk-free rate is based on the observed interest rates appropriate for the expected life. The expected life (estimated
        period of time outstanding) of the stock options granted is estimated using the &#x201c;&lt;span style="font-style: normal;"&gt;simplified&lt;/span&gt;&#x201d; method as permitted by the SEC&#x2019;s Staff Accounting Bulletin No. 110, &lt;span style="font-style: italic;"&gt;Share-Based
          Payment&lt;/span&gt;. Expected volatility is based on the volatility of the Company&#x2019;s peer group over the expected life of the stock option granted, and the Company assumes no dividends. Forfeitures are recognized as incurred.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The
        following weighted-average assumptions were used for stock options granted during the years ended December 31, 2023 and 2022: &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;Year ended&lt;/span&gt; &lt;span style="font-weight: bold;"&gt;December 31,&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" valign="bottom"&gt;2022&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Weighted average risk-free rate&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3.82&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2.52&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Weighted average volatility&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;95.15&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;90.49&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Dividend yield&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;0&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;0&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Expected term&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;5.44 years &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;5.79 years &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following table summarizes stock option activity for the years ended December 31, 2023 and 2022 (in thousands except for
        per-share and remaining contractual life data):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="font-weight: bold;"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Options&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;
                &lt;div&gt;Weighted &lt;/div&gt;
                &lt;div&gt;Average &lt;/div&gt;
                &lt;div&gt;Exercise&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Price per&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Average&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Remaining &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Contractual &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Life (in&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;years)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Aggregate&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Intrinsic&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding January 1, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;199&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;168&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;9.38&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;287&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;17&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(127&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;141&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding December 31, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;359&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;57&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;7.57&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;237&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;(207&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;19&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Outstanding December 31, 2023&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;389&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;45&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;7.04&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Options vested and exercisable at December 31, 2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;331&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;50&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6.69&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"&gt;The per-share weighted average grant-date fair value of stock options granted during the year ended December 31, 2022 and 2021
        was $2.99 and $12.91,
        respectively.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As of December 31, 2023, the unamortized stock-based compensation expense related to outstanding unvested options was approximately $0.6 million with a weighted average remaining requisite service period of 1.91 years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.&lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Vesting of all stock options is subject to continuous service with the Company through their applicable vesting dates.&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;During
























          the year ended December 31, 2022, the Company accelerated the vesting of approximately 40,000 stock options under certain time-based
          vesting stock option grants previously awarded to Dr. Howard Federoff, the Company&#x2019;s former chief executive officer, pursuant to a separation agreement entered into with Dr. Federoff. The Company also waived a performance condition under a
          performance-based stock option grant and accelerated the vesting of approximately 21,000 stock options under such grant.&#160; Lastly, the
          Company extended the post-termination exercise period from 90 days to 36 months immediately following his separation date for any options that were vested, including the options that accelerating in vesting, as described above.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;The above modifications to Dr. Federoff&#x2019;s stock options grants resulted in modification accounting under ASC 718, &lt;span style="font-style: italic;"&gt;Compensation









              &#x2013; Stock Compensation&lt;/span&gt;. As a result, the Company immediately recognized approximately $0.1 million during 2022 for the
            incremental fair value of stock options that were vested prior to the modification by calculating the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For
            stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and
            immediately recognized approximately $0.1 million during 2022 of stock compensation expense in full since there was no future service
            period required to be provided.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following table summarizes RSU activity for the years ended December 31, 2023 and 2022 (in thousands except for per-share data):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Restricted&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Stock Units&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Average&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value per&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;January 1, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;12&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;276&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;55&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;39&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Released&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(3&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;271&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;(60&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;61&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;236&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;(3&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;199&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;December 31, 2023&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;1&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;322&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Balance expected to vest at December 31, 2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;322&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;The










          Company recognizes the fair value of RSUs granted as expense on a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal
          is determined to be probable.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Outstanding




















































          RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the
          respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date,
          which is the grant date.&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In lieu of paying cash to satisfy withholding taxes due upon the settlement of vested RSUs, at the Company&#x2019;s discretion, an employee may elect to have shares of
            common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable. During the year ended December 31, 2023, less than 1,000 RSUs vested. During the year ended December 31, 2022, approximately 3,000
            RSUs vested. The Company withheld approximately 1,000 RSUs to cover withholding taxes, and the net 2,000 shares were issued upon settlement.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Stock-Based Compensation Expense&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;For the years ended December 31, 2023 and 2022, the Company recognized stock-based compensation expense as follows (in
        thousands): &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"&gt;2023
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"&gt;2022
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Research and development&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;234&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,249&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;General and administrative&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,008&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,686&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,242&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,935&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_7d83f35da7ee445c90df8bb18bb0cf15"
      unitRef="U002">724000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_cc8c4dac08864bc3953f429beaf590f4"
      unitRef="U002">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <erna:PercentageOfSharesOfCommonStockOutstanding
      contextRef="c20231231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="2"
      id="Fact_9ae364e380a04b90b08f3d6cb14c0885"
      unitRef="U008">0.05</erna:PercentageOfSharesOfCommonStockOutstanding>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod
      contextRef="c20230101to20230101_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_945c03e77ec44847b0e1e2c8a6ed1a30"
      unitRef="U002">256000</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod
      contextRef="c20240101to20240101_PlanNameAxis_EquityIncentivePlan2020Member_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="0"
      id="Fact_8d7c418ff02647dc943f6be86b4217dc"
      unitRef="U002">271000</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuableInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20230101to20231231_AwardTypeAxis_IncentiveStockOptionsMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember"
      id="Fact_df18ca3ab4cb495fa9d112ff18401180">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20230101to20231231_AwardTypeAxis_NonQualifiedStockOptionMember_PlanNameAxis_EquityIncentivePlan2020Member_RangeAxis_MaximumMember"
      id="Fact_8def3c3186b1473ca92bdfcb2dd5840e">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20231231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_8c843d53cade4ac5bc1c991cb04e9c0d"
      unitRef="U002">684000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20231231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="0"
      id="Fact_2ba894d5656e43a1a12ba74f6a62303d"
      unitRef="U002">296000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20230101to20231231_PlanNameAxis_EquityIncentivePlan2020Member"
      decimals="INF"
      id="Fact_7631f10fc3334f458cd89aae8ed0e5b6"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20231231_PlanNameAxis_InducementPlan2021Member_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_0c62928975d54481b81c702168d229fc"
      unitRef="U002">75000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20231231_PlanNameAxis_InducementPlan2021Member"
      decimals="0"
      id="Fact_455b91be74d744509d41ea6c2186048f"
      unitRef="U002">68000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20221231_PlanNameAxis_InducementPlan2021Member"
      decimals="0"
      id="Fact_1efef25d9d434f228d5cc0a363d31760"
      unitRef="U002">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20221231_PlanNameAxis_InducementPlan2021Member"
      decimals="0"
      id="Fact_1ef8cbe238c449b8bbbdb546c88781fe"
      unitRef="U002">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_31c66c958f1e437391ba9045c9da98d1">
&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;The
        following weighted-average assumptions were used for stock options granted during the years ended December 31, 2023 and 2022: &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;Year ended&lt;/span&gt; &lt;span style="font-weight: bold;"&gt;December 31,&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="text-align: center; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold; white-space: nowrap;" valign="bottom"&gt;2022&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Weighted average risk-free rate&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3.82&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2.52&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Weighted average volatility&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;95.15&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;90.49&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Dividend yield&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;0&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;%&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;0&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Expected term&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;5.44 years &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; white-space: nowrap;" valign="bottom"&gt;5.79 years &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_ce9ddbe8e3c248c397f94c11efbc0463"
      unitRef="U008">0.0382</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_b2fb6325d44445108cda34126174dc31"
      unitRef="U008">0.0252</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_2bdcd19f8bf24fba811876963d5275a3"
      unitRef="U008">0.9515</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_be9e0981ea71474491db22d51ad2a0f9"
      unitRef="U008">0.9049</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_3204cb1195ab40139baa10a49a4d6e42"
      unitRef="U008">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_a7b455bad8184a1882a1c5bd88c12b99"
      unitRef="U008">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_24d44e01804d421a9f67cb88fae82dce">P5Y5M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_fc3b56c46b394e8283a301284fdac33a">P5Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_e14ca8bd850640aaa46f800cb8a5947e">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following table summarizes stock option activity for the years ended December 31, 2023 and 2022 (in thousands except for
        per-share and remaining contractual life data):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="font-weight: bold;"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Options&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;
                &lt;div&gt;Weighted &lt;/div&gt;
                &lt;div&gt;Average &lt;/div&gt;
                &lt;div&gt;Exercise&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Price per&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Average&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Remaining &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Contractual &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Life (in&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;years)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Aggregate&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Intrinsic&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding January 1, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;199&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;168&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;9.38&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;287&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;17&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;(127&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;141&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding December 31, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;359&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;57&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;7.57&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;237&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;(207&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;19&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Outstanding December 31, 2023&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;389&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;45&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;7.04&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 52%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Options vested and exercisable at December 31, 2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;331&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;50&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;6.69&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_3cbc12106cb94e28bc2ba2a793281114"
      unitRef="U002">199000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_962df8613a8a4224a64cf732eef07a93"
      unitRef="U003">168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_828838980f994d7e8f4589c8a790d1ff">P9Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_90960bdd20024e859d6222188ffefa24"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_fefb53629e744f40ae19e0c3afd43f96"
      unitRef="U002">287000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_b448de3af2b640639fe86b9f550b2088"
      unitRef="U003">17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_b88954f186434ac684111eaf50b43b65"
      unitRef="U002">127000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_6b40bd19963544cf86ce34f216a36b72"
      unitRef="U003">141</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_40ebdaf762214f4ca989f54a2aa38325"
      unitRef="U002">359000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_5eb52d1fa659456ca8cb9b98b6ed9bea"
      unitRef="U003">57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_90a4441a7bcc433083da2998d6c3fb0c">P7Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_56cba969722a4d648e60b13cc746a625"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_34767dfd8e8645f1aaf9bcb8234a7c73"
      unitRef="U002">237000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_56246699ac154659a9c4ea217cef8b56"
      unitRef="U003">4</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_3f1cdcfd975441c4bc149ded5e28c6d0"
      unitRef="U002">207000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_aa9839c697c74e9fbffec78e5943d342"
      unitRef="U003">19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_f040de0e51124cd290ad1c6ede1aa9fe"
      unitRef="U002">389000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_acb6b56f2d02407cbc62072dc106db10"
      unitRef="U003">45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_8868ed0c351444d5b030e838a20704ef">P7Y14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_03c01dfc39f241d587ca2414b94fcae5"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_328f9b7fd4cc4cb5ac44b764f028b8ed"
      unitRef="U002">331000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_6e52760ae0784e909bd4a426354aa19c"
      unitRef="U003">50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_3bf1c12a12bc4e03887772134fb89737">P6Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_e23b4512f61a44f49214b641529ae483"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_3b837d5064564d21925f9c444c60e256"
      unitRef="U003">2.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_ede81eef33184fab94976f9821ff2ac3"
      unitRef="U003">12.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="c20231231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="1"
      id="Fact_3e284a97f99d4124aa520e17e24e123f"
      unitRef="U001">0.6</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_f2f83f6720ec44159836cb24c9b53916">P1Y10M28D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c20220101to20221231_AwardTypeAxis_TimeBasedStockOptionMember"
      decimals="0"
      id="Fact_57316ac01ade4891971ab9c1a506bd27"
      unitRef="U002">40000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c20220101to20221231_AwardTypeAxis_PerformanceBasedStockOptionMember"
      decimals="0"
      id="Fact_1a41c1f5ab154c9e832d4026cb454e6f"
      unitRef="U002">21000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"
      id="Fact_108c2bb68fdd4382aa91b017c771d4f2">P90D</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod
      contextRef="c20230101to20231231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"
      id="Fact_e5cf5142c64b419a8b453d19c0c39b62">P36M</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-5"
      id="Fact_7c3d475c64fc45f2942c2abf4d1aa4f5"
      unitRef="U001">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-5"
      id="Fact_746c62d8948d4706af56753b2bbfe864"
      unitRef="U001">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_9cd4792e81544e4da3dcf0dcca53502c">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following table summarizes RSU activity for the years ended December 31, 2023 and 2022 (in thousands except for per-share data):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Outstanding&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; Restricted&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Stock Units&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Weighted &lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Average&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Fair&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Value per&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;January 1, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;12&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;276&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;55&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;39&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Released&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(3&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;271&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;(60&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;61&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;236&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Cancelled&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;(3&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;199&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;December 31, 2023&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;1&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;322&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: bold; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Balance expected to vest at December 31, 2023&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;322&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_98e5775dea1c4a7bb8c3b7d27443412c"
      unitRef="U002">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_6f011afd38d04dad89f3ec575c2227a0"
      unitRef="U003">276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_81b7c169f7064831a56290f983cfd497"
      unitRef="U002">55000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_7011278047e0404589891d0c3dfd9cb9"
      unitRef="U003">39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_eb0686ff8da7422f8fd8308cedf533b7"
      unitRef="U002">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_354a8a7d151d410facfee63016638e80"
      unitRef="U003">271</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_444d603369294d02b3757d37a184e499"
      unitRef="U002">60000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_16fb500c981545d48a79bffe7fbbbe7e"
      unitRef="U003">61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_09e188944dc546b586bbbe68f5e804b3"
      unitRef="U002">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_865f430005a64f4c9628e8d0c85476ca"
      unitRef="U003">236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_88ec631ac5f14594971cabf9b7011fed"
      unitRef="U002">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_ef633bda0a9e475584ccebacc28eca49"
      unitRef="U003">199</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_0199d779336741d1a620a7fdaa833556"
      unitRef="U002">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_be78a5210c5d44b2aff7f2cd8a3036af"
      unitRef="U003">322</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber
      contextRef="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_614ce50a90a8471d84ee654a75930f52"
      unitRef="U002">1000</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue
      contextRef="c20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_7784cbdb235948e994f0047ec97cdec3"
      unitRef="U003">322</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantExpectedToDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_5e6423109bc4410285fa527df1c9db2e"
      unitRef="U002">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20220101to20221231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_97f3ac93487c4f6392ce5e3e9c8ef249"
      unitRef="U002">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <erna:RestrictedStockUnitesWithheldToCoverTaxes
      contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_f7ea08c117844979ab8d092a8328efc1"
      unitRef="U002">1000</erna:RestrictedStockUnitesWithheldToCoverTaxes>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20230101to20231231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_447d3deb0c164d188a05542ed71fd373"
      unitRef="U002">2000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="c20230101to20231231"
      id="Text_ba87933c6b6740c9be4aa9fc77f92191">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;For the years ended December 31, 2023 and 2022, the Company recognized stock-based compensation expense as follows (in
        thousands): &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 54pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"&gt;2023
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"&gt;2022
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Research and development&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;234&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,249&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;General and administrative&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,008&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,686&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,242&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;$&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,935&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;
</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20230101to20231231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_1936e5f74679499086b3481385df7f9f"
      unitRef="U001">234000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_6a242c7555fe4f26b87217d9947ca04c"
      unitRef="U001">1249000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20230101to20231231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_e16285bb2793473f9007eb89ca0304da"
      unitRef="U001">1008000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_f9bdcf3147404e7ba06d80e8a0e1758b"
      unitRef="U001">1686000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_661918ef489e43d28f272e0518fe64dd"
      unitRef="U001">1242000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_ffd1f6fb06ab4f84ba201cdbd1366677"
      unitRef="U001">2935000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_521b4bd2711b4967be514bf5dae19c4c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;16)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Equity and Warrants&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-style: italic;"&gt;Private Placements&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt;Q4-22 PIPE Transaction&lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On November 23, 2022, the Company entered into a purchase agreement with certain
            investors pursuant to which the Company issued an aggregate of approximately 2.2 million units, with each unit consisting of (i) one share of common stock and (ii) two
            warrants, each exercisable to purchase one share of common stock at an exercise price of $3.28 per, at a purchase price of $3.53 per unit (inclusive of
            $0.125 per warrant). The transaction closed on December 2, 2022. The Company received aggregate gross proceeds of approximately $7.7 million. The Company incurred fees of approximately $0.3 million through December 31, 2022 related to the transaction.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Each warrant had an exercise price
              of $3.28 per share (subject to customary adjustments), became exercisable six months from the date of issuance, and expires &lt;span style="-sec-ix-hidden:Fact_e3ad1a6b59fa4c388062e2bab91b442b"&gt;five-and-one-half&lt;/span&gt;
              years from the date of issuance. The warrants meet the criteria for equity classification.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 27pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 9pt;"&gt;As discussed in Note 6, in connection with the December 2023
              convertible note financing, the exercise price of the warrants was reduced from $3.28 per share to $1.43 per share.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt;Q1-22 Private Placement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On March 6, 2022, the Company entered into a purchase agreement with an investor
            pursuant to which the Company issued approximately 343,000 units, each unit consisting of (i) one share of the Company&#x2019;s common stock (or, in lieu thereof, one pre-funded warrant to purchase one share of common stock) and (ii) one warrant to
            purchase one share of common stock, for an aggregate gross purchase price of approximately $12.0 million. The transaction closed on March 9, 2022. The Company issued 275,000
            shares of common stock, approximately 68,000 pre-funded warrants and warrants to purchase approximately 343,000 shares of common stock. The Company incurred fees of approximately $1.0 million through December 31, 2022 related to this transaction, which were allocated to the fair value of the pre-funded warrants and warrants and Each pre-funded
            warrant had an exercise price of $0.10 per share (subject to customary adjustments), was immediately exercisable, could be exercised
            at any time, and had no expiration date.&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
              &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Each warrant has an exercise price of $38.20 per share (subject to customary adjustments), became exercisable six months following the date of issuance, and expires &lt;span style="-sec-ix-hidden:Fact_5269f7037c524c0e8f946b93d07e4c92"&gt;five-and-one-half&lt;/span&gt;
              years from the date of issuance.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The pre-funded warrants and warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet
            the requirements of the indexation guidance under ASC 815-40. These warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations. (See Note 9 for
            more information related to changes in fair value.) Upon exercise, the fair value of the pre-funded warrants and/or warrants on the exercise date is reclassified from warrant liabilities to equity.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The fair values of the pre-funded warrants and warrants
              at the issuance date totaled $12.6 million in the aggregate, or $0.6 million more than the aggregate gross purchase price of the units sold in the offering. The $0.6 million represents an inducement to the investor to enter into the purchase agreement and was recorded in warrant liabilities expense in the accompanying consolidated statement of
              operations.&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On July 12, 2022, all the pre-funded warrants were exercised. The Company issued approximately 68,000 shares of common stock upon exercise and received approximately $7,000
            of proceeds. The fair value of the pre-funded warrants as of the exercise date (approximately $0.7 million) was reclassified from
            warrant liabilities to equity.&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In connection with the transaction, the Company and the investor also entered into a registration rights agreement pursuant to which the Company agreed to prepare and file a registration statement
              with the SEC to register the resale of the shares of common stock issued in the offering and issuable upon exercise of the pre-funded warrants and warrants. The resale registration statement became effective on May 11, 2022.&lt;/span&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0);"&gt;Pursuant to the registration rights agreement, the Company is obligated to pay the investor
            liquidated damages equal to 2% of the purchase price for the units per month, with a maximum aggregate payment of 12 of the purchase price for the units, in the event the investor is not permitted to use the registration statement to resell the securities
            registered for resale thereunder for more than a specified period of time.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;On May 24, 2022, the Company notified the investor that the investor was not able to use the registration agreement because the Company had not timely
            filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 with the SEC, and that the investor could not use the registration statement until the Company filed that quarterly report, which was filed on June 30, 2022. The
            Company accrued $0.2 million during 2022 for the contingent loss the Company incurred as liquidated damages as a result of the late
            filing, which is recorded in other expense, net for the year ended December 31, 2022 in the accompanying consolidated statements of operations. The Company paid the $0.2 million liquidated damages to the investor in June 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Note&#160;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration: underline;"&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"&gt;As discussed in Note 6, in connection with the July
              2023 and December 2023 convertible note financings, the Company issued note warrants to purchase an aggregate of approximately 14.2
              million shares of common stock.&#160; The exercise price of all such warrants is currently $1.43 per share (subject to customary
              adjustments), are expire five years following the date of issuance. All such warrants qualified for equity classification.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;The following table shows the Company&#x2019;s warrant activity for the year ended
            December 31, 2023 (in thousands except for per-share data):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Q1-22 Common&lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Q4-22&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt;July 2023 &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div style="text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Warrants&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 2023&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Balance as of January 1, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;343&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,370&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,713&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;6,094&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;8,115&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;14,209&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Balance as of December 31, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;343&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,370&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;6,094&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;8,115&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;18,922&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As of December 31, 2023, the weighted average remaining
              contractual life of the warrants outstanding was 4.68 years and the weighted average exercise price was $2.10 per share.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="margin: 0px 0.3pt 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; font-weight: normal; text-align: left; text-transform: none;"&gt;SEPA&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt;On April 5, 2023, the
            Company entered into the SEPA with Lincoln Park, pursuant to which Lincoln Park committed to purchase up to $10.0 million of the
            Company&#x2019;s common stock. Such sales of common stock by the Company, if any, are subject to certain conditions and limitations set forth in the SEPA, including a condition that the Company may not direct Lincoln Park to purchase any shares of
            common stock under the SEPA if such purchase would result in Lincoln Park beneficially owning more than 4.99% of the Company&#x2019;s
            issued and outstanding shares of common stock. Sales under the SEPA may occur from time to time, at the Company&#x2019;s sole discretion, through April 2025.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt;In consideration of
            Lincoln Park&#x2019;s entry into the SEPA, the Company issued to Lincoln Park approximately 74,000 shares of common stock (the &#x201c;Commitment
            Shares&#x201d;).&#160; The value of the Commitment Shares was recorded as a period expense and included in other expense, net, in the accompanying consolidated statements of operations for year ended December 31, 2023.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company evaluated the contract that includes the right to require Lincoln Park to purchase shares of common stock in the future (&#x201c;put right&#x201d;) considering the
              guidance in ASC 815-40, Derivatives and Hedging &#x2014; Contracts on an Entity&#x2019;s Own Equity and concluded that it is an equity-linked contract that does not qualify for equity classification, and therefore requires fair value accounting. The
              Company analyzed the terms of the freestanding put right and concluded that it has an immaterial value as of December 31, 2023.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt;During the year ended
            December 31, 2023, the Company issued and sold approximately 214,000 shares of common stock under the SEPA, including the 74,000 Commitment Shares, for gross proceeds of approximately $0.3 million.&#160; As of December 31, 2023, there were approximately 2,860,000 shares remaining to be
            sold under the SEPA.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt;In connection with entry
            into the SEPA, the Company terminated its prior purchase agreements with Lincoln Park entered into during 2021.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"&gt;Cumulative Convertible Preferred Stock &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has authorized 156,000 shares of preferred stock, all of which is designated as Series A Cumulative Convertible Preferred Stock (the &#x201c;Series A Preferred Stock&#x201d;), and all of which were issued and
            outstanding as of December 31, 2023.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Series A Preferred Stock provides for a cumulative annual dividend of $0.10 per share, payable in semi-annual installments in June and December. Dividends may be paid in cash or with shares of common stock.&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company paid approximately $16,000 in cash for payment of dividends during the years ended December 31, 2023 and 2022&lt;/span&gt;.&lt;/span&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: #FFFFFF; margin: 0px 0.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt;The Series A Preferred Stock has no voting rights and has a $1.00 per share liquidation preference over the Company&#x2019;s common
              stock. The holder of shares of Series A Preferred Stock has the right at any time to convert such shares into that number of shares of common stock that equals the number of shares of Series A Preferred Stock that are surrendered for
              conversion divided by the conversion rate.&#160; At December 31, 2023, the conversion rate was 8.8016 and, based on that conversion
              rate, one share of Series A Preferred Stock would have converted into approximately 0.11 shares of common stock, and all the
              outstanding shares of the Series A Preferred Stock would have converted into approximately 18,000 shares of common stock in the
              aggregate. There were no conversions during the years ended December 31, 2023 and 2022. There is no mandatory conversion term,
              date or any redemption features associated with the Series A Preferred Stock. The conversion rate will adjust under the following circumstances:&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0);"&gt; &lt;/span&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;1.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;If the Company (a) pays a dividend or makes a distribution in shares of its common stock, (b) subdivides its outstanding shares of common stock into a greater number of shares, (c) combines its
                    outstanding shares of common stock into a smaller number of shares, or (d) issues by reclassification of its shares of common stock any shares of its common stock (other than a change in par value, or from par value to no par value, or
                    from no par value to par value), then the conversion rate in effect immediately prior to the applicable event will be adjusted so that the holders of the Series A Preferred Stock will be entitled to receive the number of shares of
                    common stock which they would have owned or have been entitled to receive immediately following the happening of the event, had the Series A Preferred Stock been converted immediately prior to the record or effective date of the
                    applicable event.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;2.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;If the outstanding shares of the Company&#x2019;s common stock are reclassified (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a
                    subdivision, combination or stock dividend), or if the Company consolidates with or merge into another corporation and the Company is not the surviving entity, or if the Company sells all or substantially all of its property, assets,
                    business and goodwill, then the holders of the Series A Preferred Stock will thereafter be entitled upon conversion to the kind and amount of shares of stock or other equity securities, or other property or assets which would have been
                    receivable by such holders upon such reclassification, consolidation, merger or sale, if the Series A Preferred Stock had been converted immediately prior thereto.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"&gt;3.&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;If the Company issues common stock without consideration or for a consideration per share less than the then applicable Equivalent Preference Amount (as defined below), then the Equivalent Preference
                    Amount will immediately be reduced to the amount determined by dividing (A) an amount equal to the sum of (1) the number of shares of common stock outstanding immediately prior to such issuance multiplied by the Equivalent Preference
                    Amount in effect immediately prior to such issuance and (2) the consideration, if any, received by the Company upon such issuance, by (B) the total number of shares of common stock outstanding immediately after such issuance. The
                    &#x201c;Equivalent Preference Amount&#x201d; is the value that results when the liquidation preference of one share of Series A Preferred Stock (which is $1.00)
                    is multiplied by the conversion rate in effect at that time; thus the conversion rate applicable after the adjustment in the Equivalent Preference Amount as described herein will be the figure that results when the adjusted Equivalent
                    Preference Amount is divided by the liquidation preference of one share of Series A Preferred Stock.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="-5"
      id="Fact_fa66095ecb5a400ca29c2c26e4fdae96"
      unitRef="U002">2200000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="INF"
      id="Fact_126c347542e94e898c0fc42ef886698f"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <erna:NumberOfWarrantsInEachUnit
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="INF"
      id="Fact_14f6241e078d4298a8de9c28eef33e89"
      unitRef="U002">2</erna:NumberOfWarrantsInEachUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="INF"
      id="Fact_9d92686591fa41ec81da3f5522494a35"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="2"
      id="Fact_bf98abc8301b4051a94efea57416e54b"
      unitRef="U003">3.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:UnitPriceOfWarrants
      contextRef="c20221123to20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="2"
      id="Fact_ff2492c65e8e4153adb26a331e961c46"
      unitRef="U003">3.53</erna:UnitPriceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="3"
      id="Fact_5381a8d0e8b14d179861e9fff14779b4"
      unitRef="U003">0.125</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c20221202to20221202_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="-5"
      id="Fact_66966494c8874625807d493a3e6ddabd"
      unitRef="U001">7700000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <erna:TransactionFeesPayable
      contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="-5"
      id="Fact_905b60f805694655ad786a00c87f1cfe"
      unitRef="U001">300000</erna:TransactionFeesPayable>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="2"
      id="Fact_0448dbf7d12547fbbdae342b9030b5ce"
      unitRef="U003">3.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:ClassOfWarrantOrRightsExercisableTerm
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      id="Fact_b2590009db384b78b3fb52bfd31fb7ed">P6M</erna:ClassOfWarrantOrRightsExercisableTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20221123_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="2"
      id="Fact_8435e3dd01c64b4c88359f2768d372d2"
      unitRef="U003">3.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorOneMember"
      decimals="2"
      id="Fact_18c4c21ce4bd4c1397eb57e795baffdf"
      unitRef="U003">1.43</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_3b65f6f302ba40799409b02b49c1629f"
      unitRef="U002">343000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_82727e5d05104ca9b5c7b9d880841d97"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_5787be7e89f54a9f9e6c4fd91f296750"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_0ca2e1b94a894de1b94dab018243e7e3"
      unitRef="U001">12000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_8d0193b5439846ff81499eb26fbcb7f9"
      unitRef="U002">275000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_f61ef0a85d3042c8ab6e915a62267308"
      unitRef="U002">68000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_417ea3e3b2e14beeb43aa14f1b6a0732"
      unitRef="U002">343000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <erna:TransactionFeesPayable
      contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_41c6c2161bc74fbeb03bdeae3556947c"
      unitRef="U001">1000000</erna:TransactionFeesPayable>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_a2784f4355844d679f45127efb34ecad"
      unitRef="U003">0.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="2"
      id="Fact_ac723e8d8cff4bf88ae7e656454f3e09"
      unitRef="U003">38.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <erna:ClassOfWarrantOrRightsExercisableTerm
      contextRef="c20230101to20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      id="Fact_f69702c355424efebac6a24d21a62899">P6M</erna:ClassOfWarrantOrRightsExercisableTerm>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220306to20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_8c22e9cabe204f1c8abc38c4c450ee41"
      unitRef="U001">12600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <erna:OverSubscriptionAmountReceived
      contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_010e54a034c1485680425c99cd8300d6"
      unitRef="U001">600000</erna:OverSubscriptionAmountReceived>
    <erna:OverSubscriptionAmountReceived
      contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_2daa1f5cecdc423290b5ac855a40c32a"
      unitRef="U001">600000</erna:OverSubscriptionAmountReceived>
    <erna:ClassOfWarrantOrRightExercised
      contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact_2ab34474db78444b980cf145cc313d53"
      unitRef="U002">68000</erna:ClassOfWarrantOrRightExercised>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_30d903d2d31e4421adb9bc6ddaa5be0b"
      unitRef="U001">7000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="-5"
      id="Fact_ca89bd31578c4ca1a2079656ce57673e"
      unitRef="U001">700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <erna:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth
      contextRef="c20220306_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_6f4b2b2f358542a3a881536bb1f30ab8"
      unitRef="U008">0.02</erna:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth>
    <erna:ObligationToPayLiquidatedDamagesPercentage
      contextRef="c20231231_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_abfb7fe60665465fbc1e5b0cd1258947"
      unitRef="U008">0.12</erna:ObligationToPayLiquidatedDamagesPercentage>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="c20231231_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_2b77d1232ee8480ab2c7da397e45b89b"
      unitRef="U001">200000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="c20220601to20220630_RelatedPartyTransactionsByRelatedPartyAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_6e1277af9e82444f92e681f41e5af475"
      unitRef="U001">200000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-5"
      id="Fact_6f4e3715a23249e5a23ef1cba7b8f0e9"
      unitRef="U002">14200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember"
      decimals="2"
      id="Fact_c6ff0c7790b44c229a50580ffc605d0a"
      unitRef="U003">1.43</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember_LongtermDebtTypeAxis_July2023AndDecember2023ConvertibleNotesMember"
      id="Fact_fe25762c4dd446a68c9f5d5e7c1f3d96">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="c20230101to20231231"
      id="Text_be9dff19f7964586a75f66027ef892fa">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;The following table shows the Company&#x2019;s warrant activity for the year ended
            December 31, 2023 (in thousands except for per-share data):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Q1-22 Common&lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Q4-22&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt;July 2023 &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div style="text-align: center;"&gt;&lt;span style="font-weight: bold;"&gt;Warrants&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 2023&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Total&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Balance as of January 1, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;343&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,370&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,713&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;6,094&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;8,115&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;14,209&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 40%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Balance as of December 31, 2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;343&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;4,370&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;6,094&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;8,115&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;18,922&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="0"
      id="Fact_609b338425c8436f8be82beb87a63efc"
      unitRef="U002">343</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember"
      decimals="0"
      id="Fact_1d65751859ab4cb2a5a9b00a563f2bf6"
      unitRef="U002">4370</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231_ClassOfWarrantOrRightAxis_July2023WarrantsMember"
      decimals="0"
      id="Fact_cc5f29f84ab240c8ab0db56e42338f56"
      unitRef="U002">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231_ClassOfWarrantOrRightAxis_December2023WarrantsMember"
      decimals="0"
      id="Fact_f8e02b68907b41c49a34316e213bc2e2"
      unitRef="U002">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20221231"
      decimals="0"
      id="Fact_f765b50d872a41329c40686d0e221772"
      unitRef="U002">4713</us-gaap:ClassOfWarrantOrRightOutstanding>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20230101to20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="0"
      id="Fact_bd6433b138dc4396999f2294cdda5aa9"
      unitRef="U002">0</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20230101to20231231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember"
      decimals="0"
      id="Fact_ad37bf8b801b4304b1792c4b8029573e"
      unitRef="U002">0</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20230101to20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember"
      decimals="0"
      id="Fact_efb57c3b326141dcbe7edbc87e5ddc13"
      unitRef="U002">6094</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20230101to20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember"
      decimals="0"
      id="Fact_7a7d626fe7c74e4c800a43441d84976a"
      unitRef="U002">8115</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <erna:ClassOfWarrantOrRightGrantsInPeriod
      contextRef="c20230101to20231231"
      decimals="0"
      id="Fact_da3eff9b3a7d42e1b01a74ace2589c25"
      unitRef="U002">14209</erna:ClassOfWarrantOrRightGrantsInPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="0"
      id="Fact_72b198bd70c6476ab45f102066d8f964"
      unitRef="U002">343</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20231231_ClassOfWarrantOrRightAxis_CommonWarrantsOneMember"
      decimals="0"
      id="Fact_dc3249231c6a454b836c1da05b57680e"
      unitRef="U002">4370</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20231231_ClassOfWarrantOrRightAxis_July2023WarrantsMember"
      decimals="0"
      id="Fact_c40e70b3bc3d492a9d8b190e8392382e"
      unitRef="U002">6094</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20231231_ClassOfWarrantOrRightAxis_December2023WarrantsMember"
      decimals="0"
      id="Fact_46fd82393b124ef08f5776a77c0a5aba"
      unitRef="U002">8115</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20231231"
      decimals="0"
      id="Fact_e218a4cd74a14d5880c38784e35b7382"
      unitRef="U002">18922</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember"
      id="Fact_1542104966174bb0890ed4a0dce3e515">P4Y8M4D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20231231_ClassOfWarrantOrRightAxis_WarrantMember"
      decimals="2"
      id="Fact_3aedf5dd7cf34cb1ab376ea63c28674a"
      unitRef="U003">2.1</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember"
      decimals="-5"
      id="Fact_8f47478ff34a4f15bcc4abf817687e8e"
      unitRef="U001">10000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <erna:BeneficialOwnershipPercentageOfIssuedAndOutstandingShares
      contextRef="c20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_RangeAxis_MaximumMember"
      decimals="4"
      id="Fact_463bc1d97d9a4589bf0c4af0ce827892"
      unitRef="U008">0.0499</erna:BeneficialOwnershipPercentageOfIssuedAndOutstandingShares>
    <erna:EquityLineOfCreditConsiderationSharesOfCommonStock
      contextRef="c20230405to20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact_07d8a77426384021bb406be6efc7168e"
      unitRef="U002">74000</erna:EquityLineOfCreditConsiderationSharesOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c20230101to20231231_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact_69a6589b62a2459db92356a05605c562"
      unitRef="U002">214000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <erna:EquityLineOfCreditConsiderationSharesOfCommonStock
      contextRef="c20230405to20230405_LegalEntityAxis_LincolnParkCapitalFundLLCMember_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact_f9010a50fb4942c9bd8bc37e3707fbae"
      unitRef="U002">74000</erna:EquityLineOfCreditConsiderationSharesOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="c20230101to20231231_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact_663845121096440cb2c04f0c730ddf0f"
      unitRef="U001">300000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <erna:SaleOfStockNumberOfSharesToIssuedInTransaction
      contextRef="c20230101to20231231_TypeOfArrangementAxis_StandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact_d4471dfc65184b2cb430fa29b5ca0d5e"
      unitRef="U002">2860000</erna:SaleOfStockNumberOfSharesToIssuedInTransaction>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_ee8447cf0b154f5489310744b40a4d2c"
      unitRef="U002">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_7daad3fed53f4f69b9d6dcdfe4ee4428"
      unitRef="U002">156000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact_65f32448c779417da1d836668e8521ce"
      unitRef="U002">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="2"
      id="Fact_b09ef00a078d45f9ac53b3c7671ad5e7"
      unitRef="U003">0.1</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20230101to20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_ab3efc8efc49478e9ac0be6f1f93d5a3"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20221231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_9fdf266425634ec6964bdd07b4a3c07b"
      unitRef="U001">16000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="2"
      id="Fact_0dc09987d6da44fab7e97686c47aef46"
      unitRef="U003">1</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="4"
      id="Fact_d7d01e9a6315408285f0c58e473c961e"
      unitRef="U008">8.8016</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="c20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="2"
      id="Fact_6f29d2c3b3b341309dceda5d20d03ce7"
      unitRef="U002">0.11</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_b50b89457cd6415e92f9209ef4b433d8"
      unitRef="U002">18000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c20230101to20231231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="INF"
      id="Fact_d59c84d4f1614edf81e3fbedc2ac21a0"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c20220101to20221231"
      decimals="INF"
      id="Fact_af48cf12d1c44390b2b9641e2fdad6b4"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="c20231231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="2"
      id="Fact_38cc6990ce9947d89efb791a637259a8"
      unitRef="U003">1</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="c20230101to20231231"
      id="Text_5e8fbae6b1184b969719cbe3a9c28eb5">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;17)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Income Taxes&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Loss before income taxes consist of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Domestic&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,654&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,513&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Foreign&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(17&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total loss before income taxes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,671&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,534&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;For each of the years ended December 31, 2023 and 2022, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Current Tax Provision&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Federal&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;State&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Foreign &lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;1&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Deferred Tax Provision&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Federal&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(2,155&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(6,851&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;State&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;8&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1,602&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Foreign &lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;(2&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(187&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(2,149&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(8,640&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Change in valuation allowance&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2,145&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;8,681&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total tax&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: -9.6px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: nowrap; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt; (benefit) &lt;/span&gt;provision for income taxes&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(3&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;45&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2023&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred Tax Assets:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Net operating losses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,740&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,382&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Foreign net operating losses&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;784&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;782&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Stock compensation&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,141&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,173&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;&#160; &#160; In-process research and development&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,009&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,233&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Capitalized rearch and development expenses&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;3,105&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1,502&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;R&amp;amp;D credit carryforwards&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;437&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;517&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Compensation accrual&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;81&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;ROU Liabilities&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;8,932&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;334&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Other&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;132&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;549&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total gross deferred tax assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;29,283&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,553&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Valuation allowance&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(18,302&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(16,157&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred tax assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,981&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;396&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred Tax Liabilities:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Fixed assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt;"&gt;ROU Assets&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(8,349&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(291&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt;"&gt;Convertible debt&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(2,507&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Intangibles - goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(179&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(160&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total deferred tax liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,041&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(461&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred taxes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(60&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(65&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;The reconciliation of computed expected
          income taxes to effective income taxes by applying the federal statutory rate of 21% is as follows:&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 27pt;"&gt;&#160;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2023&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax at federal income tax rate&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.00&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;21.00&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State income tax, net of federal tax&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.92&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;6.52&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Foreign tax differential&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(0.01&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(0.01&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-deductible expenses/excludable items&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(0.74&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;6.09&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in valuation allowance&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(9.90&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(35.38&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; font-size: 10pt;"&gt;Convertible debt&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(11.92&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;0.00&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;br/&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credits&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.00&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;0.98&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;Uncertain tax positions&lt;br/&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;0.00&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(0.49&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(3.34&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1.11&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Benefit (provision) for income taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.01&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;(0.18&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 18pt;"&gt;&#160; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The net increase in the total valuation allowance for the year ended December 31, 2023 was an increase of approximately $2.1
              million. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets
              is dependent upon the generation of future taxable income during periods in which those temporary difference become deductible. Management considered the scheduled reversal of deferred tax liabilities, projected future taxable income and
              planning strategies in making this assessment.&#160; Based on the level of historical operating results and projections for the taxable income for the future, management has determined that it is more likely than not that the deferred taxes assets
              will not be utilized. Accordingly, the Company has recorded a full valuation allowance. The net deferred tax liability represents an indefinite life intangible liability related to tax deductible goodwill, partially offset by an indefinite
              life deferred tax asset.&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;At December 31, 2023 and 2022, the Company has available net operating loss (&#x201c;NOL&#x201d;) carryforwards of approximately $48.4 million and $35.6 million for
          federal income tax purposes, respectively, of which approximately $48.4 million can be carried forward indefinitely. The Company has
          available $39.6 million and $28.8
          million state NOLs for the years ended December 31, 2023 and 2022, respectively. The Company also has foreign NOL carryforwards of approximately $6.3
          million for each of the years ended December 31, 2023 and 2022, which carry forward indefinitely. Section 382 of the Internal Revenue Code (&#x201c;IRC&#x201d;) imposes limits on the ability to use NOL carryforwards that existed prior to a change in control to
          offset future taxable income. Such limitations would reduce, potentially significantly, the gross deferred tax assets disclosed in the table above related to the NOL carryforwards.&#160; The Company continues to disclose the NOL carryforwards at their
          original amount in the table above as no potential limitation has been quantified. The Company has also established a full valuation allowance for all deferred tax assets, including the NOL carryforwards, since the Company could not conclude that
          it was more likely than not able to generate future taxable income to realize these assets.&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;At December 31, 2023 and 2022 the Company has federal and state income tax credit carryforwards of approximately $0.4 million and $0.5 million,
          respectively. The credits begin to expire in 2041.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;In accordance with authoritative guidance, the impact of an uncertain income tax position on the income tax return must be
          recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt; 2023&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt;2022&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Beginning balance of uncertain tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;121&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Additions based on current year&#x2019;s tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;45&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Net changes based on prior year&#x2019;s tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;272&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;76&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Ending balance of uncertain tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;393&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;121&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
           &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;It
          is reasonably possible that unrecognized tax benefits may increase or decrease within the next twelve months due to tax examination changes, expiration of statute of limitations, or changes in tax law.&#160; The Company does not anticipate any
          significant changes to unrecognized tax benefits over the next 12 months. &lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The Company recognizes interest and penalties related to unrecognized tax positions within the income tax expense line in the
          accompanying consolidated statements of operations. There were no accrued interest and penalties associated with uncertain tax
          positions as of December 31, 2023 or December 31, 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;The Company is subject to U.S. federal, state, and foreign income tax. The Company&#x2019;s income tax returns are subject to
          examination by the relevant taxing authorities. As of December 31, 2023, the &lt;span style="-sec-ix-hidden:Fact_27587e86962c450fb8de5335527ed5c8"&gt;2020 &#x2013; 2023&lt;/span&gt; tax years remain subject to examination in
          the U.S. federal tax, various state, and foreign tax jurisdictions. The Company is not currently under examination by federal state, or foreign jurisdictions.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On August 16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;IRA&#x201d;) was enacted into law. Among other changes to the tax code, the IRA imposes a 1% excise tax on
            certain repurchases of corporate stock by certain publicly traded corporations. The 1% stock buyback tax applies to redemptions by domestic corporations occurring in taxable years beginning after December 31, 2022.&#160; A number of exceptions to
            the stock buyback tax are available including exceptions to certain reorganizations. However, while these exceptions may be helpful in limiting the application of the stock buyback tax in situations in which it was not intended to apply, more
            guidance will be necessary for taxpayers to analyze the potential application of these exceptions and whether they will be able to rely upon them.&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;
</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_a3f4ee5e0f204eb396b5a3cc7b336925">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Loss before income taxes consist of the following (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2023&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; text-indent: 9pt; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Domestic&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,654&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,513&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Foreign&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(17&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total loss before income taxes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,671&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,534&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_53e8570e004442f48fccf62adcc8537a"
      unitRef="U001">-21654000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f002bcfcce3a4d9ca59b3c9ac9616e20"
      unitRef="U001">-24513000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_fa4a3c646ea44b93901dcf6348c85396"
      unitRef="U001">-17000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_4ab33e32816543449c58ffd81a37f87b"
      unitRef="U001">-21000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_4c5445cfc7d740beb0076926e5debc44"
      unitRef="U001">-21671000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_6f439a6b502649b790f816ad04813f2c"
      unitRef="U001">-24534000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_d7cc4244179e400cafb6c5f814b5ad21">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;For each of the years ended December 31, 2023 and 2022, current tax provisions and current deferred tax provisions were
        recorded as follows (in thousands):&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Years ended December 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2023&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Current Tax Provision&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Federal&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;State&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;4&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Foreign &lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;1&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;4&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Deferred Tax Provision&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;Federal&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(2,155&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(6,851&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); margin-left: 9pt;"&gt;State&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;8&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(1,602&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="margin-left: 9pt;"&gt;Foreign &lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;(2&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(187&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(2,149&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;(8,640&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Change in valuation allowance&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2,145&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;8,681&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;Total tax&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: -9.6px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: nowrap; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt; (benefit) &lt;/span&gt;provision for income taxes&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(3&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;45&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_70d2a2da040d495ea5d87d7dcaf75fa6"
      unitRef="U001">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_99d588a3ac9e4192a58bbb1fd35d91de"
      unitRef="U001">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_b6f39c6ffc6442d68a42bedabe46755c"
      unitRef="U001">1000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_e2f4cdd1889b4b8e9fc7e5628342a050"
      unitRef="U001">4000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_088cd547e63743f88cfec3165211d3bc"
      unitRef="U001">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_4ba1aa3ea4094cbdb26a78acf044e430"
      unitRef="U001">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_733b0859eb7749ccbd18d33c2d48efd1"
      unitRef="U001">1000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_36300791f16047fd9dcbd3db15a47afe"
      unitRef="U001">4000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_9cb8e8faec3747fab4599926b7350477"
      unitRef="U001">-2155000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_bd733ae8decc4215a037eac8c5bc7410"
      unitRef="U001">-6851000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_701a5f0dd44e4129af5dfed079450aec"
      unitRef="U001">8000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_8d154d7ed66141a8bc39b69d74114a28"
      unitRef="U001">-1602000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_84d2cd7b7642419096cad5cb2f8ad31b"
      unitRef="U001">-2000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_05854b2c08f648b19caa0f3967b01b01"
      unitRef="U001">-187000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_e1c52032fe2049a993807dd85ac6ae6a"
      unitRef="U001">-2149000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_fe90d234ba4e473fa875132ff9c29eb3"
      unitRef="U001">-8640000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_24c52b99e3204a61935c142c375c2f3a"
      unitRef="U001">2145000</erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount>
    <erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_6add53ef7eca4eb095217b8cf84f87f0"
      unitRef="U001">8681000</erna:EffectiveIncomeTaxRateReconciliationDecreaseInDeferredTaxAssetsValuationAllowanceAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_c6731f716646404bbe16cc6d7d4aba02"
      unitRef="U001">-3000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_a2e909324a3f4175b44a9061048b6dde"
      unitRef="U001">45000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_ef8831b411254551aae495607bc6a985">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Deferred tax assets and liabilities
        consist of the effects of temporary differences as shown in the table below (in thousands). Deferred tax assets have been fully reserved by a valuation allowance since it is more likely than not that such tax benefits will not be realized.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;
        &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2023&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2022&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred Tax Assets:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Net operating losses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,740&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,382&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Foreign net operating losses&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;784&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;782&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Stock compensation&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,141&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,173&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;&#160; &#160; In-process research and development&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,009&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,233&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Capitalized rearch and development expenses&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;3,105&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1,502&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;R&amp;amp;D credit carryforwards&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;437&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;517&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Compensation accrual&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;81&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; text-indent: 9pt; margin-left: 9pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;ROU Liabilities&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;8,932&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;334&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&#160;&#160; Other&lt;br/&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;132&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;549&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total gross deferred tax assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;29,283&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,553&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Valuation allowance&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(18,302&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(16,157&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred tax assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,981&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;396&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred Tax Liabilities:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Fixed assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt;"&gt;ROU Assets&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(8,349&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(291&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="margin-left: 9pt;"&gt;Convertible debt&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(2,507&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;-&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;"&gt;Intangibles - goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(179&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(160&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total deferred tax liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,041&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(461&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred taxes&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(60&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(65&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;
</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign
      contextRef="c20231231"
      decimals="-3"
      id="Fact_fbcae8302d39444a9f1df1e6fbfd6326"
      unitRef="U001">12740000</erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign>
    <erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign
      contextRef="c20221231"
      decimals="-3"
      id="Fact_af2fca773048408aa331c9a67fd2e123"
      unitRef="U001">9382000</erna:DeferredTaxAssetsOperatingLossCarryforwardsExcludingForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="c20231231"
      decimals="-3"
      id="Fact_5c920b295c0f4bd9afbf145307630c44"
      unitRef="U001">784000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="c20221231"
      decimals="-3"
      id="Fact_5734d52ca19b4d77be8b97fd0b1e98f8"
      unitRef="U001">782000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="c20231231"
      decimals="-3"
      id="Fact_0cc4157665044a3b94b82a5e5b28ae46"
      unitRef="U001">2141000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="c20221231"
      decimals="-3"
      id="Fact_1622c186ddcb4a57890fae86376de3cf"
      unitRef="U001">2173000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="c20231231"
      decimals="-3"
      id="Fact_094b0431b0c84f5295533c40579dd103"
      unitRef="U001">1009000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="c20221231"
      decimals="-3"
      id="Fact_15cfece8f1dc4892b7ec8aeec6608956"
      unitRef="U001">1233000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
      contextRef="c20231231"
      decimals="-3"
      id="Fact_ad04a66c37604ec0bf9554cf9d19619c"
      unitRef="U001">3105000</erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
      contextRef="c20221231"
      decimals="-3"
      id="Fact_01e5b2b0ad234c6b8feff94f9c3cde32"
      unitRef="U001">1502000</erna:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="c20231231"
      decimals="-3"
      id="Fact_b7edab38f0dc45cf9cec94dec6968608"
      unitRef="U001">437000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="c20221231"
      decimals="-3"
      id="Fact_42f8b9e4a7f94907b0da38528f6d660f"
      unitRef="U001">517000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
      contextRef="c20231231"
      decimals="-3"
      id="Fact_4e93e505f0f04d3ea7e00468691da907"
      unitRef="U001">3000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
      contextRef="c20221231"
      decimals="-3"
      id="Fact_2d0852e8ccaa4469950616359521a80d"
      unitRef="U001">81000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <erna:DeferredTaxAssetsRightOfUseLiabilities
      contextRef="c20231231"
      decimals="-3"
      id="Fact_b2842311b2704cfe8f64ae89eb5cd3b4"
      unitRef="U001">8932000</erna:DeferredTaxAssetsRightOfUseLiabilities>
    <erna:DeferredTaxAssetsRightOfUseLiabilities
      contextRef="c20221231"
      decimals="-3"
      id="Fact_dc2838b4826b4c75833c86a9bdf8e248"
      unitRef="U001">334000</erna:DeferredTaxAssetsRightOfUseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="c20231231"
      decimals="-3"
      id="Fact_e28129e25cb4453cbe6324f86831ae00"
      unitRef="U001">132000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="c20221231"
      decimals="-3"
      id="Fact_bb7e286556eb4a82a8831fab082361c3"
      unitRef="U001">549000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20231231"
      decimals="-3"
      id="Fact_a525d9bddd774d3e9a9ce73fac74661e"
      unitRef="U001">29283000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20221231"
      decimals="-3"
      id="Fact_42b2a6d38446474eac2b0c5a665b2ba4"
      unitRef="U001">16553000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="c20231231"
      decimals="-3"
      id="Fact_66c39894ad95420e9e5a6c71971a445a"
      unitRef="U001">18302000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="c20221231"
      decimals="-3"
      id="Fact_cab17b49bc904a3caa002cad40db56e9"
      unitRef="U001">16157000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="c20231231"
      decimals="-3"
      id="Fact_26a5bb274fe24cf7a5606b93cf47bb8b"
      unitRef="U001">10981000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="c20221231"
      decimals="-3"
      id="Fact_c5165ecef17f4a3c82b4624a3fa97e68"
      unitRef="U001">396000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c20231231"
      decimals="-3"
      id="Fact_c276f1a16e4f4a1c85c103499ab90e2d"
      unitRef="U001">6000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c20221231"
      decimals="-3"
      id="Fact_89fe0b6f35e44e69b299d276c5a1c5c6"
      unitRef="U001">10000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <erna:DeferredTaxAssetsRightOfUseAssets
      contextRef="c20231231"
      decimals="-3"
      id="Fact_dd030c9fbe0649918d8344c5db31aaff"
      unitRef="U001">8349000</erna:DeferredTaxAssetsRightOfUseAssets>
    <erna:DeferredTaxAssetsRightOfUseAssets
      contextRef="c20221231"
      decimals="-3"
      id="Fact_07e7bc44d6af4bc7b985344772e3ca3c"
      unitRef="U001">291000</erna:DeferredTaxAssetsRightOfUseAssets>
    <erna:DeferredTaxLiabilitiesConvertibleDebt
      contextRef="c20231231"
      decimals="-3"
      id="Fact_7b569752e1394fe8bb89734ff41412dc"
      unitRef="U001">2507000</erna:DeferredTaxLiabilitiesConvertibleDebt>
    <erna:DeferredTaxLiabilitiesConvertibleDebt
      contextRef="c20221231"
      decimals="-3"
      id="Fact_36254028792c4fd6afcd2d2eb27c3ead"
      unitRef="U001">0</erna:DeferredTaxLiabilitiesConvertibleDebt>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="c20231231"
      decimals="-3"
      id="Fact_a6c69466751e4ea4b8841b3f29eb8241"
      unitRef="U001">179000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="c20221231"
      decimals="-3"
      id="Fact_9d386fea452f4c0494fb0b52940bd460"
      unitRef="U001">160000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20231231"
      decimals="-3"
      id="Fact_fcab8052a7394801a9dba056fc16dfb1"
      unitRef="U001">11041000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20221231"
      decimals="-3"
      id="Fact_8a9e838a302f4c84b20958eaaae3d469"
      unitRef="U001">461000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="c20231231"
      decimals="-3"
      id="Fact_fe64122a961a4f8e9decb92c197072b2"
      unitRef="U001">60000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="c20221231"
      decimals="-3"
      id="Fact_b78854d5bd7a4f1e92f703bfa946d4df"
      unitRef="U001">65000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_b153d71df5ac49be98073b30e08b0673">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;The reconciliation of computed expected
          income taxes to effective income taxes by applying the federal statutory rate of 21% is as follows:&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 27pt;"&gt;&#160;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2023&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax at federal income tax rate&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.00&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;21.00&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;State income tax, net of federal tax&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.92&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;6.52&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Foreign tax differential&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(0.01&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(0.01&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-deductible expenses/excludable items&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(0.74&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;6.09&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in valuation allowance&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(9.90&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;(35.38&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; font-size: 10pt;"&gt;Convertible debt&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(11.92&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;0.00&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;br/&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credits&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.00&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;0.98&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;Uncertain tax positions&lt;br/&gt;
                &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;0.00&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(0.49&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(3.34&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;1.11&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;%&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Benefit (provision) for income taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.01&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;(0.18&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;%)&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;
</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20220101to20221231"
      decimals="2"
      id="Fact_cc4f0aaf9a64487ba33b93135ec4437b"
      unitRef="U008">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20230101to20231231"
      decimals="2"
      id="Fact_9e366c8b7f064d6f9930129f8619cb6a"
      unitRef="U008">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_d031fc75908544e6920f9e16590c5f23"
      unitRef="U008">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_bcda68a636c0440e92d65620971dff88"
      unitRef="U008">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_62bf5bf3c4534bfdbf7d334b7cb50da5"
      unitRef="U008">0.0492</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_5ff7a8f33ba94d69a58c8ac0a8944d5d"
      unitRef="U008">0.0652</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_c5f46f2aec52408f805fd66ee5c22df5"
      unitRef="U008">-0.0001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_1c669490b0eb49d8816556bd6b7e30cf"
      unitRef="U008">-0.0001</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_748d9bf9f9d4473c8a29890077e27b92"
      unitRef="U008">-0.0074</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_16289f9d5fe849e68d5ace321d033f34"
      unitRef="U008">0.0609</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_12d534bf65104c599bee15c408865a9b"
      unitRef="U008">-0.099</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_cdf2e58e411c46e69db149f2b3653d3a"
      unitRef="U008">-0.3538</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <erna:EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_1d1dce816bfc499cba563731c2c7afad"
      unitRef="U008">-0.1192</erna:EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent>
    <erna:EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_7482e752a58e45d7b89a95c2587cfd54"
      unitRef="U008">0</erna:EffectiveIncomeTaxRateReconciliationConvertibleDebtPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_8d2d6e690b534e04aa513d70ff6c2370"
      unitRef="U008">-0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_9af8fe879f2a40208531b0a95feac95d"
      unitRef="U008">-0.0098</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_24ade2eb582f44e7b884088f36d63b32"
      unitRef="U008">-0</erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent>
    <erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_0d678c8921084dc090544be8897901c0"
      unitRef="U008">0.0049</erna:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_433bce862e054350b09482b9fb34d5b0"
      unitRef="U008">-0.0334</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_b0ea1633840c437cb0dfaa9da3eef24b"
      unitRef="U008">0.0111</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20230101to20231231"
      decimals="4"
      id="Fact_d2346fe2d6b743d38a106434fe2d894f"
      unitRef="U008">0.0001</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20220101to20221231"
      decimals="4"
      id="Fact_33863b6376cc410ca3002cbdcc3ffb05"
      unitRef="U008">-0.0018</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="c20230101to20231231"
      decimals="-5"
      id="Fact_91f7f47bfdd54b7ba867f0d9ce75900f"
      unitRef="U001">2100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20231231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-5"
      id="Fact_7d9fcadabadb4f7a912e97e50432d539"
      unitRef="U001">48400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20221231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-5"
      id="Fact_694a5cfd1b8b4e149cff27a295d4ab1d"
      unitRef="U001">35600000</us-gaap:OperatingLossCarryforwards>
    <erna:TaxCutsAndJobsActOperatingLossCarryforwards
      contextRef="c20231231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-5"
      id="Fact_64758985433d48c1b11b416657503a83"
      unitRef="U001">48400000</erna:TaxCutsAndJobsActOperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20231231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fact_f52a78802c24402db3d95878bf2be637"
      unitRef="U001">39600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20221231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fact_72d306fc9fdf48cdbc682e92c5af5228"
      unitRef="U001">28800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20231231_IncomeTaxAuthorityAxis_ForeignCountryMember"
      decimals="-5"
      id="Fact_485e87102945479c99368baad0e2f104"
      unitRef="U001">6300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20221231_IncomeTaxAuthorityAxis_ForeignCountryMember"
      decimals="-5"
      id="Fact_3b09c0398b6f431d89555d6509c34a82"
      unitRef="U001">6300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="c20231231"
      decimals="-5"
      id="Fact_22b5dcf9110f4a6b80aed42b8002f694"
      unitRef="U001">400000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="c20221231"
      decimals="-5"
      id="Fact_1ca5275642f2404589762c19cb21b5ae"
      unitRef="U001">500000</us-gaap:TaxCreditCarryforwardAmount>
    <erna:TaxCreditCarryforwardExpirationYear
      contextRef="c20230101to20231231"
      id="Fact_b115f536acc648369d24724295acbf67">2041</erna:TaxCreditCarryforwardExpirationYear>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="c20230101to20231231"
      id="Text_415d751357954ea8bbe74b54f23b1d54">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table summarizes amounts the
          Company recorded for uncertain tax positions as of December 31, 2023 and 2022 (in thousands):&lt;/span&gt;
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of December 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt; 2023&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; font-weight: bold;"&gt;2022&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Beginning balance of uncertain tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;121&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Additions based on current year&#x2019;s tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;45&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Net changes based on prior year&#x2019;s tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;272&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;76&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;Ending balance of uncertain tax positions&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;393&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0);"&gt;121&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
           &lt;/div&gt;
</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c20221231"
      decimals="-3"
      id="Fact_51ad6c90bf8842928b2d5d064a1413c1"
      unitRef="U001">121000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c20211231"
      decimals="-3"
      id="Fact_45baee6807154964ab9f26b384f217f2"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_cd6b3263f97f45d79187030fac79c46d"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_757c23886ecd42c5af2590ecaacb2487"
      unitRef="U001">45000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="c20230101to20231231"
      decimals="-3"
      id="Fact_c24bcf9531db4279a3327e7d129dc75f"
      unitRef="U001">272000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="c20220101to20221231"
      decimals="-3"
      id="Fact_f99e0d4475de4f0abe20d7eca0fcf3de"
      unitRef="U001">76000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c20231231"
      decimals="-3"
      id="Fact_3b4037b3f1cf4e84bfc8f07e119c1082"
      unitRef="U001">393000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c20221231"
      decimals="-3"
      id="Fact_63ce6acce11642acb339d33ca7e6e9cd"
      unitRef="U001">121000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20231231"
      decimals="0"
      id="Fact_c2b1d15039d8444c88355b499ed8d11e"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20221231"
      decimals="0"
      id="Fact_27ebddd7407944e68de4ba4d387c0a83"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="c20230101to20231231"
      id="Text_70b25e83691d4a44b87beca2cb618a2c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 35.9pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;18)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;Subsequent Event&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.2pt; margin-left: 0.2pt; font-style: italic;"&gt;CEO Inducement Grant&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;&lt;span style="font-size: 10pt;"&gt;On January 1, 2024, Sanjeev Luther was appointed as President, Chief Executive Officer and a director of the Company. Upon his appointment, he was granted
            a non-qualified stock option to purchase approximately 1,685,000 shares of the Company&#x2019;s common stock. The stock option has an
            exercise price of $1.80 per share, which was equal to the fair market value of the Company&#x2019;s common stock on the date of grant, will
            vest over four years, with 25%
            of the shares vesting on the first anniversary of the grant date and the remaining 75% of the shares vesting in equal monthly installments over the three years
            thereafter, in each case, subject to continued service. The stock option was granted pursuant to the terms of Mr. Luther&#x2019;s employment agreement and as a material inducement to his joining the Company in accordance with Nasdaq Listing Rule
            5635(c)(4).&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; margin-right: 0.2pt; margin-left: 0.2pt; font-style: italic;"&gt;Remaining Funding Received from December
          2023 Financing&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;On January 11, 2024, the second and final
          closing of the December 2023 convertible note financing occurred. At this closing, the Company received approximately $1.4 million and
          issued an aggregate of $1.4 million of December 2023 convertible notes and note warrants to purchase approximately 1.5 million shares of common stock.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; word-spacing: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.4pt; margin-left: 0.4pt;"&gt;The December 2023 convertible notes
          issued on January 11, 2024 have the same terms as those issued on December 15, 2023, except that the one issued on January 11, 2024 expire on January 11, 2029. The note warrants issued on January 11, 2024 have the same terms as the note warrants issued on December 15, 2023, except that the one issued on January 11, 2024 expire on January 11, 2029. See Note 6 for more information regarding the December 2023 convertible note financing, the December 2023 convertible notes and the note warrants.&lt;/div&gt;
</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember"
      decimals="0"
      id="Fact_55dbcd9bb3d54cd89c7a36f4a4910543"
      unitRef="U002">1685000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember"
      decimals="2"
      id="Fact_bcf227d7f17a446194a8ed7747e6f2aa"
      unitRef="U003">1.8</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember"
      id="Fact_bfd5d72d016541b1a7fe607c0ab0c2b3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"
      decimals="2"
      id="Fact_3273a08432344abdac1517f0ca97a467"
      unitRef="U008">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember"
      decimals="2"
      id="Fact_0a994114f7f74815b08efc666414c80c"
      unitRef="U008">0.75</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment
      contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember"
      id="Fact_8d1f9d607967471cada98b0141ef75fd">monthly</erna:ShareBasedCompensationArrangementByShareBasedPaymentAwardFrequencyOfPeriodicInstallment>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20240101to20240101_AwardTypeAxis_NonQualifiedStockOptionMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_PresidentChiefExecutiveOfficerAndDirectorMember_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember"
      id="Fact_3db61c96148b465cac40dfbf9e198a89">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c20240111to20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_3d6406fcd10e4a7a9f2c708620409bd0"
      unitRef="U001">1400000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_3aa56454ae1c48809499116dd6ffb00f"
      unitRef="U001">1400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20240111_ClassOfWarrantOrRightAxis_WarrantMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_7e668534fb8f4de6a47f05b6cdeb8a34"
      unitRef="U002">1500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20240111to20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember"
      id="Fact_619450d195814d1ba2e3125218e1c850">2029-01-11</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20240111to20240111_LongtermDebtTypeAxis_December2023ConvertibleNotesMember_SubsequentEventTypeAxis_SubsequentEventMember"
      id="Fact_873269ecba5240e4baf59725ccc53248">2029-01-11</us-gaap:DebtInstrumentMaturityDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
